Psyllid ID: psy16430
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 600 | 2.2.26 [Sep-21-2011] | |||||||
| Q1HKZ5 | 959 | Mitogen-activated protein | yes | N/A | 0.575 | 0.359 | 0.649 | 1e-134 | |
| Q60700 | 888 | Mitogen-activated protein | no | N/A | 0.573 | 0.387 | 0.634 | 1e-134 | |
| Q12852 | 859 | Mitogen-activated protein | yes | N/A | 0.573 | 0.400 | 0.634 | 1e-134 | |
| O43283 | 966 | Mitogen-activated protein | no | N/A | 0.575 | 0.357 | 0.646 | 1e-134 | |
| Q63796 | 888 | Mitogen-activated protein | no | N/A | 0.573 | 0.387 | 0.634 | 1e-133 | |
| Q5R8X7 | 966 | Mitogen-activated protein | no | N/A | 0.575 | 0.357 | 0.643 | 1e-133 | |
| A7J1T2 | 961 | Mitogen-activated protein | N/A | N/A | 0.575 | 0.359 | 0.643 | 1e-133 | |
| A7MBB4 | 966 | Mitogen-activated protein | no | N/A | 0.575 | 0.357 | 0.643 | 1e-132 | |
| A7J1T0 | 961 | Mitogen-activated protein | N/A | N/A | 0.575 | 0.359 | 0.643 | 1e-132 | |
| A8X775 | 857 | Mitogen-activated protein | N/A | N/A | 0.571 | 0.400 | 0.456 | 1e-88 |
| >sp|Q1HKZ5|M3K13_MOUSE Mitogen-activated protein kinase kinase kinase 13 OS=Mus musculus GN=Map3k13 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 479 bits (1232), Expect = e-134, Method: Compositional matrix adjust.
Identities = 226/348 (64%), Positives = 282/348 (81%), Gaps = 3/348 (0%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 157 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 216
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 217 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 276
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 277 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 336
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 337 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 396
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E
Sbjct: 397 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDEEL--- 453
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+ELLK
Sbjct: 454 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELLK 501
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q60700|M3K12_MOUSE Mitogen-activated protein kinase kinase kinase 12 OS=Mus musculus GN=Map3k12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1230), Expect = e-134, Method: Compositional matrix adjust.
Identities = 220/347 (63%), Positives = 279/347 (80%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D WE+PFE I DLQW+GSGAQGAVF G+ E VAVKKVR+ KETDI+HLRKL HPNI+
Sbjct: 149 DLWEVPFEEILDLQWVGSGAQGAVFLGRFHGEEVAVKKVRDLKETDIKHLRKLKHPNIIT 208
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+CA G LY +L+ G V P L +W+ IA GMNYLH +IIHR
Sbjct: 209 FKGVCTQAPCYCILMEFCAQGQLYEVLRAGRPVTPSLLVDWSMGIAGGMNYLHLHKIIHR 268
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPN+LI + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIWS
Sbjct: 269 DLKSPNMLITYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIWS 328
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PS+CPDGF++L++ CW++ P +RP
Sbjct: 329 FGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSSCPDGFKILLRQCWNSKPRNRP 388
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SF+QIL HLDIAS +VL E Y+K Q W+EE+++H ++++ + + + EE +L+
Sbjct: 389 SFRQILLHLDIASADVLSTPQETYFKSQAEWREEVKLHFEKIKSEGTCLHRLEE---ELV 445
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
+R EL+HA D+REHYERKLERAN LY+EL+A+ + L+ +E+ELL+
Sbjct: 446 MRRREELRHALDIREHYERKLERANNLYMELNALMLQLELKERELLR 492
|
May be an activator of the JNK/SAPK pathway. Phosphorylates beta-casein, histone 1 and myelin basic protein in vitro. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q12852|M3K12_HUMAN Mitogen-activated protein kinase kinase kinase 12 OS=Homo sapiens GN=MAP3K12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 478 bits (1229), Expect = e-134, Method: Compositional matrix adjust.
Identities = 220/347 (63%), Positives = 279/347 (80%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D WE+PFE I DLQW+GSGAQGAVF G+ E VAVKKVR+ KETDI+HLRKL HPNI+
Sbjct: 116 DLWEVPFEEILDLQWVGSGAQGAVFLGRFHGEEVAVKKVRDLKETDIKHLRKLKHPNIIT 175
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+CA G LY +L+ G V P L +W+ IA GMNYLH +IIHR
Sbjct: 176 FKGVCTQAPCYCILMEFCAQGQLYEVLRAGRPVTPSLLVDWSMGIAGGMNYLHLHKIIHR 235
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPN+LI + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIWS
Sbjct: 236 DLKSPNMLITYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIWS 295
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PS+CPDGF++L++ CW++ P +RP
Sbjct: 296 FGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSSCPDGFKILLRQCWNSKPRNRP 355
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SF+QIL HLDIAS +VL E Y+K Q W+EE+++H ++++ + + + EE +L+
Sbjct: 356 SFRQILLHLDIASADVLSTPQETYFKSQAEWREEVKLHFEKIKSEGTCLHRLEE---ELV 412
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
+R EL+HA D+REHYERKLERAN LY+EL+A+ + L+ +E+ELL+
Sbjct: 413 MRRREELRHALDIREHYERKLERANNLYMELNALMLQLELKERELLR 459
|
May be an activator of the JNK/SAPK pathway. Phosphorylates beta-casein, histone 1 and myelin basic protein in vitro. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O43283|M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1229), Expect = e-134, Method: Compositional matrix adjust.
Identities = 225/348 (64%), Positives = 282/348 (81%), Gaps = 3/348 (0%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDEEL--- 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELIK 502
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q63796|M3K12_RAT Mitogen-activated protein kinase kinase kinase 12 OS=Rattus norvegicus GN=Map3k12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1228), Expect = e-133, Method: Compositional matrix adjust.
Identities = 220/347 (63%), Positives = 278/347 (80%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D WE+PFE I DLQW+GSGAQGAVF G+ E VAVKKVR+ KETDI+HLRKL HPNI+
Sbjct: 149 DLWEVPFEEILDLQWVGSGAQGAVFLGRFHGEEVAVKKVRDLKETDIKHLRKLKHPNIIT 208
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+CA G LY +L+ G V P L +W+ IA GMNYLH +IIHR
Sbjct: 209 FKGVCTQAPCYCILMEFCAQGQLYEVLRAGRPVTPSLLVDWSMGIAGGMNYLHLHKIIHR 268
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPN+LI + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIWS
Sbjct: 269 DLKSPNMLITYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIWS 328
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PS+CPDGF++L++ CW+ P +RP
Sbjct: 329 FGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSSCPDGFKILLRQCWNRKPRNRP 388
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SF+QIL HLDIAS +VL E Y+K Q W+EE+++H ++++ + + + EE +L+
Sbjct: 389 SFRQILLHLDIASADVLSTPQETYFKSQAEWREEVKLHFEKIKSEGTCLHRLEE---ELV 445
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
+R EL+HA D+REHYERKLERAN LY+EL+A+ + L+ +E+ELL+
Sbjct: 446 MRRREELRHALDIREHYERKLERANNLYMELNALMLQLELKERELLR 492
|
May be an activator of the JNK/SAPK pathway. Phosphorylates beta-casein, histone 1 and myelin basic protein in vitro. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q5R8X7|M3K13_PONAB Mitogen-activated protein kinase kinase kinase 13 OS=Pongo abelii GN=MAP3K13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1224), Expect = e-133, Method: Compositional matrix adjust.
Identities = 224/348 (64%), Positives = 282/348 (81%), Gaps = 3/348 (0%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAW+APEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWLAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDEEL--- 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELVK 502
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A7J1T2|M313A_XENLA Mitogen-activated protein kinase kinase kinase 13-A OS=Xenopus laevis GN=map3k13-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 224/348 (64%), Positives = 283/348 (81%), Gaps = 3/348 (0%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
++ WE+PFE IS+LQWLGSGAQGAVF GK R E VA+KKVREQKETDI+HLRKL HPNI+
Sbjct: 159 QETWEVPFEEISELQWLGSGAQGAVFLGKFRGEEVAIKKVREQKETDIKHLRKLKHPNII 218
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYC++MEYCA+G LY +L+ G +V P+ L +W+ IA+GMNYLH +IIH
Sbjct: 219 AFKGVCTQAPCYCLIMEYCAHGQLYEVLRAGRKVSPRLLVDWSNGIASGMNYLHLHKIIH 278
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 279 RDLKSPNVLVTHTDTVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 338
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G++LWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 339 SFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWHSKPRNR 398
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+QIL HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E
Sbjct: 399 PSFRQILMHLDIASADVLGTPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDEEL--- 455
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL++
Sbjct: 456 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEVREKELIR 503
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A7MBB4|M3K13_BOVIN Mitogen-activated protein kinase kinase kinase 13 OS=Bos taurus GN=MAP3K13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-132, Method: Compositional matrix adjust.
Identities = 224/348 (64%), Positives = 281/348 (80%), Gaps = 3/348 (0%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKTRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDEEL--- 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELIK 502
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis GN=map3k13-b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 224/348 (64%), Positives = 280/348 (80%), Gaps = 3/348 (0%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R E VA+KKVREQKETDI+HLRKL HPNI+
Sbjct: 161 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRGEEVAIKKVREQKETDIKHLRKLKHPNII 220
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA G LY +L+ G +V P+ L W+ IA+GMNYLH +IIH
Sbjct: 221 AFKGVCTQAPCYCILMEYCAQGQLYEVLRAGRKVTPKLLVEWSTGIASGMNYLHLHKIIH 280
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 281 RDLKSPNVLVTHADTVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 340
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G++LWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 341 SFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 400
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+QIL HLDIA+ +VL E Y+K Q W+EE++ H ++++ + + + +E
Sbjct: 401 PSFRQILMHLDIAAADVLGTPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDEEL--- 457
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELS++ + L+ RE+EL +
Sbjct: 458 IRRRREELRHALDIREHYERKLERANNLYMELSSIMLQLEVREKELTR 505
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A8X775|DLK1_CAEBR Mitogen-activated protein kinase kinase kinase dlk-1 OS=Caenorhabditis briggsae GN=dlk-1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 158/346 (45%), Positives = 227/346 (65%), Gaps = 3/346 (0%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFK 315
WEIPF++IS+L+WLGSG+QGAVF G+ + VAVKKV + KET+I+HLR L H NI++F
Sbjct: 55 WEIPFDAISNLEWLGSGSQGAVFHGQYENRTVAVKKVNQLKETEIKHLRHLRHKNIIEFL 114
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
GVC+++PCYCIVMEYC G L +L+ + Q +W ++IA GM+YLH ++IHRDL
Sbjct: 115 GVCSKSPCYCIVMEYCPKGQLCTVLRQKNLITRQMFSDWVKEIADGMHYLHQNKVIHRDL 174
Query: 376 KSPNVLIGSKEEAKISDFGTCR-EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
KSPN+LI +++ KI DFGT + N ST MSF GTV+WMAPE+I+ E C++K+D++S+
Sbjct: 175 KSPNILISAEDSIKICDFGTSHLQKKNDSTMMSFCGTVSWMAPEMIKKEPCNEKVDVYSF 234
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
G+VLWE+LT ETPY ++ AII+GVG++ L+LP+P P G LL+K C S +RPS
Sbjct: 235 GVVLWEMLTRETPYANIAQMAIIFGVGTNILNLPMPEEAPRGLVLLIKQCLSQKGRNRPS 294
Query: 495 FKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEF--EDDL 552
F I H +I E+ + + + ++E + K H F E+++
Sbjct: 295 FSHIRQHWEIFKPELFEMTEDEWQVAWDSYREFAKAIQYPSTVTKDHGGPKSAFAMEEEM 354
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQEL 598
+KR +L H +D+R YE KL+R N++Y +L L +E EL
Sbjct: 355 QRKRHEQLNHIKDIRHMYEAKLKRTNKMYDKLQGCFTELKLKEHEL 400
|
Component of a MAP kinase pathway that functions presynaptically to regulate synaptic architecture and presynaptic differentiation. Phosphorylates and activates mkk-4. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 600 | ||||||
| 328708441 | 719 | PREDICTED: mitogen-activated protein kin | 0.615 | 0.513 | 0.736 | 1e-167 | |
| 328708443 | 707 | PREDICTED: mitogen-activated protein kin | 0.615 | 0.521 | 0.736 | 1e-167 | |
| 307213536 | 919 | Mitogen-activated protein kinase kinase | 0.573 | 0.374 | 0.711 | 1e-152 | |
| 340716306 | 900 | PREDICTED: mitogen-activated protein kin | 0.573 | 0.382 | 0.717 | 1e-152 | |
| 380018079 | 896 | PREDICTED: mitogen-activated protein kin | 0.573 | 0.383 | 0.717 | 1e-152 | |
| 328785797 | 897 | PREDICTED: mitogen-activated protein kin | 0.573 | 0.383 | 0.717 | 1e-151 | |
| 340716304 | 879 | PREDICTED: mitogen-activated protein kin | 0.573 | 0.391 | 0.717 | 1e-151 | |
| 383858451 | 863 | PREDICTED: mitogen-activated protein kin | 0.573 | 0.398 | 0.714 | 1e-151 | |
| 345496601 | 951 | PREDICTED: mitogen-activated protein kin | 0.66 | 0.416 | 0.596 | 1e-146 | |
| 322792005 | 811 | hypothetical protein SINV_01119 [Solenop | 0.593 | 0.438 | 0.671 | 1e-144 |
| >gi|328708441|ref|XP_003243688.1| PREDICTED: mitogen-activated protein kinase kinase kinase 13-A-like isoform 2 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 594 bits (1532), Expect = e-167, Method: Compositional matrix adjust.
Identities = 277/376 (73%), Positives = 321/376 (85%), Gaps = 7/376 (1%)
Query: 229 WYKNRL-CFPTSLMARIGEFKSFVLR---DEWEIPFESISDLQWLGSGAQGAVFSGKLRS 284
W+ L C L +G+ S L+ D W+IPFESISDLQWLGSGAQGAVFSGKL++
Sbjct: 71 WFDGWLGCLKPMLGGIMGKGNSHDLKSYQDNWDIPFESISDLQWLGSGAQGAVFSGKLKN 130
Query: 285 EIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE 344
EIVAVKKVREQKETDIRHLRKLNHPNIV+FKGVCTQAPCYCIVMEYC YGPLYNLL+DGE
Sbjct: 131 EIVAVKKVREQKETDIRHLRKLNHPNIVQFKGVCTQAPCYCIVMEYCPYGPLYNLLRDGE 190
Query: 345 EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404
E+PP RL +WA+QIA+GM YLH +IIHRDLKSPNVLIG +E KISDFGT REWN ST
Sbjct: 191 EIPPMRLVSWAKQIASGMYYLHVNKIIHRDLKSPNVLIGRQEMVKISDFGTSREWNEIST 250
Query: 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS 464
KMSFAGTVAWMAPE+IRNE CS+K+DIWS+G+VLWEL+TCETPYKDVDSSAIIWGVGS+S
Sbjct: 251 KMSFAGTVAWMAPEIIRNEPCSEKVDIWSFGVVLWELMTCETPYKDVDSSAIIWGVGSNS 310
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIW 524
LHLPIPS+CPDGF+LL+K CW+ P +RPSFK I+ HLDIAS +VL P+ Y+K Q W
Sbjct: 311 LHLPIPSSCPDGFRLLIKQCWAAKPRNRPSFKHIMMHLDIASSQVLASTPDEYFKTQAQW 370
Query: 525 KEEIRVHMLEMQANKSHVPKFEEFEDDLIKKRENELKHAQDVREHYERKLERANQLYLEL 584
K+EI++HML+MQ N SH+PKFEE DLIKKR+NELKHAQD+REHYERKLERAN LY+EL
Sbjct: 371 KKEIQIHMLQMQTNGSHIPKFEE---DLIKKRKNELKHAQDIREHYERKLERANNLYMEL 427
Query: 585 SAVRMHLDQREQELLK 600
SAV + L+QRE +L++
Sbjct: 428 SAVLLQLEQRENDLIR 443
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328708443|ref|XP_001944586.2| PREDICTED: mitogen-activated protein kinase kinase kinase 13-A-like isoform 1 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1530), Expect = e-167, Method: Compositional matrix adjust.
Identities = 277/376 (73%), Positives = 321/376 (85%), Gaps = 7/376 (1%)
Query: 229 WYKNRL-CFPTSLMARIGEFKSFVLR---DEWEIPFESISDLQWLGSGAQGAVFSGKLRS 284
W+ L C L +G+ S L+ D W+IPFESISDLQWLGSGAQGAVFSGKL++
Sbjct: 59 WFDGWLGCLKPMLGGIMGKGNSHDLKSYQDNWDIPFESISDLQWLGSGAQGAVFSGKLKN 118
Query: 285 EIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE 344
EIVAVKKVREQKETDIRHLRKLNHPNIV+FKGVCTQAPCYCIVMEYC YGPLYNLL+DGE
Sbjct: 119 EIVAVKKVREQKETDIRHLRKLNHPNIVQFKGVCTQAPCYCIVMEYCPYGPLYNLLRDGE 178
Query: 345 EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404
E+PP RL +WA+QIA+GM YLH +IIHRDLKSPNVLIG +E KISDFGT REWN ST
Sbjct: 179 EIPPMRLVSWAKQIASGMYYLHVNKIIHRDLKSPNVLIGRQEMVKISDFGTSREWNEIST 238
Query: 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS 464
KMSFAGTVAWMAPE+IRNE CS+K+DIWS+G+VLWEL+TCETPYKDVDSSAIIWGVGS+S
Sbjct: 239 KMSFAGTVAWMAPEIIRNEPCSEKVDIWSFGVVLWELMTCETPYKDVDSSAIIWGVGSNS 298
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIW 524
LHLPIPS+CPDGF+LL+K CW+ P +RPSFK I+ HLDIAS +VL P+ Y+K Q W
Sbjct: 299 LHLPIPSSCPDGFRLLIKQCWAAKPRNRPSFKHIMMHLDIASSQVLASTPDEYFKTQAQW 358
Query: 525 KEEIRVHMLEMQANKSHVPKFEEFEDDLIKKRENELKHAQDVREHYERKLERANQLYLEL 584
K+EI++HML+MQ N SH+PKFEE DLIKKR+NELKHAQD+REHYERKLERAN LY+EL
Sbjct: 359 KKEIQIHMLQMQTNGSHIPKFEE---DLIKKRKNELKHAQDIREHYERKLERANNLYMEL 415
Query: 585 SAVRMHLDQREQELLK 600
SAV + L+QRE +L++
Sbjct: 416 SAVLLQLEQRENDLIR 431
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307213536|gb|EFN88945.1| Mitogen-activated protein kinase kinase kinase 12 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1402), Expect = e-152, Method: Compositional matrix adjust.
Identities = 247/347 (71%), Positives = 298/347 (85%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D+WEIPFESIS+LQWLGSGAQGAVFSGKL E+VAVKKVRE +ETDIRHLRKLNHPNIV+
Sbjct: 163 DDWEIPFESISELQWLGSGAQGAVFSGKLNKEVVAVKKVREPRETDIRHLRKLNHPNIVQ 222
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+C YGPLY+LL+ GE VPP RL +W++QIAAGM YLHS +IIHR
Sbjct: 223 FKGVCTQAPCYCIIMEFCPYGPLYDLLRAGEPVPPTRLVSWSKQIAAGMAYLHSHKIIHR 282
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPNVLIG +E KISDFGT REWN ST+MSFAGTVAWMAPE+IRNE CS+K+DIWS
Sbjct: 283 DLKSPNVLIGQREVVKISDFGTSREWNEISTRMSFAGTVAWMAPEIIRNEPCSEKVDIWS 342
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
YG+VLWELL+ E PYKDVDSSAIIWGVG++SL LPIP++CP+G+ LL+K CW+ P +RP
Sbjct: 343 YGVVLWELLSGEIPYKDVDSSAIIWGVGNNSLRLPIPNSCPEGYGLLVKQCWAAKPRNRP 402
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SFK I HL IA+ +VL +PE Y+K Q WK++IR HM++MQ+N + P+FE DLI
Sbjct: 403 SFKLIEMHLSIAAVDVLSTKPEDYFKAQQSWKKQIREHMMQMQSNSNSSPRFEA---DLI 459
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
++RE+EL+HAQD+REHYERKLER N LYLELSAV + L+ RE++++K
Sbjct: 460 RRREDELRHAQDIREHYERKLERTNNLYLELSAVLLQLELRERDVIK 506
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340716306|ref|XP_003396640.1| PREDICTED: mitogen-activated protein kinase kinase kinase 13-like isoform 2 [Bombus terrestris] gi|350406486|ref|XP_003487788.1| PREDICTED: mitogen-activated protein kinase kinase kinase 13-like isoform 2 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1400), Expect = e-152, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 297/347 (85%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D+WEIPFESIS+LQWLGSGAQGAVFSGKL E+VAVKKVRE +ETDIRHLRKLNHPNIV+
Sbjct: 140 DDWEIPFESISELQWLGSGAQGAVFSGKLNKEVVAVKKVREPRETDIRHLRKLNHPNIVQ 199
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+C YGPLY+LL+ GE VPP RL +W++QIAAGM YLH+ +IIHR
Sbjct: 200 FKGVCTQAPCYCIIMEFCPYGPLYDLLRAGEPVPPPRLVSWSKQIAAGMAYLHAHKIIHR 259
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPNVLIG E KISDFGT REWN ST+MSFAGTVAWMAPE+IRNE CS+K+DIWS
Sbjct: 260 DLKSPNVLIGQGEVVKISDFGTSREWNEISTRMSFAGTVAWMAPEIIRNEPCSEKVDIWS 319
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
YG+VLWELL+ E PYKDVDSSAIIWGVG++SLHLPIP++CP+G++LL+K CW+ P +RP
Sbjct: 320 YGVVLWELLSGEIPYKDVDSSAIIWGVGNNSLHLPIPASCPEGYRLLVKQCWAAKPRNRP 379
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SFK I HL IA+ EVL +P+ Y+K Q WK+EIR HM +MQ N P+FE DLI
Sbjct: 380 SFKHIEIHLGIAAVEVLCTKPDDYFKTQQSWKKEIRDHMKQMQTNSCSSPRFEA---DLI 436
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
++RE+EL+HAQD+REHYERKLER N LYLELSAV + L+QRE++++K
Sbjct: 437 RRREDELRHAQDIREHYERKLERTNNLYLELSAVLLQLEQRERDVIK 483
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380018079|ref|XP_003692964.1| PREDICTED: mitogen-activated protein kinase kinase kinase 13-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1399), Expect = e-152, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 297/347 (85%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D+WEIPFESIS+LQWLGSGAQGAVFSGKL E+VAVKKVRE +ETDIRHLRKLNHPNIV+
Sbjct: 140 DDWEIPFESISELQWLGSGAQGAVFSGKLNKEVVAVKKVREPRETDIRHLRKLNHPNIVQ 199
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+C YGPLY+LL+ GE VPP RL +W++QIAAGM YLH+ +IIHR
Sbjct: 200 FKGVCTQAPCYCIIMEFCPYGPLYDLLRAGEPVPPPRLVSWSKQIAAGMAYLHAHKIIHR 259
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPNVLIG E KISDFGT REWN ST+MSFAGTVAWMAPE+IRNE CS+K+DIWS
Sbjct: 260 DLKSPNVLIGQGEVVKISDFGTSREWNEISTRMSFAGTVAWMAPEIIRNEPCSEKVDIWS 319
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
YG+VLWELL+ E PYKDVDSSAIIWGVG++SLHLPIP++CP+G++LL+K CW+ P +RP
Sbjct: 320 YGVVLWELLSGEIPYKDVDSSAIIWGVGNNSLHLPIPASCPEGYRLLVKQCWAAKPRNRP 379
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SFK I HL IA+ EVL +P+ Y+K Q WK+EIR HM +MQ N P+FE DLI
Sbjct: 380 SFKHIEIHLGIAAVEVLCTKPDDYFKTQQSWKKEIRDHMKQMQTNSCSSPRFEA---DLI 436
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
++RE+EL+HAQD+REHYERKLER N LYLELSAV + L+QRE++++K
Sbjct: 437 RRREDELRHAQDIREHYERKLERTNNLYLELSAVLLQLEQRERDVIK 483
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328785797|ref|XP_397605.4| PREDICTED: mitogen-activated protein kinase kinase kinase 13-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1399), Expect = e-151, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 297/347 (85%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D+WEIPFESIS+LQWLGSGAQGAVFSGKL E+VAVKKVRE +ETDIRHLRKLNHPNIV+
Sbjct: 140 DDWEIPFESISELQWLGSGAQGAVFSGKLNKEVVAVKKVREPRETDIRHLRKLNHPNIVQ 199
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+C YGPLY+LL+ GE VPP RL +W++QIAAGM YLH+ +IIHR
Sbjct: 200 FKGVCTQAPCYCIIMEFCPYGPLYDLLRAGEPVPPPRLVSWSKQIAAGMAYLHAHKIIHR 259
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPNVLIG E KISDFGT REWN ST+MSFAGTVAWMAPE+IRNE CS+K+DIWS
Sbjct: 260 DLKSPNVLIGQGEVVKISDFGTSREWNEISTRMSFAGTVAWMAPEIIRNEPCSEKVDIWS 319
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
YG+VLWELL+ E PYKDVDSSAIIWGVG++SLHLPIP++CP+G++LL+K CW+ P +RP
Sbjct: 320 YGVVLWELLSGEIPYKDVDSSAIIWGVGNNSLHLPIPASCPEGYRLLVKQCWAAKPRNRP 379
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SFK I HL IA+ EVL +P+ Y+K Q WK+EIR HM +MQ N P+FE DLI
Sbjct: 380 SFKHIEIHLGIAAVEVLCTKPDDYFKTQQSWKKEIRDHMKQMQTNSCSSPRFEA---DLI 436
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
++RE+EL+HAQD+REHYERKLER N LYLELSAV + L+QRE++++K
Sbjct: 437 RRREDELRHAQDIREHYERKLERTNNLYLELSAVLLQLEQRERDVIK 483
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340716304|ref|XP_003396639.1| PREDICTED: mitogen-activated protein kinase kinase kinase 13-like isoform 1 [Bombus terrestris] gi|350406483|ref|XP_003487787.1| PREDICTED: mitogen-activated protein kinase kinase kinase 13-like isoform 1 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1398), Expect = e-151, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 297/347 (85%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D+WEIPFESIS+LQWLGSGAQGAVFSGKL E+VAVKKVRE +ETDIRHLRKLNHPNIV+
Sbjct: 119 DDWEIPFESISELQWLGSGAQGAVFSGKLNKEVVAVKKVREPRETDIRHLRKLNHPNIVQ 178
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+C YGPLY+LL+ GE VPP RL +W++QIAAGM YLH+ +IIHR
Sbjct: 179 FKGVCTQAPCYCIIMEFCPYGPLYDLLRAGEPVPPPRLVSWSKQIAAGMAYLHAHKIIHR 238
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPNVLIG E KISDFGT REWN ST+MSFAGTVAWMAPE+IRNE CS+K+DIWS
Sbjct: 239 DLKSPNVLIGQGEVVKISDFGTSREWNEISTRMSFAGTVAWMAPEIIRNEPCSEKVDIWS 298
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
YG+VLWELL+ E PYKDVDSSAIIWGVG++SLHLPIP++CP+G++LL+K CW+ P +RP
Sbjct: 299 YGVVLWELLSGEIPYKDVDSSAIIWGVGNNSLHLPIPASCPEGYRLLVKQCWAAKPRNRP 358
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SFK I HL IA+ EVL +P+ Y+K Q WK+EIR HM +MQ N P+FE DLI
Sbjct: 359 SFKHIEIHLGIAAVEVLCTKPDDYFKTQQSWKKEIRDHMKQMQTNSCSSPRFEA---DLI 415
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
++RE+EL+HAQD+REHYERKLER N LYLELSAV + L+QRE++++K
Sbjct: 416 RRREDELRHAQDIREHYERKLERTNNLYLELSAVLLQLEQRERDVIK 462
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383858451|ref|XP_003704715.1| PREDICTED: mitogen-activated protein kinase kinase kinase 13-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 248/347 (71%), Positives = 297/347 (85%), Gaps = 3/347 (0%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
D+WEIPFESIS+LQWLGSGAQGAVFSGKL EIVAVKKVRE +ETDI+HLRKLNHPNIV+
Sbjct: 140 DDWEIPFESISELQWLGSGAQGAVFSGKLNKEIVAVKKVREPRETDIKHLRKLNHPNIVQ 199
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQAPCYCI+ME+C YGPLY+LL+ G+ VPP RL +W++QIAAGM YLHS +IIHR
Sbjct: 200 FKGVCTQAPCYCIIMEFCPYGPLYDLLRAGKPVPPPRLVSWSKQIAAGMAYLHSHKIIHR 259
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPNVLIG E KISDFGT REWN ST+MSFAGTVAWMAPE+IRNE CS+K+DIWS
Sbjct: 260 DLKSPNVLIGQGEVVKISDFGTSREWNEISTRMSFAGTVAWMAPEIIRNEPCSEKVDIWS 319
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
YG+VLWELL+ E PYKDVDSSAIIWGVG++SLHLPIP++CP+G++LL+K CW+ P +RP
Sbjct: 320 YGVVLWELLSGEIPYKDVDSSAIIWGVGNNSLHLPIPASCPEGYRLLVKQCWAAKPHNRP 379
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SFK I HL IA+ EVL +P+ Y+K Q WK+EIR HM +MQ N P+FE DLI
Sbjct: 380 SFKHIEIHLGIAAVEVLCTKPDDYFKTQQSWKKEIRDHMKQMQTNSCSSPRFEA---DLI 436
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
++RE+EL+HAQD+REHYERKLER N LYLEL+AV + L+QRE++++K
Sbjct: 437 RRREDELRHAQDIREHYERKLERTNNLYLELNAVLLQLEQRERDVIK 483
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345496601|ref|XP_001603312.2| PREDICTED: mitogen-activated protein kinase kinase kinase 13-B-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1353), Expect = e-146, Method: Compositional matrix adjust.
Identities = 248/416 (59%), Positives = 322/416 (77%), Gaps = 20/416 (4%)
Query: 193 CREWNNKS-TKMSFAGTVAWMAPEVIRNEQ-------CSDKIDIWYKNRLCFPTSLMARI 244
C N++S T S + T A +AP+ + +++ C + + + N++ F +
Sbjct: 95 CSNINSESNTDSSESTTKATIAPDTVYSQRPFAWIAGCMQPV-VNFINKVTFSEKIKGS- 152
Query: 245 GEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLR 304
D+WEIPFE IS+L WLGSGAQGAVFSGKL+ EIVAVKKVRE +ETDIRHLR
Sbjct: 153 -------QTDDWEIPFEYISELHWLGSGAQGAVFSGKLKKEIVAVKKVREPRETDIRHLR 205
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNY 364
KLNHPNIV+FKGVCTQAPCYCI+ME+C GPLY+LL+ GE +PP RL +W++QIAAGM Y
Sbjct: 206 KLNHPNIVQFKGVCTQAPCYCIIMEFCPAGPLYDLLRAGEIIPPPRLSSWSKQIAAGMRY 265
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
LH +IIHRDLKSPNVLIG ++ KISDFGT REWN KST+M+FAGTVAWMAPE+IRNE
Sbjct: 266 LHDHKIIHRDLKSPNVLIGREDIVKISDFGTSREWNEKSTRMTFAGTVAWMAPEIIRNEP 325
Query: 425 CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484
CS+K+DIWS+G+VLWELL+ E PYKDVDSSAI++GVG+++L LPIP TCP+GF++L+++C
Sbjct: 326 CSEKVDIWSFGVVLWELLSGEIPYKDVDSSAIMYGVGNNTLRLPIPKTCPEGFKILVELC 385
Query: 485 WSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPK 544
W+ P +RPSFK I HL IA+ E+ R + Y++ Q WKEEIR HM ++Q++ S P+
Sbjct: 386 WAAKPRNRPSFKHIEMHLAIAAGELERTTQDDYFRAQQTWKEEIREHMKQIQSDNSSSPR 445
Query: 545 FEEFEDDLIKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
FE DLI++RE+EL+HAQD+REHYERKLER N LY+ELSAV + L+QRE++++K
Sbjct: 446 FEA---DLIRRREDELRHAQDIREHYERKLERTNNLYMELSAVLLQLEQRERDVMK 498
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322792005|gb|EFZ16110.1| hypothetical protein SINV_01119 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1336), Expect = e-144, Method: Compositional matrix adjust.
Identities = 241/359 (67%), Positives = 296/359 (82%), Gaps = 3/359 (0%)
Query: 242 ARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIR 301
A I E + D+WEIPFE+IS+LQWLGSGAQGAVFSGKL EIVAVKKV+E KETDIR
Sbjct: 82 AAINEKIKGLSTDDWEIPFEAISELQWLGSGAQGAVFSGKLYKEIVAVKKVKEPKETDIR 141
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAG 361
HLRKLNHPNIV FKGVCT+ PCYCI+ME+C +GPLY+LL+ GE VPP RL +W++QIAAG
Sbjct: 142 HLRKLNHPNIVHFKGVCTKPPCYCIIMEFCPFGPLYDLLRAGEPVPPARLVSWSKQIAAG 201
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 421
M YLH+ +IIHRDLKSPNVLIG E KISDFGT ++WN STKM+FAGTVAWMAPEVIR
Sbjct: 202 MAYLHAHKIIHRDLKSPNVLIGQGEVVKISDFGTSKQWNEISTKMTFAGTVAWMAPEVIR 261
Query: 422 NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
NE CS+K+DIWSYG+VLWELL+ E PYKDVDSSA++WGVGS+SLHLPIP++CP+G+ LL+
Sbjct: 262 NEPCSEKVDIWSYGVVLWELLSGEIPYKDVDSSAVMWGVGSNSLHLPIPTSCPEGYGLLV 321
Query: 482 KMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSH 541
K CWS P +RP+FK I HL IA+ +VL +PE Y+K Q WK+EI+ HM +M S
Sbjct: 322 KQCWSAKPRNRPAFKLIEMHLAIAAVDVLSTEPEDYFKAQQSWKKEIQEHMKQMPLFTST 381
Query: 542 VPKFEEFEDDLIKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
P+FE +LI++R++EL+HAQDVREHYERKLER N LYLEL+A+ + L+ RE++++K
Sbjct: 382 DPRFEA---ELIRRRKDELRHAQDVREHYERKLERTNNLYLELNAILLQLELRERDVIK 437
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 600 | ||||||
| FB|FBgn0036896 | 977 | wnd "wallenda" [Drosophila mel | 0.57 | 0.350 | 0.643 | 1.2e-134 | |
| ZFIN|ZDB-GENE-081105-15 | 981 | si:ch211-45c16.2 "si:ch211-45c | 0.575 | 0.351 | 0.660 | 1.6e-132 | |
| UNIPROTKB|E2RNS0 | 966 | MAP3K13 "Uncharacterized prote | 0.575 | 0.357 | 0.649 | 8.7e-132 | |
| UNIPROTKB|Q66H82 | 563 | LOC303823 "Protein Map3k13" [R | 0.575 | 0.612 | 0.652 | 1.1e-131 | |
| UNIPROTKB|O43283 | 966 | MAP3K13 "Mitogen-activated pro | 0.575 | 0.357 | 0.649 | 1.8e-131 | |
| MGI|MGI:2444243 | 959 | Map3k13 "mitogen-activated pro | 0.575 | 0.359 | 0.652 | 2.3e-131 | |
| UNIPROTKB|F1MGX2 | 966 | MAP3K13 "Mitogen-activated pro | 0.575 | 0.357 | 0.649 | 3.7e-131 | |
| UNIPROTKB|Q5R8X7 | 966 | MAP3K13 "Mitogen-activated pro | 0.575 | 0.357 | 0.646 | 1.3e-130 | |
| UNIPROTKB|E1C1Y9 | 955 | MAP3K13 "Uncharacterized prote | 0.575 | 0.361 | 0.649 | 2e-130 | |
| UNIPROTKB|A7MBB4 | 966 | MAP3K13 "Mitogen-activated pro | 0.575 | 0.357 | 0.646 | 2.6e-130 |
| FB|FBgn0036896 wnd "wallenda" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1247 (444.0 bits), Expect = 1.2e-134, Sum P(3) = 1.2e-134
Identities = 222/345 (64%), Positives = 285/345 (82%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVK 313
++W+IPFESI++L+WLGSGAQGAVFSG+L++E VAVKKV+E KETDI+HLRKL+H NI+K
Sbjct: 152 EDWQIPFESITELEWLGSGAQGAVFSGRLKNETVAVKKVKELKETDIKHLRKLDHENIIK 211
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
FKGVCTQ+P +CI+ME+C YGPL N+LK+ + + P RL +W++QIA GM YLHS +IIHR
Sbjct: 212 FKGVCTQSPVFCIIMEFCPYGPLQNILKEEQVMLPSRLVSWSKQIALGMQYLHSHKIIHR 271
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLKSPN+LI + E KISDFGT REWN STKMSFAGTVAWMAPEVIRNE CS+K+DIWS
Sbjct: 272 DLKSPNILISTNEVVKISDFGTSREWNEISTKMSFAGTVAWMAPEVIRNEPCSEKVDIWS 331
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
YG+VLWE+LTCE PYKDVDSSAIIWGVG++SL L +PSTCP+GF+LL+K+CW + P +RP
Sbjct: 332 YGVVLWEMLTCEIPYKDVDSSAIIWGVGNNSLKLLVPSTCPEGFKLLVKLCWKSKPRNRP 391
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
SF+QILSHLDIA E+LR + Y++ Q WKEE+R H+ E+ N +++ K+E+ DLI
Sbjct: 392 SFRQILSHLDIAGPELLRKTEKQYFETQKSWKEEVRSHLKEITQNGTNIHKYEQ---DLI 448
Query: 554 KKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQEL 598
K+R E +HAQD+R YE KL++ NQL+ ELS L ++E+E+
Sbjct: 449 KRRTAEWRHAQDIRMVYEDKLQKTNQLFFELSECMSQLQEKEKEI 493
|
|
| ZFIN|ZDB-GENE-081105-15 si:ch211-45c16.2 "si:ch211-45c16.2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1264 (450.0 bits), Expect = 1.6e-132, Sum P(2) = 1.6e-132
Identities = 230/348 (66%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
++ WE+PFE IS+LQWLGSGAQGAVF GK RSE VA+KKVREQKETDI+HLRKL HPNI+
Sbjct: 209 QEMWEVPFEEISELQWLGSGAQGAVFLGKFRSEEVAIKKVREQKETDIKHLRKLKHPNII 268
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA G LY +L+ G ++ P L +WA IA+GMNYLH +IIH
Sbjct: 269 SFKGVCTQAPCYCIIMEYCAQGQLYEVLRAGRKITPCLLVDWASGIASGMNYLHLHKIIH 328
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 329 RDLKSPNVLVTQNDSVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 388
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W P +R
Sbjct: 389 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQGKPRNR 448
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+QIL HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 449 PSFRQILLHLDIASADVLGTPQETYFKCQTEWREEVKKHFEKIKSEGTCIHRLDE---EL 505
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R +EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+ELLK
Sbjct: 506 IRRRRDELRHALDIREHYERKLERANNLYMELSAIMLQLEVREKELLK 553
|
|
| UNIPROTKB|E2RNS0 MAP3K13 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1258 (447.9 bits), Expect = 8.7e-132, Sum P(2) = 8.7e-132
Identities = 226/348 (64%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELIK 502
|
|
| UNIPROTKB|Q66H82 LOC303823 "Protein Map3k13" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 1.1e-131, Sum P(2) = 1.1e-131
Identities = 227/348 (65%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+ELLK
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELLK 502
|
|
| UNIPROTKB|O43283 MAP3K13 "Mitogen-activated protein kinase kinase kinase 13" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1258 (447.9 bits), Expect = 1.8e-131, Sum P(2) = 1.8e-131
Identities = 226/348 (64%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELIK 502
|
|
| MGI|MGI:2444243 Map3k13 "mitogen-activated protein kinase kinase kinase 13" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 2.3e-131, Sum P(2) = 2.3e-131
Identities = 227/348 (65%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 157 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 216
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 217 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 276
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 277 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 336
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 337 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 396
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 397 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 453
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+ELLK
Sbjct: 454 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELLK 501
|
|
| UNIPROTKB|F1MGX2 MAP3K13 "Mitogen-activated protein kinase kinase kinase 13" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1258 (447.9 bits), Expect = 3.7e-131, Sum P(2) = 3.7e-131
Identities = 226/348 (64%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELIK 502
|
|
| UNIPROTKB|Q5R8X7 MAP3K13 "Mitogen-activated protein kinase kinase kinase 13" [Pongo abelii (taxid:9601)] | Back alignment and assigned GO terms |
|---|
Score = 1254 (446.5 bits), Expect = 1.3e-130, Sum P(2) = 1.3e-130
Identities = 225/348 (64%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAW+APEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWLAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELVK 502
|
|
| UNIPROTKB|E1C1Y9 MAP3K13 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1254 (446.5 bits), Expect = 2.0e-130, Sum P(2) = 2.0e-130
Identities = 226/348 (64%), Positives = 284/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVR+Q ETDI+HLRKL HPNI+
Sbjct: 161 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVRDQNETDIKHLRKLKHPNII 220
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G +V P+ L +W+ IA+GMNYLH +IIH
Sbjct: 221 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKVTPRLLVDWSTGIASGMNYLHLHKIIH 280
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 281 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 340
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + P +R
Sbjct: 341 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKPRNR 400
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 401 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 457
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 458 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEVREKELIK 505
|
|
| UNIPROTKB|A7MBB4 MAP3K13 "Mitogen-activated protein kinase kinase kinase 13" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1250 (445.1 bits), Expect = 2.6e-130, Sum P(2) = 2.6e-130
Identities = 225/348 (64%), Positives = 283/348 (81%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIV 312
+D WE+PFE IS+LQWLGSGAQGAVF GK R+E VA+KKVREQ ETDI+HLRKL HPNI+
Sbjct: 158 QDTWEVPFEEISELQWLGSGAQGAVFLGKFRAEEVAIKKVREQNETDIKHLRKLKHPNII 217
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
FKGVCTQAPCYCI+MEYCA+G LY +L+ G ++ P+ L +W+ IA+GMNYLH +IIH
Sbjct: 218 AFKGVCTQAPCYCIIMEYCAHGQLYEVLRAGRKITPRLLVDWSTGIASGMNYLHLHKIIH 277
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLKSPNVL+ + KISDFGT +E ++KSTKMSFAGTVAWMAPEVIRNE S+K+DIW
Sbjct: 278 RDLKSPNVLVTHTDAVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIW 337
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S+G+VLWELLT E PYKDVDSSAIIWGVGS+SLHLP+PSTCPDGF++LMK W + +R
Sbjct: 338 SFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKILMKQTWQSKTRNR 397
Query: 493 PSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDL 552
PSF+Q L HLDIAS +VL E Y+K Q W+EE++ H ++++ + + + +E +L
Sbjct: 398 PSFRQTLMHLDIASADVLATPQETYFKSQAEWREEVKKHFEKIKSEGTCIHRLDE---EL 454
Query: 553 IKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
I++R EL+HA D+REHYERKLERAN LY+ELSA+ + L+ RE+EL+K
Sbjct: 455 IRRRREELRHALDIREHYERKLERANNLYMELSAIMLQLEMREKELIK 502
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q1HKZ5 | M3K13_MOUSE | 2, ., 7, ., 1, 1, ., 2, 5 | 0.6494 | 0.575 | 0.3597 | yes | N/A |
| Q12852 | M3K12_HUMAN | 2, ., 7, ., 1, 1, ., 2, 5 | 0.6340 | 0.5733 | 0.4004 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 600 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-83 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-83 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-78 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-71 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-70 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-61 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-60 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-52 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-51 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-49 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-47 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-47 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-47 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-46 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-46 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-45 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-45 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-44 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-44 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-43 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-43 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-43 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-42 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-42 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-41 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-41 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-41 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-40 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-39 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-38 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-38 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-38 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-38 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-38 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-38 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-38 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-37 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-37 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-37 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-37 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-37 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-36 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-36 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-35 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-35 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-34 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-34 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-34 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-33 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-33 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-33 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-33 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-33 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-32 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-32 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-32 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-32 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-32 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-32 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-32 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-32 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-32 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-31 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-31 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-31 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-30 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-30 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-30 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-30 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-30 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-30 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-30 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-29 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-29 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-29 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-29 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-29 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-29 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-28 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-28 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-28 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-28 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-28 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-28 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-27 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-26 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-25 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-25 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-25 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-25 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-24 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-24 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-23 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-23 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-23 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-22 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-22 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-21 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-20 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-18 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-17 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-14 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-13 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-13 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-12 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-09 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-09 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-09 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-08 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-05 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-04 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 0.001 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.001 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.001 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.001 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 0.002 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.002 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.002 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.003 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.003 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 262 bits (671), Expect = 1e-83
Identities = 93/252 (36%), Positives = 132/252 (52%), Gaps = 19/252 (7%)
Query: 269 LGSGAQGAVFSGKLR------SEIVAVKKVREQKETD--------IRHLRKLNHPNIVKF 314
LG GA G V+ GKL+ VAVK ++E R +RKL+HPN+VK
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
GVCT+ IVMEY G L + L+ ++ L ++A QIA GM YL SK IHR
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHR 126
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG--TVAWMAPEVIRNEQCSDKIDI 431
DL + N L+G KISDFG R+ + G + WMAPE ++ + + K D+
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186
Query: 432 WSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490
WS+G++LWE+ T E PY + + ++ + + LP P CP LM CW+ P
Sbjct: 187 WSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR-LPQPPNCPPELYDLMLQCWAEDPE 245
Query: 491 SRPSFKQILSHL 502
RP+F +++ L
Sbjct: 246 DRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 2e-83
Identities = 94/253 (37%), Positives = 132/253 (52%), Gaps = 20/253 (7%)
Query: 269 LGSGAQGAVFSGKLR------SEIVAVKKVREQKETD--------IRHLRKLNHPNIVKF 314
LG GA G V+ G L+ VAVK ++E R +RKL+HPNIVK
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
GVCT+ IVMEY G L + L+ +E+ L ++A QIA GM YL SK IH
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIH 126
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG--TVAWMAPEVIRNEQCSDKID 430
RDL + N L+G KISDFG R+ + G + WMAPE ++ + + K D
Sbjct: 127 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSD 186
Query: 431 IWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
+WS+G++LWE+ T E PY + ++ ++ + LP P CP LM CW+ P
Sbjct: 187 VWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR-LPKPPNCPPELYKLMLQCWAEDP 245
Query: 490 SSRPSFKQILSHL 502
RP+F +++ L
Sbjct: 246 EDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 8e-78
Identities = 91/253 (35%), Positives = 131/253 (51%), Gaps = 20/253 (7%)
Query: 269 LGSGAQGAVFSGKLRSE------IVAVKKVREQKETD--------IRHLRKLNHPNIVKF 314
LG GA G V+ G L+ + VAVK ++E + ++KL+HPNIV+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
GVCTQ IV EY G L + L+ GE++ + L A QIA GM YL SK +HR
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHR 126
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKID 430
DL + N L+ KISDFG R+ G + WMAPE +++ + + K D
Sbjct: 127 DLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSD 186
Query: 431 IWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
+WS+G++LWE+ T E PY + + ++ + LP P CPD LM CW+ P
Sbjct: 187 VWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYELMLQCWAYDP 245
Query: 490 SSRPSFKQILSHL 502
RP+F +++ L
Sbjct: 246 EDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 2e-71
Identities = 89/261 (34%), Positives = 135/261 (51%), Gaps = 27/261 (10%)
Query: 269 LGSGAQGAVFSGKLRSEI-----VAVKKVREQKETDIRH--------LRKLNHPNIVKFK 315
LG GA G V+ GKL+ + VAVK ++E + R ++KL HPN+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLK---------DGEEVPPQRLYNWARQIAAGMNYLH 366
GVCT+ +V+EY G L + L+ + + + L ++A QIA GM YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNE 423
SK+ +HRDL + N L+G KISDFG R+ + G + WMAPE +++
Sbjct: 123 SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182
Query: 424 QCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482
+ K D+WS+G++LWE+ T TPY + + ++ + LP P CPD LM
Sbjct: 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYELML 241
Query: 483 MCWSNAPSSRPSFKQILSHLD 503
CW P RP+F +++ L+
Sbjct: 242 SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 5e-70
Identities = 78/245 (31%), Positives = 123/245 (50%), Gaps = 12/245 (4%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH--------LRKLNHPNIVKFKGVC 318
LG G+ G V+ + + ++VA+K ++++K R L+KL HPNIV+ V
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378
+VMEYC G L++LLK + + RQI + + YLHSK I+HRDLK
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPE 126
Query: 379 NVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVL 438
N+L+ K++DFG R+ + +F GT +MAPEV+ + +DIWS G++L
Sbjct: 127 NILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVIL 186
Query: 439 WELLTCETPYKDVDS-SAIIWGVGSSSLHLPIPS-TCPDGFQLLMKMCWSNAPSSRPSFK 496
+ELLT + P+ D + +G P P + L++ P R + +
Sbjct: 187 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE 246
Query: 497 QILSH 501
+ L H
Sbjct: 247 EALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 2e-64
Identities = 88/251 (35%), Positives = 130/251 (51%), Gaps = 18/251 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
LGSG+ G V+ K + +IVAVK ++++ E IR LR+L+HPNIV+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+VMEYC G L++ L G + A QI G+ YLHS IIHRDLK
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKP 126
Query: 378 PNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD-KIDIWSYG 435
N+L+ KI+DFG ++ S+ + +F GT +MAPEV+ K+D+WS G
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186
Query: 436 IVLWELLTCETPY---KDVDSSAIIWGVGSSSLHLPIPSTCPDG--FQLLMKMCWSNAPS 490
++L+ELLT + P+ +D +I + L P + L+K C + PS
Sbjct: 187 VILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPS 246
Query: 491 SRPSFKQILSH 501
RP+ ++IL H
Sbjct: 247 KRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-61
Identities = 81/248 (32%), Positives = 120/248 (48%), Gaps = 47/248 (18%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD--------IRHLRKLNHPNIVKFKGVC 318
LG G G V+ + + + VA+K ++++ + I L+KLNHPNIVK GV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+VMEYC G L +LLK+ E ++ + QI G+ YLHS IIHRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 378 PNVLIGSKE-EAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQ-CSDKIDIWSY 434
N+L+ S + K++DFG + + + + + GT A+MAPEV+ + S+K DIWS
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
G++L+EL + L++ P RPS
Sbjct: 181 GVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS 207
Query: 495 FKQILSHL 502
K+IL HL
Sbjct: 208 AKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 1e-60
Identities = 82/250 (32%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
LG G+ G+V+ + E++AVK V +++ IR L L HPNIV++ G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 318 CTQAP--CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
I +EY + G L +LLK ++P + + RQI G+ YLHS I+HRD+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIW 432
K N+L+ S K++DFG + + T S GT WMAPEVIR E+ DIW
Sbjct: 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187
Query: 433 SYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491
S G + E+ T + P+ ++ + A ++ +GSS IP + + ++ C P
Sbjct: 188 SLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKK 247
Query: 492 RPSFKQILSH 501
RP+ ++L H
Sbjct: 248 RPTADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 89/279 (31%), Positives = 137/279 (49%), Gaps = 34/279 (12%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKVREQKE-TDIRH----- 302
WE+P E I+ ++ LG G+ G V+ G + + VA+K V E +
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA 60
Query: 303 --LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK----DGEEVPP------QR 350
+++ N ++V+ GV + +VME A G L + L+ + E P Q+
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-----KSTK 405
A +IA GM YL +K+ +HRDL + N ++ KI DFG R+ K K
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464
V WMAPE +++ + K D+WS+G+VLWE+ T E PY+ + + ++ V
Sbjct: 181 GLLP--VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
HL +P CPD LM+MCW P RP+F +I+S L
Sbjct: 239 -HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 5e-52
Identities = 83/256 (32%), Positives = 124/256 (48%), Gaps = 35/256 (13%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKGVCT 319
+G G G V+ K + VA+K ++ + + I+ L+K HPNIVK+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG--- 64
Query: 320 QAPCYC------IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA-------GMNYLH 366
Y IVME+C+ G L +LLK + + QIA G+ YLH
Sbjct: 65 ---SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES------QIAYVCKELLKGLEYLH 115
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 426
S IIHRD+K+ N+L+ S E K+ DFG + ++ + + GT WMAPEVI +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 427 DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCW 485
K DIWS GI EL + PY ++ ++ + ++ L P D F+ +K C
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235
Query: 486 SNAPSSRPSFKQILSH 501
P RP+ +Q+L H
Sbjct: 236 QKNPEKRPTAEQLLKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 17/247 (6%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVRE-----------QKETDIRHLRKLNHPNIVKFK 315
+G GA G V+ G + VA+K++ +E D+ L+ L HPNIVK+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDL--LKNLKHPNIVKYI 65
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
G + I++EY G L ++K P + + Q+ G+ YLH + +IHRD+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125
Query: 376 KSPNVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K+ N+L K++DFG + N S GT WMAPEVI S DIWS
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL 185
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
G + ELLT PY D++ A ++ + H P+P + + C+ P+ RP+
Sbjct: 186 GCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNLRPT 244
Query: 495 FKQILSH 501
KQ+L H
Sbjct: 245 AKQLLKH 251
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-49
Identities = 91/263 (34%), Positives = 137/263 (52%), Gaps = 19/263 (7%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQ--------KETDIRHLRKL 306
WEIP ES+ + LG+G G V+ G + VAVK ++ +E I ++KL
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQI--MKKL 58
Query: 307 NHPNIVKFKGVCTQA-PCYCIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMN 363
H +V+ VC++ P Y IV EY + G L + LK GE ++ +L + A QIA GM
Sbjct: 59 RHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIR 421
YL S+ IHRDL + N+L+G KI+DFG R E + + + + W APE
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 422 NEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480
+ + K D+WS+GI+L E++T PY + + ++ V +P P CP+ L
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEELYDL 236
Query: 481 MKMCWSNAPSSRPSFKQILSHLD 503
M CW P RP+F+ + S L+
Sbjct: 237 MLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 9e-49
Identities = 82/258 (31%), Positives = 121/258 (46%), Gaps = 16/258 (6%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK--------ETDIRHLRKLN 307
W I + + +G G G V G R + VAVK +++ E + + L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASV--MTTLR 58
Query: 308 HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE--VPPQRLYNWARQIAAGMNYL 365
HPN+V+ GV Q IV EY A G L + L+ + + +A + GM YL
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 366 HSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC 425
K +HRDL + NVL+ AK+SDFG +E + V W APE +R ++
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--VKWTAPEALREKKF 176
Query: 426 SDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484
S K D+WS+GI+LWE+ + PY + ++ V + P CP +MK C
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRMEAPEGCPPEVYKVMKDC 235
Query: 485 WSNAPSSRPSFKQILSHL 502
W P+ RP+FKQ+ L
Sbjct: 236 WELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 74/248 (29%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 269 LGSGAQGAVF--SGKLRSEIVAVKKV---------REQKETDIRHLRKLNHPNIVKFKGV 317
+G G+ G V+ K ++ +K++ RE +++ L+KLNHPNI+K+
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
+ CIVMEY G L +K +G+ P +++ +W Q+ + YLHS++I+HR
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 432
D+K N+ + S K+ DFG + ++ + GT +++PE+ +N+ + K DIW
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S G VL+EL T + P++ + + + + PIPS + L+ P R
Sbjct: 188 SLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEER 246
Query: 493 PSFKQILS 500
PS QIL
Sbjct: 247 PSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-47
Identities = 91/253 (35%), Positives = 125/253 (49%), Gaps = 17/253 (6%)
Query: 267 QWLGSGAQGAVFSGKLRSEI-VAVKKVREQKETDIRH--------LRKLNHPNIVKFKGV 317
+ +G G G V+ G L+ VAVK R D++ L++ +HPNIVK GV
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 318 CTQAPCYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
C Q IVME G L L K + ++L + AAGM YL SK IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT----VAWMAPEVIRNEQCSDKIDIW 432
+ N L+G KISDFG RE +S G + W APE + + + + D+W
Sbjct: 121 ARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 433 SYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491
SYGI+LWE + +TPY + + + S +P P CP+ LM CW+ P +
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238
Query: 492 RPSFKQILSHLDI 504
RPSF +I + L I
Sbjct: 239 RPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-47
Identities = 89/250 (35%), Positives = 126/250 (50%), Gaps = 24/250 (9%)
Query: 269 LGSGAQGAVFSGKLR----SEI-VAVKKVREQ----------KETDIRHLRKLNHPNIVK 313
LG G G+V G E+ VAVK ++++ +E + +L+HP IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMA--QLDHPCIVR 60
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
GVC + +VME GPL LK E+P L A Q+A GM YL SK +HR
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKST--KMSFAGT--VAWMAPEVIRNEQCSDKI 429
DL + NVL+ ++ +AKISDFG R S + + AG + W APE I + S K
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKS 179
Query: 430 DIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488
D+WSYG+ LWE + PY ++ + +I + S LP P CP +M CW
Sbjct: 180 DVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-ESGERLPRPEECPQEIYSIMLSCWKYR 238
Query: 489 PSSRPSFKQI 498
P RP+F ++
Sbjct: 239 PEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 96/281 (34%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVREQKETDIRH------- 302
EIP ++ L+ LG GA G V+ G+L + VA+K ++E E ++
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 303 -LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL------------KDGEEVP-- 347
+ L HPNIV GVCT+ C++ EY A+G L+ L E V
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 348 --PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKST 404
+ A QIAAGM YL S +HRDL + N L+G KISDFG R+ ++
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 405 KMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE-TPYKDVDSSAIIWGVG 461
++ V WM PE I + + + DIWS+G+VLWE+ + PY + +I +
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240
Query: 462 SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
S L LP P CP LM CW+ P+ RP FK I + L
Sbjct: 241 SRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 4e-46
Identities = 91/253 (35%), Positives = 130/253 (51%), Gaps = 14/253 (5%)
Query: 262 SISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--QKETDIRH----LRKLNHPNIVKF 314
++ L+ LGSG G V GK R +I VA+K +RE E D + KL+HPN+V+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV-PPQRLYNWARQIAAGMNYLHSKQIIHR 373
GVCT+ IV EY A G L N L++ + + L + + M YL S IHR
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKID 430
DL + N L+G K+SDFG R + S GT V W PEV + S K D
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 431 IWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
+WS+G+++WE+ + + PY+ +S ++ V S+ L P P +M CW P
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYRPKLAPTEVYTIMYSCWHEKP 242
Query: 490 SSRPSFKQILSHL 502
RP+FK++LS L
Sbjct: 243 EDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 88/280 (31%), Positives = 131/280 (46%), Gaps = 35/280 (12%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVR----EQKETD----IRHLR 304
+ ++ LG G G V + E VAVK + EQ +D I LR
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61
Query: 305 KLNHPNIVKFKGVCTQA--PCYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAG 361
L+H NIVK+KGVC + ++MEY G L + L + +++ +RL ++ QI G
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----TKMSFAGTVAWMAP 417
M+YL S++ IHRDL + N+L+ S++ KISDFG + K + W AP
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGS-------------S 463
E +R + S D+WS+G+ L+EL T + + G+
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LP P +CPD LMK+CW P RPSF ++ +D
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-45
Identities = 89/260 (34%), Positives = 124/260 (47%), Gaps = 26/260 (10%)
Query: 264 SDLQ---WLGSGAQGAVFSG--KLRSEIVAVKKV--------REQKETDIRHLRKLNHPN 310
SDL+ LG G+ G V+ K +I A+KK+ R+Q +++ LR P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-Q 369
+VK G + IV+EY G L +LLK ++P L ARQI G++YLH+K
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDK 428
IIHRD+K N+LI SK E KI+DFG + N + +F GTV +M+PE I+ E S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSS-------AIIWGVGSSSLHLPIPSTCPDGFQLLM 481
DIWS G+ L E + P+ AI LP F+ +
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPPPSLP-AEEFSPEFRDFI 236
Query: 482 KMCWSNAPSSRPSFKQILSH 501
C P RPS ++L H
Sbjct: 237 SACLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 82/279 (29%), Positives = 141/279 (50%), Gaps = 41/279 (14%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVK---KVREQ-------KETDI 300
P ++ ++ LG G G VF K + +V VK K +++ +E D+
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 301 RHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL-----KDGEEVPP-----QR 350
RKL+H N+V+ G+C +A + +++EY G L L KD + PP Q+
Sbjct: 62 --FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN------KST 404
+ QIA GM++L + + +HRDL + N L+ S+ E K+S ++ N ++
Sbjct: 120 V-ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSS 463
+ + W+APE ++ + S K D+WS+G+++WE+ T E P+ + ++ + +
Sbjct: 179 LIP----LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
Query: 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
L LP+P CP LM CW+ P RPSF +++S L
Sbjct: 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-44
Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 15/250 (6%)
Query: 267 QWLGSGAQGAVFSGKLRS--EIVAVKKVR------------EQKETDIRHLRKLNHPNIV 312
+ LGSG+ G+V+ G + AVK+V +Q E +I L KL HPNIV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
++ G + I +E G L LLK P + + RQI G+ YLH + +H
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-KIDI 431
RD+K N+L+ + K++DFG ++ S SF G+ WMAPEVI + DI
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 432 WSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491
WS G + E+ T + P+ ++ A ++ +G S PIP D + + C PS
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSL 245
Query: 492 RPSFKQILSH 501
RP+ ++L H
Sbjct: 246 RPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 90/259 (34%), Positives = 134/259 (51%), Gaps = 20/259 (7%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQ--------KETDIRHLRK 305
WE+ I+ LG G G V+ G K S VAVK ++E KE + +++
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV--MKE 58
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMN 363
+ HPN+V+ GVCT+ P + I+ E+ YG L + L+ + +EV L A QI++ M
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVI 420
YL K IHRDL + N L+G K++DFG R T + AG + W APE +
Sbjct: 119 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL 177
Query: 421 RNEQCSDKIDIWSYGIVLWELLTCE-TPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
+ S K D+W++G++LWE+ T +PY +D S ++ + + P CP
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPPKVYE 236
Query: 480 LMKMCWSNAPSSRPSFKQI 498
LM+ CW PS RPSF +I
Sbjct: 237 LMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 82/264 (31%), Positives = 131/264 (49%), Gaps = 19/264 (7%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVR----EQKETDIRH----LR 304
I ++ + +G G G V G+L+ VA+K ++ +++ D +
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMG 60
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMN 363
+ +HPNI++ +GV T++ I+ EY G L L++ + + +L R IA+GM
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG---TVAWMAPEVI 420
YL +HRDL + N+L+ S K+SDFG R + + G + W APE I
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 421 RNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
+ + D+WS+GIV+WE+++ E PY D+ + +I V LP P CP
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQ 239
Query: 480 LMKMCWSNAPSSRPSFKQILSHLD 503
LM CW + RP+F QI+S LD
Sbjct: 240 LMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 81/250 (32%), Positives = 118/250 (47%), Gaps = 21/250 (8%)
Query: 269 LGSGAQGAVFSGKLRSEI-----VAVKKVREQKETDI--------RHLRKLNHPNIVKFK 315
LG G+ G V G+ + VAVK ++ K +DI + L+H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
GV P +V E G L + L+ L ++A QIA GM YL SK+ IHR
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR 121
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTV--AWMAPEVIRNEQCSDKI 429
DL + N+L+ S ++ KI DFG R N M V AW APE +R S
Sbjct: 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHAS 181
Query: 430 DIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488
D+W +G+ LWE+ T E P+ + S I+ + L P CP +M CW++
Sbjct: 182 DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHN 241
Query: 489 PSSRPSFKQI 498
P+ RP+F +
Sbjct: 242 PADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 76/235 (32%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 288 AVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK------ 341
A RE +++ L +L+ PNI + GVCT P C++MEY G L L+
Sbjct: 58 ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117
Query: 342 -----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396
+ + + L A QIA+GM YL S +HRDL + N L+G KI+DFG
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 397 RE-WNNKSTKMSFAGTVA----WMAPEVIRNEQCSDKIDIWSYGIVLWELLT-C-ETPYK 449
R +++ ++ G WMA E + + + K D+W++G+ LWE+LT C E PY+
Sbjct: 178 RNLYSSDYYRVQ--GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 450 DVDSSAIIWGVG------SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498
+ +I G ++LP P CP LM CW RP+F++I
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 93/288 (32%), Positives = 141/288 (48%), Gaps = 43/288 (14%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQK-ETDIRHL--- 303
EWE+P + ++ + LG GA G V + + VAVK +++ E D+ L
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65
Query: 304 ---RKL--NHPNIVKFKGVCTQA-PCYCIVMEYCAYGPLYNLLK-----------DGEEV 346
K+ H NI+ GVCTQ P Y +V EY A+G L + L+ D
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 347 PPQRLYN-----WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401
P + L +A Q+A GM +L SK+ IHRDL + NVL+ KI+DFG R+ ++
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 402 -----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE-TPYKDVDSSA 455
K+T V WMAPE + + + + D+WS+G++LWE+ T +PY +
Sbjct: 185 IDYYRKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
++ + + P C LM+ CW PS RP+FKQ++ LD
Sbjct: 243 -LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 94/249 (37%), Positives = 124/249 (49%), Gaps = 16/249 (6%)
Query: 269 LGSGAQGAVFSGKLRSE--IVAVKKVREQKETDI--------RHLRKLNHPNIVKFKGVC 318
+G G G VFSG+LR++ VAVK RE D+ R L++ +HPNIV+ GVC
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 319 TQAPCYCIVMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
TQ IVME G L+ +G + + L AAGM YL SK IHRDL +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAA 122
Query: 378 PNVLIGSKEEAKISDFGTCREWNN---KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N L+ K KISDFG RE + ST V W APE + + S + D+WS+
Sbjct: 123 RNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSF 182
Query: 435 GIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
GI+LWE + PY ++ + + + LP P CPD LM+ CW P RP
Sbjct: 183 GILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLMERCWEYDPGQRP 241
Query: 494 SFKQILSHL 502
SF + L
Sbjct: 242 SFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 90/269 (33%), Positives = 132/269 (49%), Gaps = 22/269 (8%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFS------GKLRSEI-VAVKKVRE-----QKETDIRHL 303
WE P ++S + LG+GA G V K + + VAVK ++ ++E + L
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSEL 89
Query: 304 RKL----NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV--PPQRLYNWARQ 357
+ + NH NIV G CT ++ EYC YG L N L+ E + L +++ Q
Sbjct: 90 KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 358 IAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAW 414
+A GM +L SK IHRDL + NVL+ + KI DFG R+ N S + V W
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 415 MAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
MAPE I N + + D+WSYGI+LWE+ + PY + + + + + P
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
P +MK CW P RP+FKQI+ +
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 8e-41
Identities = 87/284 (30%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVRE----------QKETD 299
+ ++I + LG GA G VF G+ E+VAVK ++E ++E +
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 300 IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK---------DGEEVPPQR 350
+ L H NIVKF GVCT+ +V EY +G L L+ + P
Sbjct: 61 L--LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 351 L-----YNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE------W 399
L A QIA+GM YL S+ +HRDL + N L+G KI DFG R+ +
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 400 NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIW 458
M + WM PE I + + + D+WS+G+VLWE+ T + P+ + + +I
Sbjct: 179 RVGGHTML---PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 459 GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
+ L P TCP +M CW P R + K I L
Sbjct: 236 CITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 8e-41
Identities = 76/223 (34%), Positives = 112/223 (50%), Gaps = 28/223 (12%)
Query: 246 EFKSFVLRD--EWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKK--VREQKE-- 297
E L+D P E +L+ +G GA G V+ R+ + VA+KK +R+Q +
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL 61
Query: 298 --TDIRHLRKLNHPNIVKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKDGEEVP-- 347
+I ++ HPNIV + Y +VMEY G L +++ V
Sbjct: 62 IINEILIMKDCKHPNIVDYYD------SYLVGDELWVVMEYMDGGSLTDII-TQNFVRMN 114
Query: 348 -PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTK 405
PQ Y R++ G+ YLHS+ +IHRD+KS N+L+ K++DFG + KS +
Sbjct: 115 EPQIAY-VCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPY 448
S GT WMAPEVI+ + K+DIWS GI+ E+ E PY
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 79/264 (29%), Positives = 130/264 (49%), Gaps = 21/264 (7%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVREQKE-------TDIRHLRKLN 307
WE P E + + LGSG G V+ G ++ + VA+K ++ +++ L++L
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR 60
Query: 308 HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE--VPPQRLYNWARQIAAGMNYL 365
H +++ VC+ I+ E G L L+ E +P L + A Q+A GM YL
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 366 HSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR-----EWNNKSTKMSFAGTVAWMAPEVI 420
+ IHRDL + N+L+G K++DFG R + + K+ W APE
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP----YKWTAPEAA 176
Query: 421 RNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
+ S K D+WS+GI+L+E+ T + PY +++ + + ++ +P P+ CP
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-TAGYRMPCPAKCPQEIYK 235
Query: 480 LMKMCWSNAPSSRPSFKQILSHLD 503
+M CW+ P RPSFK + LD
Sbjct: 236 IMLECWAAEPEDRPSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-39
Identities = 94/275 (34%), Positives = 136/275 (49%), Gaps = 35/275 (12%)
Query: 266 LQWLGSGAQGAVFS------GKLRSEIVAVKKVREQK-------ETDIRHLRKLNHPNIV 312
+Q LG G G+V E+VAVKK++ E +I L+ L H NIV
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 313 KFKGVCTQA--PCYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
K+KGVC A +VMEY YG L + L K E + ++L +A QI GM YL SK+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--VAWMAPEVIRNEQC 425
+HRDL + N+L+ S+ KI DFG + + + K+ G + W APE + +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188
Query: 426 SDKIDIWSYGIVLWELLT-----CETPY-------KDVDSSAIIWGVGS---SSLHLPIP 470
S D+WS+G+VL+EL T C P D I++ + ++ LP P
Sbjct: 189 SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAP 248
Query: 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505
CP +MK CW+N PS RPSF ++ ++
Sbjct: 249 PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 77/258 (29%), Positives = 129/258 (50%), Gaps = 31/258 (12%)
Query: 269 LGSGAQGAVFSGKLRSEI------VAVKKVRE----QKETDI-RH---LRKLNHPNIVKF 314
LGSGA G V+ G E VA+K +RE + +I + ++HP++V+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
G+C + ++ + G L + +++ + + Q L NW QIA GM+YL K+++HR
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG---TVAWMAPEVIRNEQCSDKID 430
DL + NVL+ + + KI+DFG + + + G + WMA E I + + K D
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD 193
Query: 431 IWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSL-----HLPIPSTCPDGFQLLMKMC 484
+WSYG+ +WEL+T PY+ + + I L LP P C +++ C
Sbjct: 194 VWSYGVTVWELMTFGAKPYEGIPAVEI------PDLLEKGERLPQPPICTIDVYMVLVKC 247
Query: 485 WSNAPSSRPSFKQILSHL 502
W SRP+FK++++
Sbjct: 248 WMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 85/262 (32%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVREQ--------KETDIRHLRKL 306
WE+P E++ ++ LG+G G V+ G VA+K +++ E ++ +++L
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANL--MKQL 58
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNY 364
HP +V+ V TQ P Y I+ EY G L + LK +G ++ +L + A QIA GM +
Sbjct: 59 QHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRN 422
+ K IHRDL++ N+L+ KI+DFG R E N + + + W APE I
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 423 EQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ K D+WS+GI+L E++T PY + + +I + +P P CP+ LM
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMPRPDNCPEELYELM 236
Query: 482 KMCWSNAPSSRPSFKQILSHLD 503
++CW P RP+F+ + S L+
Sbjct: 237 RLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 83/252 (32%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVREQKETD------IRHLRKLNHPNIVK 313
+ ++ L+ LG+G G V GK R + VA+K ++E ++ + + KL+H +V+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 314 FKGVCT-QAPCYCIVMEYCAYGPLYNLLKDGEEVP-PQRLYNWARQIAAGMNYLHSKQII 371
GVCT Q P Y IV EY + G L N L++ + P +L + + GM YL SKQ I
Sbjct: 64 LYGVCTKQRPIY-IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
HRDL + N L+ + K+SDFG R + ++ + V W PEV+ + S K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 430 DIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488
D+W++G+++WE+ + + PY+ ++S + V S L L P + +M CW
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRLYRPHLASEKVYAIMYSCWHEK 241
Query: 489 PSSRPSFKQILS 500
RP+F+Q+LS
Sbjct: 242 AEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 2e-38
Identities = 88/260 (33%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQKET------DIRHLRKLNH 308
WEIP ESI ++ LG+G G V+ G S VAVK ++ + + ++ L H
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH 60
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNYLH 366
+V+ V T+ I+ EY A G L + LK +G +V +L +++ QIA GM Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
K IHRDL++ NVL+ KI+DFG R E N + + + W APE I
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 425 CSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
+ K D+WS+GI+L+E++T + PY + +S ++ + +P CPD +MK
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDIMKT 239
Query: 484 CWSNAPSSRPSFKQILSHLD 503
CW RP+F + S LD
Sbjct: 240 CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 80/256 (31%), Positives = 127/256 (49%), Gaps = 26/256 (10%)
Query: 264 SDLQWLGSGAQGAVFSG--KLRSEIVAVKKVR-EQKETD-------IRHLRKLNHPNIVK 313
+ L+ +G G+ G V+ K +++VA+K + E+ E + I+ L + P I K
Sbjct: 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLHSKQI 370
+ G + I+MEYC G +LLK G E L R++ G+ YLH +
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL----REVLLGLEYLHEEGK 119
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKI 429
IHRD+K+ N+L+ + + K++DFG + + +K +F GT WMAPEVI+ +K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK----MCW 485
DIWS GI EL E P D+ +++ + + PS + F K +C
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN----NPPSLEGNKFSKPFKDFVSLCL 235
Query: 486 SNAPSSRPSFKQILSH 501
+ P RPS K++L H
Sbjct: 236 NKDPKERPSAKELLKH 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 86/271 (31%), Positives = 137/271 (50%), Gaps = 20/271 (7%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-----VAVKKVREQKETDIRH-------- 302
+EI E I+ + +G G G V+ G S VAVK + +R
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAG 361
+R+ +HP+IVK GV T+ P + IVME G L + L + + L ++ Q++
Sbjct: 61 MRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEV 419
+ YL SK+ +HRD+ + NVL+ S + K+ DFG R ++S + G + WMAPE
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
I + + D+W +G+ +WE+L P++ V ++ +I G + LP+P CP
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLY 238
Query: 479 LLMKMCWSNAPSSRPSFKQILSHL-DIASQE 508
LM CW+ PS RP F ++ + L DI +E
Sbjct: 239 SLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-38
Identities = 86/259 (33%), Positives = 126/259 (48%), Gaps = 27/259 (10%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVREQ--------KETDIRHLRKL 306
WEI SI L+ LG+G G V+ G + VAVK ++ E I ++KL
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQI--MKKL 58
Query: 307 NHPNIVKFKGVCTQA-PCYCIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMN 363
HP +++ VCT P Y IV E YG L L+ G + +L + A Q+A+GM
Sbjct: 59 RHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR-----EWNNKS-TKMSFAGTVAWMAP 417
YL ++ IHRDL + NVL+G K++DFG R + + K + W AP
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP----IKWTAP 173
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E + S K D+WS+GI+L E++T PY + ++ ++ V +P P CP
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKE 232
Query: 477 FQLLMKMCWSNAPSSRPSF 495
+M CW P RP+F
Sbjct: 233 LYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 85/257 (33%), Positives = 131/257 (50%), Gaps = 24/257 (9%)
Query: 269 LGSGAQGAVFSGKL-----RSEIVAVKKVR----EQKETDIRH----LRKLNHPNIVKFK 315
+G+G G V G+L R VA+K ++ E++ D + + +HPNI+ +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
GV T++ I+ E+ G L + L+ DG+ Q L R IAAGM YL +HR
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ-LVGMLRGIAAGMKYLSEMNYVHR 130
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT------VAWMAPEVIRNEQCSD 427
DL + N+L+ S K+SDFG R + ++ ++ + + W APE I + +
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190
Query: 428 KIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
D+WSYGIV+WE+++ E PY D+ + +I + LP P CP LM CW
Sbjct: 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQ 249
Query: 487 NAPSSRPSFKQILSHLD 503
++RP F QI+S LD
Sbjct: 250 KDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 9e-38
Identities = 85/258 (32%), Positives = 133/258 (51%), Gaps = 26/258 (10%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKV-----------REQK-----ETDIRHLRKLNHPN 310
+GSG+ G+V+ G E++AVK+V R++ +I L++L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
IV++ G A I +EY G + LL + + N+ RQI G+NYLH++ I
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKM-----SFAGTVAWMAPEVIRNE 423
IHRD+K N+L+ +K KISDFG + E N+ STK S G+V WMAPEV++
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187
Query: 424 QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
+ K DIWS G ++ E+LT + P+ D I+ +G ++ IPS ++
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP-EIPSNISSEAIDFLEK 246
Query: 484 CWSNAPSSRPSFKQILSH 501
+ + RP+ ++L H
Sbjct: 247 TFEIDHNKRPTAAELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 92/262 (35%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVR------EQKETDIRHLRKLNH 308
WEIP ES+ ++ LG+G G V+ G VAVK ++ E + + ++KL H
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE----EVPPQRLYNWARQIAAGMNY 364
+V+ V ++ P Y IV EY + G L + LKDGE ++P L + A Q+AAGM Y
Sbjct: 61 DKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAY 117
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRN 422
+ IHRDL+S N+L+G KI+DFG R E N + + + W APE
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 423 EQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ + K D+WS+GI+L EL+T PY +++ ++ V +P P CP LM
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLHELM 236
Query: 482 KMCWSNAPSSRPSFKQILSHLD 503
CW P RP+F+ + S L+
Sbjct: 237 LQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 79/249 (31%), Positives = 124/249 (49%), Gaps = 22/249 (8%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVR-----EQKETDIRHLRKLNHPNIVKFKGVCTQA 321
LG G+ G+V+ K ++VA+K V ++ +I L++ + P IVK+ G +
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN 70
Query: 322 PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA-------GMNYLHSKQIIHRD 374
IVMEYC G + +++K + + +IAA G+ YLHS + IHRD
Sbjct: 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEE------EIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIWS 433
+K+ N+L+ + +AK++DFG + + K + GT WMAPEVI+ ++K DIWS
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
GI E+ + PY D+ I+ + + L P F +K C P R
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER 244
Query: 493 PSFKQILSH 501
PS Q+L H
Sbjct: 245 PSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 89/266 (33%), Positives = 136/266 (51%), Gaps = 20/266 (7%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKL----RSEI-VAVKKVR----EQKETDIRH----L 303
EI I+ + +G+G G VF G L R E+ VA+K ++ E++ D +
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGM 362
+ +H NI++ +GV T+ I+ EY G L L+D + E +L R IAAGM
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVA--WMAPE 418
YL +HRDL + N+L+ S E K+SDFG R E + + T + G + W APE
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477
I + + D+WS+GIV+WE+++ E PY D+ + ++ + + LP P CP
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAV 239
Query: 478 QLLMKMCWSNAPSSRPSFKQILSHLD 503
LM CW + RP F I++ LD
Sbjct: 240 YQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 90/260 (34%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR------EQKE--TDIRHLRKLNHPN 310
+ + L LG+G G V R +I+AVK +R QK+ ++ L K N P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 311 IVKFKGVC-TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR-LYNWARQIAAGMNYLHSK 368
IV F G I MEY G L +LK+ + P+R L A + G+ YLH K
Sbjct: 61 IVGFYGAFYNNGDIS-ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 369 -QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
+IIHRD+K N+L+ S+ + K+ DFG + N S +F GT ++MAPE I+ S
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 428 KIDIWSYGIVLWELLTCETPYKDVDSSAI-IWGVGSSSLHLPIPSTCPDG-----FQLLM 481
K DIWS G+ L EL T PY + I+ + ++ P P P G FQ +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFV 237
Query: 482 KMCWSNAPSSRPSFKQILSH 501
+C P RPS+K++L H
Sbjct: 238 NLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 75/253 (29%), Positives = 115/253 (45%), Gaps = 17/253 (6%)
Query: 266 LQWLGSGAQGAVFSGKLR--SEIVAVK--KVREQKETD-----IRHLRKLNHPNIVKFKG 316
+Q +GSG G V+ + E+VA+K K+ + + I L++ HPNIV + G
Sbjct: 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNW-ARQIAAGMNYLHSKQIIHRDL 375
+ IVMEYC G L ++ + + + R+ G+ YLH IHRD+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSD---KIDI 431
K N+L+ + K++DFG + K SF GT WMAPEV E+ K DI
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187
Query: 432 WSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL---HLPIPSTCPDGFQLLMKMCWSNA 488
W+ GI EL + P D+ ++ + S+ L F +K C +
Sbjct: 188 WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKD 247
Query: 489 PSSRPSFKQILSH 501
P RP+ ++L H
Sbjct: 248 PKKRPTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 6e-37
Identities = 88/255 (34%), Positives = 131/255 (51%), Gaps = 22/255 (8%)
Query: 269 LGSGAQGAVFSGKL-----RSEIVAVKKVR----EQKETDIRH----LRKLNHPNIVKFK 315
+G+G G V SG+L R VA+K ++ E++ D + + +HPNI+ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
GV T++ IV EY G L L+ DG+ Q L R IA+GM YL +HR
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ-LVGMLRGIASGMKYLSDMGYVHR 130
Query: 374 DLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVA--WMAPEVIRNEQCSDKI 429
DL + N+L+ S K+SDFG R E + ++ + G + W APE I + +
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 430 DIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488
D+WSYGIV+WE+++ E PY ++ + +I + LP P CP LM CW
Sbjct: 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPAALHQLMLDCWQKD 249
Query: 489 PSSRPSFKQILSHLD 503
+ RP F+QI+S LD
Sbjct: 250 RNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 94/283 (33%), Positives = 136/283 (48%), Gaps = 42/283 (14%)
Query: 257 EIPFESISDLQWLGSGAQGAVFS----GKLRSE---IVAVKKVREQKETDIRH------- 302
E P +I ++ +G GA G VF G L E +VAVK ++E+ D++
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 303 -LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD------------------- 342
+ + +HPNIVK GVC C++ EY AYG L L+
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 343 GEEVPP---QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE- 398
G P A+Q+AAGM YL ++ +HRDL + N L+G KI+DFG R
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 399 WNNKSTKMSF--AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE-TPYKDVDSSA 455
++ K S A + WM PE I + + + D+W+YG+VLWE+ + PY +
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
Query: 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498
+I+ V ++ L P CP LM++CWS PS RPSF I
Sbjct: 241 VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 1e-36
Identities = 89/249 (35%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 269 LGSGAQGAVFSGKLRSEI-VAVKKVREQKETDI--------RHLRKLNHPNIVKFKGVCT 319
LG G G VF G L+ + VAVK +E ++ R L++ +HPNIVK GVCT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 320 QAPCYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378
Q IVME G + L K +E+ ++L +A AAGM YL SK IHRDL +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122
Query: 379 NVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGI 436
N L+G KISDFG R+ ++ S + W APE + + S + D+WSYGI
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGI 182
Query: 437 VLWELLTCET-PYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSF 495
+LWE + PY + + V + P CPD +M+ CW P +RP F
Sbjct: 183 LLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKF 241
Query: 496 KQILSHLDI 504
++ L
Sbjct: 242 SELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 82/266 (30%), Positives = 129/266 (48%), Gaps = 34/266 (12%)
Query: 267 QWLGSGAQGAVFSG--KLRSEIVAVKKVREQKETDIRH-----------------LRKLN 307
+ +G G G V+ E++AVK+V RH L+ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 308 HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS 367
H NIV++ G T I +EY G + + L+ Q + + Q+ G+ YLHS
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN---KSTKMSFAGTVAWMAPEVIRNEQ 424
K I+HRDLK+ N+L+ + KISDFG ++ ++ MS G+V WMAPEVI +
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 425 C--SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL-- 480
S K+DIWS G V+ E+ P+ D ++ A ++ +G+ PIP PD L
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP---PDVSMNLSP 243
Query: 481 -----MKMCWSNAPSSRPSFKQILSH 501
+ C++ P +RP+ +++L H
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 87/277 (31%), Positives = 128/277 (46%), Gaps = 34/277 (12%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLR------SEI-VAVKKVRE----QKETDIRH--- 302
E+P +SI+ L+ LG GA G V+ G R E+ VAVK + E Q E+D
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 303 -LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQ-------RLYNW 354
+ K NH NIV+ GV + I++E A G L + L++ P + L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCRE-----WNNKSTKM 406
AR +A G YL IHRD+ + N L+ K AKI+DFG R+ + K +
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSL 465
+ WM PE + + K D+WS+G++LWE+ + PY + ++ V
Sbjct: 182 MLP--IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG- 238
Query: 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
L P CP +M CW + P RP+F IL +
Sbjct: 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 83/262 (31%), Positives = 127/262 (48%), Gaps = 31/262 (11%)
Query: 266 LQWLGSGAQGAVFSG-KLRS-EIVAVKKVREQKET---------DIRHLRKLNHPNIVKF 314
+G G G V++ L + E++AVK++R Q +++ L L HPN+VK+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
GV I MEYC+ G L LL+ G + + + Q+ G+ YLHS I+HRD
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-----SFAGTVAWMAPEVIRNEQCSDK- 428
+K N+ + K+ DFG + N +T M S AGT A+MAPEVI +
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 429 --IDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQL------ 479
DIWS G V+ E+ T + P+ ++D+ I++ VG+ PD QL
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-----KPPIPDSLQLSPEGKD 239
Query: 480 LMKMCWSNAPSSRPSFKQILSH 501
+ C + P RP+ ++L H
Sbjct: 240 FLDRCLESDPKKRPTASELLQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 84/257 (32%), Positives = 129/257 (50%), Gaps = 16/257 (6%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ-------KETDIRHLRKLNH 308
W + + ++ + +G G GAV G+ + VAVK ++ +ET + + KL+H
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAV--MTKLHH 58
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE--VPPQRLYNWARQIAAGMNYLH 366
N+V+ GV Y IVME + G L N L+ V +L ++ +A GM YL
Sbjct: 59 KNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 426
SK+++HRDL + N+L+ AK+SDFG R + S V W APE +++++ S
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKL-PVKWTAPEALKHKKFS 175
Query: 427 DKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485
K D+WSYG++LWE+ + PY + + V P P CP +LM CW
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP-PEGCPADVYVLMTSCW 234
Query: 486 SNAPSSRPSFKQILSHL 502
P RPSF ++ L
Sbjct: 235 ETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 82/277 (29%), Positives = 113/277 (40%), Gaps = 48/277 (17%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
LG G G V+ K EIVA+KK+R E + I L++L HPNIVK V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+V EYC L L + P + + Q+ G+ Y HS +I+HRDLK
Sbjct: 67 IHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLK 125
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVIRNEQC-SDKIDIW 432
N+LI K++DFG R + + V W APE++ + S +DIW
Sbjct: 126 PQNILINRDGVLKLADFGLARAFGIPLRTYT--HEVVTLWYRAPEILLGSKHYSTAVDIW 183
Query: 433 SYGIVLWELLT--------CE------------TP----YKDVDSSAIIWGV----GSSS 464
S G + E++T E TP + V
Sbjct: 184 SVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKD 243
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L +P P+G LL KM N P+ R S K+ L H
Sbjct: 244 LEKVLPRLDPEGIDLLSKMLQYN-PAKRISAKEALKH 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 5e-35
Identities = 78/259 (30%), Positives = 128/259 (49%), Gaps = 24/259 (9%)
Query: 267 QWLGSGAQGAVFSGK--LRSEIVAVKKVREQKET-------------DIRHLRKLNHPNI 311
Q LG+GA + + + ++AVK+V + T +IR + +LNHP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
++ G + + + +E+ A G + +LL + N+ Q+ G++YLH QII
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 372 HRDLKSPNVLIGSK-EEAKISDFGTCREWNNKST-----KMSFAGTVAWMAPEVIRNEQC 425
HRD+K N+LI S + +I+DFG K T + GT+A+MAPEV+R EQ
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDSS---AIIWGVGSSSLHLPIPSTCPDGFQLLMK 482
D+WS G V+ E+ T + P+ S A+I+ + S++ IP G + +
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL 245
Query: 483 MCWSNAPSSRPSFKQILSH 501
C P RP +++L H
Sbjct: 246 RCLELQPEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 85/256 (33%), Positives = 125/256 (48%), Gaps = 30/256 (11%)
Query: 266 LQWLGSGAQGAVFSGK--LRSEIVAVKKVR----EQKETDIRH-------LRKLNHPNIV 312
L+ +G GA GAV+ GK +VA+K + + +DI+ LR+ PNI
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWA--RQIAAGMNYLHSKQI 370
K+ G + P I+MEY G + L+K G P Y R++ + Y+H +
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGV 122
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSD-K 428
IHRD+K+ N+L+ + K+ DFG N S+K S F GT WMAPEVI + D K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD-GFQLLMK----M 483
DIWS GI ++E+ T PY DVD+ + + S P D G+ L++
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-----PPRLEDNGYSKLLREFVAA 237
Query: 484 CWSNAPSSRPSFKQIL 499
C P R S +++L
Sbjct: 238 CLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 8e-35
Identities = 89/260 (34%), Positives = 132/260 (50%), Gaps = 14/260 (5%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVR------EQKETDIRHLRKLNH 308
WEIP ES+ LG G G V+ G VA+K ++ E + + ++KL H
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRH 60
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNYLH 366
+V V ++ P Y IV E+ G L + LK DG+ + +L + A QIA GM Y+
Sbjct: 61 DKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
IHRDL++ N+L+G KI+DFG R E N + + + W APE +
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 425 CSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
+ K D+WS+GI+L EL+T PY + + ++ V +P P CP+ LMK+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHELMKL 238
Query: 484 CWSNAPSSRPSFKQILSHLD 503
CW P RP+F+ I S L+
Sbjct: 239 CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 83/249 (33%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 267 QWLGSGAQGAVFSGK-LRSEIVAVKKVRE--QKETDIRH----LRKLNHPNIVKFKGVCT 319
Q +GSG G V+ G L VA+K +RE E D + KL+HP +V+ GVCT
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 320 QAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378
+ C+V E+ +G L + L+ + + L + GM YL S +IHRDL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 379 NVLIGSKEEAKISDFGTCR----EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N L+G + K+SDFG R + ST F V W +PEV + S K D+WS+
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSKYSSKSDVWSF 187
Query: 435 GIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
G+++WE+ + +TPY++ +S ++ + ++ L P LM+ CW P RP
Sbjct: 188 GVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLASQSVYELMQHCWKERPEDRP 246
Query: 494 SFKQILSHL 502
SF +L L
Sbjct: 247 SFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 82/270 (30%), Positives = 116/270 (42%), Gaps = 39/270 (14%)
Query: 269 LGSGAQGAVFSGKLRSEIVAVKKVREQKETD----------IRHLRKLNHP-NIVKFKGV 317
LG G+ G V+ + ++VA+K + ++ E+ I+ L LNHP NIVK
Sbjct: 8 LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEE---VPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
+VMEY G L +LLK + QI + + YLHSK IIHRD
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRD 126
Query: 375 LKSPNVLIGSKE-EAKISDFGTCRE-------WNNKSTKMSFAGTVAWMAPEVIR---NE 423
+K N+L+ K+ DFG + + + + GT +MAPEV+
Sbjct: 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186
Query: 424 QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD-------- 475
S DIWS GI L+ELLT P++ +S+ L LP PS
Sbjct: 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPEL 246
Query: 476 ----GFQLLMKMCWSNAPSSRPSFKQILSH 501
LL K+ + P +R S LSH
Sbjct: 247 ISKAASDLLKKLL-AKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 90/281 (32%), Positives = 132/281 (46%), Gaps = 36/281 (12%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVRE----QKETDIRH---- 302
E+P ++ ++ LG A G ++ G L +++VA+K +++ Q+ + +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL--------------KDG---EE 345
+ +L+HPNIV GV TQ C++ EY G L+ L +DG
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 346 VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405
+ + A QIAAGM YL S +H+DL + N+LIG + KISD G RE +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 406 MSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE-TPYKDVDSSAIIWGVG 461
+ + WM PE I + S DIWS+G+VLWE+ + PY + +I V
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240
Query: 462 SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
L LP CP LM CW PS RP FK I + L
Sbjct: 241 KRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 78/251 (31%), Positives = 121/251 (48%), Gaps = 17/251 (6%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKV---------REQKETDIRHLRKLNHPNIVKF 314
L+ LG G+ G+V+ K S + A+K+V RE +IR L +NHPNI+ +
Sbjct: 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE----VPPQRLYNWARQIAAGMNYLHSKQI 370
K CIVMEY +G L + ++ +P Q ++ Q+ G+ LH ++I
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI 124
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
+HRDLKS N+L+ + + KI D G + K GT +MAPEV + S K D
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGRPYSYKSD 183
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490
IWS G +L+E+ T P++ + + V + PIP Q ++ P
Sbjct: 184 IWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSMLQVKPK 242
Query: 491 SRPSFKQILSH 501
RP+ +IL+
Sbjct: 243 LRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 89/281 (31%), Positives = 132/281 (46%), Gaps = 36/281 (12%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVREQKETDIRH------- 302
EI ++ ++ LG G V+ G L +++ VA+K ++++ E +R
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 303 LR-KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL------------KDGEEVP-- 347
+R +L HPNIV GV T+ ++ YC++ L+ L D + V
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 348 --PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405
P + QIAAGM +L S ++H+DL + NVL+ K KISD G RE
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 406 MSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE-TPYKDVDSSAIIWGVG 461
+ + WM+PE I + S DIWSYG+VLWE+ + PY + +I +
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
Query: 462 SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
+ + LP P CP LM CW+ PS RP FK I S L
Sbjct: 241 NRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 86/260 (33%), Positives = 134/260 (51%), Gaps = 14/260 (5%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVREQKET------DIRHLRKLNH 308
WEIP ES+ + LG+G G V+ VAVK ++ + + ++ L H
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH 60
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNYLH 366
+VK V T+ P Y I+ E+ A G L + LK +G + P +L +++ QIA GM ++
Sbjct: 61 DKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
+ IHRDL++ N+L+ + KI+DFG R E N + + + W APE I
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 425 CSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
+ K D+WS+GI+L E++T PY + + +I + +P P CP+ +M
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMR 238
Query: 484 CWSNAPSSRPSFKQILSHLD 503
CW N P RP+F+ I S LD
Sbjct: 239 CWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 97/313 (30%), Positives = 147/313 (46%), Gaps = 51/313 (16%)
Query: 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKL---------RSEIVAVKKVREQ-KETDIR 301
L +WE P + + + LG G G V + ++ VAVK +++ + D+
Sbjct: 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA 62
Query: 302 HL------RKL--NHPNIVKFKGVCTQ-APCYCIVMEYCAYGPLYNLLK----------- 341
L KL H NI+ GVCTQ P Y IV EY A G L L+
Sbjct: 63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTF 121
Query: 342 DGEEVPPQRL-----YNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396
D +VP ++L + A Q+A GM YL S++ IHRDL + NVL+ KI+DFG
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 397 R-----EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKD 450
R ++ K++ V WMAPE + + + + D+WS+GI++WE+ T +PY
Sbjct: 182 RGVHDIDYYKKTSNGRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239
Query: 451 VDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV- 509
+ ++ + + PS C +LM+ CW P+ RP+FKQ++ LD V
Sbjct: 240 IPVEE-LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
Query: 510 -----LRIQPEPY 517
L + E Y
Sbjct: 299 EEYLDLSMPFEQY 311
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 88/276 (31%), Positives = 140/276 (50%), Gaps = 30/276 (10%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKV------REQKE--TDI 300
WE+ E I+ L+ LG G+ G V+ G R I VAVK V RE+ E +
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 60
Query: 301 RHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK----DGE----EVPP--QR 350
++ ++V+ GV ++ +VME A+G L + L+ + E PP Q
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFA 409
+ A +IA GM YL++K+ +HRDL + N ++ KI DFG R+ + +
Sbjct: 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 410 G--TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLH 466
G V WMAPE +++ + D+WS+G+VLWE+ + E PY+ + + ++ V +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-Y 239
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
L P CP+ LM+MCW P RP+F +I++ L
Sbjct: 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 82/276 (29%), Positives = 134/276 (48%), Gaps = 30/276 (10%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKVREQKETDIR------- 301
WE+ E I+ + LG G+ G V+ G + + VA+K V E R
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 302 -HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD---------GEEVPP-QR 350
+++ N ++V+ GV +Q ++ME G L + L+ + P ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFA 409
+ A +IA GM YL++ + +HRDL + N ++ KI DFG R+ + +
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 410 G--TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLH 466
G V WM+PE +++ + D+WS+G+VLWE+ T E PY+ + + ++ V L
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL- 239
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
L P CPD LM+MCW P RPSF +I+S +
Sbjct: 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 81/257 (31%), Positives = 123/257 (47%), Gaps = 12/257 (4%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKET-----DIRHLRKLNHPN 310
W + + + LQ +G G G V G R VAVK ++ + + +L H N
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSN 60
Query: 311 IVKFKGVCTQAP-CYCIVMEYCAYGPLYNLLKD-GEEV-PPQRLYNWARQIAAGMNYLHS 367
+V+ GV + IV EY A G L + L+ G V L ++ + M YL +
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
+HRDL + NVL+ AK+SDFG +E ST+ + V W APE +R ++ S
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 428 KIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
K D+WS+GI+LWE+ + PY + ++ V + P CP +MK CW
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPVVYDVMKQCWH 237
Query: 487 NAPSSRPSFKQILSHLD 503
++RPSF Q+ L+
Sbjct: 238 LDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 91/273 (33%), Positives = 127/273 (46%), Gaps = 39/273 (14%)
Query: 266 LQW-LGSGAQGAVF----------SGKLRSEIVAVKKVREQKETDIRH----LRKLNHPN 310
L+W LG GA G VF K+ + A+K+ E D + L L H +
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 311 IVKFKGVCTQAPCYCIVMEYC----------AYGPLYNLLKDGEEVPPQRL-----YNWA 355
IV+F GVCT+ +V EY ++GP +L GE+V P +L A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 356 RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG----- 410
QIA+GM YL S +HRDL + N L+G KI DFG R+ ST G
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYRVGGRTML 186
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPI 469
+ WM PE I + + + DIWS+G+VLWE+ T + P+ + ++ I + + L
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-TQGRELER 245
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
P TCP +M+ CW P R K I S L
Sbjct: 246 PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 78/269 (28%), Positives = 119/269 (44%), Gaps = 46/269 (17%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVK--KVREQKETDIRH----LRKL-NHPNIVKFKGVCT 319
+G G G V+ + + ++VA+K + E +E +I+ LRK NHPNI F G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 320 QAPCYC------IVMEYCAYGPLYNLLKDGEEVPPQRLY-NW----ARQIAAGMNYLHSK 368
+ +VME C G + +L+K G +RL W R+ G+ YLH
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVK-GLRKKGKRLKEEWIAYILRETLRGLAYLHEN 132
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD 427
++IHRD+K N+L+ E K+ DFG + ++ + +F GT WMAPEVI ++ D
Sbjct: 133 KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD 192
Query: 428 -----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCP-------- 474
+ D+WS GI EL + P D+ +L IP P
Sbjct: 193 ASYDARSDVWSLGITAIELADGKPPLCDMHP--------MRALFK-IPRNPPPTLKSPEN 243
Query: 475 --DGFQLLMKMCWSNAPSSRPSFKQILSH 501
F + C RP +++L H
Sbjct: 244 WSKKFNDFISECLIKNYEQRPFMEELLEH 272
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 82/269 (30%), Positives = 121/269 (44%), Gaps = 49/269 (18%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVR-EQKETDIRHLRK-------LNHPNIVKFKGVC 318
+G GA V++ +E VA+K++ E+ +T + LRK NHPN+VK+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAA-------GMNYLHSKQ 369
+VM Y + G L +++K + + IA G+ YLHS
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI------IATVLKEVLKGLEYLHSNG 122
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFG--------TCREWNNKSTKMSFAGTVAWMAPEVIR 421
IHRD+K+ N+L+G KI+DFG R + T F GT WMAPEV+
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT---FVGTPCWMAPEVME 179
Query: 422 NEQCSD-KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS--TCPDG-- 476
D K DIWS+GI EL T PY ++ +L PS T D
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM----LTLQNDPPSLETGADYKK 235
Query: 477 ----FQLLMKMCWSNAPSSRPSFKQILSH 501
F+ ++ +C PS RP+ +++L H
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 269 LGSGAQGAV-------FSGKLRSEIVAVKKVREQKE--------TDIRHLRKLNHPNIVK 313
LG G G V G+ VAVK ++E ++ L+++NHP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPP------------------------Q 349
G C+Q +++EY YG L + L++ +V P
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 350 RLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA 409
L ++A QI+ GM YL +++HRDL + NVL+ + KISDFG R+ + + + +
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 410 G---TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSL 465
V WMA E + + + + D+WS+G++LWE++T PY + ++ + +
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFNLLKTGY 246
Query: 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ P C + LM CW P RP+F I L+
Sbjct: 247 RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 80/260 (30%), Positives = 122/260 (46%), Gaps = 32/260 (12%)
Query: 269 LGSGAQGAVFSGKL-RSEIVAVKKV---------------REQKETDIRHLRKLNHPNIV 312
LG GA G V+ G + +++AVK+V + Q+E D+ L+ L H NIV
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDL--LKSLKHVNIV 65
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
++ G C I ME+ G + ++L +P + +QI G+ YLH+ ++H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCRE--W---NNKSTKM--SFAGTVAWMAPEVIRNEQC 425
RD+K NV++ K+ DFG R W + + M S GT WMAPEVI
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL----LM 481
K DIWS G ++E+ T + P +D A ++ +G+ +P PD F +
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH--RGLMPRL-PDSFSAAAIDFV 242
Query: 482 KMCWSNAPSSRPSFKQILSH 501
C + RPS Q+L H
Sbjct: 243 TSCLTRDQHERPSALQLLRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 82/248 (33%), Positives = 125/248 (50%), Gaps = 20/248 (8%)
Query: 269 LGSGAQGAVFSG--KLRSEI--VAVKKVREQKETDIRH--------LRKLNHPNIVKFKG 316
LGSG G V G K+R + VA+K ++ + E +R + +L++P IV+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
VC +A +VME + GPL L +E+ + Q++ GM YL K +HRDL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121
Query: 376 KSPNVLIGSKEEAKISDFGTCREW--NNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDI 431
+ NVL+ ++ AKISDFG + ++ K AG + W APE I + S + D+
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 432 WSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490
WSYGI +WE + + PYK + ++ + L P+ CP LMK CW
Sbjct: 182 WSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAECPPEMYALMKDCWIYKWE 240
Query: 491 SRPSFKQI 498
RP+F ++
Sbjct: 241 DRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 77/258 (29%), Positives = 120/258 (46%), Gaps = 26/258 (10%)
Query: 269 LGSGAQGAVF------SGKLRSEIVAVKKV---REQKET---------DIRHLRKLNHPN 310
LG GA G V+ +G+ +AVK+V + ET +I+ L+ L H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRE----LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
IV++ G I MEY G + + LK + + RQI G+ YLHS I
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNN---KSTKM-SFAGTVAWMAPEVIRNEQCS 426
+HRD+K N+L S K+ DFG + T M S GT WM+PEVI E
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 427 DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
K D+WS G + E+LT + P+ + ++ A I+ + + + +PS + ++ +
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 487 NAPSSRPSFKQILSHLDI 504
RPS +++L H +
Sbjct: 246 ENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 79/246 (32%), Positives = 119/246 (48%), Gaps = 12/246 (4%)
Query: 269 LGSGAQGAVFSGKLRSEI-VAVKKVRE--QKETDI----RHLRKLNHPNIVKFKGVCTQA 321
LGSG G V GK R++I VA+K + E E D + + KL+HP +V+ GVCTQ
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 322 PCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380
IV E+ G L N L+ + ++ L + + + GM YL IHRDL + N
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNC 131
Query: 381 LIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVL 438
L+ S K+SDFG R + S V W PEV + S K D+WS+G+++
Sbjct: 132 LVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLM 191
Query: 439 WELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQ 497
WE+ T + P++ + ++ + S L P +M CW P RP+F +
Sbjct: 192 WEVFTEGKMPFEKKSNYEVVEMI-SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAE 250
Query: 498 ILSHLD 503
+L +
Sbjct: 251 LLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-32
Identities = 86/263 (32%), Positives = 124/263 (47%), Gaps = 18/263 (6%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVREQKETDIRH--------L 303
E+ +SI + LG+G G + G L R VA+ +R R L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGM 362
+ +H NIV+ +GV T+ IV EY + G L + L+ E ++ +L +A+GM
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--TKMSFAGTVAWMAPEVI 420
YL +H+ L + VL+ S KIS F +E +++ T MS V W APE I
Sbjct: 121 KYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 421 RNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
+ S D+WS+GIV+WE+++ E PY D+ +I V LP P CP+
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQ 239
Query: 480 LMKMCWSNAPSSRPSFKQILSHL 502
LM CW RP F QI S L
Sbjct: 240 LMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 79/248 (31%), Positives = 120/248 (48%), Gaps = 37/248 (14%)
Query: 285 EIVAVKKVREQK--------ETDIRHLRKLNHPNIVKFKGVCTQAPCYCI--VMEYCAYG 334
E VAVK ++ + + +I LR L H NIVK+KG+CT+ I +ME+ G
Sbjct: 34 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 335 PLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDF 393
L L ++ ++ ++ +A QI GM+YL S+Q +HRDL + NVL+ S+ + KI DF
Sbjct: 94 SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 153
Query: 394 GTCREWNNK----STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYK 449
G + + K V W APE + + D+WS+G+ L+ELLT Y
Sbjct: 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT----YC 209
Query: 450 DVDSSAI------------------IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491
D +SS + + V LP P CP+ LM+ CW PS
Sbjct: 210 DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK 269
Query: 492 RPSFKQIL 499
R +F+ ++
Sbjct: 270 RTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 84/260 (32%), Positives = 131/260 (50%), Gaps = 14/260 (5%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVR------EQKETDIRHLRKLNH 308
WEIP ES+ LG G G V+ G VA+K ++ E + + ++KL H
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLH 366
+V+ V ++ P Y IV EY + G L + LK G+ + +L + A QIA+GM Y+
Sbjct: 61 EKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
+HRDL++ N+L+G K++DFG R E N + + + W APE +
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 425 CSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
+ K D+WS+GI+L EL T PY + + ++ V +P P CP+ LM
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQ 238
Query: 484 CWSNAPSSRPSFKQILSHLD 503
CW P RP+F+ + + L+
Sbjct: 239 CWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 84/309 (27%), Positives = 148/309 (47%), Gaps = 31/309 (10%)
Query: 269 LGSGAQGAVFSGKLRSE------IVAVKKVREQKETDIRH--------LRKLNHPNIVKF 314
LGSGA G V+ G E VA+K++RE + +++P++ +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHSKQIIHR 373
G+C + ++ + +G L + +++ ++ + Q L NW QIA GMNYL ++++HR
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHR 133
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG---TVAWMAPEVIRNEQCSDKID 430
DL + NVL+ + + KI+DFG + + G + WMA E I + + + D
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD 193
Query: 431 IWSYGIVLWELLTCET-PYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
+WSYG+ +WEL+T + PY + +S I + LP P C ++M CW
Sbjct: 194 VWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDA 252
Query: 490 SSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHM-LEMQANKSHVPKFEEF 548
SRP F++++ +++ P+ Y +Q + R+H+ +N EE
Sbjct: 253 DSRPKFRELIIEFSKMARD-----PQRYLVIQ----GDERMHLPSPTDSNFYRALMDEED 303
Query: 549 EDDLIKKRE 557
DD++ E
Sbjct: 304 MDDVVDADE 312
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 79/261 (30%), Positives = 126/261 (48%), Gaps = 38/261 (14%)
Query: 269 LGSGAQGAVFSGKL-----RSEIVAVKKVREQKETDIRH----------LRKLNHPNIVK 313
+G G G V+ G L + AVK + + TD+ ++ +HPN++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 314 FKGVCTQ---APCYCIVMEYCAYGPLYNLLKDGEEVPPQR-LYNWARQIAAGMNYLHSKQ 369
G+C +P +V+ Y +G L N ++ P + L + Q+A GM YL SK+
Sbjct: 61 LLGICLPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCRE---------WNNKSTKMSFAGTVAWMAPEVI 420
+HRDL + N ++ K++DFG R+ N+ K+ V WMA E +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESL 174
Query: 421 RNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
+ ++ + K D+WS+G++LWEL+T PY DVDS I + L P CPD
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYCPDPLYE 233
Query: 480 LMKMCWSNAPSSRPSFKQILS 500
+M CW P RP+F +++S
Sbjct: 234 VMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 75/245 (30%), Positives = 121/245 (49%), Gaps = 20/245 (8%)
Query: 269 LGSGAQGAVFSGKLR----SEIVAVK---------KVREQKETDIRHLRKLNHPNIVKFK 315
LGSG G V G + + VAVK ++++ + +++L++P IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
G+C +A + +VME GPL L+ + V + + Q++ GM YL +HRDL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 376 KSPNVLIGSKEEAKISDFGTCR----EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
+ NVL+ ++ AKISDFG + + N K V W APE + + S K D+
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDV 181
Query: 432 WSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490
WS+G+++WE + + PYK + + + + S + P CP LMK+CW+
Sbjct: 182 WSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RMECPQRCPPEMYDLMKLCWTYGVD 240
Query: 491 SRPSF 495
RP F
Sbjct: 241 ERPGF 245
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 93/289 (32%), Positives = 140/289 (48%), Gaps = 45/289 (15%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKL---------RSEIVAVKKVR-EQKETDIRHL-- 303
WE+P + + + LG G G V + R VAVK ++ + E D+ L
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS 72
Query: 304 ----RKL--NHPNIVKFKGVCTQ-APCYCIVMEYCAYGPLYNLLK-----------DGEE 345
K+ H NI+ G CTQ P Y IV EY + G L L+ + +
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 346 VPPQR-----LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--- 397
VP ++ L + A Q+A GM YL SK+ IHRDL + NVL+ KI+DFG R
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 398 --EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSS 454
++ K+T V WMAPE + + + + D+WS+G++LWE+ T +PY V
Sbjct: 192 HIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
++ + + PS C + ++M+ CW PS RP+FKQ++ LD
Sbjct: 250 E-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 88/266 (33%), Positives = 127/266 (47%), Gaps = 33/266 (12%)
Query: 269 LGSGAQGAVFSGKLRSEI--------VAVKKVR------EQKE--TDIRHLRKLNHPNIV 312
LGSGA G V+ G + VAVK +R E+KE + + NHPNIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDG--EEVPP-----QRLYNWARQIAAGMNYL 365
K GVC I+ME G L + L+D E P + L + +A G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 366 HSKQIIHRDLKSPNVLIGSKEEA-----KISDFGTCRE-WNNKSTKMSFAG--TVAWMAP 417
IHRDL + N L+ K KI DFG R+ + + + G V WMAP
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E + + + + + D+WS+G+++WE+LT + PY +++ ++ V + L P CPD
Sbjct: 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RLQKPENCPDK 241
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHL 502
LM CW+ PS RP+F +I L
Sbjct: 242 IYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 45/279 (16%)
Query: 266 LQWLGSGAQGAVFSGK--LRSEIVAVKKVREQKETD---------IRHLRKLNHPNIVKF 314
L +G G G V+ + L EIVA+KK++ + E++ I+ L++LNHPNI+K
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
V +V E+ LY L+KD + +P + ++ Q+ G+ + HS I+HR
Sbjct: 64 LDVFRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVI-RNEQCSDKIDI 431
DLK N+LI ++ K++DFG R + + + + T + APE++ ++ S +DI
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182
Query: 432 WSYGIVLWELLTCET--PYK-DVDS-----------SAIIWGVGSSS------------- 464
WS G + ELL+ P K ++D +W +S
Sbjct: 183 WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAG 242
Query: 465 --LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L P+ P LL +M + P R + +Q L+H
Sbjct: 243 MPLPKLFPNASPQALDLLSQMLHYD-PHKRITAEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 25/208 (12%)
Query: 269 LGSGAQGAVF--SGKLRSEIVAVKKVREQK------------ETDIRHLRKLNHPNIVK- 313
LG G+ G V K ++ A+K ++++K E +I L ++NHP IVK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNI--LSRINHPFIVKL 58
Query: 314 ---FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
F+ T+ Y +V+EY G L++ L +R +A +I + YLHS I
Sbjct: 59 HYAFQ---TEEKLY-LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
I+RDLK N+L+ + K++DFG +E + S +F GT ++APEV+ + +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAII 457
D WS G++L+E+LT + P+ D I
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 88/275 (32%), Positives = 130/275 (47%), Gaps = 30/275 (10%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE--IVAVKKVREQKE-------TDIRHL 303
D WEI E LG GA G V+ + + A K ++ + E +I L
Sbjct: 4 NDIWEIIGE-------LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDIL 56
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV--PPQRLYNWARQIAAG 361
+ HPNIV I++E+C G L +++ + E PQ Y RQ+
Sbjct: 57 SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEA 115
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPE 418
+N+LHS ++IHRDLK+ N+L+ + K++DFG + NKST +F GT WMAPE
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPE 173
Query: 419 VIRNEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPST 472
V+ E D K DIWS GI L EL E P+ +++ ++ + S L PS
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK 233
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507
F +K C P RP+ ++L H ++ Q
Sbjct: 234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 9e-31
Identities = 87/283 (30%), Positives = 132/283 (46%), Gaps = 34/283 (12%)
Query: 259 PFESISDLQW---LGSGAQGAVFSGKLRSEIV----AVKKVREQKETD--------IRHL 303
P +D+++ +G G G V +++ + + A+K+++E D + L
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 61
Query: 304 RKLN-HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE--EVPP------------ 348
KL HPNI+ G C + +EY +G L + L+ E P
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 349 --QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406
Q+L ++A +A GM+YL KQ IHRDL + N+L+G AKI+DFG R K
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 181
Query: 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSL 465
V WMA E + + D+WSYG++LWE+++ TPY + + A ++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGY 240
Query: 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
L P C D LM+ CW P RPSF QIL L+ +E
Sbjct: 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 81/267 (30%), Positives = 130/267 (48%), Gaps = 27/267 (10%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGK-LRSEI-VAVKKVREQKETDIRHL-------RK 305
E+E ++ + LG G G V++ + L +++ +A+K++ E+ ++ L
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL-------KDGEEVPPQRLYNWARQI 358
L H NIV++ G ++ + I ME G L LL KD E Q + + +QI
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIIFYTKQI 117
Query: 359 AAGMNYLHSKQIIHRDLKSPNVLIGSKEEA-KISDFGTCREWN--NKSTKMSFAGTVAWM 415
G+ YLH QI+HRD+K NVL+ + KISDFGT + N T+ +F GT+ +M
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE-TFTGTLQYM 176
Query: 416 APEVIRNEQ--CSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLPIPST 472
APEVI DIWS G + E+ T + P+ ++ A ++ VG +H IP +
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQIL 499
+ + C+ P R S +L
Sbjct: 237 LSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 14/248 (5%)
Query: 266 LQWLGSGAQGAVF--SGKLRSEIVAVKKVR--------EQKETDIRHLRKLNHPNIVKFK 315
L+ +G G+ G + A+K++R E + L K+ HPNIV FK
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
IVMEYC G L +K G+ P + W Q+ G+ ++H K+++HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
D+KS N+ + + K+ DFG+ R + + ++ GT ++ PE+ N ++K DIW
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIW 184
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S G +L+EL T + P++ +I V S P+PS + L+K + P SR
Sbjct: 185 SLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSR 243
Query: 493 PSFKQILS 500
PS ILS
Sbjct: 244 PSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 39/269 (14%)
Query: 269 LGSGAQGAVFSGKLRSEI-----VAVK--KVREQKETDIRH-------LRKLNHPNIVKF 314
LG G G+V G+L + VAVK K+ ++I ++ +HPN++K
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 315 KGVCTQA------PCYCIVMEYCAYGPLYNLL------KDGEEVPPQRLYNWARQIAAGM 362
GVC +A P +++ + +G L++ L E++P Q L + IA GM
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-------TKMSFAGTVAWM 415
YL ++ IHRDL + N ++ ++DFG ++ + KM V W+
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP----VKWI 182
Query: 416 APEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474
A E + + + K D+W++G+ +WE+ T +TPY V++ I+ L P C
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IYDYLRHGNRLKQPEDCL 241
Query: 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
D LM CW P RP+F ++ L+
Sbjct: 242 DELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 85/277 (30%), Positives = 126/277 (45%), Gaps = 47/277 (16%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKET--------DIRHLRKLN-HPNIVKFKGV 317
LG G G+V+ + + E+VA+KK++++ + +++ LRKLN HPNIVK K V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
+ V EY G LY L+KD G+ + + QI G+ ++H HRDL
Sbjct: 67 FRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDL 125
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI-RNEQCSDKIDIWSY 434
K N+L+ E KI+DFG RE ++ + T + APE++ R+ S +DIW+
Sbjct: 126 KPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWAL 185
Query: 435 GIVLWELLT-----------------CE---TPYKDVDSSAI----IWG-----VGSSSL 465
G ++ EL T C TP K G +SL
Sbjct: 186 GCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSL 245
Query: 466 HLPIPSTCPDGFQLLMKMC-WSNAPSSRPSFKQILSH 501
H IP+ P+ L+ M W P RP+ Q L H
Sbjct: 246 HQLIPNASPEAIDLIKDMLRWD--PKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 43/288 (14%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKL---------RSEIVAVKKVREQ-KETDIRHL-- 303
WE + ++ + LG G G V + + VAVK +++ E D+ L
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 69
Query: 304 ----RKL--NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-----------DGEEV 346
K+ H NI+ G CTQ +++EY + G L L+ D V
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 347 PPQR-----LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401
P ++ L + Q+A GM YL S++ IHRDL + NVL+ KI+DFG R+ NN
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189
Query: 402 -----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSA 455
K+T V WMAPE + + + + D+WS+G+++WE+ T +PY +
Sbjct: 190 IDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
++ + + P+ C + ++M+ CW PS RP+FKQ++ LD
Sbjct: 248 -LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 38/271 (14%)
Query: 269 LGSGAQGAVFSGKLRSE----IVAVKKV------REQKETDIRH---LRKLNHPNIVKFK 315
LG G G+V G+L + VAVK + R + E + +++ +HPN+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 316 GVCTQA------PCYCIVMEYCAYGPLYNLL---KDGEE---VPPQRLYNWARQIAAGMN 363
GVC Q P +++ + +G L++ L + G+ +P Q L + IA+GM
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-------KSTKMSFAGTVAWMA 416
YL SK IHRDL + N ++ ++DFG ++ N + KM V W+A
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP----VKWIA 182
Query: 417 PEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475
E + + + K D+WS+G+ +WE+ T +TPY V++S I+ L P C D
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDCLD 241
Query: 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506
G LM CW P RPSF+ + L+ A
Sbjct: 242 GLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 90/278 (32%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 256 WE-IPFESISDLQWLGSGAQGAVFSGKLRSE----IVAVKKVRE-QKETDIRH------- 302
WE I FE + +G G G V ++ + A+K ++E E D R
Sbjct: 1 WEDIKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV 55
Query: 303 LRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE--EVPP----------- 348
L KL +HPNI+ G C I +EY YG L + L+ E P
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 349 ---QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405
Q+L +A +A GM YL KQ IHRDL + NVL+G +KI+DFG R K
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSS 464
V WMA E + + K D+WS+G++LWE+++ TPY + + A ++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKLPQG 234
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
+ P C D LM+ CW + P RP F QI L
Sbjct: 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 52/280 (18%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G GA G VF K R E VA+KKV ++ I+ L+ HP +VK V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ +VMEY L +L+D E +P ++ ++ R + G+ Y+H+ I+HRDLK
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126
Query: 377 SPNVLIGSKEEAKISDFGTCR-EWNNKSTKMSFA-GTVAWMAPEVIRNEQCSDK-IDIWS 433
N+LI + KI+DFG R + S T + APE++ + D +D+W+
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWA 186
Query: 434 YGIVLWELLTC------ETPYKDVDSSAIIWGV-GSSSLH-------LP----------- 468
G + ELL E D++ AI++ G+ + LP
Sbjct: 187 VGCIFAELLNGSPLFPGEN---DIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESK 243
Query: 469 -------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P P+ LL + + PS R S + L H
Sbjct: 244 PIPLEEIFPDASPEALDLLKGLLVYD-PSKRLSAAEALRH 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 78/266 (29%), Positives = 119/266 (44%), Gaps = 44/266 (16%)
Query: 272 GAQGAVFSGKLRSEI------VAVKKVREQKE--------TDIRHLRKLNHPNIVKFKGV 317
G G +F G L E V VK V++ + L L+H NI+ V
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 318 CTQAPCYCIVME-YCAYGPLYNLLKDGEEVPP--------QRLYNWARQIAAGMNYLHSK 368
C + V+ Y +G L L+ Q+L + A QIA GM+YLH +
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREW-----------NNKSTKMSFAGTVAWMAP 417
+IH+D+ + N +I + + KI+D R+ N+ K WMA
Sbjct: 137 GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK--------WMAL 188
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E + N++ S D+WS+G++LWEL+T +TPY ++D + + L P CPD
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL-KDGYRLAQPINCPDE 247
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHL 502
+M CW+ P RPSF Q++ L
Sbjct: 248 LFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 32/265 (12%)
Query: 259 PFESISDLQWLGSGAQGAVF--SGKLRSEIVAVKKVR------EQKETDI----RHLRKL 306
P + +DL+ +G G+ GAV+ +E+VA+KK+ +K DI R L++L
Sbjct: 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL 72
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA------ 360
HPN +++KG + +VMEYC G ++L + + P Q + +IAA
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYC-LGSASDIL-EVHKKPLQEV-----EIAAICHGAL 125
Query: 361 -GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 419
G+ YLHS + IHRD+K+ N+L+ K++DFG+ + S SF GT WMAPEV
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA---SLVSPANSFVGTPYWMAPEV 182
Query: 420 I---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
I Q K+D+WS GI EL + P ++++ + ++ + + + D
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY 242
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSH 501
F+ + C P RPS +++L H
Sbjct: 243 FRNFVDSCLQKIPQDRPSSEELLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 87/268 (32%), Positives = 118/268 (44%), Gaps = 54/268 (20%)
Query: 281 KLRSEIVAVKKVREQKETDIRH--------LRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332
K R +VAVK +R + R+ L +L PNI++ GVC C++ EY
Sbjct: 43 KGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYME 102
Query: 333 YGPL-----YNLLKDGEE-----VPP---------QRLYNWARQIAAGMNYLHSKQIIHR 373
G L + L D EE VPP L + A QIA+GM YL S +HR
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT-----------VAWMAPEVIRN 422
DL + N L+G KI+DFG R +AG + WMA E I
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNL--------YAGDYYRIQGRAVLPIRWMAWECILM 214
Query: 423 EQCSDKIDIWSYGIVLWELLT-C-ETPYKDVDSSAIIWGVGS------SSLHLPIPSTCP 474
+ + D+W++G+ LWE+L C E PY ++ +I G ++L P CP
Sbjct: 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP 274
Query: 475 DGFQLLMKMCWSNAPSSRPSFKQILSHL 502
G LM CWS RPSF I + L
Sbjct: 275 QGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-30
Identities = 73/219 (33%), Positives = 113/219 (51%), Gaps = 27/219 (12%)
Query: 308 HPNIVKFKGVCTQ-APCYCIVMEYCAYGPLYNLLK-----------DGEEVPPQRL---- 351
H NI+ G CTQ P Y +V EY + G L L+ D ++P ++L
Sbjct: 77 HKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 352 -YNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-----KSTK 405
+ A Q+A GM YL S++ IHRDL + NVL+ KI+DFG R+ +N K+T
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSS 464
V WMAPE + + + + D+WS+G++LWE+ T +PY + ++ +
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-LFKLLKEG 252
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ P+ C ++M+ CW PS RP+FKQ++ LD
Sbjct: 253 HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 82/260 (31%), Positives = 129/260 (49%), Gaps = 25/260 (9%)
Query: 259 PFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVR--------EQKETDIRHLRKLNH 308
P E + L+ +G G+ G V+ G E+VA+K + E + +I L + +
Sbjct: 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLY--NWARQIAAGMNYLH 366
P I ++ G + I+MEY G +LLK G P + Y R+I G++YLH
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLH 118
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQC 425
S++ IHRD+K+ NVL+ + + K++DFG + + K +F GT WMAPEVI+
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTC----PDGFQLLM 481
K DIWS GI EL E P D+ +++ + +S P T F+ +
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-----PPTLEGQYSKPFKEFV 233
Query: 482 KMCWSNAPSSRPSFKQILSH 501
+ C + P RP+ K++L H
Sbjct: 234 EACLNKDPRFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 1e-29
Identities = 87/278 (31%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 269 LGSGAQGAVFSGKLRSE------IVAVKKVREQK--ETDIRHLRK------LNHPNIVKF 314
LGSGA G V+ G E VA+K + E + ++ + + ++HP++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHSKQIIHR 373
GVC +P +V + +G L + + + ++ + Q L NW QIA GM YL ++++HR
Sbjct: 75 LGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133
Query: 374 DLKSPNVLIGSKEEAKISDFGTCR-------EWNNKSTKMSFAGTVAWMAPEVIRNEQCS 426
DL + NVL+ S KI+DFG R E+N KM + WMA E I + +
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP----IKWMALECIHYRKFT 189
Query: 427 DKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485
+ D+WSYG+ +WEL+T PY + + I + LP P C ++M CW
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERLPQPPICTIDVYMVMVKCW 248
Query: 486 SNAPSSRPSFKQI---LSHLDIASQEVLRIQPEPYYKM 520
SRP FK++ S + Q L IQ + K+
Sbjct: 249 MIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKL 286
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 86/278 (30%), Positives = 131/278 (47%), Gaps = 35/278 (12%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH--LRKLN------HPN 310
E I +L LG GA G+V +L++ I A+K + D++ LR+L P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 311 IVKFKGVCT--QAPCYCIVMEYCAYGPLYNLLKD--------GEEVPPQRLYNWARQIAA 360
IVK+ G + I MEYC G L ++ K GE+V L A +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV----LGKIAESVLK 116
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
G++YLHS++IIHRD+K N+L+ K + K+ DFG E N S +F GT +MAPE I
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-SLAGTFTGTSFYMAPERI 175
Query: 421 RNEQCSDKIDIWSYGIVLWELLTCETPY-KDVDSSAIIWGVGSSSLHLPIPS--TCPDG- 476
+ + S D+WS G+ L E+ P+ + + + S +++P P P
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235
Query: 477 ------FQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
F+ +K C P+ RP+ +L H I +Q
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 75/246 (30%), Positives = 115/246 (46%), Gaps = 29/246 (11%)
Query: 285 EIVAVKKV--------REQKETDIRHLRKLNHPNIVKFKGVCTQA--PCYCIVMEYCAYG 334
E+VAVK + + +I L+ L H NIVK+KG C++ ++MEY G
Sbjct: 34 EMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93
Query: 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394
L + L ++ +L +A+QI GM YLHS+ IHRDL + NVL+ + KI DFG
Sbjct: 94 SLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG 152
Query: 395 TCRE--WNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKD 450
+ ++ ++ G V W A E ++ + S D+WS+G+ L+ELLT +
Sbjct: 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212
Query: 451 VDSSAI-IWGVGSSSL-------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFK 496
+ G + LP P CP +LMK CW RP+F+
Sbjct: 213 PPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
Query: 497 QILSHL 502
++ L
Sbjct: 273 SLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 78/257 (30%), Positives = 128/257 (49%), Gaps = 19/257 (7%)
Query: 259 PFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVR--------EQKETDIRHLRKLNH 308
P E + L+ +G G+ G VF G ++VA+K + E + +I L + +
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
P + K+ G + I+MEY G +LL+ G Q + ++I G++YLHS+
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ-IATMLKEILKGLDYLHSE 120
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD 427
+ IHRD+K+ NVL+ + + K++DFG + + K +F GT WMAPEVI+
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 428 KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD---GFQLLMKMC 484
K DIWS GI EL E P D+ +++ + + P+ + F+ + C
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN----NPPTLTGEFSKPFKEFIDAC 236
Query: 485 WSNAPSSRPSFKQILSH 501
+ PS RP+ K++L H
Sbjct: 237 LNKDPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 72/253 (28%), Positives = 125/253 (49%), Gaps = 25/253 (9%)
Query: 266 LQWLGSGAQGAVFSG--KLRSEIVAVKKV-------REQKET--DIRHLRKLNHPNIVKF 314
L +G G+ G VF K + A+K++ RE++E + R L KL+ I+++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
IVMEY G L+ LLK G +P +++ + QI G+ +LHSK+I+H
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH 124
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIRNEQCSDKIDI 431
RD+KS N+ + + + KI D G + ++ + + GT +++PE+ ++ ++K D+
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDV 184
Query: 432 WSYGIVLWELLTCETPYKDVDSSA-----IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
W+ G+VL+E T + P+ D ++ II GV P+ L+ C +
Sbjct: 185 WALGVVLYECCTGKHPF-DANNQGALILKIIRGV-----FPPVSQMYSQQLAQLIDQCLT 238
Query: 487 NAPSSRPSFKQIL 499
RP Q+L
Sbjct: 239 KDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 71/250 (28%), Positives = 127/250 (50%), Gaps = 18/250 (7%)
Query: 266 LQWLGSGAQGAVF--SGKLRSEIVAVKKV---------REQKETDIRHLRKLNHPNIVKF 314
++ +G G+ G ++ K SE +K++ +E + ++ L K+ HPNIV F
Sbjct: 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLL--KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
+ IVMEYC G L + + G ++ +W QI+ G+ ++H ++I+H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILH 124
Query: 373 RDLKSPNVLIGSKEE-AKISDFGTCREWNNKSTKMSF--AGTVAWMAPEVIRNEQCSDKI 429
RD+KS N+ + AK+ DFG R+ N+ S ++++ GT +++PE+ +N ++K
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
DIWS G VL+EL T + P++ + ++ + PI + L+ + +P
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSP 242
Query: 490 SSRPSFKQIL 499
RPS IL
Sbjct: 243 RDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 63/260 (24%), Positives = 118/260 (45%), Gaps = 26/260 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKV---------REQKETDIRHLRKLNHPNIVKF--K 315
+G G+ G V + +S +I+ K++ ++Q +++ LR+L HPNIV++ +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLL----KDGEEVPPQRLYNWARQIAAGMNYLH----- 366
+ IVMEYC G L L+ K+ + + + ++ Q+ + H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--TKMSFAGTVAWMAPEVIRNEQ 424
++HRDLK N+ + + K+ DFG + + S K ++ GT +M+PE + +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK-TYVGTPYYMSPEQLNHMS 186
Query: 425 CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484
+K DIWS G +++EL P+ + + + IP ++K
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-RRIPYRYSSELNEVIKSM 245
Query: 485 WSNAPSSRPSFKQILSHLDI 504
+ P RPS +++L I
Sbjct: 246 LNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 50/224 (22%)
Query: 269 LGSGAQGAVFSGKLRSE--IVAVK---K---VREQKETDI---RH-LRKLN-HPNIVK-- 313
+G G+ V K + A+K K ++E+K + + L +LN HP I+K
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 314 --FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA----GMNYLHS 367
F+ + Y V+EY G L ++ + R AA + YLHS
Sbjct: 69 YTFQ---DEENLY-FVLEYAPNGELLQYIRKYGSLD----EKCTRFYAAEILLALEYLHS 120
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCR---------------------EWNNKSTKM 406
K IIHRDLK N+L+ KI+DFGT + N+
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKD 450
SF GT +++PE++ + D+W+ G +++++LT + P++
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 21/258 (8%)
Query: 259 PFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVR--------EQKETDIRHLRKLNH 308
P E + L+ +G G+ G VF G ++VA+K + E + +I L + +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
P + K+ G + I+MEY G +LL+ G + ++ R+I G++YLHS+
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE 120
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSD 427
+ IHRD+K+ NVL+ E K++DFG + + K + F GT WMAPEVI+
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 428 KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK----M 483
K DIWS GI EL E P+ ++ +++ + ++ P T + +K
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYSKPLKEFVEA 235
Query: 484 CWSNAPSSRPSFKQILSH 501
C + PS RP+ K++L H
Sbjct: 236 CLNKEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 77/247 (31%), Positives = 115/247 (46%), Gaps = 30/247 (12%)
Query: 286 IVAVKKVREQKET--------DIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLY 337
+VAVK +RE +I+ + +L PNI++ VC + C++ EY G L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 338 NLL-----------KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386
L D + L A QIA+GM YL S +HRDL + N L+G
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 387 EAKISDFGTCRE-WNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
KI+DFG R ++ ++ + WM+ E I + + D+W++G+ LWE+LT
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
Query: 444 -C-ETPYKDVDSSAIIWGVG------SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSF 495
C E PY + +I G ++LP P+ CPD LM CW RPSF
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287
Query: 496 KQILSHL 502
++I + L
Sbjct: 288 QEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 83/266 (31%), Positives = 127/266 (47%), Gaps = 39/266 (14%)
Query: 269 LGSGAQGAVF-------SGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIV 312
LG GA G VF S +VAVK +++ Q+E ++ L L H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL--LTNLQHEHIV 70
Query: 313 KFKGVCTQAPCYCIVMEYC----------AYGPLYNLLKDGE------EVPPQRLYNWAR 356
KF GVC +V EY A+GP +L DG+ E+ ++ + A
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VA 413
QIA+GM YL S+ +HRDL + N L+G+ KI DFG R+ + T +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPST 472
WM PE I + + + D+WS+G++LWE+ T + P+ + ++ +I + + L P
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV-LERPRV 249
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQI 498
CP +M CW P R + K+I
Sbjct: 250 CPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 88/267 (32%), Positives = 125/267 (46%), Gaps = 28/267 (10%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQKETD--------IRHLR 304
+ WEI E LG GA G V+ K + + +A KV E K + I L
Sbjct: 12 EVWEIIGE-------LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILA 64
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNL---LKDGEEVPPQRLYNWARQIAAG 361
NHP IVK G I++E+C G + + L G P ++ RQ+
Sbjct: 65 TCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVI--CRQMLEA 122
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG-TCREWNNKSTKMSFAGTVAWMAPEVI 420
+ YLHS +IIHRDLK+ NVL+ + K++DFG + + + SF GT WMAPEV+
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 421 RNEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCP 474
E D K DIWS GI L E+ E P+ +++ ++ + S L PS
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 475 DGFQLLMKMCWSNAPSSRPSFKQILSH 501
F+ +K P +RPS Q+L H
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEH 269
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 83/261 (31%), Positives = 121/261 (46%), Gaps = 32/261 (12%)
Query: 269 LGSGAQGAVFSGKLRSE-------IVAVKKVREQKET-------DIRHLRKLNHPNIVKF 314
LG GA G VF + + +VAVK +++ + + L L H +IVKF
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKD--------GEEVPPQRL-----YNWARQIAAG 361
GVC + +V EY +G L L+ E P L + A+QIAAG
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPE 418
M YL S+ +HRDL + N L+G KI DFG R+ + T + WM PE
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477
I + + + D+WS G+VLWE+ T + P+ + ++ +I + + L P TCP
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRPRTCPKEV 251
Query: 478 QLLMKMCWSNAPSSRPSFKQI 498
LM CW P R + K+I
Sbjct: 252 YDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 67/266 (25%), Positives = 134/266 (50%), Gaps = 36/266 (13%)
Query: 266 LQWLGSGAQGAVFSGKLRS---EIVAVKKV--------REQKETD--IRHL--------R 304
L+ LGSGA G V+ + ++ ++A+K++ ++++E D I +
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEY---CAYGPLYNLLKD-GEEVPPQRLYNWARQIAA 360
+L HPNIV++ + IVM+ G +N LK+ + +R++N Q+
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 361 GMNYLH-SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 419
+ YLH K+I+HRDL N+++G ++ I+DFG ++ +S S GT+ + PE+
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD----SSAIIWGVGSSSLHLPIP-STCP 474
++NE +K D+W++G +L+++ T + P+ + ++ I+ V + P+P
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-----YEPLPEGMYS 239
Query: 475 DGFQLLMKMCWSNAPSSRPSFKQILS 500
+ ++ C + +RP Q+ +
Sbjct: 240 EDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 35/264 (13%)
Query: 266 LQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRH--------LRKLNHPNIVKFKGV 317
++LG GA F G + +VAVK +R R+ + +L +PNI++ GV
Sbjct: 30 AEFLGEGAPE--FDG--QPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGE------------EVPPQRLYNWARQIAAGMNYL 365
C C++ EY G L L E V L A QIA+GM YL
Sbjct: 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145
Query: 366 HSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGT--VAWMAPEVIRN 422
S +HRDL + N L+G+ KI+DFG R ++ ++ + WMA E I
Sbjct: 146 ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205
Query: 423 EQCSDKIDIWSYGIVLWELLT-C-ETPYKDVDSSAIIWGVGS------SSLHLPIPSTCP 474
+ + D+W++G+ LWE+ T C E PY + +I G ++L CP
Sbjct: 206 GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCP 265
Query: 475 DGFQLLMKMCWSNAPSSRPSFKQI 498
LM CWS RP+F +I
Sbjct: 266 SPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 87/278 (31%), Positives = 147/278 (52%), Gaps = 31/278 (11%)
Query: 257 EIPFESISDLQWLGSGAQGAV-FSGKLR-SEIVAVKKV----REQKET------DIRHLR 304
E P + +DL+ +G G+ GAV F+ +R +E+VA+KK+ ++ E +++ L+
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL----KDGEEVPPQRLYNWARQIAA 360
++ HPN +++KG + +VMEYC G +LL K +EV + + A Q
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQ--- 136
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
G+ YLHS +IHRD+K+ N+L+ + K++DFG+ + S SF GT WMAPEVI
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA---SIASPANSFVGTPYWMAPEVI 193
Query: 421 ---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477
Q K+D+WS GI EL + P ++++ + ++ + + + D F
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF 253
Query: 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPE 515
+ + C P RP+ +++L H+ VLR +PE
Sbjct: 254 RNFVDSCLQKIPQDRPTSEELLKHM-----FVLRERPE 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 73/213 (34%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE--EVPP--------------QR 350
+HPNI+ G C + +EY +G L + L+ E P Q+
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG 410
L ++A +A GM+YL KQ IHRDL + N+L+G AKI+DFG R K
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPI 469
V WMA E + + D+WSYG++LWE+++ TPY + + A ++ L
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRLEK 232
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
P C D LM+ CW P RPSF QIL L
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 26/264 (9%)
Query: 257 EIPFESISDLQWLGSGAQGAVF--SGKLRSEIVAVKKVR------EQKETDI----RHLR 304
+ P E L +G G+ GAV+ + +E+VAVKK+ +K DI + L+
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL----KDGEEVPPQRLYNWARQIAA 360
+L HPN +++KG + +VMEYC G +LL K +EV + + A Q
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQ--- 132
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
G+ YLHS +IHRD+K+ N+L+ + K++DFG+ + S SF GT WMAPEVI
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA---SKSSPANSFVGTPYWMAPEVI 189
Query: 421 ---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477
Q K+D+WS GI EL + P ++++ + ++ + + + D F
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249
Query: 478 QLLMKMCWSNAPSSRPSFKQILSH 501
+ + C P RP+ ++L H
Sbjct: 250 RGFVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 75/268 (27%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 263 ISDLQWLGSGAQGAVFSGKLRSE------IVAVKKVREQKETDIRH--------LRKLNH 308
+ ++ LGSGA G V+ G + VA+K +RE + +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHS 367
P + + G+C + +V + YG L + +++ ++ + Q L NW QIA GM+YL
Sbjct: 69 PYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG---TVAWMAPEVIRNEQ 424
+++HRDL + NVL+ S KI+DFG R + T+ G + WMA E I + +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 425 CSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
+ + D+WSYG+ +WEL+T PY + + I + LP P C ++M
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDVYMIMVK 246
Query: 484 CWSNAPSSRPSFKQILSHLDIASQEVLR 511
CW RP F++++ +++ R
Sbjct: 247 CWMIDSECRPRFRELVDEFSRMARDPSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 5/216 (2%)
Query: 288 AVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYC-IVMEYCAYGPLYNLLKD--GE 344
A ++ R+ E + + L +L HPNIV ++ IVM +C G LY+ LK+ G+
Sbjct: 38 ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK 97
Query: 345 EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404
+P ++ W QIA + YLH K I+HRDLK+ NV + K+ D G R N+
Sbjct: 98 LLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157
Query: 405 KMS-FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS 463
S GT +M+PE+ N+ + K D+W+ G ++E+ T + + D +++++ +
Sbjct: 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG 217
Query: 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQIL 499
L P+P L+ S P RPS K IL
Sbjct: 218 KLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 67/247 (27%), Positives = 124/247 (50%), Gaps = 15/247 (6%)
Query: 269 LGSGAQGAVF--SGKLRSEIVAVKKV---------REQKETDIRHLRKLNHPNIVKFKGV 317
+G GA G V K ++V +K++ R + + + L+ L+HPNI+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
+ IVMEY G L ++ + + ++ QI ++++H+K I+HRDL
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 376 KSPNVLIGSKEEA-KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K+ N+L+ + KI DFG + ++KS + GT +++PE+ + + K DIW+
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
G VL+EL + + ++ + A++ + S + PD QL++ M + PS RP
Sbjct: 188 GCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML-NLDPSKRPQ 246
Query: 495 FKQILSH 501
QI++
Sbjct: 247 LSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 68/256 (26%), Positives = 121/256 (47%), Gaps = 39/256 (15%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G G V+ + + E+VA+KK+R + E + I+ L+KL HPNIV+ K +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 318 CTQAP---CYCIVMEYCAY---GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
T Y +V EY + G L + + + Q + + +Q+ G+ YLHS I+
Sbjct: 67 VTSKGKGSIY-MVFEYMDHDLTGLLDS--PEVKFTESQ-IKCYMKQLLEGLQYLHSNGIL 122
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVIRNE-QCSD 427
HRD+K N+LI + K++DFG R + ++ + V W PE++ +
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRN-SADYTNRVITLWYRPPELLLGATRYGP 181
Query: 428 KIDIWSYGIVLWELLTCETPYK---DVDSSAIIWGV-GSSSLHLPIPSTCPDGFQLLMKM 483
++D+WS G +L EL + ++ +++ I+ + GS P P + K+
Sbjct: 182 EVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS-----PTDENWPG----VSKL 232
Query: 484 CWSNAPSSRPSFKQIL 499
W + +K+ L
Sbjct: 233 PWFENLKPKKPYKRRL 248
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 12/254 (4%)
Query: 259 PFESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVREQKE-------TDIRHLRKLNHP 309
P + + + +G GA G VF+ + VA+K++ QK+ +I +++L +P
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP 76
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
NIV F +VMEY A G L +++ + + ++ R+ + +LH+ Q
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDK 428
+IHRD+KS NVL+G K++DFG C + + +K S GT WMAPEV+ + K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSN 487
+DIWS GI+ E++ E PY + + ++ + ++ + L P F+ + C
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255
Query: 488 APSSRPSFKQILSH 501
R S K++L H
Sbjct: 256 DVEKRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 10/216 (4%)
Query: 290 KKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL--KDGEEVP 347
K RE+ ++ L + HPNIV+++ + IVM+YC G LY + + G P
Sbjct: 40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP 99
Query: 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407
++ +W QI + ++H ++I+HRD+KS N+ + K+ DFG R N+ +
Sbjct: 100 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---TVE 156
Query: 408 FA----GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS 463
A GT +++PE+ N ++K DIW+ G VL+E+ T + ++ + ++ +
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG 216
Query: 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQIL 499
S + P+ S + L+ + P RPS IL
Sbjct: 217 S-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 30/260 (11%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ------------KETDIRHLRKLNHPNIVKF 314
+ GA G VF K +S +I A+K +++ E DI L + P +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
+VMEY G L +LL++ + + +I + YLHS IIHRD
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 375 LKSPNVLIGSKEEAKISDFG---------TCREWNNKSTKMSFAGTVAWMAPEVIRNEQC 425
LK N+LI S K++DFG +++ GT ++APEVI +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP-IPSTCPDGFQLLMKMC 484
S +D WS G +L+E L P+ I + + + P + L+ K+
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL 238
Query: 485 WSNAPSSRP---SFKQILSH 501
+ P R S ++I +H
Sbjct: 239 VPD-PEKRLGAKSIEEIKNH 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/249 (29%), Positives = 123/249 (49%), Gaps = 22/249 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKE-------TDIRHLRKLNHPNIVKFKGVCT 319
+G GA G V++ + + VA+K++ Q++ +I +R+ HPNIV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 320 QAPCYCIVMEYCAYGPLYNL-----LKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
+VMEY A G L ++ + +G+ + R+ + +LHS Q+IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSNQVIHRD 140
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIWS 433
+KS N+L+G K++DFG C + + +K S GT WMAPEV+ + K+DIWS
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCWSNAPSSR 492
GI+ E++ E PY + + ++ + ++ L P F+ + C R
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
Query: 493 PSFKQILSH 501
S K++L H
Sbjct: 261 GSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 76/265 (28%), Positives = 122/265 (46%), Gaps = 27/265 (10%)
Query: 261 ESISDLQWLGSGAQGAVFSGK-LRSEIVAVKK---------VREQ--KETDIRHLRKLNH 308
E + + LG+G G+V K + + V KK VR+Q +E I H +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH--ECRS 62
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
P IV F G C+ ME+ G L + K G +P + L A + G+ YL++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 369 -QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
+I+HRD+K N+L+ S+ + K+ DFG E N S +F GT +M+PE I+ + +
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQGGKYTV 181
Query: 428 KIDIWSYGIVLWELLTCETPYKD-------VDSSAIIWGVGSSSLHLPIP----STCPDG 476
K D+WS GI + EL + P+ D I + + P P S P+
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSH 501
+ + C P+ RP+ +Q+ +
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 26/262 (9%)
Query: 259 PFESISDLQWLGSGAQGAV-FSGKLRS-EIVAVKKVR------EQKETDI----RHLRKL 306
P + SDL+ +G G+ GAV F+ +R+ E+VA+KK+ +K DI R L+KL
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL----KDGEEVPPQRLYNWARQIAAGM 362
HPN ++++G + +VMEYC G +LL K +EV + + A Q G+
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQ---GL 128
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI-- 420
YLHS +IHRD+K+ N+L+ K+ DFG+ + + F GT WMAPEVI
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANXFVGTPYWMAPEVILA 185
Query: 421 -RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
Q K+D+WS GI EL + P ++++ + ++ + + + F+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245
Query: 480 LMKMCWSNAPSSRPSFKQILSH 501
+ C P RP+ + +L H
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 77/267 (28%), Positives = 122/267 (45%), Gaps = 26/267 (9%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVK--------KVREQKETDIRHLRKLNH 308
+ + +GSGA G V+ R + A+K VR Q +I LR +NH
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH 131
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR-LYNWARQIAAGMNYLHS 367
PN+VK + +++E+ G L +G + ++ L + ARQI +G+ YLH
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHR 186
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIR---NE 423
+ I+HRD+K N+LI S + KI+DFG R S GT+A+M+PE I N
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 424 QCSDKI--DIWSYGIVLWELLTCETPY---KDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
D DIWS G+ + E P+ + D ++++ + S + + F+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE-FR 305
Query: 479 LLMKMCWSNAPSSRPSFKQILSHLDIA 505
+ C P+ R S Q+L H I
Sbjct: 306 HFISCCLQREPAKRWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 78/265 (29%), Positives = 131/265 (49%), Gaps = 31/265 (11%)
Query: 269 LGSGAQGAVFSGKLRSE-----IVAVKKVREQ--KETDIRH-------LRKLNHPNIVKF 314
LG G G+V +L+SE VAVK ++ +DI +++ +HPN++K
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 315 KGVCTQA------PCYCIVMEYCAYGPLYNLL---KDGEE---VPPQRLYNWARQIAAGM 362
GV ++ P +++ + +G L+ L + GEE +P Q L + IA+GM
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGT--VAWMAPEV 419
YL SK IHRDL + N ++ ++DFG ++ ++ + A V W+A E
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 420 IRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
+ + + D+W++G+ +WE++T +TPY V++S I+ L P C +
Sbjct: 187 LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYLIKGNRLKQPPDCLEDVY 245
Query: 479 LLMKMCWSNAPSSRPSFKQILSHLD 503
LM CWS P RPSF+ + L+
Sbjct: 246 ELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 46/277 (16%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKETD------------IRHLRKLNHPNIVKF 314
LG G V+ K IVA+KK++ + + I+ L++L HPNI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV-PPQRLYNWARQIAAGMNYLHSKQIIHR 373
V +V E+ L ++KD V P + ++ G+ YLHS I+HR
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHR 126
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF-AGTVAWMAPEVIRN-EQCSDKIDI 431
DLK N+LI S K++DFG R + + + KM+ T + APE++ +D+
Sbjct: 127 DLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDM 186
Query: 432 WSYGIVLWELLTCETPY----KDVDSSAIIWGV----------GSSSLHLPI---PSTCP 474
WS G + ELL P+ D+D I+ G +SL + P
Sbjct: 187 WSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPT 245
Query: 475 DGFQL----------LMKMCWSNAPSSRPSFKQILSH 501
Q+ L++ + P+ R + +Q L H
Sbjct: 246 PLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETD-----IRHLRKLNHPNIVKFKG 316
LG+G+ G V + + + A+K K+ + K+ + R L+ + HP +V G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 317 VCTQAPCYC-IVMEYCAYGPLYNLLKDGEEVPPQ--RLYNWARQIAAGMNYLHSKQIIHR 373
Q +VMEY G L++ L+ P R Y A Q+ + YLHS I++R
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--AAQVVLALEYLHSLDIVYR 125
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLK N+L+ S KI+DFG + ++ + GT ++APE+I ++ +D W+
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVKGRT--YTLCGTPEYLAPEIILSKGYGKAVDWWA 183
Query: 434 YGIVLWELLTCETPYKD 450
GI+++E+L P+ D
Sbjct: 184 LGILIYEMLAGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 55/283 (19%)
Query: 269 LGSGAQGAVFSGKLRSE--IVAVKKVREQKETD------------IRHLRKLNHPNIVKF 314
+G GA G V+ + + VA+KKVR + ++ L HPNIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 315 KGVCTQAPCY-----CIVMEYC-----AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNY 364
VC +V E+ Y L K G +PP+ + + RQ+ G+++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATY--LSKCPKPG--LPPETIKDLMRQLLRGVDF 122
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
LHS +I+HRDLK N+L+ S + KI+DFG R ++ + S T+ + APEV+
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS 182
Query: 425 CSDKIDIWSYGIVLWELLTCE--------------------TPYKD--VDSSAIIWGV-- 460
+ +D+WS G + EL P ++ + ++
Sbjct: 183 YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFP 242
Query: 461 --GSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
S +P C +G LL KM N P R S + L H
Sbjct: 243 SYTPRSFKSFVPEICEEGLDLLKKMLTFN-PHKRISAFEALQH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 7/212 (3%)
Query: 297 ETDIRHLRKLNHPNIVKFKGVC--TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNW 354
E +I+ L+ L H IV++ G I ME+ G + + LK + +
Sbjct: 52 ECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY 111
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN----NKSTKMSFAG 410
RQI G++YLHS I+HRD+K N+L S K+ DFG + + + S G
Sbjct: 112 TRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP 470
T WM+PEVI E K DIWS G + E+LT + P+ + ++ A I+ + + + +P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231
Query: 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
D + +K + A RPS ++L H
Sbjct: 232 PHVSDHCRDFLKRIFVEA-KLRPSADELLRHT 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 7/211 (3%)
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQ--APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNW 354
E +I+ L+ L H IV++ G I MEY G + + LK + +
Sbjct: 52 ECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY 111
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN---KSTKM-SFAG 410
RQI GM+YLHS I+HRD+K N+L S K+ DFG + T + S G
Sbjct: 112 TRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP 470
T WM+PEVI E K D+WS G + E+LT + P+ + ++ A I+ + + + +P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
Query: 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
S + + + + A RPS +++L H
Sbjct: 232 SHISEHARDFLGCIFVEA-RHRPSAEELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 72/254 (28%), Positives = 128/254 (50%), Gaps = 12/254 (4%)
Query: 259 PFESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVREQKE-------TDIRHLRKLNHP 309
P + + + +G GA G V++ + VA+K++ Q++ +I +R+ +P
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP 76
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
NIV + +VMEY A G L +++ + + ++ R+ +++LHS Q
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDK 428
+IHRD+KS N+L+G K++DFG C + + +K S GT WMAPEV+ + K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSN 487
+DIWS GI+ E++ E PY + + ++ + ++ + L P F+ + C
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255
Query: 488 APSSRPSFKQILSH 501
R S K++L H
Sbjct: 256 DVDRRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 36/263 (13%)
Query: 269 LGSGAQGAVFSGKLRS-----------EIVAVKKVREQKETD-------IRHLRKLNHPN 310
LG G ++ G LR E+ V KV D + +L+H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
+VK GVC + +V EY +GPL L + V + A+Q+A+ ++YL K+
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 370 IIHRDLKSPNVLI-------GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422
++H ++ N+L+ G K+SD G ++ ++ + W+APE IRN
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RIPWIAPECIRN 178
Query: 423 EQCSDKI--DIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
Q S I D WS+G L E+ + E P + SS LP+P C + L
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR-LPMPD-CAELANL 236
Query: 480 LMKMCWSNAPSSRPSFKQILSHL 502
+ + CW+ P+ RPSF+ IL L
Sbjct: 237 INQ-CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 4/212 (1%)
Query: 291 KVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL--KDGEEVPP 348
K R +I L L HPNI+ + I MEY G LY+ + + G+
Sbjct: 41 KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE 100
Query: 349 QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMS 407
+ + + QI + ++Y+H I+HRD+K+ N+ + K+ DFG + ++ S +
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL 467
GT +M+PE+ + + + K DIW+ G VL+ELLT + + + ++ + + +
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YT 219
Query: 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQIL 499
P+ S L+ P RP+ ++L
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 24/265 (9%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQKETD--------IRHLR 304
+ WEI E LG GA G V+ + + + ++A KV + K + I L
Sbjct: 5 EFWEIIGE-------LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILA 57
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMN 363
+HPNIVK I++E+CA G + ++ + E + ++ +Q +N
Sbjct: 58 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN 117
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFG-TCREWNNKSTKMSFAGTVAWMAPEVIRN 422
YLH +IIHRDLK+ N+L + K++DFG + + + SF GT WMAPEV+
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 423 EQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDG 476
E D K D+WS GI L E+ E P+ +++ ++ + S L PS
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSH 501
F+ +K C +R + Q+L H
Sbjct: 238 FKDFLKKCLEKNVDARWTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 266 LQWLGSGAQGAVFSGKLRSE------IVAVKKVRE-------QKETD-IRHLRKLNHPNI 311
L+ LGSG G V G E VA+K +++ Q+ TD + + L+H I
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHSKQI 370
V+ G+C +V + G L + ++ + + PQRL NW QIA GM YL ++
Sbjct: 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA---GTVAWMAPEVIRNEQCSD 427
+HR+L + N+L+ S +I+DFG K ++ + WMA E I + +
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 428 KIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
+ D+WSYG+ +WE+++ PY + + + L P C ++M CW
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQICTIDVYMVMVKCWM 249
Query: 487 NAPSSRPSFKQILS 500
+ RP+FK++ +
Sbjct: 250 IDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-25
Identities = 71/254 (27%), Positives = 127/254 (50%), Gaps = 12/254 (4%)
Query: 259 PFESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVREQKE-------TDIRHLRKLNHP 309
P + + + +G GA G V++ + VA++++ Q++ +I +R+ +P
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
NIV + +VMEY A G L +++ + + ++ R+ + +LHS Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDK 428
+IHRD+KS N+L+G K++DFG C + + +K S GT WMAPEV+ + K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSN 487
+DIWS GI+ E++ E PY + + ++ + ++ + L P F+ + C
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 488 APSSRPSFKQILSH 501
R S K++L H
Sbjct: 257 DVEKRGSAKELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 60/166 (36%), Positives = 90/166 (54%), Gaps = 7/166 (4%)
Query: 340 LKDGEEVPPQRLYNWAR---QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396
+D E+ P L + R Q+A GM++L SK IHRD+ + NVL+ AKI DFG
Sbjct: 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 397 REWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVD 452
R+ N S K + V WMAPE I + + + D+WSYGI+LWE+ + ++PY +
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319
Query: 453 SSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498
++ + + + P P +MKMCW+ P+ RP+F QI
Sbjct: 320 VNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 69/254 (27%), Positives = 119/254 (46%), Gaps = 25/254 (9%)
Query: 267 QWLGSGAQGAVF--SGKLRSEIVAVKKVRE------------QKETDIRHLRKLNHPNIV 312
Q LG G+ G V+ K +K ++E Q + + L KL+HP IV
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPL----YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
KF + +CI+ EYC L L G+ + ++ W Q+ G++Y+H +
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFG-TCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
+I+HRDLK+ N+ + KI DFG + + +F GT +M+PE ++++
Sbjct: 126 RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDS 184
Query: 428 KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV--GSSSLHLPIPSTCPDGFQLLMKMCW 485
K DIWS G +L+E+ ++ + +++ + G + +P T +M+
Sbjct: 185 KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQLNSIMQSML 241
Query: 486 SNAPSSRPSFKQIL 499
+ PS RPS +IL
Sbjct: 242 NKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 56/153 (36%), Positives = 82/153 (53%), Gaps = 4/153 (2%)
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMS 407
L +++ Q+A GM++L SK IHRDL + N+L+ KI DFG R+ N S K +
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLH 466
V WMAPE I N + + D+WSYGI+LWE+ + +PY + + + +
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQIL 499
+ P P +MK CW P RP+FKQI+
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKV----------REQKETDIRHLRKLNHPNIVKFKG 316
+G G V+ L +VA+KKV R+ +I L++L+HPN++K+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
+ IV+E G L ++K +P + ++ + Q+ + + ++HSK+I+H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH 129
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDI 431
RD+K NV I + K+ D G R +++K+T S GT +M+PE I + K DI
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189
Query: 432 WSYGIVLWELLTCETPYK 449
WS G +L+E+ ++P+
Sbjct: 190 WSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 266 LQWLGSGAQGAVF-SGKLRSEIVAVKKVREQKETDIRH--LRKLNHPNIVKFKGVCTQAP 322
++ L G++G VF + K V K+ ++ T I L+ +NHP++++ K
Sbjct: 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA 130
Query: 323 CYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVL 381
C+V+ + + LY L K +P + +QI G+ YLH+++IIHRD+K+ N+
Sbjct: 131 ITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIF 189
Query: 382 IGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWEL 441
I ++ I D G + + AGTV APEV+ ++ + K DIWS GIVL+E+
Sbjct: 190 INDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
Query: 442 LTC-ETPYKDVDSS 454
L T ++D S+
Sbjct: 250 LAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKV-------REQKETDIRHLRKLNHP 309
P + + +G G+ G V +S VAVKK+ RE ++ +R HP
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
NIV+ +VME+ G L +++ Q + + +++LH++
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ-IATVCLAVLKALSFLHAQG 135
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDK 428
+IHRD+KS ++L+ S K+SDFG C + + + + S GT WMAPEVI +
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 429 IDIWSYGIVLWELLTCETPY 448
+DIWS GI++ E++ E PY
Sbjct: 196 VDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 16/259 (6%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHP 309
P E +Q +GSG G V+ + + E+ A+K ++ + D I ++ H
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHS 66
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
NIV + G + I ME+C G L ++ + ++ +R+ G+ YLHSK
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQ---C 425
+HRD+K N+L+ K++DFG + + + SF GT WMAPEV E+
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI---PSTCPDGFQLLMK 482
+ DIW+ GI EL + P D+ ++ + S+ P + F +K
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246
Query: 483 MCWSNAPSSRPSFKQILSH 501
M + P RP+ +++L H
Sbjct: 247 MALTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 20/201 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDI------RHLRKL--NHPNIVKFK 315
LG G+ G V +L+ E+ AVK +++ ++ D+ + + L HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 316 GVCTQAPCY-CIVMEYCAYGPL-YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
C Q VMEY G L +++ + G P+ + +A +I G+ +LH + II+R
Sbjct: 63 S-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHERGIIYR 120
Query: 374 DLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
DLK NVL+ S+ KI+DFG C+E +T +F GT ++APE++ + +D
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS-TFCGTPDYIAPEILSYQPYGPAVDW 179
Query: 432 WSYGIVLWELLTCETPYKDVD 452
W+ G++L+E+L ++P++ D
Sbjct: 180 WALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 26/195 (13%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G GA G V + + EIVA+KK +E ++ + ++ LR+L H NIV K
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEE----VPPQ--RLYNWARQIAAGMNYLHSKQII 371
+ +V EY LL+ E +PP R Y W Q+ + Y HS II
Sbjct: 69 FRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIW--QLLQAIAYCHSHNII 122
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--MSFAGTVAWMAPEVIRNEQCSDK- 428
HRD+K N+L+ K+ DFG R + + T + APE++ + K
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 429 IDIWSYGIVLWELLT 443
+D+W+ G ++ ELL
Sbjct: 183 VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 80/312 (25%), Positives = 137/312 (43%), Gaps = 23/312 (7%)
Query: 269 LGSGAQGAVF------SGK------LRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKG 316
LG G G V SGK L+ E++ K T+ R L+ HP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
C VMEY G L+ L R + +I + ++YLHS +I++RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 377 SPNVLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYG 435
N+++ KI+DFG C+E + +T +F GT ++APEV+ + +D W G
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 436 IVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR--- 492
+V++E++ P+ + D + + + P + D LL + + P+ R
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP-RTLSADAKSLLSGLLIKD-PNKRLGG 240
Query: 493 --PSFKQILSHLDIAS---QEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEE 547
K+I+ H Q+V + P +K Q+ + + R E A + E+
Sbjct: 241 GPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEK 300
Query: 548 FEDDLIKKRENE 559
+++D + +NE
Sbjct: 301 YDEDGMDCMDNE 312
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 30/259 (11%)
Query: 268 WLGSGAQGAVFSGKLRSEIVAVKKVREQKETD--------IRHLRKLNHPNIVKFKGVCT 319
W G G G + V VK++R D ++ R+LNHPN+++ G C
Sbjct: 7 WFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI 65
Query: 320 QAPCYCIVMEYCAYGPLYNLLKDGEEV-----PPQRLYNWARQIAAGMNYLHSKQIIHRD 374
++ Y +V+E+C G L N L+ + L A ++A+G+ +LH IH D
Sbjct: 66 ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSD 125
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQ------- 424
L N + + KI D+G E + TK A + W+APE++
Sbjct: 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185
Query: 425 CSDKIDIWSYGIVLWELLTCET-PYKDV-DSSAIIWGVGSSSLHLPIPS---TCPDGFQL 479
+ K +IWS G+ +WEL T PY D+ D + V + LP P D +
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245
Query: 480 LMKMCWSNAPSSRPSFKQI 498
+M+ CW + P +RP+ +++
Sbjct: 246 VMQFCWLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-23
Identities = 49/129 (37%), Positives = 83/129 (64%), Gaps = 5/129 (3%)
Query: 327 VMEYCAYGPL-YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK 385
VMEY G L Y++ + G+ P ++ +A +IA G+ +LHSK II+RDLK NV++ ++
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPHAVF-YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE 137
Query: 386 EEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
KI+DFG C+E + K+T+ +F GT ++APE+I + +D W++G++L+E+L
Sbjct: 138 GHIKIADFGMCKENIFGGKTTR-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 444 CETPYKDVD 452
+ P+ D
Sbjct: 197 GQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 7e-23
Identities = 79/280 (28%), Positives = 121/280 (43%), Gaps = 48/280 (17%)
Query: 269 LGSGAQGAVFSG---KLRSEIVAVKKVREQKETD------------IRHLRKLNHPNIVK 313
+G GA G VF K VA+K+VR Q + +RHL HPN+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 314 FKGVCT-----QAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHS 367
VCT + +V E+ L K E VP + + + Q+ G+++LHS
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
+++HRDLK N+L+ S + K++DFG R ++ + S T+ + APEV+ +
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 188
Query: 428 KIDIWSYGIVLWELLTCETPYK---DVDSSAIIWGV-------------------GSSSL 465
+D+WS G + E+ + ++ DVD I V S
Sbjct: 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 248
Query: 466 HLPIPSTCPD----GFQLLMKMCWSNAPSSRPSFKQILSH 501
PI D G LL+K C + P+ R S LSH
Sbjct: 249 AQPIEKFVTDIDELGKDLLLK-CLTFNPAKRISAYSALSH 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 30/206 (14%)
Query: 262 SISDLQWLG---SGAQGAVFSG--KLRSEIVAVKKVREQKE------TDIRH---LRKLN 307
S+ + + L G G V+ K EIVA+KK++ +KE T +R L KL
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62
Query: 308 HPNIVKFKGVC---TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLY-----NWARQIA 359
HPNIV K V Y +VMEY + + LK E Q Q+
Sbjct: 63 HPNIVTVKEVVVGSNLDKIY-MVMEY-----VEHDLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPE 418
+G+ +LH I+HRDLK+ N+L+ ++ KI DFG RE+ + T+ + APE
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176
Query: 419 VIRNEQC-SDKIDIWSYGIVLWELLT 443
++ + S ID+WS G + ELLT
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 71/196 (36%), Positives = 92/196 (46%), Gaps = 21/196 (10%)
Query: 266 LQWLGSGAQGAVFSGK-LRS-EIVAVKKVREQKETD---------IRHLRKLNHPNIVKF 314
L +G G G V+ + S EIVA+KKVR E D I L L HPNIV+
Sbjct: 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 315 KGVCT--QAPCYCIVMEYCAYGPLYNLLKDGEEVP---PQRLYNWARQIAAGMNYLHSKQ 369
K V +VMEYC L +LL D P Q + Q+ G+ YLH
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQD-LASLL-DNMPTPFSESQ-VKCLMLQLLRGLQYLHENF 128
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQCSDK 428
IIHRDLK N+L+ K KI+DFG R + + M+ W APE++
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 429 -IDIWSYGIVLWELLT 443
ID+W+ G +L ELL
Sbjct: 189 AIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 53/153 (34%), Positives = 78/153 (50%), Gaps = 4/153 (2%)
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG 410
L ++ Q+A GM +L SK +HRDL + NVLI + KI DFG R+ S +S
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300
Query: 411 T---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLH 466
T + WMAPE I N + D+WS+GI+LWE+ T TPY ++ + +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQIL 499
+ P+ D +M+ CW RP F Q++
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 12/267 (4%)
Query: 273 AQGAVFSGK-LRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331
A G ++ K LR E++ K T+ R L+ HP + K C VMEY
Sbjct: 18 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77
Query: 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKIS 391
G L+ L +R + +I + + YLHS+ +++RD+K N+++ KI+
Sbjct: 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKIT 137
Query: 392 DFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKD 450
DFG C+E ++ +T +F GT ++APEV+ + +D W G+V++E++ P+ +
Sbjct: 138 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
Query: 451 VDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR----PS-FKQILSH---L 502
D + + + P + P+ LL + P R PS K+++ H L
Sbjct: 198 QDHERLFELILMEEIRFP-RTLSPEAKSLLAGLL-KKDPKQRLGGGPSDAKEVMEHRFFL 255
Query: 503 DIASQEVLRIQPEPYYKMQMIWKEEIR 529
I Q+V++ + P +K Q+ + + R
Sbjct: 256 SINWQDVVQKKLLPPFKPQVTSEVDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 68/207 (32%), Positives = 91/207 (43%), Gaps = 44/207 (21%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVR--EQKETD-------IRHLRKLNHPNIVK---- 313
+GSGA G V S K VA+KK+ D I+ LR L H NI+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 314 --------FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR----LYNWARQIAAG 361
F V Y IV E L+ ++K + + LY QI G
Sbjct: 68 LRPPSPEDFNDV------Y-IVTEL-METDLHKVIKSPQPLTDDHIQYFLY----QILRG 115
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF-AGTVA--WM-AP 417
+ YLHS +IHRDLK N+L+ S + KI DFG R + + F V W AP
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 418 EVIRN-EQCSDKIDIWSYGIVLWELLT 443
E++ + + + IDIWS G + ELLT
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-22
Identities = 58/171 (33%), Positives = 85/171 (49%), Gaps = 6/171 (3%)
Query: 334 GPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKIS 391
+ NLL D E + L ++ Q+A GM +L SK +HRDL + NVL+ + KI
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 392 DFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETP 447
DFG R+ + S +S T V WMAPE I + + D+WSYGI+LWE+ + TP
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339
Query: 448 YKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498
Y + + + S + P +M CW++ P RPSF +
Sbjct: 340 YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 72/253 (28%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKG 316
+Q +GSG G V+ + E+ AVK ++ + D I +++ H NIV + G
Sbjct: 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
I MEYC G L ++ + ++ R+ G+ YLHSK +HRD+K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVI---RNEQCSDKIDIW 432
N+L+ + K++DFG + K SF GT WMAPEV +N + DIW
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIW 193
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI---PSTCPDGFQLLMKMCWSNAP 489
+ GI EL + P D+ ++ + S+ P + F +K+ + P
Sbjct: 194 AVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNP 253
Query: 490 SSRPSFKQILSHL 502
RP+ +++L+HL
Sbjct: 254 KKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 266 LQWLGSGAQGAVF-----SGKLRSEIVAVK-----------KVREQKETDIRHLRKLNHP 309
L+ LG G+ G VF +G ++ A+K +VR + E DI L ++NHP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI--LAEVNHP 58
Query: 310 NIVKFK-GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
IVK T+ Y I +++ G L+ L + + + ++A +++LHS
Sbjct: 59 FIVKLHYAFQTEGKLYLI-LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
II+RDLK N+L+ + K++DFG +E +++ SF GTV +MAPEV+ +
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 428 KIDIWSYGIVLWELLTCETPYKDVD 452
D WS+G++++E+LT P++ D
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 50/228 (21%)
Query: 269 LGSGAQGAVF------SGKL-------RSEIVAVKKVREQKETDIRHLRKLNHPNIVKFK 315
LG G G VF +GKL + E++ KV+ + T+ L L+HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVK-RVLTEQEILATLDHPFLPTLY 67
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQ--RLYNWARQIAAGMNYLHSKQII 371
C+VM+YC G L+ LL+ G+ + + R Y A ++ + YLH I+
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY--AAEVLLALEYLHLLGIV 125
Query: 372 HRDLKSPNVLIGSKEEAKISDF-------------------GTCREWNNKSTK------- 405
+RDLK N+L+ +SDF G+ R N
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185
Query: 406 ----MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYK 449
SF GT ++APEVI + +D W+ GI+L+E+L TP+K
Sbjct: 186 SFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 73/267 (27%), Positives = 114/267 (42%), Gaps = 31/267 (11%)
Query: 261 ESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQ----------KETDIRHLRKLNH 308
+ I L LG G G+V+ + +A+K++R + E DI H K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH--KAVS 58
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE---VPPQRLYNWARQIAAGMNYL 365
P IV F G + MEY G L L G +P L + G+ +L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 366 HSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
+ IIHRD+K NVL+ + K+ DFG K + G ++MAPE I++
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGG 177
Query: 425 CSDKI------DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF- 477
+ D+WS G+ + E+ PY ++ A I+ S+ + P T P G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGD-PPTLPSGYS 235
Query: 478 ---QLLMKMCWSNAPSSRPSFKQILSH 501
Q + C + P+ RP++ Q+L H
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEH 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 83/270 (30%), Positives = 113/270 (41%), Gaps = 54/270 (20%)
Query: 269 LGSGAQGAVFSGKLRSE----IVAVKKVR------EQK----ETDIRHLRKLNHPNIVKF 314
LG GA G V K+R I+AVK++R EQK + DI +R ++ P V F
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDI-SMRSVDCPYTVTF 65
Query: 315 KG---------VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYL 365
G +C + VM+ + G +P L A I + YL
Sbjct: 66 YGALFREGDVWICME------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 366 HSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI---R 421
HSK +IHRD+K NVLI + K+ DFG + K AG +MAPE I
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 422 NEQCSD-KIDIWSYGIVLWELLTCETPYKDVDSSAIIWG---------VGSSSLHLPIPS 471
N++ D K D+WS GI + EL T PY W V S LP
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDS-------WKTPFQQLKQVVEEPSPQLPAEK 232
Query: 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P+ FQ + C RP++ ++L H
Sbjct: 233 FSPE-FQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 5e-22
Identities = 68/249 (27%), Positives = 122/249 (48%), Gaps = 16/249 (6%)
Query: 269 LGSGAQGAVFSGKLRSE--IVAVKKVREQ---KETDIRH--------LRKLNHPNIVKFK 315
+G G+ G V K +++ AVK ++++ K+ + +H L+ + HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
A V++Y G L+ L+ P R +A +IA+ + YLHS II+RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 376 KSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K N+L+ S+ ++DFG C+E + T +F GT ++APEV+R + +D W
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNAPSSR 492
G VL+E+L P+ D++ + + + L L I + + L++ + ++
Sbjct: 183 GAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242
Query: 493 PSFKQILSH 501
F +I +H
Sbjct: 243 DDFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 83/286 (29%), Positives = 123/286 (43%), Gaps = 65/286 (22%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKE------TDIRH---LRKLNHPNIVKFKGV 317
+G G G V+ + + EIVA+KK+R + E T IR L++LNHPNIV+ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVP-----PQRLYNWARQIAAGMNYLHSKQIIH 372
+V E+ +L K + P P + ++ Q+ G+ Y HS +++H
Sbjct: 67 VHSENKLYLVFEFLDL----DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIR-NEQCSDKID 430
RDLK N+LI + K++DFG R + + W APE++ + Q S +D
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVD 182
Query: 431 IWSYGIVLWELLT--------CE------------TPYKDVDSSAIIW-GVGS------- 462
IWS G + E++ E TP +DV W GV S
Sbjct: 183 IWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV------WPGVTSLPDYKPT 236
Query: 463 ------SSLHLPIPSTCPDGFQLLMKM-CWSNAPSSRPSFKQILSH 501
L +P+ DG LL KM + P+ R S K L H
Sbjct: 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYD--PAKRISAKAALQH 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 24/237 (10%)
Query: 266 LQWLGSGAQGAVFSGKLRS--------EIVAVKKVREQKETDIRH----LRKLNHPNIVK 313
L+ +G GA G V + R + K V + ++ + L++LNHP +V
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 314 FK-GVCTQAPCYCIVMEYCAYGPL-YNLLKDG---EEVPPQRLYNWARQIAAGMNYLHSK 368
+ Y +V++ G L Y+L + EE + W +I + YLHSK
Sbjct: 65 LWYSFQDEENMY-LVVDLLLGGDLRYHLSQKVKFSEEQ--VKF--WICEIVLALEYLHSK 119
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
IIHRD+K N+L+ + I+DF + + S +GT +MAPEV+ + S
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA 179
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP-IPSTCP-DGFQLLMKM 483
+D WS G+ +E L + PY+ + P+T + + K+
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 269 LGSGAQGAVFSGKLRSE-----IVAVKK--VREQKETDI----RHLRKL--NHPNIVKFK 315
LG G+ G V +L+ I A+KK V E + + R + L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 316 GVCT-QAPCYCI-VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
CT Q + VMEY G L ++ R +A +I G+ +LH K II+R
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 432
DLK NVL+ KI+DFG C+E N K S F GT ++APE+++ ++ ++ +D W
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
S+G++L+E+L ++P+ D + + + H P
Sbjct: 181 SFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 52/145 (35%), Positives = 87/145 (60%), Gaps = 5/145 (3%)
Query: 327 VMEYCAYGPL-YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK 385
VMEY G L Y + + G P ++ +A +IA G+ +LHSK II+RDLK NV++ S+
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVF-YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE 137
Query: 386 EEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
KI+DFG C+E W+ +TK +F GT ++APE+I + +D W++G++L+E+L
Sbjct: 138 GHIKIADFGMCKENMWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 444 CETPYKDVDSSAIIWGVGSSSLHLP 468
+ P++ D + + ++ P
Sbjct: 197 GQAPFEGEDEDELFQSIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 28/182 (15%)
Query: 276 AVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCT---QAPCYCIVMEYCA 332
+ + I + K++ L + NHP IVK T + Y ++MEYC
Sbjct: 30 HIVETGQQEHIFSEKEI----------LEECNHPFIVKL--YRTFKDKKYIY-MLMEYCL 76
Query: 333 YGPLYNLLKD-GEEVPPQRLYNW-ARQIAAGM----NYLHSKQIIHRDLKSPNVLIGSKE 386
G L+ +L+D G + AR A + YLH++ II+RDLK N+L+ S
Sbjct: 77 GGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG 130
Query: 387 EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCET 446
K+ DFG ++ + +F GT ++APE+I N+ +D WS GI+L+ELLT
Sbjct: 131 YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190
Query: 447 PY 448
P+
Sbjct: 191 PF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 9/212 (4%)
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQAPC---YCIVMEYCAYGPLYNLLKDGEEVPPQRLYN 353
E +I+ L+ L H IV++ G C + P I +EY G + + LK +
Sbjct: 52 ECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE----WNNKSTKMSFA 409
+ RQI G++YLHS I+HRD+K N+L S K+ DFG + + + S
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI 469
GT WM+PEVI E K D+WS + E+LT + P+ + ++ A I+ + + +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML 230
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P D + +K + RP+ + +L H
Sbjct: 231 PDGVSDACRDFLKQIFVEE-KRRPTAEFLLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 7/217 (3%)
Query: 291 KVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE----V 346
K R +I L++LNHPN++K+ + IV+E G L ++K ++ +
Sbjct: 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103
Query: 347 PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406
P + ++ + Q+ + + ++HS++++HRD+K NV I + K+ D G R +++K+T
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
Query: 407 -SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETP-YKDVDSSAIIWGVGSSS 464
S GT +M+PE I + K DIWS G +L+E+ ++P Y D + +
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 223
Query: 465 LHLPIPST-CPDGFQLLMKMCWSNAPSSRPSFKQILS 500
+ P+PS + + L+ MC + P RP +
Sbjct: 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-21
Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 6/185 (3%)
Query: 266 LQWLGSGAQGAVFS---GKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAP 322
L+ GA+G F+ K +V R T+ LR +NHP+I++ KG T
Sbjct: 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNK 156
Query: 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI 382
C+++ LY L + + R + + YLH +IIHRD+K+ N+ I
Sbjct: 157 FTCLILPRYKTD-LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215
Query: 383 GSKEEAKISDFG-TCREWN-NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWE 440
+ + DFG C + N + +AGT+A APE++ + +DIWS GIVL+E
Sbjct: 216 NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
Query: 441 LLTCE 445
+ TC
Sbjct: 276 MATCH 280
|
Length = 391 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVF--SGKLRSEIVAVK------KVREQKETDIRHLRK 305
D WEI ++ +G G G V+ + K + AVK V E+ E + L+
Sbjct: 22 DTWEI-------IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74
Query: 306 L-NHPNIVKFKGVCTQAPCYC-----IVMEYCAYGPLYNLLKD----GEEVPPQRLYNWA 355
L NHPN+VKF G+ +A +V+E C G + L+K G+ + +
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 356 RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA-GTVAW 414
G+ +LH+ +IIHRD+K N+L+ ++ K+ DFG + + + + + GT W
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194
Query: 415 MAPEVIRNEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLP 468
MAPEVI EQ D + D+WS GI EL + P D+ ++ + + L
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P F + C +RPS +L H
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 6e-21
Identities = 70/259 (27%), Positives = 124/259 (47%), Gaps = 23/259 (8%)
Query: 266 LQWLGSGAQGAVFSGK-LRSEIVAVKKV-------REQKETDIRHLRKLNH-PNIVKFKG 316
++ +G+G G V+ G+ +++ +A KV E+ + +I L+K +H NI + G
Sbjct: 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 317 VCTQA------PCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSK 368
+ +VME+C G + +L+K+ G + + + R+I G+++LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQCSD 427
++IHRD+K NVL+ E K+ DFG + + + +F GT WMAPEVI ++ D
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190
Query: 428 -----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482
K D+WS GI E+ P D+ ++ + + FQ ++
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE 250
Query: 483 MCWSNAPSSRPSFKQILSH 501
C S RP+ +Q++ H
Sbjct: 251 SCLVKNHSQRPTTEQLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 7/216 (3%)
Query: 291 KVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE----V 346
K R+ +I L++LNHPN++K+ + IV+E G L ++K ++ +
Sbjct: 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103
Query: 347 PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406
P + ++ + Q+ + + ++HS++++HRD+K NV I + K+ D G R +++K+T
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
Query: 407 -SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETP-YKDVDSSAIIWGVGSSS 464
S GT +M+PE I + K DIWS G +L+E+ ++P Y D + +
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC 223
Query: 465 LHLPIPST-CPDGFQLLMKMCWSNAPSSRPSFKQIL 499
+ P+P+ + + L+ MC P RP +
Sbjct: 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVH 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 80/277 (28%), Positives = 126/277 (45%), Gaps = 46/277 (16%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKE------TDIRH---LRKLNHPNIVKFKGV 317
+G G G V+ G+ + +IVA+KK+R + E T IR L++L HPNIV + V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 318 CTQAPCYCIVMEY--CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
Q ++ E+ + L G+ + + + ++ QI G+ + HS++++HRDL
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDL 127
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQ-CSDKIDIWS 433
K N+LI +K K++DFG R + + W APEV+ S +DIWS
Sbjct: 128 KPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWS 187
Query: 434 YGIVLWELLTCETPYKDVDS---------------SAIIW-GVGS-------------SS 464
G + E+ T + P DS + +W GV S S
Sbjct: 188 IGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGS 246
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L + + DG LL KM + P+ R S K+ L+H
Sbjct: 247 LRSAVKNLDEDGLDLLEKMLIYD-PAKRISAKKALNH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 269 LGSGAQGAVFSGKLRSE--IVAVK--------KVREQKETDIRH---LRKLNHPNIVKFK 315
+G G+ G V K +S+ AVK K +EQ L+ L HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
A V++Y G L+ L+ R +A ++A+ + YLHS II+RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 376 KSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K N+L+ S+ ++DFG C+E + T +F GT ++APEV+R E +D W
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
G VL+E+L P+ D S + + L LP
Sbjct: 183 GAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 87/296 (29%), Positives = 127/296 (42%), Gaps = 69/296 (23%)
Query: 264 SDLQWLGSGAQGAVFSG--KLRSEIVAVKKV----------REQKETDIRHLRKLNHPNI 311
+L ++G GA G V S K VA+KK+ R +E I+ LR+ H NI
Sbjct: 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLRE--IKILRRFKHENI 65
Query: 312 VKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKDGEEVPPQRLYN-----WARQIAA 360
+ + + P + IV E LY L+K Q L N + QI
Sbjct: 66 IGILDI-IRPPSFESFNDVYIVQELMETD-LYKLIKT------QHLSNDHIQYFLYQILR 117
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR----EWNNKSTKMSFAGTVAWMA 416
G+ Y+HS ++HRDLK N+L+ + + KI DFG R E ++ + T + A
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 417 PEVIRNEQCSDK-IDIWSYGIVLWELLTCET--PYKD-VDSSAIIWGV-GSSSLH----- 466
PE++ N + K IDIWS G +L E+L+ P KD + +I GV G+ S
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237
Query: 467 -----------LP----------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
LP P+ P LL KM N P R + ++ L+H
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN-PHKRITVEEALAH 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 289 VKKVREQK-----ETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDG 343
V+K+ + K E + L K ++PN +K T + ++M+Y G L++LLK
Sbjct: 45 VQKIIKAKNFNAIEPMVHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE 103
Query: 344 EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI-GSKEEAKISDFGTCREWNNK 402
++ + RQ+ +N LH IIH D+K NVL +K+ + D+G C+
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163
Query: 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKD 450
S + GT+ + +PE I+ D W+ G++ +ELLT + P+K+
Sbjct: 164 SC---YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 17/230 (7%)
Query: 260 FESISDLQWLGSGAQGAVFSGKLR-SEIVAVKK---------VREQKETDIRHLRKLNHP 309
FE + +L G+G G V R S ++ +K +R Q +++ L + N P
Sbjct: 3 FEKLGEL---GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSP 59
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK- 368
IV F G I ME+ G L +LK +P L + + G+ YL K
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
+I+HRD+K N+L+ S+ E K+ DFG + + S SF GT ++M+PE ++ + +
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYTVQ 178
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSS--AIIWGVGSSSLHLPIPSTCPDG 476
DIWS G+ L E+ P D+ ++G S G
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 49/144 (34%), Positives = 85/144 (59%), Gaps = 3/144 (2%)
Query: 327 VMEYCAYGPL-YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK 385
VMEY G L Y++ + G+ PQ ++ +A +I+ G+ +LH + II+RDLK NV++ S+
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQAVF-YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE 137
Query: 386 EEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC 444
KI+DFG C+E + T +F GT ++APE+I + +D W+YG++L+E+L
Sbjct: 138 GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197
Query: 445 ETPYKDVDSSAIIWGVGSSSLHLP 468
+ P+ D + + ++ P
Sbjct: 198 QPPFDGEDEDELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 254 DEWEIPF-ESIS---DLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKET--------- 298
D++E PF + +S L +G G G VF + + +IVA+KKV + E
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 299 DIRHLRKLNHPNIVKFKGVC-TQA-------PCYCIVMEYCAY---GPLYNLLKDGEEVP 347
+I+ L+ L H N+V +C T+A + +V E+C + G L N
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW----NNKS 403
+++ + + G+ Y+H +I+HRD+K+ N+LI K++DFG R + N+K
Sbjct: 121 IKKVM---KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 404 TKMSFAGTVAWM-APEVIRNE-QCSDKIDIWSYGIVLWELLT 443
+ + W PE++ E ID+W G ++ E+ T
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 26/200 (13%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G G V+ K E+VA+KKVR E + I+ LR+LNH NIV K +
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 318 CT----------QAPCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLH 366
T + +V EY + L LL+ G + ++ +Q+ G+NY H
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHD-LMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--MSFAGTVAWMAPEVIRNEQ 424
K +HRD+K N+L+ +K + K++DFG R +N++ ++ + T+ + PE++ E+
Sbjct: 134 KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE 193
Query: 425 -CSDKIDIWSYGIVLWELLT 443
ID+WS G +L EL T
Sbjct: 194 RYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 13/268 (4%)
Query: 273 AQGAVFSGK-LRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331
A G ++ K L+ E++ K T+ R L+ HP + K C VMEY
Sbjct: 18 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77
Query: 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKI 390
G L+ L R + +I + ++YLHS K +++RDLK N+++ KI
Sbjct: 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKI 137
Query: 391 SDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYK 449
+DFG C+E + +T +F GT ++APEV+ + +D W G+V++E++ P+
Sbjct: 138 TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197
Query: 450 DVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR-----PSFKQILSHLDI 504
+ D + + + P + P+ LL + + P R K+I+ H
Sbjct: 198 NQDHEKLFELILMEEIRFP-RTLSPEAKSLLSGLLKKD-PKQRLGGGPDDAKEIMQHKFF 255
Query: 505 AS---QEVLRIQPEPYYKMQMIWKEEIR 529
A Q+V + P +K Q+ + + R
Sbjct: 256 AGIVWQDVYEKKLVPPFKPQVTSETDTR 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 47/145 (32%), Positives = 83/145 (57%), Gaps = 5/145 (3%)
Query: 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386
VME+ G L ++D R +A +I G+ +LHSK II+RDLK NV++
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG 133
Query: 387 EAKISDFGTCRE---WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
KI+DFG C+E +N+++ +F GT ++APE+++ + + +D WS+G++L+E+L
Sbjct: 134 HIKIADFGMCKENVFGDNRAS--TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 444 CETPYKDVDSSAIIWGVGSSSLHLP 468
++P+ D + + + H P
Sbjct: 192 GQSPFHGDDEDELFESIRVDTPHYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 81/282 (28%), Positives = 123/282 (43%), Gaps = 29/282 (10%)
Query: 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR--EQKETDIRHLRKLN-----H-- 308
E++ ++ GSG G V+ + + ++AVK++R KE + R L L+ H
Sbjct: 17 LENLGEI---GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDC 73
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHS 367
P IVK G I ME L LLK +P L I ++YL
Sbjct: 74 PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 368 KQ-IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 426
K +IHRD+K N+L+ + K+ DFG + K AG A+MAPE I +
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 427 DKIDI----WSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG-----F 477
K DI WS GI L EL T + PYK+ + + V + L PS P+ F
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPSLPPNEGFSPDF 249
Query: 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYK 519
+ +C + RP ++++L H I E + +++
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQ 291
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 77/245 (31%), Positives = 112/245 (45%), Gaps = 15/245 (6%)
Query: 260 FESISDLQWLGSGAQGAVF--SGKLRSEIVAVK--------KVREQKETDIRHLRKLNHP 309
FE IS+L G+G G VF S K I+A K +R Q +++ L + N P
Sbjct: 7 FEKISEL---GAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK- 368
IV F G I ME+ G L +LK +P Q L + + G+ YL K
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
+I+HRD+K N+L+ S+ E K+ DFG + + S SF GT ++M+PE ++ S +
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488
DIWS G+ L E+ P D+ + G P S + + S
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242
Query: 489 PSSRP 493
P SRP
Sbjct: 243 PDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKK---------VREQKETDIR 301
L+D+ FE IS+L G+G G V + + S ++ +K +R Q +++
Sbjct: 2 LKDD---DFERISEL---GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ 55
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAG 361
L + N P IV F G I ME+ G L +LK+ + +P + L + + G
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115
Query: 362 MNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
+ YL K QI+HRD+K N+L+ S+ E K+ DFG + + S SF GT ++M+PE +
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERL 174
Query: 421 RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456
+ S + DIWS G+ L EL P D+ +
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDI------RHL--RKLNHPNIVKFK 315
+G G+ V +L+ I A+K V+++ + DI +H+ + NHP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
V+EY G L ++ ++P + ++ +I+ +NYLH + II+RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 376 KSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K NVL+ S+ K++D+G C+E T +F GT ++APE++R E +D W+
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 435 GIVLWELLTCETPYKDVDSS 454
G++++E++ +P+ V SS
Sbjct: 183 GVLMFEMMAGRSPFDIVGSS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 272 GAQGAVFSGKLRSE-----IVAVKK---VREQKETDIRHLRKLNH-----PNIVKFKGVC 318
GA G+V+ K RS I +KK + + + T+++ R + P + K
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA----GMNYLHSKQIIHRD 374
+VMEY G +L+K +P WA+Q A G+ LH + IIHRD
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPED----WAKQYIAEVVLGVEDLHQRGIIHRD 122
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
+K N+LI K++DFG R N F GT ++APE I D WS
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 435 GIVLWELLT------CETP---YKDVDSSAIIW 458
G V++E L ETP + ++ S I W
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 269 LGSGAQGAVF------SGKLRSEIVAVKKVREQKE------TDIRHLRKLNHPNIVKFKG 316
LG G G V +GK + + K+V K+ T+ R L+ HP + K
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
C VMEY G L+ L R + +I + + YLHS +++RDLK
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIWSYG 435
N+++ KI+DFG C+E + M F GT ++APEV+ + +D W G
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 436 IVLWELLTCETPYKDVD 452
+V++E++ P+ + D
Sbjct: 183 VVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 259 PFESISDLQWLGSGAQGAV--FSGKLRSEIVAVKKVREQKE-------TDIRHLRKLNHP 309
P E + +G G+ G V + K + VAVKK+ +K+ ++ +R +H
Sbjct: 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE 79
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
N+V +VME+ G L +++ + +++ + ++YLH++
Sbjct: 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG 138
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDK 428
+IHRD+KS ++L+ S K+SDFG C + + + K S GT WMAPEVI +
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 429 IDIWSYGIVLWELLTCETPY 448
+DIWS GI++ E++ E PY
Sbjct: 199 VDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 72/266 (27%), Positives = 112/266 (42%), Gaps = 38/266 (14%)
Query: 261 ESISDLQWLGSGAQGAVFSG--KLRSEIVAVK--------KVREQKETDIRHLRKLNHPN 310
+ I + LG G G V+ L I+AVK ++++Q +++ L K + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
I+ F G I E+ G L K +P L A + G+ YL S +I
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
+HRD+K N+L+ ++ + K+ DFG + N S ++ GT A+MAPE I EQ D
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI----------PSTCPDG---- 476
+WS GI EL PY + + +P+ P P G
Sbjct: 176 VWSLGISFMELALGRFPYPQIQ--------KNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227
Query: 477 -FQLLMKMCWSNAPSSRPSFKQILSH 501
F + C P RP+ + ++ H
Sbjct: 228 KFVHFITQCMRKQPKERPAPENLMDH 253
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 79/273 (28%), Positives = 130/273 (47%), Gaps = 27/273 (9%)
Query: 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGK--LRSEIVAVK--KVREQKETDIRH----L 303
LRD I FE + + +G+G G V+ G+ ++ A+K V E +E +I+ L
Sbjct: 11 LRDPAGI-FELV---EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 304 RKLNH-PNIVKFKGV-CTQAPC-----YCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNW 354
+K +H NI + G ++P +VME+C G + +L+K+ G + +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVA 413
R+I G+ +LH+ ++IHRD+K NVL+ E K+ DFG + + + +F GT
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 414 WMAPEVIRNEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
WMAPEVI ++ D + DIWS GI E+ P D+ ++ + +
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
F ++ C SRPS +Q+L H
Sbjct: 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 6/152 (3%)
Query: 308 HPNIVKFKGVCTQAPCY-CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
HP +V C Q + C VMEY A G L + P+ ++ +A + G+ YLH
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-YAACVVLGLQYLH 118
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQ 424
+I++RDLK N+L+ ++ KI+DFG C+E T +F GT ++APEV+
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS-TFCGTPEFLAPEVLTETS 177
Query: 425 CSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456
+ +D W G++++E+L E+P+ D +
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 269 LGSGAQGAVF------SGKLRSEIVAVKKV----REQKETDIRH---LRKLNHPNIVKFK 315
+G G+ G V GK + V KK+ +EQK L+ + HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
V+++ G L+ L+ P R +A +IA+ + YLHS I++RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K N+L+ S+ ++DFG C+E +S T +F GT ++APEVIR + + +D W
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL 182
Query: 435 GIVLWELLTCETPYKDVDSSAI 456
G VL+E+L P+ D + +
Sbjct: 183 GAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 4/162 (2%)
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMS 407
L +++ Q+A GM +L S++ IHRDL + N+L+ KI DFG R+ K
Sbjct: 175 LISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLH 466
+ WMAPE I ++ + + D+WS+G++LWE+ + +PY V
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
+ P +M CW N P RP+F +++ L QE
Sbjct: 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK------------ETDIRHLRKLNHPNIVKF 314
LG G G V + ++++ ++ A KK+ +++ E I L K++ IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 315 KGVCTQAPCYCIVMEYCAYGPL-YNLLKDGEEVPPQ-RLYNWARQIAAGMNYLHSKQIIH 372
C+VM G L Y++ GE P+ R +A QI G+ +LH ++I++
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLK NVL+ +ISD G E AGT +MAPEV++ E +D +
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWF 178
Query: 433 SYGIVLWELLTCETPYKD 450
+ G L+E++ +P++
Sbjct: 179 ALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 78/282 (27%), Positives = 126/282 (44%), Gaps = 57/282 (20%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQKETD------IRH---LRKLNHPNIVKFKGV 317
+G G G V+ + + E+VA+KK+R ET+ IR L++LNHPNIVK V
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 318 C-TQAPCYCIVMEYCAYGPLYNLLK------DGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
T+ Y +V E+ L+ LK +P + ++ Q+ G+ + HS ++
Sbjct: 68 IHTENKLY-LVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQC-SDK 428
+HRDLK N+LI ++ K++DFG R + + W APE++ + S
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 429 IDIWSYGIVLWELLTCETPY---KDVDS-----------SAIIW-GVGS----------- 462
+DIWS G + E++T + ++D ++W GV S
Sbjct: 182 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW 241
Query: 463 --SSLHLPIPSTCPDGFQLLMKM-CWSNAPSSRPSFKQILSH 501
+P DG LL +M + P+ R S K L+H
Sbjct: 242 ARQDFSKVVPPLDEDGRDLLSQMLHYD--PNKRISAKAALAH 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-19
Identities = 57/185 (30%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 326 IVMEYCAYGPLYNLLKD--GEEVPPQR------LYNWARQIAAGMNYLHSKQIIHRDLKS 377
++MEY + G L +K E +P Q Y QI ++ +HS++++HRDLKS
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFY----QIVLALDEVHSRKMMHRDLKS 197
Query: 378 PNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N+ + K+ DFG +++++ + SF GT ++APE+ ++ S K D+WS
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
G++L+ELLT P+K I+ V + P P G + L+ S P+ RP+
Sbjct: 258 GVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPT 316
Query: 495 FKQIL 499
+Q+L
Sbjct: 317 TQQLL 321
|
Length = 478 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKET---------DIRHLRKLNHPNIVKFKGV 317
+G G+ G VF + R +IVA+KK E ++ +IR L++L HPN+V V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+ +V EYC + L L K+ VP + Q +N+ H IHRD+K
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKP 128
Query: 378 PNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNE-QCSDKIDIWSYG 435
N+LI + + K+ DFG R + + T + APE++ + Q +D+W+ G
Sbjct: 129 ENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG 188
Query: 436 IVLWELLTCET--PYK-DVD 452
V ELLT + P K DVD
Sbjct: 189 CVFAELLTGQPLWPGKSDVD 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 69/215 (32%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKETDI---------RHLR 304
WE+P E + L+ +GSGA G+V S K E VA+KK+ +++I L+
Sbjct: 11 WELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 305 KLNHPNIVKFKGVCTQAPCY------CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQI 358
+ H N++ V T A +VM Y L ++ G + ++ Q+
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY-MQTDLQKIM--GHPLSEDKVQYLVYQM 126
Query: 359 AAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 418
G+ Y+HS IIHRDLK N+ + E KI DFG R + + T + T + APE
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT--GYVVTRWYRAPE 184
Query: 419 VIRNEQCSDK-IDIWSYGIVLWELLTCETPYKDVD 452
VI N ++ +DIWS G ++ E+LT +T +K D
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 55/201 (27%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVRE---QKETDI------RHL--RKLNHPNIVKFK 315
+G G+ V +L+ I A+K +++ + DI +H+ NHP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 316 GVCTQAPCYC-IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
C Q V+E+ + G L ++ ++P + ++ +I+ +N+LH + II+RD
Sbjct: 63 S-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
LK NVL+ ++ K++D+G C+E T +F GT ++APE++R E +D W+
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 434 YGIVLWELLTCETPYKDVDSS 454
G++++E++ +P+ V S
Sbjct: 182 LGVLMFEMMAGRSPFDIVGMS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 55/190 (28%), Positives = 100/190 (52%), Gaps = 11/190 (5%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKK--VREQKETDIRH-----LRKLNHPNIVKFKGVCT 319
+G G+ G V ++S ++VAVKK +R+Q+ ++ +R H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 320 QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379
+VME+ G L +++ + +++ + ++ LH++ +IHRD+KS +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 380 VLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVL 438
+L+ K+SDFG C + + + + S GT WMAPE+I ++DIWS GI++
Sbjct: 147 ILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206
Query: 439 WELLTCETPY 448
E++ E PY
Sbjct: 207 IEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 48/175 (27%), Positives = 98/175 (56%), Gaps = 7/175 (4%)
Query: 284 SEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI--VMEYCAYGPLYNLLK 341
E++ +K+ + + R L++++HP I++ T+ + +MEY G L++ L+
Sbjct: 37 PEVIRLKQE-QHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR 93
Query: 342 DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401
+ +A +I + YLHSK+I++RDLK N+L+ + K++DFG ++ +
Sbjct: 94 NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153
Query: 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456
++ + GT ++APEVI+++ + +D W+ GI+++E+L P+ D + I
Sbjct: 154 RTWTL--CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 32/273 (11%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFS--GKLRSEIVAVK------KVREQKETDIRHLRK 305
D WEI ++ +G G G VF K AVK + E+ E + L+
Sbjct: 18 DTWEI-------IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA 70
Query: 306 L-NHPNIVKFKGV-----CTQAPCYCIVMEYCAYGPLYNL----LKDGEEVPPQRLYNWA 355
L +HPN+VKF G+ +V+E C G + +L LK GE + +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 356 RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAW 414
+ G+ +LH + IHRD+K N+L+ ++ K+ DFG + + + + + GT W
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 415 MAPEVIRNEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLP 468
MAPEVI EQ D + D+WS GI EL + P D+ ++ + + L
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P + F ++ C + RP+ +L H
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-19
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 16/174 (9%)
Query: 344 EEVPPQRLYN----------WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDF 393
EE + LY ++ Q+A GM +L S++ IHRDL + N+L+ KI DF
Sbjct: 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDF 223
Query: 394 GTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYK 449
G R+ + + WMAPE I + + + D+WS+G++LWE+ + +PY
Sbjct: 224 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 450 DVDSSAIIWGVGSSSLHLPIPS-TCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
V + P T P+ +Q ++ CW PS RP+F +++ HL
Sbjct: 284 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 43/219 (19%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--QKETD-------IRHLR 304
WE+P + +L +GSGA G V S VA+KK+ Q +R L+
Sbjct: 11 WEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK 69
Query: 305 KLNHPNIVKFKGVCTQAP-------CYCIVMEYCAYGPLYNLLKDGEEVPPQRL------ 351
++H N++ V T A Y +V L N++K Q+L
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVY-LVTHLMG-ADLNNIVKC------QKLSDDHIQ 121
Query: 352 ---YNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408
Y QI G+ Y+HS IIHRDLK N+ + E KI DFG R +++ T +
Sbjct: 122 FLVY----QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GY 175
Query: 409 AGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCET 446
T + APE++ N + +DIWS G ++ ELLT +T
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK----------ETDIRHLRKLNHPNIVKFKG 316
LG G G V + ++R+ ++ A KK+ +++ + R L K++ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 317 VCTQAPCYCIVMEYCAYGPL----YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
C+VM G L YN+ ++ P R + QI +G+ +LH ++II+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDI 431
RDLK NVL+ + +ISD G E + +K +AGT +MAPE+++ E+ +D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 432 WSYGIVLWELLTCETPYK 449
++ G+ L+E++ P++
Sbjct: 181 FALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 263 ISDLQW---LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLN 307
+SD + LG+G+ G V K + E A+K ++++ K ++H L +L+
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 308 HPNIVK-FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
HP IV + Y ++E+ G L+ L+ P + ++ YLH
Sbjct: 77 HPFIVNMMCSFQDENRVY-FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 426
SK II+RDLK N+L+ +K K++DFG ++ +++ + GT ++APEVI+++
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHG 193
Query: 427 DKIDIWSYGIVLWELLTCETPYKD 450
+D W+ G++L+E + P+ D
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVR-------EQKETDIRHLRKLN----HPNIVKFK 315
LG G+ G VF +L+ ++ A+K ++ + E + R L+ HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
VMEY G L ++ + R +A +I G+ +LHSK I++RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K N+L+ + KI+DFG C+E K F GT ++APE++ ++ + +D WS+
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSF 182
Query: 435 GIVLWELLTCETPYKDVD 452
G++L+E+L ++P+ D
Sbjct: 183 GVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 266 LQWLGSGAQGAVF---------SGKLRSEIVAVKKVREQKETDIRHLRK----LNH---- 308
L+ LG+GA G VF +GKL + V K QK + H R L H
Sbjct: 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQS 64
Query: 309 PNIVKFK-GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS 367
P +V T+A + ++++Y + G ++ L + + ++ +I + +LH
Sbjct: 65 PFLVTLHYAFQTEAKLH-LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK 123
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTVAWMAPEVIRNEQC 425
I++RD+K N+L+ S+ ++DFG +E+ K SF GT+ +MAPE+IR +
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 426 SDK-IDIWSYGIVLWELLTCETPY 448
K +D WS GI+++ELLT +P+
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 38/210 (18%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKF--- 314
LG G G V+ + +VA+KK+ E D I+ L+KL HPN+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 315 -----KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV---PPQRLYNWARQIAAGMNYLH 366
+ +V Y + L LL + V Q + + Q+ G+NYLH
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHD-LSGLL-ENPSVKLTESQ-IKCYMLQLLEGINYLH 132
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA-----------WM 415
I+HRD+K+ N+LI ++ KI+DFG R ++ G W
Sbjct: 133 ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWY 192
Query: 416 -APEVIRNE-QCSDKIDIWSYGIVLWELLT 443
PE++ E + + +DIW G V E+ T
Sbjct: 193 RPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 266 LQWLGSGAQGAVF---------SGKL-------RSEIVAVKKVREQKETD---IRHLRKL 306
L+ LG+GA G VF SGKL ++ IV K E T+ + H+R+
Sbjct: 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ- 63
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
P +V ++++Y G L+ L E Q + ++ +I + +LH
Sbjct: 64 -SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--MSFAGTVAWMAPEVIR-NE 423
II+RD+K N+L+ S ++DFG +E++ + SF GT+ +MAP+++R +
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 424 QCSDK-IDIWSYGIVLWELLTCETPY 448
DK +D WS G++++ELLT +P+
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 266 LQWLGSGAQGAVF-----SGKLRSEIVAVKKVRE----QKETDIRHLRK----LNH---- 308
L+ LG+GA G VF G ++ A+K +++ QK H R L
Sbjct: 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC 64
Query: 309 PNIVK-FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS 367
P +V T + ++++Y G L+ L E + + +I +++LH
Sbjct: 65 PFLVTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTVAWMAPEVIRNEQC 425
II+RD+K N+L+ S+ ++DFG +E+ + SF GT+ +MAPEVIR
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 426 --SDKIDIWSYGIVLWELLTCETPY 448
+D WS G++ +ELLT +P+
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 7/179 (3%)
Query: 271 SGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330
SG Q AV LR + + RE ++ +R H N+V+ ++ME+
Sbjct: 45 SGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99
Query: 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390
G L +++ + +++ + + YLHS+ +IHRD+KS ++L+ K+
Sbjct: 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKL 158
Query: 391 SDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPY 448
SDFG C + + K S GT WMAPEVI ++DIWS GI++ E++ E PY
Sbjct: 159 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 266 LQWLGSGAQGAVFSGKLR--SEIVAVKKVREQKE-----TDIRH---LRKLNHPNIVKFK 315
L+ LG G V+ G+ R EIVA+K++ E T IR +++L H NIV+
Sbjct: 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLK-------DGEEVPPQRLYNWARQIAAGMNYLHSK 368
V +V EY LK + P + ++ Q+ G+ + H
Sbjct: 65 DVIHTENKLMLVFEYMD-----KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQC-S 426
+++HRDLK N+LI + E K++DFG R + S W AP+V+ + S
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 427 DKIDIWSYGIVLWELLT 443
IDIWS G ++ E++T
Sbjct: 180 TSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 270 GSGAQGAVFSGKL----RSEIVAVKKVREQKET----------DIRHLRKLNHPNIVKFK 315
G G G V+ K + A+KK + KE +I LR+L H N+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 316 GVCTQAPCYCIVM--EYCAYGPLYNLLKD-----GEEVPPQRLYNWARQIAAGMNYLHSK 368
V + + + +Y + L+ ++K +PP + + QI G++YLHS
Sbjct: 69 EVFLEHADKSVYLLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 369 QIIHRDLKSPNVLI-GSKEE---AKISDFGTCREWNNKSTKMSFAG-----TVAWMAPEV 419
++HRDLK N+L+ G E KI D G R +N K T+ + APE+
Sbjct: 128 WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL-KPLADLDPVVVTIWYRAPEL 186
Query: 420 IRNEQCSDK-IDIWSYGIVLWELLTCETPYK 449
+ + K IDIW+ G + ELLT E +K
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK---MSFAGTVA 413
Q+ ++++HSK +IHRD+KS N+L+ S K+ DFG + + + +F GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
++APE+ R + S K D++S G++L+ELLT + P+ + ++ + P+P +
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSI 269
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILS----HLDIAS-QEVLRIQPEPYYKMQMIWKEEI 528
Q ++ S+ P RPS ++L+ L I+ E+++ QP ++ +I
Sbjct: 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQI 329
Query: 529 RVHMLEMQANKSHVPKFEE 547
+ +Q + + + E
Sbjct: 330 QQTKQLLQVERRRIVRQME 348
|
Length = 496 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 260 FESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKE-----TDIRH---LRKLNHP 309
E+ L LG G VF G KL +VA+K++R + E T IR L+ L H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
NIV + C +V EY L G + + + Q+ G++Y H ++
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE--VIRNEQCSD 427
I+HRDLK N+LI K E K++DFG R + + S W P ++ + + S
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 428 KIDIWSYGIVLWELLT 443
ID+W G +L+E+ T
Sbjct: 184 PIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 267 QWLGSGAQGAVFSGKLRS--EIVAVKKVR----------EQKETDIRHLR-KLNHPNIVK 313
+ LG G+ G V +L+ + AVK ++ E T+ R L NHP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 314 FKGVCTQAPCYCI-VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
C Q P VME+ G L ++ R +A +I + + +LH K II+
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
RDLK NVL+ + K++DFG C+E N T +F GT ++APE+++ +D
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 432 WSYGIVLWELLTCETPYK 449
W+ G++L+E+L P++
Sbjct: 180 WAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH-----------LRKLNHPNIVKFK 315
LG G G V + ++R+ ++ A KK+ E+K R L K+N +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKL-EKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 316 GVCTQAPCYCIVMEYCAYGPL----YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
C+V+ G L YN+ G +R +A +I G+ LH ++I+
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLHRERIV 124
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
+RDLK N+L+ +ISD G E T GTV +MAPEV++NE+ + D
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDW 184
Query: 432 WSYGIVLWELLTCETPYK 449
W G +++E++ ++P++
Sbjct: 185 WGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 28/198 (14%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQKETD------------IRHLRKLNHPNIVKF 314
+G GA G V+ + VA+K VR Q D ++ L +HPNIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 315 KGVCTQAPC-----YCIVMEYCAYGPLYNLLKDGEEVPP-----QRLYNWARQIAAGMNY 364
VC + +V E+ +L ++VPP + + + RQ G+++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ----DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
LH+ I+HRDLK N+L+ S + K++DFG R ++ + T+ + APEV+
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183
Query: 425 CSDKIDIWSYGIVLWELL 442
+ +D+WS G + E+
Sbjct: 184 YATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 6/152 (3%)
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL----YNLLKDGEEVPPQRLYNWARQI 358
L K+N P IV C+VM G L YN+ + G E+ +R+ +++ QI
Sbjct: 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM--ERVIHYSAQI 104
Query: 359 AAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 418
G+ +LHS I++RD+K NVL+ + ++SD G E + T AGT +MAPE
Sbjct: 105 TCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPE 164
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTCETPYKD 450
+++ E S +D ++ G ++E++ TP+KD
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 47/212 (22%)
Query: 266 LQWLGSGAQGAV----FSGKLRSEIVAVKKV--------------REQKETDIRHLRKLN 307
++ LG GA G V + E VA+KK+ RE K +RH R
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKL--LRHFR--G 60
Query: 308 HPNIV-----------KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR 356
H NI F + Y +ME L+ +++ G+ + ++
Sbjct: 61 HKNITCLYDMDIVFPGNFNELY----LYEELMEA----DLHQIIRSGQPLTDAHFQSFIY 112
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-----NKSTKMSFAGT 411
QI G+ Y+HS ++HRDLK N+L+ + E KI DFG R ++ N + T
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 412 VAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELL 442
+ APE++ + Q + ID+WS G +L ELL
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 64/276 (23%), Positives = 104/276 (37%), Gaps = 65/276 (23%)
Query: 285 EIVAVKKV-----------REQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333
+VAVKK+ Q+E I R+L HPNI+ + +V AY
Sbjct: 26 TLVAVKKINLDSCSKEDLKLLQQE--IITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 334 GPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKIS 391
G +LLK E +P + + + ++Y+HSK IHR +K+ ++L+ + +S
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS 143
Query: 392 DFGTCREWNNKSTKMSF--------AGTVAWMAPEVIR------NEQCSDKIDIWSYGIV 437
+ + W++PEV++ NE K DI+S GI
Sbjct: 144 GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE----KSDIYSVGIT 199
Query: 438 LWELLTCETPYKDVDS--------------------------------SAIIWGVGSSSL 465
EL P+KD+ + S+ S+
Sbjct: 200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259
Query: 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P T + F +++C P SRPS Q+L+H
Sbjct: 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 19/193 (9%)
Query: 264 SDLQWLGSGAQGAVFSGK--LRSEIVAVKKVREQKET---------DIRHLRKLNHPNIV 312
DLQ +G GA G V S + L + VA+KK+ + T +++ L+ L H NI+
Sbjct: 13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENII 72
Query: 313 KFKGVCTQAPCYCI--VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
+ +P I V E L+ LL + Q + + QI G+ Y+HS +
Sbjct: 73 SLSDIFI-SPLEDIYFVTELLGTD-LHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-KI 429
+HRDLK N+LI + KI DFG R + + T + T + APE++ Q D ++
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMT--GYVSTRYYRAPEIMLTWQKYDVEV 187
Query: 430 DIWSYGIVLWELL 442
DIWS G + E+L
Sbjct: 188 DIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 269 LGSGAQGAVFSGKLRSE--IVAVKKVREQ---KETDIRH--------LRKLNHPNIVKFK 315
+G G+ G V + ++E AVK ++++ K+ + +H L+ + HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
A V++Y G L+ L+ R +A +IA+ + YLHS I++RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 376 KSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K N+L+ S+ ++DFG C+E + T +F GT ++APEV+ + +D W
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182
Query: 435 GIVLWELLTCETPY 448
G VL+E+L P+
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 76/278 (27%), Positives = 113/278 (40%), Gaps = 43/278 (15%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKF 314
L+ +G G G VF K R EIVA+K+VR + + I L++L H NIV+
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
V +V EYC ++ P+ + ++ Q+ G+ + HS ++HRD
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQCSD-KIDIW 432
LK N+LI E K++DFG R + S W P+V+ + ID+W
Sbjct: 125 LKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 184
Query: 433 SYGIVLWELLTCETPY---KDVDS------------SAIIW-GV-------------GSS 463
S G + EL P DVD + W GV ++
Sbjct: 185 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATT 244
Query: 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
SL +P G LL + N P R S ++ L H
Sbjct: 245 SLVNVVPKLNSTGRDLLQNLLVCN-PVQRISAEEALQH 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 27/226 (11%)
Query: 247 FKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQKETDI---- 300
++ V + WE+P + DL+ +GSGA G V S R VA+KK+ ++++
Sbjct: 2 YRQEVNKTIWEVP-DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 301 -----RHLRKLNHPNIVKFKGVCTQAPC------YCIVMEYCA--YGPLYNLLKDGEEVP 347
R L+ + H N++ V T + +VM + G L K E+
Sbjct: 61 AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED-- 118
Query: 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407
R+ Q+ G+ Y+H+ IIHRDLK N+ + E KI DFG R+ +++ T
Sbjct: 119 --RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT--G 174
Query: 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVD 452
+ T + APEVI N + +DIWS G ++ E+LT + +K D
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 52/194 (26%), Positives = 100/194 (51%), Gaps = 14/194 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRHLRKLNH--------PNIVKFK 315
+G G+ V +L+ +I A+K V+++ + DI ++ H P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
+V+EY G L ++ ++P + +A +I +N+LH + II+RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 376 KSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K NVL+ + K++D+G C+E T +F GT ++APE++R E+ +D W+
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182
Query: 435 GIVLWELLTCETPY 448
G++++E++ +P+
Sbjct: 183 GVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 56/186 (30%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVR------EQKETDIRHL---RKLNHPNIVKFKGV 317
+G GA G V + + EIVA+KK + E KET +R L R L NIV+ K
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+ +V EY L L + VPP+++ ++ Q+ +++ H I+HRD+K
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128
Query: 378 PNVLIGSKEEAKISDFGTCREWN--NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYG 435
N+LI + K+ DFG R + + + + T + +PE++ +D+WS G
Sbjct: 129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG 188
Query: 436 IVLWEL 441
+L EL
Sbjct: 189 CILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 77/266 (28%), Positives = 119/266 (44%), Gaps = 38/266 (14%)
Query: 268 WLGSGAQGAVFSGKLRSEIVAVKKVR------EQKE--TDIRHLRKLNHPNIVKFKGVCT 319
W G G V SG V VK++R EQ + + + R L H N+++ G CT
Sbjct: 7 WFGKVILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT 65
Query: 320 QAPCYCIVMEYCAYGPLYNLLK-----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
+ Y +VME+C G L L+ + P L A +IA G+ +LH IH D
Sbjct: 66 EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSD 125
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT------VAWMAPEVIR----NEQ 424
L N L+ + KI D+G +NK + + + W+APE++ N
Sbjct: 126 LALRNCLLTADLTVKIGDYGLS---HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLL 182
Query: 425 CSDKI---DIWSYGIVLWELLTCET-PYKDV-DSSAIIWGVGSSSLHLPIPS---TCPDG 476
D+ ++WS G+ +WEL + PY+ + D + + V L LP P D
Sbjct: 183 VVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDR 242
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHL 502
+ +M+ CW P RPS +++ HL
Sbjct: 243 WYEVMQFCWLQ-PEQRPSAEEV--HL 265
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 4/156 (2%)
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVA 413
Q+A GM +L S++ IHRDL + N+L+ KI DFG R+ K S +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPST 472
WMAPE I ++ + + D+WS+G++LWE+ + +PY V + + P
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPEN 301
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
+M CW P RP+F ++ L QE
Sbjct: 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVF----SGKLRSEIVAVKKVREQK--ETDIRHLR 304
V+R ++ I L L G++G VF G + + V VK V K +I L+
Sbjct: 89 VVRMQYNI-------LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILK 141
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNY 364
++H I+ C+VM L+ + +P ++ R++ + Y
Sbjct: 142 TISHRAIINLIHAYRWKSTVCMVMPKYKCD-LFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFG-TCR--EWNNKSTKMSFAGTVAWMAPEVIR 421
LH + IIHRD+K+ N+ + E A + DFG C+ + ++GT+ +PE++
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA 260
Query: 422 NEQCSDKIDIWSYGIVLWELLTCETPY--KDVDSSA 455
+ K DIWS G+VL+E+ K V SS+
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
|
Length = 392 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 78/251 (31%), Positives = 123/251 (49%), Gaps = 33/251 (13%)
Query: 266 LQWLGSGAQGAVF-----SGKLRSEIVAVKK------VREQKETDIRH-------LRKLN 307
L+ LG G G VF +G +I A+K VR QK+T H L +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDT--AHTKAERNILEAVK 58
Query: 308 HPNIVKFK-GVCTQAPCYCIVMEYCAYGPLY-NLLKDG---EEVPPQRLYNWARQIAAGM 362
HP IV T Y I +EY + G L+ +L ++G E+ L +I+ +
Sbjct: 59 HPFIVDLIYAFQTGGKLYLI-LEYLSGGELFMHLEREGIFMEDTACFYL----SEISLAL 113
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIR 421
+LH + II+RDLK N+L+ ++ K++DFG C+E + + +F GT+ +MAPE++
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 422 NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+D WS G +++++LT P+ + I + L+LP P P+ LL
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP-PYLTPEARDLLK 232
Query: 482 KMCWSNAPSSR 492
K+ N PSSR
Sbjct: 233 KLLKRN-PSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVR-------EQKET--DIRHLRKLNHPNIVKFKGV 317
+G GA G V S K +E VA+KK+ + K T +I+ LR L+H N++ K +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 318 CTQAPCYCIVME-YCAY----GPLYNLLKDGEEVPPQRLYN-----WARQIAAGMNYLHS 367
P + Y Y L+ +++ Q L + + Q+ G+ Y+HS
Sbjct: 73 MP-PPHREAFNDVYIVYELMDTDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCS 426
++HRDLK N+L+ + + KI DFG R + K M+ + T + APE++ N CS
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN--CS 184
Query: 427 D---KIDIWSYGIVLWELLTCET--PYKD 450
+ ID+WS G + ELL + P KD
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 76/282 (26%), Positives = 121/282 (42%), Gaps = 56/282 (19%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQKE------TDIRH---LRKLNHPNIVKFKGV 317
+G G G V+ + R +E +A+KK+R ++E T IR L+++ H NIV+ + V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVP-----PQRLYNWARQIAAGMNYLHSKQIIH 372
+V EY +L K + P P+ + + QI G+ Y HS +++H
Sbjct: 70 VHSEKRLYLVFEYLDL----DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH 125
Query: 373 RDLKSPNVLIGSKEEA-KISDFGTCREWNNKSTKMSFAGTVAWM-APEVIR-NEQCSDKI 429
RDLK N+LI + A K++DFG R + + W APE++ + S +
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPV 185
Query: 430 DIWSYGIVLWELLTCE--------------------TPYK----------DVDSSAIIWG 459
DIWS G + E++ + TP + D S+ W
Sbjct: 186 DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKW- 244
Query: 460 VGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L +P+ P G LL KM + PS R + + L H
Sbjct: 245 -PPKDLATVVPTLEPAGVDLLSKMLRLD-PSKRITARAALEH 284
|
Length = 294 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 81/274 (29%), Positives = 119/274 (43%), Gaps = 43/274 (15%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLR----SEIVAVKKVR------EQKETDIRHLRKL---- 306
E + DL +G GA G V K+ I+AVK++R EQK R L L
Sbjct: 4 EDLKDLGEIGRGAFGTV--NKMLHKPSGTIMAVKRIRSTVDEKEQK----RLLMDLDVVM 57
Query: 307 ---NHPNIVKFKG-VCTQAPCYCIVMEYCA------YGPLYNLLKDGEEVPPQRLYNWAR 356
+ P IVKF G + + C+ I ME Y +Y +LK +P + L A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCW-ICMELMDISLDKFYKYVYEVLKS--VIPEEILGKIAV 114
Query: 357 QIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM 415
+NYL + +IIHRD+K N+L+ K+ DFG + + K AG +M
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174
Query: 416 APEVIRNEQCSD---KIDIWSYGIVLWELLTCETPYKDVDS-----SAIIWGVGSSSLHL 467
APE I + D+WS GI L+E+ T + PY +S + ++ G L
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSN 233
Query: 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
F + +C S RP +K++L H
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 62/291 (21%)
Query: 266 LQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETD-------IRHLRKL-NHPNIVK 313
LQ LG GA G V+ + E+VA+KK+ + + TD I L++L +HPNIVK
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVK 71
Query: 314 FKGVC---TQAPCYCIVMEYCAYGPLYNLLKDG--EEVPPQR-LYNWARQIAAGMNYLHS 367
V Y +V EY L+ +++ E+V + +Y Q+ + Y+HS
Sbjct: 72 LLNVIKAENDKDIY-LVFEY-METDLHAVIRANILEDVHKRYIMY----QLLKALKYIHS 125
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCR-----EWNNKSTKMS-FAGTVAWMAPEVIR 421
+IHRDLK N+L+ S K++DFG R E N ++ ++ + T + APE++
Sbjct: 126 GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL 185
Query: 422 NEQCSDK-IDIWSYGIVLWELLTC---------------------ETPYKDVDS------ 453
K +D+WS G +L E+L +D++S
Sbjct: 186 GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFA 245
Query: 454 SAIIWGVGSS---SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ ++ + S L +P D LL K+ N P+ R + ++ L H
Sbjct: 246 ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN-PNKRLTAEEALEH 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 54/245 (22%)
Query: 299 DIRHLRKLN-HPNIVKFKGVCTQAP--CYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNW 354
+I+ LR+L+ HPNI++ V +V E LY L+K + +P +R+ ++
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSY 105
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAW 414
Q+ ++++H I HRD+K N+LI + K++DFG+CR +K + T +
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTEYISTRWY 164
Query: 415 MAPEVIRNEQC-------SDKIDIWSYGIVLWELLTCE--------------------TP 447
APE C K+DIW+ G V +E+L+ TP
Sbjct: 165 RAPE------CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP 218
Query: 448 YKDVD-----SSAIIW------GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFK 496
+V S + + G G L +P+ +G LL K+ + P R + K
Sbjct: 219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKL---LPNASAEGLDLLKKLLAYD-PDERITAK 274
Query: 497 QILSH 501
Q L H
Sbjct: 275 QALRH 279
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 260 FESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKE-----TDIRH---LRKLNHP 309
E+ L LG G V+ G KL +VA+K++R + E T IR L+ L H
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSK 368
NIV + +V EY L L D G + + + Q+ G+NY H +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE--VIRNEQCS 426
+++HRDLK N+LI + E K++DFG R + + S W P ++ + S
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 427 DKIDIWSYGIVLWELLT 443
+ID+W G + +E+ T
Sbjct: 184 TQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 41/220 (18%)
Query: 250 FVLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKV-----------REQK 296
F + ++ ++ +GSGA G V S + VA+KK+ R +
Sbjct: 1 FDVGSRYKP-------IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR 53
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQAP------CYCI--VMEYCAYGPLYNLLKDGEEVPP 348
E ++ LR H NI+ + + + P Y + +ME L++++ + +
Sbjct: 54 E--LKILRHFKHDNIIAIRDI-LRPPGADFKDVYVVMDLME----SDLHHIIHSDQPLTE 106
Query: 349 QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408
+ + + Q+ G+ Y+HS +IHRDLK N+L+ E +I DFG R ++ T+ +
Sbjct: 107 EHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 409 AGT--VA---WMAPEVIRN-EQCSDKIDIWSYGIVLWELL 442
T VA + APE++ + + + ID+WS G + E+L
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 75/251 (29%), Positives = 112/251 (44%), Gaps = 56/251 (22%)
Query: 260 FESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQK------------ETDIRHLRK 305
FE+I + + +GA GAV+ + + + A+KK+ +Q E DI L
Sbjct: 3 FETI---KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTF 57
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQ--RLYNWARQIAAGMN 363
+P +V C+VMEY G LLK+ +P R+Y +A + A +
Sbjct: 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY-FAETVLA-LE 115
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFG--------------------TCREWNNKS 403
YLH+ I+HRDLK N+LI S K++DFG RE+ +K
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-C-----ETP---YKDVDSS 454
GT ++APEVI + +D W+ GI+L+E L C +TP + V S
Sbjct: 176 V----CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231
Query: 455 AIIWGVGSSSL 465
I W G +L
Sbjct: 232 DIEWPEGDEAL 242
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSG-KLRSEI-VAVKKVREQKET---------DIRHLR 304
WE+P E +L +GSGA G+V + ++ + VAVKK+ ++ ++R L+
Sbjct: 13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 305 KLNHPNIVKFKGVCTQAPCY-----CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIA 359
+ H N++ V T A ++ + L N++K +++ + QI
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQIL 130
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 419
G+ Y+HS IIHRDLK N+ + E KI DFG R +++ T + T + APE+
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 188
Query: 420 IRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVD 452
+ N + +DIWS G ++ ELLT T + D
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 51/147 (34%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 301 RHLRKLNHPNIVKFKGVCTQAPCYCIVM-EYCAYGPLYNLLKDGEEVPP---QRLYNWAR 356
R LR+L+HP ++ V C+V+ +Y + LY L G + P ++ AR
Sbjct: 212 RLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYL--GARLRPLGLAQVTAVAR 267
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG-TCREWNNKSTKMSF--AGTVA 413
Q+ + ++Y+H + IIHRD+K+ NVL+ E+ + DFG C + ST + AGTV
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWE 440
APEV+ + + +DIWS G+V++E
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 14/195 (7%)
Query: 260 FESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKE-----TDIRH---LRKLNHP 309
E+ L+ LG G VF G KL +VA+K++R + E T IR L+ L H
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSK 368
NIV + +V EY L + D G + + + QI G+ Y H +
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE--VIRNEQCS 426
+++HRDLK N+LI + E K++DFG R + + S W P ++ + + S
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 427 DKIDIWSYGIVLWEL 441
+ID+W G + +E+
Sbjct: 184 TQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 50/217 (23%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR----QIAAGMNYLHSKQIIHRDLKSPNVL 381
+VMEY G L NLL + P AR ++ ++ +H IHRD+K N+L
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLALDSVHKLGFIHRDIKPDNIL 133
Query: 382 IGSKEEAKISDFGTC----------------------------REWNNKSTKMSFA--GT 411
I + K++DFG C R + + + + GT
Sbjct: 134 IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGT 193
Query: 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA----II-WGVGSSSLH 466
++APEV+R + D WS G++L+E+L P+ II W SL
Sbjct: 194 PDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKE---SLR 250
Query: 467 LP-IPSTCPDGFQLLMKMCWSNAPSSR-PSFKQILSH 501
P P P+ L+ ++ P R SF++I SH
Sbjct: 251 FPPDPPVSPEAIDLICRLL--CDPEDRLGSFEEIKSH 285
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 40/214 (18%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKET---------------------DIRHLRK 305
LG G G V L +IVA+KKV+ + + +++ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYL 365
+ H NI+ V + +VM+ A L ++ + ++ QI G+N L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 366 HSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--------------EWNNKSTKMSFAGT 411
H +HRDL N+ I SK KI+DFG R E + +M+
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195
Query: 412 VAWM-APEVIRNEQC-SDKIDIWSYGIVLWELLT 443
W APE++ + +D+WS G + ELLT
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 35/210 (16%)
Query: 265 DLQWLGSGAQGAVFSGKLRSEI---VAVKKVR-------EQKETDIRHLRKLNHPNIVKF 314
DL+ LG G+ G VFS + S+ VAVKK+ + +I+ +R+L+H NIVK
Sbjct: 9 DLRPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 67
Query: 315 --------------KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA 360
G T+ IV EY L N+L+ G + + + Q+
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGP-LSEEHARLFMYQLLR 125
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEA-KISDFGTCR----EWNNKSTKMSFAGTVAWM 415
G+ Y+HS ++HRDLK NV I +++ KI DFG R +++K +S W
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG-YLSEGLVTKWY 184
Query: 416 -APEVIRNEQCSDK-IDIWSYGIVLWELLT 443
+P ++ + K ID+W+ G + E+LT
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH-----------LRKLNHPNIVKFK 315
LG G G V + ++R+ ++ A KK+ E+K R L K+N +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKL-EKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 316 GVCTQAPCYCIVMEYCAYGPL-YNLLKDGEE-VPPQRLYNWARQIAAGMNYLHSKQIIHR 373
C+V+ G L +++ GE R +A +I G+ LH ++I++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLK N+L+ +ISD G T GTV +MAPEV++NE+ + D W+
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186
Query: 434 YGIVLWELLTCETPYK 449
G +L+E++ ++P++
Sbjct: 187 LGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 18/197 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK----------ETDIRHLRKLNHPNIVKFKG 316
LG G G V + ++R+ ++ A KK+ +++ + R L K+N +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 317 VCTQAPCYCIVMEYCAYGPL----YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
C+V+ G L YN+ G + QR +A ++ G+ L ++I++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD--EQRAIFYAAELCCGLEDLQRERIVY 125
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
RDLK N+L+ + +ISD G + T GTV +MAPEVI NE+ + D W
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWW 185
Query: 433 SYGIVLWELLTCETPYK 449
G +++E++ ++P++
Sbjct: 186 GLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 36/124 (29%), Positives = 71/124 (57%), Gaps = 1/124 (0%)
Query: 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386
VMEY G L ++ + R +A ++ + +LH +I+RDLK N+L+ ++
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133
Query: 387 EAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE 445
K++DFG C+E N T +F GT ++APE+++ + +D W+ G++++E++ +
Sbjct: 134 HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
Query: 446 TPYK 449
P++
Sbjct: 194 PPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 12/194 (6%)
Query: 261 ESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVREQKE-----TDIRH---LRKLNHPN 310
+S L+ LG G+ V+ GK + ++VA+K +R Q+E T IR L+ L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
IV + +V EY + K + P+ + + Q+ G++Y+H + I
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE--VIRNEQCSDK 428
+HRDLK N+LI E K++DFG R + S S W P ++ + + S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 429 IDIWSYGIVLWELL 442
+D+W G + E++
Sbjct: 185 LDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 256 WEIPFESISDLQWLGSGAQGAV---FSGKLRSEIVAVKKVREQKET---------DIRHL 303
WE+P E +L +GSGA G+V + +LR + VAVKK+ ++ ++R L
Sbjct: 11 WEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 304 RKLNHPNIVKFKGVCTQAP-------CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR 356
+ + H N++ V T A Y + A L N++K +++ + +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA--DLNNIVK-CQKLSDEHVQFLIY 125
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMA 416
Q+ G+ Y+HS IIHRDLK NV + E +I DFG R+ +++ T + T + A
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVATRWYRA 183
Query: 417 PEVIRN-EQCSDKIDIWSYGIVLWELL 442
PE++ N + +DIWS G ++ ELL
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHP 309
E +L +G G+ G V K + +IVA+KK E ++ IR L++L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
N+V V + +V E+ + L +L K + R+ + QI G+ + HS
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPE-VIRNEQCSD 427
IIHRD+K N+L+ K+ DFG R + + T + APE ++ + +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 428 KIDIWSYGIVLWELLTCETPYKDVDS 453
+DIW+ G ++ E+LT E P DS
Sbjct: 181 AVDIWAVGCLVTEMLTGE-PLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLNHPNIVK--- 313
+G G G VF K + EIVA+K++++ K ++RH L +VK
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 314 -FKGVCTQAPCYC-IVMEYCAYGPL------YNLLKDGEEVPPQRLYNWARQIAAGMNYL 365
F Q Y + MEY G +L + R Y ++ ++ L
Sbjct: 69 AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----ARFY--MAEMFEAVDAL 117
Query: 366 HSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC 425
H IHRDLK N LI + K++DFG + + S G+ +MAPEV+R +
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN--SVVGSPDYMAPEVLRGKGY 175
Query: 426 SDKIDIWSYGIVLWELLTCETPY 448
+D WS G +L+E L P+
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 43/133 (32%), Positives = 75/133 (56%), Gaps = 15/133 (11%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR----QIAAGMNYLHSKQIIHRDLKSPNVL 381
+VMEY G L NL+ + ++P + WAR ++ ++ +HS IHRD+K N+L
Sbjct: 120 MVMEYMPGGDLVNLMSN-YDIPEK----WARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 382 IGSKEEAKISDFGTCREWN-NKSTKMSFA-GTVAWMAPEVIRNE----QCSDKIDIWSYG 435
+ K++DFGTC + + N + A GT +++PEV++++ + D WS G
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 436 IVLWELLTCETPY 448
+ L+E+L +TP+
Sbjct: 235 VFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 30/201 (14%)
Query: 264 SDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETDI-RHLRKL------NHPNIV 312
+L+ +GSGAQG V + + + VA+KK+ Q T R R+L NH NI+
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNII 78
Query: 313 KFKGVCTQAPCY------CIVMEY-----CAYGPLYNLLKDGEEVPPQRLYNWARQIAAG 361
V T +VME C + + D E R+ Q+ G
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELMDANLCQ---VIQMDLDHE-----RMSYLLYQMLCG 130
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 421
+ +LHS IIHRDLK N+++ S KI DFG R + T + APEVI
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 190
Query: 422 NEQCSDKIDIWSYGIVLWELL 442
+ +DIWS G ++ E++
Sbjct: 191 GMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH-----------LRKLNHPNIVKFK 315
LG G G V + ++R+ ++ A K++ E+K R L K+N +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRL-EKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 316 GVCTQAPCYCIVMEYCAYGPL----YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
C+V+ G L YN+ G E +R +A +I G+ LH + +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE--EERALFYAAEILCGLEDLHRENTV 124
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
+RDLK N+L+ +ISD G + + GTV +MAPEV+ N++ + D
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDY 184
Query: 432 WSYGIVLWELLTCETPYK 449
W G +++E++ ++P++
Sbjct: 185 WGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 53/251 (21%), Positives = 120/251 (47%), Gaps = 19/251 (7%)
Query: 271 SGAQGAVFSGKLRSEIVAV----------KKVREQKETDIRHLRKLNHPNIVKFKG---- 316
Q +++ G ++ V + K + + E +I++LR+++ NI+K G
Sbjct: 30 ENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDL 375
+ P +++EYC G L +L +++ + + A G+ L+ +++L
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL 149
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN--EQCSDKIDIWS 433
S + L+ + KI G + ++ K + + + +++ + + + K DI+S
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKN--VNFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
G+VLWE+ T + P++++ + I + + + L +P CP + +++ C S+ RP
Sbjct: 208 LGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRP 267
Query: 494 SFKQILSHLDI 504
+ K+IL +L +
Sbjct: 268 NIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAG 361
+ +++H ++ GVC + +V E+ +GPL L K+ VP A+Q+A+
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASA 129
Query: 362 MNYLHSKQIIHRDLKSPNVLI-------GSKEEAKISDFGTCREWNNKSTKMSFAGTVAW 414
++YL K ++H ++ + N+L+ G+ K+SD G ++ ++ + W
Sbjct: 130 LSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE---RIPW 186
Query: 415 MAPEVIRN-EQCSDKIDIWSYGIVLWEL-LTCETPYKDVDSSAIIWGVGSSSLHLPIPST 472
+APE + S D WS+G L E+ E P K+ + + LP PS
Sbjct: 187 IAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE-RTPSEKERFYEKKHRLPEPS- 244
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
C + L+ C + P+ RPSF+ IL L
Sbjct: 245 CKE-LATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLRSE---IVAVK-----KVREQKETD-----IRHL 303
++ +E + ++ LG+G+ G V ++E VA+K K+ +QK+ D + L
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMN 363
+NHP V G +V+E+ G + L+ + P +A QI
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE 423
YL S I++RDLK N+L+ K++DFG + + ++ + GT ++APE++ N
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--YTLCGTPEYIAPEILLNV 203
Query: 424 QCSDKIDIWSYGIVLWELLTCETPY 448
D W+ GI ++E+L P+
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 261 ESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKE-----TDIRH---LRKLNHPN 310
E+ L LG G+ V+ G KL ++VA+K++R + E T IR L+ L H N
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
IV + +V EY + G + + + Q+ G+ Y H +++
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRV 124
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----TKMSFAGTVAWMAPEVIRNEQC- 425
+HRDLK N+LI + E K++DFG R KS T + T+ + P+V+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA---KSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 426 SDKIDIWSYGIVLWELLT 443
S +D+W G + +E+ T
Sbjct: 182 STSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-14
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQ----KETDIRHLRK------LNHPNIVKFKG 316
+G G G V+ + S VA+KK+RE R LR+ L HP IV
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLK-------------DGEEVPPQRLYNWARQIAAGMN 363
+C+ M Y L +LLK + V + +I A +
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA--FLSIFHKICATIE 127
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC---------------REWNNKSTKMS- 407
Y+HSK ++HRDLK N+L+G E I D+G E N + M+
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 408 ---FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYK 449
GT +MAPE + S+ DI++ G++L+++LT PY+
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 66/232 (28%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 245 GEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETDI 300
+F S + D + L+ +GSGAQG V + + VAVKK+ Q +T
Sbjct: 5 SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 64
Query: 301 RH-------LRKLNHPNIVKFKGVCTQAPCY------CIVMEYCAYGPLYNLLKDGE--- 344
+ L+ +NH NI+ V T +VME L D
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME----------LMDANLCQ 114
Query: 345 ----EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400
E+ +R+ Q+ G+ +LHS IIHRDLK N+++ S KI DFG R
Sbjct: 115 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
Query: 401 NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD 452
+ T + APEVI + +DIWS G ++ EL+ ++ D
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 8e-14
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 16/180 (8%)
Query: 280 GKLRSEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVC-TQAPCYCIVMEYCA 332
GK + E + K+V+ Q E +I L +LNH NI+K + + ++A Y I +Y
Sbjct: 188 GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247
Query: 333 YGPLYNLLKDGEEVPPQRLYNWA-----RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE 387
LY+ + D R +Q+ + Y+H K++IHRD+K N+ + +
Sbjct: 248 --DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305
Query: 388 AKISDFGTCREWNNKSTKMSFA--GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE 445
+ DFGT + + + GTVA +PE++ + + DIWS G++L ++L+ +
Sbjct: 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
+G G+ G V + R I A+K +R+ +++ H L ++N P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+V+ + G L++ L+ R + ++ + LH +I+RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 377 SPNVLIGSKEEAKISDFGTCR-EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYG 435
N+L+ + + DFG C+ + +F GT ++APE++ + +D W+ G
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180
Query: 436 IVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477
++L+E+LT P+ D + + + + L P PDGF
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKI------LQEPLRFPDGF 216
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 18/199 (9%)
Query: 262 SISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVC 318
+ ++Q + + V++ KL S+ +K+ +E DI + N P +V+
Sbjct: 55 AFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQLFCAF 112
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378
+VMEY G L NL+ + +VP + + ++ ++ +HS +IHRD+K
Sbjct: 113 QDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 171
Query: 379 NVLIGSKEEAKISDFGTCREWNNKSTKM----SFAGTVAWMAPEVIRNEQCSD-----KI 429
N+L+ K++DFGTC + + T M + GT +++PEV+++ Q D +
Sbjct: 172 NMLLDKHGHLKLADFGTCMKMD--ETGMVRCDTAVGTPDYISPEVLKS-QGGDGYYGREC 228
Query: 430 DIWSYGIVLWELLTCETPY 448
D WS G+ L+E+L +TP+
Sbjct: 229 DWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL-------KDGEEVPPQRLYNWAR 356
R L HPNI++ G C +A Y +V EYC G L + L ++ + + QR+ A
Sbjct: 50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM---AC 106
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG---TCREWNNKSTKMSFAGTVA 413
+IAAG+ ++H +H DL N + S K+ D+G + + + T+ +
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 414 WMAPEVIRNEQCSDKI---------DIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSS 463
W+APE++ + ++W+ G+ LWEL PY + ++ V
Sbjct: 167 WLAPELVGEFH--GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224
Query: 464 SL------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498
L +P + + + +++ CW +P R + +++
Sbjct: 225 QQVKLFKPQLELPYS--ERWYEVLQFCWL-SPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 17/134 (12%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR----QIAAGMNYLHSKQIIHRDLKSPNVL 381
+VMEY G L NL+ + +VP + WAR ++ ++ +HS IHRD+K N+L
Sbjct: 120 MVMEYMPGGDLVNLMSN-YDVPEK----WARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 382 IGSKEEAKISDFGTCREWNNKSTKM--SFAGTVAWMAPEVIRNEQCSD-----KIDIWSY 434
+ K++DFGTC + N + + GT +++PEV+++ Q D + D WS
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSV 233
Query: 435 GIVLWELLTCETPY 448
G+ L+E+L +TP+
Sbjct: 234 GVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 67/268 (25%), Positives = 107/268 (39%), Gaps = 45/268 (16%)
Query: 269 LGSGAQGAVFSGKLRSEIVAVKKVREQ----KETDIRH-------------LRKLNHPNI 311
LG G +F G R E+ ++ + K D H + +L+H ++
Sbjct: 3 LGQGTFTKIFKGI-RREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
V GVC +V EY +G L LK + + A+Q+A +++L K +
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 371 IHRDLKSPNVLIGSKEEA--------KISDFGTC-----REWNNKSTKMSFAGTVAWMAP 417
H ++ + NVL+ +E+ K+SD G +E + W+ P
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--------LLERIPWVPP 173
Query: 418 EVIRNEQ-CSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475
E I N Q S D WS+G LWE+ + + P +DS + LP P
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTE- 231
Query: 476 GFQLLMKMCWSNAPSSRPSFKQILSHLD 503
L+ C P RPSF+ I+ L+
Sbjct: 232 -LANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 29/200 (14%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVKKVREQKE---------TDIRHLRKLNHPNIVKFKGV 317
+G G+ G V S E VA+KK+ + E +I+ LR L HP+IV+ K +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 318 C------TQAPCYCI--VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
Y + +ME L+ ++K +++ P+ + Q+ + Y+H+
Sbjct: 68 MLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN 123
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCR-EWNNKSTKMSFAGTVA---WMAPEVIRN--E 423
+ HRDLK N+L + + KI DFG R +N+ T + + VA + APE+ +
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 183
Query: 424 QCSDKIDIWSYGIVLWELLT 443
+ + IDIWS G + E+LT
Sbjct: 184 KYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 243 RIGEFKSFVLRDEWEIPFESISDLQWLGSGAQG---AVFSGKLRSEIVAVKKVRE--QKE 297
R F S + D + +L+ +GSGAQG A + L VA+KK+ Q +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQ 64
Query: 298 TDIRH-------LRKLNHPNIVKFKGVCTQAPCY------CIVMEYCAYGPLYNLLKDGE 344
T + ++ +NH NI+ V T IVME L +++
Sbjct: 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--M 121
Query: 345 EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404
E+ +R+ Q+ G+ +LHS IIHRDLK N+++ S KI DFG R
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 181
Query: 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELL 442
+ T + APEVI + +DIWS G ++ E++
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 61/262 (23%), Positives = 113/262 (43%), Gaps = 37/262 (14%)
Query: 269 LGSGAQGAVFSGKLR-------------SEIVAVKKVREQKETDIR--------HLRKLN 307
LG G + +++G L EI + KV + DI +R+++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 308 HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV--PPQRLYNWARQIAAGMNYL 365
H +IV GVC + +V E+ +GPL + +V P + + A+Q+A+ ++YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK-FKVAKQLASALSYL 121
Query: 366 HSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS------TKMSFAGTVAWMAPEV 419
K ++H ++ + N+L+ E + G + ++ ++ + W+APE
Sbjct: 122 EDKDLVHGNVCTKNILLA--REGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPEC 179
Query: 420 IRNEQ-CSDKIDIWSYGIVLWEL-LTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477
+ + + S D WS+G LWE+ E P KD + + + +C
Sbjct: 180 VEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC--MLVTPSC-KEL 236
Query: 478 QLLMKMCWSNAPSSRPSFKQIL 499
LM C + P+ RP F+ I+
Sbjct: 237 ADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 12/193 (6%)
Query: 262 SISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKE-----TDIRH---LRKLNHPNI 311
S +L+ LG G+ V+ G ++ ++VA+K + + E T IR L+ L H NI
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
V + V EY +++ + P + + Q+ G+ Y+H + I+
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE--VIRNEQCSDKI 429
HRDLK N+LI E K++DFG R + S S W P ++ S +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 430 DIWSYGIVLWELL 442
DIW G + E+L
Sbjct: 186 DIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 17/53 (32%), Positives = 28/53 (52%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ K++DFG R+ + +F GT +MAPEV+ + +DIW
Sbjct: 128 ILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIW 180
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 246 EFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETDIR 301
+F S + D + +L+ +GSGAQG V + + VA+KK+ Q +T +
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 302 H-------LRKLNHPNIVKFKGVCTQAPCY------CIVMEYCAYGPLYNLLKDGEEVPP 348
++ +NH NI+ V T +VME L +++ E+
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ--MELDH 118
Query: 349 QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408
+R+ Q+ G+ +LHS IIHRDLK N+++ S KI DFG R +
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178
Query: 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELL 442
T + APEVI + +DIWS G ++ E++
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 22/56 (39%), Positives = 29/56 (51%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S K++DFG + + T S GT WMAPEVIR E+ DIW
Sbjct: 132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 65/268 (24%), Positives = 100/268 (37%), Gaps = 67/268 (25%)
Query: 295 QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD------GEEVPP 348
Q E + H HPNI+ V T ++ + AYG +LLK E +
Sbjct: 47 QNEVVLSHF--FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG 104
Query: 349 QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT--CREWNNKSTKM 406
L+ R G+NYLH IHR++K+ ++LI +S N + K+
Sbjct: 105 NILFGALR----GLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 407 SF------AGTVAWMAPEVIRNEQC--SDKIDIWSYGIVLWELLTCETPYKD-------- 450
+ + W++PE++R + + K DI+S GI EL T P++D
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220
Query: 451 -----------------------------VDS--------SAIIWGVGSSSLHLPIPSTC 473
VDS + + + S L P T
Sbjct: 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSH 501
FQ L+++C P RPS +LSH
Sbjct: 281 SPAFQNLVELCLQQDPEKRPSASSLLSH 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 20/53 (37%), Positives = 29/53 (54%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S E K+ DFG + ++ + + GT WMAPEVI + K DIW
Sbjct: 129 ILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-11
Identities = 65/279 (23%), Positives = 127/279 (45%), Gaps = 50/279 (17%)
Query: 269 LGSGAQGAVFSGKLRS-------EIVAVKKVREQKET----DIRHLRKLNHPNIVKF--K 315
+G+G G VF K + + ++ + ++E++++ ++ +R+L H NIV++ +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 316 GVCTQAPCYCIVMEYCAYGPL-------YNLLKDGEEVPPQRLYNWARQIAAGMNYLHS- 367
+ I+ME+C G L Y + EE + + RQ+ + Y H+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE---HAIVDITRQLLHALAYCHNL 137
Query: 368 ------KQIIHRDLKSPNVLIGS-----------------KEEAKISDFGTCREWNNKST 404
++++HRDLK N+ + + + AKI DFG + +S
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197
Query: 405 KMSFAGTVAWMAPEVIRNEQCS--DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS 462
S GT + +PE++ +E S DK D+W+ G +++EL + +TP+ ++ + +
Sbjct: 198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK 257
Query: 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
LPI + +L+K + + RPS Q L +
Sbjct: 258 RGPDLPIKGKSKE-LNILIKNLLNLSAKERPSALQCLGY 295
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 16/135 (11%)
Query: 326 IVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS 384
+VM+Y G L LL K + +P + ++ ++ +H +HRD+K NVL+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137
Query: 385 KEEAKISDFGTCREWNNKSTKMSF--AGTVAWMAPEVIR---------NEQCSDKIDIWS 433
+++DFG+C T S GT +++PE+++ +C D WS
Sbjct: 138 NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC----DWWS 193
Query: 434 YGIVLWELLTCETPY 448
G+ ++E+L ETP+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 38/105 (36%), Positives = 53/105 (50%), Gaps = 8/105 (7%)
Query: 346 VPPQRLYN-----WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400
V PQ L + + QI G+ YLHS I+HRD+K N+L+ S KI DFG R
Sbjct: 95 VSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154
Query: 401 NKSTKMSFAGTVA--WMAPEVIRNEQ-CSDKIDIWSYGIVLWELL 442
+K V + APE++ + + +DIWS G + ELL
Sbjct: 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 36/126 (28%), Positives = 69/126 (54%), Gaps = 4/126 (3%)
Query: 326 IVMEYCAYGPLY-NLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS 384
+V +Y + G L+ +L K+G R + ++ + +LH I++RDLK N+L+ +
Sbjct: 73 LVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA 131
Query: 385 KEEAKISDFGTCR-EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK-IDIWSYGIVLWELL 442
+ DFG + + T +F GT ++APEV+ +E+ K +D WS G++++E+
Sbjct: 132 TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191
Query: 443 TCETPY 448
+P+
Sbjct: 192 CGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 37/131 (28%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYN-WARQIAAGMNYLHSKQIIHRDLKSPNVLIGS 384
+VM+Y G L LL E+ P+ + + ++ ++ +H +HRD+K NVL+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137
Query: 385 KEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIRNEQ-----CSDKIDIWSYGIV 437
+++DFG+C + N T S GT +++PE+++ + + D WS G+
Sbjct: 138 NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 197
Query: 438 LWELLTCETPY 448
++E+L ETP+
Sbjct: 198 MYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-11
Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 30/183 (16%)
Query: 287 VAVKKVREQKETDIRHLRK-----------LNHPNIVKF--KGVCTQAPCYCIVMEYCAY 333
VA+K +R + H R L HPNIV G + V EY
Sbjct: 6 VAIKLLRTDAPEE-EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYVPG 63
Query: 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI---GSKEEAKI 390
L +L +P Q+ + H++ I+HRDLK N+++ G + AK+
Sbjct: 64 RTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKV 123
Query: 391 SDFG----------TCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWE 440
DFG ++T++ GT + APE +R E + D++++G++ E
Sbjct: 124 LDFGIGTLLPGVRDADVATLTRTTEV--LGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 441 LLT 443
LT
Sbjct: 182 CLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 2/126 (1%)
Query: 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS 384
C +++ G L+ L + + +A +I G+ ++H++ +++RDLK N+L+
Sbjct: 73 CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE 132
Query: 385 KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW-SYGIVLWELLT 443
+ISD G +++ K S GT +MAPEV++ D W S G +L++LL
Sbjct: 133 HGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 444 CETPYK 449
+P++
Sbjct: 192 GHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKE------TDIRH---LRKLNH-PNIVK 313
L+ +G G G V+ + ++ ++VA+KK R + + T +R L+ L+ IV+
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 314 FKGV-----CTQAPCYCIVMEYC-----AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMN 363
V P +V EY + G +P + + ++ Q+ G+
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGR-GPGRPLPAKTIKSFMYQLLKGVA 124
Query: 364 YLHSKQIIHRDLKSPNVLIG-SKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIR 421
+ H ++HRDLK N+L+ K KI+D G R ++ + W APEV+
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184
Query: 422 -NEQCSDKIDIWSYGIVLWELLT 443
+ S +DIWS G + E+
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 49/291 (16%)
Query: 248 KSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE-----IVAVKKVREQKETDIRH 302
KS + D S+ + + G +GA + GK + + V ++I
Sbjct: 681 KSITIND----ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD 736
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGM 362
+ KL HPNIVK G+C ++ EY L +L++ + +R A IA +
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKAL 793
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTV---------- 412
+LH + SP V++G+ KI G + ++S G +
Sbjct: 794 RFLHCRC-------SPAVVVGNLSPEKIIIDGK----DEPHLRLSLPGLLCTDTKCFISS 842
Query: 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYK---DVDSSAIIWGVGS-SSLHLP 468
A++APE + ++K DI+ +G++L ELLT ++P V S + W S HL
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902
Query: 469 I---PSTCPDGF----QLLMKM-----CWSNAPSSRPSFKQILSHLDIASQ 507
+ PS D +++ M C + P++RP +L L+ AS+
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 35/131 (26%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYN-WARQIAAGMNYLHSKQIIHRDLKSPNVLIGS 384
+VM+Y G L LL E+ P+ + + ++ ++ +H +HRD+K N+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137
Query: 385 KEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIV 437
+++DFG+C + T S GT +++PE+++ + + D WS G+
Sbjct: 138 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVC 197
Query: 438 LWELLTCETPY 448
++E+L ETP+
Sbjct: 198 MYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 20/193 (10%)
Query: 269 LGSGAQGAVFSGKL--RSEIVAVKKVREQKETDIRHL---RKLNHPNIVKFKGVCTQAPC 323
+G+G+ G V+ SE VA+KKV + + R L + LNH NI+ K C
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY-YYTEC 132
Query: 324 Y---------CIVMEY---CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+ +VME+ + + + ++ +P + ++ Q+ + Y+HSK I
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFIC 192
Query: 372 HRDLKSPNVLIGSKEEA-KISDFGTCREWNNKSTKMSFAGTVAWMAPEV-IRNEQCSDKI 429
HRDLK N+LI K+ DFG+ + +S+ + + APE+ + + I
Sbjct: 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHI 252
Query: 430 DIWSYGIVLWELL 442
D+WS G ++ E++
Sbjct: 253 DLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ K++DFG + KS + S GT WMAPEVI+ + K+DIW
Sbjct: 147 ILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 5/119 (4%)
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA 413
+A +I G+ ++H++ +++RDLK N+L+ +ISD G +++ K S GT
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHG 160
Query: 414 WMAPEVIRNEQCSDKIDIW-SYGIVLWELLTCETPY---KDVDSSAIIWGVGSSSLHLP 468
+MAPEV++ D W S G +L++LL +P+ K D I + ++ LP
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/257 (23%), Positives = 94/257 (36%), Gaps = 77/257 (29%)
Query: 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386
VM+Y G + +LL P + ++ + +H IHRD+K N+LI
Sbjct: 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG 138
Query: 387 EAKISDFGTC--------------------------REWNNKST---------------- 404
K++DFG C EW + +
Sbjct: 139 HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAAR 198
Query: 405 ------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPY-----KDVDS 453
S GT ++APEV+ + D WS G++L+E+L + P+ +
Sbjct: 199 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQM 258
Query: 454 SAIIWGVGSSSLHLPIPST-CPDGFQLLMKMCWSNAPSSR------------PSFKQILS 500
I W +SLH+P + P+ L++K+C P R P FK I
Sbjct: 259 KVINW---QTSLHIPPQAKLSPEASDLIIKLC--RGPEDRLGKNGADEIKAHPFFKTI-- 311
Query: 501 HLDIASQEVLRIQPEPY 517
D +S LR Q PY
Sbjct: 312 --DFSSD--LRQQSAPY 324
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYN-WARQIAAGMNYLHSKQIIHRDLKSPNVLIGS 384
+VMEY G L +LL E+ + + + ++ ++ +H +HRD+K NVLI
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137
Query: 385 KEEAKISDFGTCREWNNKSTKMSFA----GTVAWMAPEVIRNEQCSDK------IDIWSY 434
K++DFG+ + KM + GT ++APEV+ K D WS
Sbjct: 138 TGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
Query: 435 GIVLWELLTCETPYKDVDSSA 455
G++ +E++ +P+ + +SA
Sbjct: 196 GVIAYEMIYGRSPFHE-GTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 55/250 (22%), Positives = 92/250 (36%), Gaps = 67/250 (26%)
Query: 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWAR----QIAAGMNYLHSKQIIHRDLKSPNVLI 382
VM+Y G + +LL + + L AR ++ + +H IHRD+K N+LI
Sbjct: 79 VMDYIPGGDMMSLLIR-LGIFEEDL---ARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 383 GSKEEAKISDFGTC---------------------------REWNNKSTKM--------- 406
K++DFG C ++
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194
Query: 407 --------SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIW 458
S GT ++APEV+ + D WS G++L+E+L + P+ +
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL 254
Query: 459 GVGSSSLHLPIPST---CPDGFQLLMKMCWSNAPSSR---PSFKQILSH-----LDIASQ 507
V + L IPS + L++++C R +I +H +D AS
Sbjct: 255 KVINWETTLHIPSQAKLSREASDLILRLC--CGAEDRLGKNGADEIKAHPFFKGIDFAS- 311
Query: 508 EVLRIQPEPY 517
++R Q PY
Sbjct: 312 -LIRRQKAPY 320
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 6e-09
Identities = 18/55 (32%), Positives = 27/55 (49%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAG--TVAWMAPEVIRNEQCSDKIDIW 229
L+G KISDFG R+ + G + WMAPE ++ + + K D+W
Sbjct: 134 CLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVW 188
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 299 DIRHLRKLNHPNIVKFKGV-CTQAPCYCIVMEYCAYGPLYNLLK---------DGEEVPP 348
+I LR+L HPN++ + V + A ++ A L++++K ++P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 349 QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTCREWNNKST 404
+ + QI G++YLH+ ++HRDLK N+L+ + KI+D G R +N+
Sbjct: 108 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 405 KMS----FAGTVAWMAPEVIRNEQCSDK-IDIWSYGIVLWELLTCE 445
++ T + APE++ + K IDIW+ G + ELLT E
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 20/54 (37%), Positives = 24/54 (44%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L K++DFG + N S GT WMAPEVI S DIW
Sbjct: 130 ILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIW 183
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 59/251 (23%), Positives = 94/251 (37%), Gaps = 65/251 (25%)
Query: 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386
VM+Y G + +LL E P + ++ + +H IHRD+K N+LI
Sbjct: 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG 138
Query: 387 EAKISDFGTCR--EWNNKST---------------------------------------- 404
K++DFG C W + S
Sbjct: 139 HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATK 198
Query: 405 ------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPY-----KDVDS 453
S GT ++APEV+ + + D WS G++L+E+L + P+ +
Sbjct: 199 QHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL 258
Query: 454 SAIIWGVGSSSLHLPIP-STCPDGFQLLMKMCWSNAPS-SRPSFKQILSH-----LDIAS 506
I W ++LH+P P+ L+ K+C S R I +H +D +S
Sbjct: 259 KVINW---ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315
Query: 507 QEVLRIQPEPY 517
+R QP PY
Sbjct: 316 D--IRTQPAPY 324
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 18/55 (32%), Positives = 27/55 (49%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAG--TVAWMAPEVIRNEQCSDKIDIW 229
L+G KISDFG R+ + G + WMAPE ++ + + K D+W
Sbjct: 133 CLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 299 DIRHLRKLNHPNIVKFKGVCTQAP--CYCIVMEYCAYGPLYNLLK---------DGEEVP 347
+I LR+L HPN++ + V ++ +Y + L++++K ++P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD-LWHIIKFHRASKANKKPMQLP 106
Query: 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTCREWNNKS 403
+ + QI G++YLH+ ++HRDLK N+L+ + KI+D G R +N+
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 404 TKMS----FAGTVAWMAPEVIRNEQCSDK-IDIWSYGIVLWELLTCE 445
++ T + APE++ + K IDIW+ G + ELLT E
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 18/55 (32%), Positives = 30/55 (54%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD-KIDIW 229
+L+ KI+DFG ++ S+ + +F GT +MAPEV+ K+D+W
Sbjct: 129 ILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
|
Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 24/54 (44%), Positives = 32/54 (59%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+LI SK E KI+DFG + N + +F GTV +M+PE I+ E S DIW
Sbjct: 131 LLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIW 184
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 36/159 (22%), Positives = 65/159 (40%), Gaps = 36/159 (22%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK 385
++ME+ G + LL + + + + + ++ +H IHRD+K N+L+ SK
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK 137
Query: 386 EEAKISDFGTC----------------------------------REWNNKSTKMSFA-- 409
K+SDFG C W +++F+
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197
Query: 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPY 448
GT ++APEV + D WS G++++E+L P+
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 20/54 (37%), Positives = 32/54 (59%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ + + K++DFG + + +K +F GT WMAPEVI+ +K DIW
Sbjct: 129 ILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIW 182
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 19/56 (33%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 177 VLIGSKE-EAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQ-CSDKIDIW 229
+L+ S + K++DFG + + + + + GT A+MAPEV+ + S+K DIW
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 70/242 (28%)
Query: 260 FESISDLQWLGSGAQGAV--FSGKLRSEIVAVKKVREQK------------ETDIRHLRK 305
FESI + +G GA G V K I A+KK+R+ + E DI L +
Sbjct: 3 FESI---KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAE 57
Query: 306 LNHPNIVKFKGVCT-QAPCYC-IVMEYCAYGPLYNLL--KD--GEEVPPQRLYNWARQIA 359
++P +VK + Q Y ++MEY G + LL KD EE R Y A I
Sbjct: 58 ADNPWVVKLY--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--TRFY-IAETIL 112
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR---------------------- 397
A ++ +H IHRD+K N+L+ +K K+SDFG C
Sbjct: 113 A-IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 398 ---------------EWNNKSTKMSFA--GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWE 440
W ++++ GT ++APEV + + D WS G++++E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 441 LL 442
+L
Sbjct: 232 ML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 36/159 (22%)
Query: 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK 385
++ME+ G + LL + + + + + ++ +H IHRD+K N+L+ +K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK 137
Query: 386 EEAKISDFGTC----------------------------------REW--NNKSTKMSFA 409
K+SDFG C W N + S
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197
Query: 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPY 448
GT ++APEV + D WS G++++E+L P+
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 65/261 (24%)
Query: 302 HLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL----KDG-EEVPPQRLYNWA 355
H+ KL NHPNIV ++ +V + AYG +L+ DG E+ +
Sbjct: 51 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYIL--- 107
Query: 356 RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF------- 408
+ + ++Y+H +HR +K+ ++LI + +S + N ++
Sbjct: 108 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY 167
Query: 409 -AGTVAWMAPEVIR-NEQCSD-KIDIWSYGIVLWELLTCETPYKDVDSSAIIW------- 458
+ W++PEV++ N Q D K DI+S GI EL P+KD+ ++ ++
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 227
Query: 459 --------------------------------------GVGSSSLHLPIPSTCPDGFQLL 480
G SS H P T F
Sbjct: 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH-PYNRTFSPHFHHF 286
Query: 481 MKMCWSNAPSSRPSFKQILSH 501
++ C P +RPS +L+H
Sbjct: 287 VEQCLQRNPDARPSASTLLNH 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 27/63 (42%), Positives = 36/63 (57%), Gaps = 7/63 (11%)
Query: 174 GLGVLIGSKEEAKISDFGTCR--EWNNKSTKM-----SFAGTVAWMAPEVIRNEQCSDKI 226
G +L+ +K KISDFG + E N+ STK S G+V WMAPEV++ + K
Sbjct: 134 GANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKA 193
Query: 227 DIW 229
DIW
Sbjct: 194 DIW 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 22/49 (44%), Positives = 29/49 (59%), Gaps = 5/49 (10%)
Query: 186 KISDFGTCREWNN---KSTKMSFAGTVAWMAPEVIRNEQC--SDKIDIW 229
KISDFG ++ ++ MS G+V WMAPEVI + S K+DIW
Sbjct: 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIW 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 33/135 (24%), Positives = 63/135 (46%), Gaps = 2/135 (1%)
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
PN+V +V+++ G L++ + +P + + WA ++ ++ LH +
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
I+ RDL N+L+ + +++ F E + A + APEV + ++
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD--GEAVENMYCAPEVGGISEETEA 162
Query: 429 IDIWSYGIVLWELLT 443
D WS G +L+ELLT
Sbjct: 163 CDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 9e-07
Identities = 18/56 (32%), Positives = 27/56 (48%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIW 229
L+G KISDFG R+ + G + WMAPE +++ + K D+W
Sbjct: 136 CLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVW 191
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S+ + K+ DFG + N S +F GT ++MAPE I+ S K DIW
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVN-SLAKTFVGTSSYMAPERIQGNDYSVKSDIW 183
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 36/110 (32%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFS------GKLRSEI-VAVKKVREQKETDIR----- 301
++WE P +++ + LG+GA G V GK + + VAVK ++ TD R
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS 90
Query: 302 ------HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE 345
HL H NIV G CT ++ EYC YG L N L+ E
Sbjct: 91 ELKILSHLG--QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 45/137 (32%), Positives = 64/137 (46%), Gaps = 16/137 (11%)
Query: 272 GAQGAVFSG--KLRSEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGV 317
GA G V+ G K S++ AVK V++ Q E D L K P IV
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHLYYS 72
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
A +VMEY G + +LL + + ++A ++YLH IIHRDLK
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP 132
Query: 378 PNVLIGSKEEAKISDFG 394
N+LI ++ K++DFG
Sbjct: 133 DNMLISNEGHIKLTDFG 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 24/55 (43%), Positives = 30/55 (54%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSD-KIDIW 229
+L+ + K+ DFG N S+K S F GT WMAPEVI + D K DIW
Sbjct: 132 ILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIW 186
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 16/103 (15%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFS----GKLRSE---IVAVKKVR-----EQKETDIRH 302
+WE P +S + LG+GA G V G +S+ VAVK ++ ++E +
Sbjct: 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSE 88
Query: 303 LRKL----NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK 341
L+ L NH NIV G CT ++ EYC YG L N L+
Sbjct: 89 LKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLR 131
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 1e-05
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIW 229
L+ KISDFG R+ G + WMAPE +++ + + K D+W
Sbjct: 133 CLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVW 188
|
Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 20/54 (37%), Positives = 32/54 (59%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ + +AK++DFG + + K + GT WMAPEVI+ ++K DIW
Sbjct: 130 ILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG C + + +K S GT WMAPEV+ + K+DIW
Sbjct: 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 36/176 (20%)
Query: 354 WA--RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT 411
WA Q + LH + L + + L+ E +
Sbjct: 20 WAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAF----KTPEQSR--------PD 67
Query: 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS 471
+MAPEVI+ + ++K DI+S GI L+E L E PY + + S+ L + +
Sbjct: 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPY--NEEREL-----SAILEILLNG 120
Query: 472 TCPDG---------------FQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRI 512
D F+ M++C S P R + L+H E L +
Sbjct: 121 MPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+G K++DFG C + + +K S GT WMAPEV+ + K+DIW
Sbjct: 146 VLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 4e-05
Identities = 14/54 (25%), Positives = 28/54 (51%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ + S K+ DFG + ++ + GT +++PE+ +N+ + K DIW
Sbjct: 134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 6/62 (9%)
Query: 174 GLGVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD-----KID 227
G +L+ E K+ DFG + ++ + +F GT WMAPEVI ++ D + D
Sbjct: 141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSD 200
Query: 228 IW 229
+W
Sbjct: 201 VW 202
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 22/60 (36%), Positives = 29/60 (48%), Gaps = 4/60 (6%)
Query: 174 GLGVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSD---KIDIW 229
G +L+ + K++DFG + K SF GT WMAPEV E+ K DIW
Sbjct: 129 GANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIW 188
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 5e-05
Identities = 16/54 (29%), Positives = 29/54 (53%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ + K++DFG +E + S +F GT ++APEV+ + +D W
Sbjct: 124 ILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 16/53 (30%), Positives = 32/53 (60%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+++G ++ I+DFG ++ +S S GT+ + PE+++NE +K D+W
Sbjct: 145 IMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVW 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG C + + +K S GT WMAPEV+ + K+DIW
Sbjct: 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG C + + +K S GT WMAPEV+ + K+DIW
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 19/97 (19%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW------- 229
+L+ K + K+ DFG E N S +F GT +MAPE I+ + S D+W
Sbjct: 136 ILLTRKGQVKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194
Query: 230 --YKNRLCFPTS---------LMARIGEFKSFVLRDE 255
+NR FP L++ I + L+DE
Sbjct: 195 EVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 19/53 (35%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S+ + K+ DFG E N S +F GT +M+PE I+ + + K D+W
Sbjct: 135 ILVNSRGQIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQGGKYTVKSDVW 186
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S K+SDFG C + + + + S GT WMAPEVI ++DIW
Sbjct: 146 ILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 35/106 (33%), Positives = 50/106 (47%), Gaps = 16/106 (15%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKL----RSE---IVAVKKVR-----EQKETDIRHL 303
WE P + + + LGSGA G V G RS+ VAVK ++ +K+ + L
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSEL 91
Query: 304 RKLNHP----NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE 345
+ + H NIV G CT++ I+ EYC YG L N L +
Sbjct: 92 KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRD 137
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 20/57 (35%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 174 GLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-KIDIW 229
G +L+ + K++DFG ++ S SF G+ WMAPEVI + DIW
Sbjct: 130 GANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 6/62 (9%)
Query: 174 GLGVLIGSK-EEAKISDFGTCREWNNKST-----KMSFAGTVAWMAPEVIRNEQCSDKID 227
G +LI S + +I+DFG K T + GT+A+MAPEV+R EQ D
Sbjct: 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCD 190
Query: 228 IW 229
+W
Sbjct: 191 VW 192
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 22/54 (40%), Positives = 29/54 (53%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ E K++DFG + + K + F GT WMAPEVI+ K DIW
Sbjct: 132 VLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 21/55 (38%), Positives = 34/55 (61%), Gaps = 3/55 (5%)
Query: 177 VLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
V++ S+ KI+DFG C+E W+ +TK +F GT ++APE+I + +D W
Sbjct: 132 VMLDSEGHIKIADFGMCKENMWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWW 185
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 19/109 (17%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSG-------KLRSEIVAVKKVRE-----QKETDIRH 302
+WE P + + + LG GA G V K VAVK ++E + + +
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSE 60
Query: 303 LRKL----NHPNIVKFKGVCT--QAPCYCIVMEYCAYGPLYNLLKDGEE 345
L+ L NH N+V G CT P IV E+C YG L N L+ E
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIV-EFCKYGNLSNFLRAKRE 108
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 24/148 (16%)
Query: 325 CIVMEYCAYGP--LYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVL 381
CIVM YGP L ++K G + L Q ++Y H++ ++H DLK N+L
Sbjct: 208 CIVMP--KYGPCLLDWIMKHGP-FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264
Query: 382 IGSKEEA----------------KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC 425
+ + + +I D G C + + ++ + T + +PEV+
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAIVSTRHYRSPEVVLGLGW 322
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDS 453
D+WS G +++EL T + Y D+
Sbjct: 323 MYSTDMWSMGCIIYELYTGKLLYDTHDN 350
|
Length = 467 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ + + K++DFG + + K +F GT WMAPEVI+ K DIW
Sbjct: 132 VLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 19/55 (34%), Positives = 34/55 (61%), Gaps = 3/55 (5%)
Query: 177 VLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
V++ ++ KI+DFG C+E + K+T+ +F GT ++APE+I + +D W
Sbjct: 132 VMLDAEGHIKIADFGMCKENIFGGKTTR-TFCGTPDYIAPEIIAYQPYGKSVDWW 185
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 23/62 (37%), Positives = 28/62 (45%), Gaps = 12/62 (19%)
Query: 177 VLIGSKEEAKISDFG--------TCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-KID 227
+L+G KI+DFG R + T F GT WMAPEV+ D K D
Sbjct: 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKT---FVGTPCWMAPEVMEQVHGYDFKAD 189
Query: 228 IW 229
IW
Sbjct: 190 IW 191
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 24/61 (39%), Positives = 32/61 (52%), Gaps = 10/61 (16%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSD-----KIDI 228
+L+ + K++DFG + NKST +F GT WMAPEV+ E D K DI
Sbjct: 134 ILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191
Query: 229 W 229
W
Sbjct: 192 W 192
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ + + K++DFG + + K +F GT WMAPEVI+ K DIW
Sbjct: 132 VLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 19/110 (17%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFS------GKLRS-EIVAVKKVR------EQKE--TD 299
+WE P + + + LG GA G V K S VAVK ++ E K T+
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTE 60
Query: 300 IRHLRKL-NHPNIVKFKGVCTQ--APCYCIVMEYCAYGPLYNLLKDGEEV 346
++ L + +H N+V G CT+ P IV EYC +G L N L+ E
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKREC 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S K+SDFG C + + + K S GT WMAPEVI ++DIW
Sbjct: 149 ILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 6/83 (7%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLC 235
+L+ S+ ++DFG C+E +S T +F GT ++APEVIR + + +D W C
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW-----C 181
Query: 236 FPTSLMARIGEFKSFVLRDEWEI 258
L + F RD E+
Sbjct: 182 LGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 15/55 (27%), Positives = 28/55 (50%), Gaps = 3/55 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKS--TKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ + + K+ DFG + + S K ++ GT +M+PE + + +K DIW
Sbjct: 141 IFLDANNNVKLGDFGLAKILGHDSSFAK-TYVGTPYYMSPEQLNHMSYDEKSDIW 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 20/54 (37%), Positives = 33/54 (61%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ KI+DFG C+E N K S F GT ++APE+++ ++ ++ +D W
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 19/53 (35%), Positives = 27/53 (50%), Gaps = 2/53 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ AK+SDFG +E + V W APE +R ++ S K D+W
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLP--VKWTAPEALREKKFSTKSDVW 183
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 18/102 (17%)
Query: 256 WEIPFESISDLQWLGSGAQGAV-------FSGKLRSEIVAVKKV-----REQKETDIRHL 303
WE+P +++ + LGSGA G V S + VAVK + +K+ + L
Sbjct: 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSEL 91
Query: 304 RKLNH--P--NIVKFKGVCTQ-APCYCIVMEYCAYGPLYNLL 340
+ ++H P NIV G CT+ P Y I+ EYC YG L + L
Sbjct: 92 KIMSHLGPHLNIVNLLGACTKGGPIY-IITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 27/147 (18%), Positives = 51/147 (34%), Gaps = 23/147 (15%)
Query: 264 SDLQWLGSGAQGAVFSGKLRSEIVAVKK-------VREQKETDI-RHLRKLNH--PNIVK 313
S ++ L G V+ + E +K ++E I + L + P ++
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVL- 59
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS---KQI 370
++ME+ L +EV + + A Q+A + LH +
Sbjct: 60 --ASGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCR 397
H DL N+L+ + I D+
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 21/52 (40%), Positives = 26/52 (50%), Gaps = 8/52 (15%)
Query: 186 KISDFGTCREWNNKSTKM-----SFAGTVAWMAPEVIRNEQCSDK---IDIW 229
K+ DFG + N +T M S AGT A+MAPEVI + DIW
Sbjct: 139 KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIW 190
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 22/60 (36%), Positives = 27/60 (45%), Gaps = 4/60 (6%)
Query: 174 GLGVLIGSKEEAKISDFGTCREWNN---KSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
G +L S K+ DFG + T M S GT WM+PEVI E K D+W
Sbjct: 132 GANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVW 191
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 19/55 (34%), Positives = 31/55 (56%), Gaps = 3/55 (5%)
Query: 177 VLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ S+ KI+DFG C+E +T +F GT ++APE++ + +D W
Sbjct: 127 VLLDSEGHIKIADFGMCKEGILGGVTTS-TFCGTPDYIAPEILSYQPYGPAVDWW 180
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 18/54 (33%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S+ ++DFG C+E + T +F GT ++APEV+R + +D W
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 19/53 (35%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ ++ + K+ DFG + N S ++ GT A+MAPE I EQ D+W
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISGEQYGIHSDVW 177
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 17/39 (43%), Positives = 24/39 (61%)
Query: 356 RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394
RQ+ G+ LH I+HRD+K N+L+ + KI DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 20/57 (35%), Positives = 26/57 (45%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTV--AWMAPEVIRNEQCSDKIDIW 229
+L+ S ++ KI DFG R N M V AW APE +R S D+W
Sbjct: 128 ILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVW 184
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 2/53 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ AK+SDFG +E + ST+ + V W APE +R ++ S K D+W
Sbjct: 133 VLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALREKKFSTKSDVW 183
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 21/74 (28%)
Query: 177 VLIGSKEEAKISDFGTCR---------------------EWNNKSTKMSFAGTVAWMAPE 215
+L+ KI+DFGT + N+ SF GT +++PE
Sbjct: 133 ILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192
Query: 216 VIRNEQCSDKIDIW 229
++ + D+W
Sbjct: 193 LLNEKPAGKSSDLW 206
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 20/61 (32%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLC 235
+L+ + K++DFG +E +++ SF GTV +MAPEV+ + D W L
Sbjct: 129 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 188
Query: 236 F 236
F
Sbjct: 189 F 189
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 19/56 (33%), Positives = 31/56 (55%), Gaps = 2/56 (3%)
Query: 177 VLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWY 230
+L+ S+ ++DFG +E+ K SF GT+ +MAPE+IR + K W+
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWW 191
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 186 KISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K+SDFG C + + K S GT WMAPEVI ++DIW
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 17/47 (36%), Positives = 31/47 (65%), Gaps = 3/47 (6%)
Query: 185 AKISDFGTCREWNNKSTKMSF--AGTVAWMAPEVIRNEQCSDKIDIW 229
AK+ DFG R+ N+ S ++++ GT +++PE+ +N ++K DIW
Sbjct: 141 AKLGDFGIARQLND-SMELAYTCVGTPYYLSPEICQNRPYNNKTDIW 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 17/45 (37%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 186 KISDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI+DFG C+E ++ +T +F GT ++APEV+ + +D W
Sbjct: 135 KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 19/54 (35%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S+ ++DFG C+E + T +F GT ++APEV+R E +D W
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 1/61 (1%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLC 235
VL+ S+ K++D+G C+E T +F GT ++APE++R E +D W L
Sbjct: 127 VLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 186
Query: 236 F 236
F
Sbjct: 187 F 187
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 19/54 (35%), Positives = 29/54 (53%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ K+SDFG C + + + + S GT WMAPE+I ++DIW
Sbjct: 147 ILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLC 235
+L+ ++ K++DFG C+E N T +F GT ++APE+++ + +D W L
Sbjct: 127 ILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLM 186
Query: 236 FPTSLMARIGEFKSFVLRDEWEIPFESI 263
+ +MA F++ D + FESI
Sbjct: 187 Y--EMMAGQPPFEA----DNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 600 | |||
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0576|consensus | 829 | 99.98 | ||
| KOG2052|consensus | 513 | 99.98 | ||
| KOG0668|consensus | 338 | 99.97 | ||
| KOG0670|consensus | 752 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG0984|consensus | 282 | 99.97 | ||
| KOG0590|consensus | 601 | 99.97 | ||
| KOG1024|consensus | 563 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290|consensus | 590 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1167|consensus | 418 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1345|consensus | 378 | 99.94 | ||
| KOG1164|consensus | 322 | 99.93 | ||
| KOG1187|consensus | 361 | 99.91 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0195|consensus | 448 | 99.91 | ||
| KOG1163|consensus | 341 | 99.9 | ||
| KOG1165|consensus | 449 | 99.9 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0603|consensus | 612 | 99.87 | ||
| KOG1240|consensus | 1431 | 99.85 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG0576|consensus | 829 | 99.85 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG4158|consensus | 598 | 99.84 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0606|consensus | 1205 | 99.82 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0192|consensus | 362 | 99.81 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1023|consensus | 484 | 99.78 | ||
| KOG1166|consensus | 974 | 99.77 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0581|consensus | 364 | 99.75 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033|consensus | 516 | 99.72 | ||
| KOG0591|consensus | 375 | 99.71 | ||
| KOG0590|consensus | 601 | 99.7 | ||
| KOG0598|consensus | 357 | 99.69 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG4721|consensus | 904 | 99.66 | ||
| KOG0595|consensus | 429 | 99.65 | ||
| KOG0616|consensus | 355 | 99.64 | ||
| KOG0197|consensus | 468 | 99.64 | ||
| KOG0599|consensus | 411 | 99.63 | ||
| KOG0615|consensus | 475 | 99.63 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0694|consensus | 694 | 99.59 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0983|consensus | 391 | 99.59 | ||
| KOG0984|consensus | 282 | 99.59 | ||
| KOG0986|consensus | 591 | 99.59 | ||
| KOG0601|consensus | 524 | 99.57 | ||
| KOG1026|consensus | 774 | 99.57 | ||
| KOG0600|consensus | 560 | 99.56 | ||
| KOG0696|consensus | 683 | 99.56 | ||
| KOG1006|consensus | 361 | 99.53 | ||
| KOG0578|consensus | 550 | 99.52 | ||
| KOG0593|consensus | 396 | 99.52 | ||
| KOG0575|consensus | 592 | 99.52 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.51 | |
| KOG0592|consensus | 604 | 99.51 | ||
| KOG0583|consensus | 370 | 99.51 | ||
| KOG0201|consensus | 467 | 99.5 | ||
| KOG0663|consensus | 419 | 99.5 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.5 | |
| KOG0198|consensus | 313 | 99.5 | ||
| KOG0594|consensus | 323 | 99.49 | ||
| KOG0577|consensus | 948 | 99.48 | ||
| KOG0690|consensus | 516 | 99.48 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.47 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.47 | |
| KOG4236|consensus | 888 | 99.47 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.46 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.45 | |
| KOG0601|consensus | 524 | 99.45 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.45 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.45 | |
| KOG0611|consensus | 668 | 99.45 | ||
| KOG1266|consensus | 458 | 99.45 | ||
| KOG0194|consensus | 474 | 99.44 | ||
| KOG0614|consensus | 732 | 99.44 | ||
| KOG0585|consensus | 576 | 99.44 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.44 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.43 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.43 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.43 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.43 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.43 | |
| KOG0658|consensus | 364 | 99.43 | ||
| KOG0582|consensus | 516 | 99.43 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.42 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.42 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.42 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.42 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.42 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.41 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.41 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.41 |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-72 Score=587.64 Aligned_cols=346 Identities=64% Similarity=1.163 Sum_probs=337.0
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeeceEEEeeeeccchHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
..+.|+|||+.+..+++||+|+.|.||+|+..++.||||+++...+.+|+.|++|+||||+.|.|+|....++|||||||
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 45689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCC
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT 411 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt 411 (600)
..|.|+.+++.+..++...+..|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++.+....+.++++||
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988888999999
Q ss_pred ccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q psy16430 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491 (600)
Q Consensus 412 ~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~ 491 (600)
+.|||||++++.+++.|+|||||||+||||+||..||.+.+...++|.++...+.+++|..||+.++-||++||+..|.+
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHcHhhhhhhhhccCCChhhhhhHhHHHHHHHHHHHHhhcCCCCCChhhhhHHHHHHHHHHHHHHHHHHHHHH
Q psy16430 492 RPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLIKKRENELKHAQDVREHYE 571 (600)
Q Consensus 492 RPs~~elL~~l~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~~~~~~~~~~~~~~~~~k~~ee~~~~~~~~~~~e 571 (600)
|||+.+||.|+.++..+++.++.+.+|..|..|+++.+.++..+..+.++++ .++++++++|.++++++.++|++||
T Consensus 355 RPSFrqil~HldIa~pell~~tee~yf~sq~swrEevk~h~~~it~~gt~ih---~~eeelirrR~eelrHa~DIR~~YE 431 (904)
T KOG4721|consen 355 RPSFRQILLHLDIASPELLSTTEETYFKSQASWREEVKLHFEKITSEGTCIH---RLEEELIRRRREELRHALDIREHYE 431 (904)
T ss_pred CccHHHHHHHHhhcCHHHhcccHHHHHHHHHHHHHHHHHhhhhhccCcchHH---HHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999988887655 6688899999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhhhHHHHhhhC
Q psy16430 572 RKLERANQLYLELSAVRMHLDQREQELLK 600 (600)
Q Consensus 572 ~~l~~~~~~~~~l~~~~~~~~~~e~~~~~ 600 (600)
+||+|+|++|.||++||.||+.||+||++
T Consensus 432 ~KLertN~ly~eLs~cm~qLelkEkElae 460 (904)
T KOG4721|consen 432 RKLERTNNLYMELSACMLQLELKEKELAE 460 (904)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999974
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=415.72 Aligned_cols=250 Identities=35% Similarity=0.527 Sum_probs=225.9
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeec--------cchHHHHHHHHhcCCCCcccccceeecCCc-eeE
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR--------EQKETDIRHLRKLNHPNIVKFKGVCTQAPC-YCI 326 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~--------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~-~~l 326 (600)
+...+++.+..||+|..|+||+++++ ++.+|+|.+. ++..+|+++++..+||+||.+||.|..+.. .+|
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 45568888999999999999999876 7999999993 345689999999999999999999999984 999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
+||||+||||.++++..+++++..+..++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+..+.+. ..
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 99999999999999988999999999999999999999996 89999999999999999999999999999988766 55
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCC-----ChHHHHHHhcCCCCCCCCCCC-CcHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDV-----DSSAIIWGVGSSSLHLPIPST-CPDGFQL 479 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~-~~~~l~~ 479 (600)
.+++||..|||||.+.+..|+.++||||||++++||.+|+.||... +..+.+..|..+. ++..|.. +|+++++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-pP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-PPRLPEGEFSPEFRS 313 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-CCCCCcccCCHHHHH
Confidence 7899999999999999999999999999999999999999999874 4556666666554 3455665 9999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
||..||++||.+|||++|+++|||+.....
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 999999999999999999999999976544
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=417.34 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=222.4
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeeccch--------------HHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQK--------------ETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~--------------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
+.|.+.+.||+|+||.|-+|.. +++.||||++.++. .+|+++|++|+|||||+++++|+.....
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 5677889999999999999975 47999999996432 4899999999999999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC---CCceeeccCccccccC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCREWNN 401 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~ 401 (600)
||||||++||+|.+.+-.++.+.+.....+++|++.|+.|||++||+||||||+|||++.+ ..+||+|||+|+....
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 9999999999999999988999999999999999999999999999999999999999876 6799999999999887
Q ss_pred CCCCcccCCCccccChhhhccCCC---CCccceechhHHHHHHhhCCCCCCCCChHH-HHHHhcCCCCCCCC--CCCCcH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQC---SDKIDIWSYGIVLWELLTCETPYKDVDSSA-IIWGVGSSSLHLPI--PSTCPD 475 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~---s~ksDIwSlGviLyELltG~~Pf~~~~~~~-~~~~i~~~~~~~~~--p~~~~~ 475 (600)
.+...++||||.|.|||++.+... ..++||||+||+||-+++|.+||.+..... ...+|..+.+.+.. ...+++
T Consensus 332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence 777788999999999999977543 348899999999999999999999866555 77778888776543 356899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+..+||.+||..||++|||++++|+|||+....
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 999999999999999999999999999997543
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=427.81 Aligned_cols=399 Identities=28% Similarity=0.458 Sum_probs=295.2
Q ss_pred ccccccccCChhhhhhhhccccc-ccccccc-ccc---ccccccccccCCcccee--------eccccchhhhccCCCCe
Q psy16430 101 FCSFVDKFSSPEFKTNIQERSEV-KSATHYQ-VDL---TGMAEQVRLSIPPQYQL--------ELIGGPYWFLAGCTTPD 167 (600)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~l---~~~~~~~~l~~~~r~~i--------~~~~a~~~~~~~~~~~i 167 (600)
++.+++ |.+...+.+..+.|.. --...-. .+- .....+....++.++.. ......+|||...++..
T Consensus 14 ~valyd-~~s~~~~dLsf~~Gd~~~~~~~~~~~~Ww~ar~~~~~~~g~ip~N~v~~~~~~~~~~~l~~~~Wf~~~isR~~ 92 (468)
T KOG0197|consen 14 VVALYD-YASRTPEDLSFRKGDVVLILLETTNGDWWRARSLQLGQEGYIPSNYVARNRGSPAFIKLSDEPWFFGKISREE 92 (468)
T ss_pred EEEecc-ccCCCccccccccCceEEEeeccCChhHHHHHHhhcCCCCcCcCceeeccccCCCccccccCCchhccccHHH
Confidence 445555 6666666666654444 1111100 000 01123344577777764 34455589999999888
Q ss_pred EEEec-cCCC---eeeccCCceeEeecccccccCCC--------Ccccccc-C--ceeecccccccccccCccccccccc
Q psy16430 168 ALAES-IGLG---VLIGSKEEAKISDFGTCREWNNK--------STKMSFA-G--TVAWMAPEVIRNEQCSDKIDIWYKN 232 (600)
Q Consensus 168 iHrdl-k~~N---ILLd~~~~~Kv~DFGlsr~~~~~--------~~~~~~~-G--T~~ymAPE~i~~~~~s~~~Dvy~~~ 232 (600)
.-|.| .|.| -.|-.+....-+||+++...... ++..... + ...|++... ........+.+|+++
T Consensus 93 ae~~ll~p~~~~G~flvR~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~~~~~~-~F~~l~~lv~~~~~~ 171 (468)
T KOG0197|consen 93 AERQLLAPENKEGAFLVRESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPYIDERE-LFSSLQQLVNYYSKN 171 (468)
T ss_pred HHHhhcCCCCCccceeeecccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeecCCCHHH-hhhhHHHHHhhhhcc
Confidence 77666 3333 23333333456788887643221 1111111 2 222344433 233344445556554
Q ss_pred ccc------ccccccccccccccccccccccccccccccccccCCCCcceEEEeEeece-EEEeeeecc------chHHH
Q psy16430 233 RLC------FPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE-IVAVKKVRE------QKETD 299 (600)
Q Consensus 233 ~~~------~p~sl~~~~~~~~~~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~------~~~~E 299 (600)
..- .|................+.|+++.+.+++++.||+|-||.||.|.+++. .||+|.++. .+.+|
T Consensus 172 ~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~E 251 (468)
T KOG0197|consen 172 ADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLRE 251 (468)
T ss_pred CcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHH
Confidence 332 23322111111111223789999999999999999999999999999975 899998864 45689
Q ss_pred HHHHHhcCCCCcccccceeecCCceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCC
Q psy16430 300 IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377 (600)
Q Consensus 300 i~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp 377 (600)
+++|++|+|+|||+++++|..+..+|||||||+.|+|.++++. +..+...+.+.++.|||+||+||+++++|||||..
T Consensus 252 a~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAA 331 (468)
T KOG0197|consen 252 AQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAA 331 (468)
T ss_pred HHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhh
Confidence 9999999999999999999998899999999999999999986 56799999999999999999999999999999999
Q ss_pred CCcccCCCCCceeeccCccccccCCCCC--cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChH
Q psy16430 378 PNVLIGSKEEAKISDFGTCREWNNKSTK--MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSS 454 (600)
Q Consensus 378 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~ 454 (600)
.||||+++..+||+|||+|+...+.... ....-+..|.|||.+....+|.+||||||||+||||+| |+.||.+.+..
T Consensus 332 RNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 332 RNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred hheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 9999999999999999999965544332 23345788999999999999999999999999999999 99999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 455 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
+++..+.. +.+++.|..||+.+.++|..||..+|++|||++.+...+
T Consensus 412 ev~~~le~-GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l 458 (468)
T KOG0197|consen 412 EVLELLER-GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVL 458 (468)
T ss_pred HHHHHHhc-cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHH
Confidence 99988855 468899999999999999999999999999999776654
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=427.81 Aligned_cols=246 Identities=31% Similarity=0.491 Sum_probs=230.0
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
..|...+.||+|||+.||.++. +|+.||+|++.+ ...+||++.++|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999986 589999999964 2357999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~ 407 (600)
|+|..++|..+++..++++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|..+... ....+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998744 67788
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.+|||.|.|||++.....+..+||||+||++|-|++|++||...+-.+++..|....+. +|..++...++||.++|+.
T Consensus 178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--cccccCHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999999999999999999998877654 5679999999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~~ 508 (600)
||.+|||+++||.|++|....
T Consensus 256 ~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 256 NPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred CcccCCCHHHHhcCHhhhCCC
Confidence 999999999999999996543
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=414.31 Aligned_cols=260 Identities=43% Similarity=0.686 Sum_probs=237.7
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeeceE-EEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
....|.|+..++.+.+.||+|+||+||+|.+.+.. ||+|++.. .+.+|+.+|.+++|||||+++|++.+.
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34578898999999999999999999999999988 99999974 678899999999999999999999988
Q ss_pred C-ceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCC-ccccCCCCCCcccCCCC-CceeeccCcc
Q psy16430 322 P-CYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQ-IIHRDLKSPNVLIGSKE-EAKISDFGTC 396 (600)
Q Consensus 322 ~-~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~g-IvHrDIKp~NILl~~~~-~vkL~DFGla 396 (600)
. ..+|||||+++|+|.+++.. .+.++...++.|+.||+.||.|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999977 678999999999999999999999999 99999999999999997 9999999999
Q ss_pred ccccCC-CCCcccCCCccccChhhhc--cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCC
Q psy16430 397 REWNNK-STKMSFAGTVAWMAPEVIR--NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473 (600)
Q Consensus 397 ~~~~~~-~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 473 (600)
+..... .......||+.|||||++. ...|+.++||||||++||||+||+.||.+....+....+.....++++|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 887654 3333478999999999999 5699999999999999999999999999999988888888888889999999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhhhc
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLR 511 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~~ 511 (600)
++.+..||..||..||..||++.+|+..+.........
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999866554443
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=389.65 Aligned_cols=243 Identities=27% Similarity=0.513 Sum_probs=214.9
Q ss_pred cccccccccccCCCCcceEEEeEe--eceEEEeeeec---------cchHHHHHHHHhcCCCCcccccc-eeecCC-cee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVR---------EQKETDIRHLRKLNHPNIVKFKG-VCTQAP-CYC 325 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~---------~~~~~Ei~~L~~L~HpnIv~l~~-~~~~~~-~~~ 325 (600)
+..+|++++.||.|+||.||++.. ++..+|.|.+. .....|+.+|++|+|||||++++ .|.+++ .++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 347899999999999999999974 58999999985 22346999999999999999999 454444 489
Q ss_pred EEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHh--CC--ccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 326 IVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHS--KQ--IIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~--~g--IvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
||||||.+|+|..+++. ++.+++..+|.++.|++.||.+||+ .. |+||||||.||+++.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999853 4579999999999999999999999 45 9999999999999999999999999999
Q ss_pred cccCCCC-CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC-CCCcH
Q psy16430 398 EWNNKST-KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP-STCPD 475 (600)
Q Consensus 398 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~ 475 (600)
.+..... ..+++|||+||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+-.....+|..+.++ ++| ..+|.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~-~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP-PLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC-CCcHHHhhh
Confidence 9876543 34789999999999999999999999999999999999999999999988999999888654 455 78999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
++..||..|+..||..||+...++...
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHH
Confidence 999999999999999999975555544
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=396.50 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=228.2
Q ss_pred ccccccccccccCCCCcceEEEeEe--eceEEEeeeeccch----------HHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQK----------ETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~----------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+..++|++++.||+|+||.||.++. +++.+|+|++++.. ..|..+|.+++||.||+++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 4468999999999999999999985 47899999996532 46889999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKST 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~~ 404 (600)
+|+||+.||.|..+|.+.+.|++..+..|+..|+.||.|||+.|||||||||+|||++.+|.++|+|||+|+..- ....
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999654 4445
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+...+...+..... ...|..++.+.+++++.+
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLPPGYLSEEARDLLKKL 260 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCCCccCCHHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999999999999998877763 334566899999999999
Q ss_pred hhcCCCCCC----CHHHHHHcHhhhhhh
Q psy16430 485 WSNAPSSRP----SFKQILSHLDIASQE 508 (600)
Q Consensus 485 L~~dP~~RP----s~~elL~~l~~~~~~ 508 (600)
|..||.+|. ++.+|-+|++|....
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccCC
Confidence 999999995 799999999988754
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=398.30 Aligned_cols=248 Identities=28% Similarity=0.504 Sum_probs=224.9
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.+|...+.||+|+||+||+|+++ +..||||.+.+. ...|+.+|+.++|||||.+++++..++.+|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 67888899999999999999875 689999998644 2579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC------CCceeeccCccccccCCC
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK------EEAKISDFGTCREWNNKS 403 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~------~~vkL~DFGla~~~~~~~ 403 (600)
||.||+|.++++..+.+++..++.++.||+.||++||+++||||||||.|||++.+ -.+||+|||+|+.+....
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 99999999999999999999999999999999999999999999999999999865 458999999999998887
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC-CCCCCCcHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL-PIPSTCPDGFQLLMK 482 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~~l~~LI~ 482 (600)
...+.+|+|.|||||++...+|+.|+|+||+|++||+|++|++||...+..+....+..+.... .++..++....+++.
T Consensus 170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~ 249 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLI 249 (429)
T ss_pred HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhh
Confidence 7778999999999999999999999999999999999999999999999988888776655433 345567777889999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
..+..+|..|.++.+-+.|+.+....
T Consensus 250 ~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 250 SLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHhcCccccCchHHhhhhhhcccCc
Confidence 99999999999999999998776543
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=415.29 Aligned_cols=331 Identities=27% Similarity=0.331 Sum_probs=268.3
Q ss_pred CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccccccc
Q psy16430 164 TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLMAR 243 (600)
Q Consensus 164 ~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl~~~ 243 (600)
+-.|||||+|+.||+|+.+|++|+.|||+++..-.... .|||.-|||||++. .....+|+||||++.|+......
T Consensus 115 ~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~ 189 (612)
T KOG0603|consen 115 KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTL 189 (612)
T ss_pred hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCC
Confidence 45799999999999999999999999999996533222 29999999999998 56778999999999984221100
Q ss_pred ccc----------------------------------------------------------------------cc-----
Q psy16430 244 IGE----------------------------------------------------------------------FK----- 248 (600)
Q Consensus 244 ~~~----------------------------------------------------------------------~~----- 248 (600)
.+. ++
T Consensus 190 pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~ 269 (612)
T KOG0603|consen 190 PFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSIT 269 (612)
T ss_pred CCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccc
Confidence 000 00
Q ss_pred ------------cccccccc---------------------------ccc-ccccccccccCCCCcceEEEeEee--ceE
Q psy16430 249 ------------SFVLRDEW---------------------------EIP-FESISDLQWLGSGAQGAVFSGKLR--SEI 286 (600)
Q Consensus 249 ------------~~~~~~~~---------------------------ei~-~~~~~~~~~LG~G~fG~Vy~a~~~--~~~ 286 (600)
.....+.. ..+ .++|.+...+|.|+||.|-.+... ++.
T Consensus 270 e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~ 349 (612)
T KOG0603|consen 270 ERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQE 349 (612)
T ss_pred hhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccc
Confidence 00000000 011 356777778999999999888754 688
Q ss_pred EEeeeeccc---hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHH
Q psy16430 287 VAVKKVREQ---KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGM 362 (600)
Q Consensus 287 vAvK~~~~~---~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL 362 (600)
.++|++.+. ..+|+.++... +||||+++.+++.+..+.|+|||++.|+-+.+.+.....+. ..+..|+++|+.|+
T Consensus 350 ~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av 428 (612)
T KOG0603|consen 350 PAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAV 428 (612)
T ss_pred hhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHH
Confidence 999999766 56777665554 79999999999999999999999999998888887766555 78889999999999
Q ss_pred HHhHhCCccccCCCCCCccc-CCCCCceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHH
Q psy16430 363 NYLHSKQIIHRDLKSPNVLI-GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWEL 441 (600)
Q Consensus 363 ~~LH~~gIvHrDIKp~NILl-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyEL 441 (600)
.|||++||||||+||+|||+ +..++++|+|||.++..... ..+.+-|..|.|||++....|++++||||||++||+|
T Consensus 429 ~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~M 506 (612)
T KOG0603|consen 429 DYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEM 506 (612)
T ss_pred HHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHH
Confidence 99999999999999999999 68899999999999877655 3455678999999999999999999999999999999
Q ss_pred hhCCCCCCCCChH-HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 442 LTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 442 ltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
++|+.||...... ++...+..+. +...+|+..++|+++||+.||.+||++.+++.|+|+.+
T Consensus 507 L~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 507 LTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred HhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 9999999876655 4554454433 33788999999999999999999999999999999943
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=400.39 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=227.3
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHhc-CCCCcccccceeecCCcee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRKL-NHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~ 325 (600)
...+|.+.+.||+|+|++|++|+.. ++.||||++.+.. ..|-.+|.+| .||.|++|+-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3478999999999999999999854 7899999986432 3577889999 8999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
+|+||+++|+|.++|++-+.|++..++.++.+|+.||+|||++|||||||||+|||++.++.++|+|||.|+.++....
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999987753211
Q ss_pred -------------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCC
Q psy16430 405 -------------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS 471 (600)
Q Consensus 405 -------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 471 (600)
..+++||..|.+||++.....++.+|||+||||||.|+.|.+||.+.+...+...|..-. ..+|.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~--y~fp~ 308 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD--YEFPE 308 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc--ccCCC
Confidence 145899999999999999999999999999999999999999999999999988887665 46788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
..|+.+++||+++|..||.+|+|+++|.+||+|....+
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 99999999999999999999999999999999987644
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=389.76 Aligned_cols=249 Identities=33% Similarity=0.599 Sum_probs=217.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCC--ceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAP--CYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~--~~~lV~E 329 (600)
.++...+.||+|+||.||++... +...|||.+... .++|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777889999999999999876 589999998654 578999999999999999999754444 6899999
Q ss_pred eeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCccccccC----CC
Q psy16430 330 YCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTCREWNN----KS 403 (600)
Q Consensus 330 y~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~----~~ 403 (600)
|+++|+|.+++++.+ .+++..+..+.+||++||.|||++|||||||||+|||++. ++.+||+|||++..... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999999998765 7999999999999999999999999999999999999999 79999999999987663 12
Q ss_pred CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCC-CChHHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKD-VDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
......||+.|||||++.++ ...+++|||||||++.||+||.+||.. ......+..+......+++|..+|++.++|+
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl 256 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFL 256 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 23357899999999999853 334599999999999999999999998 5555556666655556688999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
..|+..||.+|||+.++|.||+..+...
T Consensus 257 ~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 257 RKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999999877644
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=370.90 Aligned_cols=244 Identities=29% Similarity=0.465 Sum_probs=210.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.|+.+.++|+|+||+||+++++ |+.||||++.+. ..+||++|++|+|||+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 57888999999999999999864 799999999543 2579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~ 408 (600)
||+..-|.++-+.-..++.+.+..+++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+.. ...-+.+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY 161 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY 161 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence 998766666555555699999999999999999999999999999999999999999999999999999874 3444568
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CCCCC
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SLHLP 468 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~~ 468 (600)
+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+.|++.++-+.++.|... +..+|
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 89999999999987 78999999999999999999999999998876665543211 11222
Q ss_pred CC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 469 IP----------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 469 ~p----------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.| ...+..+.+|++.||..||.+|+|.+++|.|+.|
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 22 2345678999999999999999999999999987
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=392.04 Aligned_cols=247 Identities=30% Similarity=0.491 Sum_probs=225.0
Q ss_pred ccccccccccccCCCCcceEEEeEe--eceEEEeeeeccc------------hHHHHHHHHhcC-CCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ------------KETDIRHLRKLN-HPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~------------~~~Ei~~L~~L~-HpnIv~l~~~~~~~~ 322 (600)
.....|.+.+.||+|+||+|+.|.. ++..||+|++.+. ..+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3347899999999999999999986 4799999976542 136999999999 999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccc-c
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREW-N 400 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~-~ 400 (600)
.+|+|||||.||+|.+++.+.+++.+..+..+++|++.|++|||++||+||||||+|||++.+ +++||+|||++... .
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999998899999999999999999999999999999999999999999 99999999999987 4
Q ss_pred CCCCCcccCCCccccChhhhccCC-CC-CccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCC-cHHH
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIRNEQ-CS-DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTC-PDGF 477 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~~~~-~s-~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~-~~~l 477 (600)
......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+.+...+...+..+.+ .+|..+ ++++
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~~p~~~~S~~~ 251 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--KIPSYLLSPEA 251 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--cCCCCcCCHHH
Confidence 555666889999999999999877 85 799999999999999999999999888888888777654 466777 9999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+.|+.+||..||.+|+|+.+|+.|+|+..
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999999999987
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=368.53 Aligned_cols=247 Identities=26% Similarity=0.446 Sum_probs=229.3
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
...++|+.++.||.|+||.|.+++.+ +..+|+|++.++ ..+|..+|+.+.||.++++++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 44578999999999999999999864 789999998643 247899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
+||||++||.|..++++.++|++..++.++.||+.||+|||+.+|++||+||+|||+|.+|.+||+|||+|+..... +
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987655 5
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.+.||||.|+|||++...+|+.++|.|||||++|||+.|.+||.+.++..+..+|..+... +|+..+.++++|++.+|
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCcccCHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999999999999988765 57899999999999999
Q ss_pred hcCCCCC-----CCHHHHHHcHhhhhhh
Q psy16430 486 SNAPSSR-----PSFKQILSHLDIASQE 508 (600)
Q Consensus 486 ~~dP~~R-----Ps~~elL~~l~~~~~~ 508 (600)
+.|-.+| +...+|..|+||....
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred hhhhHhhhcCcCCCccccccCccccccc
Confidence 9999999 4678999999998754
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=391.00 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=225.3
Q ss_pred cccccccccccccCCCCcceEEEeEe--eceEEEeeeeccch----------HHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQK----------ETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~----------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+..++|++++.||+|+||.||+|+- +|..+|+|++++.. ..|-.+|....+|+||+++-.|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45679999999999999999999974 58999999997532 3577788888999999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC---
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN--- 401 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~--- 401 (600)
||||||++||++..+|.+.+.+++..+..++.+++.|+..||+.|+|||||||+|+|||..|.+||+|||+|..+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999853210
Q ss_pred --------------------CCC-------------------------CcccCCCccccChhhhccCCCCCccceechhH
Q psy16430 402 --------------------KST-------------------------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGI 436 (600)
Q Consensus 402 --------------------~~~-------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGv 436 (600)
... ..+.+|||-|||||++.+..|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 000 01357999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHhcCCCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHcHhhhhhhhhc
Q psy16430 437 VLWELLTCETPYKDVDSSAIIWGVGSSSL--HLPIPSTCPDGFQLLMKMCWSNAPSSRP---SFKQILSHLDIASQEVLR 511 (600)
Q Consensus 437 iLyELltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~~LI~~cL~~dP~~RP---s~~elL~~l~~~~~~~~~ 511 (600)
|+||||.|.+||.+.++.++..+|..... ..|....++++.++||.+||. ||.+|. +++||.+||||.......
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 99999999999999999999998877664 444446678999999999999 999996 699999999999875443
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=391.45 Aligned_cols=247 Identities=29% Similarity=0.528 Sum_probs=222.8
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+...|....+||+|+.|.||.|+.. ++.||||.+... ..+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 3456888899999999999999854 688999998532 3589999999999999999999988899999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
|++||+|.+++... .+++.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+.... ...+.
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 99999999998764 49999999999999999999999999999999999999999999999999999887665 45678
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-SSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
+|||+|||||++....|++++||||||++++||+-|++||-..++...++.|.. +...+..+..+|+.+++|+.+||+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhc
Confidence 999999999999999999999999999999999999999998777776666654 4455667889999999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhh
Q psy16430 488 APSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~ 506 (600)
||.+|+|+.+||+||++..
T Consensus 510 dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 510 DVEQRASAKELLEHPFLKM 528 (550)
T ss_pred chhcCCCHHHHhcChhhhh
Confidence 9999999999999999844
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=387.87 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=218.7
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeeccch--------HHHHHHHHhcC-CCCcccccceeecCC-ceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQK--------ETDIRHLRKLN-HPNIVKFKGVCTQAP-CYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~--------~~Ei~~L~~L~-HpnIv~l~~~~~~~~-~~~lV 327 (600)
.++|+++++||.|+||.||+|+. .+..||||++++.+ .+|++.|++|+ |||||++.+++.+.. .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 47899999999999999999985 47899999998765 47999999999 999999999998877 99999
Q ss_pred EeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 328 MEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||||+ .+|+++++. ++.|++..++.|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||+|+.+.....-+
T Consensus 89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT 167 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT 167 (538)
T ss_pred HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcc
Confidence 99997 689999986 4579999999999999999999999999999999999999989999999999999998877777
Q ss_pred ccCCCccccChhhhc-cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC----C---------------CCC
Q psy16430 407 SFAGTVAWMAPEVIR-NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----S---------------SLH 466 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----~---------------~~~ 466 (600)
.++.|.+|.|||++. ...|+.+.||||+|||++|+.+-++.|+|.+..+.+++|.. . .+.
T Consensus 168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~ 247 (538)
T KOG0661|consen 168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR 247 (538)
T ss_pred hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence 889999999999975 57789999999999999999999999999998777765432 1 011
Q ss_pred CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 467 LP---------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 467 ~~---------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+| .-..++.++.++|.+|+..||.+||||.++|+||+|....
T Consensus 248 ~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 248 FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 11 0123788999999999999999999999999999987553
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.72 Aligned_cols=244 Identities=27% Similarity=0.450 Sum_probs=227.7
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
-|++.+.||.|+-|.|-+|++ +|+.+|||++.+. .++||-+|+.+.||||+++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 355678899999999999986 5899999999654 4789999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccC
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
|++||-|.+++-..+++++.++..+++||+.|+.|||..+|+|||+||+|+|++..+++||+|||+|..-..+..-.+.|
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSC 172 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSC 172 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999998877777777899
Q ss_pred CCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
|+|.|.|||++.|.+| +.++||||.|||||.|+||+.||.+.+-..++.++..+.+ .+|..+|.++++||.+||..|
T Consensus 173 GSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml~VD 250 (786)
T KOG0588|consen 173 GSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRMLDVD 250 (786)
T ss_pred CCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHHhccC
Confidence 9999999999999988 5799999999999999999999999999999999988875 567999999999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~ 507 (600)
|.+|.|.++|++|||+...
T Consensus 251 p~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 251 PSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ccccccHHHHhhCchhhcC
Confidence 9999999999999998754
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=382.81 Aligned_cols=245 Identities=26% Similarity=0.503 Sum_probs=222.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|.+.+.||+|+||.||+|+.+ .+.||+|.+.+. ..+|+++++.|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 67889999999999999999865 589999998532 3579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
||.| +|..++...+.++++.+..++.+++.||.|||+++|+|||+||.|||++.++.+|+||||+|+..+... ...+.
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 9986 999999999999999999999999999999999999999999999999999999999999999876543 23457
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
.|||.|||||++.+.+|+..+|+||+||++|||++|++||....-.+.+..|...... .|...+..+..|++.+|.+|
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--CcccccHHHHHHHHHHhhcC
Confidence 8999999999999999999999999999999999999999988888888887766544 34588999999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~~ 508 (600)
|.+|.|..+++.|++.....
T Consensus 239 P~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hhhcccHHHHhcChHHhhhh
Confidence 99999999999999877643
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=368.99 Aligned_cols=257 Identities=25% Similarity=0.456 Sum_probs=221.6
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
....|.++.++|++...||.|.-++||+|+.. ++.||||++.- ...+|+..|+.++||||++++..|..+
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 34567778899999999999999999999864 79999999952 235789999999999999999999999
Q ss_pred CceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
..+|+||.||.+||+.++++. ...+++..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999999999975 235999999999999999999999999999999999999999999999999987765
Q ss_pred cCCCCC-----cccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC----
Q psy16430 400 NNKSTK-----MSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP---- 468 (600)
Q Consensus 400 ~~~~~~-----~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 468 (600)
...... .+++||++|||||++.. ..|+.|+||||||++..||.+|..||....+..++..-..+..+.+
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 433221 45789999999999643 5789999999999999999999999999998887665444433211
Q ss_pred ----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 469 ----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 469 ----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
....++..++.+|..||+.||.+|||++++|+|.||....
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 1234567899999999999999999999999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=375.39 Aligned_cols=244 Identities=24% Similarity=0.402 Sum_probs=219.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++.+.||+|+||.||+|+.. ++.||+|++... +.+|+.++++++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 478999999999999999999875 688999998532 35789999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 174 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FT 174 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ce
Confidence 9999999999999888889999999999999999999999999999999999999999999999999998764332 34
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+. ...|..++..+++||++||+.
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGRARDLVKGLLQT 252 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCCCCHHHHHHHHHHhhc
Confidence 679999999999999899999999999999999999999999888777777666554 346677899999999999999
Q ss_pred CCCCCCC-----HHHHHHcHhhhhh
Q psy16430 488 APSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs-----~~elL~~l~~~~~ 507 (600)
||.+||+ +++++.|+|+...
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCC
Confidence 9999996 7999999999763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=369.80 Aligned_cols=243 Identities=24% Similarity=0.411 Sum_probs=217.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|... ++.||+|++.. .+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999875 78999999852 2356899999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL 158 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998866432 2345
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ..+|..+++.+++||++||+.|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCCHHHHHHHHHHcCCC
Confidence 78999999999999889999999999999999999999999988877777665554 3456778999999999999999
Q ss_pred CCCCCC-----HHHHHHcHhhhhh
Q psy16430 489 PSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs-----~~elL~~l~~~~~ 507 (600)
|.+||+ +++++.|+|+...
T Consensus 237 p~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 237 RTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHHccCCccCCHHHHhcCccccCC
Confidence 999995 9999999999653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=352.93 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=223.9
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeec---------cchHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVR---------EQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~---------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.|++.+.||+|.|+.||+... +|+.+|+|++. +..++|+++-+.|+|||||++.+.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 6789999999999999998864 47888888874 234689999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC---CCceeeccCccccccCCCCCc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~ 406 (600)
++.|++|..-|-.+-.+++..+-.+++||++||.|+|.+||||||+||.|+++.+. .-+||+|||+|..++......
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~ 170 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH 170 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence 99999987665544668999999999999999999999999999999999999643 459999999999998666667
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMC 484 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~c 484 (600)
.+.|||.|||||++...+|+..+||||.||+||-|+.|.+||.+.+...+..+|..+.+..+.| ..++++.++|+++|
T Consensus 171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRM 250 (355)
T ss_pred cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHH
Confidence 8899999999999999999999999999999999999999999999999999999888776654 67899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
|..||.+|.|+.|.|+|||+.+.+
T Consensus 251 L~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 251 LTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred hccChhhhccHHHHhCCchhcchH
Confidence 999999999999999999998754
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=365.50 Aligned_cols=242 Identities=26% Similarity=0.479 Sum_probs=225.7
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.+|++.+.||+|.||.|-+|.. .++.||||.+++. ..+||++|+.|+||||+++|++|++.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 6789999999999999999974 4799999999753 257999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||..+|.|++++...+.+++.+++.+++||+.|+.|||.++++|||||.+|||+|.|+++||+|||++..+.......++
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF 212 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF 212 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988887777899
Q ss_pred CCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
+|+|.|.+||++.|.+| ++.+|.|||||+||-|+.|..||.+.+...++.+|..+.++.| ..|....-||+.||..
T Consensus 213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwmLmV 289 (668)
T KOG0611|consen 213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETPSDASGLIRWMLMV 289 (668)
T ss_pred cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCCchHHHHHHHHHhc
Confidence 99999999999999988 5899999999999999999999999999999999998887654 2345678999999999
Q ss_pred CCCCCCCHHHHHHcHhhh
Q psy16430 488 APSSRPSFKQILSHLDIA 505 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~ 505 (600)
||++|.|+++|..|.|+.
T Consensus 290 NP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 290 NPERRATIEDIASHWWVN 307 (668)
T ss_pred CcccchhHHHHhhhheee
Confidence 999999999999999976
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=375.38 Aligned_cols=245 Identities=30% Similarity=0.549 Sum_probs=221.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
..|+.++.||+|+||.||+|... ++.||+|++.- +.++|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777899999999999999865 68999999952 345799999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC-cccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~ 409 (600)
|.||++.+.++.+..+++..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++......... .+++
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv 172 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV 172 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999888755433 6899
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
|||.|||||++.+..|+.++||||||++.+||++|.+|+....+...+..|-... ++.....+++.+++||..||++||
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccccccCHHHHHHHHHHhhcCc
Confidence 9999999999999999999999999999999999999999988866665554333 334455889999999999999999
Q ss_pred CCCCCHHHHHHcHhhhh
Q psy16430 490 SSRPSFKQILSHLDIAS 506 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~ 506 (600)
+.||||.++|+|.++..
T Consensus 252 ~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 252 EFRPSAKELLKHKFIKR 268 (467)
T ss_pred ccCcCHHHHhhhHHHHh
Confidence 99999999999998866
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=382.76 Aligned_cols=269 Identities=25% Similarity=0.427 Sum_probs=233.7
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHhc-CCCCcccccceeecCCc
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRKL-NHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~L-~HpnIv~l~~~~~~~~~ 323 (600)
.+..++|.+++.||+|+||+|+++..+ ++.+|||++++.. ..|.+++... +||.++.++..|+...+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 456789999999999999999999875 5899999997642 3566776666 59999999999999999
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~ 402 (600)
+|+||||+.||++..+ ...+.|++..+..|+..|+.||+|||++|||+||||.+|||+|.+|.+||+|||+++..- ..
T Consensus 444 l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999999995444 445679999999999999999999999999999999999999999999999999999754 45
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
..+.+++|||.|||||++.+..|+.++|+|||||+||||+.|..||++.+.+++...|..... ..|..+|.+...+|+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~--~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRFLSKEAIAIMR 600 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--CCCCcccHHHHHHHH
Confidence 566789999999999999999999999999999999999999999999999999999887764 457889999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHcHhhhhhh---hhccCCChhhhhhHhHHHHH
Q psy16430 483 MCWSNAPSSRPS-----FKQILSHLDIASQE---VLRIQPEPYYKMQMIWKEEI 528 (600)
Q Consensus 483 ~cL~~dP~~RPs-----~~elL~~l~~~~~~---~~~~~~~~~~~~~~~~~~ei 528 (600)
++|.+||++|.. +++|..||+|.... +......|+|.+...-.++.
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~ 654 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV 654 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence 999999999974 68999999998754 44455566665554433433
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=374.06 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=221.7
Q ss_pred cccccccccccccccCCCCcceEEEeEeec---eEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS---EIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~---~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
...+..++|++.+.||+|+||.||+|.+.+ ..||+|.+... +.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 355677899999999999999999998643 57999988531 24689999999999999999999999
Q ss_pred CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
...|+||||+++|+|.+++..++.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... .+|..+++.+.++|
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--YFPKFLDNNCKHLM 259 (340)
T ss_pred C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHH
Confidence 2 2356799999999999988899999999999999999999999999888777777665543 35677899999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
++||+.||.+|+ |++++++|||+.+.
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999995 99999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.12 Aligned_cols=239 Identities=27% Similarity=0.454 Sum_probs=211.8
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
+.||+|+||.||+|+.. ++.||+|+++.. ..+|+.++++++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999864 689999998642 235888999999999999999999999999999999999
Q ss_pred cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCcc
Q psy16430 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVA 413 (600)
Q Consensus 335 sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~ 413 (600)
+|.+++..++.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.... ........||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 9999998888899999999999999999999999999999999999999999999999999875432 222335679999
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP 493 (600)
|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.... ..+|..+++.+.+||++||..||.+||
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 999999999999999999999999999999999999888777666655443 345678899999999999999999999
Q ss_pred -----CHHHHHHcHhhhhh
Q psy16430 494 -----SFKQILSHLDIASQ 507 (600)
Q Consensus 494 -----s~~elL~~l~~~~~ 507 (600)
++.++++|+|+...
T Consensus 239 ~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 239 GGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCHHHHHcCCCcCCC
Confidence 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.28 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=209.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccch---------HHHHHHHHhcCCCCcccccceeecC--CceeE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGVCTQA--PCYCI 326 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~~l 326 (600)
.+.|+.+++||+|.||.||+|+.. ++.||+|+++-+. .+||.+|++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 367889999999999999999864 7899999997432 5899999999999999999998776 68999
Q ss_pred EEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--
Q psy16430 327 VMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-- 403 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 403 (600)
|+|||+. +|.-++.. +-.|++.++..|++||+.||.|||++||+|||||.+||||+.+|.+||+|||+|+.+....
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9999985 78877766 4479999999999999999999999999999999999999999999999999999776544
Q ss_pred CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---CC-------CCCC----
Q psy16430 404 TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS---SS-------LHLP---- 468 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~---~~-------~~~~---- 468 (600)
..++.+-|.+|.|||++.| ..|+.++|+||.||||.||++|++.|.+.+..+.+..|-. .. ..+|
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 3345678999999999877 6799999999999999999999999999887665543311 10 0011
Q ss_pred ----C---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 469 ----I---------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 469 ----~---------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
. -...+....+|+..+|..||.+|.|+.++|.+.+|.
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 0 124578899999999999999999999999999993
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=370.51 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=214.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||.||+|+.. ++.||+|++... ..+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999875 689999998632 246889999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999886544 23456
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC------CCCcHHHHHHHH
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP------STCPDGFQLLMK 482 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p------~~~~~~l~~LI~ 482 (600)
.||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.........| ..+++++.++|.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 79999999999999899999999999999999999999999888766655543322111111 256899999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+||..+|.+|||+.+++.|+|+...
T Consensus 239 ~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.84 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=217.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|.+.+.||+|+||.||+|+.. ++.||+|+++.. +..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 789999998632 346889999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-----
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----- 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----- 403 (600)
||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999988664432
Q ss_pred -------------------------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHH
Q psy16430 404 -------------------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIW 458 (600)
Q Consensus 404 -------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~ 458 (600)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 1234578999999999999999999999999999999999999999888777666
Q ss_pred HhcC--CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHcHhhhhh
Q psy16430 459 GVGS--SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS-FKQILSHLDIASQ 507 (600)
Q Consensus 459 ~i~~--~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs-~~elL~~l~~~~~ 507 (600)
.+.. .....+....+++.+.+||.+||. ||.+||+ +.++++|||+...
T Consensus 241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6655 333334444579999999999997 9999999 9999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.00 Aligned_cols=249 Identities=31% Similarity=0.596 Sum_probs=207.7
Q ss_pred cccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccccee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVC 318 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~ 318 (600)
.|.++.++|++.+.||+|+||.||+|.+. +..||+|+++. .+.+|+.+++++ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 37888899999999999999999999742 36799999853 235689999999 899999999988
Q ss_pred ecC-CceeEEEeeeccccchhhccCC------------------------------------------------------
Q psy16430 319 TQA-PCYCIVMEYCAYGPLYNLLKDG------------------------------------------------------ 343 (600)
Q Consensus 319 ~~~-~~~~lV~Ey~~ggsL~~~l~~~------------------------------------------------------ 343 (600)
... ..+++||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 4689999999999999888642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---CcccCCCc
Q psy16430 344 --------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTV 412 (600)
Q Consensus 344 --------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~ 412 (600)
.+++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .....+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2377788899999999999999999999999999999999999999999999986533211 12344678
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~ 491 (600)
.|+|||++.+..++.++|||||||++|||++ |..||.+...................|..+++.+.+||.+||+.||.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999998899999999999999999997 999998765443333322233334557788999999999999999999
Q ss_pred CCCHHHHHHcHh
Q psy16430 492 RPSFKQILSHLD 503 (600)
Q Consensus 492 RPs~~elL~~l~ 503 (600)
|||+.+|++.+.
T Consensus 321 RPs~~el~~~l~ 332 (338)
T cd05102 321 RPTFSALVEILG 332 (338)
T ss_pred CcCHHHHHHHHH
Confidence 999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=373.85 Aligned_cols=246 Identities=23% Similarity=0.362 Sum_probs=214.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||.||+|+.. ++.||||++... +.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999874 689999998642 246899999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-----
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----- 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----- 403 (600)
||++||+|.+++..++.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------------------------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCC
Q psy16430 404 ----------------------------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYK 449 (600)
Q Consensus 404 ----------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~ 449 (600)
...+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112469999999999999899999999999999999999999999
Q ss_pred CCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHcHhhhhh
Q psy16430 450 DVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMCWSNAPSSRPS---FKQILSHLDIASQ 507 (600)
Q Consensus 450 ~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs---~~elL~~l~~~~~ 507 (600)
+.+.......+.........| ..+++.+.+||++|+. +|.+|++ +.+++.|+|+...
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 888777766665443333333 3578999999999996 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=359.75 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=209.2
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.|+..+.||+|+||.||+|... ++.||+|.+... ..+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999864 789999987531 2468999999999999999999999999999999
Q ss_pred eeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 330 YCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999999887753 34689999999999999999999999999999999999999999999999999987654443445
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH----HHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA----IIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ....+. ......+..++..+.+||++
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK--EDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh--cccccCCccCCHHHHHHHHH
Confidence 679999999999999999999999999999999999999998765422 222222 22334567789999999999
Q ss_pred hhhcCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
||+.||.+||+ ++++++|+|+...
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 99999999997 8999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=372.91 Aligned_cols=245 Identities=30% Similarity=0.555 Sum_probs=225.8
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCc-eeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPC-YCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~-~~lV 327 (600)
.++|..++.+|.|+||.++.++++ +..+++|++.- ...+|+.+++++.|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 368899999999999999988765 58899999852 23679999999999999999999998888 9999
Q ss_pred EeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-C
Q psy16430 328 MEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-T 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~ 404 (600)
|+||+||++.+.+++. ..|+++.+..|+.|++.|+.|||+++|+|||||+.|||++.++.|+|+|||+|+...... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999999763 469999999999999999999999999999999999999999999999999999988765 5
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
..+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|...+....+..+..+. ..|+|..++.+++.+|+.|
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHH
Confidence 667899999999999999999999999999999999999999999999999998887776 4578999999999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~ 505 (600)
|..+|..||++.++|.+|.+.
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred hhcCCccCCCHHHHhhChhhh
Confidence 999999999999999998765
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=340.02 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=210.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.+|..+++||+|.||.||+|++. |+.||||+++. ...+||+.|+.++|+||+.++++|.....+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999864 79999999963 23589999999999999999999999999999999
Q ss_pred eeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc-c
Q psy16430 330 YCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-S 407 (600)
Q Consensus 330 y~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~ 407 (600)
|++ .+|...++.. ..++..++..|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+....... .
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 997 5899999874 479999999999999999999999999999999999999999999999999999987654333 3
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHh----cCCCC----------------C
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV----GSSSL----------------H 466 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i----~~~~~----------------~ 466 (600)
.+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+-|++.++-+.+..+ +.... .
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 478999999999866 68999999999999999999999999988765543322 11110 0
Q ss_pred CC------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 LP------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 ~~------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.| +-...+.+..+|+.+||..||.+|+|++|+|+|++|.+.
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 11 113456778999999999999999999999999999764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=372.73 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=211.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||+||+|+.. ++.||+|++++. ...|+.++.+++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 689999998642 346888999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-----
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----- 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----- 403 (600)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987543210
Q ss_pred -------------------------------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC
Q psy16430 404 -------------------------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD 452 (600)
Q Consensus 404 -------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~ 452 (600)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 0123579999999999999999999999999999999999999999888
Q ss_pred hHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHhhhcCCC---CCCCHHHHHHcHhhhhhh
Q psy16430 453 SSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMCWSNAPS---SRPSFKQILSHLDIASQE 508 (600)
Q Consensus 453 ~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~---~RPs~~elL~~l~~~~~~ 508 (600)
.......+........+| ..+++.++++|.+|+. +|. .||++++|++|||+....
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 877777665533333333 3468899999998664 444 568999999999997653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=340.27 Aligned_cols=243 Identities=28% Similarity=0.469 Sum_probs=223.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|.+.+.||.|-||.||.|+.+ +-.||+|++-+ +..+|+++.+.|+||||+++|++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 78999999999999999999865 57899999843 3457889999999999999999999999999999
Q ss_pred eeeccccchhhcc--CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 329 EYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 329 Ey~~ggsL~~~l~--~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||.++|++...+. ....+++.....++.|++.||.|+|..+||||||||+|+|++..+.+||+|||-+.... .....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~ 180 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRK 180 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCce
Confidence 9999999999998 56789999999999999999999999999999999999999999999999999887654 55566
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
+.+||..|.|||...+..++..+|+|++|++.||++.|.+||...+..+....|...... +|..++.+++++|.+|+.
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~--~p~~is~~a~dlI~~ll~ 258 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK--FPSTISGGAADLISRLLV 258 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--CCcccChhHHHHHHHHhc
Confidence 899999999999999999999999999999999999999999999888888888766554 568999999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~ 506 (600)
.+|.+|.+..|++.|||+..
T Consensus 259 ~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 259 KNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cCccccccHHHHhhhHHHHh
Confidence 99999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.62 Aligned_cols=245 Identities=22% Similarity=0.418 Sum_probs=214.3
Q ss_pred ccccccccc--cccCCCCcceEEEeEeeceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeec----C
Q psy16430 258 IPFESISDL--QWLGSGAQGAVFSGKLRSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQ----A 321 (600)
Q Consensus 258 i~~~~~~~~--~~LG~G~fG~Vy~a~~~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~----~ 321 (600)
|+.+++... ..||+|++|.||+|.++++.||||.++. .+.+|+.+|++++||||++++|++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 444555554 6799999999999999999999999853 23479999999999999999999866 3
Q ss_pred CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
...++||||++||+|.+++...+.++......++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 56899999999999999998888899999999999999999999984 99999999999999999999999999988654
Q ss_pred CCCCCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
... ....|++.|+|||++.+ ..++.++|||||||++|||++|..||.+.+...+...+......++.|..+|+.+.
T Consensus 175 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 252 (283)
T PHA02988 175 SPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252 (283)
T ss_pred ccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence 322 24568899999999976 68899999999999999999999999998887777776555566677778999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+||.+||+.||.+|||+.+++..+..
T Consensus 253 ~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 253 CIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 99999999999999999999988753
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.97 Aligned_cols=237 Identities=24% Similarity=0.400 Sum_probs=210.2
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
||+|+||.||+|+.. ++.||+|++... ...|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 678999988532 23688999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcccCCCcccc
Q psy16430 337 YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWM 415 (600)
Q Consensus 337 ~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~Y~ 415 (600)
.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .......||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 999988888999999999999999999999999999999999999999999999999998764322 2233467999999
Q ss_pred ChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC--
Q psy16430 416 APEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP-- 493 (600)
Q Consensus 416 APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP-- 493 (600)
|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|..+++.+.++|.+||..||.+||
T Consensus 161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 9999999999999999999999999999999999888777776665543 345678899999999999999999997
Q ss_pred -CHHHHHHcHhhhhh
Q psy16430 494 -SFKQILSHLDIASQ 507 (600)
Q Consensus 494 -s~~elL~~l~~~~~ 507 (600)
++.+++.|||+...
T Consensus 239 ~~~~e~l~hp~~~~~ 253 (312)
T cd05585 239 NGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHHHcCCCcCCC
Confidence 58999999998764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=364.00 Aligned_cols=251 Identities=29% Similarity=0.431 Sum_probs=213.7
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
+..++|++++.||+|+||.||+++.. +..||+|.+.. .+.+|++++++++||||+++++++..++..++|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 45689999999999999999999875 67899998753 345789999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++...... ...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 160 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccc
Confidence 99999999999998878899999999999999999999986 6999999999999999999999999998765432 223
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC----------------------
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS---------------------- 464 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~---------------------- 464 (600)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 4678999999999998899999999999999999999999998766544332221100
Q ss_pred -----------------------CCCCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 465 -----------------------LHLPI-PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 465 -----------------------~~~~~-p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
..... ...+++++.+||.+||+.||++|||+.+|++|+|+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 00111 1246789999999999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=364.59 Aligned_cols=248 Identities=28% Similarity=0.456 Sum_probs=216.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------------------chHHHHHHHHhcCCCCcccccc
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------------------QKETDIRHLRKLNHPNIVKFKG 316 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------------------~~~~Ei~~L~~L~HpnIv~l~~ 316 (600)
.+.|+++..||+|.||.|-+|+.. ++.||||++.+ ...+||.+|++|.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 478999999999999999999864 79999999842 2247999999999999999999
Q ss_pred eeecC--CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccC
Q psy16430 317 VCTQA--PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394 (600)
Q Consensus 317 ~~~~~--~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFG 394 (600)
+..+. ..+|||+|||..|.+...--....+++.+++.|+++++.||+|||.+|||||||||+|+|++.+|+|||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 98654 5799999999999876544333339999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC------cccCCCccccChhhhccCC----CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC
Q psy16430 395 TCREWNNKSTK------MSFAGTVAWMAPEVIRNEQ----CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 395 la~~~~~~~~~------~~~~gt~~Y~APE~l~~~~----~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~ 464 (600)
.+......... ...+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....++..+|....
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 99876433211 2368999999999987622 3578999999999999999999999999999999999888
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.+|....+.+.+++||.+||.+||.+|.+..+|..|||....
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 8777767789999999999999999999999999999998754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.94 Aligned_cols=244 Identities=26% Similarity=0.417 Sum_probs=205.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|+.. ++.||+|++.. ...+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999875 58899998853 23579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--Ccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--KMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~ 407 (600)
|++++++..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 999887776665556799999999999999999999999999999999999999999999999999987643322 224
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CCCCC
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SLHLP 468 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~~ 468 (600)
..||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+... ....+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 57899999999999888999999999999999999999999876653332221110 00000
Q ss_pred -----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 469 -----------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 469 -----------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
....+|+.+.+||++||+.||.+|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 012367889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.19 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=210.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||.||+++.. ++.||||++... +.+|++++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 689999988532 346889999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-----
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----- 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----- 403 (600)
||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986321100
Q ss_pred -------------------------------------------CCcccCCCccccChhhhccCCCCCccceechhHHHHH
Q psy16430 404 -------------------------------------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWE 440 (600)
Q Consensus 404 -------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyE 440 (600)
...+.+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012469999999999999899999999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHhhhcCCCCC---CCHHHHHHcHhhhhh
Q psy16430 441 LLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMCWSNAPSSR---PSFKQILSHLDIASQ 507 (600)
Q Consensus 441 LltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~R---Ps~~elL~~l~~~~~ 507 (600)
|++|.+||.+.+.......+.........| ..++..+.+||.+||. +|.+| +|+.+++.|+|+...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999887766666555433233333 3578999999999997 67665 699999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.41 Aligned_cols=239 Identities=26% Similarity=0.460 Sum_probs=210.8
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
+.||+|+||.||+++.. ++.||+|++... ..+|+.+++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999864 689999998642 245888999999999999999999999999999999999
Q ss_pred cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCcc
Q psy16430 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVA 413 (600)
Q Consensus 335 sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~ 413 (600)
+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 9999998878899999999999999999999999999999999999999999999999999876432 222234679999
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP 493 (600)
|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ..+|..+++.+.+||++||..||.+||
T Consensus 161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 999999998899999999999999999999999999887776666554443 346778899999999999999999997
Q ss_pred -----CHHHHHHcHhhhhh
Q psy16430 494 -----SFKQILSHLDIASQ 507 (600)
Q Consensus 494 -----s~~elL~~l~~~~~ 507 (600)
++.++++|+|+...
T Consensus 239 ~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 239 GGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 89999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=370.89 Aligned_cols=246 Identities=23% Similarity=0.337 Sum_probs=209.4
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.|++++.||+|+||+||+|+.. ++.||+|++... +.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999864 589999998532 2468899999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC------
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS------ 403 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~------ 403 (600)
|++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999975431000
Q ss_pred ------------------------------------------CCcccCCCccccChhhhccCCCCCccceechhHHHHHH
Q psy16430 404 ------------------------------------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWEL 441 (600)
Q Consensus 404 ------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyEL 441 (600)
...+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 01235799999999999988999999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHhcCC--CCCCCCCCCCcHHHHHHHHHhh--hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 442 LTCETPYKDVDSSAIIWGVGSS--SLHLPIPSTCPDGFQLLMKMCW--SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 442 ltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~~l~~LI~~cL--~~dP~~RPs~~elL~~l~~~~~ 507 (600)
++|..||...+.......+... ....+....+++++.+||.+|+ ..+|..||++.+++.|+|+...
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999987776655555432 2333334468899999999954 5566669999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.14 Aligned_cols=239 Identities=26% Similarity=0.428 Sum_probs=211.5
Q ss_pred cccCCCCcceEEEeEe-----eceEEEeeeeccc-----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 267 QWLGSGAQGAVFSGKL-----RSEIVAVKKVREQ-----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~~-----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+.||+|+||.||+++. .++.||+|.++.. ...|+.+|+.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 3578999998531 24688999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~ 409 (600)
++|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC 161 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence 99999999998888899999999999999999999999999999999999999999999999999875432 22233467
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.... ...|..+++.+.++|++||..||
T Consensus 162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999998889999999999999999999999999888777766665554 35677889999999999999999
Q ss_pred CCCC-----CHHHHHHcHhhhhh
Q psy16430 490 SSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 490 ~~RP-----s~~elL~~l~~~~~ 507 (600)
.+|| ++.+++.|+|+...
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 89999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.19 Aligned_cols=239 Identities=26% Similarity=0.459 Sum_probs=211.0
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
+.||+|+||.||+++.. +..||+|+++.. ..+|+.+++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999864 689999998642 235889999999999999999999999999999999999
Q ss_pred cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCcc
Q psy16430 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVA 413 (600)
Q Consensus 335 sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~ 413 (600)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 9999998878899999999999999999999999999999999999999999999999999875432 222234679999
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP 493 (600)
|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .+|..+++.+.++|.+||..||.+||
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 9999999988999999999999999999999999998887776666554433 45678899999999999999999998
Q ss_pred -----CHHHHHHcHhhhhh
Q psy16430 494 -----SFKQILSHLDIASQ 507 (600)
Q Consensus 494 -----s~~elL~~l~~~~~ 507 (600)
++.++++|+|+...
T Consensus 239 ~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 239 GGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCHHHHHcCCCcCCC
Confidence 99999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=373.38 Aligned_cols=252 Identities=37% Similarity=0.635 Sum_probs=222.6
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeeceEEEeeeec---------cchHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVR---------EQKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~---------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
....|+|+.+++.+...||+|+||+||+|+|.|. ||||++. +.|++|+.++++-+|.||+-+.|++..++
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4478999999999999999999999999999885 8999985 34678999999999999999999998887
Q ss_pred ceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN- 400 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~- 400 (600)
. .||+.+|+|.+|+.++.-. .+|.....+.|++||++|+.|||.++|||||||..|||+.++++|||+|||++..-.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 7 8999999999999999753 479999999999999999999999999999999999999999999999999986533
Q ss_pred --CCCCCcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC---CCCCC
Q psy16430 401 --NKSTKMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL---PIPST 472 (600)
Q Consensus 401 --~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~ 472 (600)
.........|...|||||+++. .+|++.+|||||||++|||+||..||......++++.++.+-... .+...
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 2222234568899999999864 578999999999999999999999999888999999998884433 33467
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
++.++++|+..||.+++++||.+.+||..+...
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 899999999999999999999999999966543
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=350.59 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=211.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch---------HHHHHHHHhcCCCCcccccceeec--
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGVCTQ-- 320 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------~~Ei~~L~~L~HpnIv~l~~~~~~-- 320 (600)
..|+++ ..|..++.||.|+||.|+.|..+ ++.||||++..-+ .+|+++|+.++|+||+.+.+++..
T Consensus 16 ~~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 345555 55666899999999999999864 7999999996433 479999999999999999999854
Q ss_pred ---CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 321 ---APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 321 ---~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
-+.+|+|+|+|+ .+|...++.+..+++..+..+++||+.||+|+|+.||+|||+||+|++++.+..+||+|||+|+
T Consensus 95 ~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 95 RDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 346899999994 7899999998889999999999999999999999999999999999999999999999999999
Q ss_pred cccC---CCCCcccCCCccccChhhhc-cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC-----------
Q psy16430 398 EWNN---KSTKMSFAGTVAWMAPEVIR-NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----------- 462 (600)
Q Consensus 398 ~~~~---~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----------- 462 (600)
.... ....+.++.|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.|.+....+..+..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8864 22234578899999999975 47899999999999999999999999999876443332211
Q ss_pred -------------CCCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 463 -------------SSLHLPI-----PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 463 -------------~~~~~~~-----p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
....++. -...++...+|+.+||..||.+|+|++|+|.||+++.-.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 1111111 136688999999999999999999999999999987643
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.20 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=210.4
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.|++++.||+|+||.||+|+.. ++.||+|++... ..+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999864 688999998642 3468999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-------
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK------- 402 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~------- 402 (600)
||+||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988778999999999999999999999999999999999999999999999999997532100
Q ss_pred -----------------------------------------CCCcccCCCccccChhhhccCCCCCccceechhHHHHHH
Q psy16430 403 -----------------------------------------STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWEL 441 (600)
Q Consensus 403 -----------------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyEL 441 (600)
....+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 001234689999999999999999999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHhcCCCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHcHhhhhh
Q psy16430 442 LTCETPYKDVDSSAIIWGVGSSSL--HLPIPSTCPDGFQLLMKMCWSNAPSSRPS---FKQILSHLDIASQ 507 (600)
Q Consensus 442 ltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~~LI~~cL~~dP~~RPs---~~elL~~l~~~~~ 507 (600)
++|++||.+.+.......+..... ..+....+++++.++|.+|+ .+|.+|++ +++++.|+|+...
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999998887666655544332 33334567899999999976 59999987 9999999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.99 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=211.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.+|++++.||+|+||.||+|+.. ++.||+|++... ..+|+.+|++++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999864 689999998531 346899999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC------
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK------ 402 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~------ 402 (600)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999997532100
Q ss_pred --------------------------------------CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC
Q psy16430 403 --------------------------------------STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC 444 (600)
Q Consensus 403 --------------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG 444 (600)
.......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 001135799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhcCCCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHcHhhhhh
Q psy16430 445 ETPYKDVDSSAIIWGVGSSSLHL--PIPSTCPDGFQLLMKMCWSNAPSSRP---SFKQILSHLDIASQ 507 (600)
Q Consensus 445 ~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~~LI~~cL~~dP~~RP---s~~elL~~l~~~~~ 507 (600)
+.||.+.+.......+....... +....+++.+.++|.+|+ .+|.+|+ |+.++++|+|+...
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 99999888766655554433222 333467899999999976 5999999 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=368.56 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=217.3
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.+.+..++|++.+.||+|+||.||+|+.. +..||+|.+... +..|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34566789999999999999999999864 689999998531 346889999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..|+||||++||+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999999998865 35899999999999999999999999999999999999999999999999999876433
Q ss_pred C--CCcccCCCccccChhhhccC----CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCc
Q psy16430 403 S--TKMSFAGTVAWMAPEVIRNE----QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCP 474 (600)
Q Consensus 403 ~--~~~~~~gt~~Y~APE~l~~~----~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~ 474 (600)
. ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+.........| ..+|
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 2 22346799999999998653 47889999999999999999999999888777766665544333333 3679
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSS--RPSFKQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~--RPs~~elL~~l~~~~~ 507 (600)
..+.+||.+||+.+|.+ |||++++++|+|+...
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999999988 9999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=349.59 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=209.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccch---------HHHHHHHHhcCCCCcccccceeec--CCceeEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGVCTQ--APCYCIV 327 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------~~Ei~~L~~L~HpnIv~l~~~~~~--~~~~~lV 327 (600)
++|+.++.|++|+||.||+|+++ ++.||+|+++... .+||.+|.+++|||||.+..+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 78999999999999999999875 7999999997543 589999999999999999998743 3569999
Q ss_pred EeeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 328 MEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||||+. +|..++.+.+ +|...++..++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.++......
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 999984 7988887644 89999999999999999999999999999999999999999999999999999988764443
Q ss_pred -ccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc----CCC---------------C
Q psy16430 407 -SFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG----SSS---------------L 465 (600)
Q Consensus 407 -~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~----~~~---------------~ 465 (600)
..+-|.+|.|||.+.+ ..|+.++|+||+|||+.||+++++.|++....+.+..|- ... .
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 4678999999999876 678999999999999999999999999987655544321 110 0
Q ss_pred ----------CCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 ----------HLPIPST-CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ----------~~~~p~~-~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+..++.. +++.-.+|+..+|..||.+|.|+++.|+|.||...
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 0001111 56888999999999999999999999999999874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=361.66 Aligned_cols=239 Identities=27% Similarity=0.456 Sum_probs=209.9
Q ss_pred cccCCCCcceEEEeEe--eceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccc
Q psy16430 267 QWLGSGAQGAVFSGKL--RSEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
+.||+|+||.||+++. .+..||+|++... ...|+++++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999986 4689999998642 235788899999999999999999999999999999999
Q ss_pred cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 335 sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
+|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..... ........||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999887889999999999999999999997 7999999999999999999999999999875432 22223467999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ..+|..+++.+.+||.+||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 9999999999899999999999999999999999999888776666655443 34567789999999999999999999
Q ss_pred C-----CHHHHHHcHhhhhh
Q psy16430 493 P-----SFKQILSHLDIASQ 507 (600)
Q Consensus 493 P-----s~~elL~~l~~~~~ 507 (600)
+ ++.++++|+|+...
T Consensus 239 ~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 239 LGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 6 99999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=359.75 Aligned_cols=239 Identities=26% Similarity=0.437 Sum_probs=209.8
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|++... ...|+.++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 688999998642 13466777766 699999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... ........||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 99999998888899999999999999999999999999999999999999999999999999876432 22333567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+..... ..|..+++++.++|++||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999988999999999999999999999999999888877777665443 4566789999999999999999999
Q ss_pred CCH------HHHHHcHhhhhh
Q psy16430 493 PSF------KQILSHLDIASQ 507 (600)
Q Consensus 493 Ps~------~elL~~l~~~~~ 507 (600)
|++ ++++.|+|+...
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCCC
Confidence 998 999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=353.01 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=227.5
Q ss_pred ccccccccccccccCCCCcceEEEeEeec--eEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
-.+....|++++.||.|.-|+||+++..+ ..+|+|++.+. .+.|-+||+.++||.++.+|..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 44667889999999999999999999875 79999999643 3468899999999999999999999999
Q ss_pred eeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-
Q psy16430 324 YCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN- 400 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~- 400 (600)
.|+|||||+||+|..++++ ++.|++..++.|+..++.||+|||..|||+|||||+||||.++|.+-|+||.++....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999999876 4579999999999999999999999999999999999999999999999998763210
Q ss_pred ---------------------------------C-C----------------------CCCcccCCCccccChhhhccCC
Q psy16430 401 ---------------------------------N-K----------------------STKMSFAGTVAWMAPEVIRNEQ 424 (600)
Q Consensus 401 ---------------------------------~-~----------------------~~~~~~~gt~~Y~APE~l~~~~ 424 (600)
. . ...++++||-.|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0112478999999999999999
Q ss_pred CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q psy16430 425 CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS----FKQILS 500 (600)
Q Consensus 425 ~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs----~~elL~ 500 (600)
.+.++|+|+|||++|||+.|..||.+.+..+.+..|....+.++-....+..+++||+++|.+||.+|.. +.||-+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999999999999999888888777788999999999999999999998 999999
Q ss_pred cHhhhhhh
Q psy16430 501 HLDIASQE 508 (600)
Q Consensus 501 ~l~~~~~~ 508 (600)
||+|....
T Consensus 392 HpFF~gVn 399 (459)
T KOG0610|consen 392 HPFFEGVN 399 (459)
T ss_pred CccccCCC
Confidence 99998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=353.87 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=203.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.++|++.+.||.|+||.||+|... +..||+|.++. ...+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999864 68999998852 23479999999999999999999999999999999
Q ss_pred eeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 330 YCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
|+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 9975 888887653 457899999999999999999999999999999999999999999999999987654322 2234
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-------------------CCC
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-------------------LHL 467 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~ 467 (600)
..+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.... ...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 568999999999865 568999999999999999999999998877654433221100 000
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 ---------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 ---------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.....+++++.+||++||+.||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0112457889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=357.82 Aligned_cols=238 Identities=23% Similarity=0.420 Sum_probs=209.5
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|++... ...|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35899999999999875 578999998642 23567777765 799999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ........||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 99999998878899999999999999999999999999999999999999999999999999876432 22233567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... ..|..++.++.++|.+||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHc
Confidence 99999999988999999999999999999999999999888877777665543 3456789999999999999999999
Q ss_pred C-------CHHHHHHcHhhhh
Q psy16430 493 P-------SFKQILSHLDIAS 506 (600)
Q Consensus 493 P-------s~~elL~~l~~~~ 506 (600)
| +++++++|+|+..
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCC
Confidence 9 9999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=360.25 Aligned_cols=239 Identities=26% Similarity=0.446 Sum_probs=211.7
Q ss_pred cccCCCCcceEEEeEe-----eceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 267 QWLGSGAQGAVFSGKL-----RSEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
+.||+|+||.||+++. .++.||+|++... ...|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3689999998632 2468899999999999999999999999999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcccCCC
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGT 411 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt 411 (600)
+|+|.+++.+...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .......||
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~ 161 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 161 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence 9999999987778999999999999999999999999999999999999999999999999998765443 223356799
Q ss_pred ccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q psy16430 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491 (600)
Q Consensus 412 ~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~ 491 (600)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ..+|..+++.+.+||++||+.||.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred hhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 99999999998889999999999999999999999999888777776665543 3456778999999999999999999
Q ss_pred CCC-----HHHHHHcHhhhhh
Q psy16430 492 RPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 492 RPs-----~~elL~~l~~~~~ 507 (600)
||| +.+++.|+|+...
T Consensus 240 R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 240 RLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred cCCCCCCCHHHHhCCCCcCCC
Confidence 999 7889999998653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=355.36 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=200.9
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++.+.||+|+||.||+|+.. ++.||+|+++. ...+|+.+++.++||||+++++++.+....|+||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 68999999999999999999874 68999999853 235799999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
+. ++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .....
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 163 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCC
Confidence 96 567666654 4568999999999999999999999999999999999999999999999999987653322 22345
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHH-HHHHh----cCCC-----------------C
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA-IIWGV----GSSS-----------------L 465 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~-~~~~i----~~~~-----------------~ 465 (600)
.+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+ .... .
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 68999999999865 457889999999999999999999998754321 11111 0000 0
Q ss_pred CCCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 HLPIP---------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ~~~~p---------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+ ...++.+.+|+.+||+.||.+|||+.++++|+||.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00001 1245678999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=359.89 Aligned_cols=244 Identities=25% Similarity=0.423 Sum_probs=208.2
Q ss_pred ccccccccCCCCcceEEEeEe-----eceEEEeeeeccc-----------hHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVREQ-----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~~-----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
+|++++.||+|+||.||+++. .+..||+|++.+. ...|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 3688999998531 24588899999 599999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
++||||+++|+|.+++..+..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999988653322
Q ss_pred -CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCC----hHHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 404 -TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVD----SSAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 404 -~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+.. ...+++..+++.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 238 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIGPEA 238 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHH
Confidence 22346799999999999765 47889999999999999999999996432 2223333322 2345667889999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
.++|.+||+.||.+|| +++++++|+|+...
T Consensus 239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=365.43 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=212.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||.||+++.. ++.||+|+++.. ...|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 689999998531 245888999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-----
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----- 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----- 403 (600)
||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987542210
Q ss_pred -------------------------------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC
Q psy16430 404 -------------------------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD 452 (600)
Q Consensus 404 -------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~ 452 (600)
...+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0113579999999999999999999999999999999999999999888
Q ss_pred hHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHcHhhhhh
Q psy16430 453 SSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMCWSNAPSSRP---SFKQILSHLDIASQ 507 (600)
Q Consensus 453 ~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RP---s~~elL~~l~~~~~ 507 (600)
.......+........+| ..+++.++++|.+|+ .||.+|+ ++.++++||||...
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 877766665433233333 347889999999977 4999998 58999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.00 Aligned_cols=250 Identities=29% Similarity=0.452 Sum_probs=211.1
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
+..++|++.+.||+|+||.||++... +..+|+|.+.. .+.+|++++++++||||+++++++..++..|+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 55689999999999999999999875 67899998753 245799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
|||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 160 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccc
Confidence 99999999999998877899999999999999999999985 7999999999999999999999999998765332 223
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC------------------------
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS------------------------ 462 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~------------------------ 462 (600)
...||..|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence 45789999999999988899999999999999999999999986554333221110
Q ss_pred -------------------CCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 463 -------------------SSLHLPIP-STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 463 -------------------~~~~~~~p-~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.......+ ...++++++||.+||+.||++|||+.+++.|+|+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00001111 23578899999999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=357.87 Aligned_cols=244 Identities=26% Similarity=0.438 Sum_probs=213.0
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCC-CcccccceeecCCceeEEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHP-NIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~Hp-nIv~l~~~~~~~~~~~lV~ 328 (600)
+|++++.||+|+||.||+|+.. ++.||+|++... ...|+.++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999875 478999998642 23577788888765 5888999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCCCCcc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKSTKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~~~~~ 407 (600)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999999887889999999999999999999999999999999999999999999999999987532 2222334
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..++..+.+++.+||..
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhc
Confidence 679999999999999899999999999999999999999999988877777765543 345678899999999999999
Q ss_pred CCCCCCCH-----HHHHHcHhhhhh
Q psy16430 488 APSSRPSF-----KQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs~-----~elL~~l~~~~~ 507 (600)
||.+|++. .++++|||+...
T Consensus 239 ~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 239 HPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999976 899999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=359.82 Aligned_cols=246 Identities=21% Similarity=0.325 Sum_probs=212.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+++.. ++.||+|+++.. +..|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999864 689999998642 346788999999999999999999999999999
Q ss_pred eeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--C
Q psy16430 329 EYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--K 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~ 405 (600)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999775 6799999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccCCCccccChhhhc------cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC--CCCCCCCCcHHH
Q psy16430 406 MSFAGTVAWMAPEVIR------NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL--HLPIPSTCPDGF 477 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~------~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l 477 (600)
....||+.|+|||++. +..++.++|||||||++|+|++|..||...+.......+..... ..+....+++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 2346899999999986 45678899999999999999999999998877666665544332 223334678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+||+.||. +|.+|||+.+++.|+|+...
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999998 99999999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.28 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=214.5
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
..+..++|++.+.||+|+||.||+++.. ++.||+|.+.+. +.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 4456689999999999999999999875 688999988531 3468899999999999999999999999
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
+|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999999999998754 58999999999999999999999999999999999999999999999999998764332
Q ss_pred C--CcccCCCccccChhhhccC----CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcH
Q psy16430 404 T--KMSFAGTVAWMAPEVIRNE----QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPD 475 (600)
Q Consensus 404 ~--~~~~~gt~~Y~APE~l~~~----~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~ 475 (600)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.........| ..++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 2 2356799999999998754 37889999999999999999999999888777666665544333334 35689
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHcHhhhhh
Q psy16430 476 GFQLLMKMCWSNAPSS--RPSFKQILSHLDIASQ 507 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~--RPs~~elL~~l~~~~~ 507 (600)
.+++++..||..++.+ |+|+.++++|+|+...
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999999865543 8999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=374.12 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=204.1
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---hHHHHHHHHhcCCCCcccccceeecC--------Cce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVCTQA--------PCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---~~~Ei~~L~~L~HpnIv~l~~~~~~~--------~~~ 324 (600)
.+..+|++.+.||+|+||.||+|... ++.||||++... ..+|+.+|+.++||||+++++++... ..+
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 34578999999999999999999864 689999988543 35799999999999999998876321 246
Q ss_pred eEEEeeeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccc
Q psy16430 325 CIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREW 399 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~ 399 (600)
++||||+++ +|.+++. .+..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+|+..
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 799999975 6666553 456799999999999999999999999999999999999998664 7999999999877
Q ss_pred cCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC---------------
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS--------------- 463 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~--------------- 463 (600)
..........||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+....+..+...
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 301 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchh
Confidence 65544456788999999999866 46899999999999999999999999887654433322110
Q ss_pred ------------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 ------------SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 ------------~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+...+|...|+++.+||.+||+.||.+|||+.+++.||||...
T Consensus 302 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00111344578899999999999999999999999999999753
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.87 Aligned_cols=242 Identities=25% Similarity=0.434 Sum_probs=209.3
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHH---HHhcCCCCcccccceeecCCceeEE
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRH---LRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~---L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
|++++.||+|+||.||+|... ++.||||+++... ..|+++ ++.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999864 6899999986321 234443 3567899999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~ 406 (600)
|||++|++|...+.. +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999888764 4699999999999999999999999999999999999999999999999999875432 22233
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
...|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ..|..+++.+.++|.+||+
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRFLSREAISIMRRLLR 237 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhh
Confidence 56799999999999998999999999999999999999999998888777766655543 3567789999999999999
Q ss_pred cCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 487 NAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
.||.+|| ++.++++|+|+...
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999 79999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.17 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=200.6
Q ss_pred cccccccccCCCCcceEEEeEee---ceEEEeeeecc---------chHHHHHHHHhc---CCCCcccccceee-----c
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR---SEIVAVKKVRE---------QKETDIRHLRKL---NHPNIVKFKGVCT-----Q 320 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~---------~~~~Ei~~L~~L---~HpnIv~l~~~~~-----~ 320 (600)
.+|++.+.||+|+||.||+|+.. +..||+|.++. ...+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 57899998852 224577766665 6999999999874 3
Q ss_pred CCceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
...+++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999996 588888864 34589999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC-----C------
Q psy16430 399 WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH-----L------ 467 (600)
Q Consensus 399 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~-----~------ 467 (600)
...........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+...... .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 65544444567899999999998889999999999999999999999999987765554433211000 0
Q ss_pred --------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 --------------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 --------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.....+++.+.+++.+||+.||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.68 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=200.9
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC-----Ccee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA-----PCYC 325 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~-----~~~~ 325 (600)
+|++.+.||+|+||.||+|... +..||||++.. .+.+|+.++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999864 68999998753 235799999999999999999987543 2479
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
+|||||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999995 68999998878899999999999999999999999999999999999999999999999999976532211
Q ss_pred ---CcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHh---------------cC--
Q psy16430 405 ---KMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV---------------GS-- 462 (600)
Q Consensus 405 ---~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i---------------~~-- 462 (600)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+ ..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 124578999999999876 67899999999999999999999999876543221110 00
Q ss_pred ---------CCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 463 ---------SSLHLPI---PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 463 ---------~~~~~~~---p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+. ...+++.+.++|.+||+.||++|||++++++|+|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000010 12457889999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.35 Aligned_cols=245 Identities=29% Similarity=0.464 Sum_probs=207.5
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc---hHHHHHHHHhcCCCCcccccceeecC--C---ceeEEEeee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVCTQA--P---CYCIVMEYC 331 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---~~~Ei~~L~~L~HpnIv~l~~~~~~~--~---~~~lV~Ey~ 331 (600)
.|...+.+|.|+||.||.|... ++.||||++-.+ ..+|+.+|+.++|||||++.-+|... . +..+||||+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 4667788999999999999865 589999998543 35899999999999999998887422 2 456899999
Q ss_pred ccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccccCCCCCc
Q psy16430 332 AYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 332 ~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~~~ 406 (600)
+ .+|...++. +..++.-.++-++.||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.......
T Consensus 105 P-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni 183 (364)
T KOG0658|consen 105 P-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI 183 (364)
T ss_pred h-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce
Confidence 8 589888873 5779999999999999999999999999999999999999966 999999999999998887778
Q ss_pred ccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc----CCC-------------C---
Q psy16430 407 SFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG----SSS-------------L--- 465 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~----~~~-------------~--- 465 (600)
++..|..|.|||.+.+ ..|+.+.||||.||++.||+-|++.|+|.+....+..+. ... .
T Consensus 184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p 263 (364)
T KOG0658|consen 184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFP 263 (364)
T ss_pred eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCc
Confidence 8899999999999876 689999999999999999999999999977654443221 100 0
Q ss_pred ---C----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 ---H----LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ---~----~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
. .-.....+++..+|+.++|..+|.+|.++.+++.|+.|..-
T Consensus 264 ~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 264 QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 0 01334678999999999999999999999999999988643
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.37 Aligned_cols=244 Identities=30% Similarity=0.496 Sum_probs=215.7
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
++|++.+.||+|++|.||.|.. .+..||+|.+.. .+.+|+.++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999975 468999998742 23568899999999999999999999999999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC-
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK- 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 405 (600)
||||+++++|.+.+...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999998765432111
Q ss_pred ---cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 406 ---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 406 ---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
....++..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.........+..++..+.++|.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence 23567889999999998889999999999999999999999998877766666655555566678889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+||..+|.+|||+.++++|+|+
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.26 Aligned_cols=239 Identities=26% Similarity=0.460 Sum_probs=206.9
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHh-cCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRK-LNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~-L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|.++... ..|..++.. .+||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35899999999999875 5789999986432 234555554 4899999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~ 412 (600)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 999999988788999999999999999999999999999999999999999999999999999764332 2233467999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ....|..++..+.++|.+||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999989999999999999999999999999998887777666543 345677889999999999999999999
Q ss_pred CCH-HHHHHcHhhhhh
Q psy16430 493 PSF-KQILSHLDIASQ 507 (600)
Q Consensus 493 Ps~-~elL~~l~~~~~ 507 (600)
|++ .+++.|+|+...
T Consensus 239 ~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 239 LGVDGDIRQHPFFRGI 254 (316)
T ss_pred CCChHHHHcCcccCCC
Confidence 986 588899998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=368.51 Aligned_cols=261 Identities=34% Similarity=0.613 Sum_probs=233.2
Q ss_pred cccccccccccccccccccccccCCCCcceEEEeEeec------eEEEeeeecc----------chHHHHHHHHhcCCCC
Q psy16430 247 FKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS------EIVAVKKVRE----------QKETDIRHLRKLNHPN 310 (600)
Q Consensus 247 ~~~~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~----------~~~~Ei~~L~~L~Hpn 310 (600)
.+.++.+..|++..++..+.++||+|+||.||+|++.- ..||+|..+. .+.+|.++|++++|||
T Consensus 143 L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~N 222 (474)
T KOG0194|consen 143 LKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPN 222 (474)
T ss_pred ecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCC
Confidence 45667888999999999999999999999999998652 2389998863 2357999999999999
Q ss_pred cccccceeecCCceeEEEeeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCce
Q psy16430 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAK 389 (600)
Q Consensus 311 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vk 389 (600)
||++||+......+++|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+|
T Consensus 223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999999999876 599999999999999999999999999999999999999999999
Q ss_pred eeccCccccccCCCCCc-ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCC
Q psy16430 390 ISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHL 467 (600)
Q Consensus 390 L~DFGla~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 467 (600)
|+|||+++.-....... ...-+..|+|||.+....||.++|||||||++||+++ |..||.+....++...+....++.
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 99999988654222222 2235789999999999999999999999999999999 899999999999999998888889
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 468 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.|...|..+..++.+||..+|+.|||+.++.+.+.....
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999998865443
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.11 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=222.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcC-CCCcccccceeecCCceeEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV 327 (600)
+.|++.+.||.|.||.||+++.. ++.+|+|.+.+ ...+|+.+|+++. |||||.++++|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 56888899999999999999864 68999999853 3357999999998 99999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC----CCceeeccCccccccCCC
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK----EEAKISDFGTCREWNNKS 403 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~----~~vkL~DFGla~~~~~~~ 403 (600)
||+|.||.|.+.+... .+++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||++.......
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 9999999999998765 49999999999999999999999999999999999999643 479999999999887755
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCC--CCCCcHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI--PSTCPDGFQLLM 481 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~LI 481 (600)
.....+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.......+..+.+.+.. -..++..++++|
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i 273 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFI 273 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHH
Confidence 666789999999999999999999999999999999999999999999988888888777765443 356799999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||..||..|+|+.++|+|||+...
T Consensus 274 ~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 274 RKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999998764
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=381.63 Aligned_cols=252 Identities=36% Similarity=0.644 Sum_probs=226.0
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccc
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKG 316 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~ 316 (600)
.....+++..+....+.||+|+||.||+|+.. ...||||.+++ +|++|+++|..|+|||||+++|
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34456788899999999999999999999854 36899999863 5688999999999999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCC----------CC----CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDG----------EE----VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI 382 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------~~----l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl 382 (600)
+|.+++.+|+|+|||..|||.++|+.. .. ++..+.+.|+.||+.||.||-++.+|||||...|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999999999999531 22 7889999999999999999999999999999999999
Q ss_pred CCCCCceeeccCccccccCCCCCc---ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHH
Q psy16430 383 GSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIW 458 (600)
Q Consensus 383 ~~~~~vkL~DFGla~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~ 458 (600)
+++..|||+|||+++..-...... ...-..+|||||.+..++||.+||||||||+|||+++ |..||.+....+++.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 999999999999998754322111 2234789999999999999999999999999999999 999999999999999
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 459 GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 459 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+..+.. ++.|..||..+..||..||+.+|.+|||++||-..+.-
T Consensus 717 ~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 717 CIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred HHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 9999988 89999999999999999999999999999999887753
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.97 Aligned_cols=244 Identities=26% Similarity=0.425 Sum_probs=213.0
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHhc-CCCCcccccceeecCCceeEEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+|++.+.||+|+||.||+|+.. +..||+|++++.. ..|..++..+ .||+|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999875 5789999986431 2456666666 5899999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~ 407 (600)
||+++|+|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..... ......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 9999999999998878899999999999999999999999999999999999999999999999999875432 223335
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ..|..++..+.+++.+||+.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHccc
Confidence 6799999999999999999999999999999999999999999888877777765543 45677899999999999999
Q ss_pred CCCCCCC-----HHHHHHcHhhhhh
Q psy16430 488 APSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs-----~~elL~~l~~~~~ 507 (600)
||.+|++ ..++++|+|+...
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999998 4899999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=356.26 Aligned_cols=239 Identities=25% Similarity=0.464 Sum_probs=203.7
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|+++.. ...|+.++..+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999864 689999998642 23577788888 799999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~~~~~~~gt~ 412 (600)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 9999998877889999999999999999999999999999999999999999999999999987532 222334567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC--------h-HHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD--------S-SAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~--------~-~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.|+|||++.+..++.++|||||||++|+|++|+.||.... . ......+... ...+|..++..+.++|++
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~ 238 (329)
T cd05588 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVLKG 238 (329)
T ss_pred cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999996321 1 1122223333 234677889999999999
Q ss_pred hhhcCCCCCCC------HHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPS------FKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs------~~elL~~l~~~~~ 507 (600)
||+.||.+||| +.++++|+|+...
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 239 FLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999987 7999999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.47 Aligned_cols=239 Identities=27% Similarity=0.461 Sum_probs=209.8
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|... +..||+|++++. ...|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999875 578999998643 23567778777 699999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|..++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... ........||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875322 22233457899
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ..|..+++.+.+||++||..||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--RYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHccCCHHHc
Confidence 99999999999999999999999999999999999998887777666655443 4567789999999999999999999
Q ss_pred CCH-----HHHHHcHhhhhh
Q psy16430 493 PSF-----KQILSHLDIASQ 507 (600)
Q Consensus 493 Ps~-----~elL~~l~~~~~ 507 (600)
||+ .+++.|+|+...
T Consensus 239 ~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.01 Aligned_cols=239 Identities=26% Similarity=0.437 Sum_probs=207.0
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHh-cCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRK-LNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~-L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. +..||+|.++.. ...|..++.. ++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999875 678999998643 1245666665 4899999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ........||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999875322 22233567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|..++..+.++|++||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999999999999999999999999999999999888777666654433 34566789999999999999999999
Q ss_pred CCH-HHHHHcHhhhhh
Q psy16430 493 PSF-KQILSHLDIASQ 507 (600)
Q Consensus 493 Ps~-~elL~~l~~~~~ 507 (600)
|++ +++++|+|+...
T Consensus 239 ~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 239 LGVVGNIRGHPFFKTI 254 (316)
T ss_pred CCChHHHHcCCCcCCC
Confidence 997 589999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=342.64 Aligned_cols=244 Identities=33% Similarity=0.571 Sum_probs=211.0
Q ss_pred ccccccccccccCCCCcceEEEeEee-----ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
++..+|++.+.||+|+||.||+|.+. +..||+|.++.. +.+|+.++++++||||+++++++......
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 56678999999999999999999753 468999987632 35689999999999999999999999999
Q ss_pred eEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999999876 3578999999999999999999999999999999999999999999999999876543221
Q ss_pred C--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 404 T--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 404 ~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
. .....++..|+|||.+.+..++.++|||||||++||+++ |..||.+.+.......+... ...+.|..+|..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 240 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPRNCPNLLHQL 240 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHH
Confidence 1 112345678999999999999999999999999999775 99999988877776666544 3456778899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcH
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l 502 (600)
+.+||+.+|.+|||+++|++.+
T Consensus 241 i~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred HHHHcCCCchhCCCHHHHHHHH
Confidence 9999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.36 Aligned_cols=238 Identities=27% Similarity=0.454 Sum_probs=206.6
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHH-HHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIR-HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~-~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||+||+|+.. ++.||+|++.... ..|.. +++.++||||+++++++......|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999874 6899999986421 12333 45778999999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999998888899999999999999999999999999999999999999999999999999875432 22233467999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ..+..++..+.++|++||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 99999999998999999999999999999999999998887777766655443 3456679999999999999999999
Q ss_pred CCH----HHHHHcHhhhh
Q psy16430 493 PSF----KQILSHLDIAS 506 (600)
Q Consensus 493 Ps~----~elL~~l~~~~ 506 (600)
|++ .++++|+|+..
T Consensus 239 ~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 239 LGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCHHHHHcCCCcCC
Confidence 987 69999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.33 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=209.9
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.|++.+.||+|+||.||++... ++.||+|++... +.+|+.+++.++||||+++++.+..+...|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 689999988532 2468999999999999999999999999999999
Q ss_pred eeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 330 YCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 9999999988754 24689999999999999999999999999999999999999999999999999887654433345
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--CCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--SSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
..|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+.. .......+..+++.+.+||.+||
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence 6789999999999888899999999999999999999999987655332221111 11223455678999999999999
Q ss_pred hcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
..||.+|| ++++++.|+|+...
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 241 TKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred cCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 99999999 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.43 Aligned_cols=250 Identities=35% Similarity=0.614 Sum_probs=211.0
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhc-CCCCcccccce
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGV 317 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~ 317 (600)
..|.++.++|++.+.||+|+||.||+|++. +..||||+++. .+.+|+.+++.+ +||||++++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 357778889999999999999999999742 45899999853 235799999999 89999999999
Q ss_pred eecCCceeEEEeeeccccchhhccCC------------------------------------------------------
Q psy16430 318 CTQAPCYCIVMEYCAYGPLYNLLKDG------------------------------------------------------ 343 (600)
Q Consensus 318 ~~~~~~~~lV~Ey~~ggsL~~~l~~~------------------------------------------------------ 343 (600)
+......++|||||+||+|.+++...
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 99999999999999999998887532
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 344 ---------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 344 ---------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 14678889999999999999999999999999999999999999999999999866433
Q ss_pred CCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 403 STK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 403 ~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.....................|...+.++.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 347 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY 347 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence 211 12345678999999999999999999999999999998 99999876654444444344444555677889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+||.+||+.||++|||+.+|++.+.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.33 Aligned_cols=239 Identities=26% Similarity=0.457 Sum_probs=207.4
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHh-cCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRK-LNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~-L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|.++... ..|..++.. ++||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 35899999999999875 5789999986431 245666665 4899999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... ........||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998877899999999999999999999999999999999999999999999999999875422 22233567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|..++..+.++|.+||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHhccCHhhc
Confidence 9999999999899999999999999999999999999888777766654443 23556788999999999999999999
Q ss_pred CCHH-HHHHcHhhhhh
Q psy16430 493 PSFK-QILSHLDIASQ 507 (600)
Q Consensus 493 Ps~~-elL~~l~~~~~ 507 (600)
|++. ++++|+|+...
T Consensus 239 ~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 239 LGVKGDIRQHPFFREI 254 (316)
T ss_pred CCChHHHHcCcccCCC
Confidence 9996 89999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=363.25 Aligned_cols=252 Identities=34% Similarity=0.610 Sum_probs=213.9
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccc
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
..+.|.++.++|++.+.||+|+||.||+|.+. +..||+|.++. .+.+|+.+++.+ +||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 45678899999999999999999999998753 24799999863 235799999999 899999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCC----------------------------------------------------
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDG---------------------------------------------------- 343 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~---------------------------------------------------- 343 (600)
+++......++|||||++|+|.+++...
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999887431
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 344 ------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 344 ------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24678889999999999999999999999999999999999999999999998765433211
Q ss_pred ---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 406 ---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 406 ---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||.....................|...|+++.++|
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 12335678999999988899999999999999999997 99999877655544444444455566677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+||+.||.+|||+.+|++.+.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=359.89 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=214.4
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.+.+..++|++.+.||+|+||.||+++.. ++.||+|++... +.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34566789999999999999999999875 688999998531 246788999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..|+||||++||+|.++++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999999998754 5899999999999999999999999999999999999999999999999999876533
Q ss_pred C--CCcccCCCccccChhhhccC----CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC--CCCCCCCCCc
Q psy16430 403 S--TKMSFAGTVAWMAPEVIRNE----QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS--LHLPIPSTCP 474 (600)
Q Consensus 403 ~--~~~~~~gt~~Y~APE~l~~~----~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~ 474 (600)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.... ...+.+..++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 22356799999999998754 37889999999999999999999999888776666665543 2333445689
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSS--RPSFKQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~--RPs~~elL~~l~~~~~ 507 (600)
..++++|..||..++.+ ||++.++++|+|+...
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999844433 7899999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=337.16 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=224.2
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------------chHHHHHHHHhc-CCCCcccccceeecC
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------------QKETDIRHLRKL-NHPNIVKFKGVCTQA 321 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~ 321 (600)
+..|...+.||.|..++|-++..+ +..+|+|++.. .-..|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777888999999999887654 67889998731 123689999998 699999999999999
Q ss_pred CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..+++|+|.|+.|.|.+++...-.+++...+.+++|+++|+.|||.++||||||||+|||++++.+++|+|||+|..+..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCcccCCCccccChhhhcc------CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCC
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRN------EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STC 473 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~ 473 (600)
...-...+|||+|.|||.+.. ..|+..+|+||+|||+|.|+.|.+||.......++..|..+.+.+..| .++
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence 877778999999999999854 467889999999999999999999999888888888898888877655 578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+...++||.+||+.||.+|.|++++|.|||+...
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 9999999999999999999999999999999654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.67 Aligned_cols=239 Identities=26% Similarity=0.473 Sum_probs=202.5
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|++++. ...|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999865 578999998643 23567777766 799999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 99999888778899999999999999999999999999999999999999999999999999875432 22233567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC---------hHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD---------SSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~---------~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.... .......+... ...+|..++..+.++|++
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~ 238 (329)
T cd05618 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKS 238 (329)
T ss_pred cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999995311 11122222222 335677889999999999
Q ss_pred hhhcCCCCCCC------HHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPS------FKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs------~~elL~~l~~~~~ 507 (600)
||+.||.+||+ +.++++|+|+...
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 239 FLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999998 5899999999654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=342.44 Aligned_cols=245 Identities=37% Similarity=0.663 Sum_probs=212.5
Q ss_pred ccccccccccccCCCCcceEEEeEeec-------eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
++.++|++++.||+|+||.||+|...+ ..||+|.+.. .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 456789999999999999999998542 5799998853 2457899999999999999999999989
Q ss_pred ceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~ 386 (600)
..|++|||+++++|.+++... ..++...++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999988653 4578889999999999999999999999999999999999999
Q ss_pred CceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcC
Q psy16430 387 EAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGS 462 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~ 462 (600)
.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987653322 1223456889999999988889999999999999999998 9999998888777766654
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 463 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.. ..+.|..+|+.+.+|+.+||+.||.+||++.+|++++.
T Consensus 242 ~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 242 RQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred CC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 43 34567889999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.76 Aligned_cols=245 Identities=33% Similarity=0.582 Sum_probs=202.9
Q ss_pred ccccccccccccCCCCcceEEEeEee------------------ceEEEeeeecc--------chHHHHHHHHhcCCCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR------------------SEIVAVKKVRE--------QKETDIRHLRKLNHPNI 311 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~------------------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnI 311 (600)
++..+|.+.+.||+|+||.||+|.+. +..||+|.++. .+.+|+.++.+++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 45578999999999999999999742 24699998854 24578999999999999
Q ss_pred ccccceeecCCceeEEEeeeccccchhhccCC-------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccc
Q psy16430 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDG-------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIH 372 (600)
Q Consensus 312 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~-------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvH 372 (600)
+++++++.+.+..++||||+++|+|.+++... ..++...++.++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999999999999999999999999887542 23677889999999999999999999999
Q ss_pred cCCCCCCcccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh--CCCC
Q psy16430 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT--CETP 447 (600)
Q Consensus 373 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt--G~~P 447 (600)
|||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999876543221 122345788999999988889999999999999999986 6788
Q ss_pred CCCCChHHHHHHhcC------CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 448 YKDVDSSAIIWGVGS------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 448 f~~~~~~~~~~~i~~------~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
|.+.+.......+.. .......+..+|..+.+||.+||+.||.+|||+.+|...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 887766554433211 1122234567889999999999999999999999997764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=360.58 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=204.6
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc-chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
+...+|++++.||+|+||.||++... ++.||+|.... ...+|+.++++++||||+++++++......++|||++. +
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 44578999999999999999999864 68999998753 45789999999999999999999999999999999995 6
Q ss_pred cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC--CCCcccCCCc
Q psy16430 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK--STKMSFAGTV 412 (600)
Q Consensus 335 sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~gt~ 412 (600)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+
T Consensus 168 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 247 (391)
T PHA03212 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247 (391)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCcc
Confidence 88888877778999999999999999999999999999999999999999999999999998754322 1223467999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-------HHHHH----HhcC-------------------
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-------SAIIW----GVGS------------------- 462 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-------~~~~~----~i~~------------------- 462 (600)
.|+|||++.+..++.++|||||||++|||++|..||...+. ...+. ....
T Consensus 248 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 327 (391)
T PHA03212 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG 327 (391)
T ss_pred CCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence 99999999988999999999999999999999988753221 01100 0000
Q ss_pred ---CCCCCC--CC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 463 ---SSLHLP--IP-----STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 463 ---~~~~~~--~p-----~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.....+ .+ ...+.++.+||.+||+.||.+|||++++|+|+||..
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000000 00 134678999999999999999999999999999965
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=343.28 Aligned_cols=236 Identities=24% Similarity=0.416 Sum_probs=201.3
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
||+|+||+||++... ++.||+|.+... +..|+.+++.++||||+++.+++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 689999998532 24688999999999999999999999999999999999999
Q ss_pred hhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccCCC
Q psy16430 337 YNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFAGT 411 (600)
Q Consensus 337 ~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~gt 411 (600)
...+. .+..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ .....||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 87763 345689999999999999999999999999999999999999999999999999876644322 2345789
Q ss_pred ccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH----HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS----AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 412 ~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ....+..+++.+.+++.+||+.
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999865432 222222222 2345667899999999999999
Q ss_pred CCCCCC-----CHHHHHHcHhhhh
Q psy16430 488 APSSRP-----SFKQILSHLDIAS 506 (600)
Q Consensus 488 dP~~RP-----s~~elL~~l~~~~ 506 (600)
||.+|| +++++++|+|+..
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhc
Confidence 999999 8899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=350.60 Aligned_cols=238 Identities=28% Similarity=0.424 Sum_probs=205.7
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHH-HHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDI-RHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei-~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|++.... ..|. .+++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999874 6889999985321 2233 357788999999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|...+.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... ........||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 99999888777899999999999999999999999999999999999999999999999999875422 22233467999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|...+..+.++|.+||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 9999999998899999999999999999999999999888777766665543 34566788999999999999999999
Q ss_pred CCH----HHHHHcHhhhh
Q psy16430 493 PSF----KQILSHLDIAS 506 (600)
Q Consensus 493 Ps~----~elL~~l~~~~ 506 (600)
|++ .++++|+|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 239 LGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCCHHHHhCCCCcCC
Confidence 865 59999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.07 Aligned_cols=238 Identities=25% Similarity=0.436 Sum_probs=204.8
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHH-HHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDI-RHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei-~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||+||+|+.. ++.||+|++.... ..|. .+++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 5789999986421 1222 246778999999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ........||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999875432 22334567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...+..+++.+.++|.+||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 9999999999999999999999999999999999999888777766665443 23456789999999999999999999
Q ss_pred CCHH----HHHHcHhhhh
Q psy16430 493 PSFK----QILSHLDIAS 506 (600)
Q Consensus 493 Ps~~----elL~~l~~~~ 506 (600)
|++. ++++|+|+..
T Consensus 239 ~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 239 LGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCHHHHhcCcccCC
Confidence 9865 8999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=350.21 Aligned_cols=244 Identities=26% Similarity=0.441 Sum_probs=212.1
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcC-CCCcccccceeecCCceeEEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+|+..+.||+|+||.||+|+.. ++.||+|++... ...|+.+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999864 689999998642 234677777775 577888999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~ 407 (600)
||++||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999999988788999999999999999999999999999999999999999999999999998764322 22334
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ..|..++..+.+++.+||+.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHccc
Confidence 6799999999999988999999999999999999999999999888777777665443 45677899999999999999
Q ss_pred CCCCCCC-----HHHHHHcHhhhhh
Q psy16430 488 APSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs-----~~elL~~l~~~~~ 507 (600)
+|.+|++ ..++++|+|+...
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 239 HPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred CHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999997 5899999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=355.20 Aligned_cols=246 Identities=30% Similarity=0.454 Sum_probs=204.4
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
....++|+.++.||+|+||.||+|+.. ++.||||++.. .+.+|+++++.++|+||+++++++...+.+|+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 344678899999999999999999875 68999999843 24579999999999999999999999999999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CC
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 405 (600)
||||+++|+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999999998653 235678888999999999999999999999999999999999999999999998764332 22
Q ss_pred cccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 406 MSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
....||..|+|||++.. ...+.++|||||||++|||++|+.||..... ......+. .......+..++..+
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 304 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASREF 304 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCHHH
Confidence 34679999999998743 2345689999999999999999999974332 22222221 122334566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+||.+||..||.+|||+.++++|+|+...
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 999999999999999999999999999765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.53 Aligned_cols=247 Identities=35% Similarity=0.621 Sum_probs=214.1
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|.|+.++|+++++||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++......++||
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 7788899999999999999999999865 47799998753 3356899999999999999999999999999999
Q ss_pred eeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 329 EYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||+++++|.+++.. ...++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999999864 35688899999999999999999999999999999999999999999999999987654321
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+... ...+.+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 122345678999999988889999999999999999998 99999887776666655443 3445556789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHh
Q psy16430 484 CWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~ 503 (600)
||..+|++|||++++++.+.
T Consensus 240 ~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 240 CWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HccCCcccCcCHHHHHHHHh
Confidence 99999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=377.58 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=207.1
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec--C
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ--A 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~--~ 321 (600)
..+....+|.+++.||.|+||+||+|+.. +..||+|.+.. .+..|+.++++|+|||||+++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34455679999999999999999999865 57899998752 23569999999999999999998854 4
Q ss_pred CceeEEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhC-------CccccCCCCCCcccCC------
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSK-------QIIHRDLKSPNVLIGS------ 384 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~-------gIvHrDIKp~NILl~~------ 384 (600)
..+||||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 568999999999999998864 35799999999999999999999985 4999999999999964
Q ss_pred -----------CCCceeeccCccccccCCCCCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCC
Q psy16430 385 -----------KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDV 451 (600)
Q Consensus 385 -----------~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~ 451 (600)
.+.+||+|||++.............||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999987655444455679999999999854 45789999999999999999999999876
Q ss_pred ChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 452 DSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 452 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+....+..........+ ....+..+.+||..||..+|.+|||+.++|.|+|+..
T Consensus 247 ~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred CcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 55433333222222222 2456899999999999999999999999999999864
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.92 Aligned_cols=247 Identities=20% Similarity=0.352 Sum_probs=207.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||.||+++.. ++.||+|++.+ .+..|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999864 68999999853 1346788899999999999999999999999999
Q ss_pred eeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--
Q psy16430 329 EYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-- 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 405 (600)
||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999975 457999999999999999999999999999999999999999999999999998765433221
Q ss_pred cccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC---CCCcHHH
Q psy16430 406 MSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGF 477 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~~~~~~l 477 (600)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.........+ ..+++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23468999999999863 457889999999999999999999999877766655554433222222 3478999
Q ss_pred HHHHHHhhhcCCCC--CCCHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSS--RPSFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~--RPs~~elL~~l~~~~~ 507 (600)
+++|++||..++.+ ||++.+++.|+|+...
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 99999988664443 7899999999998653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.33 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=214.1
Q ss_pred cccccccccCCCCcceEEEeEee---ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR---SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
..|.+.+.||+|+||.||+|... +..||+|.+.. ....|+.+|+.++||||+++++++...+.+|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 45889999999999999999753 56788887632 235699999999999999999999999999999999
Q ss_pred eccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 331 CAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 331 ~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
++||+|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 999999887643 45689999999999999999999999999999999999999999999999999987654321
Q ss_pred -CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 -KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 -~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+..+.. .+.|..+++.+.++|.+
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~ 305 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-DPFPCPVSSGMKALLDP 305 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCccCCHHHHHHHHH
Confidence 2346799999999999998999999999999999999999999998887777776655543 34567789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
||..||++|||+.+++.++++..
T Consensus 306 ~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 306 LLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999988754
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.42 Aligned_cols=243 Identities=31% Similarity=0.534 Sum_probs=214.7
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
..-|+.++.||.|+||.||-|++. ++.||||++.- +...|++.|++++|||+|.+.|+|..+...|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 356888999999999999999854 68999999852 335799999999999999999999999999999
Q ss_pred EeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 328 MEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||||- ||-.+++.- .+++.+.+|..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|..... ..
T Consensus 105 MEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---An 180 (948)
T KOG0577|consen 105 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---AN 180 (948)
T ss_pred HHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hh
Confidence 99996 577777653 45799999999999999999999999999999999999999999999999999876543 34
Q ss_pred ccCCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 407 SFAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
+++|||+|||||++. .+.|+-++||||||+++.||...++|+..++....++.|.....+......+++.++.|+..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 789999999999974 47899999999999999999999999999999888888776654444456789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
||++-|.+|||.+++|.|+++..
T Consensus 261 CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHhhCcccCCcHHHHhhcchhcc
Confidence 99999999999999999998754
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.98 Aligned_cols=247 Identities=20% Similarity=0.350 Sum_probs=210.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+++.. ++.||+|.+.+. +..|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999875 578999998531 346788889999999999999999999999999
Q ss_pred eeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--C
Q psy16430 329 EYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--K 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~ 405 (600)
||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 46789999999999999999999999999999999999999999999999999876543222 2
Q ss_pred cccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC---CCCcHHH
Q psy16430 406 MSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGF 477 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~~~~~~l 477 (600)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......+.......+.| ..+++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 2357999999999986 3467899999999999999999999999888777777765554433333 3578999
Q ss_pred HHHHHHhhhcCCCC--CCCHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSS--RPSFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~--RPs~~elL~~l~~~~~ 507 (600)
++||++||..++.+ |+++.++++|+|+...
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99999999765544 6899999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.51 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=206.4
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHH-HHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIR-HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~-~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|++.... ..|.. +++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35899999999999864 6899999986421 22333 46778999999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..... ........||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 99999988888899999999999999999999999999999999999999999999999999875432 22334567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
.|+|||++.+..++.++|||||||++|+|++|..||...+...+...+..... ..+...+..+.++|++||..+|.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHHHhccCHHhc
Confidence 99999999999999999999999999999999999998887777766655433 3445688999999999999999999
Q ss_pred CCH----HHHHHcHhhhhh
Q psy16430 493 PSF----KQILSHLDIASQ 507 (600)
Q Consensus 493 Ps~----~elL~~l~~~~~ 507 (600)
|++ .+++.|+|+...
T Consensus 239 ~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 239 LGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 976 699999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=351.77 Aligned_cols=238 Identities=22% Similarity=0.383 Sum_probs=204.0
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHhc---CCCCcccccceeecCCceeEEEeeecc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRKL---NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~L---~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
||+|+||+||+|+.. ++.||+|++.... ..|..++..+ .||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 6899999985321 1345555554 699999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ........||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999876432 22333567999
Q ss_pred cccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q psy16430 413 AWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491 (600)
Q Consensus 413 ~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~ 491 (600)
.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+..+....+ ...+++.+.++|++||..||.+
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~ 239 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGLLNRNPQH 239 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCCHHH
Confidence 99999998754 578999999999999999999999998887777766655554332 2357899999999999999999
Q ss_pred CC----CHHHHHHcHhhhhh
Q psy16430 492 RP----SFKQILSHLDIASQ 507 (600)
Q Consensus 492 RP----s~~elL~~l~~~~~ 507 (600)
|| ++.++++|+|+...
T Consensus 240 R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 240 RLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCCHHHHhcCccccCC
Confidence 98 79999999998753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=336.52 Aligned_cols=245 Identities=29% Similarity=0.503 Sum_probs=207.8
Q ss_pred cccccccccccCCCCcceEEEeEe--eceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.++|++.+.||+|+||.||+|+. .++.||+|++... ..+|+.++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 447899999999999999999986 4688999988532 3568999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
|+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... .....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence 99999999999877789999999999999999999999999999999999999999999999999998664332 22345
Q ss_pred CCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCC---CCCCcHHHHHHHH
Q psy16430 409 AGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI---PSTCPDGFQLLMK 482 (600)
Q Consensus 409 ~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~---p~~~~~~l~~LI~ 482 (600)
.|++.|+|||.+. ...++.++|||||||++|+|++|..||...........+.......+. +..++..+.++|+
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHH
Confidence 6889999999984 345788999999999999999999999766554443333333222222 2356889999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~ 503 (600)
+||..+|++|||+++|++|+|
T Consensus 247 ~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 247 ISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.22 Aligned_cols=244 Identities=28% Similarity=0.330 Sum_probs=199.8
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCC------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAP------ 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~------ 322 (600)
.++|++.+.||+|+||.||++... +..||+|++... ..+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 378999999999999999999864 689999998532 346899999999999999999986443
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 47999999975 5655553 34889999999999999999999999999999999999999999999999999865544
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc---------------------
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG--------------------- 461 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~--------------------- 461 (600)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 44445678999999999999999999999999999999999999998766432211110
Q ss_pred -CCCCCC------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 462 -SSSLHL------------------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 462 -~~~~~~------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
...... ..+...++.+++||.+||..||++|||+.|++.|||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000000 011234678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.54 Aligned_cols=239 Identities=25% Similarity=0.460 Sum_probs=203.3
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|+.. ++.||+|+++.. ...|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 588999999743 23577778777 699999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~~~~~~~gt~ 412 (600)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 9999998877789999999999999999999999999999999999999999999999999987532 222334567999
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC------hHH-HHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD------SSA-IIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~------~~~-~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.|+|||++.+..++.++|||||||++|+|++|..||.... ... ....+... ...+|..++..+.+++.+||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L 238 (327)
T cd05617 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKGFL 238 (327)
T ss_pred ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHh
Confidence 9999999999999999999999999999999999996421 122 22223222 33467788999999999999
Q ss_pred hcCCCCCCC------HHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPS------FKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs------~~elL~~l~~~~~ 507 (600)
..||.+|++ +++++.|+|+...
T Consensus 239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 239 NKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred ccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999997 5799999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.88 Aligned_cols=247 Identities=29% Similarity=0.498 Sum_probs=215.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+-|.++..||.|+||.||+|..+ +-..|-|++... +.-||.+|..++||+||++++.|...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34566788999999999999865 345677777532 345789999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCCCCcccC
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKSTKMSFA 409 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~~~~~~~ 409 (600)
.||-+..++-. +..+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.... ......++.
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 99988877654 6789999999999999999999999999999999999999999999999999876543 334455799
Q ss_pred CCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHH
Q psy16430 410 GTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 410 gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~ 483 (600)
|||+|||||++. ..+|+.++||||||++|.||..+.+|-...++..++..|..... .+..|+.++..+.+|+++
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~ 271 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKR 271 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHH
Confidence 999999999974 46889999999999999999999999999999998888776543 345688999999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+||..||++.+||+|||+.+.
T Consensus 272 cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 272 CLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999998654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=351.56 Aligned_cols=244 Identities=27% Similarity=0.312 Sum_probs=201.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC------C
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA------P 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~------~ 322 (600)
.++|++.+.||+|+||.||+|... ++.||||++... ..+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 378999999999999999999864 688999998532 34688999999999999999987543 3
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..|+||||+++ +|.+.+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 57999999975 66666643 4788999999999999999999999999999999999999999999999999876554
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-----------------
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL----------------- 465 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~----------------- 465 (600)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 444556789999999999999999999999999999999999999988765443332211000
Q ss_pred -------------------C----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 466 -------------------H----LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 466 -------------------~----~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
. .......++.+++||.+||+.||.+|||+.++|+|+|+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 0001123567899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.66 Aligned_cols=242 Identities=25% Similarity=0.401 Sum_probs=198.1
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhc---CCCCcccccceeec-----CC
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKL---NHPNIVKFKGVCTQ-----AP 322 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L---~HpnIv~l~~~~~~-----~~ 322 (600)
+|++.+.||+|+||.||+|+.. ++.||+|.++.. ..+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999864 688999988531 23577666655 79999999998754 34
Q ss_pred ceeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5799999997 4788877653 358999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-----------------
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----------------- 463 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----------------- 463 (600)
.........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 544444567899999999998889999999999999999999999999876654433322110
Q ss_pred -CCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 464 -SLHL-------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 464 -~~~~-------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.... .....++..+.++|.+||+.||.+|||+.+++.|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 0113467889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.70 Aligned_cols=246 Identities=20% Similarity=0.350 Sum_probs=209.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+++.. ++.||+|.+.+. +..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999865 578999998531 245788889999999999999999999999999
Q ss_pred eeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--
Q psy16430 329 EYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-- 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 405 (600)
||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999976 467899999999999999999999999999999999999999999999999998766443221
Q ss_pred cccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCC---CCcHHH
Q psy16430 406 MSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS---TCPDGF 477 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~~~~l 477 (600)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......+.|. .+++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 23569999999999875 4678899999999999999999999998877776666655443334443 468999
Q ss_pred HHHHHHhhhcCCCC--CCCHHHHHHcHhhhh
Q psy16430 478 QLLMKMCWSNAPSS--RPSFKQILSHLDIAS 506 (600)
Q Consensus 478 ~~LI~~cL~~dP~~--RPs~~elL~~l~~~~ 506 (600)
.++|.+||..++.+ |++++++++|+|+..
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 99999999876654 579999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=334.97 Aligned_cols=243 Identities=30% Similarity=0.523 Sum_probs=209.9
Q ss_pred ccccccccCCCCcceEEEeEe-eceEEEeeeecc-------------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL-RSEIVAVKKVRE-------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~-~~~~vAvK~~~~-------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
+|++.+.||.|+||.||+|.. .++.+|+|.+.. .+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999986 468899998742 245689999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-----
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK----- 402 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~----- 402 (600)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999999999988778999999999999999999999999999999999999999999999999998764321
Q ss_pred --CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-CCCCCCCCCCcHHHHH
Q psy16430 403 --STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 --~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~ 479 (600)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ....+.+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID 240 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHH
Confidence 1112356889999999999888999999999999999999999999876655444333332 2334566778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+|++||+.+|.+||++.+++.|+|+
T Consensus 241 ~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 241 FVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=332.59 Aligned_cols=247 Identities=34% Similarity=0.648 Sum_probs=214.3
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
|+++..+|++.+.||+|+||.||+|... +..||+|.+... +.+|++++++++||||+++++++.....+++|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 6788889999999999999999999865 688999988643 35789999999999999999999999999999
Q ss_pred EeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 328 MEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999998653 35889999999999999999999999999999999999999999999999998876543221
Q ss_pred c--ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 406 M--SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 406 ~--~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
. ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.......+.. ....+.+..+|..+.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHH
Confidence 1 2234678999999988899999999999999999998 9999998777666555433 3455667889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~ 503 (600)
+||+.||++|||+.++++.+.
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred HHccCCcccCCCHHHHHHHHH
Confidence 999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.10 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=213.7
Q ss_pred ccccccccccccCCCCcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC----
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP---- 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~---- 322 (600)
...++|++.+.||+|+||+||+|+. .++.||||.+.. ...+|+..+..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 4457999999999999999999986 478999999853 2346888899999999999988764322
Q ss_pred ----ceeEEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccC
Q psy16430 323 ----CYCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394 (600)
Q Consensus 323 ----~~~lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFG 394 (600)
.+++||||+++|+|.++++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 36899999999999998854 3468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCC
Q psy16430 395 TCREWNNK---STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS 471 (600)
Q Consensus 395 la~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 471 (600)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..+.. .+.|.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-DPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-CCCCC
Confidence 99865432 122346799999999999998999999999999999999999999998887777666655443 35678
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.+++.+.+++.+||+.||.+|||+.+++.|+++..
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 89999999999999999999999999999998654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=331.88 Aligned_cols=243 Identities=30% Similarity=0.541 Sum_probs=209.9
Q ss_pred cccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+.++|++.+.||+|+||.||+|++.. ..+|+|.+.. .+.+|+.++++++||||+++++++......++||||+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 45678899999999999999998764 5899998753 3457999999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--ccc
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--MSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~ 408 (600)
++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+......... ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 99999999865 346899999999999999999999999999999999999999999999999998765432221 123
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.++..|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+..+. ....|...+..+.+++.+||+.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHccC
Confidence 45678999999988889999999999999999999 999999888777776665543 3345667789999999999999
Q ss_pred CCCCCCCHHHHHHcH
Q psy16430 488 APSSRPSFKQILSHL 502 (600)
Q Consensus 488 dP~~RPs~~elL~~l 502 (600)
+|.+|||+.++++.+
T Consensus 241 ~p~~Rps~~~l~~~l 255 (256)
T cd05114 241 KPEGRPTFAELLRAI 255 (256)
T ss_pred CcccCcCHHHHHHhh
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.62 Aligned_cols=250 Identities=31% Similarity=0.588 Sum_probs=208.6
Q ss_pred cccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccccee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVC 318 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~ 318 (600)
.|.++.++|++.+.||.|+||.||+|... ++.||+|+++. ....|+.+++++ +||||+++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 48889999999999999999999999643 36899998753 234688999999 899999999987
Q ss_pred ec-CCceeEEEeeeccccchhhccCC------------------------------------------------------
Q psy16430 319 TQ-APCYCIVMEYCAYGPLYNLLKDG------------------------------------------------------ 343 (600)
Q Consensus 319 ~~-~~~~~lV~Ey~~ggsL~~~l~~~------------------------------------------------------ 343 (600)
.. +..+++||||+++++|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 45788999999999999887531
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---CcccCCCcc
Q psy16430 344 -------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVA 413 (600)
Q Consensus 344 -------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~ 413 (600)
..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... .....++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578889999999999999999999999999999999999999999999999987643221 123456778
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
|+|||++.+..++.++|||||||++|+|++ |..||.+....+..............+..+++.+.+++.+||+.+|++|
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999998 9999987554433333333334445567788999999999999999999
Q ss_pred CCHHHHHHcHhh
Q psy16430 493 PSFKQILSHLDI 504 (600)
Q Consensus 493 Ps~~elL~~l~~ 504 (600)
|++.++++++.-
T Consensus 321 Ps~~ell~~l~~ 332 (337)
T cd05054 321 PTFSELVEILGD 332 (337)
T ss_pred cCHHHHHHHHHH
Confidence 999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.88 Aligned_cols=238 Identities=24% Similarity=0.379 Sum_probs=200.1
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
||+|+||.||+++.. ++.||+|.+... ...|++++++++||||+++++++..+...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 789999988531 23488999999999999999999999999999999999999
Q ss_pred hhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccc
Q psy16430 337 YNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAW 414 (600)
Q Consensus 337 ~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y 414 (600)
.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.............|++.|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 8887543 35888999999999999999999999999999999999999999999999998876544433446789999
Q ss_pred cChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q psy16430 415 MAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490 (600)
Q Consensus 415 ~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 490 (600)
+|||++.+..++.++|||||||++|+|++|..||..... ..+........... ....+++++.+||.+||+.||.
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHHhccCHh
Confidence 999999888899999999999999999999999976433 22223222222221 2246789999999999999999
Q ss_pred CCCCH----HHHHHcHhhhhh
Q psy16430 491 SRPSF----KQILSHLDIASQ 507 (600)
Q Consensus 491 ~RPs~----~elL~~l~~~~~ 507 (600)
+||++ ++++.|+|+...
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 678899998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=352.82 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=204.5
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC-----cee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP-----CYC 325 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~-----~~~ 325 (600)
+|++.+.||+|+||.||+|.. .++.||+|++.. ...+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 478999998853 2357899999999999999999997766 789
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-- 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 403 (600)
+||||+. ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999996 5788888777789999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--------------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-------------------- 462 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-------------------- 462 (600)
......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 12234678999999998774 578999999999999999999999988765443332211
Q ss_pred ---CCCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 463 ---SSLHL-------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 463 ---~~~~~-------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..... ......++.+.+||.+||+.||.+|||+.+++.|+|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 11111 1234467899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=331.21 Aligned_cols=247 Identities=33% Similarity=0.614 Sum_probs=214.1
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|+++.++|++.+.||+|+||.||+|... +..||+|.++. .+.+|+.++++++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 6788899999999999999999999864 47899999863 3457899999999999999999999999999999
Q ss_pred eeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC-
Q psy16430 329 EYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK- 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 405 (600)
||+++++|.+++... ..++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999999998754 36899999999999999999999999999999999999999999999999999876532211
Q ss_pred -cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 406 -MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 406 -~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....+..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.......+... ...+.+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence 11223467999999988889999999999999999999 99999988776666655433 3445667789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHh
Q psy16430 484 CWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~ 503 (600)
||+.+|.+||++++++..+.
T Consensus 240 ~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 240 CWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HhhcCcccCCCHHHHHHHHh
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.33 Aligned_cols=244 Identities=35% Similarity=0.630 Sum_probs=209.5
Q ss_pred ccccccccccccCCCCcceEEEeEe------eceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
++..+|++.+.||+|+||.||+|.. .+..||+|.+.. .+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 4567899999999999999999974 247899999863 34679999999999999999999999999
Q ss_pred eeEEEeeeccccchhhccCC-----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG-----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~-----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~ 386 (600)
.|+||||+++++|.+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999988422 2377888999999999999999999999999999999999999
Q ss_pred CceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcC
Q psy16430 387 EAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGS 462 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~ 462 (600)
.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997653321 1223446778999999988889999999999999999998 9999988776666555544
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 463 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.. .++.+..+++.+.+++.+||+.||.+||++.+|++++
T Consensus 242 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 242 RQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred CC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 33 3456788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=336.15 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=207.8
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccch---------HHHHHHHHhcCCCC-cccccceeecCC-----
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------ETDIRHLRKLNHPN-IVKFKGVCTQAP----- 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------~~Ei~~L~~L~Hpn-Iv~l~~~~~~~~----- 322 (600)
...|..+++||+|+||+||+|+.. |+.||+|+++-.. .+|+.+|+.|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 467888999999999999999854 7899999997443 47999999999999 999999997766
Q ss_pred -ceeEEEeeeccccchhhccCCC----CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 323 -CYCIVMEYCAYGPLYNLLKDGE----EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 323 -~~~lV~Ey~~ggsL~~~l~~~~----~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.+++|+||++ .+|..++.... .++...+..+++||+.||+|||++||+||||||.||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 7899999996 68999887643 57888999999999999999999999999999999999999999999999999
Q ss_pred cccCCC-CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc----CC--------
Q psy16430 398 EWNNKS-TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG----SS-------- 463 (600)
Q Consensus 398 ~~~~~~-~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~----~~-------- 463 (600)
...-+. .....++|..|.|||++.+. .|+...||||+|||++||+++++.|.+....+.+..|- ..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776333 34456789999999998875 78999999999999999999999999988765554331 11
Q ss_pred ----CCCCCC-----CC-------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 ----SLHLPI-----PS-------TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 ----~~~~~~-----p~-------~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+. +. ..++...+++..||+.+|.+|.|++.+|.|++|...
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 001011 11 122478999999999999999999999999988654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=332.24 Aligned_cols=247 Identities=32% Similarity=0.610 Sum_probs=215.8
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
|+.+..+|++.+.||.|+||.||+|... +..+|+|.+.. ....|+.+++.++||||+++++++......++|
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 5677789999999999999999999875 58899998753 235688999999999999999999999999999
Q ss_pred EeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 328 MEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
|||+++++|.+++.+ +..++...+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999999975 34689999999999999999999999999999999999999999999999999876643321
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+.. ....+.+..+++.+.++|.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHHH
Confidence 123346778999999988889999999999999999998 8999998877766666553 34556778899999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHh
Q psy16430 484 CWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~ 503 (600)
||+.||.+|||+.++++.+.
T Consensus 240 ~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 240 CWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HcCCCchhCcCHHHHHHHHh
Confidence 99999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=332.75 Aligned_cols=241 Identities=33% Similarity=0.550 Sum_probs=210.0
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeecc----------------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
|.+...||.|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566788999999999999864 58899997742 235688999999999999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999887652211
Q ss_pred -------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 405 -------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 405 -------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. ......+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISSEA 240 (267)
T ss_pred cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcccCHHH
Confidence 1134588999999999888899999999999999999999999998766555554433 23345667889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.++|++||+.||.+||++.++++|+|+
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=335.24 Aligned_cols=246 Identities=32% Similarity=0.594 Sum_probs=209.6
Q ss_pred ccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
|.+..++|++.+.||+|+||.||+|.+. +..||+|.+.. .+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 6777889999999999999999998754 35799998753 23468899999999999999999999
Q ss_pred CCceeEEEeeeccccchhhccCCC----------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCcee
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGE----------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~----------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
....++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999886421 3567788999999999999999999999999999999999999999
Q ss_pred eccCccccccCCCCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCC
Q psy16430 391 SDFGTCREWNNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLH 466 (600)
Q Consensus 391 ~DFGla~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~ 466 (600)
+|||++......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL- 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 999998765432211 12345788999999998889999999999999999999 7999998877766655544432
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.+.+..+++.+.+++.+||+.||.+|||+.++++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.83 Aligned_cols=244 Identities=27% Similarity=0.335 Sum_probs=200.2
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC------C
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA------P 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~------~ 322 (600)
.++|++.+.||+|+||.||++... ++.||+|++... ..+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 478999999999999999999754 688999988532 24688999999999999999988543 3
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..|+||||+++ ++.+.+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 47999999975 56666543 4889999999999999999999999999999999999999999999999999876554
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--------------------
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-------------------- 462 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-------------------- 462 (600)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 444556799999999999998999999999999999999999999987664332211100
Q ss_pred --CC-----C-------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 463 --SS-----L-------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 463 --~~-----~-------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.. . ....+...+..+.+||.+||..||.+|||+.++++|||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 0 00011224567899999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.33 Aligned_cols=249 Identities=29% Similarity=0.501 Sum_probs=214.0
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
|.++|++.+.||.|+||.||+|... +..||+|.+.. .+..|+.++++++||||+++++++..+...|+|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 4578999999999999999999874 68899998853 24468999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
|+++++|.+++.. +..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 9999999999866 4579999999999999999999999999999999999999999999999999887654322 2234
Q ss_pred cCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHH
Q psy16430 408 FAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLM 481 (600)
Q Consensus 408 ~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI 481 (600)
..+++.|+|||++. ...++.++||||||+++|+|++|..||...+.......+..... ....+..++..+.++|
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHH
Confidence 56899999999975 34567899999999999999999999998877665555544332 2344567889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+||+.+|.+|||+.++++|+|+...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 243 KSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=338.98 Aligned_cols=244 Identities=23% Similarity=0.367 Sum_probs=206.8
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
|+..+.||+|+||.||++... ++.||+|.+... ...|+.++++++|+||+.+++.+...+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999875 689999987531 24689999999999999999999999999999999
Q ss_pred eccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 331 CAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 9999999888542 35899999999999999999999999999999999999999999999999998765543333345
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH---HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS---AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. ......+..+++.+.+|+.+||
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLCKMLL 240 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHHHHHHh
Confidence 7899999999999889999999999999999999999999865432 11221111 1122345678899999999999
Q ss_pred hcCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
+.||.+||| ++++++|+|+...
T Consensus 241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 241 CKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hcCHHHccCCCCCchHHHHcChhhhcc
Confidence 999999999 9999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=328.31 Aligned_cols=242 Identities=26% Similarity=0.478 Sum_probs=211.2
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|++|.||+|... +..|++|.+.. .+.+|++++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778889999999999999864 68899998752 234688999999999999999999999999999999
Q ss_pred eccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Ccc
Q psy16430 331 CAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~ 407 (600)
++|++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999998663 5789999999999999999999999999999999999999999999999999887654322 234
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ..+.+..++..+.++|.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHccC
Confidence 568899999999998889999999999999999999999998887766666554443 3345567889999999999999
Q ss_pred CCCCCCCHHHHHHcHhh
Q psy16430 488 APSSRPSFKQILSHLDI 504 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~ 504 (600)
+|++||++.+++.++|+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=334.30 Aligned_cols=245 Identities=28% Similarity=0.501 Sum_probs=207.9
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.++|++.+.||+|+||.||+|+.. ++.||+|.++.. ..+|+.+++.++||||+++++++......|+|||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 3468999999999999999999864 688999987532 3468899999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
|+++++|.+++...+.+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987654322 22345
Q ss_pred CCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCC---CCCCcHHHHHHHH
Q psy16430 409 AGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI---PSTCPDGFQLLMK 482 (600)
Q Consensus 409 ~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~---p~~~~~~l~~LI~ 482 (600)
.|++.|+|||++. ...++.++|||||||++|+|++|..||...................+. ...++..+.++|.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence 7899999999974 456788999999999999999999999766554444333222222221 2246789999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~ 503 (600)
+||..+|++|||+++|+.|+|
T Consensus 247 ~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 247 MALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=333.07 Aligned_cols=246 Identities=35% Similarity=0.626 Sum_probs=212.6
Q ss_pred ccccccccccccccCCCCcceEEEeEeec-------eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
|+++.++|++.+.||+|+||.||+|...+ ..||+|.+... +.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 67888999999999999999999998652 67999997532 3468899999999999999999999
Q ss_pred CCceeEEEeeeccccchhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCcee
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDG----------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~----------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999988542 23678889999999999999999999999999999999999999999
Q ss_pred eccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCC
Q psy16430 391 SDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLH 466 (600)
Q Consensus 391 ~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~ 466 (600)
+|||+++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC
Confidence 99999876543221 123456789999999988889999999999999999998 99999988877766666533 34
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
...|..++..+.++|.+||+.+|++|||+.++++.+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 556778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=342.56 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=204.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.++|.+.+.||+|+||.||+|+.. +..||+|.++. ...+|+.++++++||||+++++++..++..|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367999999999999999999864 67899998852 23579999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
|+++ +|.+++.. +..++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 9975 77777654 4458899999999999999999999999999999999999999999999999987654322 2224
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC---------------------CC
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS---------------------SL 465 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~---------------------~~ 465 (600)
..+|+.|+|||++.+ ..++.++|||||||++|+|+||++||.+.+..+....+... ..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 567899999999865 56789999999999999999999999877654433221100 00
Q ss_pred CC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 HL-------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ~~-------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.. .....+++++.+||.+||+.||.+|||+.+++.|+|+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00 0112467889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=333.65 Aligned_cols=246 Identities=28% Similarity=0.506 Sum_probs=207.2
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhc-CCCCcccccceeecC------Cc
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKL-NHPNIVKFKGVCTQA------PC 323 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~------~~ 323 (600)
+.+.|++.+.||+|+||.||+|... ++.||+|.+.. ....|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3467888999999999999999864 68899999853 245788889988 699999999998642 45
Q ss_pred eeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 89999999999999998753 4689999999999999999999999999999999999999999999999999886543
Q ss_pred CC-CCcccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 402 KS-TKMSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 402 ~~-~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
.. ......|+..|+|||++. +..++.++|||||||++|+|++|..||...........+.........+..++.
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCH
Confidence 22 223467899999999986 345788999999999999999999999877665555444443333344567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+.+||.+||..||.+|||+.+++.|+|+
T Consensus 244 ~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=329.35 Aligned_cols=245 Identities=31% Similarity=0.587 Sum_probs=212.3
Q ss_pred ccccccccccccccCCCCcceEEEeEeeceEEEeeeeccc-----hHHHHHHHHhcCCCCccccccee-ecCCceeEEEe
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ-----KETDIRHLRKLNHPNIVKFKGVC-TQAPCYCIVME 329 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~-----~~~Ei~~L~~L~HpnIv~l~~~~-~~~~~~~lV~E 329 (600)
|-++..+|++.+.||+|+||.||++...+..||+|.++.. +.+|+.++++++|+|++++++++ ..++..++|||
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 5677789999999999999999999999999999998643 45799999999999999999975 45567899999
Q ss_pred eeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 330 YCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~ 158 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DT 158 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CC
Confidence 999999999987543 47899999999999999999999999999999999999999999999999987654322 23
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... .....+..+++.+.+++.+||+
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWH 237 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhc
Confidence 345678999999988889999999999999999998 99999887776666555433 3445667889999999999999
Q ss_pred cCCCCCCCHHHHHHcHh
Q psy16430 487 NAPSSRPSFKQILSHLD 503 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~ 503 (600)
.+|++|||+.++++.+.
T Consensus 238 ~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 238 LDAATRPSFLQLREQLE 254 (256)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=332.95 Aligned_cols=245 Identities=30% Similarity=0.568 Sum_probs=213.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++.+.||.|+||.||+|... +..||+|.+... +.+|+.+++.++||||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999864 689999988532 35789999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~ 409 (600)
+++++|.+++..+ .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 9999999998765 7899999999999999999999999999999999999999999999999999877644 2233457
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCC-CcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPST-CPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~~l~~LI~~cL~~d 488 (600)
+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.... ....+.. ++..+.+++.+||..+
T Consensus 160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-PPSLEGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-CCCCcccccCHHHHHHHHHHhhCC
Confidence 8899999999998889999999999999999999999998777665555444432 2233333 8899999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~ 507 (600)
|.+|||++++++|+|+...
T Consensus 239 p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 239 PKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhhCcCHHHHhhChhhcCC
Confidence 9999999999999999664
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=336.95 Aligned_cols=245 Identities=21% Similarity=0.348 Sum_probs=208.6
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
|+..+.||+|+||+||+|... ++.||+|.+... ..+|+.++++++|+||+.+++.+..++..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 567788999999999999874 689999988531 34689999999999999999999999999999999
Q ss_pred eccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 331 CAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 999999888754 346999999999999999999999999999999999999999999999999998765443333456
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--CCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--SSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
.|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+.. .......+..+++.+.+|+..||+
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 241 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHcc
Confidence 789999999999888899999999999999999999999987665433222211 111223456788999999999999
Q ss_pred cCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 487 NAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
.||.+||+ +.+++.|+|+...
T Consensus 242 ~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 242 KDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CCHhHcCCCcccChHHHHcChhhhcC
Confidence 99999999 8999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.75 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=207.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++.+.||+|+||.||++... +..+|+|.+.. ...+|++++++++||||+++++++..++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999864 57899998753 245789999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
++|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 159 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV 159 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCC
Confidence 9999999999887889999999999999999999998 59999999999999999999999999998765332 223467
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-------------------------
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS------------------------- 464 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~------------------------- 464 (600)
+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhH
Confidence 8999999999988889999999999999999999999997655433322211100
Q ss_pred ----------CCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 ----------LHLPIP-STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ----------~~~~~p-~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..+..| ..++.++.+||.+||..+|++|||+.+++.|+|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred HHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000111 1367889999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=330.90 Aligned_cols=243 Identities=32% Similarity=0.570 Sum_probs=209.3
Q ss_pred cccccccccccCCCCcceEEEeEeec-eEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+.++|++.+.||+|+||.||.|++.+ ..+|+|.+... +.+|+.++++++||||+++++++......++||||+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 45788999999999999999998765 46999987642 457899999999999999999999888999999999
Q ss_pred ccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--ccc
Q psy16430 332 AYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--MSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~ 408 (600)
.+|+|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.++........ ...
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 999999998763 46899999999999999999999999999999999999999999999999998765433211 123
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.... ....+...+..+.+++.+||+.
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRPHLASEKVYAIMYSCWHE 240 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCC
Confidence 45678999999988889999999999999999998 999998877766666554443 3345667789999999999999
Q ss_pred CCCCCCCHHHHHHcH
Q psy16430 488 APSSRPSFKQILSHL 502 (600)
Q Consensus 488 dP~~RPs~~elL~~l 502 (600)
+|.+|||+.+|+..+
T Consensus 241 ~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 241 KAEERPTFQQLLSSI 255 (256)
T ss_pred CcccCCCHHHHHHhh
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=333.52 Aligned_cols=244 Identities=36% Similarity=0.603 Sum_probs=210.3
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
+...+|.+.+.||+|+||.||+|... +..||+|.+.. .+.+|++++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 34578999999999999999999753 36899999853 3457899999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCC--------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG--------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~--------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 999999999999999998643 247888999999999999999999999999999999999999999
Q ss_pred eeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC
Q psy16430 389 KISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 389 kL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~ 464 (600)
+|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987643221 1123346788999999999999999999999999999998 999998888777776665444
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
. ...+..++..+.+++.+||+.||.+|||+.++++.+
T Consensus 242 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 242 L-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred c-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 3 344667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=335.93 Aligned_cols=242 Identities=35% Similarity=0.572 Sum_probs=204.5
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccch---------HHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
|++.+.||+|+||+||+++.. ++.||+|.+.... ..|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999976 4689999996432 23788999999999999999999999999999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc-cCCCCCcccCC
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW-NNKSTKMSFAG 410 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~-~~~~~~~~~~g 410 (600)
++++|.+++...+.++...+..++.||+.||.+||+.||+|+||||+||+++.++.++|+|||.+... ..........+
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999987778999999999999999999999999999999999999999999999999998764 22233345678
Q ss_pred CccccChhhhc-cCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCCCCC--CCCCcHHHHHHHHHh
Q psy16430 411 TVAWMAPEVIR-NEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLHLPI--PSTCPDGFQLLMKMC 484 (600)
Q Consensus 411 t~~Y~APE~l~-~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~--p~~~~~~l~~LI~~c 484 (600)
+..|+|||++. +..++.++||||||+++|+|++|..||..... ................ ....+..+.++|.+|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM 240 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence 99999999998 78889999999999999999999999998732 2222222211111111 122348999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~ 504 (600)
|+.||.+|||+.++++|||+
T Consensus 241 l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 241 LSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSSSGGGSTTHHHHHTSGGG
T ss_pred ccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.12 Aligned_cols=245 Identities=33% Similarity=0.602 Sum_probs=214.9
Q ss_pred ccccccccccccccCCCCcceEEEeEeeceEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
|.++.++|++.+.||.|+||.||+|...++.||+|.+... +.+|+.++++++|+||+++++++.+....++|||
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 4567789999999999999999999999999999998643 3468999999999999999999998899999999
Q ss_pred eeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 330 YCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|+++++|.++++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~ 158 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--S 158 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--c
Confidence 999999999997654 689999999999999999999999999999999999999999999999999987643222 3
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+... .....+..+|+.+.++|.+||.
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCccCCCHHHHHHHHHHhc
Confidence 345678999999988889999999999999999997 99999888776665555433 3345567789999999999999
Q ss_pred cCCCCCCCHHHHHHcHh
Q psy16430 487 NAPSSRPSFKQILSHLD 503 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~ 503 (600)
.+|.+|||+.+++..+.
T Consensus 238 ~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 238 LDPAKRPTFKQLREQLA 254 (256)
T ss_pred cChhhCcCHHHHHHHHh
Confidence 99999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=347.72 Aligned_cols=249 Identities=28% Similarity=0.398 Sum_probs=203.8
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC-
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA- 321 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~- 321 (600)
..|+++ ++|++++.||+|+||.||+|... +..||+|++... ..+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 9 TVWEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred HHhhhh-hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 346665 78999999999999999999864 578999998632 34689999999999999999987543
Q ss_pred -----CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 322 -----PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 322 -----~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
...|++|+++ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3478999988 6889887764 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-----------
Q psy16430 397 REWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS----------- 464 (600)
Q Consensus 397 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~----------- 464 (600)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 865432 234678999999999876 568899999999999999999999998766543332221100
Q ss_pred -----------CC-CC------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 -----------LH-LP------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 -----------~~-~~------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.. .+ .....++.+.+||.+||..||.+|||+.+++.|+|+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 00 012356678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.74 Aligned_cols=238 Identities=38% Similarity=0.689 Sum_probs=201.9
Q ss_pred ccccccCCCCcceEEEeEee------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 264 SDLQWLGSGAQGAVFSGKLR------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 264 ~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++.+.||.|+||.||+|.+. +..|+||.+.. .+.+|++.+++++||||++++|++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999988 68999999943 34568999999999999999999998888999999
Q ss_pred eeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---
Q psy16430 330 YCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--- 404 (600)
Q Consensus 330 y~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--- 404 (600)
|+++|+|.+++... ..+++..+..|+.||+.||.|||+++++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999875 6799999999999999999999999999999999999999999999999999987632211
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....+...|+|||.+.+..++.++||||||+++|||++ |+.||.+.+.......+... ...+.+..++..+.++|.+
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccceeccchhHHHHHHHHH
Confidence 123456788999999998889999999999999999999 78999999888877777444 4466788899999999999
Q ss_pred hhhcCCCCCCCHHHHHHcH
Q psy16430 484 CWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l 502 (600)
||..||.+|||+.+|++.|
T Consensus 241 C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HT-SSGGGS--HHHHHHHH
T ss_pred HcCCChhhCcCHHHHHhcC
Confidence 9999999999999998754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=334.36 Aligned_cols=244 Identities=34% Similarity=0.583 Sum_probs=210.0
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
+...+|.+.+.||.|+||.||+|... +..||+|.++.. +..|+.++..++||||+++++++....
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45678899999999999999999853 368999998632 356888999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccC----------------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD----------------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~----------------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~ 386 (600)
..++++||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999988742 13478888999999999999999999999999999999999999
Q ss_pred CceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcC
Q psy16430 387 EAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGS 462 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~ 462 (600)
.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999886543221 123346789999999988889999999999999999998 8999998887777766655
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 463 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.. ..+.+..++..+.+|+..||+.+|.+||++.+|+..+
T Consensus 242 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 242 RQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred CC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 54 3456788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=341.47 Aligned_cols=246 Identities=23% Similarity=0.406 Sum_probs=224.6
Q ss_pred cccccccccCCCCcceEEEeE--eeceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~--~~~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.-|.+.+.||+|.|++|-+|+ .+|..||||++.+. ..+|++.|+.++|||||++|++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346677889999999999997 47999999999653 3479999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC-CCCCceeeccCccccccCCCCCcc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG-SKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
+-++|+|+++|.+ ...+.+..+.+|+.||+.|+.|||...+|||||||+|+.+. .-|-|||.|||++..+.......+
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 9999999999866 35699999999999999999999999999999999999876 558999999999999888887788
Q ss_pred cCCCccccChhhhccCCCC-CccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCS-DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s-~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
.+|+..|.|||++.|..|+ +++||||||||||-|++|++||...++.+.+..|++..+ .+|..++.++++||..||.
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHHHHHHHHHHh
Confidence 9999999999999998886 789999999999999999999999999999988888865 5689999999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.||.+|.|.++|..+.|+....
T Consensus 256 RdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 256 RDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred cCchhhccHHHHhccccccCCC
Confidence 9999999999999999997653
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.94 Aligned_cols=238 Identities=29% Similarity=0.448 Sum_probs=211.4
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
||.|+||.||+|+.. +..||+|.+.. .+.+|+.+++.++||||+++++++.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999987 78999999853 234688999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccC
Q psy16430 337 YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMA 416 (600)
Q Consensus 337 ~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~A 416 (600)
.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.............+++.|+|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998877899999999999999999999999999999999999999999999999999987755433344578999999
Q ss_pred hhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC--hHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q psy16430 417 PEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD--SSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494 (600)
Q Consensus 417 PE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs 494 (600)
||.+.+..++.++|+||||+++|+|++|..||.... .......+.........|...++.+.++|.+||..+|.+||+
T Consensus 161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence 999988889999999999999999999999998776 555555555444556667777999999999999999999999
Q ss_pred -----HHHHHHcHhhhh
Q psy16430 495 -----FKQILSHLDIAS 506 (600)
Q Consensus 495 -----~~elL~~l~~~~ 506 (600)
+.++++|+|+..
T Consensus 241 ~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 241 NLKGGIKDIKKHKWFNG 257 (262)
T ss_pred CcccCHHHHhcChhhhC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=354.18 Aligned_cols=250 Identities=34% Similarity=0.602 Sum_probs=211.4
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcC-CCCcccccce
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLN-HPNIVKFKGV 317 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~-HpnIv~l~~~ 317 (600)
..|+++.++|.+.+.||+|+||.||+|+.. ...||||+++. .+.+|+.+++++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 468888899999999999999999999853 24699999853 2357999999996 9999999999
Q ss_pred eecCCceeEEEeeeccccchhhccCC------------------------------------------------------
Q psy16430 318 CTQAPCYCIVMEYCAYGPLYNLLKDG------------------------------------------------------ 343 (600)
Q Consensus 318 ~~~~~~~~lV~Ey~~ggsL~~~l~~~------------------------------------------------------ 343 (600)
+......|+|||||++|+|.+++..+
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999999998877431
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcc
Q psy16430 344 ------------------------------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVL 381 (600)
Q Consensus 344 ------------------------------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NIL 381 (600)
..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 23677888999999999999999999999999999999
Q ss_pred cCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHH
Q psy16430 382 IGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAII 457 (600)
Q Consensus 382 l~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~ 457 (600)
++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999999886543221 123456788999999988889999999999999999997 99999876554444
Q ss_pred HHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 458 WGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 458 ~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
..........+.+..++..+.++|.+||+.||++|||+.+|.+.+.
T Consensus 350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 3333344455667788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=329.22 Aligned_cols=244 Identities=30% Similarity=0.502 Sum_probs=210.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
.++|++.+.||.|+||.||+|... ++.+|+|.+.. ...+|+.++++++||||+++++++.....+|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 478899999999999999999864 57899998753 245789999999999999999999999999999999
Q ss_pred eccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 331 CAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 9999999998765 689999999999999999999999999999999999999999999999999987765432 22345
Q ss_pred CCCccccChhhhccC---CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC---CCCCCCcHHHHHHHH
Q psy16430 409 AGTVAWMAPEVIRNE---QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL---PIPSTCPDGFQLLMK 482 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~---~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~~l~~LI~ 482 (600)
.++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+....... ..+...+..+.++|.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK 241 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHH
Confidence 788999999998776 78899999999999999999999998877665555444332222 123456788999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~ 503 (600)
+||..+|..|||+.+++.|+|
T Consensus 242 ~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 242 KCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.59 Aligned_cols=245 Identities=33% Similarity=0.620 Sum_probs=206.0
Q ss_pred ccccccccccccCCCCcceEEEeEee--c--eEEEeeeecc--------chHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--S--EIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~--~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
+.+++|++.+.||+|+||.||+|.+. + ..+|+|.+.. .+.+|+.++.++ +||||+++++++.....+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 45678999999999999999999864 3 3568877653 234689999999 899999999999999999
Q ss_pred eEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 325 CIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 9999999999999988643 247889999999999999999999999999999999999999999
Q ss_pred eeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCC
Q psy16430 389 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHL 467 (600)
Q Consensus 389 kL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 467 (600)
+|+|||++.............++..|+|||++.+..++.++|||||||++|+|+| |..||.+.+.......+.. ....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~ 242 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRL 242 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCcC
Confidence 9999999864322212222334678999999988889999999999999999998 9999988776665554432 3344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 468 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
..+..+++.+.+|+.+||+.+|.+|||+++++..+.
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.64 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=215.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||++... ++.||+|.+.. ...+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999874 68999998853 2346889999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL 158 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence 99999999999988888999999999999999999999999999999999999999999999999998876544 3345
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
.+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..+. .++|...+..++++|.+||..|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK--VRFPSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--ccCCccCCHHHHHHHHHHccCC
Confidence 78999999999988888999999999999999999999998877665555554333 4566778999999999999999
Q ss_pred CCCCC-----CHHHHHHcHhhhhh
Q psy16430 489 PSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RP-----s~~elL~~l~~~~~ 507 (600)
|.+|| ++.++++|+|+...
T Consensus 237 p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 237 LTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHccCcccCCHHHHHcCcccccC
Confidence 99999 99999999998553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.87 Aligned_cols=250 Identities=34% Similarity=0.641 Sum_probs=214.5
Q ss_pred cccccccccccccccccCCCCcceEEEeEeec-------eEEEeeeeccc--------hHHHHHHHHhc-CCCCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
...|+++.++|++.+.||+|+||.||++...+ ..+|+|.+... +.+|+.+++++ +||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35788899999999999999999999998642 67999988632 34688899999 8999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccC----------------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCc
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKD----------------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~----------------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NI 380 (600)
++.....+++||||+++|+|..++.. ...+++..++.++.|++.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 99999999999999999999998843 34688999999999999999999999999999999999
Q ss_pred ccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHH
Q psy16430 381 LIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAI 456 (600)
Q Consensus 381 Ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~ 456 (600)
+++.++.++|+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999987643221 112335678999999988889999999999999999998 9999998877666
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...+... .....+..++..+.+|+.+||..||.+|||+.++++.+.
T Consensus 244 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 244 FKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred HHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 6555433 344567788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.34 Aligned_cols=243 Identities=35% Similarity=0.609 Sum_probs=209.3
Q ss_pred cccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+..+|++.+.||+|+||.||+|.+.+ ..+|+|.+.. .+.+|+.++++++||||+++++++......|+||||+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 45678899999999999999998754 5799998864 2457899999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--ccc
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--MSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~ 408 (600)
+|++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++........ ...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 99999999865 346899999999999999999999999999999999999999999999999998765432211 112
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+... ...+.+..+|..+.+++.+||..
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKLAPTEVYTIMYSCWHE 240 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhcC
Confidence 34567999999998899999999999999999999 89999887776666655433 34556677899999999999999
Q ss_pred CCCCCCCHHHHHHcH
Q psy16430 488 APSSRPSFKQILSHL 502 (600)
Q Consensus 488 dP~~RPs~~elL~~l 502 (600)
+|.+|||+.++++.+
T Consensus 241 ~p~~Rpt~~~~l~~l 255 (256)
T cd05059 241 KPEDRPAFKKLLSQL 255 (256)
T ss_pred ChhhCcCHHHHHHHh
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=328.64 Aligned_cols=244 Identities=33% Similarity=0.612 Sum_probs=210.6
Q ss_pred cccccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
..++|++.+.||+|+||.||+|.+. ...||+|.++. .+.+|+.++++++||||+++++++......+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 3478999999999999999999864 25799998753 2346889999999999999999999999999
Q ss_pred EEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
+||||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999865 34789999999999999999999999999999999999999999999999999987752211
Q ss_pred ---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 405 ---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 405 ---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ...+.+..+++.+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHH
Confidence 112345678999999998899999999999999999998 99999887777666655443 3445667889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.+||+.+|++||++.++++++.
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.63 Aligned_cols=245 Identities=35% Similarity=0.622 Sum_probs=211.0
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|+++.++|++.+.||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++. ....++||
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 6788899999999999999999999865 46799998863 3468999999999999999999875 45678999
Q ss_pred eeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 329 EYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999999999865 34589999999999999999999999999999999999999999999999999976543321
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+.......+... ...+.+...+..+.+|+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence 122345678999999988889999999999999999999 99999887776666655433 3456677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHcH
Q psy16430 484 CWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l 502 (600)
||..+|.+|||+.++.+.+
T Consensus 239 ~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 239 CWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HcccCcccCcCHHHHHHHH
Confidence 9999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.81 Aligned_cols=234 Identities=32% Similarity=0.619 Sum_probs=201.9
Q ss_pred ccCCCCcceEEEeEe----eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccc
Q psy16430 268 WLGSGAQGAVFSGKL----RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~----~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
.||+|+||.||+|.+ .+..+|+|+++. .+..|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 357899998753 23568899999999999999998854 4678999999999
Q ss_pred cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC----CcccCC
Q psy16430 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST----KMSFAG 410 (600)
Q Consensus 335 sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~g 410 (600)
+|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........ .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 9999998777899999999999999999999999999999999999999999999999999987643322 112234
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
+..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+..+. ..+.|..+++.+.++|.+||+.||
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RMECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHhccCc
Confidence 678999999988888999999999999999998 999999887777776665543 456778899999999999999999
Q ss_pred CCCCCHHHHHHcHh
Q psy16430 490 SSRPSFKQILSHLD 503 (600)
Q Consensus 490 ~~RPs~~elL~~l~ 503 (600)
.+|||+.+|...+.
T Consensus 240 ~~Rp~~~~i~~~l~ 253 (257)
T cd05116 240 DERPGFAVVELRLR 253 (257)
T ss_pred hhCcCHHHHHHHHh
Confidence 99999999988763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.92 Aligned_cols=244 Identities=33% Similarity=0.612 Sum_probs=205.8
Q ss_pred ccccccccccCCCCcceEEEeEeec----eEEEeeeecc--------chHHHHHHHHhc-CCCCcccccceeecCCceeE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLRS----EIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~l 326 (600)
+++|++.+.||+|+||.||+|.... ..+++|.++. .+.+|+.++.++ +||||+++++++......|+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 3688999999999999999998642 3468887753 245689999999 79999999999999999999
Q ss_pred EEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCcee
Q psy16430 327 VMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 99999999999998643 24788899999999999999999999999999999999999999999
Q ss_pred eccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCC
Q psy16430 391 SDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPI 469 (600)
Q Consensus 391 ~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 469 (600)
+|||++..............+..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.. ....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~~~~~ 239 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRMEK 239 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCC
Confidence 99999864332212222233567999999988889999999999999999997 9999998877766655543 334456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 470 p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+..++..+.+|+.+||+.+|.+|||+.++++.+.-
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 77889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.64 Aligned_cols=243 Identities=33% Similarity=0.550 Sum_probs=212.4
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
+|+..+.||+|+||.||+|... +..||+|.+.. .+.+|+.+++.++||||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999864 68999998742 234688999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999998877899999999999999999999999999999999999999999999999999887654443345
Q ss_pred cCCCccccChhhhccCC-CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~-~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..++..|+|||.+.... ++.++|+|||||++|+|++|..||...........+........++..+++.+.+++.+||+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence 67899999999987766 89999999999999999999999988776555555544333445667789999999999999
Q ss_pred cCCCCCCCHHHHHHcHhh
Q psy16430 487 NAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~ 504 (600)
.+|.+||++.+++.|+|+
T Consensus 241 ~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 241 RDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cCcccCcCHHHHhcCCCC
Confidence 999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.71 Aligned_cols=247 Identities=29% Similarity=0.474 Sum_probs=209.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+-|++.+.||+|+||.||+|... +..+|+|.+... +.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34678899999999999999875 578899987532 346889999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccC
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFA 409 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~ 409 (600)
++++|..++.. ..++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 99999887754 4678999999999999999999999999999999999999999999999999987654322 223457
Q ss_pred CCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCCCCCCCCcHHHHHHHHH
Q psy16430 410 GTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 410 gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~ 483 (600)
+++.|+|||++. +..++.++|||||||++|+|++|.+||...+.......+.... .....+..++..+.++|.+
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHH
Confidence 899999999984 3457789999999999999999999998877665555443332 2334566789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||+.||.+|||+.++++|+|+...
T Consensus 245 ~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 245 CLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HccCChhhCcCHHHHhcCCCEecc
Confidence 999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.18 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=205.7
Q ss_pred ccccccccccCCCCcceEEEeEee----ceEEEeeeecc--chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR----SEIVAVKKVRE--QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~--~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
..+|.+++.||.|+||.||++... +..||+|.+.. ...+|+++|++++||||+++++++......|+|||++.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 357999999999999999998753 47899998864 34689999999999999999999999999999999996
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---CcccCC
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAG 410 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~g 410 (600)
++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........ .....|
T Consensus 170 ~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~g 249 (392)
T PHA03207 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249 (392)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccccc
Confidence 67888887777899999999999999999999999999999999999999999999999999976654322 224579
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH-------HHHHHhcCCC-------------------
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-------AIIWGVGSSS------------------- 464 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-------~~~~~i~~~~------------------- 464 (600)
|+.|+|||++.+..++.++|||||||++|||++|..||.+.... .+...+....
T Consensus 250 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (392)
T PHA03207 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYA 329 (392)
T ss_pred ccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhc
Confidence 99999999999989999999999999999999999999764321 1111111000
Q ss_pred --CC--CCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 --LH--LPIP-----STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 --~~--~~~p-----~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+ ...| ...+.++.++|.+||..||.+|||+.++|.||||...
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 330 IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 0111 2346789999999999999999999999999999664
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=325.81 Aligned_cols=245 Identities=32% Similarity=0.538 Sum_probs=212.2
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.++|++.+.||+|+||.||+|... +..||+|.+.. .+.+|++++++++||||+++++++......|+++||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 478999999999999999999875 58899999863 35678999999999999999999999999999999999
Q ss_pred cccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccCC
Q psy16430 333 YGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAG 410 (600)
Q Consensus 333 ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~g 410 (600)
+++|.+++.. +..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... ......+
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 161 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIG 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccC
Confidence 9999999865 4578999999999999999999999999999999999999999999999999988765443 2234558
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.... .....+..++..+.++|.+||+.||
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 241 (256)
T cd06612 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDP 241 (256)
T ss_pred CccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcCh
Confidence 899999999988889999999999999999999999998776655444332221 1223445678899999999999999
Q ss_pred CCCCCHHHHHHcHhh
Q psy16430 490 SSRPSFKQILSHLDI 504 (600)
Q Consensus 490 ~~RPs~~elL~~l~~ 504 (600)
.+|||+.+++.|+|+
T Consensus 242 ~~Rps~~~il~~~~~ 256 (256)
T cd06612 242 EERPSAIQLLQHPFI 256 (256)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=347.68 Aligned_cols=246 Identities=26% Similarity=0.431 Sum_probs=199.4
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc-chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
..+|++++.||+|+||.||+|+.. +..||+|.... ....|+.++++++||||+++++++......++||||+. ++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 357999999999999999999875 47899998643 34679999999999999999999999999999999996 577
Q ss_pred hhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCcccc
Q psy16430 337 YNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM 415 (600)
Q Consensus 337 ~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~ 415 (600)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.............||+.|+
T Consensus 144 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~ 223 (357)
T PHA03209 144 YTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223 (357)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccccccccc
Confidence 777754 5679999999999999999999999999999999999999999999999999987644433344567999999
Q ss_pred ChhhhccCCCCCccceechhHHHHHHhhCCC-CCCCCChH----------HHHH---HhcCCCCCCC-------------
Q psy16430 416 APEVIRNEQCSDKIDIWSYGIVLWELLTCET-PYKDVDSS----------AIIW---GVGSSSLHLP------------- 468 (600)
Q Consensus 416 APE~l~~~~~s~ksDIwSlGviLyELltG~~-Pf~~~~~~----------~~~~---~i~~~~~~~~------------- 468 (600)
|||++.+..++.++|||||||++|||+++.. +|...... .+.. .+.......+
T Consensus 224 aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (357)
T PHA03209 224 APEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIE 303 (357)
T ss_pred CCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHh
Confidence 9999999899999999999999999998544 44432211 0111 0000000000
Q ss_pred --------C-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 469 --------I-------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 469 --------~-------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
. ...++..+.+||.+||+.||.+|||+.|+|+||||.+
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 304 YASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 1134667788999999999999999999999999864
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.33 Aligned_cols=246 Identities=32% Similarity=0.630 Sum_probs=212.5
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|+|+.++|+++++||+|+||.||+|... ++.||+|.+.. .+.+|+.++++++||||+++++++. ....++||
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 6788899999999999999999999864 58899998863 3467999999999999999999874 45689999
Q ss_pred eeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 329 EYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||+++++|.+++.. +..++..++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999998864 34689999999999999999999999999999999999999999999999999876653221
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.......+... ...+.+..++..+.+++.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPRPDNCPEELYELMRL 238 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 123345778999999988889999999999999999999 99999988776666655433 3456677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHh
Q psy16430 484 CWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~ 503 (600)
||..+|++|||+++++..+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 239 CWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HccCChhhCCCHHHHHHHhh
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=329.40 Aligned_cols=244 Identities=30% Similarity=0.472 Sum_probs=208.7
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeec--CCce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQ--APCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~--~~~~ 324 (600)
.+|+..+.||+|+||.||+|.. .+..||+|.+.. .+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688889999999999999985 468899998742 23568999999999999999998865 3568
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
+++|||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999999999999877789999999999999999999999999999999999999999999999999987653311
Q ss_pred ---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..............+..|..+++.++++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 11234588999999999888899999999999999999999999988776665555544444455677788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+ +||..+|.+||++++|++|||+.
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 67778999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.01 Aligned_cols=252 Identities=31% Similarity=0.480 Sum_probs=212.2
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
+-.+.+.|++++.||.|+||.||+|+.. +..||+|.+... +.+|+.+++.++||||+++++++..+...|+
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3455688999999999999999999864 588999998532 3468889999999999999999999999999
Q ss_pred EEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-C
Q psy16430 327 VMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-T 404 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~ 404 (600)
||||+++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999999999887754 4568999999999999999999999999999999999999999999999999987643322 2
Q ss_pred CcccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQ 478 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~ 478 (600)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... ....+..++..+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 23456889999999984 34567899999999999999999999988766555444433322 2234567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
++|.+||..||++||++.++++|+|+...
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=327.75 Aligned_cols=246 Identities=32% Similarity=0.590 Sum_probs=210.3
Q ss_pred ccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|+++.++|++.++||+|+||.||+|++.+ ..||+|+++. .+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 67888999999999999999999998754 5799998863 24678999999999999999998754 5678999
Q ss_pred eeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC-
Q psy16430 329 EYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK- 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 405 (600)
||+++|+|.+++.. +..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999999999975 345789999999999999999999999999999999999999999999999999766433221
Q ss_pred -cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 406 -MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 406 -~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... ...+.+..++..+.+++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCCccccCHHHHHHHHH
Confidence 13346778999999988889999999999999999999 89999887776666555333 3345567789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHh
Q psy16430 484 CWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~ 503 (600)
||+.||.+|||+.++++.+.
T Consensus 239 ~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 239 CWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred HccCCcccCCCHHHHHHHHH
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=337.29 Aligned_cols=248 Identities=27% Similarity=0.479 Sum_probs=220.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc-----hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-----KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-----~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.+-|.++.+||+|+||.||+|.++ |..+|||.+.-. .-.|+.+|++++.|++|++||.+.....+|||||||.
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 356889999999999999999765 799999998632 3478999999999999999999999999999999999
Q ss_pred cccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccCC
Q psy16430 333 YGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAG 410 (600)
Q Consensus 333 ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~g 410 (600)
.|++.++++. ++++++.++..+++..+.||+|||...-||||||..|||++.+|.+||+|||.|..+.+.- ...+..|
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcccc
Confidence 9999999874 5789999999999999999999999999999999999999999999999999998876543 3446789
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
||.|||||++..-.|+.++||||||++..||..|++||.+..+...+..+-... ..+.-|..+++++.+|+++||.++|
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~P 271 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKP 271 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCH
Confidence 999999999999999999999999999999999999999988876666553332 2333467789999999999999999
Q ss_pred CCCCCHHHHHHcHhhhhh
Q psy16430 490 SSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~~ 507 (600)
++|-|+-++++|+++.+.
T Consensus 272 E~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 272 EERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHHHHHHHhhhhhhcCC
Confidence 999999999999998764
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.01 Aligned_cols=242 Identities=27% Similarity=0.442 Sum_probs=202.9
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++.+.||+|+||.||+|.. .+..||+|.+... +.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4678889999999999999986 4688999988532 34689999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG 410 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~g 410 (600)
+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... ......|
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVG 155 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCC
Confidence 999988654 34788899999999999999999999999999999999999999999999998765433 2234678
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-------HHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-------SAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
|..|+|||++.+..++.++|||||||++|+|++|..||..... ......+.............++.+.++|.+
T Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (279)
T cd06619 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ 235 (279)
T ss_pred ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHH
Confidence 9999999999988899999999999999999999999965322 122222222221111234578899999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||+.+|.+||++++++.|+|+...
T Consensus 236 ~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 236 CMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999665
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=325.45 Aligned_cols=242 Identities=30% Similarity=0.542 Sum_probs=208.4
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec-CCceeEEEe
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ-APCYCIVME 329 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~-~~~~~lV~E 329 (600)
+|++.+.||.|++|.||++... ++.||+|.+.. ...+|+.++++++|||++++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999864 57899998842 23568899999999999999998764 446899999
Q ss_pred eeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCc
Q psy16430 330 YCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 406 (600)
|+++++|.+++.. +..+++.+++.++.|++.||.+||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999998865 3468999999999999999999999999999999999999999999999999988664322 223
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
...+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+.. .+.+...++.+.+++.+||+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGELIATMLS 239 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCccccCHHHHHHHHHHhc
Confidence 45689999999999998899999999999999999999999988776666555544433 34567788999999999999
Q ss_pred cCCCCCCCHHHHHHcHhh
Q psy16430 487 NAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~ 504 (600)
.||.+|||+.+++.|+|+
T Consensus 240 ~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 240 KRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.54 Aligned_cols=248 Identities=25% Similarity=0.453 Sum_probs=214.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|... +..||+|.+... +..|+++++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 589999988532 346889999999999999999999999999999
Q ss_pred eeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 329 EYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 5689999999999999999999999999999999999999999999999999875432111
Q ss_pred ----------------------------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHH
Q psy16430 405 ----------------------------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456 (600)
Q Consensus 405 ----------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~ 456 (600)
.....||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 1124678899999999988899999999999999999999999998887766
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHHcHhhhhhh
Q psy16430 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS----FKQILSHLDIASQE 508 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs----~~elL~~l~~~~~~ 508 (600)
...+.......+.....++.+.++|.+||..||.+||| +++++.|+|+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 66655544444444447999999999999999999999 99999999997654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.14 Aligned_cols=245 Identities=34% Similarity=0.576 Sum_probs=210.6
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
|...+|.+.+.||+|+||.||++... +..+|+|.+.. .+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 45678999999999999999999742 35689998853 24578999999999999999999999999
Q ss_pred eeEEEeeeccccchhhccCCC-------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCcee
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGE-------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~-------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
.++||||+++++|.+++...+ .+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999886432 4899999999999999999999999999999999999999999999
Q ss_pred eccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCC
Q psy16430 391 SDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLH 466 (600)
Q Consensus 391 ~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~ 466 (600)
+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~- 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV- 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 99999876533221 122345778999999998889999999999999999998 9999998887777666655543
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+.+..++..+.+|+.+||+.||.+|||+.+++..+.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 3456678899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=360.59 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=199.9
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCC------CCcccccceeec
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNH------PNIVKFKGVCTQ 320 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~H------pnIv~l~~~~~~ 320 (600)
...+...+|++++.||+|+||+||+|... ++.||||+++. ....|+.+++.+.| ++++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34455688999999999999999999864 68899999863 23457777777754 458888888865
Q ss_pred C-CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCC------------
Q psy16430 321 A-PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKE------------ 386 (600)
Q Consensus 321 ~-~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~------------ 386 (600)
. ..+|+||+++ |++|.+++.+.+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999998 67888888877889999999999999999999998 5999999999999998765
Q ss_pred ----CceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC
Q psy16430 387 ----EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS 462 (600)
Q Consensus 387 ----~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~ 462 (600)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+.......+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 499999998764322 23356899999999999999999999999999999999999999987765443322111
Q ss_pred CC-------------------------CCCCC-C--------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 463 SS-------------------------LHLPI-P--------------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 463 ~~-------------------------~~~~~-p--------------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.. ..... + ...++.+.+||.+||+.||.+|||++|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 00 00000 0 01245678999999999999999999999999
Q ss_pred hhhhh
Q psy16430 503 DIASQ 507 (600)
Q Consensus 503 ~~~~~ 507 (600)
|+...
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 99764
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.31 Aligned_cols=250 Identities=32% Similarity=0.608 Sum_probs=212.8
Q ss_pred ccccccccccccccccCCCCcceEEEeEeec---------eEEEeeeeccc--------hHHHHHHHHhc-CCCCccccc
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS---------EIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
+.|+++.++|.+.+.||+|+||.||+|+..+ ..+|+|.+... +..|+.+++.+ +||||++++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4678888999999999999999999997532 46999988632 34588899999 799999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+++......|+||||+++|+|.+++... ..++..++..++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 9999999999999999999999998653 247888999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
|+++.++.++|+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999999876543211 112234578999999988889999999999999999998 899998877766
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
....+... ...+.+..++..+.+|+.+||..+|.+|||+.+++..+.-
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 251 LFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 65555433 3445677889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.95 Aligned_cols=244 Identities=29% Similarity=0.457 Sum_probs=205.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++...||+|+||.||+|+.. ++.||+|++.. .+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 68999998742 23578999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
|+++++|..++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99999998888777779999999999999999999999999999999999999999999999999998765433 22345
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CCCCC
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SLHLP 468 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~~ 468 (600)
.++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+... ....+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 67889999999876 55789999999999999999999999877654433322110 00001
Q ss_pred C----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 469 I----------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 469 ~----------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
. ....+..+.+||.+||+.+|++|||+.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 12457889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=330.21 Aligned_cols=252 Identities=27% Similarity=0.484 Sum_probs=209.1
Q ss_pred cccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhc-CCCCcccccceee----
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKL-NHPNIVKFKGVCT---- 319 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L-~HpnIv~l~~~~~---- 319 (600)
.+.+....++|++.+.||+|+||.||+|... ++.+|+|.... ...+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3566677899999999999999999999864 68899998753 245688999999 6999999999873
Q ss_pred -cCCceeEEEeeeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccC
Q psy16430 320 -QAPCYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394 (600)
Q Consensus 320 -~~~~~~lV~Ey~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFG 394 (600)
.+..+++||||++|++|.+++. .+..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 3456899999999999998764 34568899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCcccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCC
Q psy16430 395 TCREWNNKS-TKMSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHL 467 (600)
Q Consensus 395 la~~~~~~~-~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~ 467 (600)
++....... ......|++.|+|||++.. ..++.++|||||||++|+|++|..||...........+.... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 987664322 2234568999999999753 457889999999999999999999998776544443332221 222
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
..+..++..+.++|.+||+.||.+|||+.++++|+|+
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 3456678899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=322.26 Aligned_cols=235 Identities=38% Similarity=0.718 Sum_probs=208.1
Q ss_pred cccCCCCcceEEEeEee-----ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR-----SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|... +..||+|.+... ..+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36999999999999876 678999998643 34688999999999999999999999999999999999
Q ss_pred ccchhhccCC---------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 334 GPLYNLLKDG---------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 334 gsL~~~l~~~---------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999875 679999999999999999999999999999999999999999999999999998765432
Q ss_pred --CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 404 --TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 404 --~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..+|..+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYEL 239 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHH
Confidence 2234567889999999988889999999999999999999 6999999887777766655 33556678889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcH
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l 502 (600)
+.+||..+|.+|||+.++++++
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHccCCcccCcCHHHHHHhh
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.71 Aligned_cols=242 Identities=21% Similarity=0.392 Sum_probs=196.8
Q ss_pred cccccCCC--CcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 265 DLQWLGSG--AQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 265 ~~~~LG~G--~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
++.+||+| +||+||++... ++.||+|.+... ..+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 77899999864 689999998632 346889999999999999999999999999999999
Q ss_pred ccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC------
Q psy16430 332 AYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS------ 403 (600)
Q Consensus 332 ~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~------ 403 (600)
++|+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 99999999864 3458999999999999999999999999999999999999999999999998654432111
Q ss_pred --CCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC-------------
Q psy16430 404 --TKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH------------- 466 (600)
Q Consensus 404 --~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------------- 466 (600)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 0112356788999999876 46889999999999999999999999875544333222111100
Q ss_pred -------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 467 -------------------------------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 467 -------------------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.+....+++.+.+||.+||+.||++|||++++++|+|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0111235678999999999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.59 Aligned_cols=243 Identities=30% Similarity=0.469 Sum_probs=208.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecC--Cce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQA--PCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~ 324 (600)
.+|++.+.||+|+||.||.|... +..||+|.+.. .+.+|+.+++++.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999864 68899998741 234689999999999999999988653 468
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC--
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-- 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 402 (600)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999987777899999999999999999999999999999999999999999999999998765321
Q ss_pred --CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 403 --STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 403 --~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.........|...+..+.++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 112235688999999999888899999999999999999999999987766555555444444455667788899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
|.+|+. +|.+||+++++++|+|+
T Consensus 242 i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 242 LKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHhc-ChhhCCCHHHHhcCccc
Confidence 999995 99999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.34 Aligned_cols=241 Identities=26% Similarity=0.377 Sum_probs=211.8
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+|++.+.||.|+||.||+|... +..||+|.+.. ...+|++++++++||||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999875 68899998853 23568899999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccC
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
|+.|++|.+++.....+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99999999999877789999999999999999999999999999999999999999999999999988765544444567
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ......... .....|...+..+.++|.+||+
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHcc
Confidence 88999999999888899999999999999999999999987764 333222221 3445667789999999999999
Q ss_pred cCCCCCCCH--HHHHHcHhh
Q psy16430 487 NAPSSRPSF--KQILSHLDI 504 (600)
Q Consensus 487 ~dP~~RPs~--~elL~~l~~ 504 (600)
.||.+||++ +++++|+||
T Consensus 239 ~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CChhHcCCccHHHHhcCCCC
Confidence 999999999 999999985
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.22 Aligned_cols=246 Identities=29% Similarity=0.595 Sum_probs=207.6
Q ss_pred ccccccccccccCCCCcceEEEeEee--c----eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--S----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
+...+|++.+.||+|+||.||+|++. + ..||+|.++. .+.+|+.+++.++||||++++|++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34578999999999999999999863 2 3489999752 234688999999999999999998765 5
Q ss_pred eeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.++|++|+++|+|.+++... ..++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 67999999999999998764 46889999999999999999999999999999999999999999999999999876543
Q ss_pred CCCc---ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 403 STKM---SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 403 ~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
.... ...++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ......+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHH
Confidence 2221 2334678999999999899999999999999999998 99999887766554333 33445566778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+++.+||..+|.+|||+.+++.++.-.
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=324.21 Aligned_cols=239 Identities=31% Similarity=0.540 Sum_probs=208.6
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+|++.+.||.|+||.||+++.. +..+|+|.++. ...+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999864 68899998742 2356888999999999999999999999999999999
Q ss_pred ccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 332 AYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
++++|.+++.. +..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 99999988754 3468999999999999999999999999999999999999999999999999987664332 22345
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
.|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..+.. .+.+..++..+.++|.+||+.|
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHHhCC
Confidence 789999999999988899999999999999999999999998877766666654443 3466778899999999999999
Q ss_pred CCCCCCHHHHHHc
Q psy16430 489 PSSRPSFKQILSH 501 (600)
Q Consensus 489 P~~RPs~~elL~~ 501 (600)
|.+|||+.+++..
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.31 Aligned_cols=247 Identities=27% Similarity=0.488 Sum_probs=211.2
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
..+|++.+.||+|+||.||+|.. .+..||+|.+.. .+.+|+.+++.+.||||+++++.+......|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46889999999999999999985 468899998853 235688999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........ .....
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 177 (296)
T cd06654 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177 (296)
T ss_pred cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCccc
Confidence 999999999865 4589999999999999999999999999999999999999999999999999876543222 22357
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-SSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. .....+.+..++..+.++|.+||..+
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (296)
T cd06654 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (296)
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCC
Confidence 89999999999888889999999999999999999999987765443332222 22233345678899999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~ 507 (600)
|.+|||+.+++.|+|+...
T Consensus 258 p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 258 VEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cccCcCHHHHhhChhhhcc
Confidence 9999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=349.33 Aligned_cols=251 Identities=33% Similarity=0.586 Sum_probs=214.0
Q ss_pred cccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeeccc--------hHHHHHHHHhcC-CCCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQ--------KETDIRHLRKLN-HPNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~--------~~~Ei~~L~~L~-HpnIv~l~~ 316 (600)
...|+++.++|.+.+.||+|+||.||+|++. +..||+|+++.. +.+|+.+|.++. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3469999999999999999999999999864 367999998632 346899999997 999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCC-----------------------------------------------------
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDG----------------------------------------------------- 343 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------------------------------------------------- 343 (600)
++......++||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 999999999999999999999888532
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCC
Q psy16430 344 ---------------------------------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378 (600)
Q Consensus 344 ---------------------------------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~ 378 (600)
..++...++.++.||+.||.|||+.||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 13566778889999999999999999999999999
Q ss_pred CcccCCCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChH
Q psy16430 379 NVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSS 454 (600)
Q Consensus 379 NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~ 454 (600)
|||++.++.++|+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999999998653221 1223456789999999988889999999999999999998 89999876655
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 455 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
............++.|..++..+.+|+.+||..+|.+||++.+|+..+.
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 5544444445556677788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.54 Aligned_cols=241 Identities=31% Similarity=0.549 Sum_probs=213.0
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch-------HHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccch
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK-------ETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLY 337 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~-------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 337 (600)
-.||+|.||+||.|++. ...+|||.+.... ..||.+-++|+|.|||+++|.+.+++++-|.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999965 4678999986432 46899999999999999999999999999999999999999
Q ss_pred hhccC-CCCC--CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC-CCCCceeeccCccccccC-CCCCcccCCCc
Q psy16430 338 NLLKD-GEEV--PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG-SKEEAKISDFGTCREWNN-KSTKMSFAGTV 412 (600)
Q Consensus 338 ~~l~~-~~~l--~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 412 (600)
++++. -+++ .+..+-.+.+||++||.|||++.|||||||-+|+||+ -.|.+||+|||.++.+.. ...+.++.||.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence 99976 3666 7888999999999999999999999999999999996 579999999999988754 34455789999
Q ss_pred cccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCC-ChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 413 AWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDV-DSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 413 ~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
.|||||++.. ..|+.++|||||||++.||.||++||... ++.....+++--...+++|..++.+.+.||.+|+.+||
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~ 820 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDP 820 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCc
Confidence 9999999965 46889999999999999999999999764 44556667777777889999999999999999999999
Q ss_pred CCCCCHHHHHHcHhhhhh
Q psy16430 490 SSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~~ 507 (600)
.+||++.++|..|++...
T Consensus 821 ~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 821 CDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ccCccHHHhccCcccccC
Confidence 999999999999987644
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=371.52 Aligned_cols=249 Identities=34% Similarity=0.645 Sum_probs=219.4
Q ss_pred cccccccccccccCCCCcceEEEeEeec-------eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
.++.+..+....||+|+||.||.|...+ ..||||.+++ .+.+|..+|+.++|||||+++|++.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 4667888999999999999999998652 3599999864 356789999999999999999999999
Q ss_pred CceeEEEeeeccccchhhccCC-------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccC
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDG-------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~-------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFG 394 (600)
...+|++|||+||+|..+|++. ..++..+++.++.||+.|+.||+++++|||||..+|+|++....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999999864 358899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCcc--cCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCC
Q psy16430 395 TCREWNNKS-TKMS--FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIP 470 (600)
Q Consensus 395 la~~~~~~~-~~~~--~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 470 (600)
+|+.+.... .... ..-...|||||.+..+.++.++|||||||+|||++| |..||.+.+..++..-+..+. +++.|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P 926 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP 926 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC
Confidence 999543322 1111 234678999999999999999999999999999999 999999999988888666666 88999
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 471 ~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
..||+.+.++|..||+.+|++||++..|++.+.-..
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 999999999999999999999999999999654433
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=330.14 Aligned_cols=244 Identities=34% Similarity=0.623 Sum_probs=206.3
Q ss_pred cccccccccccCCCCcceEEEeEeec------------------eEEEeeeeccc--------hHHHHHHHHhcCCCCcc
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLRS------------------EIVAVKKVREQ--------KETDIRHLRKLNHPNIV 312 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------------------~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv 312 (600)
+..+|++.+.||+|+||.||+|.... ..||+|.+... +.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 45789999999999999999987532 46899998632 34689999999999999
Q ss_pred cccceeecCCceeEEEeeeccccchhhccCCC-----------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcc
Q psy16430 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-----------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVL 381 (600)
Q Consensus 313 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NIL 381 (600)
++++++..+...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987654 6899999999999999999999999999999999999
Q ss_pred cCCCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh--CCCCCCCCChHHH
Q psy16430 382 IGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT--CETPYKDVDSSAI 456 (600)
Q Consensus 382 l~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt--G~~Pf~~~~~~~~ 456 (600)
++.++.++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 9999999999999987654322 1223456788999999988889999999999999999998 7889987766555
Q ss_pred HHHhcCC------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 457 IWGVGSS------SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 457 ~~~i~~~------~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
...+... ....+.+..+|.++.+++.+||+.||.+|||+.+|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 5443321 222344567789999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.86 Aligned_cols=249 Identities=29% Similarity=0.500 Sum_probs=203.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCC-ce
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAP-CY 324 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~-~~ 324 (600)
+++.-..++|...+.||+|+||.||+|...+ ..||||++.. ++.+|+.++.+++|||+|+++|+|.+.+ ..
T Consensus 68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 68 DELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 4455566889999999999999999999876 8999998742 3678999999999999999999999888 49
Q ss_pred eEEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCC---ccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 325 CIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQ---IIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~g---IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
+||+||+++|+|.+++.... ++++.....|+.++|.||+|||+.. ||||||||+|||+|.+.++||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999997654 8999999999999999999999964 999999999999999999999999999766
Q ss_pred cC-CCCCccc-CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC---hH-HHHH---HhcCCCCC----
Q psy16430 400 NN-KSTKMSF-AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD---SS-AIIW---GVGSSSLH---- 466 (600)
Q Consensus 400 ~~-~~~~~~~-~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~---~~-~~~~---~i~~~~~~---- 466 (600)
.. ....... .||.+|+|||++..+..+.++||||||++|.||+||+.|..... .. ...| .+..+...
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 54 3322233 89999999999998899999999999999999999998877432 11 1111 11121111
Q ss_pred CCCC-CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 467 LPIP-STCP-----DGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 467 ~~~p-~~~~-----~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
+.+. ...+ ..+..+..+|++.+|.+||++.+++..+
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 1111 2222 2366778899999999999999998777
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=329.06 Aligned_cols=245 Identities=33% Similarity=0.563 Sum_probs=206.9
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
+..++|++.+.||+|+||.||+|.+. +..||+|.+.. .+..|+.++++++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45578999999999999999999874 36799998752 2456888999999999999999998888
Q ss_pred ceeEEEeeeccccchhhccCCC-------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC---Cceeec
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGE-------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE---EAKISD 392 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~-------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~---~vkL~D 392 (600)
..++||||++|++|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999986532 488899999999999999999999999999999999998654 589999
Q ss_pred cCccccccCCCCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCC
Q psy16430 393 FGTCREWNNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLP 468 (600)
Q Consensus 393 FGla~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 468 (600)
||+++........ .....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCC
Confidence 9999876332211 12234568999999988889999999999999999997 99999987776665554333 2345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 469 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.|..+|..+.+++.+||+.+|++|||+.++++++.
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 57788999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.70 Aligned_cols=246 Identities=33% Similarity=0.586 Sum_probs=208.2
Q ss_pred ccccccccccccccCCCCcceEEEeEee-------ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
|+++.++|++.+.||+|+||.||+|..+ +..||+|.+... +.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 7888999999999999999999998753 357999987522 3468889999999999999999998
Q ss_pred CCceeEEEeeeccccchhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCcee
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDG----------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~----------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
....|+||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 89999999999999999998642 22456778899999999999999999999999999999999999999
Q ss_pred eccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCC
Q psy16430 391 SDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLH 466 (600)
Q Consensus 391 ~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~ 466 (600)
+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+.......+..+. .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-Y 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C
Confidence 99999876543221 112345678999999988889999999999999999998 899999887776665554433 2
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.+.+..+++.+.+++.+||+.||.+|||+.++++.+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 345667889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.89 Aligned_cols=243 Identities=25% Similarity=0.435 Sum_probs=205.7
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|+. .++.||||.+.. .+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999986 468999997642 2356899999999999999999999999999999
Q ss_pred eeeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 329 EYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
||+++++|.+++. ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999988874 234588999999999999999999999999999999999999999999999999887654322
Q ss_pred -CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh--HHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 405 -KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS--SAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 405 -~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......+.........+..++..+.++|
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV 241 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 2235688999999999888899999999999999999999999965432 3444444443333333456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+||..+|.+|||+.++++.+.
T Consensus 242 ~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 242 SMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred HHHCCCCcccCcCHHHHHHHHH
Confidence 9999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.85 Aligned_cols=246 Identities=28% Similarity=0.498 Sum_probs=205.3
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhc-CCCCcccccceeec------CCc
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKL-NHPNIVKFKGVCTQ------APC 323 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L-~HpnIv~l~~~~~~------~~~ 323 (600)
+.+.|++.+.||.|+||.||+|... ++.||+|.+.. ....|+.+++++ +||||+++++++.. ...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 4578899999999999999999874 58899998743 235678888888 79999999999842 457
Q ss_pred eeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.|+||||+++|+|.+++.. +..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 8999999999999998865 34588888999999999999999999999999999999999999999999999876543
Q ss_pred C-CCCcccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 402 K-STKMSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 402 ~-~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
. .......|++.|+|||++. +..++.++|||||||++|+|++|..||...........+.........+..++.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCH
Confidence 2 2233467899999999975 346788999999999999999999999876655544443333322233456889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+.+||.+||+.||.+|||+.+|+.|+|+
T Consensus 254 ~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.09 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=203.7
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.++|++.+.||.|+||.||+|+.. +..||+|.++. ...+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 467999999999999999999864 68899998852 23579999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
|++ ++|.+++.. +..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 997 578887754 4568999999999999999999999999999999999999999999999999987654322 2223
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----------------C---CCC
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----------------S---LHL 467 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----------------~---~~~ 467 (600)
..+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+... . ...
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 467899999999865 45788999999999999999999999887654433221100 0 000
Q ss_pred C---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 468 P---------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 468 ~---------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+ ....+++.+++||.+||+.||.+|||++++++|+|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 11346788999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=322.49 Aligned_cols=242 Identities=24% Similarity=0.402 Sum_probs=212.0
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|+.++.||.|+||.||.++. .+..+++|.+.. .+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999988875 468899998642 245789999999999999999999999999999999
Q ss_pred eccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 331 CAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 468999999999999999999999999999999999999999999999999988764433 2334
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..+... +.+..++..+.++|.+||..
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHHHHHHHHHHccc
Confidence 67899999999998888899999999999999999999999988877777666555443 34567889999999999999
Q ss_pred CCCCCCCHHHHHHcHhh
Q psy16430 488 APSSRPSFKQILSHLDI 504 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~ 504 (600)
+|.+|||+.++++++++
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.21 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=208.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++++.||+|+||.||++... +..||+|.++. .+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999875 78999998753 234689999999999999999999999999999999
Q ss_pred eccccchhhccCC---CCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 331 CAYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 331 ~~ggsL~~~l~~~---~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
+++++|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 159 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-AK 159 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-cc
Confidence 9999999888763 378999999999999999999997 599999999999999999999999999987654332 23
Q ss_pred ccCCCccccChhhhccC------CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH---hcCCCCCCCCCCCCcHHH
Q psy16430 407 SFAGTVAWMAPEVIRNE------QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG---VGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~---i~~~~~~~~~p~~~~~~l 477 (600)
...+++.|+|||++.+. .++.++|||||||++|+|++|..||........... +.. ......+..+++++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTLPSGYSDDA 238 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-cCCCCCCcccCHHH
Confidence 34688899999998553 357899999999999999999999976554433322 222 22344566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.++|.+||+.+|.+||++.+++.|+|+....
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.68 Aligned_cols=246 Identities=30% Similarity=0.541 Sum_probs=212.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+.|+.++.||.|+||.||.|... +..||+|.+.. .+.+|+.++++++||||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 56888899999999999999864 68999998753 235688999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
++|++|.+++.. +++++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccccc
Confidence 999999998875 4689999999999999999999999999999999999999999999999999876644322 22346
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+... .....+..++..+.+++.+||+.+|
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-NPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-CCCCCchhhhHHHHHHHHHHcccCc
Confidence 788999999998888999999999999999999999999887766555444222 2334556788999999999999999
Q ss_pred CCCCCHHHHHHcHhhhhhh
Q psy16430 490 SSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~~~ 508 (600)
.+||++.+++.|+|+....
T Consensus 242 ~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 242 SFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ccCcCHHHHHhChHhhhcc
Confidence 9999999999999986653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=323.86 Aligned_cols=246 Identities=35% Similarity=0.630 Sum_probs=213.8
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|+++.++|++.+.||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++......++||
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 6788899999999999999999999865 46799998863 3467999999999999999999999888999999
Q ss_pred eeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 329 EYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999998753 3689999999999999999999999999999999999999999999999999876643211
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+.......+.. ....+.+...|..+.+++.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence 112335678999999998889999999999999999998 9999988877666665543 33455667789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcH
Q psy16430 484 CWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l 502 (600)
||..+|.+||+++++++.+
T Consensus 240 ~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 240 CWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HcccCcccCCCHHHHHHHH
Confidence 9999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.12 Aligned_cols=242 Identities=26% Similarity=0.466 Sum_probs=210.7
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|+..+.||+|+||.||++.. .+..+|+|.+.. .+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999876 468899998753 245789999999999999999999999999999999
Q ss_pred eccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccccCCCCCcc
Q psy16430 331 CAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~~~~ 407 (600)
+++++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.+ +.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9999999999753 458999999999999999999999999999999999999855 4689999999987765544445
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+.... ..+.+..++..+.+++.+||..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-FAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-CCCCCCCcCHHHHHHHHHHccC
Confidence 678999999999988888999999999999999999999998877666655554433 3355677899999999999999
Q ss_pred CCCCCCCHHHHHHcHhh
Q psy16430 488 APSSRPSFKQILSHLDI 504 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~ 504 (600)
+|.+|||+.++++||++
T Consensus 240 ~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 240 DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.68 Aligned_cols=249 Identities=35% Similarity=0.616 Sum_probs=211.8
Q ss_pred cccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccccee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVC 318 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~ 318 (600)
.|.+..++|.+.+.||+|+||.||+|... +..||+|.++. .+.+|+.+++++ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 46677789999999999999999999742 35799998753 245689999999 799999999999
Q ss_pred ecCCceeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 319 TQAPCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 319 ~~~~~~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
...+..|+||||+++|+|.+++... ..+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999999998653 23899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCC
Q psy16430 397 REWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPST 472 (600)
Q Consensus 397 ~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 472 (600)
........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....................+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 86543321 112346788999999988889999999999999999998 99999887665544444344444455667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.++.+.+++.+||+.+|++|||+.+++..+.
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 8899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=328.66 Aligned_cols=244 Identities=34% Similarity=0.565 Sum_probs=208.4
Q ss_pred ccccccccccccCCCCcceEEEeEe-------eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~-------~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
+.+.+|...+.||+|+||.||++.. .+..+|+|.+.. .+.+|+++++.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 4567889999999999999999963 246789998753 34678999999999999999999999999
Q ss_pred eeEEEeeeccccchhhccCCC---------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGE---------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~---------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
.++||||+++++|.+++...+ .+++..+..++.||+.||+|||+.|++||||||+|||+++++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 999999999999999986532 47889999999999999999999999999999999999999999
Q ss_pred eeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC
Q psy16430 389 KISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 389 kL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~ 464 (600)
+|+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999875533221 122345788999999998899999999999999999998 999998877766665554433
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
....+..+|+.+.+||.+||+.||.+||++.+|+..+
T Consensus 242 -~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 242 -ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred -cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 3455678899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=324.21 Aligned_cols=246 Identities=34% Similarity=0.613 Sum_probs=209.9
Q ss_pred ccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|+++.++|.+...||+|+||.||+|...+ ..+|+|.+.. .+.+|+.++++++|||++++++++.. ...++||
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 67778899999999999999999998754 5799998753 34579999999999999999998754 5678999
Q ss_pred eeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 329 EYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||+++++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999998653 3478899999999999999999999999999999999999999999999999976543221
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.. ....+.+...+..+.+++.+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHH
Confidence 122346778999999988889999999999999999999 9999998777666555543 33445667789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHh
Q psy16430 484 CWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~ 503 (600)
||..||.+||+++++++.+.
T Consensus 239 ~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 239 CWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HccCCcccCcCHHHHHHHHh
Confidence 99999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=331.37 Aligned_cols=248 Identities=27% Similarity=0.470 Sum_probs=210.1
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
+..++|++++.||+|+||.||++... +..||+|++.. .+.+|+++++.++||||+++++++.....+++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34578999999999999999999875 78899998642 245789999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
|||+++++|.+++...+.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~ 160 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-AD 160 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cC
Confidence 9999999999999887789999999999999999999997 599999999999999999999999999987553322 23
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH-----------HHHHHhcCCCCCCCCC-CCCc
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-----------AIIWGVGSSSLHLPIP-STCP 474 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~p-~~~~ 474 (600)
...|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.... ...++ ..++
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLPSSDFP 239 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCCchhcC
Confidence 457899999999998888999999999999999999999999865432 1222222222 12222 2378
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..+.+|+.+||+.||.+|||+.++++++|+...
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 899999999999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.95 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=214.8
Q ss_pred cccccc-cccCCCCcceEEEeEe--eceEEEeeeeccc--hHHHHHHHHhc-CCCCcccccceeec----CCceeEEEee
Q psy16430 261 ESISDL-QWLGSGAQGAVFSGKL--RSEIVAVKKVREQ--KETDIRHLRKL-NHPNIVKFKGVCTQ----APCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~-~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~--~~~Ei~~L~~L-~HpnIv~l~~~~~~----~~~~~lV~Ey 330 (600)
++|++. ++||-|-.|.|-.+.. +++.+|+|++... ..+|+++--.. .|||||.++++|.+ ..++.+|||.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 455543 6799999999988765 4789999999654 45788764444 69999999999853 4578899999
Q ss_pred eccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCceeeccCccccccCCCCC
Q psy16430 331 CAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~~~~ 405 (600)
++||.|.+.+..++ .|++.++..|++||..|+.|||+.+|.||||||+|+|.+. |..+||+|||+|+........
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L 220 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL 220 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccc
Confidence 99999999998755 5999999999999999999999999999999999999974 457999999999987766666
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCCCCCC--CCCcHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLHLPIP--STCPDGFQL 479 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p--~~~~~~l~~ 479 (600)
.+.+.||+|.|||++...+|+..+|+||+||++|-|++|.+||..... ..+..+|..+.+.+|.| +.+|+..++
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKd 300 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKD 300 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHH
Confidence 788999999999999999999999999999999999999999986543 44556677888777766 467999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQEVL 510 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~ 510 (600)
+|+.+|..+|.+|.|+.++++|||+.+....
T Consensus 301 lIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 301 LIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred HHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 9999999999999999999999999876543
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.33 Aligned_cols=251 Identities=29% Similarity=0.400 Sum_probs=210.4
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccch------HHHHHHHHhcC-C-----CCcccccceeecCCceeEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK------ETDIRHLRKLN-H-----PNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~------~~Ei~~L~~L~-H-----pnIv~l~~~~~~~~~~~lV 327 (600)
+|.+++.||+|+||.|.+|... ++.||||+++... ..|+.+|..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 7899999999999999999864 6999999997543 56899999996 3 4899999999999999999
Q ss_pred EeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC--CCceeeccCccccccCCC
Q psy16430 328 MEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK--EEAKISDFGTCREWNNKS 403 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~--~~vkL~DFGla~~~~~~~ 403 (600)
+|.+. .+|+++++.+. .++...++.++.||+.||.+||+.||||+||||+|||+... ..|||+|||.|.......
T Consensus 267 fELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v 345 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV 345 (586)
T ss_pred ehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence 99995 79999998754 68999999999999999999999999999999999999754 479999999998765543
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC--------------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------- 463 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------- 463 (600)
. ++..+..|.|||++.|.+|+.+.||||||||++||++|.+.|++.+..+.+..|..-
T Consensus 346 y--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~ 423 (586)
T KOG0667|consen 346 Y--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT 423 (586)
T ss_pred e--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence 3 778899999999999999999999999999999999999999998875554422110
Q ss_pred C------------------------------CCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 464 S------------------------------LHLPIP-----------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 464 ~------------------------------~~~~~p-----------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
. ...-.| ..-...+.+||++||..||.+|+|+.++|+||
T Consensus 424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence 0 000011 01134689999999999999999999999999
Q ss_pred hhhhhhhhccCCC
Q psy16430 503 DIASQEVLRIQPE 515 (600)
Q Consensus 503 ~~~~~~~~~~~~~ 515 (600)
|+...........
T Consensus 504 fl~~~~~~~~~~~ 516 (586)
T KOG0667|consen 504 FLTGTSLERRNQS 516 (586)
T ss_pred ccccccccccCCC
Confidence 9987665544433
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=325.92 Aligned_cols=267 Identities=28% Similarity=0.452 Sum_probs=236.0
Q ss_pred cccccccccccccCCCCcceEEEeEe--eceEEEeeeeccch----------HHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQK----------ETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~----------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+..++|..++.||+|.||.|.+++- .++.+|+|++++.. ..|-++|+..+||.+..+.-.|+....+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678999999999999999999875 47999999997643 2467889999999999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~ 403 (600)
|+||||+.||.|.-++.+.+.|++...+.+...|+.||.|||+++||.||||.+|+|++.+|.+||+|||+++.-- ...
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999998643 344
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
...+++|||.|.|||++....|+.++|.|.+||++|||++|+.||...+...+...|....+. +|..++++.+.|+..
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k--FPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK--FPRTLSPEAKTLLSG 401 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc--CCccCCHHHHHHHHH
Confidence 556899999999999999999999999999999999999999999999988887777666554 578999999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHcHhhhhhhh---hccCCChhhhhhHhHH
Q psy16430 484 CWSNAPSSRP-----SFKQILSHLDIASQEV---LRIQPEPYYKMQMIWK 525 (600)
Q Consensus 484 cL~~dP~~RP-----s~~elL~~l~~~~~~~---~~~~~~~~~~~~~~~~ 525 (600)
+|.+||.+|. .+.+|.+|.+|+.... ......|+|++|....
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSe 451 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSE 451 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccc
Confidence 9999999995 6899999999987643 3344566777666543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=329.95 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=199.1
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|++|.||+|+.. +..||+|+++. ...+|+.++++++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 68999998752 245789999999999999999999999999999999
Q ss_pred eccccchhhccC---CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Cc
Q psy16430 331 CAYGPLYNLLKD---GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KM 406 (600)
Q Consensus 331 ~~ggsL~~~l~~---~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 406 (600)
++ ++|.+++.. +..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 97 578777643 35689999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----------------------
Q psy16430 407 SFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS---------------------- 463 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~---------------------- 463 (600)
...+++.|+|||++.+ ..++.++|||||||++|+|+||++||.+.+.......+...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 3457899999999865 45788999999999999999999999876543322211000
Q ss_pred -----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 464 -----SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 464 -----~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.........+++++.++|++||+.||.+|||+.+|+.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00001123478899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=321.74 Aligned_cols=235 Identities=38% Similarity=0.669 Sum_probs=200.0
Q ss_pred cccCCCCcceEEEeEe--eceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 267 QWLGSGAQGAVFSGKL--RSEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
+.||+|+||.||+|+. .++.||+|.+.. .+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999986 478899998753 246789999999999999999999999999999999999999
Q ss_pred hhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc---ccCCCc
Q psy16430 337 YNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTV 412 (600)
Q Consensus 337 ~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~gt~ 412 (600)
.+++.. +..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......... ...++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 999865 3468999999999999999999999999999999999999999999999999987644321111 112345
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~ 491 (600)
.|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ....+.+..++..+.+++.+||+.+|++
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence 7999999988889999999999999999998 9999987776555544433 3344567788999999999999999999
Q ss_pred CCCHHHHHHcH
Q psy16430 492 RPSFKQILSHL 502 (600)
Q Consensus 492 RPs~~elL~~l 502 (600)
|||+.++++.+
T Consensus 240 Rps~~~~~~~l 250 (252)
T cd05084 240 RPSFSTVHQEL 250 (252)
T ss_pred CcCHHHHHHHH
Confidence 99999998765
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=330.39 Aligned_cols=247 Identities=32% Similarity=0.556 Sum_probs=210.8
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
++..+|.+.+.||+|+||.||+|+.. +..+++|.+.. .+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 34567888999999999999999743 35689998853 34678999999999999999999999999
Q ss_pred eeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE 387 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~ 387 (600)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 99999999999999998643 23788999999999999999999999999999999999999999
Q ss_pred ceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCC
Q psy16430 388 AKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSS 463 (600)
Q Consensus 388 vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~ 463 (600)
++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999999876543221 123456788999999998899999999999999999999 99999888777666655444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 464 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
. ....+..+|..+.+++.+||+.+|.+|||+.++++.+.-.
T Consensus 242 ~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 242 R-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred C-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 3 2344567889999999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=331.76 Aligned_cols=248 Identities=28% Similarity=0.496 Sum_probs=213.7
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
..+|++.+.||.|+||.||+|.. .++.||+|.+.. ...+|+.+++.++||||+++++++......|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 36799999999999999999985 468999998853 234689999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
+++++|..++.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 176 (296)
T cd06655 98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (296)
T ss_pred cCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcC
Confidence 999999998865 3589999999999999999999999999999999999999999999999999876543322 23456
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-CCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
++..|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+... ......+..+++.+.++|.+||..|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 256 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcC
Confidence 889999999998888999999999999999999999999887765544433322 2233456678899999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~~ 508 (600)
|.+|||+.+++.|+|+....
T Consensus 257 p~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 257 VEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hhhCCCHHHHhhChHhhhcc
Confidence 99999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=335.08 Aligned_cols=238 Identities=24% Similarity=0.353 Sum_probs=186.5
Q ss_pred ccccCCCCcceEEEeEee----ceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceeec--CCceeEEEeeeccc
Q psy16430 266 LQWLGSGAQGAVFSGKLR----SEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCTQ--APCYCIVMEYCAYG 334 (600)
Q Consensus 266 ~~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~~--~~~~~lV~Ey~~gg 334 (600)
..+||+|+||.||+|+.. ++.||+|.+.. ...+|+.++++++||||+++++++.. ....|+||||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 357999999999999853 47899998863 34679999999999999999998853 456899999996 5
Q ss_pred cchhhccC---------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc----CCCCCceeeccCccccccC
Q psy16430 335 PLYNLLKD---------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 335 sL~~~l~~---------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl----~~~~~vkL~DFGla~~~~~ 401 (600)
+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 77776642 1258899999999999999999999999999999999999 4557899999999987643
Q ss_pred CC----CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChH---------HHHHHh---cCC-
Q psy16430 402 KS----TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS---------AIIWGV---GSS- 463 (600)
Q Consensus 402 ~~----~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~---------~~~~~i---~~~- 463 (600)
.. ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||...... .....+ ...
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244 (317)
T ss_pred CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence 32 1234678999999999876 45889999999999999999999999753321 000000 000
Q ss_pred ------------------------CCCC--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 464 ------------------------SLHL--------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 464 ------------------------~~~~--------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.... ......+..+.+||++||+.||.+|||++|+|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred ChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 0001234578899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.88 Aligned_cols=244 Identities=34% Similarity=0.531 Sum_probs=208.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|+..+.||+|+||.||++... ++.||+|.+... +.+|++++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999876 688999987532 35688999999999999999999999999999999
Q ss_pred eccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 331 CAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TF 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cc
Confidence 9999999999765 789999999999999999999999 99999999999999999999999999998765433222 26
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC-----hHHHHHHhcCCCCCCCCCCC-CcHHHHHHHH
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD-----SSAIIWGVGSSSLHLPIPST-CPDGFQLLMK 482 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~p~~-~~~~l~~LI~ 482 (600)
.++..|+|||.+.+..++.++||||||+++|+|++|..||...+ .......+.... ....+.. +++.+.++|.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCChhhcCHHHHHHHH
Confidence 78899999999988899999999999999999999999997652 222222222222 2233333 8899999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+||..||.+|||+.+++.|+|+..
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 239 LCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHcCCCchhCcCHHHHhhCchhhc
Confidence 999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=339.55 Aligned_cols=250 Identities=30% Similarity=0.579 Sum_probs=205.8
Q ss_pred cccccccccccccccCCCCcceEEEeEe-------eceEEEeeeeccc--------hHHHHHHHHhc-CCCCccccccee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFKGVC 318 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~-------~~~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~~~~ 318 (600)
.|+++.++|++.+.||.|+||.||+|.+ .++.||||.++.. ..+|+.++.++ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 3788889999999999999999999973 3578999998632 34689999999 689999999987
Q ss_pred ec-CCceeEEEeeeccccchhhccCC------------------------------------------------------
Q psy16430 319 TQ-APCYCIVMEYCAYGPLYNLLKDG------------------------------------------------------ 343 (600)
Q Consensus 319 ~~-~~~~~lV~Ey~~ggsL~~~l~~~------------------------------------------------------ 343 (600)
.. +...++||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 54 45688999999999999887532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---Ccc
Q psy16430 344 -------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMS 407 (600)
Q Consensus 344 -------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~ 407 (600)
..++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1357778889999999999999999999999999999999999999999999876532211 112
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..++..|+|||++.+..++.++||||||+++|+|++ |..||...................+.|..+++.+.+++..||+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 345678999999988889999999999999999997 9999987654333333223333445566778899999999999
Q ss_pred cCCCCCCCHHHHHHcHhh
Q psy16430 487 NAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~ 504 (600)
.||.+|||+.+|++++..
T Consensus 321 ~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 321 GEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CChhhCcCHHHHHHHHHH
Confidence 999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=325.69 Aligned_cols=243 Identities=33% Similarity=0.552 Sum_probs=205.9
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeecc-----------------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-----------------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-----------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
+|.+.+.||.|+||.||+|.. .++.||+|.++. .+..|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356778899999999999975 468899998742 2346889999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..++||||+++++|.+++...+.++...+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999998765432
Q ss_pred C---CCcccCCCccccChhhhccCC--CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC----CCC
Q psy16430 403 S---TKMSFAGTVAWMAPEVIRNEQ--CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP----STC 473 (600)
Q Consensus 403 ~---~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p----~~~ 473 (600)
. ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.........+ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1 122356889999999987654 7899999999999999999999998766555444433333222222 346
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+..+.++|.+||..+|.+|||+.++++|+|+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.98 Aligned_cols=240 Identities=29% Similarity=0.557 Sum_probs=203.1
Q ss_pred cccccccCCCCcceEEEeEee-----ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCc-----
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPC----- 323 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~----- 323 (600)
|++.+.||+|+||.||.|... +..||+|.++.. +.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 267999988532 3468899999999999999998765443
Q ss_pred -eeEEEeeeccccchhhccC------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 324 -YCIVMEYCAYGPLYNLLKD------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 324 -~~lV~Ey~~ggsL~~~l~~------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
.++||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 7999999999999888743 235899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCC
Q psy16430 397 REWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPST 472 (600)
Q Consensus 397 ~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 472 (600)
+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+..+. ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcC
Confidence 86543321 112335678999999988889999999999999999999 999998887777666655443 4456778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
++..+.+++.+||+.||.+|||+.+++.++.
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.77 Aligned_cols=243 Identities=31% Similarity=0.546 Sum_probs=207.7
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeecc-------------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
+|+..+.||+|+||.||+|.. .++.||+|.+.. .+..|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999985 468899998852 23568999999999999999999999999999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCCC-
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKST- 404 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~- 404 (600)
||||+++++|.+++...+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998878899999999999999999999999999999999999998775 599999999877653211
Q ss_pred ----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 405 ----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 405 ----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
.....++..|+|||.+.+..++.++||||+|+++|+|++|..||..... ......+.........+...++.+
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence 1234678899999999888899999999999999999999999975442 222333333333445667788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+++.+||..+|.+|||+.++++|+|+
T Consensus 241 ~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 241 RDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 999999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.41 Aligned_cols=252 Identities=32% Similarity=0.607 Sum_probs=213.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEee---------ceEEEeeeeccc--------hHHHHHHHHhc-CCCCccccc
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
..|.++.++|.+.+.||+|+||.||+|+.. ...||+|.++.. +.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 467888899999999999999999999742 357999987632 34688899999 699999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+++......|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999989999999999999999998542 347888899999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543211 112234568999999988889999999999999999999 999998887766
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
....+... .....+..++..+.+++.+||..+|.+|||+.++++.+.-..
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 LFKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 66655443 234556788999999999999999999999999999886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=324.63 Aligned_cols=246 Identities=29% Similarity=0.532 Sum_probs=205.8
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhc-CCCCcccccceeecCC------c
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKL-NHPNIVKFKGVCTQAP------C 323 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~------~ 323 (600)
+.++|++.+.||.|+||.||+|... ++.+|+|.+.. .+.+|+.+++++ .||||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4578999999999999999999874 57899998753 346789999998 7999999999986544 4
Q ss_pred eeEEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 324 YCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
+|+||||+++++|.+++.. +..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 8999999999999988754 357899999999999999999999999999999999999999999999999998765
Q ss_pred cCCC-CCcccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCC
Q psy16430 400 NNKS-TKMSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPST 472 (600)
Q Consensus 400 ~~~~-~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~ 472 (600)
.... ......|+..|+|||++.. ..++.++|||||||++|+|++|..||...........+..... ....+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPEN 243 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhh
Confidence 4322 2234568999999999754 3467899999999999999999999987665555544433322 2222344
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
++..+.+||.+||..||.+|||+.+++.|+|+
T Consensus 244 ~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 244 WSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred cCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=330.08 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=197.0
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|+||.||+|+.. +..||+|.++. ...+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999874 68899998852 235799999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Cccc
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~ 408 (600)
+++ +|.+++.. ++.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 974 67776654 56799999999999999999999999999999999999999999999999999886543322 2234
Q ss_pred CCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCC-CCChHHHHHHhcC------------------CCCC--
Q psy16430 409 AGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYK-DVDSSAIIWGVGS------------------SSLH-- 466 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~-~~~~~~~~~~i~~------------------~~~~-- 466 (600)
.+++.|+|||++.+. .++.++|||||||++|+|+||..||. +.+.......+.. ....
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 678999999998764 46899999999999999999888854 3333222221100 0000
Q ss_pred -------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 467 -------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 467 -------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
......+++.+.++|++||+.||.+|||+.+++.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 01113467899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=325.06 Aligned_cols=249 Identities=30% Similarity=0.511 Sum_probs=206.1
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
++++.+++.....||+|+||.||+|... +..||+|.+.. .+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4455566666678999999999999864 57899998753 24578999999999999999999999999999
Q ss_pred EEeeeccccchhhccCC-CCC--CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCccccccCC
Q psy16430 327 VMEYCAYGPLYNLLKDG-EEV--PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTCREWNNK 402 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~-~~l--~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~ 402 (600)
||||+++++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999998753 445 78889999999999999999999999999999999976 679999999998765432
Q ss_pred C-CCcccCCCccccChhhhccC--CCCCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 403 S-TKMSFAGTVAWMAPEVIRNE--QCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 403 ~-~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
. ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...... ..............+|..+++.+.
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence 2 22234688999999998654 3788999999999999999999999765432 222222222334456778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+++.+||+.+|.+|||+.+++.|||+
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=327.22 Aligned_cols=244 Identities=31% Similarity=0.547 Sum_probs=210.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+.|+..+.||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++..+...|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45788899999999999999864 67899998752 245789999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence 999999998865 4689999999999999999999999999999999999999999999999999876654322 22356
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
++..|+|||++.+..++.++|||||||++|+|++|..||...........+.... ....+..++..+.++|.+||+.+|
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCCc
Confidence 8899999999998889999999999999999999999998766655554433322 233456678899999999999999
Q ss_pred CCCCCHHHHHHcHhhhh
Q psy16430 490 SSRPSFKQILSHLDIAS 506 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~ 506 (600)
.+|||+.+++.|+|+..
T Consensus 242 ~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 242 RFRPTAKELLKHKFITR 258 (277)
T ss_pred ccCcCHHHHHHhHHHHH
Confidence 99999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=322.58 Aligned_cols=243 Identities=33% Similarity=0.610 Sum_probs=209.4
Q ss_pred ccccccccccccccCCCCcceEEEeEeeceEEEeeeeccc-----hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ-----KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~-----~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
|-++.++|++.+.||+|+||.||.+...+..||+|.++.. +.+|+.++++++||||+++++++..+ ..++||||
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4456788999999999999999999988999999998643 45789999999999999999998665 47899999
Q ss_pred eccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 331 CAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 157 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--DNS 157 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--CCC
Confidence 9999999998653 357899999999999999999999999999999999999999999999999987643221 223
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..+..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+... .....+..+|+.+.+++.+||+.
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 236 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLMTSCWET 236 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcCC
Confidence 44678999999988889999999999999999998 99999988776666555443 34445677899999999999999
Q ss_pred CCCCCCCHHHHHHcH
Q psy16430 488 APSSRPSFKQILSHL 502 (600)
Q Consensus 488 dP~~RPs~~elL~~l 502 (600)
+|.+||++++++..+
T Consensus 237 ~p~~Rp~~~~l~~~l 251 (254)
T cd05083 237 EPKKRPSFHKLREKL 251 (254)
T ss_pred ChhhCcCHHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=321.80 Aligned_cols=242 Identities=26% Similarity=0.493 Sum_probs=211.3
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|+||.||.++.. ++.||+|.+.. ...+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999864 68899998742 245789999999999999999999999999999999
Q ss_pred eccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Ccc
Q psy16430 331 CAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~ 407 (600)
+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999999988653 3578999999999999999999999999999999999999999999999999876644322 123
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+. ..+.+..++..+.++|.+||+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-YPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-CCCCcccCCHHHHHHHHHHhhC
Confidence 468889999999988889999999999999999999999998877777666655444 3345677899999999999999
Q ss_pred CCCCCCCHHHHHHcHhh
Q psy16430 488 APSSRPSFKQILSHLDI 504 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~ 504 (600)
+|.+||++.+++.|+|+
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=322.94 Aligned_cols=244 Identities=28% Similarity=0.516 Sum_probs=207.4
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++.+.||.|+||+||+|.. .+..+|+|++.. ...+|+..++.++|+||+++++.+......++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999986 467899998752 235788999999999999999999999999999999
Q ss_pred eccccchhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--
Q psy16430 331 CAYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-- 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~---~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 405 (600)
+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999998753 45899999999999999999999999999999999999999999999999998776543222
Q ss_pred ---cccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCC---CCCCcHHH
Q psy16430 406 ---MSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPI---PSTCPDGF 477 (600)
Q Consensus 406 ---~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~---p~~~~~~l 477 (600)
....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+............. ..+. ...+++.+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 335689999999998776 788999999999999999999999987766554444333221 1111 13678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+++.+||..||.+|||+.+|+.||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.85 Aligned_cols=248 Identities=31% Similarity=0.610 Sum_probs=212.7
Q ss_pred cccccccccccccccCCCCcceEEEeEee---------ceEEEeeeeccc--------hHHHHHHHHhc-CCCCcccccc
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
.|++..++|.+.+.||+|+||.||+|+.. +..||+|.+... ..+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 47788899999999999999999999742 247999988532 34688999999 8999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCc
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NI 380 (600)
++......|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999998653 2467788999999999999999999999999999999
Q ss_pred ccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHH
Q psy16430 381 LIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAI 456 (600)
Q Consensus 381 Ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~ 456 (600)
+++.++.++|+|||+++....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+...+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999987643221 122345678999999988889999999999999999998 8999998887777
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...+... .....+..++..+.+|+.+||..+|.+|||+.++++.+.
T Consensus 249 ~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 249 FKLLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred HHHHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 6665443 344556788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=325.37 Aligned_cols=246 Identities=30% Similarity=0.629 Sum_probs=213.0
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
++.++|++++.||+|+||.||+|+.. ...||+|.+.. .+.+|++++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 34578999999999999999999853 36799998742 2467899999999999999999999989
Q ss_pred ceeEEEeeeccccchhhccCCC---------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeecc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGE---------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDF 393 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~---------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DF 393 (600)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999987644 6899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC--CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCC
Q psy16430 394 GTCREWNNKS--TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIP 470 (600)
Q Consensus 394 Gla~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 470 (600)
|++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+.......+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 9987543221 1223456788999999988888999999999999999999 889998877777776666666666667
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 471 ~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
..+|..+.+++.+||+.+|.+|||+.+++..+.
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.18 Aligned_cols=245 Identities=32% Similarity=0.567 Sum_probs=203.4
Q ss_pred ccccccccccccCCCCcceEEEeEeec----------------eEEEeeeeccc--------hHHHHHHHHhcCCCCccc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLRS----------------EIVAVKKVREQ--------KETDIRHLRKLNHPNIVK 313 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~~----------------~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~ 313 (600)
++..+|++.+.||+|+||.||++...+ ..||+|.++.. +.+|++++++++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 456789999999999999999987532 35899988642 456999999999999999
Q ss_pred ccceeecCCceeEEEeeeccccchhhccCC------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcc
Q psy16430 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDG------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVL 381 (600)
Q Consensus 314 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NIL 381 (600)
+++++......++||||+++++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999999988542 13678889999999999999999999999999999999
Q ss_pred cCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh--CCCCCCCCChHHH
Q psy16430 382 IGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT--CETPYKDVDSSAI 456 (600)
Q Consensus 382 l~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt--G~~Pf~~~~~~~~ 456 (600)
++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999876533221 112345778999999988889999999999999999998 7789987766555
Q ss_pred HHHhcC------CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 457 IWGVGS------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 457 ~~~i~~------~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
...+.. .......+..+|+.+.+|+.+||+.||.+|||+.+|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 443211 1122334566789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.21 Aligned_cols=241 Identities=30% Similarity=0.601 Sum_probs=205.0
Q ss_pred ccccccccCCCCcceEEEeEeec-------eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
+|++.+.||+|+||.||+|.... ..+|+|.+.. .+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998542 5688888753 24568999999999999999999999999999
Q ss_pred EEeeeccccchhhccCC------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc
Q psy16430 327 VMEYCAYGPLYNLLKDG------------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI 382 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~------------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl 382 (600)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999887532 247788999999999999999999999999999999999
Q ss_pred CCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHH
Q psy16430 383 GSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIW 458 (600)
Q Consensus 383 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~ 458 (600)
++++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999876533221 122345778999999988889999999999999999998 999998877766555
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 459 GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 459 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+. .....+.+..++..+.+++.+||+.+|.+||++.++++.+.
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 241 LLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 443 33455667788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=332.27 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=212.4
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
..+|++++.||+|+||.||+|.. .+..||+|.+.. ...+|+.+++.++||||+++++++..+...|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 37899999999999999999985 478999998853 234688999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 176 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCccc
Confidence 999999999865 4588999999999999999999999999999999999999999999999999876543322 22356
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-CCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+... ......+..++..+.+++.+||..+
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 256 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 889999999999888999999999999999999999999876654433322222 2222345678899999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~~~ 509 (600)
|.+|||+.+++.|+|+.....
T Consensus 257 p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 257 VDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred hhhCcCHHHHhcCchhccccc
Confidence 999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.81 Aligned_cols=244 Identities=33% Similarity=0.608 Sum_probs=208.9
Q ss_pred cccccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+..+|++.+.||+|+||.||+|... +..+|+|.++. .+.+|+.++++++||||+++++++..+...|
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3467889999999999999999863 24799998753 2356899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
+||||+++++|.+++... +.++..++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999998754 4689999999999999999999999999999999999999999999999999987654321
Q ss_pred C----cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 405 K----MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 405 ~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
. ....++..|+|||.+.+..++.++|||||||++|++++ |..||...+.......+... ...+.+..+|+.+.+
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAALHQ 240 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHHHH
Confidence 1 11223568999999998889999999999999999886 99999888776666655443 345666778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
++.+||+.+|.+|||+.++++.+.
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred HHHHHcccCchhCCCHHHHHHHHH
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.88 Aligned_cols=246 Identities=33% Similarity=0.628 Sum_probs=211.0
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
|+++.++|++.+.||+|+||.||+|... +..+|+|.+.. .+.+|+.++++++|+||+++++++.. ...++||
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 7888999999999999999999999864 46799998753 34578999999999999999999877 7789999
Q ss_pred eeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 329 EYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||+++++|.+++.. +..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 99999999999865 34578889999999999999999999999999999999999999999999999876543221
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....++..|+|||++.+..++.++|||||||++|++++ |..||.+.+.......+... ...+.+...+.++.+++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNIMMR 238 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCCCcccCCHHHHHHHHH
Confidence 112345678999999988889999999999999999999 99999987776666555433 3445567788999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHh
Q psy16430 484 CWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~ 503 (600)
||+.+|++||++.++++.+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 239 CWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred HcccCcccCcCHHHHHHHHh
Confidence 99999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.95 Aligned_cols=245 Identities=33% Similarity=0.541 Sum_probs=213.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++.+.||.|++|.||+|+.. ++.||+|++... +.+|+..+.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999875 689999987533 35788999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc-cc
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~ 408 (600)
+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.......... ..
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9999999999877889999999999999999999999 999999999999999999999999999988765433322 45
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC---hHHHHHHhcCCCCCCCCCCC-CcHHHHHHHHHh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD---SSAIIWGVGSSSLHLPIPST-CPDGFQLLMKMC 484 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~-~~~~l~~LI~~c 484 (600)
.++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+... .....+.. ++..+.++|.+|
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CCCCCCcccCCHHHHHHHHHH
Confidence 68899999999988889999999999999999999999998773 34444444332 23344555 899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~ 506 (600)
|..+|.+|||+.++++|+|+..
T Consensus 240 l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 240 LQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ccCChhhCCCHHHHHhCHHHHh
Confidence 9999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.42 Aligned_cols=243 Identities=32% Similarity=0.597 Sum_probs=209.8
Q ss_pred cccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+..+|++.+.||+|+||.||+|.+. +..+|+|.+.. .+.+|++++++++||||+++++++......++||||+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4568889999999999999999875 67899998764 3567999999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--Cccc
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--KMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~ 408 (600)
++++|.+++.. .+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ ....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 99999999865 35689999999999999999999999999999999999999999999999999876543221 1123
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+..+ .....+...+..+.+|+.+||+.
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~ 240 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCWKE 240 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHccc
Confidence 45678999999988889999999999999999998 99999887777766665443 23344666789999999999999
Q ss_pred CCCCCCCHHHHHHcH
Q psy16430 488 APSSRPSFKQILSHL 502 (600)
Q Consensus 488 dP~~RPs~~elL~~l 502 (600)
+|.+|||+.++++.+
T Consensus 241 ~p~~Rp~~~~~l~~l 255 (256)
T cd05112 241 RPEDRPSFSLLLHQL 255 (256)
T ss_pred ChhhCCCHHHHHHhh
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.19 Aligned_cols=244 Identities=35% Similarity=0.662 Sum_probs=208.7
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
++.++|++.+.||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 56688999999999999999999853 47899998753 2456899999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCC----------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG----------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~----------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NI 380 (600)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999998632 2367888999999999999999999999999999999
Q ss_pred ccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHH
Q psy16430 381 LIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAI 456 (600)
Q Consensus 381 Ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~ 456 (600)
+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876532211 112335678999999988899999999999999999998 8899988887777
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
...+..+.. .+.+..++..+.+||.+||+.+|.+|||+.++++.+
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 242 IYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred HHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 666655443 345677899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.41 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=210.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||.||++... ++.||+|.+... +.+|+++++.++||||+++++.+..+...|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999865 578999988532 236888999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-----
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----- 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----- 403 (600)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999886421100
Q ss_pred -----------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCC-CC
Q psy16430 404 -----------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI-PS 471 (600)
Q Consensus 404 -----------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~-p~ 471 (600)
......++..|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+.......+. +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 011245788999999998888999999999999999999999999988777666655444333222 23
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHcHhhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPS---FKQILSHLDIASQ 507 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs---~~elL~~l~~~~~ 507 (600)
.+++.+.++|.+||+.||.+||+ +.++++|+|+...
T Consensus 241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 67899999999999999999998 7999999998553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=321.45 Aligned_cols=239 Identities=32% Similarity=0.591 Sum_probs=199.0
Q ss_pred ccccccCCCCcceEEEeEeec----eEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC------Cce
Q psy16430 264 SDLQWLGSGAQGAVFSGKLRS----EIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA------PCY 324 (600)
Q Consensus 264 ~~~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~------~~~ 324 (600)
.+.+.||+|+||.||+|.+.. ..||+|.++. .+..|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 466889999999999998653 3689998742 234688899999999999999976322 246
Q ss_pred eEEEeeeccccchhhccC------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 325 CIVMEYCAYGPLYNLLKD------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999999887631 23488999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 399 WNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 399 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+..+. ..+.+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDCL 240 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCC
Confidence 643221 112345778999999998899999999999999999999 899998877766666655443 334566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
..+.++|.+||+.||.+|||+.+|++.+.
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.43 Aligned_cols=242 Identities=25% Similarity=0.444 Sum_probs=204.5
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|.. .+..+|||.+.. .+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999985 478999997642 2346899999999999999999999999999999
Q ss_pred eeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 329 EYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998763 35689999999999999999999999999999999999999999999999999876643322
Q ss_pred -CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh--HHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 405 -KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS--SAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 405 -~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
.....++..|+|||++.+..++.++||||||+++|+|++|..||.+... ......+.........+..+++.+.+++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence 2245689999999999888899999999999999999999999976543 2333333333322233456889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcH
Q psy16430 482 KMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l 502 (600)
.+||..||.+|||+.+|++.+
T Consensus 242 ~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 242 NMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred HHhcCCCcccCCCHHHHHHHH
Confidence 999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.13 Aligned_cols=245 Identities=33% Similarity=0.608 Sum_probs=203.4
Q ss_pred ccccccccccccCCCCcceEEEeEee------------------ceEEEeeeecc--------chHHHHHHHHhcCCCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR------------------SEIVAVKKVRE--------QKETDIRHLRKLNHPNI 311 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~------------------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnI 311 (600)
++.++|++.+.||+|+||.||+++.. ...||+|.++. .+.+|+.+++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 35578999999999999999998532 24689998863 23578999999999999
Q ss_pred ccccceeecCCceeEEEeeeccccchhhccCCC-----------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCc
Q psy16430 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-----------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380 (600)
Q Consensus 312 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NI 380 (600)
+++++++......++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999886532 366778999999999999999999999999999999
Q ss_pred ccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh--CCCCCCCCChHH
Q psy16430 381 LIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT--CETPYKDVDSSA 455 (600)
Q Consensus 381 Ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt--G~~Pf~~~~~~~ 455 (600)
|++.++.++|+|||++........ .....+++.|+|||+..+..++.++|||||||++|||++ |..||...+...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876543221 112334678999999888889999999999999999998 789998776655
Q ss_pred HHHHhc------CCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 456 IIWGVG------SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 456 ~~~~i~------~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
...... ......+.+..+++.+.+|+.+||+.||.+|||+.+|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 443321 11223345677889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.03 Aligned_cols=242 Identities=33% Similarity=0.577 Sum_probs=206.0
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|+||.||+|.. .+..||+|.++.. +..|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999986 4688999998532 24688999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC-----
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK----- 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~----- 405 (600)
+++++|.+++..+..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 999999999988777899999999999999999999999999999999999999999999999998876543221
Q ss_pred cccCCCccccChhhhccCC---CCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCCCCCCCCC--CCcHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQ---CSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLPIPS--TCPDGFQL 479 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~---~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~--~~~~~l~~ 479 (600)
....+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+. ......+.. ......|. .+++.+.+
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHHHHH
Confidence 1346789999999997765 78999999999999999999999976643 333333333 22333444 34899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+|.+||+.+|.+|||+.+++.|+|+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.21 Aligned_cols=243 Identities=30% Similarity=0.588 Sum_probs=204.5
Q ss_pred cccccccccccCCCCcceEEEeEee--ce----EEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SE----IVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~----~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
...+|++.+.||+|+||+||+|++. +. .||+|.++. .+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3478899999999999999999863 32 589998753 23467888999999999999999865 457
Q ss_pred eEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
+++|+|+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 799999999999999976 3568999999999999999999999999999999999999999999999999998765332
Q ss_pred CC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 404 TK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 404 ~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.. ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+... ...+.+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERLPQPPICTIDVYM 242 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCCCccCCHHHHH
Confidence 21 12234678999999988889999999999999999998 99999887766555544433 334556778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
++.+||..||++||++.+++..+.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999997764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.15 Aligned_cols=242 Identities=25% Similarity=0.460 Sum_probs=209.3
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceee--cCCceeEEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCT--QAPCYCIVM 328 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~--~~~~~~lV~ 328 (600)
+|++.+.||.|+||.||++... +..||+|.+.. ....|+.++++++||||+++++++. .....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999764 58899998752 2345889999999999999999775 345689999
Q ss_pred eeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhH-----hCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 329 EYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLH-----SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 329 Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH-----~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
||+++++|.+++.. ...+++..++.++.||+.||.||| +.+++||||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999998864 457899999999999999999999 899999999999999999999999999999877
Q ss_pred cCCCC-CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 400 NNKST-KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 400 ~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
..... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... ....+..++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-FRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-CCCCccccCHHHH
Confidence 54433 334578999999999988889999999999999999999999999887666666555443 3356778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+++.+||+.+|.+|||+.+|++||++
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=319.25 Aligned_cols=234 Identities=32% Similarity=0.596 Sum_probs=198.9
Q ss_pred ccCCCCcceEEEeEee----ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecccc
Q psy16430 268 WLGSGAQGAVFSGKLR----SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGP 335 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~----~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 335 (600)
.||+|+||.||+|.+. +..||+|.+... +.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 356999988532 357899999999999999999885 457899999999999
Q ss_pred chhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC----cccCC
Q psy16430 336 LYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK----MSFAG 410 (600)
Q Consensus 336 L~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~----~~~~g 410 (600)
|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 9999864 457899999999999999999999999999999999999999999999999998765432211 11233
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..+ ...+.|..+++++.++|.+||..+|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 578999999988889999999999999999996 99999988777666555443 3456778889999999999999999
Q ss_pred CCCCCHHHHHHcHh
Q psy16430 490 SSRPSFKQILSHLD 503 (600)
Q Consensus 490 ~~RPs~~elL~~l~ 503 (600)
++||++.+|.+.+.
T Consensus 240 ~~Rp~~~~i~~~l~ 253 (257)
T cd05115 240 EDRPNFAKVEERMR 253 (257)
T ss_pred hhCcCHHHHHHHHh
Confidence 99999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.28 Aligned_cols=244 Identities=27% Similarity=0.557 Sum_probs=203.8
Q ss_pred cccccccccccCCCCcceEEEeEee--ce----EEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SE----IVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~----~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
..++|++++.||.|+||.||+|.+. +. .+++|.+... +..|+..+++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 3468889999999999999999873 32 5788887422 2346667889999999999998754 457
Q ss_pred eEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++|+||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 899999999999999965 4578999999999999999999999999999999999999999999999999998654322
Q ss_pred C---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 404 T---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 404 ~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+..+ ...+.+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERLAQPQICTIDVYM 242 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCCCCCCCHHHHH
Confidence 1 123456778999999988889999999999999999998 99999988766655444333 344556778899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
++.+||..||++|||+.++++.+..
T Consensus 243 li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHH
Confidence 9999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.26 Aligned_cols=248 Identities=29% Similarity=0.477 Sum_probs=206.7
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhc-CCCCcccccceeecC-----C
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKL-NHPNIVKFKGVCTQA-----P 322 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~-----~ 322 (600)
.-+.++|++.+.||+|+||.||+|... ++.+|+|.+.. ....|+.+++++ +||||+++++++... .
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 334688999999999999999999864 68899998853 234688889998 899999999998643 3
Q ss_pred ceeEEEeeeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 323 CYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
..|+||||+++++|.++++ .+..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 5899999999999998875 345789999999999999999999999999999999999999999999999999886
Q ss_pred ccCCC-CCcccCCCccccChhhhccC-----CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCCCCCC
Q psy16430 399 WNNKS-TKMSFAGTVAWMAPEVIRNE-----QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPS 471 (600)
Q Consensus 399 ~~~~~-~~~~~~gt~~Y~APE~l~~~-----~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~ 471 (600)
..... ......|+..|+|||++... .++.++|||||||++|+|++|++||...+.......+.... .....+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 54332 22345688999999998543 36889999999999999999999998877655554443332 2223345
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
..+..+.++|.+||+.+|++|||+.++++|+|+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 677889999999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.96 Aligned_cols=245 Identities=30% Similarity=0.543 Sum_probs=207.0
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
+.+.|++.+.||+|+||.||+|... ++.||+|.+.. .+.+|+.+++.++||||+++++++......|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3467899999999999999999864 68999998752 23478899999999999999999999999999
Q ss_pred EEeeeccccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 327 VMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
||||+. |++.+++. ....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 999997 46666654 3456899999999999999999999999999999999999999999999999998754332
Q ss_pred cccCCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.........+..++..+.++|.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD 248 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHH
Confidence 2456888999999874 3567889999999999999999999998877666555544333222234457889999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+||+.+|.+||++.+++.|+|+...
T Consensus 249 ~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 249 SCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHhcCChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=318.01 Aligned_cols=235 Identities=32% Similarity=0.597 Sum_probs=203.6
Q ss_pred cccCCCCcceEEEeEeec-----eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLRS-----EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|++|.||+|.+.. ..||+|.+... +.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998642 36999998643 3468999999999999999999988 889999999999
Q ss_pred ccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC----Ccc
Q psy16430 334 GPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST----KMS 407 (600)
Q Consensus 334 gsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~ 407 (600)
++|.+.+.... .+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999987643 689999999999999999999999999999999999999999999999999987644221 113
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.......+.+..+|..+.+++.+||+
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWA 239 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCC
Confidence 456789999999998899999999999999999998 9999988877777666654444555667789999999999999
Q ss_pred cCCCCCCCHHHHHHcH
Q psy16430 487 NAPSSRPSFKQILSHL 502 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l 502 (600)
.+|++|||+.++++.+
T Consensus 240 ~~p~~Rps~~~~~~~l 255 (257)
T cd05040 240 HNPADRPTFAALREFL 255 (257)
T ss_pred CCcccCCCHHHHHHHh
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=321.20 Aligned_cols=243 Identities=33% Similarity=0.629 Sum_probs=207.0
Q ss_pred ccccccccccCCCCcceEEEeEeec-----eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
..+|++.+.||+|+||.||+|.... ..||+|.+.. .+..|+.++++++||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 3568889999999999999998652 4699999753 23568999999999999999999999999999
Q ss_pred EEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 327 VMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
||||+++++|.+++.. .+.++..+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 9999999999999875 456899999999999999999999999999999999999999999999999998765432221
Q ss_pred cc----c--CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 406 MS----F--AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 406 ~~----~--~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
.. . ..+..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+.. ....+.+..+|..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ 241 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPMDCPTALH 241 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCcCCCcccCCHHHH
Confidence 11 1 12457999999998899999999999999999886 9999988877766666533 344556678899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+++.+||..+|.+||++.+|+..+.
T Consensus 242 ~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 242 QLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=315.53 Aligned_cols=243 Identities=34% Similarity=0.583 Sum_probs=214.6
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC--CceeEEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA--PCYCIVM 328 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~~lV~ 328 (600)
+|++.+.||+|++|.||+|... +..|++|++... +.+|+.++++++||||+++++.+... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999876 789999988532 35689999999999999999999888 8899999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---C
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---K 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~ 405 (600)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999998877899999999999999999999999999999999999999999999999999887765543 3
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC-hHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD-SSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+........+|...+..+.++|.+|
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 240 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHh
Confidence 45678999999999988889999999999999999999999998765 34444445444455567788899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~ 504 (600)
|..||.+||++.+++.|+|+
T Consensus 241 l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 241 LRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.54 Aligned_cols=244 Identities=26% Similarity=0.443 Sum_probs=205.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|... ++.||+|.++. .+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999875 68899998752 34578999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--CCcc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~ 407 (600)
|++++++..+......+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 99988887777666779999999999999999999999999999999999999999999999999988765443 2234
Q ss_pred cCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC----------------CCC---CC
Q psy16430 408 FAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----------------SSL---HL 467 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----------------~~~---~~ 467 (600)
..++..|+|||++.+. .++.++||||||+++|+|++|.+||.+.........+.. ... ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 6688999999999887 789999999999999999999999987655433322110 000 00
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 -----------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 -----------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
..+..++..+.+||++||..+|++|||+++++.|+|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1233458899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.18 Aligned_cols=237 Identities=24% Similarity=0.372 Sum_probs=202.7
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
||+|+||+||++... ++.||+|.+... +..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 689999988531 24688999999999999999999999999999999999999
Q ss_pred hhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccc
Q psy16430 337 YNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAW 414 (600)
Q Consensus 337 ~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y 414 (600)
.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99987644 6899999999999999999999999999999999999999999999999998766543333445678899
Q ss_pred cChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q psy16430 415 MAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490 (600)
Q Consensus 415 ~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 490 (600)
+|||++.+..++.++|||||||++|+|++|+.||..... ..+...+. ......+..+++.+.++|.+||+.||.
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--EMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--cccccCCccCCHHHHHHHHHHccCChh
Confidence 999999888899999999999999999999999977543 22222211 223345667899999999999999999
Q ss_pred CCC-----CHHHHHHcHhhhhh
Q psy16430 491 SRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 491 ~RP-----s~~elL~~l~~~~~ 507 (600)
+|| ++.+++.|+|+...
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred HccCCCcccHHHHHhChhhhcC
Confidence 999 89999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.98 Aligned_cols=235 Identities=37% Similarity=0.656 Sum_probs=201.0
Q ss_pred cccCCCCcceEEEeEee--c---eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--S---EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~---~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|.+. + ..+|+|.+... +..|+.++++++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 67999998632 346889999999999999999876 4568999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc----ccC
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM----SFA 409 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~----~~~ 409 (600)
++|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||+++......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 9999999887789999999999999999999999999999999999999999999999999988664332211 122
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+... ...+.+..++..+.++|.+||..+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~ 238 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEECPQEIYSIMLSCWKYR 238 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhcCC
Confidence 3568999999988889999999999999999998 99999888776665555443 344667788999999999999999
Q ss_pred CCCCCCHHHHHHcHh
Q psy16430 489 PSSRPSFKQILSHLD 503 (600)
Q Consensus 489 P~~RPs~~elL~~l~ 503 (600)
|.+|||+.++++.+.
T Consensus 239 p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 239 PEDRPTFSELESTFR 253 (257)
T ss_pred hhhCcCHHHHHHHHH
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.42 Aligned_cols=240 Identities=33% Similarity=0.593 Sum_probs=197.2
Q ss_pred cccccccCCCCcceEEEeEe------eceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec--CCceeE
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ--APCYCI 326 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~--~~~~~l 326 (600)
|++++.||+|+||+||++.. .+..||+|.++.. +.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 3578999988632 3468999999999999999998754 346899
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
||||+++++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164 (283)
T ss_pred EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhh
Confidence 99999999999998764 599999999999999999999999999999999999999999999999999887643322
Q ss_pred --CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH--H------------HHHhcCCCCCCC
Q psy16430 405 --KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA--I------------IWGVGSSSLHLP 468 (600)
Q Consensus 405 --~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~--~------------~~~i~~~~~~~~ 468 (600)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||....... . ...........+
T Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05080 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244 (283)
T ss_pred ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCC
Confidence 112345677999999988889999999999999999999999986533210 0 001111223345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 469 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+..++..+.+++.+||+.+|++|||+++++..+.
T Consensus 245 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 245 CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 56778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.33 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=199.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeec-cchHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccch
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR-EQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLY 337 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~-~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 337 (600)
..|.+.+.||+|+||.||+|.+. ++.||||... ....+|+++|++++|||||++++++......++|||++. ++|.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~ 247 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY 247 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence 47889999999999999999875 5789999753 345789999999999999999999999999999999995 6788
Q ss_pred hhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---CcccCCCcc
Q psy16430 338 NLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVA 413 (600)
Q Consensus 338 ~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~ 413 (600)
+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... .....||+.
T Consensus 248 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 327 (461)
T PHA03211 248 TYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327 (461)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcC
Confidence 77755 35699999999999999999999999999999999999999999999999999986543221 224579999
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC--------hHHHHHHhcCCCCCC-CC---------------
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD--------SSAIIWGVGSSSLHL-PI--------------- 469 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~--------~~~~~~~i~~~~~~~-~~--------------- 469 (600)
|+|||++.+..++.++|||||||++|||++|..|+.... ...+...+....... ..
T Consensus 328 Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~ 407 (461)
T PHA03211 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHR 407 (461)
T ss_pred CcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhh
Confidence 999999999999999999999999999999876543211 122222221111100 00
Q ss_pred -----------C-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 470 -----------P-----STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 470 -----------p-----~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+ ...+..+.+||.+||+.||.+|||+.|+|+|+||..
T Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 408 AARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 123567899999999999999999999999999853
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.75 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=208.9
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+.|.....||+|+||.||++.. .+..||||.+.. .+.+|+..++.++||||+++++.+...+..|+||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 4555667899999999999986 468999998753 2457889999999999999999999999999999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccCC
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAG 410 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~g 410 (600)
++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......|
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 180 (292)
T cd06658 102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG 180 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence 99999998854 468999999999999999999999999999999999999999999999999987654322 2234568
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
+..|+|||.+.+..++.++||||||+++|||++|..||...+.......+.... ...+.....+..+.+++.+||..||
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCCh
Confidence 999999999988889999999999999999999999998877655544432221 1122234578899999999999999
Q ss_pred CCCCCHHHHHHcHhhhhhh
Q psy16430 490 SSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~~~ 508 (600)
.+|||++++++|+|+....
T Consensus 261 ~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 261 SQRATAQELLQHPFLKLAG 279 (292)
T ss_pred hHCcCHHHHhhChhhhccC
Confidence 9999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.99 Aligned_cols=247 Identities=29% Similarity=0.404 Sum_probs=200.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccch--------HHHHHH-HHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK--------ETDIRH-LRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~--------~~Ei~~-L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|+.. ++.||+|.++... ..|+.. ++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999875 6899999886432 234443 566789999999999999999999999
Q ss_pred eeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 330 YCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 330 y~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
|++ |+|.+++.. +..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 997 577666542 34689999999999999999999998 999999999999999999999999999887654333
Q ss_pred CcccCCCccccChhhhcc----CCCCCccceechhHHHHHHhhCCCCCCCCC-hHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRN----EQCSDKIDIWSYGIVLWELLTCETPYKDVD-SSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSlGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.... .......+............+|..+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 334568899999998865 456889999999999999999999997533 222222222222111122457899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+|.+||..+|.+|||+.+++.|+|+....
T Consensus 240 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 240 FVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 99999999999999999999999997753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=320.67 Aligned_cols=235 Identities=34% Similarity=0.637 Sum_probs=197.3
Q ss_pred ccCCCCcceEEEeEeec----eEEEeeeecc--------chHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeeccc
Q psy16430 268 WLGSGAQGAVFSGKLRS----EIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~~----~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
.||+|+||.||+|+..+ ..+|+|.+.. .+.+|+.+++++ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998643 3578888753 234689999999 8999999999999999999999999999
Q ss_pred cchhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 335 PLYNLLKDGE----------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 335 sL~~~l~~~~----------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
+|.+++.... .++..++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~ 161 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 161 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccc
Confidence 9999986432 478899999999999999999999999999999999999999999999999864
Q ss_pred ccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 399 WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 399 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
............+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.. ....+.+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (270)
T cd05047 162 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEV 240 (270)
T ss_pred cchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCcCCHHH
Confidence 332211222334667999999988889999999999999999997 9999988776665554433 23445566788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+++.+||..||.+|||+.+++..+.
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 241 YDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred HHHHHHHcccChhhCCCHHHHHHHHH
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.69 Aligned_cols=251 Identities=31% Similarity=0.596 Sum_probs=213.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEee---------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccc
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
..|++...+|++.+.||+|+||.||+|+.. ...||+|.++. .+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 578888889999999999999999999743 23689998753 235689999999 799999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+++......++||||+++|+|.+++... ..++..++..++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 9999999999999999999999998642 236778889999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
||++.++.++|+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999886543221 112334568999999998899999999999999999998 899999888777
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+... ...+.+..++..+.+++.+||+.+|.+|||+.+++.++.-.
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 245 LFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred HHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 66655443 34456678899999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=321.04 Aligned_cols=246 Identities=32% Similarity=0.542 Sum_probs=208.5
Q ss_pred ccccccccccccCCCCcceEEEeEee------ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec-CC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ-AP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~-~~ 322 (600)
+..++|++.+.||+|+||.||+|.+. +..||+|.+... +.+|+.++++++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 55688999999999999999999865 378999987632 3568899999999999999998755 56
Q ss_pred ceeEEEeeeccccchhhccCC--------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG--------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~--------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFG 394 (600)
..+++++|+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999999999988542 458899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCC
Q psy16430 395 TCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIP 470 (600)
Q Consensus 395 la~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 470 (600)
+++.+..... .....++..|+|||++.+..++.++|||||||++|++++ |+.||...+.......+.. ......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCCCCC
Confidence 9986543221 122345778999999988889999999999999999999 9999998777665554443 3344556
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 471 ~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
..+|+.+.+++.+||..||++|||+.+++..+.-
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 6789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=319.14 Aligned_cols=245 Identities=33% Similarity=0.616 Sum_probs=208.9
Q ss_pred ccccccccccccCCCCcceEEEeEee--c---eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--S---EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~---~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
|...+|+..+.||+|+||.||+|... + ..+|+|.+... +..|++++++++||||+++.+++......
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 44567888999999999999999864 2 37999987532 35688999999999999999999999999
Q ss_pred eEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
|+||||+++++|.+++.. .+.+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999865 4578999999999999999999999999999999999999999999999999987664322
Q ss_pred CCc----ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 404 TKM----SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 404 ~~~----~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
... ....+..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+... ...+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCHHHH
Confidence 111 1223457999999988889999999999999999997 99999887776666666443 34555677899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+++.+||+.+|.+||++.++++.+.
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.74 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=203.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|... ++.||+|.+.. .+.+|+++++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999874 68899998742 23578999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Cccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~ 408 (600)
|+++++|..+......+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 999999988877666799999999999999999999999999999999999999999999999999887543322 2235
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CCCC-
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SLHL- 467 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~- 467 (600)
.++..|+|||++.+ ..++.++||||||+++|+|++|.+||...........+... ....
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 67899999999865 45688999999999999999999999765543322211100 0000
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 ---------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 ---------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.....++..+.+|+.+||+.+|.+||++.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123568899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=319.08 Aligned_cols=242 Identities=29% Similarity=0.453 Sum_probs=209.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecC--Cce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQA--PCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~ 324 (600)
.+|++.+.||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57888999999999999999864 68899998631 235689999999999999999998654 458
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC--
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-- 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 402 (600)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 899999999999999987777999999999999999999999999999999999999999999999999999865321
Q ss_pred --CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 403 --STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 403 --~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+........+|...++.+.++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence 111235689999999999888889999999999999999999999988776666666555555566788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~ 503 (600)
|.+||+ +|..||++.+++.||+
T Consensus 242 i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred HHHHhc-CcccCccHHHHhcCCC
Confidence 999999 5799999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.61 Aligned_cols=237 Identities=25% Similarity=0.394 Sum_probs=185.4
Q ss_pred cccCCCCcceEEEeEee----ceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceee--cCCceeEEEeeecccc
Q psy16430 267 QWLGSGAQGAVFSGKLR----SEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCT--QAPCYCIVMEYCAYGP 335 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~--~~~~~~lV~Ey~~ggs 335 (600)
.+||+|+||.||+|+.. +..||+|.+.. ...+|+.++++++||||+++++++. .+...++||||+++ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence 57999999999999854 37899998864 3467999999999999999999884 45678999999974 6
Q ss_pred chhhccC---------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc----CCCCCceeeccCccccccCC
Q psy16430 336 LYNLLKD---------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 336 L~~~l~~---------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl----~~~~~vkL~DFGla~~~~~~ 402 (600)
|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 7666531 2247889999999999999999999999999999999999 45678999999999876543
Q ss_pred CC----CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHH---------HHHH----hcC--
Q psy16430 403 ST----KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA---------IIWG----VGS-- 462 (600)
Q Consensus 403 ~~----~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~---------~~~~----i~~-- 462 (600)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||.+||....... .... +..
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (317)
T cd07867 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPA 245 (317)
T ss_pred cccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCC
Confidence 21 224568999999999876 457899999999999999999999997533210 0000 000
Q ss_pred ----------------------CCCC--------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 463 ----------------------SSLH--------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 463 ----------------------~~~~--------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.... .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 246 DKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00011235678899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.28 Aligned_cols=244 Identities=31% Similarity=0.546 Sum_probs=207.2
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcC---CCCcccccceeecCCceeEEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLN---HPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~---HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.|+..+.||+|+||.||+|... +..||+|.++. .+.+|+.+++++. |||++++++++......|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778889999999999999864 68999998753 2456888888886 999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Ccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~ 407 (600)
||+++++|.+++..+ .+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence 999999999998664 789999999999999999999999999999999999999999999999999887654332 234
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCC-CCcHHHHHHHHHhh
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS-TCPDGFQLLMKMCW 485 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~l~~LI~~cL 485 (600)
..|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+..... ...+. ..+.++.+++.+||
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 239 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-PRLEDNGYSKLLREFVAACL 239 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCC-CCCCcccCCHHHHHHHHHHc
Confidence 578999999999865 4568999999999999999999999988766555443333322 22333 37889999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+||++.+++.|+|+...
T Consensus 240 ~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 240 DEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCCcccCcCHHHHhhChHhhcc
Confidence 9999999999999999999654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=314.63 Aligned_cols=242 Identities=30% Similarity=0.542 Sum_probs=213.5
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||.|+||.||++... +..||+|.+... ...|+++++.++|||++++.+.+......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999976 789999998532 34688999999999999999999999999999999
Q ss_pred eccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CC
Q psy16430 331 CAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TK 405 (600)
Q Consensus 331 ~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 405 (600)
+++++|.+++.. +..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 999999998875 3679999999999999999999999999999999999999999999999999988765443 22
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+............ ..+.+..++..+.+++.+||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 34568899999999988889999999999999999999999998877666666554443 44566788999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhh
Q psy16430 486 SNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~ 504 (600)
..+|.+|||+.+++.|+|+
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=322.08 Aligned_cols=245 Identities=30% Similarity=0.537 Sum_probs=211.5
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+-|++++.||+|+||.||+|.. .+..||+|.+.. .+.+|+.++++++||||+++++++..+...|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4577888999999999999975 368999998752 245788999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~ 409 (600)
+++++|.+++.. ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 999999998865 468999999999999999999999999999999999999999999999999987654332 122356
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.... ....+..++..+.+++.+||+.+|
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCCh
Confidence 8889999999988888999999999999999999999998877666555543332 334556788999999999999999
Q ss_pred CCCCCHHHHHHcHhhhhh
Q psy16430 490 SSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~~ 507 (600)
.+||++.+++.|+|+...
T Consensus 242 ~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 242 SFRPTAKELLKHKFIVRF 259 (277)
T ss_pred hhCcCHHHHHhCHHHhhh
Confidence 999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=364.05 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=225.1
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
......++|.+++.||+|+||.|..++.+ ++.||+|++.+ .|..|-.+|..-+.+-|++++-.|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34566799999999999999999999875 68999999864 2346778888889999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
++|+||||++||+|..++.+..++++..++.|+..|+.||.-||+.|+|||||||+|||+|..|.+||+|||.+-.+...
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999999988779999999999999999999999999999999999999999999999999999887654
Q ss_pred CC--CcccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCC
Q psy16430 403 ST--KMSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STC 473 (600)
Q Consensus 403 ~~--~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~ 473 (600)
+. ....+|||-|.|||++.. +.|++.+|+||+||++|||+.|..||...+-...+.+|.+..-.+.+| ..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 43 235789999999999853 568899999999999999999999999988888888888875445555 668
Q ss_pred cHHHHHHHHHhhhcCCCCCCC---HHHHHHcHhhhhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPS---FKQILSHLDIASQEV 509 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs---~~elL~~l~~~~~~~ 509 (600)
|+..++||.+++. +|..|.. ++++-.||||.+..+
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 9999999999765 6889988 999999999987543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.99 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=204.5
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc------------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
+|++.+.||.|+||.||+|... ++.||+|.++.. ...|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999864 689999998532 23588999999999999999999999999999
Q ss_pred EeeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-C
Q psy16430 328 MEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-K 405 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 405 (600)
|||+ +++|.+++.... .+++..+..++.||++||.|||++||+||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999998765 799999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-------------C------
Q psy16430 406 MSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-------------L------ 465 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-------------~------ 465 (600)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+.......+.... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 23456888999999854 467899999999999999999988887766543332221100 0
Q ss_pred --CC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 466 --HL-----PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 466 --~~-----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
.. ......+..+.++|.+||..||.+|||+.+++.|+|+.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 00 011345788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=338.71 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=210.9
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc---------chHHHHHHHHhc-CCCCcccccceeecCC
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE---------QKETDIRHLRKL-NHPNIVKFKGVCTQAP 322 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~---------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~ 322 (600)
.-+.|....|+++++||+||.+.||++... .+.||+|++.. .+.+|+..|.+| .|.+||++++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 456778889999999999999999999876 47888887742 346899999999 4999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCH-HHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPP-QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~-~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+|+||||-+ .+|..+|+......+ -.++.|..|++.|+.++|..||||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 9999999764 689999987654333 5788999999999999999999999999999999 577999999999998766
Q ss_pred CCCC---cccCCCccccChhhhccC-----------CCCCccceechhHHHHHHhhCCCCCCCCC-hHHHHHHhcCCCCC
Q psy16430 402 KSTK---MSFAGTVAWMAPEVIRNE-----------QCSDKIDIWSYGIVLWELLTCETPYKDVD-SSAIIWGVGSSSLH 466 (600)
Q Consensus 402 ~~~~---~~~~gt~~Y~APE~l~~~-----------~~s~ksDIwSlGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~~ 466 (600)
..+. .+.+||+.|||||.+... +.++++||||||||||+|+.|++||.... ....+..|.+....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 5433 357899999999998542 25679999999999999999999998754 44455566666555
Q ss_pred CCCCCCCcHH-HHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 LPIPSTCPDG-FQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 ~~~p~~~~~~-l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.++|...+.. +.++|+.||..||.+|||+.++|+||++.-.
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 5666555444 9999999999999999999999999987543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=318.08 Aligned_cols=238 Identities=25% Similarity=0.383 Sum_probs=202.1
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHH-HHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRH-LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~-L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+.||+|+||.||+|... ++.||+|.++... ..|..+ ....+||||+++++++..+...|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999874 6899999986421 123333 3445899999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCcc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA 413 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~ 413 (600)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....+++.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999998878899999999999999999999999999999999999999999999999999875433 234568899
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC--CCCCCCCcHHHHHHHHHhhhcCCCC
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH--LPIPSTCPDGFQLLMKMCWSNAPSS 491 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~l~~LI~~cL~~dP~~ 491 (600)
|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...... ...+..+++.+.++|.+||+.+|++
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 238 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence 99999998888899999999999999999999999988777666555443322 2234468899999999999999999
Q ss_pred CC---CHHHHHHcHhhhhh
Q psy16430 492 RP---SFKQILSHLDIASQ 507 (600)
Q Consensus 492 RP---s~~elL~~l~~~~~ 507 (600)
|| ++++++.|+|+...
T Consensus 239 R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 239 RLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCCcHHHHHcChHhhcC
Confidence 99 55899999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.02 Aligned_cols=245 Identities=32% Similarity=0.588 Sum_probs=207.6
Q ss_pred cccccccccccccCCCCcceEEEeEeec-----eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
++..++|++.+.||+|+||.||+|.+.+ ..||+|.... .+.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 3556789999999999999999998642 3689998753 24568999999999999999999875 45
Q ss_pred eeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.|+||||+++++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 78999999999999999764 35899999999999999999999999999999999999999999999999998765433
Q ss_pred CCC--cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 STK--MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+..+. ..+.+..+|..+.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYS 239 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHH
Confidence 211 12234568999999988889999999999999999986 999998887766665554433 44567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+|.+||..+|.+|||+.+++..+.
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.75 Aligned_cols=240 Identities=25% Similarity=0.406 Sum_probs=197.2
Q ss_pred cccccccCCCCcceEEEeEe--eceEEEeeeeccch--------HHHHHHHHhcC-CCCcccccceeecC--CceeEEEe
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQK--------ETDIRHLRKLN-HPNIVKFKGVCTQA--PCYCIVME 329 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~--------~~Ei~~L~~L~-HpnIv~l~~~~~~~--~~~~lV~E 329 (600)
|++.+.||+|+||.||+|.. .+..||+|.++... ..|+.+++++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999986 46889999886421 25788888885 99999999999877 88999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
|++ ++|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +.++|+|||++............
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence 997 477777765 457899999999999999999999999999999999999999 99999999999876554444445
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC----------------CCCCCCC--
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----------------SSLHLPI-- 469 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----------------~~~~~~~-- 469 (600)
.++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.. .......
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcc
Confidence 68999999998644 5578899999999999999999999987765443322211 0000111
Q ss_pred ---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 470 ---------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 470 ---------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
...++..+.++|.+||+++|.+|||+++++.|+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 13567899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=316.08 Aligned_cols=242 Identities=26% Similarity=0.471 Sum_probs=205.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|... ++.||+|.++. ...+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999875 78999998742 2357899999999999999999999999999999
Q ss_pred eeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 329 EYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
||+++++|.+++.. +..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999988853 3458999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh--HHHHHHhcCCCCCCCCCC-CCcHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS--SAIIWGVGSSSLHLPIPS-TCPDGFQLL 480 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~-~~~~~l~~L 480 (600)
......+++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..+. ..+.|. .++..+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-YPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-CCCCChhhcCHHHHHH
Confidence 22345688999999999888899999999999999999999999965432 23333333332 233444 788899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~ 503 (600)
|.+||..+|.+|||+.+|++.+.
T Consensus 241 i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred HHHHcCCCcccCCCHHHHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=317.28 Aligned_cols=238 Identities=28% Similarity=0.406 Sum_probs=207.7
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
||.|+||.||+++.. ++.+|+|.+... ..+|++++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 699999999999975 789999988532 34678899999999999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---------CCcc
Q psy16430 337 YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS---------TKMS 407 (600)
Q Consensus 337 ~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---------~~~~ 407 (600)
.+++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999876789999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..++..|+|||.+.+..++.++||||||+++|+|++|..||...........+.......+.....++.+.+++.+||+.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 240 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence 56788999999998888899999999999999999999999988887777666654444333333489999999999999
Q ss_pred CCCCCCCH---HHHHHcHhhhh
Q psy16430 488 APSSRPSF---KQILSHLDIAS 506 (600)
Q Consensus 488 dP~~RPs~---~elL~~l~~~~ 506 (600)
+|.+|||+ .++++|+|+..
T Consensus 241 ~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 241 DPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CHhhcCCCccHHHHhcCccccC
Confidence 99999999 99999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=310.86 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=209.3
Q ss_pred cccccccccccccccccCCCCcceEEEeEe--eceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecC--
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQA-- 321 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~-- 321 (600)
++..-|+.++|.+.+.||+|||+.||+++. ++..||+|++.-. ..+|++..++++|||+++++++...+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 455668889999999999999999999983 5789999998522 34689999999999999999886433
Q ss_pred ---CceeEEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCCCCCceeec
Q psy16430 322 ---PCYCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGSKEEAKISD 392 (600)
Q Consensus 322 ---~~~~lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~~~~vkL~D 392 (600)
...||+++|...|+|.+.+.. +..+++.+++.|+.+|++||++||+.. +.||||||.|||+++.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 348999999999999998853 447999999999999999999999998 99999999999999999999999
Q ss_pred cCccccccCCCC----------CcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCC--hHHHH
Q psy16430 393 FGTCREWNNKST----------KMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVD--SSAII 457 (600)
Q Consensus 393 FGla~~~~~~~~----------~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~--~~~~~ 457 (600)
||.+....-.-. ...-..|..|.|||.+.- ...+.++|||||||+||.|+.|..||...- ...+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 999876532111 112457999999999854 456789999999999999999999996421 12233
Q ss_pred HHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 458 WGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 458 ~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.++.++.+..|....+|+.+.++|+.||+.||.+||++.+++.++.
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 3455666777777779999999999999999999999999999874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.32 Aligned_cols=235 Identities=37% Similarity=0.658 Sum_probs=200.6
Q ss_pred cccCCCCcceEEEeEee-ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccch
Q psy16430 267 QWLGSGAQGAVFSGKLR-SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLY 337 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 337 (600)
+.||+|+||.||+|... +..+|+|.+... +.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999864 578999987532 346889999999999999999999999999999999999999
Q ss_pred hhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--cccCCCccc
Q psy16430 338 NLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--MSFAGTVAW 414 (600)
Q Consensus 338 ~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~gt~~Y 414 (600)
+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......... ....++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y 160 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccc
Confidence 98865 346889999999999999999999999999999999999999999999999998754332211 122346779
Q ss_pred cChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy16430 415 MAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493 (600)
Q Consensus 415 ~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP 493 (600)
+|||++.+..++.++||||||+++|+|++ |..||.+.........+... .....+..++..+.+++.+||..+|.+||
T Consensus 161 ~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (250)
T cd05085 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRCWDYKPENRP 239 (250)
T ss_pred cCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCC
Confidence 99999988889999999999999999998 99999887776665555433 34455677899999999999999999999
Q ss_pred CHHHHHHcH
Q psy16430 494 SFKQILSHL 502 (600)
Q Consensus 494 s~~elL~~l 502 (600)
|+.++++.+
T Consensus 240 ~~~~l~~~l 248 (250)
T cd05085 240 KFSELQKEL 248 (250)
T ss_pred CHHHHHHHh
Confidence 999998865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=333.05 Aligned_cols=243 Identities=26% Similarity=0.345 Sum_probs=200.4
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC------Cc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA------PC 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~------~~ 323 (600)
.+|++.+.||+|+||.||+|.. .++.||+|.+.. ...+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 7899999999999999999986 468999998853 223689999999999999999988543 35
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
.|+||||+. ++|.+.+... ++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred EEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 799999996 5788777643 8999999999999999999999999999999999999999999999999998765544
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---------------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--------------------- 462 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--------------------- 462 (600)
......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV 252 (353)
T ss_pred CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence 44456789999999999999999999999999999999999999987654322211100
Q ss_pred --CC-C------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 463 --SS-L------------HLP-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 463 --~~-~------------~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.. . ..+ .+...++.+.++|.+||+.||.+|||+.++|.|+|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00 0 000 01234677899999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=320.32 Aligned_cols=242 Identities=32% Similarity=0.589 Sum_probs=199.4
Q ss_pred cccccccccCCCCcceEEEeEe------eceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC--Cce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA--PCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~ 324 (600)
..|++++.||+|+||.||+++. .+..||+|.++. .+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999874 357899999852 245789999999999999999998765 568
Q ss_pred eEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999998654 458999999999999999999999999999999999999999999999999998764332
Q ss_pred C----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---------------HHHHHHhcCCC
Q psy16430 404 T----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---------------SAIIWGVGSSS 464 (600)
Q Consensus 404 ~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---------------~~~~~~i~~~~ 464 (600)
. .....++..|+|||++.+..++.++|||||||++|+|+++..|+..... ......+ ...
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL-EEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-HcC
Confidence 1 1234567789999999888899999999999999999998766532110 1111111 122
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...+.+..++..+.+|+.+||+.||.+|||+++++..+.
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 234556778999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=313.37 Aligned_cols=238 Identities=38% Similarity=0.695 Sum_probs=206.2
Q ss_pred cccccccCCCCcceEEEeEeec------eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLRS------EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+++.+.||.|+||.||++.... ..||+|.+... +..|+..++.++||||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998764 78999998632 346889999999999999999999989999999
Q ss_pred eeeccccchhhccCCCC--CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 329 EYCAYGPLYNLLKDGEE--VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~--l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||+++++|.+++..... +++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999976443 8999999999999999999999999999999999999999999999999988765432211
Q ss_pred --ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 407 --SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 407 --~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
...+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+.......+.... ..+.+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHH
Confidence 2336789999999988889999999999999999998 899998877776666655443 345567789999999999
Q ss_pred hhhcCCCCCCCHHHHHHc
Q psy16430 484 CWSNAPSSRPSFKQILSH 501 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~ 501 (600)
||..||.+|||+.++++.
T Consensus 240 ~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 240 CWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HCcCChhhCcCHHHHHhh
Confidence 999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=321.22 Aligned_cols=242 Identities=29% Similarity=0.431 Sum_probs=202.0
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|+||.||+|+.. +..||+|++.. .+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 68999999853 235789999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--Ccc
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--KMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~ 407 (600)
+ +++|.+++.. ...+++.+++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999998864 45789999999999999999999999999999999999999999999999999887654331 234
Q ss_pred cCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CCCC
Q psy16430 408 FAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SLHL 467 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~ 467 (600)
..++..|+|||++.+. .++.++||||+||++|+|++|.+||.+.+.......+... ....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 5689999999998654 4689999999999999999999888776654333222110 0000
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 ---------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 ---------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
......+..+.++|++||..+|.+|||+++++.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0112457899999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.64 Aligned_cols=248 Identities=33% Similarity=0.613 Sum_probs=224.1
Q ss_pred ccccccccccccccCCCCcceEEEeEee-----ceEEEeeeec--------cchHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVR--------EQKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~--------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
-||+...+.+.+.||.|.||.|++|+.+ ...||||.++ .+|..|..+|-+++||||+++.|+.+...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 3677788889999999999999999865 3689999985 35678999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+.||+|||++|+|..+|+. .+.|+.-++..+++.|+.|++||-+.|+|||||...||||+.+-.+|++|||+++.+.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999999999976 46799999999999999999999999999999999999999999999999999998865
Q ss_pred CC-CCcccC---CCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 402 KS-TKMSFA---GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 402 ~~-~~~~~~---gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
.. ...+.. -+..|.|||.+...+++.+|||||+|++|||.++ |+.||.+.+..+++..|.. .+++|.|.+||..
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~-gyRLPpPmDCP~a 862 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ-GYRLPPPMDCPAA 862 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh-ccCCCCCCCCcHH
Confidence 44 222222 2578999999999999999999999999999887 9999999999999988854 5788999999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.+||..||++|-.+||.+.||+.++..
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 9999999999999999999999999863
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=321.86 Aligned_cols=246 Identities=29% Similarity=0.416 Sum_probs=200.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcC-CCCcccccceeecCCceeEEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.++|+..+.||+|+||.||++... +..||+|.+.. .+.+|+.++.++. ||||+++++++..+...+++|
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 467888899999999999999864 68999998853 2346888888886 999999999999888999999
Q ss_pred eeeccccchhhc-----cCCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 329 EYCAYGPLYNLL-----KDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 329 Ey~~ggsL~~~l-----~~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
||+. +++.++. .....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 9986 4554432 1246799999999999999999999985 9999999999999999999999999999876544
Q ss_pred CCCcccCCCccccChhhhccC---CCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCC---CCCCCCCCCcH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNE---QCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSS---LHLPIPSTCPD 475 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~---~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~---~~~~~p~~~~~ 475 (600)
.......|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ......+.... .....+..++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 433445689999999998765 688999999999999999999999976542 12222222221 11122235789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.+.+||.+||+.+|.+|||+++|+.|+|+..
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 9999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=353.40 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=211.2
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-c-eEEEeeeecc-------chHHHHHHHHhcC-CCCccccccee-ec--
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-S-EIVAVKKVRE-------QKETDIRHLRKLN-HPNIVKFKGVC-TQ-- 320 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~-~~vAvK~~~~-------~~~~Ei~~L~~L~-HpnIv~l~~~~-~~-- 320 (600)
..++|...++++.+.|.+|||+.||+|+.. + ..||+|++-- ...+||.+|++|+ |+|||.+++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 345666788899999999999999999975 3 7999998842 2357999999996 99999999942 11
Q ss_pred -C---CceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCCCCCceeec
Q psy16430 321 -A---PCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGSKEEAKISD 392 (600)
Q Consensus 321 -~---~~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~~~~vkL~D 392 (600)
. -.++|.||||.||+|-++++. ...|++.++++|+.|+++|+.+||... |||||||-+||||+.+|..||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 1 246899999999999999974 346999999999999999999999997 99999999999999999999999
Q ss_pred cCccccccCCCCC----------cccCCCccccChhhh---ccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH
Q psy16430 393 FGTCREWNNKSTK----------MSFAGTVAWMAPEVI---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG 459 (600)
Q Consensus 393 FGla~~~~~~~~~----------~~~~gt~~Y~APE~l---~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~ 459 (600)
||.+......... ....-|+.|+|||++ .+.++++|+|||+|||+||-||....||.+.... +
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----a 265 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----A 265 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----e
Confidence 9998754322211 113469999999986 5678899999999999999999999999876443 3
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 460 VGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 460 i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|..+.+.+|....+++.+++||+.||+.||.+||++-|++.++.....
T Consensus 266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 557788888778999999999999999999999999999999875543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=310.72 Aligned_cols=242 Identities=33% Similarity=0.587 Sum_probs=208.7
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
+|+..+.||+|++|.||++... +..+++|++... ..+|+..+++++||||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778889999999999999975 688999988543 4578999999999999999999999999999999999
Q ss_pred cccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCC
Q psy16430 333 YGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT 411 (600)
Q Consensus 333 ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt 411 (600)
+++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+.............++
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 160 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT 160 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecC
Confidence 99999998765 57999999999999999999999999999999999999999999999999998876554323456789
Q ss_pred ccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHHhhhcCCC
Q psy16430 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCWSNAPS 490 (600)
Q Consensus 412 ~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~cL~~dP~ 490 (600)
..|+|||.+.+..++.++||||||+++|+|++|..||...+............. ..+.+..++..+.++|.+||+.||.
T Consensus 161 ~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 240 (253)
T cd05122 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPE 240 (253)
T ss_pred CcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChh
Confidence 999999999888889999999999999999999999988755444444333221 2222333489999999999999999
Q ss_pred CCCCHHHHHHcHh
Q psy16430 491 SRPSFKQILSHLD 503 (600)
Q Consensus 491 ~RPs~~elL~~l~ 503 (600)
+|||+.+++.|+|
T Consensus 241 ~R~t~~~~l~~~~ 253 (253)
T cd05122 241 KRPTAEQLLKHPF 253 (253)
T ss_pred hCCCHHHHhcCCC
Confidence 9999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=324.78 Aligned_cols=248 Identities=24% Similarity=0.413 Sum_probs=210.1
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
..|.....||+|+||.||+|.. .+..||+|.+.. ...+|+.+++.++||||+++++++..+...|+||||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 3445566799999999999986 478999999742 2356889999999999999999999999999999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccCC
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAG 410 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~g 410 (600)
++++|..++.. ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ......|
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 99999987754 568999999999999999999999999999999999999999999999999987654332 2234578
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... ....+...+..+.++|.+||+.+|
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCc
Confidence 9999999999888899999999999999999999999987776655554433221 122345678899999999999999
Q ss_pred CCCCCHHHHHHcHhhhhhhh
Q psy16430 490 SSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 490 ~~RPs~~elL~~l~~~~~~~ 509 (600)
.+||++.++++|+|+.....
T Consensus 260 ~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 260 QERATAQELLDHPFLLQTGL 279 (297)
T ss_pred ccCcCHHHHhhChhhccCCC
Confidence 99999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=323.40 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=207.3
Q ss_pred cccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhc-CCCCcccccceeecC
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFKGVCTQA 321 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~~~~~~~ 321 (600)
...|.++.++|++.+.||+|+||.||+|.+. +..||||.++.. ...|+.++.+. .||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 4467788899999999999999999999986 789999998632 12355555555 599999999999999
Q ss_pred CceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
...|+||||+. +++.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999999985 467666654 4578999999999999999999997 59999999999999999999999999998876
Q ss_pred cCCCCCcccCCCccccChhhhccCC----CCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCC-CCCCCCCCC
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRNEQ----CSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSS-LHLPIPSTC 473 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~-~~~~~p~~~ 473 (600)
..........++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+.... ...+....+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence 5444334456788999999987543 78899999999999999999999976433 23333332222 222223357
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+..+.+||.+||..||.+||++.+++.|+|+...
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 8999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.91 Aligned_cols=249 Identities=30% Similarity=0.532 Sum_probs=214.5
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
..+.|+....||+|+||.||+|... +..||+|.+.. .+.+|+..++.++|+||+++++++......|+|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3467888899999999999999976 68899999863 245789999999999999999999999999999999
Q ss_pred eccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 331 CAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
+++++|.+++.... .++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 99999999998765 79999999999999999999999999999999999999999999999999887654322 12234
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..... ....+..++..+.++|.+||+.
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVK 256 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhcc
Confidence 578899999999888899999999999999999999999988776555444433322 2223344889999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~ 507 (600)
+|.+|||+.+++.|+|+...
T Consensus 257 ~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 257 DPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ChhhCcCHHHHhhChHhhcc
Confidence 99999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=323.68 Aligned_cols=243 Identities=28% Similarity=0.402 Sum_probs=201.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC--CceeEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA--PCYCIV 327 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~~lV 327 (600)
++|++.+.||.|+||.||+|... ++.+|+|.++. ...+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 67999999999999999999975 68899998852 124689999999999999999998777 889999
Q ss_pred EeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CC
Q psy16430 328 MEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TK 405 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 405 (600)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99997 5888887653 458999999999999999999999999999999999999999999999999988765432 22
Q ss_pred cccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC---------------------
Q psy16430 406 MSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS--------------------- 463 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~--------------------- 463 (600)
....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...+.......+...
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 335578899999998654 4688999999999999999999999876654433322100
Q ss_pred --------CCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 464 --------SLHLPIPST-CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 464 --------~~~~~~p~~-~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.....++.. .++.+.++|++||+.||++|||+.|++.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 001112222 58889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.89 Aligned_cols=240 Identities=22% Similarity=0.391 Sum_probs=200.0
Q ss_pred ccccccccc--CCCCcceEEEeEee--ceEEEeeeeccch--HHHHHHHHhc-CCCCcccccceeecCCceeEEEeeecc
Q psy16430 261 ESISDLQWL--GSGAQGAVFSGKLR--SEIVAVKKVREQK--ETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 261 ~~~~~~~~L--G~G~fG~Vy~a~~~--~~~vAvK~~~~~~--~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
++|.+.+.+ |+|+||.||++... +..+|+|.+.... ..|+.....+ +||||+++++++...+..|+||||+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 93 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD 93 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCC
Confidence 355555555 99999999999854 6889999986542 2244333323 799999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCCCCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~gt~ 412 (600)
++|.++++.+..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...... ....++.
T Consensus 94 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~ 170 (267)
T PHA03390 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTL 170 (267)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCC
Confidence 99999998877899999999999999999999999999999999999999888 9999999998765432 2346899
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHH----HHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI----IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
.|+|||++.+..++.++||||||+++|+|++|..||........ ..... ....+.+..+++.+.++|.+||+.+
T Consensus 171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~ 248 (267)
T PHA03390 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYN 248 (267)
T ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHHhccC
Confidence 99999999988899999999999999999999999986543321 11111 2233455678999999999999999
Q ss_pred CCCCCC-HHHHHHcHhhh
Q psy16430 489 PSSRPS-FKQILSHLDIA 505 (600)
Q Consensus 489 P~~RPs-~~elL~~l~~~ 505 (600)
|.+||+ ++++++|+|+.
T Consensus 249 p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 249 INYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hhhCCchHHHHhcCCccc
Confidence 999996 69999999985
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=321.12 Aligned_cols=242 Identities=25% Similarity=0.407 Sum_probs=199.1
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|+.++.||.|++|.||+|+.. +..||||.+.. .+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 68899998852 245799999999999999999999999999999999
Q ss_pred eccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Ccc
Q psy16430 331 CAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~ 407 (600)
+. ++|.+++.. +..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 96 578887754 45689999999999999999999999999999999999999999999999999876543222 223
Q ss_pred cCCCccccChhhhccCC-CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-CC--------------------
Q psy16430 408 FAGTVAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SL-------------------- 465 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~-~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~-------------------- 465 (600)
..+++.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+.......+... ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 45688999999886644 588999999999999999999999876553332221100 00
Q ss_pred ------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 466 ------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 466 ------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.......+++.+.++|.+||+.||.+|||+.+++.|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000123467889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.57 Aligned_cols=242 Identities=28% Similarity=0.537 Sum_probs=208.3
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|+||.||+|... +..||+|.+.. ...+|+.+++.++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999875 58899999842 235789999999999999999999999999999999
Q ss_pred eccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCCC-Cc
Q psy16430 331 CAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKST-KM 406 (600)
Q Consensus 331 ~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~-~~ 406 (600)
+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999886533 578999999999999999999999999999999999998875 469999999877654322 22
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..... .+.+...+..+.++|.+||.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNFSRDLRSLISQLFK 239 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCCCHHHHHHHHHHhc
Confidence 34689999999999888899999999999999999999999988776666655544432 34456778999999999999
Q ss_pred cCCCCCCCHHHHHHcHhh
Q psy16430 487 NAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~ 504 (600)
.+|++|||+.+++.|+|+
T Consensus 240 ~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 240 VSPRDRPSITSILKRPFL 257 (257)
T ss_pred cChhhCcCHHHHhhCCCC
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.14 Aligned_cols=251 Identities=34% Similarity=0.647 Sum_probs=224.9
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeec--eEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
..|.|+....++...++||-|.||.||.|.|+. -.||||.++++ |..|..+|+.++|||+|+++|+|..+..
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 448999999999999999999999999999984 68999999753 5678999999999999999999999999
Q ss_pred eeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
+|||+|||..|+|.++++.. ..++.-.++.++.||..|+.||..+++|||||...|+|+.++..||++|||+++....
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999999999864 3467777889999999999999999999999999999999999999999999998865
Q ss_pred CCCCc--ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 402 KSTKM--SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 402 ~~~~~--~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
...+. ...-...|.|||-+....++.++|||+|||+|||+.| |-.||++.+..+++. +....++..-|..||+.+.
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-LLEkgyRM~~PeGCPpkVY 496 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-LLEKGYRMDGPEGCPPKVY 496 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-HHhccccccCCCCCCHHHH
Confidence 43322 2344778999999999999999999999999999998 999999998877665 4466788899999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.||+.||+.+|.+||++.++-+.++
T Consensus 497 eLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred HHHHHHhcCCcccCccHHHHHHHHH
Confidence 9999999999999999999977654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.94 Aligned_cols=238 Identities=21% Similarity=0.363 Sum_probs=196.6
Q ss_pred ccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHH---HhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 268 WLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHL---RKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L---~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.||+|+||.||++... ++.+|+|.+.... .+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 6899999875321 2233333 33479999999999998899999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCc
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTV 412 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~ 412 (600)
+++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... .....|++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence 99999999887889999999999999999999999999999999999999999999999999987654332 23356899
Q ss_pred cccChhhhc-cCCCCCccceechhHHHHHHhhCCCCCCCCChHH--HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 413 AWMAPEVIR-NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA--IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 413 ~Y~APE~l~-~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~--~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
.|+|||.+. +..++.++||||+||++|+|++|..||....... ..... ........|..+++.+.++|.+||..||
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 999999986 4568899999999999999999999997543211 11111 1122344567789999999999999999
Q ss_pred CCCC-----CHHHHHHcHhhhhh
Q psy16430 490 SSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 490 ~~RP-----s~~elL~~l~~~~~ 507 (600)
.+|| |++++++|+|+...
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCC
Confidence 9999 69999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=356.85 Aligned_cols=240 Identities=29% Similarity=0.523 Sum_probs=195.4
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec----------
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ---------- 320 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~---------- 320 (600)
.+|+.+..||+||||.||+++. .|+.||||++.-. ..+|+..|.+|+|||||+++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4678889999999999999985 4899999999754 4579999999999999999754421
Q ss_pred --------------------------------------------------------------------------------
Q psy16430 321 -------------------------------------------------------------------------------- 320 (600)
Q Consensus 321 -------------------------------------------------------------------------------- 320 (600)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CceeEEEeeeccccchhhccCCCCC-CHHHHHHHHHHHHHHHHHhHhCCc
Q psy16430 321 ---------------------A--------PCYCIVMEYCAYGPLYNLLKDGEEV-PPQRLYNWARQIAAGMNYLHSKQI 370 (600)
Q Consensus 321 ---------------------~--------~~~~lV~Ey~~ggsL~~~l~~~~~l-~~~~i~~i~~qIl~aL~~LH~~gI 370 (600)
+ ..+||-||||+..++.+++..+... ....++.++++|++||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 1258899999998888888876654 577899999999999999999999
Q ss_pred cccCCCCCCcccCCCCCceeeccCcccccc-------------------CCCCCcccCCCccccChhhhccC---CCCCc
Q psy16430 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWN-------------------NKSTKMSFAGTVAWMAPEVIRNE---QCSDK 428 (600)
Q Consensus 371 vHrDIKp~NILl~~~~~vkL~DFGla~~~~-------------------~~~~~~~~~gt~~Y~APE~l~~~---~~s~k 428 (600)
|||||||.||+++.++.|||+|||+|.... +....++.+||.-|+|||++.+. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998621 01123457899999999999764 49999
Q ss_pred cceechhHHHHHHhhCCCCCCC-CChHHHHHHhcCCCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 429 IDIWSYGIVLWELLTCETPYKD-VDSSAIIWGVGSSSLHLP---IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 429 sDIwSlGviLyELltG~~Pf~~-~~~~~~~~~i~~~~~~~~---~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+|+||||+|++||+. ||.. +....++..+.++.++.+ ....+ +.-..+|+.|++.||++||||.|+|++-++
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 999999999999985 5653 344555666666655444 12222 345789999999999999999999998665
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.32 Aligned_cols=245 Identities=25% Similarity=0.436 Sum_probs=208.8
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.|...+.||+|++|.||++... +..+|+|++.. ...+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4556678999999999999854 68899998742 23568899999999999999999999999999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccCCC
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGT 411 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~gt 411 (600)
|++|.+++.. +.++...+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ......|+
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 178 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT 178 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCC
Confidence 9999999877 568999999999999999999999999999999999999999999999999887654322 22235689
Q ss_pred ccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHHhhhcCCC
Q psy16430 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCWSNAPS 490 (600)
Q Consensus 412 ~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~cL~~dP~ 490 (600)
+.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+.++|.+||+.+|.
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 258 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA 258 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChh
Confidence 999999999888899999999999999999999999988776655555443321 1122334789999999999999999
Q ss_pred CCCCHHHHHHcHhhhhh
Q psy16430 491 SRPSFKQILSHLDIASQ 507 (600)
Q Consensus 491 ~RPs~~elL~~l~~~~~ 507 (600)
+|||+.++++|+|+...
T Consensus 259 ~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 259 QRATAAELLNHPFLAKA 275 (285)
T ss_pred hCcCHHHHccCcccccC
Confidence 99999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=319.00 Aligned_cols=242 Identities=25% Similarity=0.438 Sum_probs=211.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcC-CCCcccccceeecCCceeEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV 327 (600)
++|.+.+.||+|+||.||+|... +..||+|++.. ....|+.+++++. ||||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999874 68999998854 1346788899998 99999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--- 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--- 404 (600)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998887899999999999999999999999999999999999999999999999999876543221
Q ss_pred ------------------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC
Q psy16430 405 ------------------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH 466 (600)
Q Consensus 405 ------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~ 466 (600)
.....++..|+|||++.+..++.++||||||++++++++|..||...+.......+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK--LE 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--cC
Confidence 1234578999999999888889999999999999999999999998776555554442 23
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHHcHhh
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSF----KQILSHLDI 504 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~----~elL~~l~~ 504 (600)
...|..+++.+.++|.+||+.+|.+|||+ +++++|+|+
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 35667789999999999999999999999 999999985
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.14 Aligned_cols=244 Identities=35% Similarity=0.612 Sum_probs=198.8
Q ss_pred ccccccccccCCCCcceEEEeEe------eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeec--CCce
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQ--APCY 324 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~--~~~~ 324 (600)
..+|++++.||+|+||.||++.. .+..||+|.+.. .+.+|++++++++||||+++++++.. ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35788999999999999999874 357899999853 34579999999999999999998643 4568
Q ss_pred eEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999998653 468999999999999999999999999999999999999999999999999998764332
Q ss_pred CC----cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHH---------------HHHhcCCC
Q psy16430 404 TK----MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI---------------IWGVGSSS 464 (600)
Q Consensus 404 ~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~---------------~~~i~~~~ 464 (600)
.. ....++..|+|||++.+..++.++|||||||++|||++|..|+........ ...+....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 21 112234569999999888899999999999999999998777643321110 01111222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...+.+..++..+.+|+.+||..+|++|||+.+|+..+.
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 344556778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.07 Aligned_cols=236 Identities=32% Similarity=0.608 Sum_probs=195.8
Q ss_pred cccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceee-cCCceeEEEeeec
Q psy16430 267 QWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCT-QAPCYCIVMEYCA 332 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~-~~~~~~lV~Ey~~ 332 (600)
+.||+|+||.||+|.+. ...||+|.+.. .+..|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999853 35799998743 2346888899999999999999764 4566899999999
Q ss_pred cccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-----CCc
Q psy16430 333 YGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-----TKM 406 (600)
Q Consensus 333 ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~ 406 (600)
+|+|.+++... ...+...+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999998653 346778888999999999999999999999999999999999999999999987653321 112
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
...++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+.... ..+.+..+|+.+.+++.+||
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHc
Confidence 3346778999999988889999999999999999999 577888777666555554432 34456678899999999999
Q ss_pred hcCCCCCCCHHHHHHcHh
Q psy16430 486 SNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~ 503 (600)
..+|++||++.+++..+.
T Consensus 240 ~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 240 HPKPEMRPTFSELVSRIE 257 (262)
T ss_pred CCChhhCCCHHHHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=322.78 Aligned_cols=249 Identities=28% Similarity=0.487 Sum_probs=211.0
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
..+|.+.+.||+|+||.||++.. .+..||+|.+.. .+.+|+.++++++||||+++++++......|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46888999999999999999975 467899998753 235688899999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
+++++|.+++.+. .++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 176 (293)
T cd06647 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (293)
T ss_pred CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccccc
Confidence 9999999998753 578999999999999999999999999999999999999999999999998876543322 22356
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-CCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ......+...+..+.++|.+||..+
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 256 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 889999999998888899999999999999999999999876654433332222 2222334557889999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~~~ 509 (600)
|.+||++.+++.|+|+.....
T Consensus 257 p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 257 VEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred hhhCcCHHHHhcCHHHhcCcc
Confidence 999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.10 Aligned_cols=263 Identities=29% Similarity=0.447 Sum_probs=212.9
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccchH--------HHHHHHHhc-CCCCcccccceeecCCc
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQKE--------TDIRHLRKL-NHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~--------~Ei~~L~~L-~HpnIv~l~~~~~~~~~ 323 (600)
....+.++++.+..||+|+.|.|++++.+ +...|||.+++... .++.++... ..|+||+.+|+|..+..
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 34456678889999999999999999876 49999999975431 223333332 48999999999999999
Q ss_pred eeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
+++.||.|. .-+..+++. .+++++..+-.+...++.||.||-++ ||+|||+||+|||+|..|++||||||++..+.+
T Consensus 166 V~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 VFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 999999985 345555544 56799999999999999999999975 899999999999999999999999999998877
Q ss_pred CCCCcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCC-hHHHHHHhcCCCC-CCCCCCCCcHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVD-SSAIIWGVGSSSL-HLPIPSTCPDG 476 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~-~~~~p~~~~~~ 476 (600)
+.......|-+.|||||.+.- ..|+.++||||||++++||.||..||.+.+ ..+++..+.+... .++.....|++
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~ 324 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPD 324 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHH
Confidence 777677789999999999853 467889999999999999999999999854 3444444544332 22223458999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhhhccCCChhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYY 518 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~~~~~~~~~ 518 (600)
+.+|+..||.+|+.+||.+.++|+|+++...+....+...+|
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF 366 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWF 366 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHH
Confidence 999999999999999999999999999877766555444333
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=321.39 Aligned_cols=243 Identities=26% Similarity=0.368 Sum_probs=195.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
.+|.+.+.||+|+||.||+|... +..||+|.+.. ...+|+.+++.++|+||+++++++..+...|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 67899999999999999999754 78999998853 235799999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
+. +++.+.+.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... .....
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence 96 566655543 4567888999999999999999999999999999999999999999999999987643322 22334
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcC----------------CC-----C
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGS----------------SS-----L 465 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~----------------~~-----~ 465 (600)
.+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. +....+.. .. .
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 57899999999865 45788999999999999999999999865432 11111100 00 0
Q ss_pred CCCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 466 HLPIP---------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 466 ~~~~p---------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
....+ ...+..+.+++.+|+..||.+|||+++++.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 1235789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.59 Aligned_cols=244 Identities=30% Similarity=0.589 Sum_probs=208.3
Q ss_pred cccccccccccCCCCcceEEEeEee--c----eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--S----EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~----~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
...+|++.+.||+|+||.||+|... + ..+|+|..... +.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 4478899999999999999999864 2 36899987532 3468999999999999999999877 788
Q ss_pred eEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999998763 468999999999999999999999999999999999999999999999999998765332
Q ss_pred CCc---ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 404 TKM---SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 404 ~~~---~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
... ...++..|+|||.+....++.++|||||||++||+++ |..||.+.....+...+... ...+.|..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQPPICTIDVYM 242 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCCCCCCCHHHHH
Confidence 211 1223568999999988889999999999999999998 99999988877766655543 345667778899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
++.+||..||..|||+.++++.+.-
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHH
Confidence 9999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=314.52 Aligned_cols=241 Identities=24% Similarity=0.500 Sum_probs=205.6
Q ss_pred ccccccccCCCCcceEEEeEee---ceEEEeeeeccc-----------------hHHHHHHHHh-cCCCCcccccceeec
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR---SEIVAVKKVREQ-----------------KETDIRHLRK-LNHPNIVKFKGVCTQ 320 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~-----------------~~~Ei~~L~~-L~HpnIv~l~~~~~~ 320 (600)
+|++.+.||+|+||.||+|... +..+|+|.+... ...|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999875 478999987421 2346666654 799999999999999
Q ss_pred CCceeEEEeeeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
++..++||||++|++|.+++. ....+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988773 34568999999999999999999996 6899999999999999999999999999
Q ss_pred cccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 396 CREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 396 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
+.............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+............+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence 98765544344567899999999999888999999999999999999999999887776666665555444333346789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.+.++|.+||+.||++||++.++..++
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=310.39 Aligned_cols=235 Identities=37% Similarity=0.652 Sum_probs=201.5
Q ss_pred cccCCCCcceEEEeEee-ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccch
Q psy16430 267 QWLGSGAQGAVFSGKLR-SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLY 337 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 337 (600)
++||.|+||.||++... ++.||+|.+.. .+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999876 78999998753 2457899999999999999999999999999999999999999
Q ss_pred hhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC---cccCCCcc
Q psy16430 338 NLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK---MSFAGTVA 413 (600)
Q Consensus 338 ~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~ 413 (600)
+++.. ...++...+..++.+++.||.|||++|++||||+|+||+++.++.++|+|||++......... ....++..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 160 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceec
Confidence 99865 456889999999999999999999999999999999999999999999999998765422111 11234567
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
|+|||.+.+..++.++|||||||++|+|++ |..||...........+... ...+.+..++..+.+++.+||..+|.+|
T Consensus 161 y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R 239 (251)
T cd05041 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLMLQCWAYDPENR 239 (251)
T ss_pred cCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHhccChhhC
Confidence 999999988889999999999999999999 89999887765555554333 3445677889999999999999999999
Q ss_pred CCHHHHHHcH
Q psy16430 493 PSFKQILSHL 502 (600)
Q Consensus 493 Ps~~elL~~l 502 (600)
||+.++++.+
T Consensus 240 p~~~ell~~l 249 (251)
T cd05041 240 PSFSEIYNEL 249 (251)
T ss_pred cCHHHHHHHh
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.75 Aligned_cols=245 Identities=31% Similarity=0.503 Sum_probs=201.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec--CCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ--APCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~--~~~~~lV~ 328 (600)
++|...+.||.|++|.||++... ++.+|+|.+.. .+.+|++++++++||||+++++++.. ...+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999874 68999998853 24578999999999999999998854 34689999
Q ss_pred eeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 329 EYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 329 Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999887642 45688999999999999999999999999999999999999999999999999876543222
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC-----hHHHHHHhcCCCC-CC--CCC--CCCc
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD-----SSAIIWGVGSSSL-HL--PIP--STCP 474 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~-----~~~~~~~i~~~~~-~~--~~p--~~~~ 474 (600)
....++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+..... .. ..+ ...+
T Consensus 161 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd06621 161 -GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239 (287)
T ss_pred -ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchH
Confidence 23467889999999988899999999999999999999999998652 2233333322111 11 111 2356
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+.+.++|.+||..+|.+|||+.+++.|+|+..
T Consensus 240 ~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 88999999999999999999999999999844
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.34 Aligned_cols=250 Identities=28% Similarity=0.403 Sum_probs=204.7
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC--Ccee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA--PCYC 325 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~~ 325 (600)
+.++|++.+.||.|+||.||+|... ++.||+|.++.. ..+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3478999999999999999999864 689999998521 34799999999999999999998654 4689
Q ss_pred EEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999997 478777764 46789999999999999999999999999999999999999999999999999987654322
Q ss_pred -CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-----------------
Q psy16430 405 -KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL----------------- 465 (600)
Q Consensus 405 -~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~----------------- 465 (600)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 223345788999999865 5678999999999999999999999988776655443322100
Q ss_pred CCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 466 HLPIP-----------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 466 ~~~~p-----------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
....+ ...++.+.++|.+||+.||.+|||+++++.|+|+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 00000 124788999999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.86 Aligned_cols=237 Identities=20% Similarity=0.331 Sum_probs=198.5
Q ss_pred ccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHH---HHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 268 WLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDI---RHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei---~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.||+|+||.||+|... ++.||+|.+.... ..|. ..++...||||+.+++++......|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999864 6899999875321 1232 33445689999999999999999999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCc
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTV 412 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~ 412 (600)
|++|..++...+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....... .....|+.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence 99999999877889999999999999999999999999999999999999999999999999987654322 23457899
Q ss_pred cccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCC---hHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 413 AWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVD---SSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 413 ~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
.|+|||++.+. .++.++||||+||++|+|++|..||.+.. ........ .......|..++..+.+++.+||..+
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGLLQRD 237 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHHhhcC
Confidence 99999998754 68899999999999999999999998763 22222222 12234566778999999999999999
Q ss_pred CCCCC-----CHHHHHHcHhhhhh
Q psy16430 489 PSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RP-----s~~elL~~l~~~~~ 507 (600)
|.+|| ++.++++|+|+...
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccCC
Confidence 99999 99999999999664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.22 Aligned_cols=240 Identities=31% Similarity=0.531 Sum_probs=210.2
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||.|+||.||+++.. +..+|+|.+.. ....|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999764 67899998753 224688899999999999999999999999999999
Q ss_pred eccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 331 CAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 331 ~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
+++++|.+++.. +..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 999999998865 356899999999999999999999999999999999999999999999999999876554 223
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..... .+.+..++.++.+++.+||+
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-PPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCchhhCHHHHHHHHHHcC
Confidence 45688999999999988899999999999999999999999998887666665554433 34556788999999999999
Q ss_pred cCCCCCCCHHHHHHcHh
Q psy16430 487 NAPSSRPSFKQILSHLD 503 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~ 503 (600)
.+|.+|||+.++++||.
T Consensus 239 ~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 239 VKPKLRPNCDKILASPA 255 (256)
T ss_pred CCcccCCCHHHHhcCCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.85 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=223.4
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
...|.+...||+|.|+.|.+|++. +..||||.+.+. ..+|+++|..|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 357888999999999999999864 789999998643 357999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||+.+|.+++++.+.+.+.+..+..++.|++.|++|||+++|||||||++|||++.+.++||+|||++..+.......++
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~ 214 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTF 214 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999877777889
Q ss_pred CCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+.+-......+..+.++. |-..+.++.++|+++|..
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI--p~~ms~dce~lLrk~lvl 292 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI--PFYMSCDCEDLLRKFLVL 292 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc--cceeechhHHHHHHhhcc
Confidence 99999999999999777 589999999999999999999999988776666666665554 455677899999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~ 507 (600)
+|.+|++.+++..|.|....
T Consensus 293 ~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 293 NPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred CccccCCHHHhhhhcccchh
Confidence 99999999999999997543
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.70 Aligned_cols=247 Identities=32% Similarity=0.619 Sum_probs=218.2
Q ss_pred cccccccccccccccCCCCcceEEEeEeec------eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS------EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
.+++..+.++..+.||.|-||.||.|.+.+ -.||||..+. .+..|..+|++++|||||+++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 466777888889999999999999998642 4699998864 34678999999999999999999976
Q ss_pred CCceeEEEeeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
. ..|||||+++.|.|..+++.++ .++......++.||+.||.|||+.++|||||...|||+.+...|||+|||+++.+
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 5 5789999999999999998654 6899999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCc--ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 400 NNKSTKM--SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 400 ~~~~~~~--~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
.....-. ...-+..|||||.+.-..++.+||||-|||++||++. |..||.+....+++..+.++. ++|.|..||+.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe-RlP~P~nCPp~ 620 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE-RLPCPPNCPPA 620 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC-CCCCCCCCChH
Confidence 7554322 2334678999999999999999999999999999998 999999998888887776554 78999999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+..|+.+||.++|.+||.+.+|...+.
T Consensus 621 LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 999999999999999999999877664
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.44 Aligned_cols=244 Identities=24% Similarity=0.407 Sum_probs=197.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.++|++.+.||+|++|.||+|... ++.||+|.+... ..+|+.++++++||||+++++++.+....|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368999999999999999999864 689999998532 3469999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
|+.+ +|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++...... ....
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 9974 88888765 3468999999999999999999999999999999999999999999999999987543221 1123
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHh---cCCC----------------CC
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGV---GSSS----------------LH 466 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i---~~~~----------------~~ 466 (600)
..++..|+|||++.+ ..++.++||||+|+++|+|++|..||.+... ......+ .... ..
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 356889999999865 4578999999999999999999999976552 1111110 0000 00
Q ss_pred C----C-----CCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 467 L----P-----IPSTCP--DGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 467 ~----~-----~p~~~~--~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
. + .....+ ..+.+++.+||+.+|.+|||+.+++.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0 001233 788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.81 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=202.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC-----Cce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA-----PCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~-----~~~ 324 (600)
.+|++.+.||.|+||+||+|+.. +..||||.+... ..+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 57899999999999999999864 689999987532 24688999999999999999988544 347
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-C
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-S 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~ 403 (600)
|+||||+. ++|.+++..++.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 99999996 689888888888999999999999999999999999999999999999999999999999999876443 2
Q ss_pred CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc---C-----------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG---S----------------- 462 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~---~----------------- 462 (600)
......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 2234568899999998865 468899999999999999999999997754322111100 0
Q ss_pred ------CCCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 463 ------SSLH---LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 463 ------~~~~---~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.... ......+++.+.++|++||+.+|.+|||+.++++|+|+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 01124578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=313.00 Aligned_cols=234 Identities=30% Similarity=0.578 Sum_probs=189.7
Q ss_pred ccCCCCcceEEEeEee----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecccc
Q psy16430 268 WLGSGAQGAVFSGKLR----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGP 335 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 335 (600)
.||+|+||.||+|... ...+|+|.+.. .+.+|+..++.++||||+++++.+......|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 35788887642 23468889999999999999999999999999999999999
Q ss_pred chhhccCCC-----CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---CCcc
Q psy16430 336 LYNLLKDGE-----EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS---TKMS 407 (600)
Q Consensus 336 L~~~l~~~~-----~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~ 407 (600)
|.+++.... ..++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence 999986532 24677888999999999999999999999999999999999999999999986543221 1122
Q ss_pred cCCCccccChhhhcc-------CCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhc-CCCCCC---CCCCCCcH
Q psy16430 408 FAGTVAWMAPEVIRN-------EQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVG-SSSLHL---PIPSTCPD 475 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-------~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~-~~~~~~---~~p~~~~~ 475 (600)
..+++.|+|||++.. ..++.++|||||||++|+|++ |..||...........+. ...... ..+..+++
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd05042 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSD 241 (269)
T ss_pred CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCH
Confidence 345778999999743 356789999999999999999 889998876655544432 222222 23456889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.+.+++..|| .||++|||+++|++.+
T Consensus 242 ~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 242 RWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 9999999999 5999999999999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.70 Aligned_cols=242 Identities=33% Similarity=0.569 Sum_probs=212.4
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+|++.+.||+|++|.||+|... +..||+|.+... +.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999864 578999998532 35788999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
+++++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 99999999998878899999999999999999999999999999999999999999999999999987654332 23456
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 489 (600)
++..|+|||.+.+..++.++||||||+++|+|++|..||...+........... .....+..+++.+.+++.+||..+|
T Consensus 161 ~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred cchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHHhCCh
Confidence 889999999998878899999999999999999999999887765555554433 2345677889999999999999999
Q ss_pred CCCCCHHHHHHcHhh
Q psy16430 490 SSRPSFKQILSHLDI 504 (600)
Q Consensus 490 ~~RPs~~elL~~l~~ 504 (600)
++|||+.+++.++|+
T Consensus 240 ~~R~~~~~~l~~~~~ 254 (254)
T cd06627 240 NLRPTAKQLLKHPWI 254 (254)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.59 Aligned_cols=243 Identities=29% Similarity=0.533 Sum_probs=207.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+.|+..+.||+|+||.||+|+.. +..||+|.+.. .+.+|+.++++++|||++++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45788899999999999999864 68899998852 2346889999999999999999999999999999
Q ss_pred eeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 329 EYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
||+.| +|.+.+.. ...+++.++..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++...... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~ 180 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NS 180 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---cc
Confidence 99975 67666643 566899999999999999999999999999999999999999999999999988754332 24
Q ss_pred cCCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 408 FAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 408 ~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
..|++.|+|||++. +..++.++|||||||++|+|++|..||...+.......+.........+..+++.+.++|.+|
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 56889999999974 456889999999999999999999999887766666655555444444566889999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+.+|.+||++.+++.|+|+...
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhcc
Confidence 99999999999999999998554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.08 Aligned_cols=234 Identities=29% Similarity=0.462 Sum_probs=207.8
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
||.|+||.||++... ++.+|+|.+.. ....|+.++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999875 68999998753 235688999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcccCCCcccc
Q psy16430 337 YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWM 415 (600)
Q Consensus 337 ~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~Y~ 415 (600)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 999988778999999999999999999999999999999999999999999999999998776543 2233456889999
Q ss_pred ChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy16430 416 APEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSF 495 (600)
Q Consensus 416 APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~ 495 (600)
|||...+...+.++|+||||+++|+|++|..||...+.......+.. ...+.+...+..+.++|++||..||.+||++
T Consensus 161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 99999888889999999999999999999999988776666555544 3456777789999999999999999999999
Q ss_pred ---HHHHHcHhh
Q psy16430 496 ---KQILSHLDI 504 (600)
Q Consensus 496 ---~elL~~l~~ 504 (600)
+++++|+||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=365.69 Aligned_cols=241 Identities=31% Similarity=0.526 Sum_probs=210.8
Q ss_pred cccccccCCCCcceEEEeEe--eceEEEeeeec---------cchHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVR---------EQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~---------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
++-..+||.|.||.||.|.. +|...|+|.++ +...+|..++..|+|||+|++||+-.+....+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 44557899999999999974 47889999774 23468999999999999999999999999999999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC-----c
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-----M 406 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-----~ 406 (600)
+||+|.+++..++..++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+...... .
T Consensus 1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 99999999998888888889999999999999999999999999999999999999999999999887654321 2
Q ss_pred ccCCCccccChhhhccC---CCCCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 407 SFAGTVAWMAPEVIRNE---QCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~---~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
...||+.|||||++.+. .-..++|||||||++.||+||+.||...+.. ++.+.+..+. .+++|..++.+-++||.
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-~Pq~P~~ls~~g~dFle 1475 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-KPQIPERLSSEGRDFLE 1475 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-CCCCchhhhHhHHHHHH
Confidence 47899999999999763 3457899999999999999999999987654 4555555544 56788889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.||..||..|.++.||++|-+-
T Consensus 1476 ~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred HHHhcCchhhhHHHHHHHhhcc
Confidence 9999999999999999998643
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.40 Aligned_cols=229 Identities=26% Similarity=0.436 Sum_probs=188.0
Q ss_pred ccCCCCcceEEEeEee--------------------------ceEEEeeeecc-------chHHHHHHHHhcCCCCcccc
Q psy16430 268 WLGSGAQGAVFSGKLR--------------------------SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKF 314 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~--------------------------~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l 314 (600)
.||+|+||.||+|... ...||+|.+.. .+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999998642 13588898853 23457788999999999999
Q ss_pred cceeecCCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-------
Q psy16430 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE------- 386 (600)
Q Consensus 315 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~------- 386 (600)
++++......++||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999998865 56789999999999999999999999999999999999997643
Q ss_pred CceeeccCccccccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHh-hCCCCCCCCChHHHHHHhcCCC
Q psy16430 387 EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELL-TCETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELl-tG~~Pf~~~~~~~~~~~i~~~~ 464 (600)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||..............
T Consensus 162 ~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-- 236 (274)
T cd05076 162 FIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK-- 236 (274)
T ss_pred eeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh--
Confidence 3799999987644322 22357888999998865 56789999999999999995 69999987765544332221
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
....|...++.+.++|.+||+.+|.+|||+.+|++++
T Consensus 237 -~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 237 -KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1233444567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.50 Aligned_cols=241 Identities=26% Similarity=0.397 Sum_probs=199.6
Q ss_pred cccccccCCCCcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
|++.+.||.|++|.||+|.. .+..||+|++.. .+.+|+.+++.++||||+++++++.+....|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999986 478999998752 2457999999999999999999999999999999999
Q ss_pred ccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Cccc
Q psy16430 332 AYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~ 408 (600)
+ ++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5 68998887654 689999999999999999999999999999999999999999999999999876543221 1234
Q ss_pred CCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC------------------------
Q psy16430 409 AGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS------------------------ 463 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~------------------------ 463 (600)
.+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+.......+...
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 568899999987654 5688999999999999999999999876654332221110
Q ss_pred -C--CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 464 -S--LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 464 -~--~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
. ........++..+.++|.+||+.||.+|||+++++.|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 0001124567899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=312.79 Aligned_cols=234 Identities=35% Similarity=0.629 Sum_probs=198.5
Q ss_pred ccCCCCcceEEEeEeec--------eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 268 WLGSGAQGAVFSGKLRS--------EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~~--------~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
.||+|+||.||+|+... ..+|+|.+.. .+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998642 5799998743 2357899999999999999999999999999999999
Q ss_pred ccccchhhccC-------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-----CceeeccCccccc
Q psy16430 332 AYGPLYNLLKD-------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-----EAKISDFGTCREW 399 (600)
Q Consensus 332 ~ggsL~~~l~~-------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-----~vkL~DFGla~~~ 399 (600)
++++|.+++.. ...+++.++..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 99999999853 23478899999999999999999999999999999999999877 8999999998765
Q ss_pred cCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 400 NNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 400 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+... .....+..+|.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
T cd05044 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPENCPD 240 (269)
T ss_pred ccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCcccchH
Confidence 43211 112345788999999998899999999999999999998 99999887776665554333 23455677899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.+.++|.+||..+|.+||+++++++.+
T Consensus 241 ~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 241 KIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.90 Aligned_cols=234 Identities=28% Similarity=0.537 Sum_probs=188.9
Q ss_pred ccCCCCcceEEEeEee----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecccc
Q psy16430 268 WLGSGAQGAVFSGKLR----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGP 335 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 335 (600)
.||+|+||.||+|.+. +..+|+|.++. .+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999754 35799998753 23468999999999999999999998889999999999999
Q ss_pred chhhccCC-----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---Ccc
Q psy16430 336 LYNLLKDG-----EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMS 407 (600)
Q Consensus 336 L~~~l~~~-----~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~ 407 (600)
|.+++... ...+...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ 161 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCC
Confidence 99998642 2356677888999999999999999999999999999999999999999999875433221 123
Q ss_pred cCCCccccChhhhccC-------CCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHh-cCCCCCCC---CCCCCcH
Q psy16430 408 FAGTVAWMAPEVIRNE-------QCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGV-GSSSLHLP---IPSTCPD 475 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~-------~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i-~~~~~~~~---~p~~~~~ 475 (600)
..++..|+|||++.+. .++.++||||||+++|||++ |..||............ .......+ .....++
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd05087 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSD 241 (269)
T ss_pred cCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCCh
Confidence 4577889999998542 35789999999999999996 99999877665543322 22222222 2235678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.+.++|.+|| .+|++|||+++|+..+
T Consensus 242 ~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 242 RWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred HHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 8999999999 6899999999999765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=336.90 Aligned_cols=250 Identities=33% Similarity=0.592 Sum_probs=223.4
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeec-----eEEEeeeecc--------chHHHHHHHHhcCCCCccccccee
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVC 318 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~ 318 (600)
....--|+.+.+.+.++||+|+||+|++|.|+. -.||||.++. +|.+|+.+|.+|+|||++++||+.
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV 180 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV 180 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee
Confidence 344556888999999999999999999999873 5799999863 467899999999999999999999
Q ss_pred ecCCceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 319 TQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 319 ~~~~~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
.+ ....+|||+++.|||.+.+++ ...|....+..|+.||+.||.||.++++|||||...|+|+.....|||+|||+.
T Consensus 181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence 87 667899999999999999976 446888999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccc----CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCC
Q psy16430 397 REWNNKSTKMSF----AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPS 471 (600)
Q Consensus 397 ~~~~~~~~~~~~----~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 471 (600)
+.+........+ .-...|+|||.++...++.+||||+|||+||||+| |+.||.+.....++..+. ...+++-|.
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk 338 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPK 338 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCC
Confidence 988766544332 23567999999999999999999999999999999 999999999999999887 556788999
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.||.++.++++.||..+|.+|||+..|.+...
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 99999999999999999999999999975543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=318.69 Aligned_cols=245 Identities=30% Similarity=0.538 Sum_probs=207.3
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
+...|+..+.||+|+||.||+|+.. +..+|+|.+.. .+.+|+++++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4466888899999999999999864 67899998752 23468899999999999999999999999999
Q ss_pred EEeeeccccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 327 VMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
||||+. |++.+.+. ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 999997 57776664 3456899999999999999999999999999999999999999999999999998765432
Q ss_pred cccCCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++..+.+||+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence 2356889999999974 3567889999999999999999999998876655555544444333345578899999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+||..+|.+||++.+++.|+|+...
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=310.75 Aligned_cols=229 Identities=28% Similarity=0.479 Sum_probs=189.2
Q ss_pred cccCCCCcceEEEeEeece------------EEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 267 QWLGSGAQGAVFSGKLRSE------------IVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~~~------------~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+.||+|+||.||+|...+. .+++|.+.. .+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 3689999999999987642 488887653 23468899999999999999999887 7789999
Q ss_pred eeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-------CceeeccCcccccc
Q psy16430 329 EYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-------EAKISDFGTCREWN 400 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-------~vkL~DFGla~~~~ 400 (600)
||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999997655 789999999999999999999999999999999999999887 79999999988654
Q ss_pred CCCCCcccCCCccccChhhhccC--CCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIRNE--QCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
. .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+........... . ..+......+
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~ 233 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-H--RLPMPDCAEL 233 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-C--CCCCCCchHH
Confidence 3 2234567889999999776 78999999999999999999 68888776543333222211 1 1222234889
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.++|.+||..+|.+|||+.++++.+
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 234 ANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.57 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=219.7
Q ss_pred cccccccccccccCCCCcceEEEeEe--eceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+..+.|+.-+.||+||||.||-++. +|+.||.|++.+. ..+|-.+|.+++.+.||.+--.|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34457788889999999999998764 5789999987432 24688999999999999999999999999
Q ss_pred eEEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|+||..|.||+|.-+|.+.+ .|++..++.++.+|+-||++||+.+||.||+||+|||+|+.|.++|+|+|+|..+...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999998887754 7999999999999999999999999999999999999999999999999999999888
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
......+||.+|||||++.+..|+.+.|.|||||+||||+.|+.||..... .++-..+.... ...+...|++.+
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~--~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP--EEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--hhcccccCHHHH
Confidence 777778999999999999999999999999999999999999999986543 23333333332 345688999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHcHhhhhhhh
Q psy16430 479 LLMKMCWSNAPSSRP-----SFKQILSHLDIASQEV 509 (600)
Q Consensus 479 ~LI~~cL~~dP~~RP-----s~~elL~~l~~~~~~~ 509 (600)
+|.+.+|.+||.+|. +++++-+||.|....+
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 999999999999996 6789999999987543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.83 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=194.9
Q ss_pred ccccccccCCCCcceEEEeEe----eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecC--Ccee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL----RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQA--PCYC 325 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~----~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~~ 325 (600)
.|++.+.||+|+||.||+|.. .+..||+|.+.. ...+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 377888999999999999986 458999999875 235689999999999999999999887 7899
Q ss_pred EEEeeeccccchhhccC-----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC----CCCceeeccCcc
Q psy16430 326 IVMEYCAYGPLYNLLKD-----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS----KEEAKISDFGTC 396 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~-----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~----~~~vkL~DFGla 396 (600)
+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 56555532 236899999999999999999999999999999999999999 899999999998
Q ss_pred ccccCCCC----CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHH---------HH----H
Q psy16430 397 REWNNKST----KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA---------II----W 458 (600)
Q Consensus 397 ~~~~~~~~----~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~---------~~----~ 458 (600)
........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+..... .. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643322 223567899999998866 457899999999999999999999998654321 00 0
Q ss_pred Hhc--------------------CCCCCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 459 GVG--------------------SSSLHLPIP-----------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 459 ~i~--------------------~~~~~~~~p-----------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+. ........+ ...+..+.+++.+||+.||.+|||+.+++.|+||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 000001111 1456789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.64 Aligned_cols=230 Identities=24% Similarity=0.449 Sum_probs=188.2
Q ss_pred cccCCCCcceEEEeEee--------------ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 267 QWLGSGAQGAVFSGKLR--------------SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--------------~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+.||+|+||.||+|++. ...||+|.+.. .+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 35899999999999743 23588898753 2345778899999999999999999988999
Q ss_pred EEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC-------ceeeccCccc
Q psy16430 326 IVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE-------AKISDFGTCR 397 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~-------vkL~DFGla~ 397 (600)
+||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888865 456899999999999999999999999999999999999987654 8999999987
Q ss_pred cccCCCCCcccCCCccccChhhhc-cCCCCCccceechhHHHHHHh-hCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIR-NEQCSDKIDIWSYGIVLWELL-TCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGviLyELl-tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
..... ....++..|+|||++. +..++.++|||||||++|+|+ +|..||............ .... ......++
T Consensus 161 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~ 234 (262)
T cd05077 161 TVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQC--MLVTPSCK 234 (262)
T ss_pred cccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCc--cCCCCChH
Confidence 55322 2346788999999986 467889999999999999998 589998876544433211 2221 22334567
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.+.+||.+||+.||.+||++.+|+.++
T Consensus 235 ~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 235 ELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.59 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=196.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcC-CCCcccccceeecCCc-----
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLN-HPNIVKFKGVCTQAPC----- 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~----- 323 (600)
++|++.+.||+|+||.||+|... ++.||+|.++. ...+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999864 68999998752 2357999999995 6999999999876655
Q ss_pred eeEEEeeeccccchhhccC-----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCccc
Q psy16430 324 YCIVMEYCAYGPLYNLLKD-----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTCR 397 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~-----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla~ 397 (600)
.|+||||+++ +|.+++.. +..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.++|+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999985 78777643 245899999999999999999999999999999999999998 8899999999987
Q ss_pred cccCCCC-CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC----CCC------
Q psy16430 398 EWNNKST-KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----SSL------ 465 (600)
Q Consensus 398 ~~~~~~~-~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----~~~------ 465 (600)
....... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 6543222 123356889999998865 4578999999999999999999999987665443332211 000
Q ss_pred ------------CC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 466 ------------HL----PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 466 ------------~~----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.. .....++..+.+||.+||..||.+|||+.+++.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 00 0013467889999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.29 Aligned_cols=241 Identities=30% Similarity=0.544 Sum_probs=203.5
Q ss_pred cccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
|...+.||+|+||.||+|+. .+..||+|.+.. ...+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999986 468999998852 234688999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccC
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
+. |++.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..... .....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~ 178 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFV 178 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcc
Confidence 96 566666643 55789999999999999999999999999999999999999999999999998764322 23457
Q ss_pred CCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 410 GTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 410 gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
|+..|+|||++. ...++.++|||||||++|+|++|..||...+.......+............++..+.+|+.+||+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 258 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence 889999999974 35678899999999999999999999988776665555544333333345677889999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+|.+||++.+++.|+|+...
T Consensus 259 ~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 259 KIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred CChhhCcCHHHHhcCcccCCC
Confidence 999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.47 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=202.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeec----CCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQ----APCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~----~~~~~ 325 (600)
.+|++.+.||.|+||.||+|... +..||+|++... ..+|+.++++++||||+++++++.. ....|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999854 789999987532 3468999999999999999998753 34689
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
+||||+. ++|.+++..++.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999996 68999988777899999999999999999999999999999999999999999999999999876543221
Q ss_pred ----CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC-----------------
Q psy16430 405 ----KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----------------- 462 (600)
Q Consensus 405 ----~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----------------- 462 (600)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 123468899999999865 4678999999999999999999999987654332211100
Q ss_pred -------CCCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 463 -------SSLHLPI-----PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 463 -------~~~~~~~-----p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
....... ....++.+.++|++||+.+|.+|||+.+++.|+|+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0000111 134688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=354.96 Aligned_cols=242 Identities=27% Similarity=0.379 Sum_probs=197.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|... ++.||+|+++. .+.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999864 68999999853 2457899999999999999999999999999999
Q ss_pred eeeccccchhhccCC-----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 329 EYCAYGPLYNLLKDG-----------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~-----------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
||++||+|.+++... ..++...+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988531 234567788999999999999999999999999999999999999999999997
Q ss_pred cccCCC-------------------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHH
Q psy16430 398 EWNNKS-------------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIW 458 (600)
Q Consensus 398 ~~~~~~-------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~ 458 (600)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..||...+......
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 652110 0112469999999999999999999999999999999999999998765544332
Q ss_pred Hhc-CCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH-HHHcH
Q psy16430 459 GVG-SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQ-ILSHL 502 (600)
Q Consensus 459 ~i~-~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~e-lL~~l 502 (600)
... ...........+|+.+.+++.+||..||.+||+..+ ++..+
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 211 111111122467899999999999999999976544 44443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.90 Aligned_cols=244 Identities=24% Similarity=0.406 Sum_probs=195.4
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCC------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAP------ 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~------ 322 (600)
.++|++.+.||+|+||.||+|... ++.||+|.+... ..+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999864 689999987421 246899999999999999999886543
Q ss_pred --ceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 323 --CYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 323 --~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
..++||||+. ++|.+.+... ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 3599999996 4777776543 46899999999999999999999999999999999999999999999999999866
Q ss_pred cCCCCC-----cccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--CCCC-----
Q psy16430 400 NNKSTK-----MSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--SSLH----- 466 (600)
Q Consensus 400 ~~~~~~-----~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--~~~~----- 466 (600)
...... ....++..|+|||.+.+. .++.++||||||+++|+|++|.+||.+.+.......+.. +...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 432211 234578899999988664 468899999999999999999999987665332211110 0000
Q ss_pred ----------CCC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 467 ----------LPI-------------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 467 ----------~~~-------------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
... +...++.+.+||.+||..||.+|||++++++|+||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 11235678899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.56 Aligned_cols=230 Identities=27% Similarity=0.434 Sum_probs=190.3
Q ss_pred cccCCCCcceEEEeEee---------ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 267 QWLGSGAQGAVFSGKLR---------SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+.||+|+||.||+|... ...||+|.+.. .+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999753 23488888753 235678899999999999999999988899999999
Q ss_pred eccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC--------ceeeccCccccccC
Q psy16430 331 CAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE--------AKISDFGTCREWNN 401 (600)
Q Consensus 331 ~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~--------vkL~DFGla~~~~~ 401 (600)
+++|+|.+++..+ ..+++..+..++.||+.||.|||+.||+||||||+||+++.++. ++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 9999999999764 45899999999999999999999999999999999999987765 69999998865432
Q ss_pred CCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhC-CCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
. ....+++.|+|||++.+ ..++.++|||||||++|+|++| ..||...+......... . ....|...+..+.+
T Consensus 161 ~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~ 234 (258)
T cd05078 161 K---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-D--RHQLPAPKWTELAN 234 (258)
T ss_pred c---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-c--cccCCCCCcHHHHH
Confidence 2 23567889999999976 4578999999999999999998 57776665544333221 2 23455667789999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l 502 (600)
+|.+||+.||++|||+++|++.+
T Consensus 235 li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 235 LINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHhccChhhCCCHHHHHHhc
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.98 Aligned_cols=244 Identities=25% Similarity=0.429 Sum_probs=205.9
Q ss_pred ccccccccCCCCcceEEEeEe-----eceEEEeeeecc-----------chHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVRE-----------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~-----------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
+|++.+.||.|+||.||.|+. .+..||+|.++. ...+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 468899998853 234688999999 599999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999987654322
Q ss_pred -CCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 404 -TKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 404 -~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ..+...+... ..+.|..+++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 238 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMSAL 238 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--CCCCCccCCHH
Confidence 2224568999999999865 3467899999999999999999999974322 2233333222 23456778999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 477 FQLLMKMCWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
+.+++.+||+.||.+|| ++++++.|+|+...
T Consensus 239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 99999999999999997 89999999998553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.67 Aligned_cols=246 Identities=27% Similarity=0.356 Sum_probs=207.1
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC-----cee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP-----CYC 325 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~-----~~~ 325 (600)
+|++.+.||.|+||.||+|+.. +..||+|++.. .+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999865 68999998753 2356899999999999999999987765 789
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-- 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 403 (600)
+||||++ ++|.+++..+..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999997 5899998887789999999999999999999999999999999999999999999999999998765443
Q ss_pred --CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC---------------
Q psy16430 404 --TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL--------------- 465 (600)
Q Consensus 404 --~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--------------- 465 (600)
......++..|+|||++.+. .++.++||||||+++|+|++|.+||.+.+.......+....-
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 12345678999999999887 789999999999999999999999988776544333221100
Q ss_pred ---------C-----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 466 ---------H-----LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 466 ---------~-----~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
. .......+..+.++|.+||+.+|.+|||+.+++.|+|+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0 001233678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.42 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=200.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||.|++|.||+|... ++.||+|.+.. .+.+|++++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999864 68899998753 23578999999999999999999999999999999
Q ss_pred eeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCccccccCCCC-C
Q psy16430 330 YCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTCREWNNKST-K 405 (600)
Q Consensus 330 y~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~-~ 405 (600)
|++ ++|.+.+.... .+++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++........ .
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 996 57777775433 3578888999999999999999999999999999999985 45799999999976543221 2
Q ss_pred cccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---CCC----------------
Q psy16430 406 MSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS---SSL---------------- 465 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~---~~~---------------- 465 (600)
....+++.|+|||++.+ ..++.++|||||||++|+|+||.+||...+.......+.. ...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 23467899999999866 4578999999999999999999999987665444332211 000
Q ss_pred ----CCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 ----HLP----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ----~~~----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
... .....++.+.+++.+||+.+|.+||++.+++.|+|+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 000 123467889999999999999999999999999998654
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.07 Aligned_cols=244 Identities=35% Similarity=0.617 Sum_probs=203.0
Q ss_pred ccccccccccCCCCcceEEEeEee------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec--CCc
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ--APC 323 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~--~~~ 323 (600)
.+.|++.+.||+|+||.||+|++. +..||+|.+.. .+.+|+++++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 367888899999999999999854 57899998853 24578999999999999999999876 567
Q ss_pred eeEEEeeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.++||||+++++|.+++.... .++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 899999999999999997644 6899999999999999999999999999999999999999999999999999876532
Q ss_pred CCC----cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH--------------HHHHhcCCC
Q psy16430 403 STK----MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA--------------IIWGVGSSS 464 (600)
Q Consensus 403 ~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~--------------~~~~i~~~~ 464 (600)
... ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 211 12334567999999988889999999999999999999999986543221 111122233
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...+.+..++..+.+++.+||+.+|.+|||+.+|++.+.
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 344556778899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=316.55 Aligned_cols=245 Identities=24% Similarity=0.417 Sum_probs=207.1
Q ss_pred cccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
|.....||+|+||.||++.. ++..||+|++.. .+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 44456799999999999986 468999998742 235688999999999999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccCCCc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~gt~ 412 (600)
++|.+++.. +.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ......|++
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 999998754 468999999999999999999999999999999999999999999999999887654322 223456889
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-CCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSNAPSS 491 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~cL~~dP~~ 491 (600)
.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+... .........++..+.+++.+||+.+|.+
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCccc
Confidence 999999998888899999999999999999999999877665544433221 1122233567889999999999999999
Q ss_pred CCCHHHHHHcHhhhhhh
Q psy16430 492 RPSFKQILSHLDIASQE 508 (600)
Q Consensus 492 RPs~~elL~~l~~~~~~ 508 (600)
||++.+++.|+|+....
T Consensus 261 R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 261 RATAAELLKHPFLAKAG 277 (292)
T ss_pred CcCHHHHhcChHHhccC
Confidence 99999999999997764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.08 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=199.8
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+|++.+.||.|++|.||+|+.. +..||+|.++. ...+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999974 68999998753 2346899999999999999999999999999999999
Q ss_pred ccccchhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Ccc
Q psy16430 332 AYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMS 407 (600)
Q Consensus 332 ~ggsL~~~l~~~---~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~ 407 (600)
++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 85 788877543 3589999999999999999999999999999999999999999999999999876543222 223
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----------------CCCCC--
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----------------SLHLP-- 468 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----------------~~~~~-- 468 (600)
..++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... .....
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 457889999999865 45688999999999999999999999877654433322110 00000
Q ss_pred ---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 469 ---------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 469 ---------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+...++..+.++|.+||+.||.+||++.++++|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112457889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=316.95 Aligned_cols=245 Identities=31% Similarity=0.567 Sum_probs=204.5
Q ss_pred cccccccccccCCCCcceEEEeEee--c----eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--S----EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~----~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
..++|+..+.||+|+||.||+|.+. + ..||+|.+... +.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3467888999999999999999863 3 35788877532 34688999999999999999998654 46
Q ss_pred eEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++|+||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 7999999999999998764 368999999999999999999999999999999999999999999999999998764332
Q ss_pred CC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 404 TK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 404 ~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.. ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ....+.+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERLPQPPICTIDVYM 242 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHH
Confidence 21 12345778999999988899999999999999999997 9999988765554444433 3344556778899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
++..||..+|++||++.+++..+...
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=313.70 Aligned_cols=241 Identities=30% Similarity=0.493 Sum_probs=199.8
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcC-CCCcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
|++.+.||+|+||.||+|... ++.||||.+... ..+|+..+++++ ||||+++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567788999999999999974 688999987542 235888899999 999999999999999999999999
Q ss_pred ccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccC
Q psy16430 332 AYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 332 ~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
+|+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence 788988887644 78999999999999999999999999999999999999999999999999998765544444567
Q ss_pred CCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---C--------------CCCCC---
Q psy16430 410 GTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS---S--------------SLHLP--- 468 (600)
Q Consensus 410 gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~---~--------------~~~~~--- 468 (600)
++..|+|||++.+ ..++.++|+||||+++|+|++|.+||...........+.. . .....
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence 8899999998754 5578999999999999999999999987665443322111 0 00000
Q ss_pred --------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 469 --------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 469 --------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.....+..+.++|++||+.+|.+|||+.+++.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 011236789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.83 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=196.9
Q ss_pred ccccccCCCCcceEEEeEeeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccc
Q psy16430 264 SDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 264 ~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
.+.+.+|.|+++.||+++.+++.||+|++.. .+.+|+.+++.++||||+++++++......+++|||+++|
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 3455567777777777777889999999853 2357899999999999999999999999999999999999
Q ss_pred cchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--------
Q psy16430 335 PLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-------- 404 (600)
Q Consensus 335 sL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-------- 404 (600)
+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 99999875 34689999999999999999999999999999999999999999999999998875532211
Q ss_pred CcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-----------------
Q psy16430 405 KMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL----------------- 465 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~----------------- 465 (600)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||..............+..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 123457788999999866 3578999999999999999999999987655433221111100
Q ss_pred ---------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 ---------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ---------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+...+..+.+|+.+||..||++|||++++++|||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 001112335678999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=321.41 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=193.9
Q ss_pred cccCCC--CcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSG--AQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G--~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
..||.| +||+||++++ .++.||+|.+.. .+.+|+.+++.++||||+++++++..+...++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999987 579999999852 234678888889999999999999999999999999999
Q ss_pred ccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC------
Q psy16430 334 GPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK------ 405 (600)
Q Consensus 334 gsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~------ 405 (600)
++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999988753 35899999999999999999999999999999999999999999999999865433211110
Q ss_pred --cccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-----------------
Q psy16430 406 --MSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS----------------- 464 (600)
Q Consensus 406 --~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~----------------- 464 (600)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+..............
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 11235667999999876 347899999999999999999999998766544332221110
Q ss_pred ----------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 ----------------------------LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ----------------------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
...+.+..+++.+.+||++||+.||.+|||+.++++|+|+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0111223467789999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=312.68 Aligned_cols=241 Identities=26% Similarity=0.417 Sum_probs=199.8
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC--CceeEEEe
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA--PCYCIVME 329 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~~~lV~E 329 (600)
|++.+.||+|+||.||+|... ++.+|+|.+... +.+|+.++++++|||++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999875 589999999643 35689999999999999999999887 88999999
Q ss_pred eeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--CCc
Q psy16430 330 YCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--TKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~ 406 (600)
|+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9974 888888664 579999999999999999999999999999999999999999999999999988765443 122
Q ss_pred ccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC--------------------
Q psy16430 407 SFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-------------------- 465 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 465 (600)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3456889999998765 4578999999999999999999999987765443332211000
Q ss_pred -CC--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 466 -HL--------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 466 -~~--------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.. .....++..+.+++++||+.+|.+||++.+++.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 0111237889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=308.40 Aligned_cols=241 Identities=29% Similarity=0.524 Sum_probs=201.6
Q ss_pred ccccccccCCCCcceEEEeEeec--eEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
+|.+.+.||+|+||.||++.... ..+++|.++. ....|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998653 3444444431 123578899999999999999999988999999
Q ss_pred Eeeeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 328 MEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
|||+++++|.+++. .+..+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999999988874 2456899999999999999999999999999999999999964 679999999987654332
Q ss_pred -CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 404 -TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 404 -~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..+. ....+..++..+.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-CCCCcchhcHHHHHHHH
Confidence 2234568899999999988888999999999999999999999998776655555544332 33456678899999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+||..+|++||++.++++|+|+
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=316.48 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=199.3
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC----
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP---- 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~---- 322 (600)
+..++|++.+.||+|+||.||+|... ++.||+|.++. ...+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999974 68899999853 2246899999999999999999986654
Q ss_pred ------ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 323 ------CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 323 ------~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
.+++||||+++ ++...+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999986 56666554 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC--CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---CCCC---
Q psy16430 396 CREWNNKST--KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS---SSLH--- 466 (600)
Q Consensus 396 a~~~~~~~~--~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~---~~~~--- 466 (600)
+........ .....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.. ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 887644321 122346788999998865 4568899999999999999999999987665433322211 0000
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 467 ----------------------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 467 ----------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
......+|..+.++|.+||+.||.+|||+.+++.|+|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00122468899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.48 Aligned_cols=247 Identities=26% Similarity=0.318 Sum_probs=202.5
Q ss_pred cccc-cccccCCCCcceEEEeEee--ceEEEeeeeccc---------------------hHHHHHHHHhcCCCCcccccc
Q psy16430 261 ESIS-DLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------------------KETDIRHLRKLNHPNIVKFKG 316 (600)
Q Consensus 261 ~~~~-~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------------------~~~Ei~~L~~L~HpnIv~l~~ 316 (600)
++|. +.+.||+|+||+||+|... ++.||+|+++.. ..+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 4567999999999999854 688999987531 347899999999999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
++......|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999997 689999887778999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC---------------CCCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHh
Q psy16430 397 REWNNK---------------STKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV 460 (600)
Q Consensus 397 ~~~~~~---------------~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i 460 (600)
...... .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+.......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 765411 111123468889999998764 4689999999999999999999999887765443322
Q ss_pred cC----CCC---------------CC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 461 GS----SSL---------------HL-------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 461 ~~----~~~---------------~~-------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.. ... .. ......++.+.++|.+||+.+|.+|||+++++.|+|+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 11 000 00 01134578899999999999999999999999999997653
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.10 Aligned_cols=234 Identities=25% Similarity=0.487 Sum_probs=187.6
Q ss_pred ccCCCCcceEEEeEeec----eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecccc
Q psy16430 268 WLGSGAQGAVFSGKLRS----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGP 335 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~~----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 335 (600)
.||+|+||.||+|+..+ ..+++|.+.. .+.+|+.+++.++||||+++++.+......|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 59999999999997532 3466776542 23567888999999999999999999999999999999999
Q ss_pred chhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC---CCCccc
Q psy16430 336 LYNLLKDG----EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK---STKMSF 408 (600)
Q Consensus 336 L~~~l~~~----~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~---~~~~~~ 408 (600)
|.+++... ..++...+..++.||+.||.|||+.+++||||||+|||++.++.++|+|||++...... ......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 99998653 34567778899999999999999999999999999999999999999999987643221 112245
Q ss_pred CCCccccChhhhcc-------CCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC----CCCCCCCCCcHH
Q psy16430 409 AGTVAWMAPEVIRN-------EQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS----LHLPIPSTCPDG 476 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-------~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~~~~ 476 (600)
.++..|+|||++.. ..++.++|||||||++|||++ |..||...+.......+.... ..+..+..+++.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHH
Confidence 67899999999743 245789999999999999997 678998777655554432221 123344567889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
+.+++..|| .+|.+|||+++|++.+
T Consensus 242 ~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 242 WYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 999999999 6799999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=311.75 Aligned_cols=241 Identities=28% Similarity=0.434 Sum_probs=197.8
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhc---CCCCcccccceeecCCc-----
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKL---NHPNIVKFKGVCTQAPC----- 323 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L---~HpnIv~l~~~~~~~~~----- 323 (600)
|++.+.||+|+||.||+|+.. +..||+|.++. ...+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999975 68999999862 133577666655 69999999999987766
Q ss_pred eeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+++|||+. ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 899999997 4788877653 3589999999999999999999999999999999999999999999999999887655
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-----------------
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS----------------- 464 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~----------------- 464 (600)
........++..|+|||++.+..++.++|||||||++|+|++|.+||.+....+....+....
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 444344567899999999998889999999999999999999999998876554433321100
Q ss_pred -CCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 465 -LHL-------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 465 -~~~-------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
... ......++.+.++|.+||+.||.+||++.+++.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 0011345778999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=329.63 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=234.2
Q ss_pred cccccccccccccCCCCcceEEEeEeeceE--EEeeeeccch----------HHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRSEI--VAVKKVREQK----------ETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~----------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+...+++.+..||-|+||.|=+++.+++. +|+|++++.. -.|-++|..+++|.||++|-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 355678888889999999999999877654 8999886432 3578899999999999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
|++||-|-||.|...+++.+.|++..+..++..+++|++|||++|||+|||||+|+|++.+|.+||.|||+|+.+.....
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
+.+++|||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++..++..|..+.-...+|..++....+||+++
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 88999999999999999999999999999999999999999999999999999999888878888999999999999999
Q ss_pred hhcCCCCCCC-----HHHHHHcHhhhhhh
Q psy16430 485 WSNAPSSRPS-----FKQILSHLDIASQE 508 (600)
Q Consensus 485 L~~dP~~RPs-----~~elL~~l~~~~~~ 508 (600)
...+|.+|.. +.+|-.|-||..-.
T Consensus 656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 656 CRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 9999999975 89999999998643
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=322.97 Aligned_cols=245 Identities=26% Similarity=0.407 Sum_probs=197.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC-----Ccee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA-----PCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~-----~~~~ 325 (600)
++|++.+.||+|+||.||+|... ++.||+|.+.. ....|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 67999999999999999999864 68999998752 134689999999999999999987543 3579
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
+||||+. ++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 85 lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 85 IVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 9999996 578777754 5699999999999999999999999999999999999999999999999999876543221
Q ss_pred ---CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc---------------C---
Q psy16430 405 ---KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG---------------S--- 462 (600)
Q Consensus 405 ---~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~---------------~--- 462 (600)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+. .
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 123568999999998754 568899999999999999999999998765432211110 0
Q ss_pred ------CCCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 463 ------SSLHLP-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 463 ------~~~~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
...... .....++.+.++|.+||+.+|.+|||+.+++.|+|+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000 012457789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.91 Aligned_cols=240 Identities=28% Similarity=0.456 Sum_probs=206.0
Q ss_pred ccccCCCCcceEEEeEee--ceEEEeeee------c-----cchHHHHHHHHhcCCCCcccccceeecCCc--eeEEEee
Q psy16430 266 LQWLGSGAQGAVFSGKLR--SEIVAVKKV------R-----EQKETDIRHLRKLNHPNIVKFKGVCTQAPC--YCIVMEY 330 (600)
Q Consensus 266 ~~~LG~G~fG~Vy~a~~~--~~~vAvK~~------~-----~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~--~~lV~Ey 330 (600)
...||+|+|-+||+|-+. |..||=-.+ + .++..|+.+|+.|+||||+++|++|.+... ..+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 356999999999999865 333332111 1 345679999999999999999999976554 7889999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC--CccccCCCCCCcccCCC-CCceeeccCccccccCCCCCcc
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK--QIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~--gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~~~~ 407 (600)
+..|+|..++++.+.++...+..|++||++||.|||++ .|||||||.+||||+.+ |.|||+|+|+|......... +
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak-s 203 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK-S 203 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc-e
Confidence 99999999999999999999999999999999999998 59999999999999865 89999999999987665444 4
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCC-ChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDV-DSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..|||.|||||+.. ..|+..+||||||+++.||+|+.+||... ++.+++.++..+..+..+...-.+++++||.+||.
T Consensus 204 vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA 282 (632)
T ss_pred eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence 89999999999987 78999999999999999999999999865 55666667777765555556668899999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~ 508 (600)
. .+.|||+.|+|.|++|....
T Consensus 283 ~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 283 T-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred C-chhccCHHHHhhChhhcccc
Confidence 9 99999999999999998763
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.17 Aligned_cols=240 Identities=29% Similarity=0.538 Sum_probs=198.4
Q ss_pred cccccccCCCCcceEEEeEee-----ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCC------
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAP------ 322 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~------ 322 (600)
|.+.+.||+|+||.||+|.+. +..||||.+... +.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999753 478999988542 347899999999999999999875432
Q ss_pred ceeEEEeeeccccchhhccC------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
..+++++|+.+|+|.+++.. ...++...+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 24789999999999877632 124788899999999999999999999999999999999999999999999998
Q ss_pred ccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCC
Q psy16430 397 REWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPST 472 (600)
Q Consensus 397 ~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 472 (600)
+....... .....+++.|++||.+.+..++.++|||||||++|+|++ |.+||.+.+.......+.... ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCC
Confidence 86543221 122345678999999988889999999999999999999 999998877766555444332 2344567
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+++.+.+++.+||+.+|.+|||+.+++..+.
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 7899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=313.74 Aligned_cols=244 Identities=26% Similarity=0.426 Sum_probs=204.0
Q ss_pred ccccccccCCCCcceEEEeEee-----ceEEEeeeecc-----------chHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE-----------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~-----------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
+|++.+.||+|+||.||+++.. +..||||.++. .+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999998743 47899998853 134688899999 599999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
|+||||+++++|.+.+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999988777899999999999999999999999999999999999999999999999999876543322
Q ss_pred --CcccCCCccccChhhhccCC--CCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 405 --KMSFAGTVAWMAPEVIRNEQ--CSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 405 --~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
.....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||..... ......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 238 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMSAE 238 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccCHH
Confidence 22356899999999987654 68899999999999999999999964322 2222222222 23566778899
Q ss_pred HHHHHHHhhhcCCCCCCC---HHHHHHcHhhhhh
Q psy16430 477 FQLLMKMCWSNAPSSRPS---FKQILSHLDIASQ 507 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs---~~elL~~l~~~~~ 507 (600)
+.++|.+||+.||++||| +.++++|+|+...
T Consensus 239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 999999999999999998 5677999988654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=311.75 Aligned_cols=241 Identities=27% Similarity=0.453 Sum_probs=200.4
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
|++.+.||+|++|.||+|... ++.+|+|.+... ...|+.++++++||||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567788999999999999864 688999987532 356899999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccC
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFA 409 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~ 409 (600)
++ +|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 75 77777755 4678999999999999999999999999999999999999999999999999988765443 222356
Q ss_pred CCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-------------------CC---
Q psy16430 410 GTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-------------------LH--- 466 (600)
Q Consensus 410 gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-------------------~~--- 466 (600)
++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+.... ..
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 78899999998776 78899999999999999999999998776544332221100 00
Q ss_pred ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 467 ------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 467 ------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
......++..+.++|.+||+.||.+||++.+++.|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00123467899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.50 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=195.1
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC-------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA------- 321 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~------- 321 (600)
.++|++.+.||+|+||.||+|... ++.||+|.+.. ...+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 378999999999999999999864 68899998742 235799999999999999999987443
Q ss_pred -CceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 322 -PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 322 -~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
..+++||||+.+ ++...+.. ...+++..+..++.|+++||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 346999999975 56655543 457999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCC------------cccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC---
Q psy16430 400 NNKSTK------------MSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS--- 463 (600)
Q Consensus 400 ~~~~~~------------~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~--- 463 (600)
...... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 432111 12356888999998765 45789999999999999999999999877654433221110
Q ss_pred C------------------CCCCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 464 S------------------LHLPIP-------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 464 ~------------------~~~~~p-------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
. .....+ ...++.+.++|.+||..||.+|||+.+++.|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000000 2334678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=341.76 Aligned_cols=246 Identities=23% Similarity=0.389 Sum_probs=189.5
Q ss_pred cccccccccCCCCcceEEEeEeec---eEE------------------Eeeeec------cchHHHHHHHHhcCCCCccc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRS---EIV------------------AVKKVR------EQKETDIRHLRKLNHPNIVK 313 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~---~~v------------------AvK~~~------~~~~~Ei~~L~~L~HpnIv~ 313 (600)
++|++++.||+|+||.||++..+. ..+ +.|.+. ..+.+|+.+|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 689999999999999999986532 111 112221 23467999999999999999
Q ss_pred ccceeecCCceeEEEeeeccccchhhccCC-----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDG-----EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 314 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~-----~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
+++++......|+||+++. ++|.+++... .......+..++.||+.||.|||++|||||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999995 5666665432 224466788899999999999999999999999999999999999
Q ss_pred eeeccCccccccCCCC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCC-CCCCCC--hHHHHHHhcC-
Q psy16430 389 KISDFGTCREWNNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCET-PYKDVD--SSAIIWGVGS- 462 (600)
Q Consensus 389 kL~DFGla~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~-Pf~~~~--~~~~~~~i~~- 462 (600)
||+|||++..+..... .....||+.|+|||++.+..++.++|||||||++|||++|.. ||.... ....+..+..
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 9999999987654322 234679999999999999999999999999999999999875 443322 1111111100
Q ss_pred ---CCCCC---------------------C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 463 ---SSLHL---------------------P-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 463 ---~~~~~---------------------~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+ . ....++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus 387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 00000 0 012356678889999999999999999999999999764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.26 Aligned_cols=249 Identities=28% Similarity=0.397 Sum_probs=205.0
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
.|++. ++|++...||+|+||.||+|+.. +..||+|++... ..+|+.+++++.||||+++++++.....
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 45554 67999999999999999999875 688999987531 2368999999999999999998865554
Q ss_pred ------eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 324 ------YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 324 ------~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 5789988875 469999999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC----------
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH---------- 466 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~---------- 466 (600)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65433 234567889999999865 46789999999999999999999999877655443332211000
Q ss_pred ----------------C---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 467 ----------------L---PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 467 ----------------~---~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
. ......++.+.++|.+||+.||.+|||+.+|+.|+|+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0 01124588999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.83 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=200.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhc-CCCCcccccceeecC--CceeE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKL-NHPNIVKFKGVCTQA--PCYCI 326 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L-~HpnIv~l~~~~~~~--~~~~l 326 (600)
++|++.+.||+|+||.||+|... +..+|+|++... ...|+.+++++ +||||+++++++... ...|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 67889999999999999999864 688999987431 34689999999 999999999988543 46899
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--- 403 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--- 403 (600)
||||++ ++|..++..+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 999997 5898888765 78899999999999999999999999999999999999999999999999988654322
Q ss_pred ---CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----------------
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS---------------- 463 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~---------------- 463 (600)
......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.........+...
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 1123568999999998755 56788999999999999999999999876544332221110
Q ss_pred -----------CCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 -----------SLH--LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 -----------~~~--~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
... ......++..+.++|..||+.||.+|||+.+++.|+|+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000 01112368899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.09 Aligned_cols=264 Identities=26% Similarity=0.420 Sum_probs=227.5
Q ss_pred cccccccccccccCCCCcceEEEeEeec--eEEEeeeeccch----------HHHHHHHHhc-CCCCcccccceeecCCc
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQK----------ETDIRHLRKL-NHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~----------~~Ei~~L~~L-~HpnIv~l~~~~~~~~~ 323 (600)
.|...+|..+..||.|+||.|-+|..++ +.+|||+++++. ..|-++|... +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4556789999999999999999998765 789999987643 2355555544 57889999999999999
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc-cCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW-NNK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~-~~~ 402 (600)
+|+||||+.||+|--.|+.-+++.+..+..++..|+-||-+||++|||.||||.+|||++.+|.+||+|||+++.- ...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999999863 344
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
.++.+++|||.|+|||++...+|+.++|+||+||+||||+.|++||.+.+..++...|..... ..|..+|.+...+++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~ick 582 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAICK 582 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHHHH
Confidence 556689999999999999999999999999999999999999999999999999999887765 467899999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHcHhhhhhhh---hccCCChhhhhhH
Q psy16430 483 MCWSNAPSSRPS-----FKQILSHLDIASQEV---LRIQPEPYYKMQM 522 (600)
Q Consensus 483 ~cL~~dP~~RPs-----~~elL~~l~~~~~~~---~~~~~~~~~~~~~ 522 (600)
..|.+.|.+|.. -.+|-.|++|..... .+....|++++..
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 999999999963 367888998876532 2233344454433
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.63 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=202.7
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC--
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP-- 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~-- 322 (600)
|.+. ++|++++.||+|+||.||+|... +..||||++.. ...+|+.++++++||||+++++++....
T Consensus 11 ~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVP-DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccc-cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4443 67999999999999999999754 68899998742 2346899999999999999999986543
Q ss_pred ----ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 323 ----CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 323 ----~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 6788888764 5689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC-----------
Q psy16430 399 WNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH----------- 466 (600)
Q Consensus 399 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~----------- 466 (600)
.... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+......
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 5432 224567899999999876 45789999999999999999999999876654333221110000
Q ss_pred ------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 ------------------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 ------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
......+++.+.++|.+||..||.+|||+.+++.|+|+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 01124567889999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=322.84 Aligned_cols=248 Identities=32% Similarity=0.565 Sum_probs=215.7
Q ss_pred ccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
-++|.+.+.+.++||+|-||.|.++...+ ..||+|.++. .+.+|+++|.+|+|||||.++|+|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 46778889999999999999999999887 9999999963 45689999999999999999999999999999
Q ss_pred EEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 327 VMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
||||+++|+|.+++..+. .........|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-....
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999999997763 234566778999999999999999999999999999999999999999999996543322
Q ss_pred ---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh--CCCCCCCCChHHHHHHhcC------CCCCCCCCCCC
Q psy16430 405 ---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT--CETPYKDVDSSAIIWGVGS------SSLHLPIPSTC 473 (600)
Q Consensus 405 ---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~p~~~ 473 (600)
....+-+..|||||.+..++++.+||||+||+++||+++ ...||...+.+++...... ...-+..|..|
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 123456789999999999999999999999999999886 8899999988887765432 12234568899
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
|..+.++|.+||..+-.+|||++++..++.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 999999999999999999999999987763
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=306.12 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=207.5
Q ss_pred cccCCCCcceEEEeE--eeceEEEeeeeccc-------hHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 267 QWLGSGAQGAVFSGK--LRSEIVAVKKVREQ-------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~--~~~~~vAvK~~~~~-------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
+.||+|+|+.|--+. .++..||||++.++ .-+|++++.++ .|+||++++++|+++..+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998776 45789999999653 35799999888 599999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC---CceeeccCccccccCCC--------CC
Q psy16430 337 YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE---EAKISDFGTCREWNNKS--------TK 405 (600)
Q Consensus 337 ~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~---~vkL~DFGla~~~~~~~--------~~ 405 (600)
...|.+...|++.++..++++|+.||.|||.+||.|||+||+|||....+ -||||||.+..-..... ..
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L 243 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL 243 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence 99999999999999999999999999999999999999999999997654 48999998876442111 11
Q ss_pred cccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCCh---------------HHHHHHhcCCCC
Q psy16430 406 MSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---------------SAIIWGVGSSSL 465 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---------------~~~~~~i~~~~~ 465 (600)
.+.+|+..|||||+.. ...|+.++|.||||+|||-|++|.+||.+.-. ..+...|..+.+
T Consensus 244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY 323 (463)
T KOG0607|consen 244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY 323 (463)
T ss_pred cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC
Confidence 2568999999999863 24678899999999999999999999976432 444556777776
Q ss_pred CCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhhhc
Q psy16430 466 HLPIP--STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLR 511 (600)
Q Consensus 466 ~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~~ 511 (600)
.+|-. ..+|.+.+++|..+|..|+.+|.++.++++|||+.......
T Consensus 324 eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 324 EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 65532 46899999999999999999999999999999987654433
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.48 Aligned_cols=241 Identities=15% Similarity=0.215 Sum_probs=186.8
Q ss_pred ccccccccccccCCCCcceEEEeEeec-----eEEEeeeeccc---hHH---------------HHHHHHhcCCCCcccc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKVREQ---KET---------------DIRHLRKLNHPNIVKF 314 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~---~~~---------------Ei~~L~~L~HpnIv~l 314 (600)
+..++|++.+.||+|+||.||+|...+ ..+|+|+.... ... +...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 445789999999999999999998653 35666653211 111 1223455689999999
Q ss_pred cceeecCC----ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCcee
Q psy16430 315 KGVCTQAP----CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 315 ~~~~~~~~----~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
++++.... ..+++|+++. .++.+.+......++..+..++.|++.||.|||+.||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 3467888774 466666665555788889999999999999999999999999999999999999999
Q ss_pred eccCccccccCCC--------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-HHH-----
Q psy16430 391 SDFGTCREWNNKS--------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAI----- 456 (600)
Q Consensus 391 ~DFGla~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~----- 456 (600)
+|||+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 9999998663221 11235699999999999999999999999999999999999999987632 221
Q ss_pred ---HHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 457 ---IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 457 ---~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
...+..+.. ....+++.+.++++.||..+|.+||++.+|++.+
T Consensus 248 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 122222221 2345689999999999999999999999998753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.42 Aligned_cols=249 Identities=28% Similarity=0.373 Sum_probs=201.2
Q ss_pred ccccccccccccccCCCCcceEEEeEe--eceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC---
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA--- 321 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~--- 321 (600)
|++. ++|++.+.||+|+||.||+|.. .++.||+|++... ..+|+.++++++||||+++++++...
T Consensus 13 ~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred hhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 4444 7899999999999999999975 4689999988532 34689999999999999999987533
Q ss_pred ---CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 322 ---PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 322 ---~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
...|++++++ +++|.++++. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478899887 6889887765 4589999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-------------
Q psy16430 399 WNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS------------- 464 (600)
Q Consensus 399 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~------------- 464 (600)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 5332 234568899999999866 567889999999999999999999998765433322211000
Q ss_pred -----------C--CC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 465 -----------L--HL---PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 465 -----------~--~~---~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
. .. ......++.+.++|.+||+.||.+|||+.+++.|+|+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0 00 001235788999999999999999999999999999976433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.13 Aligned_cols=241 Identities=29% Similarity=0.429 Sum_probs=200.0
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
|+..+.||+|+||.||+|+.. ++.||+|.+... ...|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999875 689999988642 246899999999999999999999999999999999
Q ss_pred ccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccC
Q psy16430 332 AYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFA 409 (600)
Q Consensus 332 ~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~ 409 (600)
+ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 7 5899999775 579999999999999999999999999999999999999999999999999988765432 222345
Q ss_pred CCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--------------------CCCCC-
Q psy16430 410 GTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--------------------SSLHL- 467 (600)
Q Consensus 410 gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--------------------~~~~~- 467 (600)
++..|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......+.. .....
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 67889999998766 789999999999999999999999987664433222110 00000
Q ss_pred ------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 ------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 ------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
......+..+.++|++||..||.+||++.+++.|||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0011347789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.95 Aligned_cols=247 Identities=29% Similarity=0.430 Sum_probs=200.2
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC-
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP- 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~- 322 (600)
.|++. .+|.+.+.||+|+||.||+|... ++.||+|++.. ...+|+.+++.++||||+++++++....
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 45664 58999999999999999999854 78999998853 2357899999999999999999986543
Q ss_pred -----ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 323 -----CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 323 -----~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.+|+||||+. .+|..++. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4689999996 46766542 468999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC------------
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS------------ 464 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~------------ 464 (600)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 65322 234567889999999866 468899999999999999999999998876544333221100
Q ss_pred ----------CC-CC------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 ----------LH-LP------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ----------~~-~~------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.. .+ .....+..+.+||.+||+.||.+||++.+++.|+|+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00 00 012457789999999999999999999999999999664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.31 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=196.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecC----------
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQA---------- 321 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~---------- 321 (600)
.+|++.+.||.|+||.||+|... +..||+|++.. ...+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67899999999999999999864 68999998743 245789999999999999999876543
Q ss_pred ----CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCcc
Q psy16430 322 ----PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTC 396 (600)
Q Consensus 322 ----~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla 396 (600)
...|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35789999997 588887764 46899999999999999999999999999999999999974 567899999998
Q ss_pred ccccCCCC----CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-------
Q psy16430 397 REWNNKST----KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS------- 464 (600)
Q Consensus 397 ~~~~~~~~----~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~------- 464 (600)
........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 76533211 122357889999998754 567889999999999999999999998766544333221110
Q ss_pred ------------------CCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 465 ------------------LHL---PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 465 ------------------~~~---~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
... ......+..+.+||.+||+.||.+|||+.+++.|+|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000 012346788999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.52 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=196.8
Q ss_pred ccccccccCCCCcceEEEeEee----ceEEEeeeecc---------chHHHHHHHHhc-CCCCcccccceeec----CCc
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR----SEIVAVKKVRE---------QKETDIRHLRKL-NHPNIVKFKGVCTQ----APC 323 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~---------~~~~Ei~~L~~L-~HpnIv~l~~~~~~----~~~ 323 (600)
+|++.+.||+|+||.||+++.. +..||+|.+.. ...+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999865 45899998753 234688999999 59999999987532 245
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
.|++|+|+. ++|.+.+..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999986 6899988877889999999999999999999999999999999999999999999999999998654322
Q ss_pred C-----CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---------------
Q psy16430 404 T-----KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--------------- 462 (600)
Q Consensus 404 ~-----~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--------------- 462 (600)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 123568999999998765 5688999999999999999999999987653322211100
Q ss_pred C-----------CCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 463 S-----------SLHLP---IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 463 ~-----------~~~~~---~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
. ..... ....++..+.+++.+||+.||.+|||+.+++.|+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 0 00000 11235788999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.94 Aligned_cols=225 Identities=21% Similarity=0.289 Sum_probs=191.7
Q ss_pred CCcceEEEeEee--ceEEEeeeeccc--hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccchhhccCCCCCC
Q psy16430 272 GAQGAVFSGKLR--SEIVAVKKVREQ--KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVP 347 (600)
Q Consensus 272 G~fG~Vy~a~~~--~~~vAvK~~~~~--~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~ 347 (600)
|.||.||+++.. ++.||+|.++.. ...|...+....||||+++++++......++||||++||+|.+++.....++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 83 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCC
Confidence 899999999864 688999999764 3455556666689999999999999999999999999999999988777799
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccChhhhccCCCCC
Q psy16430 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427 (600)
Q Consensus 348 ~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ 427 (600)
+..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.
T Consensus 84 ~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 161 (237)
T cd05576 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETE 161 (237)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCc
Confidence 9999999999999999999999999999999999999999999999987665432 22345677899999998888899
Q ss_pred ccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHcH
Q psy16430 428 KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSF-----KQILSHL 502 (600)
Q Consensus 428 ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~-----~elL~~l 502 (600)
++||||+|+++|+|++|..||....... .......+|..+++.+.++|.+||+.||.+||++ +++++||
T Consensus 162 ~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~ 235 (237)
T cd05576 162 ACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHP 235 (237)
T ss_pred hhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence 9999999999999999999876432210 1112234567789999999999999999999985 9999999
Q ss_pred hh
Q psy16430 503 DI 504 (600)
Q Consensus 503 ~~ 504 (600)
|+
T Consensus 236 ~~ 237 (237)
T cd05576 236 FF 237 (237)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=341.68 Aligned_cols=138 Identities=30% Similarity=0.432 Sum_probs=127.9
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|.+++.||.|+||.||+|... ++.||||+++. .+..|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999976 78999999863 345688899999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
|||+.|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999877789999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.28 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=200.9
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec-CCc
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ-APC 323 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~-~~~ 323 (600)
|.+. ++|++.+.||.|+||.||+|... +..||+|++.. ....|+.++++++||||+++++++.. ...
T Consensus 6 ~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEIT-NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccc-cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4443 67999999999999999999754 68899998642 34579999999999999999999865 567
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
.|+||||+ +++|..+++. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||.+......
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 89999998 5688888764 45888889999999999999999999999999999999999999999999998754332
Q ss_pred CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc---------------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG--------------------- 461 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~--------------------- 461 (600)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 234567889999998765 568999999999999999999999998765422111000
Q ss_pred ---CCCCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 462 ---SSSLHLPI-----PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 462 ---~~~~~~~~-----p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
......+. ...+++.+.++|++||+.+|.+|||+.+++.|+|+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00000111 134678999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.46 Aligned_cols=238 Identities=30% Similarity=0.449 Sum_probs=208.3
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecccc
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGP 335 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 335 (600)
+.||+|.||+||-|+++ |+.||||++.+ +..+|+.+|+++.||.||.+...|+..+..++|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 67999999999999864 79999999853 23579999999999999999999999999999999996 56
Q ss_pred chhhcc--CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC---CCceeeccCccccccCCCCCcccCC
Q psy16430 336 LYNLLK--DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCREWNNKSTKMSFAG 410 (600)
Q Consensus 336 L~~~l~--~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~~g 410 (600)
+.++|- ..+++++.....++.||+.||.|||.+||+|.||||+|||+.+. ..+||||||+|+.+.+.+...+.+|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 666653 35789999999999999999999999999999999999999755 4799999999999999888889999
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHHHHHHhhhcC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~LI~~cL~~d 488 (600)
||.|.|||+++++.|+.+-|+||.|||+|--++|..||.... ++-.+|.+..+-.| .-..+++...+||..+|+..
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVk 806 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVK 806 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999997543 33344444443332 23568999999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~ 507 (600)
-.+|.|.+..|.|+|+.+.
T Consensus 807 m~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 807 MRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHhcchHhhccchhhhcc
Confidence 9999999999999998664
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=330.42 Aligned_cols=249 Identities=37% Similarity=0.655 Sum_probs=216.5
Q ss_pred cccccccccccccccCCCCcceEEEeEee---------ceEEEeeeecc--------chHHHHHHHHhc-CCCCcccccc
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
.|+++.+++++.+.||+|.||.|++|... ...||||..+. .+..|+++|+.+ .||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 79999999999999999999999999743 35799999863 345789999988 5999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCc
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGE----------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NI 380 (600)
++...+..++|+||+..|+|.++++..+ .++..+++.++.||+.|++||++.++|||||...||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999997654 388899999999999999999999999999999999
Q ss_pred ccCCCCCceeeccCccccccCCCCC--cccC--CCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCC-hH
Q psy16430 381 LIGSKEEAKISDFGTCREWNNKSTK--MSFA--GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVD-SS 454 (600)
Q Consensus 381 Ll~~~~~vkL~DFGla~~~~~~~~~--~~~~--gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~-~~ 454 (600)
|++.+..+||+|||+|+........ .... -...|||||.+....|+.++||||||++|||++| |..||.+.. ..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9999999999999999965433221 1122 3456999999999999999999999999999999 999999866 44
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 455 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+ ......+.++..|..|++++.++|+.||+.+|.+||++.++...+.-
T Consensus 530 ~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 530 EL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 44 43445666788999999999999999999999999999999988754
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.23 Aligned_cols=229 Identities=30% Similarity=0.536 Sum_probs=188.8
Q ss_pred cccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCC------ceeEEE
Q psy16430 265 DLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAP------CYCIVM 328 (600)
Q Consensus 265 ~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~------~~~lV~ 328 (600)
.-+.||.|+||.||+|+++ |+.||||.++.. .-+|+++|++|+|||||+++++-+... ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3467999999999999864 899999998752 247999999999999999999865433 467999
Q ss_pred eeeccccchhhccC---CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC--CC--CceeeccCccccccC
Q psy16430 329 EYCAYGPLYNLLKD---GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS--KE--EAKISDFGTCREWNN 401 (600)
Q Consensus 329 Ey~~ggsL~~~l~~---~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~--~~--~vkL~DFGla~~~~~ 401 (600)
|||.||||...+++ ...+++.+++.++..++.||.|||++||+||||||.||++-. +| ..||+|||.|+.+++
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d 176 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD 176 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence 99999999999975 346999999999999999999999999999999999999842 23 479999999999998
Q ss_pred CCCCcccCCCccccChhhhc-cCCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCC------------
Q psy16430 402 KSTKMSFAGTVAWMAPEVIR-NEQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSS------------ 464 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~------------ 464 (600)
.+...+++||..|.+||+.. .+.|+..+|.|||||++|+++||..||..... .++.+.+....
T Consensus 177 ~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~e 256 (732)
T KOG4250|consen 177 NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEE 256 (732)
T ss_pred CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeeccc
Confidence 88888999999999999998 48899999999999999999999999964322 23444332211
Q ss_pred -------CCCCCCCCCcHH----HHHHHHHhhhcCCCCCC
Q psy16430 465 -------LHLPIPSTCPDG----FQLLMKMCWSNAPSSRP 493 (600)
Q Consensus 465 -------~~~~~p~~~~~~----l~~LI~~cL~~dP~~RP 493 (600)
..+|.|...+.. +-..+..+|..+|.+|.
T Consensus 257 Ngpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 257 NGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 133445555443 45577788899999998
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=273.75 Aligned_cols=245 Identities=27% Similarity=0.446 Sum_probs=203.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.+|...++||+|.||+||+|+.. .+.||+|.++-+ ..+|+-+|+.++|.|||+++++...+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777889999999999999865 589999999632 3579999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC-cc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~ 407 (600)
||. .+|..+... ++.++.+.++.++.|++.||.|+|++++.|||+||.|.||+.+|.+|++|||+++.++-+... ..
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 996 578777765 678999999999999999999999999999999999999999999999999999987654432 23
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHh----cCCCC-------C------CC
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGV----GSSSL-------H------LP 468 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i----~~~~~-------~------~~ 468 (600)
.+-|..|.+|.++.+ +-|+.+.|+||.|||+.|+.. |++.|++.+..+.+..| +.... . .|
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 467999999999877 567899999999999999987 99999998876655433 21110 0 00
Q ss_pred -CCC---------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 469 -IPS---------TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 469 -~p~---------~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.|. ..+..-+++++.+|.-+|..|.+++..++||.|..
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 111 12234588999999999999999999999998865
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=295.31 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=204.8
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch--------HHHHHH-HHhcCCCCcccccceeecCCc
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK--------ETDIRH-LRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~--------~~Ei~~-L~~L~HpnIv~l~~~~~~~~~ 323 (600)
.|++..++++.+..||.|+||+|++-.++ ++..|||+++... ..|... ++.-+.||||++||.+..++.
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 35566688899999999999999988765 7999999997322 223332 344479999999999988889
Q ss_pred eeEEEeeeccccchhhcc-----CCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 324 YCIVMEYCAYGPLYNLLK-----DGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~-----~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.||.||+|. .||..+.+ ....++++.+-.|....+.||.||-.. .||||||||+|||++..|.+||||||++.
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 999999996 56665543 245689999999999999999999875 89999999999999999999999999998
Q ss_pred cccCCCCCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCCC-CCCCCC--
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSL-HLPIPS-- 471 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~-~~~~p~-- 471 (600)
.+..+-..+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||..||.+.+. .+.+..+..+.. .+..+.
T Consensus 217 qLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 217 QLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC 296 (361)
T ss_pred hHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc
Confidence 8876665556678899999999854 4588899999999999999999999998765 222333333332 222333
Q ss_pred -CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 472 -TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 472 -~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.++..+..+|..||.+|-+.||.+.+++.+++.....
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 3788999999999999999999999999999876543
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.84 Aligned_cols=249 Identities=28% Similarity=0.524 Sum_probs=213.0
Q ss_pred cccccccccccccCCCCcceEEEeEe--eceEEEeeeecc------chHHHHHHHHhc-CCCCcccccceee-----cCC
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE------QKETDIRHLRKL-NHPNIVKFKGVCT-----QAP 322 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~------~~~~Ei~~L~~L-~HpnIv~l~~~~~-----~~~ 322 (600)
-.+.+.|.+...||.|.+|.||+++. .++.+|+|+... ..+.|.++|+.+ .|||++.++|+|. .++
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34456677889999999999999874 478889998753 234566778776 6999999999984 356
Q ss_pred ceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
.+|||||||.|||..+++++ +.++.+..+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||++..++
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 79999999999999999976 5679999999999999999999999999999999999999999999999999998876
Q ss_pred CCC-CCcccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCC
Q psy16430 401 NKS-TKMSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTC 473 (600)
Q Consensus 401 ~~~-~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~ 473 (600)
... ...++.|||.|||||++.. ..|+..+|+||||++..||.-|.+|+.++.+...+..|-.... .+.-|...
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW 254 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW 254 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence 543 4457899999999999865 3466799999999999999999999999988877776644332 22336778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+..+.++|..||.+|..+||+..++|+||++.
T Consensus 255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred HHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 99999999999999999999999999999876
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.73 Aligned_cols=244 Identities=26% Similarity=0.354 Sum_probs=199.4
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCC--C----CcccccceeecCCcee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNH--P----NIVKFKGVCTQAPCYC 325 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~H--p----nIv~l~~~~~~~~~~~ 325 (600)
..+|.++..+|+|.||.|-.+-+. +..||||+++. ...-|+++|.++.+ | -+|++.++|...++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 478999999999999999988654 68999999863 33468999999943 2 3788899999999999
Q ss_pred EEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-------------------
Q psy16430 326 IVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS------------------- 384 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~------------------- 384 (600)
||+|.+ |-|+.++++++. +++...++.+++|++++++|||+.+++|.||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 999988 579999998865 6899999999999999999999999999999999999842
Q ss_pred -CCCceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH---HHHHh
Q psy16430 385 -KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA---IIWGV 460 (600)
Q Consensus 385 -~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~---~~~~i 460 (600)
+..++|+|||.|....... .+.+.|..|.|||++.+-.++..+||||+||||+|+.||...|...++.+ +...+
T Consensus 247 ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred CCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 2248999999998754433 56788999999999999999999999999999999999999998876544 22222
Q ss_pred cCC------------------CCCC---------------CCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy16430 461 GSS------------------SLHL---------------PIP--------STCPDGFQLLMKMCWSNAPSSRPSFKQIL 499 (600)
Q Consensus 461 ~~~------------------~~~~---------------~~p--------~~~~~~l~~LI~~cL~~dP~~RPs~~elL 499 (600)
... .+.. +.| ......+.+||++||.+||.+|+|+.|+|
T Consensus 325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence 110 0000 000 00123589999999999999999999999
Q ss_pred HcHhhhh
Q psy16430 500 SHLDIAS 506 (600)
Q Consensus 500 ~~l~~~~ 506 (600)
.||+|+.
T Consensus 405 ~HpFF~~ 411 (415)
T KOG0671|consen 405 SHPFFAR 411 (415)
T ss_pred cCHHhhc
Confidence 9999865
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=291.53 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=200.0
Q ss_pred cccccccccCCCCcceEEEeEee------ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeec-CCce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQ-APCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~-~~~~ 324 (600)
..|+.+..||+|.||.||+|... ...+|||+++.. .-+|+.+++.++||||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56889999999999999999532 247999999754 3579999999999999999999866 8899
Q ss_pred eEEEeeeccccchhhccC-----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC----CCceeeccCc
Q psy16430 325 CIVMEYCAYGPLYNLLKD-----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK----EEAKISDFGT 395 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~-----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~----~~vkL~DFGl 395 (600)
++++||.+. +|..+|+- .+.++...+..++.||+.|+.|||++=|+||||||.||||..+ |.|||+|||+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999985 78888752 3468999999999999999999999999999999999999877 8999999999
Q ss_pred cccccCCCCC----cccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCCh-------------HHHH
Q psy16430 396 CREWNNKSTK----MSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDS-------------SAII 457 (600)
Q Consensus 396 a~~~~~~~~~----~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-------------~~~~ 457 (600)
++.+.+.-.. ...+-|.+|.|||.+.| ..||++.||||.|||+.||+|-++.|.+... ..+.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9988654322 24567999999999877 6789999999999999999999988865322 1111
Q ss_pred HHhcCCCC-CCC----CC--------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 458 WGVGSSSL-HLP----IP--------------------------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 458 ~~i~~~~~-~~~----~p--------------------------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
..++.... ..| +| ..-++...+|+..||..||.+|.|+++.|+|++|..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 11111100 000 00 112445788999999999999999999999999987
Q ss_pred hhhh
Q psy16430 507 QEVL 510 (600)
Q Consensus 507 ~~~~ 510 (600)
..+.
T Consensus 343 d~lp 346 (438)
T KOG0666|consen 343 DPLP 346 (438)
T ss_pred CCCC
Confidence 6544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=281.31 Aligned_cols=232 Identities=31% Similarity=0.555 Sum_probs=200.6
Q ss_pred CcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccchhhccC
Q psy16430 273 AQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD 342 (600)
Q Consensus 273 ~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~ 342 (600)
+||.||+|... +..+|+|++.. .+.+|++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 58999999853 345789999999999999999999998999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccChhhhcc
Q psy16430 343 GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422 (600)
Q Consensus 343 ~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~ 422 (600)
...++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~ 160 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG 160 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc
Confidence 66689999999999999999999999999999999999999999999999999988765544445678899999999988
Q ss_pred CCCCCccceechhHHHHHHhhCCCCCCC-CChHHHHHHhcCCCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy16430 423 EQCSDKIDIWSYGIVLWELLTCETPYKD-VDSSAIIWGVGSSSLHLPIPST-CPDGFQLLMKMCWSNAPSSRPSFKQILS 500 (600)
Q Consensus 423 ~~~s~ksDIwSlGviLyELltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~-~~~~l~~LI~~cL~~dP~~RPs~~elL~ 500 (600)
..++.++||||||+++|+|++|..||.. .+.......+............ ++..+.+++.+||..+|++||++.++++
T Consensus 161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 8889999999999999999999999987 4444444444443333222222 8899999999999999999999999999
Q ss_pred cHhh
Q psy16430 501 HLDI 504 (600)
Q Consensus 501 ~l~~ 504 (600)
++|+
T Consensus 241 ~~~~ 244 (244)
T smart00220 241 HPFF 244 (244)
T ss_pred CCCC
Confidence 9875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=316.94 Aligned_cols=253 Identities=20% Similarity=0.191 Sum_probs=180.7
Q ss_pred ccccccccccccccCCCCcceEEEeEee------ceEEEeeeeccchHHHHHHHHhcC---CCCccccccee------ec
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVREQKETDIRHLRKLN---HPNIVKFKGVC------TQ 320 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~Ei~~L~~L~---HpnIv~l~~~~------~~ 320 (600)
.....++|++.+.||+|+||.||+|++. +..||+|++......|+.+..++. +.+++.+...+ ..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 3445689999999999999999999864 568999998765555554444443 33333333221 35
Q ss_pred CCceeEEEeeeccccchhhccCCCC--------------------CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEE--------------------VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~--------------------l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NI 380 (600)
....++||||+++++|.+++..... .....+..++.||+.||.|||++||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 5678999999999999988864321 12344678999999999999999999999999999
Q ss_pred ccCC-CCCceeeccCccccccCC--CCCcccCCCccccChhhhccC----------------------CCCCccceechh
Q psy16430 381 LIGS-KEEAKISDFGTCREWNNK--STKMSFAGTVAWMAPEVIRNE----------------------QCSDKIDIWSYG 435 (600)
Q Consensus 381 Ll~~-~~~vkL~DFGla~~~~~~--~~~~~~~gt~~Y~APE~l~~~----------------------~~s~ksDIwSlG 435 (600)
|++. ++.+||+|||+|+..... .......+|+.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 579999999999865432 223356789999999976432 233467999999
Q ss_pred HHHHHHhhCCCCCCCCChHHHHHHhcCCCC-------------CC------CCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q psy16430 436 IVLWELLTCETPYKDVDSSAIIWGVGSSSL-------------HL------PIPSTCPDGFQLLMKMCWSNAPSSRPSFK 496 (600)
Q Consensus 436 viLyELltG~~Pf~~~~~~~~~~~i~~~~~-------------~~------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ 496 (600)
|+||||+++..|+.... ......+..... .. ......+....+||.+||+.||.+|||+.
T Consensus 367 viL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 99999999776654321 111111111000 00 01111233456899999999999999999
Q ss_pred HHHHcHhhhhhhh
Q psy16430 497 QILSHLDIASQEV 509 (600)
Q Consensus 497 elL~~l~~~~~~~ 509 (600)
++|+|||+.....
T Consensus 446 e~L~Hpff~~~~~ 458 (566)
T PLN03225 446 AALAHPYFDREGL 458 (566)
T ss_pred HHhCCcCcCCCCc
Confidence 9999999987544
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=288.22 Aligned_cols=252 Identities=24% Similarity=0.447 Sum_probs=216.0
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHhc-CCCCcccccceeec
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRKL-NHPNIVKFKGVCTQ 320 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~L-~HpnIv~l~~~~~~ 320 (600)
..|.+...+|.+++.||+|+|+.|..+++. .+.+|+|++++.. +.|-.+..+- +||.+|-++.+|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 467778899999999999999999999865 5899999997653 2344444443 79999999999999
Q ss_pred CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc-
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW- 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~- 399 (600)
+..+++|.||++||+|--++...++++++.++.+...|+.||.|||++|||.||||.+|+|++..|.+||+|+|+++.-
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999999999888888889999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCC-------CChHH-HHHHhcCCCCCCCCCC
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKD-------VDSSA-IIWGVGSSSLHLPIPS 471 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~-------~~~~~-~~~~i~~~~~~~~~p~ 471 (600)
.....+.+++|||.|.|||++++..|..++|+|+||++++||+.|+.||.- .+.+. +...+...+ ..+|.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--iripr 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPR 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--ccccc
Confidence 445566789999999999999999999999999999999999999999962 12222 233333333 34677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC------CHHHHHHcHhhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRP------SFKQILSHLDIASQ 507 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RP------s~~elL~~l~~~~~ 507 (600)
..|.....+++..|.+||.+|. .+.++..|++|...
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 8888889999999999999995 57888899888754
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.15 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=211.3
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
-.-|..++.||-|+||.|.+++. +...||+|.+++. .+.|-.||..-+++-||+||-.|.+...+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34577788899999999999974 4678999988643 24688899999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-------
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN------- 400 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~------- 400 (600)
|+|++||++-.+|-+.+.|++..++.|+..+..|+++.|..|+|||||||+|||||.+|.+||+|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999986321
Q ss_pred --CC-----------------CC-----------------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC
Q psy16430 401 --NK-----------------ST-----------------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC 444 (600)
Q Consensus 401 --~~-----------------~~-----------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG 444 (600)
.. .. ..+.+||+.|+|||++....|+..+|+||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 00 00 0125799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhcCC--CCCCCCCCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHcHhhhhhhh
Q psy16430 445 ETPYKDVDSSAIIWGVGSS--SLHLPIPSTCPDGFQLLMKMCWSNAPSSRP---SFKQILSHLDIASQEV 509 (600)
Q Consensus 445 ~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP---s~~elL~~l~~~~~~~ 509 (600)
++||...++.....++.+- .+..+....++.++.++|.++ ..+++.|. .+++|-.|+||....+
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccch
Confidence 9999988877666665543 344455577899999999884 45788886 4778999999987644
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.46 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=205.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeec--------------cchHHHHHHHHhcCCCCcccccceee-cCCc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR--------------EQKETDIRHLRKLNHPNIVKFKGVCT-QAPC 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~--------------~~~~~Ei~~L~~L~HpnIv~l~~~~~-~~~~ 323 (600)
++|-++++||+|||+.||+|-+- .+.||+|+-. +...+|.++-+.|+||.||++|++|. +...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 56888899999999999999753 6889999863 11236888999999999999999994 5678
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC--CccccCCCCCCcccCC---CCCceeeccCcccc
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK--QIIHRDLKSPNVLIGS---KEEAKISDFGTCRE 398 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~--gIvHrDIKp~NILl~~---~~~vkL~DFGla~~ 398 (600)
+|-|+|||+|.+|.-+++.++.+++.+++.|+.||+.||.||.+. .|||-||||.|||+-. .|.+||+|||+++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999999999999999999999999999986 6999999999999954 36799999999998
Q ss_pred ccCCCCC--------cccCCCccccChhhhcc----CCCCCccceechhHHHHHHhhCCCCCCCCChHH-HHHH---hcC
Q psy16430 399 WNNKSTK--------MSFAGTVAWMAPEVIRN----EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA-IIWG---VGS 462 (600)
Q Consensus 399 ~~~~~~~--------~~~~gt~~Y~APE~l~~----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~-~~~~---i~~ 462 (600)
....+.. ....||.+|++||.+.- ..++.++||||+|||+|.++.|+.||....... ++.. +..
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 7654322 23679999999998742 356889999999999999999999998654432 2221 223
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 463 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+|..+.++.+.++||++||++--++|.+..++..+|.+.
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 3455666678899999999999999999999999999998764
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=281.44 Aligned_cols=248 Identities=24% Similarity=0.405 Sum_probs=200.9
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec-------
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ------- 320 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~------- 320 (600)
....|..+.+||+|.||.||+|+.. ++.||+|++-. ...+|+++|..|+|+|++.++++|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3466788899999999999999854 57899988632 23579999999999999999998732
Q ss_pred -CCceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 321 -APCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 321 -~~~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
...+|+||.+|+. +|.-++.+. .+++..++..++.+++.||.|+|.+.|+|||+||.|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 2358999999974 788888764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCC-----cccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--CC------
Q psy16430 399 WNNKSTK-----MSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--SS------ 464 (600)
Q Consensus 399 ~~~~~~~-----~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--~~------ 464 (600)
++..... ...+-|..|.+||.+.| ..|+++.|||..|||+.||+||.+.+.+.+....+..|.. +.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 7543221 23456999999999876 6789999999999999999999999998877555443210 00
Q ss_pred -----------C-CCCCCC-------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 -----------L-HLPIPS-------------TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 -----------~-~~~~p~-------------~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+ ..|.|. .-.+...+|+..+|..||.+|++++++++|.||-..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 011111 123578899999999999999999999999998553
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=301.71 Aligned_cols=247 Identities=20% Similarity=0.240 Sum_probs=185.0
Q ss_pred cccccccccccCCCCcceEEEeEe------------------eceEEEeeeeccch---------------------HHH
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL------------------RSEIVAVKKVREQK---------------------ETD 299 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~------------------~~~~vAvK~~~~~~---------------------~~E 299 (600)
..++|.+.++||+|+||+||+|.. .++.||||++.... ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 468999999999999999999863 23579999975311 135
Q ss_pred HHHHHhcCCCCc-----ccccceeec--------CCceeEEEeeeccccchhhccCC-----------------------
Q psy16430 300 IRHLRKLNHPNI-----VKFKGVCTQ--------APCYCIVMEYCAYGPLYNLLKDG----------------------- 343 (600)
Q Consensus 300 i~~L~~L~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~ggsL~~~l~~~----------------------- 343 (600)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766554 667777643 35689999999999998887531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc--cCCCccccChhhh
Q psy16430 344 -EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVI 420 (600)
Q Consensus 344 -~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~--~~gt~~Y~APE~l 420 (600)
..++...+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++........... ..+|+.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1234567889999999999999999999999999999999999999999999876543322222 2358899999987
Q ss_pred ccCC--------------------C--CCccceechhHHHHHHhhCCC-CCCCCChHH----------HHH-HhcCCCCC
Q psy16430 421 RNEQ--------------------C--SDKIDIWSYGIVLWELLTCET-PYKDVDSSA----------IIW-GVGSSSLH 466 (600)
Q Consensus 421 ~~~~--------------------~--s~ksDIwSlGviLyELltG~~-Pf~~~~~~~----------~~~-~i~~~~~~ 466 (600)
.... + ..+.||||+||++|+|++|.. ||.+..... ..+ .+......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5422 1 134799999999999999875 775422111 111 12223334
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHHcHhhh
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAP---SSRPSFKQILSHLDIA 505 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP---~~RPs~~elL~~l~~~ 505 (600)
++.....++..++|+.+||..+| .+|+|++|+|+|+||.
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 44456678999999999999866 6899999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=331.80 Aligned_cols=237 Identities=24% Similarity=0.382 Sum_probs=188.7
Q ss_pred ccccccccCCCCcceEEEeEe--eceEEEeeeeccc---hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 262 SISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~---~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
.+.....||+|+||.||+|+. .+..||+|++... ...|+..+++++|||||+++|++.+....|+||||+++|+|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 455667899999999999985 4789999988642 35679999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHhH---hCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCcc
Q psy16430 337 YNLLKDGEEVPPQRLYNWARQIAAGMNYLH---SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA 413 (600)
Q Consensus 337 ~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH---~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~ 413 (600)
.++++. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+..... .....+|+.
T Consensus 771 ~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~ 843 (968)
T PLN00113 771 SEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSA 843 (968)
T ss_pred HHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCcccccc
Confidence 999963 889999999999999999999 6699999999999999988887775 665443321 123468899
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---H--HHHHHhc---------CCCCCC--CCCCCCcHHH
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---S--AIIWGVG---------SSSLHL--PIPSTCPDGF 477 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~--~~~~~i~---------~~~~~~--~~p~~~~~~l 477 (600)
|+|||++.+..++.++|||||||++|||+||+.||..... . ....... ...... +.+......+
T Consensus 844 y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (968)
T PLN00113 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923 (968)
T ss_pred ccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHH
Confidence 9999999999999999999999999999999999854211 1 1110000 000000 1111223467
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
.+++.+||+.||.+|||+.++++.+.-.
T Consensus 924 ~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 924 MNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 8899999999999999999999998643
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.94 Aligned_cols=238 Identities=32% Similarity=0.604 Sum_probs=209.4
Q ss_pred cccccccCCCCcceEEEeEee------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
....++||+|+||+||+|.|- +-+||+|++.. .+..|+-+|.+++|||++++++++.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 455678999999999999864 36899999853 2356888999999999999999997665 77999
Q ss_pred eeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 329 EYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
+|+++|+|.++++.. ..+-.+..+.|..||++||.|||.+++|||||-..||||..-..+||.|||+++.+........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999999864 5688899999999999999999999999999999999999999999999999998876554433
Q ss_pred c---CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 408 F---AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 408 ~---~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
. .-.+.|||-|.+....|+.++|||||||++||++| |..||.+....++-..+..+. +++.|..|+-++..+|.+
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqPpiCtiDVy~~mvk 935 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQPPICTIDVYMVMVK 935 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCCCCccHHHHHHHHH
Confidence 2 33678999999999999999999999999999999 999999999888877666555 488999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHcH
Q psy16430 484 CWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l 502 (600)
||..|+..||+++++....
T Consensus 936 Cwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 936 CWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred HhccCcccCccHHHHHHHH
Confidence 9999999999999987765
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.48 Aligned_cols=240 Identities=30% Similarity=0.448 Sum_probs=193.9
Q ss_pred cccccccCCCCcce-EEEeEeeceEEEeeeeccch----HHHHHHHHhc-CCCCcccccceeecCCceeEEEeeeccccc
Q psy16430 263 ISDLQWLGSGAQGA-VFSGKLRSEIVAVKKVREQK----ETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 263 ~~~~~~LG~G~fG~-Vy~a~~~~~~vAvK~~~~~~----~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 336 (600)
|.-.+.+|.|+-|+ ||+|...++.||||.+-..+ .+|+..|+.- .|||||++++.-.+....||..|.|. .+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 44456799999986 69999999999999986543 5899999887 69999999999999999999999996 689
Q ss_pred hhhccCC-CCC---CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---C--CCceeeccCccccccCCCC---
Q psy16430 337 YNLLKDG-EEV---PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---K--EEAKISDFGTCREWNNKST--- 404 (600)
Q Consensus 337 ~~~l~~~-~~l---~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~--~~vkL~DFGla~~~~~~~~--- 404 (600)
.+++... ..+ ..-..+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++.+.....
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 9999763 111 11345788999999999999999999999999999976 2 4689999999998865432
Q ss_pred -CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCC-CCCCcHHHHHHH
Q psy16430 405 -KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPI-PSTCPDGFQLLM 481 (600)
Q Consensus 405 -~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~~~l~~LI 481 (600)
..+..||-+|+|||++....-+.++||+||||++|+.++ |..||.+....+ ..|..+...+.. ......+..+||
T Consensus 670 r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI 747 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEAKDLI 747 (903)
T ss_pred cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHHHHHH
Confidence 234679999999999998888889999999999999999 599998754432 223333332211 111112899999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
.+|+.++|..||++.+||.||.|=
T Consensus 748 ~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 748 SRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred HHhcCCCcccCCCHHHHhCCCccC
Confidence 999999999999999999999653
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=277.67 Aligned_cols=273 Identities=27% Similarity=0.342 Sum_probs=214.9
Q ss_pred cccccccccCCCCcceEEEeE--eeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC------c
Q psy16430 261 ESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP------C 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~--~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~------~ 323 (600)
.+|..+..+|.|.. .|..+- ..++.||+|++.. +..+|...+..++|+||++++.+|+-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 67888899999999 666665 3478999998843 3357999999999999999999985443 4
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
+|+|||||. .+|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..+..+||.|||+|+.....-
T Consensus 96 ~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred HHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccc
Confidence 799999996 68888876 346778899999999999999999999999999999999999999999999998766554
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHh----cCCC---------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV----GSSS--------------- 464 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i----~~~~--------------- 464 (600)
..+.++.|..|.|||++.+..+.+.+||||+||++.||++|...|++.+.-+...++ +...
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 445678899999999999988999999999999999999999999887643322111 1000
Q ss_pred ----------C---------C--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh----hhhhhccCCChhh-
Q psy16430 465 ----------L---------H--LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA----SQEVLRIQPEPYY- 518 (600)
Q Consensus 465 ----------~---------~--~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~----~~~~~~~~~~~~~- 518 (600)
. + ...+..-+..+++++.+||..||++|.|++++|+||.+. ..++...++++..
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~ 332 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDK 332 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCchhhh
Confidence 0 0 001112245789999999999999999999999999874 4444444444331
Q ss_pred ------hhhHhHHHHHHHHHHHHhh
Q psy16430 519 ------KMQMIWKEEIRVHMLEMQA 537 (600)
Q Consensus 519 ------~~~~~~~~ei~~~~~~~~~ 537 (600)
.....|+++|...+++...
T Consensus 333 ~~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 333 QLDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred hcccccCCHHHHHHHHHHHHHhhcc
Confidence 2245688888877777654
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=288.83 Aligned_cols=243 Identities=27% Similarity=0.438 Sum_probs=195.1
Q ss_pred ccccccccccCCCCcceEEEeEeeceEEEeeeecc----chHHHHHHHH--hcCCCCcccccceeecCC----ceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE----QKETDIRHLR--KLNHPNIVKFKGVCTQAP----CYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~----~~~~Ei~~L~--~L~HpnIv~l~~~~~~~~----~~~lV~E 329 (600)
...+++++.||+|.||.||+|+..++.||||++.. .+.+|-++.+ .+.|+||++|+++-.... .++||++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45678889999999999999999999999999964 3455655544 568999999999865444 7899999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC---------CccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK---------QIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~---------gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
|.+.|+|.++++.+ .+++....+++..+++||+|||+. .|+|||||..||||..++++.|+|||+|..+.
T Consensus 289 fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred eccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 99999999999875 489999999999999999999974 59999999999999999999999999999876
Q ss_pred CCC---CCcccCCCccccChhhhccCC-CC-----CccceechhHHHHHHhhCCC------------CCC-----CCChH
Q psy16430 401 NKS---TKMSFAGTVAWMAPEVIRNEQ-CS-----DKIDIWSYGIVLWELLTCET------------PYK-----DVDSS 454 (600)
Q Consensus 401 ~~~---~~~~~~gt~~Y~APE~l~~~~-~s-----~ksDIwSlGviLyELltG~~------------Pf~-----~~~~~ 454 (600)
... .....+||.+|||||++.+.. +. .+.||||+|.+||||++.-. ||. ..+..
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 432 223478999999999997632 22 37999999999999997432 332 11224
Q ss_pred HHHHHhcCCCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 455 AIIWGVGSSSLHLPIPST-----CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 455 ~~~~~i~~~~~~~~~p~~-----~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
++...+.....++.+|.. -...+++.+..||+.||+-|.|+.=+.+..+
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 444445555556666543 3467999999999999999999987766654
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=301.25 Aligned_cols=249 Identities=30% Similarity=0.510 Sum_probs=221.7
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
|-++|..++.+|+|+||.||++++. ++..|+|+++- ..++|+-+++..+|||||.++|.+.....++++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4588999999999999999999864 78999999963 23678999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~ 408 (600)
||.||+|.+...-.+++++.++..+++..+.||+|||+.|-+|||||-.||++++.|.+|++|||.+..+... ....++
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 9999999999988899999999999999999999999999999999999999999999999999998877644 334578
Q ss_pred CCCccccChhhh---ccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC---CCCCCcHHHHHHHH
Q psy16430 409 AGTVAWMAPEVI---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP---IPSTCPDGFQLLMK 482 (600)
Q Consensus 409 ~gt~~Y~APE~l---~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p~~~~~~l~~LI~ 482 (600)
.||++|||||+- +.+.|...+|||++|+...|+-.-++|-.+..+....+...+..+.++ .+...++.+.+|++
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK 252 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVK 252 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHH
Confidence 999999999985 456889999999999999999998999888888777777666665544 34568899999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+|.++|.+|||++.+|.|+.+...
T Consensus 253 ~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 253 GALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999977654
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=283.23 Aligned_cols=241 Identities=30% Similarity=0.477 Sum_probs=194.9
Q ss_pred cccccccccCCCCcceEEEeEeeceEEEeeeeccch----HHHHHHHH--hcCCCCcccccceeecCC----ceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK----ETDIRHLR--KLNHPNIVKFKGVCTQAP----CYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~----~~Ei~~L~--~L~HpnIv~l~~~~~~~~----~~~lV~Ey 330 (600)
..+++.+.||+|.||.||+|+|+|+.||||++.... .+|.++.+ .|+|+||+.|++.-..+. .+|||++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 567888999999999999999999999999996443 34555554 569999999998753332 58999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC--------CccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK--------QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~--------gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.+.|||+|++.. ..++.+...+++..++.||+|||.. .|.|||||+.||||.+++.+.|+|+|+|......
T Consensus 291 He~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 291 HEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred ccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 999999999987 5689999999999999999999964 4999999999999999999999999999877654
Q ss_pred CC-----CcccCCCccccChhhhccCC----C--CCccceechhHHHHHHhhC----------CCCCCCC-----ChHHH
Q psy16430 403 ST-----KMSFAGTVAWMAPEVIRNEQ----C--SDKIDIWSYGIVLWELLTC----------ETPYKDV-----DSSAI 456 (600)
Q Consensus 403 ~~-----~~~~~gt~~Y~APE~l~~~~----~--s~ksDIwSlGviLyELltG----------~~Pf~~~-----~~~~~ 456 (600)
.. ....+||.+|||||++...- + -..+||||||.++||++.. .+||.+. +.+++
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM 449 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence 32 23578999999999986521 1 2469999999999999742 4688653 33555
Q ss_pred HHHhcCCCCCCCCCCCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 457 IWGVGSSSLHLPIPSTCP-----DGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~~~~-----~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
...+....+++.+|.... ..+..+|+.||..||.-|.|+--|-+.+
T Consensus 450 rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 450 RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 555666677777776542 3578899999999999999987665554
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=263.47 Aligned_cols=245 Identities=18% Similarity=0.314 Sum_probs=199.1
Q ss_pred ccccccccccCCCCcceEEEeE--eeceEEEeeeecc----chHHHHHHHHhcC-CCCcccccceeecC--CceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVRE----QKETDIRHLRKLN-HPNIVKFKGVCTQA--PCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~--~~~~~vAvK~~~~----~~~~Ei~~L~~L~-HpnIv~l~~~~~~~--~~~~lV~Ey 330 (600)
.++|++.+++|+|.|+.||.|. .+++.++||+++. ...+|+++|+.|. ||||++++++..+. ....+|+||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 4789999999999999999998 4578899999863 4578999999997 99999999998665 457799999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccccCCCCCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
+.+.+...+.. .++.-++..++.+++.||.|||+.||+|||+||.|+||+.. ..++|+|+|+|.+......-.-.+
T Consensus 117 v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRV 193 (338)
T KOG0668|consen 117 VNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
T ss_pred hccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeee
Confidence 98887766653 47888999999999999999999999999999999999865 579999999999887665555566
Q ss_pred CCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCC-CCChHHHHHHhcC----C---------C--C-------
Q psy16430 410 GTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYK-DVDSSAIIWGVGS----S---------S--L------- 465 (600)
Q Consensus 410 gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~-~~~~~~~~~~i~~----~---------~--~------- 465 (600)
.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||- +.+..+.+-+|.. . . +
T Consensus 194 ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i 273 (338)
T KOG0668|consen 194 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI 273 (338)
T ss_pred ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH
Confidence 7888999999865 567889999999999999999888874 4443332221110 0 0 0
Q ss_pred -------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 -------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 -------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
........+++..+|+.++|..|-.+|||++|.+.||+|...
T Consensus 274 ~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 274 LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 001112346899999999999999999999999999998653
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=285.42 Aligned_cols=243 Identities=21% Similarity=0.304 Sum_probs=202.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccch------HHHHHHHHhcC------CCCcccccceeecCCceeE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK------ETDIRHLRKLN------HPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~------~~Ei~~L~~L~------HpnIv~l~~~~~~~~~~~l 326 (600)
..|.+....|.|-||+|.+|... +..||||+++... ..|+++|++|+ --|+++++-.|...+++||
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 67888888999999999999865 6899999997542 57999999995 3589999999999999999
Q ss_pred EEeeeccccchhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccccCC
Q psy16430 327 VMEYCAYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNK 402 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~---~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~ 402 (600)
|+|-+. .+|.+++++- -.+....+..|+.|+..||..|-..||+|.||||+||||+.. ..+||||||.|......
T Consensus 512 VFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 512 VFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred Eehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc
Confidence 999884 7899999863 358889999999999999999999999999999999999865 56899999999887665
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC------------CCC-----
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS------------SSL----- 465 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~------------~~~----- 465 (600)
..+ .+.-+..|.|||++.|.+|+...|+||+||+||||.||+..|++.+...++...+. +.+
T Consensus 591 eit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHF 669 (752)
T KOG0670|consen 591 EIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHF 669 (752)
T ss_pred ccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhc
Confidence 432 34557789999999999999999999999999999999999999887776542211 000
Q ss_pred -----------------------CCCCC-----------CCCc-------HHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 466 -----------------------HLPIP-----------STCP-------DGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 466 -----------------------~~~~p-----------~~~~-------~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
...-| ..+| ..+++|+..||..||++|.|..++|.||+|
T Consensus 670 D~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 670 DQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred ccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcc
Confidence 00001 0111 368999999999999999999999999987
Q ss_pred h
Q psy16430 505 A 505 (600)
Q Consensus 505 ~ 505 (600)
.
T Consensus 750 ~ 750 (752)
T KOG0670|consen 750 T 750 (752)
T ss_pred c
Confidence 4
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=267.48 Aligned_cols=245 Identities=25% Similarity=0.383 Sum_probs=197.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccch---------HHHHHHHHhcCCCCcccccceeecCC-----ce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGVCTQAP-----CY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------~~Ei~~L~~L~HpnIv~l~~~~~~~~-----~~ 324 (600)
.+++.-+.||.|+||+||.+++. ++.||+|++..-+ -+|+++|.-++|.|++..+++..-.+ .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34555678999999999999864 7999999986433 46899999999999999998875443 36
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
|+|+|++. .+|..+|-.-..++.+.+.-+++||+.||+|||+.||+||||||.|+|+++|..+||||||+++.......
T Consensus 133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 78999985 68999998888899999999999999999999999999999999999999999999999999998765433
Q ss_pred C--cccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc--------------------
Q psy16430 405 K--MSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG-------------------- 461 (600)
Q Consensus 405 ~--~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~-------------------- 461 (600)
. ...+-|.+|.|||++.| ..|+.++||||.|||+.||+..+..|...++.+.+..|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2 22456889999999877 678999999999999999999999998766543332111
Q ss_pred ---CCCCCCC-C--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 462 ---SSSLHLP-I--------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 462 ---~~~~~~~-~--------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.+....| . +..-..+...++..++.+||++|.+..+.+.|+....
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1111111 1 1122346778889999999999999999999997654
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=255.14 Aligned_cols=206 Identities=31% Similarity=0.449 Sum_probs=170.4
Q ss_pred ccccccccccccccCCCCcceEEEe--EeeceEEEeeeeccch--------HHHHHHHH-hcCCCCcccccceeecCCce
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQK--------ETDIRHLR-KLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a--~~~~~~vAvK~~~~~~--------~~Ei~~L~-~L~HpnIv~l~~~~~~~~~~ 324 (600)
++++.+++..+..||+|+||.|=+- ..+|...|+|.++... .+|+.+.. ...+|.+|.+||........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 6778888888999999999987544 4568999999986432 23444433 33699999999999999999
Q ss_pred eEEEeeeccccchhh----ccCCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 325 CIVMEYCAYGPLYNL----LKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~----l~~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
+|.||.|. .||..+ ++.++.+++..+-+|+..++.||.|||++ .+||||+||+|||++.+|.+|+||||++..+
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999996 577655 45678899999999999999999999997 8999999999999999999999999999888
Q ss_pred cCCCCCcccCCCccccChhhhcc----CCCCCccceechhHHHHHHhhCCCCCCCC-ChHHHHHHhcC
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRN----EQCSDKIDIWSYGIVLWELLTCETPYKDV-DSSAIIWGVGS 462 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSlGviLyELltG~~Pf~~~-~~~~~~~~i~~ 462 (600)
.++-..+--.|-..|||||.+.. ..|+-+|||||||+++.||.+++.||... ++.+.+.++..
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 76655544678889999998743 47899999999999999999999999753 45555555443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=302.56 Aligned_cols=353 Identities=24% Similarity=0.329 Sum_probs=255.6
Q ss_pred ccchhhhccCCCCeEEEeccCCCeeeccCC-ceeEeecccccccCC-CCc---cccccC-ceeeccccccccc-ccCccc
Q psy16430 154 GGPYWFLAGCTTPDALAESIGLGVLIGSKE-EAKISDFGTCREWNN-KST---KMSFAG-TVAWMAPEVIRNE-QCSDKI 226 (600)
Q Consensus 154 ~a~~~~~~~~~~~iiHrdlk~~NILLd~~~-~~Kv~DFGlsr~~~~-~~~---~~~~~G-T~~ymAPE~i~~~-~~s~~~ 226 (600)
.+.-|+|- ...+.|||+||.|.+++..+ ..|++|||+|..+.. ... ....+| ++.|+|||..... ......
T Consensus 134 s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~ 211 (601)
T KOG0590|consen 134 SGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSV 211 (601)
T ss_pred cCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCc
Confidence 33345563 34599999999999999999 999999999987655 222 224678 9999999998764 346778
Q ss_pred ccccccccccccccccccc-----------------------cc------------------------cccccccccccc
Q psy16430 227 DIWYKNRLCFPTSLMARIG-----------------------EF------------------------KSFVLRDEWEIP 259 (600)
Q Consensus 227 Dvy~~~~~~~p~sl~~~~~-----------------------~~------------------------~~~~~~~~~ei~ 259 (600)
|+||-|++..-.-...... .+ ......+.|...
T Consensus 212 d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 212 DVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 9999998876211100000 00 000011112111
Q ss_pred ----------c--------------ccc-ccccccCCCCcceEEEeEee--ceEEEeeeec----cc---------hHHH
Q psy16430 260 ----------F--------------ESI-SDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR----EQ---------KETD 299 (600)
Q Consensus 260 ----------~--------------~~~-~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~----~~---------~~~E 299 (600)
. +.| .....+|.|++|.|+..... ....+.|.++ .. ...|
T Consensus 292 ~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE 371 (601)
T KOG0590|consen 292 KRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSE 371 (601)
T ss_pred cccccccccccccccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhh
Confidence 0 012 23457899999977766532 2334444332 11 1123
Q ss_pred HHHHHhcCCCCcccccceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 300 IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 300 i~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+-+-..+.|||++..+..+.+....+-+||||++ +|..++...+.++..++-.++.|++.|+.|||+.||.|||+||+|
T Consensus 372 ~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~en 450 (601)
T KOG0590|consen 372 FCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLEN 450 (601)
T ss_pred eeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCcccc
Confidence 3344567999999888887666666566999998 999999988889999999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCC-----CCcccCCCccccChhhhccCCCCC-ccceechhHHHHHHhhCCCCCCCCCh
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKS-----TKMSFAGTVAWMAPEVIRNEQCSD-KIDIWSYGIVLWELLTCETPYKDVDS 453 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~-ksDIwSlGviLyELltG~~Pf~~~~~ 453 (600)
++++.+|.+||+|||.+..+.... .....+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||.....
T Consensus 451 ll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 451 LLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred EEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 999999999999999987765332 234578999999999999988875 69999999999999999999976544
Q ss_pred HHHH--HHhcCCCC-----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 454 SAII--WGVGSSSL-----HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 454 ~~~~--~~i~~~~~-----~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
.+.. ........ ...+...+|...+.+|.+||+.||.+|.|+++|++.+|+.....
T Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 531 SDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred cccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 3221 11111111 11123456888999999999999999999999999999987643
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=266.72 Aligned_cols=249 Identities=28% Similarity=0.488 Sum_probs=209.1
Q ss_pred ccccccccccccccccCCCCcceEEEeEeec-------eEEEeeeeccch--------HHHHHHHHhcCCCCccccccee
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQK--------ETDIRHLRKLNHPNIVKFKGVC 318 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~--------~~Ei~~L~~L~HpnIv~l~~~~ 318 (600)
.++.+..++++....+-+|.||.||.|.|.. +.|-+|.++... ..|--.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3555666788889999999999999997652 456667665432 2455566677899999999987
Q ss_pred e-cCCceeEEEeeeccccchhhcc-----C---CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCce
Q psy16430 319 T-QAPCYCIVMEYCAYGPLYNLLK-----D---GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAK 389 (600)
Q Consensus 319 ~-~~~~~~lV~Ey~~ggsL~~~l~-----~---~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vk 389 (600)
. +....++++.++.-|+|..++. + ...++..++..++.|++.|++|||++||||.||...|++|++.-.+|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 4 4456788899998999999986 1 13477788899999999999999999999999999999999999999
Q ss_pred eeccCccccccCCCCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCC
Q psy16430 390 ISDFGTCREWNNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSL 465 (600)
Q Consensus 390 L~DFGla~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~ 465 (600)
|+|=.+++.+-..... .+-..+..|||||.+.+..|+.++||||||++||||+| |+.||...++.++...+.+ ++
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-Gy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-GY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-cc
Confidence 9999999876543221 12334678999999999999999999999999999999 9999999999998877754 46
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 466 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
++..|-+||+++..+|..||...|++||+++|+..-+.
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 78889999999999999999999999999999988763
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=278.17 Aligned_cols=190 Identities=30% Similarity=0.473 Sum_probs=170.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccch---------------HHHHHHHHhcC---CCCcccccceee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------------ETDIRHLRKLN---HPNIVKFKGVCT 319 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------------~~Ei~~L~~L~---HpnIv~l~~~~~ 319 (600)
+.+|+.++.+|+|+||.|++|.++ ...|+||.+.+.. ..||.+|..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456899999999999999999876 4789999885431 35999999997 999999999999
Q ss_pred cCCceeEEEeee-ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 320 QAPCYCIVMEYC-AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 320 ~~~~~~lV~Ey~-~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
+++++||+||-- +|.+|.++|.....+++.++..|++|++.|+++||+.||||||||-+|+.++.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999976 5669999999889999999999999999999999999999999999999999999999999998876
Q ss_pred ccCCCCCcccCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCC
Q psy16430 399 WNNKSTKMSFAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKD 450 (600)
Q Consensus 399 ~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~ 450 (600)
..+ .....++||..|.|||++.|.+| +..-|||++|++||.++..+.||..
T Consensus 720 ~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 544 34457899999999999999887 5678999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=240.95 Aligned_cols=201 Identities=40% Similarity=0.676 Sum_probs=180.7
Q ss_pred cCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccchh
Q psy16430 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN 338 (600)
Q Consensus 269 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ 338 (600)
||+|++|.||++... ++.+++|++... +.+|+..++.+.|++|+++++++......+++||+++|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 699999999999987 789999998643 5579999999999999999999999899999999999999999
Q ss_pred hccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCccccccCCC-CCcccCCCcccc
Q psy16430 339 LLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTCREWNNKS-TKMSFAGTVAWM 415 (600)
Q Consensus 339 ~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~-~~~~~~gt~~Y~ 415 (600)
++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 98765 46899999999999999999999999999999999999998 8999999999988765432 123356788999
Q ss_pred ChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q psy16430 416 APEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494 (600)
Q Consensus 416 APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs 494 (600)
+||.+... .++.++|+||+|+++++| ..+.+++..|++.+|.+||+
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999876 788999999999999999 67899999999999999999
Q ss_pred HHHHHHcH
Q psy16430 495 FKQILSHL 502 (600)
Q Consensus 495 ~~elL~~l 502 (600)
+.++++++
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=266.23 Aligned_cols=122 Identities=27% Similarity=0.362 Sum_probs=105.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcC-----C---CCcccccceee----
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLN-----H---PNIVKFKGVCT---- 319 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~-----H---pnIv~l~~~~~---- 319 (600)
..+|.+.++||.|-|++||++-+. ++.||+|+++.. ...||++|++++ | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 368999999999999999999865 689999999743 357999999883 3 47999999985
Q ss_pred cCCceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCccc
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLI 382 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl 382 (600)
++.++|+|+|++ |.+|..+|+. -+.++...+..|++||+.||.|||.. ||||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 456899999999 6788888865 34699999999999999999999986 99999999999998
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=292.09 Aligned_cols=199 Identities=18% Similarity=0.201 Sum_probs=150.2
Q ss_pred HhcCC-CCccccccee-------ecCCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccC
Q psy16430 304 RKLNH-PNIVKFKGVC-------TQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374 (600)
Q Consensus 304 ~~L~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrD 374 (600)
+.++| +||+.++++| .....++.+|||+ +++|.+++.. ...+++.+++.+++||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 35566 6888888887 2334677889987 5699999965 45699999999999999999999999999999
Q ss_pred CCCCCcccCC-------------------CCCceeeccCccccccCCC-----------------CCcccCCCccccChh
Q psy16430 375 LKSPNVLIGS-------------------KEEAKISDFGTCREWNNKS-----------------TKMSFAGTVAWMAPE 418 (600)
Q Consensus 375 IKp~NILl~~-------------------~~~vkL~DFGla~~~~~~~-----------------~~~~~~gt~~Y~APE 418 (600)
|||+||||+. ++.+|++|||+++...... ......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999954 4456777777775421100 001245889999999
Q ss_pred hhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q psy16430 419 VIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498 (600)
Q Consensus 419 ~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~el 498 (600)
++.+..++.++|||||||+||||++|.+|+..... ....+...... +......+....++..||.++|.+|||+.++
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLP-PQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcC-hhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 99999999999999999999999999988764322 11111111111 1111224556789999999999999999999
Q ss_pred HHcHhhhh
Q psy16430 499 LSHLDIAS 506 (600)
Q Consensus 499 L~~l~~~~ 506 (600)
++|+|+..
T Consensus 263 l~h~~~~~ 270 (793)
T PLN00181 263 LQSEFINE 270 (793)
T ss_pred hhchhhhh
Confidence 99999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=237.56 Aligned_cols=198 Identities=35% Similarity=0.562 Sum_probs=171.4
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
|.+.+.||+|++|.||++... +..+|+|.+... +.+|+..+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456788999999999999875 488999998642 3468899999999999999999998899999999999
Q ss_pred cccchhhccCCCC-CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--CCcccC
Q psy16430 333 YGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--TKMSFA 409 (600)
Q Consensus 333 ggsL~~~l~~~~~-l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~ 409 (600)
+++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 9999999987666 8999999999999999999999999999999999999999999999999988775543 233456
Q ss_pred CCccccChhhh-ccCCCCCccceechhHHHHHHhhCCCCCCC-CChH-HHHHHh
Q psy16430 410 GTVAWMAPEVI-RNEQCSDKIDIWSYGIVLWELLTCETPYKD-VDSS-AIIWGV 460 (600)
Q Consensus 410 gt~~Y~APE~l-~~~~~s~ksDIwSlGviLyELltG~~Pf~~-~~~~-~~~~~i 460 (600)
++..|++||.+ ....++.++||||||+++++|++|+.||.. .+.. .+...+
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 78899999998 667788899999999999999999999977 4444 444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=254.39 Aligned_cols=243 Identities=23% Similarity=0.387 Sum_probs=192.9
Q ss_pred cccccccccCCCCcceEEEeEe-----eceEEEeeeecc-----chHHHHHHHHhc-CCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVRE-----QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~-----~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.|..+++||+|+|++||++.. ..+.||+|.+.. ...+|+++|..+ .+.||+++.+++..++..++|||
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 6788899999999999999974 357899999853 457899999998 59999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCccccccC-------
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTCREWNN------- 401 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~------- 401 (600)
|++.....++... ++..++..+++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||+|.....
T Consensus 116 ~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred ccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 9999888888765 678999999999999999999999999999999999984 47789999999861100
Q ss_pred -C-------C------------------------------CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHh
Q psy16430 402 -K-------S------------------------------TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELL 442 (600)
Q Consensus 402 -~-------~------------------------------~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELl 442 (600)
. . ......||++|.|||++.. ...++++||||.|+|+..++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0 0 0012459999999999854 56789999999999999999
Q ss_pred hCCCCCCCCCh-----HHHH---------H------H--hcC-CC-------------C------C--------CCCCCC
Q psy16430 443 TCETPYKDVDS-----SAII---------W------G--VGS-SS-------------L------H--------LPIPST 472 (600)
Q Consensus 443 tG~~Pf~~~~~-----~~~~---------~------~--i~~-~~-------------~------~--------~~~p~~ 472 (600)
++..||-.... .++. . . +.. .. . . ......
T Consensus 273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~ 352 (418)
T KOG1167|consen 273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV 352 (418)
T ss_pred ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence 99999854321 0000 0 0 000 00 0 0 000122
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.+..+.+|+.+||..||.+|.|+++.|.|++|..
T Consensus 353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 3558999999999999999999999999998864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=226.40 Aligned_cols=162 Identities=25% Similarity=0.315 Sum_probs=130.7
Q ss_pred ccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCc
Q psy16430 334 GPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTV 412 (600)
Q Consensus 334 gsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~ 412 (600)
|+|.+++.. +..+++.+++.++.||+.||.|||+.+ ||+|||++.++.+++ ||++....... ..||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 688899876 456999999999999999999999998 999999999999999 99987654322 26899
Q ss_pred cccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCC-----CCCCCCcH--HHHHHHHHh
Q psy16430 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHL-----PIPSTCPD--GFQLLMKMC 484 (600)
Q Consensus 413 ~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~-----~~p~~~~~--~l~~LI~~c 484 (600)
.|||||++.+..++.++|||||||++|||++|+.||...... .....+....... +.+...+. .+.++|.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 999999999999999999999999999999999999765432 2222221111111 11223333 699999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|..||.+|||+.+++.|++....
T Consensus 149 l~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 149 ASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=230.77 Aligned_cols=243 Identities=21% Similarity=0.307 Sum_probs=183.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccch------HHHHHHHHhc-CCCCcccccce-eecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK------ETDIRHLRKL-NHPNIVKFKGV-CTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~------~~Ei~~L~~L-~HpnIv~l~~~-~~~~~~~~lV~Ey 330 (600)
+.|.+.+.||+|.||.+-+++++ ++.+++|.+.+.. .+|...--.| .|.||+.-|++ |+..+.++++|||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 67899999999999999999987 4789999987543 3333322223 48999998876 6777788899999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC--CCCceeeccCccccccCCCCCccc
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS--KEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
++.|+|.+-+... .+-+.-...++.|+++||.|||+.++||||||.+||||.. ...+||||||.++..+..-. ..
T Consensus 104 aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~--~~ 180 (378)
T KOG1345|consen 104 APRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK--YL 180 (378)
T ss_pred CccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh--hh
Confidence 9999999888764 3788889999999999999999999999999999999953 34799999999875433211 22
Q ss_pred CCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCC---hHHHHHHhcCCCCCCCCC---CCCcHHH
Q psy16430 409 AGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVD---SSAIIWGVGSSSLHLPIP---STCPDGF 477 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p---~~~~~~l 477 (600)
..+..|.+||+... -...+.+|||.||+++|.++||.+||.... ....-+.-..+......| ...++.+
T Consensus 181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a 260 (378)
T KOG1345|consen 181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKA 260 (378)
T ss_pred hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHH
Confidence 34667899998643 234689999999999999999999997422 111111111122222233 4467888
Q ss_pred HHHHHHhhhcCCCCC---CCHHHHHHcHhhhh
Q psy16430 478 QLLMKMCWSNAPSSR---PSFKQILSHLDIAS 506 (600)
Q Consensus 478 ~~LI~~cL~~dP~~R---Ps~~elL~~l~~~~ 506 (600)
..+.++-|..+|++| .++......+|...
T Consensus 261 ~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 261 LRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred HHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 999999999999999 56666666666643
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=230.93 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=196.3
Q ss_pred ccccccccCCCCcceEEEeEeec---eEEEeeeecc-------chHHHHHHHHhcCC----CCccccccee-ecCCceeE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLRS---EIVAVKKVRE-------QKETDIRHLRKLNH----PNIVKFKGVC-TQAPCYCI 326 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~~---~~vAvK~~~~-------~~~~Ei~~L~~L~H----pnIv~l~~~~-~~~~~~~l 326 (600)
.|.+.+.||+|+||.||.+.... ..+|+|.... ....|+.++..+.. +++..+++.+ ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78999999999999999998654 4689988753 35678899988863 6899999998 57778999
Q ss_pred EEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-----CCceeeccCccc--
Q psy16430 327 VMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-----EEAKISDFGTCR-- 397 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-----~~vkL~DFGla~-- 397 (600)
||+.+ |.+|.++.+.. +.++..++..++.|++.+|.+||+.|++||||||+|++++.. ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99988 78999988543 579999999999999999999999999999999999999865 369999999998
Q ss_pred cccCCC--------C-CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC
Q psy16430 398 EWNNKS--------T-KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468 (600)
Q Consensus 398 ~~~~~~--------~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~ 468 (600)
.+.... . ...+.||..|+++.+..+...+.+.|+||++.++.+++.|..||.+.........+........
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~ 257 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL 257 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence 321111 1 2245699999999999999999999999999999999999999987664322222211111111
Q ss_pred ---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 469 ---IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 469 ---~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.....+..+..+...+-..+...+|.+..+...+.-..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 258 TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 33456788899999888899999999999988865433
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-26 Score=244.43 Aligned_cols=149 Identities=19% Similarity=0.244 Sum_probs=119.2
Q ss_pred Cccccccccchhhhhhccccccccccc-cccccCChhhhhhhhcccccccccccccccccccccccccCCccceeecccc
Q psy16430 77 INKVEHAGWLDWTRLTKLSVCWRPFCS-FVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGG 155 (600)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a 155 (600)
.|.|+..+=+.=..|.+|.|||.+.=. ++.||+.-. ||++..+.| +.... +|+|.+|++||+++|
T Consensus 119 ~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~-------nGsL~d~L~------~~~~~-~L~W~~R~kIa~g~A 184 (361)
T KOG1187|consen 119 LNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMP-------NGSLEDHLH------GKKGE-PLDWETRLKIALGAA 184 (361)
T ss_pred HHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccC-------CCCHHHHhC------CCCCC-CCCHHHHHHHHHHHH
Confidence 455666666666789999999998763 555553221 567765555 32332 899999999999999
Q ss_pred c--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccc-cCceeecccccccccccCcccccccc
Q psy16430 156 P--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSF-AGTVAWMAPEVIRNEQCSDKIDIWYK 231 (600)
Q Consensus 156 ~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~-~GT~~ymAPE~i~~~~~s~~~Dvy~~ 231 (600)
+ +|||..|.++||||||||+|||||+++++||+|||+|+..+. .....+. .||.+|+|||++..+..+.++|||||
T Consensus 185 ~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySF 264 (361)
T KOG1187|consen 185 RGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSF 264 (361)
T ss_pred HHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccc
Confidence 9 579999999999999999999999999999999999987655 3332233 89999999999999999999999999
Q ss_pred cccccccc
Q psy16430 232 NRLCFPTS 239 (600)
Q Consensus 232 ~~~~~p~s 239 (600)
|+++..+-
T Consensus 265 GVvllEli 272 (361)
T KOG1187|consen 265 GVVLLELI 272 (361)
T ss_pred hHHHHHHH
Confidence 99987653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=212.08 Aligned_cols=242 Identities=33% Similarity=0.447 Sum_probs=197.8
Q ss_pred cccccccCCCCcceEEEeEeeceEEEeeeecc----------chHHHHHHHHhcCCC-CcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE----------QKETDIRHLRKLNHP-NIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~----------~~~~Ei~~L~~L~Hp-nIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
|.+...||.|+||.||.+... ..+|+|.+.. .+.+|+.+++.+.|+ +|+++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 567788999999999999987 7788888742 235678889999988 7999999997777789999999
Q ss_pred ccccchhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCC----
Q psy16430 332 AYGPLYNLLKDGE---EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKS---- 403 (600)
Q Consensus 332 ~ggsL~~~l~~~~---~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~---- 403 (600)
.++++.+++.... .++...+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999998777654 799999999999999999999999999999999999999888 69999999998655432
Q ss_pred ---CCcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCC---CCCC
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLH---LPIP 470 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~---~~~p 470 (600)
......||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ......+...... ....
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence 2346789999999999987 5788999999999999999999999877653 3333333222221 1122
Q ss_pred CCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 471 STC----PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 471 ~~~----~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
... ...+.+++..++..+|..|.+..+...+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 222 25799999999999999999999888874443
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=213.68 Aligned_cols=241 Identities=29% Similarity=0.531 Sum_probs=205.2
Q ss_pred cccccccccccccCCCCcceEEEeEeeceEEEeeeec---------cchHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVR---------EQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~---------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.|++.++.++.+|.+...|..|+|+|.+..++.|++. .++..|.-.|+-+.||||+.++|.|...+.+.++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 4677888889999999999999999999888888763 4566788888889999999999999999999999
Q ss_pred EeeeccccchhhccCCCC--CCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCCCCCceee--ccCccccccC
Q psy16430 328 MEYCAYGPLYNLLKDGEE--VPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGSKEEAKIS--DFGTCREWNN 401 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~--l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~~~~vkL~--DFGla~~~~~ 401 (600)
..||+.|||+.++..+.. ++..++.+++.+++.|++|||+.. |.---+....++|+++-+++|+ |--++..
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence 999999999999987543 677899999999999999999973 4444688999999999887775 3222111
Q ss_pred CCCCcccCCCccccChhhhccCCCC---CccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCS---DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s---~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
.....-.|.||+||.+...+-+ .++|+|||++++|||.|.+.||.+..+.+.-.++.-..++..+|..++..+.
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 1123457899999999876543 5899999999999999999999999999988888888899999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.||.-|+..||.+||.++.|+-.++
T Consensus 420 klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred HHHHHHhcCCCCcCCCcceehhhHH
Confidence 9999999999999999998876653
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=201.95 Aligned_cols=244 Identities=20% Similarity=0.300 Sum_probs=199.7
Q ss_pred ccccccccccccCCCCcceEEEeEe--eceEEEeeeecc-----chHHHHHHHHhcCC-CCcccccceeecCCceeEEEe
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-----QKETDIRHLRKLNH-PNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-----~~~~Ei~~L~~L~H-pnIv~l~~~~~~~~~~~lV~E 329 (600)
|-...|.++++||+|+||.+|.|.. .+..||||.-+. +...|.++.+.|++ ..|..+..++.+..+-.+||+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3347899999999999999999985 479999998754 44678889888864 678888888888889999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC---CCceeeccCccccccCCCC-
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~- 404 (600)
++ |.||.+++.- .+.|+..+++-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+.+..+
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 98 7899998864 4579999999999999999999999999999999999999743 5789999999987654322
Q ss_pred -------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHH---HHHhcCCCCCCC---CCC
Q psy16430 405 -------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI---IWGVGSSSLHLP---IPS 471 (600)
Q Consensus 405 -------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~---~~~i~~~~~~~~---~p~ 471 (600)
.....||..|.+-....+...+...|+-|+|.+|.++..|..||.+...... ...|.......+ ...
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 1246799999999888888889999999999999999999999998765332 333433333322 346
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
..|.++...+..|-..--++-|+..-+-+..
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 7899999999999999999999987554443
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=208.13 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=201.7
Q ss_pred cccccccccCCCCcceEEEeE--eeceEEEeeeecc-----chHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGK--LRSEIVAVKKVRE-----QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~--~~~~~vAvK~~~~-----~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
-.|.+.++||+|+||.++.|+ .+++.||||.-.. +...|.+..+.| ..++|...|-+...+.+-.||||++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 468899999999999999998 4689999998753 346788888887 4799999998888888889999998
Q ss_pred cccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-----CCceeeccCccccccCCCCC-
Q psy16430 333 YGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-----EEAKISDFGTCREWNNKSTK- 405 (600)
Q Consensus 333 ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-----~~vkL~DFGla~~~~~~~~~- 405 (600)
|.||.++..- ++.|+..++..++.|++.-++|+|++.+|.|||||+|+||... ..+.|+|||+|+.+.+..+.
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 7899998865 5679999999999999999999999999999999999999754 35899999999987655432
Q ss_pred -------cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCCCCC---CCC
Q psy16430 406 -------MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLHLPI---PST 472 (600)
Q Consensus 406 -------~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~---p~~ 472 (600)
.+..||..||+-....+...+.+.|+-|||-++++.+-|..||.+... .+...+|+......++ ...
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g 266 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEG 266 (449)
T ss_pred cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhc
Confidence 356799999999999999999999999999999999999999998644 4555666655544333 356
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHc
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSH 501 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~ 501 (600)
+|.++...++..-..+-.+-|+++-+..-
T Consensus 267 ~P~efa~Yl~yvR~L~F~E~PDYdylr~L 295 (449)
T KOG1165|consen 267 FPEEFATYLRYVRRLDFFETPDYDYLRKL 295 (449)
T ss_pred CHHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 78899998888888888899998755443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=220.59 Aligned_cols=154 Identities=19% Similarity=0.213 Sum_probs=123.3
Q ss_pred ccccccccccccCCCCcceEEEeEe---eceEEEeeeecc------------chHHHHHHHHhcCCCCccc-ccceeecC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL---RSEIVAVKKVRE------------QKETDIRHLRKLNHPNIVK-FKGVCTQA 321 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~---~~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~-l~~~~~~~ 321 (600)
.-.+.|.+.+.||+|+||+||+|.+ .++.||||++.. .+.+|+++|++++|+||+. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 3347899999999999999999986 357789998532 2468999999999999985 4432
Q ss_pred CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCC-CCCCcccCCCCCceeeccCcccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL-KSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDI-Kp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
+..|+||||++|++|... ... . ...++.|++.||.|||+.||+|||| ||+|||++.++.++|+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 457999999999999632 111 1 1467899999999999999999999 9999999999999999999998765
Q ss_pred CCCCC---------cccCCCccccChhhhcc
Q psy16430 401 NKSTK---------MSFAGTVAWMAPEVIRN 422 (600)
Q Consensus 401 ~~~~~---------~~~~gt~~Y~APE~l~~ 422 (600)
..... .+..+++.|+|||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 43211 23567888999999854
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-23 Score=224.73 Aligned_cols=230 Identities=23% Similarity=0.356 Sum_probs=197.6
Q ss_pred cCCCCcceEEEeE-----eeceEEEeeeeccc---------hHHHHHHHHhcC-CCCcccccceeecCCceeEEEeeecc
Q psy16430 269 LGSGAQGAVFSGK-----LRSEIVAVKKVREQ---------KETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 269 LG~G~fG~Vy~a~-----~~~~~vAvK~~~~~---------~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+|.|+||.|++++ ..+..+|+|+.++. ...|..++..++ ||.+|+++..++.+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999764 34677888876432 235677787786 99999999999999999999999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCcc
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA 413 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~ 413 (600)
|.|...+.+...+++.....+...++.|+.++|+.||+|||+|++||+++.+|.+++.|||+++..-..... +||..
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYE 158 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchh
Confidence 999999988888999999999999999999999999999999999999999999999999999876544332 89999
Q ss_pred ccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy16430 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493 (600)
Q Consensus 414 Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP 493 (600)
|||||++. ....++|.||||+++++|+||..||.+ ++...|... .+++|...+..+++++..++..+|.+|.
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence 99999998 567899999999999999999999998 444444333 3567888999999999999999999996
Q ss_pred C-----HHHHHHcHhhhhhhh
Q psy16430 494 S-----FKQILSHLDIASQEV 509 (600)
Q Consensus 494 s-----~~elL~~l~~~~~~~ 509 (600)
- +.++++|..+.....
T Consensus 231 g~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 231 GAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred ccCcchhHHHhccchheeeeH
Confidence 4 578999998876543
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-22 Score=223.37 Aligned_cols=234 Identities=21% Similarity=0.214 Sum_probs=179.7
Q ss_pred ccccccccCCCCcceEEEeEeeceEEEeeeeccch--------H---HHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK--------E---TDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~--------~---~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++...+.||++.|=.|.+|+++...|+||++-++. . .|++ ...+++||++.+.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 56677889999999999999887779999985432 2 2344 5556899999999888888889999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc--cCC--CCC-
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW--NNK--STK- 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~--~~~--~~~- 405 (600)
.. .+|+|.+..+.-+..-+.+.|+.||+.||..+|..||+|||||.+||||+.-+-+.|+||..-+.. ... ...
T Consensus 103 vk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred Hh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 96 589999988777888889999999999999999999999999999999999999999999865432 111 111
Q ss_pred ---cccCCCccccChhhhccC----------C-CCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC-CCC--
Q psy16430 406 ---MSFAGTVAWMAPEVIRNE----------Q-CSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS-LHL-- 467 (600)
Q Consensus 406 ---~~~~gt~~Y~APE~l~~~----------~-~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~-~~~-- 467 (600)
.+.....+|.|||.+... . .+++-||||+||+++||++ |++||.-. +.... ..+. ...
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aY-r~~~~~~~e~ 257 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAY-RSGNADDPEQ 257 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhH-hccCccCHHH
Confidence 122345689999987431 2 5678999999999999998 89998521 11111 1110 000
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHc
Q psy16430 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501 (600)
Q Consensus 468 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~ 501 (600)
.+...-+..++.+|..|++.||++|.|+++.|+.
T Consensus 258 ~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0011123468999999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=193.74 Aligned_cols=163 Identities=15% Similarity=0.144 Sum_probs=130.4
Q ss_pred ccccccccccCCCCcceEEEeEeeceEEEeeeeccc----------------hHHHHHHHHhcCCCCcccccceeecC--
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ----------------KETDIRHLRKLNHPNIVKFKGVCTQA-- 321 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~----------------~~~Ei~~L~~L~HpnIv~l~~~~~~~-- 321 (600)
..+|..++.||.|+||.||++...+..+|||.++.. +++|++.+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 378999999999999999998877788999999621 35788899999999999998886533
Q ss_pred ------CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 322 ------PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 322 ------~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
+..+|||||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.++ ++|+|||.
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~ 180 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG 180 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence 35789999999999987732 333 2456999999999999999999999999999888 99999998
Q ss_pred cccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHh
Q psy16430 396 CREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELL 442 (600)
Q Consensus 396 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELl 442 (600)
.......... .-++....+..++|+||||+++.-+.
T Consensus 181 ~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 181 KRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 7654322111 11344456678999999999887653
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=213.96 Aligned_cols=340 Identities=19% Similarity=0.201 Sum_probs=237.1
Q ss_pred hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeeccccccc---ccccCccccccccc
Q psy16430 157 YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIR---NEQCSDKIDIWYKN 232 (600)
Q Consensus 157 ~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i~---~~~~s~~~Dvy~~~ 232 (600)
.|+|. ..=+|||||..||||++.|.+|++|||.+..+..... ..++.||+.|||||+.. .+.|...+|+|+.|
T Consensus 126 ~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~g 202 (829)
T KOG0576|consen 126 KYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALG 202 (829)
T ss_pred hhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccc
Confidence 45554 4569999999999999999999999999976543322 34689999999999863 56799999999999
Q ss_pred cccccccccccccc-----------cccccccccccccccccccccccCCCCcceEEEeEeec-eEEEeeeeccch--HH
Q psy16430 233 RLCFPTSLMARIGE-----------FKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVREQK--ET 298 (600)
Q Consensus 233 ~~~~p~sl~~~~~~-----------~~~~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~--~~ 298 (600)
+...........-. .++.......+-+..-+...+-+++|+++.+++.+... +....+.+.... .-
T Consensus 203 itAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl 282 (829)
T KOG0576|consen 203 ITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRL 282 (829)
T ss_pred cchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHH
Confidence 87764433221110 11111222233344556677778999999999998653 333355554433 34
Q ss_pred HHHHHHhcCCCC-cccccceeecCCceeEEEeeeccc-cchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCC
Q psy16430 299 DIRHLRKLNHPN-IVKFKGVCTQAPCYCIVMEYCAYG-PLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375 (600)
Q Consensus 299 Ei~~L~~L~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~gg-sL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDI 375 (600)
++++|.+++||| .+..++-++.+...+++|+++.++ +...... ..-.+..-++..+.+.-.+++++||+.-=+|+|
T Consensus 283 ~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d- 361 (829)
T KOG0576|consen 283 AIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD- 361 (829)
T ss_pred HHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc-
Confidence 788999999999 777788888888999999999877 3322221 112344455666777788899999998778998
Q ss_pred CCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH
Q psy16430 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA 455 (600)
Q Consensus 376 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~ 455 (600)
||+.+ ++..+..||+....+.......+..+|+.++|||+.....+....|+||+|.-..+|.-|.+|-.. +..
T Consensus 362 ---~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~ 435 (829)
T KOG0576|consen 362 ---NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPA 435 (829)
T ss_pred ---ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Ccc
Confidence 77774 478999999999888777666778899999999999999999999999999988888888777544 111
Q ss_pred HHHHhcCCCCCCCC-C-CCCcHHH-HHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 456 IIWGVGSSSLHLPI-P-STCPDGF-QLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 456 ~~~~i~~~~~~~~~-p-~~~~~~l-~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
....+..+.-.+.. + ...++.. .++...|+...|..|+.....+.+-.|..
T Consensus 436 ~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 436 VLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 11111111100000 0 1111112 24667788888888888877776654443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=186.55 Aligned_cols=132 Identities=18% Similarity=0.219 Sum_probs=107.1
Q ss_pred ccccCCCCcceEEEeEe-eceEEEeeeeccch---------------------------------HHHHHHHHhcCCCCc
Q psy16430 266 LQWLGSGAQGAVFSGKL-RSEIVAVKKVREQK---------------------------------ETDIRHLRKLNHPNI 311 (600)
Q Consensus 266 ~~~LG~G~fG~Vy~a~~-~~~~vAvK~~~~~~---------------------------------~~Ei~~L~~L~HpnI 311 (600)
...||+|+||.||+|.. +++.||||+++... ..|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999986 47899999985321 138889999988887
Q ss_pred ccccceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHh-HhCCccccCCCCCCcccCCCCCcee
Q psy16430 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYL-HSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 312 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~L-H~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
.....+... ..+|||||++|+++.......+.++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 544433222 2389999999887765544456799999999999999999999 799999999999999998 578999
Q ss_pred eccCcccccc
Q psy16430 391 SDFGTCREWN 400 (600)
Q Consensus 391 ~DFGla~~~~ 400 (600)
+|||+|....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05147 159 IDVSQSVEHD 168 (190)
T ss_pred EEccccccCC
Confidence 9999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=190.05 Aligned_cols=192 Identities=24% Similarity=0.332 Sum_probs=143.8
Q ss_pred CCCCcccccceeec---------------------------CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHH
Q psy16430 307 NHPNIVKFKGVCTQ---------------------------APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIA 359 (600)
Q Consensus 307 ~HpnIv~l~~~~~~---------------------------~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl 359 (600)
+|||||.+.++|.+ +..+|+||.-++ .+|..++-.+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999887743 234689998886 57888886543 56677788999999
Q ss_pred HHHHHhHhCCccccCCCCCCcccC--CC--CCceeeccCccccccC-------CCCCcccCCCccccChhhhccCC----
Q psy16430 360 AGMNYLHSKQIIHRDLKSPNVLIG--SK--EEAKISDFGTCREWNN-------KSTKMSFAGTVAWMAPEVIRNEQ---- 424 (600)
Q Consensus 360 ~aL~~LH~~gIvHrDIKp~NILl~--~~--~~vkL~DFGla~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~---- 424 (600)
+|+.|||.+||.|||+|.+|||+. ++ ..+.|+|||.+---.. .+......|+-.-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 33 3578999998643222 11222456888999999985432
Q ss_pred --CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy16430 425 --CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILS 500 (600)
Q Consensus 425 --~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~ 500 (600)
-..++|.|+.|.+.||+++...||.+......-...-....-+++|+.+|+.+++++..+|+.||++|+|..-.-+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1358999999999999999999998732211111101112234678999999999999999999999999765444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=180.99 Aligned_cols=133 Identities=18% Similarity=0.235 Sum_probs=108.3
Q ss_pred ccccCCCCcceEEEeEee-ceEEEeeeeccc---------------------------------hHHHHHHHHhcCCCCc
Q psy16430 266 LQWLGSGAQGAVFSGKLR-SEIVAVKKVREQ---------------------------------KETDIRHLRKLNHPNI 311 (600)
Q Consensus 266 ~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~---------------------------------~~~Ei~~L~~L~HpnI 311 (600)
...||+|+||.||+|... |+.||||+++.. ...|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999875 899999998642 1357788999999988
Q ss_pred ccccceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCcee
Q psy16430 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 312 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL 390 (600)
.....+.... .|+||||++|+++.........++...+..++.|++.+|.+||+ .||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 6554443332 48999999988554432234568889999999999999999999 9999999999999998 889999
Q ss_pred eccCccccccC
Q psy16430 391 SDFGTCREWNN 401 (600)
Q Consensus 391 ~DFGla~~~~~ 401 (600)
+|||++.....
T Consensus 159 iDFG~a~~~~~ 169 (190)
T cd05145 159 IDVSQAVELDH 169 (190)
T ss_pred EEcccceecCC
Confidence 99999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-20 Score=211.69 Aligned_cols=217 Identities=27% Similarity=0.398 Sum_probs=167.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccchHHHHHHHHhcCCCCcccccceeecCCceeEEEeeeccccchh
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN 338 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ 338 (600)
.+|..++.|..|+||.||.++++ .+.+|+|+-++.. +++. |..+- ++ .+.| |+-..
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn-----ilt~a----~n--pfvv------gDc~t 140 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN-----ILTFA----GN--PFVV------GDCAT 140 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc-----ccccc----CC--ccee------chhhh
Confidence 67888999999999999999876 6889985443321 2221 22221 11 2222 55666
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---------------
Q psy16430 339 LLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--------------- 403 (600)
Q Consensus 339 ~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--------------- 403 (600)
.++.-++++... +.+++|||+.||+|||+||+|.+|+.-|.+|+.|||+++...-..
T Consensus 141 llk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~E 212 (1205)
T KOG0606|consen 141 LLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHE 212 (1205)
T ss_pred hcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHH
Confidence 677666666544 789999999999999999999999999999999999986532110
Q ss_pred -CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC-CCCCCcHHHHHHH
Q psy16430 404 -TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP-IPSTCPDGFQLLM 481 (600)
Q Consensus 404 -~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~l~~LI 481 (600)
.....+|||.|.|||++..+.|+..+|+|++|+|+||.+.|..||.+.++++++..+.......+ -...++++.+++|
T Consensus 213 f~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli 292 (1205)
T KOG0606|consen 213 FQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLI 292 (1205)
T ss_pred hhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHH
Confidence 01236899999999999999999999999999999999999999999999988877655443332 3456789999999
Q ss_pred HHhhhcCCCCC---CCHHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSR---PSFKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~R---Ps~~elL~~l~~~~~ 507 (600)
.++|..+|..| +.+-++.+|.+|..-
T Consensus 293 ~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 293 EQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred HHHHHhChHhhcccchhhhhhhccceeec
Confidence 99999999999 466777788776544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=178.31 Aligned_cols=176 Identities=16% Similarity=0.107 Sum_probs=136.9
Q ss_pred cccccCCCCcceEEEeEeeceEEEeeeecc-----------chHHHHHHHHhcC-CCCcccccceeecCCceeEEEeeec
Q psy16430 265 DLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-----------QKETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 265 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-----------~~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
+...|++|+||+||.+...+..++.+.+.. .+.+|+++|++|. |++|++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 456799999999998888788888666531 3568999999995 5889999886 34689999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCC-CCCCcccCCCCCceeeccCccccccCCCCC------
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL-KSPNVLIGSKEEAKISDFGTCREWNNKSTK------ 405 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDI-Kp~NILl~~~~~vkL~DFGla~~~~~~~~~------ 405 (600)
|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 82 G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~ 154 (218)
T PRK12274 82 GAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAR 154 (218)
T ss_pred CccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHH
Confidence 9988754321 1 2357889999999999999999999 799999999999999999999865543321
Q ss_pred --------cccCCCccccChhhhcc-CCCC-CccceechhHHHHHHhhCCCCCCCC
Q psy16430 406 --------MSFAGTVAWMAPEVIRN-EQCS-DKIDIWSYGIVLWELLTCETPYKDV 451 (600)
Q Consensus 406 --------~~~~gt~~Y~APE~l~~-~~~s-~ksDIwSlGviLyELltG~~Pf~~~ 451 (600)
.....++.|++|+...- ...+ ...+.++.|+-+|.++|+..|+.+.
T Consensus 155 rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 155 EDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 01235788888876432 1233 5678889999999999998887543
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-21 Score=205.35 Aligned_cols=132 Identities=23% Similarity=0.265 Sum_probs=102.7
Q ss_pred cccccCChh-hhhhhhcccccccccccccccccccccccccCCccceeeccccchh-hhccCCCCeEEEeccCCCeeecc
Q psy16430 104 FVDKFSSPE-FKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPYW-FLAGCTTPDALAESIGLGVLIGS 181 (600)
Q Consensus 104 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~~-~~~~~~~~iiHrdlk~~NILLd~ 181 (600)
|++++..+. .-.+|.|.-+.++...+ ||.. ....++|..++.+++++|+++ |+|...+ ||||||||.||||+.
T Consensus 104 f~G~~~~~~~~~~iVtEy~~~GsL~~~---l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~ 178 (362)
T KOG0192|consen 104 FYGACTSPPGSLCIVTEYMPGGSLSVL---LHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDL 178 (362)
T ss_pred EEEEEcCCCCceEEEEEeCCCCcHHHH---Hhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcC
Confidence 666667766 23678885554444443 2232 346799999999999999975 3333334 999999999999999
Q ss_pred CC-ceeEeecccccccCCC-CccccccCceeeccccccc--ccccCccccccccccccccccc
Q psy16430 182 KE-EAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIR--NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 182 ~~-~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i~--~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
++ ++||||||+++..... ...+...||+.|||||++. ...|+.++|+||||+++|.+-.
T Consensus 179 ~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t 241 (362)
T KOG0192|consen 179 KGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT 241 (362)
T ss_pred CCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH
Confidence 98 9999999999976543 3344578999999999999 5699999999999999998744
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=185.29 Aligned_cols=222 Identities=18% Similarity=0.213 Sum_probs=138.6
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcC----------CCCcccccceee
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLN----------HPNIVKFKGVCT 319 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~----------HpnIv~l~~~~~ 319 (600)
.+.....||.|++|.||.+++. ++.+|+|++... ..+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456678999999999999976 599999998421 112211111111 112222222211
Q ss_pred ---------cC---C-----ceeEEEeeeccccchhhccC---CCC----CCHHHHHHHHHHHHHHHHHhHhCCccccCC
Q psy16430 320 ---------QA---P-----CYCIVMEYCAYGPLYNLLKD---GEE----VPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375 (600)
Q Consensus 320 ---------~~---~-----~~~lV~Ey~~ggsL~~~l~~---~~~----l~~~~i~~i~~qIl~aL~~LH~~gIvHrDI 375 (600)
.. . ..+++|+-+. ++|.+++.- ... +.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2367788774 678777531 111 122223556689999999999999999999
Q ss_pred CCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccChhhhcc--------CCCCCccceechhHHHHHHhhCCCC
Q psy16430 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN--------EQCSDKIDIWSYGIVLWELLTCETP 447 (600)
Q Consensus 376 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSlGviLyELltG~~P 447 (600)
+|+|++++.+|.+.|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|.+|..|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999877655433221 334578999998744 2467899999999999999999999
Q ss_pred CCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy16430 448 YKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492 (600)
Q Consensus 448 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 492 (600)
|........... .+......|+.++.||..+|+.||.+|
T Consensus 250 f~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 987654322110 122223788999999999999999987
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-18 Score=185.50 Aligned_cols=203 Identities=32% Similarity=0.581 Sum_probs=162.1
Q ss_pred HHhcCCCCcccccceeecCCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCc-cccCCCCCCc
Q psy16430 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQI-IHRDLKSPNV 380 (600)
Q Consensus 303 L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gI-vHrDIKp~NI 380 (600)
|+.+.|.|+.+++|.+.+++..++|.+||..|+|.+.+.. .-.++.-....++++|+.||.|||+..| .|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4578999999999999999999999999999999999987 3467777888999999999999999876 9999999999
Q ss_pred ccCCCCCceeeccCccccccCC---CCCcccCCCccccChhhhccC-------CCCCccceechhHHHHHHhhCCCCCCC
Q psy16430 381 LIGSKEEAKISDFGTCREWNNK---STKMSFAGTVAWMAPEVIRNE-------QCSDKIDIWSYGIVLWELLTCETPYKD 450 (600)
Q Consensus 381 Ll~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~Y~APE~l~~~-------~~s~ksDIwSlGviLyELltG~~Pf~~ 450 (600)
+++..-.+||+|||+....... .......-...|.|||.+.+. ..+.+.||||||++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998766421 111112235679999998763 146789999999999999999999975
Q ss_pred C----ChHHHHHHhcCCCC---CCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 451 V----DSSAIIWGVGSSSL---HLPIP--STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 451 ~----~~~~~~~~i~~~~~---~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
. ++.+++..+..... ++.+. ...++.+..+++.||..+|..||+++++-......
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 2 23455555554222 22222 14556899999999999999999999998776543
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-19 Score=204.80 Aligned_cols=194 Identities=20% Similarity=0.299 Sum_probs=161.9
Q ss_pred cccccccccccccccccCCCCcceEEEeEee-ceEEEeeeeccchHHH----HHHHHhcC---CCCcccccceeecCCce
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQKETD----IRHLRKLN---HPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~E----i~~L~~L~---HpnIv~l~~~~~~~~~~ 324 (600)
...+++..+.|.+-+.||+|+||.||.|... ++.||||+-+...-=| .+++.+|+ -+.|..+...+...+.-
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3456677788999999999999999999854 7999999987543323 34555665 34566666666666777
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-------CCCceeeccCccc
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-------KEEAKISDFGTCR 397 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-------~~~vkL~DFGla~ 397 (600)
++|+||.+.|+|.++++..+.+++..+..++.|++..+++||..+||||||||+|+||.. +..++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999998889999999999999999999999999999999999999952 3468999999987
Q ss_pred ccc---CCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCC
Q psy16430 398 EWN---NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCET 446 (600)
Q Consensus 398 ~~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~ 446 (600)
.+. +.......++|-.+-.+|+..|.+++..+|.|.|+-+++-|+.|++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 654 3333445678999999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=172.49 Aligned_cols=130 Identities=15% Similarity=0.222 Sum_probs=102.1
Q ss_pred cccccccCCCCcceEEEeEeeceEEEeeeecc-------chHHHHHHHHhc-----CCCCcccccceeecCC---cee-E
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-------QKETDIRHLRKL-----NHPNIVKFKGVCTQAP---CYC-I 326 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-------~~~~Ei~~L~~L-----~HpnIv~l~~~~~~~~---~~~-l 326 (600)
+...+.||+|+||.||........ +||++.. ...+|+.+++.+ +||||++++|++.++. .++ +
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 344567999999999973333333 6888753 246899999999 6799999999998764 333 7
Q ss_pred EEee--eccccchhhccCCCCCCHHHHHHHHHHHHHHH-HHhHhCCccccCCCCCCcccCCC----CCceeeccCcc
Q psy16430 327 VMEY--CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGM-NYLHSKQIIHRDLKSPNVLIGSK----EEAKISDFGTC 396 (600)
Q Consensus 327 V~Ey--~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL-~~LH~~gIvHrDIKp~NILl~~~----~~vkL~DFGla 396 (600)
|||| +.+++|.++++++ .+++. ..++.|++.++ +|||+++|+||||||+|||++.. ..++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 5579999999764 46665 35688888888 99999999999999999999743 37999995543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-18 Score=172.25 Aligned_cols=136 Identities=20% Similarity=0.198 Sum_probs=107.6
Q ss_pred ccccccccCCCCcceEEEeE---eeceEEEeeeeccc-------------------------------hHHHHHHHHhcC
Q psy16430 262 SISDLQWLGSGAQGAVFSGK---LRSEIVAVKKVREQ-------------------------------KETDIRHLRKLN 307 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~---~~~~~vAvK~~~~~-------------------------------~~~Ei~~L~~L~ 307 (600)
-|++.+.||+|+||.||+|. ..++.||+|.++.. ...|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777889999999999998 35799999988632 246888888887
Q ss_pred CCCcccccceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCC-ccccCCCCCCcccCCCC
Q psy16430 308 HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ-IIHRDLKSPNVLIGSKE 386 (600)
Q Consensus 308 HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~g-IvHrDIKp~NILl~~~~ 386 (600)
+.+ +.+..++.. ...++||||++|++|.........+....+..++.|++.+|.+||+.| |+||||||+||+++ ++
T Consensus 109 ~~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~ 185 (237)
T smart00090 109 EAG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG 185 (237)
T ss_pred hcC-CCCCeeeEe-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC
Confidence 532 222222222 235899999999888776544455677778899999999999999999 99999999999998 88
Q ss_pred CceeeccCcccccc
Q psy16430 387 EAKISDFGTCREWN 400 (600)
Q Consensus 387 ~vkL~DFGla~~~~ 400 (600)
.++|+|||.+....
T Consensus 186 ~i~LiDFg~a~~~~ 199 (237)
T smart00090 186 KVVIIDVSQSVELD 199 (237)
T ss_pred CEEEEEChhhhccC
Confidence 99999999887543
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-20 Score=188.36 Aligned_cols=137 Identities=26% Similarity=0.276 Sum_probs=94.6
Q ss_pred cccccccc-cccccccCChhh-hhhhhcccccccccccccccccccccccccCCccce--eecc--ccchhhhccCCCCe
Q psy16430 94 LSVCWRPF-CSFVDKFSSPEF-KTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQ--LELI--GGPYWFLAGCTTPD 167 (600)
Q Consensus 94 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~--i~~~--~a~~~~~~~~~~~i 167 (600)
|.-|+-|. =.+|+.|-++.- --+++|+-..+|++.. +.. ...|+.+.- |+.. .+..|||+. ++|
T Consensus 131 l~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~----~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~I 200 (364)
T KOG0581|consen 131 LRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDI----LKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKI 200 (364)
T ss_pred HhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHH----Hhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCe
Confidence 34454333 234666655552 4667773333232221 111 123444433 3333 344567764 789
Q ss_pred EEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccccc
Q psy16430 168 ALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 168 iHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
|||||||+|||+++.|.+||||||.|+.+-.. ...+++||..|||||.+.+..|+.++|+||+|...+.+-.+
T Consensus 201 IHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G 273 (364)
T KOG0581|consen 201 IHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG 273 (364)
T ss_pred eeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC
Confidence 99999999999999999999999999976443 44578999999999999999999999999999988766543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.8e-18 Score=166.37 Aligned_cols=127 Identities=21% Similarity=0.320 Sum_probs=110.6
Q ss_pred cccCCCCcceEEEeEeeceEEEeeeecc---------------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 267 QWLGSGAQGAVFSGKLRSEIVAVKKVRE---------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+.||+|++|.||+|.+.+..|++|+... ...+|+.++..+.|++|.....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999888999997532 2346888999999999988877777777889999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
+|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998865332 7889999999999999999999999999999998 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=162.43 Aligned_cols=123 Identities=21% Similarity=0.368 Sum_probs=104.3
Q ss_pred ccCCCCcceEEEeEeeceEEEeeeecc---------------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 268 WLGSGAQGAVFSGKLRSEIVAVKKVRE---------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.||+|+||.||+|.+.+..|++|.... ...+|+++++.+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 389999999999999899999998532 12368899999998887666556666677899999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
|++|.+.+..... .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988754321 7899999999999999999999999999998 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-18 Score=183.16 Aligned_cols=175 Identities=29% Similarity=0.460 Sum_probs=135.6
Q ss_pred CceeEEEeeeccccchhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~---~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
.++||.|++|...+|.+.+... ...+......++.|++.|+.| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3588999999999999999643 346677889999999999999 9999999999999999999999999999877
Q ss_pred ccCCC-------CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCC
Q psy16430 399 WNNKS-------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIP 470 (600)
Q Consensus 399 ~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 470 (600)
..... ......||..||+||.+.+..|+.++||||||++|+|+++ =..+|.. ......+..+.+++.+-
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFL 482 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHh
Confidence 65544 3335679999999999999999999999999999999997 2222221 11222233343332222
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 471 ~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
..+| .-..|+.+++.+.|.+||++.+..-|.+
T Consensus 483 ~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~ 514 (516)
T KOG1033|consen 483 QDYP-EEYTLLQQLLSPSPEERPSAIEVALHEF 514 (516)
T ss_pred hcCc-HHHHHHHHhcCCCcccCchHHHHhhhhh
Confidence 3333 3468999999999999997666555543
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.3e-19 Score=173.87 Aligned_cols=124 Identities=19% Similarity=0.186 Sum_probs=94.4
Q ss_pred cCCccce--eeccccchhhhccC--CC-CeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeeccccc
Q psy16430 143 SIPPQYQ--LELIGGPYWFLAGC--TT-PDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEV 216 (600)
Q Consensus 143 ~~~~r~~--i~~~~a~~~~~~~~--~~-~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~ 216 (600)
.++.+.. +...-++|++|-|. .+ -|+||||||+||+|+++|+||++||||+|.+....+ ..+.+|||.||.||.
T Consensus 120 ~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~ 199 (375)
T KOG0591|consen 120 LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPER 199 (375)
T ss_pred cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHH
Confidence 4555544 44444556665443 22 399999999999999999999999999998866544 557999999999999
Q ss_pred ccccccCccccccccccccccccccccccccccccccccccccccccccccccCCCCcceEE
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVF 278 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~sl~~~~~~~~~~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy 278 (600)
+...+|+.++|+||.|++.|....+.++.. .+ .-+++.++|-+|-|..++
T Consensus 200 i~~~~Y~~kSDiWslGCllyEMcaL~~PF~------g~------n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 200 IHESGYNFKSDIWSLGCLLYEMCALQSPFY------GD------NLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHhcCCCcc------cc------cHHHHHHHHHcCCCCCCc
Confidence 999999999999999999997654332221 11 335677889999887655
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.7e-18 Score=192.36 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=199.9
Q ss_pred cccccccccccCCCCcceEEEeEee---ceEEEeeeeccc---------hHHHHHHHHhcC-CCCcccccceeecCCcee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR---SEIVAVKKVREQ---------KETDIRHLRKLN-HPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~---------~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~ 325 (600)
+...|.+.+.||+|+|+.|-..... ...+|+|.+... ...|..+-..+. |+|++.+++...+....+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3466778888999999999877643 456777766422 123555666666 999999999999999999
Q ss_pred EEEeeeccccchhhc-cCCC-CCCHHHHHHHHHHHHHHHHHhH-hCCccccCCCCCCcccCCCC-CceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLL-KDGE-EVPPQRLYNWARQIAAGMNYLH-SKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l-~~~~-~l~~~~i~~i~~qIl~aL~~LH-~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 401 (600)
++++|..|+++.+.+ .... ..+...+-.++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5554 6788888999999999999999 99999999999999999999 999999999988765
Q ss_pred -CCCC---cccCC-CccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH--hcC-CCCCCCCCCC
Q psy16430 402 -KSTK---MSFAG-TVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG--VGS-SSLHLPIPST 472 (600)
Q Consensus 402 -~~~~---~~~~g-t~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~--i~~-~~~~~~~p~~ 472 (600)
.... ...+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||........... ... ..........
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 3222 23568 9999999999874 446889999999999999999999976554332211 111 1112334567
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.+....+++..++..+|..|.+.+++..++|...
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7889999999999999999999999999999877
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-18 Score=176.11 Aligned_cols=86 Identities=20% Similarity=0.376 Sum_probs=73.1
Q ss_pred ccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeeccccccc-CCCCccccccCceeecccccccccccCccccccc
Q psy16430 152 LIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWY 230 (600)
Q Consensus 152 ~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~-~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~ 230 (600)
+..|.+|||.. .||||||||.|||||.+|+++++|||||+.. ..+..+.++|||+-|||||++...+|+..+||||
T Consensus 134 i~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWs 210 (357)
T KOG0598|consen 134 IVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWS 210 (357)
T ss_pred HHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHh
Confidence 33455667764 6999999999999999999999999999954 3344556789999999999999999999999999
Q ss_pred cccccccccc
Q psy16430 231 KNRLCFPTSL 240 (600)
Q Consensus 231 ~~~~~~p~sl 240 (600)
.|++++..-.
T Consensus 211 LGillYeML~ 220 (357)
T KOG0598|consen 211 LGILLYEMLT 220 (357)
T ss_pred HHHHHHHHhh
Confidence 9999986543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=156.66 Aligned_cols=129 Identities=22% Similarity=0.173 Sum_probs=103.5
Q ss_pred cccccccCCCCcceEEEeEe-eceEEEeeeeccc-----------------------------hHHHHHHHHhcCCCC--
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL-RSEIVAVKKVREQ-----------------------------KETDIRHLRKLNHPN-- 310 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~-~~~~vAvK~~~~~-----------------------------~~~Ei~~L~~L~Hpn-- 310 (600)
|.+.+.||+|+||.||++.. .++.||||+++.. ...|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778899999999999987 4789999975421 245777888887774
Q ss_pred cccccceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCcee
Q psy16430 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI 390 (600)
Q Consensus 311 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL 390 (600)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 344333 2345899999999998765431 345678899999999999999999999999999999999999
Q ss_pred eccCccccccC
Q psy16430 391 SDFGTCREWNN 401 (600)
Q Consensus 391 ~DFGla~~~~~ 401 (600)
+|||++.....
T Consensus 167 iDfg~~~~~~~ 177 (198)
T cd05144 167 IDWPQMVSTDH 177 (198)
T ss_pred EECCccccCCC
Confidence 99999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=179.91 Aligned_cols=128 Identities=20% Similarity=0.253 Sum_probs=108.4
Q ss_pred cccccccCCCCcceEEEeEeeceEEEeeeec---------------cchHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLRSEIVAVKKVR---------------EQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~---------------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
|...+.||+|+||+||+|.+.+..+++|+.. ..+.+|+++++.++|++++....++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4557899999999999999877666655431 1235789999999999999887777777778999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
|||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999998875 356789999999999999999999999999999 6789999999998753
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.7e-18 Score=178.85 Aligned_cols=79 Identities=48% Similarity=0.736 Sum_probs=73.3
Q ss_pred hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccccccCccccccccccccc
Q psy16430 157 YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCF 236 (600)
Q Consensus 157 ~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~ 236 (600)
-|||.+ +|||||||..|||+..+-++||||||.++.+....+..+++||+.|||||+|++.+++.|+|+|||||++|
T Consensus 226 ~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLW 302 (904)
T KOG4721|consen 226 NYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLW 302 (904)
T ss_pred HHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHH
Confidence 467765 59999999999999999999999999999988777788999999999999999999999999999999999
Q ss_pred cc
Q psy16430 237 PT 238 (600)
Q Consensus 237 p~ 238 (600)
..
T Consensus 303 Em 304 (904)
T KOG4721|consen 303 EM 304 (904)
T ss_pred HH
Confidence 64
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.7e-18 Score=176.65 Aligned_cols=87 Identities=23% Similarity=0.323 Sum_probs=74.8
Q ss_pred ccccchhhhccCCCCeEEEeccCCCeeeccC------CceeEeecccccccCCCCccccccCceeecccccccccccCcc
Q psy16430 152 LIGGPYWFLAGCTTPDALAESIGLGVLIGSK------EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 225 (600)
Q Consensus 152 ~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~------~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~ 225 (600)
++.|..++|.. .||||||||.||||+.. -.+||+|||+||.+..+....+.||++.|||||++...+|+.|
T Consensus 118 LA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAK 194 (429)
T KOG0595|consen 118 LASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAK 194 (429)
T ss_pred HHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccch
Confidence 34444556654 59999999999999986 4689999999999988777778999999999999999999999
Q ss_pred cccccccccccccccc
Q psy16430 226 IDIWYKNRLCFPTSLM 241 (600)
Q Consensus 226 ~Dvy~~~~~~~p~sl~ 241 (600)
+|.||-|++.|.+-.+
T Consensus 195 ADLWSiG~Ilyq~l~g 210 (429)
T KOG0595|consen 195 ADLWSIGTILYQCLTG 210 (429)
T ss_pred hhHHHHHHHHHHHHhC
Confidence 9999999999976543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.1e-17 Score=163.55 Aligned_cols=81 Identities=19% Similarity=0.327 Sum_probs=71.9
Q ss_pred ccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccc
Q psy16430 154 GGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNR 233 (600)
Q Consensus 154 ~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~ 233 (600)
.|.+|+|+. .||+|||||.|||||.+|++||.|||+|+.+... +.+.||||-|||||+++..+|+.++|||++|+
T Consensus 155 lAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGV 229 (355)
T KOG0616|consen 155 LALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGV 229 (355)
T ss_pred HHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHH
Confidence 345678774 4999999999999999999999999999987444 55789999999999999999999999999999
Q ss_pred cccccc
Q psy16430 234 LCFPTS 239 (600)
Q Consensus 234 ~~~p~s 239 (600)
+.+..-
T Consensus 230 LIYEMl 235 (355)
T KOG0616|consen 230 LIYEML 235 (355)
T ss_pred HHHHHH
Confidence 998753
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-17 Score=177.38 Aligned_cols=102 Identities=21% Similarity=0.229 Sum_probs=84.5
Q ss_pred cccccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCcccccc--Cceeeccc
Q psy16430 137 AEQVRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFA--GTVAWMAP 214 (600)
Q Consensus 137 ~~~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~--GT~~ymAP 214 (600)
+++..++.++=+.++.++|+++-+.+ +.++|||||.++|||++++..|||+||||||....+.++.+.. -...|.||
T Consensus 295 ~~~~~l~~~~Ll~~a~qIaeGM~YLe-s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAP 373 (468)
T KOG0197|consen 295 REGGLLNLPQLLDFAAQIAEGMAYLE-SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAP 373 (468)
T ss_pred cCCCccchHHHHHHHHHHHHHHHHHH-hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCH
Confidence 34566788888889999999874444 4689999999999999999999999999999655554443322 24689999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+..+.||.++|||||||++|..-
T Consensus 374 Ea~~~~~FS~kSDVWSFGVlL~E~f 398 (468)
T KOG0197|consen 374 EALNYGKFSSKSDVWSFGVLLWELF 398 (468)
T ss_pred HHHhhCCcccccceeehhhhHHHHh
Confidence 9999999999999999999999763
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.4e-18 Score=165.24 Aligned_cols=138 Identities=20% Similarity=0.243 Sum_probs=100.3
Q ss_pred hhccccccccccccccccCChhhhhhhhc---ccccccccccccccccccccccccCCccceee--ccccchhhhccCCC
Q psy16430 91 LTKLSVCWRPFCSFVDKFSSPEFKTNIQE---RSEVKSATHYQVDLTGMAEQVRLSIPPQYQLE--LIGGPYWFLAGCTT 165 (600)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~--~~~a~~~~~~~~~~ 165 (600)
|.+++|-- ---...|+|+++.|-++|++ +|++ ++.+ .+...||=..--.|+ +-.+-.|+|..
T Consensus 76 LRqv~GHP-~II~l~D~yes~sF~FlVFdl~prGEL--FDyL-------ts~VtlSEK~tR~iMrqlfegVeylHa~--- 142 (411)
T KOG0599|consen 76 LRQVMGHP-YIIDLQDVYESDAFVFLVFDLMPRGEL--FDYL-------TSKVTLSEKETRRIMRQLFEGVEYLHAR--- 142 (411)
T ss_pred HHHhcCCC-cEEEeeeeccCcchhhhhhhhcccchH--HHHh-------hhheeecHHHHHHHHHHHHHHHHHHHHh---
Confidence 55666632 12345789999999999999 5654 2221 111222222222222 22344677764
Q ss_pred CeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc------cccCcccccccccccccccc
Q psy16430 166 PDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN------EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 166 ~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~------~~~s~~~Dvy~~~~~~~p~s 239 (600)
.||||||||.|||||+++.+||+|||+|..+..+..-...||||||+|||.+.. ..|+..+|.|+.|+++|..-
T Consensus 143 ~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 143 NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred hhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence 599999999999999999999999999999988877777999999999998863 45889999999999999654
Q ss_pred cc
Q psy16430 240 LM 241 (600)
Q Consensus 240 l~ 241 (600)
.+
T Consensus 223 aG 224 (411)
T KOG0599|consen 223 AG 224 (411)
T ss_pred cC
Confidence 43
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.6e-17 Score=166.88 Aligned_cols=102 Identities=21% Similarity=0.233 Sum_probs=78.0
Q ss_pred CCCeEEEeccCCCeeeccC---CceeEeecccccccCCCCccccccCceeeccccccccccc---Ccccccccccccccc
Q psy16430 164 TTPDALAESIGLGVLIGSK---EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC---SDKIDIWYKNRLCFP 237 (600)
Q Consensus 164 ~~~iiHrdlk~~NILLd~~---~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~---s~~~Dvy~~~~~~~p 237 (600)
+++|+||||||.||||..+ ..+||+|||+|+..+.+....+.|||+.|.|||++.+..+ ..++|+||.|+++|-
T Consensus 294 ~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 294 SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred HcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEE
Confidence 4689999999999999887 7899999999998887777778999999999999987654 357799999999986
Q ss_pred ccccccccccccccccccccccccccccccccCCCCcce
Q psy16430 238 TSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGA 276 (600)
Q Consensus 238 ~sl~~~~~~~~~~~~~~~~ei~~~~~~~~~~LG~G~fG~ 276 (600)
+-.+-.+ | .-...+-+..+.|++|.|..
T Consensus 374 cLsG~pP-----F------S~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 374 CLSGYPP-----F------SEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred EeccCCC-----c------ccccCCccHHHHHhcCcccc
Confidence 5322111 0 01112223457889998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-15 Score=144.65 Aligned_cols=129 Identities=25% Similarity=0.267 Sum_probs=93.2
Q ss_pred ccccCCCCcceEEEeEee-ceEEEeeeeccch-------------------------------HHHHHHHHhcCCCC--c
Q psy16430 266 LQWLGSGAQGAVFSGKLR-SEIVAVKKVREQK-------------------------------ETDIRHLRKLNHPN--I 311 (600)
Q Consensus 266 ~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~-------------------------------~~Ei~~L~~L~Hpn--I 311 (600)
.+.||+|+||+||+|... ++.||||+++... ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999876 7899999876421 12333344443322 2
Q ss_pred ccccceeecCCceeEEEeeeccccchh-hccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCce
Q psy16430 312 VKFKGVCTQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAK 389 (600)
Q Consensus 312 v~l~~~~~~~~~~~lV~Ey~~ggsL~~-~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vk 389 (600)
.+.++. ...++||||++|+++.. .+.... . ...+..++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 333322 23589999999854322 121111 1 16788999999999999999 9999999999999999 89999
Q ss_pred eeccCccccccC
Q psy16430 390 ISDFGTCREWNN 401 (600)
Q Consensus 390 L~DFGla~~~~~ 401 (600)
|+|||.+.....
T Consensus 155 liDfg~a~~~~~ 166 (187)
T cd05119 155 IIDVPQAVEIDH 166 (187)
T ss_pred EEECcccccccC
Confidence 999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.6e-15 Score=136.27 Aligned_cols=127 Identities=19% Similarity=0.209 Sum_probs=110.5
Q ss_pred cccccCCCCcceEEEeEeeceEEEeeeeccc-----hHHHHHHHHhcCC--CCcccccceeecCCceeEEEeeeccccch
Q psy16430 265 DLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ-----KETDIRHLRKLNH--PNIVKFKGVCTQAPCYCIVMEYCAYGPLY 337 (600)
Q Consensus 265 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~-----~~~Ei~~L~~L~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 337 (600)
+++.||+|+++.||++...+..+++|..... +..|+..++.+.| .++++++++....+..+++|||++|+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 4577999999999999988889999998653 5789999999976 58999998888778899999999988776
Q ss_pred hhccCCCCCCHHHHHHHHHHHHHHHHHhHhC---CccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 338 NLLKDGEEVPPQRLYNWARQIAAGMNYLHSK---QIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 338 ~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~---gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
.+ +......++.+++.+|.+||.. +++|||++|.||+++..+.++++|||.+..
T Consensus 82 ~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 5566778899999999999985 799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-16 Score=172.42 Aligned_cols=80 Identities=23% Similarity=0.412 Sum_probs=71.1
Q ss_pred hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeecccccccccccCccccccccccccc
Q psy16430 158 WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCF 236 (600)
Q Consensus 158 ~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~ 236 (600)
|||.+ +|||||||-.|||||.+|++||+|||||+... .+..+.++|||+-|||||++....|+.++|||+|||+++
T Consensus 483 fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLly 559 (694)
T KOG0694|consen 483 FLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLY 559 (694)
T ss_pred HHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHH
Confidence 45654 59999999999999999999999999999754 455667899999999999999999999999999999999
Q ss_pred cccc
Q psy16430 237 PTSL 240 (600)
Q Consensus 237 p~sl 240 (600)
..-.
T Consensus 560 eML~ 563 (694)
T KOG0694|consen 560 EMLV 563 (694)
T ss_pred HHHc
Confidence 7643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.8e-15 Score=149.46 Aligned_cols=127 Identities=16% Similarity=0.203 Sum_probs=100.8
Q ss_pred cccC-CCCcceEEEeEeeceEEEeeeecc--------------------chHHHHHHHHhcCCCCc--ccccceeecC-C
Q psy16430 267 QWLG-SGAQGAVFSGKLRSEIVAVKKVRE--------------------QKETDIRHLRKLNHPNI--VKFKGVCTQA-P 322 (600)
Q Consensus 267 ~~LG-~G~fG~Vy~a~~~~~~vAvK~~~~--------------------~~~~Ei~~L~~L~HpnI--v~l~~~~~~~-~ 322 (600)
..|| .||.|+||.+...+..++||.+.. ...+|+.++.+|.|++| +..+++.... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 899999999988888899987632 13469999999998875 5666654332 2
Q ss_pred c---eeEEEeeecc-ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 323 C---YCIVMEYCAY-GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 323 ~---~~lV~Ey~~g-gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
. .++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++.++.++|+|||.+..
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 2 3599999997 688888765 3455543 57899999999999999999999999999888999999998765
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=3e-16 Score=154.82 Aligned_cols=100 Identities=17% Similarity=0.208 Sum_probs=77.8
Q ss_pred ccCCccce--eeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc-
Q psy16430 142 LSIPPQYQ--LELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR- 218 (600)
Q Consensus 142 l~~~~r~~--i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~- 218 (600)
..++.|.- +...+-.|+++......|||||+||+|||+|..|++|+||||+|..+-....++..+|.+.|||||.+.
T Consensus 186 ~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp 265 (391)
T KOG0983|consen 186 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDP 265 (391)
T ss_pred CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCC
Confidence 34777764 333333344444445679999999999999999999999999998765555566789999999999885
Q ss_pred --ccccCcccccccccccccccccc
Q psy16430 219 --NEQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 219 --~~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
...|+-.+||||+|+..+....+
T Consensus 266 ~~~~kYDiRaDVWSlGITlveLaTg 290 (391)
T KOG0983|consen 266 PDKPKYDIRADVWSLGITLVELATG 290 (391)
T ss_pred CCCCccchhhhhhhhccchhhhhcc
Confidence 45688999999999999876543
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-16 Score=152.51 Aligned_cols=92 Identities=21% Similarity=0.210 Sum_probs=71.8
Q ss_pred eeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc----ccccCcc
Q psy16430 150 LELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR----NEQCSDK 225 (600)
Q Consensus 150 i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~----~~~~s~~ 225 (600)
|+.-+-.++-|.+..-.|||||+||+|||++.+|.+|+||||+|..+......+--.|...|||||.+. ...|+-+
T Consensus 153 Ia~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vk 232 (282)
T KOG0984|consen 153 IAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVK 232 (282)
T ss_pred hHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceee
Confidence 555555554333335679999999999999999999999999998765444444467889999999875 3479999
Q ss_pred cccccccccccccccc
Q psy16430 226 IDIWYKNRLCFPTSLM 241 (600)
Q Consensus 226 ~Dvy~~~~~~~p~sl~ 241 (600)
+|+||.|+.++....+
T Consensus 233 sDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 233 SDVWSLGITMIEMAIL 248 (282)
T ss_pred hhhhhhhhhhhhhhhc
Confidence 9999999999876543
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.8e-16 Score=165.52 Aligned_cols=98 Identities=18% Similarity=0.069 Sum_probs=82.7
Q ss_pred cccCCccce-eeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 141 RLSIPPQYQ-LELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 141 ~l~~~~r~~-i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++.=.+|.. .+..++-++-|.+ ...||+|||||.|||||+.|+++|+|.|||..+..+....+.+||.||||||++.+
T Consensus 282 ~gF~e~ra~FYAAEi~cGLehlH-~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n 360 (591)
T KOG0986|consen 282 PGFDEQRARFYAAEIICGLEHLH-RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN 360 (591)
T ss_pred CCCchHHHHHHHHHHHhhHHHHH-hcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcC
Confidence 344455655 5555555666655 46799999999999999999999999999999888877777899999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.|+..+|||+.|++.+..-
T Consensus 361 e~Y~~s~Dwf~lGCllYemi 380 (591)
T KOG0986|consen 361 EVYDFSPDWFSLGCLLYEMI 380 (591)
T ss_pred CcccCCccHHHHHhHHHHHH
Confidence 99999999999999998764
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-15 Score=164.44 Aligned_cols=270 Identities=19% Similarity=0.196 Sum_probs=198.9
Q ss_pred CCCCeEEEeccCCCeeeccC-CceeEeecccccccCCCCc------cccccCceeecccccccccccCcccccccccccc
Q psy16430 163 CTTPDALAESIGLGVLIGSK-EEAKISDFGTCREWNNKST------KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLC 235 (600)
Q Consensus 163 ~~~~iiHrdlk~~NILLd~~-~~~Kv~DFGlsr~~~~~~~------~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~ 235 (600)
.+..|+|=|+||.||.+..+ ...+..|||++..++.... ....-|...|++||++. +.++...|+|++|.+.
T Consensus 239 hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~ 317 (524)
T KOG0601|consen 239 HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVI 317 (524)
T ss_pred CCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhh
Confidence 35679999999999999999 8899999999997765432 11235788899999875 5566677777766443
Q ss_pred ccccccccccccccccccccccccccccccccccCCCCcceEEEeEeeceEEEeeeeccchHHHHHHHHhcCCCCccccc
Q psy16430 236 FPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHPNIVKFK 315 (600)
Q Consensus 236 ~p~sl~~~~~~~~~~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~Ei~~L~~L~HpnIv~l~ 315 (600)
.++. ...|.+++.++
T Consensus 318 l~~~-----------------------------------------------------------------l~~~~~~~g~~ 332 (524)
T KOG0601|consen 318 LEAI-----------------------------------------------------------------LGSHLPSVGKN 332 (524)
T ss_pred HhhH-----------------------------------------------------------------hhcccccCCCC
Confidence 3221 12477777777
Q ss_pred ceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFG 394 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFG 394 (600)
..|......|+--|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence 7777777777999999999887666444557888899999999999999999999999999999999876 788999999
Q ss_pred ccccccCCCCCcccCCCcccc--ChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCC
Q psy16430 395 TCREWNNKSTKMSFAGTVAWM--APEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPST 472 (600)
Q Consensus 395 la~~~~~~~~~~~~~gt~~Y~--APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 472 (600)
....+.-. .....+...++ +|.......+..+.|++|||..+.+.++|.+.-...... ..+..+. .+....
T Consensus 413 ~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~--~p~~~~ 485 (524)
T KOG0601|consen 413 CWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGD--TPNLPG 485 (524)
T ss_pred ccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeeccc--ccCCCc
Confidence 87642211 11222333444 555566677789999999999999999986532222111 1122222 223333
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+..+.+.+...++..||++.++..|..+.
T Consensus 486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 448899999999999999999999998887653
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-16 Score=175.53 Aligned_cols=144 Identities=17% Similarity=0.149 Sum_probs=111.5
Q ss_pred hhccccccccccccccccCChhhhhhhhc-ccccccccccccccccccccccccCCccceeeccccchhhhccCCCCeEE
Q psy16430 91 LTKLSVCWRPFCSFVDKFSSPEFKTNIQE-RSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPYWFLAGCTTPDAL 169 (600)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiH 169 (600)
+-||.|=|++--..++|||+-+++.+-.= +...+...+.. + +.....+|+-.+-+.||..+|.++-|.. +...||
T Consensus 551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~-~--g~~~~~~L~~~q~L~iA~QIAaGM~YLs-~~~FVH 626 (774)
T KOG1026|consen 551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLA-S--GQDTPPPLSTSQFLHIATQIAAGMEYLS-SHHFVH 626 (774)
T ss_pred eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCcccccc-C--CCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCcccc
Confidence 57999999999999999999888766322 22222222211 0 1112445888888889999999886664 577999
Q ss_pred EeccCCCeeeccCCceeEeecccccccCCCCcccc---ccCceeecccccccccccCccccccccccccccc
Q psy16430 170 AESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMS---FAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 170 rdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~---~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|||.++|+|++++.+|||+||||+|.+...+++.. ..=..+||+||.|..++||.++|||||||++|..
T Consensus 627 RDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 627 RDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred cchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 99999999999999999999999997655544321 1224799999999999999999999999999986
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.4e-16 Score=164.16 Aligned_cols=123 Identities=19% Similarity=0.143 Sum_probs=87.4
Q ss_pred cccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceee--ccccchhhhccCCCCeEEEeccCCCe
Q psy16430 100 PFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLE--LIGGPYWFLAGCTTPDALAESIGLGV 177 (600)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~--~~~a~~~~~~~~~~~iiHrdlk~~NI 177 (600)
-.|++|+||++-|+-..+......=.++..++. .++ +..|..|.| +++|+|||||++||
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIK----------------c~mkQLl~Gl~~cH---~~gvlHRDIK~SNi 249 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIK----------------CYMKQLLEGLEYCH---SRGVLHRDIKGSNI 249 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCCcccChHHHH----------------HHHHHHHHHHHHHh---hcCeeeccccccce
Confidence 359999999999995543332211122222211 111 112223333 46899999999999
Q ss_pred eeccCCceeEeecccccccCCCC--ccccccCceeecccccccc-cccCcccccccccccccccccc
Q psy16430 178 LIGSKEEAKISDFGTCREWNNKS--TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 178 LLd~~~~~Kv~DFGlsr~~~~~~--~~~~~~GT~~ymAPE~i~~-~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
|||.+|++||+|||||+.+.... ..++.+-|.||-|||++.+ ..|+.++|+||-|+++...-..
T Consensus 250 Lidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 250 LIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred EEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 99999999999999999775543 3566778999999998876 4599999999999988765443
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.4e-16 Score=159.01 Aligned_cols=89 Identities=24% Similarity=0.334 Sum_probs=77.3
Q ss_pred eeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccc-cCCCCccccccCceeecccccccccccCccccc
Q psy16430 150 LELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 228 (600)
Q Consensus 150 i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~-~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dv 228 (600)
.|..+|.++|+.+ ++.||+||||-.||+||++|++||+|||+|+. +-.+.++.++|||+.|+|||++...+|+.++||
T Consensus 455 YAaEiaigLFFLh-~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDW 533 (683)
T KOG0696|consen 455 YAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 533 (683)
T ss_pred hhHHHHHHhhhhh-cCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhH
Confidence 5566677776654 57899999999999999999999999999995 344556668999999999999999999999999
Q ss_pred ccccccccccc
Q psy16430 229 WYKNRLCFPTS 239 (600)
Q Consensus 229 y~~~~~~~p~s 239 (600)
|||||++|..-
T Consensus 534 Wa~GVLLyEml 544 (683)
T KOG0696|consen 534 WAFGVLLYEML 544 (683)
T ss_pred HHHHHHHHHHH
Confidence 99999999653
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-15 Score=150.22 Aligned_cols=92 Identities=17% Similarity=0.211 Sum_probs=72.3
Q ss_pred eeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc--cccCcccc
Q psy16430 150 LELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN--EQCSDKID 227 (600)
Q Consensus 150 i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~--~~~s~~~D 227 (600)
|.++...|+=|....-+|||||+||+|||||+.|.+|+||||+|..+......+.-+|...|||||.+.. ..|+-.+|
T Consensus 172 ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSD 251 (361)
T KOG1006|consen 172 ITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSD 251 (361)
T ss_pred eeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhh
Confidence 3333333443444456799999999999999999999999999987655545556789999999999863 35889999
Q ss_pred cccccccccccccc
Q psy16430 228 IWYKNRLCFPTSLM 241 (600)
Q Consensus 228 vy~~~~~~~p~sl~ 241 (600)
+||.|+.++....+
T Consensus 252 vWSLGITL~EvAtG 265 (361)
T KOG1006|consen 252 VWSLGITLYEVATG 265 (361)
T ss_pred hhhhcceEeeeecC
Confidence 99999999877544
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.3e-15 Score=160.44 Aligned_cols=78 Identities=23% Similarity=0.426 Sum_probs=70.2
Q ss_pred CCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccccccccCccccccccccccccccccc
Q psy16430 165 TPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLMA 242 (600)
Q Consensus 165 ~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl~~ 242 (600)
.+|||||||..||||+.+|.+||+|||+|..+.... ...+.+||+.|||||++....|+.++|+||+|+..+....+.
T Consensus 388 ~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 388 RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred cceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 579999999999999999999999999999876655 456799999999999999999999999999999998765543
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.7e-15 Score=151.51 Aligned_cols=90 Identities=17% Similarity=0.188 Sum_probs=75.7
Q ss_pred cccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeecccccccc-cccCccccccc
Q psy16430 153 IGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWY 230 (600)
Q Consensus 153 ~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~~-~~~s~~~Dvy~ 230 (600)
..|..|.|.+ .||||||||.|||++.+|++|+||||+||.+. .+...+..+.|.||.|||.+.+ -+|+..+|+|+
T Consensus 111 l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWA 187 (396)
T KOG0593|consen 111 LKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWA 187 (396)
T ss_pred HHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchh
Confidence 3445666664 49999999999999999999999999999876 6667778899999999998876 68999999999
Q ss_pred ccccccccccccccc
Q psy16430 231 KNRLCFPTSLMARIG 245 (600)
Q Consensus 231 ~~~~~~p~sl~~~~~ 245 (600)
-|++......+..+.
T Consensus 188 iGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 188 IGCVFAELLTGEPLW 202 (396)
T ss_pred hhHHHHHHhcCCcCC
Confidence 999887766555443
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-15 Score=164.97 Aligned_cols=125 Identities=17% Similarity=0.185 Sum_probs=88.7
Q ss_pred ccccCChhhhhhhhc---ccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 105 VDKFSSPEFKTNIQE---RSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 105 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
++-|+..++=-++.| ++++-.. +. + +.++.=+.-.-+...+.. -|+|. ..|||||||-.|++|
T Consensus 84 ~~~FEDs~nVYivLELC~~~sL~el-------~K-r-rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL 151 (592)
T KOG0575|consen 84 YHFFEDSNNVYIVLELCHRGSLMEL-------LK-R-RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFL 151 (592)
T ss_pred eeEeecCCceEEEEEecCCccHHHH-------HH-h-cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheee
Confidence 444888888777777 4444221 12 1 112221111112223333 45554 359999999999999
Q ss_pred ccCCceeEeecccccccCCC-CccccccCceeecccccccccccCcccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
++++++||+|||||..+... ....+.||||.|+|||++....++..+|+||-|++++..=.+
T Consensus 152 ~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G 214 (592)
T KOG0575|consen 152 NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVG 214 (592)
T ss_pred cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhC
Confidence 99999999999999877543 556789999999999999999999999999999999865433
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-15 Score=157.12 Aligned_cols=96 Identities=21% Similarity=0.166 Sum_probs=78.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++...+.+ |+|. .+||||||||+|||+++++.+||+|||+++............||.+|||||++.
T Consensus 98 ~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05631 98 GFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174 (285)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhc
Confidence 35566666666666664 5554 579999999999999999999999999998765444444568999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|+++|..-
T Consensus 175 ~~~~~~~~DvwslGvil~el~ 195 (285)
T cd05631 175 NEKYTFSPDWWGLGCLIYEMI 195 (285)
T ss_pred CCCCCcccCchhHHHHHHHHH
Confidence 999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.5e-15 Score=160.28 Aligned_cols=85 Identities=16% Similarity=0.323 Sum_probs=70.8
Q ss_pred ccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC------------cc--ccccCceeecccccccc
Q psy16430 154 GGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS------------TK--MSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 154 ~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~------------~~--~~~~GT~~ymAPE~i~~ 219 (600)
.|.+|+|. .+||||||||.|||||++|.+||+|||.|+.++... .. .+++||..|.+||++.+
T Consensus 185 dAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~ 261 (604)
T KOG0592|consen 185 DALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND 261 (604)
T ss_pred HHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC
Confidence 34456665 469999999999999999999999999999764321 11 45899999999999999
Q ss_pred cccCcccccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
+..+..+|+|+||+++|.+-.+
T Consensus 262 ~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 262 SPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred CCCCcccchHHHHHHHHHHhcC
Confidence 9999999999999999976433
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.3e-16 Score=163.96 Aligned_cols=140 Identities=19% Similarity=0.238 Sum_probs=96.7
Q ss_pred hccccccccccccccccCChhhhhhhhccccccccccccccccc-ccccccccCCccceeeccccchhhhccCCCCeEEE
Q psy16430 92 TKLSVCWRPFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTG-MAEQVRLSIPPQYQLELIGGPYWFLAGCTTPDALA 170 (600)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHr 170 (600)
.+.+-|-.-.|.++.|+..++.-.+|+|+........+..+ ++ ..+..+-.+.+. +..|.+|+|. .+|+||
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Q----lisav~y~H~---~gi~HR 144 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQ----LISAVAYCHS---RGIVHR 144 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHH----HHHHHHHHHh---CCEeeC
Confidence 34444445778888888888888888884433222222212 11 111111111111 2233345554 469999
Q ss_pred eccCCCeeeccC-CceeEeeccccccc-CCCCccccccCceeecccccccccc-cC-cccccccccccccccc
Q psy16430 171 ESIGLGVLIGSK-EEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQ-CS-DKIDIWYKNRLCFPTS 239 (600)
Q Consensus 171 dlk~~NILLd~~-~~~Kv~DFGlsr~~-~~~~~~~~~~GT~~ymAPE~i~~~~-~s-~~~Dvy~~~~~~~p~s 239 (600)
||||.|||||.+ +.+||+|||+|... ..+....+.|||+.|+|||++.+.. |+ .++|+||.|+++|-.-
T Consensus 145 DLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 145 DLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred CCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 999999999999 99999999999977 3555566799999999999999877 85 8899999999998654
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.2e-15 Score=156.16 Aligned_cols=86 Identities=24% Similarity=0.467 Sum_probs=73.7
Q ss_pred ccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeecccccccccccCccccccc
Q psy16430 152 LIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIRNEQCSDKIDIWY 230 (600)
Q Consensus 152 ~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~ 230 (600)
+..|..|+|.. +.||||||++||||...|.+|++|||++..+..... ..+++||+.|||||++....|+.++|+||
T Consensus 120 ~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWS 196 (467)
T KOG0201|consen 120 VLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWS 196 (467)
T ss_pred HHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhh
Confidence 44556777775 599999999999999999999999999987765544 35799999999999999889999999999
Q ss_pred cccccccccc
Q psy16430 231 KNRLCFPTSL 240 (600)
Q Consensus 231 ~~~~~~p~sl 240 (600)
.|++.+..-.
T Consensus 197 LGITaiEla~ 206 (467)
T KOG0201|consen 197 LGITAIELAK 206 (467)
T ss_pred hhHHHHHHhc
Confidence 9999885443
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-15 Score=150.93 Aligned_cols=86 Identities=20% Similarity=0.257 Sum_probs=71.6
Q ss_pred cccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccccc-cccCccccccc
Q psy16430 153 IGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWY 230 (600)
Q Consensus 153 ~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~-~~~s~~~Dvy~ 230 (600)
-.|..|+|+.. |+|||||++|+|+...|.+|||||||||.++... ..+..+-|.||-|||.+.+ ..|+.++|.||
T Consensus 187 L~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWS 263 (419)
T KOG0663|consen 187 LRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWS 263 (419)
T ss_pred HHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhh
Confidence 34456788876 9999999999999999999999999999887653 3456778999999998775 45999999999
Q ss_pred ccccccccccc
Q psy16430 231 KNRLCFPTSLM 241 (600)
Q Consensus 231 ~~~~~~p~sl~ 241 (600)
.|+++...-..
T Consensus 264 vGCI~aE~l~~ 274 (419)
T KOG0663|consen 264 VGCIFAELLTQ 274 (419)
T ss_pred HHHHHHHHHhc
Confidence 99988765443
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.1e-15 Score=157.04 Aligned_cols=97 Identities=19% Similarity=0.271 Sum_probs=76.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++..++. .|+|. ..+|+||||||+|||++.++.+||+|||+++.... ........||+.|||||++.
T Consensus 92 l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05594 92 FSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHc
Confidence 455555555555555 45664 35799999999999999999999999999985432 22233467999999999999
Q ss_pred ccccCccccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+..++.++|+||+|++++..-.
T Consensus 170 ~~~~~~~~DiwslG~il~el~t 191 (325)
T cd05594 170 DNDYGRAVDWWGLGVVMYEMMC 191 (325)
T ss_pred cCCCCCccccccccceeeeecc
Confidence 8899999999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.8e-15 Score=153.00 Aligned_cols=96 Identities=22% Similarity=0.408 Sum_probs=74.7
Q ss_pred ccCCccceeeccccchhhhccCCCCeEEEeccCCCeeecc-CCceeEeecccccccCC----CCccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGS-KEEAKISDFGTCREWNN----KSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~-~~~~Kv~DFGlsr~~~~----~~~~~~~~GT~~ymAPE~ 216 (600)
-+...+|.-.+..+.+|+| +.+||||||||+||||+. ++.+||+|||+++.... ......+.||+.|||||+
T Consensus 116 E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEv 192 (313)
T KOG0198|consen 116 EPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEV 192 (313)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchh
Confidence 3444555555666667888 567999999999999999 79999999999987653 112335889999999999
Q ss_pred ccccccC-ccccccccccccccccc
Q psy16430 217 IRNEQCS-DKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 217 i~~~~~s-~~~Dvy~~~~~~~p~sl 240 (600)
+.++... .++|+||+|++..+.-.
T Consensus 193 i~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 193 IRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred hcCCCcCCccchhhhcCCEEEeccC
Confidence 9964333 48999999998887643
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.5e-15 Score=152.12 Aligned_cols=86 Identities=23% Similarity=0.261 Sum_probs=72.5
Q ss_pred ccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccccc-ccCcccccc
Q psy16430 152 LIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIRNE-QCSDKIDIW 229 (600)
Q Consensus 152 ~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~~~-~~s~~~Dvy 229 (600)
+-.|.+|+|.+ +|+||||||.|||++..|.+|++|||+|+.+.. ....++.++|.+|-|||++.+. .|+..+|+|
T Consensus 129 ll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiW 205 (323)
T KOG0594|consen 129 LLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIW 205 (323)
T ss_pred HHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchH
Confidence 44555677765 599999999999999999999999999998763 3345678899999999998876 699999999
Q ss_pred ccccccccccc
Q psy16430 230 YKNRLCFPTSL 240 (600)
Q Consensus 230 ~~~~~~~p~sl 240 (600)
|.|++..+...
T Consensus 206 s~GcIfaEm~~ 216 (323)
T KOG0594|consen 206 SLGCIFAEMFT 216 (323)
T ss_pred hHHHHHHHHHh
Confidence 99999887643
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.8e-15 Score=157.58 Aligned_cols=78 Identities=27% Similarity=0.444 Sum_probs=66.5
Q ss_pred chhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc---ccccCccccccccc
Q psy16430 156 PYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR---NEQCSDKIDIWYKN 232 (600)
Q Consensus 156 ~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~---~~~~s~~~Dvy~~~ 232 (600)
.+|||.+ ..||||||+.||||++.|.||++|||.|-...+ ..+++|||.|||||+|. .|.|+.++||||.|
T Consensus 139 LaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLG 212 (948)
T KOG0577|consen 139 LAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 212 (948)
T ss_pred HHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeecc
Confidence 3677765 489999999999999999999999998865433 34689999999999986 47899999999999
Q ss_pred ccccccc
Q psy16430 233 RLCFPTS 239 (600)
Q Consensus 233 ~~~~p~s 239 (600)
+.|....
T Consensus 213 ITCIELA 219 (948)
T KOG0577|consen 213 ITCIELA 219 (948)
T ss_pred chhhhhh
Confidence 9998543
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-14 Score=146.93 Aligned_cols=86 Identities=22% Similarity=0.422 Sum_probs=75.1
Q ss_pred eeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccc-cCCCCccccccCceeecccccccccccCccccc
Q psy16430 150 LELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 228 (600)
Q Consensus 150 i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~-~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dv 228 (600)
-.+..|.+|||+ +.||+||||-.|+|||.+|++||+|||||+. +..+.++.++||||-|+|||++.+..|+.++||
T Consensus 275 aEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDW 351 (516)
T KOG0690|consen 275 AEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDW 351 (516)
T ss_pred HHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeeh
Confidence 344456678887 5699999999999999999999999999995 444555668999999999999999999999999
Q ss_pred cccccccccc
Q psy16430 229 WYKNRLCFPT 238 (600)
Q Consensus 229 y~~~~~~~p~ 238 (600)
|..||+++..
T Consensus 352 WG~GVVMYEM 361 (516)
T KOG0690|consen 352 WGVGVVMYEM 361 (516)
T ss_pred hhhhHHHHHH
Confidence 9999999865
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.4e-15 Score=155.86 Aligned_cols=96 Identities=19% Similarity=0.269 Sum_probs=75.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++..++. .|+|. .+||||||||+|||++.++.+||+|||+++.... .......+||+.|||||++.
T Consensus 92 ~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05571 92 FSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhc
Confidence 444444444444444 56664 4699999999999999999999999999985422 22334578999999999999
Q ss_pred ccccCccccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+..++.++|+||+|++++..-.
T Consensus 169 ~~~~~~~~DiwSlG~il~ellt 190 (323)
T cd05571 169 DNDYGRAVDWWGLGVVMYEMMC 190 (323)
T ss_pred CCCCCccccCcccchhhhhhhc
Confidence 8899999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.2e-15 Score=156.78 Aligned_cols=95 Identities=22% Similarity=0.288 Sum_probs=76.6
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++...+.+ |+|. .+|+||||||.|||++.++.+||+|||+++.... .......+||+.|||||++.
T Consensus 98 ~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 98 FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhc
Confidence 5555555566666664 5654 4799999999999999999999999999985432 22334578999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
...++.++|+||+|++++..-
T Consensus 175 ~~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 175 YQPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred CCCCCCccchhchhHHHHHHH
Confidence 999999999999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=5e-15 Score=156.73 Aligned_cols=120 Identities=23% Similarity=0.345 Sum_probs=94.3
Q ss_pred cCChhhhhhhhcccccccccccccccccccccccccCCccce----eeccccchhhhccCCCCeEEEeccCCCeeeccCC
Q psy16430 108 FSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQ----LELIGGPYWFLAGCTTPDALAESIGLGVLIGSKE 183 (600)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~----i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~ 183 (600)
|+-+|.-+.|+|-...+-+.-. ++ .+.+.++.|.. .-+.+|..|||+. .|+||||||.||||.+..
T Consensus 632 ~ET~ervFVVMEKl~GDMLEMI------LS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~ 701 (888)
T KOG4236|consen 632 FETPERVFVVMEKLHGDMLEMI------LS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASAS 701 (888)
T ss_pred ecCCceEEEEehhhcchHHHHH------HH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCC
Confidence 8999998888882222111111 11 13355666654 3345677788875 599999999999998754
Q ss_pred ---ceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccc
Q psy16430 184 ---EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFP 237 (600)
Q Consensus 184 ---~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p 237 (600)
.+|+||||+||.++......+++||+.|+|||++++..|...-|.||-|++.+-
T Consensus 702 ~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYV 758 (888)
T KOG4236|consen 702 PFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYV 758 (888)
T ss_pred CCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEE
Confidence 599999999999999888889999999999999999999999999999999884
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.3e-15 Score=152.51 Aligned_cols=94 Identities=16% Similarity=0.201 Sum_probs=77.7
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++.+ |+|. .+|+||||||+|||++.++.+||+|||+++............||+.|+|||.+..
T Consensus 107 ~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (290)
T cd07862 107 VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhC
Confidence 5556666666666664 5664 4699999999999999999999999999987654444445779999999999988
Q ss_pred cccCccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~ 238 (600)
..++.++|+||+|++++..
T Consensus 184 ~~~~~~~DiwslG~il~el 202 (290)
T cd07862 184 SSYATPVDLWSVGCIFAEM 202 (290)
T ss_pred CCCCCccchHHHHHHHHHH
Confidence 8899999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.8e-15 Score=158.20 Aligned_cols=96 Identities=20% Similarity=0.193 Sum_probs=72.7
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-------------------
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS------------------- 200 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~------------------- 200 (600)
++......++..++. .|+|. .+||||||||.|||++.++.+||+|||+|+.+....
T Consensus 98 l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (363)
T cd05628 98 LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174 (363)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccc
Confidence 333333334434444 56664 479999999999999999999999999997543210
Q ss_pred -----------------ccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 201 -----------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 201 -----------------~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
...+.+||+.|||||++.+..++.++|+||+|++++..-.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred ccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 0124689999999999998899999999999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.2e-14 Score=151.12 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=189.5
Q ss_pred cccccccccCC--CCcceEEEeEe----eceEEEeeeec---------cchHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 261 ESISDLQWLGS--GAQGAVFSGKL----RSEIVAVKKVR---------EQKETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 261 ~~~~~~~~LG~--G~fG~Vy~a~~----~~~~vAvK~~~---------~~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
..+.+.+.+|. |.+|.||.++. ....+|+|+-+ ....+|+....++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999876 35788998743 2234566665666 499999999999999999
Q ss_pred eEEEeeeccccchhhccCCC-CCCHHHHHHHHHHHHH----HHHHhHhCCccccCCCCCCcccCCC-CCceeeccCcccc
Q psy16430 325 CIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAA----GMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCRE 398 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~----aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~ 398 (600)
++-+|+|. .+|..+...-. .++...++..+.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999995 67777766543 4888999999999999 9999999999999999999999999 8999999999888
Q ss_pred ccCCCCCc------ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCC
Q psy16430 399 WNNKSTKM------SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPST 472 (600)
Q Consensus 399 ~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 472 (600)
+....... ...|...|++||...+ -++..+||||+|.++.+..+|..+......... ..+.....+..+...
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGYIPLEFCEG 350 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccccCchhhhcC
Confidence 76554222 2257888999998865 678999999999999999988766543311100 011112223333445
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
.+..+...+.+|++.+|..|++++.++.+..+....+
T Consensus 351 ~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~ 387 (524)
T KOG0601|consen 351 GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF 387 (524)
T ss_pred cchhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence 5667777999999999999999999999887665433
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.9e-15 Score=154.83 Aligned_cols=96 Identities=19% Similarity=0.271 Sum_probs=76.0
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC-CccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i 217 (600)
.+++.+...++...+. .|+|. .+|+||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++
T Consensus 91 ~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~ 167 (328)
T cd05593 91 VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167 (328)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhh
Confidence 3555555555555555 45664 47999999999999999999999999999854322 223356899999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 168 ~~~~~~~~~DiwslGvil~ell 189 (328)
T cd05593 168 EDNDYGRAVDWWGLGVVMYEMM 189 (328)
T ss_pred cCCCCCccCCccccchHHHHHh
Confidence 9889999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.2e-15 Score=164.78 Aligned_cols=131 Identities=17% Similarity=0.167 Sum_probs=90.1
Q ss_pred cccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc
Q psy16430 104 FVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS 181 (600)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~ 181 (600)
.++.|...++-.+|+|..+..++...... ......++++.....++..++. .|+|. .+||||||||.|||++.
T Consensus 130 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~ 204 (478)
T PTZ00267 130 HFDDFKSDDKLLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMP 204 (478)
T ss_pred EEEEEEECCEEEEEEECCCCCCHHHHHHH--HHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECC
Confidence 45556666666777774333222221101 0112223444444445445555 44554 57999999999999999
Q ss_pred CCceeEeecccccccCCCC---ccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 182 KEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 182 ~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++.+||+|||+++.+.... ...+.+||++|||||++.+..++.++|+||+|++++..-
T Consensus 205 ~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 265 (478)
T PTZ00267 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265 (478)
T ss_pred CCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH
Confidence 9999999999998764332 133567999999999999899999999999999998653
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=4e-15 Score=153.37 Aligned_cols=130 Identities=15% Similarity=0.244 Sum_probs=93.3
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccC
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSK 182 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~ 182 (600)
..|-||+.-+.-.+|+|+.+...+--|...-..++++.+--+... +-.|-.|-|.+ .++|||||-.|||||.+
T Consensus 117 ~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQ----IvSAVhYCHkn---rVvHRDLKLENILLD~N 189 (668)
T KOG0611|consen 117 QIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQ----IVSAVHYCHKN---RVVHRDLKLENILLDQN 189 (668)
T ss_pred ehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHH----HHHHHHHHhhc---cceecccchhheeecCC
Confidence 346789999999999997665433333211001111111111111 11222344443 59999999999999999
Q ss_pred CceeEeecccccccCCCCccccccCceeeccccccccccc-Ccccccccccccccccc
Q psy16430 183 EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 183 ~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
+++||+||||+..+..+..-.++||++-|..||++.+.+| +..+|.||.|++++...
T Consensus 190 ~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLV 247 (668)
T KOG0611|consen 190 NNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLV 247 (668)
T ss_pred CCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHh
Confidence 9999999999998877777778999999999999999888 47799999999998654
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-14 Score=145.85 Aligned_cols=202 Identities=22% Similarity=0.323 Sum_probs=145.8
Q ss_pred HHHHhcCCCCcccccceeecCC-----ceeEEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhC--C
Q psy16430 301 RHLRKLNHPNIVKFKGVCTQAP-----CYCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSK--Q 369 (600)
Q Consensus 301 ~~L~~L~HpnIv~l~~~~~~~~-----~~~lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~--g 369 (600)
..|-++-|.|||+++.++.+.. ...+++||+..|++..+|++ +..+......+|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3466678999999999986543 47889999999999999975 34688888999999999999999997 5
Q ss_pred ccccCCCCCCcccCCCCCceeeccCccccccC-----CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC
Q psy16430 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC 444 (600)
Q Consensus 370 IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG 444 (600)
|+|+++..+.|++..+|-+|+.--........ ........+-++|.|||.-.....+.++|||+||....+|..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888763221111100 0001123467899999986666677899999999999999987
Q ss_pred CCCCCCCChH-HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 445 ETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 445 ~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..--...... .....+....... ..+.-+.++..|++..|..||++.+++.||-....
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~l-----en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGL-----ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred eeccCCCcceeehhhhhhhheeec-----cCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 7543222211 1111111111111 11223678899999999999999999999966544
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.1e-15 Score=159.18 Aligned_cols=96 Identities=21% Similarity=0.224 Sum_probs=78.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccc-cccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~-~~~GT~~ymAPE~i 217 (600)
.+++.+++..+.++|.+ |+|. .++|||||.++|+|++.++++||+|||||+......... ...-...|+|||.+
T Consensus 258 ~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl 334 (474)
T KOG0194|consen 258 SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETL 334 (474)
T ss_pred CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhh
Confidence 58888899988888885 5554 469999999999999999999999999998653222222 12245799999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
..+.|+.++||||||++||..-
T Consensus 335 ~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 335 NTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred ccCccccccchhheeeeEEeee
Confidence 9999999999999999999763
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.8e-15 Score=154.59 Aligned_cols=134 Identities=17% Similarity=0.272 Sum_probs=101.8
Q ss_pred cccccccc-cccccccCChhhhhhhhc---ccccccccccccccccccccccccCCc---cce-eeccccchhhhccCCC
Q psy16430 94 LSVCWRPF-CSFVDKFSSPEFKTNIQE---RSEVKSATHYQVDLTGMAEQVRLSIPP---QYQ-LELIGGPYWFLAGCTT 165 (600)
Q Consensus 94 ~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~l~~~~---r~~-i~~~~a~~~~~~~~~~ 165 (600)
+-.||-+| |..|--|....|--+.+| +|++ |+-. +.+ ++++. |+- -....|-+|||.+
T Consensus 474 m~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGEl--WTiL-------rdR--g~Fdd~tarF~~acv~EAfeYLH~k--- 539 (732)
T KOG0614|consen 474 MMECRSDFIVRLYRTFRDSKYVYMLMEACLGGEL--WTIL-------RDR--GSFDDYTARFYVACVLEAFEYLHRK--- 539 (732)
T ss_pred HHhcCchHHHHHHHHhccchhhhhhHHhhcCchh--hhhh-------hhc--CCcccchhhhhHHHHHHHHHHHHhc---
Confidence 55788776 556666777777666667 4443 4431 222 23332 332 2233445778764
Q ss_pred CeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccccc
Q psy16430 166 PDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 166 ~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
.||+|||||.|.+||.+|.+|+.|||+|+.++.+..+-++|||+-|.|||++.+...+.++|+|+.|++++..-.+
T Consensus 540 ~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 540 GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG 615 (732)
T ss_pred CceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence 5999999999999999999999999999999888777889999999999999999999999999999999865433
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-14 Score=151.10 Aligned_cols=96 Identities=22% Similarity=0.192 Sum_probs=71.8
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc------cccccCceeecc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST------KMSFAGTVAWMA 213 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~------~~~~~GT~~ymA 213 (600)
|+..+...+..|+.. +|||- ++||||||||+|+||+++|++||+|||.|.....+.. -...+||+.|||
T Consensus 207 ls~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A 283 (576)
T KOG0585|consen 207 LSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA 283 (576)
T ss_pred ccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccc
Confidence 444444444445544 45654 5799999999999999999999999999986533221 123789999999
Q ss_pred cccccccc----cCccccccccccccccccc
Q psy16430 214 PEVIRNEQ----CSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 214 PE~i~~~~----~s~~~Dvy~~~~~~~p~sl 240 (600)
||.+.++. .+.+.|+||.||++|-.-.
T Consensus 284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllf 314 (576)
T KOG0585|consen 284 PELCSGGNSFSYSGFALDIWALGVTLYCLLF 314 (576)
T ss_pred hHhhcCCCCccccchhhhhhhhhhhHHHhhh
Confidence 99987743 3678999999999886543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.3e-15 Score=154.25 Aligned_cols=96 Identities=18% Similarity=0.277 Sum_probs=75.6
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC-CccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++. .|+|. .+|+||||||+|||++.++.+||+|||+++..... .......||+.|||||++
T Consensus 91 ~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 167 (323)
T cd05595 91 VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccc
Confidence 3455555555555555 45654 47999999999999999999999999999854222 223346799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 168 ~~~~~~~~~DiwSlGvil~ell 189 (323)
T cd05595 168 EDNDYGRAVDWWGLGVVMYEMM 189 (323)
T ss_pred cCCCCCchhchhhhHHHHHHHH
Confidence 9889999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.9e-15 Score=153.31 Aligned_cols=95 Identities=19% Similarity=0.306 Sum_probs=75.2
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++...+. .|+|. .+|+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.
T Consensus 93 ~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05591 93 FDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169 (321)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHc
Confidence 445544445555555 45664 3699999999999999999999999999985432 22334567999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 170 ~~~~~~~~DvwslG~il~el~ 190 (321)
T cd05591 170 ELEYGPSVDWWALGVLMYEMM 190 (321)
T ss_pred CCCCCCccceechhHHHHHHh
Confidence 889999999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.8e-15 Score=150.74 Aligned_cols=96 Identities=10% Similarity=0.078 Sum_probs=78.4
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..++|...+.++.+.|.+ |+|.. ..++||||||+|||+++++.+||+|||+++..... .....||..|+|||++
T Consensus 117 ~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~ 192 (283)
T PHA02988 117 KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKML 192 (283)
T ss_pred CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--cccccCcccccCHHHh
Confidence 357888888888888885 45542 34779999999999999999999999999865332 2245789999999998
Q ss_pred cc--cccCcccccccccccccccc
Q psy16430 218 RN--EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~--~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+ ..++.++|+||||+++|..-
T Consensus 193 ~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 193 NDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred hhccccccchhhhhHHHHHHHHHH
Confidence 76 67999999999999999763
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.7e-15 Score=154.06 Aligned_cols=96 Identities=22% Similarity=0.321 Sum_probs=77.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.+...++..++.+ |+|. .+||||||||.|||++.++.+||+|||+++...... .....+||+.|||||++
T Consensus 97 ~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 173 (323)
T cd05615 97 KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHH
Confidence 35666666677666665 5553 579999999999999999999999999998643322 23356799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 174 ~~~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 174 AYQPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred cCCCCCCccchhhhHHHHHHHH
Confidence 9888999999999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.8e-15 Score=153.77 Aligned_cols=95 Identities=23% Similarity=0.307 Sum_probs=74.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~ 218 (600)
+.+.....++...+. .|+|. .+|+||||||.|||++.++.+||+|||+++... ........+||+.|+|||++.
T Consensus 93 l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05618 93 LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHc
Confidence 444444445545555 56664 469999999999999999999999999998542 222334578999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 170 ~~~~~~~~DiwslG~il~el~ 190 (329)
T cd05618 170 GEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred CCCCCCccceecccHHHHHHh
Confidence 888999999999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.7e-15 Score=156.58 Aligned_cols=131 Identities=15% Similarity=0.206 Sum_probs=85.5
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeecc
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGS 181 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~ 181 (600)
+..+++|...++-.+|+|..+..++..+... ...+..+..++...+..|..|+|. .+|+||||||+|||++.
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~ 177 (370)
T cd05621 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDK 177 (370)
T ss_pred eeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECC
Confidence 3444555666666677773332222221101 011112222222333444466775 46999999999999999
Q ss_pred CCceeEeecccccccCCCCc--cccccCceeeccccccccc----ccCccccccccccccccccc
Q psy16430 182 KEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVIRNE----QCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 182 ~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i~~~----~~s~~~Dvy~~~~~~~p~sl 240 (600)
++.+||+|||+|+....... ..+.+||++|||||++... .++.++|+||+|++++..-.
T Consensus 178 ~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~ 242 (370)
T cd05621 178 HGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 242 (370)
T ss_pred CCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence 99999999999987643322 2356899999999998753 37889999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.7e-14 Score=146.65 Aligned_cols=85 Identities=19% Similarity=0.257 Sum_probs=70.9
Q ss_pred ccchhhhccCCCCeEEEeccCCCeeeccC-CceeEeecccccccCCCCccccccCceeeccccccccc-ccCcccccccc
Q psy16430 154 GGPYWFLAGCTTPDALAESIGLGVLIGSK-EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE-QCSDKIDIWYK 231 (600)
Q Consensus 154 ~a~~~~~~~~~~~iiHrdlk~~NILLd~~-~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~-~~s~~~Dvy~~ 231 (600)
.|.+|+|. ..|.||||||.|+|+|.+ |.+||||||-|+.+..+....+..=|..|-|||.+.+. .|+.++|+||-
T Consensus 136 rgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSa 212 (364)
T KOG0658|consen 136 RGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSA 212 (364)
T ss_pred HHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhh
Confidence 45567776 569999999999999987 89999999999987666655666679999999988764 59999999999
Q ss_pred cccccccccc
Q psy16430 232 NRLCFPTSLM 241 (600)
Q Consensus 232 ~~~~~p~sl~ 241 (600)
|+++...-.+
T Consensus 213 GCV~aELl~g 222 (364)
T KOG0658|consen 213 GCVMAELLKG 222 (364)
T ss_pred hHHHHHHhcC
Confidence 9988765443
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.9e-14 Score=148.24 Aligned_cols=81 Identities=25% Similarity=0.366 Sum_probs=66.0
Q ss_pred cchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----c-ccccCceeeccccccc--ccccCcccc
Q psy16430 155 GPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----K-MSFAGTVAWMAPEVIR--NEQCSDKID 227 (600)
Q Consensus 155 a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~-~~~~GT~~ymAPE~i~--~~~~s~~~D 227 (600)
|..|||+. +-|||||||.|||||++|.+|++|||.+-.+...+. . .+++||+.|||||++. ...|+.|+|
T Consensus 138 aL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaD 214 (516)
T KOG0582|consen 138 ALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKAD 214 (516)
T ss_pred HHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhh
Confidence 44678875 589999999999999999999999999875433222 2 4578999999999954 356999999
Q ss_pred ccccccccccc
Q psy16430 228 IWYKNRLCFPT 238 (600)
Q Consensus 228 vy~~~~~~~p~ 238 (600)
+||||+.....
T Consensus 215 IwSfGITA~EL 225 (516)
T KOG0582|consen 215 IWSFGITACEL 225 (516)
T ss_pred hhhhhHHHHHH
Confidence 99999988754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-14 Score=151.73 Aligned_cols=95 Identities=15% Similarity=0.203 Sum_probs=74.9
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC-CccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++...+. .|+|. .+|+||||||.|||++.++.+||+|||+++..... ......+||+.|+|||++.
T Consensus 90 ~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 166 (312)
T cd05585 90 FDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166 (312)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHc
Confidence 444444445544545 55664 56999999999999999999999999999864322 2234578999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 167 ~~~~~~~~DvwslGvil~el~ 187 (312)
T cd05585 167 GHGYTKAVDWWTLGVLLYEML 187 (312)
T ss_pred CCCCCCccceechhHHHHHHH
Confidence 989999999999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-14 Score=151.20 Aligned_cols=87 Identities=22% Similarity=0.390 Sum_probs=70.7
Q ss_pred eeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeecccccccccccCccc
Q psy16430 150 LELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIRNEQCSDKI 226 (600)
Q Consensus 150 i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~~~~~s~~~ 226 (600)
++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++
T Consensus 101 ~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (321)
T cd05603 101 YAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177 (321)
T ss_pred HHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcC
Confidence 4444444 56664 4699999999999999999999999999985322 2233457899999999999988899999
Q ss_pred ccccccccccccc
Q psy16430 227 DIWYKNRLCFPTS 239 (600)
Q Consensus 227 Dvy~~~~~~~p~s 239 (600)
|+||+|++++..-
T Consensus 178 DiwslG~il~el~ 190 (321)
T cd05603 178 DWWCLGAVLYEML 190 (321)
T ss_pred cccccchhhhhhh
Confidence 9999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-14 Score=153.51 Aligned_cols=96 Identities=22% Similarity=0.319 Sum_probs=76.5
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeeccccccc-CCCCccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~-~~~~~~~~~~GT~~ymAPE~i 217 (600)
.+.+.....++...+. .|+|. .+|+||||||.|||++.++.+||+|||+++.. .........+||+.|+|||++
T Consensus 92 ~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 168 (329)
T cd05588 92 KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168 (329)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHH
Confidence 3555555555555555 45664 47999999999999999999999999999853 223334457899999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 169 ~~~~~~~~~DiwslG~~l~el~ 190 (329)
T cd05588 169 RGEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred cCCCCCCccceechHHHHHHHH
Confidence 9989999999999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-14 Score=151.84 Aligned_cols=95 Identities=20% Similarity=0.291 Sum_probs=75.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
++++...+.++..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++....... ..+..+|..|||||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 45666656666666664 5664 5799999999999999999999999999986533221 22345678999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
++.+..++.++|+||||+++|..
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el 269 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEI 269 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHH
Confidence 99988999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.5e-15 Score=153.64 Aligned_cols=96 Identities=22% Similarity=0.298 Sum_probs=76.8
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i 217 (600)
.+.+.....++...+. .|+|. .+|+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++
T Consensus 92 ~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 168 (327)
T cd05617 92 KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168 (327)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHH
Confidence 3555555556655555 45664 469999999999999999999999999998532 23334457899999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 169 ~~~~~~~~~DiwslGvil~ell 190 (327)
T cd05617 169 RGEEYGFSVDWWALGVLMFEMM 190 (327)
T ss_pred CCCCCCchheeehhHHHHHHHH
Confidence 9899999999999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-14 Score=152.57 Aligned_cols=95 Identities=20% Similarity=0.294 Sum_probs=74.3
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~ 218 (600)
++......++...+. +|+|. .+|+||||||+|||++.++.+||+|||+++... .........||+.|||||++.
T Consensus 93 l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (320)
T cd05590 93 FDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169 (320)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHc
Confidence 344444444444444 56764 469999999999999999999999999998542 222334578999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 170 ~~~~~~~~DiwslG~il~el~ 190 (320)
T cd05590 170 EMLYGPSVDWWAMGVLLYEML 190 (320)
T ss_pred CCCCCCccchhhhHHHHHHHh
Confidence 888999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-14 Score=155.45 Aligned_cols=96 Identities=22% Similarity=0.233 Sum_probs=79.6
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..++|.....|+..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++.........+..||..|+|||++
T Consensus 152 ~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~ 228 (357)
T PHA03209 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL 228 (357)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeec
Confidence 457777777777777775 5664 46999999999999999999999999999854333334457799999999999
Q ss_pred cccccCccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
....++.++|+||+|+++|..
T Consensus 229 ~~~~~~~~~DiwSlGvvl~el 249 (357)
T PHA03209 229 ARDKYNSKADIWSAGIVLFEM 249 (357)
T ss_pred CCCCCCchhhHHHHHHHHHHH
Confidence 988999999999999999864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-14 Score=152.30 Aligned_cols=95 Identities=21% Similarity=0.331 Sum_probs=75.2
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++...+. .|+|. .+|+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.
T Consensus 98 ~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 98 FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhc
Confidence 444555555555555 55664 479999999999999999999999999997532 222334578999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|+++|..-
T Consensus 175 ~~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 175 YQPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred CCCCCcccchhhhHHHHHHHH
Confidence 988999999999999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.41 E-value=2e-14 Score=150.89 Aligned_cols=96 Identities=21% Similarity=0.361 Sum_probs=74.8
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
+.......++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++.... .......+||+.|||||++.
T Consensus 93 ~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05604 93 FPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR 169 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHc
Confidence 333333334444444 56664 4799999999999999999999999999985422 22344578999999999999
Q ss_pred ccccCccccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+..++.++|+||+|++++..-.
T Consensus 170 ~~~~~~~~DvwslG~il~el~~ 191 (325)
T cd05604 170 KQPYDNTVDWWCLGAVLYEMLY 191 (325)
T ss_pred CCCCCCcCccccccceehhhhc
Confidence 9999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-14 Score=153.70 Aligned_cols=83 Identities=19% Similarity=0.259 Sum_probs=66.4
Q ss_pred cchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC----------------------------------
Q psy16430 155 GPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---------------------------------- 200 (600)
Q Consensus 155 a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---------------------------------- 200 (600)
|..|+|. .+|+||||||.|||++.++.+|++|||+++.+....
T Consensus 113 aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (377)
T cd05629 113 AIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189 (377)
T ss_pred HHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3356664 469999999999999999999999999996321100
Q ss_pred --------------ccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 201 --------------TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 201 --------------~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
...+.+||++|+|||++.+..++.++|+||+|++++..-.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 243 (377)
T cd05629 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243 (377)
T ss_pred chhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhc
Confidence 0012579999999999998899999999999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-14 Score=151.03 Aligned_cols=83 Identities=20% Similarity=0.403 Sum_probs=68.9
Q ss_pred ccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeecccccccccccCccccccccc
Q psy16430 154 GGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKN 232 (600)
Q Consensus 154 ~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~ 232 (600)
.|..|+|. .+|+||||||+|||++.++.+||+|||+++.... .......+||+.|||||++.+..++.++|+||+|
T Consensus 107 ~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 183 (325)
T cd05602 107 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 183 (325)
T ss_pred HHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCcccccccc
Confidence 33356664 4699999999999999999999999999985432 2234457899999999999998999999999999
Q ss_pred ccccccc
Q psy16430 233 RLCFPTS 239 (600)
Q Consensus 233 ~~~~p~s 239 (600)
++++..-
T Consensus 184 ~il~el~ 190 (325)
T cd05602 184 AVLYEML 190 (325)
T ss_pred HHHHHHh
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 600 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-60 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-42 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-40 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-40 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-39 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-38 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-38 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-38 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-38 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-38 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-37 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-37 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-37 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-37 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-37 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-37 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-37 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-37 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-37 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-37 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-37 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-37 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-36 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-36 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-36 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-36 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-36 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-36 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-36 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-36 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-36 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-36 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-36 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-36 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-36 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-36 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-36 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-36 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-36 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-35 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-35 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-35 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-35 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-35 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-34 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-34 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-34 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-34 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-34 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-34 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-34 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-34 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-33 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-33 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-33 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-33 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-33 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-33 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-33 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-33 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-33 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-33 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-33 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-33 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-33 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-33 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-33 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-33 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-32 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-32 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-32 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-32 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-32 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-32 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-32 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-32 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-32 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-32 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-32 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-32 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-32 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-31 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-31 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-31 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-31 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-31 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-31 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-31 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-31 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-31 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-31 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-31 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-31 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-31 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-31 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-31 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-31 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-31 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-31 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-31 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-31 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-31 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-31 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-31 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-31 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-31 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-31 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-31 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-31 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-31 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-31 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-31 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-31 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-31 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-31 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-31 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-31 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-31 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-31 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-31 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-31 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-31 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-31 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-31 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-31 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-31 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-31 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-31 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-31 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-31 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-31 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-31 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-31 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-31 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-31 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-31 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-31 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-31 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-31 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-31 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-31 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-31 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-31 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-31 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-30 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-30 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-30 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-30 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-30 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-30 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-30 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-30 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-30 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-30 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-30 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-30 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-30 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-30 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-30 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-30 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-30 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-30 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-30 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-30 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-30 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-30 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-30 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-30 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-29 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-29 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-29 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-29 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-29 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-29 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-29 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-29 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-29 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-29 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-29 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-29 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-29 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-29 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-29 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-29 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-29 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-29 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-29 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-29 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-29 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-29 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-29 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-29 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-29 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-29 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-28 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-28 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-28 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-28 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-28 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-28 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-28 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-28 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-28 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-28 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-28 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-28 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-28 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-28 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-28 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-28 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-28 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-28 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-28 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-28 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-28 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-28 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-28 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-28 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-28 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-28 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-28 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-28 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-28 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-28 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-28 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-28 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-28 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-28 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-28 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-28 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-28 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-28 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-28 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-28 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-27 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-27 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-27 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-27 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-27 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-27 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-27 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-27 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-27 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-27 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-27 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-27 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-27 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-27 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-27 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-27 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-27 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-27 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-27 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-27 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-27 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-27 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-27 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-27 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-27 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-27 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-27 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-27 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-27 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-27 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-27 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-27 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-27 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-27 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-27 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-27 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-27 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-27 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-27 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-27 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-27 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-26 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-26 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-26 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-26 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-26 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-26 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-26 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-26 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-26 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-26 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-26 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-26 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-26 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-26 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-26 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-26 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-26 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-26 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-26 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-26 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-26 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-26 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-26 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-26 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-25 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-25 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-25 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-25 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-25 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-25 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-25 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-25 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-25 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-25 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-25 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-25 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-25 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-25 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-25 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-25 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-25 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-25 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-25 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-24 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-24 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-24 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-24 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-24 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-24 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-24 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-23 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-23 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-23 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-23 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-23 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-23 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-23 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-23 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-22 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-22 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-22 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-22 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-21 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-21 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-21 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-21 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-21 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-21 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-20 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-20 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-20 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-20 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-20 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-19 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-19 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-19 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-19 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-19 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-19 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-19 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-19 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-19 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-19 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-18 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-18 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-18 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-17 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-17 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-11 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-123
Identities = 95/272 (34%), Positives = 149/272 (54%), Gaps = 15/272 (5%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD---------IRHLR 304
D+ +IP+ ++ + +G+G+ G V + VAVK + EQ + ++
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD---GEEVPPQRLYNWARQIAAG 361
+L HPNIV F G TQ P IV EY + G LY LL E++ +R + A +A G
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 362 MNYLHSK--QIIHRDLKSPNVLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPE 418
MNYLH++ I+HR+LKSPN+L+ K K+ DFG R + + S AGT WMAPE
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
V+R+E ++K D++S+G++LWEL T + P+ +++ + ++ VG L IP
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQEVL 510
+++ CW+N P RPSF I+ L + +
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 33/118 (27%), Positives = 50/118 (42%), Gaps = 35/118 (29%)
Query: 177 VLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLC 235
+L+ K K+ DFG R + + S AGT WMAPEV+R+E ++K D++
Sbjct: 170 LLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY------ 223
Query: 236 FPTSLMARIGEFKSF--VLRDEWEI-----PFESISDLQWLGSGAQGAVFSGKLRSEI 286
SF +L WE+ P+ +++ Q AV R EI
Sbjct: 224 -------------SFGVIL---WELATLQQPWGNLNPAQ-----VVAAVGFKCKRLEI 260
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 360 bits (926), Expect = e-122
Identities = 123/270 (45%), Positives = 156/270 (57%), Gaps = 24/270 (8%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD-----------IRHLR 304
EI F ++ + +G G G V+ + VAVK R + D +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNY 364
L HPNI+ +GVC + P C+VME+ GPL +L G+ +PP L NWA QIA GMNY
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 365 LHSK---QIIHRDLKSPNVLIGSKEE--------AKISDFGTCREWNNKSTKMSFAGTVA 413
LH + IIHRDLKS N+LI K E KI+DFG REW+ +TKMS AG A
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYA 179
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
WMAPEVIR S D+WSYG++LWELLT E P++ +D A+ +GV + L LPIPSTC
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P+ F LM+ CW+ P SRPSF IL L
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 38/109 (34%), Positives = 45/109 (41%), Gaps = 35/109 (32%)
Query: 185 AKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLMARI 244
KI+DFG REW+ +TKMS AG AWMAPEVIR S D+W
Sbjct: 155 LKITDFGLAREWHR-TTKMSAAGAYAWMAPEVIRASMFSKGSDVW--------------- 198
Query: 245 GEFKSF--VLRDEWEI-----PFESISDLQWLGSGAQGAVFSGKLRSEI 286
S+ +L WE+ PF I L V KL I
Sbjct: 199 ----SYGVLL---WELLTGEVPFRGIDGLAVA-----YGVAMNKLALPI 235
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-111
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 22/270 (8%)
Query: 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD---------IRH 302
+ I F+ ++ L L G ++ G+ + + VK ++ + +
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 303 LRKLNHPNIVKFKGVCTQAPC--YCIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQI 358
LR +HPN++ G C P ++ + YG LYN+L +G V + +A +
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 359 AAGMNYLHSKQ--IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMA 416
A GM +LH+ + I L S +V+I A+IS + + AW+A
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVA 176
Query: 417 PEVIRNEQ---CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
PE ++ + D+WS+ ++LWEL+T E P+ D+ + I V L IP
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LMK+C + P+ RP F I+ L+
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 24/120 (20%), Positives = 39/120 (32%), Gaps = 41/120 (34%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ---CSDKIDIWYKNR 233
V+I A+IS + + AW+APE ++ + D+W
Sbjct: 144 VMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQKKPEDTNRRSADMW---- 195
Query: 234 LCFPTSLMARIGEFKSF--VLRDEWEI-----PFESISDLQWLGSGAQGAVFSGKLRSEI 286
SF +L WE+ PF +S+++ V LR I
Sbjct: 196 ---------------SFAVLL---WELVTREVPFADLSNMEIG-----MKVALEGLRPTI 232
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-111
Identities = 98/300 (32%), Positives = 141/300 (47%), Gaps = 23/300 (7%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD-----IRHLRKLNHP 309
I ++ I + +G GA G V K R++ VA+K++ + E +R L ++NHP
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHP 61
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE---EVPPQRLYNWARQIAAGMNYLH 366
NIVK G C C+VMEY G LYN+L E +W Q + G+ YLH
Sbjct: 62 NIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 367 S---KQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422
S K +IHRDLK PN+L+ + KI DFGT + T G+ AWMAPEV
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN--KGSAAWMAPEVFEG 177
Query: 423 EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI-IWGVGSSSLHLPIPSTCPDGFQLLM 481
S+K D++S+GI+LWE++T P+ ++ A I + P+ P + LM
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237
Query: 482 KMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMI------WKEEIRVHMLEM 535
CWS PS RPS ++I+ + + Y Q + E V E
Sbjct: 238 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEF 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 29/109 (26%), Positives = 41/109 (37%), Gaps = 35/109 (32%)
Query: 185 AKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLMARI 244
KI DFGT + T G+ AWMAPEV S+K D++
Sbjct: 145 LKICDFGTACDIQTHMTNN--KGSAAWMAPEVFEGSNYSEKCDVF--------------- 187
Query: 245 GEFKSF--VLRDEWEI-----PFESISDLQWLGSGAQGAVFSGKLRSEI 286
S+ +L WE+ PF+ I + AV +G R +
Sbjct: 188 ----SWGIIL---WEVITRRKPFDEIGGPAFR---IMWAVHNG-TRPPL 225
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-109
Identities = 74/281 (26%), Positives = 131/281 (46%), Gaps = 27/281 (9%)
Query: 248 KSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD-------- 299
++ + EW+IPFE + + +G G G V+ G+ E VA++ + +++ +
Sbjct: 20 QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKR 78
Query: 300 -IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV-PPQRLYNWARQ 357
+ R+ H N+V F G C P I+ C LY++++D + V + A++
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 358 IAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR-----EWNNKSTKMSF-AGT 411
I GM YLH+K I+H+DLKS NV + + I+DFG + + K+ G
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 412 VAWMAPEVIRN---------EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS 462
+ +APE+IR S D+++ G + +EL E P+K + AIIW +G+
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
++ CW+ RP+F +++ L+
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 16/104 (15%), Positives = 31/104 (29%), Gaps = 44/104 (42%)
Query: 186 KISDFGTCR-----EWNNKSTKMSF-AGTVAWMAPEVIRN---------EQCSDKIDIWY 230
I+DFG + + K+ G + +APE+IR S D++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF- 227
Query: 231 KNRLCFPTSLMARIGEFKSF--VLRDEWEI-----PFESISDLQ 267
+ + +E+ PF++
Sbjct: 228 ------------------ALGTIW---YELHAREWPFKTQPAEA 250
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-109
Identities = 102/276 (36%), Positives = 146/276 (52%), Gaps = 22/276 (7%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD---------IRHL 303
D+WEIP I+ Q +GSG+ G V+ GK + VAVK + T + L
Sbjct: 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGM 362
RK H NI+ F G T P IV ++C LY+ L E ++L + ARQ A GM
Sbjct: 75 RKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE---WNNKSTKMSFAGTVAWMAPEV 419
+YLH+K IIHRDLKS N+ + KI DFG E W+ +G++ WMAPEV
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 420 IRNEQ---CSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLH---LPIPST 472
IR + S + D++++GIVL+EL+T + PY ++++ II VG SL + S
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
CP + LM C RPSF +IL+ ++ ++E
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 39/123 (31%)
Query: 177 VLIGSKEEAKISDFGTCRE---WNNKSTKMSFAGTVAWMAPEVIRNEQ---CSDKIDIWY 230
+ + KI DFG E W+ +G++ WMAPEVIR + S + D++
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY- 209
Query: 231 KNRLCFPTSLMARIGEFKSF--VLRDEWEI-----PFESISDLQWLGSGAQGAVFSGKLR 283
+F VL +E+ P+ +I++ V G L
Sbjct: 210 ------------------AFGIVL---YELMTGQLPYSNINNRD----QIIEMVGRGSLS 244
Query: 284 SEI 286
++
Sbjct: 245 PDL 247
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-108
Identities = 79/283 (27%), Positives = 125/283 (44%), Gaps = 32/283 (11%)
Query: 249 SFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD------- 299
F + I + +G G G V G+L +VA+K +
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 300 -------IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRL 351
+ + LNHPNIVK G+ P +VME+ G LY+ L D +
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 352 YNWARQIAAGMNYLHSK--QIIHRDLKSPNVLIGSKEE-----AKISDFGTCREWNNKST 404
IA G+ Y+ ++ I+HRDL+SPN+ + S +E AK++DFG ++ + +
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184
Query: 405 KMSFAGTVAWMAPEVI--RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS--AIIWGV 460
G WMAPE I E ++K D +S+ ++L+ +LT E P+ + I +
Sbjct: 185 --GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 461 GSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
L IP CP + ++++CWS P RP F I+ L
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 27/124 (21%), Positives = 44/124 (35%), Gaps = 41/124 (33%)
Query: 177 VLIGSKEE-----AKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI--RNEQCSDKIDIW 229
+ + S +E AK++DFG ++ + + G WMAPE I E ++K D +
Sbjct: 155 IFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 230 YKNRLCFPTSLMARIGEFKSF--VLRDEWEI-----PFESISDLQWLGSGAQGAVFSGKL 282
SF +L + I PF+ S + + L
Sbjct: 213 -------------------SFAMIL---YTILTGEGPFDEYSYGK---IKFINMIREEGL 247
Query: 283 RSEI 286
R I
Sbjct: 248 RPTI 251
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 3e-92
Identities = 76/290 (26%), Positives = 120/290 (41%), Gaps = 26/290 (8%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH-------L 303
+ + LG G G R E++ +K++ E R +
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVM 61
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGM 362
R L HPN++KF GV + + EY G L ++K + P + ++A+ IA+GM
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE---------------WNNKSTKMS 407
YLHS IIHRDL S N L+ + ++DFG R ++ + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG-SSSLH 466
G WMAPE+I +K+D++S+GIVL E++ D + +G+ L
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEP 516
P CP F + C P RPSF ++ L+ + P
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 14/68 (20%), Positives = 27/68 (39%), Gaps = 15/68 (22%)
Query: 177 VLIGSKEEAKISDFGTCRE---------------WNNKSTKMSFAGTVAWMAPEVIRNEQ 221
L+ + ++DFG R ++ + + G WMAPE+I
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198
Query: 222 CSDKIDIW 229
+K+D++
Sbjct: 199 YDEKVDVF 206
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-76
Identities = 96/266 (36%), Positives = 131/266 (49%), Gaps = 16/266 (6%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE--IVAVKKVREQKETDIRH-------- 302
+D+W + E + + +G G G VFSG+LR++ +VAVK RE D++
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAG 361
L++ +HPNIV+ GVCTQ IVME G L+ G + + L AAG
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGT--VAWMAPE 418
M YL SK IHRDL + N L+ K KISDFG RE + V W APE
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477
+ + S + D+WS+GI+LWE + +PY ++ + V LP P CPD
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAV 344
Query: 478 QLLMKMCWSNAPSSRPSFKQILSHLD 503
LM+ CW+ P RPSF I L
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 18/56 (32%), Positives = 24/56 (42%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIW 229
L+ K KISDFG RE + V W APE + + S + D+W
Sbjct: 244 CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-75
Identities = 68/298 (22%), Positives = 117/298 (39%), Gaps = 50/298 (16%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ------KETDIRHLRKLNH 308
+ I ++ +G G G V+ GK R E VAVK +ET+I + H
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRH 90
Query: 309 PNIVKFKGVCTQ----APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNY 364
NI+ F + ++ +Y G LY+ LK + + + A +G+ +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCH 149
Query: 365 LHSKQ--------IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-----MSFAGT 411
LH++ I HRDLKS N+L+ I+D G ++ + + + + GT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 412 VAWMAPEVI------RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS------------ 453
+M PEV+ + Q D++S+G++LWE+ V+
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 454 ---SAIIWGVGSSSLHLPIPST-----CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ V L P+ C LM CW++ P+SR + ++ L
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 20/128 (15%), Positives = 42/128 (32%), Gaps = 30/128 (23%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-----MSFAGTVAWMAPEVI------RNEQCSDK 225
+L+ I+D G ++ + + + + GT +M PEV+ + Q
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 226 IDIWYKNRLCFPTS-------LMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVF 278
D++ S + R +E+++P+ + + V
Sbjct: 233 ADMY---------SFGLILWEVARRCVSGGIV---EEYQLPYHDLVPSDPSYEDMREIVC 280
Query: 279 SGKLRSEI 286
KLR
Sbjct: 281 IKKLRPSF 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 4e-75
Identities = 71/296 (23%), Positives = 113/296 (38%), Gaps = 50/296 (16%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ------KETDIRHLRKLNHPN 310
I+ L+ +G G G V+ G + E VAVK + +ET++ + L H N
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHEN 63
Query: 311 IVKFKGVCT----QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
I+ F + ++ Y G LY+ L+ + IA+G+ +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLH 122
Query: 367 SKQ--------IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-----MSFAGTVA 413
+ I HRDLKS N+L+ + I+D G + + + GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 414 WMAPEVIRNEQCSD------KIDIWSYGIVLWELLTCETPYKDVDSSAIIWG-------- 459
+MAPEV+ D ++DIW++G+VLWE+ V+ +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 460 -------VGSSSLHLPIPST-----CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
V IP+ LMK CW PS+R + +I L
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 21/128 (16%), Positives = 42/128 (32%), Gaps = 30/128 (23%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-----MSFAGTVAWMAPEVIRNEQCSD------K 225
+L+ + I+D G + + + GT +MAPEV+ D +
Sbjct: 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203
Query: 226 IDIWYKNRLCFPTS-------LMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVF 278
+DIW + + R+ ++++ PF + + V
Sbjct: 204 VDIW---------AFGLVLWEVARRMVSNGIV---EDYKPPFYDVVPNDPSFEDMRKVVC 251
Query: 279 SGKLRSEI 286
+ R I
Sbjct: 252 VDQQRPNI 259
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 7e-74
Identities = 78/262 (29%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-------QKETDIRHLRK 305
R W + + + LQ +G G G V G R VAVK ++ E + + +
Sbjct: 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASV--MTQ 242
Query: 306 LNHPNIVKFKGVCTQ-APCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGM 362
L H N+V+ GV + IV EY A G L + L+ + L ++ + M
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422
YL +HRDL + NVL+ AK+SDFG +E ++ V W APE +R
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALRE 360
Query: 423 EQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
++ S K D+WS+GI+LWE+ + PY + ++ V + P CP +M
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYDVM 419
Query: 482 KMCWSNAPSSRPSFKQILSHLD 503
K CW ++RP+F Q+ L+
Sbjct: 420 KNCWHLDAATRPTFLQLREQLE 441
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 19/53 (35%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ AK+SDFG +E ++ V W APE +R ++ S K D+W
Sbjct: 320 VLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 370
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-72
Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 51/308 (16%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ------KETDIRHLRKLNH 308
+I + +G G G V+ GK R E VAVK + +E +I L H
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRH 95
Query: 309 PNIVKFKGVCTQ----APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNY 364
NI+ F + +V +Y +G L++ L V + + A A+G+ +
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAH 154
Query: 365 LHSKQ--------IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA-----GT 411
LH + I HRDLKS N+L+ I+D G ++ + + A GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 412 VAWMAPEVIRNE------QCSDKIDIWSYGIVLWELLTC----------ETPYKDVDSS- 454
+MAPEV+ + + + DI++ G+V WE+ + PY D+ S
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 455 ----AIIWGVGSSSLHLPIPST-----CPDGFQLLMKMCWSNAPSSRPSFKQILSHL-DI 504
+ V L IP+ +M+ CW ++R + +I L +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 505 ASQEVLRI 512
+ QE +++
Sbjct: 335 SQQEGIKM 342
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 14/64 (21%), Positives = 27/64 (42%), Gaps = 11/64 (17%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFA-----GTVAWMAPEVIRNE------QCSDK 225
+L+ I+D G ++ + + A GT +MAPEV+ + + +
Sbjct: 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 226 IDIW 229
DI+
Sbjct: 238 ADIY 241
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-72
Identities = 79/262 (30%), Positives = 120/262 (45%), Gaps = 16/262 (6%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-------QKETDIRHLRK 305
R W + + + LQ +G G G V G R VAVK ++ E + + +
Sbjct: 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASV--MTQ 70
Query: 306 LNHPNIVKFKGVCTQ-APCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAGM 362
L H N+V+ GV + IV EY A G L + L+ + L ++ + M
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422
YL +HRDL + NVL+ AK+SDFG +E ++ V W APE +R
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALRE 188
Query: 423 EQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
++ S K D+WS+GI+LWE+ + PY + ++ V + P CP +M
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEVM 247
Query: 482 KMCWSNAPSSRPSFKQILSHLD 503
K CW + RPSF Q+ L+
Sbjct: 248 KNCWHLDAAMRPSFLQLREQLE 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 19/53 (35%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ AK+SDFG +E ++ V W APE +R ++ S K D+W
Sbjct: 148 VLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 198
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-72
Identities = 87/283 (30%), Positives = 137/283 (48%), Gaps = 23/283 (8%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--------QKETDIRHL 303
DEWE+P E++ ++ LG+G G V+ G VAVK +++ E ++ +
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL--M 62
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIAAG 361
++L H +V+ V TQ P Y I+ EY G L + LK G ++ +L + A QIA G
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEV 419
M ++ + IHRDL++ N+L+ KI+DFG R + + W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
I + K D+WS+GI+L E++T PY + + +I + + P CP+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPEELY 240
Query: 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQ 521
LM++CW P RP+F + S L E E Y+ Q
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL-----EDFFTATEGQYQPQ 278
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 6e-72
Identities = 87/286 (30%), Positives = 137/286 (47%), Gaps = 18/286 (6%)
Query: 233 RLCFPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE--IVAVK 290
L +P + + D+WE+ I+ LG G G V+ G + VAVK
Sbjct: 192 TLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 251
Query: 291 KVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK- 341
++E KE + ++++ HPN+V+ GVCT+ P + I+ E+ YG L + L+
Sbjct: 252 TLKEDTMEVEEFLKEAAV--MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 309
Query: 342 -DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400
+ +EV L A QI++ M YL K IHR+L + N L+G K++DFG R
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369
Query: 401 NKSTKMSFAGTVA--WMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAII 457
+ W APE + + S K D+W++G++LWE+ T +PY +D S +
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429
Query: 458 WGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + P CP+ LM+ CW PS RPSF +I +
Sbjct: 430 ELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 15/55 (27%), Positives = 22/55 (40%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WMAPEVIRNEQCSDKIDIW 229
L+G K++DFG R + W APE + + S K D+W
Sbjct: 349 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-71
Identities = 79/280 (28%), Positives = 124/280 (44%), Gaps = 22/280 (7%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-----VAVKKVREQKETDIRHLR--- 304
I + + L+ LG G+ G V G+ + VAVK ++ + +
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 305 -------KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWAR 356
L+H N+++ GV P +V E G L + L+ + L +A
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--V 412
Q+A GM YL SK+ IHRDL + N+L+ +++ KI DFG R N+ M
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPS 471
AW APE ++ S D W +G+ LWE+ T + P+ ++ S I+ + LP P
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLR 511
CP +M CW++ P RP+F + L A +R
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 17/57 (29%), Positives = 25/57 (43%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIW 229
+L+ +++ KI DFG R N+ M AW APE ++ S D W
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-71
Identities = 83/267 (31%), Positives = 131/267 (49%), Gaps = 18/267 (6%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--------QKETDIR 301
+ +D WEIP ES+ LG G G V+ G VA+K ++ +E +
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV- 232
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIA 359
++KL H +V+ V ++ P Y IV EY + G L + LK G+ + +L + A QIA
Sbjct: 233 -MKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAP 417
+GM Y+ +HRDL++ N+L+G K++DFG R + + W AP
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E + + K D+WS+GI+L EL T PY + + ++ V +P P CP+
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPES 409
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503
LM CW P RP+F+ + + L+
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 14/55 (25%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG R + + W APE + + K D+W
Sbjct: 311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-71
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 23/270 (8%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-----VAVKKVRE----------QKE 297
++ I E + + LG G G V+ G + VAVK ++ E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 298 TDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWAR 356
I ++ L+HP+IVK G+ + P + I+ME YG L + L+ + + L ++
Sbjct: 64 AVI--MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAW 414
QI M YL S +HRD+ N+L+ S E K+ DFG R ++ + + W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 415 MAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
M+PE I + + D+W + + +WE+L+ + P+ +++ +I + LP P C
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLPKPDLC 239
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P LM CW PS RP F +++ L
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-71
Identities = 86/267 (32%), Positives = 134/267 (50%), Gaps = 18/267 (6%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--------QKETDIR 301
+D WEIP ES+ + LG+G G V+ VAVK ++ E ++
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV- 236
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQIA 359
++ L H +VK V T+ P Y I+ E+ A G L + LK +G + P +L +++ QIA
Sbjct: 237 -MKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAP 417
GM ++ + IHRDL++ N+L+ + KI+DFG R + + W AP
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E I + K D+WS+GI+L E++T PY + + +I + +P P CP+
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEE 413
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503
+M CW N P RP+F+ I S LD
Sbjct: 414 LYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 15/55 (27%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIW 229
+L+ + KI+DFG R + + W APE I + K D+W
Sbjct: 315 ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-71
Identities = 81/264 (30%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--------QKETDIRHL 303
WEI + ++ L+ LG+G G V GK R + VA+K ++E +E + +
Sbjct: 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKV--M 73
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGM 362
L+H +V+ GVCT+ I+ EY A G L N L++ Q+L + + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVI 420
YL SKQ +HRDL + N L+ + K+SDFG R + S V W PEV+
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 421 RNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
+ S K DIW++G+++WE+ + + PY+ +S + + L L P +
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYT 252
Query: 480 LMKMCWSNAPSSRPSFKQILSHLD 503
+M CW RP+FK +LS++
Sbjct: 253 IMYSCWHEKADERPTFKILLSNIL 276
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-70
Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 16/262 (6%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--------QKETDIRHLRK 305
+W I ++ +Q +GSG G V G ++ VA+K +RE +E ++ + K
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEV--MMK 59
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNY 364
L+HP +V+ GVC + C+V E+ +G L + L+ + L + GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVIRN 422
L +IHRDL + N L+G + K+SDFG R + S V W +PEV
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 179
Query: 423 EQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ S K D+WS+G+++WE+ + + PY++ +S ++ + S+ L P +M
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQIM 238
Query: 482 KMCWSNAPSSRPSFKQILSHLD 503
CW P RP+F ++L L
Sbjct: 239 NHCWRERPEDRPAFSRLLRQLA 260
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-70
Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 18/268 (6%)
Query: 250 FVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--------QKETDI 300
+ +D WEIP ES+ LG G G V+ G VA+K ++ +E +
Sbjct: 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV 315
Query: 301 RHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--DGEEVPPQRLYNWARQI 358
++KL H +V+ V ++ P Y IV EY + G L + LK G+ + +L + A QI
Sbjct: 316 --MKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372
Query: 359 AAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMA 416
A+GM Y+ +HRDL++ N+L+G K++DFG R + + W A
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 417 PEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475
PE + + K D+WS+GI+L EL T PY + + ++ V +P P CP+
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE 491
Query: 476 GFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LM CW P RP+F+ + + L+
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 14/55 (25%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG R + + W APE + + K D+W
Sbjct: 394 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-70
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 25/274 (9%)
Query: 251 VLRDEWEIPFESIS-DLQWLGSGAQGAVFSGKLRSEI----VAVKKVRE----------- 294
+ E + + ++ + + LGSG G V G + + VAVK ++
Sbjct: 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 295 QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNW 354
E ++ +++L++P IV+ G+C +VME GPL L+ V + +
Sbjct: 66 LAEANV--MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIEL 122
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT- 411
Q++ GM YL +HRDL + NVL+ ++ AKISDFG + + K G
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 412 -VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPI 469
V W APE I + S K D+WS+G+++WE + + PY+ + S + + +
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGC 241
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P+ CP LM +CW+ +RP F + L
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 21/57 (36%), Positives = 28/57 (49%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIW 229
VL+ ++ AKISDFG + + K G V W APE I + S K D+W
Sbjct: 148 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-70
Identities = 87/267 (32%), Positives = 133/267 (49%), Gaps = 22/267 (8%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSE--IVAVKKVRE--------QKETDIRHL 303
D+WE+ I+ LG G G V+ G + VAVK ++E KE + +
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV--M 63
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAG 361
+++ HPN+V+ GVCT+ P + I+ E+ YG L + L++ +EV L A QI++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN----KSTKMSFAGTVAWMAP 417
M YL K IHRDL + N L+G K++DFG R F + W AP
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAP 181
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E + + S K D+W++G++LWE+ T +PY +D S + + + P CP+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEK 240
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503
LM+ CW PS RPSF +I +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 16/57 (28%), Positives = 23/57 (40%), Gaps = 6/57 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNN----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+G K++DFG R F + W APE + + S K D+W
Sbjct: 142 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVW 196
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-70
Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 40/292 (13%)
Query: 249 SFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVRE-------- 294
+ +D + + LG G G+V + +VAVK+++
Sbjct: 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 295 -QKETDIRHLRKLNHPNIVKFKGVCTQA---PCYCIVMEYCAYGPLYN-LLKDGEEVPPQ 349
Q+E I L+ L+ IVK++GV +VMEY G L + L + +
Sbjct: 71 FQREIQI--LKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRARLDAS 127
Query: 350 RLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMS 407
RL ++ QI GM YL S++ +HRDL + N+L+ S+ KI+DFG + + +
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 408 FAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464
G + W APE + + S + D+WS+G+VL+EL T C+ + G
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 465 LH-------------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LP P CP LMK+CW+ +P RPSF + LD
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 4e-70
Identities = 90/261 (34%), Positives = 132/261 (50%), Gaps = 16/261 (6%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-VAVKKVRE--------QKETDIRHLRKL 306
E+ E I+ L+ LGSG G V GK + + VAVK ++E +E + KL
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQT--MMKL 60
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYL 365
+HP +VKF GVC++ IV EY + G L N L+ G+ + P +L + GM +L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 366 HSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAWMAPEVIRNE 423
S Q IHRDL + N L+ K+SDFG R + S V W APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 424 QCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482
+ S K D+W++GI++WE+ + + PY +S ++ V S L P D +M
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASDTIYQIMY 239
Query: 483 MCWSNAPSSRPSFKQILSHLD 503
CW P RP+F+Q+LS ++
Sbjct: 240 SCWHELPEKRPTFQQLLSSIE 260
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 6e-70
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-----VAVKKVRE----------QKE 297
++EI E I + +G G G V G S VA+K + +E
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66
Query: 298 TDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWAR 356
+R+ +HP+IVK GV T+ P + I+ME C G L + L + L +A
Sbjct: 67 ALT--MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--VAW 414
Q++ + YL SK+ +HRD+ + NVL+ S + K+ DFG R + + + G + W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 415 MAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
MAPE I + + D+W +G+ +WE+L P++ V ++ +I + + LP+P C
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNC 242
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P LM CW+ PS RP F ++ + L
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-69
Identities = 77/283 (27%), Positives = 136/283 (48%), Gaps = 26/283 (9%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLRSEI------VAVKKVREQKETDIRH--------L 303
+ ++ LGSGA G V+ G E VA+K++RE +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQIAAGM 362
+++P++ + G+C + ++ + +G L + + + + + Q L NW QIA GM
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEV 419
NYL ++++HRDL + NVL+ + + KI+DFG + + + G + WMA E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
I + + + D+WSYG+ +WEL+T PY + +S I + LP P C
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 249
Query: 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQ 521
++M+ CW SRP F++++ ++ R P+ Y +Q
Sbjct: 250 MIMRKCWMIDADSRPKFRELIIEFS----KMAR-DPQRYLVIQ 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 15/56 (26%), Positives = 27/56 (48%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIW 229
VL+ + + KI+DFG + + + G + WMA E I + + + D+W
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-69
Identities = 85/296 (28%), Positives = 144/296 (48%), Gaps = 27/296 (9%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI------VAVKKVRE---------- 294
VL+ EI ++ + +G+G G V+ G L++ VA+K ++
Sbjct: 34 VLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 93
Query: 295 QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYN 353
E I + + +H NI++ +GV ++ I+ EY G L L++ + E +L
Sbjct: 94 LGEAGI--MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGT- 411
R IAAGM YL + +HRDL + N+L+ S K+SDFG R ++ + +G
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 412 --VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLP 468
+ W APE I + + D+WS+GIV+WE++T E PY ++ + ++ + + LP
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLP 270
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD--IASQEVLRIQPEPYYKMQM 522
P CP LM CW + RP F I+S LD I + + L+ + ++ +
Sbjct: 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSI 326
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-69
Identities = 89/274 (32%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-----VAVKKVRE----------Q 295
EI I + +GSG G V G+LR VA+K ++
Sbjct: 39 GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 296 KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNW 354
E I + + +HPNI++ +GV T+ IV EY G L L+ + + +L
Sbjct: 99 SEASI--MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT- 411
R + AGM YL +HRDL + NVL+ S K+SDFG R E + + + G
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 412 -VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPI 469
+ W APE I S D+WS+G+V+WE+L E PY ++ + +I V LP
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEGYRLPA 275
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P CP LM CW + RP F QI+S LD
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-68
Identities = 90/285 (31%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVREQKETDIRH----- 302
D + + LQ LG G G+V + E+VAVKK++ E +R
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 62
Query: 303 --LRKLNHPNIVKFKGVCTQAPCY--CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQ 357
L+ L H NIVK+KGVC A ++MEY YG L + L+ E + +L + Q
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 358 IAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--VA 413
I GM YL +K+ IHRDL + N+L+ ++ KI DFG + + + K+ G +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGV----GSSSLH-- 466
W APE + + S D+WS+G+VL+EL T E + G H
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 467 --------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LP P CPD ++M CW+N + RPSF+ + +D
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-68
Identities = 86/288 (29%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVRE----------QK 296
D + ++ LG G G V + E VAVK ++ +K
Sbjct: 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK 72
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQAPCY--CIVMEYCAYGPLYN-LLKDGEEVPPQRLYN 353
E +I LR L H NIVK+KG+CT+ ++ME+ G L L K+ ++ ++
Sbjct: 73 EIEI--LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT 411
+A QI GM+YL S+Q +HRDL + NVL+ S+ + KI DFG + E + + +
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 412 --VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAII-----WGVGSS 463
V W APE + + D+WS+G+ L ELLT C++ + + + +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 464 SLH--------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
L LP P CPD LM+ CW PS+R SF+ ++ +
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 3e-68
Identities = 89/274 (32%), Positives = 136/274 (49%), Gaps = 24/274 (8%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE-----IVAVKKVRE----------Q 295
V E+ +IS + +G+G G V SG+L+ VA+K ++
Sbjct: 35 VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 94
Query: 296 KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNW 354
E I + + +HPNI++ +GV T++ IV EY G L + L+ + + +L
Sbjct: 95 GEASI--MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGT-- 411
R IA+GM YL +HRDL + N+LI S K+SDFG R ++ + G
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 412 -VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPI 469
+ W +PE I + + D+WSYGIVLWE+++ E PY ++ + +I V LP
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPP 271
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P CP LM CW ++RP F+QI+S LD
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-68
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 21/272 (7%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE------IVAVKKVREQKETDIRH-- 302
+ + L+ LGSG G V G E V +K + ++
Sbjct: 3 MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV 62
Query: 303 ------LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWA 355
+ L+H +IV+ G+C + +V +Y G L + ++ + PQ L NW
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121
Query: 356 RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---V 412
QIA GM YL ++HR+L + NVL+ S + +++DFG ++ ++ +
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPS 471
WMA E I + + + D+WSYG+ +WEL+T PY + + + + L P
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQPQ 240
Query: 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
C ++M CW + RP+FK++ +
Sbjct: 241 ICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 13/56 (23%), Positives = 27/56 (48%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIW 229
VL+ S + +++DFG ++ ++ + WMA E I + + + D+W
Sbjct: 146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVW 201
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-68
Identities = 93/291 (31%), Positives = 136/291 (46%), Gaps = 35/291 (12%)
Query: 248 KSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVREQKETDIR 301
+F RD + + LQ LG G G+V + E+VAVKK++ E +R
Sbjct: 28 SAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 87
Query: 302 H-------LRKLNHPNIVKFKGVCTQAPCY--CIVMEYCAYGPLYN-LLKDGEEVPPQRL 351
L+ L H NIVK+KGVC A ++MEY YG L + L K E + +L
Sbjct: 88 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 147
Query: 352 YNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFA 409
+ QI GM YL +K+ IHRDL + N+L+ ++ KI DFG + + + K+
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 410 GT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGV----GS 462
G + W APE + + S D+WS+G+VL+EL T E + G
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 463 SSLH----------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
H LP P CPD ++M CW+N + RPSF+ + +D
Sbjct: 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 5e-68
Identities = 77/269 (28%), Positives = 121/269 (44%), Gaps = 21/269 (7%)
Query: 254 DEWEIPFESISDLQW-LGSGAQGAVFSGKLRSEI----VAVKKVREQKETDIRH------ 302
+ + +++ LG G G+V G R VA+K +++ E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 303 --LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIA 359
+ +L++P IV+ GVC +VME GPL+ L EE+P + Q++
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--VAWM 415
GM YL K +HRDL + NVL+ ++ AKISDFG + ++ AG + W
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 416 APEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474
APE I + S + D+WSYG+ +WE L+ + PYK + ++ + + P CP
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECP 239
Query: 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LM CW RP F + +
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIW 229
VL+ ++ AKISDFG + ++ AG + W APE I + S + D+W
Sbjct: 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-67
Identities = 86/288 (29%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR------SEIVAVKKVRE----------QK 296
D + ++ LG G G V E+VAVK ++ ++
Sbjct: 23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ 82
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQA---PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYN 353
E DI LR L H +I+K+KG C A +VMEY G L + L + +L
Sbjct: 83 EIDI--LRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYLPR-HSIGLAQLLL 138
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT 411
+A+QI GM YLH++ IHRDL + NVL+ + KI DFG + ++ ++ G
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 412 --VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGV---GSSSL 465
V W APE ++ + D+WS+G+ L+ELLT C++ + G+ + L
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 466 H----------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LP P CP LMK CW S RP+F+ ++ L
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 9e-67
Identities = 67/310 (21%), Positives = 108/310 (34%), Gaps = 61/310 (19%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ------KETDIRHLRKLN 307
E + +++ L+ +G G GAV+ G L VAVK E +I + +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLME 65
Query: 308 HPNIVKFKGVCTQAPC-----YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGM 362
H NI +F + Y +VMEY G L L A + G+
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGL 124
Query: 363 NYLHS---------KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-------- 405
YLH+ I HRDL S NVL+ + ISDFG
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 406 -MSFAGTVAWMAPEVIRN-------EQCSDKIDIWSYGIVLWELLTCET---PYKDVDSS 454
+S GT+ +MAPEV+ E ++D+++ G++ WE+ T P + V
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 455 AIIWG---------------VGSSSLHLPIPSTCPD------GFQLLMKMCWSNAPSSRP 493
+ + V P + + ++ CW +R
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 494 SFKQILSHLD 503
+ + +
Sbjct: 305 TAQXAEERMA 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 24/124 (19%), Positives = 39/124 (31%), Gaps = 14/124 (11%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK---------MSFAGTVAWMAPEVIRNEQCSDKID 227
VL+ + ISDFG +S GT+ +MAPEV+ +
Sbjct: 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210
Query: 228 IWYKNRLCFPTSL-----MARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKL 282
K + L R + E+++ F++ Q V K
Sbjct: 211 SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ 270
Query: 283 RSEI 286
R +
Sbjct: 271 RPKF 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-65
Identities = 88/290 (30%), Positives = 125/290 (43%), Gaps = 42/290 (14%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQ-KETDIRHLRK 305
+WE P +S + LG+GA G V + VAVK ++ T+ L
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 306 --------LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK---------------- 341
NH NIV G CT ++ EYC YG L N L+
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 342 --DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399
D + + L +++ Q+A GM +L SK IHRDL + N+L+ KI DFG R+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 400 NN-----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDS 453
N V WMAPE I N + + D+WSYGI LWEL + +PY +
Sbjct: 196 KNDSNYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 454 SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + + + P P +MK CW P RP+FKQI+ ++
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-65
Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 23/274 (8%)
Query: 249 SFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-----VAVKKVRE--------- 294
+ ++EI E I + +G G G V G S VA+K +
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 295 -QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLY 352
+E +R+ +HP+IVK GV T+ P + I+ME C G L + L + L
Sbjct: 438 FLQEALT--MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLI 494
Query: 353 NWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT- 411
+A Q++ + YL SK+ +HRD+ + NVL+ S + K+ DFG R + + + G
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 412 -VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPI 469
+ WMAPE I + + D+W +G+ +WE+L P++ V ++ +I + + LP+
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPM 613
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P CP LM CW+ PS RP F ++ + L
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 65/298 (21%), Positives = 109/298 (36%), Gaps = 50/298 (16%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ------KETDIRHLRKLN 307
+ + L+ G G V+ +L +E VAVK Q E ++ L +
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMK 76
Query: 308 HPNIVKFKGVCTQAPC----YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMN 363
H NI++F G + ++ + G L + LK V L + A +A G+
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLA 135
Query: 364 YLHSKQ----------IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK---MSFAG 410
YLH I HRD+KS NVL+ + A I+DFG ++ + G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 411 TVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPY----------------K 449
T +MAPEV+ +ID+++ G+VLWEL + T +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 450 DVDSSAIIWGVGSSSLHLPIPSTCPDGFQL-----LMKMCWSNAPSSRPSFKQILSHL 502
+ V + + ++ CW + +R S + +
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 8/61 (13%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK---MSFAGTVAWMAPEVIR-----NEQCSDKIDI 228
VL+ + A I+DFG ++ + GT +MAPEV+ +ID+
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221
Query: 229 W 229
+
Sbjct: 222 Y 222
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 21/265 (7%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLRSEI------VAVKKVREQKETDIRH--------L 303
+ ++ LGSGA G V+ G E VA+K++RE +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQIAAGM 362
+++P++ + G+C + ++ + +G L + + + + + Q L NW QIA GM
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEV 419
NYL ++++HRDL + NVL+ + + KI+DFG + + + G + WMA E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
I + + + D+WSYG+ +WEL+T PY + +S I + LP P C
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 249
Query: 479 LLMKMCWSNAPSSRPSFKQILSHLD 503
++M CW SRP F++++
Sbjct: 250 MIMVKCWMIDADSRPKFRELIIEFS 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 15/56 (26%), Positives = 27/56 (48%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIW 229
VL+ + + KI+DFG + + + G + WMA E I + + + D+W
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-65
Identities = 81/287 (28%), Positives = 124/287 (43%), Gaps = 34/287 (11%)
Query: 250 FVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKVREQKETDIRH 302
F I I LG GA G VF + + + VAVK ++E E+ +
Sbjct: 30 FSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD 89
Query: 303 LR-------KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-------------- 341
+ L H +IV+F GVCT+ +V EY +G L L+
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 342 -DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-W 399
+ +L A Q+AAGM YL +HRDL + N L+G KI DFG R+ +
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 400 NNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAI 456
+ ++ + WM PE I + + + D+WS+G+VLWE+ T + P+ + ++
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
Query: 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
I + L P CP +M+ CW P R S K + + L
Sbjct: 270 IDCITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 6e-65
Identities = 87/294 (29%), Positives = 128/294 (43%), Gaps = 38/294 (12%)
Query: 248 KSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKVRE------ 294
K+ + D E+P ++I+ ++ LG GA G V+ G++ VAVK + E
Sbjct: 17 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 295 ----QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-------DG 343
E I + K NH NIV+ GV Q+ I+ME A G L + L+
Sbjct: 77 ELDFLMEALI--ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP 134
Query: 344 EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCREWN 400
+ L + AR IA G YL IHRD+ + N L+ AKI DFG R+
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 401 N-----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSS 454
K V WM PE + K D WS+G++LWE+ + PY +
Sbjct: 195 RASYYRKGGCAMLP--VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
Query: 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
++ V S + P CP +M CW + P RP+F IL ++ +Q+
Sbjct: 253 EVLEFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 9e-65
Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 39/286 (13%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE---------QKE 297
I I + LG GA G VF + +VAVK +++ Q+E
Sbjct: 8 HVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE 67
Query: 298 TDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD--------------- 342
++ L L H +IVKF GVC +V EY +G L L+
Sbjct: 68 AEL--LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 343 -GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WN 400
E+ ++ + A QIA+GM YL S+ +HRDL + N L+G+ KI DFG R+ ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 401 NKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAII 457
++ + WM PE I + + + D+WS+G++LWE+ T + P+ + ++ +I
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 458 WGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + L P CP +M CW P R + K+I L
Sbjct: 246 ECITQGRV-LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-64
Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 39/284 (13%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSE----IVAVKKVRE----------QKETD 299
+ + I +G G G V +++ + A+K+++E E +
Sbjct: 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 77
Query: 300 IRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK----------------D 342
+ L KL +HPNI+ G C + +EY +G L + L+
Sbjct: 78 V--LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 343 GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN- 401
+ Q+L ++A +A GM+YL KQ IHRDL + N+L+G AKI+DFG R
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195
Query: 402 -KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWG 459
K T V WMA E + + D+WSYG++LWE+++ TPY + + +
Sbjct: 196 VKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 460 VGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ L P C D LM+ CW P RPSF QIL L+
Sbjct: 254 LPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-64
Identities = 84/283 (29%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKVRE----------QK 296
DEWE+ E I+ + LG G+ G V+ G + + VA+K V E
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL----------KDGEEV 346
E + +++ N ++V+ GV +Q ++ME G L + L
Sbjct: 78 EASV--MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 347 PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN----- 401
++ A +IA GM YL++ + +HRDL + N ++ KI DFG R+
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGV 460
K K V WM+PE +++ + D+WS+G+VLWE+ T E PY+ + + ++ V
Sbjct: 196 KGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 461 GSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
L L P CPD LM+MCW P RPSF +I+S +
Sbjct: 254 MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-64
Identities = 90/342 (26%), Positives = 150/342 (43%), Gaps = 45/342 (13%)
Query: 233 RLCFPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR--------- 283
+ ++A + E++ WE+P + + + LG GA G V +
Sbjct: 42 ENLYFQGMLAGVSEYE-LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR 100
Query: 284 SEIVAVKKVREQ-KETDIRHLRK--------LNHPNIVKFKGVCTQAPCYCIVMEYCAYG 334
VAVK ++ E D+ L H NI+ G CTQ +++EY + G
Sbjct: 101 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 160
Query: 335 PLYNLLK----------------DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378
L L+ E++ + L + A Q+A GM YL SK+ IHRDL +
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220
Query: 379 NVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYG 435
NVL+ KI+DFG R+ ++ V WMAPE + + + + D+WS+G
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 436 IVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
++LWE+ T +PY V + + + PS C + ++M+ CW PS RP+
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 339
Query: 495 FKQILSHLD-----IASQEVLRIQPEPYYKMQMIWKEEIRVH 531
FKQ++ LD ++QE+ ++ + E + +
Sbjct: 340 FKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-64
Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 34/292 (11%)
Query: 248 KSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKVRE------ 294
K+ + D E+P ++I+ ++ LG GA G V+ G++ VAVK + E
Sbjct: 58 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 295 ----QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-------DG 343
E I + K NH NIV+ GV Q+ I++E A G L + L+
Sbjct: 118 ELDFLMEALI--ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 344 EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCRE-W 399
+ L + AR IA G YL IHRD+ + N L+ AKI DFG R+ +
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 400 NNKSTKMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAI 456
+ V WM PE + K D WS+G++LWE+ + PY + +
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
+ V S + P CP +M CW + P RP+F IL ++ +Q+
Sbjct: 296 LEFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-64
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 33/297 (11%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSE-----IVAVKKVREQKETDIRH------ 302
++ IP + + + LG G G+V +L+ E VAVK ++
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 303 ---LRKLNHPNIVKFKGVCTQ------APCYCIVMEYCAYGPLYNLLK------DGEEVP 347
+++ +HP++ K GV + P +++ + +G L+ L + +P
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407
Q L + IA GM YL S+ IHRDL + N ++ ++DFG R+ +
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 408 FAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSS 463
+ V W+A E + + + D+W++G+ +WE++T +TPY ++++ I +
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
Query: 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD--IASQEVLRIQPEPYY 518
+ L P C + LM CWS P RPSF + L+ + VL +P Y
Sbjct: 256 NR-LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 6e-64
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE----------QK 296
++WE P ++ + LG+GA G V VAVK ++
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 297 ETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD------------- 342
E I + L H NIV G CT ++ EYC YG L N L+
Sbjct: 99 ELKI--MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 343 -GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401
+ L +++ Q+A GM +L SK IHRD+ + NVL+ + AKI DFG R+ N
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 402 -----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSA 455
V WMAPE I + + + D+WSYGI+LWE+ + PY + ++
Sbjct: 217 DSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274
Query: 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + + P+ P +M+ CW+ P+ RP+F+QI S L
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-64
Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVREQ-KETDIRHL 303
+WE P + ++ + LG GA G V + + VAVK +++ E D+ L
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 304 RK--------LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-------------- 341
H NI+ G CTQ +++EY + G L L+
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 342 --DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399
E++ + L + Q+A GM YL S++ IHRDL + NVL+ KI+DFG R+
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 400 NNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSA 455
NN V WMAPE + + + + D+WS+G+++WE+ T +PY +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + + P+ C + ++M+ CW PS RP+FKQ++ LD
Sbjct: 268 LFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 7e-64
Identities = 70/290 (24%), Positives = 131/290 (45%), Gaps = 32/290 (11%)
Query: 254 DEWEIPFES--ISDLQWLGSGAQGAVFSGKLRSEI-----VAVKKVRE----------QK 296
+ IP E + +G G G V+ G+ + A+K + +
Sbjct: 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR 71
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQA-PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNW 354
E + +R LNHPN++ G+ +++ Y +G L ++ + L ++
Sbjct: 72 EGLL--MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--- 411
Q+A GM YL ++ +HRDL + N ++ K++DFG R+ ++
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 412 --VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLP 468
V W A E ++ + + K D+WS+G++LWELLT PY+ +D + + + LP
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLP 248
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYY 518
P CPD +M+ CW P+ RP+F+ ++ ++ +++ +Y
Sbjct: 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE----QIVSALLGDHY 294
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 7e-64
Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 48/295 (16%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE----------QK 296
+WE P +++ + LG G G V VAVK ++E
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--------------- 341
E ++ L+++NHP+++K G C+Q +++EY YG L L+
Sbjct: 76 EFNV--LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 342 ---------DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISD 392
D + L ++A QI+ GM YL +++HRDL + N+L+ + KISD
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 393 FGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPY 448
FG R+ + + + + V WMA E + + + + D+WS+G++LWE++T PY
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 449 KDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + + + + P C + LM CW P RP F I L+
Sbjct: 254 PGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-63
Identities = 87/285 (30%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI-------VAVKKVRE----------QKET 298
EI ++ ++ LG G V+ G L VA+K +++ + E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 299 DIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD---------------- 342
+ +L HPN+V GV T+ ++ YC++G L+ L
Sbjct: 64 ML--RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 343 GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402
+ P + QIAAGM YL S ++H+DL + NVL+ K KISD G RE
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 403 ST-KMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIW 458
K+ + WMAPE I + S DIWSYG+VLWE+ + PY + ++
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 459 GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + + LP P CP LM CW+ PS RP FK I S L
Sbjct: 242 MIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-63
Identities = 86/305 (28%), Positives = 132/305 (43%), Gaps = 51/305 (16%)
Query: 246 EFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE---- 294
+F+ + +WE P E++ + LGSGA G V + S VAVK ++E
Sbjct: 30 DFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 89
Query: 295 ------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK------ 341
E + + +L +H NIV G CT + ++ EYC YG L N L+
Sbjct: 90 SEREALMSELKM--MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 342 -----------------DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS 384
D + + L +A Q+A GM +L K +HRDL + NVL+
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 385 KEEAKISDFGTCREWNN-----KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLW 439
+ KI DFG R+ + V WMAPE + + K D+WSYGI+LW
Sbjct: 208 GKVVKICDFGLARDIMSDSNYVVRGNARLP--VKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 440 ELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498
E+ + PY + A + + + + P + ++M+ CW+ RPSF +
Sbjct: 266 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325
Query: 499 LSHLD 503
S L
Sbjct: 326 TSFLG 330
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 6e-63
Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSE-----IVAVKKVREQKETDIRH------ 302
++ I + + LG G G+V G L+ E VAVK ++ +
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 303 ---LRKLNHPNIVKFKGVCTQ-----APCYCIVMEYCAYGPLYNLLK------DGEEVPP 348
++ +HPN+++ GVC + P +++ + YG L+ L + +P
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 349 QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408
Q L + IA GM YL ++ +HRDL + N ++ ++DFG ++ +
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 409 AGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSS 464
V W+A E + + + K D+W++G+ +WE+ T TPY V + + +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
L P C D +M CW P RP+F + L+
Sbjct: 267 R-LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 8e-63
Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 43/291 (14%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQKETDIRHLRK 305
+WE P + + + LG GA G V VAVK ++E R
Sbjct: 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--GATHSEHRA 76
Query: 306 L-----------NHPNIVKFKGVCTQA--PCYCIVMEYCAYGPLYNLLK----------- 341
L +H N+V G CT+ P +++E+C +G L L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 342 -----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396
+ + + L ++ Q+A GM +L S++ IHRDL + N+L+ K KI DFG
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 397 REWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVD 452
R+ + + WMAPE I + + + D+WS+G++LWE+ + +PY V
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 453 SSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ P M CW PS RP+F +++ HL
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-62
Identities = 84/305 (27%), Positives = 140/305 (45%), Gaps = 40/305 (13%)
Query: 237 PTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIV 287
T ++A + E++ +WE P + ++ + LG G G V + + V
Sbjct: 58 DTPMLAGVSEYE-LPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV 116
Query: 288 AVKKVREQ-KETDIRHLRK--------LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN 338
AVK +++ E D+ L H NI+ G CTQ +++EY + G L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 339 LLK----------------DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI 382
L+ E++ + L + Q+A GM YL S++ IHRDL + NVL+
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236
Query: 383 GSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLW 439
KI+DFG R+ NN V WMAPE + + + + D+WS+G+++W
Sbjct: 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296
Query: 440 ELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498
E+ T +PY + + + + P+ C + ++M+ CW PS RP+FKQ+
Sbjct: 297 EIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355
Query: 499 LSHLD 503
+ LD
Sbjct: 356 VEDLD 360
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-62
Identities = 65/278 (23%), Positives = 110/278 (39%), Gaps = 39/278 (14%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEI---------VAVKKVRE---------QKE 297
+I E + + LG G +F G R V +K + + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA 62
Query: 298 TDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWAR 356
+ + KL+H ++V GVC +V E+ +G L LK + A+
Sbjct: 63 ASM--MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE--------AKISDFGTCRE-WNNKSTKMS 407
Q+AA M++L +IH ++ + N+L+ +E+ K+SD G +
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 408 FAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSL 465
+ W+ PE I N + + D WS+G LWE+ + + P +DS +
Sbjct: 181 ----IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRH 235
Query: 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LP P L+ C P RPSF+ I+ L+
Sbjct: 236 QLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-62
Identities = 71/271 (26%), Positives = 112/271 (41%), Gaps = 12/271 (4%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVR--EQKETDIRHLRKLNHPN 310
E+ ++ +G G+ G V K + AVKKVR + ++ L+ P
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPR 111
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
IV G + P I ME G L L+K +P R + Q G+ YLH+++I
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 371 IHRDLKSPNVLIGSK-EEAKISDFGTCR------EWNNKSTKMSFAGTVAWMAPEVIRNE 423
+H D+K+ NVL+ S A + DFG + T GT MAPEV+ +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 424 QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDGFQLLMK 482
C K+DIWS ++ +L P+ + + S IP +C ++
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 483 MCWSNAPSSRPSFKQILSHLDIASQEVLRIQ 513
P R S ++ + A QEV ++
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKALQEVGGLK 322
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 20/60 (33%), Positives = 26/60 (43%), Gaps = 7/60 (11%)
Query: 177 VLIGSK-EEAKISDFGTCR------EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ S A + DFG + T GT MAPEV+ + C K+DIW
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-62
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 32/290 (11%)
Query: 254 DEWEIPFE--SISDLQWLGSGAQGAVFSGKLRSE-----IVAVKKVRE----------QK 296
I + + +G G G V+ G L AVK +
Sbjct: 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT 75
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQA-PCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNW 354
E I ++ +HPN++ G+C ++ +V+ Y +G L N + + + L +
Sbjct: 76 EGII--MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA- 413
Q+A GM YL SK+ +HRDL + N ++ K K++DFG R+ +K T A
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 414 ----WMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLP 468
WMA E ++ ++ + K D+WS+G++LWEL+T PY DV++ I + L
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LL 252
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYY 518
P CPD +M CW RPSF +++S + + +Y
Sbjct: 253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS----AIFSTFIGEHY 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-61
Identities = 77/298 (25%), Positives = 131/298 (43%), Gaps = 34/298 (11%)
Query: 254 DEWEIPFE--SISDLQWLGSGAQGAVFSGKLRSE-----IVAVKKVRE----------QK 296
I + + +G G G V+ G L AVK +
Sbjct: 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT 139
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQA-PCYCIVMEYCAYGPLYNLL-KDGEEVPPQRLYNW 354
E I ++ +HPN++ G+C ++ +V+ Y +G L N + + + L +
Sbjct: 140 EGII--MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGT--- 411
Q+A GM +L SK+ +HRDL + N ++ K K++DFG R+ +K T
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 412 --VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLP 468
V WMA E ++ ++ + K D+WS+G++LWEL+T PY DV++ I + L
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LL 316
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD-----IASQEVLRIQPEPYYKMQ 521
P CPD +M CW RPSF +++S + + + + Y ++
Sbjct: 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA-TYVNVK 373
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-61
Identities = 88/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE----------QK 296
E P +I ++ +G GA G VF + +VAVK ++E Q+
Sbjct: 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 99
Query: 297 ETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK--------------- 341
E + + + ++PNIVK GVC C++ EY AYG L L+
Sbjct: 100 EAAL--MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 342 ---------DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISD 392
+ ARQ+AAGM YL ++ +HRDL + N L+G KI+D
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217
Query: 393 FGTCREWNNKST-KMSFAGT--VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPY 448
FG R + K + WM PE I + + + D+W+YG+VLWE+ + PY
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 449 KDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ +I+ V ++ L P CP LM++CWS P+ RPSF I L
Sbjct: 278 YGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 9e-61
Identities = 76/270 (28%), Positives = 122/270 (45%), Gaps = 21/270 (7%)
Query: 253 RDEWEIPFESISDLQW-LGSGAQGAVFSGKLRSE----IVAVKKVREQKETDIRH----- 302
+ + +++ LG G G+V G R VA+K +++ E
Sbjct: 327 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 386
Query: 303 ---LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQI 358
+ +L++P IV+ GVC +VME GPL+ L+ EE+P + Q+
Sbjct: 387 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 445
Query: 359 AAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGT--VAW 414
+ GM YL K +HR+L + NVL+ ++ AKISDFG + ++ AG + W
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 415 MAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
APE I + S + D+WSYG+ +WE L+ + PYK + ++ + + P C
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPEC 564
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P LM CW RP F + +
Sbjct: 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-60
Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---IRHLRKLNHPNIVKFKG---- 316
++ +GSG G VF K R + +K+V+ E ++ L KL+H NIV + G
Sbjct: 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 317 ------------VCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGM 362
++ C I ME+C G L ++ GE++ QI G+
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422
+Y+HSK++I+RDLK N+ + ++ KI DFG N + GT+ +M+PE I +
Sbjct: 136 DYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS 195
Query: 423 EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482
+ ++D+++ G++L ELL + + I + L++
Sbjct: 196 QDYGKEVDLYALGLILAELLHVCDTAFETSK------FFTDLRDGIISDIFDKKEKTLLQ 249
Query: 483 MCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEP 516
S P RP+ +IL L + + + +
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 13/53 (24%), Positives = 27/53 (50%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ + ++ KI DFG N + GT+ +M+PE I ++ ++D++
Sbjct: 153 IFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY 205
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-59
Identities = 75/254 (29%), Positives = 117/254 (46%), Gaps = 25/254 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKGVCT 319
LG G G V++G+ S +A+K++ E+ I + L H NIV++ G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 320 QAPCYCIVMEYCAYGPLYNLLK-------DGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
+ I ME G L LL+ D E+ + + +QI G+ YLH QI+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT----IGFYTKQILEGLKYLHDNQIVH 145
Query: 373 RDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQ--CSDK 428
RD+K NVLI + KISDFGT + + +F GT+ +MAPE+I
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487
DIWS G + E+ T + P+ ++ A ++ VG +H IP + + + C+
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 488 APSSRPSFKQILSH 501
P R +L
Sbjct: 266 DPDKRACANDLLVD 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 21/57 (36%), Positives = 28/57 (49%), Gaps = 4/57 (7%)
Query: 177 VLIGSKE-EAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQ--CSDKIDIW 229
VLI + KISDFGT + + +F GT+ +MAPE+I DIW
Sbjct: 153 VLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-59
Identities = 68/252 (26%), Positives = 111/252 (44%), Gaps = 21/252 (8%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKG- 316
+G G+ V+ G + VA +++++K T L+ L HPNIV+F
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 317 ---VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ--II 371
C +V E G L LK + + + L +W RQI G+ +LH++ II
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 372 HRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
HRDLK N+ I KI D G K + GT +MAPE+ E+ + +D
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY-EEKYDESVD 211
Query: 431 IWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
++++G+ + E+ T E PY + + + I V S + +++ C
Sbjct: 212 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
Query: 490 SSRPSFKQILSH 501
R S K +L+H
Sbjct: 272 DERYSIKDLLNH 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 2/46 (4%)
Query: 184 EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI D G K + GT +MAPE+ E+ + +D++
Sbjct: 170 SVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY-EEKYDESVDVY 213
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-58
Identities = 73/335 (21%), Positives = 139/335 (41%), Gaps = 19/335 (5%)
Query: 257 EIPFESISD---LQWLGSGAQGAVFSGKLRS--EIVAVKKV---------REQKETDIRH 302
+ F+S+ LQ +G G+ G K +K++ RE+ ++
Sbjct: 17 NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAA 360
L + HPNIV+++ + IVM+YC G L+ + G ++ +W QI
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEV 419
+ ++H ++I+HRD+KS N+ + ++ DFG R N+ + GT +++PE+
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
N+ ++K DIW+ G VL+EL T + ++ ++ + S S P+ +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRS 255
Query: 480 LMKMCWSNAPSSRPSFKQILSHLDIASQ-EVLRIQPEPYYKMQMIWKEEIRVHMLEMQAN 538
L+ + P RPS IL IA + E + + + + +
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315
Query: 539 KSHVPKFEEFEDDLIKKRENELKHAQDVREHYERK 573
S I K + +++ ++K
Sbjct: 316 ASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDKK 350
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 14/54 (25%), Positives = 27/54 (50%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ + ++ DFG R N+ + GT +++PE+ N+ ++K DIW
Sbjct: 156 IFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIW 209
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-57
Identities = 65/256 (25%), Positives = 120/256 (46%), Gaps = 21/256 (8%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKV----------REQKETDIRHLRKLNHPNIVK 313
+ +G G V+ VA+KKV R +I L++LNHPN++K
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
+ + IV+E G L ++K +P + ++ + Q+ + + ++HS++
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDK 428
++HRD+K NV I + K+ D G R +++K+T S GT +M+PE I + K
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 216
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSS--AIIWGVGSSSLHLPIPSTC-PDGFQLLMKMCW 485
DIWS G +L+E+ ++P+ + ++ + + P+PS + + L+ MC
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLPSDHYSEELRQLVNMCI 275
Query: 486 SNAPSSRPSFKQILSH 501
+ P RP +
Sbjct: 276 NPDPEKRPDVTYVYDV 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 19/54 (35%), Positives = 28/54 (51%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
V I + K+ D G R +++K+T S GT +M+PE I + K DIW
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-55
Identities = 47/249 (18%), Positives = 91/249 (36%), Gaps = 18/249 (7%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD----------IRHLRKLNHPNIVK 313
L LG G+ G VF + + + AVK+ H + HP V+
Sbjct: 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
+ + + E C L + G +P +++ + R + +LHS+ ++H
Sbjct: 122 LEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
D+K N+ +G + K+ DFG E G +MAPE++ D++
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGSYGTAADVF 239
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
S G+ + E+ + + L + + ++ M P R
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQQL---RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296
Query: 493 PSFKQILSH 501
+ + +L+
Sbjct: 297 ATAEALLAL 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 12/53 (22%), Positives = 21/53 (39%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ +G + K+ DFG E G +MAPE++ D++
Sbjct: 188 IFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGSYGTAADVF 239
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-54
Identities = 63/259 (24%), Positives = 117/259 (45%), Gaps = 24/259 (9%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKV---------REQKETDIRHLRKLNHPNIVKF 314
L +G+G+ G + +S +I+ K++ ++ +++ LR+L HPNIV++
Sbjct: 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 315 KG--VCTQAPCYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSK 368
+ IVMEYC G L +++ + + + + + Q+ + H +
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 369 -----QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRN 422
++HRDLK NV + K+ K+ DFG R N+ ++ +F GT +M+PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 423 EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482
++K DIWS G +L+EL P+ + + IP D ++
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEIIT 249
Query: 483 MCWSNAPSSRPSFKQILSH 501
+ RPS ++IL +
Sbjct: 250 RMLNLKDYHRPSVEEILEN 268
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 18/54 (33%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
V + K+ K+ DFG R N+ ++ +F GT +M+PE + ++K DIW
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIW 200
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 57/285 (20%), Positives = 99/285 (34%), Gaps = 50/285 (17%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IR 301
E+ L+ +GSG G+VF R I A+K+ ++ +
Sbjct: 10 TTEFHE-------LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 302 HLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWAR 356
L H ++V++ + I EYC G L + + + L +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLI-------------------GSKEEAKISDFGTCR 397
Q+ G+ Y+HS ++H D+K N+ I +K KI D G
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 398 EWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456
++ G ++A EV++ K DI++ + + E ++ D
Sbjct: 183 RISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236
Query: 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
W IP F L+K+ P RPS ++ H
Sbjct: 237 -WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 16/72 (22%), Positives = 29/72 (40%), Gaps = 4/72 (5%)
Query: 159 FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218
F++ + P+A +E +K KI D G ++ G ++A EV++
Sbjct: 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQ 203
Query: 219 NEQ-CSDKIDIW 229
K DI+
Sbjct: 204 ENYTHLPKADIF 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-51
Identities = 65/274 (23%), Positives = 107/274 (39%), Gaps = 41/274 (14%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKV--------REQKETDIRHLRKLNHPNIVKFK 315
+Q LG G G VF K + A+K++ RE+ +++ L KL HP IV++
Sbjct: 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 316 GVCTQAPCY------------CIVMEYCAYGPLYNLLKD---GEEVPPQRLYNWARQIAA 360
+ I M+ C L + + EE + QIA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG-------------TCREWNNKSTKMS 407
+ +LHSK ++HRDLK N+ + K+ DFG +
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL 467
GT +M+PE I S K+DI+S G++L+ELL P+ +
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFP 246
Query: 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P+ + ++++ S +P RP I+ +
Sbjct: 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 14/66 (21%), Positives = 22/66 (33%), Gaps = 13/66 (19%)
Query: 177 VLIGSKEEAKISDFG-------------TCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 223
+ + K+ DFG + GT +M+PE I S
Sbjct: 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208
Query: 224 DKIDIW 229
K+DI+
Sbjct: 209 HKVDIF 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 73/335 (21%), Positives = 136/335 (40%), Gaps = 36/335 (10%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVREQKETD---------IRHLRKLNHPN--IVKFKG 316
+GSG VF +I A+K V ++ + I +L KL + I++
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+VME C L + LK + + P ++ + + ++ +H I+H DLK
Sbjct: 77 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 135
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRN----------- 422
N LI K+ DFG + +T + S GTV +M PE I++
Sbjct: 136 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194
Query: 423 EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ S K D+WS G +L+ + +TP++ + + + + + + + P Q ++
Sbjct: 195 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 254
Query: 482 KMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSH 541
K C P R S ++L+H ++IQ P +M EE++ + ++ S
Sbjct: 255 KCCLKRDPKQRISIPELLAH------PYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSP 308
Query: 542 VPKFEEFEDDLIKKRENELKHAQDVREHYERKLER 576
+ L + H + +E+K +
Sbjct: 309 -NSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 342
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 17/58 (29%), Positives = 26/58 (44%), Gaps = 14/58 (24%)
Query: 186 KISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRN-----------EQCSDKIDIW 229
K+ DFG + +T + S GTV +M PE I++ + S K D+W
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-50
Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 40/275 (14%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVR------EQKETDIRHLRKLNHPNIVKFKGV 317
+ LG GA G V + A+KK+R +++ L LNH +V++
Sbjct: 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 318 CTQAPCY-------------CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMN 363
+ + I MEYC G LY+L+ + RQI ++
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM---------------SF 408
Y+HS+ IIHRDLK N+ I KI DFG + + + S
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 409 AGTVAWMAPEVIRNEQCSD-KIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLH 466
GT ++A EV+ + KID++S GI+ +E++ T + V+ + S
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS-VSIEFP 249
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ ++++ + P+ RP + +L+
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 16/69 (23%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM---------------SFAGTVAWMAPEVIRNEQ 221
+ I KI DFG + + + S GT ++A EV+
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 222 CSD-KIDIW 229
+ KID++
Sbjct: 207 HYNEKIDMY 215
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 9e-50
Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 39/274 (14%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKG 316
+Q LG G V + A+K++ ++ D R NHPNI++
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 317 VCTQAP----CYCIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSK 368
C + +++ + G L+N ++ G + ++ I G+ +H+K
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA----------GTVAWMAPE 418
HRDLK N+L+G + + + D G+ + A T+++ APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 419 VI---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA-----IIWGVGSSSLHLPIP 470
+ + ++ D+WS G VL+ ++ E PY V + + L +P
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV----QNQLSIPQS 269
Query: 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504
L+ + P RP +LS L+
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 16/108 (14%), Positives = 41/108 (37%), Gaps = 24/108 (22%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFA----------GTVAWMAPEVI---RNEQCS 223
+L+G + + + D G+ + A T+++ APE+ +
Sbjct: 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224
Query: 224 DKIDIW------YKNRLCFPTS---LMARIGEFKSFVLRDEWEIPFES 262
++ D+W Y + F ++ + G+ + ++++ IP
Sbjct: 225 ERTDVWSLGCVLYA--MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP 270
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-50
Identities = 72/335 (21%), Positives = 135/335 (40%), Gaps = 36/335 (10%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVREQKETD---------IRHLRKLNHPN--IVKFKG 316
+GSG VF +I A+K V ++ + I +L KL + I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+VME C L + LK + + P ++ + + ++ +H I+H DLK
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRN----------- 422
N LI K+ DFG + +T + S G V +M PE I++
Sbjct: 183 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 423 EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ S K D+WS G +L+ + +TP++ + + + + + + + P Q ++
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 301
Query: 482 KMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSH 541
K C P R S ++L+H ++IQ P +M EE++ + ++ S
Sbjct: 302 KCCLKRDPKQRISIPELLAH------PYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSP 355
Query: 542 VPKFEEFEDDLIKKRENELKHAQDVREHYERKLER 576
+ L + H + +E+K +
Sbjct: 356 -NSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 389
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 16/58 (27%), Positives = 25/58 (43%), Gaps = 14/58 (24%)
Query: 186 KISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRN-----------EQCSDKIDIW 229
K+ DFG + +T + S G V +M PE I++ + S K D+W
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-49
Identities = 62/260 (23%), Positives = 111/260 (42%), Gaps = 29/260 (11%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVREQKETD---------IRHLRKLNHPN--IVKFKG 316
+GSG VF +I A+K V ++ + I +L KL + I++
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+VME C L + LK + + P ++ + + ++ +H I+H DLK
Sbjct: 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 154
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRN----------- 422
N LI K+ DFG + +T + S GTV +M PE I++
Sbjct: 155 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213
Query: 423 EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ S K D+WS G +L+ + +TP++ + + + + + + + P Q ++
Sbjct: 214 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 273
Query: 482 KMCWSNAPSSRPSFKQILSH 501
K C P R S ++L+H
Sbjct: 274 KCCLKRDPKQRISIPELLAH 293
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 17/58 (29%), Positives = 26/58 (44%), Gaps = 14/58 (24%)
Query: 186 KISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRN-----------EQCSDKIDIW 229
K+ DFG + +T + S GTV +M PE I++ + S K D+W
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-46
Identities = 73/324 (22%), Positives = 122/324 (37%), Gaps = 54/324 (16%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR------EQKE--TDIRHLRKL 306
E+ + + LG+G G VF + ++A K + + + +++ L +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
N P IV F G I ME+ G L +LK +P Q L + + G+ YL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 367 SK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC 425
K +I+HRD+K N+L+ S+ E K+ DFG + + S SF GT ++M+PE ++
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY 207
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP----------------- 468
S + DIWS G+ L E+ P D+ + G
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 469 ----------------IPSTCP---------DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
I + P FQ + C P+ R KQ++ H
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 504 IASQEVLRIQPEPYYKMQMIWKEE 527
I + + + + +
Sbjct: 328 IKRSDAEEVDFAGWLCSTIGLNQP 351
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 19/53 (35%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S+ E K+ DFG + + S SF GT ++M+PE ++ S + DIW
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIW 214
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 87/382 (22%), Positives = 149/382 (39%), Gaps = 52/382 (13%)
Query: 244 IGEFKSFVLRD-EWEIPFESISDLQW-----LGSGAQGA-VFSGKLRSEIVAVKKVREQK 296
+G S D + E + + + LG GA+G V+ G + VAVK++ +
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC 60
Query: 297 ETDIRH----LRKLN-HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR- 350
+ LR+ + HPN++++ I +E CA L ++ +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE 119
Query: 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE-----AKISDFGTCREWNNKSTK 405
+Q +G+ +LHS I+HRDLK N+LI A ISDFG C++
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 406 MS----FAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAII 457
S GT W+APE++ E + +DI+S G V + +++ P+
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239
Query: 458 WGVGSSSLHLPIPSTC--PDGFQLLMKMCWSNAPSSRPSFKQILSH------------LD 503
+G+ SL P +L+ KM + P RPS K +L H
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMD-PQKRPSAKHVLKHPFFWSLEKQLQFFQ 298
Query: 504 IASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLIKKRENELKHA 563
S + + + Q+ E +++M + ++ + DL K R +
Sbjct: 299 DVSDRIEKESLDGPIVKQL---ERGGRAVVKMDWRE-NITV--PLQTDLRKFRTYKGGSV 352
Query: 564 QDVREHYERKLERANQLYLELS 585
+D+ R + Y EL
Sbjct: 353 RDLL----RAMRNKKHHYRELP 370
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 19/65 (29%), Positives = 28/65 (43%), Gaps = 12/65 (18%)
Query: 177 VLIGSKEE-----AKISDFGTCREWNNKSTKMS----FAGTVAWMAPEVIR---NEQCSD 224
+LI A ISDFG C++ S GT W+APE++ E +
Sbjct: 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY 208
Query: 225 KIDIW 229
+DI+
Sbjct: 209 TVDIF 213
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-46
Identities = 73/269 (27%), Positives = 109/269 (40%), Gaps = 28/269 (10%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR----EQKETDIR-----HLRK 305
E+ + + + LG GA G V + +I+AVK++R Q++ + +R
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAG 361
++ P V F G + I ME L K G+ +P L A I
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 362 MNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
+ +LHSK +IHRD+K NVLI + + K+ DFG + K AG +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 421 RNEQCSD----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E K DIWS GI + EL PY + + + P P D
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---PFQQLKQVVEEPSPQLPADK 238
Query: 477 ----FQLLMKMCWSNAPSSRPSFKQILSH 501
F C RP++ +++ H
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQH 267
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 20/57 (35%), Positives = 25/57 (43%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD----KIDIW 229
VLI + + K+ DFG + K AG +MAPE I E K DIW
Sbjct: 141 VLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIW 197
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-46
Identities = 74/263 (28%), Positives = 127/263 (48%), Gaps = 30/263 (11%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHP 309
P + + + +G GA G V++ + + VA++++ Q++ I +R+ +P
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAA------- 360
NIV + +VMEY A G L +++ + +E QIAA
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----------GQIAAVCRECLQ 127
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEV 419
+ +LHS Q+IHRD+KS N+L+G K++DFG C + + +K + GT WMAPEV
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQ 478
+ + K+DIWS GI+ E++ E PY + + ++ + ++ L P F+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 479 LLMKMCWSNAPSSRPSFKQILSH 501
+ C R S K++L H
Sbjct: 248 DFLNRCLEMDVEKRGSAKELLQH 270
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 20/54 (37%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG C + + +K + GT WMAPEV+ + K+DIW
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 12/254 (4%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHP 309
P + +G G+ G V + + VAVK + +K+ + +R H
Sbjct: 43 PRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
N+V+ ++ME+ G L +++ Q + + YLH++
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-VCEAVLQALAYLHAQG 161
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDK 428
+IHRD+KS ++L+ K+SDFG C + + K S GT WMAPEVI + +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCWSN 487
+DIWS GI++ E++ E PY + + S L + ++
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 488 APSSRPSFKQILSH 501
P R + +++L H
Sbjct: 282 DPQERATAQELLDH 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK-MSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ K+SDFG C + + K S GT WMAPEVI + ++DIW
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIW 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-45
Identities = 81/266 (30%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 259 PFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKETD-------IRHLRKLNHP 309
P E + LG GA G V+ K + A K + + E + I L +HP
Sbjct: 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 76
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA-------GM 362
IVK G I++E+C G + ++ + + + QI +
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP------QIQVVCRQMLEAL 130
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIR 421
N+LHSK+IIHRDLK+ NVL+ + + +++DFG + K SF GT WMAPEV+
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 422 NEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPD 475
E D K DIWS GI L E+ E P+ +++ ++ + S L PS
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250
Query: 476 GFQLLMKMCWSNAPSSRPSFKQILSH 501
F+ +K+ P +RPS Q+L H
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEH 276
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 22/59 (37%), Positives = 30/59 (50%), Gaps = 6/59 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD-----KIDIW 229
VL+ + + +++DFG + K SF GT WMAPEV+ E D K DIW
Sbjct: 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-45
Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 25/297 (8%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR----EQKETDIR-----HL 303
++ + +L +GSG G V+ + R ++AVK++R +++ I L
Sbjct: 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMN 363
+ + P IV+ G I ME + +P + L I +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 364 YLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422
YL K +IHRD+K N+L+ + + K+ DFG + K AG A+MAPE I
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP 198
Query: 423 EQCSD-----KIDIWSYGIVLWELLTCETPYKDVDS-----SAIIWGVGSSSLHLPIPST 472
+ + D+WS GI L EL T + PYK+ + + + + LP
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV---LQEEPPLLPGHMG 255
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIR 529
FQ +K C + RP + ++L H I E L + ++K M E R
Sbjct: 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR 312
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 5/58 (8%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-----KIDIW 229
+L+ + + K+ DFG + K AG A+MAPE I + + D+W
Sbjct: 156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-45
Identities = 75/316 (23%), Positives = 121/316 (38%), Gaps = 32/316 (10%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR----EQKETDIR-----H 302
W+ E + DL +G GA G+V + +I+AVK++R E+++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR-----LYNWARQ 357
+R + P IV+F G + I ME + K V L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 358 IAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMA 416
+N+L +IIHRD+K N+L+ K+ DFG + + K AG +MA
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 417 PEVIRNEQCSD----KIDIWSYGIVLWELLTCETPYKDVDS-----SAIIWGVGSSSLHL 467
PE I + D+WS GI L+EL T PY +S + + V L
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---VKGDPPQL 250
Query: 468 PIPSTC--PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWK 525
F + +C + S RP +K++L H I E ++ Y +
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQM 310
Query: 526 EEIRVHMLEMQANKSH 541
+ + + H
Sbjct: 311 PATPSSPMYVDHHHHH 326
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 15/57 (26%), Positives = 23/57 (40%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD----KIDIW 229
+L+ K+ DFG + + K AG +MAPE I + D+W
Sbjct: 157 ILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 81/271 (29%), Positives = 127/271 (46%), Gaps = 47/271 (17%)
Query: 259 PFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVR-EQKETD-------IRHLRKLNH 308
P E + L+ +G G+ G VF G ++VA+K + E+ E + I L + +
Sbjct: 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 79
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAA------ 360
P + K+ G + I+MEY G +LL+ G +E QIA
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----------TQIATILREIL 129
Query: 361 -GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPE 418
G++YLHS++ IHRD+K+ NVL+ E K++DFG + + + + +F GT WMAPE
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCP---- 474
VI+ K DIWS GI EL E P+ ++ ++ IP P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLE 240
Query: 475 ----DGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ ++ C + PS RP+ K++L H
Sbjct: 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ E K++DFG + + + + +F GT WMAPEVI+ K DIW
Sbjct: 150 VLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 203
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-44
Identities = 76/259 (29%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 259 PFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVR-EQKETD----IRHLRKLNHPNI 311
P E L+ LG G+ G+V+ K +IVA+K+V E + I +++ + P++
Sbjct: 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHV 86
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA-------GMNY 364
VK+ G + IVMEYC G + ++++ + + +IA G+ Y
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED------EIATILQSTLKGLEY 140
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNE 423
LH + IHRD+K+ N+L+ ++ AK++DFG + + K + GT WMAPEVI+
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 424 QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMK 482
+ DIWS GI E+ + PY D+ I+ + ++ P D F +K
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 483 MCWSNAPSSRPSFKQILSH 501
C +P R + Q+L H
Sbjct: 261 QCLVKSPEQRATATQLLQH 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 19/54 (35%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ ++ AK++DFG + + K + GT WMAPEVI+ + DIW
Sbjct: 156 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIW 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 31/270 (11%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKLRS--EIVAVK--KVREQKETD----IRHLRKL-NHP 309
P ++ +G+G G V+ G+ ++ A+K V +E + I L+K +H
Sbjct: 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR 81
Query: 310 NIVKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKDGEEVPPQRLYNWA--RQIAAG 361
NI + G + +VME+C G + +L+K+ + + + R+I G
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVI 420
+++LH ++IHRD+K NVL+ E K+ DFG + + + +F GT WMAPEVI
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 421 RNEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475
++ D K D+WS GI E+ P D+ ++ + + P P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----PAPRLKSK 257
Query: 476 G----FQLLMKMCWSNAPSSRPSFKQILSH 501
FQ ++ C S RP+ +Q++ H
Sbjct: 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 21/59 (35%), Positives = 30/59 (50%), Gaps = 6/59 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD-----KIDIW 229
VL+ E K+ DFG + + + +F GT WMAPEVI ++ D K D+W
Sbjct: 160 VLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 33/279 (11%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVR-EQKETD-------IRHLRK 305
W I + + +GSGA V + + E VA+K++ E+ +T I+ + +
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWA-RQIAA---- 360
+HPNIV + +VM+ + G + +++K + IA
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 361 ---GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC------REWNNKSTKMSFAGT 411
G+ YLH IHRD+K+ N+L+G +I+DFG + + +F GT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 412 VAWMAPEVIRNEQCSD-KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV---GSSSLHL 467
WMAPEV+ + D K DIWS+GI EL T PY ++ SL
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 468 PIPSTCPDG-----FQLLMKMCWSNAPSSRPSFKQILSH 501
+ F+ ++ +C P RP+ ++L H
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 20/60 (33%), Positives = 29/60 (48%), Gaps = 7/60 (11%)
Query: 177 VLIGSKEEAKISDFGTC------REWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-KIDIW 229
+L+G +I+DFG + + +F GT WMAPEV+ + D K DIW
Sbjct: 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 68/301 (22%), Positives = 115/301 (38%), Gaps = 59/301 (19%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK---KVREQKETD-----IRHLRKLNHPNIVKFKGV- 317
LG GA VF G+ + ++ A+K + + D L+KLNH NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 318 -CTQAPCYCIVMEYCAYGPLYNLLKDGE---EVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
T ++ME+C G LY +L++ +P R + GMN+L I+HR
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 374 DLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-- 427
++K N++ E+ K++DFG RE + +S GT ++ P++
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 428 ------KIDIWSYGIVLWELLTCETPYKDVDSSA--------IIWGVGSS---------- 463
+D+WS G+ + T P++ + II G S
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256
Query: 464 -----SLHLPIPSTCPDGFQLLMK------MCWSNAPSSRPSFKQILSHL-DIASQEVLR 511
S +P+ + G Q+L+ + F Q + DI +
Sbjct: 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFDQFFAETSDILHRGNSH 314
Query: 512 I 512
Sbjct: 315 H 315
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 12/52 (23%), Positives = 22/52 (42%), Gaps = 8/52 (15%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD--------KIDIW 229
K++DFG RE + +S GT ++ P++ +D+W
Sbjct: 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-42
Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 15/245 (6%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G G V+ + + I+A+K V Q ++ L HPNI++ G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
A +++EY G +Y L+ + QR + ++A ++Y HSK++IHRD+K
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGI 436
N+L+GS E KI+DFG + S + GT+ ++ PE+I +K+D+WS G+
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 195
Query: 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFK 496
+ +E L + P++ + P L+ ++ N PS RP +
Sbjct: 196 LCYEFLVGKPPFEANTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHN-PSQRPMLR 253
Query: 497 QILSH 501
++L H
Sbjct: 254 EVLEH 258
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 8e-05
Identities = 18/53 (33%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+GS E KI+DFG + S + GT+ ++ PE+I +K+D+W
Sbjct: 140 LLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLW 191
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 71/316 (22%), Positives = 123/316 (38%), Gaps = 59/316 (18%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKV----------REQKETDIRHLRKLNHPNIVKFKG 316
LG GA VF G+ + ++ A+K + +E ++ L+KLNH NIVK
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV--LKKLNHKNIVKLFA 74
Query: 317 V--CTQAPCYCIVMEYCAYGPLYNLLKD---GEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+ T ++ME+C G LY +L++ +P R + GMN+L I+
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 372 HRDLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
HR++K N++ E+ K++DFG RE + +S GT ++ P++
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194
Query: 428 --------KIDIWSYGIVLWELLTCETPYKDVDSSA--------IIWGVGSS-------- 463
+D+WS G+ + T P++ + II G S
Sbjct: 195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKA 254
Query: 464 -------SLHLPIPSTCPDGFQLLMKMCWSNA----PSSRPSFKQILSHL-DIASQEVLR 511
S +P+ + G Q+L+ +N F Q + DI + V+
Sbjct: 255 ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIH 314
Query: 512 IQPEPYYKMQMIWKEE 527
+ I+
Sbjct: 315 VFSLQQMTAHKIYIHS 330
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 12/52 (23%), Positives = 22/52 (42%), Gaps = 8/52 (15%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD--------KIDIW 229
K++DFG RE + +S GT ++ P++ +D+W
Sbjct: 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 84/315 (26%), Positives = 137/315 (43%), Gaps = 65/315 (20%)
Query: 259 PFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKV---REQKETD-------IRHLRKL 306
P + SDL+ +G G+ GAV+ SE+VA+KK+ +Q +R L+KL
Sbjct: 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA------ 360
HPN ++++G + +VMEYC G +LL+ ++ + +IAA
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV------EIAAVTHGAL 164
Query: 361 -GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 419
G+ YLHS +IHRD+K+ N+L+ K+ DFG+ ++ F GT WMAPEV
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEV 221
Query: 420 IRNEQCSD---KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCP-- 474
I K+D+WS GI EL + P ++++ + ++ I
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---------HIAQNESPA 272
Query: 475 -------DGFQLLMKMCWSNAPSSRPSFKQILSH---------------LDIASQEVLRI 512
+ F+ + C P RP+ + +L H + V +
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVREL 332
Query: 513 QPEPYYKMQMIWKEE 527
Y KM+ I +E
Sbjct: 333 DNLQYRKMKKILFQE 347
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 18/56 (32%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD---KIDIW 229
+L+ K+ DFG+ ++ F GT WMAPEVI K+D+W
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVW 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 67/250 (26%), Positives = 106/250 (42%), Gaps = 23/250 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G F E+ A K RE+ +I R L H ++V F G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+V+E C L L K + + + RQI G YLH ++IHRDLK
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNK-----STKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
N+ + E KI DFG K K GT ++APEV+ + S ++D+
Sbjct: 143 LGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 432 WSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491
WS G +++ LL + P++ + + +P P L+ KM ++ P++
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTD-PTA 256
Query: 492 RPSFKQILSH 501
RP+ ++L+
Sbjct: 257 RPTINELLND 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 62/245 (25%), Positives = 110/245 (44%), Gaps = 15/245 (6%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G G V+ + + I+A+K V Q +I L HPNI++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+++E+ G LY L+ QR + ++A ++Y H +++IHRD+K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK 141
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGI 436
N+L+G K E KI+DFG + + + GT+ ++ PE+I + +K+D+W G+
Sbjct: 142 PENLLMGYKGELKIADFGWSVHAPSLRRR-TMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200
Query: 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFK 496
+ +E L P+ + + + L P P L+ K+ + P R K
Sbjct: 201 LCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP-PFLSDGSKDLISKLLRYH-PPQRLPLK 258
Query: 497 QILSH 501
++ H
Sbjct: 259 GVMEH 263
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 17/53 (32%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+G K E KI+DFG + + + GT+ ++ PE+I + +K+D+W
Sbjct: 145 LLMGYKGELKIADFGWSVHAPSLRRR-TMCGTLDYLPPEMIEGKTHDEKVDLW 196
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-41
Identities = 67/250 (26%), Positives = 106/250 (42%), Gaps = 23/250 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G F E+ A K RE+ +I R L H ++V F G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+V+E C L L K + + + RQI G YLH ++IHRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNK-----STKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
N+ + E KI DFG K K GT ++APEV+ + S ++D+
Sbjct: 169 LGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 432 WSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491
WS G +++ LL + P++ + + +P P L+ KM ++ P++
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTD-PTA 282
Query: 492 RPSFKQILSH 501
RP+ ++L+
Sbjct: 283 RPTINELLND 292
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 26/252 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G+ V+ + VA+K + ++ + +++ +L HP+I++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 317 V-CTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
Y +V+E C G + LK+ + ++ QI GM YLHS I+HRD
Sbjct: 79 YFEDSNYVY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGTVAWMAPEVIRNEQCSDKI 429
L N+L+ KI+DFG + + GT +++PE+ +
Sbjct: 138 LTLSNLLLTRNMNIKIADFG----LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
D+WS G + + LL P+ + V + +P + L+ ++ N P
Sbjct: 194 DVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP-SFLSIEAKDLIHQLLRRN-P 251
Query: 490 SSRPSFKQILSH 501
+ R S +L H
Sbjct: 252 ADRLSLSSVLDH 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 12/58 (20%), Positives = 23/58 (39%), Gaps = 9/58 (15%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKST-----KMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ KI+DFG + + GT +++PE+ + D+W
Sbjct: 143 LLLTRNMNIKIADFG----LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVW 196
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 4/178 (2%)
Query: 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAK 389
+ + + L ++ Q+A GM +L S++ IHRDL + N+L+ K K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 390 ISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-E 445
I DFG R+ + + WMAPE I + + + D+WS+G++LWE+ +
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293
Query: 446 TPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+PY V + P M CW PS RP+F +++ HL
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 38/160 (23%), Positives = 60/160 (37%), Gaps = 25/160 (15%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVRE----------QK 296
+WE P + + + LG GA G V VAVK ++E
Sbjct: 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 74
Query: 297 ETDI-RHLRKLNHPNIVKFKGVCTQAPC-YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNW 354
E I H+ +H N+V G CT+ +++E+C +G L L+
Sbjct: 75 ELKILIHIG--HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-YKTK 131
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394
+ G +Y+ + I DLK I S + + S F
Sbjct: 132 GARFRQGKDYVGA---IPVDLKRRLDSITSSQSSASSGFV 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGT---VAWMAPEVIRNEQCSDKIDIW 229
+L+ K KI DFG R+ + + WMAPE I + + + D+W
Sbjct: 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 279
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 76/278 (27%), Positives = 121/278 (43%), Gaps = 49/278 (17%)
Query: 269 LGSGAQGAV-FSGKLRSEIVAVKKVREQKETDIRH----LRKL-NHPNIVKFKGVCTQAP 322
LG G+ G V F G + VAVK++ L + +HPN++++ T
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82
Query: 323 CYCIVMEYC---------AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
I +E C + LK +E P L RQIA+G+ +LHS +IIHR
Sbjct: 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL---RQIASGVAHLHSLKIIHR 139
Query: 374 DLKSPNVLIGSKEE-------------AKISDFGTCR-----EWNNKSTKMSFAGTVAWM 415
DLK N+L+ + ISDFG C+ + + ++ + +GT W
Sbjct: 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWR 199
Query: 416 APEVIRN-------EQCSDKIDIWSYGIVLWELLTC-ETPY--KDVDSSAIIWGVGSSSL 465
APE++ + + IDI+S G V + +L+ + P+ K S II G+ S
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE 259
Query: 466 --HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L S + L+ +M + P RP+ ++L H
Sbjct: 260 MKCLHDRSLIAEATDLISQMIDHD-PLKRPTAMKVLRH 296
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 12/57 (21%)
Query: 185 AKISDFGTCR-----EWNNKSTKMSFAGTVAWMAPEVIRN-------EQCSDKIDIW 229
ISDFG C+ + + ++ + +GT W APE++ + + IDI+
Sbjct: 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-39
Identities = 70/250 (28%), Positives = 110/250 (44%), Gaps = 19/250 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETDIRH----LRKLNHPNIVKFKGV 317
LGSGA G V + + A+K V + + L+ L+HPNI+K
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
Y +VME G L++ + + +Q+ +G+ YLH I+HRDLK
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP 164
Query: 378 PNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N+L+ SKE+ KI DFG + N+ GT ++APEV+R ++ +K D+WS
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSI 223
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL---PIPSTCPDGFQLLMKMCWSNAPSS 491
G++L+ LL P+ I+ V + L+ +M +
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD-SQR 282
Query: 492 RPSFKQILSH 501
R S +Q L H
Sbjct: 283 RISAQQALEH 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/55 (36%), Positives = 31/55 (56%), Gaps = 4/55 (7%)
Query: 178 LIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+ SKE+ KI DFG + N+ GT ++APEV+R ++ +K D+W
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVW 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 6e-39
Identities = 76/357 (21%), Positives = 127/357 (35%), Gaps = 47/357 (13%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKETD--------IRHLRKLNHPNIVKFKGV- 317
LG+G G V + E VA+K+ R++ I+ ++KLNHPN+V + V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 318 -----CTQAPCYCIVMEYCAYGPLYNLLKDGE------EVPPQRLYNWARQIAAGMNYLH 366
+ MEYC G L L E E P + L I++ + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL---SDISSALRYLH 138
Query: 367 SKQIIHRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE 423
+IIHRDLK N+++ + KI D G +E + F GT+ ++APE++ +
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198
Query: 424 QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
+ + +D WS+G + +E +T P+ + + W D +
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLP-NWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257
Query: 484 CWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVP 543
P+ + Q +L Q +
Sbjct: 258 SVLPTPNHLSGILAGKLERWL--QCMLMWHQR-----QRGTDPQNPNV-----------G 299
Query: 544 KFEEFEDDLIKKRENELKHAQDVREHYERKLERANQLYLELSAVRMHLDQREQELLK 600
F+ + L K + + Y Q + + EQELL+
Sbjct: 300 CFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQ 356
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 13/44 (29%), Positives = 24/44 (54%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI D G +E + F GT+ ++APE++ ++ + +D W
Sbjct: 164 KIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYW 207
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 58/286 (20%), Positives = 106/286 (37%), Gaps = 45/286 (15%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRHLRK--------LNHPNIVKFKGVC 318
L G V+ + A+K++ +E R + + HPNIV+F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 319 TQAPC--------YCIVMEYCAYGPLYNLL---KDGEEVPPQRLYNWARQIAAGMNYLHS 367
+ + ++ E C G L L + + + Q + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 368 KQ--IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA-------------GTV 412
++ IIHRDLK N+L+ ++ K+ DFG+ ++ A T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 413 AWMAPEVI---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI 469
+ PE+I N +K DIW+ G +L+ L + P++D I+ + +P
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----NGKYSIPP 270
Query: 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPE 515
T F L++ P R S +++ L + P+
Sbjct: 271 HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ-EIAAARNVNPK 315
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 72/250 (28%), Positives = 115/250 (46%), Gaps = 19/250 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETDIRH----LRKLNHPNIVKFKGV 317
LG G+ G V K R + AVK + + + I L+KL+HPNI+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+ + IV E G L++ + + +Q+ +G+ Y+H I+HRDLK
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 378 PNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N+L+ SKE+ KI DFG + + GT ++APEV+R +K D+WS
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSA 208
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL---PIPSTCPDGFQLLMKMCWSNAPSS 491
G++L+ LL+ P+ + I+ V + + D L+ KM + PS
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH-PSL 267
Query: 492 RPSFKQILSH 501
R + Q L H
Sbjct: 268 RITATQCLEH 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 19/55 (34%), Positives = 28/55 (50%), Gaps = 4/55 (7%)
Query: 178 LIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+ SKE+ KI DFG + + GT ++APEV+R +K D+W
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVW 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 20/251 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK----------ETDIRHLRKLNHPNIVKFKG 316
LG G+ G V K + + AVK + +++ +++ L++L+HPNI+K
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ +V E G L++ + + RQ+ +G+ Y+H +I+HRDLK
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 377 SPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
N+L+ SK + +I DFG + GT ++APEV+ +K D+WS
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWS 212
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL---PIPSTCPDGFQLLMKMCWSNAPS 490
G++L+ LL+ P+ + I+ V L+ KM PS
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV-PS 271
Query: 491 SRPSFKQILSH 501
R S + L H
Sbjct: 272 MRISARDALDH 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 4/55 (7%)
Query: 178 LIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+ SK + +I DFG + GT ++APEV+ +K D+W
Sbjct: 158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVW 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 44/223 (19%), Positives = 82/223 (36%), Gaps = 25/223 (11%)
Query: 255 EWEIPFESISDLQWLGSGAQ--GAVFSG--KLRSEIVAVKKVR-EQKETD--------IR 301
+ L +G G + V K E V V+++ E + +
Sbjct: 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELH 78
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLY--NWARQIA 359
+ NHPNIV ++ +V + AYG +L+ L + +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK--------MSFAGT 411
++Y+H +HR +K+ ++LI + +S + + +
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 412 VAWMAPEVIRNEQC--SDKIDIWSYGIVLWELLTCETPYKDVD 452
+ W++PEV++ K DI+S GI EL P+KD+
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 10/63 (15%), Positives = 22/63 (34%), Gaps = 10/63 (15%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTK--------MSFAGTVAWMAPEVIRNEQC--SDKI 226
+LI + +S + + + + W++PEV++ K
Sbjct: 159 ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 218
Query: 227 DIW 229
DI+
Sbjct: 219 DIY 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 65/329 (19%), Positives = 110/329 (33%), Gaps = 38/329 (11%)
Query: 190 FGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLMARIGEFKS 249
FG E NK ++A + + E+ ++ +A++
Sbjct: 19 FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA------------LAKLEHPGI 66
Query: 250 FVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRHLRKLNHP 309
+ W + + L S + IR + +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVK-----IRRMDPFSTK 121
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLH 366
N V + I M+ C L + + E+ + QIA + +LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFG-------------TCREWNNKSTKMSFAGTVA 413
SK ++HRDLK N+ + K+ DFG +T GT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPST 472
+M+PE I S K+DI+S G++L+ELL T + II V + L
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLFTQK 298
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P ++ M + P+ RP I+ +
Sbjct: 299 YPQEHMMVQDMLSPS-PTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 15/66 (22%), Positives = 23/66 (34%), Gaps = 13/66 (19%)
Query: 177 VLIGSKEEAKISDFG-------------TCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 223
+ + K+ DFG +T GT +M+PE I S
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254
Query: 224 DKIDIW 229
K+DI+
Sbjct: 255 HKVDIF 260
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 20/78 (25%), Positives = 33/78 (42%), Gaps = 10/78 (12%)
Query: 266 LQWLGSGAQGAVFSG--KLRSEIVAVKKV--------REQKETDIRHLRKLNHPNIVKFK 315
+Q +G G G VF K+ A+K++ RE+ +++ L KL HP IV++
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 316 GVCTQAPCYCIVMEYCAY 333
+ P E
Sbjct: 71 NAWLETPPEKWQEEMDEI 88
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 65/261 (24%), Positives = 118/261 (45%), Gaps = 30/261 (11%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK--------------------ETDIRHLRKL 306
LGSGA G V K ++ A+K +++ + +I L+ L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
+HPNI+K V + +V E+ G L+ + + + N +QI +G+ YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 367 SKQIIHRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE 423
I+HRD+K N+L+ +K KI DFG ++ GT ++APEV++ +
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-K 222
Query: 424 QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV--GSSSLHLPI-PSTCPDGFQLL 480
+ ++K D+WS G++++ LL P+ + II V G + + +L+
Sbjct: 223 KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELI 282
Query: 481 MKMCWSNAPSSRPSFKQILSH 501
M + + R + ++ L+
Sbjct: 283 KLMLTYD-YNKRCTAEEALNS 302
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 1/44 (2%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI DFG ++ GT ++APEV++ ++ ++K D+W
Sbjct: 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVW 231
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 49/287 (17%), Positives = 98/287 (34%), Gaps = 56/287 (19%)
Query: 269 LGSGAQGAVFSGKLRSEIVAVK------------------------KVREQKETDIRHLR 304
L G + + ++ A+K + + +++ +
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDG---EEVPPQRLYNW-----AR 356
+ + + +G+ T I+ EY + + ++ + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 357 QIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM 415
+ +Y+H+ K I HRD+K N+L+ K+SDFG +K K GT +M
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSRGTYEFM 217
Query: 416 APEVIRNEQCSD--KIDIWSYGIVLWELLTCETP----------YKDV---------DSS 454
PE NE + K+DIWS GI L+ + P + ++ D +
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRN 277
Query: 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
++ + + + L N P+ R + + L H
Sbjct: 278 HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN-PAERITSEDALKH 323
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 3/55 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD--KIDIW 229
+L+ K+SDFG +K K GT +M PE NE + K+DIW
Sbjct: 183 ILMDKNGRVKLSDFGESEYMVDKKIK-GSRGTYEFMPPEFFSNESSYNGAKVDIW 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 58/316 (18%), Positives = 119/316 (37%), Gaps = 28/316 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKGVCT 319
LGSGA G V ++ + K + D I + +L+HP ++
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 320 QAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378
+++E+ + G L++ + + ++ + N+ RQ G+ ++H I+H D+K
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178
Query: 379 NVLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGI 436
N++ +K+ + KI DFG + N T + APE++ E D+W+ G+
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWSNAPSSRP 493
+ + LL+ +P+ D + V S P+ + + P R
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE-PRKRL 297
Query: 494 SFKQILSHLDIASQEVLRIQPEP-------YYKMQMIWKEEIRV-----HMLEMQANKSH 541
+ L H + P K++ + + + + + H
Sbjct: 298 TVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKH 357
Query: 542 VPKFEEFEDDLIKKRE 557
P+ + D ++E
Sbjct: 358 RPQEYQIYDSYFDRKE 373
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
++ +K+ + KI DFG + N T + APE++ E D+W
Sbjct: 180 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 52/304 (17%), Positives = 113/304 (37%), Gaps = 27/304 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK--KVREQKETDIRH----LRKLNHPNIVKFKGVCTQ 320
LG G G V S + K KV+ + ++ L H NI+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 321 APCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379
++ E+ + ++ + E+ + + ++ Q+ + +LHS I H D++ N
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 380 VLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIV 437
++ ++ + KI +FG R+ + APEV +++ S D+WS G +
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 438 LWELLTCETPYKDVDSSAIIWGVGSSSLHL---PIPSTCPDGFQLLMKMCWSNAPSSRPS 494
++ LL+ P+ + II + ++ + + ++ SR +
Sbjct: 193 VYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE-RKSRMT 251
Query: 495 FKQILSH------LDIASQEVLRIQPEPYYKMQMIWKEEIRV-----HMLEMQANKSHVP 543
+ L H ++ S +V+R + K+++ + + A +S
Sbjct: 252 ASEALQHPWLKQKIERVSTKVIRTLKH-RRYYHTLIKKDLNMVVSAARISCGGAIRSQKG 310
Query: 544 KFEE 547
Sbjct: 311 VSVA 314
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 12/54 (22%), Positives = 23/54 (42%), Gaps = 2/54 (3%)
Query: 178 LIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ ++ + KI +FG R+ + APEV +++ S D+W
Sbjct: 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMW 187
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 73/257 (28%), Positives = 108/257 (42%), Gaps = 31/257 (12%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKE---TDIRHLRKLNHPNIVKFKGVC 318
LGSGA G V + RS +K + + E +I L+ L+HPNI+K V
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYN------WARQIAAGMNYLHSKQIIH 372
IVME C G L + + + +Q+ + Y HS+ ++H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIV--SAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 373 RDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
+DLK N+L KI DFG + + + AGT +MAPEV + + K
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKC 206
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL-----PIPSTCPDGFQLLMKMC 484
DIWS G+V++ LLT P+ + + P+ D LL +M
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVD---LLKQML 263
Query: 485 WSNAPSSRPSFKQILSH 501
+ P RPS Q+L H
Sbjct: 264 TKD-PERRPSAAQVLHH 279
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 72/310 (23%), Positives = 140/310 (45%), Gaps = 30/310 (9%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVK---------KVREQKETDIRHLRKLNHPNIVKFKGV 317
+G G V + L VA+K ++ ++R ++ LNHPNIVK V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
++MEY + G +++ L + + + RQI + + Y H K+I+HRDLK+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 378 PNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKIDIWSYGI 436
N+L+ + KI+DFG E+ +F G + APE+ + ++ ++D+WS G+
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNAPSSRPS 494
+L+ L++ P+ + + V +P + + C + LL + N P R +
Sbjct: 203 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN---LLKRFLVLN-PIKRGT 258
Query: 495 FKQILSH---LDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDD 551
+QI+ ++ L+ EP + ++ M+ M ++ + ++
Sbjct: 259 LEQIMKDRWINAGHEEDELKPFVEPELDISD---QKRIDIMVGMGYSQEEI------QES 309
Query: 552 LIKKRENELK 561
L K + +E+
Sbjct: 310 LSKMKYDEIT 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 269 LGSGAQGAVFSGKLRSEIVAVKKVREQKETDIRH-----------LRKLNHPNIVKFKGV 317
+G G G V+ G + + VAVKK+ + + K H N+V+ G
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPP----QRLYNWARQIAAGMNYLHSKQIIHR 373
+ C+V Y G L + L + PP R A+ A G+N+LH IHR
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC-KIAQGAANGINFLHENHHIHR 157
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREW-NNKSTKMS--FAGTVAWMAPEVIRNEQCSDKID 430
D+KS N+L+ AKISDFG R T M+ GT A+MAPE +R + + K D
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSD 216
Query: 431 IWSYGIVLWELLT 443
I+S+G+VL E++T
Sbjct: 217 IYSFGVVLLEIIT 229
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVKKVREQKETD---IRHLR-------KLNHPNIVKFKG 316
+G G G V+ + +R IVA+K + E +D ++ +L P++V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ M L +L+ + P R RQI + ++ H+ HRD+K
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK 161
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKM----SFAGTVAWMAPEVIRNEQCSDKIDIW 432
N+L+ + + A + DFG K+ + GT+ +MAPE + + DI+
Sbjct: 162 PENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL--PIPS 471
+ VL+E LT PY D +++ H+ IP
Sbjct: 220 ALTCVLYECLTGSPPY-QGDQLSVMGA------HINQAIPR 253
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 69/279 (24%), Positives = 106/279 (37%), Gaps = 50/279 (17%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G+ G VF + R +IVA+KK E ++ IR L++L HPN+V V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ +V EYC + + + L VP + + Q +N+ H IHRD+K
Sbjct: 71 FRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK 129
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVI-RNEQCSDKIDIW 432
N+LI K+ DFG R S VA W +PE++ + Q +D+W
Sbjct: 130 PENILITKHSVIKLCDFGFARLLTGPSDYYD--DEVATRWYRSPELLVGDTQYGPPVDVW 187
Query: 433 SYGIVLWELLTCE--------------------TP----------YKDVDSSAIIWGVGS 462
+ G V ELL+ + I
Sbjct: 188 AIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDM 247
Query: 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L L P+ LL + P+ R + +Q+L H
Sbjct: 248 EPLELKFPNISYPALGLLKGCLHMD-PTERLTCEQLLHH 285
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 16/248 (6%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKGVCT 319
LG+GA G V R+ A K V E+D I+ + L HP +V
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 320 QAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378
++ E+ + G L+ + + ++ + RQ+ G+ ++H +H DLK
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 284
Query: 379 NVLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGI 436
N++ +K K+ DFG + K + GT + APEV + D+WS G+
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI---PSTCPDGFQLLMKMCWSNAPSSRP 493
+ + LL+ +P+ + + V S ++ DG + K+ ++ P++R
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD-PNTRM 403
Query: 494 SFKQILSH 501
+ Q L H
Sbjct: 404 TIHQALEH 411
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 14/55 (25%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
++ +K K+ DFG + K + GT + APEV + D+W
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 300 IRHLRKLNHPNIVKFKGV---CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR 356
I L+KL+HPN+VK V + Y +V E GP+ + + + + +
Sbjct: 87 IAILKKLDHPNVVKLVEVLDDPNEDHLY-MVFELVNQGPVMEVPTLKP-LSEDQARFYFQ 144
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWM 415
+ G+ YLH ++IIHRD+K N+L+G KI+DFG E+ +S GT A+M
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFM 204
Query: 416 APEVIRNEQ---CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPST 472
APE + + +D+W+ G+ L+ + + P+ D + + S +L P
Sbjct: 205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD 264
Query: 473 CPDGFQ-LLMKMCWSNAPSSRPSFKQILSH 501
+ + L+ +M N P SR +I H
Sbjct: 265 IAEDLKDLITRMLDKN-PESRIVVPEIKLH 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQ---CSDKIDIW 229
+L+G KI+DFG E+ +S GT A+MAPE + + +D+W
Sbjct: 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 53/248 (21%), Positives = 96/248 (38%), Gaps = 17/248 (6%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKGVCT 319
+G G+ G V + A KK+ + D I ++ L+HPNI++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 320 QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379
+VME C G L+ + + + + + Y H + HRDLK N
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPEN 136
Query: 380 VLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGI 436
L + K+ DFG + + GT +++P+V+ + D WS G+
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGV 195
Query: 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWSNAPSSRP 493
+++ LL P+ S ++ + + P + P L+ ++ + P R
Sbjct: 196 MMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKS-PKQRI 254
Query: 494 SFKQILSH 501
+ Q L H
Sbjct: 255 TSLQALEH 262
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 269 LGSGAQGAVFSGK-LR-SEIVAVKKVREQKETDIRHLRK----------LNHPNIVKFKG 316
LG G V+ + + VA+K + L++ L+H NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
V + CY +VMEY L ++ + N+ QI G+ + H +I+HRD+K
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK 138
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA--GTVAWMAPEVIRNEQCSDKIDIWSY 434
N+LI S + KI DFG + + S + GTV + +PE + E + DI+S
Sbjct: 139 PQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198
Query: 435 GIVLWELLTCETPYK 449
GIVL+E+L E P+
Sbjct: 199 GIVLYEMLVGEPPFN 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 56/255 (21%), Positives = 111/255 (43%), Gaps = 16/255 (6%)
Query: 262 SISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH-------LRKLNHPNIV 312
++S + LG G G V + + +A K ++ + D + +L+H N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+ +VMEY G L++ ++ + + + +QI G+ ++H I+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 372 HRDLKSPNVLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
H DLK N+L +++ KI DFG R + + GT ++APEV+ + S
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT 269
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWS 486
D+WS G++ + LL+ +P+ + + + + + L + + + K+
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK 329
Query: 487 NAPSSRPSFKQILSH 501
S R S + L H
Sbjct: 330 E-KSWRISASEALKH 343
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 16/55 (29%), Positives = 27/55 (49%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L +++ KI DFG R + + GT ++APEV+ + S D+W
Sbjct: 218 ILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 73/250 (29%), Positives = 117/250 (46%), Gaps = 19/250 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETDIRH----LRKLNHPNIVKFKGV 317
LG G+ G V K R + AVK + + + I L+KL+HPNI+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+ + IV E G L++ + + +Q+ +G+ Y+H I+HRDLK
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 378 PNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N+L+ SKE+ KI DFG + + GT ++APEV+R +K D+WS
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSA 208
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWSNAPSS 491
G++L+ LL+ P+ + I+ V + +P + D L+ KM + PS
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH-PSL 267
Query: 492 RPSFKQILSH 501
R + Q L H
Sbjct: 268 RITATQCLEH 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 73/261 (27%), Positives = 117/261 (44%), Gaps = 31/261 (11%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK---------------ETDIRHLRKLNHPNI 311
LGSGA G V R + VA++ + ++K ET+I L+KLNHP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+K K A Y IV+E G L++ + + + + Q+ + YLH II
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 372 HRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC--- 425
HRDLK NVL+ S+EE KI+DFG + S + GT ++APEV+ +
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 426 SDKIDIWSYGIVLWELLTCETP--YKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLL 480
+ +D WS G++L+ L P + ++ + S + L+
Sbjct: 322 NRAVDCWSLGVILFICL-SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLV 380
Query: 481 MKMCWSNAPSSRPSFKQILSH 501
K+ + P +R + ++ L H
Sbjct: 381 KKLLVVD-PKARFTTEEALRH 400
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 18/250 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGV 317
LG GA V ++ A K + +K E + R RKL HPNIV+
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+ + +V + G L+ + E + +QI + Y HS I+HR+LK
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133
Query: 378 PNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N+L+ SK + K++DFG E N+ FAGT +++PEV++ + S +DIW+
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 193
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWSNAPSS 491
G++L+ LL P+ D D + + + + P P + P+ L+ M N P
Sbjct: 194 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN-PKK 252
Query: 492 RPSFKQILSH 501
R + Q L
Sbjct: 253 RITADQALKV 262
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 20/55 (36%), Positives = 32/55 (58%), Gaps = 3/55 (5%)
Query: 178 LIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+ SK + K++DFG E N+ FAGT +++PEV++ + S +DIW
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 191
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-32
Identities = 34/287 (11%), Positives = 76/287 (26%), Gaps = 57/287 (19%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD----------IRHLRKLNHPNIVKFKG 316
L G + VF + E A+K E +L + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 317 VC--------------------------TQAPCYCIVMEYCA------YGPLYNLLKDGE 344
Y ++M + + L +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 345 EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404
+ L+ Q+ L SK ++H N+ I + D + +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249
Query: 405 KMSFAGTVAWMAPEVIRNEQC--SDKIDIWSYGIVLWELLTCETPYKDVDSS-------A 455
+ + V + E + + ++ W G+ ++ + P+ V
Sbjct: 250 --ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307
Query: 456 IIWGVGSSSLHLPIPSTCPDGFQ-LLMKMCWSNAPSSRPSFKQILSH 501
+ G+ SL + PD + L+ + + R + +
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD-RRRRLLPLEAMET 353
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 39/291 (13%), Positives = 91/291 (31%), Gaps = 39/291 (13%)
Query: 245 GEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQKE 297
+ + + E+++ + + LG GA V+ + +K +
Sbjct: 49 CKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP 108
Query: 298 TD-------IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR 350
+ + L+ +KF +V E +YG L N + + P +
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168
Query: 351 LYN-----WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA-----------KISDFG 394
+ +A ++ + +H +IIH D+K N ++G+ + D G
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 395 TCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDV 451
+ + T + E++ N+ + +ID + ++ +L V
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK--V 286
Query: 452 DSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
+ LP + F +++ + +L
Sbjct: 287 KNEGGECKPEGLFRRLPHLDMWNEFFHVMLNI----PDCHHLPSLDLLRQK 333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 72/299 (24%), Positives = 112/299 (37%), Gaps = 67/299 (22%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK------------ETDIRHLRKLNHPNIVKF 314
+G G+ G V I A+K + + K +T++R ++KL+HPNI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWA------------------- 355
V C+VME C G L + L + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 356 ---------------------RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA--KISD 392
RQI + ++YLH++ I HRD+K N L + + K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 393 FGTCREWNNKSTK-----MSFAGTVAWMAPEVIRNEQCS--DKIDIWSYGIVLWELLTCE 445
FG +E+ + + AGT ++APEV+ S K D WS G++L LL
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 446 TPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
P+ V+ + I V + L P P LL + N R + L H
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN-VDERFDAMRALQH 331
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 50/246 (20%), Positives = 89/246 (36%), Gaps = 41/246 (16%)
Query: 269 LGSGAQGAVFSGK---LRSEIVAVKKVREQKETDI--------RHLRKLNHPNIVK---- 313
+ G G ++ + V +K + + + + L ++ HP+IV+
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 314 --FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
Y IVMEY L G+++P + +I ++YLHS ++
Sbjct: 148 VEHTDRHGDPVGY-IVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLV 204
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
+ DLK N+++ ++E+ K+ D G N+ GT + APE++R + DI
Sbjct: 205 YNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLY---GTPGFQAPEIVRTGP-TVATDI 259
Query: 432 WSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ----LLMKMCWSN 487
++ G L L G LP + LL +
Sbjct: 260 YTVGRTLAALTLDLPTRN-----------GRYVDGLPEDDPVLKTYDSYGRLLRRAI-DP 307
Query: 488 APSSRP 493
P R
Sbjct: 308 DPRQRF 313
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK--------KVREQKETDIRHLRKLNHPNIVKFKGVC 318
LG GA G V R E VAVK E + +I + LNH N+VKF G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 319 TQAPCYCIVMEYCAYGPLYN-LLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
+ + +EYC+ G L++ + D E QR + Q+ AG+ YLH I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLMAGVVYLHGIGITHRDI 131
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQ-CSDKIDI 431
K N+L+ ++ KISDFG + + + GT+ ++APE+++ + ++ +D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 432 WSYGIVLWELLTCETPYKDVDSSAIIWG--VGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
WS GIVL +L E P+ S + + P LL K+ N P
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN-P 250
Query: 490 SSRPSFKQILSH 501
S+R + I
Sbjct: 251 SARITIPDIKKD 262
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 59/255 (23%), Positives = 110/255 (43%), Gaps = 23/255 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKET---------DIRH----LRKLNHPNIVK 313
LGSG V + +S A K +++++ +I LR++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
V +++E + G L++ L E + + ++ +QI G+NYLH+K+I H
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 374 DLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
DLK N+++ K K+ DFG E + + GT ++APE++ E +
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWS 486
D+WS G++ + LL+ +P+ + + S S T + K+
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVK 259
Query: 487 NAPSSRPSFKQILSH 501
R + ++ L H
Sbjct: 260 E-TRKRLTIQEALRH 273
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 13/44 (29%), Positives = 22/44 (50%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K+ DFG E + + GT ++APE++ E + D+W
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 19/194 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK---------ETDIRH----LRKLNHPNIVK 313
LGSG V + +S A K +++++ DI L+++ HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
V +++E A G L++ L + E + + + +QI G+ YLHS QI H
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 374 DLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
DLK N+++ + KI DFG + + + + GT ++APE++ E +
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 430 DIWSYGIVLWELLT 443
D+WS G++ + LL+
Sbjct: 199 DMWSIGVITYILLS 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 13/44 (29%), Positives = 23/44 (52%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI DFG + + + + GT ++APE++ E + D+W
Sbjct: 158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 71/276 (25%), Positives = 110/276 (39%), Gaps = 45/276 (16%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G G VF K R EIVA+K+VR + + I L++L H NIV+ V
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+V E+C L ++ P+ + ++ Q+ G+ + HS+ ++HRDLK
Sbjct: 70 LHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQC-SDKIDIWSY 434
N+LI E K+++FG R + S W P+V+ + S ID+WS
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
Query: 435 GIVLWELLTCETPY----KDVDSSAIIW------------GVGS-------------SSL 465
G + EL P D I+ + +SL
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248
Query: 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+P G LL + N P R S ++ L H
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCN-PVQRISAEEALQH 283
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 50/194 (25%), Positives = 94/194 (48%), Gaps = 19/194 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKET---------DIRH----LRKLNHPNIVK 313
LGSG V + + + A K +++++ + +I LR++ HPNI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
+ +++E + G L++ L + E + + +QI G++YLHSK+I H
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 374 DLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
DLK N+++ K K+ DFG + + + GT ++APE++ E +
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEA 192
Query: 430 DIWSYGIVLWELLT 443
D+WS G++ + LL+
Sbjct: 193 DMWSIGVITYILLS 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 12/44 (27%), Positives = 22/44 (50%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K+ DFG + + + GT ++APE++ E + D+W
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 195
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 269 LGSGAQGAVFSGK-LR-SEIVAVKKVREQKETDIRHLRK----------LNHPNIVKFKG 316
LG G V + LR VAVK +R D + LNHP IV
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV---A 76
Query: 317 V-------CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
V P IVMEY L +++ + P+R +N+ H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM----SFAGTVAWMAPEVIRNEQC 425
IIHRD+K N++I + K+ DFG R + + + GT +++PE R +
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 426 SDKIDIWSYGIVLWELLTCETPYK 449
+ D++S G VL+E+LT E P+
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 25/290 (8%), Positives = 64/290 (22%), Gaps = 67/290 (23%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK---KVREQKETDIRHLRK------------------ 305
LG A + E V I+ +++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 306 --------------LNHPNIVKFKGVCTQ--APCYCIVMEYCA------YGPLYNLLKDG 343
+++ + + L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 344 EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403
+ + Q+ + LH ++H L+ ++++ + ++ F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260
Query: 404 TKMSFAGTVAWMAPEVIRNEQCSD-----------KIDIWSYGIVLWELLTCETPYKDVD 452
+ + + PE+ D W+ G+V++ + + P
Sbjct: 261 V---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 453 SSAIIWGVGSSSLHLPIPSTCPDGFQ-LLMKMCWSNAPSSRPSFKQILSH 501
+ P + LL R Q +
Sbjct: 318 ALGGS------EWIFRSCKNIPQPVRALLEGFLRYP-KEDRLLPLQAMET 360
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 5/64 (7%), Positives = 16/64 (25%), Gaps = 14/64 (21%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-----------K 225
+++ + ++ F + + + + PE+
Sbjct: 237 IVLDQRGGVFLTGFEHLVRDGARVV---SSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 226 IDIW 229
D W
Sbjct: 294 FDAW 297
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 61/252 (24%), Positives = 110/252 (43%), Gaps = 27/252 (10%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVK-----KVREQKETD----------IRHLRKLNHPNI 311
LGSGA G V++ K +++ V VK KV E + I L ++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGP-LYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
+K + + +VME G L+ + + RQ+ + + YL K I
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKI 429
IHRD+K N++I K+ DFG+ +F GT+ + APEV+ ++
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPEL 211
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
++WS G+ L+ L+ E P+ +++ + +H P + L+ + P
Sbjct: 212 EMWSLGVTLYTLVFEENPFCELEE--TVEAA----IHPP-YLVSKELMSLVSGLLQPV-P 263
Query: 490 SSRPSFKQILSH 501
R + +++++
Sbjct: 264 ERRTTLEKLVTD 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 66/256 (25%), Positives = 113/256 (44%), Gaps = 33/256 (12%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK---KVREQKETDIRH----LRKLNHPNIVKFKGVCT 319
LGSGA VF K R ++ A+K K +++ + + L+K+ H NIV + +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 320 QAPCYCIVMEYCAYGPLYNLL--------KDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
Y +VM+ + G L++ + KD V +Q+ + + YLH I+
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLV--------IQQVLSAVKYLHENGIV 128
Query: 372 HRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
HRDLK N+L + EE I+DFG + N + GT ++APEV+ + S
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEVLAQKPYSKA 187
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCW 485
+D WS G++ + LL P+ + S + + P + +
Sbjct: 188 VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLE 247
Query: 486 SNAPSSRPSFKQILSH 501
+ P+ R + ++ LSH
Sbjct: 248 KD-PNERYTCEKALSH 262
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 9e-04
Identities = 14/44 (31%), Positives = 22/44 (50%), Gaps = 1/44 (2%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
I+DFG + N + GT ++APEV+ + S +D W
Sbjct: 149 MITDFGLSKMEQNGIMS-TACGTPGYVAPEVLAQKPYSKAVDCW 191
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK--------KVREQKETDIRHLRKLNHPNIVKFKGVC 318
LG GA G V R E VAVK E + +I + LNH N+VKF G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 319 TQAPCYCIVMEYCAYGPLYN-LLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
+ + +EYC+ G L++ + D E QR + Q+ AG+ YLH I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLMAGVVYLHGIGITHRDI 131
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQ-CSDKIDI 431
K N+L+ ++ KISDFG + + + GT+ ++APE+++ + ++ +D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 432 WSYGIVLWELLTCETPYKDVDSSAIIWG--VGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
WS GIVL +L E P+ S + + P LL K+ N P
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN-P 250
Query: 490 SSRPSFKQILSH 501
S+R + I
Sbjct: 251 SARITIPDIKKD 262
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 62/285 (21%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G+ G V + + IVA+KK E + I+ L++L H N+V V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
C + + +V E+ + + + L+ + Q + + QI G+ + HS IIHRD+K
Sbjct: 93 CKKKKRWYLVFEFVDHT-ILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVI-RNEQCSDKIDIW 432
N+L+ K+ DFG R VA W APE++ + + +D+W
Sbjct: 152 PENILVSQSGVVKLCDFGFARTLAAPGEVYD--DEVATRWYRAPELLVGDVKYGKAVDVW 209
Query: 433 SYGIVLWELLT--------------------CETPYKDVDSSAIIW-GVGS--------- 462
+ G ++ E+
Sbjct: 210 AIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR------HQELFNKNPVFAGVRL 263
Query: 463 ------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L P L K + P RP ++L H
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHID-PDKRPFCAELLHH 307
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 18/250 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETDIRH----LRKLNHPNIVKFKGV 317
LG GA V ++ A K K+ + + RKL HPNIV+
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+ + +V + G L+ + E + +QI + Y HS I+HR+LK
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 156
Query: 378 PNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N+L+ SK + K++DFG E N+ FAGT +++PEV++ + S +DIW+
Sbjct: 157 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWSNAPSS 491
G++L+ LL P+ D D + + + + P P + P+ L+ M N P
Sbjct: 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN-PKK 275
Query: 492 RPSFKQILSH 501
R + Q L
Sbjct: 276 RITADQALKV 285
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 20/55 (36%), Positives = 32/55 (58%), Gaps = 3/55 (5%)
Query: 178 LIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+ SK + K++DFG E N+ FAGT +++PEV++ + S +DIW
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 71/332 (21%), Positives = 129/332 (38%), Gaps = 38/332 (11%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH-------------LRKLNHPNIVK 313
LGSG V + +S A K +++++ R LR++ HPNI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
V +++E + G L++ L E + + ++ +QI G+NYLH+K+I H
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 374 DLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
DLK N+++ K K+ DFG E + + GT ++APE++ E +
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWS 486
D+WS G++ + LL+ +P+ + + + S T + K+
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVK 259
Query: 487 NAPSSRPSFKQILSH-----LDIASQEVLRIQPEPYYKMQMI-----WKEEIRV-----H 531
R + ++ L H +D V R + WK + H
Sbjct: 260 E-TRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNH 318
Query: 532 MLEMQANKSHVPKFEEFEDDLIKKRENELKHA 563
+ K H+ E+ + EN +
Sbjct: 319 LTRSLMKKVHLRTSEDLRNCESDTEENIARRK 350
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 13/44 (29%), Positives = 22/44 (50%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K+ DFG E + + GT ++APE++ E + D+W
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 74/281 (26%), Positives = 108/281 (38%), Gaps = 57/281 (20%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGVC 318
+G G G V+ + E A+KK+R +KE + I L++L H NIVK V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEV-PPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
+V E+ L LL E ++ Q+ G+ Y H ++++HRDLK
Sbjct: 70 HTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128
Query: 378 PNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA-WM-APEVIRNEQC-SDKIDIWSY 434
N+LI + E KI+DFG R + K + V W AP+V+ + S IDIWS
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 435 GIVLWELLT--------------------CETPYKDVDSSAIIW-GVGS----------- 462
G + E++ TP W V
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK------NWPNVTELPKYDPNFTVY 241
Query: 463 --SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ G LL KM + P+ R + KQ L H
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLD-PNQRITAKQALEH 281
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 56/286 (19%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVREQ-----KE--TDIRHLRKLNHPNIVKFKGVCTQ 320
+G G G V+ G LR VA+K+ + +E T+I L HP++V G C +
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106
Query: 321 APCYCIVMEYCAYGPLYNLL--KDGEEVP---PQRLYNWARQIAA----GMNYLHSKQII 371
++ +Y G L L D + QRL +I G++YLH++ II
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL-----EICIGAARGLHYLHTRAII 161
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNK-----STKMSFAGTVAWMAPEVIRNEQCS 426
HRD+KS N+L+ KI+DFG ++ ST + GT+ ++ PE + +
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV--KGTLGYIDPEYFIKGRLT 219
Query: 427 DKIDIWSYGIVLWELLTCETP-------------------YKDVDSSAIIWGVGSSSLHL 467
+K D++S+G+VL+E+L + + + I+ +L
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV----DPNLAD 275
Query: 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQ 513
I F C + + RPS +L L + LR+Q
Sbjct: 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL----EYALRLQ 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 70/281 (24%), Positives = 110/281 (39%), Gaps = 56/281 (19%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGVC 318
+G G G V+ K IVA+K++R E + I L++L+HPNIV V
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEV-PPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
C +V E+ L +L + + ++ + Q+ G+ + H +I+HRDLK
Sbjct: 89 HSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP 147
Query: 378 PNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQC-SDKIDIWSYG 435
N+LI S K++DFG R + + W AP+V+ + S +DIWS G
Sbjct: 148 QNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 436 IVLWELLT--------------------CETPYKDVDSSAIIW-GVGS------------ 462
+ E++T TP W V
Sbjct: 208 CIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR------EWPQVQELPLWKQRTFQVF 261
Query: 463 --SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
IP C +G LL M + P+ R S + ++H
Sbjct: 262 EKKPWSSIIPGFCQEGIDLLSNMLCFD-PNKRISARDAMNH 301
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 77/252 (30%), Positives = 119/252 (47%), Gaps = 23/252 (9%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVK------KVREQKETDIRHLRKLNHPNIVKFKGVCTQ 320
+GSG G KL E+VAVK + E + +I + R L HPNIV+FK V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380
I+MEY + G LY + + + +Q+ +G++Y HS QI HRDLK N
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147
Query: 381 LIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKIDIWSYGIV 437
L+ KI DFG + S S GT A++APEV+ ++ D+WS G+
Sbjct: 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207
Query: 438 LWELLTCETPYKDVDSSA----IIWGVGSSSLHLP----IPSTCPDGFQLLMKMCWSNAP 489
L+ +L P++D + I + S +P I C L+ ++ ++ P
Sbjct: 208 LYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH---LISRIFVAD-P 263
Query: 490 SSRPSFKQILSH 501
++R S +I +H
Sbjct: 264 ATRISIPEIKTH 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 30/200 (15%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK--------------ETDIRHLRKLNHPNIV 312
+G G V R + AVK V K E I L HP+IV
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI--CHMLKHPHIV 89
Query: 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLY------NWARQIAAGMNYLH 366
+ + +V E+ L + + +Y ++ RQI + Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIV--KRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 367 SKQIIHRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRN 422
IIHRD+K VL+ SKE + K+ FG + GT +MAPEV++
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
Query: 423 EQCSDKIDIWSYGIVLWELL 442
E +D+W G++L+ LL
Sbjct: 208 EPYGKPVDVWGCGVILFILL 227
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 18/57 (31%), Positives = 27/57 (47%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEA---KISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ SKE + K+ FG + GT +MAPEV++ E +D+W
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVW 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 259 PFESISDL----QWLGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETDIRHLRKLN 307
+++SD LG GA V+ K + + A+K ++ T+I L +L+
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS 106
Query: 308 HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL--------KDGEEVPPQRLYNWARQIA 359
HPNI+K K + +V+E G L++ + +D + +QI
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA--------VKQIL 158
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMA 416
+ YLH I+HRDLK N+L + KI+DFG + ++ + GT + A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 417 PEVIRNEQCSDKIDIWSYGIVLWELL 442
PE++R ++D+WS GI+ + LL
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILL 244
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 24/234 (10%)
Query: 283 RSEIVAVKKVREQKETDIRHLRKLNHPNIVKFKGVCTQA--PCYCIVMEYCAYGP--LYN 338
+ ++ + + +I+ LR+L H N+++ V +VMEYC G + +
Sbjct: 40 KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 99
Query: 339 LLKDGEEVPPQRLYNWA-----RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDF 393
+ + R Q+ G+ YLHS+ I+H+D+K N+L+ + KIS
Sbjct: 100 SVPEK------RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISAL 153
Query: 394 GTCREWNNKSTKMSFA----GTVAWMAPEVIRNEQCSD--KIDIWSYGIVLWELLTCETP 447
G E + G+ A+ PE+ K+DIWS G+ L+ + T P
Sbjct: 154 GVA-EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
Query: 448 YKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
++ + + +G S +P P LL M P+ R S +QI H
Sbjct: 213 FEGDNIYKLFENIGKGSYAIP-GDCGPPLSDLLKGMLEYE-PAKRFSIRQIRQH 264
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
LG G+ V + S A+K + ++ KE + + + +L+HP VK
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLL-KDG---EEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
+ Y G L + K G E R Y +I + + YLH K IIH
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--TRFY--TAEIVSALEYLHGKGIIH 153
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKI 429
RDLK N+L+ +I+DFGT + + +S + SF GT +++PE++ +
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 213
Query: 430 DIWSYGIVLWELLTCETPYKDVD 452
D+W+ G ++++L+ P++ +
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGN 236
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 14/47 (29%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 186 KISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDIW 229
+I+DFGT + + +S + SF GT +++PE++ + D+W
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETDIRH----LRKLNH-PNIVKFKG 316
LG G V +S + A K + + +I H L P ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLL--KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
V +++EY A G +++L + E V + +QI G+ YLH I+H D
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156
Query: 375 LKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
LK N+L+ S KI DFG R+ + GT ++APE++ + + D+
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDM 216
Query: 432 WSYGIVLWELLT 443
W+ GI+ + LLT
Sbjct: 217 WNIGIIAYMLLT 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 13/44 (29%), Positives = 22/44 (50%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI DFG R+ + GT ++APE++ + + D+W
Sbjct: 174 KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMW 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 19/251 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGV 317
LG GA V + A + +K E + R R L HPNIV+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
++ + ++ + G L+ + E + +QI + + H ++HR+LK
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKP 138
Query: 378 PNVLIGSKEEA---KISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIWS 433
N+L+ SK + K++DFG E + FAGT +++PEV+R + +D+W+
Sbjct: 139 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWA 198
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMKMCWSNAPS 490
G++L+ LL P+ D D + + + + P P + P+ L+ KM N PS
Sbjct: 199 CGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN-PS 257
Query: 491 SRPSFKQILSH 501
R + + L H
Sbjct: 258 KRITAAEALKH 268
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 18/56 (32%), Positives = 30/56 (53%), Gaps = 4/56 (7%)
Query: 178 LIGSKEEA---KISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
L+ SK + K++DFG E + FAGT +++PEV+R + +D+W
Sbjct: 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 19/248 (7%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G G V G+ L VAVK V + + +I++L+ HP+I+K
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
V + + +VMEY + G L++ + V +QI + ++Y H ++HRDLK
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKIDIWSYG 435
NVL+ + AKI+DFG ++ + G+ + APEVI ++DIWS G
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 436 IVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNAPSSRP 493
++L+ LL P+ D + + ++P + + LLM M + P R
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT---LLMHMLQVD-PLKRA 254
Query: 494 SFKQILSH 501
+ K I H
Sbjct: 255 TIKDIREH 262
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 71/284 (25%), Positives = 112/284 (39%), Gaps = 56/284 (19%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVR-EQKE----TDIRH---LRKLNHPNIVKFK 315
L LG G V+ GK + +VA+K++R E +E T IR L+ L H NIV
Sbjct: 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
+ +V EY L L D G + + + Q+ G+ Y H ++++HRD
Sbjct: 67 DIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQC-SDKIDIW 432
LK N+LI + E K++DFG R + + W P+++ S +ID+W
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMW 185
Query: 433 SYGIVLWELLT--------------------CETPYKDVDSSAIIW-GVGS--------- 462
G + +E+ T TP ++ W G+ S
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE------TWPGILSNEEFKTYNY 239
Query: 463 -----SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+L P DG LL K+ +R S + + H
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFE-GRNRISAEDAMKH 282
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 23/191 (12%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH----LRKL-NHPNIVKFKGVCTQA 321
LG G+ + + AVK + ++ E + + L+ HPNIVK V
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 322 PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYN------WARQIAAGMNYLHSKQIIHRDL 375
+VME G L+ +K ++ ++ R++ + ++++H ++HRDL
Sbjct: 79 LHTFLVMELLNGGELFERIKK------KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 376 KSPNVLIGSKEEA---KISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDI 431
K N+L + + KI DFG R + + T+ + APE++ + D+
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192
Query: 432 WSYGIVLWELL 442
WS G++L+ +L
Sbjct: 193 WSLGVILYTML 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 84/383 (21%), Positives = 149/383 (38%), Gaps = 79/383 (20%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQKETDIRH---LRKLNHPNIVKFKG 316
+ ++ + +G+G+ G VF KL S+ VA+KKV + K R +R + HPN+V K
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 317 V------CTQAPCYCIVMEYCA---YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS 367
+V+EY Y + K + +P + + Q+ + Y+HS
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 368 KQIIHRDLKSPNVLI-GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI-RNEQC 425
I HRD+K N+L+ K+ DFG+ + +S+ + + APE+I
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNY 219
Query: 426 SDKIDIWSYGIVLWELLTCE--------------------TPYKDVDSSAIIWGVGSSSL 465
+ IDIWS G V+ EL+ + TP ++ I + + +
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ-----IKTMNPNYM 274
Query: 466 H--LP-----------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRI 512
P P T PD L+ ++ PS+R + + L H
Sbjct: 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT-PSARLTAIEALCH----------- 322
Query: 513 QPEPYYKMQMIWKEEIRVHMLEMQANKSHVPK---FEEFEDDLIKKRENELKHAQDVREH 569
P++ +E+R M N +P + + E + + L E
Sbjct: 323 ---PFF-------DELRTGEARM-PNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAEL 371
Query: 570 YERKLERANQLYLELSAVRMHLD 592
R ++ N + L ++++ LD
Sbjct: 372 LSRGIDVHNFQPIPLESLKVTLD 394
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 64/197 (32%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-------KVREQKETDIRH--------LRKLNHPNI 311
LGSGA G V R + VA+K + +E D L+KLNHP I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+K K A Y IV+E G L++ + + + + Q+ + YLH II
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 372 HRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC--- 425
HRDLK NVL+ S+EE KI+DFG + S + GT ++APEV+ +
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 426 SDKIDIWSYGIVLWELL 442
+ +D WS G++L+ L
Sbjct: 197 NRAVDCWSLGVILFICL 213
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 67/285 (23%), Positives = 106/285 (37%), Gaps = 55/285 (19%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVR-EQKE----TDIRH---LRKLNHPNIVKFKGVC 318
LG+G V+ G ++ VA+K+V+ + +E T IR +++L H NIV+ V
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 319 TQAPCYCIVMEYC-----AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
+V E+ Y + + + + Q+ G+ + H +I+HR
Sbjct: 73 HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHR 132
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVIRNEQC-SDKI 429
DLK N+LI + + K+ DFG R + S V W AP+V+ + S I
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS--SEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 430 DIWSYGIVLWELLT--------------------CETP----------YKDVDSSAIIWG 459
DIWS G +L E++T TP + +
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 460 VGSSSLHLP---IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
L + L + N P R S KQ L H
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN-PDMRLSAKQALHH 294
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 65/295 (22%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH---LRKLNHPNIVKFK 315
S +D + +G+G+ G V+ KL E+VA+KKV + K R +RKL+H NIV+ +
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 316 GV------CTQAPCYCIVMEYCAYGP--LYNLLKD----GEEVPPQ--RLYNWARQIAAG 361
+V++Y P +Y + + + +P +LY + Q+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMY--QLFRS 168
Query: 362 MNYLHSKQIIHRDLKSPNVLI-GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
+ Y+HS I HRD+K N+L+ K+ DFG+ ++ +S+ + + APE+I
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228
Query: 421 RNEQC-SDKIDIWSYGIVLWELLTCE--------------------TPYKDVDSSAIIWG 459
+ ID+WS G VL ELL + TP ++ I
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ-----IRE 283
Query: 460 VGS--SSLHLP-----------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ + P P T P+ L ++ P++R + + +H
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT-PTARLTPLEACAH 337
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 70/308 (22%), Positives = 127/308 (41%), Gaps = 26/308 (8%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G+ G V + VA+K + + E +I +L+ L HP+I+K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
V T +V+EY G L++ + + + + + +QI + Y H +I+HRDLK
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKIDIWSYG 435
N+L+ KI+DFG + + + G+ + APEVI + ++D+WS G
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 436 IVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNAPSSRP 493
IVL+ +L P+ D + V S +P + L+ +M ++ P R
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS---LIRRMIVAD-PMQRI 251
Query: 494 SFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
+ ++I ++P + + M ++ + + L
Sbjct: 252 TIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE------DYIVEALR 305
Query: 554 KKRENELK 561
NE+K
Sbjct: 306 SDENNEVK 313
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 262 SISD---LQWLGSGAQGAVFSGKLR--SEIVAVKKVREQKET-----DIRH-------LR 304
+++D L+ LG G G V + + A+K +R KE ++ H L+
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQ 60
Query: 305 KLNHPNIVKFKGVCTQAP-CYCIVMEYCAYGPL-YNLLKDGE-EVPPQRLYNWARQIAAG 361
HP + K Q C VMEY G L ++L ++ R Y +I +
Sbjct: 61 NTRHPFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSA 117
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEV 419
+ YLHS+ +++RD+K N+++ KI+DFG C+E + + K +F GT ++APEV
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEV 176
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
+ + +D W G+V++E++ P+ + D + + + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 17/46 (36%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI+DFG C+E + + K +F GT ++APEV+ + +D W
Sbjct: 145 KITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 189
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 58/253 (22%), Positives = 117/253 (46%), Gaps = 29/253 (11%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------------IRHLRKLNH--PNI 311
LGSG G+V+SG S VA+K V + + +D + L+K++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 312 VKFKGVCTQAPCYCIVMEYCA-YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQI 370
++ + + +++E L++ + + + + ++ Q+ + + H+ +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 170
Query: 371 IHRDLKSPNVLI-GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDK 428
+HRD+K N+LI ++ E K+ DFG+ + F GT + PE IR +
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRS 229
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488
+WS GI+L++++ + P++ + II G + Q L++ C +
Sbjct: 230 AAVWSLGILLYDMVCGDIPFEHDEE--IIRGQ------VFFRQRVSSECQHLIRWCLALR 281
Query: 489 PSSRPSFKQILSH 501
PS RP+F++I +H
Sbjct: 282 PSDRPTFEEIQNH 294
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 31/286 (10%), Positives = 66/286 (23%), Gaps = 60/286 (20%)
Query: 269 LGSGAQGAVFSG--KLRSEIVAVKKVREQKETD-------------IRHLRK-------- 305
LG A + E V + +R LR
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 306 -----------LNHPNIVKFKGVCTQAPCYCIVMEYCAY-----------GPLYNLLKDG 343
+ P K V ++ + Y L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 344 EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403
+ + Q+ + LH ++H L+ ++++ + ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 404 TKM--SFAGTVAWMAPEVIRNEQ-----CSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456
A ++ Q + D W+ G+ ++ + + P D +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 457 IWGVGSSSLHLPIPSTCPDGFQ-LLMKMCWSNAPSSRPSFKQILSH 501
P + LL R Q +
Sbjct: 326 S------EWIFRSCKNIPQPVRALLEGFLRYP-KEDRLLPLQAMET 364
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 70/231 (30%), Positives = 115/231 (49%), Gaps = 30/231 (12%)
Query: 262 SISD---LQWLGSGAQGAVF-----SGKLRSEIVAVK-------KVREQKETDI--RHLR 304
S L+ LG G+ G VF SG ++ A+K KVR++ T + L
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 305 KLNHPNIVKFKGVCTQAPCY-CIVMEYCAYGPL-YNLLKDG---EEVPPQRLYNWARQIA 359
++NHP IVK Q +++++ G L L K+ EE + Y ++A
Sbjct: 82 EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFY--LAELA 136
Query: 360 AGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAP 417
+++LHS II+RDLK N+L+ + K++DFG +E + K SF GTV +MAP
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAP 195
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
EV+ + D WS+G++++E+LT P++ D + + + L +P
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 18/46 (39%), Positives = 25/46 (54%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K++DFG +E + K SF GTV +MAPEV+ + D W
Sbjct: 166 KLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWW 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 70/300 (23%), Positives = 114/300 (38%), Gaps = 36/300 (12%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETDIRHLRKLNHPNIVKFKGVCTQA 321
+G G+ ++ AVK K +E +I LR HPNI+ K V
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI-LLRYGQHPNIITLKDVYDDG 88
Query: 322 PCYCIVMEYCAYGPLYNLL--------KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
+V E G L + + ++ V I + YLH++ ++HR
Sbjct: 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKTVEYLHAQGVVHR 140
Query: 374 DLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDK 428
DLK N+L + +I DFG ++ ++ + T ++APEV+ +
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA 200
Query: 429 IDIWSYGIVLWELLTCETP---YKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLMK 482
DIWS G++L+ +LT TP D I+ +GS L S L+ K
Sbjct: 201 CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSK 260
Query: 483 MCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHV 542
M + P R + +L H I + L + K + + N+S V
Sbjct: 261 MLHVD-PHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPV 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 60/255 (23%), Positives = 110/255 (43%), Gaps = 31/255 (12%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK-----KVREQKETD--------IRHLRKLN----HP 309
LG G G VF+G + VA+K +V + L K+ HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGP-LYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
+++ + +V+E L++ + + + + Q+ A + + HS+
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158
Query: 369 QIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CS 426
++HRD+K N+LI + AK+ DFG+ +++ F GT + PE I Q +
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DFDGTRVYSPPEWISRHQYHA 217
Query: 427 DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
+WS GI+L++++ + P++ I+ L P+ L++ C +
Sbjct: 218 LPATVWSLGILLYDMVCGDIPFERDQE--ILEA------ELHFPAHVSPDCCALIRRCLA 269
Query: 487 NAPSSRPSFKQILSH 501
PSSRPS ++IL
Sbjct: 270 PKPSSRPSLEEILLD 284
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 65/285 (22%), Positives = 112/285 (39%), Gaps = 62/285 (21%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVR-----EQKE----TDIR---HLRKLNHPNIVKF 314
LG G V+ + ++ +IVA+KK++ E K+ T +R L++L+HPNI+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
+V ++ L ++KD + P + + G+ YLH I+HR
Sbjct: 78 LDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVIRNEQC-SDKI 429
DLK N+L+ K++DFG + + + + + V W APE++ + +
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGV 194
Query: 430 DIWSYGIVLWELLT--------------------CETPYKDVDSSAIIW-GVGS------ 462
D+W+ G +L ELL TP + W + S
Sbjct: 195 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP------TEEQWPDMCSLPDYVT 248
Query: 463 ------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
LH + D L+ + N P +R + Q L
Sbjct: 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN-PCARITATQALKM 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 74/290 (25%), Positives = 114/290 (39%), Gaps = 68/290 (23%)
Query: 269 LGSGAQGAVF---SGKLRSEIVAVKKVREQKETD------IR------HLRKLNHPNIVK 313
+G GA G VF K VA+K+VR Q + IR HL HPN+V+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 314 FKGVCTQAPCYC-----IVMEYCAYGPLYNLLKDGEEV--PPQRLYNWARQIAAGMNYLH 366
VCT + +V E+ L L E P + + + Q+ G+++LH
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVIRNE 423
S +++HRDLK N+L+ S + K++DFG R + S +M+ V W APEV+
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQS 194
Query: 424 QCSDKIDIWSYGIVLWELLT--------------------CETPYKDVDSSAIIW-GVGS 462
+ +D+WS G + E+ P ++ W +
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE------DWPRDVA 248
Query: 463 -----------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ + G LL+K N P+ R S LSH
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN-PAKRISAYSALSH 297
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 55/253 (21%), Positives = 110/253 (43%), Gaps = 23/253 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
+G G+ G V + ++ A+K + +Q + ++R+ ++ L HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 317 VCTQAPCY-CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
Q +V++ G L L+ + + + ++ ++YL +++IIHRD+
Sbjct: 83 -SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD---KIDIW 432
K N+L+ I+DF ++ + AGT +MAPE+ + + + +D W
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWW 201
Query: 433 SYGIVLWELLTCETPYKDVDSSA---IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
S G+ +ELL PY S++ I+ ++ + P + + LL K+ N P
Sbjct: 202 SLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP-SAWSQEMVSLLKKLLEPN-P 259
Query: 490 SSR-PSFKQILSH 501
R + +
Sbjct: 260 DQRFSQLSDVQNF 272
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 10/39 (25%), Positives = 19/39 (48%)
Query: 185 AKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 223
I+DF ++ + AGT +MAPE+ + + +
Sbjct: 154 VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 33/232 (14%)
Query: 231 KNRLCFPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVA 288
+ ++ + E K + + D++++ Q LG G G V R + A
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQL------SKQVLGLGVNGKVLECFHRRTGQKCA 58
Query: 289 VK----KVREQKETDIRHLRKLNHPNIVKFKGVC----TQAPCYCIVMEYCAYGPLYN-L 339
+K + ++E D H + P+IV V C I+ME G L++ +
Sbjct: 59 LKLLYDSPKARQEVDH-HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 340 LKDGEEVPPQRLYN------WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA---KI 390
+ G++ + R I + +LHS I HRD+K N+L SKE+ K+
Sbjct: 118 QERGDQA-----FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 391 SDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELL 442
+DFG +E + + T ++APEV+ E+ D+WS G++++ LL
Sbjct: 173 TDFGFAKETTQNAL-QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 70/248 (28%), Positives = 112/248 (45%), Gaps = 19/248 (7%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVK----------KVREQKETDIRHLRKLNHPNIVKFKG 316
LG G G V GK L VAVK V + +I++L+ HP+I+K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
V + +VMEY + G L++ + + + +QI +G++Y H ++HRDLK
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKIDIWSYG 435
NVL+ + AKI+DFG ++ + G+ + APEVI ++DIWS G
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203
Query: 436 IVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNAPSSRP 493
++L+ LL P+ D + + + P + + LL M + P R
Sbjct: 204 VILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS---LLKHMLQVD-PMKRA 259
Query: 494 SFKQILSH 501
+ K I H
Sbjct: 260 TIKDIREH 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 65/286 (22%), Positives = 109/286 (38%), Gaps = 61/286 (21%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
LG G G V+ E VA+K++R + E + + L++L H NI++ K V
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377
++ EY L + +V + + ++ Q+ G+N+ HS++ +HRDLK
Sbjct: 102 IHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP 160
Query: 378 PNVLIGSKEEA-----KISDFGTCREWNNKSTKMSFAGTVAWM-APEVIRNEQC-SDKID 430
N+L+ + + KI DFG R + + + W PE++ + S +D
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVD 220
Query: 431 IWSYGIVLWELLT--------------------CETPYKDVDSSAIIW-GVGS------- 462
IWS + E+L P W GV +
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT------TWPGVTALPDWKQS 274
Query: 463 ------SSLHLPIPSTC-PDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+L + + +G LL M + P R S K L H
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD-PVKRISAKNALEH 319
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVREQK--------ETDIRHLRKLNHPNIVKFKGVCT 319
LG G G V+ G+L +VAVK+++E++ +T++ + H N+++ +G C
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97
Query: 320 QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNW-ARQ-----IAAGMNYLHSK---QI 370
+V Y A G + + L++ E P +W RQ A G+ YLH +I
Sbjct: 98 TPTERLLVYPYMANGSVASCLRERPESQPP--LDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIRNEQCSDK 428
IHRD+K+ N+L+ + EA + DFG + + K T ++ GT+ +APE + + S+K
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 215
Query: 429 IDIWSYGIVLWELLTCETPY 448
D++ YG++L EL+T + +
Sbjct: 216 TDVFGYGVMLLELITGQRAF 235
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
LG G G V + ++R+ ++ A KK+ ++ K L K+N +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 317 VCTQAPCY-CIVMEYCAYGPL-YNLLKDGEEV-PPQRLYNWARQIAAGMNYLHSKQIIHR 373
+ C+V+ G L +++ G+ P R +A +I G+ LH ++I++R
Sbjct: 252 -AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLK N+L+ +ISD G T GTV +MAPEV++NE+ + D W+
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 434 YGIVLWELLTCETPYKDVD 452
G +L+E++ ++P++
Sbjct: 371 LGCLLYEMIAGQSPFQQRK 389
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 17/44 (38%), Positives = 23/44 (52%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ISD G T GTV +MAPEV++NE+ + D W
Sbjct: 326 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 71/292 (24%), Positives = 109/292 (37%), Gaps = 70/292 (23%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKE---------TDIR------HLRKLNHPNI 311
+G GA G V+ + VA+K VR + +R L HPN+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 312 VKFKGVCTQAPCYC-----IVMEYCAYGPLYNLLKDGEEV--PPQRLYNWARQIAAGMNY 364
V+ VC + +V E+ L L P + + + RQ G+++
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA--WM-APEVIR 421
LH+ I+HRDLK N+L+ S K++DFG R + S +M+ V W APEV+
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRAPEVLL 192
Query: 422 NEQCSDKIDIWSYGIVLWELLT--------------------CETPYKDVDSSAIIW-GV 460
+ +D+WS G + E+ P +D W
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED------DWPRD 246
Query: 461 GS-----------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
S + +P G QLL++M N P R S + L H
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN-PHKRISAFRALQH 297
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 32/233 (13%)
Query: 262 SISD---LQWLGSGAQGAVF-----SGKLRSEIVAVKKVRE----QKETDIRH------- 302
L+ LG G G VF +G +I A+K +++ + D H
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 303 LRKLNHPNIVKFKGVCTQAPCY-CIVMEYCAYGPL-YNLLKDG---EEVPPQRLYNWARQ 357
L ++ HP IV Q +++EY + G L L ++G E+ Y +
Sbjct: 75 LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT--ACFY--LAE 129
Query: 358 IAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWM 415
I+ + +LH K II+RDLK N+++ + K++DFG C+E + T +F GT+ +M
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH-TFCGTIEYM 188
Query: 416 APEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
APE++ + +D WS G +++++LT P+ + I + L+LP
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K++DFG C+E + T +F GT+ +MAPE++ + +D W
Sbjct: 161 KLTDFGLCKESIHDGTVTH-TFCGTIEYMAPEILMRSGHNRAVDWW 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 26/194 (13%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK----KVREQKETDIRHLRKLNHPNIVKFKGVC---- 318
LG G G V + E A+K + ++E ++ H R P+IV+ V
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLY 128
Query: 319 TQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLY------NWARQIAAGMNYLHSKQII 371
C IVME G L++ + G + + + I + YLHS I
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSINIA 183
Query: 372 HRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
HRD+K N+L SK K++DFG +E + ++ + T ++APEV+ E+
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 243
Query: 429 IDIWSYGIVLWELL 442
D+WS G++++ LL
Sbjct: 244 CDMWSLGVIMYILL 257
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 25/219 (11%)
Query: 262 SISD---LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRHLRK-------- 305
+ D L+ +G G+ V +L+ I A+K V+++ + DI ++
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 306 LNHPNIVKFKGVCTQAPCY-CIVMEYCAYGPL-YNLLKDGE-EVPPQRLYNWARQIAAGM 362
NHP +V C Q V+EY G L +++ + + R Y + +I+ +
Sbjct: 67 SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLAL 123
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVI 420
NYLH + II+RDLK NVL+ S+ K++D+G C+E +T +F GT ++APE++
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEIL 182
Query: 421 RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG 459
R E +D W+ G++++E++ +P+ V SS
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K++D+G C+E +T +F GT ++APE++R E +D W
Sbjct: 150 KLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWW 194
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
+G GA G V + + ++ A+K + + K +D + N P +V+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 317 VCTQAPCY-CIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
Q Y +VMEY G L NL+ + + R Y ++ ++ +HS IHRD
Sbjct: 137 -AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY--TAEVVLALDAIHSMGFIHRD 193
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIRNEQCSDK---- 428
+K N+L+ K++DFGTC + N + GT +++PEV++++
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPST 472
D WS G+ L+E+L +TP+ + + L P
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 24/230 (10%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
+G GA V K++ ++ A+K + + K ++ L + I +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 317 VCTQAPCY-CIVMEYCAYGPLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
Q Y +VMEY G L LL K GE +P + + +I ++ +H +HRD
Sbjct: 129 -AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 375 LKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDK---- 428
+K N+L+ +++DFG+C + + + GT +++PE+++
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247
Query: 429 ---IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475
D W+ G+ +E+ +TP+ ++ + HL +P
Sbjct: 248 GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 56/261 (21%), Positives = 106/261 (40%), Gaps = 29/261 (11%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK----------------KVREQKETDIRHLRKLN-HP 309
LG G V + + AVK ++RE ++ LRK++ HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
NI++ K + +V + G L++ L + + + R + + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-- 427
I+HRDLK N+L+ K++DFG + + GT +++APE+I +
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204
Query: 428 ----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLL 480
++D+WS G++++ LL P+ ++ + S + P L+
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 481 MKMCWSNAPSSRPSFKQILSH 501
+ P R + ++ L+H
Sbjct: 265 SRFLVVQ-PQKRYTAEEALAH 284
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRHLR--------KLNHPNIVKFK 315
LG G+ G VF + + + A+K +++ + D+ HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 316 GVCTQAPCY-CIVMEYCAYGPL-YNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIH 372
Q VMEY G L Y++ + ++ Y A +I G+ +LHSK I++
Sbjct: 85 C-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLHSKGIVY 141
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
RDLK N+L+ KI+DFG C+E + T +F GT ++APE++ ++ + +D
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVD 200
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
WS+G++L+E+L ++P+ D + + + P
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 16/46 (34%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI+DFG C+E + T +F GT ++APE++ ++ + +D W
Sbjct: 158 KIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWW 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRHLR--------KLNHPNIVKFK 315
LG G+ G V +++ ++ AVK +++ ++ D+ NHP + +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 316 GVCTQAPCY-CIVMEYCAYGPL-YNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIH 372
C Q P VME+ G L +++ K + R Y A +I + + +LH K II+
Sbjct: 91 C-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEIISALMFLHDKGIIY 147
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
RDLK NVL+ + K++DFG C+E N +T +F GT ++APE+++ +D
Sbjct: 148 RDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVD 206
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI 469
W+ G++L+E+L P++ + + + + + P
Sbjct: 207 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K++DFG C+E N +T +F GT ++APE+++ +D W
Sbjct: 164 KLADFGMCKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWW 208
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRHLRK--------LNHPNIVKFK 315
+G G+ V +L+ I A++ V+++ + DI ++ NHP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 316 GVCTQAPCY-CIVMEYCAYGPL-YNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIH 372
C Q V+EY G L +++ + + R Y + +I+ +NYLH + II+
Sbjct: 120 S-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLHERGIIY 176
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
RDLK NVL+ S+ K++D+G C+E +T +F GT ++APE++R E +D
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVD 235
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWG 459
W+ G++++E++ +P+ V SS
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
K++D+G C+E +T +F GT ++APE++R E +D W
Sbjct: 193 KLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWW 237
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
LG G G V K ++ A+K ++++ + ++ H L+ HP + K
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 317 VCTQAP-CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ-IIHRD 374
Q C VMEY G L+ L R + +I + ++YLHS++ +++RD
Sbjct: 216 -SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 375 LKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
LK N+++ KI+DFG C+E + + K +F GT ++APEV+ + +D W
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 333
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
G+V++E++ P+ + D + + + P
Sbjct: 334 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 369
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 17/46 (36%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI+DFG C+E + + K +F GT ++APEV+ + +D W
Sbjct: 289 KITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 28/231 (12%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
+G GA G V KL++ ++ A+K + + K + L + I
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 317 VCTQAPCY-CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR----QIAAGMNYLHSKQII 371
Q +VM+Y G L LL E+ P+ AR ++ ++ +H +
Sbjct: 142 -AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE---EMARFYLAEMVIAIDSVHQLHYV 197
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDK- 428
HRD+K N+L+ +++DFG+C + + GT +++PE+++ +
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 429 ----IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475
D WS G+ ++E+L ETP+ + + P+ D
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 59/290 (20%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G G VF + R + VA+KKV + E + I+ L+ L H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 318 CTQAPCYC--------IVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSK 368
C +V ++C + L LL + + + + + G+ Y+H
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWN--NKSTKMSFAGTVA--WM-APEVIRNE 423
+I+HRD+K+ NVLI K++DFG R ++ S + V W PE++ E
Sbjct: 144 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 203
Query: 424 QC-SDKIDIWSYGIVLWELLT--------------------CETP----YKDVDS----- 453
+ ID+W G ++ E+ T C + + +VD+
Sbjct: 204 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 263
Query: 454 --SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ L P L+ K+ + P+ R L+H
Sbjct: 264 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD-PAQRIDSDDALNH 312
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 62/305 (20%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKETD-------IRHLRK 305
+++ DL+ LG G G VFS + VA+KK+ I+ +R+
Sbjct: 6 GFDLG-SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 306 LNHPNIVKFKGVCTQAPCYC--------------IVMEYCAYGPLYNLLKDGEEVPPQRL 351
L+H NIVK + + IV EY L N+L+ G +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHAR 123
Query: 352 YNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSF-A 409
+ Q+ G+ Y+HS ++HRDLK N+ I +++ KI DFG R + + +
Sbjct: 124 L-FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 410 GTVA--WM-APEVIRN-EQCSDKIDIWSYGIVLWELLTCET--PYKD-VD---------- 452
+ W +P ++ + + ID+W+ G + E+LT +T ++
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 453 --SSAIIWGVGSSS----LHLP----------IPSTCPDGFQLLMKMCWSNAPSSRPSFK 496
+ S + +P + L ++ + P R + +
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS-PMDRLTAE 301
Query: 497 QILSH 501
+ LSH
Sbjct: 302 EALSH 306
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 79/318 (24%), Positives = 121/318 (38%), Gaps = 72/318 (22%)
Query: 241 MARIGEFKSF-VLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--Q 295
+ R F V + WE+P ++ +GSGA G+V S K E VA+KK+ Q
Sbjct: 4 LIRKKGFYKQDVNKTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62
Query: 296 KETD-------IRHLRKLNHPNIVKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKD 342
E + L+ + H N++ V T A +VM + L ++
Sbjct: 63 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIMG- 120
Query: 343 GEEVPPQRLYN-----WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397
+ Q+ G+ Y+HS ++HRDLK N+ + E KI DFG R
Sbjct: 121 ------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
Query: 398 EWNNKSTKMSFAGTVA--W-MAPEVIRN-EQCSDKIDIWSYGIVLWELLTCET--PYKD- 450
+ + T G V W APEVI + + +DIWS G ++ E+LT +T KD
Sbjct: 175 HADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229
Query: 451 VD------------SSAIIWGVGSS---------------SLHLPIPSTCPDGFQLLMKM 483
+D + + + P P LL KM
Sbjct: 230 LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 289
Query: 484 CWSNAPSSRPSFKQILSH 501
+ R + Q L+H
Sbjct: 290 LELD-VDKRLTAAQALTH 306
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 22/239 (9%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
LG+G+ G V K + A+K + +Q K I H L+ +N P +VK +
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 317 VCTQAPCY-CIVMEYCAYGPLYNLLKDGEEVPPQ--RLYNWARQIAAGMNYLHSKQIIHR 373
+ +VMEY A G +++ L+ R Y A QI YLHS +I+R
Sbjct: 109 -SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLTFEYLHSLDLIYR 165
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
DLK N+LI + +++DFG + ++ + GT +APE+I ++ + +D W+
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWA 223
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
G++++E+ P+ I + S + P D LL + + + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP-SHFSSDLKDLLRNLLQVD-LTKR 280
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 246 EFKSF-VLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETD- 299
F S + + + + +L+ +GSGAQG V + + VA+KK+ Q +T
Sbjct: 10 NFYSVEIGDSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68
Query: 300 ------IRHLRKLNHPNIVKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKDGEEVP 347
+ ++ +NH NI+ V T IVME L +++ E+
Sbjct: 69 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQ--MELD 125
Query: 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407
+R+ Q+ G+ +LHS IIHRDLK N+++ S KI DFG R
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
+ T + APEVI + +DIWS G ++ E++
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLNHPNIVKFKG 316
LG G G VF+ ++++ ++ A KK+ ++ K + L K++ IV
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 317 VCTQAPCY-CIVMEYCAYGPL----YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+ C+VM G + YN+ +D R + QI +G+ +LH + II
Sbjct: 253 -AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 429
+RDLK NVL+ +ISD G E TK +AGT +MAPE++ E+ +
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYAGTPGFMAPELLLGEEYDFSV 370
Query: 430 DIWSYGIVLWELLTCETPYKDVD 452
D ++ G+ L+E++ P++
Sbjct: 371 DYFALGVTLYEMIAARGPFRARG 393
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 16/46 (34%), Positives = 24/46 (52%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ISD G E TK +AGT +MAPE++ E+ +D +
Sbjct: 329 RISDLGLAVELKAGQTKTK-GYAGTPGFMAPELLLGEEYDFSVDYF 373
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 65/228 (28%), Positives = 116/228 (50%), Gaps = 25/228 (10%)
Query: 262 SISD---LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH--------LRK 305
SD L+ +G G+ G V + ++ AVK ++++ K+ + +H L+
Sbjct: 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 306 LNHPNIVKFKGVCTQAPCY-CIVMEYCAYGPL-YNLLKDGEEVPPQ-RLYNWARQIAAGM 362
+ HP +V Q V++Y G L Y+L ++ + P+ R Y A +IA+ +
Sbjct: 96 VKHPFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--AAEIASAL 152
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVI 420
YLHS I++RDLK N+L+ S+ ++DFG C+E +N +T +F GT ++APEV+
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS-TFCGTPEYLAPEVL 211
Query: 421 RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
+ +D W G VL+E+L P+ +++ + + + L L
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
++DFG C+E +N +T +F GT ++APEV+ + +D W
Sbjct: 179 VLTDFGLCKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWW 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 70/302 (23%)
Query: 261 ESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKET------DIRHLRKLNHPNIV 312
+ + G G G V GK +S VA+KKV + ++ L L+HPNIV
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 313 KFKGV-------CTQAPCYCIVMEYCAYGP--LYNLLK----DGEEVPPQ--RLYNWARQ 357
+ + + +VMEY P L+ + PP +++ + Q
Sbjct: 83 QLQSYFYTLGERDRRDIYLNVVMEYV---PDTLHRCCRNYYRRQVAPPPILIKVFLF--Q 137
Query: 358 IAAGMNYLH--SKQIIHRDLKSPNVLI-GSKEEAKISDFGTCREWNNKSTKMSFAGTVAW 414
+ + LH S + HRD+K NVL+ + K+ DFG+ ++ + +++ + +
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 415 MAPEVIRNEQC-SDKIDIWSYGIVLWELLTCE--------------------TP------ 447
APE+I Q + +DIWS G + E++ E P
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257
Query: 448 --------YKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQIL 499
+S I W S+ + + LL + P R + L
Sbjct: 258 KLNPSHTDVDLYNSKGIPW---SNVFSDHSLKDAKEAYDLLSALLQYL-PEERMKPYEAL 313
Query: 500 SH 501
H
Sbjct: 314 CH 315
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 22/218 (10%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRHLR--------KLNHPNIVKFK 315
LG G+ G V + + E+ AVK +++ ++ D+ P + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 316 GVCTQAPCY-CIVMEYCAYGPL-YNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIH 372
C Q VMEY G L Y++ + G + P Y A +IA G+ +L SK II+
Sbjct: 88 S-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQSKGIIY 144
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
RDLK NV++ S+ KI+DFG C+E W+ +TK +F GT ++APE+I + +D
Sbjct: 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVD 203
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
W++G++L+E+L + P++ D + + ++ P
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 241
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 19/46 (41%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI+DFG C+E W+ +TK +F GT ++APE+I + +D W
Sbjct: 161 KIADFGMCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWW 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 84/311 (27%), Positives = 130/311 (41%), Gaps = 60/311 (19%)
Query: 242 ARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKE 297
AR G ++ V + WE+ DLQ +GSGA GAV S VA+KK+ Q E
Sbjct: 7 ARSGFYRQEVTKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE 65
Query: 298 TD-------IRHLRKLNHPNIVKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKDGE 344
+R L+ + H N++ V T +VM + L L+K E
Sbjct: 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLMK-HE 123
Query: 345 EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404
++ R+ Q+ G+ Y+H+ IIHRDLK N+ + E KI DFG R+ +++ T
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183
Query: 405 KMSFAGTVA--WM-APEVIRN-EQCSDKIDIWSYGIVLWELLTCET--PYKD-VD----- 452
G V W APEVI N + + +DIWS G ++ E++T +T D +D
Sbjct: 184 -----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 453 -------SSAIIWGVGSS---------------SLHLPIPSTCPDGFQLLMKMCWSNAPS 490
+ + + S + + P LL KM +
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD-AE 297
Query: 491 SRPSFKQILSH 501
R + + L+H
Sbjct: 298 QRVTAGEALAH 308
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 40/206 (19%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVK---------------KVREQKETDIRHLRKL-NHPN 310
+G G V R+ AVK +VRE + LR++ HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLL--------KDGEEVPPQRLYNWARQIAAGM 362
I+ + +V + G L++ L K+ + R + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI--------MRSLLEAV 213
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422
++LH+ I+HRDLK N+L+ + ++SDFG GT ++APE+++
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 423 EQCSD------KIDIWSYGIVLWELL 442
++D+W+ G++L+ LL
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLL 299
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 262 SISD---LQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRH-------LRKL 306
S+ D L+ LG+G+ G V + R A+K ++++ + + H L +
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 307 NHPNIVKFKGVCTQAPCY-CIVMEYCAYGPLYNLL-KDG---EEVPPQRLYNWARQIAAG 361
HP I++ G Q ++M+Y G L++LL K V + Y A ++
Sbjct: 64 THPFIIRMWG-TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV--AKFY--AAEVCLA 118
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 421
+ YLHSK II+RDLK N+L+ KI+DFG + + GT ++APEV+
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVS 176
Query: 422 NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456
+ + ID WS+GI+++E+L TP+ D ++
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 22/218 (10%)
Query: 269 LGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRHLR--------KLNHPNIVKFK 315
LG G+ G V + + E+ AVK +++ ++ D+ P + +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 316 GVCTQAPCY-CIVMEYCAYGPL-YNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIH 372
C Q VMEY G L Y++ + G + P Y A +IA G+ +L SK II+
Sbjct: 409 S-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQSKGIIY 465
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
RDLK NV++ S+ KI+DFG C+E W+ +TK +F GT ++APE+I + +D
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVD 524
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP 468
W++G++L+E+L + P++ D + + ++ P
Sbjct: 525 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-26
Identities = 44/199 (22%), Positives = 88/199 (44%), Gaps = 19/199 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQ---KETDIRH-------LRKLN---HPNIVK 313
+G G G V+ + ++ A+K + ++ + L ++ P IV
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 314 FKGVCTQAPCY-CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIH 372
P +++ G L+ L + +A +I G+ ++H++ +++
Sbjct: 257 MSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 373 RDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK-IDI 431
RDLK N+L+ +ISD G +++ K + GT +MAPEV++ D D
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 432 WSYGIVLWELLTCETPYKD 450
+S G +L++LL +P++
Sbjct: 375 FSLGCMLFKLLRGHSPFRQ 393
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 14/45 (31%), Positives = 23/45 (51%), Gaps = 2/45 (4%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK-IDIW 229
+ISD G +++ K + GT +MAPEV++ D D +
Sbjct: 332 RISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWF 375
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 73/316 (23%), Positives = 118/316 (37%), Gaps = 64/316 (20%)
Query: 245 GEFKSFVLRD-EWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETD 299
+F S + D + + + +L+ +GSGAQG V + + VA+KK+ Q +T
Sbjct: 46 NQFYSVEVGDSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104
Query: 300 -------IRHLRKLNHPNIVKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKDGEEV 346
+ ++ +NH NI+ V T +VME L +++ E+
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQ--MEL 161
Query: 347 PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406
+R+ Q+ G+ +LHS IIHRDLK N+++ S KI DFG R
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
Query: 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCE--------------------T 446
+ T + APEVI + +DIWS G ++ E++ + T
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 447 P---------------------YKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485
P Y + + + LL KM
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341
Query: 486 SNAPSSRPSFKQILSH 501
+ P+ R S L H
Sbjct: 342 ID-PAKRISVDDALQH 356
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 58/291 (19%), Positives = 100/291 (34%), Gaps = 73/291 (25%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRHLRK--------LNHPNIVKFKGVC 318
LG GA V + + AVK + +Q + + H N+++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYN------WARQIAAGMNYLHSKQIIH 372
+ + +V E G + + + +R +N + +A+ +++LH+K I H
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHK------RRHFNELEASVVVQDVASALDFLHNKGIAH 134
Query: 373 RDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTK--------MSFAGTVAWMAPEVIR 421
RDLK N+L + KI DF ++ G+ +MAPEV+
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 422 NEQCSDK-----IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
D+WS G++L+ LL+ P+ G S CP
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPF---------VGRCGSDCGWDRGEACPAC 245
Query: 477 FQLLMKM-----------CWSN----A-----------PSSRPSFKQILSH 501
+L + W++ A R S Q+L H
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 71/324 (21%)
Query: 241 MARIGEFKSFVLRDE-WEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE---- 294
M GE L E + + +++ SG+ GAV +G VA+K+V
Sbjct: 2 MQAKGEAAMRDLIAELHAMQ-SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 295 -------QKETD-------IRHLRKLNHPNIVKFKGVCTQAPC------YCIVMEYCAYG 334
IR L +HPNI+ + + Y +V E
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY-LVTELMRTD 119
Query: 335 PLYNLLKDGEEV-PPQR----LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAK 389
L ++ D V PQ +Y I G++ LH ++HRDL N+L+ +
Sbjct: 120 -LAQVIHDQRIVISPQHIQYFMY----HILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174
Query: 390 ISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCET-- 446
I DF RE + K + + APE++ + + +D+WS G V+ E+ +
Sbjct: 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
Query: 447 PYKD-VD------------SSAIIWGVGSS----------------SLHLPIPSTCPDGF 477
+ + S + +P+ P
Sbjct: 235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL 294
Query: 478 QLLMKMCWSNAPSSRPSFKQILSH 501
L+ KM N P R S +Q L H
Sbjct: 295 DLIAKMLEFN-PQRRISTEQALRH 317
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 57/313 (18%)
Query: 241 MARIGEFKSFVLRD-EWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE-QK 296
MA ++R +++ ++L ++G GA G V S L VA+KK+ +
Sbjct: 7 MAAAAAAGPEMVRGQVFDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH 65
Query: 297 ETD-------IRHLRKLNHPNIVKFKGVCTQAPC------YCIVMEYCAYGPLYNLLKDG 343
+T I+ L + H NI+ + Y IV + LY LLK
Sbjct: 66 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY-IVQDLMETD-LYKLLK-T 122
Query: 344 EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403
+ + + + QI G+ Y+HS ++HRDLK N+L+ + + KI DFG R +
Sbjct: 123 QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 404 TKMSF-AGTVA--WM-APEVIRN-EQCSDKIDIWSYGIVLWELLTCET--PYKD-VD--- 452
F VA W APE++ N + + IDIWS G +L E+L+ P K +D
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 453 ---------SSAIIWGVGSS---------------SLHLPIPSTCPDGFQLLMKMCWSNA 488
S + + + + P+ LL KM N
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN- 301
Query: 489 PSSRPSFKQILSH 501
P R +Q L+H
Sbjct: 302 PHKRIEVEQALAH 314
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 76/319 (23%), Positives = 109/319 (34%), Gaps = 90/319 (28%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE-QKETD-------IRHLR 304
+ I LG GA G V S K EIVA+KK+ K I+ L+
Sbjct: 6 VYNIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 305 KLNHPNIVKFKGVCTQAPCYC------IVMEYCAYGPLYNLLKDGEEVPPQRL------- 351
H NI+ + + I+ E L+ ++ Q L
Sbjct: 65 HFKHENIITIFNIQR-PDSFENFNEVYIIQELMQTD-LHRVIS------TQMLSDDHIQY 116
Query: 352 --YNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW-NNKSTKMSF 408
Y Q + LH +IHRDLK N+LI S + K+ DFG R + +
Sbjct: 117 FIY----QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 409 AGTVAWM----------APEVIRN-EQCSDKIDIWSYGIVLWELLTCE------------ 445
G + M APEV+ + S +D+WS G +L EL
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 446 --------TPYKDVDSSAIIWGVGSS---------------SLHLPIPSTCPDGFQLLMK 482
TP+ D D + + S L P P G LL +
Sbjct: 233 LLIFGIIGTPHSDND----LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 483 MCWSNAPSSRPSFKQILSH 501
M + P+ R + K+ L H
Sbjct: 289 MLVFD-PAKRITAKEALEH 306
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 82/317 (25%), Positives = 125/317 (39%), Gaps = 60/317 (18%)
Query: 236 FPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFS--GKLRSEIVAVKKVR 293
R ++ + + WE+P E +L +GSGA G+V + VAVKK+
Sbjct: 5 HHHHSQERPTFYRQELNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS 63
Query: 294 E--QKETD-------IRHLRKLNHPNIVKFKGVCTQAPCYC------IVMEYCAYGPLYN 338
Q +R L+ + H N++ V T A +V L N
Sbjct: 64 RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNN 122
Query: 339 LLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398
++K +++ + QI G+ Y+HS IIHRDLK N+ + E KI DFG R
Sbjct: 123 IVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181
Query: 399 WNNKSTKMSFAGTVA--W-MAPEVIRN-EQCSDKIDIWSYGIVLWELLTCET--PYKD-V 451
++ T G VA W APE++ N + +DIWS G ++ ELLT T P D +
Sbjct: 182 TADEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236
Query: 452 D------------SSAIIWGVGSS---------------SLHLPIPSTCPDGFQLLMKMC 484
D + ++ + S + P LL KM
Sbjct: 237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 296
Query: 485 WSNAPSSRPSFKQILSH 501
+ R + Q L+H
Sbjct: 297 VLD-SDKRITAAQALAH 312
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 269 LGSGAQGAVF-----SGKLRSEIVAVKKVRE----QKETDIRH-------LRKLNH-PNI 311
LG+GA G VF SG ++ A+K +++ QK H L + P +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 312 VKFKGVCTQAPCY-CIVMEYCAYGPL-YNLLKDG---EEVPPQRLYNWARQIAAGMNYLH 366
V Q ++++Y G L +L + E ++Y +I + +LH
Sbjct: 122 VTLHY-AFQTETKLHLILDYINGGELFTHLSQRERFTEHE--VQIY--VGEIVLALEHLH 176
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIR-NE 423
II+RD+K N+L+ S ++DFG +E + F GT+ +MAP+++R +
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 424 QCSDK-IDIWSYGIVLWELLTCETPYKDVD 452
DK +D WS G++++ELLT +P+
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 11/38 (28%), Positives = 20/38 (52%), Gaps = 2/38 (5%)
Query: 186 KISDFGTCRE--WNNKSTKMSFAGTVAWMAPEVIRNEQ 221
++DFG +E + F GT+ +MAP+++R
Sbjct: 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 236
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 55/260 (21%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVRE----QKETDIRHLRKLNHPNIVKFKGVC---- 318
LG G G V + E A+K +++ ++E ++ H R P+IV+ V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLY 84
Query: 319 TQAPCYCIVMEYCAYGPLYN-LLKDGEEVPPQRLY------NWARQIAAGMNYLHSKQII 371
C IVME G L++ + G + + + I + YLHS I
Sbjct: 85 AGRKCLLIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 372 HRDLKSPNVLIGSKEEA---KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
HRD+K N+L SK K++DFG A E E+
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETTG-EKYDKS 178
Query: 429 IDIWSYGIVLWELLTCETPY----KDVDSSAIIWGVGSSSLHLPIP---STCPDGFQLLM 481
D+WS G++++ LL P+ S + + P P + L+
Sbjct: 179 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 238
Query: 482 KMCWSNAPSSRPSFKQILSH 501
+ + P+ R + + ++H
Sbjct: 239 NLLKTE-PTQRMTITEFMNH 257
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 61/307 (19%), Positives = 108/307 (35%), Gaps = 75/307 (24%)
Query: 269 LGSGAQGAVFSGKLRS----EIVAVKKVREQKET-----DIRHLRKLNHPNIVKFKGVCT 319
+G G G V+ K + + A+K++ + +I LR+L HPN++ + V
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 320 QAPCYCI--VMEYC--------AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
+ + +Y + K ++P + + QI G++YLH+
Sbjct: 89 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 370 IIHRDLKSPNVLIGSKEEA----KISDFGTCREWNNKSTKMSFAGTVA---WM-APEVIR 421
++HRDLK N+L+ + KI+D G R +N+ ++ V W APE++
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 422 NEQC-SDKIDIWSYGIVLWELLT-----------------------------CETP---- 447
+ + IDIW+ G + ELLT P
Sbjct: 209 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268
Query: 448 -------------YKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
KD + + F LL K+ + P R +
Sbjct: 269 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD-PIKRIT 327
Query: 495 FKQILSH 501
+Q +
Sbjct: 328 SEQAMQD 334
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 60/398 (15%), Positives = 125/398 (31%), Gaps = 99/398 (24%)
Query: 260 FESIS----DLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH---LRKLNHPN 310
E+ S + LG+G+ G V + A+KKV + R ++ L+H N
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 311 IVKFK------GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR-------------- 350
I+K G P G + + V
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 351 --LYNWAR-------------------QIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EA 388
L+ + Q+ + ++HS I HRD+K N+L+ SK+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 389 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCET- 446
K+ DFG+ ++ +++ + + APE++ + + ID+WS G V EL+ +
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241
Query: 447 -PYKD-VD------------SSAIIWGVGSS------------SLHLPIPS-TCPDGFQL 479
+ +D + + + +P T L
Sbjct: 242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301
Query: 480 LMKMCWSNAPSSRPSFKQILSH--LDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQA 537
L ++ P R + + ++H D + +
Sbjct: 302 LEQILRYE-PDLRINPYEAMAHPFFD----HLRNSYESEVKNNSNFPHGVNQ-------- 348
Query: 538 NKSHVPKFEEFEDDLIKKRENELKHAQDVREHYERKLE 575
++P+ F + + + + + +++ +
Sbjct: 349 ---NIPQLFNFSPYELSIIPGNVLN-RILPKNFSPNYK 382
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 57/242 (23%), Positives = 84/242 (34%), Gaps = 50/242 (20%)
Query: 250 FVLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETD------ 299
F +P ++ +G G+ G V+ K + VA+KKV + D
Sbjct: 16 FQGIKNVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR 74
Query: 300 -IRHLRKLNHPNIVKFKGVCTQAPCYC-----IVMEYCAYGPLYNLLKDGEEVPPQR--- 350
I L +L I++ + IV+E L L K + +
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHIKT 133
Query: 351 -LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFA 409
LY + G N++H IIHRDLK N L+ K+ DFG R N++
Sbjct: 134 ILY----NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 410 GTVAWM-----------------------APEVIRNEQCSDK-IDIWSYGIVLWELLTCE 445
APE+I ++ K IDIWS G + ELL
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 446 TP 447
Sbjct: 250 QS 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 34/266 (12%), Positives = 67/266 (25%), Gaps = 48/266 (18%)
Query: 269 LGSGAQGAVFSG---KLRSEIVAVKKVREQKETDI----------RHLRKLNHPNIVKFK 315
G + L + VA+ V Q L +++ P + +
Sbjct: 39 HGGVPPLQFWQALDTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
V +V E+ G L + P + +AA + H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYG 435
V + + ++ T M ++ DI G
Sbjct: 156 HPSRVRVSIDGDVVLAYPAT-------------------MPDANPQD-------DIRGIG 189
Query: 436 IVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP-----STCPDGFQLLMKMCWSNAPS 490
L+ LL P + + + + PI P +
Sbjct: 190 ASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGG 249
Query: 491 SRPSFKQILSHLDIASQEVLRIQPEP 516
R + +L+ + A+ R +
Sbjct: 250 IRSA-STLLNLMQQATAVADRTEVLG 274
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 8e-22
Identities = 58/243 (23%), Positives = 88/243 (36%), Gaps = 57/243 (23%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETD-------IRHL 303
+W+IP + +G+G+ G V KL +VA+KK+ + D I L
Sbjct: 48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAIL 106
Query: 304 RKLNHPNIVKFKGVCTQAPC------YCIVMEYCAYGPLYNLLKDGEEVPPQR----LYN 353
+LNH ++VK + Y +V+E L + + LY
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELY-VVLEIADSD-FKKLFRTPVYLTELHIKTLLY- 163
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA 413
+ G+ Y+HS I+HRDLK N L+ K+ DFG R + S
Sbjct: 164 ---NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 414 WM----------------------------APEVIRN-EQCSDKIDIWSYGIVLWELLTC 444
APE+I E ++ ID+WS G + ELL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 445 ETP 447
Sbjct: 281 IKE 283
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVREQKETDI-------R 301
EW + ++ LG G VF +E V VK ++ K+ I
Sbjct: 27 SHVVEWGNQ-DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE 85
Query: 302 HLRKLNHPNIVK----FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQR-LYNWAR 356
+LR PNI+ K ++ P V E+ L + + + +Y
Sbjct: 86 NLR--GGPNIITLADIVKDPVSRTPAL--VFEHVNNTDFKQLYQTLTDYDIRFYMY---- 137
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWM 415
+I ++Y HS I+HRD+K NV+I + + ++ D+G ++ + +
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197
Query: 416 APEVIRNEQCSDK-IDIWSYGIVLWELLTCETP 447
PE++ + Q D +D+WS G +L ++ + P
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 50/231 (21%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSG--KLRSEIVAVKKVRE--QKETD-------IRHL 303
+ + ++ LG GA G V+ + E+VAVKK+ + Q TD I L
Sbjct: 4 DRHVL-RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 304 RKLN-HPNIVKFKGVCTQAPCYC---IVMEYCAYGPLYNLLKDGEEVPPQR----LYNWA 355
+L+ H NIV V A +V +Y L+ +++ + P +Y
Sbjct: 63 TELSGHENIVNLLNVLR-ADNDRDVYLVFDYMETD-LHAVIR-ANILEPVHKQYVVY--- 116
Query: 356 RQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM 415
Q+ + YLHS ++HRD+K N+L+ ++ K++DFG R + N +
Sbjct: 117 -QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 416 ----------------------APEVIRN-EQCSDKIDIWSYGIVLWELLT 443
APE++ + + ID+WS G +L E+L
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 266 LQWLGSGAQGAVFSGK--LRSEIVAVKKVR------EQKETDIRHLRKLNH------PNI 311
L+ +G G+ G V + VA+K VR Q +IR L L N+
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVP--PQRLYNWARQIAAGMNYLHSKQ 369
+ T C+ E + LY L+K + + +A I ++ LH +
Sbjct: 162 IHMLENFTFRNHICMTFELLSMN-LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 370 IIHRDLKSPNVLIGS--KEEAKISDFGT-CREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 426
IIH DLK N+L+ + K+ DFG+ C E T + + + APEVI +
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SRFYRAPEVILGARYG 277
Query: 427 DKIDIWSYGIVLWELLT 443
ID+WS G +L ELLT
Sbjct: 278 MPIDMWSLGCILAELLT 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 43/217 (19%)
Query: 266 LQWLGSGAQGAVFSGK--LRSEIVAVKKVR------EQKETDIRHLRKLN---------- 307
++ LG G V+ K + + VA+K VR E E +I+ L+++N
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 308 -HPNIVK------FKGVCTQAPCYCIVMEYCAYGP-LYNLLK--DGEEVPPQRLYNWARQ 357
+I+K KG +V E G L L+K + +P + ++Q
Sbjct: 84 GANHILKLLDHFNHKGPNGVH--VVMVFE--VLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 358 IAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEA------KISDFGT-CREWNNKSTKMSFA 409
+ G++Y+H + IIH D+K NVL+ + KI+D G C + + +
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ-- 197
Query: 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCET 446
T + +PEV+ DIWS +++EL+T +
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 266 LQWLGSGAQGAVFSGK--LRSEIVAVKKVR------EQKETDIRHLRKLNHP------NI 311
+G G+ G V + E VA+K ++ Q + ++R L +N I
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVP--PQRLYNWARQIAAGMNYLHSK- 368
V K C+V E +Y LY+LL++ +A+Q+ + +L +
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE 177
Query: 369 -QIIHRDLKSPNVLI--GSKEEAKISDFGT-CREWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
IIH DLK N+L+ + KI DFG+ C+ + + + +PEV+
Sbjct: 178 LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ---SRFYRSPEVLLGMP 234
Query: 425 CSDKIDIWSYGIVLWELLT 443
ID+WS G +L E+ T
Sbjct: 235 YDLAIDMWSLGCILVEMHT 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 57/269 (21%), Positives = 96/269 (35%), Gaps = 33/269 (12%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVKKVREQKETDIRHL-------RKLNH-PNIVKFKGVC 318
+GSG+ G ++ G E VA+K E +T L + + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 319 TQAPCYCIVMEYCAYGP-LYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ +VME GP L +L + + + A Q+ + + Y+HSK IHRD+K
Sbjct: 75 AEGDYNVMVMEL--LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK 132
Query: 377 SPNVLIGSKEEAK---ISDFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNEQC 425
N L+G ++ I DFG +++ + T + GT + + +
Sbjct: 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 192
Query: 426 SDKIDIWSYGIVLWELLTCETP---YKDVDSSAIIWGVGSSSLHLPIPSTC---PDGFQL 479
S + D+ S G VL P K + + PI C P F
Sbjct: 193 SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT 252
Query: 480 LMKMCWSNAPSSRPSFKQILSHLDIASQE 508
+ C S +P + +
Sbjct: 253 YLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 58/222 (26%), Positives = 82/222 (36%), Gaps = 55/222 (24%)
Query: 266 LQWLGSGAQGAV---FSGKLRSEIVAVK------KVREQKETDIRHLRKLNHP------N 310
+ LG GA G V K VAVK + E ++I+ L LN
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 311 IVK------FKGVCTQAPCYCIVMEYCAYGP-LYNLLKDGEEV--PPQRLYNWARQIAAG 361
V+ G CIV E G Y+ +K+ + + A QI
Sbjct: 79 CVQMLEWFEHHG------HICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEA-------------------KISDFG-TCREWNN 401
+N+LHS ++ H DLK N+L + K+ DFG + +
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
ST +S T + APEVI S D+WS G +L E
Sbjct: 191 HSTLVS---TRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 49/222 (22%), Positives = 78/222 (35%), Gaps = 55/222 (24%)
Query: 266 LQWLGSGAQGAVFSGKLRS---EIVAVK------KVREQKETDIRHLRKLNHP------N 310
+ LG G G V + VA+K K RE +I L+K+
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 311 IVKFKGVCTQAPC------YCIVMEYCAYGP-LYNLLKDGEEV--PPQRLYNWARQIAAG 361
V CI E G + LK+ P + + A Q+
Sbjct: 84 CVLMSD------WFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEA-------------------KISDFG-TCREWNN 401
+ +LH Q+ H DLK N+L + E +++DFG + +
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
+T ++ T + PEVI + D+WS G +L+E
Sbjct: 196 HTTIVA---TRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 51/226 (22%), Positives = 82/226 (36%), Gaps = 59/226 (26%)
Query: 266 LQWLGSGAQGAVFSG--KLRSEIVAVK------KVREQKETDIRHLRKLNH-----PNIV 312
++ +G G G V + AVK K + + L+K+ + NIV
Sbjct: 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 313 KFKGVCTQAPC------YCIVMEYCAYGP-LYNLLKDGEEV--PPQRLYNWARQIAAGMN 363
K+ G C++ E GP LY ++ + + + +I +N
Sbjct: 100 KYHG------KFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEA-------------------------KISDFG-TCR 397
YL + H DLK N+L+ K+ DFG
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 398 EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
+ + + ++ T + APEVI N D+WS+G VL EL T
Sbjct: 212 KSDYHGSIIN---TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 58/269 (21%), Positives = 97/269 (36%), Gaps = 33/269 (12%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVKKVREQKETDIRHL-------RKLN-HPNIVKFKGVC 318
+GSG+ G ++ G +E VA+K E +T L R L I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 319 TQAPCYCIVMEYCAYGP-LYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ +VM+ GP L +L ++ + + A Q+ + ++HSK +HRD+K
Sbjct: 73 VEGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
Query: 377 SPNVLIGSKEEAK---ISDFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNEQC 425
N L+G A I DFG +++ + ST + GT + + +
Sbjct: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ 190
Query: 426 SDKIDIWSYGIVLWELLTCETP---YKDVDSSAIIWGVGSSSLHLPIPSTC---PDGFQL 479
S + D+ S G VL L P K + + I + C P F
Sbjct: 191 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFAS 250
Query: 480 LMKMCWSNAPSSRPSFKQILSHLDIASQE 508
C S +P + +
Sbjct: 251 YFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 59/271 (21%), Positives = 103/271 (38%), Gaps = 35/271 (12%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVKKVREQKETDIRHLRK--------LNHPNIVKFKGVC 318
+G G+ G +F G L ++ VA+K E + +D LR I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 319 TQAPCYCIVMEYCAYGP-LYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ +V++ GP L +LL G + + + A+Q+ A + +H K +++RD+K
Sbjct: 76 QEGLHNVLVIDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 133
Query: 377 SPNVLIG---SKEEAKIS--DFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNE 423
N LIG SK I DFG + + + TK + +GT +M+
Sbjct: 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR 193
Query: 424 QCSDKIDIWSYGIVLWELLTCETP---YKDVDSSAIIWGVGSSSLHLPIPSTC---PDGF 477
+ S + D+ + G V L P K + +G P+ C P+ F
Sbjct: 194 EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEF 253
Query: 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
M + A + P + + +
Sbjct: 254 YKYMHYARNLAFDATPDYDYLQGLFSKVLER 284
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 47/200 (23%), Positives = 77/200 (38%), Gaps = 29/200 (14%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVKKVREQKETDIRHLRK--------LNHPNIVKFKGVC 318
+G G G + GK +E VA+K E ++ L + I +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 319 TQAPCYCIVMEYCAYGP-LYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+V+E GP L +L + + A Q+ + M Y+HSK +I+RD+K
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVK 132
Query: 377 SPNVLIGSKEEAK-----ISDFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNE 423
N LIG I DF +E+ + TK S GT +M+ +
Sbjct: 133 PENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK 192
Query: 424 QCSDKIDIWSYGIVLWELLT 443
+ S + D+ + G + L
Sbjct: 193 EQSRRDDLEALGHMFMYFLR 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 51/280 (18%), Positives = 89/280 (31%), Gaps = 90/280 (32%)
Query: 242 ARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGK--LRSEIVAVK------KVR 293
+IG+ + + + ++ LG G V+ + VA+K
Sbjct: 29 VKIGD----LFNGRYHV-------IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT 77
Query: 294 EQKETDIRHLRKL-----NHPN---IVK----FKGVCTQAPC---YCIVMEYCAYGP-LY 337
E +IR L+ + N PN +V+ FK C+V E G L
Sbjct: 78 ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK---ISGVNGTHICMVFE--VLGHHLL 132
Query: 338 NLLK--DGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFG 394
+ + + +P + +Q+ G++YLH+K +IIH D+K N+L+ E+
Sbjct: 133 KWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192
Query: 395 TCREWNNKSTKMSFAGTVAWM--------------------------------------- 415
EW V+
Sbjct: 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE 252
Query: 416 --------APEVIRNEQCSDKIDIWSYGIVLWELLTCETP 447
+ EV+ + DIWS + +EL T +
Sbjct: 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 26/215 (12%), Positives = 72/215 (33%), Gaps = 43/215 (20%)
Query: 269 LGSGAQGAVFSG----------KLRSEIVAVK--------------KVREQKETDIRHLR 304
QG ++ + + ++K R K + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 305 KLN---HPNIVKFKGVCTQAPCY-CIVMEYCAYGP-LYNLLK--DGEEVPPQRLYNWARQ 357
KL I G Y +V+ G L + L + + + A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 358 IAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI--SDFGTCREWNNKST--------KMS 407
+ + +LH + +H ++ + N+ + ++++++ + +G + +
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELL 442
G + +++ ++ + S + D+ S G + + L
Sbjct: 228 HEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 5e-09
Identities = 69/488 (14%), Positives = 143/488 (29%), Gaps = 148/488 (30%)
Query: 190 FGTCREWNNKSTKMSFAGTV-----AWMAPEVIRNE--QCSDKIDIW--YKNRLCFPTSL 240
F T + + F V ++ I+ E Q S ++ ++RL +
Sbjct: 68 FWTLLSKQEEMVQK-FVEEVLRINYKFLM-SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 241 MARIGEFKSFVLRDEWEIPFESISD-LQWLGSGA----QGAVFSGK--LRSEIVAVKKVR 293
A K V R + P+ + L L G + SGK + ++ KV+
Sbjct: 126 FA-----KYNVSRLQ---PYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177
Query: 294 EQKETDIR--HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRL 351
+ + I +L+ N P V Q Y I + + D R+
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEM---LQKLLYQIDPNWTS-------RSDHSSNIKLRI 227
Query: 352 YNWARQIAAGMNYLHSKQ-----IIHRDLKSPNVL----IGSK-----EEAKISDFGTCR 397
++ ++ L SK ++ ++++ + K +++DF +
Sbjct: 228 HSIQAELR---RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 398 EWNNKSTKMSFAG-----------TVAWMAPEVIRNEQCS--------------DKIDIW 432
+ S P+ + E + D + W
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
Query: 433 SYGIVLWELLTCETPYKDVDSS----------------AIIWGVGSSSLHLPIPSTCPDG 476
W+ + C+ ++SS ++ IP+
Sbjct: 345 DN----WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF------PPSAHIPTI---- 390
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQ 536
L+ + W + S +++ L ++ QP+ I + + +
Sbjct: 391 ---LLSLIWFDVIKSDVM--VVVNKL--HKYSLVEKQPKEST---------ISIPSIYL- 433
Query: 537 ANKSHVPKFEEFEDDLIKKRENELKHAQDVREHYE--RKLERANQLYLEL-----SAVRM 589
+L K ENE + + +HY + + + + L S +
Sbjct: 434 --------------ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH 479
Query: 590 HLDQREQE 597
HL E
Sbjct: 480 HLKNIEHP 487
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 3e-08
Identities = 80/622 (12%), Positives = 173/622 (27%), Gaps = 172/622 (27%)
Query: 12 EEFEDDLIKKRE-NELKHAQDVREHYERNMLCI---QEELGQLSLESPDDRS-----TDT 62
++ ++ K E + + ++D R + QEE+ Q +E + +
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 63 SDIPSQPSLHNPSGINKVEHAGWLDWTRLTKLSVCWRPFCSFVDKFSSPEFKTNIQER-S 121
QPS+ I + + + D K +V R + +++
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRL-YNDNQVFAKYNV-SRL-----------QPYLKLRQALL 145
Query: 122 EVKSATHYQVDLTGM--------AEQVRLSIPPQYQLELIGGPYWF-LAGCTTPDALAES 172
E++ A + V + G+ A V LS Q +++ +W L C +P+ + E
Sbjct: 146 ELRPAKN--VLIDGVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLKNCNSPETVLEM 201
Query: 173 I-GLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYK 231
+ L I ++ + +R ++ K
Sbjct: 202 LQKLLYQIDPNWTSRSDH----------------------SSNIKLRIHSIQAELRRLLK 239
Query: 232 NRLCFPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKK 291
++ + L+ VL + + F+ L +I+
Sbjct: 240 SKP-YENCLL---------VLLNVQN---AKAWN-----------AFN--LSCKILLT-- 271
Query: 292 VREQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRL 351
R ++ TD H ++ T V Y L +++P +
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDE----VKSLLL---KY-LDCRPQDLPRE-- 321
Query: 352 YNWARQIAAGMNYLHSKQIIHRDLKSPNV--LIGSKEEAKISDFGTCREWNN------KS 403
+P +I I D W+N
Sbjct: 322 ---VLTT------------------NPRRLSIIA----ESIRDG-LAT-WDNWKHVNCDK 354
Query: 404 TKMSFAGTVAWMAPEVIRN--EQCS---DKIDIWSYGI--VLWELLTCETPYKDVD---- 452
++ + P R ++ S I + ++W + V+
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI-PTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 453 -SSAIIWGVGSS----SLHLPIPSTCP----------DGFQLLMKMCWSNAPSSRP---S 494
S S+ S++L + D + + +
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473
Query: 495 FKQILSHLDIASQ-EVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDDLI 553
+ I HL E + + + + + +++IR A+ S + + L
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFRFL-EQKIRHDSTAWNASGSILNTLQ----QLK 528
Query: 554 KKRENELKHAQDVREHYERKLE 575
+ + D YER +
Sbjct: 529 FYK----PYICDNDPKYERLVN 546
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 30/215 (13%), Positives = 68/215 (31%), Gaps = 43/215 (20%)
Query: 269 LGSGAQGAVFSGKLRS-------EIVAVKKVRE---------------QKETDIRHLRKL 306
+G G G ++ + S VK K I+ +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 307 NH------PNIVKFKGVCTQAPCY-CIVMEYCAYGP-LYNLLKD-GEEVPPQRLYNWARQ 357
P Y ++M+ +G L + + + + + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 358 IAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKI--SDFGTCREWNNKSTKM--------S 407
I + Y+H + +H D+K+ N+L+ K ++ D+G + +
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELL 442
GT+ + + + S + D+ G + + L
Sbjct: 221 HDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 35/212 (16%), Positives = 69/212 (32%), Gaps = 40/212 (18%)
Query: 269 LGSGAQGAVFSGK--LRSEIVAVKKV-----------REQK----------ETDIRHLRK 305
+GSG G ++ + E A V E K ++
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 306 LNHPNIVKFKG----VCTQAPCYCIVMEYCAYGP-LYNLLKDGEEVPPQRLYNWARQIAA 360
L++ I F G +VME G L + + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKI--SDFGTCREWNNKSTKM--------SFAG 410
+ Y+H + +H D+K+ N+L+G K ++ +D+G + G
Sbjct: 163 VLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELL 442
T+ + + + + S + D+ G + L
Sbjct: 223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 2e-08
Identities = 26/192 (13%), Positives = 48/192 (25%), Gaps = 56/192 (29%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVR------------------------ 293
+P E + + +G G G VF VA+K +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 294 EQKETDIRHLRKLNHPNIVKFKGVCTQAPCY----------------------------- 324
++ + + + V Y
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 325 -CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLI 382
IV+E+ G ++ + Q+ A + + + HRDL NVL+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLAT-AKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 383 GSKEEAKISDFG 394
K+
Sbjct: 196 KKTSLKKLHYTL 207
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 600 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.81 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.81 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.8 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.78 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.78 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.76 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.75 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.73 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.73 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.73 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.72 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.72 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.71 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.63 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.6 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.57 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.57 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.55 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.54 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.52 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.51 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.51 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.5 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.49 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.49 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.49 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.49 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.48 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.48 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.48 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.48 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.47 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.47 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.47 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.47 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.46 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.46 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.46 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.46 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.46 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.46 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.45 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.45 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.45 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.45 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.44 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.44 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.43 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.43 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.43 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.43 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.43 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.43 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.43 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.42 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.42 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.41 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.41 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.41 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.41 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.41 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.41 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.41 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.41 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.41 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.41 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.41 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.41 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.41 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.41 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.4 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.4 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.4 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.4 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.4 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.4 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.4 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.4 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.39 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.39 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.39 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.39 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.39 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.39 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.39 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.39 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.39 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.39 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.39 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.39 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.38 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.38 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.38 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.38 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.38 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.38 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.38 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.38 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.37 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.37 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.37 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.37 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.36 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.36 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.36 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.36 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.35 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.35 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.35 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.35 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.35 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.35 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.35 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.35 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.35 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.35 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.35 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.34 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.34 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.34 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.34 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.34 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.34 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.34 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.34 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.34 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.34 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.33 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.33 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.33 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.33 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.33 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.33 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.33 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.33 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.33 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.33 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.33 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.33 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.33 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.32 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.32 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.32 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.32 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.32 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.32 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.32 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.32 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.32 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.31 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.31 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.31 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.31 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.31 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.31 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.31 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.31 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.31 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.31 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.3 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.3 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.3 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.3 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.3 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.3 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.3 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.3 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.3 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.3 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.3 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.3 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.3 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.3 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.29 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.29 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.29 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.29 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.29 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.29 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.29 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.29 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.29 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.28 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.28 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.28 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.28 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.28 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.27 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.27 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.27 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.27 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.27 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.27 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.27 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.26 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.26 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.25 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.25 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.25 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.25 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.25 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.24 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.24 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.24 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.24 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.24 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.24 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.24 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.24 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.24 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.24 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.23 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.23 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.23 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.23 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.22 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.22 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.22 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.21 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.21 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.2 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.2 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.2 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.2 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.19 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.19 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=474.93 Aligned_cols=247 Identities=26% Similarity=0.492 Sum_probs=218.1
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.++|++++.||+|+||+||+|++. ++.||||++.. .+.+|+.+|++|+|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 478999999999999999999865 78999999853 2467999999999999999999999999999999
Q ss_pred eeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CC
Q psy16430 329 EYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TK 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 405 (600)
|||+||+|.+++.. +..+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 99999999999964 3467999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..++...+..+.. .+.+..+|+++++||.+||
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~L 261 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYSYDLRSLVSQLF 261 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHc
Confidence 356899999999999999999999999999999999999999999999888888877654 3567789999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||+.|+|+|+|+...
T Consensus 262 ~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 262 KRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp CSSGGGSCCHHHHHTSHHHHTT
T ss_pred cCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=471.06 Aligned_cols=247 Identities=24% Similarity=0.413 Sum_probs=223.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
.+.|++++.||+|+||+||+|++. ++.||||++.. .+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 467999999999999999999875 78999999852 357899999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~ 409 (600)
|+||+|.+++.+ +.+++.++..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+... ....+.+
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 231 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 231 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence 999999999976 46999999999999999999999999999999999999999999999999999987544 3345689
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+.... ...+.+..+|+++++||.+||+.|
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~d 311 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 311 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999999999999999999988887777665442 233445678999999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~ 507 (600)
|.+|||+.|+|+||||...
T Consensus 312 P~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 312 PAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp TTTSCCHHHHTTCGGGGGC
T ss_pred hhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-57 Score=468.57 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=224.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++++.||+|+||+||+|+.. ++.||||++.+ .+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 478999999999999999999865 78999999853 235799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---C
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS---T 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~ 404 (600)
||||+||+|.+++++.+.+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.... .
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999999875332 2
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
..+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+...+...+..... .+|..+++++++||.+|
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--DFPEKFFPKARDLVEKL 268 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTCCHHHHHHHHHH
T ss_pred ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCcccCHHHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999998888888877654 45778999999999999
Q ss_pred hhcCCCCCCCHHH------HHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQ------ILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~e------lL~~l~~~~~ 507 (600)
|+.||.+|||++| |++||||...
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 9999999999987 5778887654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=456.12 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=207.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||+||+|+.. ++.||||++.+ .+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 79999999853 2457999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||| +|+|.+++.+.+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........+.
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 999 6799999988889999999999999999999999999999999999999999999999999999887665555678
Q ss_pred CCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
+||+.|||||++.+..+ +.++|||||||++|+|+||+.||.+.+...+...+..+.. ++|..+|+++++||.+||+.
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--TLPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCS
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccC
Confidence 99999999999998876 5799999999999999999999999888888777766653 45778999999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhh
Q psy16430 488 APSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~ 506 (600)
||.+|||++|+++|+|+..
T Consensus 250 dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 250 NPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SGGGSCCHHHHHHCHHHHT
T ss_pred ChhHCcCHHHHHcCccccc
Confidence 9999999999999999953
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=466.21 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=220.6
Q ss_pred cccccccccccccCCCCcceEEEeEe-----eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.++.++|++++.||+|+||+||+|+. .++.||||++++ .+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45568899999999999999999975 357899999853 3467999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.+|||||||+||+|.+++.+.+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999875433
Q ss_pred -CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 403 -STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 403 -~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
....+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..++...+..... ++|..+|+++++||
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 257 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLL 257 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--CCCCcCCHHHHHHH
Confidence 334567899999999999999999999999999999999999999999999888888776653 56788999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
++||+.||.+||| ++|+++||||...
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999998 5899999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=457.70 Aligned_cols=254 Identities=36% Similarity=0.555 Sum_probs=213.5
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
..+.|+|+.+++++.+.||+|+||+||+|++.+ .||||+++. .+.+|+.+|++++|||||+++|++.+ +
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 345799999999999999999999999999776 489998852 35689999999999999999998865 5
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+|||||||+||+|.+++.. .+.+++.++..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 68999999999999999965 46799999999999999999999999999999999999999999999999999987643
Q ss_pred CC---CCcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH-hcCCCCC---CCCCC
Q psy16430 402 KS---TKMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG-VGSSSLH---LPIPS 471 (600)
Q Consensus 402 ~~---~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~-i~~~~~~---~~~p~ 471 (600)
.. ...+.+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+....+.. +..+... ...+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 22 2335689999999999964 3589999999999999999999999998766544433 3333222 23457
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+|+.+.+||.+||+.||.+|||+.+|+++++....
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 899999999999999999999999999999876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=472.63 Aligned_cols=248 Identities=24% Similarity=0.422 Sum_probs=224.0
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.+.|++++.||+|+||.||+|++. ++.||||++.. .+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 4467999999999999999999975 78999999852 35689999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~ 408 (600)
||+||+|.++++. +.+++.++..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... ....+.
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 9999999999975 46999999999999999999999999999999999999999999999999999987544 334567
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-CCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+.... .....+..+|+++++||.+||..
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence 89999999999999999999999999999999999999999988888777765443 23445567899999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+|||+.|+|+|+||...
T Consensus 388 dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 388 DPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp STTTSCCHHHHTTCGGGGGC
T ss_pred ChhHCcCHHHHhcCHHhcCC
Confidence 99999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=454.17 Aligned_cols=241 Identities=27% Similarity=0.436 Sum_probs=209.8
Q ss_pred ccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec----CCceeEEE
Q psy16430 264 SDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ----APCYCIVM 328 (600)
Q Consensus 264 ~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~----~~~~~lV~ 328 (600)
++.+.||+|+||+||+|.+. +..||+|++.. .+.+|+++|++|+|||||+++++|.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999875 68999999853 24689999999999999999999864 35689999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCC-CCCceeeccCccccccCCCCC
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGS-KEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~~ 405 (600)
|||+||+|.+++++.+.+++..+..|+.||+.||.|||++| ||||||||+|||++. ++.+||+|||+|+.... ...
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~ 187 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFA 187 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSB
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-Ccc
Confidence 99999999999998888999999999999999999999998 999999999999984 78999999999986433 334
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
.+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+. ..+...+..+..+...+..+++++++||.+|
T Consensus 188 ~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 266 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266 (290)
T ss_dssp EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHH
Confidence 46789999999999865 699999999999999999999999987654 4444555555444456677899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~ 506 (600)
|+.||.+|||++|+|+|||+..
T Consensus 267 L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 267 IRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=463.42 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=222.3
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc--hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
....+.|++.++||+|+||.||+|++. ++.||||+++.. ..+|+.+|++++|||||++++++.+++.+|||||||+
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 344577899999999999999999865 789999999754 3579999999999999999999999999999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCCC------C
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKST------K 405 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~------~ 405 (600)
||+|.+++++.+.+++..+..|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+..... .
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~ 213 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence 999999999888899999999999999999999999999999999999999887 599999999987654321 2
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC-CCCCCCCcHHHHHHHHHh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH-LPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l~~LI~~c 484 (600)
...+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+...+...+...... ..+|..+|+.+.+||.+|
T Consensus 214 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~ 293 (336)
T 4g3f_A 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293 (336)
T ss_dssp CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHH
T ss_pred CccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHH
Confidence 2467999999999999999999999999999999999999999987776666666554433 246788999999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQEVL 510 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~~~~ 510 (600)
|+.||.+|||+.||++++..+.....
T Consensus 294 L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 294 LRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 99999999999999999876665443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-55 Score=453.05 Aligned_cols=248 Identities=34% Similarity=0.582 Sum_probs=223.2
Q ss_pred cccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCT 319 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~ 319 (600)
..+|+..++++++.||+|+||+||+|++. ++.||||+++. .+.+|+.+|++++|||||+++|++.
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 45788899999999999999999999863 47899999853 3578999999999999999999999
Q ss_pred cCCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG 383 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~ 383 (600)
+++.+|||||||++|+|.+++... ..+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999998542 3589999999999999999999999999999999999999
Q ss_pred CCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHH
Q psy16430 384 SKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWG 459 (600)
Q Consensus 384 ~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~ 459 (600)
.++.+||+|||+|+...... ......||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++...
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998764332 2334679999999999999999999999999999999998 8999999999888887
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 460 VGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 460 i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+..+. .++.|..+|+.+.+||.+||+.||.+|||+.+|++++.
T Consensus 260 i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 260 IRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 76654 46788999999999999999999999999999999884
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=452.83 Aligned_cols=247 Identities=34% Similarity=0.564 Sum_probs=219.3
Q ss_pred ccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
..|+.++|.+.+.||+|+||+||+|++. +..||||+++. .+.+|+++|++++|||||+++|++.++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3577899999999999999999999863 57899999863 356899999999999999999999999
Q ss_pred CceeEEEeeeccccchhhccCC-------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDG-------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~-------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
+.+|||||||+||+|.++++.. ..+++.++..|+.||+.||.|||+++||||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999643 369999999999999999999999999999999999999999999
Q ss_pred eeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC
Q psy16430 389 KISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 389 kL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~ 464 (600)
||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987644322 223568999999999999999999999999999999999 999999999888888776654
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.++.|..+|+++.+||.+||+.||++|||+.+|+..+.
T Consensus 248 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 248 -VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 45678899999999999999999999999999977654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=452.74 Aligned_cols=249 Identities=32% Similarity=0.547 Sum_probs=216.5
Q ss_pred cccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
.+.|+.++|.+.++||+|+||+||+|++. +..||||+++. .+.+|+++|++++|||||+++|+|.+
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45677789999999999999999999863 57899999863 35689999999999999999999999
Q ss_pred CCceeEEEeeeccccchhhccCC---------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDG---------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK 385 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~---------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~ 385 (600)
.+.+|||||||++|+|.++++.. +++++.+++.|+.||+.||.|||+++||||||||+|||++.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999999999998643 358999999999999999999999999999999999999999
Q ss_pred CCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhc
Q psy16430 386 EEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVG 461 (600)
Q Consensus 386 ~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~ 461 (600)
+.+||+|||+|+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999998764332 2234679999999999999999999999999999999999 999999999888887776
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 462 SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 462 ~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+. +++.|..+|+++.+||.+||+.||++|||+.+|++++.-
T Consensus 275 ~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 275 QGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred cCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 553 567888999999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=457.38 Aligned_cols=251 Identities=30% Similarity=0.576 Sum_probs=219.5
Q ss_pred cccccccccccccccccCCCCcceEEEeEeec-------eEEEeeeecc--------chHHHHHHHHhcCC-CCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVRE--------QKETDIRHLRKLNH-PNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~--------~~~~Ei~~L~~L~H-pnIv~l~~ 316 (600)
.+.|+|+.++|++.+.||+|+||+||+|++.+ +.||||.+.. .+.+|+++|++++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 45799999999999999999999999998653 6899999853 24579999999976 89999999
Q ss_pred eeec-CCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 317 VCTQ-APCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 317 ~~~~-~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+|.+ +..+|||||||++|+|.++|+.. ..+++.++..|+.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 45789999999999999999642 348899999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
||++.++.+||+|||+|+....... ..+.+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+...
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654322 234678999999999999999999999999999999998 999999876554
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+........+++.|..+|+++.+||.+||+.||.+|||+.+|++|+.
T Consensus 296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 444443444567788999999999999999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=443.90 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=210.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeec------CCc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQ------APC 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~------~~~ 323 (600)
++|++++.||+|+||+||+|++. ++.||||+++.. ..+|+++|++|+|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 67999999999999999999865 799999998632 3479999999999999999998753 367
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK- 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~- 402 (600)
+|||||||+ |+|.+++..++.+++.++..|++||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 899999996 679999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred ----CCCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC-----------
Q psy16430 403 ----STKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH----------- 466 (600)
Q Consensus 403 ----~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~----------- 466 (600)
....+.+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+....+..+......
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 223467899999999998775 5689999999999999999999999998877666544321100
Q ss_pred -------------CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 -------------LP-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 -------------~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+ ....+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00 013468899999999999999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=437.71 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=193.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC--------
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP-------- 322 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~-------- 322 (600)
++|++++.||+|+||+||+|++. ++.||||+++. .+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 47899999999999999999865 78999999852 2457999999999999999999986543
Q ss_pred ----ceeEEEeeeccccchhhccCCCCC---CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 323 ----CYCIVMEYCAYGPLYNLLKDGEEV---PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 323 ----~~~lV~Ey~~ggsL~~~l~~~~~l---~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
.+|+|||||+||+|.+++...+.+ +...++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 379999999999999999876544 4456889999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhc
Q psy16430 396 CREWNNKST-------------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVG 461 (600)
Q Consensus 396 a~~~~~~~~-------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~ 461 (600)
|+....... ..+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+... ......+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 987654321 123579999999999999999999999999999999996 7865332 22233333
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 462 SSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 462 ~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.... ++.+...++.+.+||++||+.||.+|||+.|+++|+|+.+.
T Consensus 242 ~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 242 NLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp TTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3322 12223445678899999999999999999999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=428.43 Aligned_cols=244 Identities=20% Similarity=0.308 Sum_probs=201.8
Q ss_pred cccccccccCCCCcceEEEeEee-----ceEEEeeeecc-----chHHHHHHHHhc-CCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE-----QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~-----~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.|++.+.||+|+||+||+|+.+ ++.||+|++.. ...+|+++|+.+ +|||||+++++|.+.+++|+|||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 67999999999999999999753 58899998853 245799999998 69999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccccCCC-----
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNKS----- 403 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~----- 403 (600)
||+||+|.++++ .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 999999999985 49999999999999999999999999999999999999876 799999999997553221
Q ss_pred ------------------------CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCC-hHHHH
Q psy16430 404 ------------------------TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVD-SSAII 457 (600)
Q Consensus 404 ------------------------~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~-~~~~~ 457 (600)
...+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||...+ ....+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 11235799999999999775 58999999999999999999999996543 22222
Q ss_pred HHhcC--------------------------------------C--------------CCCCCCCCCCcHHHHHHHHHhh
Q psy16430 458 WGVGS--------------------------------------S--------------SLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 458 ~~i~~--------------------------------------~--------------~~~~~~p~~~~~~l~~LI~~cL 485 (600)
..+.. . ....+....+|+++.+||++||
T Consensus 258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL 337 (361)
T 4f9c_A 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL 337 (361)
T ss_dssp HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 11100 0 0001122457899999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||++|+|+||||.+.
T Consensus 338 ~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 338 DLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CSCTTTSCCHHHHHTSGGGTTC
T ss_pred cCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=421.26 Aligned_cols=242 Identities=27% Similarity=0.404 Sum_probs=198.6
Q ss_pred cccccccccCCCCcceEEEeEeeceEEEeeeeccch------HHHHHHHHhcCCCCcccccceeecCC----ceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK------ETDIRHLRKLNHPNIVKFKGVCTQAP----CYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~------~~Ei~~L~~L~HpnIv~l~~~~~~~~----~~~lV~Ey 330 (600)
.+|.+.+.||+|+||+||+|+++++.||||++.... +.|+..+.+++|||||+++|++.+++ .+||||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 467888999999999999999999999999996532 34566667889999999999997653 57999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC--------CccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK--------QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~--------gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|+||+|.++++.. .+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 9999999999764 589999999999999999999987 9999999999999999999999999999876543
Q ss_pred CC-----CcccCCCccccChhhhccC------CCCCccceechhHHHHHHhhCCCCCCCC---------------ChHHH
Q psy16430 403 ST-----KMSFAGTVAWMAPEVIRNE------QCSDKIDIWSYGIVLWELLTCETPYKDV---------------DSSAI 456 (600)
Q Consensus 403 ~~-----~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGviLyELltG~~Pf~~~---------------~~~~~ 456 (600)
.. ....+||+.|||||++.+. .++.++|||||||+||||+||.+||... ....+
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 32 2245799999999999764 3677999999999999999997765321 12334
Q ss_pred HHHhcCCCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 457 IWGVGSSSLHLPIPST-----CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~~-----~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...+.....++++|.. +++.+.+||.+||+.||++|||+.+|++.+.
T Consensus 242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 4445555555555543 3457899999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=451.15 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=224.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
++|++++.||+|+||.||+|+.. ++.||+|++... ..+|+.+|+.|+|||||+++++|.+...+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999865 789999998532 357999999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC--CCceeeccCccccccCCCCCccc
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK--EEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~--~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
+||+|.+++.. .+.+++.++..+++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+.........
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~ 316 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence 99999998864 4679999999999999999999999999999999999999854 89999999999988766555677
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHHHHHHhhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~LI~~cL~ 486 (600)
+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+......++ .+..+|+++++||.+||+
T Consensus 317 ~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~ 396 (573)
T 3uto_A 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396 (573)
T ss_dssp CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSC
T ss_pred EECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 899999999999999999999999999999999999999999999888888877655443 346789999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~ 507 (600)
.||.+|||+.|+|+|+||...
T Consensus 397 ~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 397 ADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp SSGGGSCCHHHHHHSTTTSCC
T ss_pred CChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=450.52 Aligned_cols=248 Identities=19% Similarity=0.318 Sum_probs=216.2
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHH---HHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETD---IRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~E---i~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
+..++|++++.||+|+||.||+|+.. ++.||||++.+.. .+| +.+++.++|||||+++++|.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 34578999999999999999999875 7899999985321 223 45666779999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.+|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999877544
Q ss_pred CCCcccCCCccccChhhhc-cCCCCCccceechhHHHHHHhhCCCCCCCCC---hHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIR-NEQCSDKIDIWSYGIVLWELLTCETPYKDVD---SSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGviLyELltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
. ..+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+.+ ...+...+.... ..+|..+|++++
T Consensus 346 ~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~~a~ 422 (689)
T 3v5w_A 346 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELR 422 (689)
T ss_dssp C-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred C-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCHHHH
Confidence 3 34679999999999996 4679999999999999999999999997643 334444444433 456788999999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHHcHhhhhhh
Q psy16430 479 LLMKMCWSNAPSSRPS-----FKQILSHLDIASQE 508 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs-----~~elL~~l~~~~~~ 508 (600)
+||.+||+.||.+|++ +++|++||||....
T Consensus 423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred HHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 9999999999999998 79999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=400.96 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=224.2
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.++|++++.||+|+||.||+|++ +++.||||++... ..+|+++|+.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 47899999999999999999986 4789999998532 347999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 173 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTT
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccc
Confidence 99999999999988788999999999999999999999999999999999999999999999999999877665555667
Q ss_pred CCCccccChhhhccCCCC-CccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCS-DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s-~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+..+.. ..|..+++.+.+||++||..
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~ 251 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMSTDCENLLKRFLVL 251 (328)
T ss_dssp SSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHCCS
T ss_pred cCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHCCC
Confidence 899999999999887775 799999999999999999999999998888877766654 45677899999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+|||++++++|+|+...
T Consensus 252 dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 252 NPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp STTTSCCHHHHTTCTTTTTT
T ss_pred ChhHCcCHHHHhcCHhhcCC
Confidence 99999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=397.34 Aligned_cols=248 Identities=25% Similarity=0.454 Sum_probs=223.7
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+..++|++++.||+|+||.||+|+.. ++.||+|++++. ..+|+.+|+.++||||+++++++.+...+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999875 789999998642 356899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KST 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~ 404 (600)
+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 9999999999999998878899999999999999999999999999999999999999999999999999986432 333
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
..+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+..... .+|..+++.+.+||.+|
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 4467899999999999999999999999999999999999999999888877777665543 45678999999999999
Q ss_pred hhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
|+.||.+|| +++++++|+||...
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999 99999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=401.15 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=223.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+.|++.+.||+|+||.||+|+.. ++.||+|++.. .+.+|+.+|++++||||+++++++.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 67999999999999999999875 78999999853 2468999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC----CceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE----EAKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~----~vkL~DFGla~~~~~ 401 (600)
+||||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 9999999999999998888899999999999999999999999999999999999998776 799999999988766
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQL 479 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~ 479 (600)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+......++ .+..+++.+++
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 251 (361)
T 2yab_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251 (361)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHH
Confidence 5555567899999999999998999999999999999999999999999988888877766654433 23678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
||.+||..||.+|||+.++++|||+..
T Consensus 252 li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 252 FIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=389.93 Aligned_cols=254 Identities=37% Similarity=0.654 Sum_probs=217.0
Q ss_pred cccccccccccccccccccCCCCcceEEEeEeeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 251 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
...+.++++.++|++.+.||+|+||+||+|+..+..||||++.. .+.+|+.++++++||||+++++++.+.
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 44567889999999999999999999999999999999999853 235799999999999999999999999
Q ss_pred CceeEEEeeeccccchhhccCCCC---CCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDGEE---VPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~~~---l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
...++||||+++|+|.+++...+. +++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999987553 999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 397 REWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 397 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.........|..+++
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 7654332 233567999999999999999999999999999999999999999999888877776555566678889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+.+||.+||+.||.+|||+.++++.+.-
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=387.20 Aligned_cols=248 Identities=27% Similarity=0.495 Sum_probs=219.1
Q ss_pred cccccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.++|++.+.||+|+||.||+|.. .++.||+|++.. .+.+|+.++++++||||+++++++...+..|+|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 347899999999999999999975 478999999852 24579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-Cccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~ 408 (600)
|++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence 99999999999764 589999999999999999999999999999999999999999999999999987654432 3456
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-SSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. .......+..+++.+.+||.+||+.
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 256 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccC
Confidence 899999999999999999999999999999999999999998877665554432 3334455678899999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+|||+.++++|+|+...
T Consensus 257 dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 257 DVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp STTTSCCHHHHTTCGGGGGC
T ss_pred ChhHCcCHHHHhhChhhccc
Confidence 99999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=400.51 Aligned_cols=249 Identities=24% Similarity=0.424 Sum_probs=218.3
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCc
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~ 323 (600)
.+..++|++++.||+|+||.||+|+.. ++.||||++++. ...|..+++.+ +||||+++++++.+...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 355689999999999999999999875 689999998643 24688889888 79999999999999999
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-C
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-K 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~ 402 (600)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999986432 2
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+..... ..|..+++.+.+||+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLHEDATGILK 256 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 334467899999999999999999999999999999999999999999998888888776654 456778999999999
Q ss_pred HhhhcCCCCCCCH------HHHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSF------KQILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~------~elL~~l~~~~~ 507 (600)
+||+.||.+||++ +++++|+||...
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999999 999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=402.15 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=221.7
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|.. .++.||+|++.. .+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 6799999999999999999986 478999999853 23579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC---CCCCceeeccCccccccCCCC-C
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG---SKEEAKISDFGTCREWNNKST-K 405 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~~~-~ 405 (600)
||+||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........ .
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~ 170 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence 999999999998888899999999999999999999999999999999999998 457899999999987654332 3
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKM 483 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~ 483 (600)
....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..+....+.+ ..+++.+.+||.+
T Consensus 171 ~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 250 (444)
T 3soa_A 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250 (444)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHH
Confidence 45789999999999999899999999999999999999999999998888888777766555443 4789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
||+.||.+|||+.++|+|||+.....
T Consensus 251 ~L~~dP~~Rpta~e~L~hp~~~~~~~ 276 (444)
T 3soa_A 251 MLTINPSKRITAAEALKHPWISHRST 276 (444)
T ss_dssp HSCSSTTTSCCHHHHHHSCTTHHHHH
T ss_pred HcCCChhHCCCHHHHhcCccccCCcc
Confidence 99999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=393.30 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=222.9
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|... +..||+|++.. .+.+|+.++++++||||+++++++.+....|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 67999999999999999999875 68999999853 23579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC---CCceeeccCccccccCCCCCc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~ 406 (600)
|++||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..........
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~ 188 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence 99999999999888889999999999999999999999999999999999999865 459999999998876555555
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMC 484 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~c 484 (600)
...||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..+....+.+ ..+++.+.+||.+|
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHH
T ss_pred cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 6789999999999999899999999999999999999999999988888777776665554433 46799999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
|+.||.+|||+.++|+|+|+....
T Consensus 269 L~~dP~~R~t~~e~l~hp~~~~~~ 292 (362)
T 2bdw_A 269 LTVNPKKRITADQALKVPWICNRE 292 (362)
T ss_dssp SCSSGGGSCCHHHHTTSHHHHTHH
T ss_pred cCCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999997653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=380.66 Aligned_cols=246 Identities=25% Similarity=0.433 Sum_probs=213.9
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------------------------------chHHHHHHH
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------------------------------QKETDIRHL 303 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------------------------------~~~~Ei~~L 303 (600)
..++|++.+.||+|+||.||+|+.. ++.||||++.. .+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4578999999999999999999864 78999999853 245799999
Q ss_pred HhcCCCCcccccceeec--CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcc
Q psy16430 304 RKLNHPNIVKFKGVCTQ--APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVL 381 (600)
Q Consensus 304 ~~L~HpnIv~l~~~~~~--~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NIL 381 (600)
++++||||+++++++.+ ....|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999976 5678999999999999987654 57999999999999999999999999999999999999
Q ss_pred cCCCCCceeeccCccccccCCCC-CcccCCCccccChhhhccCC---CCCccceechhHHHHHHhhCCCCCCCCChHHHH
Q psy16430 382 IGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIRNEQ---CSDKIDIWSYGIVLWELLTCETPYKDVDSSAII 457 (600)
Q Consensus 382 l~~~~~vkL~DFGla~~~~~~~~-~~~~~gt~~Y~APE~l~~~~---~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~ 457 (600)
++.++.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 99999999999999987654322 23467999999999997654 367899999999999999999999988877776
Q ss_pred HHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 458 WGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 458 ~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
..+.......+.+..+++.+.+||.+||+.||.+|||+.++++|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 666666555566678899999999999999999999999999999984
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=391.18 Aligned_cols=247 Identities=19% Similarity=0.269 Sum_probs=221.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
++|++.+.||+|+||.||+|... +..||+|.+... ..+|+.+++.++||||+++++++.+....++|||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 68999999999999999999875 689999998532 3579999999999999999999999999999999999
Q ss_pred cccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC--CCCceeeccCccccccCCCCCcccC
Q psy16430 333 YGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS--KEEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 333 ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.............
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 164 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccccc
Confidence 99999999764 47999999999999999999999999999999999999987 7899999999998876555445567
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCC--CCCCcHHHHHHHHHhhhc
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI--PSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~LI~~cL~~ 487 (600)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+. ...+|+.+.+||.+||..
T Consensus 165 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 244 (321)
T 1tki_A 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244 (321)
T ss_dssp SCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCS
T ss_pred CChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCC
Confidence 999999999999888899999999999999999999999998888887777666544332 247899999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+|||+.++++|||+...
T Consensus 245 dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 245 ERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SGGGSCCHHHHHHSHHHHSC
T ss_pred ChhHCcCHHHHhcChhhccC
Confidence 99999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=389.12 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=220.9
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+.|++.+.||+|+||.||+|+.. +..||+|++.. .+.+|+.+|++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57899999999999999999875 68999998853 2468999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC----CceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE----EAKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~----~vkL~DFGla~~~~~ 401 (600)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999998888899999999999999999999999999999999999998877 799999999988765
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQL 479 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~ 479 (600)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+ .+..+++.+.+
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHH
Confidence 5555567899999999999988999999999999999999999999998887777666654443332 23578899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+||+.||.+|||+.++++|||+...
T Consensus 251 li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 251 FIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=387.83 Aligned_cols=246 Identities=26% Similarity=0.444 Sum_probs=223.0
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+..++|++++.||+|+||.||+|+.. ++.||+|++++. ..+|+.+++.++||||+++++++.+....|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34578999999999999999999874 789999998642 246889999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~ 160 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--T 160 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--B
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--c
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999875432 3
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ..|..+++.+.++|.+||
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL 238 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI 238 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHh
Confidence 456899999999999999999999999999999999999999999888877777766543 456788999999999999
Q ss_pred hcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
..||.+|| +++++++|+||...
T Consensus 239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 239 TRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999 99999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=393.20 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=208.5
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
....++|++++.||+|+||+||+++.. ++.||||++.. ...+|+.+++.++||||+++++++.+...+|+||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 345688999999999999999999874 78999999863 3468999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC--ceeeccCccccccCCCCCc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE--AKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~--vkL~DFGla~~~~~~~~~~ 406 (600)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.........
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99999999999987778999999999999999999999999999999999999987765 9999999998654444445
Q ss_pred ccCCCccccChhhhccCCCCCc-cceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDK-IDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~k-sDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+.......+.+..+++.+.+||
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 6789999999999988877655 8999999999999999999987543 3444555555555555667899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+||+.||.+|||+.++++|+|+...
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 256 SRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999999999653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=398.10 Aligned_cols=249 Identities=24% Similarity=0.450 Sum_probs=217.2
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCc
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~ 323 (600)
.+..++|++++.||+|+||.||+|+.. ++.||+|++++. ...|..++.++ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 355689999999999999999999875 689999998643 35688888877 89999999999999999
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~ 402 (600)
+|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999998633 33
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC---------hHHHHHHhcCCCCCCCCCCCC
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD---------SSAIIWGVGSSSLHLPIPSTC 473 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~---------~~~~~~~i~~~~~~~~~p~~~ 473 (600)
....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.... ...+...+.... ..+|..+
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~ 285 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSL 285 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTS
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcC
Confidence 44456789999999999999999999999999999999999999996432 222333343333 4567789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH------HHHHHcHhhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSF------KQILSHLDIASQ 507 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~------~elL~~l~~~~~ 507 (600)
++.+.+||++||+.||.+||++ .+|++||||...
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999999984 899999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=393.83 Aligned_cols=249 Identities=25% Similarity=0.440 Sum_probs=221.9
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCc
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~ 323 (600)
.+..++|++.+.||+|+||.||+|+.. ++.||||+++.. ...|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455689999999999999999999975 789999998643 24678888876 99999999999999999
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-C
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-K 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~ 402 (600)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 999999999999999998877899999999999999999999999999999999999999999999999999986532 2
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+..... ..|..+++.+.+||.
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 250 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--FYPRWLEKEAKDLLV 250 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC--CCCcccCHHHHHHHH
Confidence 334467899999999999999999999999999999999999999999888888777765543 456789999999999
Q ss_pred HhhhcCCCCCCCHH-HHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSFK-QILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~~-elL~~l~~~~~ 507 (600)
+||..||.+||++. +|++|+||...
T Consensus 251 ~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 251 KLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999999998 99999999865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=395.15 Aligned_cols=253 Identities=22% Similarity=0.369 Sum_probs=222.9
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecC
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
....+..++|++++.||+|+||.||+|+.. ++.||+|++... ..+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345677899999999999999999999865 588999998532 34799999999999999999999999
Q ss_pred CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
...|+||||+.||+|..++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999988766
Q ss_pred CCCCcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCC---hHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVD---SSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
.....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+... ....|..+++
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~p~~~s~ 245 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--VVTYPSAWSQ 245 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--CCCCCTTSCH
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--ccCCCCcCCH
Confidence 666667889999999999864 458999999999999999999999997533 33333333333 2456778999
Q ss_pred HHHHHHHHhhhcCCCCCCC-HHHHHHcHhhhhhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPS-FKQILSHLDIASQE 508 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs-~~elL~~l~~~~~~ 508 (600)
.+.+||.+||+.||.+||+ ++++++|+|+....
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 9999999999999999998 99999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.21 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=217.8
Q ss_pred cccccccccccccccCCCCcceEEEeEe-----eceEEEeeeeccc-----------hHHHHHHHHhcCCCCccccccee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVREQ-----------KETDIRHLRKLNHPNIVKFKGVC 318 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~~-----------~~~Ei~~L~~L~HpnIv~l~~~~ 318 (600)
...+..++|++.+.||+|+||.||+|+. .++.||+|+++.. ..+|+.++++++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 3456678999999999999999999986 4689999998642 34689999999999999999999
Q ss_pred ecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 319 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
...+..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999998878899999999999999999999999999999999999999999999999999876
Q ss_pred ccCC-CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 399 WNNK-STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 399 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|..+++.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~ 248 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEA 248 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTSCHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHH
Confidence 4332 23345689999999999999899999999999999999999999999988877777666554 34567889999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
.+||.+||..||.+|| ++.++++||||...
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999999 89999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=388.97 Aligned_cols=248 Identities=25% Similarity=0.452 Sum_probs=216.6
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
+..++|++++.||+|+||.||+|+.. ++.||+|++.+. ..+|+.+++++ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 44578999999999999999999875 689999998643 34688889887 899999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~ 403 (600)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ...
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999998643 233
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCC---------ChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDV---------DSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||... ....+...+.... ..+|..++
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s 243 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLS 243 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCCTTSC
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCCCCCC
Confidence 344678999999999999999999999999999999999999999752 2233333443333 34677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCH------HHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSF------KQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~------~elL~~l~~~~~ 507 (600)
..+.+||.+||+.||.+||++ .++++||||...
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 999999999999999999995 899999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=391.00 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=221.4
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
+..++|++++.||+|+||.||+|+.. ++.||||+++.. ...|..++..+ +||||+++++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45589999999999999999999975 688999998643 24678888877 799999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~ 403 (600)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 99999999999999998877899999999999999999999999999999999999999999999999999986432 33
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+..... ..|..+++.+.+||.+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 254 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKG 254 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHH
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHH
Confidence 34467899999999999999999999999999999999999999999988888877766554 4567899999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
||..||.+|| ++++|++|+||...
T Consensus 255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 255 LMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 9999999999 47999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=393.62 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=217.3
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|.+.+.||+|+||.||+|.+ .++.||+|++.. .+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 37899999999999999999997 468999999853 346799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|||+ +|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 9999 688999888778899999999999999999999999999999999999999999999999999987766655567
Q ss_pred cCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
.+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+.........+... ....|..+|+.+.+||++||+
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS--CCCCCTTSCHHHHHHHHTTSC
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCCCcccCCHHHHHHHHHHcC
Confidence 789999999999988776 68999999999999999999999876554443333222 335677889999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~ 507 (600)
.||.+|||+.++++|||+...
T Consensus 245 ~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 245 ADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SSGGGSCCHHHHTTCHHHHTT
T ss_pred CChhHCcCHHHHHhChhhccC
Confidence 999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=390.49 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=223.6
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
...++|++++.||+|+||.||+|+.. ++.||+|++... ..+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999875 789999998532 346899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 99999999999999988778999999999999999999999999999999999999999999999999999876443 3
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+..+.. ..|..+++.+.+||.+||
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL 273 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHS
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 356899999999999999999999999999999999999999999888888777766643 456789999999999999
Q ss_pred hcCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
+.||.+||+ +++|++|+|+...
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999998 9999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=373.86 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=222.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|... ++.||+|++... +.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 78999999999999999999865 689999998532 3579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC---ceeeccCccccccCCCCCc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~---vkL~DFGla~~~~~~~~~~ 406 (600)
|+++++|.+.+.....+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||++..........
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence 9999999999887788999999999999999999999999999999999999986655 9999999998776655555
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMC 484 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~c 484 (600)
...||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+.+ ..+++.+.+||.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (284)
T 3kk8_A 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245 (284)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999988887777766655544433 57899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
|+.||.+|||+.++++|+|+....
T Consensus 246 l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 246 LTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp SCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cccChhhCCCHHHHhcCccccCCh
Confidence 999999999999999999997653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=400.29 Aligned_cols=253 Identities=38% Similarity=0.633 Sum_probs=223.0
Q ss_pred cccccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 251 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
...+.|+++.++|++.+.||+|+||.||+|++. ++.||||.++. .+.+|+++|++++||||+++++++..
T Consensus 104 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp CCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 445789999999999999999999999999985 78999999853 34579999999999999999999999
Q ss_pred CCceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
....|+||||+++|+|.++++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999999999764 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 400 NNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 400 ~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+ ...+.|..+|+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 342 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPD 342 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCCCCCTTCCH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCH
Confidence 432211 12235778999999998899999999999999999998 99999998887776655443 45677888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+.+||.+||+.||.+|||+.+|++.+.-
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 99999999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=375.91 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=206.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++++.||+|+||+||+|+.. ++.||+|++.. ...+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 67999999999999999999874 68999999852 23579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
|++++.+..+...++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence 99875555555556789999999999999999999999999999999999999999999999999998765432 23356
Q ss_pred CCCccccChhhhccCC-CCCccceechhHHHHHHhhCCCC-CCCCChHHHHHHhcC----CC------------------
Q psy16430 409 AGTVAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETP-YKDVDSSAIIWGVGS----SS------------------ 464 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~-~s~ksDIwSlGviLyELltG~~P-f~~~~~~~~~~~i~~----~~------------------ 464 (600)
.||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.......+.. ..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence 7899999999997765 79999999999999999987777 555555444433211 00
Q ss_pred -----CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 465 -----LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 465 -----~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
........+++.+.+||.+||+.||.+|||++++++||||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 001122357899999999999999999999999999999965
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=407.33 Aligned_cols=252 Identities=33% Similarity=0.603 Sum_probs=223.1
Q ss_pred cccccccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 251 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
...+.|+++.++|++.+.||+|+||.||+|.+. +..||||+++. .+.+|+.+|++++||||+++++++. ...
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 346789999999999999999999999999986 67899999864 3468999999999999999999986 567
Q ss_pred eeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.|+||||+++|+|.+++... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 89999999999999999753 3689999999999999999999999999999999999999999999999999987643
Q ss_pred CC--CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 402 KS--TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 402 ~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ...+.|..+|+.+.
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELY 415 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTSCHHHH
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHH
Confidence 21 1223456889999999998899999999999999999999 99999998888777766544 45667889999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+||.+||+.||.+|||+.+|+..+.-
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHH
Confidence 99999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=385.07 Aligned_cols=247 Identities=29% Similarity=0.426 Sum_probs=214.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeec--------cchHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR--------EQKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~--------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++++.||+|+||.||+|... ++.||||++. ..+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 78999999999999999999865 7899999984 2346899999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---CCcc
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS---TKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~ 407 (600)
++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 166 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCS
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCC
Confidence 9999999999988889999999999999999999999999999999999999999999999999998654322 2235
Q ss_pred cCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 408 FAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
..||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... .............+....+++.+.+||.+||
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 246 (323)
T 3tki_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246 (323)
T ss_dssp CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHc
Confidence 689999999999987665 77899999999999999999999876543 2222222333333334678999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||+.|+++|+|+...
T Consensus 247 ~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 247 VENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp CSSTTTSCCHHHHTTCTTTTCC
T ss_pred cCChhhCcCHHHHhhChhhccc
Confidence 9999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=386.98 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=205.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc-----hHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-----KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-----~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.+.|++.+.||+|+||.||+|+.. ++.||||++... +.+|+.++++++||||+++++++.+....++||||++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 367899999999999999999975 578999998643 4579999999999999999999999999999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCceeeccCccccccCCCCCcccC
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
+|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.............
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 211 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence 9999999988888999999999999999999999999999999999999975 7899999999998766544445678
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH-HHHHhcCCCCCC--CCCCCCcHHHHHHHHHhhh
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA-IIWGVGSSSLHL--PIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~-~~~~i~~~~~~~--~~p~~~~~~l~~LI~~cL~ 486 (600)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+....... +....++..+.+||.+||+
T Consensus 212 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 291 (349)
T 2w4o_A 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIV 291 (349)
T ss_dssp -CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSC
T ss_pred CCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHcc
Confidence 9999999999999899999999999999999999999998766544 444444444332 2336789999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.||.+|||+.++++|+|+....
T Consensus 292 ~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 292 LDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp SSGGGSCCHHHHHHSTTTTSTT
T ss_pred CChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999997653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=385.69 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=216.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---chHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeeccc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYG 334 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 334 (600)
++|++.+.||+|+||.||+|... ++.||||++.. ...+|+.++.++ +||||+++++++.+....|+|||||+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 67999999999999999999875 78999999964 346899999888 7999999999999999999999999999
Q ss_pred cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC----CCceeeccCccccccCC-CCCcccC
Q psy16430 335 PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK----EEAKISDFGTCREWNNK-STKMSFA 409 (600)
Q Consensus 335 sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~----~~vkL~DFGla~~~~~~-~~~~~~~ 409 (600)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++...... ....+.+
T Consensus 102 ~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 181 (342)
T 2qr7_A 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181 (342)
T ss_dssp BHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSS
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccC
Confidence 999999888889999999999999999999999999999999999998543 24999999999876543 2334578
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCC---CChHHHHHHhcCCCCCCC--CCCCCcHHHHHHHHHh
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKD---VDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMC 484 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~---~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~LI~~c 484 (600)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+ .+...+...+..+....+ .+..+++.+.+||++|
T Consensus 182 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 261 (342)
T 2qr7_A 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKM 261 (342)
T ss_dssp CCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHH
T ss_pred CCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHH
Confidence 99999999999888899999999999999999999999986 344556666655554433 3467899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
|..||.+|||+.++++|+|+....
T Consensus 262 L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 262 LHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp TCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred CCCChhHCcCHHHHhcCCeecCcc
Confidence 999999999999999999997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=400.94 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=219.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++++.||+|+||+||+|+.. ++.||||++.. .+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 67999999999999999999875 78999999842 24579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC---CCCCceeeccCccccccCCCCCc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG---SKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||+||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..........
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 181 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence 999999999988778899999999999999999999999999999999999995 45679999999998776655555
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMC 484 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~c 484 (600)
...||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+..+....+.| ..+|+.+++||.+|
T Consensus 182 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 260 (486)
T 3mwu_A 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (486)
T ss_dssp CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHH
T ss_pred CCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHH
Confidence 6789999999999976 58999999999999999999999999999888888777766554443 56899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+.||.+|||+.++|+|||+...
T Consensus 261 L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 261 LTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp TCSSTTTSCCHHHHHHCHHHHHT
T ss_pred cCCChhhCcCHHHHhcCHhhccC
Confidence 99999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=398.14 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=223.6
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.+.+..++|++++.||+|+||.||+|+.. ++.||+|++.+ .+.+|+.+++.++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 45677789999999999999999999875 68999999853 2457999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999999999999999875 46899999999999999999999999999999999999999999999999999876544
Q ss_pred C--CCcccCCCccccChhhhccCC----CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC--CCCCCCCCCc
Q psy16430 403 S--TKMSFAGTVAWMAPEVIRNEQ----CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS--LHLPIPSTCP 474 (600)
Q Consensus 403 ~--~~~~~~gt~~Y~APE~l~~~~----~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~ 474 (600)
. ...+.+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+.... ...+.+..++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 3 233678999999999997755 7899999999999999999999999998888877776543 3344445789
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSS--RPSFKQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~--RPs~~elL~~l~~~~~ 507 (600)
+.+++||++||..+|.+ ||++++|++|+||...
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999988 9999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=369.73 Aligned_cols=245 Identities=48% Similarity=0.880 Sum_probs=212.7
Q ss_pred cccccccccccccCCCCcceEEEeEeeceEEEeeeecc-----------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+++.++|++.+.||+|+||.||+|.+.+..||||+++. .+.+|+.+++.++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 56778999999999999999999999999999999853 2357899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCC---ccccCCCCCCcccCC--------CCCceeeccC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ---IIHRDLKSPNVLIGS--------KEEAKISDFG 394 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~g---IvHrDIKp~NILl~~--------~~~vkL~DFG 394 (600)
+||||+++++|.+++.. +.+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999864 57999999999999999999999999 899999999999986 6789999999
Q ss_pred ccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 395 TCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 395 la~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
++........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+.+..++
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccC
Confidence 9986654332 346799999999999999999999999999999999999999999988888877777777778889999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.+.++|.+||+.||.+|||+.++++++.
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 241 EPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 99999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=396.52 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=202.9
Q ss_pred cccccc-cccCCCCcceEEEeEee--ceEEEeeeecc--chHHHHHHHH-hcCCCCcccccceeec----CCceeEEEee
Q psy16430 261 ESISDL-QWLGSGAQGAVFSGKLR--SEIVAVKKVRE--QKETDIRHLR-KLNHPNIVKFKGVCTQ----APCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~-~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--~~~~Ei~~L~-~L~HpnIv~l~~~~~~----~~~~~lV~Ey 330 (600)
++|.+. +.||+|+||+||+|... ++.||||++.. ...+|+.++. ..+||||+++++++.. ...+|+||||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 567776 68999999999999875 68999999964 3467888774 4589999999999865 5678999999
Q ss_pred eccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCceeeccCccccccCCCCC
Q psy16430 331 CAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~~~~ 405 (600)
|+||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++........
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~ 220 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCcc
Confidence 99999999997643 5999999999999999999999999999999999999987 788999999999876655444
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH----HHHHhcCCCCCCCC--CCCCcHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA----IIWGVGSSSLHLPI--PSTCPDGFQL 479 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~----~~~~i~~~~~~~~~--p~~~~~~l~~ 479 (600)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+..+....+. ...+++.+.+
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 300 (400)
T 1nxk_A 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300 (400)
T ss_dssp ------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHH
Confidence 56789999999999999999999999999999999999999998654321 22233333333332 3568999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
||++||+.||.+|||+.++++|+|+....
T Consensus 301 li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 301 LIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=380.03 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=206.9
Q ss_pred ccccccccccCCCCcceEEEeEee-ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.++|++++.||+|+||+||+|+.. ++.||+|++.. ...+|+.++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 378999999999999999999974 68999999853 23579999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
|+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ....
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 178 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence 9985 67766654 4569999999999999999999999999999999999999999999999999998765332 2334
Q ss_pred cCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---CCCCC----------------
Q psy16430 408 FAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS---SSLHL---------------- 467 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~---~~~~~---------------- 467 (600)
..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.. .....
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 578999999999876 5689999999999999999999999987665444333211 00000
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 468 ---------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 468 ---------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0123467899999999999999999999999999999653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=401.71 Aligned_cols=254 Identities=19% Similarity=0.343 Sum_probs=223.0
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.+.+..++|++++.||+|+||.||+|+.. ++.||+|++.+ .+.+|+.++..++||||+++++++.+..
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 45567789999999999999999999975 58999999853 2467999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999987 57899999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CcccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC---C
Q psy16430 402 KST--KMSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP---S 471 (600)
Q Consensus 402 ~~~--~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~ 471 (600)
... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.......+.........| .
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 332 23468999999999987 4578999999999999999999999999988888777765443223333 4
Q ss_pred CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHcHhhhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSS--RPSFKQILSHLDIASQE 508 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~--RPs~~elL~~l~~~~~~ 508 (600)
.+++.+++||++||..+|.+ ||+++++++||||....
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 58999999999999888888 99999999999998643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=369.22 Aligned_cols=250 Identities=30% Similarity=0.583 Sum_probs=221.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEe-eceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKL-RSEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~-~~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
..|.++.++|++.+.||+|+||.||+|.+ .+..||+|++.. .+.+|+.++++++||||+++++++.+....++
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 46888999999999999999999999997 468899999864 34689999999999999999999999999999
Q ss_pred EEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--
Q psy16430 327 VMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-- 403 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 403 (600)
||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999999999999965 4568999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+... .....|..+++.+.+++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHH
Confidence 2234567889999999999999999999999999999999 99999998888777766554 345567788999999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+||+.||.+|||+.++++++.-
T Consensus 242 ~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHHHHH
Confidence 9999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=403.79 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=223.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++.+.||+|+||.||+|+.. ++.||||++.. .+.+|+.++++++||||+++++++.+....|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999874 68999999842 245799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc---CCCCCceeeccCccccccCCCC
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI---GSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~~~~ 404 (600)
|||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999999888889999999999999999999999999999999999999 4678999999999987766555
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMK 482 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~ 482 (600)
.....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+..+....+.| ..+|+.+++||.
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 263 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHH
T ss_pred cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHH
Confidence 556789999999999876 68999999999999999999999999999888888877776555444 568999999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+||+.||.+|||+.++|+|||+...
T Consensus 264 ~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 264 KMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=404.00 Aligned_cols=249 Identities=31% Similarity=0.582 Sum_probs=220.5
Q ss_pred cccccccccccccccccCCCCcceEEEeEeeceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceeecCC-ceeE
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCTQAP-CYCI 326 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~~~~-~~~l 326 (600)
.+.|+++.++|++.+.||+|+||.||+|++.++.||||.++. .+.+|+.+|++++||||+++++++.... ..|+
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 567999999999999999999999999999999999999864 3568999999999999999999986654 7999
Q ss_pred EEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 327 VMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 999999999999997643 37999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+ ...+.|..+|+.+.+||.+
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence 23467899999999999999999999999999999998 99999988777766666544 4567788999999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~ 504 (600)
||+.||.+|||+.++++.+.-
T Consensus 422 cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp HTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHHHHH
Confidence 999999999999999988753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=376.56 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=208.0
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc------------chHHHHHHHHhc---CCCCcccccceeecCC
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE------------QKETDIRHLRKL---NHPNIVKFKGVCTQAP 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~------------~~~~Ei~~L~~L---~HpnIv~l~~~~~~~~ 322 (600)
.++|++.+.||+|+||+||+|+. .++.||||++.. ...+|+.+++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 47899999999999999999995 478999999852 345777777766 4999999999997655
Q ss_pred -----ceeEEEeeeccccchhhccCCCC--CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 323 -----CYCIVMEYCAYGPLYNLLKDGEE--VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 323 -----~~~lV~Ey~~ggsL~~~l~~~~~--l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
..++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 4799999997 599999876543 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC---CCC-----
Q psy16430 396 CREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS---LHL----- 467 (600)
Q Consensus 396 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~---~~~----- 467 (600)
+.............||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+.... ...
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 987766555566789999999999999999999999999999999999999999888766555432110 000
Q ss_pred -----------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 468 -----------------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 468 -----------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+++.+.+||.+||+.||.+|||+.++|+|+|+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0123578899999999999999999999999999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=401.24 Aligned_cols=251 Identities=26% Similarity=0.447 Sum_probs=218.6
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.+.+..++|++++.||+|+||.||+|+.. ++.||||++... ..+|+.+++.++||||+++++++...+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34566789999999999999999999864 689999998642 245788888999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999887889999999999999999999998 9999999999999999999999999999986433
Q ss_pred -CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 402 -KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 402 -~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..... .+|..+++.+.+|
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 379 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RFPRTLGPEAKSL 379 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHH
Confidence 2333457899999999999999999999999999999999999999999888877777665543 4567899999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 481 MKMCWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 481 I~~cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
|.+||+.||.+|| |++++++|+||...
T Consensus 380 i~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999999 99999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=379.82 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=221.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+.|++.+.||+|+||.||+|+.. ++.||+|++.. .+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 67899999999999999999875 68999998853 2468999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC----CceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE----EAKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~----~vkL~DFGla~~~~~ 401 (600)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 9999999999999998888899999999999999999999999999999999999999887 799999999988766
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQL 479 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~ 479 (600)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+ .+..+++.+.+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (321)
T 2a2a_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251 (321)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHH
Confidence 5555567899999999999999999999999999999999999999999888777776665543322 23578899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
||.+||..||.+|||+.++++|+|+..
T Consensus 252 li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 252 FIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHcCCChhhCcCHHHHhcCccccC
Confidence 999999999999999999999999854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=371.31 Aligned_cols=246 Identities=21% Similarity=0.352 Sum_probs=220.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
++|++.+.||+|+||.||+|... +..||+|++.. .+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 57899999999999999999875 46899999853 3467999999999999999999999999999999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc---CCCCCceeeccCccccccCCCCCccc
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI---GSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++............
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 168 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence 999999999887889999999999999999999999999999999999999 77889999999999887665555667
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHhhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMCWS 486 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~ 486 (600)
.||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+.......+.......+.. ..+++.+.+||.+||+
T Consensus 169 ~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (277)
T 3f3z_A 169 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLT 247 (277)
T ss_dssp CSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred CCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHcc
Confidence 899999999998764 8999999999999999999999999988888777776665443321 3688999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~ 507 (600)
.||.+|||+.++++|+|+...
T Consensus 248 ~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 248 KSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp SSTTTSCCHHHHTTSHHHHHH
T ss_pred CChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=399.71 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=224.1
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
..++|.+.+.||+|+||.||+|++. ++.||||++.. ...+|+.+++.++||||+++++++......|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3478999999999999999999875 78999999853 23579999999999999999999999999999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||||++||+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 173 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998876655555
Q ss_pred ccCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+.. ..|..+++.+.+||++||
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L 251 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--YTPQYLNPSVISLLKHML 251 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--CCCTTCCHHHHHHHHHHT
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--CCCccCCHHHHHHHHHHc
Confidence 6789999999999988765 6899999999999999999999999888777777766543 456788999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||+.++++|+|+...
T Consensus 252 ~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 252 QVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=370.38 Aligned_cols=248 Identities=27% Similarity=0.499 Sum_probs=218.0
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
...++|++.+.||+|+||.||+|... +..||+|++.. .+.+|+.++++++||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34589999999999999999999875 57899999843 2456899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 164 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-R 164 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-c
Confidence 999999999999999887789999999999999999999999999999999999999999999999999986554332 2
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... ...|..+++.+.+||.+||
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISRLL 242 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHC
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--CCCCCcCCHHHHHHHHHHh
Confidence 35678999999999999999999999999999999999999999988777766665443 3456788999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+.||.+|||+.++++|+|+....
T Consensus 243 ~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999997653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=384.52 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=212.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
+.|++.+.||+|+||.||+|... ++.||||++.. .+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 67899999999999999999864 68999998842 24689999999999999999999999999999
Q ss_pred EEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC---ceeeccCccccc
Q psy16430 327 VMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCREW 399 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~---vkL~DFGla~~~ 399 (600)
|||||+|++|.+.+.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999999887743 345899999999999999999999999999999999999986654 999999999877
Q ss_pred cCCCC-CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHH
Q psy16430 400 NNKST-KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDG 476 (600)
Q Consensus 400 ~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~ 476 (600)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ......+.......+ ....+++.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHH
Confidence 65432 335679999999999999899999999999999999999999998754 344444444433322 12568899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+.+||.+||..||.+|||+.++++|+|+....
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 99999999999999999999999999997653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=384.62 Aligned_cols=254 Identities=30% Similarity=0.562 Sum_probs=218.8
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccc
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
....|+++.++|++.+.||+|+||.||+|++. ++.||||+++. .+.+|+.+++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 44578999999999999999999999999843 48899999864 245799999999 789999999
Q ss_pred ceeecCC-ceeEEEeeeccccchhhccCCCC-------------------------------------------------
Q psy16430 316 GVCTQAP-CYCIVMEYCAYGPLYNLLKDGEE------------------------------------------------- 345 (600)
Q Consensus 316 ~~~~~~~-~~~lV~Ey~~ggsL~~~l~~~~~------------------------------------------------- 345 (600)
+++.+.+ ..++||||++||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9987754 48999999999999999976432
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---C
Q psy16430 346 -----------------VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---K 405 (600)
Q Consensus 346 -----------------l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~ 405 (600)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 88999999999999999999999999999999999999999999999999986643322 2
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...................|..+++.+.++|.+|
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 24568899999999999999999999999999999998 99999987655544444344445667788999999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~ 505 (600)
|+.||.+|||+.++++|+.-.
T Consensus 333 l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp TCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=384.83 Aligned_cols=250 Identities=31% Similarity=0.613 Sum_probs=219.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEee---------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccc
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
..|+++.++|++.+.||+|+||.||+|++. +..||||+++. .+.+|+.+++++ +||||++++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 357788899999999999999999999853 36799999863 245799999999 899999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGE----------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+++.+.+.+|+||||+++|+|.+++.... .++...++.++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999987532 47899999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+...
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999998765432 2223567889999999999999999999999999999999 999999988777
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
....+..+ .....|..+++.+.++|.+||+.||.+|||+.++++++.-
T Consensus 314 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 314 LFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 76655444 3456778899999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=400.05 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=219.9
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------------------chHHHHHHHHhcCCCCccccccee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------------------QKETDIRHLRKLNHPNIVKFKGVC 318 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------------------~~~~Ei~~L~~L~HpnIv~l~~~~ 318 (600)
++|++++.||+|+||+||+|+.. +..||+|++.. ...+|+.+|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 78999999999999999999875 58899999853 134799999999999999999999
Q ss_pred ecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC---CceeeccCc
Q psy16430 319 TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE---EAKISDFGT 395 (600)
Q Consensus 319 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~---~vkL~DFGl 395 (600)
.+...+|+|||||+||+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 99999999999999999999998778899999999999999999999999999999999999998776 699999999
Q ss_pred cccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCC
Q psy16430 396 CREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STC 473 (600)
Q Consensus 396 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~ 473 (600)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+...+...+..+....+.+ ..+
T Consensus 196 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (504)
T 3q5i_A 196 SSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274 (504)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred CEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCC
Confidence 988766655566789999999999874 68999999999999999999999999999888888877766544332 578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+.+.+||++||+.||.+|||+.++|+|||+...
T Consensus 275 s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 9999999999999999999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=380.64 Aligned_cols=254 Identities=33% Similarity=0.583 Sum_probs=222.2
Q ss_pred cccccccccccccccccCCCCcceEEEeEe-------eceEEEeeeecc--------chHHHHHHHHhc-CCCCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~-------~~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
...|+++.++|++.+.||+|+||.||+|++ .+..||+|.+.. .+.+|+.+++++ +||||+++++
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 346889999999999999999999999986 346899999853 245799999999 8999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCCC-----------------------CCCHHHHHHHHHHHHHHHHHhHhCCcccc
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGE-----------------------EVPPQRLYNWARQIAAGMNYLHSKQIIHR 373 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHr 373 (600)
++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 37899999999999999999999999999
Q ss_pred CCCCCCcccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCC
Q psy16430 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYK 449 (600)
Q Consensus 374 DIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~ 449 (600)
||||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987654332 123457889999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 450 DVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 450 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+.........+.......+.+..+++.+.+||.+||+.||.+|||+.++++++....
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 877655555555555666778889999999999999999999999999999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=406.34 Aligned_cols=250 Identities=34% Similarity=0.652 Sum_probs=222.8
Q ss_pred cccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+.|+++.++|++.+.||+|+||.||+|.+. +..||||.++. .+.+|+.+|++++||||+++++++.....+
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 4679999999999999999999999999986 68999999863 346899999999999999999999999999
Q ss_pred eEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|+||||+++|+|.++++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999999975 345899999999999999999999999999999999999999999999999999876433
Q ss_pred CC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 ST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+...+...+.. ....+.|..+|+.+.+
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPEGCPEKVYE 450 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCCTTCCHHHHH
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 21 223456789999999998899999999999999999999 9999999887766655543 4556778899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
||.+||+.||.+|||+.+|++.+.
T Consensus 451 li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCcChhHCcCHHHHHHHHH
Confidence 999999999999999999998875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=388.97 Aligned_cols=253 Identities=20% Similarity=0.360 Sum_probs=212.2
Q ss_pred cccccccccccccccCCC--CcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC
Q psy16430 255 EWEIPFESISDLQWLGSG--AQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G--~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
.+....++|++++.||+| +||.||+|+.. ++.||||++... +.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 445566899999999999 99999999975 789999998632 34699999999999999999999999
Q ss_pred CceeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
+.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999998764 67999999999999999999999999999999999999999999999999988654
Q ss_pred cCC--------CCCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC----
Q psy16430 400 NNK--------STKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL---- 465 (600)
Q Consensus 400 ~~~--------~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~---- 465 (600)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 321 11223478999999999987 6789999999999999999999999988665544433322111
Q ss_pred ----------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 466 ----------------------------------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 466 ----------------------------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
..+.+..+++.+.+||.+||+.||.+|||+.++|+|+|+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 1123456789999999999999999999999999999997
Q ss_pred hh
Q psy16430 506 SQ 507 (600)
Q Consensus 506 ~~ 507 (600)
..
T Consensus 339 ~~ 340 (389)
T 3gni_B 339 QI 340 (389)
T ss_dssp GC
T ss_pred HH
Confidence 64
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=388.92 Aligned_cols=248 Identities=21% Similarity=0.364 Sum_probs=220.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+.|++++.||+|+||.||+|... ++.||+|++.. .+.+|+.+|++++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 67999999999999999999875 68999999864 2457999999999999999999999999999999999
Q ss_pred ccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC--CCCceeeccCccccccCCCCCccc
Q psy16430 332 AYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS--KEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++............
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 210 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence 999999998764 47999999999999999999999999999999999999974 467999999999887655444556
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC--CCCCCCcHHHHHHHHHhhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL--PIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~~LI~~cL~ 486 (600)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....... .....+++.+.+||.+||+
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 290 (387)
T 1kob_A 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 290 (387)
T ss_dssp CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred ccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcC
Confidence 89999999999999899999999999999999999999999988877776665544332 3345789999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.||.+|||+.++++|+|+....
T Consensus 291 ~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 291 KEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp SSGGGSCCHHHHHTSTTTSSCC
T ss_pred CChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999997653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=372.47 Aligned_cols=245 Identities=26% Similarity=0.371 Sum_probs=205.6
Q ss_pred cccccccccCCCCcceEEEeEee-ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++++.||+|+||.||+|+.. ++.||+|++.. ...+|+.++++++||||+++++++...+..|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 67999999999999999999875 68999999852 235799999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
+++ +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 985 88888865 4679999999999999999999999999999999999999999999999999998765332 22345
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC----CC------------CCC----
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----SS------------LHL---- 467 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----~~------------~~~---- 467 (600)
.||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.. .. ...
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence 78999999999876 4589999999999999999999999998876555443311 00 000
Q ss_pred -------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 468 -------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 468 -------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.....+++.+.+||.+||+.||.+|||+.++++|+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012457899999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=394.63 Aligned_cols=253 Identities=20% Similarity=0.350 Sum_probs=219.8
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.+.+..++|++++.||+|+||.||+|+.. ++.||||++++ .+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 45567789999999999999999999974 78999999853 2457899999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999999999763 4799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CcccCCCccccChhhhc-------cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC--CCCC-C
Q psy16430 402 KST--KMSFAGTVAWMAPEVIR-------NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS--LHLP-I 469 (600)
Q Consensus 402 ~~~--~~~~~gt~~Y~APE~l~-------~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~--~~~~-~ 469 (600)
... ....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+.......+.... ...+ .
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 432 23468999999999987 3568999999999999999999999999988877776665432 2222 2
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCC---CCHHHHHHcHhhhhhh
Q psy16430 470 PSTCPDGFQLLMKMCWSNAPSSR---PSFKQILSHLDIASQE 508 (600)
Q Consensus 470 p~~~~~~l~~LI~~cL~~dP~~R---Ps~~elL~~l~~~~~~ 508 (600)
+..+|+.+++||++||. +|.+| |+++++++|+||....
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 46789999999999999 99998 6999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=370.03 Aligned_cols=253 Identities=28% Similarity=0.376 Sum_probs=200.7
Q ss_pred ccccccccccccccCCCCcceEEEeEe--eceEEEeeeeccch---------HHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~---------~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
+++..++|++.+.||+|+||.||+|+. .++.||+|+++... ..+...++.++||||+++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 567889999999999999999999997 57999999986431 1233446778999999999999999999
Q ss_pred eEEEeeeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 325 CIVMEYCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
++||||++| +|.+++. .+..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999974 7766654 456899999999999999999999998 9999999999999999999999999999877
Q ss_pred cCCCCCcccCCCccccChhhh----ccCCCCCccceechhHHHHHHhhCCCCCCCC-ChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVI----RNEQCSDKIDIWSYGIVLWELLTCETPYKDV-DSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDIwSlGviLyELltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
..........||+.|+|||++ .+..++.++|||||||++|+|++|..||... ..................+..++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 665555556799999999996 5567889999999999999999999999863 33333333333333333456789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
+.+.+||.+||+.||.+|||+.++++|||+.....
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 99999999999999999999999999999987544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=366.87 Aligned_cols=251 Identities=31% Similarity=0.562 Sum_probs=220.5
Q ss_pred cccccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
...|+++.++|++++.||+|+||.||+|++.+ ..||+|++.. .+.+|+.++++++||||+++++++.+....+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 35788999999999999999999999998764 6899999864 3468999999999999999999999999999
Q ss_pred EEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999999976 5679999999999999999999999999999999999999999999999999998664321
Q ss_pred -CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 404 -TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 404 -~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+... .....+..+++.+.++|
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 254 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIM 254 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-cCCCCCCcCCHHHHHHH
Confidence 2223457889999999998899999999999999999998 99999998887777766544 34556778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+||+.||.+|||+.++++++.-
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHHHHH
Confidence 99999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.83 Aligned_cols=249 Identities=35% Similarity=0.581 Sum_probs=220.4
Q ss_pred cccccccccccccccCCCCcceEEEeEeec-eEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.|++..++|++.+.||+|+||.||+|+..+ ..||+|++... +.+|+.++++++||||+++++++.+....++|
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 467888999999999999999999998764 68999998642 46899999999999999999999999999999
Q ss_pred EeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--
Q psy16430 328 MEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-- 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 404 (600)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999999764 4599999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+.... ....|..+++.+.++|.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCCCcChHHHHHHHHH
Confidence 223456788999999999899999999999999999999 999999988877776665443 445567789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~ 504 (600)
||+.||.+|||+.++++++.-
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~ 261 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSSIEP 261 (268)
T ss_dssp TTCSSGGGSCCHHHHHHHHGG
T ss_pred HcCCChhhCcCHHHHHHHHHH
Confidence 999999999999999999854
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=372.04 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=207.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++++.||+|+||.||+|+.. ++.||+|++.. .+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 78999998843 23479999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 162 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCC
Confidence 99999999999888889999999999999999999999999999999999999999999999999998765332 23356
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CCCCC
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SLHLP 468 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~~ 468 (600)
.||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... ....+
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCC
Confidence 78999999999876 67899999999999999999999999988765554332110 01111
Q ss_pred CC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 469 IP----------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 469 ~p----------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+ ..+++.+.+||.+||+.||.+|||++++++|+|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 11 3578899999999999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=379.49 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=212.0
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc---------chHHHHHHHHhcCC--CCcccccceeecCCc
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE---------QKETDIRHLRKLNH--PNIVKFKGVCTQAPC 323 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~---------~~~~Ei~~L~~L~H--pnIv~l~~~~~~~~~ 323 (600)
..+....|++++.||+|+||.||+|... ++.||||++.. .+.+|+.+|++++| |||+++++++.....
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4566688999999999999999999864 68899999852 24579999999987 999999999999999
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
.|+||| +.+++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999999 55789999999888899999999999999999999999999999999999996 6789999999998765432
Q ss_pred C---CcccCCCccccChhhhcc-----------CCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCCCCCC
Q psy16430 404 T---KMSFAGTVAWMAPEVIRN-----------EQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLP 468 (600)
Q Consensus 404 ~---~~~~~gt~~Y~APE~l~~-----------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~~~~ 468 (600)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 2 235679999999999865 6788899999999999999999999987543 344444555555667
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 469 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.|...+..+.+||.+||+.||.+|||+.++++|||+...
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 788889999999999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=385.41 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=210.6
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
+...+.||+|+||.||+|+.. ++.||+|+++. .+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 344678999999999999864 78999999864 245799999999999999999999999999999999999
Q ss_pred ccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc--CCCCCceeeccCccccccCCCCCcccCC
Q psy16430 334 GPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI--GSKEEAKISDFGTCREWNNKSTKMSFAG 410 (600)
Q Consensus 334 gsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~~~g 410 (600)
++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.............|
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g 250 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence 9999888643 469999999999999999999999999999999999999 5667899999999988766555556679
Q ss_pred CccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHHHHHHhhhcC
Q psy16430 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 411 t~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~LI~~cL~~d 488 (600)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+ ....+++.+.+||.+||+.|
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 330 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKE 330 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSS
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCC
Confidence 9999999999988999999999999999999999999999888777776655543332 23568999999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~ 507 (600)
|.+|||+.++++|||+...
T Consensus 331 p~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 331 KSWRISASEALKHPWLSDH 349 (373)
T ss_dssp GGGSCCHHHHHHSHHHHCH
T ss_pred hhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=366.91 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=221.8
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+..++|++.+.||+|+||.||+|+.. +..||+|++.. .+.+|+.++++++||||+++++++.+....|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999875 68899999843 2457899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... ..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 169 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RR 169 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CB
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-cc
Confidence 99999999999999988778999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... ...|..+++.+.++|.+||
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHS
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--cCCCCcCCHHHHHHHHHHh
Confidence 35679999999999999899999999999999999999999999888777766665543 3456788999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
..||.+|||+.++++|+|+....
T Consensus 248 ~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 248 RYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHHC
T ss_pred hcCHhhCCCHHHHhhCHHHHhhc
Confidence 99999999999999999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=388.06 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=217.2
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHH-HHhcCCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRH-LRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~-L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
+..++|++++.||+|+||.||+|+.. ++.||||++.+.. ..|..+ ++.++||||+++++++.+...+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 44578999999999999999999975 5889999986432 234443 4567999999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-CCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-NKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~~~ 403 (600)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ...
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999998643 333
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+..... ..+..++..+.+||.+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSARHLLEG 272 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--CCCSSSCHHHHHHHHH
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999999888888777766543 4567889999999999
Q ss_pred hhhcCCCCCCCH----HHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPSF----KQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs~----~elL~~l~~~~~ 507 (600)
||+.||.+||++ .++++|+||...
T Consensus 273 lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 999999999986 799999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=399.42 Aligned_cols=246 Identities=30% Similarity=0.448 Sum_probs=218.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.|++++.||+|+||+||+|+.. +..||+|++... +.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57999999999999999999975 688999998532 3579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC---CCceeeccCccccccCCCCCc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~ 406 (600)
||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++..........
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 196 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence 99999999998877889999999999999999999999999999999999999764 459999999998877655556
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMC 484 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~c 484 (600)
...||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+...+...+..+....+.+ ..+|+.+.+||++|
T Consensus 197 ~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 275 (494)
T 3lij_A 197 ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275 (494)
T ss_dssp CCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred ccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHH
Confidence 678999999999986 468999999999999999999999999999888888877766554433 57899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+.||.+|||+.++|+|||+...
T Consensus 276 L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 276 LQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp TCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=384.29 Aligned_cols=254 Identities=32% Similarity=0.553 Sum_probs=221.1
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCccccccee
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVC 318 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~ 318 (600)
+.++++.++|++.+.||+|+||.||+|++. +..||||+++. .+.+|+.++++++||||+++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 445677899999999999999999999853 46899999853 245789999999999999999999
Q ss_pred ecCCceeEEEeeeccccchhhccCC-------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC---Cc
Q psy16430 319 TQAPCYCIVMEYCAYGPLYNLLKDG-------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE---EA 388 (600)
Q Consensus 319 ~~~~~~~lV~Ey~~ggsL~~~l~~~-------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~---~v 388 (600)
.+....++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999998653 3589999999999999999999999999999999999998554 59
Q ss_pred eeeccCccccccCC---CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC
Q psy16430 389 KISDFGTCREWNNK---STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 389 kL~DFGla~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~ 464 (600)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999865322 22234568999999999999999999999999999999998 999999998888777765554
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
....+..+++.+.+||.+||+.||.+|||+.+|+++++.....
T Consensus 304 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 -RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 4456788999999999999999999999999999999876553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=368.65 Aligned_cols=245 Identities=29% Similarity=0.418 Sum_probs=207.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|.+.+.||+|+||.||+|+.. +..||+|++.. .+.+|++++++++||||+++++++.+....|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 67999999999999999999865 68999999853 246799999999999999999999999999999999
Q ss_pred eccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc---CCCCCceeeccCccccccCCC
Q psy16430 331 CAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI---GSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 331 ~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~~~ 403 (600)
+++|+|.+.+.. +..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 999999988843 4679999999999999999999999999999999999999 455789999999998776555
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC-CCCCCcHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP-IPSTCPDGFQLLMK 482 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~l~~LI~ 482 (600)
......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+........ ....+++.+.+||.
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 260 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLK 260 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHH
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHH
Confidence 555678999999999986 4688999999999999999999999999887776655544333222 22447899999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+||+.||.+|||+.++++|+|+.+
T Consensus 261 ~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 261 QMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=379.83 Aligned_cols=239 Identities=24% Similarity=0.427 Sum_probs=212.8
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeeccc---------------hHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ---------------KETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~---------------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
++|++.+.||+|+||.||+|+. .++.||||++... +.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 6799999999999999999975 4789999988532 3469999999999999999999999999
Q ss_pred eeEEEeeeccc-cchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 324 YCIVMEYCAYG-PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 324 ~~lV~Ey~~gg-sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999766 99999998888999999999999999999999999999999999999999999999999999887666
Q ss_pred CCCcccCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... . .......|..+++.+.+||
T Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~--~~~~~~~~~~~~~~l~~li 255 (335)
T 3dls_A 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T--VEAAIHPPYLVSKELMSLV 255 (335)
T ss_dssp CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G--TTTCCCCSSCCCHHHHHHH
T ss_pred CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H--HhhccCCCcccCHHHHHHH
Confidence 55556789999999999988776 7899999999999999999999976332 1 1122345667899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+||+.||.+|||+.++++|+|+...
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 256 SGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999999999999999999653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=367.22 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=215.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
++|++.+.||+|+||.||+|+.. ++.||+|.+.. .+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57899999999999999999875 68999998753 2467999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC----CceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE----EAKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~----~vkL~DFGla~~~~~ 401 (600)
+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998777899999999999999999999999999999999999998876 799999999987765
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQL 479 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~ 479 (600)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+ .+..+++.+.+
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence 5444556799999999999988999999999999999999999999999888777666654443322 23578899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+||..||.+|||+.++++|+|+...
T Consensus 245 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=364.51 Aligned_cols=246 Identities=28% Similarity=0.525 Sum_probs=218.9
Q ss_pred cccccccccccccccCCCCcceEEEeEeeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC--Cc
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA--PC 323 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~--~~ 323 (600)
.+.++.++|++.+.||+|+||.||+|++.+..||+|++.. .+.+|+.++++++||||+++++++.+. ..
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 4677889999999999999999999999999999999863 245788899999999999999999877 78
Q ss_pred eeEEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999999999999998755 4899999999999999999999999 999999999999999999999988876543
Q ss_pred cCCCCCcccCCCccccChhhhccCCCCC---ccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRNEQCSD---KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~---ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
.. ....||+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+.......+.........+..+++.
T Consensus 164 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 164 QS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp SC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred cc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 22 2457899999999998765544 7999999999999999999999988887777776666677788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.++|.+||+.||.+|||+.++++.+.-
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=376.15 Aligned_cols=249 Identities=34% Similarity=0.594 Sum_probs=217.8
Q ss_pred ccccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.++..++|++.+.||+|+||.||+|++. +..||||+++. .+.+|+.++++++||||+++++++.+..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4566789999999999999999999873 45799999864 2457999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..|+||||++||+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999999654 5799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 402 KST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 402 ~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... ...+.+..+++.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 282 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHA 282 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHH
Confidence 322 122346788999999998899999999999999999999 99999998888877766554 455677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+.+||..||..||.+|||+.+|++.+.-.
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999998643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=398.98 Aligned_cols=251 Identities=32% Similarity=0.585 Sum_probs=218.0
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
..+.|+++.++|++.+.||+|+||.||+|.+.+ ..||||+++. .+.+|+.+|++++||||+++++++.+ ...
T Consensus 175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred CccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 467899999999999999999999999999875 6799999863 35689999999999999999999876 678
Q ss_pred eEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|+||||+++|+|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999999974 356899999999999999999999999999999999999999999999999999876533
Q ss_pred CC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 ST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.. .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+ ...+.|..+|+.+.+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 21 223457889999999998899999999999999999999 99999998888777766544 456778899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
||.+||+.||.+|||+++|++.+.-
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~~L~~ 437 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQAFLED 437 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=378.51 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=211.7
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
.++|++.+.||+|+||.||+|... +..||+|++.. .+.+|+.++++++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 378999999999999999999864 57899998853 2457999999999999999999999999999
Q ss_pred EEEeeeccccchhhccC----------------------------------------CCCCCHHHHHHHHHHHHHHHHHh
Q psy16430 326 IVMEYCAYGPLYNLLKD----------------------------------------GEEVPPQRLYNWARQIAAGMNYL 365 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~----------------------------------------~~~l~~~~i~~i~~qIl~aL~~L 365 (600)
+||||++||+|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998852 11235778899999999999999
Q ss_pred HhCCccccCCCCCCcccCCCC--CceeeccCccccccCCC-----CCcccCCCccccChhhhcc--CCCCCccceechhH
Q psy16430 366 HSKQIIHRDLKSPNVLIGSKE--EAKISDFGTCREWNNKS-----TKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGI 436 (600)
Q Consensus 366 H~~gIvHrDIKp~NILl~~~~--~vkL~DFGla~~~~~~~-----~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGv 436 (600)
|+.||+||||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999998664322 1234679999999999965 67899999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 437 iLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
++|+|++|..||.+.+.......+.......+.+ ..+++.+.+||.+||+.||.+|||+.++++|||+...
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999988888777766655544433 3578999999999999999999999999999999653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=365.04 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=212.1
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+..++|++.+.||+|+||.||+|+.. ++.||||++.. .+.+|+.+++.++||||+++++++......|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 44578999999999999999999875 78999999853 2357899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 99999999999999988778999999999999999999999999999999999999999999999999999877655444
Q ss_pred cccCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.... ...|..++..+.++|.+|
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~ 245 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEYLNRSVATLLMHM 245 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--ccCchhcCHHHHHHHHHH
Confidence 55678999999999987665 589999999999999999999999888777766665443 345677899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+.||.+|||+.++++|+|+...
T Consensus 246 l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 246 LQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp TCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCChhhCCCHHHHHhChhhccC
Confidence 99999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=375.37 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=196.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
.++|++++.||+|+||.||+|... ++.||+|++.. ...+|+.++++++||||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 368999999999999999999864 78999999852 24579999999999999999999999999999999
Q ss_pred eeccccchhhccCC------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 330 YCAYGPLYNLLKDG------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 330 y~~ggsL~~~l~~~------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
|++ |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 998 5888887532 358999999999999999999999999999999999999999999999999998765332
Q ss_pred -CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----C------------C
Q psy16430 404 -TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----S------------L 465 (600)
Q Consensus 404 -~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----~------------~ 465 (600)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... . .
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 2335678999999999976 46899999999999999999999999988776655433210 0 0
Q ss_pred ----------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 ----------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ----------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+..+++.+.+||.+||+.||.+|||+.++++|||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 001123578899999999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=371.89 Aligned_cols=253 Identities=35% Similarity=0.615 Sum_probs=220.6
Q ss_pred ccccccccccccccccccCCCCcceEEEeEe-------eceEEEeeeecc--------chHHHHHHHHhc-CCCCccccc
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~-------~~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
....|+++.++|++.+.||+|+||.||+|++ .+..||+|.+.. .+.+|+.+++++ +||||++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 3456889999999999999999999999985 358999999863 235799999999 999999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCCC------------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGE------------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKS 377 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~------------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp 377 (600)
+++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 99999999999999999999999987543 489999999999999999999999999999999
Q ss_pred CCcccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCCh
Q psy16430 378 PNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDS 453 (600)
Q Consensus 378 ~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~ 453 (600)
+||+++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999987654432 223457889999999999999999999999999999999 9999988776
Q ss_pred HHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 454 SAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 454 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
................+..+++.+.++|.+||+.||.+|||+.++++++.-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 554444444445556677899999999999999999999999999999854
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=375.76 Aligned_cols=250 Identities=34% Similarity=0.647 Sum_probs=220.6
Q ss_pred cccccccccccccccCCCCcceEEEeEeec-------eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCT 319 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~ 319 (600)
.++++.++|++.+.||+|+||.||+|+..+ +.||||.++.. +.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 467788999999999999999999999764 88999998642 457999999999999999999999
Q ss_pred cCCceeEEEeeeccccchhhccCC------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCC
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKDG------------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~~------------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDI 375 (600)
+....|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999998653 56899999999999999999999999999999
Q ss_pred CCCCcccCCCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCC
Q psy16430 376 KSPNVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDV 451 (600)
Q Consensus 376 Kp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~ 451 (600)
||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999998654322 2234568999999999999899999999999999999999 99999998
Q ss_pred ChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 452 DSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 452 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+.......+..+.. ...|..+++.+.++|.+||+.||.+|||+.++++++.-.
T Consensus 281 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 281 AHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp CHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ChHHHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 88887777665543 456788999999999999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=374.20 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=215.5
Q ss_pred ccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeec
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
.|...+.||+|+||.||+|+.. ++.||||++.. .+.+|+.++++++||||+++++++......++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 4666778999999999999874 78999999853 24579999999999999999999999999999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccCCC
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGT 411 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~gt 411 (600)
|++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ......||
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 204 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 204 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCC
Confidence 9999999875 469999999999999999999999999999999999999999999999999998765432 23456899
Q ss_pred ccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHHhhhcCCC
Q psy16430 412 VAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMCWSNAPS 490 (600)
Q Consensus 412 ~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~cL~~dP~ 490 (600)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ....+..+++.+.++|.+||+.||.
T Consensus 205 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 284 (321)
T 2c30_A 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284 (321)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChh
Confidence 999999999998999999999999999999999999998887766665544332 2223456789999999999999999
Q ss_pred CCCCHHHHHHcHhhhhhh
Q psy16430 491 SRPSFKQILSHLDIASQE 508 (600)
Q Consensus 491 ~RPs~~elL~~l~~~~~~ 508 (600)
+|||+.++++|+|+....
T Consensus 285 ~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 285 ERATAQELLDHPFLLQTG 302 (321)
T ss_dssp TSCCHHHHHTSGGGGGCC
T ss_pred hCcCHHHHhcChhhccCC
Confidence 999999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.25 Aligned_cols=242 Identities=22% Similarity=0.353 Sum_probs=192.0
Q ss_pred cccCCCCcceEEEeEee--ceEEEeeeeccc----hHHHHHHHHhcC-CCCcccccceeecCCceeEEEeeeccccchhh
Q psy16430 267 QWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----KETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNL 339 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~ 339 (600)
+.||+|+||.||+|... ++.||||++... ..+|+.+++.+. ||||+++++++.+....|+||||++||+|.++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence 67999999999999975 689999999754 357899999997 99999999999999999999999999999999
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC---CceeeccCccccccCCC-CCcccCCCcccc
Q psy16430 340 LKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE---EAKISDFGTCREWNNKS-TKMSFAGTVAWM 415 (600)
Q Consensus 340 l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~---~vkL~DFGla~~~~~~~-~~~~~~gt~~Y~ 415 (600)
+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ......||+.|+
T Consensus 97 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~ 176 (325)
T 3kn6_A 97 IKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176 (325)
T ss_dssp HHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCcc
Confidence 99888899999999999999999999999999999999999997665 79999999998664432 233567899999
Q ss_pred ChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-------HHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHhhh
Q psy16430 416 APEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-------SAIIWGVGSSSLHLPIP--STCPDGFQLLMKMCWS 486 (600)
Q Consensus 416 APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~ 486 (600)
|||++.+..++.++|||||||++|+|++|..||.+.+. ......+..+....+.+ ..+++.+.+||.+||+
T Consensus 177 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHC
T ss_pred CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCC
Confidence 99999999999999999999999999999999986443 34555555554433222 3678999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.||.+|||+.++++|+|+....
T Consensus 257 ~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 257 VDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCTTTCCCTTTSTTCGGGCTTC
T ss_pred CChhHCCCHHHHhcChhhccCc
Confidence 9999999999999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=373.06 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=203.5
Q ss_pred cccccc-cccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhc-CCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDL-QWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~-~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.|++. +.||+|+||.||+|.. .++.||||++.. ...+|+.++.++ +||||+++++++.+.+.+|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567775 7899999999999986 478999999853 245799999885 79999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC---ceeeccCccccccCCC---
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCREWNNKS--- 403 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~---vkL~DFGla~~~~~~~--- 403 (600)
|++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 9999999999988788999999999999999999999999999999999999988765 9999999987654221
Q ss_pred -----CCcccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCCh---------------HHHHH
Q psy16430 404 -----TKMSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDS---------------SAIIW 458 (600)
Q Consensus 404 -----~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---------------~~~~~ 458 (600)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .....
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 1123569999999999875 5688999999999999999999999987542 22333
Q ss_pred HhcCCCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 459 GVGSSSLHLPIP--STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 459 ~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.+.......+.+ ..+++.+.+||.+||+.||.+|||+.++++|+|+....
T Consensus 252 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 444443332211 46789999999999999999999999999999997653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=370.19 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=219.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
++|.+.+.||+|+||.||+|+.. ++.||+|.+... +.+|+.++++++||||+++++++.+....|+||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 67889999999999999999874 789999998632 467999999999999999999999999999999999
Q ss_pred ccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc---CCCCCceeeccCccccccCCCCCccc
Q psy16430 332 AYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI---GSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++...... .....
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 167 (304)
T 2jam_A 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTA 167 (304)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHH
T ss_pred CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccc
Confidence 999999999877789999999999999999999999999999999999999 67889999999998764432 22345
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC--CCCCCCcHHHHHHHHHhhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL--PIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~~LI~~cL~ 486 (600)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+.... +.+..+++.+.+||.+||.
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (304)
T 2jam_A 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLE 247 (304)
T ss_dssp HSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHC
T ss_pred cCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcC
Confidence 68999999999999899999999999999999999999999988877776665554433 3446789999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.||.+|||+.++++|+|+....
T Consensus 248 ~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 248 KDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp SSTTTSCCHHHHHTSHHHHSSC
T ss_pred CChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999997653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=380.34 Aligned_cols=253 Identities=32% Similarity=0.606 Sum_probs=222.9
Q ss_pred ccccccccccccccccCCCCcceEEEeEee---------ceEEEeeeecc--------chHHHHHHHHhc-CCCCccccc
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
..|+++.++|.+.+.||+|+||.||+|+.. +..||||++.. .+.+|+.+++++ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 467888999999999999999999999853 26799999863 245799999999 999999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+++...+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 9999999999999999999999998653 348999999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765432 2234567899999999999999999999999999999999 999999988877
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+.... ....+..+++.+.+||.+||+.||.+|||+.++++++.-...
T Consensus 302 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 302 LFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 776665443 456678899999999999999999999999999999875543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=367.08 Aligned_cols=248 Identities=30% Similarity=0.538 Sum_probs=219.5
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+.+.|++++.||+|+||.||+|... ++.||+|++.. .+.+|+.++++++||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999864 68999999852 3467999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
||+++++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 99999999999875 569999999999999999999999999999999999999999999999999998765433 2335
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.... ....+..++..+.+||.+||+.
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHCCS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHHHHcCC
Confidence 679999999999999899999999999999999999999999888776665554333 3355678899999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhhhh
Q psy16430 488 APSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~~~ 508 (600)
||.+|||+.++++|+|+....
T Consensus 258 dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 258 EPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp SGGGSCCHHHHTTCHHHHHHC
T ss_pred ChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999997653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=389.12 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=202.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.++|.+.+.||+|+||.||+|... ++.||||++.. .+.+|+.+|++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 378999999999999999999865 58999999853 24679999999999999999999864 4
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC---CceeeccCccccc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE---EAKISDFGTCREW 399 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~---~vkL~DFGla~~~ 399 (600)
..|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5789999999999999998888999999999999999999999999999999999999997544 5999999999887
Q ss_pred cCCCCCcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCC--CCCCCC
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHL--PIPSTC 473 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~--~~p~~~ 473 (600)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+....... .....+
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 372 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence 66555556789999999999853 56788999999999999999999999865432 2222333333222 122568
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
++.+.+||.+||+.||.+|||+.++++|||+...
T Consensus 373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 8999999999999999999999999999999654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=387.05 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=197.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcC-CCCcccccceeecCC--ceeE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLN-HPNIVKFKGVCTQAP--CYCI 326 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~-HpnIv~l~~~~~~~~--~~~l 326 (600)
++|++++.||+|+||.||+|.+. ++.||||++... ..+|+.+++++. ||||+++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 68999999999999999999864 789999998532 246899999997 999999999996543 7899
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC----
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK---- 402 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~---- 402 (600)
|||||+ ++|..+++. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 999997 589888876 46899999999999999999999999999999999999999999999999999865321
Q ss_pred ------------------CCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC
Q psy16430 403 ------------------STKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS 463 (600)
Q Consensus 403 ------------------~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~ 463 (600)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 11224679999999999976 67899999999999999999999999988876655443210
Q ss_pred CCC---------------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q psy16430 464 SLH---------------------------------------------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQI 498 (600)
Q Consensus 464 ~~~---------------------------------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~el 498 (600)
... ...+..+++.+.+||.+||+.||.+|||+.++
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 000 00123678999999999999999999999999
Q ss_pred HHcHhhhhh
Q psy16430 499 LSHLDIASQ 507 (600)
Q Consensus 499 L~~l~~~~~ 507 (600)
|+|||+..-
T Consensus 327 l~Hp~~~~~ 335 (388)
T 3oz6_A 327 LKHPFVSIF 335 (388)
T ss_dssp TTSTTTTTT
T ss_pred hCCHHHHHh
Confidence 999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=366.03 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=192.4
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++.+.||+|+||.||+|+. .++.||+|.+.. .+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999986 478999999853 245789999999999999999999999999999
Q ss_pred EeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CC
Q psy16430 328 MEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TK 405 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 405 (600)
|||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 9999999999999764 679999999999999999999999999999999999999999999999999998765322 22
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.... ...|..++..+.+||.+||
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 247 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAKDLIHQLL 247 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTTSCHHHHHHHHHHS
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCccccCHHHHHHHHHHc
Confidence 34678999999999998889999999999999999999999998776655554443332 3456778999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||+.++++|+|+...
T Consensus 248 ~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 248 RRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp CSSGGGSCCHHHHTTSTTTC--
T ss_pred ccCHhhCCCHHHHhcCccccCC
Confidence 9999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=384.80 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=209.2
Q ss_pred ccccccccccccccCCCCcceEEEeEe--eceEEEeeeeccc---hHHHHHHHHhcCCCCcccccceeec----------
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVCTQ---------- 320 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~---~~~Ei~~L~~L~HpnIv~l~~~~~~---------- 320 (600)
+++..++|++.+.||+|+||+||+|+. +++.||||++... ..+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 345568899999999999999999986 4789999998643 3589999999999999999999843
Q ss_pred ----------------------------CCceeEEEeeeccccchhhc----cCCCCCCHHHHHHHHHHHHHHHHHhHhC
Q psy16430 321 ----------------------------APCYCIVMEYCAYGPLYNLL----KDGEEVPPQRLYNWARQIAAGMNYLHSK 368 (600)
Q Consensus 321 ----------------------------~~~~~lV~Ey~~ggsL~~~l----~~~~~l~~~~i~~i~~qIl~aL~~LH~~ 368 (600)
....++||||+++ +|.+.+ ..+..+++..++.++.||+.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3348899999985 666555 4467899999999999999999999999
Q ss_pred CccccCCCCCCcccC-CCCCceeeccCccccccCCCCCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCC
Q psy16430 369 QIIHRDLKSPNVLIG-SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCET 446 (600)
Q Consensus 369 gIvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~ 446 (600)
||+||||||+|||++ .++.+||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999999997 6889999999999987666666677899999999998764 58999999999999999999999
Q ss_pred CCCCCChHHHHHHhcCC-----------------CC----------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy16430 447 PYKDVDSSAIIWGVGSS-----------------SL----------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQIL 499 (600)
Q Consensus 447 Pf~~~~~~~~~~~i~~~-----------------~~----------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL 499 (600)
||.+.+.......+... .. ....+..+|+.+.+||.+||+.||.+|||+.+++
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 99988776555443210 00 0113556889999999999999999999999999
Q ss_pred HcHhhhhh
Q psy16430 500 SHLDIASQ 507 (600)
Q Consensus 500 ~~l~~~~~ 507 (600)
+|+||...
T Consensus 321 ~hp~f~~~ 328 (383)
T 3eb0_A 321 AHPFFDHL 328 (383)
T ss_dssp TSGGGHHH
T ss_pred cCHHHHHH
Confidence 99999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=369.55 Aligned_cols=251 Identities=30% Similarity=0.601 Sum_probs=220.3
Q ss_pred cccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccce
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGV 317 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~ 317 (600)
...|+++.++|.+.+.||+|+||.||+|... +..||+|++... +.+|+.++++++||||++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 4578888999999999999999999999752 378999998642 3579999999999999999999
Q ss_pred eecCCceeEEEeeeccccchhhccCCC------------------------CCCHHHHHHHHHHHHHHHHHhHhCCcccc
Q psy16430 318 CTQAPCYCIVMEYCAYGPLYNLLKDGE------------------------EVPPQRLYNWARQIAAGMNYLHSKQIIHR 373 (600)
Q Consensus 318 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~------------------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHr 373 (600)
+.+.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999999999999997543 38899999999999999999999999999
Q ss_pred CCCCCCcccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCC
Q psy16430 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYK 449 (600)
Q Consensus 374 DIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~ 449 (600)
||||+||+++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987644322 223467889999999999889999999999999999999 999999
Q ss_pred CCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 450 DVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 450 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.+.......+.... ....+..+++.+.++|.+||+.||.+|||+.++++++.-
T Consensus 255 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 255 GIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp TCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 888776666554443 456678899999999999999999999999999999853
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=380.98 Aligned_cols=245 Identities=20% Similarity=0.389 Sum_probs=218.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------------chHHHHHHHHhc-CCCCcccccceeecCC
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------------QKETDIRHLRKL-NHPNIVKFKGVCTQAP 322 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~ 322 (600)
++|++.+.||+|+||.||+|+.. ++.||||+++. .+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57899999999999999999875 78999998853 234688999999 7999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999987778999999999999999999999999999999999999999999999999999887665
Q ss_pred CCCcccCCCccccChhhhcc------CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCc
Q psy16430 403 STKMSFAGTVAWMAPEVIRN------EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCP 474 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~ 474 (600)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..+....+.+ ..++
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 333 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 55556789999999999864 357889999999999999999999999888777776666555443332 5678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
..+.+||.+||+.||.+|||+.++++||||.
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 9999999999999999999999999999984
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=379.41 Aligned_cols=243 Identities=30% Similarity=0.543 Sum_probs=213.7
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+.|++++.||+|+||.||+|+. .++.||||++.. .+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5688999999999999999985 479999999852 2457999999999999999999999999999999
Q ss_pred eeeccccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 329 EYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
||+. |+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cc
Confidence 9997 56777764 4567999999999999999999999999999999999999999999999999999865432 34
Q ss_pred cCCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 408 FAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 408 ~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
..||+.|+|||++. +..++.++|||||||++|||++|..||.+.+.......+.........+..+++.+.+||.+|
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 67999999999985 467899999999999999999999999988877766666555544455677899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+.||.+|||+.++++|+|+...
T Consensus 290 l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp TCSSGGGSCCHHHHTTCHHHHSC
T ss_pred cccChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=366.85 Aligned_cols=248 Identities=23% Similarity=0.398 Sum_probs=220.1
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------------chHHHHHHHHhcC-CCCcccccceeec
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------------QKETDIRHLRKLN-HPNIVKFKGVCTQ 320 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------------~~~~Ei~~L~~L~-HpnIv~l~~~~~~ 320 (600)
.++|++.+.||+|+||.||+|... ++.||||++.. .+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999874 68999999842 2346889999995 9999999999999
Q ss_pred CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
....++||||+++++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999999999887789999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCCcccCCCccccChhhhc------cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CC
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIR------NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--ST 472 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~ 472 (600)
.........||+.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.......+.+ ..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccc
Confidence 555555678999999999985 3567889999999999999999999999888777776665555444333 46
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 89999999999999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.79 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=213.1
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+..++|++.+.||+|+||+||+|.+. ++.||+|++.. .+.+|+.++++++||||+++++++.++...++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 45689999999999999999999975 68999998743 3457999999999999999999999999999999
Q ss_pred eeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCC--
Q psy16430 329 EYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK-- 405 (600)
Q Consensus 329 Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 405 (600)
||+++|+|.++++. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999999976 567999999999999999999999999999999999999999999999999999876433221
Q ss_pred -------------cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHh-cCCCCCCCCCC
Q psy16430 406 -------------MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV-GSSSLHLPIPS 471 (600)
Q Consensus 406 -------------~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i-~~~~~~~~~p~ 471 (600)
....||+.|+|||++.+..++.++|||||||++|+|++|..||............ .........+.
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCT
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCC
Confidence 1457999999999999999999999999999999999999998764321110000 00001123467
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhhhccC
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQ 513 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~~~~ 513 (600)
.+|+.+.++|.+||+.||.+|||+.++++.+.-....+....
T Consensus 247 ~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 788999999999999999999999999998876555444433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=364.40 Aligned_cols=249 Identities=31% Similarity=0.592 Sum_probs=207.0
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
..|++..++|++.+.||+|+||.||+|.+. +..||+|.+.. .+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 467888899999999999999999999864 35799999753 2457899999999999999999985
Q ss_pred CCceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
.+..|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 45688999999999999999754 46999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 400 NNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 400 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.... ..+.+..+|+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 245 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPT 245 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHH
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHH
Confidence 54322 223456789999999998899999999999999999997 999999888777766665443 34677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.++|.+||+.||.+|||+.++++++.-
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=361.88 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=212.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++.+.||+|+||.||+|... ++.||+|++.. .+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 67899999999999999999875 78999999853 235799999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---CCcc
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS---TKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~ 407 (600)
+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence 9999999999888889999999999999999999999999999999999999999999999999998654322 2234
Q ss_pred cCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 408 FAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
..||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... .............+....+++.+.+||.+||
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHC
Confidence 678999999999987665 67899999999999999999999876543 2222222222233334568999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||+.++++|+|+...
T Consensus 247 ~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 247 VENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp CSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCCchhCCCHHHHhcCccccCh
Confidence 9999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=373.17 Aligned_cols=247 Identities=21% Similarity=0.366 Sum_probs=217.6
Q ss_pred ccccccccccCCCCcceEEEeEeeceEEEeeeec------------------------cchHHHHHHHHhcCCCCccccc
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVR------------------------EQKETDIRHLRKLNHPNIVKFK 315 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~------------------------~~~~~Ei~~L~~L~HpnIv~l~ 315 (600)
.++|++.+.||+|+||.||+|+..++.||||.+. ..+.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4789999999999999999999989999999984 3346899999999999999999
Q ss_pred ceeecCCceeEEEeeeccccchhh------ccC--CCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNL------LKD--GEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKE 386 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~------l~~--~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~ 386 (600)
+++.+.+..|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC
Confidence 999999999999999999999998 665 5679999999999999999999999 9999999999999999999
Q ss_pred CceeeccCccccccCCCCCcccCCCccccChhhhccC-CCCC-ccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCC
Q psy16430 387 EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE-QCSD-KIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSS 463 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~-ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~ 463 (600)
.++|+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||...+. ......+...
T Consensus 190 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 9999999999876443 33456799999999999876 5665 99999999999999999999998776 6666666555
Q ss_pred CCCCCCC-----------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 SLHLPIP-----------------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 ~~~~~~p-----------------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+.. ..+++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 4433321 5689999999999999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=358.65 Aligned_cols=249 Identities=30% Similarity=0.579 Sum_probs=220.5
Q ss_pred cccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.|.++.++|++.+.||+|+||.||+|.+. +..||+|++.. .+.+|+.++++++||||+++++++.+.+..++|
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 58889999999999999999999999974 67899999864 346799999999999999999999999999999
Q ss_pred EeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--C
Q psy16430 328 MEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--T 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~ 404 (600)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999999764 568999999999999999999999999999999999999999999999999988654321 1
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+... .....+..+++.+.++|.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcCCCCccCcHHHHHHHHH
Confidence 223567889999999998899999999999999999999 99999998887777666554 3445677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~ 504 (600)
||+.||.+|||+.++++++.-
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp HTCSSGGGSCCHHHHHHHHHH
T ss_pred HccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999853
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=379.00 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=216.2
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
++..++|++.+.||+|+||.||+|+.. +..||+|++.. .+.+|+.++++++||||+++++++...+..|+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 455689999999999999999999976 78999999853 24578999999999999999999999999999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++...... ..
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 187 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 187 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C-
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 999999999999998877899999999999999999999996 9999999999999999999999999998765432 22
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHh-------------------------
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV------------------------- 460 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i------------------------- 460 (600)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 3467999999999999999999999999999999999999999887654432221
Q ss_pred -----------------cCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhhh
Q psy16430 461 -----------------GSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVL 510 (600)
Q Consensus 461 -----------------~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~ 510 (600)
.........+..++..+.+||.+||+.||.+|||+.++++|+|+......
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 11111222234578999999999999999999999999999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=366.42 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=221.2
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
..+|.+.+.||+|+||.||+|+.. ++.||+|++... +.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999975 688999988532 35689999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~ 406 (600)
|||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence 999999999999988778999999999999999999999999999999999999999999999999999876533 2233
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
...||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.... ...|..+++.+.++|.+||+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~ 251 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQ 251 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCccccCHHHHHHHHHHcc
Confidence 4678999999999998889999999999999999999999999888777666665543 34567889999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
.||.+|||+.++++|+|+.....
T Consensus 252 ~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 252 TDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp SSGGGSCCGGGGGGSHHHHTSCC
T ss_pred cChhhCcCHHHHhhChheecCCc
Confidence 99999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=375.37 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=204.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.++|++++.||+|+||.||+|... ++.||||+++. .+.+|+.++++++||||+++++++.+....|+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 478999999999999999999754 78999999852 2357999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC-----CCCCceeeccCccccccCCC
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG-----SKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~-----~~~~vkL~DFGla~~~~~~~ 403 (600)
||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 9998 59999998888899999999999999999999999999999999999994 44559999999998765332
Q ss_pred -CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC---------------
Q psy16430 404 -TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH--------------- 466 (600)
Q Consensus 404 -~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 466 (600)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 23345789999999999774 5899999999999999999999999988776655543211000
Q ss_pred -CCC------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 -LPI------------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 -~~~------------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
... +..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 000 11267899999999999999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=380.96 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=211.5
Q ss_pred ccccccccccccCCCCcceEEEeEee-ceEEEeeeecc---------chHHHHHHHHhcC--CCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE---------QKETDIRHLRKLN--HPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~---------~~~~Ei~~L~~L~--HpnIv~l~~~~~~~~~~~ 325 (600)
+...+|++++.||+|+||.||+|... ++.||||++.. .+.+|+.+|+++. ||||+++++++.....+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34467999999999999999999865 68899999852 2357999999996 599999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
+||| +.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 56789999998888899999999999999999999999999999999999995 68999999999987654322
Q ss_pred --CcccCCCccccChhhhcc-----------CCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCCCCCCCC
Q psy16430 405 --KMSFAGTVAWMAPEVIRN-----------EQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLPIP 470 (600)
Q Consensus 405 --~~~~~gt~~Y~APE~l~~-----------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p 470 (600)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+.......+.|
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 235679999999999865 3688899999999999999999999987543 34455555666666777
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 471 ~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
...+..+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 8889999999999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=366.91 Aligned_cols=244 Identities=26% Similarity=0.410 Sum_probs=207.4
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++++.||+|+||.||+|+.. +..||+|.+.. .+.+|+.++++++||||+++++++...+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 378999999999999999999864 68999998732 345799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--C
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--K 405 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~ 405 (600)
|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC---CCCCCCcHHHHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL---PIPSTCPDGFQLLMK 482 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~~l~~LI~ 482 (600)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+............... ..+..+|+.+.++|.
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 249 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVIL 249 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHH
T ss_pred CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHH
Confidence 34579999999999999999999999999999999999999999888766554443333221 245678999999999
Q ss_pred HhhhcCCCCCC-CHHHHHHcHh
Q psy16430 483 MCWSNAPSSRP-SFKQILSHLD 503 (600)
Q Consensus 483 ~cL~~dP~~RP-s~~elL~~l~ 503 (600)
+||..||.+|| +++++...+.
T Consensus 250 ~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 250 RATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHhcCCHhHccccHHHHHHHHH
Confidence 99999999999 6776666554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=376.84 Aligned_cols=248 Identities=29% Similarity=0.401 Sum_probs=204.6
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC-
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP- 322 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~- 322 (600)
.|++. ++|++++.||+|+||.||+|... ++.||||++.. ...+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 20 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp EECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eeeec-ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 34553 78999999999999999999864 78999999843 2357999999999999999999997653
Q ss_pred -----ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 323 -----CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 323 -----~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.+|+||||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 7899999876 569999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC------------
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS------------ 464 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~------------ 464 (600)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 177 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 177 QADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 76433 335678999999999877 689999999999999999999999999887655443322100
Q ss_pred -----------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 -----------------LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 -----------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.........++.+.+||.+||..||.+|||+.++|+|||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0001234678999999999999999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=406.43 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=223.4
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhc-CCCCcccccceeecCC
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKL-NHPNIVKFKGVCTQAP 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~ 322 (600)
..+..++|++++.||+|+||.||+|+.. ++.||||++++. ...|..++..+ +||||+++++++.+..
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 3456689999999999999999999875 578999998642 24577888877 7999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc-C
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN-N 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~ 401 (600)
.+|+||||++||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999999999999887889999999999999999999999999999999999999999999999999998643 3
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 481 (600)
.....+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...+...+..... .+|..+++++.+||
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 573 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAIC 573 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC--CCCTTSCHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHHH
Confidence 3344567899999999999999999999999999999999999999999999888888877654 45678999999999
Q ss_pred HHhhhcCCCCCCCH-----HHHHHcHhhhhhh
Q psy16430 482 KMCWSNAPSSRPSF-----KQILSHLDIASQE 508 (600)
Q Consensus 482 ~~cL~~dP~~RPs~-----~elL~~l~~~~~~ 508 (600)
++||+.||.+||++ ++|++|+||....
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999997 9999999998643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=371.70 Aligned_cols=252 Identities=34% Similarity=0.621 Sum_probs=219.3
Q ss_pred cccccccccccccccccCCCCcceEEEeEeec-------eEEEeeeeccc--------hHHHHHHHHhc-CCCCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
...|+++.++|++.+.||+|+||.||+|...+ ..||+|.+... +.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34688999999999999999999999998642 47999998642 45799999999 8999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccC--------------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKD--------------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI 382 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~--------------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl 382 (600)
++...+..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999999999999864 2458999999999999999999999999999999999999
Q ss_pred CCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHH
Q psy16430 383 GSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIW 458 (600)
Q Consensus 383 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~ 458 (600)
+.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999987644322 223457889999999999899999999999999999999 999999877655555
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 459 GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 459 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+.........+..+++.+.++|.+||+.||.+|||+.++++++.-
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 5444455566778889999999999999999999999999998854
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.72 Aligned_cols=251 Identities=31% Similarity=0.607 Sum_probs=220.4
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
..++|+++.++|++.+.||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++.+ +..
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 45789999999999999999999999999976 46899999863 34689999999999999999999864 458
Q ss_pred eEEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 89999999999999997643 6999999999999999999999999999999999999999999999999999876543
Q ss_pred CC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 ST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.. .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+... .....+..+++.+.+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQ 241 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHHHHH
Confidence 22 223457889999999998889999999999999999999 99999998887776666444 345567889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+|.+||+.||.+|||+.++++.+.-
T Consensus 242 li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=398.96 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=219.1
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+..++|++.+.||+|+||.||+|+.. ++.||+|++... ..+|+.+|++++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 55688999999999999999999874 789999998532 357899999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999987644 49999999999999999999999999999999999999999999999999998876555
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC----hHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD----SSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ...+...+... ....+..+++.+.+
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~~~d 418 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQARS 418 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHHHHH
Confidence 5556789999999999999899999999999999999999999998753 23344444333 23456789999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 480 LMKMCWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 480 LI~~cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
||.+||+.||.+|| ++++|++|+||...
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 99999999999999 89999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.72 Aligned_cols=246 Identities=26% Similarity=0.417 Sum_probs=210.3
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeec----CCc
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQ----APC 323 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~----~~~ 323 (600)
....|.+.+.||+|+||.||+|... +..||+|.+... +.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3456888899999999999999875 578999988532 3578999999999999999998854 456
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccC-CCCCceeeccCcccccc
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIG-SKEEAKISDFGTCREWN 400 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~ 400 (600)
+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999988788999999999999999999999999 99999999999997 78899999999997544
Q ss_pred CCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+.........+...++.+.+
T Consensus 184 ~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 261 (290)
T 1t4h_A 184 AS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp TT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred cc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHH
Confidence 33 2335679999999998864 589999999999999999999999988554 44444444444444556678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
||.+||+.||.+|||+.++++|+|+..
T Consensus 262 li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=385.21 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=193.7
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec---
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ--- 320 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~--- 320 (600)
.|.++ ++|++++.||+|+||.||+|... ++.||||++.. .+.+|+.+|++++||||+++++++..
T Consensus 48 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 34554 78999999999999999999764 78999999853 23579999999999999999999843
Q ss_pred --CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 321 --APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 321 --~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 356899999985 78999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCC----------------------------CCcccCCCccccChhhh-ccCCCCCccceechhHHHHHHhh------
Q psy16430 399 WNNKS----------------------------TKMSFAGTVAWMAPEVI-RNEQCSDKIDIWSYGIVLWELLT------ 443 (600)
Q Consensus 399 ~~~~~----------------------------~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSlGviLyELlt------ 443 (600)
..... .....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 64221 12345789999999986 56679999999999999999998
Q ss_pred -----CCCCCCCCChH--------------------HHHHH----hcCC----------------------CCC---CCC
Q psy16430 444 -----CETPYKDVDSS--------------------AIIWG----VGSS----------------------SLH---LPI 469 (600)
Q Consensus 444 -----G~~Pf~~~~~~--------------------~~~~~----i~~~----------------------~~~---~~~ 469 (600)
|.+||.+.+.. ..+.. +... ... ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 77778664410 00000 0000 000 011
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 470 p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
....++.+.+||++||..||.+|||++|+|+||||....
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 235689999999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.97 Aligned_cols=251 Identities=34% Similarity=0.651 Sum_probs=222.3
Q ss_pred cccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+.|++..++|++.+.||+|+||.||+|.+. +..||+|.+.. .+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3578999999999999999999999999976 68999999864 345799999999999999999999999999
Q ss_pred eEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999999975 345899999999999999999999999999999999999999999999999999876543
Q ss_pred CCC--cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 STK--MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+... .....+..+|+.+.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYE 243 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCCHHHHH
Confidence 322 23456889999999999999999999999999999999 99999988877666555433 445677889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
||.+||..||.+|||+.++++.+.-
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=390.64 Aligned_cols=244 Identities=27% Similarity=0.350 Sum_probs=199.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecCC------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQAP------ 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~~------ 322 (600)
.++|++++.||+|+||+||+|... ++.||||++... ..+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 378999999999999999999864 789999998532 347999999999999999999996543
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.+|+||||++++ |.+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 569999999865 6565543 4899999999999999999999999999999999999999999999999999887665
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC------------------
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS------------------ 464 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~------------------ 464 (600)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 55556789999999999999999999999999999999999999999887655444332100
Q ss_pred ----C---CCC----CCCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 465 ----L---HLP----IPST-----------CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 465 ----~---~~~----~p~~-----------~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
. ... .+.. .++.+.+||.+||..||.+|||++|+|+|||+..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0 000 0000 1567999999999999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=374.92 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=207.4
Q ss_pred ccccccccccccccccCCCCcceEEEeEeeceEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCC----c
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAP----C 323 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~----~ 323 (600)
..|.+...+|++.+.||+|+||.||+|++.++.||||++... .+.|+.++++++||||+++++++.... .
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 356677899999999999999999999999999999998643 245788899999999999999997654 3
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC----------CccccCCCCCCcccCCCCCceeecc
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK----------QIIHRDLKSPNVLIGSKEEAKISDF 393 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~----------gIvHrDIKp~NILl~~~~~vkL~DF 393 (600)
+++||||+++|+|.++++.+ .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 69999999999999999764 599999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCC---CcccCCCccccChhhhcc-----CCCCCccceechhHHHHHHhhCCCCCCCCCh------------
Q psy16430 394 GTCREWNNKST---KMSFAGTVAWMAPEVIRN-----EQCSDKIDIWSYGIVLWELLTCETPYKDVDS------------ 453 (600)
Q Consensus 394 Gla~~~~~~~~---~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGviLyELltG~~Pf~~~~~------------ 453 (600)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654322 234679999999999976 3456688999999999999999999975421
Q ss_pred ----HHHHHHhcCCCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 454 ----SAIIWGVGSSSLHLPIPS-----TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 454 ----~~~~~~i~~~~~~~~~p~-----~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
......+......+..+. .+++.+.+||.+||+.||.+|||+.++++.+.-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 222222333333333222 235669999999999999999999999998864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=372.77 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=204.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++++.||+|+||.||+|+.. ++.||+|+++.. ..+|+.++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 67999999999999999999875 689999998632 23689999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
++ |+|.+++.. +..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .....
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 97 578887765 4569999999999999999999999999999999999999999999999999998655332 22345
Q ss_pred CCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC---CCCC-----------------
Q psy16430 409 AGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS---SLHL----------------- 467 (600)
Q Consensus 409 ~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~---~~~~----------------- 467 (600)
.||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... ....
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 78999999999876 56899999999999999999999999998876655433210 0000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 468 --------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 468 --------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..+..+++.+.+||.+||+.||.+|||+.|+++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0123568899999999999999999999999999999765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=374.32 Aligned_cols=243 Identities=26% Similarity=0.419 Sum_probs=199.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC--------
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP-------- 322 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~-------- 322 (600)
++|++.+.||+|+||.||+|+.. ++.||||+++. .+.+|+.+|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57899999999999999999875 78999999852 3467999999999999999999985543
Q ss_pred -------------------------------------------------ceeEEEeeeccccchhhccCCCC---CCHHH
Q psy16430 323 -------------------------------------------------CYCIVMEYCAYGPLYNLLKDGEE---VPPQR 350 (600)
Q Consensus 323 -------------------------------------------------~~~lV~Ey~~ggsL~~~l~~~~~---l~~~~ 350 (600)
..++|||||+|++|.+++..... .++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 37999999999999999987543 45556
Q ss_pred HHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-------------CCcccCCCccccCh
Q psy16430 351 LYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-------------TKMSFAGTVAWMAP 417 (600)
Q Consensus 351 i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-------------~~~~~~gt~~Y~AP 417 (600)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 89999999999999999999999999999999999999999999998765432 22345799999999
Q ss_pred hhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q psy16430 418 EVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQ 497 (600)
Q Consensus 418 E~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~e 497 (600)
|++.+..++.++|||||||++|+|++|..|+... ......+..... ...+...++.+.+||.+||+.||.+|||+.+
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCC-CcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 9999999999999999999999999987765321 122222222211 1122345678899999999999999999999
Q ss_pred HHHcHhhhh
Q psy16430 498 ILSHLDIAS 506 (600)
Q Consensus 498 lL~~l~~~~ 506 (600)
+++|+||.+
T Consensus 323 ~l~~~~f~~ 331 (332)
T 3qd2_B 323 IIENAIFEN 331 (332)
T ss_dssp HHHSTTCCC
T ss_pred Hhhchhhhc
Confidence 999999853
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=369.92 Aligned_cols=244 Identities=22% Similarity=0.448 Sum_probs=205.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC--ceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP--CYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~--~~~lV 327 (600)
.++|++.+.||+|+||.||+|+.. ++.||||++.. ...+|+.++++++||||+++++++.... ..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 478999999999999999999976 78999999863 2357999999999999999999987655 78999
Q ss_pred EeeeccccchhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc----CCCCCceeeccCcccccc
Q psy16430 328 MEYCAYGPLYNLLKDGE---EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTCREWN 400 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~---~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl----~~~~~vkL~DFGla~~~~ 400 (600)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999999997643 39999999999999999999999999999999999999 777889999999998876
Q ss_pred CCCCCcccCCCccccChhhhc--------cCCCCCccceechhHHHHHHhhCCCCCCCCCh----HHHHHHhcCCCC---
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIR--------NEQCSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSL--- 465 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~--------~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----~~~~~~i~~~~~--- 465 (600)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||..... ......+..+..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 665555678999999999986 46789999999999999999999999975332 233333222111
Q ss_pred ----------------CC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 466 ----------------HL----PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 466 ----------------~~----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.. ..+..+++.+.++|++||+.||.+|||++|+++||.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11 122345678999999999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=369.84 Aligned_cols=241 Identities=20% Similarity=0.357 Sum_probs=200.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhc-CCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|+++++||+|+||+||+|+.. ++.||||++... ...|+..+.++ +||||+++++++.+....|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999975 789999987532 12344444444 8999999999999999999999
Q ss_pred eeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 329 EYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 329 Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
||+ +++|.+++.. +..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 999 5688887765 45699999999999999999999999999999999999999999999999999987765555556
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+.........+..+++.+.+||.+||+.
T Consensus 216 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 291 (311)
T 3p1a_A 216 QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEP 291 (311)
T ss_dssp CCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred cCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCC
Confidence 679999999999876 789999999999999999999777655332 2233333333344567899999999999999
Q ss_pred CCCCCCCHHHHHHcHhhhh
Q psy16430 488 APSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 488 dP~~RPs~~elL~~l~~~~ 506 (600)
||.+|||+.++++|||+.+
T Consensus 292 dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 292 DPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp STTTSCCHHHHHTSGGGSC
T ss_pred ChhhCcCHHHHHhCccccC
Confidence 9999999999999999853
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=376.13 Aligned_cols=243 Identities=25% Similarity=0.340 Sum_probs=206.4
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc------chHHHHHHHHhcC-----CCCcccccceeecCCceeE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE------QKETDIRHLRKLN-----HPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~------~~~~Ei~~L~~L~-----HpnIv~l~~~~~~~~~~~l 326 (600)
.++|++++.||+|+||.||+|+. .++.||||+++. ....|+.+++.+. ||||+++++++......|+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 47899999999999999999997 478999999863 2356889999986 9999999999999999999
Q ss_pred EEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC--------------------
Q psy16430 327 VMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-------------------- 384 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-------------------- 384 (600)
||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99999 899999997643 5999999999999999999999999999999999999975
Q ss_pred -----CCCceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH
Q psy16430 385 -----KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG 459 (600)
Q Consensus 385 -----~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~ 459 (600)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 270 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 788999999999865432 2356799999999999999999999999999999999999999998776555443
Q ss_pred hcCCCCCC------------------------CCC--------------------CCCcHHHHHHHHHhhhcCCCCCCCH
Q psy16430 460 VGSSSLHL------------------------PIP--------------------STCPDGFQLLMKMCWSNAPSSRPSF 495 (600)
Q Consensus 460 i~~~~~~~------------------------~~p--------------------~~~~~~l~~LI~~cL~~dP~~RPs~ 495 (600)
+....... ..| ...++.+.+||.+||+.||.+|||+
T Consensus 271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 350 (360)
T 3llt_A 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350 (360)
T ss_dssp HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence 32111000 011 1123778899999999999999999
Q ss_pred HHHHHcHhhh
Q psy16430 496 KQILSHLDIA 505 (600)
Q Consensus 496 ~elL~~l~~~ 505 (600)
.++|+|+|+.
T Consensus 351 ~elL~hp~f~ 360 (360)
T 3llt_A 351 AELLKHKFLE 360 (360)
T ss_dssp HHHTTSGGGC
T ss_pred HHHhcCcccC
Confidence 9999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=370.00 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=212.2
Q ss_pred cccccc-cccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhc-CCCCcccccceeecCCceeEE
Q psy16430 261 ESISDL-QWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 261 ~~~~~~-~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV 327 (600)
+.|.+. +.||+|+||.||+|... ++.||+|++.. ...+|+.+++.+ .||||+++++++.+....|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 456666 78999999999999875 78999999853 245789999998 469999999999999999999
Q ss_pred EeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCceeeccCccccccCC
Q psy16430 328 MEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEAKISDFGTCREWNNK 402 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~ 402 (600)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999999999999865 367999999999999999999999999999999999999987 789999999999887655
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC--CCCCCCCCcHHHHHH
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL--HLPIPSTCPDGFQLL 480 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~~L 480 (600)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ..+.+..+++.+.+|
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 555567899999999999999999999999999999999999999999888776665544333 333446789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
|.+||+.||.+|||+.++++|+|+.....
T Consensus 268 i~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 268 IQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 99999999999999999999999976543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=371.92 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=209.2
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
...++|++++.||+|+||.||+|+.. ++.||+|++.. .+.+|+.++++++||||+++++++.+....|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 34588999999999999999999976 78999998842 23579999999999999999999999999999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CC
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 405 (600)
||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 99999999999988877889999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CC
Q psy16430 406 MSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SL 465 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 465 (600)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 346789999999999775 7899999999999999999999999988765544332110 00
Q ss_pred CCC----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 HLP----------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ~~~----------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..+ ....+++.+.+||.+||+.||.+|||+.++|+|+|+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 000 113578999999999999999999999999999999654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=401.23 Aligned_cols=250 Identities=32% Similarity=0.595 Sum_probs=222.4
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
..+.|+++.++|++.+.||+|+||.||+|.+.+ ..||||+++. .+.+|+.+|++++||||+++++++.+ ...
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 467899999999999999999999999999875 6799999863 35689999999999999999999876 678
Q ss_pred eEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|+||||+++|+|.++++. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999999974 356899999999999999999999999999999999999999999999999999876432
Q ss_pred C--CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 S--TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
. ......++..|+|||++.+..++.++|||||||+||||++ |..||.+....++...+..+ ...+.+..+++.+.+
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHD 495 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 1 1223457889999999998899999999999999999999 99999998888777766543 456678899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
||.+||+.||.+|||+.+|++.+.
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.21 Aligned_cols=253 Identities=27% Similarity=0.492 Sum_probs=211.9
Q ss_pred cccccccccccccccCCCCcceEEEeEe--eceEEEeeeecc------chHHHHHHHHhc-CCCCcccccceeec-----
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE------QKETDIRHLRKL-NHPNIVKFKGVCTQ----- 320 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~------~~~~Ei~~L~~L-~HpnIv~l~~~~~~----- 320 (600)
.+....++|++.+.||+|+||.||+|++ .++.||||++.. .+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3444568899999999999999999997 578999999853 346899999999 79999999999876
Q ss_pred -CCceeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 321 -APCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 321 -~~~~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
....|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 46789999999999999999753 569999999999999999999999999999999999999999999999999988
Q ss_pred cccCCC-CCcccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCC
Q psy16430 398 EWNNKS-TKMSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS 471 (600)
Q Consensus 398 ~~~~~~-~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 471 (600)
...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+.........+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 257 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence 765332 233467999999999986 56788999999999999999999999998887766665555444444567
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+++.+.+||.+||..||.+|||+.++++|+|+...
T Consensus 258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 789999999999999999999999999999999654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.56 Aligned_cols=251 Identities=29% Similarity=0.523 Sum_probs=213.4
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
..+.++|++.+.||+|+||.||+|... ++.||+|.+.. .+.+|+.++++++||||+++++++...+..|+|||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 345678999999999999999999875 78999999853 34689999999999999999999999999999999
Q ss_pred eeccccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcc
Q psy16430 330 YCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 407 (600)
|+++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 999999999986 35679999999999999999999999999999999999999999999999999998765432 2335
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-CCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ......+..+++.+.+||.+||.
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 264 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTC
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHcc
Confidence 67899999999999989999999999999999999999999988776655544332 22333456689999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~ 507 (600)
.||.+|||+.++++|+|+...
T Consensus 265 ~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 265 KSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp SCTTTSCCHHHHTTSHHHHTC
T ss_pred CChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=381.84 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=202.2
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC---
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA--- 321 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~--- 321 (600)
+.++ ++|++.+.||+|+||.||+|... ++.||||++.. ...+|+.+|++++||||+++++++...
T Consensus 22 ~~i~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 22 VHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCC-TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ceec-CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 3443 78999999999999999999865 68999999864 235799999999999999999998765
Q ss_pred --CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 322 --PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 322 --~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
...|+||||++ ++|.++++....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 56899999996 599999998888999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-----------------------CcccCCCccccChhhh-ccCCCCCccceechhHHHHHHhhC-----------
Q psy16430 400 NNKST-----------------------KMSFAGTVAWMAPEVI-RNEQCSDKIDIWSYGIVLWELLTC----------- 444 (600)
Q Consensus 400 ~~~~~-----------------------~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSlGviLyELltG----------- 444 (600)
..... ....+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 53321 2456899999999986 556799999999999999999984
Q ss_pred CCCCCCCCh-----------------HHH------------------------HHHhcCCCCCCCC-----CCCCcHHHH
Q psy16430 445 ETPYKDVDS-----------------SAI------------------------IWGVGSSSLHLPI-----PSTCPDGFQ 478 (600)
Q Consensus 445 ~~Pf~~~~~-----------------~~~------------------------~~~i~~~~~~~~~-----p~~~~~~l~ 478 (600)
.++|.+.+. ... ...+.......+. ...+++.+.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 444544321 000 0001111111111 145789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+||.+||..||.+|||++++|+|||+...
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.79 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=221.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
..+|.+.+.||+|+||.||+++.. ++.||+|++... +.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999875 588999998532 35689999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~ 406 (600)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence 999999999999988788999999999999999999999999999999999999999999999999999876533 2234
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ...+..+++.+.+||.+||+
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~ 277 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQ 277 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcc
Confidence 5679999999999999889999999999999999999999999888776666555443 34567889999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
.||.+|||+.++++|+|+.....
T Consensus 278 ~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 278 TDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp SSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CChhHCcCHHHHhcCccccCCCc
Confidence 99999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=365.51 Aligned_cols=252 Identities=32% Similarity=0.587 Sum_probs=221.1
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccc
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKG 316 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~ 316 (600)
..+.|++..++|++.+.||+|+||.||+|.+. +..||+|.+... +.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 44678899999999999999999999999764 578999998532 457899999999999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDG----------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~ 386 (600)
++.+....++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999998642 4578999999999999999999999999999999999999999
Q ss_pred CceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcC
Q psy16430 387 EAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGS 462 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~ 462 (600)
.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 999999999986643321 123456889999999999899999999999999999999 8999999888777776655
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 463 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
... .+.+..+++.+.+||.+||+.||.+|||+.++++++.-
T Consensus 256 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 256 GGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred CCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 543 45677899999999999999999999999999999853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=358.79 Aligned_cols=253 Identities=30% Similarity=0.551 Sum_probs=219.5
Q ss_pred ccccccccccccc-ccCCCCcceEEEeEe----eceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecC
Q psy16430 255 EWEIPFESISDLQ-WLGSGAQGAVFSGKL----RSEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~-~LG~G~fG~Vy~a~~----~~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
.|.+..++|.+.. .||+|+||.||+|.+ .+..||+|+++.. +.+|+.++++++||||+++++++ ..
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 5677788998887 999999999999975 3678999998642 35799999999999999999999 45
Q ss_pred CceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 668999999999999999865 4569999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 401 NKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 401 ~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
.... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.... ..+.|..+|+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~ 240 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPP 240 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCH
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCCCCcCH
Confidence 3322 123456899999999988889999999999999999998 999999888777766665543 4566788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
.+.++|.+||+.||.+|||+.+++++++-.....
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998655443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=372.00 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=207.6
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCc----e
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPC----Y 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~----~ 324 (600)
++|++.+.||+|+||.||+|+. .++.||||+++.. +.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 7899999999999999999995 4789999998642 3578888899999999999999866543 4
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999987644321
Q ss_pred ----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHH
Q psy16430 405 ----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQ 478 (600)
Q Consensus 405 ----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~ 478 (600)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...............+ .+..+++.+.
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (311)
T 3ork_A 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251 (311)
T ss_dssp ----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHH
T ss_pred ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHH
Confidence 2235689999999999999999999999999999999999999999887776655444432221 2356899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+||.+||+.||.+||++.+++.++|+...
T Consensus 252 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 252 AVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 99999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=368.41 Aligned_cols=248 Identities=27% Similarity=0.518 Sum_probs=198.9
Q ss_pred ccccccccccccccccCCCCcceEEEeEeec-----eEEEeeeecc---------chHHHHHHHHhcCCCCcccccceee
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCT 319 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~ 319 (600)
..+.++.++|++.+.||+|+||.||+|++.. ..||||++.. .+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 4567788999999999999999999998653 2799999853 2457999999999999999999997
Q ss_pred cCCce------eEEEeeeccccchhhccCC------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC
Q psy16430 320 QAPCY------CIVMEYCAYGPLYNLLKDG------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE 387 (600)
Q Consensus 320 ~~~~~------~lV~Ey~~ggsL~~~l~~~------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~ 387 (600)
..... ++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 76654 9999999999999998532 25899999999999999999999999999999999999999999
Q ss_pred ceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCC
Q psy16430 388 AKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSS 463 (600)
Q Consensus 388 vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~ 463 (600)
+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999987644322 123456889999999999999999999999999999999 99999998877776665544
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 464 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
. ....+..+++.+.+||.+||+.||.+|||+.++++.+
T Consensus 256 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 256 N-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp C-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred C-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 3 4456778999999999999999999999955544443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=366.70 Aligned_cols=253 Identities=30% Similarity=0.572 Sum_probs=215.8
Q ss_pred cccccccccccccccccCCCCcceEEEeEe-------eceEEEeeeeccc--------hHHHHHHHHhc-CCCCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKL-------RSEIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~-------~~~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
...|+++.++|++.+.||+|+||.||+|++ .++.||||++... +.+|+.+++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 346788889999999999999999999974 3488999998642 35789999999 7999999999
Q ss_pred eeecCC-ceeEEEeeeccccchhhccCCCC----------------CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 317 VCTQAP-CYCIVMEYCAYGPLYNLLKDGEE----------------VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 317 ~~~~~~-~~~lV~Ey~~ggsL~~~l~~~~~----------------l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
++...+ .+++||||+++++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 58999999999999999976543 8899999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
|+++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 9999999999999999987644322 123567889999999999999999999999999999998 999998876544
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
..............+..+++.+.++|.+||+.||.+|||+.++++++.-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33333233334566778899999999999999999999999999998643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=365.46 Aligned_cols=254 Identities=26% Similarity=0.464 Sum_probs=199.0
Q ss_pred ccccccccccccccccCCCCcceEEEeEe--eceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
..|.+..++|++.+.||+|+||.||+|.. .++.||||.+.. .+.+|+.++++++||||+++++++...+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 35778889999999999999999999986 478999998853 23468888899999999999999999999
Q ss_pred eeEEEeeeccccchhhccC--------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 324 YCIVMEYCAYGPLYNLLKD--------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~--------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
.++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999863 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC------CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC---
Q psy16430 396 CREWNNKS------TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL--- 465 (600)
Q Consensus 396 a~~~~~~~------~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--- 465 (600)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 87654321 1224578999999999876 5789999999999999999999999988776554433322211
Q ss_pred -----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 -----HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 -----~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.......+++.+.++|.+||+.||.+|||+.++++|+|+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 112345678999999999999999999999999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=364.44 Aligned_cols=249 Identities=34% Similarity=0.599 Sum_probs=206.7
Q ss_pred ccccccccccccccCCCCcceEEEeEe------eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeec--
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQ-- 320 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~-- 320 (600)
..+..++|++++.||+|+||.||+|++ .++.||||++.. .+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 345668999999999999999999984 468999999864 34579999999999999999999854
Q ss_pred CCceeEEEeeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
...+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 456899999999999999997643 5999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH----------------HHHHH
Q psy16430 400 NNKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS----------------AIIWG 459 (600)
Q Consensus 400 ~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~----------------~~~~~ 459 (600)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 54321 22345788899999999999999999999999999999999998653221 11111
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 460 VGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 460 i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+ ......+.|..+|+.+.+||.+||+.||.+|||+.++++.+.-.
T Consensus 245 ~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 245 L-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp H-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred H-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 2 23345567889999999999999999999999999999988543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=361.16 Aligned_cols=250 Identities=31% Similarity=0.578 Sum_probs=211.7
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeeceEEEeeeeccc-----hHHHHHHHHhcCCCCcccccceeec-CCcee
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ-----KETDIRHLRKLNHPNIVKFKGVCTQ-APCYC 325 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~-----~~~Ei~~L~~L~HpnIv~l~~~~~~-~~~~~ 325 (600)
....|.+..++|++.+.||+|+||.||+|+..++.||+|.+... +.+|+.++++++||||+++++++.. .+..+
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 34568888999999999999999999999999999999998643 4579999999999999999998654 45789
Q ss_pred EEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
+||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999999999997643 38999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+... .....+..+++.+.++|.
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 248 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMK 248 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHH
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHHH
Confidence 23467889999999999899999999999999999998 99999988777766665443 345667889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+||+.||.+|||+.++++.+.-
T Consensus 249 ~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 249 NCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCChhhCCCHHHHHHHHHH
Confidence 9999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=369.88 Aligned_cols=246 Identities=29% Similarity=0.435 Sum_probs=207.9
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
++|++.+.||+|+||.||+|... ++.||||++.. .+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 67899999999999999999864 68999998853 2467999999999999999999987655
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC---ceeeccCcccccc
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCREWN 400 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~---vkL~DFGla~~~~ 400 (600)
.|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988888999999999999999999999999999999999999987654 9999999998765
Q ss_pred CCCCCcccCCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCC--CCCCCCc
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHL--PIPSTCP 474 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~--~~p~~~~ 474 (600)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||...... .....+..+.... ..+..++
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (322)
T 2ycf_A 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248 (322)
T ss_dssp CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence 443333467899999999974 467889999999999999999999999765432 2222222222221 1235678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.+.+||.+||..||.+|||+.++++|+|+...
T Consensus 249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 999999999999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=368.37 Aligned_cols=252 Identities=31% Similarity=0.608 Sum_probs=220.3
Q ss_pred cccccccccccccccccCCCCcceEEEeEee---------ceEEEeeeeccc--------hHHHHHHHHhc-CCCCcccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR---------SEIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKF 314 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l 314 (600)
...|+++.++|++.+.||+|+||.||+|++. +..||+|++... +.+|+.+++++ +||||+++
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 3467888899999999999999999999853 468999998642 35789999999 89999999
Q ss_pred cceeecCCceeEEEeeeccccchhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCC
Q psy16430 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGE----------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378 (600)
Q Consensus 315 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~ 378 (600)
++++...+..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997643 3889999999999999999999999999999999
Q ss_pred CcccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChH
Q psy16430 379 NVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSS 454 (600)
Q Consensus 379 NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~ 454 (600)
|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654322 223457889999999988889999999999999999999 99999998877
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 455 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
.....+.... ..+.+..+++.+.++|.+||+.||.+|||+.++++++.-.
T Consensus 267 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7766554443 4456788999999999999999999999999999998644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=369.39 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=204.2
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec--------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ-------- 320 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~-------- 320 (600)
.++|++++.||+|+||.||+|+.. ++.||+|++.. ...+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 378999999999999999999974 68999998742 23579999999999999999999876
Q ss_pred CCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
.+..|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 4468999999986 56555544 467999999999999999999999999999999999999999999999999999876
Q ss_pred cCC-----CCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC--CCCCCC-C
Q psy16430 400 NNK-----STKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS--SLHLPI-P 470 (600)
Q Consensus 400 ~~~-----~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~--~~~~~~-p 470 (600)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+... ...... +
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 422 12234678999999999876 56899999999999999999999999988776555443221 111110 1
Q ss_pred C---------------------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 471 S---------------------------TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 471 ~---------------------------~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
. ..++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 0 026779999999999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=361.22 Aligned_cols=246 Identities=29% Similarity=0.465 Sum_probs=217.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++.+.||+|+||.||+|+.. ++.||+|++.. .+.+|+.++++++||||+++++++.+....++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 68999999999999999999874 78999999853 23579999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC---CCceeeccCccccccCCCCCc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK---EEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~ 406 (600)
|+++++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+||+++.+ +.+||+|||++..........
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~ 181 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence 99999999988777789999999999999999999999999999999999999754 469999999998776554444
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCC--CCCcHHHHHHHHHh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--STCPDGFQLLMKMC 484 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~c 484 (600)
...||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+..+....+.+ ..+++.+.++|.+|
T Consensus 182 ~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 260 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (287)
T ss_dssp CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHH
Confidence 5568999999999876 48999999999999999999999999988887777766665544433 57899999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|..||.+|||+.++++|+|+...
T Consensus 261 l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 261 LTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp TCSSGGGSCCHHHHHHSHHHHHH
T ss_pred cccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=374.43 Aligned_cols=249 Identities=24% Similarity=0.431 Sum_probs=212.8
Q ss_pred cccccccccccccCCCCcceEEEeEe-----eceEEEeeeecc-----------chHHHHHHHHhc-CCCCcccccceee
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVRE-----------QKETDIRHLRKL-NHPNIVKFKGVCT 319 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~-----------~~~~Ei~~L~~L-~HpnIv~l~~~~~ 319 (600)
.+..++|++++.||+|+||.||+|+. .++.||||+++. ...+|+.+++++ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 34568999999999999999999987 578999999853 234689999999 6999999999999
Q ss_pred cCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
.....++||||+++|+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999988778999999999999999999999999999999999999999999999999999865
Q ss_pred cCCC--CCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCCCCC----hHHHHHHhcCCCCCCCCCC
Q psy16430 400 NNKS--TKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYKDVD----SSAIIWGVGSSSLHLPIPS 471 (600)
Q Consensus 400 ~~~~--~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p~ 471 (600)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...+...+... ..+.+.
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 287 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQ 287 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--CCCCCc
Confidence 4322 2234679999999999975 357899999999999999999999997532 23333333222 345677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHcHhhhhh
Q psy16430 472 TCPDGFQLLMKMCWSNAPSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 472 ~~~~~l~~LI~~cL~~dP~~RP-----s~~elL~~l~~~~~ 507 (600)
.++..+.+||.+||..||.+|| |++++++|+|+...
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 8899999999999999999999 99999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.36 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=203.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhc-CCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|... ++.||+|.+... ..+|+..+..+ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67899999999999999999975 789999998632 34678888888 9999999999999999999999
Q ss_pred eeeccccchhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-------------------
Q psy16430 329 EYCAYGPLYNLLKDG----EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK------------------- 385 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~----~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~------------------- 385 (600)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999999753 679999999999999999999999999999999999999844
Q ss_pred CCceeeccCccccccCCCCCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC
Q psy16430 386 EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 386 ~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~ 464 (600)
..++|+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+....... .+...
T Consensus 171 ~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~- 243 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQG- 243 (289)
T ss_dssp CCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHHTT-
T ss_pred eEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHHcC-
Confidence 479999999998765432 34689999999999765 56689999999999999999998876543322 22222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....|..+++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2345677899999999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=376.41 Aligned_cols=249 Identities=34% Similarity=0.591 Sum_probs=207.2
Q ss_pred ccccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.++...+|++.+.||+|+||.||+|+.. +..||||.++. .+.+|+.++++++||||+++++++.+..
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3566789999999999999999999864 57899999853 2457999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..++||||+++|+|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999999764 4699999999999999999999999999999999999999999999999999987654
Q ss_pred CCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 402 KST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 402 ~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+... ...+.+..++..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 278 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPPPMDCPAA 278 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-EECCCCTTCBHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCccccHH
Confidence 321 112345788999999999999999999999999999998 99999998887777666444 345667789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+.++|.+||+.||.+|||+.++++.+.-.
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999988644
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=370.41 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=206.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
.++|++.+.||+|+||.||+|+.. ++.||||++.. ...+|+.++++++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 478999999999999999999875 68999999852 2357999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999986 788877654 468999999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC---CC-------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS---LH------------- 466 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~---~~------------- 466 (600)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.... ..
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 3345678999999999865 457899999999999999999999999887766554432110 00
Q ss_pred -----CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 -----LP-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 -----~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.. ....+++.+.+||.+||..||.+|||+.|+++|+|+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 00 014567899999999999999999999999999999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=361.09 Aligned_cols=254 Identities=39% Similarity=0.633 Sum_probs=200.7
Q ss_pred cccccccccccccccccccccCCCCcceEEEeEeeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceee
Q psy16430 249 SFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCT 319 (600)
Q Consensus 249 ~~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~ 319 (600)
+....+.++|+.++|++.+.||+|+||.||+|+..+ .||+|+++. .+.+|+.++++++||||+++++++
T Consensus 12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ------CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 344567889999999999999999999999998766 499998852 246799999999999999999965
Q ss_pred cCCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
.....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 45668999999999999999854 45799999999999999999999999999999999999999999999999999976
Q ss_pred ccCC---CCCcccCCCccccChhhhc---cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHH-HHhcCCCCCC---C
Q psy16430 399 WNNK---STKMSFAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAII-WGVGSSSLHL---P 468 (600)
Q Consensus 399 ~~~~---~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~-~~i~~~~~~~---~ 468 (600)
.... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+....... ..+....... .
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 5432 2223457899999999986 567888999999999999999999999886554433 3333333222 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 469 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+..+|+.+.+||.+||+.||.+|||+.++++.+.-
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 345789999999999999999999999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=370.47 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=197.7
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCc------
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPC------ 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~------ 323 (600)
...++|++.+.||+|+||.||+|+.. ++.||||++.. ....+++.++.++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 44578999999999999999999975 68999998843 23466777888999999999999855333
Q ss_pred -eeEEEeeeccccch---hhccCCCCCCHHHHHHHHHHHHHHHHHhH--hCCccccCCCCCCcccCC-CCCceeeccCcc
Q psy16430 324 -YCIVMEYCAYGPLY---NLLKDGEEVPPQRLYNWARQIAAGMNYLH--SKQIIHRDLKSPNVLIGS-KEEAKISDFGTC 396 (600)
Q Consensus 324 -~~lV~Ey~~ggsL~---~~l~~~~~l~~~~i~~i~~qIl~aL~~LH--~~gIvHrDIKp~NILl~~-~~~vkL~DFGla 396 (600)
.++||||++++.+. ..+.....+++..+..++.|++.||.||| +.||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 78999999865322 33345677999999999999999999999 999999999999999996 899999999999
Q ss_pred ccccCCCCCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC-----------
Q psy16430 397 REWNNKSTKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS----------- 464 (600)
Q Consensus 397 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~----------- 464 (600)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 887766555667899999999998664 48999999999999999999999999887765554432100
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 465 -------------------LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 465 -------------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.....+..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00112234678999999999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=391.32 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=218.0
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+..++|.+++.||+|+||.||+|+.. ++.||+|++.+. ..+|+.++++++||||+++++++.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 355688999999999999999999874 789999998532 34689999999999999999999999999
Q ss_pred eEEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 325 CIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999998865 3469999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC-CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC----hHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 401 NKST-KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD----SSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 401 ~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ...+...+.... ...|..+++
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCcccCH
Confidence 4433 334689999999999999999999999999999999999999998753 344444444443 345678999
Q ss_pred HHHHHHHHhhhcCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
.+.+||++||+.||.+||+ +++|++||||...
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9999999999999999996 5899999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=367.08 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=208.6
Q ss_pred ccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.+...++|++.+.||+|+||.||+|++. ++.||||++.. .+.+|+.+++.++||||+++++++...+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 3445688999999999999999999975 68999998753 346799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCC----CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 328 MEYCAYGPLYNLLKDGE----EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~----~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
|||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999996543 58999999999999999999999999999999999999999999999999998654322
Q ss_pred ---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHH----H---HHhcCC--------CC
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI----I---WGVGSS--------SL 465 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~----~---~~i~~~--------~~ 465 (600)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...... . ...... ..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 12335689999999999988999999999999999999999999976543211 0 011111 11
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 466 HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 466 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+..++..+.+++.+||+.||.+|||+.+++++++..
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1122334567899999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.57 Aligned_cols=244 Identities=12% Similarity=0.098 Sum_probs=198.4
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHH---HHHHhcCCCCccccc---
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDI---RHLRKLNHPNIVKFK--- 315 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei---~~L~~L~HpnIv~l~--- 315 (600)
..|..+.++|++.+.||+|+||.||+|+.. ++.||||++.. .+.+|+ +.+++++||||++++
T Consensus 66 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 66 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp ESSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred eecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 345556788999999999999999999854 78999999852 235788 455566899999998
Q ss_pred ----ceeecCC-----------------ceeEEEeeeccccchhhccCCCCCCH-------HHHHHHHHHHHHHHHHhHh
Q psy16430 316 ----GVCTQAP-----------------CYCIVMEYCAYGPLYNLLKDGEEVPP-------QRLYNWARQIAAGMNYLHS 367 (600)
Q Consensus 316 ----~~~~~~~-----------------~~~lV~Ey~~ggsL~~~l~~~~~l~~-------~~i~~i~~qIl~aL~~LH~ 367 (600)
+++...+ ..|+||||+ +|+|.+++...+.+++ ..++.++.||+.||.|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 5554443 378999999 6899999976554555 7888899999999999999
Q ss_pred CCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccChhhhccC-----------CCCCccceechhH
Q psy16430 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE-----------QCSDKIDIWSYGI 436 (600)
Q Consensus 368 ~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~s~ksDIwSlGv 436 (600)
+||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999999986433 2234567 999999999887 8999999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 437 iLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
++|||++|+.||.+.+.......+. ..+..+|+.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999999998765433222221 2236789999999999999999999999999999998653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=365.69 Aligned_cols=248 Identities=33% Similarity=0.605 Sum_probs=215.6
Q ss_pred ccccccccccccCCCCcceEEEeEee--ce--EEEeeeecc--------chHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SE--IVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~--~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
+..++|++.+.||+|+||.||+|+.. +. .||+|.+.. .+.+|+.+++++ +||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 55689999999999999999999865 34 459998853 245799999999 899999999999999999
Q ss_pred eEEEeeeccccchhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 325 CIVMEYCAYGPLYNLLKDGE----------------EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~----------------~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999997653 69999999999999999999999999999999999999999999
Q ss_pred eeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCC
Q psy16430 389 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHL 467 (600)
Q Consensus 389 kL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 467 (600)
||+|||++.............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ...
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~ 260 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRL 260 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCC
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-CCC
Confidence 9999999875544333344567889999999998889999999999999999998 99999998887777666544 345
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 468 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
..+..+++.+.+||.+||..||.+|||+.++++++.-..
T Consensus 261 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 567788999999999999999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.86 Aligned_cols=244 Identities=27% Similarity=0.334 Sum_probs=196.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP------ 322 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~------ 322 (600)
.++|++++.||+|+||.||+|... ++.||||++.. ...+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 378999999999999999999864 78999999853 2357899999999999999999987654
Q ss_pred ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 68999999975 6877775 35899999999999999999999999999999999999999999999999999876654
Q ss_pred CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC---------------
Q psy16430 403 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL--------------- 467 (600)
Q Consensus 403 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 467 (600)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 181 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp ---------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 44456789999999999999999999999999999999999999999887766555443221000
Q ss_pred -----C--------------CCC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 468 -----P--------------IPS------TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 468 -----~--------------~p~------~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
. .|. ..++.+.+||.+||..||.+|||++++++|||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 011 11578999999999999999999999999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=362.51 Aligned_cols=249 Identities=31% Similarity=0.512 Sum_probs=211.6
Q ss_pred cccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
+.+.|++++.||+|+||.||+|+.. +..||+|++.. .+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3478999999999999999999976 68999999853 24579999999999999999999999999999999
Q ss_pred eeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcc
Q psy16430 330 YCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~ 407 (600)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 9999999998865 567999999999999999999999999999999999999999999999999987643221 12234
Q ss_pred cCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHH
Q psy16430 408 FAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLM 481 (600)
Q Consensus 408 ~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI 481 (600)
..||+.|+|||++. +..++.++||||||+++|+|++|..||...+.......+..... ....+..++..+.++|
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHH
Confidence 57899999999983 56788999999999999999999999998887766655543332 2334567899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 482 KMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 482 ~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+||+.||.+|||+.++++|+|+...
T Consensus 257 ~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 257 KIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999999999999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=356.34 Aligned_cols=242 Identities=33% Similarity=0.634 Sum_probs=207.9
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeec--------------cchHHHHHHHHhcCCCCcccccceeecC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR--------------EQKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~--------------~~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
+..++|++.+.||+|+||.||+|+.. ++.||+|++. ..+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45689999999999999999999874 7899999884 2346799999999999999999998765
Q ss_pred CceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCCCCC-----ceeecc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGSKEE-----AKISDF 393 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~~~~-----vkL~DF 393 (600)
. ++||||+++|+|.+.+.. ...+++..++.++.|++.||.|||+.| |+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 4 699999999999887754 457999999999999999999999999 999999999999988776 999999
Q ss_pred CccccccCCCCCcccCCCccccChhhhc--cCCCCCccceechhHHHHHHhhCCCCCCCCChHHH--HHHhcCCCCCCCC
Q psy16430 394 GTCREWNNKSTKMSFAGTVAWMAPEVIR--NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI--IWGVGSSSLHLPI 469 (600)
Q Consensus 394 Gla~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~--~~~i~~~~~~~~~ 469 (600)
|++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...+.........
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence 99975433 233467999999999983 45678899999999999999999999987654333 3444455566677
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 470 p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+..+|+.+.++|.+||+.||.+|||+.++++.+.
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 8899999999999999999999999999998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=357.84 Aligned_cols=248 Identities=30% Similarity=0.568 Sum_probs=215.8
Q ss_pred cccccccccccccc-ccCCCCcceEEEeEee----ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceee
Q psy16430 254 DEWEIPFESISDLQ-WLGSGAQGAVFSGKLR----SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCT 319 (600)
Q Consensus 254 ~~~ei~~~~~~~~~-~LG~G~fG~Vy~a~~~----~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~ 319 (600)
.++.++.++|.+.+ .||+|+||.||+|.+. +..||||+++. .+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 45677788999998 9999999999999643 58899999863 245799999999999999999999
Q ss_pred cCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
..+..++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 56678999999999999999988888999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC----cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 400 NNKSTK----MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 400 ~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
...... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+.... ....+..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCP 246 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCC
Confidence 543221 22446789999999988889999999999999999999 999999988877766665543 456678899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.+.++|.+||+.||.+|||+.++++.+.
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=365.49 Aligned_cols=246 Identities=28% Similarity=0.547 Sum_probs=210.4
Q ss_pred cccccccccccCCCCcceEEEeEee--ce----EEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR--SE----IVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~----~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
..++|++++.||+|+||.||+|++. +. .||+|.+.. .+.+|+.++++++||||+++++++. ....
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 4578999999999999999999864 33 378887632 3457999999999999999999986 4568
Q ss_pred eEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++||||+++|+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 8999999999999998764 579999999999999999999999999999999999999999999999999998765433
Q ss_pred C---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 404 T---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 404 ~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
. .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... ....+..++..+.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQPQICTIDVYM 248 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-BCCCCTTBCTTTTH
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CCCCCCcCcHHHHH
Confidence 2 234567889999999999999999999999999999999 999999887777666554443 45567778899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+|.+||..||.+|||+.++++++.-..
T Consensus 249 li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 249 VMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999986443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=364.24 Aligned_cols=245 Identities=18% Similarity=0.285 Sum_probs=206.3
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc----chHHHHHHHHhcC-CCCcccccceeec--CCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----QKETDIRHLRKLN-HPNIVKFKGVCTQ--APCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----~~~~Ei~~L~~L~-HpnIv~l~~~~~~--~~~~~lV~Ey 330 (600)
.++|++.+.||+|+||.||+|+. .++.||||++.. .+.+|+.++++++ ||||+++++++.+ ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 37899999999999999999976 468999999863 3568999999997 9999999999987 6678999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCCCCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
+++++|.+++.. +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.............
T Consensus 115 ~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 191 (330)
T 3nsz_A 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191 (330)
T ss_dssp CCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCC
T ss_pred cCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccccc
Confidence 999999998864 89999999999999999999999999999999999999776 89999999998776655555678
Q ss_pred CCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHh-------------cCCC----------
Q psy16430 410 GTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGV-------------GSSS---------- 464 (600)
Q Consensus 410 gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i-------------~~~~---------- 464 (600)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+ ....
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (330)
T 3nsz_A 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 271 (330)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHH
T ss_pred ccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhh
Confidence 9999999999877 6789999999999999999999999954332 1111110 0000
Q ss_pred ------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 ------------LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+..+++.+.+||.+||+.||.+|||++++|+|+||...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 272 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0111223378999999999999999999999999999999653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=364.91 Aligned_cols=253 Identities=33% Similarity=0.558 Sum_probs=215.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCccccccee
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVC 318 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~ 318 (600)
+..++..++|++.+.||+|+||.||+|++. +..||||.+.. .+.+|+.++++++||||+++++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 445677899999999999999999999843 46899999853 245789999999999999999999
Q ss_pred ecCCceeEEEeeeccccchhhccCC-------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCc
Q psy16430 319 TQAPCYCIVMEYCAYGPLYNLLKDG-------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEA 388 (600)
Q Consensus 319 ~~~~~~~lV~Ey~~ggsL~~~l~~~-------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~v 388 (600)
......|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999999754 34889999999999999999999999999999999999984 4469
Q ss_pred eeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC
Q psy16430 389 KISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 389 kL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~ 464 (600)
+|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987654322 1223567899999999998899999999999999999998 999999888777766665543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
....+..+++.+.++|.+||+.||.+|||+.+++++++....
T Consensus 263 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 -RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 345677899999999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=358.47 Aligned_cols=250 Identities=19% Similarity=0.260 Sum_probs=211.1
Q ss_pred cccccccccccCCCCcceEEEeEe--eceEEEeeeecc-----chHHHHHHHHhc-CCCCcccccceeecCCceeEEEee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-----QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-----~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
-.++|++.+.||+|+||.||+|.. .++.||||++.. ...+|+.+++.+ +|+|++++++++......++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 347899999999999999999984 579999998853 457899999999 799999999999999999999999
Q ss_pred eccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC-----ceeeccCccccccCCCC
Q psy16430 331 CAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE-----AKISDFGTCREWNNKST 404 (600)
Q Consensus 331 ~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~-----vkL~DFGla~~~~~~~~ 404 (600)
+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9 89999999764 46999999999999999999999999999999999999987765 99999999987654322
Q ss_pred --------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC---hHHHHHHhcCCCCCC---CCC
Q psy16430 405 --------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD---SSAIIWGVGSSSLHL---PIP 470 (600)
Q Consensus 405 --------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~---~~~~~~~i~~~~~~~---~~p 470 (600)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ .......+....... ...
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 246 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHH
Confidence 234679999999999999999999999999999999999999998743 233333222221111 123
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 471 ~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
..+|+.+.++|.+||+.||.+|||+++|++.+.-.....
T Consensus 247 ~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 247 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 578999999999999999999999999999987544433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=377.16 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=206.0
Q ss_pred cccccccccCCCCcceEEEeEee-ceEEEeeeeccc---hHHHHHHHHhcCCCCcccccceeecCC------ceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVCTQAP------CYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~---~~~Ei~~L~~L~HpnIv~l~~~~~~~~------~~~lV~Ey 330 (600)
.+|++.+.||+|+||+||+|+.. +..||+|++... ..+|+.+++.++||||+++++++.... .+++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 57999999999999999999974 456999988543 357999999999999999999985433 37899999
Q ss_pred eccccchhhc---cCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC-CCCCceeeccCccccccCCCCCc
Q psy16430 331 CAYGPLYNLL---KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG-SKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 331 ~~ggsL~~~l---~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
++++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.........
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~ 199 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCc
Confidence 9876443332 2356799999999999999999999999999999999999998 78999999999998876665556
Q ss_pred ccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------------CCC
Q psy16430 407 SFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS-------------------SLH 466 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~ 466 (600)
...||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+... ...
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 279 (394)
T 4e7w_A 200 SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP 279 (394)
T ss_dssp SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCC
T ss_pred ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccc
Confidence 77899999999998764 5899999999999999999999999988765544432210 000
Q ss_pred --------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 --------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 --------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
...+..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 280 QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 01234578999999999999999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=373.11 Aligned_cols=248 Identities=29% Similarity=0.378 Sum_probs=191.9
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC--
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA-- 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~-- 321 (600)
.|+++ ++|++++.||+|+||.||+|... ++.||||++.. ...+|+.+++.++||||+++++++...
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 45555 78999999999999999999754 78999999853 234799999999999999999998654
Q ss_pred ----CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 322 ----PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 322 ----~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
...|+||||+ +++|.++++. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5679999999 6899998876 569999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC--C----------
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS--S---------- 464 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~--~---------- 464 (600)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 181 HTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 75432 234679999999999877 67899999999999999999999999988765544332210 0
Q ss_pred ----------C-C-CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 ----------L-H-LP-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ----------~-~-~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
. . .. .....++.+.+||.+||..||.+|||+.++|+|||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 0 0 00 113567899999999999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.42 Aligned_cols=247 Identities=26% Similarity=0.444 Sum_probs=213.1
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceee--cCCceeE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCT--QAPCYCI 326 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~--~~~~~~l 326 (600)
.++|++.+.||+|+||.||+|+.. ++.||+|.+.. .+.+|+.++++++||||+++++++. .....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 378999999999999999999874 68999999853 2357899999999999999999874 4678999
Q ss_pred EEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCC-----ccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 327 VMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQ-----IIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~g-----IvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999864 345999999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCC-CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 398 EWNNKST-KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 398 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..+.. ...+..+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-ccCCcccCHH
Confidence 7643321 1235689999999999998999999999999999999999999999887777666655543 3567789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.++|.+||+.||.+|||+.+|++++|+...
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 9999999999999999999999999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=361.85 Aligned_cols=253 Identities=28% Similarity=0.528 Sum_probs=216.2
Q ss_pred ccccccccccccccccccCCCCcceEEEeEeeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
....|+++.++|++.+.||+|+||.||+|+..+ .||+|++.. .+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 446789999999999999999999999999876 489998752 3457899999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..++||||++|++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++ ++.++|+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999999998754 699999999999999999999999999999999999997 78999999999875432
Q ss_pred C------CCCcccCCCccccChhhhcc---------CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC
Q psy16430 402 K------STKMSFAGTVAWMAPEVIRN---------EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH 466 (600)
Q Consensus 402 ~------~~~~~~~gt~~Y~APE~l~~---------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~ 466 (600)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 1 12223568999999999864 35788999999999999999999999998888887777666554
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
...+..++..+.++|.+||..||.+|||+.++++.+.-..
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 4445578899999999999999999999999999986443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.21 Aligned_cols=250 Identities=31% Similarity=0.586 Sum_probs=213.3
Q ss_pred cccccccccccccccCCCCcceEEEeEeec------eEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS------EIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
.+++..++|++.+.||+|+||.||+|.... ..||+|.++.. +.+|+.++++++||||+++++++..
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 356778899999999999999999998652 45999998632 3578999999999999999999999
Q ss_pred CCceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
....++||||+++|+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999753 67999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 400 NNKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 400 ~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+..+ ...+.+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCcccCC
Confidence 54321 122346789999999998899999999999999999999 99999988887777666544 3456678899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+.+.++|.+||+.||.+|||+.++++++.-.
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999999998644
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.04 Aligned_cols=251 Identities=27% Similarity=0.485 Sum_probs=209.3
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.++.+..++|++.+.||+|+||.||+|+.. ++.||||++.. .+.+|+.++++++||||+++++++......
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 456677799999999999999999999864 78999999853 346899999999999999999999999999
Q ss_pred eEEEeeeccccchhhccCCC----CCCHHHHHHHHHHHHHHHHHhHhC---CccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 325 CIVMEYCAYGPLYNLLKDGE----EVPPQRLYNWARQIAAGMNYLHSK---QIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~----~l~~~~i~~i~~qIl~aL~~LH~~---gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997543 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCC-----Ch---HHHHHHhcC-----
Q psy16430 398 EWNNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDV-----DS---SAIIWGVGS----- 462 (600)
Q Consensus 398 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~-----~~---~~~~~~i~~----- 462 (600)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||... .. .........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 7653322 23456999999999998888999999999999999999999999521 10 111111111
Q ss_pred ----CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 463 ----SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 463 ----~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.......+...+..+.+++.+||+.||.+|||+.+++++++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111112223345789999999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.66 Aligned_cols=251 Identities=27% Similarity=0.519 Sum_probs=208.1
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceee
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCT 319 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~ 319 (600)
..+.+..++|.+.+.||+|+||.||+|... +..||+|.+.. .+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 456777899999999999999999999764 35899999852 2457899999999999999999987
Q ss_pred cCC-----ceeEEEeeeccccchhhcc------CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 320 QAP-----CYCIVMEYCAYGPLYNLLK------DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 320 ~~~-----~~~lV~Ey~~ggsL~~~l~------~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
... ..++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 654 3599999999999999883 34579999999999999999999999999999999999999999999
Q ss_pred eeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCC
Q psy16430 389 KISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 389 kL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~ 464 (600)
||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 999999998764332 1223457889999999999999999999999999999999 999999888776666554443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+..+++.+.++|.+||..||.+|||+.++++++.-.
T Consensus 267 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 267 -RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp -CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4456788999999999999999999999999999998643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=359.37 Aligned_cols=246 Identities=37% Similarity=0.703 Sum_probs=205.2
Q ss_pred cccccccccccccCCCCcceEEEeEeeceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
.++.++|++.+.||+|+||.||+|++.++.||+|.+.. .+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 35678999999999999999999999999999999864 34679999999999999999998874 478999999
Q ss_pred ccccchhhccCCC---CCCHHHHHHHHHHHHHHHHHhHh---CCccccCCCCCCcccCCCCC-ceeeccCccccccCCCC
Q psy16430 332 AYGPLYNLLKDGE---EVPPQRLYNWARQIAAGMNYLHS---KQIIHRDLKSPNVLIGSKEE-AKISDFGTCREWNNKST 404 (600)
Q Consensus 332 ~ggsL~~~l~~~~---~l~~~~i~~i~~qIl~aL~~LH~---~gIvHrDIKp~NILl~~~~~-vkL~DFGla~~~~~~~~ 404 (600)
+||+|.+++.... .++...++.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 9999999997654 37889999999999999999999 89999999999999998886 7999999987654322
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh--HHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS--SAIIWGVGSSSLHLPIPSTCPDGFQLLMK 482 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 482 (600)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+.+.. ....+.+..+|+.+.++|.
T Consensus 161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 238 (307)
T 2eva_A 161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRPPLIKNLPKPIESLMT 238 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCCCCBTTCCHHHHHHHH
T ss_pred -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCCCCcccccCHHHHHHHH
Confidence 235689999999999999999999999999999999999999986433 233333333 2344566789999999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+||+.||.+|||+.++++++.-...
T Consensus 239 ~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 239 RCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHhcCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999875543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=356.40 Aligned_cols=249 Identities=29% Similarity=0.526 Sum_probs=212.5
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-----ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
..|.+..++|++.+.||+|+||.||+|.+. +..||+|.+... +.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 356778899999999999999999999864 246999998642 3579999999999999999999865
Q ss_pred CCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
+ ..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 56899999999999999965 346999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 400 NNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 400 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+... ...+.+..+++.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 242 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCCTTCCHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCCCCCCHH
Confidence 54322 223457889999999998899999999999999999998 99999887766655554433 244567789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.++|.+||..||.+|||+.++++++.-
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 9999999999999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=356.45 Aligned_cols=253 Identities=29% Similarity=0.504 Sum_probs=211.4
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
.+....++|.....||+|+||.||+|... +..||+|.+.. .+.+|+.+++.++||||+++++++...+..+
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 34455677777889999999999999864 68899998853 2457999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-CCCceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLLKDG---EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-KEEAKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~---~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~ 401 (600)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999999998754 24678899999999999999999999999999999999987 89999999999987654
Q ss_pred CC-CCcccCCCccccChhhhccCC--CCCccceechhHHHHHHhhCCCCCCCCChHH-HHHHhcCCCCCCCCCCCCcHHH
Q psy16430 402 KS-TKMSFAGTVAWMAPEVIRNEQ--CSDKIDIWSYGIVLWELLTCETPYKDVDSSA-IIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 402 ~~-~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGviLyELltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~l 477 (600)
.. ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ..............+..+++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 32 233567899999999997643 7899999999999999999999997654322 2222222233445678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+||.+||+.||.+|||+.++++|+|+...
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=370.35 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=199.8
Q ss_pred cccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------------------chHHHHHHHHhcCCCCcccccce
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------------------QKETDIRHLRKLNHPNIVKFKGV 317 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------------------~~~~Ei~~L~~L~HpnIv~l~~~ 317 (600)
....++|++.+.||+|+||.||+|... +..||||++.. .+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 344588999999999999999999754 78999998842 34689999999999999999999
Q ss_pred eec-----CCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceee
Q psy16430 318 CTQ-----APCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKIS 391 (600)
Q Consensus 318 ~~~-----~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~ 391 (600)
+.. ....|+||||++ |+|.+.+.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 843 346899999998 567776654 4579999999999999999999999999999999999999999999999
Q ss_pred ccCccccccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--------
Q psy16430 392 DFGTCREWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-------- 462 (600)
Q Consensus 392 DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-------- 462 (600)
|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9999987655555556789999999999877 6789999999999999999999999998776554443321
Q ss_pred ---------------CCC-CC------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 463 ---------------SSL-HL------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 463 ---------------~~~-~~------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
... .. ..+..+++.+.+||.+||+.||.+|||+.++++|||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 000 00 1124568899999999999999999999999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=357.99 Aligned_cols=248 Identities=32% Similarity=0.545 Sum_probs=209.4
Q ss_pred ccccccccccccccCCCCcceEEEeEe------eceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
..+....|++++.||+|+||.||+|++ .++.||+|++.. .+.+|+.++++++||||+++++++...
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 344557799999999999999999984 468999999863 346799999999999999999999776
Q ss_pred --CceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 322 --PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 322 --~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 678999999999999999944 56799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCC--------------ChHHHHHHh
Q psy16430 399 WNNKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDV--------------DSSAIIWGV 460 (600)
Q Consensus 399 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~--------------~~~~~~~~i 460 (600)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..|+... .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654432 23456888999999999989999999999999999999999886432 111122222
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 461 GSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 461 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.......+.+..+++.+.+||.+||+.||.+|||+.++++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2334456678889999999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=365.51 Aligned_cols=243 Identities=21% Similarity=0.272 Sum_probs=206.4
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeecc-----chHHHHHHHHhc-CCCCcccccceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-----QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-----~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
++|++.+.||+|+||.||+|+. .++.||||++.. .+.+|+.+++++ +||||+++++++......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 7899999999999999999985 479999999853 467899999999 9999999999999999999999999
Q ss_pred cccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC-----ceeeccCccccccCCCC--
Q psy16430 333 YGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE-----AKISDFGTCREWNNKST-- 404 (600)
Q Consensus 333 ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~-----vkL~DFGla~~~~~~~~-- 404 (600)
+++|.+++.. ++.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~ 167 (330)
T 2izr_A 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK 167 (330)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc
Confidence 8999999975 467999999999999999999999999999999999999998876 99999999987654322
Q ss_pred ------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCCCC---CCCC
Q psy16430 405 ------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLHLP---IPST 472 (600)
Q Consensus 405 ------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~---~p~~ 472 (600)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ......+.......+ ....
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (330)
T 2izr_A 168 HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCEN 247 (330)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhcc
Confidence 2356799999999999999999999999999999999999999987543 233333322211111 1234
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+| .+.++|..||+.||.+||++++|++.+.-.
T Consensus 248 ~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 248 FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 56 999999999999999999999999987633
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=356.61 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=209.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-----------chHHHHHHHHhcCCCCccccccee--ecCCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-----------QKETDIRHLRKLNHPNIVKFKGVC--TQAPCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-----------~~~~Ei~~L~~L~HpnIv~l~~~~--~~~~~~~ 325 (600)
++|++.+.||+|+||.||+|... +..||+|++.. .+.+|+.++++++||||+++++++ .+....|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 68999999999999999999874 68999999853 235789999999999999999998 4556889
Q ss_pred EEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 326 IVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
+||||++++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999876 6666543 4579999999999999999999999999999999999999999999999999998764322
Q ss_pred ---CCcccCCCccccChhhhccCCC--CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRNEQC--SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~~~~--s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
......||+.|+|||++.+... +.++||||||+++|+|++|..||.+.+.......+.... ...+..+++.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~l~ 241 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIPGDCGPPLS 241 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCCSSSCHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--CCCCCccCHHHH
Confidence 2234578999999999976443 779999999999999999999999988877777665554 345678999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+||.+||+.||.+|||+.++++|+|+....
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 999999999999999999999999997653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=369.16 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=206.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC-----Ccee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA-----PCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~-----~~~~ 325 (600)
.+|++++.||+|+||.||+|... +..||||++.. .+.+|++++++++||||+++++++... ...|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 68999999999999999999864 68999999862 345799999999999999999998654 4689
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
+||||++ |+|.++++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 9999997 589988875 4599999999999999999999999999999999999999999999999999987653322
Q ss_pred ---CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-----------------
Q psy16430 405 ---KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----------------- 463 (600)
Q Consensus 405 ---~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----------------- 463 (600)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 234589999999998754 55899999999999999999999999887765444332110
Q ss_pred -------CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 -------SLHLP-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 -------~~~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..... ....+++.+.+||.+||+.||.+|||+.++++|||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 124578899999999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.38 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=206.2
Q ss_pred cccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
...|+++ ++|.+.+.||+|+||.||+|... ++.||||++.. .+.+|+.+++.++||||+++++++...
T Consensus 35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 3456665 78999999999999999999864 78999999863 235799999999999999999999877
Q ss_pred Cce------eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 322 PCY------CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 322 ~~~------~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
... |+||||+. ++|.+++. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 654 99999997 67888774 3499999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC----------
Q psy16430 396 CREWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS---------- 464 (600)
Q Consensus 396 a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~---------- 464 (600)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 191 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 191 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 9865433 234678999999999877 788999999999999999999999999887655544332100
Q ss_pred -------------CCC------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 -------------LHL------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 -------------~~~------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
... ..+..+++.+.+||.+||+.||.+|||+.++++|+||...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 1124578999999999999999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=358.73 Aligned_cols=242 Identities=26% Similarity=0.431 Sum_probs=206.6
Q ss_pred cccccccccccccCCCCcceEEEeEeec---------eEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRS---------EIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
++..++|++.+.||+|+||.||+|.... ..||+|.+.. .+.+|+.++++++||||+++++++.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 4667899999999999999999998653 5799999853 24578999999999999999999999
Q ss_pred CCceeEEEeeeccccchhhccCCCC-CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC--------ceee
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE--------AKIS 391 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~-l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~--------vkL~ 391 (600)
.+..++||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999999977554 999999999999999999999999999999999999998877 9999
Q ss_pred ccCccccccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCC
Q psy16430 392 DFGTCREWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPI 469 (600)
Q Consensus 392 DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 469 (600)
|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......... ....
T Consensus 164 Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~---~~~~ 237 (289)
T 4fvq_A 164 DPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED---RHQL 237 (289)
T ss_dssp CCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---TCCC
T ss_pred cCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc---cCCC
Confidence 99998754322 23457899999999987 778999999999999999999 5566666655544433322 2344
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 470 PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 470 p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+...++.+.+||.+||+.||.+|||+.++++++.-
T Consensus 238 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 56668889999999999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=377.83 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=204.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---hHHHHHHHHhcCCCCcccccceeecC------CceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVCTQA------PCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---~~~Ei~~L~~L~HpnIv~l~~~~~~~------~~~~lV~E 329 (600)
.+|++.+.||+|+||.||+|++. ++.||||++... ..+|+++|++++||||+++++++... ..+++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 46899999999999999999974 789999998643 35799999999999999999988432 24679999
Q ss_pred eeccccchhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccccCCCC
Q psy16430 330 YCAYGPLYNLLK----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNNKST 404 (600)
Q Consensus 330 y~~ggsL~~~l~----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~ 404 (600)
|+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 212 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC
Confidence 9986 5555543 35679999999999999999999999999999999999999965 5689999999987765555
Q ss_pred CcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC-----------------CCCC
Q psy16430 405 KMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-----------------SSLH 466 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-----------------~~~~ 466 (600)
.....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+....+..+.. ....
T Consensus 213 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~ 292 (420)
T 1j1b_A 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292 (420)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCC
T ss_pred ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhc
Confidence 5567899999999998764 789999999999999999999999998876544433211 0011
Q ss_pred CC----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 467 LP----------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 467 ~~----------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+ ++..+++.+.+||.+||..||.+|||+.++++|+||...
T Consensus 293 ~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 11 234578999999999999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.18 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=210.2
Q ss_pred ccccccccccCCCCcceEEEeEee---ceEEEeeeecc---------chHHHHHHHHhc---CCCCcccccceee-----
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR---SEIVAVKKVRE---------QKETDIRHLRKL---NHPNIVKFKGVCT----- 319 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~---------~~~~Ei~~L~~L---~HpnIv~l~~~~~----- 319 (600)
.++|++.+.||+|+||.||+|+.. ++.||+|+++. ...+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999873 68999998852 345788777766 8999999999986
Q ss_pred cCCceeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.....++||||++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5567899999997 6899988653 359999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----C---------
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----S--------- 464 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----~--------- 464 (600)
............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 766544445577999999999999989999999999999999999999999988776554433210 0
Q ss_pred ------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 ------------LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+..+++.+.+||.+||..||.+|||+.++++|+|+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0001235678999999999999999999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=358.61 Aligned_cols=243 Identities=29% Similarity=0.470 Sum_probs=199.9
Q ss_pred ccccccccccCCCCcceEEEeEeeceEEEeeeeccch----HHHHHHHHh--cCCCCcccccceeec----CCceeEEEe
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK----ETDIRHLRK--LNHPNIVKFKGVCTQ----APCYCIVME 329 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~----~~Ei~~L~~--L~HpnIv~l~~~~~~----~~~~~lV~E 329 (600)
.++|++.+.||+|+||.||+|+++++.||||++.... ..|.+++.. ++||||+++++++.. ....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 4789999999999999999999999999999986543 346666666 799999999998643 345899999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhH--------hCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH--------SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH--------~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
|+++|+|.++++. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 165 (301)
T 3q4u_A 87 YHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165 (301)
T ss_dssp CCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred hccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence 9999999999965 46999999999999999999999 99999999999999999999999999999976654
Q ss_pred CCC-----CcccCCCccccChhhhccC------CCCCccceechhHHHHHHhhC----------CCCCCCCCh-----HH
Q psy16430 402 KST-----KMSFAGTVAWMAPEVIRNE------QCSDKIDIWSYGIVLWELLTC----------ETPYKDVDS-----SA 455 (600)
Q Consensus 402 ~~~-----~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGviLyELltG----------~~Pf~~~~~-----~~ 455 (600)
... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||..... ..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~ 245 (301)
T 3q4u_A 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245 (301)
T ss_dssp TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh
Confidence 332 2235799999999999876 445799999999999999999 889865322 22
Q ss_pred HHHHhcCCCCCCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 456 IIWGVGSSSLHLPIP-----STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p-----~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
....+.........| ..+++.+.+||.+||+.||.+|||+.++++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 222232233333333 235688999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=364.68 Aligned_cols=247 Identities=29% Similarity=0.601 Sum_probs=210.2
Q ss_pred ccccccccccccCCCCcceEEEeEee--ce----EEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SE----IVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~----~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
+..++|++.+.||+|+||.||+|++. ++ .||+|.++. .+.+|+.++++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 34578999999999999999999864 33 468887642 3457999999999999999999998754
Q ss_pred eeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.++||+|+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 7899999999999999876 467999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 403 STK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 403 ~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ...+.+..++..+.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVY 249 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTBCHHHH
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-CCCCCCccCCHHHH
Confidence 322 23456889999999999999999999999999999999 99999988877666555443 34566788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+++.+||+.||.+|||+.++++++....
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 9999999999999999999999986543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=368.85 Aligned_cols=246 Identities=16% Similarity=0.208 Sum_probs=197.3
Q ss_pred cccccccccccCCCCcceEEEeEe-----eceEEEeeeeccc------------------hHHHHHHHHhcCCCCccccc
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVREQ------------------KETDIRHLRKLNHPNIVKFK 315 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~~------------------~~~Ei~~L~~L~HpnIv~l~ 315 (600)
..++|++.+.||+|+||.||+|.. .+..||+|++... +.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 347899999999999999999987 4588999988532 12456677888999999999
Q ss_pred ceeec----CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC--Cce
Q psy16430 316 GVCTQ----APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE--EAK 389 (600)
Q Consensus 316 ~~~~~----~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~--~vk 389 (600)
+++.. ....|+||||+ +++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99877 77899999999 999999998877899999999999999999999999999999999999998877 999
Q ss_pred eeccCccccccCCCC--------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCC--ChHHHHHH
Q psy16430 390 ISDFGTCREWNNKST--------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDV--DSSAIIWG 459 (600)
Q Consensus 390 L~DFGla~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~--~~~~~~~~ 459 (600)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +.......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999987643221 13457999999999999989999999999999999999999999653 22211111
Q ss_pred hcC--CCCCC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 460 VGS--SSLHL-----PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 460 i~~--~~~~~-----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
... ..... ..+..+|+.+.++|.+||..||.+|||+.+|++.+.-.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 100 00000 01227889999999999999999999999999998643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=362.45 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=190.9
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHH-HHHhcCCCCcccccceeec
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIR-HLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~-~L~~L~HpnIv~l~~~~~~ 320 (600)
....|.+..++|++++.||+|+||.||+|... ++.||||++... ...|+. +++.++||||+++++++..
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 34568888999999999999999999999975 799999998642 123444 5667799999999999999
Q ss_pred CCceeEEEeeeccccchhhccC-----CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccC
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKD-----GEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFG 394 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~-----~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFG 394 (600)
.+..++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999985 77777652 56799999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCccccChhhh----ccCCCCCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCC---C
Q psy16430 395 TCREWNNKSTKMSFAGTVAWMAPEVI----RNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSL---H 466 (600)
Q Consensus 395 la~~~~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~---~ 466 (600)
++.............||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.... .....+..+.. .
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 99877655444455799999999998 4567899999999999999999999999875432 22222222211 1
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 467 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
...+..+++.+.+||.+||+.||.+|||+.++++|+|+....
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 112246899999999999999999999999999999997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=375.13 Aligned_cols=250 Identities=14% Similarity=0.100 Sum_probs=190.0
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch----------HHHHHHHHhc--CCCCccccc-----
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK----------ETDIRHLRKL--NHPNIVKFK----- 315 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~----------~~Ei~~L~~L--~HpnIv~l~----- 315 (600)
.+.....+|++.+.||+|+||.||+|++. ++.||||++.... .+|+.+++.| +||||++++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 34455567999999999999999999864 7899999987522 3564434444 699988755
Q ss_pred --ceeecC-----------------CceeEEEeeeccccchhhccCC-CCCCHHHH------HHHHHHHHHHHHHhHhCC
Q psy16430 316 --GVCTQA-----------------PCYCIVMEYCAYGPLYNLLKDG-EEVPPQRL------YNWARQIAAGMNYLHSKQ 369 (600)
Q Consensus 316 --~~~~~~-----------------~~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i------~~i~~qIl~aL~~LH~~g 369 (600)
+++... ..+|+||||++ |+|.+++... ..++.... ..++.||+.||.|||++|
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 444332 23799999998 8999999763 34455555 677799999999999999
Q ss_pred ccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCC
Q psy16430 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETP 447 (600)
Q Consensus 370 IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~P 447 (600)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999998764322 14567799999999987 7899999999999999999999999
Q ss_pred CCCCChHHHH-------HHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 448 YKDVDSSAII-------WGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 448 f~~~~~~~~~-------~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|.+....... ..........+.+..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9876432110 00111223334446889999999999999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=361.84 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=205.8
Q ss_pred ccccccccccCCCCcceEEEeEe---eceEEEeeeecc------chHHHHHHHHhcCCC------CcccccceeecCCce
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL---RSEIVAVKKVRE------QKETDIRHLRKLNHP------NIVKFKGVCTQAPCY 324 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~---~~~~vAvK~~~~------~~~~Ei~~L~~L~Hp------nIv~l~~~~~~~~~~ 324 (600)
.++|++.+.||+|+||.||+|.. .++.||||+++. ...+|+.+++.++|+ +|+++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 36899999999999999999976 468999999864 345788888888655 599999999999999
Q ss_pred eEEEeeeccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC------------------
Q psy16430 325 CIVMEYCAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS------------------ 384 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~------------------ 384 (600)
|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999 789999987654 6899999999999999999999999999999999999987
Q ss_pred -CCCceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC
Q psy16430 385 -KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS 463 (600)
Q Consensus 385 -~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~ 463 (600)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 249 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249 (339)
T ss_dssp SCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred cCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 668999999999865432 23567999999999999999999999999999999999999999987765543322110
Q ss_pred CC------------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHc
Q psy16430 464 SL------------------------------------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501 (600)
Q Consensus 464 ~~------------------------------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~ 501 (600)
.. ....+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 00 001122346789999999999999999999999999
Q ss_pred Hhhhh
Q psy16430 502 LDIAS 506 (600)
Q Consensus 502 l~~~~ 506 (600)
+|+..
T Consensus 330 p~f~~ 334 (339)
T 1z57_A 330 PFFDL 334 (339)
T ss_dssp GGGGG
T ss_pred HHHHH
Confidence 99965
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=359.60 Aligned_cols=250 Identities=32% Similarity=0.534 Sum_probs=210.0
Q ss_pred cccccccccccccCCCCcceEEEeEe------eceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec--
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ-- 320 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~-- 320 (600)
.+....|++++.||+|+||.||++.+ .++.||||++... +.+|+.++++++||||+++++++.+
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 34444559999999999999988864 4688999998643 4679999999999999999999976
Q ss_pred CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
...+++||||+++|+|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 45789999999999999999765 49999999999999999999999999999999999999999999999999998775
Q ss_pred CCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH--------------HHHHhcC
Q psy16430 401 NKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA--------------IIWGVGS 462 (600)
Q Consensus 401 ~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~--------------~~~~i~~ 462 (600)
.... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 4332 224568889999999999889999999999999999999999997543211 1112223
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 463 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+.+..+++.+.+||++||+.||.+|||+.++++.+.-...
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 344566788899999999999999999999999999998865443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.11 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=183.7
Q ss_pred ccccccc-ccCCCCcceEEEeEee--ceEEEeeeeccch--HHHH-HHHHhcCCCCcccccceeec----CCceeEEEee
Q psy16430 261 ESISDLQ-WLGSGAQGAVFSGKLR--SEIVAVKKVREQK--ETDI-RHLRKLNHPNIVKFKGVCTQ----APCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~-~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~--~~Ei-~~L~~L~HpnIv~l~~~~~~----~~~~~lV~Ey 330 (600)
++|.+++ .||+|+||.||+|... ++.||||++.... ..|+ ..++.+.||||+++++++.. ....++||||
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 6788865 6999999999999876 7899999996543 2333 34667799999999999865 4558999999
Q ss_pred eccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCceeeccCccccccCCCCC
Q psy16430 331 CAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~~~~ 405 (600)
++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... ..
T Consensus 108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~ 186 (336)
T 3fhr_A 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-AL 186 (336)
T ss_dssp CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-cc
Confidence 99999999997643 6999999999999999999999999999999999999976 455999999999866433 22
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHH----HHhcCCCC--CCCCCCCCcHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAII----WGVGSSSL--HLPIPSTCPDGFQL 479 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~----~~i~~~~~--~~~~p~~~~~~l~~ 479 (600)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... ..+..... ..+....+++.+.+
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (336)
T 3fhr_A 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQ 266 (336)
T ss_dssp -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHH
T ss_pred ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHH
Confidence 3467899999999998888999999999999999999999999876554332 11222222 22233578999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhhhhhcc
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQEVLRI 512 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~~~ 512 (600)
||.+||+.||.+|||+.++++|||+........
T Consensus 267 li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 299 (336)
T 3fhr_A 267 LIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299 (336)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred HHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence 999999999999999999999999987654443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=353.47 Aligned_cols=241 Identities=29% Similarity=0.536 Sum_probs=209.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeec---cchHHHHHHHHhcCCCCcccccceeec---------------
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR---EQKETDIRHLRKLNHPNIVKFKGVCTQ--------------- 320 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~---~~~~~Ei~~L~~L~HpnIv~l~~~~~~--------------- 320 (600)
.+|++.+.||+|+||.||+|+.. ++.||+|.+. ....+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 57899999999999999999975 7899999986 356789999999999999999998854
Q ss_pred -CCceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 321 -APCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 321 -~~~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
....++||||+++++|.+++.. +..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 170 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence 4458999999999999999964 3579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
............||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+... ..+..++..+
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~ 244 (284)
T 2a19_B 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG----IISDIFDKKE 244 (284)
T ss_dssp ESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT----CCCTTSCHHH
T ss_pred eccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc----cccccCCHHH
Confidence 876655555677999999999999999999999999999999999999987532 1222222222 3456788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.++|.+||+.||.+|||+.+++++++....
T Consensus 245 ~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 245 KTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 999999999999999999999999986543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=360.95 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=205.2
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
..|+++ ++|.+.+.||+|+||.||+|... ++.||||++.. .+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 345554 78999999999999999999864 79999999853 2357899999999999999999997765
Q ss_pred c------eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 323 C------YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 323 ~------~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
. +|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred ccccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4 499999997 688888753 4999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC------------
Q psy16430 397 REWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS------------ 463 (600)
Q Consensus 397 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~------------ 463 (600)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 865432 234678999999999877 67899999999999999999999999987765443332110
Q ss_pred --------------C---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 --------------S---LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 --------------~---~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
. .....+..+++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 0012235678999999999999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=374.89 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=205.5
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhc------CCCCcccccceeecCCcee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKL------NHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L------~HpnIv~l~~~~~~~~~~~ 325 (600)
..+|++++.||+|+||.||+|... ++.||||+++.. ..+|+.+++.+ +|+||+++++++......|
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 357999999999999999999865 689999999643 34688888777 6789999999999999999
Q ss_pred EEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC--ceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE--AKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~--vkL~DFGla~~~~~ 401 (600)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.....
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9999996 6888888654 35999999999999999999999999999999999999999887 99999999976543
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC------------------
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS------------------ 463 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~------------------ 463 (600)
. ..+..||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+....+..+...
T Consensus 255 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~ 332 (429)
T 3kvw_A 255 R--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF 332 (429)
T ss_dssp C--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred c--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence 2 33568999999999999999999999999999999999999999988765554332110
Q ss_pred ----CCC---------------------------C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 464 ----SLH---------------------------L--------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 464 ----~~~---------------------------~--------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
... . .++...++.+.+||++||+.||.+|||+.|+|+|||+
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412 (429)
T ss_dssp BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence 000 0 0112347889999999999999999999999999999
Q ss_pred hhh
Q psy16430 505 ASQ 507 (600)
Q Consensus 505 ~~~ 507 (600)
...
T Consensus 413 ~~~ 415 (429)
T 3kvw_A 413 RRR 415 (429)
T ss_dssp C--
T ss_pred ccC
Confidence 764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.44 Aligned_cols=249 Identities=31% Similarity=0.560 Sum_probs=210.3
Q ss_pred ccccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
..+..++|++.+.||+|+||.||+|++. ...||+|+++. .+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 3456689999999999999999999863 23699998853 23578999999999999999999977
Q ss_pred CCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
.. .++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 65 8899999999999999875 356999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 400 NNKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 400 ~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+.......+.+..+|
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 54332 123457889999999998889999999999999999999 9999999988888877777666677788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+.+.++|.+||..||.+|||+.++++++.-.
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=356.76 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=212.2
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc---------chHHHHHHHHhcC--CCCcccccceee
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE---------QKETDIRHLRKLN--HPNIVKFKGVCT 319 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~---------~~~~Ei~~L~~L~--HpnIv~l~~~~~ 319 (600)
....+.+..++|++++.||+|+||.||+|... ++.||+|++.. .+.+|+.++++++ ||||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 44556777789999999999999999999865 68899999852 2357899999997 599999999999
Q ss_pred cCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
.....|+||| +.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++...
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 9999999999 56789999998888899999999999999999999999999999999999995 589999999999876
Q ss_pred cCCCC---CcccCCCccccChhhhcc-----------CCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCC
Q psy16430 400 NNKST---KMSFAGTVAWMAPEVIRN-----------EQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSS 464 (600)
Q Consensus 400 ~~~~~---~~~~~gt~~Y~APE~l~~-----------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~ 464 (600)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 54322 224578999999999865 4678899999999999999999999987543 33344444555
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 465 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+..++..+.++|.+||+.||.+|||+.++++|+|+...
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 5566778889999999999999999999999999999999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=369.64 Aligned_cols=250 Identities=14% Similarity=0.207 Sum_probs=200.0
Q ss_pred ccccccccccccCCCCcceEEEeEee-------ceEEEeeeeccch---HHH---------------HHHHHhcCCCCcc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQK---ETD---------------IRHLRKLNHPNIV 312 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~---~~E---------------i~~L~~L~HpnIv 312 (600)
+..++|++.+.||+|+||.||+|.+. ++.||||++.... ..| +..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34578999999999999999999864 3689999986432 233 3345566899999
Q ss_pred cccceeecC----CceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC--CC
Q psy16430 313 KFKGVCTQA----PCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG--SK 385 (600)
Q Consensus 313 ~l~~~~~~~----~~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~--~~ 385 (600)
++++++... ...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998654 4589999999 99999999764 6799999999999999999999999999999999999999 88
Q ss_pred CCceeeccCccccccCCCCC--------cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHH
Q psy16430 386 EEAKISDFGTCREWNNKSTK--------MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAII 457 (600)
Q Consensus 386 ~~vkL~DFGla~~~~~~~~~--------~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~ 457 (600)
+.+||+|||+++.+...... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 99999999999876432211 2345999999999999999999999999999999999999999864322111
Q ss_pred HHhcCCCCC---------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 458 WGVGSSSLH---------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 458 ~~i~~~~~~---------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
......... ...+..+|+.+.++|..||+.||.+|||+.+|++.+.-....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 110000000 011357789999999999999999999999999988654443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=354.97 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=195.6
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccch---------HHHHHHHHhcCCCCcccccceeecCC
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQK---------ETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~---------~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
..+.+..++|++++.||+|+||.||+|+.. ++.||||++.... ..+..+++.++||||+++++++....
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 456677789999999999999999999975 7899999986421 12334677889999999999999999
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
..++||||+ ++.+..+... ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 4555555543 56799999999999999999999995 99999999999999999999999999998765
Q ss_pred CCCCCcccCCCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCC-hHHHHHHhcCC-CCCCCCCCCC
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVD-SSAIIWGVGSS-SLHLPIPSTC 473 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~-~~~~~~~i~~~-~~~~~~p~~~ 473 (600)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||.... .......+... ....+....+
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence 554445567999999999984 4578899999999999999999999998743 33333333322 2223334568
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhhhc
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLR 511 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~~ 511 (600)
++.+.+||.+||+.||.+|||+.++++|+|+.......
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccccc
Confidence 99999999999999999999999999999997655433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=355.24 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=199.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceee------------
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCT------------ 319 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~------------ 319 (600)
++|++++.||+|+||.||+|... ++.||+|++.. .+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 68999999999999999999876 78999998853 3457999999999999999998873
Q ss_pred --cCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC-CCCCceeeccCcc
Q psy16430 320 --QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG-SKEEAKISDFGTC 396 (600)
Q Consensus 320 --~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~-~~~~vkL~DFGla 396 (600)
+....|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 4467899999997 689998865 5689999999999999999999999999999999999997 5679999999999
Q ss_pred ccccCCC----CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC------
Q psy16430 397 REWNNKS----TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL------ 465 (600)
Q Consensus 397 ~~~~~~~----~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~------ 465 (600)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 8764321 2234567999999999865 6789999999999999999999999998876555443322110
Q ss_pred ----------------C-C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 ----------------H-L-----PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ----------------~-~-----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
. . ..+..+++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred hhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 0 0 1124678999999999999999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.98 Aligned_cols=248 Identities=31% Similarity=0.552 Sum_probs=211.4
Q ss_pred ccccccccccccCCCCcceEEEeEe------eceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceee--cCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCT--QAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~--~~~ 322 (600)
+..++|++++.||+|+||.||+|++ .+..||||++... +.+|+.++++++||||+++++++. +..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4457899999999999999999984 4689999998632 467999999999999999999885 556
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 78999999999999999976 45699999999999999999999999999999999999999999999999999987654
Q ss_pred CCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH--------------HHHHHhcCC
Q psy16430 402 KST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS--------------AIIWGVGSS 463 (600)
Q Consensus 402 ~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~--------------~~~~~i~~~ 463 (600)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .........
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 322 22356888999999999988999999999999999999999998654332 111222233
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 464 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+.+..+++.+.+||.+||+.||.+|||+.++++++.-.
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 445567888999999999999999999999999999998644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=356.15 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=203.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++.+.||+|+||.||+|+.. ++.||+|++... +.+|+.++++++||||+++++++...+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999864 789999998532 35789999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--CC
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS--TK 405 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~ 405 (600)
|||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 9999999999999887889999999999999999999999999999999999999999999999999987765432 22
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHHh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~c 484 (600)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+..... ....+..+|+.+.++|.+|
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 272 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARG 272 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHH
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHh
Confidence 245789999999999998999999999999999999999999998766544443333221 2234577899999999999
Q ss_pred hhcCCCCCC-CHHHHHHcHhhh
Q psy16430 485 WSNAPSSRP-SFKQILSHLDIA 505 (600)
Q Consensus 485 L~~dP~~RP-s~~elL~~l~~~ 505 (600)
|+.||.+|| |++++++.+.-.
T Consensus 273 l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 273 MAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp TCSSGGGSCSSHHHHHHHHHHT
T ss_pred ccCCHHHHHHhHHHHHHHHHHH
Confidence 999999999 999999887643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.71 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=192.9
Q ss_pred ccccccccccccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcC-CCCcccccceee--
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLN-HPNIVKFKGVCT-- 319 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~-HpnIv~l~~~~~-- 319 (600)
....+++...+|++.+.||+|+||.||+|++ .++.||||++.. .+.+|+.+++++. ||||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 19 VGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp TTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred hcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 3456677778999999999999999999997 578999998843 2457889999996 999999999983
Q ss_pred ------cCCceeEEEeeeccccchhhccC---CCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccCCCCCc
Q psy16430 320 ------QAPCYCIVMEYCAYGPLYNLLKD---GEEVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 320 ------~~~~~~lV~Ey~~ggsL~~~l~~---~~~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~~~~~v 388 (600)
....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3445899999996 688888754 567999999999999999999999999 9999999999999999999
Q ss_pred eeeccCccccccCCCCC-------------cccCCCccccChhhh---ccCCCCCccceechhHHHHHHhhCCCCCCCCC
Q psy16430 389 KISDFGTCREWNNKSTK-------------MSFAGTVAWMAPEVI---RNEQCSDKIDIWSYGIVLWELLTCETPYKDVD 452 (600)
Q Consensus 389 kL~DFGla~~~~~~~~~-------------~~~~gt~~Y~APE~l---~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~ 452 (600)
||+|||++......... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876543211 135689999999998 56678899999999999999999999998765
Q ss_pred hHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 453 SSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 453 ~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
..... ......+.+..++..+.+||.+||+.||.+|||+.+++++++.....
T Consensus 258 ~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 258 KLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 44333 23334455667788899999999999999999999999999765543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=350.98 Aligned_cols=245 Identities=31% Similarity=0.567 Sum_probs=207.5
Q ss_pred ccccccccccCCCCcceEEEeEeec-----eEEEeeeecc--------chHHHHHHHHhcCCCCccccccee-ecCCcee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVC-TQAPCYC 325 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~-~~~~~~~ 325 (600)
..+|++.+.||+|+||.||+|+... ..||+|.+.. .+.+|+.++++++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568889999999999999998542 3689998853 245799999999999999999985 5566889
Q ss_pred EEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999999976 4568999999999999999999999999999999999999999999999999998664322
Q ss_pred ----CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 404 ----TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 404 ----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+.......+.... ....+..+|+.+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 262 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLY 262 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCCCCccCCHHHH
Confidence 1224567889999999999999999999999999999999 777888776665555554443 3455778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
++|.+||+.||.+|||+.++++.+.-.
T Consensus 263 ~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 263 EVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999988543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=349.16 Aligned_cols=252 Identities=27% Similarity=0.553 Sum_probs=210.6
Q ss_pred cccccc--ccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 256 WEIPFE--SISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 256 ~ei~~~--~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
+.++.+ .|...+.||+|+||.||+|++. +..||+|.+.. .+.+|+.++++++||||+++++++.+
T Consensus 14 ~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 344444 3456689999999999999853 24799999863 23578999999999999999999976
Q ss_pred CCce-eEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 321 APCY-CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 321 ~~~~-~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
.+.. ++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 6554 999999999999999976 45789999999999999999999999999999999999999999999999999986
Q ss_pred ccCC-----CCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCC
Q psy16430 399 WNNK-----STKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPST 472 (600)
Q Consensus 399 ~~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 472 (600)
.... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+.... ..+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 252 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-RLPQPEY 252 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-CCCCCTT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-CCCCCcc
Confidence 5432 12234568899999999999999999999999999999999 566666666666555554433 4566788
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+++.+.++|.+||+.||.+|||+.++++.+.-....
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998654433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=358.61 Aligned_cols=247 Identities=29% Similarity=0.607 Sum_probs=206.5
Q ss_pred ccccccccccccCCCCcceEEEeEee--ce----EEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SE----IVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~----~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
+..++|++++.||+|+||.||+|.+. ++ .||+|.+.. .+.+|+.++++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 34578999999999999999999864 33 457776632 3467999999999999999999998754
Q ss_pred eeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
.++||+|+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 7899999999999999875 457999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 403 STK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 403 ~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ...+.+..++..+.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 249 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVY 249 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTBCHHHH
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHH
Confidence 222 23456889999999999999999999999999999999 99999998877766655444 34566788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+||.+||..||.+|||+.++++.+.-..
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999886543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.72 Aligned_cols=249 Identities=24% Similarity=0.428 Sum_probs=200.7
Q ss_pred cccccccccccCCCCcceEEEeEe--eceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
...+|++.+.||+|+||.||+|.. .++.||+|++.. .+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999986 478999998853 23579999999999999999999999999999
Q ss_pred EEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 327 VMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999998863 567999999999999999999999999999999999999999999999999998876543
Q ss_pred CC-CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC--hHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 ST-KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD--SSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+.........+..+++.+.+
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 22 234578999999999999899999999999999999999999997643 334444454444443444678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||.+||+.||.+|||+.++++++.-...
T Consensus 270 li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 270 LVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999864443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=360.91 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=204.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC-----Ccee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA-----PCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~-----~~~~ 325 (600)
++|++.+.||+|+||.||+|+.. ++.||||++.. ...+|+.++++++||||+++++++... ...|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 78999999999999999999875 78999999853 234799999999999999999987653 6789
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST- 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 404 (600)
+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 9999997 589888876 4699999999999999999999999999999999999999999999999999987643211
Q ss_pred ----------CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---CCC-----
Q psy16430 405 ----------KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS---SSL----- 465 (600)
Q Consensus 405 ----------~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~---~~~----- 465 (600)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.. ...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence 123578999999998764 6789999999999999999999999998876544332210 000
Q ss_pred ----------------CCC------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 ----------------HLP------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 ----------------~~~------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..+ .+..+++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 124678999999999999999999999999999999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.03 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=197.3
Q ss_pred cccccccccccccccCCCCcceEEEeEeeceEEEeeeeccch----HHH--HHHHHhcCCCCcccccceee-----cCCc
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK----ETD--IRHLRKLNHPNIVKFKGVCT-----QAPC 323 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~----~~E--i~~L~~L~HpnIv~l~~~~~-----~~~~ 323 (600)
.+.++.++|++.+.||+|+||.||+|+..++.||||++.... ..| +..+..++||||+++++.+. ....
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 456778999999999999999999999999999999986432 233 33344589999999997542 3336
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC---------CccccCCCCCCcccCCCCCceeeccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK---------QIIHRDLKSPNVLIGSKEEAKISDFG 394 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~---------gIvHrDIKp~NILl~~~~~vkL~DFG 394 (600)
+|+||||+++|+|.+++.... .++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 789999999999999997644 58899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC---------CCcccCCCccccChhhhcc-------CCCCCccceechhHHHHHHhhCCCCCCCCCh-----
Q psy16430 395 TCREWNNKS---------TKMSFAGTVAWMAPEVIRN-------EQCSDKIDIWSYGIVLWELLTCETPYKDVDS----- 453 (600)
Q Consensus 395 la~~~~~~~---------~~~~~~gt~~Y~APE~l~~-------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~----- 453 (600)
++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998764321 1224579999999999976 4566789999999999999999766533211
Q ss_pred -------------HHHHHHhcCCCCCCCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 454 -------------SAIIWGVGSSSLHLPIPST------CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 454 -------------~~~~~~i~~~~~~~~~p~~------~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
......+........+|.. +++.+.+||.+||+.||.+|||+.++++.+.-..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1111222222333333333 4568999999999999999999999999886443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.93 Aligned_cols=242 Identities=22% Similarity=0.311 Sum_probs=197.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcC--------CCCcccccceee----c
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLN--------HPNIVKFKGVCT----Q 320 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~--------HpnIv~l~~~~~----~ 320 (600)
++|++.+.||+|+||+||+|+.. ++.||||++... ..+|+.+++.+. ||||+++++++. .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 78999999999999999999764 789999999643 357899998885 788999999987 5
Q ss_pred CCceeEEEeeeccccchhhc-cCC-CCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccCCCC-----------
Q psy16430 321 APCYCIVMEYCAYGPLYNLL-KDG-EEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIGSKE----------- 386 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l-~~~-~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~~~~----------- 386 (600)
....|+||||+. ++|.+.+ ... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 117 GTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp EEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred CceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 668999999995 4555554 332 5699999999999999999999999 999999999999998775
Q ss_pred --------------------------------------CceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCc
Q psy16430 387 --------------------------------------EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428 (600)
Q Consensus 387 --------------------------------------~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k 428 (600)
.+||+|||++...... .....||+.|+|||++.+..++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~ 273 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTP 273 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcH
Confidence 7999999999876543 334679999999999999999999
Q ss_pred cceechhHHHHHHhhCCCCCCCCCh------HHHHHHh----cCC--------CC-------------------------
Q psy16430 429 IDIWSYGIVLWELLTCETPYKDVDS------SAIIWGV----GSS--------SL------------------------- 465 (600)
Q Consensus 429 sDIwSlGviLyELltG~~Pf~~~~~------~~~~~~i----~~~--------~~------------------------- 465 (600)
+|||||||++|+|++|..||.+.+. ......+ ... ..
T Consensus 274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (397)
T 1wak_A 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353 (397)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence 9999999999999999999986542 1111111 000 00
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 466 ---HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 466 ---~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+...++.+.+||.+||+.||.+|||+.++|+|+||.
T Consensus 354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0011233457789999999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=357.41 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=206.3
Q ss_pred cccccccccccccccccccCCCCcceEEEeEe--eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceee--
Q psy16430 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCT-- 319 (600)
Q Consensus 251 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~-- 319 (600)
...+.+.++.++|++.+.||+|+||.||+++. .++.||||++.. .+.+|+.+++.++||||+++++++.
T Consensus 19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 34456677889999999999999999999985 478999998843 3457999999999999999999986
Q ss_pred --cCCceeEEEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeecc
Q psy16430 320 --QAPCYCIVMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDF 393 (600)
Q Consensus 320 --~~~~~~lV~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DF 393 (600)
.....++||||+++|+|.+++.. +..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 34478999999999999998864 567999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCC----------cccCCCccccChhhhccCC---CCCccceechhHHHHHHhhCCCCCCCCCh--HHHHH
Q psy16430 394 GTCREWNNKSTK----------MSFAGTVAWMAPEVIRNEQ---CSDKIDIWSYGIVLWELLTCETPYKDVDS--SAIIW 458 (600)
Q Consensus 394 Gla~~~~~~~~~----------~~~~gt~~Y~APE~l~~~~---~s~ksDIwSlGviLyELltG~~Pf~~~~~--~~~~~ 458 (600)
|++......... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 998765321111 1245799999999987543 68999999999999999999999954211 11111
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 459 GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 459 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+ ......+.+..+++.+.++|.+||+.||.+|||+.++++++.-
T Consensus 259 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 259 AV-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp HH-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Hh-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence 12 1233445567789999999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.72 Aligned_cols=244 Identities=27% Similarity=0.480 Sum_probs=200.2
Q ss_pred cccccccccCCCCcceEEEeEeeceEEEeeeeccch----HHHHHHHHh--cCCCCcccccceeecC----CceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK----ETDIRHLRK--LNHPNIVKFKGVCTQA----PCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~----~~Ei~~L~~--L~HpnIv~l~~~~~~~----~~~~lV~Ey 330 (600)
++|++.+.||+|+||.||+|+.+++.||||++.... ..|.+++.. ++||||+++++++... ...|+||||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 689999999999999999999999999999986432 234455544 4899999999998776 678999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC--------CccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK--------QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~--------gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
+++|+|.++++.. .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 195 (337)
T 3mdy_A 117 HENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195 (337)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccc
Confidence 9999999999764 699999999999999999999999 9999999999999999999999999999766433
Q ss_pred CCC-----cccCCCccccChhhhccCCCCCc------cceechhHHHHHHhhC----------CCCCCCCCh-----HHH
Q psy16430 403 STK-----MSFAGTVAWMAPEVIRNEQCSDK------IDIWSYGIVLWELLTC----------ETPYKDVDS-----SAI 456 (600)
Q Consensus 403 ~~~-----~~~~gt~~Y~APE~l~~~~~s~k------sDIwSlGviLyELltG----------~~Pf~~~~~-----~~~ 456 (600)
... ....||+.|+|||++.+..++.. +|||||||++|||++| ..||..... ...
T Consensus 196 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 275 (337)
T 3mdy_A 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275 (337)
T ss_dssp -------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred cccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhh
Confidence 221 24579999999999988766665 9999999999999999 777765321 223
Q ss_pred HHHhcCCCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 457 IWGVGSSSLHLPIPS-----TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~-----~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
...+.........+. .+++.+.+||.+||+.||.+|||+.++++++.-.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 333333333333433 5678899999999999999999999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=348.68 Aligned_cols=247 Identities=20% Similarity=0.293 Sum_probs=205.3
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeec-----cchHHHHHHHHhcCCCCccccccee-ecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVR-----EQKETDIRHLRKLNHPNIVKFKGVC-TQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~-----~~~~~Ei~~L~~L~HpnIv~l~~~~-~~~~~~~lV~Ey~~ 332 (600)
++|++.+.||+|+||.||+|+. .++.||||++. ..+.+|+.+++.++|++++..+..+ ......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 7899999999999999999995 47999999875 3457899999999998877766655 6677889999999
Q ss_pred cccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC---CCCCceeeccCccccccCCCC----
Q psy16430 333 YGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG---SKEEAKISDFGTCREWNNKST---- 404 (600)
Q Consensus 333 ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~~~---- 404 (600)
+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence 899999997 356799999999999999999999999999999999999994 788999999999987654332
Q ss_pred ----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCCCC---CCCCCc
Q psy16430 405 ----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLHLP---IPSTCP 474 (600)
Q Consensus 405 ----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~---~p~~~~ 474 (600)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+.......+ .+..+|
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T 3uzp_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 247 (296)
T ss_dssp CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSC
T ss_pred ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCC
Confidence 2346799999999999999999999999999999999999999986432 112222211111111 236788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
+.+.++|.+||+.||.+|||+.++++.+.-....
T Consensus 248 ~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 248 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999988654433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=383.92 Aligned_cols=248 Identities=29% Similarity=0.553 Sum_probs=211.4
Q ss_pred ccccccccccccc-ccCCCCcceEEEeEee----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 255 EWEIPFESISDLQ-WLGSGAQGAVFSGKLR----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~-~LG~G~fG~Vy~a~~~----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
.|.+..+++.+.. .||+|+||.||+|.+. +..||||+++. .+.+|+++|++++|||||++++++..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 3555566666666 7999999999999864 46799999863 24679999999999999999999976
Q ss_pred CceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
+..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 568999999999999999865 4569999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC----cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 401 NKSTK----MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 401 ~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
..... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+. ..+.|..+|+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~ 566 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPP 566 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-CCCCCTTCCH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCH
Confidence 33221 12345689999999999999999999999999999998 999999988888777765543 5677889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
.+.+||.+||+.||.+|||+.+|++.+.-
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 99999999999999999999999887753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=348.11 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=203.4
Q ss_pred cccccccccCCCCcceEEEeEe--eceEEEeeeec-----cchHHHHHHHHhcCCCCccccccee-ecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVR-----EQKETDIRHLRKLNHPNIVKFKGVC-TQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~-----~~~~~Ei~~L~~L~HpnIv~l~~~~-~~~~~~~lV~Ey~~ 332 (600)
++|++.+.||+|+||.||+|+. .++.||||++. .....|+.+++.++|++++..++.+ ......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 6899999999999999999985 47899999864 3467899999999998887777665 6677889999999
Q ss_pred cccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc---CCCCCceeeccCccccccCCCC----
Q psy16430 333 YGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI---GSKEEAKISDFGTCREWNNKST---- 404 (600)
Q Consensus 333 ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~~~~---- 404 (600)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~ 167 (296)
T 4hgt_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence 8999999874 5679999999999999999999999999999999999999 7889999999999987654322
Q ss_pred ----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH---HHHHHhcCCCCCCC---CCCCCc
Q psy16430 405 ----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS---AIIWGVGSSSLHLP---IPSTCP 474 (600)
Q Consensus 405 ----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~---~~~~~i~~~~~~~~---~p~~~~ 474 (600)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. .....+.......+ ....+|
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T 4hgt_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 247 (296)
T ss_dssp CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSC
T ss_pred CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCC
Confidence 22467999999999999999999999999999999999999999874431 11111111111111 235678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.+.+||.+||+.||.+|||+.++++.+.-...
T Consensus 248 ~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 248 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 999999999999999999999999998864443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=386.93 Aligned_cols=247 Identities=30% Similarity=0.570 Sum_probs=211.6
Q ss_pred cccccccccccc-cccCCCCcceEEEeEee----ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 255 EWEIPFESISDL-QWLGSGAQGAVFSGKLR----SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 255 ~~ei~~~~~~~~-~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
.|.++...+.+. +.||+|+||.||+|.+. ++.||||+++. .+.+|+.+|++++|||||++++++..
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 455555555554 37999999999999653 57899999863 24579999999999999999999965
Q ss_pred CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
...++||||+++|+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 442 -~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 442 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred -CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 4588999999999999999888889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcH
Q psy16430 401 NKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPD 475 (600)
Q Consensus 401 ~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 475 (600)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+...+...+..+. ..+.|..+|+
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~ 599 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPR 599 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCH
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCH
Confidence 4321 123456889999999999999999999999999999998 999999998887777665543 5567889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 476 GFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 476 ~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+.+||..||+.||.+|||+.+|++.+.
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9999999999999999999999998875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=364.18 Aligned_cols=246 Identities=30% Similarity=0.560 Sum_probs=200.3
Q ss_pred cccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceee-cCCceeE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCT-QAPCYCI 326 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~-~~~~~~l 326 (600)
..|++.+.||+|+||.||+|++. ...||+|.++. .+.+|+.++++++||||+++++++. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34678899999999999999864 24689998853 2457889999999999999999864 4567899
Q ss_pred EEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC--
Q psy16430 327 VMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-- 403 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 403 (600)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999764 468899999999999999999999999999999999999999999999999998654322
Q ss_pred ---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.......+..+. ....|..+|+.+.+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~ 327 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYE 327 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHHHHH
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 1123457889999999999999999999999999999999 788998776655555544443 44567789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+|.+||+.||.+|||+.++++++.-...
T Consensus 328 li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 328 VMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999865443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=368.34 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=184.9
Q ss_pred cccc-ccccCCCCcceEEEeEee----ceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceee--cCCceeEEEe
Q psy16430 262 SISD-LQWLGSGAQGAVFSGKLR----SEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCT--QAPCYCIVME 329 (600)
Q Consensus 262 ~~~~-~~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~--~~~~~~lV~E 329 (600)
.|.+ .++||+|+||.||+|++. +..||||++.. ...+|+.+|++++||||+++++++. .....|+|||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 4555 457999999999999854 57899999863 3568999999999999999999994 4678999999
Q ss_pred eeccccchhhccC---------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc----CCCCCceeeccCcc
Q psy16430 330 YCAYGPLYNLLKD---------GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTC 396 (600)
Q Consensus 330 y~~ggsL~~~l~~---------~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl----~~~~~vkL~DFGla 396 (600)
|+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 997 477777642 1249999999999999999999999999999999999999 67789999999999
Q ss_pred ccccCCC----CCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChH---------HHHHHh--
Q psy16430 397 REWNNKS----TKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS---------AIIWGV-- 460 (600)
Q Consensus 397 ~~~~~~~----~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~---------~~~~~i-- 460 (600)
+...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.... ..+..+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 8765431 2234679999999999987 45899999999999999999999999765431 111111
Q ss_pred --cCCCCC--------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 461 --GSSSLH--------------------------------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 461 --~~~~~~--------------------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
...... .......++.+.+||.+||..||.+|||+.|+|+||||..
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 100000 0001122678899999999999999999999999999976
Q ss_pred hh
Q psy16430 507 QE 508 (600)
Q Consensus 507 ~~ 508 (600)
..
T Consensus 340 ~~ 341 (405)
T 3rgf_A 340 DP 341 (405)
T ss_dssp SS
T ss_pred CC
Confidence 53
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=360.15 Aligned_cols=248 Identities=11% Similarity=0.185 Sum_probs=204.7
Q ss_pred ccccccccccCCCCcceEEEeEee----------ceEEEeeeeccc--hHHHHHHHHhcCCCCccc--------------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR----------SEIVAVKKVREQ--KETDIRHLRKLNHPNIVK-------------- 313 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~----------~~~vAvK~~~~~--~~~Ei~~L~~L~HpnIv~-------------- 313 (600)
.++|++.+.||+|+||.||+|+.. ++.||+|.+... +.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 478999999999999999999864 578999999754 789999999999999988
Q ss_pred -ccceeec-CCceeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC--C
Q psy16430 314 -FKGVCTQ-APCYCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE--E 387 (600)
Q Consensus 314 -l~~~~~~-~~~~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~--~ 387 (600)
+++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 4556654 67889999999 99999999875 6799999999999999999999999999999999999999988 8
Q ss_pred ceeeccCccccccCCCC--------CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCC--hHHHH
Q psy16430 388 AKISDFGTCREWNNKST--------KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVD--SSAII 457 (600)
Q Consensus 388 vkL~DFGla~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~--~~~~~ 457 (600)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...+.
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 279 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM 279 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH
Confidence 99999999987643221 123579999999999999899999999999999999999999998754 22222
Q ss_pred HHh---cCCCCCCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhh
Q psy16430 458 WGV---GSSSLHLP----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 458 ~~i---~~~~~~~~----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~ 508 (600)
... ........ ....+++.+.+||.+||+.||.+|||+.++++.+.-....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 280 KQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 211 11111111 1125689999999999999999999999999998654443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.72 Aligned_cols=243 Identities=27% Similarity=0.478 Sum_probs=198.0
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeec------------
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQ------------ 320 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~------------ 320 (600)
++|++++.||+|+||.||+|+.. ++.||||++... +.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 57899999999999999999864 789999998642 3579999999999999999998754
Q ss_pred -CCceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 321 -APCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 321 -~~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
....|+||||+++|+|.+++.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 3568999999999999999975 34678899999999999999999999999999999999999999999999999886
Q ss_pred ccCC---------------CCCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCC-ChHHHHHHhc
Q psy16430 399 WNNK---------------STKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDV-DSSAIIWGVG 461 (600)
Q Consensus 399 ~~~~---------------~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~-~~~~~~~~i~ 461 (600)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||... +.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~ 242 (303)
T 1zy4_A 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLR 242 (303)
T ss_dssp TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcc
Confidence 5422 112345689999999999764 68999999999999999998 55432 2333333333
Q ss_pred CCC--CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 462 SSS--LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 462 ~~~--~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
... .....+...++.+.++|.+||+.||.+|||+.++++|+|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 332 233345677889999999999999999999999999999854
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=351.14 Aligned_cols=241 Identities=29% Similarity=0.442 Sum_probs=201.1
Q ss_pred cccccccCCCCcceEEEeEeeceEEEeeeecc-----------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
|...+.||+|+||.||+|...++.||+|++.. .+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 34458899999999999999999999998853 2457999999999999999999999999999999999
Q ss_pred ccccchhhccC---CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC---C
Q psy16430 332 AYGPLYNLLKD---GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST---K 405 (600)
Q Consensus 332 ~ggsL~~~l~~---~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~ 405 (600)
++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........ .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 99999998863 45699999999999999999999999999999999999999999999999999887654322 2
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH----HHHHhcCC---------CCCCCCCCC
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA----IIWGVGSS---------SLHLPIPST 472 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~----~~~~i~~~---------~~~~~~p~~ 472 (600)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... +...+... ......+..
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence 24578999999999865 57899999999999999999999998654321 11111111 011123344
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+++.+.+++.+||+.||.+|||+.++++++.-
T Consensus 272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 56789999999999999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=355.25 Aligned_cols=242 Identities=23% Similarity=0.425 Sum_probs=209.1
Q ss_pred cccccccccccccCCCCcceEEEeEe--eceEEEeeeeccc-------------hHHHHHHHHhcC--CCCcccccceee
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ-------------KETDIRHLRKLN--HPNIVKFKGVCT 319 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~-------------~~~Ei~~L~~L~--HpnIv~l~~~~~ 319 (600)
+.-.++|++.+.||+|+||.||+|.. .++.||||++... +.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457899999999999999999986 4789999998532 347999999996 599999999999
Q ss_pred cCCceeEEEeeecc-ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC-CCCCceeeccCccc
Q psy16430 320 QAPCYCIVMEYCAY-GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG-SKEEAKISDFGTCR 397 (600)
Q Consensus 320 ~~~~~~lV~Ey~~g-gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~-~~~~vkL~DFGla~ 397 (600)
..+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999975 89999998878899999999999999999999999999999999999998 77899999999998
Q ss_pred cccCCCCCcccCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ... .. ....+..+++.
T Consensus 199 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~----~~--~~~~~~~~~~~ 269 (320)
T 3a99_A 199 LLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII----RG--QVFFRQRVSSE 269 (320)
T ss_dssp ECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH----HC--CCCCSSCCCHH
T ss_pred cccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hhh----cc--cccccccCCHH
Confidence 765432 335679999999999987665 678999999999999999999997542 111 11 22356778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 9999999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=367.35 Aligned_cols=246 Identities=22% Similarity=0.448 Sum_probs=205.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC--ceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP--CYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~--~~~lV 327 (600)
.++|++.+.||+|+||.||+|++. ++.||||++.. ...+|+.++++++||||+++++++.... ..|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 478999999999999999999976 78999999863 2357999999999999999999987655 78999
Q ss_pred EeeeccccchhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc----CCCCCceeeccCcccccc
Q psy16430 328 MEYCAYGPLYNLLKDGE---EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTCREWN 400 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~---~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl----~~~~~vkL~DFGla~~~~ 400 (600)
|||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999999997643 39999999999999999999999999999999999999 777789999999998876
Q ss_pred CCCCCcccCCCccccChhhhcc--------CCCCCccceechhHHHHHHhhCCCCCCCCC----hHHHHHHhcCCCC---
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIRN--------EQCSDKIDIWSYGIVLWELLTCETPYKDVD----SSAIIWGVGSSSL--- 465 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSlGviLyELltG~~Pf~~~~----~~~~~~~i~~~~~--- 465 (600)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+..+..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 6555556789999999999865 567789999999999999999999996432 2333333322211
Q ss_pred ----------------CCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 466 ----------------HLP----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 466 ----------------~~~----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
..+ ++..+++.+.++|++||..||.+|||+.++++.+.-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 011 1233467899999999999999999999999888543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.31 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=205.6
Q ss_pred cccccccccCCCCcceEEEeEeeceEEEeeeeccc----hHHHHHHHHh--cCCCCcccccceeecCC----ceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ----KETDIRHLRK--LNHPNIVKFKGVCTQAP----CYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~----~~~Ei~~L~~--L~HpnIv~l~~~~~~~~----~~~lV~Ey 330 (600)
++|++.+.||+|+||.||+|+.+++.||||++... ...|++++.. ++||||+++++++.... ..|+||||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 68999999999999999999999999999999653 3467788877 79999999999998775 78999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhH--------hCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH--------SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH--------~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
+++|+|.+++.. ..+++..++.++.|++.||.||| +.||+||||||+|||++.++.+||+|||++......
T Consensus 122 ~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 200 (342)
T 1b6c_B 122 HEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200 (342)
T ss_dssp CTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred cCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccc
Confidence 999999999976 46899999999999999999999 899999999999999999999999999999876544
Q ss_pred CC-----CcccCCCccccChhhhccCC------CCCccceechhHHHHHHhhC----------CCCCCCCC-----hHHH
Q psy16430 403 ST-----KMSFAGTVAWMAPEVIRNEQ------CSDKIDIWSYGIVLWELLTC----------ETPYKDVD-----SSAI 456 (600)
Q Consensus 403 ~~-----~~~~~gt~~Y~APE~l~~~~------~s~ksDIwSlGviLyELltG----------~~Pf~~~~-----~~~~ 456 (600)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|++| ..||.... ....
T Consensus 201 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 280 (342)
T 1b6c_B 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280 (342)
T ss_dssp TTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHH
Confidence 32 23457999999999997652 33689999999999999999 78987642 2334
Q ss_pred HHHhcCCCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 457 IWGVGSSSLHLPIPS-----TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~-----~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
...+.........+. .+++.+.+||.+||+.||.+|||+.++++++.-.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 444444444444443 3457899999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.84 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=201.7
Q ss_pred cccccccccCCCCcceEEEeEee--c-eEEEeeeecc------chHHHHHHHHhcCCCC------cccccceeecCCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--S-EIVAVKKVRE------QKETDIRHLRKLNHPN------IVKFKGVCTQAPCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~-~~vAvK~~~~------~~~~Ei~~L~~L~Hpn------Iv~l~~~~~~~~~~~ 325 (600)
++|++.+.||+|+||.||+|... + ..||+|+++. ...+|+.++++++|++ ++.+++++...+..|
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 78999999999999999999864 3 7899999864 2356888999887655 899999999999999
Q ss_pred EEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc-------------------CC
Q psy16430 326 IVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI-------------------GS 384 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl-------------------~~ 384 (600)
+||||+. +++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 99 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 99 IAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp EEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred EEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence 9999995 5666665443 469999999999999999999999999999999999999 56
Q ss_pred CCCceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCC
Q psy16430 385 KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS 464 (600)
Q Consensus 385 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~ 464 (600)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 178 ~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 178 NTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp CCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 789999999999865432 235679999999999999999999999999999999999999999877654433221100
Q ss_pred CC------------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 465 LH------------------------------------------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 465 ~~------------------------------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
.. .......++.+.+||.+||+.||.+|||+.++++|+
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 335 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSG
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 011122356899999999999999999999999999
Q ss_pred hhhhh
Q psy16430 503 DIASQ 507 (600)
Q Consensus 503 ~~~~~ 507 (600)
|+...
T Consensus 336 ~f~~~ 340 (355)
T 2eu9_A 336 FFAGL 340 (355)
T ss_dssp GGGGC
T ss_pred hhcCC
Confidence 99764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.77 Aligned_cols=251 Identities=34% Similarity=0.592 Sum_probs=208.6
Q ss_pred cccccccccccccccCCCCcceEEEeEe------eceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKL------RSEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~------~~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
...+...+|++++.||+|+||.||+|++ .++.||+|++.. .+.+|+.++++++||||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3445668899999999999999999984 468999999853 346799999999999999999998654
Q ss_pred C--ceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccc
Q psy16430 322 P--CYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCRE 398 (600)
Q Consensus 322 ~--~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~ 398 (600)
. ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 3 789999999999999999764 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH---------------HHHH
Q psy16430 399 WNNKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA---------------IIWG 459 (600)
Q Consensus 399 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~---------------~~~~ 459 (600)
...... .....++..|+|||++.+..++.++|||||||++|+|++|..||....... .+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 654322 223457888999999998889999999999999999999999986431110 0111
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 460 VGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 460 i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
........+.+..+|+.+.+||.+||+.||.+|||+.++++.+.-.
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1222334566788999999999999999999999999999987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.08 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=200.0
Q ss_pred cccccccccccCCCCcceEEEeEe--eceEEEeeeeccc------hHHHHHHHHhcC-----------CCCcccccceee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ------KETDIRHLRKLN-----------HPNIVKFKGVCT 319 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~------~~~Ei~~L~~L~-----------HpnIv~l~~~~~ 319 (600)
...+|++.+.||+|+||.||+|+. .++.||||++... ..+|+.+++++. ||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 347899999999999999999986 4799999998643 457888888876 899999999987
Q ss_pred cCC----ceeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCCcccC------CCC
Q psy16430 320 QAP----CYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSK-QIIHRDLKSPNVLIG------SKE 386 (600)
Q Consensus 320 ~~~----~~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~-gIvHrDIKp~NILl~------~~~ 386 (600)
... .+++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++ ..+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 544 789999999 8899999875 34699999999999999999999998 999999999999995 334
Q ss_pred CceeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChH------HHHHHh
Q psy16430 387 EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSS------AIIWGV 460 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~------~~~~~i 460 (600)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+
T Consensus 176 ~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 7999999999876543 23457899999999999999999999999999999999999999865421 111111
Q ss_pred cC--CC--------------------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy16430 461 GS--SS--------------------------------------LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILS 500 (600)
Q Consensus 461 ~~--~~--------------------------------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~ 500 (600)
.. +. .....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 00 00 011233455788999999999999999999999999
Q ss_pred cHhhhhh
Q psy16430 501 HLDIASQ 507 (600)
Q Consensus 501 ~l~~~~~ 507 (600)
|+|+...
T Consensus 334 hp~f~~~ 340 (373)
T 1q8y_A 334 HPWLKDT 340 (373)
T ss_dssp CGGGTTC
T ss_pred Chhhhcc
Confidence 9999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.65 Aligned_cols=242 Identities=25% Similarity=0.426 Sum_probs=201.6
Q ss_pred cccccccccccccCCCCcceEEEeEe--eceEEEeeeeccc-------------hHHHHHHHHhc----CCCCcccccce
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVREQ-------------KETDIRHLRKL----NHPNIVKFKGV 317 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~-------------~~~Ei~~L~~L----~HpnIv~l~~~ 317 (600)
+.-.++|++.+.||+|+||.||+|+. .++.||||++... ..+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33457899999999999999999986 4689999998532 24689999998 89999999999
Q ss_pred eecCCceeEEEee-eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC-CCCCceeeccCc
Q psy16430 318 CTQAPCYCIVMEY-CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG-SKEEAKISDFGT 395 (600)
Q Consensus 318 ~~~~~~~~lV~Ey-~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~-~~~~vkL~DFGl 395 (600)
+...+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999998877899999999999999999999999999999999999999 789999999999
Q ss_pred cccccCCCCCcccCCCccccChhhhccCCCC-CccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 396 CREWNNKSTKMSFAGTVAWMAPEVIRNEQCS-DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 396 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
+....... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... ... .. ....+..++
T Consensus 187 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~----~~--~~~~~~~~~ 257 (312)
T 2iwi_A 187 GALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EIL----EA--ELHFPAHVS 257 (312)
T ss_dssp CEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH----HT--CCCCCTTSC
T ss_pred hhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HHh----hh--ccCCcccCC
Confidence 98765432 3456799999999999876664 58999999999999999999997532 221 11 234567889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 999999999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=355.44 Aligned_cols=244 Identities=15% Similarity=0.200 Sum_probs=201.8
Q ss_pred cccccccccccccccccCCCCcceEEEeE-------eeceEEEeeeeccc----hHHHHHHHHhcC---CCCccccccee
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGK-------LRSEIVAVKKVREQ----KETDIRHLRKLN---HPNIVKFKGVC 318 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~-------~~~~~vAvK~~~~~----~~~Ei~~L~~L~---HpnIv~l~~~~ 318 (600)
...+++..++|.+.+.||+|+||+||+|. ..++.||||++... +..|+.+++.+. |+||+++++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 35677888999999999999999999994 34689999999754 456788888886 99999999999
Q ss_pred ecCCceeEEEeeeccccchhhcc-----CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---------
Q psy16430 319 TQAPCYCIVMEYCAYGPLYNLLK-----DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS--------- 384 (600)
Q Consensus 319 ~~~~~~~lV~Ey~~ggsL~~~l~-----~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~--------- 384 (600)
...+..|+|||||+||+|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 99999999999999999999996 3567999999999999999999999999999999999999998
Q ss_pred --CCCceeeccCccccccC---CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH
Q psy16430 385 --KEEAKISDFGTCREWNN---KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG 459 (600)
Q Consensus 385 --~~~vkL~DFGla~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~ 459 (600)
++.+||+|||+|+.... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||....... +.
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~ 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--CK 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--EE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--ee
Confidence 89999999999976532 223345679999999999999999999999999999999999999996543211 00
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHcH
Q psy16430 460 VGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP-SFKQILSHL 502 (600)
Q Consensus 460 i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP-s~~elL~~l 502 (600)
+ ... ......++.+.+++..||+.+|.+|+ +++++.+.+
T Consensus 295 ~-~~~---~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 295 P-EGL---FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp E-CSC---CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred e-chh---ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 1 000 01113478899999999999999995 555555443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=363.91 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=201.9
Q ss_pred cccccccccccccccCCCCcce-EEEeEeeceEEEeeeecc----chHHHHHHHHhc-CCCCcccccceeecCCceeEEE
Q psy16430 255 EWEIPFESISDLQWLGSGAQGA-VFSGKLRSEIVAVKKVRE----QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~-Vy~a~~~~~~vAvK~~~~----~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
.+.+...+|.+.+.||+|+||+ ||.+...++.||||++.. ...+|+.+|+++ +|||||++++++.+....|+||
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 4556667899999999999998 556667789999999864 347899999999 7999999999999999999999
Q ss_pred eeeccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---C--CCceeeccCccccccCC
Q psy16430 329 EYCAYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---K--EEAKISDFGTCREWNNK 402 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~--~~vkL~DFGla~~~~~~ 402 (600)
|||. |+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. + ..+||+|||++......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9996 58999887643 4666778899999999999999999999999999999953 2 25779999999876543
Q ss_pred C----CCcccCCCccccChhhhc---cCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCC-CCCCC
Q psy16430 403 S----TKMSFAGTVAWMAPEVIR---NEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLP-IPSTC 473 (600)
Q Consensus 403 ~----~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~ 473 (600)
. ......||+.|+|||++. ...++.++|||||||++|+|++ |..||...........+........ .+...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 2 223467999999999997 4567889999999999999999 9999977665554443333322222 22334
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 667899999999999999999999999999865
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.77 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=201.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcC-CC-----CcccccceeecCCcee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLN-HP-----NIVKFKGVCTQAPCYC 325 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~-Hp-----nIv~l~~~~~~~~~~~ 325 (600)
.++|++.+.||+|+||+||+|... ++.||||+++.. ...|+.+++.++ |+ +|+++++++...+..|
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 378999999999999999999865 689999999643 346788888875 44 4999999999999999
Q ss_pred EEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhH--hCCccccCCCCCCcccC--CCCCceeeccCccccc
Q psy16430 326 IVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLH--SKQIIHRDLKSPNVLIG--SKEEAKISDFGTCREW 399 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH--~~gIvHrDIKp~NILl~--~~~~vkL~DFGla~~~ 399 (600)
+||||++ ++|.+++... +.+++..+..++.||+.||.||| +.||+||||||+|||++ .++.+||+|||++...
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9999996 5899988754 46999999999999999999999 47999999999999995 4678999999999876
Q ss_pred cCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCC-------------
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLH------------- 466 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------------- 466 (600)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 212 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (382)
T 2vx3_A 212 GQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKAR 289 (382)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHH
T ss_pred ccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHH
Confidence 433 23567999999999999999999999999999999999999999988776554433211000
Q ss_pred ----------------------CCCCC---------------------------CCcHHHHHHHHHhhhcCCCCCCCHHH
Q psy16430 467 ----------------------LPIPS---------------------------TCPDGFQLLMKMCWSNAPSSRPSFKQ 497 (600)
Q Consensus 467 ----------------------~~~p~---------------------------~~~~~l~~LI~~cL~~dP~~RPs~~e 497 (600)
...+. ..++.+.+||.+||+.||.+|||+.+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e 369 (382)
T 2vx3_A 290 KFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369 (382)
T ss_dssp HHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHH
Confidence 00000 00147899999999999999999999
Q ss_pred HHHcHhhhh
Q psy16430 498 ILSHLDIAS 506 (600)
Q Consensus 498 lL~~l~~~~ 506 (600)
+|+||||..
T Consensus 370 ~L~hp~f~~ 378 (382)
T 2vx3_A 370 ALQHSFFKK 378 (382)
T ss_dssp HTTSGGGCC
T ss_pred HhcCccccc
Confidence 999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=380.29 Aligned_cols=249 Identities=31% Similarity=0.594 Sum_probs=215.2
Q ss_pred ccccccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ 320 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~ 320 (600)
..+++..++|++.+.||+|+||.||+|.+. +..||+|.+.. .+.+|+.++++++||||+++++++.+
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 467788899999999999999999999864 36799998753 34578999999999999999999854
Q ss_pred CCceeEEEeeeccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 5689999999999999999754 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 400 NNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 400 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+. ..+.|..+|+.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 620 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPT 620 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHH
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHH
Confidence 54322 123456789999999998999999999999999999997 999999988877777665543 45677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.+||.+||..||.+|||+.++++.+.-
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9999999999999999999999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=338.86 Aligned_cols=230 Identities=25% Similarity=0.417 Sum_probs=188.2
Q ss_pred cccccc-cccCCCCcceEEEeEee--ceEEEeeeecc--chHHHHHHH-HhcCCCCcccccceeec----CCceeEEEee
Q psy16430 261 ESISDL-QWLGSGAQGAVFSGKLR--SEIVAVKKVRE--QKETDIRHL-RKLNHPNIVKFKGVCTQ----APCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~-~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--~~~~Ei~~L-~~L~HpnIv~l~~~~~~----~~~~~lV~Ey 330 (600)
++|.+. +.||+|+||.||+|... ++.||+|++.. ...+|+.++ +.++||||+++++++.. ....++||||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 567777 77999999999999864 68999999964 346788887 56699999999999876 6778999999
Q ss_pred eccccchhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCceeeccCccccccCCCCC
Q psy16430 331 CAYGPLYNLLKDGE--EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~~--~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~~~~ 405 (600)
++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----- 171 (299)
T ss_dssp CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----
Confidence 99999999997643 6999999999999999999999999999999999999998 7889999999886432
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC--CCCCC----CCCcHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL--HLPIP----STCPDGFQL 479 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p----~~~~~~l~~ 479 (600)
+..++.++|||||||++|+|++|..||.+.........+..... ....+ ..+++.+.+
T Consensus 172 ----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T 3m2w_A 172 ----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235 (299)
T ss_dssp ----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHH
T ss_pred ----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHH
Confidence 23567899999999999999999999987665443322211111 11222 568999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhhhhhc
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQEVLR 511 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~~~~~ 511 (600)
||.+||+.||.+|||+.++++|+|+.......
T Consensus 236 li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 236 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred HHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 99999999999999999999999998765433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.85 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=191.9
Q ss_pred cccccccc-ccccccCCCCcceEEE-eEeeceEEEeeeeccc----hHHHHHHHHhc-CCCCcccccceeecCCceeEEE
Q psy16430 256 WEIPFESI-SDLQWLGSGAQGAVFS-GKLRSEIVAVKKVREQ----KETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 256 ~ei~~~~~-~~~~~LG~G~fG~Vy~-a~~~~~~vAvK~~~~~----~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++....++ ...+.||+|+||+||. +...++.||||++... ..+|+.+++++ +||||+++++++.+....|+||
T Consensus 9 ~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 9 FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp CSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 33344444 4457899999999965 4556899999998654 35789999876 8999999999999999999999
Q ss_pred eeeccccchhhccCCCCC-------CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-------------CCc
Q psy16430 329 EYCAYGPLYNLLKDGEEV-------PPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-------------EEA 388 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l-------~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-------------~~v 388 (600)
|||. |+|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9996 6999999765432 333567899999999999999999999999999999754 479
Q ss_pred eeeccCccccccCCCC-----CcccCCCccccChhhhcc-------CCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 389 KISDFGTCREWNNKST-----KMSFAGTVAWMAPEVIRN-------EQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 389 kL~DFGla~~~~~~~~-----~~~~~gt~~Y~APE~l~~-------~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999987654322 124579999999999965 578999999999999999999 999998765433
Q ss_pred HHHHhcCCCCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 456 IIWGVGSSSLHLP-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 456 ~~~~i~~~~~~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.. +.......+ .+..+++.+.+||.+||+.||.+|||+.++++|||+..
T Consensus 248 ~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 SN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 21 111211111 12235688999999999999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.91 Aligned_cols=244 Identities=20% Similarity=0.284 Sum_probs=203.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeec-----cchHHHHHHHHhcCCC-CcccccceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVR-----EQKETDIRHLRKLNHP-NIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~-----~~~~~Ei~~L~~L~Hp-nIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
++|++.+.||+|+||.||+|++. ++.||||++. ..+..|+++++.+.|+ +|..+..++......++||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 68999999999999999999864 7899999874 3467899999999874 5555666667788899999999
Q ss_pred cccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCccc---CCCCCceeeccCccccccCCCCC---
Q psy16430 333 YGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLI---GSKEEAKISDFGTCREWNNKSTK--- 405 (600)
Q Consensus 333 ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~~~~~--- 405 (600)
+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++........
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence 8999999974 5679999999999999999999999999999999999999 57899999999999876543321
Q ss_pred -----cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCCC---CCCCCCCc
Q psy16430 406 -----MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSLH---LPIPSTCP 474 (600)
Q Consensus 406 -----~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~---~~~p~~~~ 474 (600)
....||+.|+|||++.+..++.++|||||||+||+|++|..||.+... ...+..+...... ...+..++
T Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (483)
T 3sv0_A 166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYP 245 (483)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSC
T ss_pred ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCc
Confidence 256799999999999999999999999999999999999999987543 2222222211111 12235778
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+++.+||..||+.||.+||++.+|++.+.-.
T Consensus 246 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 246 TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999999887543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.49 Aligned_cols=236 Identities=18% Similarity=0.154 Sum_probs=189.7
Q ss_pred ccccccccccccCCCCcceEEEeEeeceEEEeeeecc---------------chHHHHHHHHhcC---------------
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------------QKETDIRHLRKLN--------------- 307 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------------~~~~Ei~~L~~L~--------------- 307 (600)
++.++|++.+.||+|+||.||+|+++++.||||++.. .+.+|+.+++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4558899999999999999999999999999999863 2467999998886
Q ss_pred -----------CCCcccccceeec-------------CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHH
Q psy16430 308 -----------HPNIVKFKGVCTQ-------------APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMN 363 (600)
Q Consensus 308 -----------HpnIv~l~~~~~~-------------~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~ 363 (600)
||||+++++++.+ ....|+|||||++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 5555555555544 6789999999999977776654 56899999999999999999
Q ss_pred HhH-hCCccccCCCCCCcccCCCC--------------------CceeeccCccccccCCCCCcccCCCccccChhhhcc
Q psy16430 364 YLH-SKQIIHRDLKSPNVLIGSKE--------------------EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 422 (600)
Q Consensus 364 ~LH-~~gIvHrDIKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~ 422 (600)
||| +.||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 99999999999999999887 8999999999876542 3579999999999987
Q ss_pred CCCCCccceechhHH-HHHHhhCCCCCCCCCh-HHHHHHhc-CCCCC----CCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy16430 423 EQCSDKIDIWSYGIV-LWELLTCETPYKDVDS-SAIIWGVG-SSSLH----LPIPSTCPDGFQLLMKMCWSNAPSSRPSF 495 (600)
Q Consensus 423 ~~~s~ksDIwSlGvi-LyELltG~~Pf~~~~~-~~~~~~i~-~~~~~----~~~p~~~~~~l~~LI~~cL~~dP~~RPs~ 495 (600)
.. +.++||||||++ .+++++|..||.+... ......+. ..... .+.+..+++++.+||++||+.| |+
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa 325 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA 325 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence 66 889999998777 7788889999964221 11111111 11111 1112357889999999999976 99
Q ss_pred HHHH-HcHhh
Q psy16430 496 KQIL-SHLDI 504 (600)
Q Consensus 496 ~elL-~~l~~ 504 (600)
.++| +||||
T Consensus 326 ~e~l~~Hp~f 335 (336)
T 2vuw_A 326 TDLLCQHSLF 335 (336)
T ss_dssp HHHHHHCGGG
T ss_pred HHHHhcCCCc
Confidence 9999 99997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=371.53 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=202.9
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeec------CCc
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQ------APC 323 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~------~~~ 323 (600)
.++|++.+.||+|+||.||+|.+. ++.||||+++.. +.+|+.++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999864 789999998542 4579999999999999999998755 677
Q ss_pred eeEEEeeeccccchhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC---ceeeccCccc
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGE---EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCR 397 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~---~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~---vkL~DFGla~ 397 (600)
.|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999997643 6999999999999999999999999999999999999997765 8999999999
Q ss_pred cccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH--------------hcCC
Q psy16430 398 EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG--------------VGSS 463 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~--------------i~~~ 463 (600)
............||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... ...+
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 87666555667899999999999999999999999999999999999999976533221100 0001
Q ss_pred CC----CCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 SL----HLP----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 ~~----~~~----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.. ..+ .+..+++.+.+||.+||..||.+|||+.++++|+||...
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 00 111 223467899999999999999999999999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.67 Aligned_cols=243 Identities=14% Similarity=0.103 Sum_probs=191.7
Q ss_pred cccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCC-CCccccc------
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNH-PNIVKFK------ 315 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~H-pnIv~l~------ 315 (600)
.+..+...|...+.||+|+||+||+|++. ++.||||++.. .+.+|+.+++.+.| +|...+.
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 34455667888999999999999999976 79999999862 23578888888877 3222111
Q ss_pred ---------------ceeec-----CCceeEEEeeeccccchhhcc------C-CCCCCHHHHHHHHHHHHHHHHHhHhC
Q psy16430 316 ---------------GVCTQ-----APCYCIVMEYCAYGPLYNLLK------D-GEEVPPQRLYNWARQIAAGMNYLHSK 368 (600)
Q Consensus 316 ---------------~~~~~-----~~~~~lV~Ey~~ggsL~~~l~------~-~~~l~~~~i~~i~~qIl~aL~~LH~~ 368 (600)
.++.. ...++++|+++ +++|.+++. . ++.+++..++.++.||+.||.|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11111 22457778766 588998884 1 34577888999999999999999999
Q ss_pred CccccCCCCCCcccCCCCCceeeccCccccccCCCCCcccCCCccccChhhh----------ccCCCCCccceechhHHH
Q psy16430 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI----------RNEQCSDKIDIWSYGIVL 438 (600)
Q Consensus 369 gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l----------~~~~~s~ksDIwSlGviL 438 (600)
||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999998875543 334567 999999999 555678899999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 439 WELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 439 yELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+|++|+.||.+.+.......+. .....+|+.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999998766543332221 2224678999999999999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.56 Aligned_cols=218 Identities=14% Similarity=0.116 Sum_probs=183.5
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||.||+|++. ++.||||++.. .+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999976 79999999853 2457899999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
||++|++|.++++.+ ....++..++.||+.||.|||++||+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 999999999999653 4666789999999999999999999999999999999999999998544
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHH---HhcCCCCCC--CCCCCCcHHHHHHHHH
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIW---GVGSSSLHL--PIPSTCPDGFQLLMKM 483 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~---~i~~~~~~~--~~p~~~~~~l~~LI~~ 483 (600)
|++ .++.++|||||||++|+|++|+.||.+.+...... ......... ..+..+|+.+.+||.+
T Consensus 175 -----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (286)
T 3uqc_A 175 -----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242 (286)
T ss_dssp -----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred -----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence 333 36889999999999999999999998866533211 111111111 1235789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||+.||.+| |+.++++.+.-...
T Consensus 243 ~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 243 SVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HcccCCccC-CHHHHHHHHHHHhc
Confidence 999999999 99999999875543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=359.58 Aligned_cols=230 Identities=20% Similarity=0.247 Sum_probs=190.4
Q ss_pred ccccccccccCCCCcceEEEeEee---ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCc-----
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR---SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPC----- 323 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~----- 323 (600)
.++|++.+.||+|+||.||+|.+. ++.||||++.. .+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999864 68999998853 23578999999999999999999977655
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
.|+||||++|++|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++......
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 7999999999999988765 69999999999999999999999999999999999999875 8999999999876543
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC-CCCCCcHHHHHHHH
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP-IPSTCPDGFQLLMK 482 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~l~~LI~ 482 (600)
....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+.... ..... .....++.+.+||.
T Consensus 235 --~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp --SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHHHHHHHH
T ss_pred --CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHHHHHHHh
Confidence 3467999999999987654 88999999999999999999998753210 10000 01123578999999
Q ss_pred HhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 483 MCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 483 ~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+||+.||.+||+..+.+.+.+..
T Consensus 303 ~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999887777776654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=307.04 Aligned_cols=221 Identities=16% Similarity=0.112 Sum_probs=151.8
Q ss_pred ccCCCCcceEEEeE--eeceEEEeeeecc-----------------chHHHHHHHHhc-CCCCcccccceeecCCceeEE
Q psy16430 268 WLGSGAQGAVFSGK--LRSEIVAVKKVRE-----------------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 268 ~LG~G~fG~Vy~a~--~~~~~vAvK~~~~-----------------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++.|+.|.+..++ ..++.||+|.+.. .+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46778888777665 3588999999853 245799999999 799999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 406 (600)
|||++|++|.++|..++++++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ...
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 9999999999999998888775 478999999999999999999999999999999999999999998775433 334
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
+.+||+.|||||++.+ .+..++|+||+|+++++|.++..|+. ...+. .. +. ...+..+...+..
T Consensus 398 t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~-----~~l~~---~~-----~~--~~~~~~l~~~l~~ 461 (569)
T 4azs_A 398 NLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWL-----YAVWQ---EP-----VE--RWNFVLLLALFEK 461 (569)
T ss_dssp HHHHHHHHHHHHHC------------------CCCCTTHHHHH-----HHHHT---SC-----GG--GCSHHHHHHHHHT
T ss_pred CceechhhccHHHhCC-CCCCcccccccccchhhhccccchhH-----HHhhc---CC-----CC--CCcHHHHHHHHhC
Confidence 5789999999999976 46778999999999988877654431 11110 00 00 0124566667777
Q ss_pred cCCCCCCCHHHHHHcHhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~ 507 (600)
.+|..||.......++|....
T Consensus 462 ~~~~~~~~~~~~~~~~~~~~~ 482 (569)
T 4azs_A 462 KAKLPSAEQQRGATEQWIIAQ 482 (569)
T ss_dssp GGGSCCGGGSSCCHHHHHHHH
T ss_pred CCCCCCCChhhhccchhHHHH
Confidence 778778776666666665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=266.20 Aligned_cols=175 Identities=19% Similarity=0.187 Sum_probs=144.5
Q ss_pred cccccCCCCcceEEEeEeeceEEEeeeecc---------------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 265 DLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 265 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
..+.||+|+||.||+|+..+..+|+|+... .+.+|++++++++||||+++..++......|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 356899999999999988888999997531 24689999999999999976666667778899999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-----
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST----- 404 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----- 404 (600)
|++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 9999999999876 5689999999999999999999999999999988 999999999998754322
Q ss_pred ---CcccCCCccccChhhhcc--CCCCCccceechhHHHHHHhhCCCCCC
Q psy16430 405 ---KMSFAGTVAWMAPEVIRN--EQCSDKIDIWSYGIVLWELLTCETPYK 449 (600)
Q Consensus 405 ---~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGviLyELltG~~Pf~ 449 (600)
..+..||+.|||||++.. ..|+..+|+||.++-..+.+.++.+|.
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 125679999999999977 677888999999999999888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-23 Score=213.13 Aligned_cols=137 Identities=22% Similarity=0.215 Sum_probs=114.3
Q ss_pred ccccccccCCCCcceEEEeEee-ceEEEeeeecc-------------------------chHHHHHHHHhcCCCCccccc
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE-------------------------QKETDIRHLRKLNHPNIVKFK 315 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~-------------------------~~~~Ei~~L~~L~HpnIv~l~ 315 (600)
.|++.+.||+|+||.||+|.+. ++.||||.++. .+.+|+.+|++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 3445699999999999999984 78999999852 2458999999999 5 7777
Q ss_pred ceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCc
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGT 395 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGl 395 (600)
+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||+.||+||||||+|||++ ++.+||+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 76644 55699999999999988 432 34567999999999999999999999999999999 99999999999
Q ss_pred cccccCCCCCcccCCCccccChhhhcc
Q psy16430 396 CREWNNKSTKMSFAGTVAWMAPEVIRN 422 (600)
Q Consensus 396 a~~~~~~~~~~~~~gt~~Y~APE~l~~ 422 (600)
|+. +..++|||++..
T Consensus 239 a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 239 SVE------------VGEEGWREILER 253 (282)
T ss_dssp CEE------------TTSTTHHHHHHH
T ss_pred CeE------------CCCCCHHHHHHH
Confidence 863 445789998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-22 Score=208.97 Aligned_cols=140 Identities=19% Similarity=0.138 Sum_probs=101.6
Q ss_pred hhhhccccccccccccccccCChhhhhhhhccccccccccccc---cc----ccccccccccCCccceeeccccch--hh
Q psy16430 89 TRLTKLSVCWRPFCSFVDKFSSPEFKTNIQERSEVKSATHYQV---DL----TGMAEQVRLSIPPQYQLELIGGPY--WF 159 (600)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l----~~~~~~~~l~~~~r~~i~~~~a~~--~~ 159 (600)
..+.+|.|||...-..+.|++.-+. |++..+.+... +. ........++|..++.|+.++|.+ |+
T Consensus 89 pNIV~l~g~~~~~~~~~lV~Ey~~~-------G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 89 PNVVCLLGVVTKDQPLSMIFSYCSH-------GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCSS-------CBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcceEEEECCEEEEEEEcCCC-------CcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567888888765444444443333 33333322100 00 011223568999999999999996 45
Q ss_pred hccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeecccccccccccCccccccccccccc
Q psy16430 160 LAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCF 236 (600)
Q Consensus 160 ~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~ 236 (600)
|. .+||||||||+||||++++++||+|||+|+...... ...+.+||++|||||++.++.|+.++||||||+++|
T Consensus 162 H~---~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 162 SS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HH---TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred Hh---CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 54 469999999999999999999999999999764332 233578999999999999999999999999999999
Q ss_pred cc
Q psy16430 237 PT 238 (600)
Q Consensus 237 p~ 238 (600)
..
T Consensus 239 El 240 (308)
T 4gt4_A 239 EV 240 (308)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-22 Score=207.37 Aligned_cols=98 Identities=20% Similarity=0.238 Sum_probs=78.6
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAP 214 (600)
.+++|.+++.|+.++|.+ |+|. .+||||||||+||||++++.+||+|||+|+...... ...+.+||+.||||
T Consensus 127 ~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAP 203 (307)
T 3omv_A 127 TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203 (307)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCH
Confidence 458999999999998886 5664 579999999999999999999999999998754322 23457899999999
Q ss_pred cccc---ccccCccccccccccccccccc
Q psy16430 215 EVIR---NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 215 E~i~---~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
|++. .++|+.++|+||||+++|..-.
T Consensus 204 E~l~~~~~~~y~~ksDVwS~Gvvl~Ellt 232 (307)
T 3omv_A 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMT 232 (307)
T ss_dssp HHHHCCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhhccCCCCCCcHHHhHhHHHHHHHHHH
Confidence 9986 3569999999999999997643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.4e-22 Score=205.43 Aligned_cols=99 Identities=16% Similarity=0.227 Sum_probs=79.6
Q ss_pred cccCCccceeeccccch--hhhccC-----CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----cccccCc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGC-----TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGT 208 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~-----~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----~~~~~GT 208 (600)
+++|..++.|+.++|.+ |+|..+ .++||||||||+|||||.++++||+|||+|+....... ..+.+||
T Consensus 96 ~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 96 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccc
Confidence 58899999988888884 677653 46899999999999999999999999999997644322 2246899
Q ss_pred eeeccccccccc------ccCcccccccccccccccc
Q psy16430 209 VAWMAPEVIRNE------QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 209 ~~ymAPE~i~~~------~~s~~~Dvy~~~~~~~p~s 239 (600)
++|||||++.+. .++.++|+||||+++|..-
T Consensus 176 ~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp GGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 999999998653 4788999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=8.3e-22 Score=206.40 Aligned_cols=97 Identities=16% Similarity=0.211 Sum_probs=76.7
Q ss_pred cccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecc
Q psy16430 139 QVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMA 213 (600)
Q Consensus 139 ~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymA 213 (600)
..+++|.+++.|+.++|.+ |+|. .+||||||||+||||++++.+||+|||+|+....... ..+.+||++|||
T Consensus 152 ~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA 228 (329)
T 4aoj_A 152 PGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 228 (329)
T ss_dssp CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccC
Confidence 3569999999999999986 4554 5699999999999999999999999999997644322 335789999999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++.+..|+.++|+||||+++|..
T Consensus 229 PE~~~~~~~~~~sDvwS~Gvvl~El 253 (329)
T 4aoj_A 229 PESILYRKFTTESDVWSFGVVLWEI 253 (329)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhcCCCCCccccccchHHHHHHH
Confidence 9999999999999999999999975
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=182.96 Aligned_cols=128 Identities=16% Similarity=0.207 Sum_probs=102.7
Q ss_pred cccccccCCCCcceEEEeEe--eceE--EEeeeecc-------------------------------chHHHHHHHHhcC
Q psy16430 263 ISDLQWLGSGAQGAVFSGKL--RSEI--VAVKKVRE-------------------------------QKETDIRHLRKLN 307 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~--~~~~--vAvK~~~~-------------------------------~~~~Ei~~L~~L~ 307 (600)
|++.+.||+|+||.||+|.. .++. ||||+++. ...+|+.+|+++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999987 5788 99998532 2457899999998
Q ss_pred CCCc--ccccceeecCCceeEEEeeecc-c----cchhhccCCCCCCHHHHHHHHHHHHHHHHHhH-hCCccccCCCCCC
Q psy16430 308 HPNI--VKFKGVCTQAPCYCIVMEYCAY-G----PLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH-SKQIIHRDLKSPN 379 (600)
Q Consensus 308 HpnI--v~l~~~~~~~~~~~lV~Ey~~g-g----sL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH-~~gIvHrDIKp~N 379 (600)
|+++ +.+++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8865 333332 356899999943 3 55554332 345678899999999999999 9999999999999
Q ss_pred cccCCCCCceeeccCccccc
Q psy16430 380 VLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~ 399 (600)
||++. .++|+|||+|...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99988 9999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=9.3e-22 Score=203.32 Aligned_cols=97 Identities=16% Similarity=0.242 Sum_probs=83.3
Q ss_pred cccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecc
Q psy16430 139 QVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMA 213 (600)
Q Consensus 139 ~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymA 213 (600)
...++|.+++.|+.++|.+ |+|. .+||||||||+||||++++++||+|||+|+....... ....+||++|||
T Consensus 122 ~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA 198 (299)
T 4asz_A 122 PTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 198 (299)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcC
Confidence 3568999999999999886 5654 5799999999999999999999999999997644332 223579999999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++.+..|+.++|+||||+++|..
T Consensus 199 PE~~~~~~~~~k~DVwS~Gvvl~El 223 (299)
T 4asz_A 199 PESIMYRKFTTESDVWSLGVVLWEI 223 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-21 Score=204.00 Aligned_cols=96 Identities=20% Similarity=0.244 Sum_probs=82.7
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAP 214 (600)
..++|..++.++.++|.++ +|. .+||||||||+||||++++++||||||+|+.+..... +.+.+||+.||||
T Consensus 180 ~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 180 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 256 (353)
T ss_dssp TCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence 4588888888888888865 553 5799999999999999999999999999997644332 3357899999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.+..|+.++||||||+++|..
T Consensus 257 E~l~~~~y~~ksDVwS~Gv~l~El 280 (353)
T 4ase_A 257 ETIFDRVYTIQSDVWSFGVLLWEI 280 (353)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCcccEeehHHHHHHH
Confidence 999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-20 Score=194.12 Aligned_cols=97 Identities=18% Similarity=0.146 Sum_probs=77.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeecc-CCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGS-KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~-~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|.. .++||||||||+||||++ +|.+||+|||+|+.... ....+.+||+.|||||++
T Consensus 125 ~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~ 202 (290)
T 3fpq_A 125 VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHc
Confidence 45566655566666664 56654 467999999999999985 79999999999986433 334568999999999998
Q ss_pred cccccCccccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
. ++|+.++|+||+|+++|..-.
T Consensus 203 ~-~~y~~~~DiwSlGvilyellt 224 (290)
T 3fpq_A 203 E-EKYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp G-TCCCTHHHHHHHHHHHHHHHH
T ss_pred C-CCCCcHHHHHHHHHHHHHHHH
Confidence 6 569999999999999997643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-20 Score=197.14 Aligned_cols=129 Identities=20% Similarity=0.228 Sum_probs=93.8
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
..++++|..++.-.+|+|.-+.+++..+. . ...++...-..++..++. .|+|. .+||||||||.||||
T Consensus 134 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l---~----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl 203 (346)
T 4fih_A 134 VEMYNSYLVGDELWVVMEFLEGGALTDIV---T----HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 203 (346)
T ss_dssp CCEEEEEEETTEEEEEECCCTTEEHHHHH---H----HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcEEEEEEECCEEEEEEeCCCCCcHHHHH---H----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEE
Confidence 44566666666667777733333322211 0 122444444445555555 56775 469999999999999
Q ss_pred ccCCceeEeecccccccCCCC-ccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.+|.+||+|||+|+.+.... ...+.+||+.|||||++.+..|+.++|+||+|+++|..-.
T Consensus 204 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 265 (346)
T 4fih_A 204 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 265 (346)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999999775443 3456899999999999999999999999999999997643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.6e-20 Score=194.16 Aligned_cols=130 Identities=18% Similarity=0.144 Sum_probs=89.5
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
..++++|+.+++-.+|+|.-+..++..+. ....++++.....++..++. .|+|. .+||||||||+||||
T Consensus 113 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l------~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl 183 (336)
T 4g3f_A 113 VPLYGAVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLL 183 (336)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHH------HHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEE
T ss_pred CcEEEEEEECCEEEEEEeccCCCcHHHHH------HHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEE
Confidence 34455566555556777732222222211 11124555555556666666 45664 469999999999999
Q ss_pred ccCC-ceeEeecccccccCCCCc------cccccCceeecccccccccccCccccccccccccccccc
Q psy16430 180 GSKE-EAKISDFGTCREWNNKST------KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 180 d~~~-~~Kv~DFGlsr~~~~~~~------~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.+| .+||+|||+|+.+..... ..+++||+.|||||++.+..|+.++|+||+|+++|..-.
T Consensus 184 ~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt 251 (336)
T 4g3f_A 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251 (336)
T ss_dssp CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 9998 599999999997644321 224689999999999999999999999999999997643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.9e-20 Score=197.25 Aligned_cols=88 Identities=16% Similarity=0.224 Sum_probs=73.2
Q ss_pred eeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeecccccccccccCccc
Q psy16430 150 LELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIRNEQCSDKI 226 (600)
Q Consensus 150 i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i~~~~~s~~~ 226 (600)
|+..++. .|+|. .+||||||||+||||+.+|.+||+|||+|+.+..... ..+.+||+.|||||++.+..|+.++
T Consensus 130 ~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~ 206 (350)
T 4b9d_A 130 WFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS 206 (350)
T ss_dssp HHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHH
T ss_pred HHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHH
Confidence 4444444 56765 4699999999999999999999999999997654322 3457899999999999999999999
Q ss_pred cccccccccccccc
Q psy16430 227 DIWYKNRLCFPTSL 240 (600)
Q Consensus 227 Dvy~~~~~~~p~sl 240 (600)
|+||+|+++|..-.
T Consensus 207 DiwSlGvilyemlt 220 (350)
T 4b9d_A 207 DIWALGCVLYELCT 220 (350)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999997643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=6e-20 Score=197.86 Aligned_cols=130 Identities=19% Similarity=0.211 Sum_probs=92.9
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
..++++|...+.-.+|+|.-+.+++..+. ....++...-..|+..++. .|+|. .+||||||||.||||
T Consensus 211 V~l~~~~~~~~~~~iVmEy~~gG~L~~~i-------~~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl 280 (423)
T 4fie_A 211 VEMYNSYLVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 280 (423)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHH-------HHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEE
T ss_pred CceEEEEEECCEEEEEEeCCCCCcHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEE
Confidence 44566666666666777733333322211 0112333333334444444 56765 469999999999999
Q ss_pred ccCCceeEeecccccccCCCC-ccccccCceeecccccccccccCcccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
+.+|.+||+|||+|+.+.... ...+.+||+.|||||++.+..|+.++|+||+|+++|.+-.+
T Consensus 281 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 343 (423)
T 4fie_A 281 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343 (423)
T ss_dssp CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999999765443 34568999999999999999999999999999999976443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-20 Score=190.00 Aligned_cols=130 Identities=14% Similarity=0.168 Sum_probs=89.5
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeec--cccchhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLEL--IGGPYWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~--~~a~~~~~~~~~~~iiHrdlk~~NILL 179 (600)
+.++++|+..++-.+|+|.-+..++..+... ...++-..-..++. ..|..|+|. .+||||||||.||||
T Consensus 95 v~l~~~~~~~~~~yivmEy~~gG~L~~~i~~------~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl 165 (311)
T 4aw0_A 95 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILL 165 (311)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHH------HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CeEEEEEEeCCEEEEEEecCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEE
Confidence 4456667666666677773222222111101 11122111122333 334467776 469999999999999
Q ss_pred ccCCceeEeecccccccCCCC---ccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.+|.+||+|||+|+.+.... ...+.+||+.|||||++.+..|+.++|+||+|+++|..-.
T Consensus 166 ~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 229 (311)
T 4aw0_A 166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229 (311)
T ss_dssp CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999764332 2446899999999999999999999999999999997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=4.3e-20 Score=191.12 Aligned_cols=130 Identities=18% Similarity=0.150 Sum_probs=88.4
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
+..+++|+.++.-.+|+|.-+..++..+. .....++...-..++..++. .|+|. .+||||||||+|||+
T Consensus 89 v~l~~~~~~~~~~~ivmEy~~gg~L~~~l------~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl 159 (304)
T 3ubd_A 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILL 159 (304)
T ss_dssp ECEEEEEEETTEEEEEECCCTTCEEHHHH------HHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEE
T ss_pred CeEEEEEEECCEEEEEEEcCCCCCHHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEE
Confidence 34455566666556777732222221111 01122333333334444444 56775 469999999999999
Q ss_pred ccCCceeEeecccccccCCC-CccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.+|.+||+|||+|+..... ....+.+||+.|||||++.+..|+.++|+||+|+++|..-.
T Consensus 160 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt 221 (304)
T 3ubd_A 160 DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221 (304)
T ss_dssp CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHh
Confidence 99999999999999865433 33456899999999999999999999999999999997643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-19 Score=185.34 Aligned_cols=129 Identities=14% Similarity=0.120 Sum_probs=79.6
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
+.++++|+.++.-.+|+|.-..+-..+. ....+++...-..+...++. .|+|. .+||||||||.||||
T Consensus 76 v~~~~~~~~~~~~~ivmEy~~g~L~~~l-------~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl 145 (275)
T 3hyh_A 76 IKLYDVIKSKDEIIMVIEYAGNELFDYI-------VQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLL 145 (275)
T ss_dssp CCEEEEEECSSEEEEEEECCCEEHHHHH-------HHSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEE
T ss_pred CeEEEEEEECCEEEEEEeCCCCCHHHHH-------HHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEE
Confidence 3455566666666777773221111111 11123443333334444444 56775 469999999999999
Q ss_pred ccCCceeEeecccccccCCCCccccccCceeeccccccccccc-Cccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC-SDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~-s~~~Dvy~~~~~~~p~sl 240 (600)
+.++.+||+|||+|+.........+.+||+.|||||++.+..+ +.++|+||+|+++|..-.
T Consensus 146 ~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt 207 (275)
T 3hyh_A 146 DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 207 (275)
T ss_dssp CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH
Confidence 9999999999999987665555567899999999999998876 578999999999997543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=5.9e-19 Score=182.33 Aligned_cols=86 Identities=19% Similarity=0.261 Sum_probs=65.1
Q ss_pred eeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-------------cccccCceeeccc
Q psy16430 150 LELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-------------KMSFAGTVAWMAP 214 (600)
Q Consensus 150 i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-------------~~~~~GT~~ymAP 214 (600)
|+..++. .|+|. .+||||||||+||||+.+|.+||+|||+|+.+..... .++.+||+.||||
T Consensus 123 i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP 199 (299)
T 4g31_A 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199 (299)
T ss_dssp HHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCH
T ss_pred HHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence 4444444 56775 4699999999999999999999999999997643221 2346899999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.+..|+.++|+||+|+++|..
T Consensus 200 E~~~~~~y~~~~DiwSlGvilyel 223 (299)
T 4g31_A 200 EQIHGNSYSHKVDIFSLGLILFEL 223 (299)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=169.66 Aligned_cols=129 Identities=16% Similarity=0.128 Sum_probs=94.6
Q ss_pred cccccccCCCCcceEEEeEee-ceEEEeeeeccc-----------------------------hHHHHHHHHhcCCCCcc
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVREQ-----------------------------KETDIRHLRKLNHPNIV 312 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~-----------------------------~~~Ei~~L~~L~HpnIv 312 (600)
|++...||.|++|.||+|... |+.||||+++.. ...|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 778899999999999999864 789999986421 01244455555333332
Q ss_pred cccceeecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCC-----
Q psy16430 313 KFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE----- 387 (600)
Q Consensus 313 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~----- 387 (600)
...-+.. ...+|||||++|++|..+.. ......++.||+.+|.+||+.|||||||||.|||++.++.
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 1111111 12379999999998876643 2345678899999999999999999999999999987763
Q ss_pred -----ceeeccCccccc
Q psy16430 388 -----AKISDFGTCREW 399 (600)
Q Consensus 388 -----vkL~DFGla~~~ 399 (600)
+.|+||+.+...
T Consensus 249 ~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECCCTTCEET
T ss_pred ccccceEEEEeCCcccC
Confidence 889999977643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.6e-18 Score=191.19 Aligned_cols=130 Identities=15% Similarity=0.124 Sum_probs=89.9
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeecc--ccchhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELI--GGPYWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~--~a~~~~~~~~~~~iiHrdlk~~NILL 179 (600)
+..+++|+.+++-.+|+|.-+.+.+.... .....++...-..++.. .|..|+|. .+||||||||.||||
T Consensus 255 V~l~~~f~~~~~lylVmEy~~GGdL~~~l------~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILl 325 (689)
T 3v5w_A 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILL 325 (689)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHH------HHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEE
T ss_pred eEEEEEEEECCEEEEEEecCCCCcHHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEE
Confidence 45667788888777888833322222111 01112222211123333 34456665 469999999999999
Q ss_pred ccCCceeEeecccccccCCCCccccccCceeecccccccc-cccCcccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~-~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
|.+|++||+|||+|+.+.... ..+.+||+.|||||++.. ..|+.++|+||+|+++|.+-.+
T Consensus 326 d~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG 387 (689)
T 3v5w_A 326 DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387 (689)
T ss_dssp CTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred eCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999765433 346799999999999975 5799999999999999965433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-17 Score=175.74 Aligned_cols=128 Identities=16% Similarity=0.124 Sum_probs=85.9
Q ss_pred ccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceee--ccccchhhhccCCCCeEEEeccCCCee
Q psy16430 101 FCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLE--LIGGPYWFLAGCTTPDALAESIGLGVL 178 (600)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~--~~~a~~~~~~~~~~~iiHrdlk~~NIL 178 (600)
-...+++|..+++-.+|+|.-+..++.... . .++...-..++ +..|..|+|. .+||||||||+|||
T Consensus 82 Iv~l~~~~~~~~~~~lvmE~~~g~~L~~~~----~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiL 149 (361)
T 4f9c_A 82 VMGVKYCFRKNDHVVIAMPYLEHESFLDIL----N-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFL 149 (361)
T ss_dssp BCCCSEEEEETTEEEEEEECCCCCCHHHHH----T-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CceEEEEEEECCEEEEEEeCCCcccHHHHH----c-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeE
Confidence 344566777777777888743332222211 0 12222222233 3345567775 46999999999999
Q ss_pred eccC-CceeEeecccccccCCCC-----------------------------ccccccCceeeccccccccc-ccCcccc
Q psy16430 179 IGSK-EEAKISDFGTCREWNNKS-----------------------------TKMSFAGTVAWMAPEVIRNE-QCSDKID 227 (600)
Q Consensus 179 Ld~~-~~~Kv~DFGlsr~~~~~~-----------------------------~~~~~~GT~~ymAPE~i~~~-~~s~~~D 227 (600)
++.+ +.+||+|||+|+...... ..++.+||++|||||++.+. .|+.++|
T Consensus 150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D 229 (361)
T 4f9c_A 150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID 229 (361)
T ss_dssp EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHH
T ss_pred EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc
Confidence 9987 799999999998543211 12346899999999998765 4899999
Q ss_pred ccccccccccccc
Q psy16430 228 IWYKNRLCFPTSL 240 (600)
Q Consensus 228 vy~~~~~~~p~sl 240 (600)
+||.|++++..-.
T Consensus 230 iWSlG~il~ell~ 242 (361)
T 4f9c_A 230 MWSAGVIFLSLLS 242 (361)
T ss_dssp HHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHH
Confidence 9999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.7e-17 Score=171.59 Aligned_cols=132 Identities=8% Similarity=0.004 Sum_probs=95.3
Q ss_pred cccccccCChhhhhhhhcc---cccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCC
Q psy16430 102 CSFVDKFSSPEFKTNIQER---SEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLG 176 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~N 176 (600)
..++++|...+.-.+|+|. +++..+.+. +.......+++.....|+..++.+ |+|. .+||||||||+|
T Consensus 130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~N 202 (365)
T 3e7e_A 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINL----YKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDN 202 (365)
T ss_dssp CCEEEEEECSSCEEEEECCCCSCBHHHHHHH----HHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGG
T ss_pred hhhheeeecCCCcEEEEeccCCCcHHHHHHH----hhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHH
Confidence 3344445455555677773 333332221 111123457788888888777775 5554 469999999999
Q ss_pred eeecc-----------CCceeEeecccccccC---CCCccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 177 VLIGS-----------KEEAKISDFGTCREWN---NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 177 ILLd~-----------~~~~Kv~DFGlsr~~~---~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
|||+. ++.+||+|||+|+... ........+||++|||||++.+..++.++|+||+|+++|..-.
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 99999 8999999999997543 2223445789999999999999999999999999999997643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-16 Score=170.50 Aligned_cols=97 Identities=16% Similarity=0.163 Sum_probs=73.5
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC-----CccccccCceeecc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-----STKMSFAGTVAWMA 213 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-----~~~~~~~GT~~ymA 213 (600)
.++...-..++..++. .|+|. .+||||||||.|||++.+|.+||+|||+|+.+... ....+.+||+.|||
T Consensus 154 ~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~A 230 (398)
T 4b99_A 154 PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230 (398)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcC
Confidence 3444443344444444 56665 46999999999999999999999999999975432 22346899999999
Q ss_pred ccccccc-ccCccccccccccccccccc
Q psy16430 214 PEVIRNE-QCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 214 PE~i~~~-~~s~~~Dvy~~~~~~~p~sl 240 (600)
||++.+. .++.++|+||+|++++.+-.
T Consensus 231 PEv~~~~~~~~~~~DiWSlG~il~ell~ 258 (398)
T 4b99_A 231 PELMLSLHEYTQAIDLWSVGCIFGEMLA 258 (398)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCChhheehhHHHHHHHHH
Confidence 9998765 46899999999999987643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.55 E-value=7.8e-17 Score=180.81 Aligned_cols=129 Identities=17% Similarity=0.148 Sum_probs=88.9
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd 180 (600)
.++++|+.++.-.+++|.-+..++..+. . .....++...-..++..++. .|+|. ..||||||||.||||+
T Consensus 218 ~l~~~~~~~~~~~iv~E~~~gg~L~~~i---~--~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~ 289 (573)
T 3uto_A 218 NLHDAFEDDNEMVMIYEFMSGGELFEKV---A--DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFT 289 (573)
T ss_dssp CEEEEEECSSEEEEEEECCCCCBHHHHH---T--CTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEES
T ss_pred eEEEEEEECCEEEEEEeecCCCcHHHHH---H--HhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhcccc
Confidence 3455555555556666632222211111 0 01112333333334444444 56665 4699999999999998
Q ss_pred cC--CceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 181 SK--EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 181 ~~--~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+ +.+||+|||+|+.+.......+.+||+.|||||++.+..|+.++|+||+|+++|.+-
T Consensus 290 ~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 290 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp SSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 65 899999999999887666666789999999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.9e-16 Score=163.69 Aligned_cols=137 Identities=17% Similarity=0.208 Sum_probs=98.5
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
...+++|..++...+++|.-...+....... ......+++|..+..|+..+|. .|+|..+.++|+||||||.|||+
T Consensus 90 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp CCCCEEECCSSCCEEEEECCTTCBHHHHHHC--CSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred cceEEEEecCCceEEEEEeccCCCHHHHHHh--ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 3344445555555677773322222221111 1122345788888887776666 57888777799999999999999
Q ss_pred ccCCceeEeecccccccCCCCc--cccccCceeecccccccccccCccccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.++.+||+|||+++....... .....||++|+|||++.+..++.++|+||+|++++..-.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 230 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence 9999999999999987643322 334669999999999998899999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-16 Score=163.66 Aligned_cols=96 Identities=14% Similarity=0.162 Sum_probs=77.2
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..++|..+..|+..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++............||++|+|||++
T Consensus 152 ~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~ 228 (311)
T 3p1a_A 152 ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL 228 (311)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHh
Confidence 357888888877777775 5665 36999999999999999999999999999877655555567899999999998
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+ .++.++|+||+|++++..-
T Consensus 229 ~~-~~~~~~DiwslG~il~el~ 249 (311)
T 3p1a_A 229 QG-SYGTAADVFSLGLTILEVA 249 (311)
T ss_dssp GT-CCSTHHHHHHHHHHHHHHH
T ss_pred cC-CCCchhhHHHHHHHHHHHH
Confidence 75 7999999999999988653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-16 Score=168.71 Aligned_cols=96 Identities=23% Similarity=0.325 Sum_probs=77.3
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeeccccccc-CCCCccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREW-NNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~-~~~~~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++. .|+|. .+||||||||.||||+.+|.+||+|||+|+.. .......+.+||+.|||||++
T Consensus 149 ~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l 225 (396)
T 4dc2_A 149 KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225 (396)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhh
Confidence 3455555445555555 56665 36999999999999999999999999999863 333445568999999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 226 ~~~~~~~~~DiwslGvllyell 247 (396)
T 4dc2_A 226 RGEDYGFSVDWWALGVLMFEMM 247 (396)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHH
T ss_pred cCCCCChHHHHHHHHHHHHHHH
Confidence 9999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-16 Score=160.57 Aligned_cols=99 Identities=17% Similarity=0.241 Sum_probs=78.5
Q ss_pred cccCCccceeeccccc--hhhhccC-----CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----cccccCc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGC-----TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGT 208 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~-----~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----~~~~~GT 208 (600)
.+++...+.|+..+|. .|+|... +.+||||||||+|||++.++.+||+|||+|+....... .....||
T Consensus 101 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 180 (301)
T 3q4u_A 101 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180 (301)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCC
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccc
Confidence 4677777777777766 4677322 67899999999999999999999999999986544322 2235899
Q ss_pred eeeccccccccc------ccCcccccccccccccccc
Q psy16430 209 VAWMAPEVIRNE------QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 209 ~~ymAPE~i~~~------~~s~~~Dvy~~~~~~~p~s 239 (600)
+.|+|||++.+. .++.++|+||+|+++|..-
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~ 217 (301)
T 3q4u_A 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217 (301)
T ss_dssp GGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence 999999999876 5667899999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.5e-16 Score=166.13 Aligned_cols=97 Identities=13% Similarity=0.103 Sum_probs=79.9
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec--cCCceeEeecccccccCCCCc--------cccccC
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG--SKEEAKISDFGTCREWNNKST--------KMSFAG 207 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd--~~~~~Kv~DFGlsr~~~~~~~--------~~~~~G 207 (600)
..+++...+.|+..+|.+ |+|.. +||||||||.|||++ .++.+||+|||+|+.+..... ....+|
T Consensus 147 ~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~g 223 (364)
T 3op5_A 147 KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223 (364)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCC
Confidence 457888888888877775 56653 799999999999999 889999999999986543221 123569
Q ss_pred ceeecccccccccccCcccccccccccccccc
Q psy16430 208 TVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 208 T~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|+.|||||++.+..++.++|+||+|++++..-
T Consensus 224 t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 224 TIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999989999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-16 Score=168.81 Aligned_cols=95 Identities=14% Similarity=0.152 Sum_probs=74.5
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVI 217 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i 217 (600)
+++.....++..++. .|+|. .+||||||||+||||+.+|.+||+|||+|+....... ....+||++|||||++
T Consensus 172 l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l 248 (437)
T 4aw2_A 172 LPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248 (437)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHH
Confidence 444444444444444 56775 4699999999999999999999999999987644332 2347899999999998
Q ss_pred c-----ccccCcccccccccccccccc
Q psy16430 218 R-----NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~-----~~~~s~~~Dvy~~~~~~~p~s 239 (600)
. .+.++.++|+||+|++++..-
T Consensus 249 ~~~~~~~~~~~~~~DvwSlGvil~ell 275 (437)
T 4aw2_A 249 QAMEGGKGRYGPECDWWSLGVCMYEML 275 (437)
T ss_dssp HHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred hhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence 7 567899999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.49 E-value=5.4e-16 Score=166.27 Aligned_cols=96 Identities=18% Similarity=0.209 Sum_probs=72.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeecc---CCceeEeecccccccCCCCccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGS---KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~---~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
.+++.....|+..++.+ |+|. .+||||||||.|||++. ++.+||+|||+++.........+.+||+.|+|||
T Consensus 157 ~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 233 (400)
T 1nxk_A 157 AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233 (400)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHh
Confidence 46676667777666664 5664 46999999999999998 7899999999999765544445678999999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++....++.++|+||+|++++..-
T Consensus 234 ~~~~~~~~~~~DiwslG~il~ell 257 (400)
T 1nxk_A 234 VLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_dssp GSCCCCSSSHHHHHHHHHHHHHHH
T ss_pred hcCCCCCCCcccHHHHHHHHHHHH
Confidence 999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.49 E-value=5.8e-16 Score=162.32 Aligned_cols=95 Identities=18% Similarity=0.282 Sum_probs=75.3
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|. .+||||||||.|||++.+|.+||+|||+|+.... .....+.+||+.|+|||++.
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 178 (337)
T 1o6l_A 102 FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGS
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhc
Confidence 334444444444444 56775 3699999999999999999999999999986433 33345678999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 179 ~~~~~~~~DiwslG~il~ell 199 (337)
T 1o6l_A 179 DNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp SSCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCCchhhcccchhHHHHHh
Confidence 999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.8e-16 Score=163.98 Aligned_cols=95 Identities=15% Similarity=0.143 Sum_probs=76.5
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++......++..++. .|+|. .+||||||||.|||++.+|.+||+|||+|+.........+.+||+.|+|||++..
T Consensus 112 l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 112 FKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeecc
Confidence 444444445555555 45665 3699999999999999999999999999998766555667899999999999864
Q ss_pred ---cccCcccccccccccccccc
Q psy16430 220 ---EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ---~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 189 ~~~~~~~~~~DiwSlG~il~ell 211 (384)
T 4fr4_A 189 RKGAGYSFAVDWWSLGVTAYELL 211 (384)
T ss_dssp CSSCCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCCCCccceeechHHHHHHHH
Confidence 45889999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.3e-16 Score=165.28 Aligned_cols=95 Identities=19% Similarity=0.255 Sum_probs=71.4
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|.. +||||||||.||||+.+|.+||+|||+|+.... .....+.+||+.|||||++.
T Consensus 121 ~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 121 FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcC
Confidence 444444444444444 566653 699999999999999999999999999986433 23345688999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 198 ~~~~~~~~DiwslG~il~ell 218 (353)
T 3txo_A 198 EMLYGPAVDWWAMGVLLYEML 218 (353)
T ss_dssp HHHCTTHHHHHHHHHHHHHHH
T ss_pred CCCcCCccCCCcchHHHHHHH
Confidence 999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1e-15 Score=175.01 Aligned_cols=127 Identities=19% Similarity=0.227 Sum_probs=90.0
Q ss_pred cccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc
Q psy16430 104 FVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS 181 (600)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~ 181 (600)
.+++|+..+.-.+|+|.-+..++.... .....+++.....++..++. .|+|. .+||||||||.||||+.
T Consensus 407 l~~~~~~~~~~~lV~E~~~gg~L~~~l------~~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~ 477 (674)
T 3pfq_A 407 LHSCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDS 477 (674)
T ss_dssp EEEECBCSSEEEEEEECCCSCBHHHHH------HHHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECS
T ss_pred EEEEEEeCCEEEEEEeCcCCCcHHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcC
Confidence 344455555555666633222221110 11123555555556656655 45665 47999999999999999
Q ss_pred CCceeEeecccccccC-CCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 182 KEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 182 ~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+|.+||+|||+|+... ......+.+||+.|||||++....++.++|+||+|++++..-
T Consensus 478 ~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyell 536 (674)
T 3pfq_A 478 EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536 (674)
T ss_dssp SSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHH
T ss_pred CCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHH
Confidence 9999999999998643 333445689999999999999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=6.4e-16 Score=163.09 Aligned_cols=95 Identities=22% Similarity=0.319 Sum_probs=76.3
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|. .+||||||||.|||++.+|.+||+|||+|+.... .....+.+||+.|+|||++.
T Consensus 118 ~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (353)
T 2i0e_A 118 FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhc
Confidence 444444445555555 45665 3799999999999999999999999999986432 33345678999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 195 ~~~~~~~~DiwslG~il~ell 215 (353)
T 2i0e_A 195 YQPYGKSVDWWAFGVLLYEML 215 (353)
T ss_dssp TCCBSTHHHHHHHHHHHHHHH
T ss_pred CCCcCCcccccchHHHHHHHH
Confidence 999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=5e-16 Score=168.61 Aligned_cols=97 Identities=19% Similarity=0.274 Sum_probs=76.6
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC-CccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++. .|+|. ..+||||||||.||||+.++.+||+|||+|+..... ......+||++|+|||++
T Consensus 244 ~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 244 VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321 (446)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhc
Confidence 3555555556555555 56675 246999999999999999999999999999864332 334467899999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 322 ~~~~~~~~~DiwslG~il~ell 343 (446)
T 4ejn_A 322 EDNDYGRAVDWWGLGVVMYEMM 343 (446)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCCccchhhhHHHHHHHh
Confidence 9999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.3e-16 Score=157.54 Aligned_cols=96 Identities=16% Similarity=0.258 Sum_probs=77.7
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---------------c
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---------------K 202 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---------------~ 202 (600)
..+++.....++..++.+ |+|. .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 103 ~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (310)
T 3s95_A 103 SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179 (310)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccc
Confidence 346777777777777775 5664 4699999999999999999999999999986543221 1
Q ss_pred ccccCceeecccccccccccCccccccccccccccc
Q psy16430 203 MSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 203 ~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
...+||+.|+|||++.+..++.++|+||+|++++..
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 215 (310)
T 3s95_A 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215 (310)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 146799999999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=8.5e-16 Score=161.62 Aligned_cols=95 Identities=18% Similarity=0.269 Sum_probs=76.4
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC-CccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++..++. .|+|.. +||||||||.|||++.+|.+||+|||+|+..... ....+.+||+.|+|||++.
T Consensus 115 ~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 191 (345)
T 1xjd_A 115 FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhc
Confidence 445555555555555 566653 6999999999999999999999999999864332 2345688999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 192 ~~~~~~~~DiwslG~il~ell 212 (345)
T 1xjd_A 192 GQKYNHSVDWWSFGVLLYEML 212 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhhHHHHHHHHHHh
Confidence 999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=8.4e-16 Score=158.70 Aligned_cols=98 Identities=23% Similarity=0.332 Sum_probs=70.3
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++...+.++..++.+ |+|.. .++||||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+
T Consensus 133 ~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~ 211 (309)
T 3p86_A 133 QLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211 (309)
T ss_dssp HSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhh
Confidence 36667777777677664 56653 3569999999999999999999999999998654332 23357899999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|+++|..-
T Consensus 212 ~~~~~~~~~DiwslG~il~ell 233 (309)
T 3p86_A 212 RDEPSNEKSDVYSFGVILWELA 233 (309)
T ss_dssp TTCCCCTTHHHHHHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-15 Score=170.81 Aligned_cols=130 Identities=16% Similarity=0.094 Sum_probs=92.1
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd 180 (600)
..+++|...++-.+|+|.-+..++.... .. .....+++.....++..++. .|+|.. +||||||||.||||+
T Consensus 248 ~l~~~~~~~~~l~lVmEy~~gg~L~~~l---~~-~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld 320 (576)
T 2acx_A 248 SLAYAYETKDALCLVLTLMNGGDLKFHI---YH-MGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLD 320 (576)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHH---HS-SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCEEEEEEEcCCCCcHHHHH---Hh-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEe
Confidence 3345555555556676632222221111 01 11123555555555555555 566653 699999999999999
Q ss_pred cCCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+|.+||+|||+|+.........+.+||+.|||||++.+..++.++|+||+|++++..-
T Consensus 321 ~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLl 379 (576)
T 2acx_A 321 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379 (576)
T ss_dssp TTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHH
T ss_pred CCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence 99999999999999876655555679999999999999989999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=9.6e-16 Score=161.07 Aligned_cols=95 Identities=23% Similarity=0.307 Sum_probs=75.8
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|. .+|+||||||.|||++.+|.+||+|||+|+... ......+.+||+.|+|||++.
T Consensus 107 l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 183 (345)
T 3a8x_A 107 LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccC
Confidence 444444445444544 56665 369999999999999999999999999998643 333345678999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 184 ~~~~~~~~DiwslG~il~ell 204 (345)
T 3a8x_A 184 GEDYGFSVDWWALGVLMFEMM 204 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCChHHhHHHHHHHHHHHH
Confidence 999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-15 Score=155.45 Aligned_cols=129 Identities=13% Similarity=0.175 Sum_probs=92.7
Q ss_pred ccccccCChhhhhhhhcc---cccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCe
Q psy16430 103 SFVDKFSSPEFKTNIQER---SEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGV 177 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NI 177 (600)
..+++|...+.-.+++|. +++..+.. . .......++|..++.++..++.+ |+|. .+|+||||||.||
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~--~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Ni 170 (321)
T 2qkw_B 99 SLIGFCDERNEMILIYKYMENGNLKRHLY---G--SDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINI 170 (321)
T ss_dssp CEEEECCCTTCCEEEEECCTTCBTGGGSS---S--SCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTE
T ss_pred eEEEEEcCCCeEEEEEEcCCCCcHHHHHh---c--cCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHE
Confidence 334444545555666663 33333222 1 11122357788888877777775 5665 4799999999999
Q ss_pred eeccCCceeEeecccccccCCCC---ccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 178 LIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 178 LLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 171 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (321)
T 2qkw_B 171 LLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235 (321)
T ss_dssp EECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH
T ss_pred EECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHH
Confidence 99999999999999998643321 223466999999999999999999999999999998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-15 Score=165.01 Aligned_cols=129 Identities=12% Similarity=0.106 Sum_probs=88.5
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd 180 (600)
..+++|...++-.+|+|.-+..++..+. . ..+..+++.....++..++. .|+|. .+||||||||.||||+
T Consensus 125 ~l~~~~~~~~~~~lVmE~~~gg~L~~~l---~--~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld 196 (412)
T 2vd5_A 125 QLHFAFQDENYLYLVMEYYVGGDLLTLL---S--KFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLD 196 (412)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHH---H--HHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred eEEEEEeeCCEEEEEEcCCCCCcHHHHH---H--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeec
Confidence 3445566666666777733222222211 0 11123444444444444444 56665 4699999999999999
Q ss_pred cCCceeEeecccccccCCCCc--cccccCceeeccccccc-------ccccCcccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVIR-------NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i~-------~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+|.+||+|||+|+....... ....+||+.|||||++. ...++.++|+||+|++++..-
T Consensus 197 ~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell 264 (412)
T 2vd5_A 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264 (412)
T ss_dssp TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence 999999999999987654433 23478999999999987 356899999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=9.8e-16 Score=158.89 Aligned_cols=98 Identities=18% Similarity=0.244 Sum_probs=75.2
Q ss_pred ccCCccceeeccccc--hhhhccC------CCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---------cccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGC------TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---------TKMS 204 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~------~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---------~~~~ 204 (600)
+++.....|+..++. .|+|..+ .++||||||||+|||++.++.+||+|||+|+.+.... ....
T Consensus 108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~ 187 (336)
T 3g2f_A 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187 (336)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CC
T ss_pred cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccccc
Confidence 355555566666665 5677653 2389999999999999999999999999998654321 1224
Q ss_pred ccCceeecccccccc-------cccCcccccccccccccccc
Q psy16430 205 FAGTVAWMAPEVIRN-------EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 205 ~~GT~~ymAPE~i~~-------~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+||+.|+|||++.+ ..++.++|+||+|+++|..-
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell 229 (336)
T 3g2f_A 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229 (336)
T ss_dssp TTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence 679999999999876 46778899999999998653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-15 Score=162.43 Aligned_cols=87 Identities=21% Similarity=0.369 Sum_probs=72.0
Q ss_pred eeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccC-CCCccccccCceeecccccccccccCccc
Q psy16430 150 LELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWN-NKSTKMSFAGTVAWMAPEVIRNEQCSDKI 226 (600)
Q Consensus 150 i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~-~~~~~~~~~GT~~ymAPE~i~~~~~s~~~ 226 (600)
++..++. .|+|. .+||||||||.|||++.+|.+||+|||+|+... ......+.+||+.|+|||++.+..++.++
T Consensus 144 ~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (373)
T 2r5t_A 144 YAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV 220 (373)
T ss_dssp HHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHH
T ss_pred HHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchh
Confidence 4444444 56665 469999999999999999999999999998643 23334568999999999999999999999
Q ss_pred ccccccccccccc
Q psy16430 227 DIWYKNRLCFPTS 239 (600)
Q Consensus 227 Dvy~~~~~~~p~s 239 (600)
|+||+|++++..-
T Consensus 221 DiwslG~il~ell 233 (373)
T 2r5t_A 221 DWWCLGAVLYEML 233 (373)
T ss_dssp HHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHH
Confidence 9999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.1e-15 Score=164.64 Aligned_cols=84 Identities=18% Similarity=0.278 Sum_probs=69.5
Q ss_pred cccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccccccccc----cCccc
Q psy16430 153 IGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVIRNEQ----CSDKI 226 (600)
Q Consensus 153 ~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i~~~~----~s~~~ 226 (600)
..|..|+|. .+||||||||.||||+.+|.+||+|||+|+....... ..+.+||+.|||||++.... ++.++
T Consensus 178 ~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~ 254 (410)
T 3v8s_A 178 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 254 (410)
T ss_dssp HHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHH
T ss_pred HHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcc
Confidence 334456775 3699999999999999999999999999987654432 33678999999999997655 88999
Q ss_pred ccccccccccccc
Q psy16430 227 DIWYKNRLCFPTS 239 (600)
Q Consensus 227 Dvy~~~~~~~p~s 239 (600)
|+||+|++++..-
T Consensus 255 DiwSlGvilyell 267 (410)
T 3v8s_A 255 DWWSVGVFLYEML 267 (410)
T ss_dssp HHHHHHHHHHHHH
T ss_pred eEecchHHHHHHH
Confidence 9999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-15 Score=167.91 Aligned_cols=95 Identities=19% Similarity=0.200 Sum_probs=76.7
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|. .+||||||||.||||+.+|.+||+|||+++.+..... ..+.+||+.|||||++.
T Consensus 286 l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~ 362 (543)
T 3c4z_A 286 FQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362 (543)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHT
T ss_pred ccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhc
Confidence 444444445545555 56665 3699999999999999999999999999997655433 33468999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|+++|..-
T Consensus 363 ~~~~~~~~DiwSlGvilyell 383 (543)
T 3c4z_A 363 GEEYDFSVDYFALGVTLYEMI 383 (543)
T ss_dssp TCCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCChHHhcCcchHHHHHHH
Confidence 999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-15 Score=159.28 Aligned_cols=95 Identities=15% Similarity=0.229 Sum_probs=76.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++......++..++. .|+|. .+|+||||||+|||++.++.+||+|||+++...........+||++|+|||++.+
T Consensus 111 l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 111 MKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccC
Confidence 444444444444445 56665 3699999999999999999999999999987765555566889999999999988
Q ss_pred cccC-cccccccccccccccc
Q psy16430 220 EQCS-DKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s-~~~Dvy~~~~~~~p~s 239 (600)
..++ .++|+||+|++++..-
T Consensus 188 ~~~~~~~~DiwslG~il~ell 208 (328)
T 3fe3_A 188 KKYDGPEVDVWSLGVILYTLV 208 (328)
T ss_dssp CCCCSHHHHHHHHHHHHHHHH
T ss_pred CCcCCchhhhhhhHHHHHHHH
Confidence 8765 7899999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-15 Score=156.64 Aligned_cols=93 Identities=18% Similarity=0.256 Sum_probs=74.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++......++..++. .|+|. .+|+||||||.|||++.+|.+||+|||+++..... ..+.+||+.|+|||++.+
T Consensus 103 ~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 103 FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcC
Confidence 344444445545555 45664 47999999999999999999999999999875432 345789999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 178 ~~~~~~~DiwslG~il~ell 197 (318)
T 1fot_A 178 KPYNKSIDWWSFGILIYEML 197 (318)
T ss_dssp CCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCcccchhhhHHHHHHHH
Confidence 99999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-15 Score=155.18 Aligned_cols=95 Identities=20% Similarity=0.347 Sum_probs=76.4
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|.. +|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||++.
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 189 (297)
T 3fxz_A 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189 (297)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhc
Confidence 444444555555555 456653 699999999999999999999999999987654332 34578999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 190 ~~~~~~~~DiwslG~il~ell 210 (297)
T 3fxz_A 190 RKAYGPKVDIWSLGIMAIEMI 210 (297)
T ss_dssp CSCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.5e-15 Score=158.97 Aligned_cols=96 Identities=18% Similarity=0.187 Sum_probs=78.2
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCC----ceeEeecccccccCCCCccccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE----EAKISDFGTCREWNNKSTKMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~----~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAP 214 (600)
.+++.....++..++. .|+|. .+|+||||||.|||++.++ .+||+|||+++...........+||+.|+||
T Consensus 111 ~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aP 187 (361)
T 2yab_A 111 SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187 (361)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECc
Confidence 3555555556666666 45665 4799999999999999887 7999999999977655445567899999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++.+..++.++|+||+|++++..-
T Consensus 188 E~~~~~~~~~~~DiwslGvil~~ll 212 (361)
T 2yab_A 188 EIVNYEPLGLEADMWSIGVITYILL 212 (361)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred hHHcCCCCCccccHHHHHHHHHHHH
Confidence 9999889999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.6e-15 Score=157.42 Aligned_cols=97 Identities=15% Similarity=0.143 Sum_probs=79.5
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCc-----eeEeecccccccCCCCc--------ccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEE-----AKISDFGTCREWNNKST--------KMS 204 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~-----~Kv~DFGlsr~~~~~~~--------~~~ 204 (600)
..+++.....|+..++.+ |+|. .+||||||||+|||++.++. +||+|||+|+.+..... ...
T Consensus 100 ~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~ 176 (330)
T 2izr_A 100 RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176 (330)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCC
Confidence 357777777777777775 5664 36999999999999999887 99999999987543321 235
Q ss_pred ccCceeecccccccccccCcccccccccccccccc
Q psy16430 205 FAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 205 ~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 211 (330)
T 2izr_A 177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL 211 (330)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCccccChHHHcCCCCCchhHHHHHHHHHHHHh
Confidence 78999999999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.8e-15 Score=152.05 Aligned_cols=95 Identities=18% Similarity=0.170 Sum_probs=79.7
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|.. +|+||||||.|||++.++.+||+|||+|+...........+||+.|+|||++.+
T Consensus 117 ~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 117 LPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcC
Confidence 666666666666666 456654 599999999999999999999999999987665555556789999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 194 ~~~~~~~DiwslG~il~~l~ 213 (308)
T 3g33_A 194 STYATPVDMWSVGCIFAEMF 213 (308)
T ss_dssp SCCCSTHHHHHHHHHHHHTT
T ss_pred CCCCchHHHHHHHHHHHHHH
Confidence 99999999999999988654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=3.1e-15 Score=155.03 Aligned_cols=96 Identities=15% Similarity=0.161 Sum_probs=76.7
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAP 214 (600)
..+++.....++..++.+ |+|.. +||||||||.|||++.++.+||+|||+|+....... .....||.+|+||
T Consensus 110 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 186 (325)
T 3kex_A 110 GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186 (325)
T ss_dssp GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccCh
Confidence 357777777777666664 56643 699999999999999999999999999997644332 2346688899999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|.+.+..++.++|+||+|++++..
T Consensus 187 E~~~~~~~~~~~Di~slG~~l~el 210 (325)
T 3kex_A 187 ESIHFGKYTHQSDVWSYGVTVWEL 210 (325)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHhccCCCChhhHhHHhHHHHHHH
Confidence 999999999999999999998874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-15 Score=155.35 Aligned_cols=96 Identities=24% Similarity=0.339 Sum_probs=80.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++...... ......||+.|+|||++
T Consensus 137 ~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2c30_A 137 RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhh
Confidence 46777777777777764 5665 479999999999999999999999999998765432 23457899999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 214 ~~~~~~~~~Dv~slG~il~el~ 235 (321)
T 2c30_A 214 SRSLYATEVDIWSLGIMVIEMV 235 (321)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.43 E-value=2e-15 Score=158.29 Aligned_cols=96 Identities=16% Similarity=0.166 Sum_probs=77.9
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++. .|+|.. +|+||||||.|||++.++.+||+|||+++.........+.+||+.|+|||++.
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~ 180 (336)
T 3h4j_B 104 RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180 (336)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHc
Confidence 3555555555555555 466754 69999999999999999999999999998766555555678999999999998
Q ss_pred cccc-Ccccccccccccccccc
Q psy16430 219 NEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
+..+ +.++|+||+|++++..-
T Consensus 181 ~~~~~~~~~DiwslG~il~~ll 202 (336)
T 3h4j_B 181 GKLYAGPEVDVWSCGIVLYVML 202 (336)
T ss_dssp CSGGGCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCccchhHHHHHHHHHH
Confidence 8776 67899999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.43 E-value=4e-15 Score=157.63 Aligned_cols=95 Identities=20% Similarity=0.291 Sum_probs=77.4
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE 215 (600)
.+++...+.++..++.+ |+|. .+||||||||.|||++.++.+||+|||+++...... ......||+.|+|||
T Consensus 199 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 275 (370)
T 2psq_A 199 QMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 275 (370)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence 46666666676666664 5665 469999999999999999999999999998654332 223456789999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
++.+..++.++|+||+|+++|..
T Consensus 276 ~~~~~~~~~~~DvwslG~il~el 298 (370)
T 2psq_A 276 ALFDRVYTHQSDVWSFGVLMWEI 298 (370)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-15 Score=155.71 Aligned_cols=96 Identities=16% Similarity=0.165 Sum_probs=78.8
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCC----ceeEeecccccccCCCCccccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKE----EAKISDFGTCREWNNKSTKMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~----~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++ .+||+|||+++............||+.|+||
T Consensus 110 ~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 186 (326)
T 2y0a_A 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186 (326)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCc
Confidence 45666666666666664 5664 4699999999999999988 7999999999877554444567899999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++....++.++|+||+|++++..-
T Consensus 187 E~~~~~~~~~~~DiwslG~il~~ll 211 (326)
T 2y0a_A 187 EIVNYEPLGLEADMWSIGVITYILL 211 (326)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred eeecCCCCCcHHHHHHHHHHHHHHH
Confidence 9999889999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=8.3e-15 Score=160.19 Aligned_cols=95 Identities=19% Similarity=0.114 Sum_probs=70.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|.. +||||||||.|||++.++.+||+|||+|+........+..+||++|+|||++.+
T Consensus 161 l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 161 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC
Confidence 444444444444444 567654 699999999999999999999999999997765555566889999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 238 ~~~~~~~DiwSlG~il~ell 257 (464)
T 3ttj_A 238 MGYKENVDIWSVGCIMGEMV 257 (464)
T ss_dssp CCCCTTHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHH
Confidence 99999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=2.6e-15 Score=155.90 Aligned_cols=96 Identities=15% Similarity=0.154 Sum_probs=78.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeecc--CCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGS--KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~--~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++. ++.+||+|||+++............||+.|+|||+
T Consensus 98 ~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 174 (321)
T 1tki_A 98 ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHH
Confidence 35555566666666664 5665 47999999999999997 78999999999998766555556789999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|++++..-
T Consensus 175 ~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 175 HQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp HTTCEECHHHHHHHHHHHHHHHH
T ss_pred hcCCCCCchhhHHHHHHHHHHHH
Confidence 99888999999999999998653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.4e-15 Score=156.02 Aligned_cols=96 Identities=17% Similarity=0.229 Sum_probs=79.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....|+..++.+ |+|.. +||||||||.|||++.++.+||+|||+++.........+.+||+.|+|||++.
T Consensus 126 ~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 202 (335)
T 3dls_A 126 RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202 (335)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhc
Confidence 46666666666666664 56653 69999999999999999999999999999776655555678999999999998
Q ss_pred cccc-Ccccccccccccccccc
Q psy16430 219 NEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
+..+ +.++|+||+|++++..-
T Consensus 203 ~~~~~~~~~DiwslG~il~el~ 224 (335)
T 3dls_A 203 GNPYRGPELEMWSLGVTLYTLV 224 (335)
T ss_dssp TCCBCSHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCcccchhHHHHHHHHH
Confidence 8776 78899999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.1e-14 Score=158.22 Aligned_cols=95 Identities=18% Similarity=0.139 Sum_probs=70.4
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-------------------
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS------------------- 200 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~------------------- 200 (600)
+++.....++..++. .|+|.. +||||||||+||||+.++.+||+|||+|+......
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (458)
T 3rp9_A 153 LTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229 (458)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccc
Confidence 444444445555555 566653 69999999999999999999999999998653211
Q ss_pred ---------ccccccCceeecccccc-cccccCcccccccccccccccc
Q psy16430 201 ---------TKMSFAGTVAWMAPEVI-RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 201 ---------~~~~~~GT~~ymAPE~i-~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
..+..+||++|+|||++ ....++.++|+||+|++++..-
T Consensus 230 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp ---------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 12346899999999986 4567999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.41 E-value=2.9e-15 Score=157.71 Aligned_cols=93 Identities=17% Similarity=0.239 Sum_probs=75.5
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++......++..++. .|+|. .+||||||||.|||++.+|.+||+|||+++..... ..+.+||+.|+|||++.+
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 138 FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcC
Confidence 444444445555555 45664 46999999999999999999999999999876433 345789999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 213 ~~~~~~~DiwslG~il~ell 232 (350)
T 1rdq_E 213 KGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCCcCCEecccHhHhHHh
Confidence 99999999999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=5.6e-15 Score=152.89 Aligned_cols=100 Identities=14% Similarity=0.183 Sum_probs=76.6
Q ss_pred cccCCccceeeccccch--hhhccC-----CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----cccccCc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGC-----TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGT 208 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~-----~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----~~~~~GT 208 (600)
.+++.....++..++.+ |+|..+ .++||||||||.|||++.++.+||+|||+++....... .....||
T Consensus 130 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 209 (337)
T 3mdy_A 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209 (337)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccC
Confidence 46666667776666664 566542 34899999999999999999999999999986543322 1246899
Q ss_pred eeecccccccccccCcc------ccccccccccccccc
Q psy16430 209 VAWMAPEVIRNEQCSDK------IDIWYKNRLCFPTSL 240 (600)
Q Consensus 209 ~~ymAPE~i~~~~~s~~------~Dvy~~~~~~~p~sl 240 (600)
+.|+|||++.....+.. +|+||+|+++|..-.
T Consensus 210 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp GGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred cceeChhhcccccCCccccCccccchHHHHHHHHHHHh
Confidence 99999999987766655 899999999987643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.8e-15 Score=156.75 Aligned_cols=96 Identities=14% Similarity=0.188 Sum_probs=77.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec--cCCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG--SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd--~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
.+++.....++..++.+ |+|.+ ..+||||||||.|||++ .++.+||+|||+|+..... .....||+.|+|||+
T Consensus 153 ~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~ 229 (382)
T 2vx3_A 153 GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEV 229 (382)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHH
Confidence 36666666666666664 55543 56899999999999994 5788999999999876433 335689999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|++++..-
T Consensus 230 ~~~~~~~~~~DiwSlG~il~ell 252 (382)
T 2vx3_A 230 LLGMPYDLAIDMWSLGCILVEMH 252 (382)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HcCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=2.9e-15 Score=155.26 Aligned_cols=100 Identities=17% Similarity=0.202 Sum_probs=79.1
Q ss_pred cccCCccceeeccccch--hhhccC-------CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGC-------TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGT 208 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~-------~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT 208 (600)
.++|.....|+..+|.+ |+|..+ +++||||||||+|||++.++.+||+|||+|+....... .....||
T Consensus 117 ~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccC
Confidence 36777777777777774 566542 34899999999999999999999999999987644322 3346899
Q ss_pred eeecccccccc-----cccCccccccccccccccccc
Q psy16430 209 VAWMAPEVIRN-----EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 209 ~~ymAPE~i~~-----~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.|+|||++.+ ..++.++|+||+|+++|..-.
T Consensus 197 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t 233 (322)
T 3soc_A 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233 (322)
T ss_dssp GGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh
Confidence 99999999876 456778999999999997643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.41 E-value=3.6e-15 Score=151.80 Aligned_cols=96 Identities=16% Similarity=0.140 Sum_probs=76.2
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++. .|+|.. +|+||||||.|||++.++.+||+|||+++...... ......||+.|+|||++
T Consensus 97 ~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~ 173 (292)
T 3o0g_A 97 DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173 (292)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHH
Confidence 4555555556666666 456653 69999999999999999999999999998764332 23456899999999998
Q ss_pred cccc-cCcccccccccccccccc
Q psy16430 218 RNEQ-CSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~-~s~~~Dvy~~~~~~~p~s 239 (600)
.+.. ++.++|+||+|++++..-
T Consensus 174 ~~~~~~~~~~DiwslG~il~~l~ 196 (292)
T 3o0g_A 174 FGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp TTCSCCCTHHHHHHHHHHHHHHT
T ss_pred cCCCCcCchHHHHHHHHHHHHHH
Confidence 7766 799999999999988653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=3.2e-15 Score=159.67 Aligned_cols=134 Identities=18% Similarity=0.145 Sum_probs=87.6
Q ss_pred ccccccccccccccccCChhhhhhhhcccc--cccccccccccccccccccccCCccceeeccccch--hhhccCCCCeE
Q psy16430 93 KLSVCWRPFCSFVDKFSSPEFKTNIQERSE--VKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDA 168 (600)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~ii 168 (600)
+|...+.-....+++|...++-.+++|... +..+.. ....+++..+..|+..++.+ |+|. .+||
T Consensus 110 ~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~---------~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iv 177 (390)
T 2zmd_A 110 KLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK---------KKKSIDPWERKSYWKNMLEAVHTIHQ---HGIV 177 (390)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHH---------HCSSCCHHHHHHHHHHHHHHHHHHHT---TTCC
T ss_pred HcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCee
Confidence 333333344555555566666667777322 211111 11245555566666666664 5664 4699
Q ss_pred EEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccccccc-----------cccCccccccccccc
Q psy16430 169 LAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRN-----------EQCSDKIDIWYKNRL 234 (600)
Q Consensus 169 Hrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE~i~~-----------~~~s~~~Dvy~~~~~ 234 (600)
||||||.|||++ ++.+||+|||+++.+..... ....+||+.|+|||++.. ..++.++|+||+|++
T Consensus 178 HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi 256 (390)
T 2zmd_A 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256 (390)
T ss_dssp CCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred ecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence 999999999995 58899999999987644322 235689999999999865 468899999999999
Q ss_pred ccccc
Q psy16430 235 CFPTS 239 (600)
Q Consensus 235 ~~p~s 239 (600)
++..-
T Consensus 257 l~ell 261 (390)
T 2zmd_A 257 LYYMT 261 (390)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.8e-15 Score=152.70 Aligned_cols=89 Identities=18% Similarity=0.255 Sum_probs=71.7
Q ss_pred cceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-------------ccccccCceee
Q psy16430 147 QYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-------------TKMSFAGTVAW 211 (600)
Q Consensus 147 r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-------------~~~~~~GT~~y 211 (600)
...++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++...... .....+||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 4445555555 45664 469999999999999999999999999998765432 12346799999
Q ss_pred cccccccccccCccccccccccccccc
Q psy16430 212 MAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 212 mAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+|||++.+..++.++|+||+|++++..
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el 269 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFEL 269 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHH
Confidence 999999999999999999999999865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.41 E-value=1.7e-15 Score=157.24 Aligned_cols=95 Identities=15% Similarity=0.182 Sum_probs=75.8
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++...+.++..++.+ |+|. .+||||||||+|||++.++.+||+|||+|+....... .....||+.|+|||
T Consensus 113 ~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3poz_A 113 NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChH
Confidence 46666666666666664 5665 3799999999999999999999999999987644332 22356788999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
++.+..++.++|+||+|++++..
T Consensus 190 ~~~~~~~~~~~Di~slG~il~el 212 (327)
T 3poz_A 190 SILHRIYTHQSDVWSYGVTVWEL 212 (327)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCCchhhhhhhHHHHHHH
Confidence 99999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.41 E-value=4.3e-15 Score=157.00 Aligned_cols=95 Identities=22% Similarity=0.272 Sum_probs=76.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCC---ceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE---EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~---~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
+++.....++..++. .|+|.. +|+||||||.|||++.++ .+||+|||+++...........+||++|+|||+
T Consensus 125 ~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~ 201 (362)
T 2bdw_A 125 YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHH
Confidence 455555555555555 456653 699999999999998654 599999999987765544456789999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|++++..-
T Consensus 202 ~~~~~~~~~~DiwslG~il~~ll 224 (362)
T 2bdw_A 202 LKKDPYSKPVDIWACGVILYILL 224 (362)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HccCCCCchhhHHHHHHHHHHHH
Confidence 99889999999999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.5e-14 Score=153.77 Aligned_cols=95 Identities=16% Similarity=0.182 Sum_probs=71.7
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC--------------------
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-------------------- 199 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-------------------- 199 (600)
+++.....++..++. .|+|. .+||||||||+|||++.++.+||+|||+|+.+...
T Consensus 106 ~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (388)
T 3oz6_A 106 LEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182 (388)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccc
Confidence 444444444444444 56775 36999999999999999999999999999865321
Q ss_pred --CccccccCceeecccccccc-cccCcccccccccccccccc
Q psy16430 200 --STKMSFAGTVAWMAPEVIRN-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 200 --~~~~~~~GT~~ymAPE~i~~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
...+..+||++|+|||++.+ ..++.++|+||+|++++..-
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 225 (388)
T 3oz6_A 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225 (388)
T ss_dssp -------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence 11234689999999999876 67899999999999998653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=4.7e-15 Score=150.77 Aligned_cols=96 Identities=15% Similarity=0.098 Sum_probs=78.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCc-----eeEeecccccccCCCCc--------cccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEE-----AKISDFGTCREWNNKST--------KMSF 205 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~-----~Kv~DFGlsr~~~~~~~--------~~~~ 205 (600)
.+++.....|+..++.+ |+|. .+|+||||||+|||++.++. +||+|||+++....... ....
T Consensus 102 ~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 178 (298)
T 1csn_A 102 KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCC
Confidence 46777777777777775 4553 47999999999999988776 99999999987644321 2346
Q ss_pred cCceeecccccccccccCcccccccccccccccc
Q psy16430 206 AGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 206 ~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 179 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 212 (298)
T 1csn_A 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 212 (298)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 7999999999999989999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=5e-15 Score=152.86 Aligned_cols=96 Identities=14% Similarity=0.178 Sum_probs=78.6
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee----ccCCceeEeecccccccCCCCccccccCceeecccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI----GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL----d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
+++.....++..++.+ |+|. .+||||||||.|||+ +.++.+||+|||+++.........+..||+.|+|||
T Consensus 109 ~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 185 (319)
T 4euu_A 109 LPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185 (319)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHH
Confidence 6666666677666664 5665 369999999999999 888899999999999776655555678999999999
Q ss_pred ccc--------ccccCccccccccccccccccc
Q psy16430 216 VIR--------NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 216 ~i~--------~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
++. ...++.++|+||+|+++|..-.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~ 218 (319)
T 4euu_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (319)
T ss_dssp HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH
T ss_pred HhhhccccccccCCCCcHHHHHHHHHHHHHHHh
Confidence 986 4678999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-15 Score=157.11 Aligned_cols=138 Identities=18% Similarity=0.177 Sum_probs=88.7
Q ss_pred hhccccccccccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeE
Q psy16430 91 LTKLSVCWRPFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDA 168 (600)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~ii 168 (600)
|.+|...+.-....+++|...++-.+++|.... +...+ ......+++..+..++..++.+ |+|. .+||
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~------l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ii 130 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSW------LKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIV 130 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEECCCSE-EHHHH------HHHSCCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCC-CHHHH------HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 344443333444555656666666777773222 11111 0112346666666666666664 5665 3699
Q ss_pred EEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccccccc-----------cccCccccccccccc
Q psy16430 169 LAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRN-----------EQCSDKIDIWYKNRL 234 (600)
Q Consensus 169 Hrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE~i~~-----------~~~s~~~Dvy~~~~~ 234 (600)
||||||.|||++ ++.+||+|||+|+....... ....+||++|+|||++.+ ..++.++|+||+|++
T Consensus 131 HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i 209 (343)
T 3dbq_A 131 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209 (343)
T ss_dssp CCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred cCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence 999999999997 67899999999987644322 235689999999999865 678899999999999
Q ss_pred ccccc
Q psy16430 235 CFPTS 239 (600)
Q Consensus 235 ~~p~s 239 (600)
++..-
T Consensus 210 l~ell 214 (343)
T 3dbq_A 210 LYYMT 214 (343)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.9e-15 Score=154.63 Aligned_cols=130 Identities=17% Similarity=0.189 Sum_probs=89.5
Q ss_pred ccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCee
Q psy16430 101 FCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVL 178 (600)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NIL 178 (600)
.+.++++|...+.-.+|+|.-+..++..+. . .....+++.....|+..++.+ |+|. .+|+||||||.|||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l---~--~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl 183 (325)
T 3kul_A 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFL---R--THDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVL 183 (325)
T ss_dssp BCCEEEEECGGGCCEEEEECCTTCBHHHHH---H--TTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCcEEEEEEeCCccEEEeeCCCCCcHHHHH---H--hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEE
Confidence 344455555566556777733222222211 0 112346777777777777764 5664 46999999999999
Q ss_pred eccCCceeEeecccccccCCCCc----cccccCceeecccccccccccCccccccccccccccc
Q psy16430 179 IGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 179 Ld~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|+||+|++++..
T Consensus 184 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 247 (325)
T 3kul_A 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247 (325)
T ss_dssp ECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred ECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999987643321 2234567899999999989999999999999998864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.40 E-value=3e-15 Score=153.12 Aligned_cols=96 Identities=20% Similarity=0.193 Sum_probs=72.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
++++.....++...+.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||.
T Consensus 107 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~ 183 (294)
T 4eqm_A 107 PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183 (294)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhH
Confidence 46666666666666664 5664 4699999999999999999999999999987644322 234679999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|+++|..-
T Consensus 184 ~~~~~~~~~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 184 AKGEATDECTDIYSIGIVLYEML 206 (294)
T ss_dssp HHTCCCCTTHHHHHHHHHHHHHH
T ss_pred hcCCCCCchHhHHHHHHHHHHHH
Confidence 99999999999999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.9e-15 Score=160.12 Aligned_cols=95 Identities=12% Similarity=0.031 Sum_probs=77.6
Q ss_pred cccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 139 QVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 139 ~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
+..+++..++.|+..++.+ |+|. .+||||||||+|||++.++.+||+|||+++..... ..+.+| +.|||||+
T Consensus 205 ~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~ 278 (413)
T 3dzo_A 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPET 278 (413)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchh
Confidence 3457788888876677664 5664 46999999999999999999999999999865433 345678 99999999
Q ss_pred c----------cccccCcccccccccccccccc
Q psy16430 217 I----------RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i----------~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+ ....++.++|+||+|+++|..-
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp HHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred hhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9 5556888999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.7e-15 Score=157.43 Aligned_cols=96 Identities=18% Similarity=0.164 Sum_probs=77.9
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee--ccCCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI--GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL--d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
.+++.....++..++. .|+|. .+|+||||||.|||+ +.++.+||+|||+++...........+||++|+|||+
T Consensus 183 ~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 259 (373)
T 2x4f_A 183 NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259 (373)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhh
Confidence 4566666666666666 45665 369999999999999 5678899999999997765554455689999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+....++.++|+||+|++++..-
T Consensus 260 ~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 260 VNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp HTTCBCCHHHHHHHHHHHHHHHH
T ss_pred ccCCCCCcHHhHHHHHHHHHHHH
Confidence 99888999999999999998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.5e-15 Score=152.60 Aligned_cols=98 Identities=17% Similarity=0.208 Sum_probs=65.0
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-------------ccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-------------KMS 204 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-------------~~~ 204 (600)
..+++.....|+..++.+ |+|.. .++|+||||||.|||++.++.+||+|||+++....... ...
T Consensus 131 ~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (337)
T 3ll6_A 131 GPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209 (337)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhcc
Confidence 357777777777777775 45543 34699999999999999999999999999987543221 114
Q ss_pred ccCceeecccccc---cccccCccccccccccccccc
Q psy16430 205 FAGTVAWMAPEVI---RNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 205 ~~GT~~ymAPE~i---~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
..||+.|+|||++ .+..++.++|+||+|++++..
T Consensus 210 ~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp --------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred ccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence 5699999999998 566788999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.4e-15 Score=158.43 Aligned_cols=95 Identities=24% Similarity=0.280 Sum_probs=76.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccc---cccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~---~~~GT~~ymAPE 215 (600)
.+++...+.++..+|.+ |+|. .+||||||||+|||++.++.+||+|||+|+......... ...+|+.|+|||
T Consensus 209 ~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE 285 (377)
T 3cbl_A 209 RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285 (377)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHh
Confidence 46666777777777775 5665 469999999999999999999999999998654432211 233577899999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+..+.++.++|+||+|+++|..
T Consensus 286 ~~~~~~~~~~~DvwslG~il~el 308 (377)
T 3cbl_A 286 ALNYGRYSSESDVWSFGILLWET 308 (377)
T ss_dssp HHHHCEEEHHHHHHHHHHHHHHH
T ss_pred HhccCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=7.4e-15 Score=156.87 Aligned_cols=129 Identities=16% Similarity=0.110 Sum_probs=91.0
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd 180 (600)
..+++|...+.-.+++|.-+..++.... . .....+++.....++..++.+ |+|. .+|+||||||.|||++
T Consensus 112 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l----~-~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~ 183 (387)
T 1kob_A 112 NLHDAFEDKYEMVLILEFLSGGELFDRI----A-AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCE 183 (387)
T ss_dssp CEEEEEECSSEEEEEEECCCCCBHHHHT----T-CTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEES
T ss_pred eEEEEEEeCCEEEEEEEcCCCCcHHHHH----H-hhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEe
Confidence 3445555555556677633322222111 0 112245666666666666664 5664 4699999999999998
Q ss_pred c--CCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 181 S--KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 181 ~--~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
. .+.+||+|||+++...........+||+.|+|||++....++.++|+||+|++++..-
T Consensus 184 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 184 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp STTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred cCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 4 4779999999999776554445578999999999999989999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.5e-14 Score=151.41 Aligned_cols=97 Identities=14% Similarity=0.146 Sum_probs=76.3
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc-CCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS-KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~-~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++...+. +|+|.+ +.+||||||||.|||++. ++.+||+|||+++............||+.|+|||++.
T Consensus 126 ~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (360)
T 3e3p_A 126 PPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF 204 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHc
Confidence 344444444444444 567743 578999999999999997 8999999999999776655555678999999999986
Q ss_pred ccc-cCcccccccccccccccc
Q psy16430 219 NEQ-CSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~-~s~~~Dvy~~~~~~~p~s 239 (600)
+.. ++.++|+||+|++++..-
T Consensus 205 ~~~~~~~~~Di~slG~il~ell 226 (360)
T 3e3p_A 205 GNQHYTTAVDIWSVGCIFAEMM 226 (360)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHH
Confidence 544 899999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.39 E-value=5.2e-15 Score=155.47 Aligned_cols=95 Identities=21% Similarity=0.216 Sum_probs=74.7
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCc---eeEeecccccccCCCCc-cccccCceeecccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEE---AKISDFGTCREWNNKST-KMSFAGTVAWMAPE 215 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~---~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE 215 (600)
++......++..++. .|+|. .+||||||||.|||++.++. +||+|||+++....... ....+||+.|+|||
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE 203 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHH
Confidence 444444445555555 56665 36999999999999987654 99999999987654432 34578999999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++.+..++.++|+||+|++++..-
T Consensus 204 ~~~~~~~~~~~DiwslG~il~~ll 227 (351)
T 3c0i_A 204 VVKREPYGKPVDVWGCGVILFILL 227 (351)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred HHcCCCCCchHhhHHHHHHHHHHH
Confidence 999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.5e-15 Score=157.88 Aligned_cols=95 Identities=19% Similarity=0.199 Sum_probs=75.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCC---ceeEeecccccccCCC---CccccccCceeec
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKE---EAKISDFGTCREWNNK---STKMSFAGTVAWM 212 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~---~~Kv~DFGlsr~~~~~---~~~~~~~GT~~ym 212 (600)
.+++...+.++..+|.+ |+|. .+||||||||.|||++.++ .+||+|||+|+..... .......||+.|+
T Consensus 177 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~ 253 (367)
T 3l9p_A 177 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGC
T ss_pred cccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEE
Confidence 46666667777777775 5665 3699999999999999555 5999999999854221 1233467899999
Q ss_pred ccccccccccCccccccccccccccc
Q psy16430 213 APEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 213 APE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|||++.+..++.++|+||+|++++..
T Consensus 254 aPE~~~~~~~~~~~DvwslG~il~el 279 (367)
T 3l9p_A 254 PPEAFMEGIFTSKTDTWSFGVLLWEI 279 (367)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=7e-15 Score=159.03 Aligned_cols=94 Identities=16% Similarity=0.156 Sum_probs=77.3
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCc--eeEeecccccccCCCCccccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEE--AKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~--~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
.+++.....|+..++. .|+|.. +||||||||.|||++.++. +||+|||+|+..... ..+.+||+.|+|||+
T Consensus 196 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~ 270 (429)
T 3kvw_A 196 GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEV 270 (429)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCc--ccccCCCCCccChHH
Confidence 3666666666666666 456653 6999999999999999987 999999999865433 335689999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|++++..-
T Consensus 271 ~~~~~~~~~~DiwSlG~il~ell 293 (429)
T 3kvw_A 271 ILGARYGMPIDMWSLGCILAELL 293 (429)
T ss_dssp HHTBCCCTHHHHHHHHHHHHHHH
T ss_pred HhCCCCCchHHHHhHHHHHHHHH
Confidence 99999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=7.7e-15 Score=151.68 Aligned_cols=95 Identities=20% Similarity=0.179 Sum_probs=74.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++...... ......||+.|+|||++.
T Consensus 105 ~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 181 (317)
T 2pmi_A 105 LELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhh
Confidence 444444445445555 56665 479999999999999999999999999998764332 233568999999999987
Q ss_pred c-cccCcccccccccccccccc
Q psy16430 219 N-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
+ ..++.++|+||+|++++..-
T Consensus 182 ~~~~~~~~~DiwslG~il~el~ 203 (317)
T 2pmi_A 182 GSRTYSTSIDIWSCGCILAEMI 203 (317)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHH
Confidence 6 46899999999999998654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=8.4e-15 Score=164.18 Aligned_cols=124 Identities=8% Similarity=-0.076 Sum_probs=71.8
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
+..++.|+....-.+|+|.-+..++.... ..+.+++. + +|...++. .|+|. .+||||||||+||||
T Consensus 305 ~~~~~~~ed~~~~yLVMEyv~G~~L~d~i------~~~~~l~~--~-~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL 372 (569)
T 4azs_A 305 PAVLAHGENAQSGWLVMEKLPGRLLSDML------AAGEEIDR--E-KILGSLLRSLAALEK---QGFWHDDVRPWNVMV 372 (569)
T ss_dssp CCEEEEEECSSEEEEEEECCCSEEHHHHH------HTTCCCCH--H-HHHHHHHHHHHHHHH---TTCEESCCCGGGEEE
T ss_pred eEEEEEEEECCEEEEEEecCCCCcHHHHH------HhCCCCCH--H-HHHHHHHHHHHHHHH---CCceeccCchHhEEE
Confidence 44556677777778898843333322211 11122321 1 24444444 56665 469999999999999
Q ss_pred ccCCceeEeecccccccCCCC-ccccccCceeecccccccccccCccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.+|.+||+|||+|+...... ...+.+||++|||||++.+ .+...+|+|+.|+.++..
T Consensus 373 ~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l 431 (569)
T 4azs_A 373 DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNL 431 (569)
T ss_dssp CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCC
T ss_pred CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhh
Confidence 999999999999999765443 3446889999999999864 567789999999876644
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=9e-15 Score=154.55 Aligned_cols=94 Identities=6% Similarity=-0.027 Sum_probs=75.0
Q ss_pred cccCCcc------ceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeec
Q psy16430 141 RLSIPPQ------YQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWM 212 (600)
Q Consensus 141 ~l~~~~r------~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ym 212 (600)
.+.+..+ +.++..++. +|+|. .+||||||||.|||++.++.+||+|||+|+..... .....||+.|+
T Consensus 184 ~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~ 258 (371)
T 3q60_A 184 VYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYA 258 (371)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGC
T ss_pred ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCc
Confidence 3456666 555455555 56774 46999999999999999999999999999866432 22456779999
Q ss_pred ccccccc--cccCcccccccccccccccc
Q psy16430 213 APEVIRN--EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 213 APE~i~~--~~~s~~~Dvy~~~~~~~p~s 239 (600)
|||++.+ ..++.++|+||+|++++..-
T Consensus 259 aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 259 PREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp CHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred ChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 9999987 67999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.39 E-value=4.1e-15 Score=157.87 Aligned_cols=95 Identities=16% Similarity=0.218 Sum_probs=67.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++...+.|+..+|.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....+|++|+||
T Consensus 143 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aP 219 (373)
T 2qol_A 143 QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219 (373)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccCh
Confidence 46777777777777775 5664 4699999999999999999999999999987643321 1123467889999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.+..++.++|+||+|+++|..
T Consensus 220 E~~~~~~~~~~~Dv~SlG~il~el 243 (373)
T 2qol_A 220 EAIAYRKFTSASDVWSYGIVLWEV 243 (373)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hhhccCCcCchhcHHHHHHHHHHH
Confidence 999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.2e-15 Score=155.45 Aligned_cols=96 Identities=16% Similarity=0.175 Sum_probs=67.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeecc---CCceeEeecccccccCCCCccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGS---KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~---~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++. ++.+||+|||+++...........+||+.|+|||
T Consensus 144 ~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 220 (349)
T 2w4o_A 144 YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE 220 (349)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHH
Confidence 35555556666666664 5665 36999999999999976 8899999999998765544445678999999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++.+..++.++|+||+|++++..-
T Consensus 221 ~~~~~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 221 ILRGCAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccchHHHHHHHHHHH
Confidence 999989999999999999998653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.39 E-value=9.9e-15 Score=160.14 Aligned_cols=96 Identities=21% Similarity=0.223 Sum_probs=77.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.++......++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++.........+.+||+.|+|||++.
T Consensus 112 ~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (476)
T 2y94_A 112 RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188 (476)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhcc
Confidence 35555555566566664 5664 479999999999999999999999999999776555555678999999999998
Q ss_pred cccc-Ccccccccccccccccc
Q psy16430 219 NEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
+..+ +.++|+||+|++++..-
T Consensus 189 ~~~~~~~~~DiwSlGvil~ell 210 (476)
T 2y94_A 189 GRLYAGPEVDIWSSGVILYALL 210 (476)
T ss_dssp TCCBCSHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCcceehhhHHHHHHHh
Confidence 8765 67899999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=4.9e-15 Score=154.02 Aligned_cols=95 Identities=17% Similarity=0.273 Sum_probs=70.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC-CccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK-STKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~-~~~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|.. +||||||||.|||++.++.+||+|||+++..... ......+||+.|+|||++.
T Consensus 118 ~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (327)
T 3a62_A 118 FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCc
Confidence 333334444444544 566653 6999999999999999999999999999864332 2234578999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 195 ~~~~~~~~DiwslG~il~el~ 215 (327)
T 3a62_A 195 RSGHNRAVDWWSLGALMYDML 215 (327)
T ss_dssp TSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHHHH
Confidence 889999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.39 E-value=6.4e-15 Score=156.15 Aligned_cols=93 Identities=11% Similarity=0.011 Sum_probs=76.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+.+..++.|+..++.+ |+|.. +||||||||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.
T Consensus 202 ~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~ 275 (377)
T 3byv_A 202 SLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEA 275 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHH
T ss_pred cccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhc
Confidence 45567777777777774 56653 699999999999999999999999999986433 3345678 9999999998
Q ss_pred cc-----------ccCcccccccccccccccc
Q psy16430 219 NE-----------QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~-----------~~s~~~Dvy~~~~~~~p~s 239 (600)
.. .++.++|+||+|+++|..-
T Consensus 276 ~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp HHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 87 8999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.38 E-value=5.9e-15 Score=162.62 Aligned_cols=97 Identities=18% Similarity=0.219 Sum_probs=78.2
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPE 215 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE 215 (600)
..+++...+.++..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++....... .....+|..|+|||
T Consensus 313 ~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE 389 (495)
T 1opk_A 313 QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389 (495)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHh
Confidence 346666777777777775 5665 4699999999999999999999999999997644322 22345678999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++....++.++|+||||+++|..-
T Consensus 390 ~~~~~~~~~~sDvwSlG~~l~el~ 413 (495)
T 1opk_A 390 SLAYNKFSIKSDVWAFGVLLWEIA 413 (495)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCcHHhHHhHHHHHHHHH
Confidence 999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-14 Score=147.87 Aligned_cols=96 Identities=20% Similarity=0.219 Sum_probs=75.9
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++. .|+|.. +|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||.+
T Consensus 133 ~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 209 (298)
T 2zv2_A 133 PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhh
Confidence 4666666666666666 456653 699999999999999999999999999987654332 3356899999999998
Q ss_pred cccc---cCcccccccccccccccc
Q psy16430 218 RNEQ---CSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~---~s~~~Dvy~~~~~~~p~s 239 (600)
.... ++.++|+||+|++++..-
T Consensus 210 ~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 210 SETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp CTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred ccCCCCCCCchhhhHhHHHHHHHHH
Confidence 7655 377899999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.38 E-value=1.7e-14 Score=155.49 Aligned_cols=97 Identities=15% Similarity=0.174 Sum_probs=75.4
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccC-CceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSK-EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~-~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++. .|+|. .+||||||||.|||++.+ +.+||+|||+++.+..........||++|+|||++
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~ 228 (420)
T 1j1b_A 152 TLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228 (420)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHH
Confidence 3445444445555555 45664 479999999999999965 57899999999976555445567899999999998
Q ss_pred ccc-ccCccccccccccccccccc
Q psy16430 218 RNE-QCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 218 ~~~-~~s~~~Dvy~~~~~~~p~sl 240 (600)
.+. .++.++|+||+|++++..-.
T Consensus 229 ~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 229 FGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCchhhhHHHHHHHHHHHh
Confidence 764 68999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-14 Score=153.76 Aligned_cols=96 Identities=20% Similarity=0.260 Sum_probs=78.8
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAP 214 (600)
..+++.....|+..++.+ |+|. .+||||||||+|||++.++.+||+|||+|+...... ......||+.|+||
T Consensus 186 ~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 262 (382)
T 3tt0_A 186 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262 (382)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred cccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence 346777777777777775 5664 479999999999999999999999999998664432 23345688999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.+..++.++|+||+|++++..
T Consensus 263 E~~~~~~~~~~~DiwslG~il~el 286 (382)
T 3tt0_A 263 EALFDRIYTHQSDVWSFGVLLWEI 286 (382)
T ss_dssp HHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCchhHHHHHHHHHHHH
Confidence 999999999999999999998865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-14 Score=150.98 Aligned_cols=130 Identities=15% Similarity=0.122 Sum_probs=86.5
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd 180 (600)
..+++|...+.-.+++|.-...+...+. .......+++.....++...+.+ |+|. .+|+||||||.|||++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLC----LPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLS 165 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGG----SSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEES
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHH----HHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEe
Confidence 3344455555556666632222222211 11112345666666666666664 5664 3699999999999999
Q ss_pred c---CCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 181 S---KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 181 ~---~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
. ++.+||+|||+++............||+.|+|||++....++.++|+||+|++++..-
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH
Confidence 8 7899999999999775544445578999999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=8.5e-15 Score=152.08 Aligned_cols=96 Identities=16% Similarity=0.268 Sum_probs=76.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE 215 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++.+.... .....+||+.|+|||
T Consensus 101 ~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 177 (323)
T 3tki_A 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177 (323)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcH
Confidence 46666666666666664 5664 469999999999999999999999999998653222 233578999999999
Q ss_pred ccccccc-Ccccccccccccccccc
Q psy16430 216 VIRNEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
++.+..+ +.++|+||+|++++..-
T Consensus 178 ~~~~~~~~~~~~DiwslG~il~~ll 202 (323)
T 3tki_A 178 LLKRREFHAEPVDVWSCGIVLTAML 202 (323)
T ss_dssp HHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCCCcccHHHHHHHHHHHH
Confidence 9987765 77899999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.38 E-value=9.9e-15 Score=153.06 Aligned_cols=93 Identities=17% Similarity=0.103 Sum_probs=74.5
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc-------------------------CCceeEeeccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS-------------------------KEEAKISDFGTCR 194 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~-------------------------~~~~Kv~DFGlsr 194 (600)
+++.....++..++. .|+|. .+||||||||+|||++. ++.+||+|||+|+
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~ 210 (360)
T 3llt_A 134 FHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCce
Confidence 455555555555555 45664 46999999999999975 7899999999998
Q ss_pred ccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 195 EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 195 ~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
..... .....||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 211 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 211 FKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp ETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 64332 33568999999999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-14 Score=158.22 Aligned_cols=95 Identities=18% Similarity=0.217 Sum_probs=74.3
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec---cCCceeEeecccccccCCCCc-cccccCceeecccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG---SKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPE 215 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd---~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE 215 (600)
++......++..++. .|+|.. +|+||||||.|||++ .++.+||+|||+|+....... ....+||++|+|||
T Consensus 107 ~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE 183 (444)
T 3soa_A 107 YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183 (444)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHH
Confidence 444444445545555 566653 699999999999999 457899999999987654332 34578999999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++....++.++|+||+|++++..-
T Consensus 184 ~l~~~~~~~~~DIwSlGvilyell 207 (444)
T 3soa_A 184 VLRKDPYGKPVDLWACGVILYILL 207 (444)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCCccccHHHHHHHHHHH
Confidence 999889999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.5e-14 Score=156.34 Aligned_cols=96 Identities=20% Similarity=0.160 Sum_probs=73.0
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC------------------
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS------------------ 200 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~------------------ 200 (600)
.+++.....++..++. .|+|.. +||||||||+|||++.++.+||+|||+|+......
T Consensus 125 ~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (432)
T 3n9x_A 125 FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201 (432)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccc
Confidence 4566666666656655 456653 69999999999999999999999999999754322
Q ss_pred -----ccccccCceeecccccc-cccccCcccccccccccccccc
Q psy16430 201 -----TKMSFAGTVAWMAPEVI-RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 201 -----~~~~~~GT~~ymAPE~i-~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
..+..+||++|+|||++ ....++.++|+||+|++++..-
T Consensus 202 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell 246 (432)
T 3n9x_A 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246 (432)
T ss_dssp ---------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred cchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence 12457899999999986 5566999999999999998653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-14 Score=149.97 Aligned_cols=95 Identities=18% Similarity=0.125 Sum_probs=73.4
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|. .+|+||||||.|||++.++.+||+|||+|+...... ......||+.|+|||++.
T Consensus 116 ~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (311)
T 3niz_A 116 LQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhc
Confidence 444445555555555 45664 479999999999999999999999999998764332 234568999999999987
Q ss_pred c-cccCcccccccccccccccc
Q psy16430 219 N-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
+ ..++.++|+||+|++++..-
T Consensus 193 ~~~~~~~~~DiwslG~il~~ll 214 (311)
T 3niz_A 193 GSKKYSTSVDIWSIGCIFAEMI 214 (311)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCchHHhHHHHHHHHHHH
Confidence 6 56899999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.37 E-value=4.1e-15 Score=150.61 Aligned_cols=98 Identities=20% Similarity=0.152 Sum_probs=67.8
Q ss_pred ccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..+++.....|+..++. .|+|.. .+|+||||||.|||++.++.+||+|||+++............||+.|+|||.+
T Consensus 104 ~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 104 QTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181 (290)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhc
Confidence 45677777777766666 456654 36999999999999999999999999999876555444456899999999996
Q ss_pred ----cccccCcccccccccccccccc
Q psy16430 218 ----RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ----~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
....++.++|+||+|++++..-
T Consensus 182 ~~~~~~~~~~~~~Di~slG~il~~l~ 207 (290)
T 3fme_A 182 NPELNQKGYSVKSDIWSLGITMIELA 207 (290)
T ss_dssp SCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred ChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence 5567889999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-14 Score=148.57 Aligned_cols=96 Identities=20% Similarity=0.249 Sum_probs=70.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCc-eeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEE-AKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~-~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++...+.++..+|. .|+|.....+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.
T Consensus 99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~ 176 (307)
T 2eva_A 99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFE 176 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHT
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhC
Confidence 344444555555555 5677765578999999999999999886 799999999865332 23457999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 177 ~~~~~~~~Di~slG~il~el~ 197 (307)
T 2eva_A 177 GSNYSEKCDVFSWGIILWEVI 197 (307)
T ss_dssp CCCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHH
Confidence 889999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.36 E-value=4.4e-14 Score=150.89 Aligned_cols=95 Identities=15% Similarity=0.148 Sum_probs=75.4
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec-cCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG-SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd-~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++..++. .|+|. .+|+||||||+|||++ .++.+||+|||+|+............||+.|+|||++.
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~ 214 (394)
T 4e7w_A 138 MPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIF 214 (394)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHc
Confidence 444444445555555 56665 3699999999999999 79999999999999775555555678999999999986
Q ss_pred cc-ccCcccccccccccccccc
Q psy16430 219 NE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
+. .++.++|+||+|++++..-
T Consensus 215 ~~~~~~~~~DiwSlG~il~ell 236 (394)
T 4e7w_A 215 GATNYTTNIDIWSTGCVMAELM 236 (394)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHH
Confidence 54 5899999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.36 E-value=6.6e-15 Score=160.25 Aligned_cols=96 Identities=18% Similarity=0.239 Sum_probs=76.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++...+.++..+|.+ |+|. .+||||||||+|||++.++.+||+|||+|+....... .....+|..|+|||+
T Consensus 280 ~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~ 356 (454)
T 1qcf_A 280 KQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356 (454)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHH
Confidence 35555666666666664 5664 3699999999999999999999999999987644322 223457889999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..+.++.++|+||||+++|..-
T Consensus 357 ~~~~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 357 INFGSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHH
T ss_pred hccCCCCcHHHHHhHHHHHHHHH
Confidence 99999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-14 Score=149.57 Aligned_cols=96 Identities=18% Similarity=0.178 Sum_probs=78.8
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCC----ceeEeecccccccCCCCccccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKE----EAKISDFGTCREWNNKSTKMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~----~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++ .+||+|||+++............||+.|+||
T Consensus 111 ~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aP 187 (321)
T 2a2a_A 111 SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187 (321)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCc
Confidence 45666666666666664 5664 4799999999999999988 7999999999877655444567899999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++.+..++.++|+||+|++++..-
T Consensus 188 E~~~~~~~~~~~Di~slG~il~~l~ 212 (321)
T 2a2a_A 188 EIVNYEPLGLEADMWSIGVITYILL 212 (321)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccCCCCCCccccHHHHHHHHHHH
Confidence 9999899999999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-14 Score=145.25 Aligned_cols=96 Identities=13% Similarity=0.074 Sum_probs=78.3
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee---ccCCceeEeecccccccCCCCc--------cccccC
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI---GSKEEAKISDFGTCREWNNKST--------KMSFAG 207 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL---d~~~~~Kv~DFGlsr~~~~~~~--------~~~~~G 207 (600)
.+++.....++..++.+ |+|. .+|+||||||+|||+ +.++.+||+|||+++....... .....|
T Consensus 101 ~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~g 177 (296)
T 4hgt_A 101 KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCC
Confidence 46777777777777775 5664 369999999999999 8899999999999987644321 224679
Q ss_pred ceeecccccccccccCcccccccccccccccc
Q psy16430 208 TVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 208 T~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|+.|+|||.+.+..++.++|+||+|++++..-
T Consensus 178 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 4hgt_A 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CccccchHHhcCCCCCchhHHHHHHHHHHHHh
Confidence 99999999999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-14 Score=145.40 Aligned_cols=98 Identities=31% Similarity=0.441 Sum_probs=71.3
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc--------CCceeEeecccccccCCCCccccccCcee
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS--------KEEAKISDFGTCREWNNKSTKMSFAGTVA 210 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~--------~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ 210 (600)
.+++.....++...+. .|+|.....+|+||||||.|||++. ++.+||+|||+++...... .....||+.
T Consensus 101 ~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~ 179 (271)
T 3dtc_A 101 RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYA 179 (271)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccc
Confidence 4556666666666666 5677765557999999999999996 7789999999998654332 234679999
Q ss_pred ecccccccccccCcccccccccccccccc
Q psy16430 211 WMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 211 ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|+|||.+.+..++.++|+||+|++++..-
T Consensus 180 y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 208 (271)
T 3dtc_A 180 WMAPEVIRASMFSKGSDVWSYGVLLWELL 208 (271)
T ss_dssp GSCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred eeCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999889999999999999988653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=8.4e-15 Score=151.11 Aligned_cols=95 Identities=12% Similarity=0.150 Sum_probs=69.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++.....|+..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 45666666666666664 5665 3699999999999999999999999999986544322 22355788999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHH
Confidence 99999999999999999998864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=8.7e-15 Score=156.60 Aligned_cols=95 Identities=19% Similarity=0.145 Sum_probs=69.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee----ccCCceeEeecccccccCCCC----ccccccCceee
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI----GSKEEAKISDFGTCREWNNKS----TKMSFAGTVAW 211 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL----d~~~~~Kv~DFGlsr~~~~~~----~~~~~~GT~~y 211 (600)
+++.....|+..++. .|+|.. +||||||||.|||+ +.++.+||+|||+|+...... .....+||++|
T Consensus 125 l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 201 (405)
T 3rgf_A 125 LPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201 (405)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcc
Confidence 555555556666666 456653 59999999999999 778999999999998764321 23357899999
Q ss_pred ccccccccc-ccCcccccccccccccccc
Q psy16430 212 MAPEVIRNE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 212 mAPE~i~~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
+|||++.+. .++.++|+||+|++++..-
T Consensus 202 ~aPE~~~~~~~~~~~~DiwSlG~il~ell 230 (405)
T 3rgf_A 202 RAPELLLGARHYTKAIDIWAIGCIFAELL 230 (405)
T ss_dssp CCHHHHTTCCSCCHHHHHHHHHHHHHHHH
T ss_pred cCchhhcCCCcccchhhhHHHHHHHHHHH
Confidence 999998774 4899999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-14 Score=151.31 Aligned_cols=96 Identities=16% Similarity=0.140 Sum_probs=59.0
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCC---ceeEeecccccccCCCC-ccccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE---EAKISDFGTCREWNNKS-TKMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~---~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAP 214 (600)
.+++.....|+..++. .|+|. .+|+||||||.|||++.++ .+||+|||+++...... ...+.+||+.|+||
T Consensus 102 ~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aP 178 (325)
T 3kn6_A 102 HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCH
Confidence 4556666666666666 45664 4699999999999998766 89999999998654432 23457899999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++.+..++.++|+||+|++++..-
T Consensus 179 E~~~~~~~~~~~DiwslG~il~~ll 203 (325)
T 3kn6_A 179 ELLNQNGYDESCDLWSLGVILYTML 203 (325)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCccchHHHHHHHHHHH
Confidence 9999999999999999999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-14 Score=150.86 Aligned_cols=96 Identities=21% Similarity=0.235 Sum_probs=77.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++...+.++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 168 ~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 244 (344)
T 1rjb_A 168 VLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244 (344)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence 46777777777777775 5664 4799999999999999999999999999986543322 22456788999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+.+..++.++|+||+|++++..-
T Consensus 245 ~~~~~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 245 SLFEGIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred HhccCCCChhHhHHHHHHHHHHHH
Confidence 999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.4e-14 Score=149.76 Aligned_cols=95 Identities=14% Similarity=0.112 Sum_probs=76.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|.. +|+||||||.|||++.++.+||+|||+++...... .....+||+.|+|||++
T Consensus 108 ~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 108 VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184 (346)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHh
Confidence 46666666666666664 56653 59999999999999999999999999998764332 33457899999999998
Q ss_pred ccc-ccCccccccccccccccc
Q psy16430 218 RNE-QCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 218 ~~~-~~s~~~Dvy~~~~~~~p~ 238 (600)
.+. .++.++|+||+|++++..
T Consensus 185 ~~~~~~~~~~DiwslG~il~el 206 (346)
T 1ua2_A 185 FGARMYGVGVDMWAVGCILAEL 206 (346)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCchhhhHhHHHHHHHH
Confidence 654 488999999999998865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.35 E-value=8.7e-15 Score=148.81 Aligned_cols=95 Identities=21% Similarity=0.190 Sum_probs=71.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++...... ......||+.|+|||++.
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 173 (288)
T 1ob3_A 97 LESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchhee
Confidence 455555555555555 45665 479999999999999999999999999998764332 233467999999999987
Q ss_pred c-cccCcccccccccccccccc
Q psy16430 219 N-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
+ ..++.++|+||+|++++..-
T Consensus 174 ~~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 174 GSKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHH
Confidence 5 45899999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.6e-14 Score=144.74 Aligned_cols=95 Identities=20% Similarity=0.196 Sum_probs=76.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++...+.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||.
T Consensus 100 ~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 176 (268)
T 3sxs_A 100 GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176 (268)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHH
Confidence 46666677777666664 5665 4699999999999999999999999999986644332 223556788999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.+..++.++|+||+|++++..
T Consensus 177 ~~~~~~~~~~Di~slG~il~~l 198 (268)
T 3sxs_A 177 FHYFKYSSKSDVWAFGILMWEV 198 (268)
T ss_dssp HHHSEEETTHHHHHHHHHHHHH
T ss_pred HhccCCchhhhhHHHHHHHHHH
Confidence 9988999999999999998865
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.35 E-value=4.2e-14 Score=149.57 Aligned_cols=95 Identities=19% Similarity=0.112 Sum_probs=65.8
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++...........+||+.|+|||++.+
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 124 LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTT
T ss_pred cCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcC
Confidence 344444445555555 45665 3699999999999999999999999999987654444455789999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 201 ~~~~~~~DiwslG~il~el~ 220 (371)
T 2xrw_A 201 MGYKENVDIWSVGCIMGEMI 220 (371)
T ss_dssp CCCCTTHHHHHHHHHHHHHH
T ss_pred CCCCchHhHHHHHHHHHHHH
Confidence 89999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=3e-14 Score=144.29 Aligned_cols=97 Identities=21% Similarity=0.314 Sum_probs=76.4
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCc-----eeEeecccccccCCCCccccccCceeec
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEE-----AKISDFGTCREWNNKSTKMSFAGTVAWM 212 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~-----~Kv~DFGlsr~~~~~~~~~~~~GT~~ym 212 (600)
..+++.....++...+.+ |+|.. ..+|+||||||+|||++.++. +||+|||+++.... ......||+.|+
T Consensus 117 ~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~ 193 (287)
T 4f0f_A 117 HPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWM 193 (287)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTS
T ss_pred CCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCcccc
Confidence 356777777777777665 56653 345999999999999988876 99999999985433 234578999999
Q ss_pred ccccc--cccccCcccccccccccccccc
Q psy16430 213 APEVI--RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 213 APE~i--~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|||.+ ....++.++|+||+|++++..-
T Consensus 194 aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 194 APETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp CGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred CchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 99998 4456788999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.9e-14 Score=152.14 Aligned_cols=128 Identities=17% Similarity=0.256 Sum_probs=89.6
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd 180 (600)
.++++|....+..+++|.-+..+...+. .....+++.....++..++. .|+|. .+|+||||||.|||++
T Consensus 164 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l------~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 164 TLIDSYESSSFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234 (365)
T ss_dssp CEEEEEEBSSEEEEEECCCTTCBHHHHH------HHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred EEEEEEeeCCEEEEEEEeCCCCcHHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 3444455555556666632222222111 11124556666666666666 45665 3699999999999999
Q ss_pred cCCceeEeecccccccCCCCccccccCceeecccccccc------cccCcccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN------EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~------~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+|.+||+|||+++.+.........+||+.|+|||++.+ ..++.++|+||+|++++..-
T Consensus 235 ~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell 299 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299 (365)
T ss_dssp TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH
Confidence 999999999999987765555556789999999999863 35888999999999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.2e-14 Score=149.96 Aligned_cols=95 Identities=16% Similarity=0.224 Sum_probs=74.8
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-----ccccccCceeecc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-----TKMSFAGTVAWMA 213 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-----~~~~~~GT~~ymA 213 (600)
.+++.....|+..++. .|+|. .+|+||||||.|||++.++.+||+|||+|+.+.... ......||++|+|
T Consensus 120 ~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 196 (351)
T 3mi9_A 120 KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196 (351)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccC
Confidence 3556666666666666 45664 369999999999999999999999999998654221 2234679999999
Q ss_pred cccccc-cccCccccccccccccccc
Q psy16430 214 PEVIRN-EQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~-~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++.+ ..++.++|+||+|++++..
T Consensus 197 PE~~~~~~~~~~~~DiwslG~il~el 222 (351)
T 3mi9_A 197 PELLLGERDYGPPIDLWGAGCIMAEM 222 (351)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred chhhcCCCCCCcHhHHHHHHHHHHHH
Confidence 998875 4579999999999998865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=8.3e-15 Score=152.14 Aligned_cols=96 Identities=20% Similarity=0.252 Sum_probs=77.3
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAP 214 (600)
..+++...+.|+..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++...... ......||+.|+||
T Consensus 169 ~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 245 (343)
T 1luf_A 169 PPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence 457777777777777775 5664 369999999999999999999999999998654322 12346789999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|.+.+..++.++|+||+|+++|..
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 246 ESIFYNRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hhhccCCcCcccccHHHHHHHHHH
Confidence 999989999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-14 Score=156.94 Aligned_cols=92 Identities=24% Similarity=0.299 Sum_probs=73.9
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++...+.++..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++..... .....+|+.|+|||.+.+
T Consensus 286 ~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~ 360 (450)
T 1k9a_A 286 LGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE 360 (450)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcC
Confidence 4566666677777775 5665 36999999999999999999999999999854332 223467899999999999
Q ss_pred cccCccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~ 238 (600)
..++.++|+||+|+++|..
T Consensus 361 ~~~~~~sDvwslG~~l~el 379 (450)
T 1k9a_A 361 KKFSTKSDVWSFGILLWEI 379 (450)
T ss_dssp SCCCHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2e-14 Score=154.86 Aligned_cols=96 Identities=21% Similarity=0.212 Sum_probs=67.7
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccC---CceeEeecccccccCCCCccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSK---EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~---~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
.+++.....++..++. .|+|. .+||||||||+|||++.+ +.+||+|||+|+.........+.+||++|+|||
T Consensus 235 ~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 311 (419)
T 3i6u_A 235 RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311 (419)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCce
Confidence 4566666666666666 45664 369999999999999754 459999999999776554455678999999999
Q ss_pred ccc---ccccCcccccccccccccccc
Q psy16430 216 VIR---NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~---~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++. ...++.++|+||+|++++..-
T Consensus 312 ~~~~~~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 312 VLVSVGTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp TTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred eeecCCCCCCCchhhhHhHHHHHHHHH
Confidence 985 366888999999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.9e-14 Score=143.66 Aligned_cols=96 Identities=16% Similarity=0.199 Sum_probs=79.8
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++............||+.|+|||.+.
T Consensus 118 ~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (284)
T 2a19_B 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS 194 (284)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhc
Confidence 46666666666666664 5664 369999999999999999999999999998776554455678999999999999
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..++.++|+||+|++++..-
T Consensus 195 ~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 195 SQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp CSCCCTHHHHHHHHHHHHHHH
T ss_pred cCCCcchhhhHHHHHHHHHHH
Confidence 889999999999999988653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-14 Score=164.23 Aligned_cols=96 Identities=19% Similarity=0.245 Sum_probs=74.4
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeecc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMA 213 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymA 213 (600)
..+++.....|+..+|.+ |+|. .+||||||||.|||++.++.+||+|||+|+.+..... .....+|+.|+|
T Consensus 431 ~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~A 507 (613)
T 2ozo_A 431 EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507 (613)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeC
Confidence 346777777777777775 5664 4699999999999999999999999999987643322 112346689999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++.+..++.++|+||||+++|..
T Consensus 508 PE~~~~~~~~~~sDvwSlGv~l~el 532 (613)
T 2ozo_A 508 PECINFRKFSSRSDVWSYGVTMWEA 532 (613)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhhhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-14 Score=148.53 Aligned_cols=94 Identities=14% Similarity=0.200 Sum_probs=76.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee-------------------ccCCceeEeecccccccCCC
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI-------------------GSKEEAKISDFGTCREWNNK 199 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL-------------------d~~~~~Kv~DFGlsr~~~~~ 199 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||+ +.++.+||+|||+++.....
T Consensus 119 ~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 195 (355)
T 2eu9_A 119 PYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc
Confidence 46666666677666665 5664 479999999999999 67889999999999864332
Q ss_pred CccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 200 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 200 ~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.....||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 196 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 196 --HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp --CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred --ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence 33568999999999999999999999999999998653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=8.8e-15 Score=150.59 Aligned_cols=96 Identities=13% Similarity=0.224 Sum_probs=70.0
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 112 ~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 112 PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188 (311)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCH
Confidence 3556666666666666 45665 3699999999999999999999999999986543321 2246799999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+.+..++.++|+||+|++++..-
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~~ll 213 (311)
T 3ork_A 189 EQARGDSVDARSDVYSLGCVLYEVL 213 (311)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHH
Confidence 9999999999999999999998653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.34 E-value=3.3e-14 Score=144.27 Aligned_cols=96 Identities=13% Similarity=0.074 Sum_probs=78.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee---ccCCceeEeecccccccCCCCc--------cccccC
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI---GSKEEAKISDFGTCREWNNKST--------KMSFAG 207 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL---d~~~~~Kv~DFGlsr~~~~~~~--------~~~~~G 207 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||+ +.++.+||+|||+++....... .....|
T Consensus 101 ~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~g 177 (296)
T 3uzp_A 101 KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccc
Confidence 46667777777777775 5664 469999999999999 5889999999999987644322 234679
Q ss_pred ceeecccccccccccCcccccccccccccccc
Q psy16430 208 TVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 208 T~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|+.|+|||.+.+..++.++|+||+|++++..-
T Consensus 178 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 3uzp_A 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccCChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence 99999999999989999999999999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-14 Score=149.28 Aligned_cols=96 Identities=11% Similarity=0.146 Sum_probs=78.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCC--ceeEeecccccccCCCCc--------cccccCc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKE--EAKISDFGTCREWNNKST--------KMSFAGT 208 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~--~~Kv~DFGlsr~~~~~~~--------~~~~~GT 208 (600)
.+++.....|+..++.+ |+|. .+||||||||.|||++.++ .+||+|||+|+.+..... .....||
T Consensus 147 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt 223 (345)
T 2v62_A 147 TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223 (345)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCC
Confidence 56777777777777775 5664 3799999999999999888 999999999986533211 1346899
Q ss_pred eeecccccccccccCcccccccccccccccc
Q psy16430 209 VAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 209 ~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.|+|||++.+..++.++|+||+|+++|..-
T Consensus 224 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell 254 (345)
T 2v62_A 224 IEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254 (345)
T ss_dssp TTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999888999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-14 Score=152.90 Aligned_cols=95 Identities=18% Similarity=0.239 Sum_probs=72.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVI 217 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i 217 (600)
+++.....++..++. .|+|. .+||||||||.|||++.++.+||+|||+++.+..... ....+||+.|+|||++
T Consensus 156 ~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 156 FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhh
Confidence 444555555555555 45664 3699999999999999999999999999986543222 3346899999999998
Q ss_pred cc--cccCcccccccccccccccc
Q psy16430 218 RN--EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~--~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+ ..++.++|+||+|++++..-
T Consensus 233 ~~~~~~~~~~~DvwslG~il~ell 256 (355)
T 1vzo_A 233 RGGDSGHDKAVDWWSLGVLMYELL 256 (355)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCchhhHHHHHHHHHHHH
Confidence 75 34788999999999998653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.4e-14 Score=154.77 Aligned_cols=96 Identities=14% Similarity=0.176 Sum_probs=77.8
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee----ccCCceeEeecccccccCCCCccccccCceeecccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI----GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL----d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
+++.....++..++.+ |+|.. +||||||||.|||+ +.++.+||+|||+++............||+.|+|||
T Consensus 109 l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE 185 (396)
T 4eut_A 109 LPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185 (396)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHH
Confidence 6666666666666664 56653 69999999999999 888889999999999776555555678999999999
Q ss_pred cccc--------cccCccccccccccccccccc
Q psy16430 216 VIRN--------EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 216 ~i~~--------~~~s~~~Dvy~~~~~~~p~sl 240 (600)
++.. ..++.++|+||+|+++|..-.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t 218 (396)
T 4eut_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (396)
T ss_dssp HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhccccccccccCCCcHHHHHHHHHHHHHHHH
Confidence 9865 567889999999999987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-14 Score=150.18 Aligned_cols=99 Identities=16% Similarity=0.227 Sum_probs=77.5
Q ss_pred cccCCccceeeccccch--hhhccC-----CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----cccccCc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGC-----TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGT 208 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~-----~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----~~~~~GT 208 (600)
.+++.....++..+|.+ |+|... +.+|+||||||.|||++.++.+||+|||+++....... .....||
T Consensus 135 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt 214 (342)
T 1b6c_B 135 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214 (342)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCC
T ss_pred CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcC
Confidence 46677777777777764 566422 56899999999999999999999999999987644332 2346799
Q ss_pred eeeccccccccc------ccCcccccccccccccccc
Q psy16430 209 VAWMAPEVIRNE------QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 209 ~~ymAPE~i~~~------~~s~~~Dvy~~~~~~~p~s 239 (600)
+.|+|||.+... .++.++|+||+|++++..-
T Consensus 215 ~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp GGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 999999998765 3446899999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.2e-14 Score=150.11 Aligned_cols=94 Identities=20% Similarity=0.287 Sum_probs=75.9
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE~ 216 (600)
+++.....++..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++...... ......||+.|+|||+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence 6666666676666664 5665 369999999999999999999999999998653322 1234678999999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.+..++.++|+||+|++++..
T Consensus 267 ~~~~~~~~~~Di~slG~il~el 288 (359)
T 3vhe_A 267 IFDRVYTIQSDVWSFGVLLWEI 288 (359)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHH
T ss_pred hcCCCCCchhhhhhHHHHHHHH
Confidence 9999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.1e-14 Score=147.28 Aligned_cols=95 Identities=18% Similarity=0.260 Sum_probs=66.4
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||+
T Consensus 112 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 188 (281)
T 1mp8_A 112 SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188 (281)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhh
Confidence 45666666666666664 5665 4799999999999999999999999999987644322 223557889999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+....++.++|+||+|++++..
T Consensus 189 ~~~~~~~~~~Di~slG~~l~el 210 (281)
T 1mp8_A 189 INFRRFTSASDVWMFGVCMWEI 210 (281)
T ss_dssp HHHCCCSHHHHHHHHHHHHHHH
T ss_pred cccCCCCCccCchHHHHHHHHH
Confidence 9988999999999999998864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.2e-14 Score=144.89 Aligned_cols=95 Identities=22% Similarity=0.276 Sum_probs=76.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCc---eeEeecccccccCCCCccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEE---AKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~---~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
+++.....++...+. .|+|. .+|+||||||.|||++.++. +||+|||++.............||++|+|||.
T Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (284)
T 3kk8_A 102 YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchh
Confidence 455555555555555 45665 36999999999999987655 99999999987665544556789999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|++++..-
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 179 LKKDPYSKPVDIWACGVILYILL 201 (284)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHH
T ss_pred hcCCCCCcccchHHHHHHHHHHH
Confidence 99999999999999999988653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.1e-14 Score=153.69 Aligned_cols=96 Identities=21% Similarity=0.178 Sum_probs=65.4
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCc--eeEeecccccccCCCCccccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEE--AKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~--~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
.+++.....++...+. .|+|. .+|+||||||.|||++.++. +||+|||+|+...........+||++|+|||+
T Consensus 112 ~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 188 (361)
T 3uc3_A 112 RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188 (361)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhh
Confidence 3555555555555555 45664 46999999999999998776 99999999985444434445789999999999
Q ss_pred ccccccCcc-cccccccccccccc
Q psy16430 217 IRNEQCSDK-IDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~-~Dvy~~~~~~~p~s 239 (600)
+.+..++.+ +|+||+|++++..-
T Consensus 189 ~~~~~~~~~~~DiwslG~il~ell 212 (361)
T 3uc3_A 189 LLRQEYDGKIADVWSCGVTLYVML 212 (361)
T ss_dssp HHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred hcCCCCCCCeeeeehhHHHHHHHH
Confidence 988887655 89999999988653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.2e-14 Score=150.63 Aligned_cols=96 Identities=21% Similarity=0.212 Sum_probs=75.3
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++............+|+.|+|||.+
T Consensus 137 ~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 213 (327)
T 1fvr_A 137 STLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 213 (327)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhh
Confidence 346666677777777665 5664 47999999999999999999999999999854333233345678899999999
Q ss_pred cccccCccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
....++.++|+||+|++++..
T Consensus 214 ~~~~~~~~~Di~slG~il~el 234 (327)
T 1fvr_A 214 NYSVYTTNSDVWSYGVLLWEI 234 (327)
T ss_dssp HHCEECHHHHHHHHHHHHHHH
T ss_pred ccccCCchhcchHHHHHHHHH
Confidence 988899999999999999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-14 Score=152.68 Aligned_cols=96 Identities=19% Similarity=0.277 Sum_probs=67.6
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----cccccCceeecc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGTVAWMA 213 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----~~~~~GT~~ymA 213 (600)
.+++.....++..+|. .|+|. .+||||||||.|||++.++.+||+|||+++....... .....||+.|+|
T Consensus 188 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~a 264 (373)
T 3c1x_A 188 NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264 (373)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccC
Confidence 3555555666666666 45665 3699999999999999999999999999986533221 233567889999
Q ss_pred cccccccccCcccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
||.+.+..++.++|+||+|+++|..-
T Consensus 265 PE~~~~~~~~~~~DvwSlG~il~ell 290 (373)
T 3c1x_A 265 LESLQTQKFTTKSDVWSFGVLLWELM 290 (373)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred hHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=3.5e-14 Score=145.24 Aligned_cols=97 Identities=23% Similarity=0.263 Sum_probs=77.7
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAP 214 (600)
.+++|..+..|+..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 128 ~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP 204 (307)
T 2nru_A 128 PPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204 (307)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence 457788888877777775 5664 4699999999999999999999999999986543221 2346799999999
Q ss_pred ccccccccCccccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
|.+.+ .++.++|+||+|++++..-.
T Consensus 205 E~~~~-~~~~~~Dv~slG~il~~l~~ 229 (307)
T 2nru_A 205 EALRG-EITPKSDIYSFGVVLLEIIT 229 (307)
T ss_dssp HHHTT-EECTHHHHHHHHHHHHHHHH
T ss_pred HHhcC-CCCccchhHHHHHHHHHHHH
Confidence 98764 58899999999999986543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1e-14 Score=150.86 Aligned_cols=98 Identities=16% Similarity=0.173 Sum_probs=58.8
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..+++.....++...+.+ |+|.. .+|+||||||.|||++.++.+||+|||+++............||+.|+|||++
T Consensus 120 ~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 120 DVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 197 (327)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------------------
T ss_pred ccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceee
Confidence 345566666666666664 56653 36999999999999999999999999999876554444456899999999998
Q ss_pred ----cccccCcccccccccccccccc
Q psy16430 218 ----RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ----~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
....++.++|+||+|++++..-
T Consensus 198 ~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 198 DPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp --------CCSHHHHHHHHHHHHHHH
T ss_pred ccccCcCCCCchhhHHHHHHHHHHHH
Confidence 4566899999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.33 E-value=5.2e-14 Score=146.57 Aligned_cols=97 Identities=20% Similarity=0.210 Sum_probs=78.6
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..+++.....++..++.+ |+|. ..+|+||||||.|||++.++.+||+|||+++..... ......||+.|+|||.+
T Consensus 146 ~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~ 222 (348)
T 2pml_X 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFF 222 (348)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGG
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhh
Confidence 456777777777777775 5665 357999999999999999999999999999876443 33456799999999999
Q ss_pred ccc-ccCc-ccccccccccccccc
Q psy16430 218 RNE-QCSD-KIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~-~~s~-~~Dvy~~~~~~~p~s 239 (600)
.+. .++. ++|+||+|++++..-
T Consensus 223 ~~~~~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 223 SNESSYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp SSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCcchhhHHHHHHHHHHHH
Confidence 877 6666 899999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.5e-14 Score=146.46 Aligned_cols=95 Identities=18% Similarity=0.251 Sum_probs=76.9
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 146 ~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 222 (314)
T 2ivs_A 146 ALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence 46666666676666664 5665 3699999999999999999999999999987644322 22356789999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 223 ~~~~~~~~~~~Di~slG~il~el 245 (314)
T 2ivs_A 223 SLFDHIYTTQSDVWSFGVLLWEI 245 (314)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHH
T ss_pred hhcCCCcCchhhHHHHHHHHHHH
Confidence 99988999999999999998865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-14 Score=156.84 Aligned_cols=96 Identities=18% Similarity=0.241 Sum_probs=73.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++...+.++..+|.+ |+|. .+||||||||+|||++.++.+||+|||+++....... .....||..|+|||.
T Consensus 276 ~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~ 352 (452)
T 1fmk_A 276 YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352 (452)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhH
Confidence 46677777777777775 5664 4699999999999999999999999999987643322 223557889999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..+.++.++|+||+|+++|..-
T Consensus 353 ~~~~~~~~~sDvwslG~~l~el~ 375 (452)
T 1fmk_A 353 ALYGRFTIKSDVWSFGILLTELT 375 (452)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCccccHHhHHHHHHHHH
Confidence 99999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.4e-14 Score=164.58 Aligned_cols=95 Identities=22% Similarity=0.245 Sum_probs=74.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....|+..++.+ |+|. .+||||||||+||||+.++.+||+|||+|+.+..... .....||+.|+||
T Consensus 465 ~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~AP 541 (635)
T 4fl3_A 465 HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 541 (635)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeCh
Confidence 46677777777777775 5664 4699999999999999999999999999987644321 2235578899999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.+..++.++|+||+|++++..
T Consensus 542 E~~~~~~~~~~sDvwSlGv~l~el 565 (635)
T 4fl3_A 542 ECINYYKFSSKSDVWSFGVLMWEA 565 (635)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-14 Score=154.61 Aligned_cols=89 Identities=19% Similarity=0.286 Sum_probs=65.6
Q ss_pred cceeeccccc--hhhhccCCCCeEEEeccCCCeeeccC-------------CceeEeecccccccCCCCc-----ccccc
Q psy16430 147 QYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSK-------------EEAKISDFGTCREWNNKST-----KMSFA 206 (600)
Q Consensus 147 r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~-------------~~~Kv~DFGlsr~~~~~~~-----~~~~~ 206 (600)
...|+..+|. .|+|. .+||||||||.|||++.+ +.+||+|||+|+....... ....+
T Consensus 117 ~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~ 193 (434)
T 2rio_A 117 PISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193 (434)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-------------
T ss_pred HHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCC
Confidence 3445666666 45664 469999999999999764 4899999999997654322 22468
Q ss_pred Cceeecccccccc-------cccCccccccccccccccc
Q psy16430 207 GTVAWMAPEVIRN-------EQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 207 GT~~ymAPE~i~~-------~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++|+|||++.+ ..++.++|+||+|++++..
T Consensus 194 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~el 232 (434)
T 2rio_A 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232 (434)
T ss_dssp -CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHH
T ss_pred CCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHH
Confidence 9999999999865 5689999999999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-14 Score=149.38 Aligned_cols=95 Identities=24% Similarity=0.273 Sum_probs=76.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++...+.++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 160 ~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 236 (333)
T 2i1m_A 160 TASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 236 (333)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHH
Confidence 35566666666666664 5665 3799999999999999999999999999986543322 22356788999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 237 ~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 237 SIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCChHHHHHHHHHHHHHH
Confidence 99989999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-14 Score=144.92 Aligned_cols=95 Identities=20% Similarity=0.235 Sum_probs=76.0
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++...+. .|+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||.
T Consensus 102 ~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (269)
T 4hcu_A 102 LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 178 (269)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHH
Confidence 3566666666666666 45664 4699999999999999999999999999986544321 234567889999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.+..++.++|+||+|++++..
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~l 200 (269)
T 4hcu_A 179 FSFSRYSSKSDVWSFGVLMWEV 200 (269)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHH
T ss_pred hcCCCCCchhhhHHHHHHHHHH
Confidence 9989999999999999998865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.9e-14 Score=146.41 Aligned_cols=96 Identities=10% Similarity=0.139 Sum_probs=72.1
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAP 214 (600)
..+++...+.++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 142 ~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 218 (313)
T 3brb_A 142 KHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218 (313)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCc
Confidence 356777777777777775 4554 4799999999999999999999999999986644321 2235678899999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|.+.+..++.++|+||+|++++..
T Consensus 219 E~~~~~~~~~~~Di~slG~il~el 242 (313)
T 3brb_A 219 ESLADRVYTSKSDVWAFGVTMWEI 242 (313)
T ss_dssp HHHHSSCCCHHHHHHHHHHHHHHH
T ss_pred hhhcCCCccchhhhHHHHHHHHHH
Confidence 999999999999999999998865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-14 Score=146.94 Aligned_cols=95 Identities=22% Similarity=0.280 Sum_probs=77.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
++++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 141 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 217 (313)
T 1t46_A 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence 46777777777777665 5665 3799999999999999999999999999987654332 22356788999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 218 ~~~~~~~~~~~Di~slG~il~el 240 (313)
T 1t46_A 218 SIFNCVYTFESDVWSYGIFLWEL 240 (313)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhcCCCCChHHHHHHHHHHHHHH
Confidence 99999999999999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.32 E-value=7.3e-14 Score=148.27 Aligned_cols=97 Identities=11% Similarity=0.131 Sum_probs=77.0
Q ss_pred ccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec-cCCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 140 VRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG-SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd-~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
..+++.....++..++. .|+|. .+|+||||||+|||++ .++.+||+|||+|+............||+.|+|||+
T Consensus 136 ~~l~~~~~~~i~~qi~~aL~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 136 RSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPEL 212 (383)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHH
Confidence 34555555556656666 45663 4799999999999998 688999999999997755555556789999999999
Q ss_pred cccc-ccCcccccccccccccccc
Q psy16430 217 IRNE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+. .++.++|+||+|++++..-
T Consensus 213 ~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 213 MLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred hcCCCCCCcchhhhhHHHHHHHHH
Confidence 8765 4899999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-14 Score=148.97 Aligned_cols=96 Identities=20% Similarity=0.178 Sum_probs=73.8
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----------cccccC
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----------KMSFAG 207 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----------~~~~~G 207 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... ....+|
T Consensus 108 ~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~g 184 (353)
T 2b9h_A 108 MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccc
Confidence 45666666666666664 5664 3699999999999999999999999999986543211 123579
Q ss_pred ceeecccccccc-cccCcccccccccccccccc
Q psy16430 208 TVAWMAPEVIRN-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 208 T~~ymAPE~i~~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
|+.|+|||++.. ..++.++|+||+|++++..-
T Consensus 185 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 217 (353)
T 2b9h_A 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217 (353)
T ss_dssp CGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccCCeeeccCCCccchhhHHHHHHHHHHHH
Confidence 999999998764 67899999999999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.8e-14 Score=147.92 Aligned_cols=96 Identities=16% Similarity=0.178 Sum_probs=69.5
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++...... ......||++|+|||++
T Consensus 96 ~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~ 172 (324)
T 3mtl_A 96 IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172 (324)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhh
Confidence 3555555555555555 45664 469999999999999999999999999998654332 23346789999999998
Q ss_pred cc-cccCcccccccccccccccc
Q psy16430 218 RN-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+ ..++.++|+||+|++++..-
T Consensus 173 ~~~~~~~~~~DiwslG~il~~l~ 195 (324)
T 3mtl_A 173 LGSTDYSTQIDMWGVGCIFYEMA 195 (324)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHH
T ss_pred cCCCCCCcHHHHHHHHHHHHHHH
Confidence 76 56899999999999988653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.8e-12 Score=126.71 Aligned_cols=132 Identities=14% Similarity=0.051 Sum_probs=109.6
Q ss_pred cccccccccCCCCcceEEEeEeeceEEEeeeecc-------chHHHHHHHHhcC-CCCcccccceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-------QKETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-------~~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
..|++...+|.|+.+.||++...+..+++|.... ...+|+.+++.+. +..+.++++++...+..|+||||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 4577778889999999999987788999999863 4678999999984 6778889999988889999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh---------------------------------------------
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS--------------------------------------------- 367 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~--------------------------------------------- 367 (600)
|.+|.+.+. +......++.+++.+|..||+
T Consensus 94 G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 94 GVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp SEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred CeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 999887642 223345788999999999998
Q ss_pred --------------CCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 368 --------------KQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 368 --------------~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
..++|||++|.|||++.++.+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-14 Score=151.25 Aligned_cols=129 Identities=16% Similarity=0.168 Sum_probs=87.1
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL 179 (600)
+.++++|...++-.+|+|.-+..+..... .....++......++..++. .|+|.. +||||||||.|||+
T Consensus 79 v~~~~~~~~~~~~~lv~E~~~gg~L~~~i------~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~ 149 (342)
T 2qr7_A 79 ITLKDVYDDGKYVYVVTELMKGGELLDKI------LRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILY 149 (342)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHH------HTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEcCCEEEEEEeCCCCCcHHHHH------HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEE
Confidence 34455555556556677632221111110 11123444555555555555 456653 69999999999998
Q ss_pred ccC----CceeEeecccccccCCCC-ccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 180 GSK----EEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 180 d~~----~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
..+ +.+||+|||+++...... ...+.+||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 150 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 214 (342)
T 2qr7_A 150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214 (342)
T ss_dssp SSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHh
Confidence 543 359999999998764432 344578999999999999888999999999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.31 E-value=2.3e-14 Score=144.82 Aligned_cols=129 Identities=17% Similarity=0.157 Sum_probs=89.5
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL 179 (600)
...+++|...+.-.+++|.-...+...+. . .....+++.....++...+.+ |+|. .+|+||||||.|||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l---~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili 153 (283)
T 3gen_A 82 VQLYGVCTKQRPIFIITEYMANGCLLNYL---R--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 153 (283)
T ss_dssp CCEEEEECSSSSEEEEECCCTTCBHHHHH---H--CGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEE
T ss_pred eeEEEEEecCCCeEEEEeccCCCcHHHHH---H--HhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEE
Confidence 34445555555545666632222222111 0 112346666666677666664 5664 479999999999999
Q ss_pred ccCCceeEeecccccccCCCCc--cccccCceeecccccccccccCccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.++.+||+|||+++....... .....||+.|+|||.+.+..++.++|+||+|++++..
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l 214 (283)
T 3gen_A 154 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214 (283)
T ss_dssp CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999986644322 2235678899999999989999999999999998865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.31 E-value=6.5e-14 Score=142.19 Aligned_cols=96 Identities=17% Similarity=0.145 Sum_probs=74.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec-cCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG-SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd-~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|.. ..+|+||||||.|||++ .++.+||+|||++...... ......||+.|+|||++
T Consensus 125 ~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~ 202 (290)
T 1t4h_A 125 VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHH
Confidence 35555566666666664 56654 35699999999999998 7899999999999754333 23456799999999987
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
. +.++.++|+||+|++++..-
T Consensus 203 ~-~~~~~~~Di~slG~~l~~l~ 223 (290)
T 1t4h_A 203 E-EKYDESVDVYAFGMCMLEMA 223 (290)
T ss_dssp G-TCCCTHHHHHHHHHHHHHHH
T ss_pred h-ccCCCcchHHHHHHHHHHHH
Confidence 6 56899999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=6.2e-14 Score=147.30 Aligned_cols=94 Identities=23% Similarity=0.303 Sum_probs=76.5
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
.++++.....++..++.+ |+|.. +|+||||||+|||++.++.+||+|||+++..... ...+||+.|+|||++
T Consensus 149 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~ 222 (348)
T 1u5q_A 149 KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVI 222 (348)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhh
Confidence 356677777777666664 56653 6999999999999999999999999999865432 346899999999998
Q ss_pred c---ccccCcccccccccccccccc
Q psy16430 218 R---NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~---~~~~s~~~Dvy~~~~~~~p~s 239 (600)
. .+.++.++|+||+|++++..-
T Consensus 223 ~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 223 LAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp HTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred ccccCCCCCcHHHHHHHHHHHHHHH
Confidence 4 567899999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.31 E-value=3.8e-14 Score=143.04 Aligned_cols=94 Identities=20% Similarity=0.320 Sum_probs=71.8
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|. .+|+||||||.|||++.++.+||+|||++...... ......||+.|+|||.+.+
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 106 FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhcc
Confidence 445555555555555 45664 47999999999999999999999999999754332 2335689999999999998
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 182 ~~~~~~~Di~slG~il~~l~ 201 (279)
T 3fdn_A 182 RMHDEKVDLWSLGVLCYEFL 201 (279)
T ss_dssp CCCCTTHHHHHHHHHHHHHH
T ss_pred CCCCccchhHhHHHHHHHHH
Confidence 88999999999999988653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-14 Score=143.22 Aligned_cols=96 Identities=14% Similarity=0.173 Sum_probs=56.9
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
++++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++...... ......||+.|+|||.+
T Consensus 108 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (278)
T 3cok_A 108 PFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184 (278)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchh
Confidence 45666666666666664 5665 379999999999999999999999999998764322 23356799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
....++.++|+||+|++++..-
T Consensus 185 ~~~~~~~~~Di~slG~il~~l~ 206 (278)
T 3cok_A 185 TRSAHGLESDVWSLGCMFYTLL 206 (278)
T ss_dssp -------CTHHHHHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHH
Confidence 9888999999999999998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.31 E-value=2e-14 Score=146.07 Aligned_cols=96 Identities=23% Similarity=0.250 Sum_probs=70.1
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee---ccCCceeEeecccccccCCCCccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI---GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL---d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAP 214 (600)
..+++.....|+..++.+ |+|. .+|+||||||.|||+ +.++.+||+|||+++............||+.|+||
T Consensus 119 ~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP 195 (285)
T 3is5_A 119 KALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195 (285)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCCh
Confidence 345666666666666664 5664 469999999999999 55678999999999876555445567899999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+. +.++.++|+||+|++++..-
T Consensus 196 E~~~-~~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 196 EVFK-RDVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp HHHT-TCCCHHHHHHHHHHHHHHHH
T ss_pred HHhc-cCCCcccCeehHHHHHHHHH
Confidence 9986 56889999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4e-14 Score=144.02 Aligned_cols=96 Identities=19% Similarity=0.217 Sum_probs=78.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++...... ......||+.|+|||.+
T Consensus 111 ~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (294)
T 2rku_A 111 ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187 (294)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchh
Confidence 45666666666666664 5665 369999999999999999999999999998764332 23346799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 188 ~~~~~~~~~Di~slG~~l~~l~ 209 (294)
T 2rku_A 188 SKKGHSFEVDVWSIGCIMYTLL 209 (294)
T ss_dssp TTSCBCTHHHHHHHHHHHHHHH
T ss_pred ccCCCCchhhHHHHHHHHHHHH
Confidence 9888999999999999988653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.4e-14 Score=145.73 Aligned_cols=94 Identities=15% Similarity=0.178 Sum_probs=75.0
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc-------------------CCceeEeecccccccCCC
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS-------------------KEEAKISDFGTCREWNNK 199 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~-------------------~~~~Kv~DFGlsr~~~~~ 199 (600)
++++.....++..++. .|+|. .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 114 ~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 114 PFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC
T ss_pred CCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc
Confidence 3555555556666666 45665 36999999999999998 668999999999865332
Q ss_pred CccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 200 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 200 ~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.....||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 191 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (339)
T 1z57_A 191 --HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228 (339)
T ss_dssp --CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred --cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH
Confidence 33568999999999999889999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.8e-14 Score=147.56 Aligned_cols=96 Identities=19% Similarity=0.217 Sum_probs=78.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++...... ......||..|+|||++
T Consensus 137 ~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (335)
T 2owb_A 137 ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 213 (335)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHh
Confidence 45666666666666664 5665 369999999999999999999999999998764332 23456799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 214 ~~~~~~~~~Di~slG~il~~l~ 235 (335)
T 2owb_A 214 SKKGHSFEVDVWSIGCIMYTLL 235 (335)
T ss_dssp HTSCBCTHHHHHHHHHHHHHHH
T ss_pred ccCCCCchhhHHHHHHHHHHHH
Confidence 9888999999999999988653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.31 E-value=3.7e-14 Score=144.32 Aligned_cols=96 Identities=17% Similarity=0.210 Sum_probs=73.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||..|+||
T Consensus 110 ~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 186 (295)
T 3ugc_A 110 RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186 (295)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCH
T ss_pred ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCc
Confidence 36666666666666664 5664 4799999999999999999999999999987643321 2235678889999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+.+..++.++|+||+|++++..-
T Consensus 187 E~~~~~~~~~~~Di~slG~~l~~l~ 211 (295)
T 3ugc_A 187 ESLTESKFSVASDVWSFGVVLYELF 211 (295)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.2e-14 Score=145.27 Aligned_cols=92 Identities=16% Similarity=0.199 Sum_probs=73.7
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCc--------eeEeecccccccCCCCccccccCceee
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEE--------AKISDFGTCREWNNKSTKMSFAGTVAW 211 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~--------~Kv~DFGlsr~~~~~~~~~~~~GT~~y 211 (600)
+++..+..++..++.+ |+|. .+|+||||||.|||++.++. +||+|||+++..... ....||+.|
T Consensus 110 ~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y 183 (289)
T 4fvq_A 110 INILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPW 183 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcc
Confidence 5666666666666664 5664 46999999999999999987 999999999755332 235689999
Q ss_pred cccccccc-cccCcccccccccccccccc
Q psy16430 212 MAPEVIRN-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 212 mAPE~i~~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
+|||.+.+ ..++.++|+||+|++++..-
T Consensus 184 ~aPE~~~~~~~~~~~~DiwslG~il~el~ 212 (289)
T 4fvq_A 184 VPPECIENPKNLNLATDKWSFGTTLWEIC 212 (289)
T ss_dssp SCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred cCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence 99999987 67899999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4e-14 Score=142.64 Aligned_cols=95 Identities=13% Similarity=0.125 Sum_probs=76.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee---ccCCceeEeecccccccCCCCccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI---GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL---d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
.+++.....|+...+.+ |+|. .+|+||||||.|||+ +.++.+||+|||+++............||+.|+|||
T Consensus 102 ~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE 178 (277)
T 3f3z_A 102 VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178 (277)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChH
Confidence 35566666666666664 5664 469999999999999 888999999999998776555555678999999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+.+ .++.++|+||+|++++..-
T Consensus 179 ~~~~-~~~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 179 VLEG-LYGPECDEWSAGVMMYVLL 201 (277)
T ss_dssp HHTT-CBCTTHHHHHHHHHHHHHH
T ss_pred Hhcc-cCCchhhehhHHHHHHHHH
Confidence 9864 4899999999999988653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.30 E-value=5.4e-14 Score=148.93 Aligned_cols=94 Identities=18% Similarity=0.176 Sum_probs=65.8
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++. .|+|. .+|+||||||+|||++.++.+||+|||+++..... .....||++|+|||++.
T Consensus 128 ~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~ 202 (367)
T 2fst_X 128 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIML 202 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHc
Confidence 4556656666666666 45664 46999999999999999999999999999865432 33568999999999987
Q ss_pred c-cccCcccccccccccccccc
Q psy16430 219 N-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
+ ..++.++|+||+|++++..-
T Consensus 203 ~~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 203 NWMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp TCCSCCTTHHHHHHHHHHHHHH
T ss_pred CCcCCCchhhHHHHHHHHHHHH
Confidence 6 67899999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=6.6e-14 Score=147.97 Aligned_cols=95 Identities=17% Similarity=0.189 Sum_probs=76.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCC-----------------------------------
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKE----------------------------------- 183 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~----------------------------------- 183 (600)
.+++.....|+..++.+ |+|..+ +||||||||.|||++.++
T Consensus 142 ~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (397)
T 1wak_A 142 GLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219 (397)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccc
Confidence 45666666666666664 566543 799999999999999875
Q ss_pred --------------ceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 184 --------------EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 184 --------------~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+||+|||+++..... ....+||+.|+|||++.+..++.++|+||+|++++..-
T Consensus 220 ~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp TSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 7999999999865432 33468999999999999999999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.2e-14 Score=145.82 Aligned_cols=95 Identities=15% Similarity=0.102 Sum_probs=69.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~ 218 (600)
+++.....++...+. .|+|. .+|+||||||.|||++.++.+||+|||+++...... ......||++|+|||++.
T Consensus 99 ~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (311)
T 4agu_A 99 VPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHh
Confidence 555555556655555 45664 369999999999999999999999999998764332 234568999999999987
Q ss_pred c-cccCcccccccccccccccc
Q psy16430 219 N-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
+ ..++.++|+||+|++++..-
T Consensus 176 ~~~~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 176 GDTQYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHH
T ss_pred cCCCCCcchhhHHHHHHHHHHH
Confidence 5 56899999999999988653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=2.5e-14 Score=143.99 Aligned_cols=93 Identities=16% Similarity=0.129 Sum_probs=72.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccC-------------------CceeEeecccccccCCC
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSK-------------------EEAKISDFGTCREWNNK 199 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~-------------------~~~Kv~DFGlsr~~~~~ 199 (600)
.+++.....|+..++.+ |+|. .+|+||||||.|||++.+ +.+||+|||+++.....
T Consensus 111 ~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 111 YFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc
Confidence 46666666777777775 5665 369999999999999844 47999999999876443
Q ss_pred CccccccCceeeccccccccc-ccCcccccccccccccccc
Q psy16430 200 STKMSFAGTVAWMAPEVIRNE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 200 ~~~~~~~GT~~ymAPE~i~~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
. ...||+.|+|||.+... .++.++|+||+|++++..-
T Consensus 188 ~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (289)
T 1x8b_A 188 Q---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225 (289)
T ss_dssp C---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred c---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence 2 34699999999998765 5668999999999988553
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=2e-13 Score=144.40 Aligned_cols=93 Identities=22% Similarity=0.178 Sum_probs=73.5
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++......++..++. .|+|. .+|+||||||+|||++.++.+||+|||+++..... .+..+||++|+|||++.+
T Consensus 125 l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 125 LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhC
Confidence 444444445545555 56665 36999999999999999999999999999875432 345689999999999876
Q ss_pred -cccCcccccccccccccccc
Q psy16430 220 -EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 -~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 200 ~~~~~~~~DiwslG~il~ell 220 (367)
T 1cm8_A 200 WMRYTQTVDIWSVGCIMAEMI 220 (367)
T ss_dssp TTCCCTTHHHHHHHHHHHHHH
T ss_pred CCCCChhhhHHHHHHHHHHHH
Confidence 67999999999999988653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.30 E-value=4e-14 Score=150.40 Aligned_cols=95 Identities=11% Similarity=0.048 Sum_probs=73.4
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC--------ccccccCceee
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS--------TKMSFAGTVAW 211 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~--------~~~~~~GT~~y 211 (600)
+++.....++..++. .|+|. .+||||||||.|||++.++.+||+|||++....... .....+||+.|
T Consensus 125 ~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 201 (389)
T 3gni_B 125 MNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201 (389)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccc
Confidence 455555555555555 56665 369999999999999999999999999987532211 12235799999
Q ss_pred cccccccc--cccCcccccccccccccccc
Q psy16430 212 MAPEVIRN--EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 212 mAPE~i~~--~~~s~~~Dvy~~~~~~~p~s 239 (600)
+|||++.+ ..++.++|+||+|++++..-
T Consensus 202 ~aPE~~~~~~~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 202 LSPEVLQQNLQGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp SCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred cCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence 99999987 57899999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.30 E-value=3.7e-14 Score=143.93 Aligned_cols=140 Identities=16% Similarity=0.189 Sum_probs=83.6
Q ss_pred hhcccccccc---ccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCC
Q psy16430 91 LTKLSVCWRP---FCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTT 165 (600)
Q Consensus 91 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~ 165 (600)
+.++.++|.. ++.+++.+...+.-.+++|.-+..+..... . .....+++.....++..++. .|+|..
T Consensus 64 i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l---~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~--- 135 (303)
T 1zy4_A 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---H--SENLNQQRDEYWRLFRQILEALSYIHSQ--- 135 (303)
T ss_dssp BCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHH---H--HSCGGGCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhh---h--ccccccchHHHHHHHHHHHHHHHHHHhC---
Confidence 3445555544 333444445555556666633222221111 0 11123444444555555555 456653
Q ss_pred CeEEEeccCCCeeeccCCceeEeecccccccCCC---------------CccccccCceeeccccccccc-ccCcccccc
Q psy16430 166 PDALAESIGLGVLIGSKEEAKISDFGTCREWNNK---------------STKMSFAGTVAWMAPEVIRNE-QCSDKIDIW 229 (600)
Q Consensus 166 ~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~---------------~~~~~~~GT~~ymAPE~i~~~-~~s~~~Dvy 229 (600)
+|+||||||.|||++.++.+||+|||+++..... .......||+.|+|||.+.+. .++.++|+|
T Consensus 136 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 215 (303)
T 1zy4_A 136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215 (303)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHH
T ss_pred CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHH
Confidence 6999999999999999999999999999865321 112346799999999998754 689999999
Q ss_pred ccccccccc
Q psy16430 230 YKNRLCFPT 238 (600)
Q Consensus 230 ~~~~~~~p~ 238 (600)
|+|++++..
T Consensus 216 slG~il~~l 224 (303)
T 1zy4_A 216 SLGIIFFEM 224 (303)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.6e-14 Score=145.57 Aligned_cols=100 Identities=20% Similarity=0.231 Sum_probs=75.9
Q ss_pred ccccCCccceeeccccc--hhhhccC--CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGP--YWFLAGC--TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~--~~~~~~~--~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAP 214 (600)
..+++.....|+..++. .|+|... ..+|+||||||.|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 106 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 185 (279)
T 2w5a_A 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185 (279)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccCh
Confidence 34677777777777666 4577653 24599999999999999999999999999987644322 2346799999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+.+..++.++|+||+|++++..-
T Consensus 186 E~~~~~~~~~~~Di~slG~il~~l~ 210 (279)
T 2w5a_A 186 EQMNRMSYNEKSDIWSLGCLLYELC 210 (279)
T ss_dssp HHHHCC-CCHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCchhhHHHHHHHHHHHH
Confidence 9999888999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.30 E-value=5.2e-14 Score=146.27 Aligned_cols=95 Identities=20% Similarity=0.284 Sum_probs=77.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++...+.++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 153 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 229 (334)
T 2pvf_A 153 QMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229 (334)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence 36666667776666664 5665 3699999999999999999999999999987654322 23356789999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
++.+..++.++|+||+|++++..
T Consensus 230 ~~~~~~~~~~~Di~slG~il~el 252 (334)
T 2pvf_A 230 ALFDRVYTHQSDVWSFGVLMWEI 252 (334)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHH
T ss_pred HhcCCCcChHHHHHHHHHHHHHH
Confidence 99988899999999999998865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.30 E-value=8.5e-14 Score=152.97 Aligned_cols=95 Identities=15% Similarity=0.102 Sum_probs=78.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee---ccCCceeEeecccccccCCCCc--------cccccC
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI---GSKEEAKISDFGTCREWNNKST--------KMSFAG 207 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL---d~~~~~Kv~DFGlsr~~~~~~~--------~~~~~G 207 (600)
.+++...+.|+..++.+ |+|. .+||||||||.|||| +.++.+||+|||+++.+..... .....|
T Consensus 99 ~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~g 175 (483)
T 3sv0_A 99 KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175 (483)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCC
Confidence 47777777777777774 5665 369999999999999 6889999999999987644322 125789
Q ss_pred ceeecccccccccccCccccccccccccccc
Q psy16430 208 TVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 208 T~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|+.|+|||++.+..++.++|+||+|+++|.+
T Consensus 176 t~~Y~aPE~~~~~~~s~~sDvwSlGvil~el 206 (483)
T 3sv0_A 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYF 206 (483)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CccccCHHHhcCCCCChHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.8e-14 Score=151.55 Aligned_cols=91 Identities=22% Similarity=0.307 Sum_probs=64.4
Q ss_pred Cccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc-----CCceeEeecccccccCCCC----ccccccCceeecc
Q psy16430 145 PPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS-----KEEAKISDFGTCREWNNKS----TKMSFAGTVAWMA 213 (600)
Q Consensus 145 ~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~-----~~~~Kv~DFGlsr~~~~~~----~~~~~~GT~~ymA 213 (600)
.....++..++. .|+|. .+||||||||.|||++. ...+||+|||+|+...... .....+||++|+|
T Consensus 118 ~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~A 194 (432)
T 3p23_A 118 LEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194 (432)
T ss_dssp SCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCC
T ss_pred hhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccC
Confidence 334445555555 46665 36999999999999953 3357899999998765332 2335789999999
Q ss_pred ccccc---ccccCccccccccccccccc
Q psy16430 214 PEVIR---NEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~---~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++. ...++.++|+||+|++++..
T Consensus 195 PE~l~~~~~~~~t~~~DiwSlG~il~el 222 (432)
T 3p23_A 195 PEMLSEDCKENPTYTVDIFSAGCVFYYV 222 (432)
T ss_dssp GGGTSCC---CCCTHHHHHHHHHHHHHH
T ss_pred hhhhhcccccCCCcHHHHHHHHHHHHHH
Confidence 99997 45677899999999998865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.30 E-value=6.7e-14 Score=144.20 Aligned_cols=95 Identities=16% Similarity=0.189 Sum_probs=78.2
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++............||+.|+|||++.+
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 117 VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhc
Confidence 5566666666666664 5665 3699999999999999999999999999987654444455789999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 194 ~~~~~~~Di~slG~il~~l~ 213 (326)
T 1blx_A 194 SSYATPVDLWSVGCIFAEMF 213 (326)
T ss_dssp CCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcchhHHHHHHHHHHHH
Confidence 99999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.30 E-value=1.8e-13 Score=141.39 Aligned_cols=93 Identities=9% Similarity=0.038 Sum_probs=73.5
Q ss_pred CCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCC-ceeEeecccccccCCCCccccccCceeecccccccc-
Q psy16430 144 IPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN- 219 (600)
Q Consensus 144 ~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~-~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~- 219 (600)
......++..++. .|+|. .+|+||||||.|||++.++ .+||+|||+|+............||..|+|||.+.+
T Consensus 129 ~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (330)
T 3nsz_A 129 DYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCC
Confidence 3333445555555 45664 4699999999999999777 899999999987765555556789999999999876
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 206 ~~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 206 QMYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp CCCCTHHHHHHHHHHHHHHH
T ss_pred CcCCchhhHHHHHHHHHHHH
Confidence 66899999999999988653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.30 E-value=3.7e-14 Score=143.18 Aligned_cols=96 Identities=17% Similarity=0.176 Sum_probs=74.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCC----ceeEeecccccccCCCCccccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKE----EAKISDFGTCREWNNKSTKMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~----~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.||+++.++ .+||+|||+++............||+.|+||
T Consensus 104 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP 180 (283)
T 3bhy_A 104 SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180 (283)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCc
Confidence 46666667777677665 4564 4799999999999999887 7999999999876554444456799999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++....++.++|+||+|++++..-
T Consensus 181 E~~~~~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 181 EIVNYEPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ceecCCCCCcchhhhhHHHHHHHHH
Confidence 9999889999999999999988653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.3e-14 Score=147.42 Aligned_cols=97 Identities=7% Similarity=0.075 Sum_probs=79.5
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCC--ceeEeecccccccCCCC--------ccccccC
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKE--EAKISDFGTCREWNNKS--------TKMSFAG 207 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~--~~Kv~DFGlsr~~~~~~--------~~~~~~G 207 (600)
..+++...+.|+..++.+ |+|.. +||||||||.|||++.++ .+||+|||+++.+.... ......|
T Consensus 154 ~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g 230 (352)
T 2jii_A 154 HVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEG 230 (352)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccC
Confidence 457777788877777775 46653 799999999999999998 89999999998654321 1234589
Q ss_pred ceeecccccccccccCcccccccccccccccc
Q psy16430 208 TVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 208 T~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|+.|+|||++.+..++.++|+||+|++++..-
T Consensus 231 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 231 DLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999889999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.1e-14 Score=158.38 Aligned_cols=96 Identities=18% Similarity=0.241 Sum_probs=78.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++...+.|+..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++....... .....+|..|+|||+
T Consensus 359 ~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~ 435 (535)
T 2h8h_A 359 YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435 (535)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHH
Confidence 46677777777777775 5664 4699999999999999999999999999987643321 223457889999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+..+.++.++|+||||+++|.+-
T Consensus 436 ~~~~~~~~~sDvwSlGv~l~el~ 458 (535)
T 2h8h_A 436 ALYGRFTIKSDVWSFGILLTELT 458 (535)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHT
T ss_pred hccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.4e-14 Score=155.57 Aligned_cols=95 Identities=17% Similarity=0.245 Sum_probs=76.0
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee---ccCCceeEeecccccccCCCCccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI---GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL---d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
.+++.....|+..++. .|+|.. +||||||||.|||+ +.++.+||+|||+|+.+.........+||+.|+|||
T Consensus 122 ~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 198 (484)
T 3nyv_A 122 RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198 (484)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCce
Confidence 3555555566666656 456653 69999999999999 567899999999998776555555678999999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++.+ .++.++|+||+|++++..-
T Consensus 199 ~~~~-~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 199 VLHG-TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp HHHT-CCCTHHHHHHHHHHHHHHH
T ss_pred eecC-CCCCcceeHHHHHHHHHHH
Confidence 9865 7999999999999998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5.2e-14 Score=154.78 Aligned_cols=94 Identities=20% Similarity=0.238 Sum_probs=74.2
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc---CCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS---KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~---~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
+++.....|+..++. .|+|. .+||||||||.|||++. ++.+||+|||+|+...........+||+.|+|||+
T Consensus 133 ~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~ 209 (494)
T 3lij_A 133 FNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209 (494)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHH
Confidence 455555555555555 45665 36999999999999976 45699999999987765555556789999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+. +.++.++|+||+|++++..-
T Consensus 210 l~-~~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 210 LR-KKYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp HT-TCBCTHHHHHHHHHHHHHHH
T ss_pred Hc-ccCCCchhHHHHHHHHHHHH
Confidence 86 56999999999999998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.29 E-value=4e-14 Score=145.81 Aligned_cols=95 Identities=17% Similarity=0.198 Sum_probs=76.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++...+.++..++.+ |+|.. +|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 134 ~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChh
Confidence 34666666666666664 56653 699999999999999999999999999986543322 22356789999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 211 ~~~~~~~~~~~Di~slG~il~el 233 (322)
T 1p4o_A 211 SLKDGVFTTYSDVWSFGVVLWEI 233 (322)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hhccCCCCchhhHHHHHHHHHHH
Confidence 99989999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.29 E-value=7.4e-14 Score=141.32 Aligned_cols=94 Identities=20% Similarity=0.326 Sum_probs=75.5
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||++...... ......||+.|+|||++.+
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 111 FDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhcc
Confidence 4555555566666664 5664 47999999999999999999999999999765432 2335689999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 187 ~~~~~~~Di~slG~il~~l~ 206 (284)
T 2vgo_A 187 KTHDEKVDLWCAGVLCYEFL 206 (284)
T ss_dssp CCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCcccchhhHHHHHHHHH
Confidence 89999999999999988653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=5.8e-14 Score=142.66 Aligned_cols=96 Identities=15% Similarity=0.204 Sum_probs=76.8
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-----ccccccCceeecc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-----TKMSFAGTVAWMA 213 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-----~~~~~~GT~~ymA 213 (600)
.+++.....++..++.+ |+|.. +|+||||||.|||++.++.+||+|||+++...... ......||+.|+|
T Consensus 120 ~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a 196 (298)
T 3pls_A 120 NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196 (298)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccC
Confidence 45666666666666664 56653 69999999999999999999999999998653322 2234678999999
Q ss_pred cccccccccCcccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
||.+.+..++.++|+||+|++++..-
T Consensus 197 PE~~~~~~~~~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 197 LESLQTYRFTTKSDVWSFGVLLWELL 222 (298)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhhhccCCCChhhchhhHHHHHHHHh
Confidence 99999999999999999999988653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=4e-14 Score=147.41 Aligned_cols=129 Identities=16% Similarity=0.155 Sum_probs=84.1
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL 179 (600)
+..+++|...+.-.+++|.-...++..+. . .....+++...+.++..++.+ |+|.. +|+||||||.|||+
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~ 180 (333)
T 1mqb_A 109 IRLEGVISKYKPMMIITEYMENGALDKFL----R-EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILV 180 (333)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHH----H-HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CcEEEEEecCCCcEEEEeCCCCCcHHHHH----H-hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEE
Confidence 33445555555556666633222222211 0 112346677777777777764 56653 69999999999999
Q ss_pred ccCCceeEeecccccccCCCCc----cccccCceeecccccccccccCccccccccccccccc
Q psy16430 180 GSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 180 d~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.++.+||+|||+++....... .....||+.|+|||.+.+..++.++|+||+|++++..
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 243 (333)
T 1mqb_A 181 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243 (333)
T ss_dssp CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHH
Confidence 9999999999999987543221 2234568899999999988999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.5e-14 Score=146.09 Aligned_cols=95 Identities=15% Similarity=0.182 Sum_probs=69.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.+++...+.++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 113 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3lzb_A 113 NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHH
Confidence 35555566666666664 5664 3699999999999999999999999999987643322 22355788999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 190 ~~~~~~~~~~~Di~slG~il~el 212 (327)
T 3lzb_A 190 SILHRIYTHQSDVWSYGVTVWEL 212 (327)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCCChHHHHHHHHHHHHHH
Confidence 99999999999999999998875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.29 E-value=6.2e-14 Score=154.55 Aligned_cols=129 Identities=16% Similarity=0.185 Sum_probs=90.5
Q ss_pred ccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCee
Q psy16430 101 FCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVL 178 (600)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NIL 178 (600)
.+..+++|+..++-.+|+|.-+..+..... .....+++.....|+..++. .|+|. .+||||||||.|||
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l------~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQI------INRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENIL 178 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHH------HHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHH------HHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEE
Confidence 334455555555556666633222221111 11134566666666666666 45665 36999999999999
Q ss_pred eccCC---ceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 179 IGSKE---EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 179 Ld~~~---~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++.++ .+||+|||+|+...........+||+.|+|||++. +.++.++|+||+|++++..-
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL 241 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH
T ss_pred EecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHH
Confidence 99876 69999999999776555555678999999999987 56999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=7.2e-14 Score=142.77 Aligned_cols=96 Identities=23% Similarity=0.342 Sum_probs=78.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++...... ......||+.|+|||++
T Consensus 115 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 191 (303)
T 3a7i_A 115 PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191 (303)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHH
Confidence 46666666676666665 5665 369999999999999999999999999998765433 23356799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 192 ~~~~~~~~~Di~slG~il~~l~ 213 (303)
T 3a7i_A 192 KQSAYDSKADIWSLGITAIELA 213 (303)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHH
T ss_pred hcCCCCchhhhHHHHHHHHHHc
Confidence 9999999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=5.7e-14 Score=143.03 Aligned_cols=95 Identities=19% Similarity=0.296 Sum_probs=74.6
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-----ccccccCceeecc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-----TKMSFAGTVAWMA 213 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-----~~~~~~GT~~ymA 213 (600)
.+++.....++..++. .|+|. .+|+||||||.|||++.++.+||+|||+++...... ......||+.|+|
T Consensus 124 ~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~a 200 (298)
T 3f66_A 124 NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccC
Confidence 3555666666656666 45664 469999999999999999999999999998654332 1234567889999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||.+.+..++.++|+||+|++++..
T Consensus 201 PE~~~~~~~~~~~Di~slG~il~~l 225 (298)
T 3f66_A 201 LESLQTQKFTTKSDVWSFGVLLWEL 225 (298)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hHHhcCCCCChHHHHHHHHHHHHHH
Confidence 9999999999999999999998865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.28 E-value=7.1e-14 Score=145.37 Aligned_cols=86 Identities=12% Similarity=-0.026 Sum_probs=66.9
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCC--------------------ceeEeecccccccCCC
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE--------------------EAKISDFGTCREWNNK 199 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~--------------------~~Kv~DFGlsr~~~~~ 199 (600)
++......|+..++. .|+|+ +.+||||||||+|||++.++ .+||+|||+|+.....
T Consensus 158 ~~~~~~~~i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~ 235 (336)
T 2vuw_A 158 SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC
Confidence 444445555555555 46662 24699999999999999987 8999999999876432
Q ss_pred CccccccCceeecccccccccccCccccccccccc
Q psy16430 200 STKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRL 234 (600)
Q Consensus 200 ~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~ 234 (600)
..+||+.|||||++.+.. +.++|+||++..
T Consensus 236 ----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~ 265 (336)
T 2vuw_A 236 ----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKK 265 (336)
T ss_dssp ----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHH
T ss_pred ----cEEEeecccChhhhcCCC-ccceehhhhhCC
Confidence 358999999999998665 889999998544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=6.7e-14 Score=153.46 Aligned_cols=94 Identities=18% Similarity=0.236 Sum_probs=71.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec---cCCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG---SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd---~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
+++.....++..++. .|+|. .+||||||||.|||++ .++.+||+|||+|+...........+||+.|+|||+
T Consensus 118 ~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 194 (486)
T 3mwu_A 118 FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194 (486)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHH
Confidence 445555555555555 45665 3699999999999995 456799999999987655544556789999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+ .++.++|+||+|++++..-
T Consensus 195 ~~~-~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 195 LRG-TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp GGS-CCCHHHHHHHHHHHHHHHH
T ss_pred hCC-CCCchhhHHHHHHHHHHHH
Confidence 874 6999999999999998653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=3.8e-14 Score=144.47 Aligned_cols=96 Identities=18% Similarity=0.241 Sum_probs=77.9
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||..|+||
T Consensus 122 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 198 (302)
T 4e5w_A 122 KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198 (302)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCH
T ss_pred cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCC
Confidence 46666667666666664 5664 4699999999999999999999999999987654332 2346788999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+.+..++.++|+||+|++++..-
T Consensus 199 E~~~~~~~~~~~Di~slG~il~~l~ 223 (302)
T 4e5w_A 199 ECLMQSKFYIASDVWSFGVTLHELL 223 (302)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred eeecCCCCCcchhHHHHHHHHHHHH
Confidence 9999999999999999999998653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=9.5e-14 Score=145.67 Aligned_cols=96 Identities=14% Similarity=0.108 Sum_probs=68.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++.+ |+|.. +|+||||||.|||++.++.+||+|||+++............||+.|+|||++.
T Consensus 130 ~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~ 206 (362)
T 3pg1_A 130 VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206 (362)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhc
Confidence 46666666666666664 56653 69999999999999999999999999998655544455678999999999987
Q ss_pred c-cccCcccccccccccccccc
Q psy16430 219 N-EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~-~~~s~~~Dvy~~~~~~~p~s 239 (600)
+ ..++.++|+||+|++++..-
T Consensus 207 ~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 207 QFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp TCTTCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCcHhHHHhHHHHHHHHH
Confidence 6 67899999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=3.5e-14 Score=143.67 Aligned_cols=96 Identities=18% Similarity=0.218 Sum_probs=76.7
Q ss_pred ccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccc
Q psy16430 140 VRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPE 215 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE 215 (600)
..+++.....++...+. .|+|.. +|+||||||.||+++.++.+||+|||+++....... .....||+.|+|||
T Consensus 106 ~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 182 (288)
T 3kfa_A 106 QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182 (288)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHH
T ss_pred CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChh
Confidence 34666666666666666 456653 699999999999999999999999999987654332 22355788999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 183 ~~~~~~~~~~~Di~slG~il~~l 205 (288)
T 3kfa_A 183 SLAYNKFSIKSDVWAFGVLLWEI 205 (288)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hhccCCCCchhhHHHHHHHHHHH
Confidence 99989999999999999998865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=5e-14 Score=146.20 Aligned_cols=96 Identities=15% Similarity=0.121 Sum_probs=71.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++...... ......||++|+|||++
T Consensus 120 ~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~ 196 (331)
T 4aaa_A 120 GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196 (331)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccc
Confidence 35666666666666664 5665 369999999999999999999999999998654332 23456799999999998
Q ss_pred ccc-ccCcccccccccccccccc
Q psy16430 218 RNE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
.+. .++.++|+||+|++++..-
T Consensus 197 ~~~~~~~~~~Di~slG~il~~l~ 219 (331)
T 4aaa_A 197 VGDVKYGKAVDVWAIGCLVTEMF 219 (331)
T ss_dssp TTCTTCCTHHHHHHHHHHHHHHH
T ss_pred cCCCCcchHHHHHHHHHHHHHHH
Confidence 765 6889999999999998653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=9.4e-14 Score=138.74 Aligned_cols=94 Identities=15% Similarity=0.130 Sum_probs=74.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++.+ |+|. ...+|+||||||.|||++.++.++|+|||++..... ....||+.|+|||.+.
T Consensus 107 ~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~ 181 (271)
T 3kmu_A 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQ 181 (271)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhc
Confidence 46777777777777775 4554 345699999999999999999999999998764322 2457899999999998
Q ss_pred ccccCc---ccccccccccccccc
Q psy16430 219 NEQCSD---KIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~---~~Dvy~~~~~~~p~s 239 (600)
+..++. ++|+||+|++++..-
T Consensus 182 ~~~~~~~~~~~Di~slG~il~el~ 205 (271)
T 3kmu_A 182 KKPEDTNRRSADMWSFAVLLWELV 205 (271)
T ss_dssp SCGGGSCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCchhhHHHHHHHHHHHH
Confidence 765554 799999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.27 E-value=7.1e-14 Score=145.37 Aligned_cols=88 Identities=22% Similarity=0.239 Sum_probs=66.8
Q ss_pred eeeccccc--hhhhccCCCCeEEEeccCCCeeeccCC--ceeEeecccccccCCCC-----ccccccCceeecccccccc
Q psy16430 149 QLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE--EAKISDFGTCREWNNKS-----TKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 149 ~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~--~~Kv~DFGlsr~~~~~~-----~~~~~~GT~~ymAPE~i~~ 219 (600)
.|+..++. .|+|.. +|+||||||.|||++.++ .+||+|||+++.+.... ......||+.|+|||++..
T Consensus 172 ~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 35555555 456653 699999999999998776 89999999998653211 1235679999999999865
Q ss_pred --cccCcccccccccccccccc
Q psy16430 220 --EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 --~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 249 ~~~~~~~~~DiwslG~il~el~ 270 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLL 270 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHH
Confidence 67889999999999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=5.8e-14 Score=145.25 Aligned_cols=130 Identities=20% Similarity=0.216 Sum_probs=88.7
Q ss_pred cccccccccCChhhhhhhhcccc-cccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCC
Q psy16430 100 PFCSFVDKFSSPEFKTNIQERSE-VKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLG 176 (600)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~N 176 (600)
-....+++|..++.-.+++|... ..+...+. .....+++.....++..++.+ |+|. .+|+||||||.|
T Consensus 109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l------~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~N 179 (320)
T 3a99_A 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI------TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDEN 179 (320)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHH------HHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred CceEEEEEEecCCcEEEEEEcCCCCccHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHH
Confidence 34445555555555566666322 11111110 112345555555566666664 5664 469999999999
Q ss_pred eeec-cCCceeEeecccccccCCCCccccccCceeeccccccccccc-Ccccccccccccccccc
Q psy16430 177 VLIG-SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 177 ILLd-~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
||++ .++.+||+|||+++..... ......||+.|+|||++....+ +.++|+||+|++++..-
T Consensus 180 Ill~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 243 (320)
T 3a99_A 180 ILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243 (320)
T ss_dssp EEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence 9999 7899999999999876443 2335679999999999887766 67889999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=6.2e-14 Score=141.33 Aligned_cols=95 Identities=19% Similarity=0.242 Sum_probs=77.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||..|+|||.
T Consensus 105 ~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 181 (279)
T 1qpc_A 105 KLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181 (279)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhh
Confidence 46677777777777665 5664 4699999999999999999999999999987654332 223557889999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+....++.++|+||+|++++..
T Consensus 182 ~~~~~~~~~~Di~slG~il~el 203 (279)
T 1qpc_A 182 INYGTFTIKSDVWSFGILLTEI 203 (279)
T ss_dssp HHHCEECHHHHHHHHHHHHHHH
T ss_pred hccCCCCchhhhHHHHHHHHHH
Confidence 9988899999999999998865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=7.1e-14 Score=159.27 Aligned_cols=95 Identities=18% Similarity=0.260 Sum_probs=74.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++..+|.+ |+|. .+||||||||.|||++.++.+||+|||+++....... .....||+.|||||+
T Consensus 487 ~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~ 563 (656)
T 2j0j_A 487 SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563 (656)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHH
Confidence 46666666666666664 5665 3699999999999999999999999999987644332 223567889999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.+..++.++|+||+|+++|..
T Consensus 564 ~~~~~~~~~~DiwSlG~il~el 585 (656)
T 2j0j_A 564 INFRRFTSASDVWMFGVCMWEI 585 (656)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHH
T ss_pred hcCCCCCchhhHHHHHHHHHHH
Confidence 9989999999999999998864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=8.9e-14 Score=141.41 Aligned_cols=96 Identities=16% Similarity=0.221 Sum_probs=77.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++............||+.|+|||++.
T Consensus 120 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 120 TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhc
Confidence 45566666666666664 5664 469999999999999999999999999998765554455678999999999985
Q ss_pred ------ccccCcccccccccccccccc
Q psy16430 219 ------NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ------~~~~s~~~Dvy~~~~~~~p~s 239 (600)
...++.++|+||+|++++..-
T Consensus 197 ~~~~~~~~~~~~~~Di~slG~~l~~l~ 223 (298)
T 1phk_A 197 CSMNDNHPGYGKEVDMWSTGVIMYTLL 223 (298)
T ss_dssp HHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred cccccccccCCcccccHhHHHHHHHHH
Confidence 456788999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-13 Score=138.71 Aligned_cols=96 Identities=16% Similarity=0.268 Sum_probs=75.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE 215 (600)
.+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++...... ......||+.|+|||
T Consensus 101 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (276)
T 2yex_A 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177 (276)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChH
Confidence 35555666666666664 5664 469999999999999999999999999998653221 133467999999999
Q ss_pred ccccccc-Ccccccccccccccccc
Q psy16430 216 VIRNEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
.+.+..+ +.++|+||+|++++..-
T Consensus 178 ~~~~~~~~~~~~Di~slG~il~~l~ 202 (276)
T 2yex_A 178 LLKRREFHAEPVDVWSCGIVLTAML 202 (276)
T ss_dssp GGTCSSBCHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCcchHHHHHHHHHHHH
Confidence 9987665 77899999999998653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=5e-14 Score=145.85 Aligned_cols=95 Identities=20% Similarity=0.203 Sum_probs=74.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeecc---CCceeEeecccccccCCCCc---cccccCceeec
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGS---KEEAKISDFGTCREWNNKST---KMSFAGTVAWM 212 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~---~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ym 212 (600)
.+++...+.++..++.+ |+|. .+|+||||||.|||++. ++.+||+|||+++....... .....||+.|+
T Consensus 136 ~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 212 (327)
T 2yfx_A 136 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212 (327)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGC
T ss_pred cccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCccee
Confidence 46666677777777765 5664 36999999999999994 44699999999986433221 22456899999
Q ss_pred ccccccccccCccccccccccccccc
Q psy16430 213 APEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 213 APE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|||.+.+..++.++|+||+|++++..
T Consensus 213 aPE~~~~~~~~~~~Di~slG~il~el 238 (327)
T 2yfx_A 213 PPEAFMEGIFTSKTDTWSFGVLLWEI 238 (327)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CHhHhcCCCCCchhhHHHHHHHHHHH
Confidence 99999989999999999999998865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-13 Score=142.06 Aligned_cols=96 Identities=20% Similarity=0.263 Sum_probs=77.9
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++...... ......||+.|+|||.+
T Consensus 121 ~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (314)
T 3com_A 121 TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197 (314)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhc
Confidence 45666666666666664 5664 469999999999999999999999999998664432 23356799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+..++.++|+||+|++++..-
T Consensus 198 ~~~~~~~~~Di~slG~il~~l~ 219 (314)
T 3com_A 198 QEIGYNCVADIWSLGITAIEMA 219 (314)
T ss_dssp SSSCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHHH
Confidence 9889999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-13 Score=145.41 Aligned_cols=96 Identities=19% Similarity=0.183 Sum_probs=74.7
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....|+..++. .|+|. .+||||||||.|||++.++.+||+|||+++....... ....+||++|+||
T Consensus 124 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 200 (364)
T 3qyz_A 124 HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCC
Confidence 3555555556656655 45665 3699999999999999999999999999986543321 2346899999999
Q ss_pred cccccc-ccCcccccccccccccccc
Q psy16430 215 EVIRNE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
|++..+ .++.++|+||+|++++..-
T Consensus 201 E~~~~~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 201 EIMLNSKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp HHHHTBCSCSTHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCcchhHHHHHHHHHHHH
Confidence 987544 4899999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.25 E-value=2.6e-14 Score=150.04 Aligned_cols=95 Identities=19% Similarity=0.253 Sum_probs=73.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|.. .+|+||||||.|||++.++.+||+|||+++..... ......||+.|+|||++.+
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 128 IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG 204 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC
Confidence 445555555555555 566653 25999999999999999999999999999754322 2334689999999999999
Q ss_pred cccCcccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 205 ~~~~~~~Di~slG~il~~l~ 224 (360)
T 3eqc_A 205 THYSVQSDIWSMGLSLVEMA 224 (360)
T ss_dssp CCCSHHHHHHHHHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHH
Confidence 99999999999999998653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.25 E-value=9.7e-14 Score=142.19 Aligned_cols=94 Identities=20% Similarity=0.287 Sum_probs=75.8
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE~ 216 (600)
+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||.
T Consensus 145 ~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 221 (316)
T 2xir_A 145 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 221 (316)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchh
Confidence 5666666666666664 5665 4799999999999999999999999999986543322 224568899999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.+..++.++|+||+|++++..
T Consensus 222 ~~~~~~~~~~Di~slG~il~~l 243 (316)
T 2xir_A 222 IFDRVYTIQSDVWSFGVLLWEI 243 (316)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHH
T ss_pred hccccccchhHHHHHHHHHHHH
Confidence 9999999999999999998865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-13 Score=140.72 Aligned_cols=97 Identities=20% Similarity=0.292 Sum_probs=67.2
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAP 214 (600)
..+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++...... ......||+.|+||
T Consensus 115 ~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (289)
T 3og7_A 115 TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191 (289)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCc
Confidence 346666666666666664 5664 469999999999999999999999999998654321 22346799999999
Q ss_pred cccc---ccccCcccccccccccccccc
Q psy16430 215 EVIR---NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~---~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+. ...++.++|+||+|++++..-
T Consensus 192 E~~~~~~~~~~~~~~Di~slG~il~el~ 219 (289)
T 3og7_A 192 EVIRMQDSNPYSFQSDVYAFGIVLYELM 219 (289)
T ss_dssp HHHC----CCSCHHHHHHHHHHHHHHHH
T ss_pred hhhcccCCCCCCcccchHHHHHHHHHHH
Confidence 9986 566888999999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=6e-14 Score=143.82 Aligned_cols=96 Identities=21% Similarity=0.242 Sum_probs=66.7
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++....... .....||+.|+|||.+
T Consensus 132 ~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (310)
T 2wqm_A 132 LIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208 (310)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHh
Confidence 35555555666666664 5664 3699999999999999999999999999986544322 2346799999999999
Q ss_pred cccccCcccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
....++.++|+||+|++++..-
T Consensus 209 ~~~~~~~~~Dv~slG~il~~l~ 230 (310)
T 2wqm_A 209 HENGYNFKSDIWSLGCLLYEMA 230 (310)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCchhhHHHHHHHHHHHH
Confidence 9899999999999999988653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=7.8e-14 Score=143.31 Aligned_cols=136 Identities=19% Similarity=0.159 Sum_probs=87.7
Q ss_pred hhccccccccccccccccCChhhhhhhhcccc--cccccccccccccccccccccCCccceeeccccch--hhhccCCCC
Q psy16430 91 LTKLSVCWRPFCSFVDKFSSPEFKTNIQERSE--VKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTP 166 (600)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~ 166 (600)
+.+|...+.-....+++|...++-.+++|... +..+.. ....+++.....++..++.+ |+|. .+
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~---------~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ 147 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK---------KKKSIDPWERKSYWKNMLEAVHTIHQ---HG 147 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHH---------HCSSCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Confidence 44554434444555566666666667777322 211111 12345666666666666664 5665 36
Q ss_pred eEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccccccc-----------cccCccccccccc
Q psy16430 167 DALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRN-----------EQCSDKIDIWYKN 232 (600)
Q Consensus 167 iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE~i~~-----------~~~s~~~Dvy~~~ 232 (600)
|+||||||.|||+++ +.+||+|||+++....... .....||+.|+|||.+.+ ..++.++|+||+|
T Consensus 148 ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG 226 (313)
T 3cek_A 148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226 (313)
T ss_dssp CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence 999999999999965 8999999999987644322 234679999999999865 4688899999999
Q ss_pred ccccccc
Q psy16430 233 RLCFPTS 239 (600)
Q Consensus 233 ~~~~p~s 239 (600)
++++..-
T Consensus 227 ~il~el~ 233 (313)
T 3cek_A 227 CILYYMT 233 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.24 E-value=6.1e-14 Score=144.04 Aligned_cols=96 Identities=15% Similarity=0.154 Sum_probs=69.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCc---eeEeecccccccCCCC--------ccccccCc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEE---AKISDFGTCREWNNKS--------TKMSFAGT 208 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~---~Kv~DFGlsr~~~~~~--------~~~~~~GT 208 (600)
+++.....++..++. .|+|.. +|+||||||.|||++.++. +||+|||+++...... .....+||
T Consensus 108 ~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt 184 (316)
T 2ac3_A 108 FNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCC
Confidence 455555555555555 456654 6999999999999998876 9999999998653211 12245699
Q ss_pred eeecccccccc-----cccCccccccccccccccccc
Q psy16430 209 VAWMAPEVIRN-----EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 209 ~~ymAPE~i~~-----~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.|+|||++.. ..++.++|+||+|++++..-.
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~ 221 (316)
T 2ac3_A 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221 (316)
T ss_dssp GGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH
T ss_pred cCccChHHhhcccccccCCCcccccHhHHHHHHHHHH
Confidence 99999999875 568899999999999986543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=6.3e-14 Score=140.06 Aligned_cols=95 Identities=20% Similarity=0.229 Sum_probs=75.8
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++...+.+ |+|. .+|+||||||.||+++.++.+||+|||+++....... .....||..|+|||.
T Consensus 100 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 176 (267)
T 3t9t_A 100 LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176 (267)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhh
Confidence 35666666666666664 5664 3699999999999999999999999999986543221 223567889999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+....++.++|+||+|++++..
T Consensus 177 ~~~~~~~~~~Di~slG~il~~l 198 (267)
T 3t9t_A 177 FSFSRYSSKSDVWSFGVLMWEV 198 (267)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHH
T ss_pred hcCCCccchhchhhhHHHHHHH
Confidence 9988999999999999998865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-13 Score=142.56 Aligned_cols=96 Identities=18% Similarity=0.198 Sum_probs=66.5
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||.
T Consensus 130 ~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 206 (309)
T 2h34_A 130 PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206 (309)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHH
Confidence 35666666666666664 5665 3699999999999999999999999999986544321 234679999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|++++..-
T Consensus 207 ~~~~~~~~~~Di~slG~il~~l~ 229 (309)
T 2h34_A 207 FSESHATYRADIYALTCVLYECL 229 (309)
T ss_dssp TCC----CCCHHHHHHHHHHHHH
T ss_pred HcCCCCCchHhHHHHHHHHHHHH
Confidence 99899999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.24 E-value=9.1e-14 Score=140.67 Aligned_cols=95 Identities=16% Similarity=0.242 Sum_probs=73.6
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....++...+. .|+|. .+|+||||||.|||++.++.+||+|||+++....... .....||..|+||
T Consensus 117 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (291)
T 1u46_A 117 HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193 (291)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCc
Confidence 3556666666666666 45665 3799999999999999999999999999987644322 2235678899999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|.+.+..++.++|+||+|++++..
T Consensus 194 E~~~~~~~~~~~Di~slG~il~~l 217 (291)
T 1u46_A 194 ESLKTRTFSHASDTWMFGVTLWEM 217 (291)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred hhhcCCCCCchhhHHHHHHHHHHH
Confidence 999988899999999999998865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-13 Score=138.69 Aligned_cols=95 Identities=18% Similarity=0.233 Sum_probs=73.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeeccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEV 216 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~ 216 (600)
.+++.....++...+.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||.
T Consensus 109 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 185 (281)
T 3cc6_A 109 SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185 (281)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchh
Confidence 35566666666666664 5664 4699999999999999999999999999986644322 223567889999999
Q ss_pred ccccccCccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+.+..++.++|+||+|++++..
T Consensus 186 ~~~~~~~~~~Di~slG~il~~l 207 (281)
T 3cc6_A 186 INFRRFTTASDVWMFAVCMWEI 207 (281)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHH
T ss_pred hccCCCCchhccHHHHHHHHHH
Confidence 9988999999999999998865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=6.5e-14 Score=145.47 Aligned_cols=96 Identities=16% Similarity=0.121 Sum_probs=67.4
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee-----ccCCceeEeecccccccCCCC-ccccccCceeec
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI-----GSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWM 212 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL-----d~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ym 212 (600)
.+++.....|+..++. .|+|. .+||||||||.|||+ +..+.+||+|||+++...... ......||+.|+
T Consensus 128 ~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~ 204 (329)
T 3gbz_A 128 DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204 (329)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCcccc
Confidence 3555555556666666 45665 369999999999999 455569999999998764332 234567899999
Q ss_pred cccccccc-ccCcccccccccccccccc
Q psy16430 213 APEVIRNE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 213 APE~i~~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
|||++.+. .++.++|+||+|++++..-
T Consensus 205 aPE~~~~~~~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 205 PPEILLGSRHYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 99998764 4899999999999988653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-13 Score=142.99 Aligned_cols=94 Identities=18% Similarity=0.171 Sum_probs=74.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec------cCCceeEeecccccccCCCCccccccCceeecc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG------SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMA 213 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd------~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymA 213 (600)
+++.....|+..++. .|+|..+ +||||||||.|||++ ..+.+||+|||+++..... .....||+.|+|
T Consensus 128 ~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~a 203 (373)
T 1q8y_A 128 IPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRS 203 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCC
T ss_pred CcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccC
Confidence 555555556666666 4566542 699999999999995 3448999999999866432 334689999999
Q ss_pred cccccccccCcccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
||++.+..++.++|+||+|++++..-
T Consensus 204 PE~~~~~~~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 204 PEVLLGAPWGCGADIWSTACLIFELI 229 (373)
T ss_dssp HHHHHTCCCCTHHHHHHHHHHHHHHH
T ss_pred cHHHhCCCCCchHhHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-13 Score=141.34 Aligned_cols=96 Identities=17% Similarity=0.223 Sum_probs=78.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||..|+||
T Consensus 123 ~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (327)
T 3lxl_A 123 RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199 (327)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCH
Confidence 46677777776666664 5664 4799999999999999999999999999987644322 2235688999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+.+..++.++|+||+|++++..-
T Consensus 200 E~~~~~~~~~~~Di~slG~il~~ll 224 (327)
T 3lxl_A 200 ESLSDNIFSRQSDVWSFGVVLYELF 224 (327)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCChHHhHHHHHHHHHHHH
Confidence 9999889999999999999998653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=6e-13 Score=150.90 Aligned_cols=97 Identities=19% Similarity=0.272 Sum_probs=80.2
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCc---eeEeecccccccCCCCccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEE---AKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~---~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
.+++.....|+..++.+ |+|. .+|+||||||.|||++.++. +||+|||+++............||++|+|||
T Consensus 117 ~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE 193 (676)
T 3qa8_A 117 GLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193 (676)
T ss_dssp CCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChH
Confidence 46777777777777664 5665 46999999999999997764 9999999999776555555678999999999
Q ss_pred cccccccCccccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
++.+..++.++|+||+|++++..-.
T Consensus 194 ~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 194 LLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp SSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred HhccCCCCchhHHHHHHHHHHHHHH
Confidence 9999999999999999999986543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=9.6e-14 Score=144.81 Aligned_cols=96 Identities=18% Similarity=0.187 Sum_probs=60.1
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeecc---CCceeEeecccccccCCCCccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGS---KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~---~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAP 214 (600)
..+++.....++..++.+ |+|.. +|+||||||.|||++. ++.+||+|||+++..... ......||+.|+||
T Consensus 123 ~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aP 198 (336)
T 3fhr_A 123 QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAP 198 (336)
T ss_dssp CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccCh
Confidence 346677777777666664 56653 6999999999999986 456999999999865432 23346789999999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++....++.++|+||+|++++..-
T Consensus 199 E~~~~~~~~~~~Di~slG~il~~l~ 223 (336)
T 3fhr_A 199 EVLGPEKYDKSCDMWSLGVIMYILL 223 (336)
T ss_dssp -----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCCCCCchhhHHHHHHHHHHHH
Confidence 9998889999999999999998653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=2.4e-13 Score=137.85 Aligned_cols=95 Identities=19% Similarity=0.261 Sum_probs=77.0
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++....... .....||+.|+||
T Consensus 106 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (287)
T 1u59_A 106 EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182 (287)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCH
Confidence 46667777777777765 5664 3699999999999999999999999999987644322 2234578999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|.+.+..++.++|+||+|++++..
T Consensus 183 E~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 183 ECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCchhhHHHHHHHHHHH
Confidence 999988899999999999998865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-13 Score=142.37 Aligned_cols=95 Identities=22% Similarity=0.243 Sum_probs=73.2
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCc---eeEeecccccccCCCCccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEE---AKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~---~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
+++.....++..++. .|+|. .+|+||||||.|||++.++. +||+|||+++............||+.|+|||+
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~ 187 (322)
T 2ycf_A 111 LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchh
Confidence 444455555555555 45664 46999999999999987664 99999999987655443445679999999999
Q ss_pred cc---ccccCcccccccccccccccc
Q psy16430 217 IR---NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~---~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+. ...++.++|+||+|++++..-
T Consensus 188 ~~~~~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 188 LVSVGTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp HHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred hccCCCCCCCchhhHHHHHHHHHHHH
Confidence 74 466889999999999988653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=7.3e-14 Score=142.06 Aligned_cols=98 Identities=20% Similarity=0.261 Sum_probs=73.6
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC------ccccccCceee
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS------TKMSFAGTVAW 211 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~------~~~~~~GT~~y 211 (600)
..+++.....++..++.+ |+|. .+|+||||||.||+++.++.+||+|||+++...... ......||+.|
T Consensus 116 ~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y 192 (303)
T 2vwi_A 116 GVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192 (303)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccc
Confidence 346666677777666665 5664 369999999999999999999999999998654321 12346799999
Q ss_pred cccccccc-cccCccccccccccccccccc
Q psy16430 212 MAPEVIRN-EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 212 mAPE~i~~-~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+|||++.. ..++.++|+||+|++++..-.
T Consensus 193 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 193 MAPEVMEQVRGYDFKADIWSFGITAIELAT 222 (303)
T ss_dssp CCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred cCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence 99999876 568999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=9.5e-14 Score=139.59 Aligned_cols=95 Identities=19% Similarity=0.183 Sum_probs=66.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|.. +|+||||||.||+++.++.+||+|||+++............||+.|+|||.+.+
T Consensus 108 ~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 108 VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcC
Confidence 455555556666666 456653 699999999999999999999999999987655444445689999999999987
Q ss_pred ccc-Ccccccccccccccccc
Q psy16430 220 EQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~~-s~~~Dvy~~~~~~~p~s 239 (600)
..+ +.++|+||+|++++..-
T Consensus 185 ~~~~~~~~Di~slG~~l~~l~ 205 (276)
T 2h6d_A 185 RLYAGPEVDIWSCGVILYALL 205 (276)
T ss_dssp SCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHHH
Confidence 765 67899999999988653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.5e-13 Score=140.90 Aligned_cols=97 Identities=16% Similarity=0.194 Sum_probs=66.3
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++.+ |+|.. .+|+||||||.|||++.++.+||+|||+++............||+.|+|||.+.
T Consensus 120 ~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 120 PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197 (318)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcc
Confidence 45555555666666664 56652 269999999999999999999999999998765544444568999999999984
Q ss_pred -----ccccCcccccccccccccccc
Q psy16430 219 -----NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 -----~~~~s~~~Dvy~~~~~~~p~s 239 (600)
...++.++|+||+|++++..-
T Consensus 198 ~~~~~~~~~~~~~Di~slG~il~~l~ 223 (318)
T 2dyl_A 198 PPDPTKPDYDIRADVWSLGISLVELA 223 (318)
T ss_dssp --------CCTHHHHHHHHHHHHHHH
T ss_pred cccccccCCccccchhhHHHHHHHHH
Confidence 456888999999999998653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.3e-13 Score=155.60 Aligned_cols=91 Identities=18% Similarity=0.214 Sum_probs=74.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.++|.+...|+..++.+ |+|. .+||||||||.|||++.+ .+||+|||+++..... ....||++|||||++.
T Consensus 178 ~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~ 250 (681)
T 2pzi_A 178 KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVR 250 (681)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHc
Confidence 46777777777777775 5664 369999999999999986 8999999999876443 3467999999999987
Q ss_pred ccccCcccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~s 239 (600)
++ .+.++|+||+|++++..-
T Consensus 251 ~~-~~~~sDi~slG~~l~~l~ 270 (681)
T 2pzi_A 251 TG-PTVATDIYTVGRTLAALT 270 (681)
T ss_dssp HC-SCHHHHHHHHHHHHHHHH
T ss_pred CC-CCCceehhhhHHHHHHHH
Confidence 65 488999999999998653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.22 E-value=6.2e-13 Score=140.57 Aligned_cols=93 Identities=19% Similarity=0.159 Sum_probs=71.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|.. +|+||||||.|||++.++.+||+|||+++..... .....||++|+|||++.+
T Consensus 141 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 141 FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcC
Confidence 555555556655555 456653 6999999999999999999999999999865332 335689999999999876
Q ss_pred -cccCcccccccccccccccc
Q psy16430 220 -EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 -~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 216 ~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 216 WMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp CSCCCTTHHHHHHHHHHHHHH
T ss_pred CCCCCcHHhHHHHHHHHHHHH
Confidence 67899999999999998653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.7e-13 Score=139.18 Aligned_cols=95 Identities=17% Similarity=0.134 Sum_probs=70.4
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCC------CccccccCceeec
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNK------STKMSFAGTVAWM 212 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~------~~~~~~~GT~~ym 212 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++ ++.+||+|||+++..... .......||+.|+
T Consensus 126 ~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~ 201 (319)
T 2y4i_B 126 VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201 (319)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCccccc
Confidence 46777777777777775 5665 3699999999999998 679999999998754321 1122356999999
Q ss_pred ccccccc---------cccCcccccccccccccccc
Q psy16430 213 APEVIRN---------EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 213 APE~i~~---------~~~s~~~Dvy~~~~~~~p~s 239 (600)
|||.+.. ..++.++|+||+|++++..-
T Consensus 202 aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp CHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred ChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 9999864 34788999999999988653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-13 Score=139.04 Aligned_cols=93 Identities=24% Similarity=0.270 Sum_probs=70.7
Q ss_pred CCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc-CCceeEeecccccccCCCC-ccccccCceeecccccccc
Q psy16430 144 IPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS-KEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 144 ~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~-~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~ 219 (600)
+.....++..++. .|+|. .+|+||||||.|||++. ++.+||+|||+++...... ......||+.|+|||++..
T Consensus 121 ~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (295)
T 2clq_A 121 EQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcC
Confidence 3333345555555 45665 36999999999999998 8999999999998764322 2335679999999999876
Q ss_pred cc--cCcccccccccccccccc
Q psy16430 220 EQ--CSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 ~~--~s~~~Dvy~~~~~~~p~s 239 (600)
.. ++.++|+||+|++++..-
T Consensus 198 ~~~~~~~~~Di~slG~il~~l~ 219 (295)
T 2clq_A 198 GPRGYGKAADIWSLGCTIIEMA 219 (295)
T ss_dssp GGGGCSHHHHHHHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHH
Confidence 54 788999999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.6e-13 Score=140.37 Aligned_cols=94 Identities=16% Similarity=0.170 Sum_probs=74.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeee---ccCCceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLI---GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILL---d~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
+++.....++...+. .|+|. .+|+||||||.|||+ +.++.+||+|||+++..... ......||+.|+|||.
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~ 178 (304)
T 2jam_A 103 YTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEV 178 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHH
Confidence 444445555555555 45665 369999999999999 78899999999999765332 2334679999999999
Q ss_pred ccccccCcccccccccccccccc
Q psy16430 217 IRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 217 i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+.+..++.++|+||+|++++..-
T Consensus 179 ~~~~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 179 LAQKPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp BSSCSCCHHHHHHHHHHHHHHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999988653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.9e-13 Score=139.74 Aligned_cols=95 Identities=16% Similarity=0.204 Sum_probs=76.1
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeecccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAPE 215 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAPE 215 (600)
+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||..|+|||
T Consensus 131 ~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (318)
T 3lxp_A 131 IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChH
Confidence 5666666666666664 5665 3699999999999999999999999999987654332 22456889999999
Q ss_pred cccccccCcccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
.+.+..++.++|+||+|++++..-
T Consensus 208 ~~~~~~~~~~~Di~slG~il~~ll 231 (318)
T 3lxp_A 208 CLKEYKFYYASDVWSFGVTLYELL 231 (318)
T ss_dssp HHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999889999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=4.3e-13 Score=140.36 Aligned_cols=93 Identities=19% Similarity=0.159 Sum_probs=71.1
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|.. +|+||||||.|||++.++.+||+|||+++..... .....||++|+|||++.+
T Consensus 123 ~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 123 FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhC
Confidence 555555556666666 456653 6999999999999999999999999999865332 335689999999999876
Q ss_pred -cccCcccccccccccccccc
Q psy16430 220 -EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 220 -~~~s~~~Dvy~~~~~~~p~s 239 (600)
..++.++|+||+|++++..-
T Consensus 198 ~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 198 WMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp CSCCCTTHHHHHHHHHHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHH
Confidence 67899999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2e-13 Score=140.29 Aligned_cols=97 Identities=15% Similarity=0.128 Sum_probs=74.9
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----------cccccC
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----------KMSFAG 207 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----------~~~~~G 207 (600)
..+++.....++..++.+ |+|.. +|+||||||.|||++.++.+||+|||+++....... .....|
T Consensus 129 ~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~g 205 (317)
T 2buj_A 129 NFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccC
Confidence 456677777777777765 56653 799999999999999999999999999876432110 123568
Q ss_pred ceeecccccccccc---cCcccccccccccccccc
Q psy16430 208 TVAWMAPEVIRNEQ---CSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 208 T~~ymAPE~i~~~~---~s~~~Dvy~~~~~~~p~s 239 (600)
|+.|+|||.+.... ++.++|+||+|+++|..-
T Consensus 206 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp CGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred CcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 99999999987543 688999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2e-13 Score=140.80 Aligned_cols=95 Identities=23% Similarity=0.263 Sum_probs=66.5
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeeccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~ 218 (600)
++......++..++. .|+|.. +|+||||||.|||++.++.+||+|||+++...... ......||+.|+|||++.
T Consensus 126 ~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 126 LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhc
Confidence 444444445555555 456653 69999999999999999999999999998654332 233467999999999987
Q ss_pred -----ccccCcccccccccccccccc
Q psy16430 219 -----NEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 -----~~~~s~~~Dvy~~~~~~~p~s 239 (600)
...++.++|+||+|++++..-
T Consensus 203 ~~~~~~~~~~~~~Di~slG~il~~l~ 228 (326)
T 2x7f_A 203 CDENPDATYDFKSDLWSLGITAIEMA 228 (326)
T ss_dssp --------CCTTHHHHHHHHHHHHHH
T ss_pred cccccCcCCCccchHHHHHHHHHHHH
Confidence 566889999999999998653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.3e-13 Score=139.58 Aligned_cols=129 Identities=19% Similarity=0.174 Sum_probs=86.8
Q ss_pred ccccccccCChhhhhhhhcc-cccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCe
Q psy16430 101 FCSFVDKFSSPEFKTNIQER-SEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGV 177 (600)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NI 177 (600)
....+++|...+.-.+++|. ....++..+. .....+++.....++..++.+ |+|.. +|+||||||.||
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 170 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYI------TEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI 170 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHH------HHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence 34445555555555666663 2222221111 112346666677766666664 56653 699999999999
Q ss_pred eec-cCCceeEeecccccccCCCCccccccCceeecccccccccccC-cccccccccccccccc
Q psy16430 178 LIG-SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS-DKIDIWYKNRLCFPTS 239 (600)
Q Consensus 178 LLd-~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s-~~~Dvy~~~~~~~p~s 239 (600)
+++ .++.+||+|||+++..... ......||..|+|||++.+..+. .++|+||+|++++..-
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 999 8899999999999876443 23456799999999998877664 4899999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.2e-13 Score=138.87 Aligned_cols=96 Identities=17% Similarity=0.210 Sum_probs=77.3
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAP 214 (600)
.+++.....++..++.+ |+|. .+|+||||||.|||++.++.+||+|||+++....... .....||..|+||
T Consensus 141 ~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 217 (326)
T 2w1i_A 141 RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217 (326)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECc
Confidence 36666666676666664 5664 4799999999999999999999999999987654322 2235678889999
Q ss_pred ccccccccCcccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|.+.+..++.++|+||+|++++..-
T Consensus 218 E~~~~~~~~~~~Di~slG~il~el~ 242 (326)
T 2w1i_A 218 ESLTESKFSVASDVWSFGVVLYELF 242 (326)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999888999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-13 Score=136.56 Aligned_cols=94 Identities=22% Similarity=0.241 Sum_probs=74.1
Q ss_pred ccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeecccc
Q psy16430 142 LSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMAPE 215 (600)
Q Consensus 142 l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymAPE 215 (600)
+++.....++..++.+ |+|.. +|+||||||.|||++.++.+||+|||+++....... .....||+.|+|||
T Consensus 114 ~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 190 (291)
T 1xbb_A 114 VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190 (291)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChH
Confidence 5555666666666664 56653 699999999999999999999999999987644322 22345778999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||+|++++..
T Consensus 191 ~~~~~~~~~~~Di~slG~il~~l 213 (291)
T 1xbb_A 191 CINYYKFSSKSDVWSFGVLMWEA 213 (291)
T ss_dssp HHHHCEEEHHHHHHHHHHHHHHH
T ss_pred HhccCCCChhhhHHHHHHHHHHH
Confidence 99988899999999999998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 600 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-76 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-07 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-71 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-07 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-05 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-06 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-06 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-08 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-06 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 0.002 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-05 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 0.002 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-07 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-06 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-06 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-07 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-08 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-06 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-05 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-04 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-07 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-06 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-05 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-09 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-06 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-04 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-06 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-05 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-05 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-05 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-04 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-04 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-06 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-04 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-54 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-06 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-05 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-52 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-50 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-06 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-04 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 0.001 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-04 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-05 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 0.002 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-04 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 0.003 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 6e-76
Identities = 96/270 (35%), Positives = 137/270 (50%), Gaps = 22/270 (8%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD---------IRHLR 304
D+WEIP I+ Q +GSG+ G V+ GK + VAVK + T + LR
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGMN 363
K H NI+ F G T P IV ++C LY+ L E +L + ARQ A GM+
Sbjct: 60 KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR---EWNNKSTKMSFAGTVAWMAPEVI 420
YLH+K IIHRDLKS N+ + KI DFG W+ +G++ WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 421 RNEQC---SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP----IPSTC 473
R + S + D++++GIVL+EL+T + PY ++++ I + P + S C
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
P + LM C RP F QIL+ ++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (115), Expect = 9e-07
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 6/59 (10%)
Query: 177 VLIGSKEEAKISDFGTCR---EWNNKSTKMSFAGTVAWMAPEVIRNEQC---SDKIDIW 229
+ + KI DFG W+ +G++ WMAPEVIR + S + D++
Sbjct: 135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 5e-71
Identities = 81/264 (30%), Positives = 124/264 (46%), Gaps = 13/264 (4%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQKETD-----IRHLRKLNHPN 310
W + + + LQ +G G G V G R VAVK ++ + +L H N
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSN 61
Query: 311 IVKFKGVCTQAP-CYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHS 367
+V+ GV + IV EY A G L + L+ + L ++ + M YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 368 KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
+HRDL + NVL+ AK+SDFG +E + ST+ + V W APE +R ++ S
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALREKKFST 179
Query: 428 KIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
K D+WS+GI+LWE+ + PY + ++ V + P CP +MK CW
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEVMKNCWH 238
Query: 487 NAPSSRPSFKQILSHLD-IASQEV 509
+ RPSF Q+ L+ I + E+
Sbjct: 239 LDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (116), Expect = 5e-07
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 2/53 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ AK+SDFG +E + ST+ + V W APE +R ++ S K D+W
Sbjct: 134 VLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALREKKFSTKSDVW 184
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 8e-69
Identities = 81/262 (30%), Positives = 130/262 (49%), Gaps = 12/262 (4%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVREQKETD------IRHLRK 305
DEWE+P E++ ++ LG+G G V+ G VAVK +++ + +++
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQ 64
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMN 363
L H +V+ V TQ P Y I+ EY G L + LK G ++ +L + A QIA GM
Sbjct: 65 LQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIR 421
++ + IHRDL++ N+L+ KI+DFG R E N + + + W APE I
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 422 NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ K D+WS+GI+L E++T ++ + + P CP+ LM
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 482 KMCWSNAPSSRPSFKQILSHLD 503
++CW P RP+F + S L+
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLE 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (103), Expect = 3e-05
Identities = 17/55 (30%), Positives = 25/55 (45%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ KI+DFG R E N + + + W APE I + K D+W
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (540), Expect = 1e-64
Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 18/258 (6%)
Query: 259 PFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD----------IRHLRKL 306
P + SDL+ +G G+ GAV+ + E+VA+KK+ + +R L+KL
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
HPN ++++G + +VMEYC L + + + G+ YLH
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR---NE 423
S +IHRD+K+ N+L+ K+ DFG+ ++ F GT WMAPEVI
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILAMDEG 189
Query: 424 QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
Q K+D+WS GI EL + P ++++ + ++ + + + F+ +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 484 CWSNAPSSRPSFKQILSH 501
C P RP+ + +L H
Sbjct: 250 CLQKIPQDRPTSEVLLKH 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.1 bits (109), Expect = 6e-06
Identities = 19/56 (33%), Positives = 27/56 (48%), Gaps = 6/56 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR---NEQCSDKIDIW 229
+L+ K+ DFG+ ++ F GT WMAPEVI Q K+D+W
Sbjct: 146 ILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVW 198
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-64
Identities = 79/262 (30%), Positives = 126/262 (48%), Gaps = 12/262 (4%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVREQKETD------IRHLRK 305
+D WEIP ES+ LG G G V+ G VA+K ++ + + ++K
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKK 68
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPL--YNLLKDGEEVPPQRLYNWARQIAAGMN 363
L H +V+ V ++ P Y IV EY + G L + + G+ + +L + A QIA+GM
Sbjct: 69 LRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIR 421
Y+ +HRDL++ N+L+G K++DFG R E N + + + W APE
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 422 NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ + K D+WS+GI+L EL T + + +P P CP+ LM
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247
Query: 482 KMCWSNAPSSRPSFKQILSHLD 503
CW P RP+F+ + + L+
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLE 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (111), Expect = 3e-06
Identities = 16/55 (29%), Positives = 26/55 (47%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCR--EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG R E N + + + W APE + + K D+W
Sbjct: 144 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 198
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 5e-64
Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 15/245 (6%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD----------IRHLRKLNHPNIVKFKG 316
LG G G V+ + + I+A+K + + + + L HPNI++ G
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
A +++EY G +Y L+ + QR + ++A ++Y HSK++IHRD+K
Sbjct: 74 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 133
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGI 436
N+L+GS E KI+DFG + S + + GT+ ++ PE+I +K+D+WS G+
Sbjct: 134 PENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 192
Query: 437 VLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFK 496
+ +E L + P++ + S + P +G + L+ + PS RP +
Sbjct: 193 LCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLR 250
Query: 497 QILSH 501
++L H
Sbjct: 251 EVLEH 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (129), Expect = 2e-08
Identities = 18/53 (33%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+GS E KI+DFG + S + + GT+ ++ PE+I +K+D+W
Sbjct: 137 LLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 188
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-64
Identities = 77/256 (30%), Positives = 128/256 (50%), Gaps = 12/256 (4%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVREQKETD------IRHLRKLNHPN 310
I + ++ L+ LG+G G V GK R VA+K ++E ++ + + L+H
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQ 369
+V+ GVCT+ I+ EY A G L N L++ Q+L + + M YL SKQ
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTVAWMAPEVIRNEQCSD 427
+HRDL + N L+ + K+SDFG R + ++ + V W PEV+ + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 428 KIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
K DIW++G+++WE+ + + PY+ +S + + L L P + +M CW
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYTIMYSCWH 239
Query: 487 NAPSSRPSFKQILSHL 502
RP+FK +LS++
Sbjct: 240 EKADERPTFKILLSNI 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.1 bits (114), Expect = 1e-06
Identities = 17/55 (30%), Positives = 26/55 (47%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREW--NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+ + K+SDFG R + ++ + V W PEV+ + S K DIW
Sbjct: 131 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-63
Identities = 86/301 (28%), Positives = 138/301 (45%), Gaps = 43/301 (14%)
Query: 246 EFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQKET 298
+F+ + +WE P E++ + LGSGA G V + S VAVK ++E+ ++
Sbjct: 22 DFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 81
Query: 299 D--------IRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE---- 345
++ + +L +H NIV G CT + ++ EYC YG L N L+ E
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 346 -------------------VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386
+ + L +A Q+A GM +L K +HRDL + NVL+ +
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201
Query: 387 EAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT 443
KI DFG R+ + S + + V WMAPE + + K D+WSYGI+LWE+ +
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 444 C-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
PY + A + + + + P + ++M+ CW+ RPSF + S L
Sbjct: 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 503 D 503
Sbjct: 322 G 322
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.002
Identities = 18/56 (32%), Positives = 27/56 (48%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ + KI DFG R+ + S + + V WMAPE + + K D+W
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 5e-63
Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH-------L 303
D WEI + LG GA G V+ + + + A K + + E ++ L
Sbjct: 11 EDFWEI-------IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 304 RKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAGM 362
+HPNIVK I++E+CA G + ++ + E + ++ +Q +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIR 421
NYLH +IIHRDLK+ N+L + K++DFG + + SF GT WMAPEV+
Sbjct: 124 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 422 NEQCSD-----KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS-LHLPIPSTCPD 475
E D K D+WS GI L E+ E P+ +++ ++ + S L PS
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 476 GFQLLMKMCWSNAPSSRPSFKQILSH 501
F+ +K C +R + Q+L H
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQH 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (103), Expect = 3e-05
Identities = 20/59 (33%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSD-----KIDIW 229
+L + K++DFG + + SF GT WMAPEV+ E D K D+W
Sbjct: 141 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 6e-63
Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 12/267 (4%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKE------TDIRHLRK 305
D+WE+ I+ LG G G V+ G + VAVK ++E + +++
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69
Query: 306 LNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL--KDGEEVPPQRLYNWARQIAAGMN 363
+ HPN+V+ GVCT+ P + I+ E+ YG L + L + +EV L A QI++ M
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 364 YLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIR 421
YL K IHRDL + N L+G K++DFG R + + W APE +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 422 NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLM 481
+ S K D+W++G++LWE+ T + ++ + + P CP+ LM
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249
Query: 482 KMCWSNAPSSRPSFKQILSHLDIASQE 508
+ CW PS RPSF +I + QE
Sbjct: 250 RACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.6 bits (89), Expect = 0.002
Identities = 15/55 (27%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIRNEQCSDKIDIW 229
L+G K++DFG R + + W APE + + S K D+W
Sbjct: 146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-62
Identities = 73/252 (28%), Positives = 118/252 (46%), Gaps = 20/252 (7%)
Query: 269 LGSGAQGAVFSGKLRS----EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFK 315
LGSG G V G + + VAVK ++ + +++L++P IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
G+C + +VME GPL L+ V + + Q++ GM YL +HRDL
Sbjct: 75 GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 376 KSPNVLIGSKEEAKISDFGTCR----EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDI 431
+ NVL+ ++ AKISDFG + + N + V W APE I + S K D+
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193
Query: 432 WSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490
WS+G+++WE + + PY+ + S + + + P+ CP LM +CW+
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWTYDVE 252
Query: 491 SRPSFKQILSHL 502
+RP F + L
Sbjct: 253 NRPGFAAVELRL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (122), Expect = 1e-07
Identities = 21/64 (32%), Positives = 30/64 (46%), Gaps = 4/64 (6%)
Query: 177 VLIGSKEEAKISDFGTCR----EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKN 232
VL+ ++ AKISDFG + + N + V W APE I + S K D+W
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197
Query: 233 RLCF 236
L +
Sbjct: 198 VLMW 201
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-62
Identities = 70/244 (28%), Positives = 122/244 (50%), Gaps = 12/244 (4%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKGVCT 319
+G GA G V++ + + VA++++ Q++ I +R+ +PNIV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 320 QAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379
+VMEY A G L +++ + ++ R+ + +LHS Q+IHRD+KS N
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 380 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVL 438
+L+G K++DFG C + + +K S GT WMAPEV+ + K+DIWS GI+
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 439 WELLTCETPYKDVDSSAIIWGVGSS-SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQ 497
E++ E PY + + ++ + ++ + L P F+ + C R S K+
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 498 ILSH 501
+L H
Sbjct: 267 LLQH 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.8 bits (108), Expect = 7e-06
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+G K++DFG C + + +K S GT WMAPEV+ + K+DIW
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-62
Identities = 73/256 (28%), Positives = 120/256 (46%), Gaps = 10/256 (3%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVREQKETD------IRHLRKLNHPN 310
I ++ +Q +GSG G V G + + VA+K +RE ++ + KL+HP
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 311 IVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEV-PPQRLYNWARQIAAGMNYLHSKQ 369
+V+ GVC + C+V E+ +G L + L+ + + L + GM YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 370 IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIRNEQCSD 427
+IHRDL + N L+G + K+SDFG R + S V W +PEV + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 428 KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487
K D+WS+G+++WE+ + + S++ + S+ L P +M CW
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241
Query: 488 APSSRPSFKQILSHLD 503
P RP+F ++L L
Sbjct: 242 RPEDRPAFSRLLRQLA 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (112), Expect = 2e-06
Identities = 18/55 (32%), Positives = 25/55 (45%), Gaps = 2/55 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIRNEQCSDKIDIW 229
L+G + K+SDFG R + S V W +PEV + S K D+W
Sbjct: 132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 7e-61
Identities = 68/252 (26%), Positives = 111/252 (44%), Gaps = 21/252 (8%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G+ V+ G VA +++++K T L+ L HPNIV+F
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 318 CTQA----PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK--QII 371
C +V E G L LK + + + L +W RQI G+ +LH++ II
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 136
Query: 372 HRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 430
HRDLK N+ I KI D G K + GT +MAPE+ + + +D
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYEE-KYDESVD 194
Query: 431 IWSYGIVLWELLTCETPYKDVDSSAIIWG-VGSSSLHLPIPSTCPDGFQLLMKMCWSNAP 489
++++G+ + E+ T E PY + ++A I+ V S + +++ C
Sbjct: 195 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 254
Query: 490 SSRPSFKQILSH 501
R S K +L+H
Sbjct: 255 DERYSIKDLLNH 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.8 bits (121), Expect = 2e-07
Identities = 13/52 (25%), Positives = 22/52 (42%), Gaps = 2/52 (3%)
Query: 178 LIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ G KI D G K + GT +MAPE+ + + +D++
Sbjct: 147 ITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYEE-KYDESVDVY 196
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-60
Identities = 66/271 (24%), Positives = 119/271 (43%), Gaps = 31/271 (11%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRH 302
+++E+ L +G+G+ G + +S +I+ K++ T+ +
Sbjct: 4 EDYEV-------LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL 56
Query: 303 LRKLNHPNIVKFKGVCTQAP--CYCIVMEYCAYGPLYNLLKDGEE----VPPQRLYNWAR 356
LR+L HPNIV++ IVMEYC G L +++ G + + + +
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116
Query: 357 QIAAGMNYLHSK-----QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAG 410
Q+ + H + ++HRDLK NV + K+ K+ DFG R N+ ++ +F G
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP 470
T +M+PE + ++K DIWS G +L+EL P+ + + IP
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIP 235
Query: 471 STCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
D ++ + RPS ++IL +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (124), Expect = 6e-08
Identities = 18/54 (33%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIW 229
V + K+ K+ DFG R N+ ++ +F GT +M+PE + ++K DIW
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 198
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-60
Identities = 76/262 (29%), Positives = 117/262 (44%), Gaps = 20/262 (7%)
Query: 258 IPFESISD---LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD--------IRHLR 304
+PF + D +Q LG GA G V R E VAVK V ++ D I +
Sbjct: 1 VPF--VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 305 KLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNY 364
LNH N+VKF G + + +EYC+ G L++ ++ +P + Q+ AG+ Y
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW---NNKSTKMSFAGTVAWMAPEVIR 421
LH I HRD+K N+L+ ++ KISDFG + N + GT+ ++APE+++
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 422 NEQCSD-KIDIWSYGIVLWELLTCETPYK-DVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479
+ +D+WS GIVL +L E P+ DS +L
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 480 LMKMCWSNAPSSRPSFKQILSH 501
L+ PS+R + I
Sbjct: 239 LLHKILVENPSARITIPDIKKD 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (109), Expect = 5e-06
Identities = 15/57 (26%), Positives = 30/57 (52%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCREW---NNKSTKMSFAGTVAWMAPEVIRNEQCSD-KIDIW 229
+L+ ++ KISDFG + N + GT+ ++APE+++ + +D+W
Sbjct: 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 201 bits (512), Expect = 6e-60
Identities = 62/322 (19%), Positives = 126/322 (39%), Gaps = 19/322 (5%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRHLRKLNHPNIVKFKG 316
L+ LGSGA G V ++ + K + D I + +L+HP ++
Sbjct: 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
+++E+ + G L++ + ++ + N+ RQ G+ ++H I+H D+
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 153
Query: 376 KSPNVLIGSKE--EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWS 433
K N++ +K+ KI DFG + N T + APE++ E D+W+
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 213
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNAPSS 491
G++ + LL+ +P+ D + V S+ + +K P
Sbjct: 214 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273
Query: 492 RPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFEDD 551
R + L H + P + I +++I+ + A + + + F
Sbjct: 274 RLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI-RQKIKEKYADWPAPQPAIGRIANFS-- 330
Query: 552 LIKKRENELKHAQDVREHYERK 573
R++ + Q +++RK
Sbjct: 331 --SLRKHRPQEYQIYDSYFDRK 350
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 44.3 bits (104), Expect = 3e-05
Identities = 13/44 (29%), Positives = 18/44 (40%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI DFG + N T + APE++ E D+W
Sbjct: 169 KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 212
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-59
Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 21/259 (8%)
Query: 262 SISDLQWLGSGAQGAVFSGKLRS----EIVAVKKVREQKETD--------IRHLRKLNHP 309
I+D++ LG G G+V G R VA+K +++ E + + +L++P
Sbjct: 11 LIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69
Query: 310 NIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSK 368
IV+ GVC +VME GPL+ L EE+P + Q++ GM YL K
Sbjct: 70 YIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCR----EWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
+HRDL + NVL+ ++ AKISDFG + + + + + + + W APE I +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 425 CSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483
S + D+WSYG+ +WE L+ + PYK + ++ + + P CP LM
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSD 247
Query: 484 CWSNAPSSRPSFKQILSHL 502
CW RP F + +
Sbjct: 248 CWIYKWEDRPDFLTVEQRM 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 3e-04
Identities = 17/57 (29%), Positives = 30/57 (52%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCR----EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ ++ AKISDFG + + + + + + + W APE I + S + D+W
Sbjct: 140 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-59
Identities = 84/296 (28%), Positives = 130/296 (43%), Gaps = 32/296 (10%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLRSE----IVAVKKVREQKETD--------IRHLR 304
+ + I +G G G V +++ + A+K+++E D + L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 305 KL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD----------------GEEVP 347
KL +HPNI+ G C + +EY +G L + L+ +
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 348 PQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407
Q+L ++A +A GM+YL KQ IHRDL + N+L+G AKI+DFG R K
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLH 466
V WMA E + + D+WSYG++LWE+++ TPY + + + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYR 244
Query: 467 LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD-IASQEVLRIQPEPYYKMQ 521
L P C D LM+ CW P RPSF QIL L+ + + + Y K
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFT 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 3e-07
Identities = 18/60 (30%), Positives = 25/60 (41%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCF 236
+L+G AKI+DFG R K V WMA E + + D+W L +
Sbjct: 158 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 199 bits (507), Expect = 3e-59
Identities = 61/264 (23%), Positives = 110/264 (41%), Gaps = 18/264 (6%)
Query: 256 WEIPFESISD----LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------IRH 302
EI + + D + LG+GA G V R+ A K V E+D I+
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAG 361
+ L HP +V ++ E+ + G L+ + D ++ + RQ+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKE--EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 419
+ ++H +H DLK N++ +K E K+ DFG + K + GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 420 IRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGF 477
+ D+WS G++ + LL+ +P+ + + V S ++ S +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 478 QLLMKMCWSNAPSSRPSFKQILSH 501
+ ++ P++R + Q L H
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEH 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 47.4 bits (112), Expect = 3e-06
Identities = 15/55 (27%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 177 VLIGSKE--EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
++ +K E K+ DFG + K + GT + APEV + D+W
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 3e-59
Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 22/269 (8%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKV--------REQKETDIRH 302
EI + Q +G+G G V SG L+ VA+K + R ++
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNL-LKDGEEVPPQRLYNWARQIAAG 361
+ + +HPN++ +GV T++ I+ E+ G L + ++ + +L R IAAG
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF------AGTVAWM 415
M YL +HRDL + N+L+ S K+SDFG R + ++ ++ + W
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200
Query: 416 APEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474
APE I+ + + D+WSYGIV+WE+++ E PY D+ + +I + LP P CP
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLPPPMDCP 259
Query: 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
LM CW + RP F QI++ LD
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.8 bits (100), Expect = 6e-05
Identities = 15/59 (25%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSF------AGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S K+SDFG R + ++ ++ + W APE I+ + + D+W
Sbjct: 159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 6e-59
Identities = 69/298 (23%), Positives = 110/298 (36%), Gaps = 54/298 (18%)
Query: 257 EIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD--------IRHLRKL 306
E+ + + LG+G G VF + ++A K + + + ++ L +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
N P IV F G I ME+ G L +LK +P Q L + + G+ YL
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 367 SKQ-IIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC 425
K I+HRD+K N+L+ S+ E K+ DFG + + SF GT ++M+PE ++
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTHY 180
Query: 426 SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI---------------- 469
S + DIWS G+ L E+ P D+ + G
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 470 --------------------------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
FQ + C P+ R KQ++ H
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (133), Expect = 6e-09
Identities = 18/53 (33%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S+ E K+ DFG + + SF GT ++M+PE ++ S + DIW
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTHYSVQSDIW 187
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 88/288 (30%), Positives = 126/288 (43%), Gaps = 38/288 (13%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQKETD------- 299
+WE P +S + LG+GA G V VAVK ++
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 300 -IRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK---------------- 341
++ L L NH NIV G CT ++ EYC YG L N L+
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 342 --DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399
D + + L +++ Q+A GM +L SK IHRDL + N+L+ KI DFG R+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 400 NNKSTKMS---FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETP-YKDVDSSA 455
N S + V WMAPE I N + + D+WSYGI LWEL + + Y + +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ + + P P +MK CW P RP+FKQI+ ++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-58
Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 17/270 (6%)
Query: 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKV--------REQKETDIR 301
++EI E I + +G G G V G S VA+K RE+ +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNL-LKDGEEVPPQRLYNWARQIAA 360
+R+ +HP+IVK GV T+ I+ME C G L + + L +A Q++
Sbjct: 61 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPE 418
+ YL SK+ +HRD+ + NVL+ S + K+ DFG R + + + + WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478
I + + D+W +G+ +WE+L + + G + LP+P CP
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 479 LLMKMCWSNAPSSRPSFKQILSHLDIASQE 508
LM CW+ PS RP F ++ + L +E
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 5e-58
Identities = 67/286 (23%), Positives = 117/286 (40%), Gaps = 22/286 (7%)
Query: 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD--------IR 301
+RD ++ LG+GA V + + ++VA+K + ++ I
Sbjct: 7 IRDIYDF-------RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 59
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAG 361
L K+ HPNIV + ++M+ + G L++ + + + Q+
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCREWNNKSTKMSFAGTVAWMAPE 418
+ YLH I+HRDLK N+L S +E ISDFG + + S + GT ++APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179
Query: 419 VIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV--GSSSLHLPIPSTCPDG 476
V+ + S +D WS G++ + LL P+ D + + + + P D
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQM 522
+ ++ P R + +Q L H IA L Q+
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.1 bits (114), Expect = 1e-06
Identities = 16/55 (29%), Positives = 26/55 (47%)
Query: 175 LGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L + + ISDFG + + S + GT ++APEV+ + S +D W
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCW 193
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-57
Identities = 75/266 (28%), Positives = 117/266 (43%), Gaps = 22/266 (8%)
Query: 258 IPFESISDLQWLGSGAQGAVFSGKLRSE-----IVAVKKVREQKETD----------IRH 302
I + + L+ LG G+ G V G+ + VAVK ++ + +
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNL-LKDGEEVPPQRLYNWARQIAAG 361
+ L+H N+++ GV P +V E G L + K L +A Q+A G
Sbjct: 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM----SFAGTVAWMAP 417
M YL SK+ IHRDL + N+L+ +++ KI DFG R AW AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
E ++ S D W +G+ LWE+ T + P+ ++ S I+ + LP P CP
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHL 502
+M CW++ P RP+F + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 1e-04
Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 4/58 (6%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM----SFAGTVAWMAPEVIRNEQCSDKIDIWY 230
+L+ +++ KI DFG R AW APE ++ S D W
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-57
Identities = 77/267 (28%), Positives = 119/267 (44%), Gaps = 19/267 (7%)
Query: 256 WEIPFESISDLQWLGSGAQGAVFSGKLRSE------IVAVKKV--------REQKETDIR 301
EI ++ + +G+G G V+ G L++ VA+K + R +
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNL-LKDGEEVPPQRLYNWARQIAA 360
+ + +H NI++ +GV ++ I+ EY G L + E +L R IAA
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS----TKMSFAGTVAWMA 416
GM YL + +HRDL + N+L+ S K+SDFG R + T + W A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 417 PEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476
PE I + + D+WS+GIV+WE++T S+ + + LP P CP
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241
Query: 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503
LM CW + RP F I+S LD
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 8e-06
Identities = 16/57 (28%), Positives = 24/57 (42%), Gaps = 4/57 (7%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKS----TKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S K+SDFG R + T + W APE I + + D+W
Sbjct: 141 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW 197
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 82/307 (26%), Positives = 135/307 (43%), Gaps = 27/307 (8%)
Query: 269 LGSGAQGAVFSGKLRSE------IVAVKKVREQKETD--------IRHLRKLNHPNIVKF 314
LGSGA G V+ G E VA+K++RE + +++P++ +
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
G+C + I L + + + + Q L NW QIA GMNYL ++++HRD
Sbjct: 77 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 136
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDI 431
L + NVL+ + + KI+DFG + + + + WMA E I + + + D+
Sbjct: 137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 196
Query: 432 WSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPS 490
WSYG+ +WEL+T PY + +S I + LP P C ++M CW
Sbjct: 197 WSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDAD 255
Query: 491 SRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEEFED 550
SRP F++++ + P+ Y +Q +E +N EE D
Sbjct: 256 SRPKFRELIIEF-----SKMARDPQRYLVIQG---DERMHLPSPTDSNFYRALMDEEDMD 307
Query: 551 DLIKKRE 557
D++ E
Sbjct: 308 DVVDADE 314
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 2e-05
Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDIW 229
VL+ + + KI+DFG + + + + WMA E I + + + D+W
Sbjct: 142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 197
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-56
Identities = 50/251 (19%), Positives = 101/251 (40%), Gaps = 17/251 (6%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD----------IRHLRKLNHPNIVKFKG 316
LG G+ V + + A+K + ++ + +L+HP VK
Sbjct: 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 317 VCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+ Y G L ++ + +I + + YLH K IIHRDLK
Sbjct: 76 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 135
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDIWS 433
N+L+ +I+DFGT + + +S + SF GT +++PE++ + D+W+
Sbjct: 136 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 195
Query: 434 YGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRP 493
G ++++L+ P++ + I + L P + L++ + R
Sbjct: 196 LGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVEKLLVLDATKRL 253
Query: 494 SFKQILSHLDI 504
+++ + +
Sbjct: 254 GCEEMEGYGPL 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 1e-05
Identities = 15/56 (26%), Positives = 30/56 (53%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ +I+DFGT + + +S + SF GT +++PE++ + D+W
Sbjct: 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 194
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (477), Expect = 1e-55
Identities = 87/293 (29%), Positives = 130/293 (44%), Gaps = 44/293 (15%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQKETD------- 299
E P +I ++ +G GA G VF + +VAVK ++E+ D
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 300 -IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEE------------- 345
+ + ++PNIVK GVC C++ EY AYG L L+
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 346 -----------VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFG 394
+ ARQ+AAGM YL ++ +HRDL + N L+G KI+DFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 395 TCR---EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKD 450
R + + A + WM PE I + + + D+W+YG+VLWE+ + PY
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 451 VDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ +I+ V ++ L P CP LM++CWS P+ RPSF I L
Sbjct: 246 MAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.3 bits (101), Expect = 5e-05
Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 3/56 (5%)
Query: 177 VLIGSKEEAKISDFGTCR---EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
L+G KI+DFG R + + A + WM PE I + + + D+W
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 226
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 74/334 (22%), Positives = 148/334 (44%), Gaps = 30/334 (8%)
Query: 246 EFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVRE----QKETD 299
+ K + D++++ + + G G G V + E A+K +++ ++E +
Sbjct: 3 QIKKNAIIDDYKVTSQVL------GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE 56
Query: 300 IRHLRKLNHPNIVKFKGVC----TQAPCYCIVMEYCAYGPLYNLLKD--GEEVPPQRLYN 353
+ H R P+IV+ V C IVME G L++ ++D + +
Sbjct: 57 L-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEE---AKISDFGTCREWNNKSTKMSFAG 410
+ I + YLHS I HRD+K N+L SK K++DFG +E + ++ +
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV------GSSS 464
T ++APEV+ E+ D+WS G++++ LL P+ AI G+ G
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIW 524
P S + ++L++ P+ R + + ++H I + ++ P + +++
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI--MQSTKVPQTPLHTSRVLK 293
Query: 525 KEEIRVHMLEMQANKSHVPKFEEFEDDLIKKREN 558
+++ R ++ + + ++E IKK E+
Sbjct: 294 EDKERWEDVKEEMTSALATMRVDYEQIKIKKIED 327
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (97), Expect = 2e-04
Identities = 19/91 (20%), Positives = 39/91 (42%), Gaps = 10/91 (10%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW---------YKNRLCF 236
K++DFG +E + ++ + T ++APEV+ E+ D+W F
Sbjct: 154 KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213
Query: 237 PT-SLMARIGEFKSFVLRDEWEIPFESISDL 266
+ +A K+ + ++E P S++
Sbjct: 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 52/280 (18%), Positives = 104/280 (37%), Gaps = 19/280 (6%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD------IRHLRKLNHPNIVKFKGV 317
+ LG G G V S + K V+ + I L H NI+
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 318 CTQAPCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
++ E+ + ++ + E+ + + ++ Q+ + +LHS I H D++
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129
Query: 377 SPNVLIGSKEEA--KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
N++ ++ + KI +FG R+ + APEV +++ S D+WS
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWSNAPSSR 492
G +++ LL+ P+ + II + ++ + SR
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249
Query: 493 PSFKQILSH------LDIASQEVLRIQPEPYYKMQMIWKE 526
+ + L H ++ S +V+R Y +I K+
Sbjct: 250 MTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKD 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (97), Expect = 2e-04
Identities = 12/44 (27%), Positives = 19/44 (43%)
Query: 186 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
KI +FG R+ + APEV +++ S D+W
Sbjct: 144 KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMW 187
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQKETD------- 299
DEWE+ E I+ + LG G+ G V+ G + VA+K V E
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 300 -IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKD----------GEEVPP 348
+++ N ++V+ GV +Q ++ME G L + L+
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 349 QRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-- 406
++ A +IA GM YL++ + +HRDL + N ++ KI DFG R+
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 407 -SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSS 464
V WM+PE +++ + D+WS+G+VLWE+ T E PY+ + + ++ V
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHL 502
L L P CPD LM+MCW P RPSF +I+S +
Sbjct: 253 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-55
Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 27/272 (9%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-----EIVAVKKVREQKETD-------- 299
+ F + +G G G V+ G L AVK + +
Sbjct: 24 PSSLIVHFNEV-----IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 300 IRHLRKLNHPNIVKFKGVCTQAP-CYCIVMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQ 357
++ +HPN++ G+C ++ +V+ Y +G L N ++ + + L + Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 358 IAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR-----EWNNKSTKMSFAGTV 412
+A GM +L SK+ +HRDL + N ++ K K++DFG R E+++ K V
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 413 AWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPS 471
WMA E ++ ++ + K D+WS+G++LWEL+T PY DV++ I + L P
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPE 257
Query: 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
CPD +M CW RPSF +++S +
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (108), Expect = 7e-06
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 177 VLIGSKEEAKISDFGTCR-----EWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
++ K K++DFG R E+++ K V WMA E ++ ++ + K D+W
Sbjct: 161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 185 bits (470), Expect = 8e-55
Identities = 58/269 (21%), Positives = 109/269 (40%), Gaps = 27/269 (10%)
Query: 260 FESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKV----------------REQKETDIR 301
+E+ + LG G V + + AVK + RE ++
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 302 HLRKLN-HPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAA 360
LRK++ HPNI++ K + +V + G L++ L + + + R +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 361 GMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
+ LH I+HRDLK N+L+ K++DFG + + GT +++APE+I
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 421 RNEQC------SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIP--ST 472
++D+WS G++++ LL P+ ++ + S + P
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
D + L+ P R + ++ L+H
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAH 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 41.6 bits (97), Expect = 1e-04
Identities = 13/59 (22%), Positives = 26/59 (44%), Gaps = 6/59 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC------SDKIDIW 229
+L+ K++DFG + + GT +++APE+I ++D+W
Sbjct: 141 ILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-54
Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 20/269 (7%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-----------IRHLRKLNHPNIVKFK 315
LG G+ G VF + + + A+K +++ HP +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
VMEY G L ++ + R +A +I G+ +LHSK I++RDL
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 129
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIWSY 434
K N+L+ KI+DFG C+E K +F GT ++APE++ ++ + +D WS+
Sbjct: 130 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189
Query: 435 GIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPS 494
G++L+E+L ++P+ D + + + P + L+ + P R
Sbjct: 190 GVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLG 247
Query: 495 FK-QILSH---LDIASQEVLRIQPEPYYK 519
+ I H +I +E+ R + +P ++
Sbjct: 248 VRGDIRQHPLFREINWEELERKEIDPPFR 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 6e-06
Identities = 17/55 (30%), Positives = 30/55 (54%), Gaps = 1/55 (1%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQCSDKIDIWY 230
+L+ KI+DFG C+E K +F GT ++APE++ ++ + +D W
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWS 188
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-53
Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 37/287 (12%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS---------EIVAVKKVREQKETD----- 299
WE+P + + + LG GA G V + VAVK ++
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 300 ---IRHLRKL-NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLK-------------- 341
+ ++ + H NI+ G CTQ +++EY + G L L+
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 342 --DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399
E++ + L + A Q+A GM YL SK+ IHRDL + NVL+ KI+DFG R+
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 400 NNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAI 456
++ + V WMAPE + + + + D+WS+G++LWE+ T
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
++ + + PS C + ++M+ CW PS RP+FKQ++ LD
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 51/294 (17%)
Query: 269 LGSGAQGAVFSGKLRSEIVAVKKVR------EQKETDIRHLRKLNHPNIVKFKGVCTQ-- 320
+G G G V+ GK R E VAVK +E +I L H NI+ F +
Sbjct: 11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 70
Query: 321 --APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS--------KQI 370
+V +Y +G L++ L V + + A A+G+ +LH I
Sbjct: 71 GTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 371 IHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-----FAGTVAWMAPEVIRNE-- 423
HRDLKS N+L+ I+D G ++ + + GT +MAPEV+ +
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 189
Query: 424 ----QCSDKIDIWSYGIVLWELLTCETPYK---------------DVDSSAIIWGVGSSS 464
+ + DI++ G+V WE+ + D + V
Sbjct: 190 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 249
Query: 465 LHLPIPST-----CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD-IASQEVLRI 512
L IP+ +M+ CW ++R + +I L ++ QE +++
Sbjct: 250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 303
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 4e-05
Identities = 19/121 (15%), Positives = 41/121 (33%), Gaps = 16/121 (13%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMS-----FAGTVAWMAPEVIRNE------QCSDK 225
+L+ I+D G ++ + + GT +MAPEV+ + + +
Sbjct: 139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198
Query: 226 IDIWYKNRLCFPTSLMARIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRSE 285
DI+ + +++++P+ + + V KLR
Sbjct: 199 ADIY-----AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 253
Query: 286 I 286
I
Sbjct: 254 I 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 2e-52
Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 37/287 (12%)
Query: 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVREQKETD------- 299
+WE P + + + LG GA G V VAVK ++E
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 300 --IRHLRKLNHPNIVKFKGVCTQ-APCYCIVMEYCAYGPLYNLLKDGEE----------- 345
+ +H N+V G CT+ +++E+C +G L L+
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 346 -----VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400
+ + L ++ Q+A GM +L S++ IHRDL + N+L+ K KI DFG R+
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 401 NKSTKM---SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAI 456
+ + WMAPE I + + + D+WS+G++LWE+ + +PY V
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 457 IWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503
+ P M CW PS RP+F +++ HL
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-50
Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 29/288 (10%)
Query: 261 ESISD----LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------------IR 301
E++ D + LGSG V + +S A K +++++ +
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 302 HLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAG 361
L+++ HPN++ V +++E A G L++ L + E + + + +QI G
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 362 MNYLHSKQIIHRDLKSPNVLI----GSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAP 417
+ YLHS QI H DLK N+++ K KI DFG + + + + GT ++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 418 EVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV--GSSSLHLPIPSTCPD 475
E++ E + D+WS G++ + LL+ +P+ + V + S
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 476 GFQLLMKMCWSNAPSSRPSFKQILSH---LDIASQEVL-RIQPEPYYK 519
+ ++ P R + + L H +Q+ L P ++
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 4e-06
Identities = 18/63 (28%), Positives = 29/63 (46%)
Query: 167 DALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKI 226
D E+I L K KI DFG + + + + GT ++APE++ E +
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 227 DIW 229
D+W
Sbjct: 198 DMW 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (439), Expect = 2e-50
Identities = 61/273 (22%), Positives = 101/273 (36%), Gaps = 29/273 (10%)
Query: 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD--------- 299
L D +E+ + LG G V + VAVK +R D
Sbjct: 4 HLSDRYEL-------GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRR 56
Query: 300 -IRHLRKLNHPNIVKFKGVC----TQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNW 354
++ LNHP IV P IVMEY L +++ + P+R
Sbjct: 57 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 116
Query: 355 ARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM----SFAG 410
+N+ H IIHRD+K N++I + K+ DFG R + + + G
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176
Query: 411 TVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP-- 468
T +++PE R + + D++S G VL+E+LT E P+ ++ + P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 469 IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
++ + P +R +
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (435), Expect = 3e-49
Identities = 66/260 (25%), Positives = 121/260 (46%), Gaps = 24/260 (9%)
Query: 262 SISD---LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD----------IRHLRKL 306
S+ D L+ LG+G+ G V + R A+K ++++ L +
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 307 NHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLH 366
HP I++ G A ++M+Y G L++LL+ + P +A ++ + YLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 367 SKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCS 426
SK II+RDLK N+L+ KI+DFG + + + + GT ++APEV+ + +
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKPYN 179
Query: 427 DKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486
ID WS+GI+++E+L TP+ D ++ + ++ L P + + L+ +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLIT 237
Query: 487 NAPSSR-----PSFKQILSH 501
S R + + +H
Sbjct: 238 RDLSQRLGNLQNGTEDVKNH 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.8 bits (95), Expect = 3e-04
Identities = 15/53 (28%), Positives = 27/53 (50%), Gaps = 2/53 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ KI+DFG + + + + GT ++APEV+ + + ID W
Sbjct: 135 ILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWW 185
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-48
Identities = 59/270 (21%), Positives = 122/270 (45%), Gaps = 36/270 (13%)
Query: 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------- 299
L ++++ LGSG G+V+SG S VA+K V + + +D
Sbjct: 2 LESQYQV-------GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 54
Query: 300 ---IRHLRKLN--HPNIVKFKGVCTQAPCYCIVMEYCA-YGPLYNLLKDGEEVPPQRLYN 353
+ L+K++ +++ + + +++E L++ + + + + +
Sbjct: 55 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLI-GSKEEAKISDFGTCREWNNKSTKMSFAGTV 412
+ Q+ + + H+ ++HRD+K N+LI ++ E K+ DFG+ + + F GT
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTR 173
Query: 413 AWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPS 471
+ PE IR + +WS GI+L++++ + P++ II G +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRG------QVFFRQ 225
Query: 472 TCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
Q L++ C + PS RP+F++I +H
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 3e-04
Identities = 13/54 (24%), Positives = 24/54 (44%), Gaps = 2/54 (3%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ-CSDKIDIW 229
++ ++ E K+ DFG+ + + F GT + PE IR + +W
Sbjct: 142 LIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 194
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 23/275 (8%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD----------IRHLRKLNHPNIVK 313
L+ LG G G V + ++ A+K +R++ R L+ HP +
Sbjct: 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
K C VMEY G L+ L +R + +I + + YLHS+ +++R
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 374 DLKSPNVLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 432
D+K N+++ KI+DFG C+E ++ +T +F GT ++APEV+ + +D W
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSR 492
G+V++E++ P+ + D + + + P T + L+ P R
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 493 PS-----FKQILSH---LDIASQEVLRIQPEPYYK 519
K+++ H L I Q+V++ + P +K
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFK 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 0.001
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 177 VLIGSKEEAKISDFGTCRE-WNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+++ KI+DFG C+E ++ +T +F GT ++APEV+ + +D W
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 4e-47
Identities = 46/255 (18%), Positives = 104/255 (40%), Gaps = 23/255 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-------------IRHLRKLNHPNIVK 313
+G G G V+ + ++ A+K + +++ + + + P IV
Sbjct: 12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71
Query: 314 FKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHR 373
+++ G L+ L + +A +I G+ ++H++ +++R
Sbjct: 72 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131
Query: 374 DLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD-KIDIW 432
DLK N+L+ +ISD G +++ K S GT +MAPEV++ D D +
Sbjct: 132 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWF 190
Query: 433 SYGIVLWELLTCETPYKDVDSSAIIW-GVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSS 491
S G +L++LL +P++ + + ++ + +P + + L++ +
Sbjct: 191 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 250
Query: 492 RPS-----FKQILSH 501
R +++
Sbjct: 251 RLGCLGRGAQEVKES 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (405), Expect = 2e-45
Identities = 49/276 (17%), Positives = 98/276 (35%), Gaps = 27/276 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-----IRHLRKLNH-PNIVKFKGVCTQ 320
+G G+ G +F G + VA+K + + R + L I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380
+V++ L G + + + A+Q+ A + +H K +++RD+K N
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 381 LIGSKE-----EAKISDFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNEQCSD 427
LIG + DFG + + + TK + +GT +M+ + S
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 428 KIDIWSYGIVLWELLTCETPY---KDVDSSAIIWGVGSSSLHLPI---PSTCPDGFQLLM 481
+ D+ + G V L P+ K + +G P+ + P+ F M
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 482 KMCWSNAPSSRPSFKQILSHLDIASQEVLRIQPEPY 517
+ A + P + + + + + E +
Sbjct: 253 HYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.3 bits (96), Expect = 2e-04
Identities = 10/52 (19%), Positives = 21/52 (40%), Gaps = 8/52 (15%)
Query: 186 KISDFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNEQCSDKIDIW 229
+ DFG + + + TK + +GT +M+ + S + D+
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLE 197
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 57/279 (20%), Positives = 109/279 (39%), Gaps = 44/279 (15%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD------------IRHLRKLNHPNI 311
L +LG G V+ + ++ +IVA+KK++ ++ I+ L++L+HPNI
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 312 VKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+ +V ++ + + + P + + G+ YLH I+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS-FAGTVAWMAPEVIRNEQCSD-KI 429
HRDLK N+L+ K++DFG + + + + + T + APE++ + +
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 430 DIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSS--------------------- 464
D+W+ G +L ELL + I +G+ +
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 465 --LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
LH + D L+ + N P +R + Q L
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFN-PCARITATQALKM 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-44
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 46/282 (16%)
Query: 266 LQWLGSGAQGAVFSGKLRS---EIVAVKKVREQKETD------------IRHLRKLNHPN 310
+ +G GA G VF + VA+K+VR Q + +RHL HPN
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 311 IVKFKGVCTQAP-----CYCIVMEYCAYGPL-YNLLKDGEEVPPQRLYNWARQIAAGMNY 364
+V+ VCT + +V E+ Y VP + + + Q+ G+++
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 365 LHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ 424
LHS +++HRDLK N+L+ S + K++DFG R ++ + S T+ + APEV+
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191
Query: 425 CSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLH-------------- 466
+ +D+WS G + E+ + ++ I+ +G
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251
Query: 467 -------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ + + L+ C + P+ R S LSH
Sbjct: 252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 7e-05
Identities = 15/53 (28%), Positives = 29/53 (54%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIW 229
+L+ S + K++DFG R ++ + S T+ + APEV+ + +D+W
Sbjct: 147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLW 199
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 1e-43
Identities = 47/260 (18%), Positives = 92/260 (35%), Gaps = 25/260 (9%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD-----IRHLRKLNHPNIVKFKGVC-TQ 320
+GSG+ G ++ G + E VA+K + + + + + + C +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNV 380
+VME + + + A Q+ + + Y+HSK IHRD+K N
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134
Query: 381 LIGSKE---EAKISDFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNEQCSDKI 429
L+G + I DFG +++ + T + GT + + + S +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 430 DIWSYGIVLWELLTCETPYKDVDSSAIIWGV------GSSSLHLPIPSTCPDGFQLLMKM 483
D+ S G VL P++ + ++ S+ + P F +
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 484 CWSNAPSSRPSFKQILSHLD 503
C S +P + +
Sbjct: 255 CRSLRFDDKPDYSYLRQLFR 274
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.9 bits (87), Expect = 0.002
Identities = 11/63 (17%), Positives = 21/63 (33%), Gaps = 8/63 (12%)
Query: 175 LGVLIGSKEEAKISDFGTCREWNNKSTKM--------SFAGTVAWMAPEVIRNEQCSDKI 226
L L I DFG +++ + T + GT + + + S +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 227 DIW 229
D+
Sbjct: 195 DLE 197
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 4e-43
Identities = 70/334 (20%), Positives = 133/334 (39%), Gaps = 44/334 (13%)
Query: 252 LRDEWEIPFESISDL------QWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---- 299
+WE P ++ + L + LG+G+ G V K + A+K + +QK
Sbjct: 26 FLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI 85
Query: 300 ------IRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYN 353
R L+ +N P +VK + +VMEY A G +++ L+
Sbjct: 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVA 413
+A QI YLHS +I+RDLK N+LI + +++DFG + + GT
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWTLCGTPE 203
Query: 414 WMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTC 473
+APE+I ++ + +D W+ G++++E+ P+ I + S + PS
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHF 261
Query: 474 PDGFQLLMKMCWSNAPSSR-----PSFKQILSHLDIASQEVLRIQPEPYYKM---QMIWK 525
+ L++ + R I +H ++ I++
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH--------------KWFATTDWIAIYQ 307
Query: 526 EEIRVHMLEMQANKSHVPKFEEFEDDLIKKRENE 559
++ + F+++E++ I+ NE
Sbjct: 308 RKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINE 341
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 63/282 (22%), Positives = 116/282 (41%), Gaps = 45/282 (15%)
Query: 264 SDLQWLGSGAQGAVFSGKLRS--EIVAVKKVR---EQKETDIRHLRKLNHPNIVKFKGVC 318
+D + +G+G+ G V+ KL E+VA+KKV K +++ +RKL+H NIV+ +
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 319 TQA------PCYCIVMEYCAYGPLYNLL---KDGEEVPPQRLYNWARQIAAGMNYLHSKQ 369
+ +V++Y + + +P + + Q+ + Y+HS
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 370 IIHRDLK-SPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSD- 427
I HRD+K +L K+ DFG+ ++ +S+ + + APE+I
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 428 KIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGSSSLH----------------- 466
ID+WS G VL ELL + + II +G+ +
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262
Query: 467 -------LPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ P T P+ L ++ P++R + + +H
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYT-PTARLTPLEACAH 303
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (376), Expect = 2e-41
Identities = 66/275 (24%), Positives = 108/275 (39%), Gaps = 39/275 (14%)
Query: 266 LQWLGSGAQGAVFSGKLRS-EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFK 315
L+ +G G G V+ + E A+KK+R +KE + I L++L H NIVK
Sbjct: 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375
V +V E+ L + ++ Q+ G+ Y H ++++HRDL
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 376 KSPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQ-CSDKIDIWS 433
K N+LI + E KI+DFG R + K T+ + AP+V+ + S IDIWS
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 434 YGIVLWELLTCETPYKDVDSS----AIIWGVGSSSLHLP--------------------- 468
G + E++ + V + I +G+ +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 469 --IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ L+ P+ R + KQ L H
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 41/274 (14%)
Query: 269 LGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKFKGV 317
+G G G V+ + + E+VA+KK+R ET+ I L++LNHPNIVK V
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 318 CTQAPCYCIVMEYCAYGPL-YNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLK 376
+V E+ + +P + ++ Q+ G+ + HS +++HRDLK
Sbjct: 70 IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 377 SPNVLIGSKEEAKISDFGTCREWNNKSTKM-SFAGTVAWMAPEVIRNEQ-CSDKIDIWSY 434
N+LI ++ K++DFG R + T+ + APE++ + S +DIWS
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 435 GIVLWELLTCETPYKDVDSSA----IIWGVGSSSLHL----------------------- 467
G + E++T + I +G+ +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+ + + L+ P+ R S K L+H
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 70/278 (25%), Positives = 111/278 (39%), Gaps = 43/278 (15%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKF 314
L+ +G G G VF K R EIVA+K+VR + + I L++L H NIV+
Sbjct: 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 315 KGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374
V +V E+C ++ P+ + ++ Q+ G+ + HS+ ++HRD
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126
Query: 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAG-TVAWMAPEVIRNEQCSD-KIDIW 432
LK N+LI E K+++FG R + S T+ + P+V+ + ID+W
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186
Query: 433 SYGIVLWELLTCETPY-----------------------------KDVDSSAIIWGVGSS 463
S G + EL P K D ++
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 464 SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
SL +P G LL + N P R S ++ L H
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCN-PVQRISAEEALQH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 70/328 (21%), Positives = 119/328 (36%), Gaps = 57/328 (17%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD--------IRHLRKLNHPNIVKFK 315
L ++G GA G V S VA+KK+ + I+ L + H NI+
Sbjct: 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 316 GVCTQAPC----YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQII 371
+ ++ + LY LLK + + + QI G+ Y+HS ++
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSANVL 131
Query: 372 HRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTV----AWMAPEVIRNEQCSD 427
HRDLK N+L+ + + KI DFG R + F + APE++ N +
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 428 -KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV-------------------------- 460
IDIWS G +L E+L+ + + +
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251
Query: 461 ----GSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH------LDIASQEVL 510
+ P+ LL KM N P R +Q L+H D + + +
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFN-PHKRIEVEQALAHPYLEQYYDPSDEPIA 310
Query: 511 RIQPEPYYKMQMIWKEEIRVHMLEMQAN 538
+ ++ + KE+++ + E A
Sbjct: 311 EAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-39
Identities = 58/264 (21%), Positives = 107/264 (40%), Gaps = 28/264 (10%)
Query: 266 LQWLGSGAQGAVFSGKLRS-----EIVAVKKVREQKETD-----------IRHLRKLNH- 308
L+ LG+GA G VF + S ++ A+K +++ + L +
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 309 PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
P +V ++++Y G L+ L E + + +I + +LH
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS--FAGTVAWMAPEVIRNEQCS 426
II+RD+K N+L+ S ++DFG +E+ T+ + F GT+ +MAP+++R
Sbjct: 149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 208
Query: 427 D--KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV--GSSSLHLPIPSTCPDGFQLLMK 482
+D WS G++++ELLT +P+ + P P + L++
Sbjct: 209 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ 268
Query: 483 MCWSNAPSSRPSF-----KQILSH 501
P R +I H
Sbjct: 269 RLLMKDPKKRLGCGPRDADEIKEH 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 9e-39
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 61/305 (20%)
Query: 257 EIPF-ESISD---LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IR 301
E PF + +S L +G G G VF + R + VA+KKV + E + I+
Sbjct: 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 302 HLRKLNHPNIVKFKGVCTQAP--------CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYN 353
L+ L H N+V +C +V ++C + L + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 354 WARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM-----SF 408
+ + G+ Y+H +I+HRD+K+ NVLI K++DFG R ++ +
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 409 AGTVAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETPYKDVDS----SAIIWGVGS- 462
T+ + PE++ E+ ID+W G ++ E+ T + + I GS
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 463 --------------------------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFK 496
L P L+ K+ + P+ R
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD-PAQRIDSD 300
Query: 497 QILSH 501
L+H
Sbjct: 301 DALNH 305
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 5e-04
Identities = 15/59 (25%), Positives = 26/59 (44%), Gaps = 6/59 (10%)
Query: 177 VLIGSKEEAKISDFGTCREWNNKSTKM-----SFAGTVAWMAPEVIRNEQ-CSDKIDIW 229
VLI K++DFG R ++ + T+ + PE++ E+ ID+W
Sbjct: 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 82/344 (23%), Positives = 143/344 (41%), Gaps = 31/344 (9%)
Query: 243 RIGEFKSFVLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD- 299
R G ++ V + WE+ DLQ +GSGA GAV S VA+KK+ +++
Sbjct: 1 RSGFYRQEVTKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 59
Query: 300 --------IRHLRKLNHPNIVKFKGVCTQAPC------YCIVMEYCAYGPLYNLLKDGEE 345
+R L+ + H N++ V T + +VM + G L E+
Sbjct: 60 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK 117
Query: 346 VPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405
+ R+ Q+ G+ Y+H+ IIHRDLK N+ + E KI DFG R+ +++ T
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT- 176
Query: 406 MSFAGTVAWMAPEVIRNEQCSD-KIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSS 464
+ T + APEVI N +DIWS G ++ E++T +T +K D + + +
Sbjct: 177 -GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 465 LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEVLR--IQPEPYYKMQM 522
P + F IL++ + +L + + ++
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 523 IWKEEIRVH-MLEMQANKSHVPKFEEFED--DLIKKRENELKHA 563
E H E + P+ ++++D D + + +E K
Sbjct: 296 ---GEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 9e-36
Identities = 50/298 (16%), Positives = 103/298 (34%), Gaps = 53/298 (17%)
Query: 254 DEWEIPFESISD---LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETDIRH----LR 304
+ + + + D ++ LG G VF + E V VK ++ K+ I+ L
Sbjct: 25 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE 84
Query: 305 KLN-HPNIVKFKGVCTQAP--CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAG 361
L PNI+ + +V E+ L + + + + +I
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA 141
Query: 362 MNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 420
++Y HS I+HRD+K NV+I + + ++ D+G ++ + + PE++
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 421 RNEQCSD-KIDIWSYGIVLWELLTCETPYKDVDSSA-----IIWGVGS------------ 462
+ Q D +D+WS G +L ++ + P+ + I +G+
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 463 -------------------SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH 501
+H + SR + ++ + H
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 37.9 bits (87), Expect = 0.003
Identities = 11/81 (13%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 157 YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216
Y G D ++ ++ + ++ D+G ++ + + PE+
Sbjct: 144 YCHSMGIMHRDVKPHNV---MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 217 IRNEQCSD-KIDIWYKNRLCF 236
+ + Q D +D+W +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLA 221
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-34
Identities = 61/253 (24%), Positives = 99/253 (39%), Gaps = 21/253 (8%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IRHLRKLNHPNIVKF 314
L+ +GSGAQG V + VA+KK+ + + ++ +NH NI+
Sbjct: 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 315 KGVCTQAPC------YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK 368
V T +VME + E+ +R+ Q+ G+ +LHS
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 369 QIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDK 428
IIHRDLK N+++ S KI DFG R + T + APEVI +
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 429 IDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488
+DIWS G ++ E++ + + D V L P P + +
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCPEFMKKLQPTVRNYVENRP 257
Query: 489 PSSRPSFKQILSH 501
+ +F ++
Sbjct: 258 KYAGLTFPKLFPD 270
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 79/335 (23%), Positives = 129/335 (38%), Gaps = 57/335 (17%)
Query: 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLRS--EIVAVKKVREQKETD---------IR 301
+ WE+P E +L +GSGA G+V + VAVKK+ ++ +R
Sbjct: 11 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 302 HLRKLNHPNIVKFKGVCTQAPC-----YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWAR 356
L+ + H N++ V T A ++ + L N++K + +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-Y 128
Query: 357 QIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMA 416
QI G+ Y+HS IIHRDLK N+ + E KI DFG R +++ T T + A
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--TRWYRA 186
Query: 417 PEVIRNEQCSD-KIDIWSYGIVLWELLTCETPYKDVDSS----AIIWGVGSSSLHLP--- 468
PE++ N + +DIWS G ++ ELLT T + D I+ VG+ L
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 469 -----------------------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSH---- 501
P LL KM + R + Q L+H
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD-SDKRITAAQALAHAYFA 305
Query: 502 -LDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEM 535
E + + ++ + + +E + +
Sbjct: 306 QYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 340
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 2e-22
Identities = 64/357 (17%), Positives = 112/357 (31%), Gaps = 90/357 (25%)
Query: 266 LQWLGSGAQGAVFSGKLRS--EIVAVKKVR------EQKETDIRHLRKLNHPNIVKFKGV 317
++ LG G V+ K VA+K VR E E +I+ L+++N + K +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 318 CTQAP---------------CYCIVMEYCAYGPLYNLLKDGEE-VPPQRLYNWARQIAAG 361
+V E L + K +P + ++Q+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 362 MNYLHSKQ-IIHRDLKSPNVLIGSKEE----AKISDFGTCREWNNKSTKMSFAGTVAWMA 416
++Y+H + IIH D+K NVL+ + +I + T + +
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 417 PEVIRNEQCSDKIDIWSYGIVLWELLTCETPY---------KDVDSSAIIWGVGSS---- 463
PEV+ DIWS +++EL+T + + KD D A I +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 464 ---------------------------------SLHLPIPSTCPDGFQLLMKMCWSNAPS 490
+ + P
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317
Query: 491 SRPSFKQILSHLDIASQEVLRIQPEPYYKMQMIWKEEIRVHMLEMQANKSHVPKFEE 547
R +++H P+ K + EEIRV E+ + S +P + E
Sbjct: 318 KRADAGGLVNH--------------PWLK-DTLGMEEIRVPDRELYGSGSDIPGWFE 359
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 1e-17
Identities = 35/194 (18%), Positives = 57/194 (29%), Gaps = 46/194 (23%)
Query: 269 LGSGAQGAVFSGKLRS-EIVAVKKVR-------------------------EQKETDIRH 302
+G G + AVF+ VK + + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 303 LRKLNHPNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGM 362
L+KL + K ++ME LY + + + I +
Sbjct: 68 LQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRVRVENPD-------EVLDMILEEV 116
Query: 363 NYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR- 421
+ + I+H DL NVL+ S+E I DF E + + V I
Sbjct: 117 AKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDV-----RNIIT 170
Query: 422 --NEQCSDKIDIWS 433
+ + DI S
Sbjct: 171 YFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 600 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.73 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.72 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.72 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.72 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.71 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.7 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.7 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.7 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.69 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.69 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.69 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.69 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.68 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.68 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.68 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.68 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.68 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.67 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.67 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.66 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.66 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.66 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.65 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.65 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.64 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.64 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.63 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.63 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.62 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.62 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.62 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.61 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.61 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.61 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.6 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.6 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.6 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.6 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.59 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.59 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.58 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.58 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.57 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.57 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.55 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.51 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.5 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.49 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.47 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.47 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.47 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.45 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.44 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.42 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.4 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.39 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.38 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.32 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.29 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.26 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.24 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.2 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.25 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.85 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 81.16 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=447.05 Aligned_cols=244 Identities=27% Similarity=0.508 Sum_probs=223.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++.+.||+|+||+||+|+.. ++.||+|++.+ .+.+|+.++++++|||||++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999875 68999999852 2357999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~ 164 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTL 164 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEET
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-cccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999998765432 3456
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
.||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ..+|..+|+++++||.+||+.|
T Consensus 165 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp TEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHHHHHHccCC
Confidence 89999999999999999999999999999999999999999998888887776654 3567889999999999999999
Q ss_pred CCCCCCHHHHHHcHhhhhh
Q psy16430 489 PSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~~ 507 (600)
|.+|||++|+|+|||+.+.
T Consensus 243 p~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 243 PSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp GGGSCCHHHHHTCHHHHHH
T ss_pred HhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=444.79 Aligned_cols=246 Identities=29% Similarity=0.421 Sum_probs=215.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++++.||+|+||+||+|++. ++.||||++.. .+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 67999999999999999999875 78999999842 346899999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---CCcc
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS---TKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~ 407 (600)
|+||+|.+++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ...+
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 9999999999988899999999999999999999999999999999999999999999999999998764332 2345
Q ss_pred cCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChH-HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 408 FAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSS-AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.+||+.|||||++.+..+ +.++|||||||++|||++|++||...... .............+.+..+|+++.+||.+||
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHc
Confidence 789999999999988776 57899999999999999999999765543 2233333333333444678999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~ 506 (600)
+.||.+|||++|+++||||..
T Consensus 245 ~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 245 VENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp CSSTTTSCCHHHHTTCTTTTC
T ss_pred CCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999853
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=446.53 Aligned_cols=246 Identities=27% Similarity=0.486 Sum_probs=220.4
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
.++|++++.||+|+||+||+|+.. ++.||||++.. .+.+|+.+|++++|||||++++++.+.+.+|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999864 79999999853 246899999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~ 409 (600)
|+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... .....+
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 177 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccc
Confidence 999999998865 469999999999999999999999999999999999999999999999999998875433 344578
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS-SSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+.. .....+.|..+|+.+++||.+||+.|
T Consensus 178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 257 (293)
T d1yhwa1 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (293)
T ss_dssp SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSS
T ss_pred cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999998887766655443 33445567789999999999999999
Q ss_pred CCCCCCHHHHHHcHhhhh
Q psy16430 489 PSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 489 P~~RPs~~elL~~l~~~~ 506 (600)
|.+|||+.|+|+|+|+..
T Consensus 258 P~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 258 VEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TTTSCCHHHHTTCGGGGG
T ss_pred hhHCcCHHHHhcCHhhCC
Confidence 999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-54 Score=448.10 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=210.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc--------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ--------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~--------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+.|++.+.||+|+||+||+|+.. ++.||||++... +.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56999999999999999999875 789999998532 34799999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC---CCCCceeeccCccccccCCCCCcc
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG---SKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|+||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.........+
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 168 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence 99999999998888999999999999999999999999999999999999995 468999999999987766555566
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHHHHHHhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~LI~~cL 485 (600)
.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+.......+.......+ .+..+|+.+.+||.+||
T Consensus 169 ~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 248 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248 (307)
T ss_dssp ----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred eeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHc
Confidence 7899999999999999999999999999999999999999999988888877776665443 44678999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||+.|+++|||+...
T Consensus 249 ~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 249 EKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CSSGGGSCCHHHHHHSTTTTSS
T ss_pred cCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=440.54 Aligned_cols=252 Identities=38% Similarity=0.626 Sum_probs=212.4
Q ss_pred ccccccccccccccccCCCCcceEEEeEeeceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
|+|+|+.++|++.+.||+|+||+||+|++.+ .||||+++. .+.+|+.+|++++|||||++++++.+ +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 5799999999999999999999999998765 599999852 34579999999999999999998754 568
Q ss_pred eEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
++|||||+||+|.+++.. +..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999999999865 4679999999999999999999999999999999999999999999999999998765322
Q ss_pred ---CCcccCCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHH-hcCCCCC---CCCCCCC
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWG-VGSSSLH---LPIPSTC 473 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~-i~~~~~~---~~~p~~~ 473 (600)
...+..||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+....... +..+... ...+..+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 2235679999999999864 3578999999999999999999999998766544433 3222222 2356788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 474 PDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 474 ~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
|+.+.+||.+||+.||.+|||+.+|+++++....
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999875443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=450.00 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=214.5
Q ss_pred cccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCceeE
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~l 326 (600)
++..++|++++.||+|+||+||+|+.. ++.||+|+++. .+.+|+.+|++++|||||+++++|.++..+|+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 566789999999999999999999975 79999999853 23579999999999999999999999999999
Q ss_pred EEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCCceeeccCccccccCCCCC
Q psy16430 327 VMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 405 (600)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~ 160 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-A 160 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-C
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-c
Confidence 99999999999999888889999999999999999999997 599999999999999999999999999998765432 3
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhc------------------------
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVG------------------------ 461 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~------------------------ 461 (600)
.+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.........
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 45789999999999999999999999999999999999999998765432211000
Q ss_pred -----------------CCCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhhhh
Q psy16430 462 -----------------SSSLHLPIP-STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQEV 509 (600)
Q Consensus 462 -----------------~~~~~~~~p-~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~~~ 509 (600)
.....+..+ ..+|.++.+||.+||..||.+|||++|+|+|||+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 000011112 246789999999999999999999999999999976543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=440.39 Aligned_cols=244 Identities=26% Similarity=0.448 Sum_probs=207.2
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeec--CCceeE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQ--APCYCI 326 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~--~~~~~l 326 (600)
.++|++++.||+|+||+||+|+.. ++.||+|++... +.+|+++|++++|||||++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 378999999999999999999865 789999998532 3579999999999999999999854 456899
Q ss_pred EEeeeccccchhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhCC-----ccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 327 VMEYCAYGPLYNLLKD----GEEVPPQRLYNWARQIAAGMNYLHSKQ-----IIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 327 V~Ey~~ggsL~~~l~~----~~~l~~~~i~~i~~qIl~aL~~LH~~g-----IvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
|||||+||+|.+++.+ ++.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999998853 467999999999999999999999976 9999999999999999999999999998
Q ss_pred cccCCC-CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 398 EWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 398 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
...... ...+..||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..++...+..+... ++|..+|++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHH
Confidence 875433 334578999999999999999999999999999999999999999999888888777666543 567889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.+||.+||+.||.+|||++|+++|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-54 Score=445.47 Aligned_cols=243 Identities=30% Similarity=0.499 Sum_probs=219.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
+.|+.++.||+|+||+||+|+.. ++.||||++.. .+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999864 78999999853 2457999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
|||+||+|..++..++++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~ 171 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSF 171 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Ccc
Confidence 99999999888777788999999999999999999999999999999999999999999999999999865432 356
Q ss_pred CCCccccChhhhcc---CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 409 AGTVAWMAPEVIRN---EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 409 ~gt~~Y~APE~l~~---~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
.||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+.......+.........+..+|+.+++||.+||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 89999999999864 458899999999999999999999999988888877776666655666789999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~ 506 (600)
+.||.+|||++++|+|||+..
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHS
T ss_pred cCChhHCcCHHHHHhCHHhcC
Confidence 999999999999999999965
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=441.85 Aligned_cols=245 Identities=29% Similarity=0.483 Sum_probs=217.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+.|++++.||+|+||+||+|++. +..||||++.. .+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999875 68999999853 3568999999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcccC
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMSFA 409 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~ 409 (600)
+||+|.+++.+ .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ....+..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~ 171 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccc
Confidence 99999998754 567999999999999999999999999999999999999999999999999999765432 2223578
Q ss_pred CCccccChhhhc-----cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC-CCCCCCCCcHHHHHHHHH
Q psy16430 410 GTVAWMAPEVIR-----NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL-HLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 410 gt~~Y~APE~l~-----~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~ 483 (600)
||+.|+|||++. +..|+.++|||||||++|+|+||++||.+.+..+....+..... ....|..+|+++++||++
T Consensus 172 Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~ 251 (288)
T d2jfla1 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251 (288)
T ss_dssp SCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 999999999984 45688999999999999999999999999888777776655443 344567889999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~ 505 (600)
||+.||.+|||++|+++|||+.
T Consensus 252 ~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 252 CLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp HSCSSTTTSCCHHHHTTSGGGC
T ss_pred HccCChhHCcCHHHHhcCcccC
Confidence 9999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=441.52 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=218.6
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++++.||+|+||+||+|+.. ++.||||++.. .+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 478999999999999999999875 78999999853 245799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC---C
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS---T 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~ 404 (600)
||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
..+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+..... .+|..+++.+++||++|
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--CCCTTCCHHHHHHHHTT
T ss_pred cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHH
Confidence 3356899999999999999999999999999999999999999999988888887776653 46788999999999999
Q ss_pred hhcCCCCCCCHHHH------HHcHhhhh
Q psy16430 485 WSNAPSSRPSFKQI------LSHLDIAS 506 (600)
Q Consensus 485 L~~dP~~RPs~~el------L~~l~~~~ 506 (600)
|+.||.+|||++|+ ++||||..
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999885 66666654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=439.46 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=224.3
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-------------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
+.|++++.||+|+||+||+|+.. ++.||||++.+ .+.+|+.+|++++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56999999999999999999975 78999998842 2468999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC----CceeeccCccccccC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE----EAKISDFGTCREWNN 401 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~----~vkL~DFGla~~~~~ 401 (600)
+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999998888899999999999999999999999999999999999998776 499999999998776
Q ss_pred CCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQL 479 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~ 479 (600)
.....+..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......+ .+..+|+.+++
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence 6666677899999999999999999999999999999999999999999998888887776655433 34678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||++||+.||.+|||++|+++|+|+...
T Consensus 250 li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 250 FIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-53 Score=435.97 Aligned_cols=250 Identities=34% Similarity=0.639 Sum_probs=219.5
Q ss_pred cccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCce
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.+.|+|+.++|++.+.||+|+||+||+|++. ++.||||+++. .+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 4679999999999999999999999999875 68999999853 356899999999999999999999999999
Q ss_pred eEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 325 CIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|+|||||++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999999864 357899999999999999999999999999999999999999999999999999876544
Q ss_pred CCC--cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCC-CCCCChHHHHHHhcCCCCCCCCCCCCcHHHHH
Q psy16430 403 STK--MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETP-YKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQL 479 (600)
Q Consensus 403 ~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~P-f~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 479 (600)
... ....||+.|+|||++.+..++.++|||||||++|||++|..| |.+.+...+... ......++.|..+|+.+.+
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHHHH
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH-HhcCCCCCCCccchHHHHH
Confidence 322 234588999999999999999999999999999999996555 455555544443 3445667888899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
||.+||+.||.+|||+.+|++.+.
T Consensus 248 li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHH
Confidence 999999999999999999988663
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=443.26 Aligned_cols=248 Identities=25% Similarity=0.454 Sum_probs=226.5
Q ss_pred ccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
|..++|++++.||+|+||.||+|+.. ++.||||++++. ..+|+.+|++++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45689999999999999999999864 789999998632 357999999999999999999999999999
Q ss_pred EEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC-CCC
Q psy16430 326 IVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN-KST 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-~~~ 404 (600)
+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999987654 334
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...+...+.... ..+|..+|+++++||++|
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHhh
Confidence 456789999999999999999999999999999999999999999999888887776665 356788999999999999
Q ss_pred hhcCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 485 WSNAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 485 L~~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
|++||.+||+ ++++++||||...
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999994 9999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-53 Score=445.85 Aligned_cols=248 Identities=22% Similarity=0.364 Sum_probs=223.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
++|++++.||+|+||.||+|+.. ++.||||++... +.+|+.+|++++|||||++++++.+.+.+|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 68999999999999999999865 799999998542 357999999999999999999999999999999999
Q ss_pred ccccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC--CCCceeeccCccccccCCCCCccc
Q psy16430 332 AYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS--KEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
+||+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.........+.
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 9999999885 4567999999999999999999999999999999999999964 578999999999988766666678
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHHHHHHhhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~LI~~cL~ 486 (600)
.||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+ ....+|+.+++||.+||+
T Consensus 186 ~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 265 (350)
T d1koaa2 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 265 (350)
T ss_dssp CSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCC
T ss_pred cCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 899999999999999999999999999999999999999999988888887766654433 235689999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQE 508 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~~ 508 (600)
.||.+|||+.|+|+|||+....
T Consensus 266 ~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 266 ADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp SSGGGSCCHHHHHHSTTTSCTT
T ss_pred CChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999997654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=441.82 Aligned_cols=250 Identities=33% Similarity=0.590 Sum_probs=222.7
Q ss_pred ccccccccccccccccCCCCcceEEEeEeec-------eEEEeeeecc--------chHHHHHHHHhc-CCCCcccccce
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGV 317 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~ 317 (600)
..|+|+.++|++.+.||+|+||+||+|++.+ ..||+|.+.. .+.+|+.+|+++ +|||||+++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 4689999999999999999999999998653 4699998853 245799999998 89999999999
Q ss_pred eecCCceeEEEeeeccccchhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccC
Q psy16430 318 CTQAPCYCIVMEYCAYGPLYNLLKDG-----------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRD 374 (600)
Q Consensus 318 ~~~~~~~~lV~Ey~~ggsL~~~l~~~-----------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrD 374 (600)
+.+.+..|+|||||+||+|.++++.. ..+++..++.++.||+.||.|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999653 2488999999999999999999999999999
Q ss_pred CCCCCcccCCCCCceeeccCccccccCCCCC---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCC
Q psy16430 375 LKSPNVLIGSKEEAKISDFGTCREWNNKSTK---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKD 450 (600)
Q Consensus 375 IKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~ 450 (600)
|||+|||++.++.+||+|||+|+........ .+..||+.|||||++.+..++.++|||||||++|||+| |.+||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544322 24568999999999999999999999999999999998 8999998
Q ss_pred CChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 451 VDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 451 ~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+....+..+.....+++.|..+|+.+.+||.+||+.||++|||+++|++||.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 87766666666677778889999999999999999999999999999999984
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=429.76 Aligned_cols=250 Identities=32% Similarity=0.607 Sum_probs=219.8
Q ss_pred cccccccccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 251 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
...++|+|+.++|++.+.||+|+||.||+|+++ +..||||+++. .+.+|+.+|++++|||||+++|++.+ +.
T Consensus 3 ~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 356899999999999999999999999999986 47899999863 35689999999999999999998865 56
Q ss_pred eeEEEeeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 78999999999999977653 3599999999999999999999999999999999999999999999999999987754
Q ss_pred CC--CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 402 KS--TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 402 ~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.......+..+ ..++.|..+|+.+.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~ 240 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELY 240 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCcccChHHHH
Confidence 32 2234678999999999998899999999999999999999 56666777777666666544 45677889999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
+||.+||+.||++|||+++|++.+
T Consensus 241 ~li~~cl~~~P~~Rpt~~ei~~~L 264 (272)
T d1qpca_ 241 QLMRLCWKERPEDRPTFDYLRSVL 264 (272)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHh
Confidence 999999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=429.66 Aligned_cols=241 Identities=27% Similarity=0.437 Sum_probs=208.8
Q ss_pred cccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec----CCceeEE
Q psy16430 263 ISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ----APCYCIV 327 (600)
Q Consensus 263 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~----~~~~~lV 327 (600)
|++.+.||+|+||+||+|++. +..||+|++.. .+.+|+++|++++|||||++++++.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999875 67899998853 24579999999999999999999854 4568999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCCcccC-CCCCceeeccCccccccCCCC
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQ--IIHRDLKSPNVLIG-SKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~g--IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~ 404 (600)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+..... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~ 169 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-F 169 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-S
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-c
Confidence 999999999999988888999999999999999999999998 99999999999997 4789999999999864432 3
Q ss_pred CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh-HHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS-SAIIWGVGSSSLHLPIPSTCPDGFQLLMKM 483 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 483 (600)
..+.+||+.|||||++.+ .++.++|||||||++|||++|+.||.+... ..+...+..+......+..+++++++||.+
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence 346789999999999865 699999999999999999999999987654 444455555544445667789999999999
Q ss_pred hhhcCCCCCCCHHHHHHcHhhh
Q psy16430 484 CWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 484 cL~~dP~~RPs~~elL~~l~~~ 505 (600)
||+.||++|||++|+|+||||.
T Consensus 249 ~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 249 CIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGC
T ss_pred HccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999973
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.1e-53 Score=444.07 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=223.9
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------hHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
+++|++++.||+|+||.||+|+.. ++.||||++... +.+|+.+|++++|||||+++++|.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 367999999999999999999864 789999998642 35799999999999999999999999999999999
Q ss_pred eccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC--CCCCceeeccCccccccCCCCCcc
Q psy16430 331 CAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG--SKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~--~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|+||+|.+.+.. +.++++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 999999887765 44799999999999999999999999999999999999998 568999999999998876666667
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCCCcHHHHHHHHHhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~LI~~cL 485 (600)
..||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+.......+.......+ .+..+|+++.+||.+||
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 267 (352)
T d1koba_ 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267 (352)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTS
T ss_pred ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 7899999999999999999999999999999999999999999998888877766654433 44678999999999999
Q ss_pred hcCCCCCCCHHHHHHcHhhhhh
Q psy16430 486 SNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~~~~~ 507 (600)
+.||.+|||+.|+|+|+|+...
T Consensus 268 ~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 268 QKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSGGGSCCHHHHHTSTTTSSC
T ss_pred cCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-52 Score=426.82 Aligned_cols=246 Identities=22% Similarity=0.377 Sum_probs=222.3
Q ss_pred ccccccccccCCCCcceEEEeEe--eceEEEeeeecc----------------chHHHHHHHHhcC-CCCcccccceeec
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKL--RSEIVAVKKVRE----------------QKETDIRHLRKLN-HPNIVKFKGVCTQ 320 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~----------------~~~~Ei~~L~~L~-HpnIv~l~~~~~~ 320 (600)
+++|++.+.||+|+||+||+|+. +++.||||++.. .+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 37899999999999999999987 469999999853 2457999999997 9999999999999
Q ss_pred CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
++.+|||||||+||+|.++++..+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCcccCCCccccChhhhcc------CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCC--CCCC
Q psy16430 401 NKSTKMSFAGTVAWMAPEVIRN------EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLP--IPST 472 (600)
Q Consensus 401 ~~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~ 472 (600)
.........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+..+....+ ....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 6655566789999999999864 3467899999999999999999999999998888777766655443 3357
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
+|+++++||.+||+.||.+|||++|+++|+|+.
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 899999999999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-52 Score=433.21 Aligned_cols=243 Identities=26% Similarity=0.447 Sum_probs=223.2
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHHhcCCCCcccccceeecCCceeEEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVM 328 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~ 328 (600)
++|++++.||+|+||+||+|+.. ++.||||++++. +.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 68999999999999999999865 789999998532 357999999999999999999999999999999
Q ss_pred eeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCccc
Q psy16430 329 EYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
|||+||+|..++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... ..+.
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~ 161 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTL 161 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876543 3457
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+..+.. ..|..+|+++.++|.+||..|
T Consensus 162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSC
T ss_pred cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhC
Confidence 899999999999999999999999999999999999999999998888887776653 456789999999999999999
Q ss_pred CCCCC-----CHHHHHHcHhhhhh
Q psy16430 489 PSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 489 P~~RP-----s~~elL~~l~~~~~ 507 (600)
|.+|| |++++++|||+...
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccccchhhHHHHHcCcccccC
Confidence 99996 99999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=419.91 Aligned_cols=245 Identities=30% Similarity=0.572 Sum_probs=208.7
Q ss_pred ccccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
|+.++|++++.||+|+||+||+|++. ++.||||+++. .+.+|++++++++|||||+++|++..++..++||||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 45688999999999999999999975 57899999863 356899999999999999999999999999999999
Q ss_pred eccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--Ccc
Q psy16430 331 CAYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--KMS 407 (600)
Q Consensus 331 ~~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~ 407 (600)
|++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....... ...
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999999988654 5689999999999999999999999999999999999999999999999999987654332 224
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
..||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..++...+..+ ...+.|..+|+.+.+||.+||+
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHHHHHHcc
Confidence 678999999999999999999999999999999999 67778777777777666554 4556788899999999999999
Q ss_pred cCCCCCCCHHHHHHcHh
Q psy16430 487 NAPSSRPSFKQILSHLD 503 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~ 503 (600)
.||.+|||+++|++++.
T Consensus 241 ~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 241 ERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp SSGGGSCCHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHH
Confidence 99999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-52 Score=426.23 Aligned_cols=247 Identities=33% Similarity=0.625 Sum_probs=209.6
Q ss_pred ccccccccccccccCCCCcceEEEeEee--c---eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--S---EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~---~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
.+++.++|++.+.||+|+||+||+|++. + ..||||.+.. .+.+|+.+|++++|||||+++|++.+.+
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 3567789999999999999999999864 2 3689998742 3568999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+|+|||||+||+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999998876 45799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC------cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCc
Q psy16430 402 KSTK------MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCP 474 (600)
Q Consensus 402 ~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 474 (600)
.... ....||+.|||||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+ ..++.|..+|
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCccch
Confidence 3221 12457899999999999999999999999999999998 89999999888887777554 4567788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.+.+||.+||+.||.+|||+.+|++.+.
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=415.74 Aligned_cols=243 Identities=31% Similarity=0.558 Sum_probs=219.9
Q ss_pred cccccccccccCCCCcceEEEeEee-ceEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+.++|++.+.||+|+||+||+|+++ +..||||+++. .+.+|+.++++++||||++++|++.+++.+++||||+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 4578999999999999999999986 56899999863 3468999999999999999999999999999999999
Q ss_pred ccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC--Cccc
Q psy16430 332 AYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST--KMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~ 408 (600)
++|+|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 99999998654 45789999999999999999999999999999999999999999999999999987654332 2346
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
.||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+ ...+.|..+|+.+.+||.+||+.
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccccHHHHHHHHHHccC
Confidence 78999999999999999999999999999999998 89999999998888877664 46678899999999999999999
Q ss_pred CCCCCCCHHHHHHcH
Q psy16430 488 APSSRPSFKQILSHL 502 (600)
Q Consensus 488 dP~~RPs~~elL~~l 502 (600)
||++|||+++|++|+
T Consensus 241 dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 241 KADERPTFKILLSNI 255 (258)
T ss_dssp SGGGSCCHHHHHHHH
T ss_pred CHhHCcCHHHHHHHh
Confidence 999999999999997
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=432.22 Aligned_cols=248 Identities=19% Similarity=0.283 Sum_probs=223.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcCCCCcccccceeecCCceeEEEeee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYC 331 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~ 331 (600)
+++|++++.||+|+||+||+|.+. ++.||||+++.. +.+|+.+|++++|||||++++++.+++.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 478999999999999999999865 789999999643 358999999999999999999999999999999999
Q ss_pred ccccchhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC--CCceeeccCccccccCCCCCccc
Q psy16430 332 AYGPLYNLLKDGE-EVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK--EEAKISDFGTCREWNNKSTKMSF 408 (600)
Q Consensus 332 ~ggsL~~~l~~~~-~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~--~~vkL~DFGla~~~~~~~~~~~~ 408 (600)
+||+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+ ..+||+|||++............
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999997654 79999999999999999999999999999999999999854 47999999999887665555567
Q ss_pred CCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCC--CCCCcHHHHHHHHHhhh
Q psy16430 409 AGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPI--PSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~LI~~cL~ 486 (600)
.+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+......++. +..+|+++++||++||.
T Consensus 164 ~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 243 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred ccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHcc
Confidence 8999999999999999999999999999999999999999999998888888776654432 24789999999999999
Q ss_pred cCCCCCCCHHHHHHcHhhhhh
Q psy16430 487 NAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~elL~~l~~~~~ 507 (600)
.||.+|||++|+++|||+...
T Consensus 244 ~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 244 KERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SSGGGSCCHHHHHHSHHHHSC
T ss_pred CChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=434.22 Aligned_cols=244 Identities=24% Similarity=0.384 Sum_probs=223.3
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCCceeEE
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
.++|++++.||+|+||.||+|++. ++.||||++.+ .+.+|+++|+.++|||||++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 478999999999999999999875 78999999853 235799999999999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCcc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKMS 407 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 407 (600)
|||+.||+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..... ..+
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999877543 335
Q ss_pred cCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhc
Q psy16430 408 FAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSN 487 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 487 (600)
..||+.|||||++.+..++.++|||||||++|+|+||..||.+.+.......+..... ..|..+|+++.+||++||+.
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCS
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHhhh
Confidence 7899999999999999999999999999999999999999999988888887766653 45678999999999999999
Q ss_pred CCCCCC-----CHHHHHHcHhhhhh
Q psy16430 488 APSSRP-----SFKQILSHLDIASQ 507 (600)
Q Consensus 488 dP~~RP-----s~~elL~~l~~~~~ 507 (600)
||.+|+ |+++|++|+||...
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CHHhccccccccHHHHHcCccccCC
Confidence 999994 99999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=428.68 Aligned_cols=245 Identities=25% Similarity=0.441 Sum_probs=220.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHHHHHHHH-hcCCCCcccccceeecCCceeEE
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KETDIRHLR-KLNHPNIVKFKGVCTQAPCYCIV 327 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~Ei~~L~-~L~HpnIv~l~~~~~~~~~~~lV 327 (600)
++|.+++.||+|+||+||+|+.. ++.||||++++. ...|..++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999874 799999999632 234556554 68999999999999999999999
Q ss_pred EeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCc
Q psy16430 328 MEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKM 406 (600)
Q Consensus 328 ~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 406 (600)
||||+||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999998765433 333
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWS 486 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 486 (600)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+.... +..|..+|+.+.+||++||+
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSC
T ss_pred ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHHHHHhcc
Confidence 4689999999999999999999999999999999999999999999888888776654 35678899999999999999
Q ss_pred cCCCCCCCHH-HHHHcHhhhhh
Q psy16430 487 NAPSSRPSFK-QILSHLDIASQ 507 (600)
Q Consensus 487 ~dP~~RPs~~-elL~~l~~~~~ 507 (600)
.||.+|||+. ++++|||+...
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTC
T ss_pred cCCCCCcCHHHHHHhCchhccC
Confidence 9999999995 89999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=418.47 Aligned_cols=246 Identities=30% Similarity=0.570 Sum_probs=214.6
Q ss_pred ccccccccccccc-cCCCCcceEEEeEee----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 256 WEIPFESISDLQW-LGSGAQGAVFSGKLR----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~-LG~G~fG~Vy~a~~~----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
|.++.++|.+.+. ||+|+||.||+|.+. +..||||+++. .+.+|+++|++++|||||+++|++.. +
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 4566678888884 999999999999754 35799999853 24579999999999999999999865 4
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.+|+|||||+||+|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 68999999999999998754 46799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 402 KST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 402 ~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
... .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++...+..+. +++.|..+|++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~ 240 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPE 240 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHH
Confidence 322 224568999999999999999999999999999999998 999999988887777765543 56778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.+||.+||+.||++|||+.+|++.+.
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 999999999999999999999976653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-51 Score=433.54 Aligned_cols=245 Identities=19% Similarity=0.311 Sum_probs=213.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeeccc----------hHH---HHHHHHhcCCCCcccccceeecCCce
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ----------KET---DIRHLRKLNHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~----------~~~---Ei~~L~~L~HpnIv~l~~~~~~~~~~ 324 (600)
.++|++++.||+|+||.||+|+.. ++.||||++.+. ..+ ++.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999875 789999998532 122 35667777899999999999999999
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
|+|||||+||+|.+++.+...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999998775443
Q ss_pred CcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChH---HHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 405 KMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSS---AIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 405 ~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
.....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.+.. .+...+ .......|..+|+++++|
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSL 239 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS--SSCCCCCCSSSCHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCCCCHHHHHH
Confidence 345689999999999864 56899999999999999999999999875443 222222 223445678899999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHHcHhhhhh
Q psy16430 481 MKMCWSNAPSSRPS-----FKQILSHLDIASQ 507 (600)
Q Consensus 481 I~~cL~~dP~~RPs-----~~elL~~l~~~~~ 507 (600)
|.+||+.||.+||| ++++++||||.+.
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999999 7999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=416.49 Aligned_cols=247 Identities=31% Similarity=0.598 Sum_probs=209.2
Q ss_pred cccccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecC
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
.|+|+.++|++.+.||+|+||.||+|++. +..||||.++. .+.+|+.+|++++|||||+++|++. .
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 48999999999999999999999999864 25689998752 2457999999999999999999996 4
Q ss_pred CceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 322 PCYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 322 ~~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
+.+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999988654 5579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC--CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHH
Q psy16430 401 NKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGF 477 (600)
Q Consensus 401 ~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 477 (600)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+. .++.|..+|+.+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL 238 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHH
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHH
Confidence 4322 234568999999999999999999999999999999998 999999998888877776554 457788999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 478 QLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 478 ~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
.+||.+||+.||.+|||+.+|++++.
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=417.20 Aligned_cols=234 Identities=31% Similarity=0.606 Sum_probs=206.2
Q ss_pred cccCCCCcceEEEeEee----ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEeeecc
Q psy16430 267 QWLGSGAQGAVFSGKLR----SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEYCAY 333 (600)
Q Consensus 267 ~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey~~g 333 (600)
++||+|+||+||+|.+. ++.||||+++. .+.+|+++|++++|||||+++|++.. +..|+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 36899999853 24579999999999999999999865 457899999999
Q ss_pred ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC----CcccC
Q psy16430 334 GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST----KMSFA 409 (600)
Q Consensus 334 gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~ 409 (600)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999987654322 22357
Q ss_pred CCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcC
Q psy16430 410 GTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNA 488 (600)
Q Consensus 410 gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 488 (600)
||+.|||||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+ .+++.|..+|+.+.+||.+||+.|
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHcCCC
Confidence 8999999999999999999999999999999998 99999999888877776554 456778899999999999999999
Q ss_pred CCCCCCHHHHHHcH
Q psy16430 489 PSSRPSFKQILSHL 502 (600)
Q Consensus 489 P~~RPs~~elL~~l 502 (600)
|.+|||+.+|+..+
T Consensus 251 p~~RPs~~~i~~~L 264 (277)
T d1xbba_ 251 VENRPGFAAVELRL 264 (277)
T ss_dssp TTTSCCHHHHHHHH
T ss_pred HhHCcCHHHHHHHh
Confidence 99999999996644
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=426.74 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=210.3
Q ss_pred ccccccc-ccCCCCcceEEEeEee--ceEEEeeeecc--chHHHHHHHHhc-CCCCcccccceeec----CCceeEEEee
Q psy16430 261 ESISDLQ-WLGSGAQGAVFSGKLR--SEIVAVKKVRE--QKETDIRHLRKL-NHPNIVKFKGVCTQ----APCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~-~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--~~~~Ei~~L~~L-~HpnIv~l~~~~~~----~~~~~lV~Ey 330 (600)
++|.++. .||+|+||+||+|++. ++.||||+++. ...+|+.++.++ +|||||+++++|.+ ...+|+||||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 6888875 5999999999999864 68999999965 346799887654 89999999999865 4678999999
Q ss_pred eccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC---CCCceeeccCccccccCCCCC
Q psy16430 331 CAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS---KEEAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 331 ~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~~~~ 405 (600)
|+||+|.+++.+. ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+........
T Consensus 91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~ 170 (335)
T d2ozaa1 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170 (335)
T ss_dssp CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC
T ss_pred CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCcc
Confidence 9999999999763 46999999999999999999999999999999999999985 457999999999987766666
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHH----HhcCCCCCCCCC--CCCcHHHHH
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIW----GVGSSSLHLPIP--STCPDGFQL 479 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~----~i~~~~~~~~~p--~~~~~~l~~ 479 (600)
....||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+...... .+.......+.+ ..+|+++.+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 250 (335)
T d2ozaa1 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250 (335)
T ss_dssp CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHH
T ss_pred ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHH
Confidence 67889999999999999999999999999999999999999998766544332 233333333322 357899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 480 LMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 480 LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
||++||+.||++|||+.|+++|+|+...
T Consensus 251 li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 251 LIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 9999999999999999999999999654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=414.68 Aligned_cols=246 Identities=31% Similarity=0.585 Sum_probs=214.8
Q ss_pred cccccccccccccccCCCCcceEEEeEeeceEEEeeeecc-----chHHHHHHHHhcCCCCcccccceeec-CCceeEEE
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKFKGVCTQ-APCYCIVM 328 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l~~~~~~-~~~~~lV~ 328 (600)
.|+|+.++|++.+.||+|+||.||+|+++++.||||+++. .+.+|++++++++||||++++|++.+ .+.+|+||
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3899999999999999999999999999999999999964 35689999999999999999999854 46689999
Q ss_pred eeeccccchhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCCCc
Q psy16430 329 EYCAYGPLYNLLKDG--EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKSTKM 406 (600)
Q Consensus 329 Ey~~ggsL~~~l~~~--~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 406 (600)
||+++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~ 158 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 158 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Cc
Confidence 999999999998653 35899999999999999999999999999999999999999999999999999875433 23
Q ss_pred ccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhh
Q psy16430 407 SFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCW 485 (600)
Q Consensus 407 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 485 (600)
...+|+.|+|||++.+..+++++|||||||++|||+| |++||...+..++...+..+ ..++.|..+++.+.+||.+||
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl 237 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCW 237 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHT
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHc
Confidence 4568999999999999999999999999999999998 89999998888888777554 466788899999999999999
Q ss_pred hcCCCCCCCHHHHHHcHh
Q psy16430 486 SNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 486 ~~dP~~RPs~~elL~~l~ 503 (600)
+.||.+|||+.+|++++.
T Consensus 238 ~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 238 HLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp CSSGGGSCCHHHHHHHHH
T ss_pred ccCHhHCcCHHHHHHHHH
Confidence 999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=417.06 Aligned_cols=250 Identities=32% Similarity=0.593 Sum_probs=213.1
Q ss_pred cccccccccccccccccccCCCCcceEEEeEeec-eEEEeeeecc------chHHHHHHHHhcCCCCcccccceeecCCc
Q psy16430 251 VLRDEWEIPFESISDLQWLGSGAQGAVFSGKLRS-EIVAVKKVRE------QKETDIRHLRKLNHPNIVKFKGVCTQAPC 323 (600)
Q Consensus 251 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~ 323 (600)
...++|+|+.++|++.+.||+|+||.||+|++++ ..||||++.. .+.+|+.+|++++|||||+++|++.+ +.
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 3568999999999999999999999999999864 6799999853 45789999999999999999999865 55
Q ss_pred eeEEEeeeccccchhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 324 YCIVMEYCAYGPLYNLLKD--GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~--~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
.++|||||++|+|..++.. .+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 7899999999999988764 35699999999999999999999999999999999999999999999999999987643
Q ss_pred CC--CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC-CCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHH
Q psy16430 402 KS--TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQ 478 (600)
Q Consensus 402 ~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 478 (600)
.. ......||+.|+|||++.+..++.++|||||||++|||++| .+||.+....++...+..+ ...+.+..+|+.++
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~ 244 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLH 244 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHHHH
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCCcccCHHHH
Confidence 32 22346789999999999999999999999999999999995 5556666666666665543 45678889999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 479 LLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 479 ~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
+||.+||+.||++|||+++|++.+
T Consensus 245 ~li~~cl~~dP~~Rps~~~i~~~L 268 (285)
T d1fmka3 245 DLMCQCWRKEPEERPTFEYLQAFL 268 (285)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHHH
Confidence 999999999999999999998854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=412.79 Aligned_cols=246 Identities=32% Similarity=0.615 Sum_probs=208.9
Q ss_pred cccccccccccccCCCCcceEEEeEeec------eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 257 EIPFESISDLQWLGSGAQGAVFSGKLRS------EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 257 ei~~~~~~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
||+.+.|++.+.||+|+||.||+|.+.+ ..||||++.. .+.+|+.+|++++|||||+++|++.+..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 5777889999999999999999998653 4799999853 3457999999999999999999999999
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..++|||||.++++.+++.. .+.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999887765 46799999999999999999999999999999999999999999999999999987644
Q ss_pred CC----CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC-CCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 402 KS----TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 402 ~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
.. ......||+.|||||++.+..++.++|||||||++|||++| .+||...+..++...+.. ..+++.|..+|+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-cCCCCCchhhHHH
Confidence 32 12235689999999999999999999999999999999995 555666666666665544 4566788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.+||.+||+.||++|||+.+|++.+.
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=416.93 Aligned_cols=243 Identities=22% Similarity=0.341 Sum_probs=208.2
Q ss_pred cccccCCCCcceEEEeEee--ceEEEeeeecc------------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 265 DLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE------------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 265 ~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~------------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
.+++||+|+||+||+|+.. ++.||||+++. .+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999864 78999999842 245799999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~ 409 (600)
|.|+++..+...+..+++..+..+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...+.+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 9999888888777889999999999999999999999999999999999999999999999999998765433 334568
Q ss_pred CCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----CC-------C----------C
Q psy16430 410 GTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----SL-------H----------L 467 (600)
Q Consensus 410 gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----~~-------~----------~ 467 (600)
||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+... .. . .
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 9999999999865 46799999999999999999999999988876665543210 00 0 0
Q ss_pred C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 468 P-----IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 468 ~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
. .....++++.+||.+||+.||++|||++|+|+||||.+.
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 013567899999999999999999999999999999754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=417.43 Aligned_cols=251 Identities=30% Similarity=0.576 Sum_probs=207.3
Q ss_pred cccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeeccc--------hHHHHHHHHhc-CCCCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
.+.|+|+.++|++.+.||+|+||.||+|++. ++.||||+++.. +..|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 4679999999999999999999999999864 368999998632 23566667666 6899999999
Q ss_pred eeec-CCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 317 VCTQ-APCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 317 ~~~~-~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
++.. +..+++|||||++|+|.+++... ..+++.++..++.||+.||.|||++|||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 8755 45689999999999999998542 348899999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC-CCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG-~~Pf~~~~~~~ 455 (600)
||++.++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+|| .+||.+.+...
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998764332 22346799999999999999999999999999999999986 57888776555
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...........++.|..+|+.+.+||.+||+.||.+|||+.+|++|+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 444444444566788899999999999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-50 Score=414.87 Aligned_cols=248 Identities=35% Similarity=0.650 Sum_probs=220.4
Q ss_pred cccccccccccccccCCCCcceEEEeEeec-------eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceee
Q psy16430 255 EWEIPFESISDLQWLGSGAQGAVFSGKLRS-------EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCT 319 (600)
Q Consensus 255 ~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~ 319 (600)
.|++|.++|++++.||+|+||+||+|++.+ +.||||++.. .+.+|+.+|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 588999999999999999999999998653 7899999853 3568999999999999999999999
Q ss_pred cCCceeEEEeeeccccchhhccCC------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCC
Q psy16430 320 QAPCYCIVMEYCAYGPLYNLLKDG------------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDL 375 (600)
Q Consensus 320 ~~~~~~lV~Ey~~ggsL~~~l~~~------------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDI 375 (600)
.....++||||+++|+|.+++... ..+++..++.++.||+.||+|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 999999999999999999988532 24788999999999999999999999999999
Q ss_pred CCCCcccCCCCCceeeccCccccccCCC---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC-CCCCCCC
Q psy16430 376 KSPNVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDV 451 (600)
Q Consensus 376 Kp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG-~~Pf~~~ 451 (600)
||+|||++.++.+||+|||+|+...... ...+..||+.|+|||++.+..++.++|||||||++|||++| .+||.+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998664332 22346789999999999999999999999999999999997 4789999
Q ss_pred ChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 452 DSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 452 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+..++...+..+. .++.|..+|+++.+||.+||+.||.+|||+.+|++.+.
T Consensus 247 ~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 247 AHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9888888877665 45678899999999999999999999999999988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=409.52 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=208.7
Q ss_pred cccccccccCCCCcceEEEeEee---ceEEEeeeecc---------chHHHHHHHHhc---CCCCcccccceeec-----
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR---SEIVAVKKVRE---------QKETDIRHLRKL---NHPNIVKFKGVCTQ----- 320 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~---------~~~~Ei~~L~~L---~HpnIv~l~~~~~~----- 320 (600)
++|++++.||+|+||+||+|++. ++.||||+++. ...+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999863 57899999853 235788877766 79999999999842
Q ss_pred CCceeEEEeeeccccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREW 399 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~ 399 (600)
....+++|||++++++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 346899999999887654433 4567999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----------------
Q psy16430 400 NNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS---------------- 463 (600)
Q Consensus 400 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~---------------- 463 (600)
..........||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+.......+...
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 6655566788999999999999999999999999999999999999999988876655443210
Q ss_pred ---------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 464 ---------SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 464 ---------~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
......+..+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0001134567899999999999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=407.64 Aligned_cols=249 Identities=33% Similarity=0.619 Sum_probs=215.9
Q ss_pred ccccccccccccccccCCCCcceEEEeEeec---------eEEEeeeeccc--------hHHHHHHHHhc-CCCCccccc
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLRS---------EIVAVKKVREQ--------KETDIRHLRKL-NHPNIVKFK 315 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~--------~~~Ei~~L~~L-~HpnIv~l~ 315 (600)
..|+|+.++|++.+.||+|+||.||+|+..+ ..||||+++.. +.+|...+.++ +|||||+++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4599999999999999999999999998542 47999998543 24577788887 799999999
Q ss_pred ceeecCCceeEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCC
Q psy16430 316 GVCTQAPCYCIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPN 379 (600)
Q Consensus 316 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~N 379 (600)
+++.+++..++|||||++|+|.+++... ..+++.+++.++.||+.||+|||+.|||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999643 358999999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHH
Q psy16430 380 VLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSA 455 (600)
Q Consensus 380 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~ 455 (600)
||++.++.+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+...
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999987754332 234678999999999999999999999999999999998 799999988887
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 456 IIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 456 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+...+.. ...++.|..+|+.+.+||.+||+.||.+|||+.+|++.+.
T Consensus 246 ~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 246 LFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp HHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 7766654 4567788999999999999999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=409.86 Aligned_cols=237 Identities=23% Similarity=0.435 Sum_probs=206.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc-------------hHHHHHHHHhcC--CCCcccccceeecCCc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ-------------KETDIRHLRKLN--HPNIVKFKGVCTQAPC 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~-------------~~~Ei~~L~~L~--HpnIv~l~~~~~~~~~ 323 (600)
++|++.+.||+|+||+||+|+.. ++.||||++... +.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999875 789999998532 358999999997 8999999999999999
Q ss_pred eeEEEeeecc-ccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCC-CCceeeccCccccccC
Q psy16430 324 YCIVMEYCAY-GPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSK-EEAKISDFGTCREWNN 401 (600)
Q Consensus 324 ~~lV~Ey~~g-gsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~ 401 (600)
.|+||||+.+ +++.+++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|.....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999975 6788888887889999999999999999999999999999999999999854 7899999999986544
Q ss_pred CCCCcccCCCccccChhhhccCCC-CCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 402 KSTKMSFAGTVAWMAPEVIRNEQC-SDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 402 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
. ...+..||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ .+. .. ....+..+|+++++|
T Consensus 164 ~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~----~~--~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 164 T-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII----RG--QVFFRQRVSSECQHL 234 (273)
T ss_dssp S-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH----HC--CCCCSSCCCHHHHHH
T ss_pred c-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHh----hc--ccCCCCCCCHHHHHH
Confidence 3 3345789999999999987665 577999999999999999999997632 222 22 234567899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
|++||+.||.+|||++|+++|||+.+
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=406.99 Aligned_cols=245 Identities=31% Similarity=0.570 Sum_probs=210.3
Q ss_pred ccccccccccccCCCCcceEEEeEee-----ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLR-----SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
|+.++|++++.||+|+||.||+|++. ...||||++.. .+.+|+.+|++++|||||+++|++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 55688999999999999999999864 24799998853 34679999999999999999999966 4
Q ss_pred ceeEEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 CYCIVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 ~~~lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..++|||||++|++.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999887754 45699999999999999999999999999999999999999999999999999998754
Q ss_pred CCC----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHH
Q psy16430 402 KST----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDG 476 (600)
Q Consensus 402 ~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 476 (600)
... .....||..|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....+......++.+..+|+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 332 223467889999999999999999999999999999998 899999999999988888888888888999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 477 FQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 477 l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.+||.+||+.||++|||+.+|++.+.
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999999999999999999987653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=412.64 Aligned_cols=246 Identities=33% Similarity=0.614 Sum_probs=217.9
Q ss_pred ccccccccccccCCCCcceEEEeEeec----eEEEeeeecc--------chHHHHHHHHhc-CCCCcccccceeecCCce
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKLRS----EIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKGVCTQAPCY 324 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~~~~~~~~~ 324 (600)
|++++|++.+.||+|+||+||+|++.+ ..||||++.. .+.+|+++|+++ +|||||+++|++.+.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 678999999999999999999998763 3688888742 356899999999 799999999999999999
Q ss_pred eEEEeeeccccchhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCc
Q psy16430 325 CIVMEYCAYGPLYNLLKDG----------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEA 388 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~----------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~v 388 (600)
++||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999998643 568999999999999999999999999999999999999999999
Q ss_pred eeeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC-CCCCCCCChHHHHHHhcCCCCCC
Q psy16430 389 KISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGSSSLHL 467 (600)
Q Consensus 389 kL~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG-~~Pf~~~~~~~~~~~i~~~~~~~ 467 (600)
||+|||+|+............||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+..+ ..+
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~ 245 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRL 245 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCC
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCC
Confidence 99999999877655555567799999999999999999999999999999999995 5689888888888777654 456
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhh
Q psy16430 468 PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDI 504 (600)
Q Consensus 468 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~ 504 (600)
+.|..+|+.+.+||.+||+.||++|||+++|++++.-
T Consensus 246 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 7788999999999999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-49 Score=404.38 Aligned_cols=242 Identities=23% Similarity=0.362 Sum_probs=204.9
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc----------chHHHHHHHHhcCCCCcccccceeecCC----ce
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----------QKETDIRHLRKLNHPNIVKFKGVCTQAP----CY 324 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~----~~ 324 (600)
++|++.+.||+|+||+||+|+.. ++.||||+++. .+.+|+++|+.++|||||++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 67999999999999999999864 79999999853 2457999999999999999999986543 37
Q ss_pred eEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-
Q psy16430 325 CIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS- 403 (600)
Q Consensus 325 ~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 403 (600)
|+|||||+|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987654322
Q ss_pred ---CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCCCC--CCCCCCcHHHH
Q psy16430 404 ---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSLHL--PIPSTCPDGFQ 478 (600)
Q Consensus 404 ---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~ 478 (600)
...+.+||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+..+....+......+ ..+..+|+.+.
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 246 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246 (277)
T ss_dssp ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHH
T ss_pred cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence 2335679999999999999999999999999999999999999999988877776655544332 23467899999
Q ss_pred HHHHHhhhcCCCCCC-CHHHHHHcH
Q psy16430 479 LLMKMCWSNAPSSRP-SFKQILSHL 502 (600)
Q Consensus 479 ~LI~~cL~~dP~~RP-s~~elL~~l 502 (600)
+||.+||+.||.+|| |+++++..+
T Consensus 247 ~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 247 AVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHHccCCHhHCHhHHHHHHHHH
Confidence 999999999999999 778776554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=406.38 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=207.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++++.||+|+||+||+|++. ++.||||+++. .+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999875 78999999842 34579999999999999999999999999999999
Q ss_pred eeccccchhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCC-CCCcc
Q psy16430 330 YCAYGPLYNLLK-DGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK-STKMS 407 (600)
Q Consensus 330 y~~ggsL~~~l~-~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~ 407 (600)
|+.++.+..... ....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..... .....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 998665544433 3567999999999999999999999999999999999999999999999999999876543 33345
Q ss_pred cCCCccccChhhhccCC-CCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC----------------CCCCCC-
Q psy16430 408 FAGTVAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS----------------SLHLPI- 469 (600)
Q Consensus 408 ~~gt~~Y~APE~l~~~~-~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~----------------~~~~~~- 469 (600)
..||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+... ......
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 68999999999987655 578999999999999999999999988776655443110 000000
Q ss_pred ----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 470 ----------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 470 ----------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
...+++++.+||++||+.||.+|||++|+++|+||.+.
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 12457899999999999999999999999999999643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-49 Score=403.73 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=208.9
Q ss_pred cccccccccCCCCcceEEEeEee-ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR-SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~Ey 330 (600)
++|++++.||+|+||+||+|+++ ++.||||+++. .+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999875 68999999853 346899999999999999999999999999999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-CcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-KMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~ 409 (600)
+.++++..+....+.+++..+..++.||+.||+|||+.|||||||||+|||++.++.+||+|||.|........ .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceec
Confidence 99888888888788899999999999999999999999999999999999999999999999999987654332 34567
Q ss_pred CCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC----CC------------C-------
Q psy16430 410 GTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS----SS------------L------- 465 (600)
Q Consensus 410 gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~----~~------------~------- 465 (600)
|++.|+|||.+.+ ..++.++|||||||++|||++|++||.+.+..+....+.. .. .
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccc
Confidence 8999999999875 4568999999999999999999999998877655443211 00 0
Q ss_pred ----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 466 ----HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 466 ----~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
....+..+++.+.+||++||+.||++|||++|+++||||.
T Consensus 242 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0012345788999999999999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=408.81 Aligned_cols=251 Identities=35% Similarity=0.616 Sum_probs=221.7
Q ss_pred cccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhc-CCCCcccccc
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKL-NHPNIVKFKG 316 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L-~HpnIv~l~~ 316 (600)
...|+++.++|++.+.||+|+||.||+|++. ++.||||+++. .+.+|+.+++++ +|||||++++
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3479999999999999999999999999853 46899999863 245789999999 6999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCC------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCC
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDG------------------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSP 378 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~------------------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~ 378 (600)
++.+....|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 999999999999999999999998643 25899999999999999999999999999999999
Q ss_pred CcccCCCCCceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChH
Q psy16430 379 NVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSS 454 (600)
Q Consensus 379 NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~ 454 (600)
||+++.++.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654332 224678999999999999999999999999999999998 77778777776
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 455 AIIWGVGSSSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 455 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
..+..+.....++..|..+|+.+.+||.+||+.||.+|||+.+|++.+.
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 6666665666777788899999999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=407.20 Aligned_cols=251 Identities=32% Similarity=0.585 Sum_probs=223.2
Q ss_pred ccccccccccccccccccCCCCcceEEEeEee-------ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccc
Q psy16430 252 LRDEWEIPFESISDLQWLGSGAQGAVFSGKLR-------SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKG 316 (600)
Q Consensus 252 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~ 316 (600)
..+.|+|+.++|++.+.||+|+||.||+|.+. +..||||+++. .+.+|+.++++++|||||++++
T Consensus 11 ~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 11 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred CccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 45689999999999999999999999999864 36899999863 2458999999999999999999
Q ss_pred eeecCCceeEEEeeeccccchhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC
Q psy16430 317 VCTQAPCYCIVMEYCAYGPLYNLLKDG----------EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE 386 (600)
Q Consensus 317 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~----------~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~ 386 (600)
++......++|||||++|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 999999999999999999999987531 3468899999999999999999999999999999999999999
Q ss_pred CceeeccCccccccCCCC---CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhC-CCCCCCCChHHHHHHhcC
Q psy16430 387 EAKISDFGTCREWNNKST---KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTC-ETPYKDVDSSAIIWGVGS 462 (600)
Q Consensus 387 ~vkL~DFGla~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG-~~Pf~~~~~~~~~~~i~~ 462 (600)
.+||+|||+|+....... .....||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+....+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999987654322 2335689999999999999999999999999999999997 688999988888887766
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 463 SSLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 463 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+. .++.|..+|+.+.+||.+||+.||.+|||+.+|++++.
T Consensus 251 ~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 251 GG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred CC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 54 46678899999999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=409.18 Aligned_cols=244 Identities=29% Similarity=0.595 Sum_probs=210.3
Q ss_pred ccccccccccCCCCcceEEEeEee--c----eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCCcee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--S----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYC 325 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~ 325 (600)
.++|++++.||+|+||+||+|++. + ..||+|+++. .+.+|+.+|++++|||||+++|++.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 367999999999999999999864 3 3689998752 346899999999999999999999765 567
Q ss_pred EEEeeeccccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC
Q psy16430 326 IVMEYCAYGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST 404 (600)
Q Consensus 326 lV~Ey~~ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 404 (600)
++|||+.+|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 88999999999887765 46799999999999999999999999999999999999999999999999999987654332
Q ss_pred C---cccCCCccccChhhhccCCCCCccceechhHHHHHHhh-CCCCCCCCChHHHHHHhcCCCCCCCCCCCCcHHHHHH
Q psy16430 405 K---MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLT-CETPYKDVDSSAIIWGVGSSSLHLPIPSTCPDGFQLL 480 (600)
Q Consensus 405 ~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 480 (600)
. ....||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+ .+++.|..+|+.+.+|
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVYMI 245 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCCCCCTTBCHHHHHH
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHH
Confidence 2 23568999999999999999999999999999999998 89999988877766655444 4567788999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHcHhhh
Q psy16430 481 MKMCWSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 481 I~~cL~~dP~~RPs~~elL~~l~~~ 505 (600)
|.+||+.||.+|||+.+|+.++...
T Consensus 246 i~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=407.10 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=206.8
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---hHHHHHHHHhcCCCCcccccceeec------CCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---KETDIRHLRKLNHPNIVKFKGVCTQ------APCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---~~~Ei~~L~~L~HpnIv~l~~~~~~------~~~~~lV~E 329 (600)
-+|+.+++||+|+||+||+|++. ++.||||++... ..+|+.+|++++||||++++++|.. ..++|+|||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 36889999999999999999975 789999998643 4589999999999999999999843 335789999
Q ss_pred eeccccchhh---ccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCCCC
Q psy16430 330 YCAYGPLYNL---LKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTK 405 (600)
Q Consensus 330 y~~ggsL~~~---l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 405 (600)
||+++.+..+ ......+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~ 179 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCccc
Confidence 9987644333 24466799999999999999999999999999999999999999775 8999999999887766666
Q ss_pred cccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---------------C--CCCC
Q psy16430 406 MSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS---------------S--SLHL 467 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~---------------~--~~~~ 467 (600)
.+..||+.|+|||.+.+ ..++.++||||+||++|||++|++||...+....+..+.. . ....
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 259 (350)
T d1q5ka_ 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259 (350)
T ss_dssp CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCC
T ss_pred ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccc
Confidence 67889999999998765 5789999999999999999999999998776555443311 0 0000
Q ss_pred ----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 468 ----------PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 468 ----------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
.....+++++.+||.+||..||.+|||+.|+|+|+||...
T Consensus 260 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 1123578899999999999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=402.05 Aligned_cols=248 Identities=29% Similarity=0.412 Sum_probs=203.3
Q ss_pred ccccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCC
Q psy16430 254 DEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAP 322 (600)
Q Consensus 254 ~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~ 322 (600)
..|++. ++|++++.||+|+||+||+|.+. ++.||||+++. ...+|+.+|++++|||||+++++|...+
T Consensus 12 ~~~~~~-~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 12 TAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp SEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeecC-CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 346664 79999999999999999999865 79999999863 2357999999999999999999997654
Q ss_pred ------ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 323 ------CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 323 ------~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
.+|+||||| +.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence 479999999 5677777654 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccCCCccccChhhhcc-CCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC------------
Q psy16430 397 REWNNKSTKMSFAGTVAWMAPEVIRN-EQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS------------ 463 (600)
Q Consensus 397 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~------------ 463 (600)
+..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......+...
T Consensus 169 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 169 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred eccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 876543 345689999999999876 45689999999999999999999999987765543322110
Q ss_pred -------------CC----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 464 -------------SL----HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 464 -------------~~----~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
.. ........++.+.+||.+||..||.+|||++|+|+||||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 00 01123567899999999999999999999999999999965
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=392.83 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=204.0
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeec--------
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQ-------- 320 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~-------- 320 (600)
.++|++++.||+|+||+||+|++. ++.||||++.. ...+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 378999999999999999999864 78999998742 24589999999999999999998754
Q ss_pred CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
....|+||||+.++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999988877777777789999999999999999999999999999999999999999999999999997665
Q ss_pred CCC-----CCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC--CCCCCC---
Q psy16430 401 NKS-----TKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS--SLHLPI--- 469 (600)
Q Consensus 401 ~~~-----~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~--~~~~~~--- 469 (600)
... ...+.+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+... ......
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 22346799999999998764 6899999999999999999999999987775554432111 000000
Q ss_pred ----------------C---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 470 ----------------P---------STCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 470 ----------------p---------~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
+ ...++.+.+||.+||+.||++|||++|+|+||||..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 0 012567889999999999999999999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=400.79 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=212.5
Q ss_pred ccccccccccccCCCCcceEEEeEe-----eceEEEeeeecc-----------chHHHHHHHHhcCC-CCcccccceeec
Q psy16430 258 IPFESISDLQWLGSGAQGAVFSGKL-----RSEIVAVKKVRE-----------QKETDIRHLRKLNH-PNIVKFKGVCTQ 320 (600)
Q Consensus 258 i~~~~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~-----------~~~~Ei~~L~~L~H-pnIv~l~~~~~~ 320 (600)
+..++|++++.||+|+||+||+|+. +++.||||++.+ .+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3458899999999999999999975 368999998742 23479999999977 899999999999
Q ss_pred CCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcccccc
Q psy16430 321 APCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWN 400 (600)
Q Consensus 321 ~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 400 (600)
...+++||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999998764
Q ss_pred CCC--CCcccCCCccccChhhhccC--CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC--CCCCCCCCCCCc
Q psy16430 401 NKS--TKMSFAGTVAWMAPEVIRNE--QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--SSLHLPIPSTCP 474 (600)
Q Consensus 401 ~~~--~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~ 474 (600)
... ...+..|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+.......+.. ....++.|..+|
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 332 23456799999999998754 467899999999999999999999987654322222211 122345678899
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHcHhhhh
Q psy16430 475 DGFQLLMKMCWSNAPSSRP-----SFKQILSHLDIAS 506 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RP-----s~~elL~~l~~~~ 506 (600)
+.+.+||.+||++||.+|| |++|+++||||..
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-47 Score=393.84 Aligned_cols=244 Identities=18% Similarity=0.281 Sum_probs=204.2
Q ss_pred ccccccccccCCCCcceEEEeEee--ceEEEeeeecc----chHHHHHHHHhcC-CCCcccccceeec--CCceeEEEee
Q psy16430 260 FESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE----QKETDIRHLRKLN-HPNIVKFKGVCTQ--APCYCIVMEY 330 (600)
Q Consensus 260 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~----~~~~Ei~~L~~L~-HpnIv~l~~~~~~--~~~~~lV~Ey 330 (600)
.++|++++.||+|+||+||+|+.. ++.||||+++. ...+|+.+|++++ ||||+++++++.. ...+++||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 368999999999999999999965 79999999864 3467999999995 9999999999864 4568999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCC-CceeeccCccccccCCCCCcccC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKE-EAKISDFGTCREWNNKSTKMSFA 409 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~ 409 (600)
|.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.............
T Consensus 114 ~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 190 (328)
T d3bqca1 114 VNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 190 (328)
T ss_dssp CCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCC
T ss_pred cCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccc
Confidence 9999998764 4599999999999999999999999999999999999998655 69999999999877666666778
Q ss_pred CCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHH-HHHHhc---------------CCC--------
Q psy16430 410 GTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSA-IIWGVG---------------SSS-------- 464 (600)
Q Consensus 410 gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~-~~~~i~---------------~~~-------- 464 (600)
+|+.|+|||.+.+. .++.++||||+||++|+|++|..||....... ....+. ...
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 270 (328)
T d3bqca1 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270 (328)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT
T ss_pred cCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchh
Confidence 99999999998764 57999999999999999999999997654322 111000 000
Q ss_pred ------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 465 ------------LHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 465 ------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
........+++++.+||++||..||.+|||++|+|+||||..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011122346889999999999999999999999999999965
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=385.38 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=209.4
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc---------chHHHHHHHHhcCCCCcccccceeecCCceeEEEe
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE---------QKETDIRHLRKLNHPNIVKFKGVCTQAPCYCIVME 329 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~---------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~~~~lV~E 329 (600)
++|++++.||+|+||+||+|++. ++.||||+++. .+.+|+.+|+.++||||+++++++.+....++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999974 68899999852 23589999999999999999999999999999999
Q ss_pred eeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC-CCccc
Q psy16430 330 YCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS-TKMSF 408 (600)
Q Consensus 330 y~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~ 408 (600)
++.|+++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|....... .....
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 99999999998888899999999999999999999999999999999999999999999999999998876443 33345
Q ss_pred CCCccccChhhhccCC-CCCccceechhHHHHHHhhCCCCCC-CCChHHHHHHhcC---C--------------------
Q psy16430 409 AGTVAWMAPEVIRNEQ-CSDKIDIWSYGIVLWELLTCETPYK-DVDSSAIIWGVGS---S-------------------- 463 (600)
Q Consensus 409 ~gt~~Y~APE~l~~~~-~s~ksDIwSlGviLyELltG~~Pf~-~~~~~~~~~~i~~---~-------------------- 463 (600)
.+++.|+|||++.+.. ++.++|||||||++|||++|..||. +.+..+....+.. .
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence 6789999999987654 6899999999999999999998864 4444433332210 0
Q ss_pred ----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 464 ----SLHLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 464 ----~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
......+...++.+.+||++||+.||.+|||++|+|+||||.+
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0011123456889999999999999999999999999999953
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-47 Score=395.76 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=201.6
Q ss_pred ccccccccccccccCCCCcceEEEeEee--ceEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeecCC---
Q psy16430 256 WEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQAP--- 322 (600)
Q Consensus 256 ~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~~~--- 322 (600)
|+|. ++|++++.||+|+||+||+|... ++.||||+++. .+.+|+.+|++++||||+++++++....
T Consensus 4 ~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 4454 56999999999999999999864 78999999853 2357999999999999999999986543
Q ss_pred -ceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccC
Q psy16430 323 -CYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNN 401 (600)
Q Consensus 323 -~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 401 (600)
..+++++|+.||+|.+++..+ .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|.....
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 234455667789999999764 699999999999999999999999999999999999999999999999999987643
Q ss_pred CCC----CcccCCCccccChhhhc-cCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCC-------------
Q psy16430 402 KST----KMSFAGTVAWMAPEVIR-NEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSS------------- 463 (600)
Q Consensus 402 ~~~----~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~------------- 463 (600)
... ....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+...........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 322 23467999999999984 456789999999999999999999999887654443321100
Q ss_pred -----------C--CCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 464 -----------S--LHL---PIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 464 -----------~--~~~---~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
. ... ......++.+.+||.+||+.||.+|||++++|+|||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0 000 0123567889999999999999999999999999998644
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=390.65 Aligned_cols=239 Identities=31% Similarity=0.558 Sum_probs=200.8
Q ss_pred ccccCCCCcceEEEeEeec-----eEEEeeeecc--------chHHHHHHHHhcCCCCcccccceeec-CCceeEEEeee
Q psy16430 266 LQWLGSGAQGAVFSGKLRS-----EIVAVKKVRE--------QKETDIRHLRKLNHPNIVKFKGVCTQ-APCYCIVMEYC 331 (600)
Q Consensus 266 ~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~--------~~~~Ei~~L~~L~HpnIv~l~~~~~~-~~~~~lV~Ey~ 331 (600)
.++||+|+||+||+|++.+ ..||||+++. .+.+|+++|++++|||||+++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999998642 3699999852 34689999999999999999999765 56889999999
Q ss_pred ccccchhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCCC-----C
Q psy16430 332 AYGPLYNLLKDG-EEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKST-----K 405 (600)
Q Consensus 332 ~ggsL~~~l~~~-~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-----~ 405 (600)
++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 999999988754 4577888999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCC-CChHHHHHHhcCCCCCCCCCCCCcHHHHHHHHHh
Q psy16430 406 MSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKD-VDSSAIIWGVGSSSLHLPIPSTCPDGFQLLMKMC 484 (600)
Q Consensus 406 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 484 (600)
....||+.|+|||.+.+..++.++||||||+++|||+||..||.. .+..+....+..+ .++..|..+++.+.+||.+|
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~~li~~c 270 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLYEVMLKC 270 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHHHHHHHHHH
Confidence 235689999999999999999999999999999999997666654 3334444444444 45667889999999999999
Q ss_pred hhcCCCCCCCHHHHHHcHhhh
Q psy16430 485 WSNAPSSRPSFKQILSHLDIA 505 (600)
Q Consensus 485 L~~dP~~RPs~~elL~~l~~~ 505 (600)
|+.||++|||+.||++++.-.
T Consensus 271 l~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 271 WHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp TCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHHHHH
Confidence 999999999999999998543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=394.49 Aligned_cols=243 Identities=26% Similarity=0.314 Sum_probs=192.6
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeec------CCc
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQ------APC 323 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~------~~~ 323 (600)
++|+++++||+|+||+||+|.+. ++.||||++... ..+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999875 799999998632 3579999999999999999999853 467
Q ss_pred eeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccccccCCC
Q psy16430 324 YCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNKS 403 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 403 (600)
+|+|||||.++++..+ . ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 8999999987655544 2 458999999999999999999999999999999999999999999999999998877666
Q ss_pred CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcC---------------------
Q psy16430 404 TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGS--------------------- 462 (600)
Q Consensus 404 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~--------------------- 462 (600)
......||+.|+|||++.+..+++++||||+||++|+|++|++||.+.+.......+..
T Consensus 174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T d2b1pa1 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_dssp -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence 66677899999999999999999999999999999999999999988776544332210
Q ss_pred -CCCCCC------------C------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhh
Q psy16430 463 -SSLHLP------------I------PSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIAS 506 (600)
Q Consensus 463 -~~~~~~------------~------p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~ 506 (600)
...... . +...++++.+||++||..||++|||++|+|+|||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000000 0 0123568899999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=391.83 Aligned_cols=251 Identities=28% Similarity=0.366 Sum_probs=205.8
Q ss_pred cccccccccccccccccCCCCcceEEEeEee--ceEEEeeeeccc---------hHHHHHHHHhcCCCCcccccceeecC
Q psy16430 253 RDEWEIPFESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ---------KETDIRHLRKLNHPNIVKFKGVCTQA 321 (600)
Q Consensus 253 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~---------~~~Ei~~L~~L~HpnIv~l~~~~~~~ 321 (600)
...|+++ ++|++++.||+|+||+||+|++. ++.||||+++.. ..+|+.+|++++|||||++++++...
T Consensus 11 ~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 11 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89 (348)
T ss_dssp SSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence 3457775 78999999999999999999864 799999998532 35799999999999999999998533
Q ss_pred -----CceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCcc
Q psy16430 322 -----PCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTC 396 (600)
Q Consensus 322 -----~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla 396 (600)
...++||+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred cccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 344667788889999999865 46999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccCCCccccChhhhccC-CCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHhcCCCC----------
Q psy16430 397 REWNNKSTKMSFAGTVAWMAPEVIRNE-QCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGVGSSSL---------- 465 (600)
Q Consensus 397 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i~~~~~---------- 465 (600)
...... ..+..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 169 ~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 169 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp -CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 765432 3356799999999987665 468899999999999999999999998876555443321100
Q ss_pred -------------CCC------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHhhhhh
Q psy16430 466 -------------HLP------IPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLDIASQ 507 (600)
Q Consensus 466 -------------~~~------~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~~~~~ 507 (600)
..+ ....+++.+.+||++||..||.+|||+.|+|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000 113578899999999999999999999999999999753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=386.06 Aligned_cols=242 Identities=27% Similarity=0.396 Sum_probs=197.1
Q ss_pred cccccccccCCCCcceEEEeEeeceEEEeeeeccch------HHHHHHHHhcCCCCcccccceeecCC----ceeEEEee
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQK------ETDIRHLRKLNHPNIVKFKGVCTQAP----CYCIVMEY 330 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~------~~Ei~~L~~L~HpnIv~l~~~~~~~~----~~~lV~Ey 330 (600)
.+|.+.+.||+|+||.||+|+++++.||||+++... +.|+..+.+++|||||++++++.+.. .+|+||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 567888999999999999999999999999986432 23444556789999999999986543 57999999
Q ss_pred eccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHh--------CCccccCCCCCCcccCCCCCceeeccCccccccCC
Q psy16430 331 CAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHS--------KQIIHRDLKSPNVLIGSKEEAKISDFGTCREWNNK 402 (600)
Q Consensus 331 ~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~--------~gIvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 402 (600)
|++|+|.+++++. .+++..++.++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred ccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 9999999999864 58999999999999999999996 59999999999999999999999999999877543
Q ss_pred CC-----CcccCCCccccChhhhccCC------CCCccceechhHHHHHHhhCCCCCCCC---------------ChHHH
Q psy16430 403 ST-----KMSFAGTVAWMAPEVIRNEQ------CSDKIDIWSYGIVLWELLTCETPYKDV---------------DSSAI 456 (600)
Q Consensus 403 ~~-----~~~~~gt~~Y~APE~l~~~~------~s~ksDIwSlGviLyELltG~~Pf~~~---------------~~~~~ 456 (600)
.. .....||+.|+|||++.+.. ++.++|||||||+||||+||..||... .....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 32 23467999999999987643 567899999999999999998877431 12333
Q ss_pred HHHhcCCCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 457 IWGVGSSSLHLPIPST-----CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 457 ~~~i~~~~~~~~~p~~-----~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
...+.....++++|.. .+..+.+|+.+||+.||.+|||+.||++++.
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 3344444444444433 2356999999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-44 Score=368.17 Aligned_cols=241 Identities=20% Similarity=0.271 Sum_probs=192.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-----chHHHHHHHHhcCCCCcccc-cceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-----QKETDIRHLRKLNHPNIVKF-KGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-----~~~~Ei~~L~~L~HpnIv~l-~~~~~~~~~~~lV~Ey~~ 332 (600)
++|++.+.||+|+||.||+|++. ++.||||++.. .+..|+++++.++|+|++.. .+++.+.+..++||||+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 46999999999999999999865 78999998753 45789999999987775554 555677888999999996
Q ss_pred cccchhhc-cCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccC---CCCCceeeccCccccccCCCC----
Q psy16430 333 YGPLYNLL-KDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIG---SKEEAKISDFGTCREWNNKST---- 404 (600)
Q Consensus 333 ggsL~~~l-~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~~~---- 404 (600)
+ ++...+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..++|+|||+|+.......
T Consensus 87 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (299)
T d1ckia_ 87 P-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165 (299)
T ss_dssp C-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred C-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence 4 555544 4566899999999999999999999999999999999999875 345799999999987654321
Q ss_pred ----CcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHHHHHHh---cCCCCC---CCCCCCCc
Q psy16430 405 ----KMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSAIIWGV---GSSSLH---LPIPSTCP 474 (600)
Q Consensus 405 ----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~~~~~i---~~~~~~---~~~p~~~~ 474 (600)
..+..||+.|||||++.+..++.++|||||||++|||+||..||...........+ ...... ...+..+|
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 245 (299)
T d1ckia_ 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245 (299)
T ss_dssp CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSC
T ss_pred eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCC
Confidence 23467999999999999999999999999999999999999999876553332211 111111 12346789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHcH
Q psy16430 475 DGFQLLMKMCWSNAPSSRPSFKQILSHL 502 (600)
Q Consensus 475 ~~l~~LI~~cL~~dP~~RPs~~elL~~l 502 (600)
+++.+||..||+.||.+||++.++.+.+
T Consensus 246 ~~~~~li~~cl~~~p~~RP~~~~i~~~l 273 (299)
T d1ckia_ 246 SEFATYLNFCRSLRFDDKPDYSYLRQLF 273 (299)
T ss_dssp HHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 9999999999999999999998765433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-44 Score=366.67 Aligned_cols=242 Identities=20% Similarity=0.276 Sum_probs=202.7
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeecc-----chHHHHHHHHhcCC-CCcccccceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVRE-----QKETDIRHLRKLNH-PNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~-----~~~~Ei~~L~~L~H-pnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
++|++.+.||+|+||+||+|++. ++.||||++.. ...+|++.++.|.| +|++.+++++......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 67999999999999999999865 78999998743 34689999999976 89999999999999999999999
Q ss_pred cccchhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCC-----CCCceeeccCccccccCCC---
Q psy16430 333 YGPLYNLLKD-GEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGS-----KEEAKISDFGTCREWNNKS--- 403 (600)
Q Consensus 333 ggsL~~~l~~-~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~-----~~~vkL~DFGla~~~~~~~--- 403 (600)
+++|.+++.. +..++...+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+......
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence 6889888865 457999999999999999999999999999999999999974 5689999999998764321
Q ss_pred -----CCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCCh---HHHHHHhcCCCC---CCCCCCC
Q psy16430 404 -----TKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDS---SAIIWGVGSSSL---HLPIPST 472 (600)
Q Consensus 404 -----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~---~~~~p~~ 472 (600)
...+..||+.|||||++.+..++.++|||||||++|||+||..||.+... ......+..... ....+..
T Consensus 164 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (293)
T d1csna_ 164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243 (293)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCC
Confidence 12346799999999999999999999999999999999999999986543 222222221111 1123467
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 473 CPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 473 ~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+|+++.+++..|+..+|.+||+++.+.+.+.
T Consensus 244 ~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 244 FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 8899999999999999999999988877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-40 Score=344.45 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=189.1
Q ss_pred cccccccccCCCCcceEEEeEee--ceEEEeeeeccc------hHHHHHHHHhcC-----------CCCcccccceeec-
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLR--SEIVAVKKVREQ------KETDIRHLRKLN-----------HPNIVKFKGVCTQ- 320 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~------~~~Ei~~L~~L~-----------HpnIv~l~~~~~~- 320 (600)
.+|++++.||+|+||+||+|+.. ++.||||+++.. ..+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 45999999999999999999864 799999998754 356888888774 5789999998754
Q ss_pred -CCceeEEEeeeccccchhh---ccCCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCCcccCCCCC------ce
Q psy16430 321 -APCYCIVMEYCAYGPLYNL---LKDGEEVPPQRLYNWARQIAAGMNYLHS-KQIIHRDLKSPNVLIGSKEE------AK 389 (600)
Q Consensus 321 -~~~~~lV~Ey~~ggsL~~~---l~~~~~l~~~~i~~i~~qIl~aL~~LH~-~gIvHrDIKp~NILl~~~~~------vk 389 (600)
....+++|.++..+..... ......+++..+..++.||+.||.|||+ .||+||||||+|||++.++. ++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 3456677777654433222 2335678999999999999999999998 89999999999999986653 89
Q ss_pred eeccCccccccCCCCCcccCCCccccChhhhccCCCCCccceechhHHHHHHhhCCCCCCCCChHH------H----HHH
Q psy16430 390 ISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWSYGIVLWELLTCETPYKDVDSSA------I----IWG 459 (600)
Q Consensus 390 L~DFGla~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGviLyELltG~~Pf~~~~~~~------~----~~~ 459 (600)
++|||.|...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||...+... . ...
T Consensus 173 l~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 173 IADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp ECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred Eeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 9999998865433 345679999999999999999999999999999999999999997543210 0 011
Q ss_pred hcC------------------CCC------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHcHh
Q psy16430 460 VGS------------------SSL------------------HLPIPSTCPDGFQLLMKMCWSNAPSSRPSFKQILSHLD 503 (600)
Q Consensus 460 i~~------------------~~~------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~elL~~l~ 503 (600)
+.. ... ....+...++.+.+||.+||..||.+|||++|+|+|||
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 100 000 01112234678999999999999999999999999999
Q ss_pred hhhh
Q psy16430 504 IASQ 507 (600)
Q Consensus 504 ~~~~ 507 (600)
|...
T Consensus 331 f~~~ 334 (362)
T d1q8ya_ 331 LKDT 334 (362)
T ss_dssp GTTC
T ss_pred cCCC
Confidence 9854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.3e-24 Score=203.05 Aligned_cols=155 Identities=21% Similarity=0.185 Sum_probs=117.6
Q ss_pred ccccccCCCCcceEEEeEe-eceEEEeeeeccc-------------------------hHHHHHHHHhcCCCCcccccce
Q psy16430 264 SDLQWLGSGAQGAVFSGKL-RSEIVAVKKVREQ-------------------------KETDIRHLRKLNHPNIVKFKGV 317 (600)
Q Consensus 264 ~~~~~LG~G~fG~Vy~a~~-~~~~vAvK~~~~~-------------------------~~~Ei~~L~~L~HpnIv~l~~~ 317 (600)
.+.++||+|+||+||+|+. +++.||||+++.. ...|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678899999999999985 4789999986421 1246778889999999988765
Q ss_pred eecCCceeEEEeeeccccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 318 CTQAPCYCIVMEYCAYGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSKQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 318 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.. .++||||++++.+.. ++...+..++.|++.||.|||++||+||||||+|||++++ .++|+|||+|.
T Consensus 83 ~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~ 150 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150 (191)
T ss_dssp ET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred cC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence 32 379999998876543 4455677899999999999999999999999999999865 48999999987
Q ss_pred cccCCCCCcccCCCccccCh------hhhccCCCCCccceechhHHH
Q psy16430 398 EWNNKSTKMSFAGTVAWMAP------EVIRNEQCSDKIDIWSYGIVL 438 (600)
Q Consensus 398 ~~~~~~~~~~~~gt~~Y~AP------E~l~~~~~s~ksDIwSlGviL 438 (600)
....+... .|... +.+ .+.|+.++|+||+.--+
T Consensus 151 ~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 151 EVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred cCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 65433211 11111 112 35778999999986543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.6e-20 Score=188.78 Aligned_cols=96 Identities=19% Similarity=0.235 Sum_probs=83.0
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPE 215 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE 215 (600)
..++|..++.|+.++|.++ +|. .+||||||||+||||++++.+||+|||+|+....... .....||++|||||
T Consensus 104 ~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 104 IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180 (272)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChH
Confidence 4589999999999998864 553 5799999999999999999999999999997754432 33467999999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
++.++.++.++|+||||+++|..
T Consensus 181 ~~~~~~~~~~sDvwS~Gvvl~el 203 (272)
T d1qpca_ 181 AINYGTFTIKSDVWSFGILLTEI 203 (272)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCchhhhhhhHHHHHHH
Confidence 99999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.6e-20 Score=188.29 Aligned_cols=96 Identities=18% Similarity=0.209 Sum_probs=75.1
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC----ccccccCceeecc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS----TKMSFAGTVAWMA 213 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~----~~~~~~GT~~ymA 213 (600)
..++|..++.++.++|.++ +|. .+||||||||+||||+.++.+||+|||+|+...... ......||+.|||
T Consensus 105 ~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~A 181 (283)
T d1mqba_ 105 GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181 (283)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSC
T ss_pred ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccC
Confidence 4588888888888888865 443 579999999999999999999999999999754332 1224678999999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++.++.++.++|+||||+++|..
T Consensus 182 PE~l~~~~~~~~sDI~S~Gvil~el 206 (283)
T d1mqba_ 182 PEAISYRKFTSASDVWSFGIVMWEV 206 (283)
T ss_dssp HHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHccCCCCCcccccccHHHHHHH
Confidence 9999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.6e-20 Score=186.28 Aligned_cols=98 Identities=19% Similarity=0.182 Sum_probs=72.1
Q ss_pred ccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i 217 (600)
..++|..++.|+.++|.++-|.| +.+||||||||+|||||+++.+||+|||+|+....... .....||+.|||||++
T Consensus 96 ~~~~~~~~~~i~~qia~gl~~lH-~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l 174 (263)
T d1sm2a_ 96 GLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174 (263)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHH
T ss_pred cCCCHHHHHHHHHHHHHHHHhhh-ccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHh
Confidence 45788888888888888652222 25699999999999999999999999999987644332 2346799999999999
Q ss_pred cccccCccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.++.++.++|+||||+++|..
T Consensus 175 ~~~~~~~k~DVwS~Gvil~el 195 (263)
T d1sm2a_ 175 SFSRYSSKSDVWSFGVLMWEV 195 (263)
T ss_dssp TTCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCchhhhcchHHHHHHH
Confidence 999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=3.6e-20 Score=186.81 Aligned_cols=97 Identities=19% Similarity=0.246 Sum_probs=76.9
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAP 214 (600)
..++|..++.|+.++|.+ |+|. .+||||||||+||||+.++.+||+|||+|+...... ...+..||+.||||
T Consensus 99 ~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 175 (276)
T d1uwha_ 99 TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175 (276)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCH
Confidence 358888888888888886 4554 479999999999999999999999999998764322 23357899999999
Q ss_pred ccccc---cccCcccccccccccccccc
Q psy16430 215 EVIRN---EQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 215 E~i~~---~~~s~~~Dvy~~~~~~~p~s 239 (600)
|++.. +.|+.++|+||||+++|..-
T Consensus 176 E~l~~~~~~~~~~~sDiwS~Gv~l~el~ 203 (276)
T d1uwha_ 176 EVIRMQDKNPYSFQSDVYAFGIVLYELM 203 (276)
T ss_dssp HHHTTCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCchhhhhhhHHHHHHHH
Confidence 99864 45899999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=4.4e-20 Score=190.35 Aligned_cols=96 Identities=21% Similarity=0.237 Sum_probs=80.3
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAP 214 (600)
..++|..++.|+..+|.+ |+|. .+||||||||+|||++.++.+||+|||+|+....... ..+..||+.||||
T Consensus 159 ~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 235 (325)
T d1rjba_ 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235 (325)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence 457888888888888886 4554 4799999999999999999999999999987544332 2346789999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.++.++.++|+||||+++|..
T Consensus 236 E~l~~~~~~~~~DiwS~Gvil~em 259 (325)
T d1rjba_ 236 ESLFEGIYTIKSDVWSYGILLWEI 259 (325)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCcceeccchhHHHHHH
Confidence 999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.70 E-value=5.4e-20 Score=186.46 Aligned_cols=129 Identities=16% Similarity=0.176 Sum_probs=93.4
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd 180 (600)
.++++|..++.-.+++|.-+.++...+ |+. .....+++..++.|+.++|.| |+|. .+||||||||+||||+
T Consensus 77 ~~~~~~~~~~~~~iv~E~~~~g~l~~~---l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~ 149 (287)
T d1opja_ 77 QLLGVCTREPPFYIITEFMTYGNLLDY---LRE-CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 149 (287)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHH---HHH-SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred cCCccEeeCCeeEEEeecccCcchHHH---hhh-ccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEEC
Confidence 334444444444566663333222221 111 223467888888888888775 5664 4699999999999999
Q ss_pred cCCceeEeecccccccCCCCc--cccccCceeecccccccccccCccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+++.+||+|||+|+....... .....||+.|||||++.++.++.++|+||||+++|..
T Consensus 150 ~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~el 209 (287)
T d1opja_ 150 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209 (287)
T ss_dssp GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHH
Confidence 999999999999997654332 2345688999999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.70 E-value=6.2e-20 Score=187.11 Aligned_cols=96 Identities=16% Similarity=0.243 Sum_probs=71.3
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc------cccccCceee
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST------KMSFAGTVAW 211 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~------~~~~~GT~~y 211 (600)
..++|.+++.|+.++|.+ |+|. .+||||||||+||||+.++++||+|||+|+....... .....||+.|
T Consensus 123 ~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y 199 (299)
T d1jpaa_ 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199 (299)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccc
Confidence 458888898888888886 4554 5799999999999999999999999999997644322 1224689999
Q ss_pred cccccccccccCccccccccccccccc
Q psy16430 212 MAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 212 mAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||||++.++.++.++|+||||+++|..
T Consensus 200 ~aPE~~~~~~~~~~sDvwS~Gvvl~el 226 (299)
T d1jpaa_ 200 TAPEAIQYRKFTSASDVWSYGIVMWEV 226 (299)
T ss_dssp SCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred cCHHHHhcCCCCcccccccchHHHHHH
Confidence 999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1e-19 Score=184.20 Aligned_cols=96 Identities=19% Similarity=0.234 Sum_probs=81.5
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeecc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMA 213 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymA 213 (600)
..+++..++.++.++|.++ +|. .+||||||||+||||+.++.+||+|||+|+.+..... .....||+.|||
T Consensus 104 ~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~a 180 (285)
T d1u59a_ 104 EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180 (285)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccC
Confidence 4578888888888888864 554 4799999999999999999999999999997654332 234678999999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||++.++.++.++|+||||+++|..
T Consensus 181 PE~~~~~~~~~ksDVwS~Gv~l~E~ 205 (285)
T d1u59a_ 181 PECINFRKFSSRSDVWSYGVTMWEA 205 (285)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred hHHHhCCCCCccchhhcchHHHHHH
Confidence 9999999999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=7.4e-20 Score=184.52 Aligned_cols=96 Identities=22% Similarity=0.218 Sum_probs=79.8
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeecc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMA 213 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymA 213 (600)
..++|..++.|+.++|.++ +|. .+||||||||+||||+.++.+||+|||+|+.+..... .....||+.|||
T Consensus 102 ~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~A 178 (277)
T d1xbba_ 102 RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178 (277)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCC
T ss_pred cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecC
Confidence 4588888888888888864 553 4699999999999999999999999999997654322 224679999999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||.+.++.++.++|+||||+++|..
T Consensus 179 PE~l~~~~~~~~sDiwS~Gv~l~el 203 (277)
T d1xbba_ 179 PECINYYKFSSKSDVWSFGVLMWEA 203 (277)
T ss_dssp HHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred chhhcCCCCCchhhhccchhhhhHH
Confidence 9999999999999999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.5e-19 Score=183.71 Aligned_cols=96 Identities=20% Similarity=0.244 Sum_probs=75.4
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAP 214 (600)
..+++...+.++..+|.++ +|. .+||||||||+||||++++.+||+|||+|+...... ...+..||+.||||
T Consensus 129 ~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 205 (299)
T d1ywna1 129 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205 (299)
T ss_dssp -CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence 4578888888888888864 553 579999999999999999999999999998654332 23357899999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.++.++.++|+||||+++|..
T Consensus 206 E~l~~~~~~~~sDiwS~Gvil~el 229 (299)
T d1ywna1 206 ETIFDRVYTIQSDVWSFGVLLWEI 229 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hHhhcCCCCcccceeehHHHHHHH
Confidence 999999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.3e-19 Score=185.12 Aligned_cols=99 Identities=16% Similarity=0.228 Sum_probs=80.0
Q ss_pred cccCCccceeeccccchh--hhccC-----CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----cccccCc
Q psy16430 141 RLSIPPQYQLELIGGPYW--FLAGC-----TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGT 208 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~~--~~~~~-----~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----~~~~~GT 208 (600)
+++|.+++.++.++|.++ +|..+ +.+||||||||+||||+.+|.+||+|||+++....... ....+||
T Consensus 96 ~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt 175 (303)
T d1vjya_ 96 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecc
Confidence 588999999999988864 55431 46899999999999999999999999999997644322 2347899
Q ss_pred eeeccccccccc------ccCcccccccccccccccc
Q psy16430 209 VAWMAPEVIRNE------QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 209 ~~ymAPE~i~~~------~~s~~~Dvy~~~~~~~p~s 239 (600)
++|||||++.+. .++.++|+||||+++|..-
T Consensus 176 ~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~ 212 (303)
T d1vjya_ 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp GGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence 999999998754 3678899999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=8.9e-20 Score=183.17 Aligned_cols=101 Identities=20% Similarity=0.224 Sum_probs=70.0
Q ss_pred ccccCCccceeeccccc--hhhhccC--CCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGP--YWFLAGC--TTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~--~~~~~~~--~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAP 214 (600)
..+++.....++..+|. .|+|... ..+||||||||+||||+.++.+||+|||+|+.+..... ..+.+||++||||
T Consensus 104 ~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~AP 183 (269)
T d2java1 104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183 (269)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCH
Confidence 34566666666666666 5677642 35799999999999999999999999999997654432 3457899999999
Q ss_pred ccccccccCccccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
|++.+..++.++|+||+|+++|..-.
T Consensus 184 E~l~~~~~~~~~DIwSlGvilyel~t 209 (269)
T d2java1 184 EQMNRMSYNEKSDIWSLGCLLYELCA 209 (269)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCChHHHHHhhCHHHHHHhh
Confidence 99999999999999999999997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.8e-19 Score=180.42 Aligned_cols=96 Identities=20% Similarity=0.332 Sum_probs=78.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.+++.....++..++.+ |+|. .+||||||||+||||+.++.+||+|||+|+..... .....+||+.|||||++.
T Consensus 102 ~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~ 177 (263)
T d2j4za1 102 KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIE 177 (263)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHc
Confidence 35555555566666664 5664 57999999999999999999999999999876443 234578999999999999
Q ss_pred ccccCccccccccccccccccc
Q psy16430 219 NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 219 ~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+..++.++|+||+|+++|..-.
T Consensus 178 ~~~~~~~~DiwSlGvilyell~ 199 (263)
T d2j4za1 178 GRMHDEKVDLWSLGVLCYEFLV 199 (263)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHH
T ss_pred CCCCCchhhhhhHhHHHHHHhc
Confidence 9999999999999999987543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.4e-19 Score=180.24 Aligned_cols=96 Identities=16% Similarity=0.268 Sum_probs=76.1
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE 215 (600)
.++......+...++.+ |+|. .+||||||||+|||+++++.+||+|||+|+...... ...+.+||+.|||||
T Consensus 99 ~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE 175 (271)
T d1nvra_ 99 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175 (271)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHh
Confidence 45555555566666664 5664 469999999999999999999999999999764322 234578999999999
Q ss_pred ccccccc-Ccccccccccccccccc
Q psy16430 216 VIRNEQC-SDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 216 ~i~~~~~-s~~~Dvy~~~~~~~p~s 239 (600)
++.+..+ +.++|+||+|+++|..-
T Consensus 176 ~~~~~~~~~~~~DiwSlGvilyeml 200 (271)
T d1nvra_ 176 LLKRREFHAEPVDVWSCGIVLTAML 200 (271)
T ss_dssp HHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCCCceeeeHhHHHHHHHH
Confidence 9988776 57799999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.7e-19 Score=181.83 Aligned_cols=132 Identities=17% Similarity=0.244 Sum_probs=96.4
Q ss_pred ccccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCC
Q psy16430 99 RPFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLG 176 (600)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~N 176 (600)
.--+.++++|..+++-.+|+|.-+..++..+. ....++......++..++. .|+|. .+||||||||+|
T Consensus 77 pnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~N 146 (293)
T d1yhwa1 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-------TETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDN 146 (293)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHH-------HHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred CCEeeEeEEEEECCEEEEEEEecCCCcHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHH
Confidence 33456677777777777888843333322211 1123444444455555555 45664 469999999999
Q ss_pred eeeccCCceeEeecccccccCCCC-ccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 177 VLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 177 ILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
||++.+|.+||+|||+|+.+.... .....+||+.|||||++.+..++.++|+||+|+++|..-.
T Consensus 147 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt 211 (293)
T d1yhwa1 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211 (293)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH
T ss_pred eEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh
Confidence 999999999999999999765433 3446789999999999999999999999999999997543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.2e-19 Score=183.85 Aligned_cols=126 Identities=17% Similarity=0.182 Sum_probs=89.4
Q ss_pred ccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccC
Q psy16430 105 VDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSK 182 (600)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~ 182 (600)
+++|..+++ .+|+|..+.++..++. +. .....++|.+++.|+.++|.+. +|. .+|+||||||+|||||.+
T Consensus 78 ~g~~~~~~~-~lv~Ey~~~g~l~~~~---~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~ 149 (285)
T d1fmka3 78 YAVVSEEPI-YIVTEYMSKGSLLDFL---KG-ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGEN 149 (285)
T ss_dssp EEEECSSSC-EEEECCCTTCBHHHHH---SH-HHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEecCCe-EEEEEecCCCchhhhh---hh-cccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCC
Confidence 333333444 5677744444433321 11 2234589999999999998864 554 469999999999999999
Q ss_pred CceeEeecccccccCCCC--ccccccCceeecccccccccccCccccccccccccccc
Q psy16430 183 EEAKISDFGTCREWNNKS--TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 183 ~~~Kv~DFGlsr~~~~~~--~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+++||+|||+|+.+.... ......||+.|||||++.++.++.++|+||||+++|..
T Consensus 150 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el 207 (285)
T d1fmka3 150 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 207 (285)
T ss_dssp GCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHH
Confidence 999999999999764433 23447799999999999999999999999999999965
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.68 E-value=2.1e-19 Score=183.03 Aligned_cols=99 Identities=19% Similarity=0.217 Sum_probs=80.9
Q ss_pred cccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeecccc
Q psy16430 139 QVRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPE 215 (600)
Q Consensus 139 ~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE 215 (600)
...++|..++.|+.++|.++-|.| +.+||||||||+|||||.++.+||+|||+|+...... ..++.+||+.|||||
T Consensus 134 ~~~l~~~~~~~i~~qi~~gl~ylH-~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE 212 (301)
T d1lufa_ 134 PPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212 (301)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CCCCCHHHHHHHHHHHHHHhhhcc-cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence 346888899999988888753332 3679999999999999999999999999998653322 233577999999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.+..++.++|+||||+++|..
T Consensus 213 ~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 213 SIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHccCCCChhhhhccchhhHHHH
Confidence 99999999999999999999965
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=2.3e-19 Score=181.93 Aligned_cols=129 Identities=14% Similarity=0.144 Sum_probs=87.1
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd 180 (600)
..+++|..++.-.+|+|..+..+...+. .....++......++...+. .|+|. .+||||||||+|||++
T Consensus 72 ~l~~~~~~~~~~~ivmEy~~gg~L~~~~------~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 72 KLYFTFQDDEKLYFGLSYAKNGELLKYI------RKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLN 142 (288)
T ss_dssp CEEEEEECSSEEEEEECCCTTEEHHHHH------HHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred EEEEEEEECCEEEEEEEccCCCCHHHhh------hccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccC
Confidence 3344455555556666633322222211 11123444444445555555 45554 4699999999999999
Q ss_pred cCCceeEeecccccccCCCC---ccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
.+|.+||+|||+|+.+.... ...+.+||+.|||||++.+..++.++|+||+|+++|..-.
T Consensus 143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 205 (288)
T d1uu3a_ 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205 (288)
T ss_dssp TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh
Confidence 99999999999999764332 2345789999999999999999999999999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.1e-19 Score=187.11 Aligned_cols=96 Identities=19% Similarity=0.257 Sum_probs=75.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++...+. .|+|+. .+||||||||+||||+.+|.+||+|||+|+.+... ...+.+||++|||||++.+
T Consensus 101 l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 101 IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcC
Confidence 555555555555555 567753 25999999999999999999999999999965332 2345799999999999999
Q ss_pred cccCccccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~sl 240 (600)
..|+.++|+||+|++++..-.
T Consensus 178 ~~y~~~~DiWSlGvil~ell~ 198 (322)
T d1s9ja_ 178 THYSVQSDIWSMGLSLVEMAV 198 (322)
T ss_dssp SCCCTTHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.66 E-value=7.1e-19 Score=180.59 Aligned_cols=86 Identities=19% Similarity=0.270 Sum_probs=71.9
Q ss_pred eeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccccccCcccc
Q psy16430 150 LELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 227 (600)
Q Consensus 150 i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~D 227 (600)
++..++. .|+|. .+||||||||+||||+.+|.+||+|||+|+..... ..+.+||+.|||||++.+..++.++|
T Consensus 109 ~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~D 183 (316)
T d1fota_ 109 YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSID 183 (316)
T ss_dssp HHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHH
T ss_pred HHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhh
Confidence 4444444 45654 47999999999999999999999999999976443 34678999999999999999999999
Q ss_pred ccccccccccccc
Q psy16430 228 IWYKNRLCFPTSL 240 (600)
Q Consensus 228 vy~~~~~~~p~sl 240 (600)
+||+|+++|..-.
T Consensus 184 iwSlGvilyemlt 196 (316)
T d1fota_ 184 WWSFGILIYEMLA 196 (316)
T ss_dssp HHHHHHHHHHHHH
T ss_pred ccccchhHHHHHh
Confidence 9999999997643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=9.4e-19 Score=175.72 Aligned_cols=97 Identities=16% Similarity=0.139 Sum_probs=76.3
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeecc-CCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGS-KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~-~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|.. ..+||||||||.||||++ ++.+||+|||+|+..... ...+.+||+.|||||++
T Consensus 108 ~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~ 185 (270)
T d1t4ha_ 108 VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMY 185 (270)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGG
T ss_pred cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHh
Confidence 45566666666666665 56653 467999999999999974 789999999999864332 34467899999999998
Q ss_pred cccccCccccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
. ++++.++|+||+|+++|..-.
T Consensus 186 ~-~~~~~~~DIwSlGvilyel~~ 207 (270)
T d1t4ha_ 186 E-EKYDESVDVYAFGMCMLEMAT 207 (270)
T ss_dssp G-TCCCTHHHHHHHHHHHHHHHH
T ss_pred C-CCCCCcCchhhHHHHHHHHHH
Confidence 6 469999999999999997643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=7.8e-19 Score=175.15 Aligned_cols=131 Identities=16% Similarity=0.104 Sum_probs=97.1
Q ss_pred hhhccccccccccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCe
Q psy16430 90 RLTKLSVCWRPFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPD 167 (600)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~i 167 (600)
.+.|+.|+|.....++.|.+.-+.+.+ .... ......+++..+..++.++|.+ |+|. .+|
T Consensus 60 nIv~~~g~~~~~~~~~iv~Ey~~~g~l-------~~~~--------~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~i 121 (258)
T d1k2pa_ 60 KLVQLYGVCTKQRPIFIITEYMANGCL-------LNYL--------REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121 (258)
T ss_dssp TBCCEEEEECCSSSEEEEEECCTTEEH-------HHHH--------HSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTB
T ss_pred ceeeEEEEEeeCCceEEEEEccCCCcH-------HHhh--------hccccCCcHHHHHHHHHHHHHHHHHHhh---cCc
Confidence 456778888766555555543333222 1111 1222346777788887777775 5664 469
Q ss_pred EEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccccccccccCccccccccccccccc
Q psy16430 168 ALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 168 iHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
+||||||+|||+++++.+||+|||+|+....... .....||+.|||||.+.+..++.++|+||||+++|..
T Consensus 122 iH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el 194 (258)
T d1k2pa_ 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 194 (258)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhH
Confidence 9999999999999999999999999987654432 3346799999999999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=3.7e-19 Score=182.60 Aligned_cols=96 Identities=15% Similarity=0.170 Sum_probs=78.8
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAP 214 (600)
..+++..++.++..+|.| |+|. .+||||||||.||||++++.+||+|||+|+....... .....||+.||||
T Consensus 106 ~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 182 (317)
T d1xkka_ 106 DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182 (317)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccCh
Confidence 457788888888888885 5654 4699999999999999999999999999997654332 2345789999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.++.++.++|+||||+++|..
T Consensus 183 E~l~~~~~~~~sDvwS~Gvil~el 206 (317)
T d1xkka_ 183 ESILHRIYTHQSDVWSYGVTVWEL 206 (317)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCChhhhhhhHHHHHHHH
Confidence 999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=7.3e-19 Score=179.96 Aligned_cols=126 Identities=18% Similarity=0.203 Sum_probs=89.6
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd 180 (600)
.++++|..+++-.+|+|.-..++.... . ..+.++++.....++..++.| |+|. .+||||||||+||||+
T Consensus 79 ~~~~~~~~~~~~~iv~E~~~~g~l~~~-----~-~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~ 149 (309)
T d1u5ra_ 79 QYRGCYLREHTAWLVMEYCLGSASDLL-----E-VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLS 149 (309)
T ss_dssp CEEEEEEETTEEEEEEECCSEEHHHHH-----H-HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEE
T ss_pred eEEEEEEECCEEEEEEEecCCCchHHH-----H-HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEC
Confidence 344445555555566663222221111 0 112457777777777777775 5664 4699999999999999
Q ss_pred cCCceeEeecccccccCCCCccccccCceeecccccccc---cccCccccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN---EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~---~~~s~~~Dvy~~~~~~~p~sl 240 (600)
.++.+||+|||+|+.... ....+||+.|||||++.+ +.|+.++|+||+|+++|..-.
T Consensus 150 ~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 150 EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence 999999999999986533 235689999999999853 568999999999999997643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=5.7e-19 Score=178.99 Aligned_cols=130 Identities=17% Similarity=0.150 Sum_probs=89.8
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd 180 (600)
.++++|..++.-.+|+|.-+..+...+. . ....+++......++..++.+ |+|. .+||||||||+|||++
T Consensus 73 ~l~~~~~~~~~~~lvmEy~~~g~L~~~~---~--~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~ 144 (288)
T d2jfla1 73 KLLDAFYYENNLWILIEFCAGGAVDAVM---L--ELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFT 144 (288)
T ss_dssp CEEEEEEETTEEEEEEECCTTEEHHHHH---H--HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEecCCCCcHHHHH---H--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeEC
Confidence 3444555555556777733322222211 0 112346666666666666664 5664 4699999999999999
Q ss_pred cCCceeEeecccccccCCCC-ccccccCceeeccccccc-----ccccCccccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIR-----NEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~-----~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
.+|.+||+|||+|+...... ...+.+||+.|||||++. ...|+.++|+||+|+++|..-.
T Consensus 145 ~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt 210 (288)
T d2jfla1 145 LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210 (288)
T ss_dssp TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh
Confidence 99999999999998654322 233578999999999984 4568899999999999997643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=8.4e-19 Score=179.31 Aligned_cols=100 Identities=20% Similarity=0.169 Sum_probs=82.5
Q ss_pred ccccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 138 EQVRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 138 ~~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
....++|..++.++.++|.|.-|.+ +.+||||||||+|||++.++.+||+|||+|+............||..|+|||.+
T Consensus 120 ~~~~l~~~~~~~~~~qia~gl~~lH-~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l 198 (309)
T d1fvra_ 120 TASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 198 (309)
T ss_dssp BSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH
T ss_pred ccCCCCHHHHHHHHHHHHHHHHhhh-cCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHh
Confidence 3456889999999999999763332 357999999999999999999999999999876544444456799999999999
Q ss_pred cccccCccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.++.++.++|+||||+++|..
T Consensus 199 ~~~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 199 NYSVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp HHCEECHHHHHHHHHHHHHHH
T ss_pred ccCCCCccceeehhHHHHHHH
Confidence 999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=8.6e-19 Score=175.94 Aligned_cols=98 Identities=17% Similarity=0.222 Sum_probs=69.8
Q ss_pred ccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc--cccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST--KMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~--~~~~~GT~~ymAPE~i 217 (600)
..+++...+.++..+|.++-|.+ +.+||||||||+|||+++++.+||+|||+|+....... .+...||+.|||||++
T Consensus 103 ~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l 181 (273)
T d1mp8a_ 103 YSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181 (273)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHhhhhc-ccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHh
Confidence 35777788888878877652222 25799999999999999999999999999987643322 3346789999999999
Q ss_pred cccccCccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+..++.++|+||||+++|..
T Consensus 182 ~~~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 182 NFRRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp HHCCCSHHHHHHHHHHHHHHH
T ss_pred ccCCCCCccccccchHHHHHH
Confidence 999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=2.5e-18 Score=178.03 Aligned_cols=84 Identities=20% Similarity=0.375 Sum_probs=71.4
Q ss_pred ccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCC-CCccccccCceeecccccccccccCccccccccc
Q psy16430 154 GGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNN-KSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKN 232 (600)
Q Consensus 154 ~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~-~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~ 232 (600)
.|..|+|. .+||||||||+|||++.+|.+||+|||+|+.... .....+.+||+.|||||++.+..|+.++|+||+|
T Consensus 116 ~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlG 192 (337)
T d1o6la_ 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192 (337)
T ss_dssp HHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred hhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchh
Confidence 34456665 4799999999999999999999999999997544 3344568999999999999999999999999999
Q ss_pred cccccccc
Q psy16430 233 RLCFPTSL 240 (600)
Q Consensus 233 ~~~~p~sl 240 (600)
+++|..-.
T Consensus 193 vilyeml~ 200 (337)
T d1o6la_ 193 VVMYEMMC 200 (337)
T ss_dssp HHHHHHHH
T ss_pred hHHHHHHH
Confidence 99997543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.62 E-value=1.6e-18 Score=177.15 Aligned_cols=131 Identities=16% Similarity=0.103 Sum_probs=80.1
Q ss_pred ccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCee
Q psy16430 101 FCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVL 178 (600)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NIL 178 (600)
....+++|..+++-.+|+|.-+..++..+. .....++......++..++.| |+|. .+||||||||.|||
T Consensus 69 Iv~l~~~~~~~~~~~lvmE~~~gg~L~~~l------~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil 139 (307)
T d1a06a_ 69 IVALDDIYESGGHLYLIMQLVSGGELFDRI------VEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLL 139 (307)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHH------HTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCcEEEEEEECCEEEEEEeccCCCcHHHhh------hcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEeccccee
Confidence 344455566666666777733322222211 112345555555566566664 5664 47999999999999
Q ss_pred ec---cCCceeEeecccccccCCCCccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 179 IG---SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 179 Ld---~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+. .++.+||+|||+|+.........+.+||+.|||||++.+..++.++|+||+|+++|..-.
T Consensus 140 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 204 (307)
T d1a06a_ 140 YYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204 (307)
T ss_dssp ESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh
Confidence 95 578999999999997765555556889999999999999999999999999999987543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.62 E-value=2.7e-18 Score=179.61 Aligned_cols=92 Identities=16% Similarity=0.146 Sum_probs=72.9
Q ss_pred Cccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc-cc
Q psy16430 145 PPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN-EQ 221 (600)
Q Consensus 145 ~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~-~~ 221 (600)
.....++..++. .|+|. .+||||||||+||||+.+|.+||+|||+|+.+.... ....+||+.|||||++.. ..
T Consensus 107 ~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~ 182 (364)
T d1omwa3 107 ADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVA 182 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCC
T ss_pred HHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCC
Confidence 333335545555 45664 579999999999999999999999999999765432 345689999999999875 46
Q ss_pred cCccccccccccccccccc
Q psy16430 222 CSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 222 ~s~~~Dvy~~~~~~~p~sl 240 (600)
++.++|+||+|+++|..-.
T Consensus 183 ~~~~~DiwSlGvilyemlt 201 (364)
T d1omwa3 183 YDSSADWFSLGCMLFKLLR 201 (364)
T ss_dssp CCTHHHHHHHHHHHHHHHH
T ss_pred CCcccchhHHHHHHHHHHh
Confidence 8999999999999997643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.62 E-value=2.5e-18 Score=179.01 Aligned_cols=94 Identities=17% Similarity=0.233 Sum_probs=75.5
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++...-..++..++. .|+|. .+||||||||+||||+.+|.+||+|||+|+.+... ..+.+||+.|||||++.+
T Consensus 138 l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 138 FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcC
Confidence 333333335555555 45664 46999999999999999999999999999976433 345789999999999999
Q ss_pred cccCccccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~sl 240 (600)
..++.++|+||+|+++|..-.
T Consensus 213 ~~~~~~~DiwSlGvilyemlt 233 (350)
T d1rdqe_ 213 KGYNKAVDWWALGVLIYEMAA 233 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCCccccccchhHHHHHHHh
Confidence 999999999999999997643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=5.5e-18 Score=172.33 Aligned_cols=99 Identities=19% Similarity=0.224 Sum_probs=82.3
Q ss_pred cccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC---ccccccCceeecccc
Q psy16430 139 QVRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS---TKMSFAGTVAWMAPE 215 (600)
Q Consensus 139 ~~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~---~~~~~~GT~~ymAPE 215 (600)
...+++.+.+.++.++|.++-|.| +.+||||||||.|||++.++.+||+|||+++...... ......||+.|||||
T Consensus 129 ~~~l~~~~~~~~~~qi~~al~ylH-~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (299)
T d1fgka_ 129 EEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207 (299)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred cccCCHHHHHHHHHHHHHHHHHhh-hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence 346888888888888888753322 3569999999999999999999999999999764332 233477999999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.++.|+.++|+||||+++|..
T Consensus 208 ~l~~~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 208 ALFDRIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCchhhhHHhHHHHHHh
Confidence 99999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.61 E-value=4.2e-18 Score=177.28 Aligned_cols=130 Identities=16% Similarity=0.130 Sum_probs=94.6
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL 179 (600)
...+++|...+.-.+|+|.-+..++.... . .....+++.....|+..++.+ |+|. .+||||||||+||||
T Consensus 86 v~~~~~~~~~~~~~ivmE~~~gg~L~~~l---~--~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll 157 (350)
T d1koaa2 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKV---A--DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMF 157 (350)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHH---T--CTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred CcEEEEEEECCEEEEEEEcCCCCCHHHHH---H--hhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeee
Confidence 34445555555556777743333322211 1 112346666666666666665 5664 479999999999999
Q ss_pred cc--CCceeEeecccccccCCCCccccccCceeecccccccccccCcccccccccccccccc
Q psy16430 180 GS--KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 180 d~--~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
+. ++.+||+|||+|+.+.......+.+||+.|||||++.+..++.++|+||+|+++|..-
T Consensus 158 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 158 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp SSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred ccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 64 6789999999999877666666789999999999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.61 E-value=7.1e-18 Score=175.65 Aligned_cols=131 Identities=16% Similarity=0.094 Sum_probs=93.8
Q ss_pred cccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeee
Q psy16430 102 CSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLI 179 (600)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILL 179 (600)
+..+++|..++.-.+|+|.-+..++.... ...+.+++...-..|+..++.+ |+|. .+||||||||.||||
T Consensus 89 v~~~~~~~~~~~~~ivmE~~~gg~L~~~~-----~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl 160 (352)
T d1koba_ 89 INLHDAFEDKYEMVLILEFLSGGELFDRI-----AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMC 160 (352)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHT-----TCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred CcEEEEEEECCEEEEEEEcCCCChHHHHH-----HhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccc
Confidence 44455565555556777733332221110 1112235555445555555554 5664 479999999999999
Q ss_pred c--cCCceeEeecccccccCCCCccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 180 G--SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 180 d--~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+ .++.+||+|||+|+.+.......+..||+.|||||++.+..++.++|+||+|++++..-.
T Consensus 161 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt 223 (352)
T d1koba_ 161 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223 (352)
T ss_dssp SSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred cccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh
Confidence 8 578999999999998876666667899999999999999999999999999999997543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=5.8e-18 Score=173.30 Aligned_cols=98 Identities=18% Similarity=0.239 Sum_probs=81.0
Q ss_pred ccccCCccceeeccccchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-----cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-----KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-----~~~~~GT~~ymAP 214 (600)
..+.+..++.++.++|.++.|.+ +.+|+||||||+|||||+++.+||+|||+++....... .....||+.|+||
T Consensus 125 ~~~~~~~~~~i~~qia~gL~~lH-~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aP 203 (311)
T d1r0pa_ 125 HNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203 (311)
T ss_dssp CCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCH
T ss_pred ccchHHHHHHHHHHHHHhhhhhc-ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccCh
Confidence 34567777888888888764433 45799999999999999999999999999997643321 2246789999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|.+.++.++.++|+||||+++|..
T Consensus 204 E~~~~~~~~~ksDI~SfGivl~El 227 (311)
T d1r0pa_ 204 ESLQTQKFTTKSDVWSFGVLLWEL 227 (311)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCChhHhhhhHHHHHHH
Confidence 999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=3.5e-18 Score=171.72 Aligned_cols=96 Identities=16% Similarity=0.228 Sum_probs=78.4
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc----cccccCceeecc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST----KMSFAGTVAWMA 213 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~----~~~~~GT~~ymA 213 (600)
..+++..++.++..+|.| |+|. .+||||||||+||||+.++.+||+|||+++.+..... .....||.+|||
T Consensus 106 ~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~a 182 (273)
T d1u46a_ 106 GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182 (273)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCC
Confidence 358888888888888886 5564 4699999999999999999999999999997654332 223568899999
Q ss_pred cccccccccCccccccccccccccc
Q psy16430 214 PEVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 214 PE~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
||.+.+..++.++|+||||+++|..
T Consensus 183 PE~~~~~~~~~~~Di~S~Gvil~em 207 (273)
T d1u46a_ 183 PESLKTRTFSHASDTWMFGVTLWEM 207 (273)
T ss_dssp HHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCcchhhhhhHHHHHHH
Confidence 9999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=3.1e-18 Score=171.18 Aligned_cols=94 Identities=23% Similarity=0.264 Sum_probs=74.9
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
..++|..++.|+.++|.++ +|. .+||||||||.|||++.+|.+|++|||+++..... .....||..|||||++
T Consensus 98 ~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l 172 (262)
T d1byga_ 98 SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEAL 172 (262)
T ss_dssp HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHH
T ss_pred CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC--CccccccccCCChHHH
Confidence 4588999999999998865 553 57999999999999999999999999999865432 3345789999999999
Q ss_pred cccccCccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.++.++.++|+||||+++|..
T Consensus 173 ~~~~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 173 REKKFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp HHCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCChHHHHHhHHHHHHHH
Confidence 999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=5.1e-18 Score=173.40 Aligned_cols=95 Identities=17% Similarity=0.181 Sum_probs=80.2
Q ss_pred cccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAPE 215 (600)
.++|..++.|+.++|.++ +|. .+||||||||+|||+|+++++||+|||+|+....... .....||+.|||||
T Consensus 129 ~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 129 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence 467888888888888865 443 4799999999999999999999999999986644322 33457899999999
Q ss_pred cccccccCccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
.+.++.++.++|+||||+++|..
T Consensus 206 ~l~~~~~~~~~Dv~S~G~il~El 228 (308)
T d1p4oa_ 206 SLKDGVFTTYSDVWSFGVVLWEI 228 (308)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHccCCCCcccccccHHHHHHHH
Confidence 99999999999999999998865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=8.8e-18 Score=173.74 Aligned_cols=98 Identities=17% Similarity=0.189 Sum_probs=79.9
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeecc---CCceeEeecccccccCCCCccccccCceeecccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGS---KEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPE 215 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~---~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE 215 (600)
.++......|+..++. .|+|. .+||||||||+|||++. .+.+||+|||+|+...........+||+.|||||
T Consensus 107 ~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 183 (335)
T d2ozaa1 107 AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183 (335)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCC
T ss_pred CcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcH
Confidence 4555555556555555 45664 47999999999999986 5679999999999876665566788999999999
Q ss_pred cccccccCcccccccccccccccccc
Q psy16430 216 VIRNEQCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 216 ~i~~~~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
++.+..|+.++|+||+|+++|..-.+
T Consensus 184 ~~~~~~y~~~~DiwSlGvily~lltg 209 (335)
T d2ozaa1 184 VLGPEKYDKSCDMWSLGVIMYILLCG 209 (335)
T ss_dssp CCCGGGGSHHHHHHHHHHHHHHHTTS
T ss_pred HHcCCCCCHHHHHHhhchhHHHHhhC
Confidence 99999999999999999999976443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=5.9e-18 Score=169.89 Aligned_cols=142 Identities=20% Similarity=0.203 Sum_probs=98.7
Q ss_pred hhhccccccccccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccc--hhhhccCCCCe
Q psy16430 90 RLTKLSVCWRPFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGP--YWFLAGCTTPD 167 (600)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~--~~~~~~~~~~i 167 (600)
-|.+|..++.--+..+++|+.++.-.+++|......... ++ ...+..++......++..++. .|+|. .+|
T Consensus 60 il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~---~~--~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~i 131 (273)
T d1xwsa_ 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF---DF--ITERGALQEELARSFFWQVLEAVRHCHN---CGV 131 (273)
T ss_dssp HHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHH---HH--HHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred HHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHH---HH--HhccCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Confidence 345555545556778888888887788888433211111 00 112234555555555555555 45664 579
Q ss_pred EEEeccCCCeeeccC-CceeEeecccccccCCCCccccccCceeeccccccccccc-Cccccccccccccccccc
Q psy16430 168 ALAESIGLGVLIGSK-EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQC-SDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 168 iHrdlk~~NILLd~~-~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~-s~~~Dvy~~~~~~~p~sl 240 (600)
|||||||+|||++.+ +.+||+|||+|+..... ..++.+||+.|||||++.+..+ +.++|+||+|+++|..-.
T Consensus 132 iHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~ 205 (273)
T d1xwsa_ 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205 (273)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred ccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence 999999999999954 79999999999865433 3446789999999999987775 567899999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.2e-17 Score=169.24 Aligned_cols=132 Identities=14% Similarity=0.118 Sum_probs=95.5
Q ss_pred cccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCe
Q psy16430 100 PFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGV 177 (600)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NI 177 (600)
--...+++|+.++.-.+|+|.-+..++..+. .....+++.....++..++.+ |+|. .+||||||||.||
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i------~~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Ni 144 (293)
T d1jksa_ 74 NVITLHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENI 144 (293)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHH------HHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCccccchh------ccccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceE
Confidence 3345556666666667777743332222211 112245555555566555554 5664 4699999999999
Q ss_pred eeccCC----ceeEeecccccccCCCCccccccCceeecccccccccccCccccccccccccccccc
Q psy16430 178 LIGSKE----EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 178 LLd~~~----~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
|++.++ .+|++|||+|+....+....+..||+.|||||++.+..++.++|+||+|+++|..-.
T Consensus 145 ll~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 211 (293)
T d1jksa_ 145 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211 (293)
T ss_dssp EESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred EEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc
Confidence 999887 499999999998766655667889999999999999999999999999999987543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=2e-17 Score=167.90 Aligned_cols=97 Identities=14% Similarity=0.124 Sum_probs=75.7
Q ss_pred cccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.++......++..++. .|+|. .+||||||||+|||++.++.+||+|||+|+...... ...+.+||+.|||||++
T Consensus 96 ~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~ 172 (299)
T d1ua2a_ 96 VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172 (299)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHH
Confidence 3555555555555555 46664 469999999999999999999999999998765433 33457899999999998
Q ss_pred ccc-ccCccccccccccccccccc
Q psy16430 218 RNE-QCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 218 ~~~-~~s~~~Dvy~~~~~~~p~sl 240 (600)
..+ .++.++|+||+|++++..-.
T Consensus 173 ~~~~~~~~~~DiwSlGvil~el~~ 196 (299)
T d1ua2a_ 173 FGARMYGVGVDMWAVGCILAELLL 196 (299)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCChhhhhhhcchHHHHHHh
Confidence 654 57999999999999997643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.3e-17 Score=169.31 Aligned_cols=96 Identities=16% Similarity=0.184 Sum_probs=78.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
+++.....++..++. .|+|. .+||||||||+|||++.++.+||+|||+++............||+.|||||++.+
T Consensus 113 ~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 113 VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC
Confidence 444444445555555 46665 4699999999999999999999999999987655555567889999999999999
Q ss_pred cccCccccccccccccccccc
Q psy16430 220 EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 220 ~~~s~~~Dvy~~~~~~~p~sl 240 (600)
.+|+.++|+||+|++++..-.
T Consensus 190 ~~y~~~~DiwSlG~il~ell~ 210 (305)
T d1blxa_ 190 SSYATPVDLWSVGCIFAEMFR 210 (305)
T ss_dssp CCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCChhehhhchHHHHHHHHH
Confidence 999999999999999986543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.7e-17 Score=170.45 Aligned_cols=90 Identities=19% Similarity=0.279 Sum_probs=73.9
Q ss_pred ceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccccccccCc
Q psy16430 148 YQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVIRNEQCSD 224 (600)
Q Consensus 148 ~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i~~~~~s~ 224 (600)
..++..+|. .|+|. .+||||||||.|||+++++.+|++|||+|+...... .....+||+.|||||++.+..++.
T Consensus 106 ~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (320)
T d1xjda_ 106 TFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182 (320)
T ss_dssp HHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCc
Confidence 334445555 45665 369999999999999999999999999998654433 344578999999999999999999
Q ss_pred cccccccccccccccc
Q psy16430 225 KIDIWYKNRLCFPTSL 240 (600)
Q Consensus 225 ~~Dvy~~~~~~~p~sl 240 (600)
++|+||+|+++|..-.
T Consensus 183 ~~DiwSlGvilyemlt 198 (320)
T d1xjda_ 183 SVDWWSFGVLLYEMLI 198 (320)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhHHHHHHHh
Confidence 9999999999997644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=4.5e-17 Score=166.40 Aligned_cols=96 Identities=22% Similarity=0.268 Sum_probs=81.5
Q ss_pred ccccCCccceeeccccchh--hhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc---cccccCceeeccc
Q psy16430 140 VRLSIPPQYQLELIGGPYW--FLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST---KMSFAGTVAWMAP 214 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~~--~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~---~~~~~GT~~ymAP 214 (600)
..+++..+..++.++|.+. +|. .+||||||||+|||++.++.+|++|||+++....... ....+||+.||||
T Consensus 140 ~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP 216 (311)
T d1t46a_ 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence 4688888888888888864 554 4699999999999999999999999999997644322 2347899999999
Q ss_pred ccccccccCccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPT 238 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~ 238 (600)
|++.++.++.++|+||||+++|..
T Consensus 217 E~~~~~~~~~~~DIwS~G~~l~el 240 (311)
T d1t46a_ 217 ESIFNCVYTFESDVWSYGIFLWEL 240 (311)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCcccccchHHHHHHH
Confidence 999999999999999999999965
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=2.4e-16 Score=159.56 Aligned_cols=98 Identities=13% Similarity=0.062 Sum_probs=76.1
Q ss_pred cccCCccceeeccccchhhhccCCCCeEEEeccCCCeeecc-----CCceeEeecccccccCCCC--------ccccccC
Q psy16430 141 RLSIPPQYQLELIGGPYWFLAGCTTPDALAESIGLGVLIGS-----KEEAKISDFGTCREWNNKS--------TKMSFAG 207 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~~~~~~~~~~iiHrdlk~~NILLd~-----~~~~Kv~DFGlsr~~~~~~--------~~~~~~G 207 (600)
.+++.....++...+.+.-|.| +.+||||||||+|||++. ++.+|++|||+|+.+.... ...+.+|
T Consensus 97 ~~~~~~~~~i~~q~~~~l~~lH-~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~G 175 (293)
T d1csna_ 97 KFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175 (293)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCS
T ss_pred chhhHHHHHHHHHHHHHHHHHH-HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEE
Confidence 4566666666666666542222 357999999999999975 5789999999999754321 1234689
Q ss_pred ceeecccccccccccCcccccccccccccccc
Q psy16430 208 TVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 208 T~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
|+.|||||.+.+..++.++|+||+|+++|..-
T Consensus 176 T~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell 207 (293)
T d1csna_ 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFL 207 (293)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred chhhcCHHHhcCCCCChHHHHHHhhHHHHHHH
Confidence 99999999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.50 E-value=1.5e-16 Score=159.95 Aligned_cols=129 Identities=16% Similarity=0.206 Sum_probs=92.7
Q ss_pred ccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec
Q psy16430 103 SFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG 180 (600)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd 180 (600)
..+++|..+++-.+|+|.-+..++..+. ....++++.....++..++.+ |+|. .+||||||||+|||++
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l------~~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLD 144 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHH------HHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEc
Confidence 4455566666656777733322222211 112346666666677666664 5664 3699999999999999
Q ss_pred cCCceeEeecccccccCCCCccccccCceeecccccccc------cccCccccccccccccccccc
Q psy16430 181 SKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN------EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 181 ~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~------~~~s~~~Dvy~~~~~~~p~sl 240 (600)
.++.+||+|||+|+.+.........+||+.|+|||.+.. ..++.++|+||+|++++..-.
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~ 210 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210 (277)
T ss_dssp TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc
Confidence 999999999999998766555556789999999999864 346788999999999986543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.3e-16 Score=161.81 Aligned_cols=97 Identities=18% Similarity=0.178 Sum_probs=76.4
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-ccccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-TKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-~~~~~~GT~~ymAPE~i 217 (600)
.+++.....++..++.+ |+|. .+||||||||+|||++.++.+||+|||+|+...... ......||+.|+|||.+
T Consensus 98 ~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~ 174 (298)
T d1gz8a_ 98 GIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhh
Confidence 45666655666666664 5664 569999999999999999999999999998765433 34456899999999987
Q ss_pred cccc-cCccccccccccccccccc
Q psy16430 218 RNEQ-CSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 218 ~~~~-~s~~~Dvy~~~~~~~p~sl 240 (600)
.... ++.++|+||+|++++..-.
T Consensus 175 ~~~~~~~~~~DiwSlGvily~m~~ 198 (298)
T d1gz8a_ 175 LGCKYYSTAVDIWSLGCIFAEMVT 198 (298)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred ccccCCCccccccccchhhhHHhh
Confidence 7666 4789999999999986543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.8e-16 Score=160.32 Aligned_cols=96 Identities=15% Similarity=0.156 Sum_probs=76.6
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccC--CceeEeecccccccCCCCccccccCceeecccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSK--EEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVI 217 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~--~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i 217 (600)
++......++..++. .|+|. .+||||||||.|||++.+ +.+|++|||+++.........+..||+.|+|||.+
T Consensus 99 l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~ 175 (321)
T d1tkia_ 99 LNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhc
Confidence 444444445555555 46664 469999999999999854 47999999999987665555567899999999999
Q ss_pred cccccCccccccccccccccccc
Q psy16430 218 RNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 218 ~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
.+..++.++|+||+|++++..-.
T Consensus 176 ~~~~~~~~~DiWSlGvily~ll~ 198 (321)
T d1tkia_ 176 QHDVVSTATDMWSLGTLVYVLLS 198 (321)
T ss_dssp TTCEECHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCchhhcccHHHHHHHHHh
Confidence 99999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.47 E-value=5.2e-16 Score=155.56 Aligned_cols=97 Identities=12% Similarity=0.213 Sum_probs=71.9
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC----ccccccCceeeccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS----TKMSFAGTVAWMAP 214 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~----~~~~~~GT~~ymAP 214 (600)
++++.....|+..++.+ |+|. .+||||||||+||||+.++..+++|||+++...... ...+.+||+.||||
T Consensus 107 ~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 183 (277)
T d1o6ya_ 107 PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183 (277)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCH
Confidence 46666666666666665 5653 579999999999999999999999999998653322 23457899999999
Q ss_pred ccccccccCccccccccccccccccc
Q psy16430 215 EVIRNEQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 215 E~i~~~~~s~~~Dvy~~~~~~~p~sl 240 (600)
|++.+..++.++|+||+|+++|..-.
T Consensus 184 E~~~~~~~~~~~DiwSlGvilyellt 209 (277)
T d1o6ya_ 184 EQARGDSVDARSDVYSLGCVLYEVLT 209 (277)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCcceecccchHHHHHHHh
Confidence 99999999999999999999987643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=6.2e-16 Score=156.53 Aligned_cols=97 Identities=12% Similarity=0.084 Sum_probs=76.8
Q ss_pred ccccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeec---cCCceeEeecccccccCCCC--------cccccc
Q psy16430 140 VRLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIG---SKEEAKISDFGTCREWNNKS--------TKMSFA 206 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd---~~~~~Kv~DFGlsr~~~~~~--------~~~~~~ 206 (600)
..+++.....++..++.+ |+|. .+||||||||+|||++ .+..+|++|||+|+.+.... ...+..
T Consensus 98 ~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 174 (299)
T d1ckia_ 98 RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174 (299)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCC
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcC
Confidence 346677777777766665 5664 4699999999999875 45579999999999764322 123468
Q ss_pred CceeecccccccccccCcccccccccccccccc
Q psy16430 207 GTVAWMAPEVIRNEQCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 207 GT~~ymAPE~i~~~~~s~~~Dvy~~~~~~~p~s 239 (600)
||+.|||||.+.+..++.++|+||+|++++..-
T Consensus 175 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp CCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH
T ss_pred CCccccCHHHHhCCCCCChhhEEecCHHHHHHH
Confidence 999999999999999999999999999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.8e-15 Score=156.83 Aligned_cols=98 Identities=15% Similarity=0.167 Sum_probs=77.9
Q ss_pred ccccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCC-ceeEeecccccccCCCCccccccCceeeccccc
Q psy16430 140 VRLSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEV 216 (600)
Q Consensus 140 ~~l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~-~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~ 216 (600)
..+++.....++..++. .|+|. .+||||||||+||||+.++ .+||+|||+|+.........+.+||+.|+|||.
T Consensus 117 ~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 193 (350)
T d1q5ka_ 117 QTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193 (350)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHH
Confidence 34566555555555556 45663 5799999999999999875 899999999998766655666789999999998
Q ss_pred ccc-cccCccccccccccccccccc
Q psy16430 217 IRN-EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 217 i~~-~~~s~~~Dvy~~~~~~~p~sl 240 (600)
+.. ..++.++|+||+|++++..-.
T Consensus 194 ~~~~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 194 IFGATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred hhcccCCCcceeecccceEEEehhh
Confidence 764 568999999999999987643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=2.9e-15 Score=152.80 Aligned_cols=88 Identities=17% Similarity=0.169 Sum_probs=69.3
Q ss_pred eeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC-----ccccccCceeeccccccccc-c
Q psy16430 150 LELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS-----TKMSFAGTVAWMAPEVIRNE-Q 221 (600)
Q Consensus 150 i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~-----~~~~~~GT~~ymAPE~i~~~-~ 221 (600)
|+..++.+ |+| +.+||||||||+|||++.++.+||+|||+|+.+.... ...+.+||++|+|||++.+. .
T Consensus 122 i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 198 (318)
T d3blha1 122 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD 198 (318)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSS
T ss_pred HHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCC
Confidence 44444554 555 3579999999999999999999999999998664322 23346899999999998754 6
Q ss_pred cCccccccccccccccccc
Q psy16430 222 CSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 222 ~s~~~Dvy~~~~~~~p~sl 240 (600)
++.++|+||+|++++..-.
T Consensus 199 ~~~k~DiwSlGvil~el~~ 217 (318)
T d3blha1 199 YGPPIDLWGAGCIMAEMWT 217 (318)
T ss_dssp CCTHHHHHHHHHHHHHHHH
T ss_pred CCcHHHcccCCceeeeHhh
Confidence 8999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=7.2e-15 Score=151.93 Aligned_cols=96 Identities=19% Similarity=0.170 Sum_probs=73.0
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCC----ccccccCceeecccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS----TKMSFAGTVAWMAPE 215 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~----~~~~~~GT~~ymAPE 215 (600)
+++.....++..++. .|+|. .+||||||||+||||+.++.+||+|||+|+...... .....+||+.|+|||
T Consensus 106 l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 106 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHH
Confidence 444443344444444 56775 379999999999999999999999999998654322 133577999999999
Q ss_pred cccc-cccCccccccccccccccccc
Q psy16430 216 VIRN-EQCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 216 ~i~~-~~~s~~~Dvy~~~~~~~p~sl 240 (600)
++.. ..++.++|+||+|++++.+-.
T Consensus 183 ~l~~~~~~~~~~DiwSlG~il~eml~ 208 (345)
T d1pmea_ 183 IMLNSKGYTKSIDIWSVGCILAEMLS 208 (345)
T ss_dssp GTTTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred HhhcCCCCCchhhhhccCceehHHhh
Confidence 9855 457889999999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.40 E-value=1.1e-15 Score=153.59 Aligned_cols=97 Identities=21% Similarity=0.161 Sum_probs=71.9
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeecccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVI 217 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i 217 (600)
.++......|+..++.+ |+|. .+||||||||+|||++.++.+|++|||+|........ .....||+.|+|||.+
T Consensus 96 ~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~ 172 (286)
T d1ob3a_ 96 GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172 (286)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHH
T ss_pred CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHH
Confidence 35555555566555564 5664 4699999999999999999999999999987644332 3456799999999998
Q ss_pred ccc-ccCccccccccccccccccc
Q psy16430 218 RNE-QCSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 218 ~~~-~~s~~~Dvy~~~~~~~p~sl 240 (600)
... .++.++|+||+|++++..-.
T Consensus 173 ~~~~~~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 173 MGSKKYSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp TTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCcceeehhcCcHHHHHHH
Confidence 654 56899999999999987643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.39 E-value=1.1e-14 Score=149.26 Aligned_cols=87 Identities=9% Similarity=0.076 Sum_probs=70.7
Q ss_pred eeccccc--hhhhccCCCCeEEEeccCCCeeeccCC-ceeEeecccccccCCCCccccccCceeeccccccccc-ccCcc
Q psy16430 150 LELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKE-EAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNE-QCSDK 225 (600)
Q Consensus 150 i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~-~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~-~~s~~ 225 (600)
++..++. .|+|. .+||||||||+|||++.++ .+|++|||+|+...........+||+.|+|||.+.+. .++.+
T Consensus 134 i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 210 (328)
T d3bqca1 134 YMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 210 (328)
T ss_dssp HHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTH
T ss_pred HHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcc
Confidence 5555555 45664 4699999999999999765 6999999999987666556677899999999998765 47999
Q ss_pred cccccccccccccc
Q psy16430 226 IDIWYKNRLCFPTS 239 (600)
Q Consensus 226 ~Dvy~~~~~~~p~s 239 (600)
+|+||+|++++..-
T Consensus 211 ~DiwslG~~l~e~~ 224 (328)
T d3bqca1 211 LDMWSLGCMLASMI 224 (328)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred cchhhhhhhhHHhc
Confidence 99999999988653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.6e-14 Score=149.08 Aligned_cols=94 Identities=21% Similarity=0.170 Sum_probs=74.6
Q ss_pred cccCCccceeeccccch--hhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccccccc
Q psy16430 141 RLSIPPQYQLELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIR 218 (600)
Q Consensus 141 ~l~~~~r~~i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~ 218 (600)
.++......++..++.+ |+|. .+||||||||+|||++.++.+|++|||+|+..... .+...||+.|+|||++.
T Consensus 117 ~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~ 191 (346)
T d1cm8a_ 117 KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVIL 191 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHH
T ss_pred cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCCc--cccccccccccCHHHHc
Confidence 35555555555555554 5664 47999999999999999999999999999876443 34578999999999987
Q ss_pred cc-ccCcccccccccccccccc
Q psy16430 219 NE-QCSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 219 ~~-~~s~~~Dvy~~~~~~~p~s 239 (600)
+. .++.++|+||+|++++..-
T Consensus 192 ~~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 192 NWMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp TTTCCCTTHHHHHHHHHHHHHH
T ss_pred CCCCCCccchhhcchHHHHHHH
Confidence 64 5689999999999998653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=3.3e-14 Score=145.70 Aligned_cols=144 Identities=14% Similarity=0.129 Sum_probs=90.4
Q ss_pred hhhhhccccccccccccccccCChhhhhhhhcccccccccccccccccccccccccCCccceeeccc--cchhhhccCCC
Q psy16430 88 WTRLTKLSVCWRPFCSFVDKFSSPEFKTNIQERSEVKSATHYQVDLTGMAEQVRLSIPPQYQLELIG--GPYWFLAGCTT 165 (600)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~r~~i~~~~--a~~~~~~~~~~ 165 (600)
..-+.||..| .--+..+++|+.+++-.+++|.....+....... ...+.-.....++... |..|+|. .
T Consensus 79 ~~il~~l~h~-pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~------~~~~~e~~~~~~~~Qi~~al~~lH~---~ 148 (322)
T d1vzoa_ 79 RQVLEHIRQS-PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ------RERFTEHEVQIYVGEIVLALEHLHK---L 148 (322)
T ss_dssp HHHHHHHHTC-TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred HHHHHhccCC-CeEEEeeeeeccCCceeeeeecccccHHHHHHHh------cccccHHHHHHHHHHHHHHHHHhhc---C
Confidence 3445555443 2245556777777776777773332222221101 0011111111122233 3345554 4
Q ss_pred CeEEEeccCCCeeeccCCceeEeecccccccCCCC--ccccccCceeeccccccccc--ccCcccccccccccccccccc
Q psy16430 166 PDALAESIGLGVLIGSKEEAKISDFGTCREWNNKS--TKMSFAGTVAWMAPEVIRNE--QCSDKIDIWYKNRLCFPTSLM 241 (600)
Q Consensus 166 ~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~--~~~~~~GT~~ymAPE~i~~~--~~s~~~Dvy~~~~~~~p~sl~ 241 (600)
+||||||||+||||+.+|.+||+|||+|+.+.... ...+..||+.|+|||.+... .++.++|+||+|++++..-.+
T Consensus 149 ~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG 228 (322)
T d1vzoa_ 149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228 (322)
T ss_dssp TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence 69999999999999999999999999998764332 23457899999999998754 467899999999999976443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.3e-13 Score=138.27 Aligned_cols=88 Identities=16% Similarity=0.176 Sum_probs=69.7
Q ss_pred eeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCc-cccccCceeecccccccccc-cCc
Q psy16430 149 QLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKST-KMSFAGTVAWMAPEVIRNEQ-CSD 224 (600)
Q Consensus 149 ~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~-~~~~~GT~~ymAPE~i~~~~-~s~ 224 (600)
.++...+. +|+|. .+||||||||+|||++.++.+|++|||.|+....... .....+++.|+|||.+.... ++.
T Consensus 105 ~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 181 (292)
T d1unla_ 105 SFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181 (292)
T ss_dssp HHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred HHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCc
Confidence 34444444 56665 4799999999999999999999999999997654433 33456788999999987665 689
Q ss_pred ccccccccccccccc
Q psy16430 225 KIDIWYKNRLCFPTS 239 (600)
Q Consensus 225 ~~Dvy~~~~~~~p~s 239 (600)
++|+||+|++++..-
T Consensus 182 ~~DiwSlG~il~ell 196 (292)
T d1unla_ 182 SIDMWSAGCIFAELA 196 (292)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hhhccccchHHHHHh
Confidence 999999999998763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=1.4e-13 Score=142.66 Aligned_cols=88 Identities=19% Similarity=0.129 Sum_probs=62.8
Q ss_pred eeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccccccCcccc
Q psy16430 150 LELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQCSDKID 227 (600)
Q Consensus 150 i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~~s~~~D 227 (600)
++..++. .|+|. .+|+||||||.|||++.++.+|++|||+++...........+||+.|+|||++.+..++.++|
T Consensus 124 ~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~D 200 (355)
T d2b1pa1 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200 (355)
T ss_dssp HHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHH
T ss_pred HHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcc
Confidence 4444444 45665 469999999999999999999999999998776655556678999999999999999999999
Q ss_pred ccccccccccccc
Q psy16430 228 IWYKNRLCFPTSL 240 (600)
Q Consensus 228 vy~~~~~~~p~sl 240 (600)
+||+|++.+..-.
T Consensus 201 iwSlG~~l~ell~ 213 (355)
T d2b1pa1 201 IWSVGCIMGEMVR 213 (355)
T ss_dssp HHHHHHHHHHHHH
T ss_pred cccccchHHHHhh
Confidence 9999999886543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.24 E-value=1.4e-13 Score=142.16 Aligned_cols=86 Identities=17% Similarity=0.144 Sum_probs=69.6
Q ss_pred eeccccch--hhhccCCCCeEEEeccCCCeeeccCCc------eeEeecccccccCCCCccccccCceeecccccccccc
Q psy16430 150 LELIGGPY--WFLAGCTTPDALAESIGLGVLIGSKEE------AKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRNEQ 221 (600)
Q Consensus 150 i~~~~a~~--~~~~~~~~~iiHrdlk~~NILLd~~~~------~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~~~ 221 (600)
+...++.+ |+|+ ..+||||||||+||||+.++. +|++|||.|+.... .....+||+.|+|||++....
T Consensus 130 i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~ 205 (362)
T d1q8ya_ 130 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP 205 (362)
T ss_dssp HHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccC
Confidence 45555554 5665 357999999999999998764 89999999986533 234578999999999999999
Q ss_pred cCcccccccccccccccc
Q psy16430 222 CSDKIDIWYKNRLCFPTS 239 (600)
Q Consensus 222 ~s~~~Dvy~~~~~~~p~s 239 (600)
++.++|+||+|++++..-
T Consensus 206 ~~~~~DiwSlG~il~el~ 223 (362)
T d1q8ya_ 206 WGCGADIWSTACLIFELI 223 (362)
T ss_dssp CCTHHHHHHHHHHHHHHH
T ss_pred CCccccccchHHHHHHHH
Confidence 999999999999987653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=1.4e-13 Score=141.82 Aligned_cols=94 Identities=18% Similarity=0.151 Sum_probs=67.9
Q ss_pred ccCCccceeeccccc--hhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeecccccccc
Q psy16430 142 LSIPPQYQLELIGGP--YWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAPEVIRN 219 (600)
Q Consensus 142 l~~~~r~~i~~~~a~--~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAPE~i~~ 219 (600)
++......++..++. .|+|. .+||||||||+|||++.+|.+|++|||+|..... ...+..||+.|+|||.+.+
T Consensus 118 l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 118 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTT
T ss_pred ccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc--ccccccccccccCchhhcC
Confidence 333333334555555 45664 4699999999999999999999999999975432 2345789999999998766
Q ss_pred cc-cCccccccccccccccccc
Q psy16430 220 EQ-CSDKIDIWYKNRLCFPTSL 240 (600)
Q Consensus 220 ~~-~s~~~Dvy~~~~~~~p~sl 240 (600)
.. ++.++|+||+|++++..-.
T Consensus 193 ~~~~~~~~DiwSlGv~l~~ll~ 214 (348)
T d2gfsa1 193 WMHYNQTVDIWSVGCIMAELLT 214 (348)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHH
T ss_pred CccCCcccchhhhhHHHHHHHh
Confidence 54 6889999999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=1.6e-06 Score=83.66 Aligned_cols=132 Identities=14% Similarity=0.064 Sum_probs=92.4
Q ss_pred cccccccccCCCCcceEEEeEeeceEEEeeeecc-------chHHHHHHHHhcC-CCCcccccceeecCCceeEEEeeec
Q psy16430 261 ESISDLQWLGSGAQGAVFSGKLRSEIVAVKKVRE-------QKETDIRHLRKLN-HPNIVKFKGVCTQAPCYCIVMEYCA 332 (600)
Q Consensus 261 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~-------~~~~Ei~~L~~L~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 332 (600)
+.|+..+..+.|+.+.||+....+..+.+|+... ....|...++.+. +--+.+++.+..+++..++||++++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 4556565555556678999988888888998753 2467888888774 3335677888888888999999999
Q ss_pred cccchhhccCCCCCCHHHHHHHHHHHHHHHHHhHhC--------------------------------------------
Q psy16430 333 YGPLYNLLKDGEEVPPQRLYNWARQIAAGMNYLHSK-------------------------------------------- 368 (600)
Q Consensus 333 ggsL~~~l~~~~~l~~~~i~~i~~qIl~aL~~LH~~-------------------------------------------- 368 (600)
|.++.+..... .....++.++...+..||+.
T Consensus 94 G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T d1j7la_ 94 GVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp SEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred ccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence 88776543221 11223344455555555531
Q ss_pred ---------------CccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 369 ---------------QIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 369 ---------------gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 25899999999999877666799999765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.25 E-value=2.4e-08 Score=93.06 Aligned_cols=65 Identities=14% Similarity=0.066 Sum_probs=43.3
Q ss_pred cchhhhccCCCCeEEEeccCCCeeeccCCceeEeecccccccCCCCccccccCceeeccc------ccccccccCccccc
Q psy16430 155 GPYWFLAGCTTPDALAESIGLGVLIGSKEEAKISDFGTCREWNNKSTKMSFAGTVAWMAP------EVIRNEQCSDKIDI 228 (600)
Q Consensus 155 a~~~~~~~~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr~~~~~~~~~~~~GT~~ymAP------E~i~~~~~s~~~Dv 228 (600)
|..|+|. .+|+||||||+|||++.++ ++++|||+|+........ .|+.. +.+ ...|+..+|+
T Consensus 115 ~l~~lH~---~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~ 182 (191)
T d1zara2 115 EVAKFYH---RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDI 182 (191)
T ss_dssp HHHHHHH---TTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCH
T ss_pred HHHHHhh---CCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccH
Confidence 3356775 4699999999999999765 789999999865432211 11111 111 2567788888
Q ss_pred ccc
Q psy16430 229 WYK 231 (600)
Q Consensus 229 y~~ 231 (600)
||-
T Consensus 183 ~s~ 185 (191)
T d1zara2 183 NSA 185 (191)
T ss_dssp HHH
T ss_pred HHH
Confidence 873
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=7e-05 Score=71.33 Aligned_cols=121 Identities=19% Similarity=0.202 Sum_probs=79.6
Q ss_pred cCCCCc-ceEEEeEeec-eEEEeeeecc----chHHHHHHHHhcCC--CCcccccceeecCCceeEEEeeeccccchhhc
Q psy16430 269 LGSGAQ-GAVFSGKLRS-EIVAVKKVRE----QKETDIRHLRKLNH--PNIVKFKGVCTQAPCYCIVMEYCAYGPLYNLL 340 (600)
Q Consensus 269 LG~G~f-G~Vy~a~~~~-~~vAvK~~~~----~~~~Ei~~L~~L~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l 340 (600)
+..|.. +.||+....+ ..+++|.... ....|...++.+.. -.+.+++.+..+++..++||++++|.++.+..
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~ 97 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH 97 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc
Confidence 444543 6789988754 5678887753 35678888887743 33566787778888899999999987764421
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhH---------------------------------------------------hC-
Q psy16430 341 KDGEEVPPQRLYNWARQIAAGMNYLH---------------------------------------------------SK- 368 (600)
Q Consensus 341 ~~~~~l~~~~i~~i~~qIl~aL~~LH---------------------------------------------------~~- 368 (600)
.+... .+.++...|.-|| ..
T Consensus 98 -----~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 98 -----LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp -----CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred -----ccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 11111 1122222222333 21
Q ss_pred ------CccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 369 ------QIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 369 ------gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 26999999999999877667899999754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00019 Score=73.65 Aligned_cols=68 Identities=16% Similarity=0.086 Sum_probs=44.4
Q ss_pred ccccCCCCcceEEEeEee--ceEEEeeeecc--------------chHHHHHHHHhcC-C--CCcccccceeecCCceeE
Q psy16430 266 LQWLGSGAQGAVFSGKLR--SEIVAVKKVRE--------------QKETDIRHLRKLN-H--PNIVKFKGVCTQAPCYCI 326 (600)
Q Consensus 266 ~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~--------------~~~~Ei~~L~~L~-H--pnIv~l~~~~~~~~~~~l 326 (600)
.+.||.|....||++... ++.++||.-.. +...|...|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 345899999999999754 56788885421 1245777777662 2 345555544 4455679
Q ss_pred EEeeecccc
Q psy16430 327 VMEYCAYGP 335 (600)
Q Consensus 327 V~Ey~~ggs 335 (600)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.90 E-value=0.011 Score=58.17 Aligned_cols=62 Identities=15% Similarity=0.130 Sum_probs=39.2
Q ss_pred ceEEEeEee-ceEEEeeeeccc------hHHHHHHHHhcCCCCc-----cccc--ceeecCCceeEEEeeeccccc
Q psy16430 275 GAVFSGKLR-SEIVAVKKVREQ------KETDIRHLRKLNHPNI-----VKFK--GVCTQAPCYCIVMEYCAYGPL 336 (600)
Q Consensus 275 G~Vy~a~~~-~~~vAvK~~~~~------~~~Ei~~L~~L~HpnI-----v~l~--~~~~~~~~~~lV~Ey~~ggsL 336 (600)
..||+++.. |..|++|+.+.. ...|...+..|....| +..- ..+...+..+.|+++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 579999864 678999998642 3567777777632222 2221 123445667889999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.88 E-value=0.008 Score=58.61 Aligned_cols=136 Identities=13% Similarity=0.069 Sum_probs=72.9
Q ss_pred ccccccccCCCCcceEEEeEeeceEEEeeeeccc-----hHHHHHHHHhcCCC-----Cccccc-c--eeecCCceeEEE
Q psy16430 262 SISDLQWLGSGAQGAVFSGKLRSEIVAVKKVREQ-----KETDIRHLRKLNHP-----NIVKFK-G--VCTQAPCYCIVM 328 (600)
Q Consensus 262 ~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~-----~~~Ei~~L~~L~Hp-----nIv~l~-~--~~~~~~~~~lV~ 328 (600)
.+.-++.|..|.-.+.|+.+..+..+++|++... ...|+.++..|... ..+... | +.........++
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence 3344456778888899999888778999998542 24566677766322 222211 1 112233455666
Q ss_pred eeeccccchhhc------------------cC-C----CCCCH------------------HHHHHHHHHHHHHHHHhHh
Q psy16430 329 EYCAYGPLYNLL------------------KD-G----EEVPP------------------QRLYNWARQIAAGMNYLHS 367 (600)
Q Consensus 329 Ey~~ggsL~~~l------------------~~-~----~~l~~------------------~~i~~i~~qIl~aL~~LH~ 367 (600)
.+..|......- .. . ..... ......+..+...+.-.+.
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 666654332110 00 0 00000 0111122222222222222
Q ss_pred ----CCccccCCCCCCcccCCCCCceeeccCccc
Q psy16430 368 ----KQIIHRDLKSPNVLIGSKEEAKISDFGTCR 397 (600)
Q Consensus 368 ----~gIvHrDIKp~NILl~~~~~vkL~DFGla~ 397 (600)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.85 E-value=0.0091 Score=60.49 Aligned_cols=74 Identities=18% Similarity=0.255 Sum_probs=48.6
Q ss_pred cccccccccccCCCCcceEEEeEeec---------eEEEeeeecc-----chHHHHHHHHhcCCCCc-ccccceeecCCc
Q psy16430 259 PFESISDLQWLGSGAQGAVFSGKLRS---------EIVAVKKVRE-----QKETDIRHLRKLNHPNI-VKFKGVCTQAPC 323 (600)
Q Consensus 259 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~-----~~~~Ei~~L~~L~HpnI-v~l~~~~~~~~~ 323 (600)
+.+++++ +.|+.|-.-.+|++...+ ..|.+++.-. ...+|..+++.+.-.++ .++++++.+
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 4455554 568888888999987542 4566665431 23578888888753344 467777643
Q ss_pred eeEEEeeeccccch
Q psy16430 324 YCIVMEYCAYGPLY 337 (600)
Q Consensus 324 ~~lV~Ey~~ggsL~ 337 (600)
.+||||++|.++.
T Consensus 117 -g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 -GRLEEYIPSRPLS 129 (395)
T ss_dssp -EEEECCCCEEECC
T ss_pred -ceEEEEeccccCC
Confidence 5899999886553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=81.16 E-value=0.17 Score=48.62 Aligned_cols=32 Identities=16% Similarity=0.001 Sum_probs=28.6
Q ss_pred CCCCeEEEeccCCCeeeccCCceeEeeccccc
Q psy16430 163 CTTPDALAESIGLGVLIGSKEEAKISDFGTCR 194 (600)
Q Consensus 163 ~~~~iiHrdlk~~NILLd~~~~~Kv~DFGlsr 194 (600)
...+|||.|+.+.||+++.+...-|-||+.|.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 45579999999999999999888899999886
|